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PL-01
MELD-BASED ALLOCATION SYSTEM
FOR LIVER TRANSPLANTATION IN
ARGENTINA: DOES IT WORK OUTSIDE
US?
L. McCormack1, A. Gadano2, J. Lendoire3,
O. Imventarza4, O. Andriani5, O. Gil6, L. Toselli7,
L. Bisigniano8 and E. de Santiban˜es2
1Hospital Aleman of Buenos Aires; 2Hospital Italiano of
Buenos Aires; 3Sanatorio Trinidad Mitre; 4Hospital
Argerich; 5Hospital Austral University; 6Sanatorio
Allende of Cordoba; 7CRAI Norte; 8INCUCAI
Background: In July 2005, Argentina was the ﬁrst
country that followed US in adopting the MELD-based
allocation system for patients requiring liver transplan-
tation. So far, this policy is not internationally validated.
Aim: To analyze the impact of the adoption of MELD-
based allocation system for elective patients on the liver
waiting list.
Methods: Between July 2005 and April 2009, 1773 adult
patients were included in the waiting list: 150 emer-
gencies and 1623 electives. Elective patients were cate-
gorized under the MELD system. Using a prospective
collected national database, we analyzed this cohort of
patients regarding mortality and probability to be
transplanted.
Results: The median waiting time increased inversely
with the MELD score and the probability to receive a LT
positively correlated with patient MELD score. With
scores ‡ 18 the probability to receive a liver remained
over 50%. However, the largest MELD category with
< 10 points (n: 433) had the lower probability to be
transplanted (3%) among all categories. In contrast,
patients with T2 hepatocellular carcinoma (22 points) are
excessively beneﬁted with the highest probability to be
transplant (84.2%), a low dropout rate (7.2%) and the
lowest mortality rate (5.4%). The waiting list mortality
increased compared with the pre-MELD period, (14.8%
vs. 10%, P < 0.01). Patients with < 18 points had
higher risk of dying than to be transplanted (16.2% vs.
10%; P < 0.01). The group with < 10 MELD points
had more than 4 fold probability to die on the waiting list
than to be transplanted (14.3% vs. 3%; P < 0.0001).
Conclusions: After MELD implementation, the waiting
list mortality increased and most patients are dying with
low MELD scores. Clearly, those candidates with early
HCC are excessively beneﬁted. A comprehensive revision
of the MELD system must be performed including cul-
tural and socio-economical variables affecting each
country individually.
PL-02
THE PREDICTIVE VALUE OF VEGF
MRNA AND TNF ALPHA MRNA
EXPRESSION IN PATIENTS WITH
CIRRHOTIC LIVER DISEASE AND
HEPATOCELLULAR CARCINOMA (HCC)
O. Hammam1, E. Abel Raoof2, S. Abeya3 and
S. A. Kishta4
1Pathology Department, Theodor Bilharz Research
Institute, Egypt; 2Hepatology & Gastroenterology
Department, Theodor Bilharz Research Institute, Egypt;
3Hematology Department, Theodor Bilharz Research
Institute, Egypt; 4Surgery Department, Theodor Bilharz
Research Institute, Egypt
Background: In HCC Management, no difference was
observed in terms of mean time to recurrence considering
Liver Resection (LR) or Transplantation (LT). The
5-year disease-free survival is insigniﬁcantly higher in
patients listed for LT than LR patients.
Aims: To study whether vascular endothelial growth
factor messenger RNA (VEGF mRNA) in the HCC
tissues on top of cirrhosis obtained from specimens after
curative resection has a prognostic value.
Methods: One hundred and sixty patients evaluated
clinically. The preoperative laboratory, radiological and
staging to patients was done. Using in situ hybridization
technique, VEGF mRNA and TNF alpha mRNA were
determined in liver tissues of, 10 controls, 50 with HCC,
50 with HCV without cirrhosis and 50 of HCV with
cirrhosis.
Results: Among the isoforms of VEGF mRNA,
VEGF165 and VEGF121 were expressed. By multivariate
analysis, a higher level of VEGF165 in HCC tissue corre-
lated with signiﬁcant risk of HCC recurrence (P = 0.038)
and signiﬁcantly with recurrence-related mortality
(P = 0.045); while VEGF121 did not. Other signiﬁcant
predictors of HCC recurrence included cellular dediffer-
entiation (P = 0.033), an absent or incomplete capsule
(P = 0.020), vascular permeation (P = 0.018), and
daughter nodules (P = 0.006). The other signiﬁcant
variables of recurrence related mortality consisted of
vascular permeation (P = 0.045), and cellular dediffer-
entiation (P = 0.053). Level of VEGF mRNA in HCC
tissues, was insigniﬁcantly correlate with tumor size, cel-
lular differentiation, capsule, daughter nodules, vascular
permeation, necrosis and hemorrhage of tumors.
Conclusion: The expression of VEGF mRNA, especially
isoform VEGF165, in HCC tissues, may play a signiﬁcant
and independent role in the prediction of postoperative
recurrence of HCC.
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PL-03
LIVER TRANSPLANTATION FOR HILAR
AND INTRAHEPATIC
CHOLANGIOCARCINOMA: THE
FRENCH EXPERIENCE OVER A
23-YEARS PERIOD
E. Boleslawski1, C. Chevallier1, D. Castaing2, B. Suc3,
J. Saric4, P. Wolf5, G. Mantion6, J. Belghiti7,
J. Gugenheim8, D. Cherqui9, Y-P. LE TREUT10,
L. Chiche11, K. Boudjema12, O. Farges7,
J-M. Re´Gimbeau13 and F-R. Pruvot1
1Hopital Huriez, CHRU de Lille; 2Hoˆpital Paul Brousse,
Villejuif; 3Hoˆpital de Rangueil CHU de Toulouse;
4Hoˆpital Saint-Andre´, CHU de Bordeaux; 5Hoˆpital
Hautepierre, CHRU de Strasbourg; 6Hoˆpital Jean-Min˜oz,
CHU de Besanc¸on; 7Hoˆpital Beaujon, Clichy; 8Hoˆpital de
l’Archet, CHU de Nice; 9Hoˆpital Henri-Mondor, Cre´teil;
10Hoˆpital de la Conception, CHU de Marseille; 11CHU
Coˆte de Nacre, Caen; 12Hoˆpital Pontchaillou, CHU de
Rennes; 13Hoˆpital Nord, CHU d’Amiens
Background: Hilar (HIL-CC) and intra-hepatic cho-
langiocarcinoma (IH-CC) are rare indications for liver
transplantation (LT), accounting for less than 1% of liver
transplants in the European Liver Transplant Registry.
Initial results were disappointing but recent north-
American series reported improving survivals in selected
patients.
Aim: To report a French multicentric review of LT for
HIL-CC and IH-CC over a 23-years period and to ana-
lyze short-term morbidity and mortality, time and pat-
terns of recurrence and long-term prognostic factors.
Methods: Clinical and histological data of liver trans-
plants performed between 1985 and 2008 for HIL-CC or
IH-CC were retrospectively recorded into a nationwide
multicentric database. Twelve French centers had trans-
planted 67 patients with HIL-CC and 26 patients with
IH-CC. They were 72 males and 25 females (M/F = 2.9)
aged 49.6 ± 9.6 years (18–70).
Results: Ninety days postoperative mortality was 14.1%
(HIL-CC: 12.5%; IH-CC: 19%; p = 0.3). Sixty percent
of patients developed recurrence within a mean time of
17 months (2–81). In 40% of cases, recurrence developed
only in the liver or hepatic pedicle (12.5%) or in the
peritoneum (27.5%). Actuarial overall and disease-free
patients survivals at 1, 3, 5 and 10 years were 75%, 38%,
29%, 24% and 63%, 29%, 23%, 20%. Thirteen patients
were alive without recurrence after 5 years. There was no
difference of survival between HIL-CC and IH-CC. Past
cholecystectomy, acute rejection and lymphatic emboli
were signiﬁcantly associated with lower survival.
Neoadjuvant radiochemotherapy and use of mycophe-
nolate mofetil in long-term immunosuppressant proto-
cols were signiﬁcantly associated with increased survival.
Conclusion: Despite high recurrence rates, liver trans-
plantation could achieve 10-years survival rate of 20%
and should be proposed in selected cases. Results seemed
to be improved by neoadjuvant radiochemotherapy and
adjustments in immunosuppressive protocols.
PL-04
LEARNERS NEEDS ASSESSMENT FOR
HEPATO-PANCREATO-BILIARY
FELLOWSHIP TRAINING: KNOWING
THE APPLICANT
A. Alseidi1, D. R. Jeyarajah2, P. D. Greig3 and
D. L. Klamen4
1Department of Surgery, United States Naval Hospital,
Okinawa, Japan; 2Department of Surgery, Methodist
Dallas Medical Center, Dallas, USA; 3Department of
Surgery, Toronto General Hospital, University of Toronto,
Toronto, Ontario, Canada; 4Department of Medical
Education, Southern Illinois University
Background: The last 5 years have brought about tan-
gible change in the training of surgeons. This is especially
true in advanced surgical training ﬁelds, including HPB
(Hepato-Pancreato-Biliary) surgery. Post-Residency
Fellowships in HPB Surgery are becoming formalized
with accreditation, case volume standards and a struc-
tured curriculum.
Objective: The objective of this study is to perform a
needs assessment of targeted learners (surgeons seeking
HPB Fellowship training).
Methods: After IRB approval, applicants to the 2010
HPB fellowship match were surveyed. Only applicants
with a complete HPB match application where included,
and all surveys where completed prior to applicants
knowing where they matched.
Results: The response rate was 55% (32/58). Responses
show a varied applicant pool, but with similar perceived
needs/deﬁciencies and similar goals. Applicants ranged
from current residents (37%) to surgeons with > 5 years
in practice (9%). The majority (> 60%) reported < 10
cases in any of heaptic, complex biliary, or pancreatic
surgery. Majority (> 80%) of applicants felt that HPB
fellowships should be two years in length. Applicant’s
response regarding ideal time allocation during the fel-
lowship was heavily weighed towards open surgery. The
majority (>70%) felt that formal exposure to hepatic
transplant is important. Applicant views on to what ex-
tent should Oncology (medical and radiation), endo-
scopy, interventional radiology, HPB pathology,
research and robotic surgery be part of the HPB fellow-
ship were attained.
Conclusion: Understanding the audience is a pillar of
adult education. This becomes especially important in the
setting of the changes within general surgical residencies
and with > 75% of graduates seeking further training.
Integral to the success of HPB fellowships is under-
standing those seeking a career in HPB Surgery and their
perceived skill gap. This study is the ﬁrst of its kind,
providing insight into the future HPB Fellows’ perceived
needs.
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PL-05
COMPARISON OF THE PROGNOSTIC
ACCURACY OF THE SIXTH AND
SEVENTH EDITIONS OF THE TNM
CLASSIFICATION FOR INTRAHEPATIC
CHOLANGIOCARCINOMA
D. Ribero, L. Capussotti, G. Nuzzo, M. Amisano,
M. Tomatis, A. Guglielmi, S. M. Giulini, L. Aldrighetti,
F. Calise, G. Gerunda and A. D. Pinna
Background: The 7th edition of the AJCC/UICC TNM
staging system introduces for the ﬁrst time a separate
staging structure for intrahepatic cholangiocarcinoma
(IHC), independent of hepatocellular carcinoma. The
main novelty is the combination of the previous T2 and
T3 cohorts into a unique new T2 group which is divided
in two subcategories.
Objective: To compare the accuracy of the 6th and the
new 7th edition of the AJCC/UICC staging system to
predict survival after liver resection for IHC.
Methods: Four hundred thirty four consecutive patients
who underwent hepatectomy with curative intent at 16
tertiary hepatobiliary centres (1990 to 2008) were iden-
tiﬁed. End points were overall (OS) and recurrence-free
survival (RFS). Survival by T cohorts and stage strata
was compared with the log-rank test.
Results: At the time of analysis 216 patients (49.7%)
were alive and 164 (37.8%) were recurrence-free after a
median follow-up of 37 months. Three- and 5-year OS
estimates were 47.1% and 32.8%, respectively; corre-
sponding RFS rates were 26.4% and 19.1%, respectively.
When comparison of survival distribution was made for
T cohorts and stage strata both the editions of the TNM
system were statistically signiﬁcant discriminators of OS
and RFS (P < 0.05). However, the survival curves of the
new T2a and T2b cohorts appear superimposed, ques-
tioning the need for such a separation. On the contrary,
the old T2 and T3 cohorts accurately stratify patients
into two distinct prognostic groups (P < 0.01). Stage I
and II of the new 7th TNM edition are signiﬁcantly
different while the old stage I and II were not. Similarly
to previously published data, only few patients (n = 4)
are allocated into the new stage III making any com-
parison meaningless.
Conclusions: The new 7th edition of the AJCC/UICC
staging system proved to be adequate although further
studies are need to conﬁrm its superiority compared to
the previous edition.
PL-06
CLINICAL FEATURES AND TREATMENT
OUTCOME OF CHOLEDOCHAL CYST IN
KOREA: A NATIONWIDE
MULTICENTER SURVEY
S. E. Lee1, J-Y. Jang1, S-W. Kim1 and Korean Pancreas
Surgery Club2
1Department of Surgery, Seoul National University
College of Medicine; 2Korean Pancreas Surgery Club
Background: Choledochal cyst is a relatively rare disease
in Western countries, while common among the eastern-
Asian. However, no larger scale data have been reported
as a form of nationwide survey in Japan as well as in
other countries.
Aim: The aim of this study is to investigate clinical fea-
ture and clinical outcome of choledochal cyst of adults
that pathologically conﬁrmed after surgical treatment in
Korea.
Methods: A nationwide multicenter study was performed
in which 13 university hospitals in Korea participated
from 1990 to 2008. A total 808 patients undergoing
surgery for choledochal cyst were enrolled. The clinico-
pathologic ﬁndings & long-term follow-up results were
analyzed after the consensus meeting of the Korean
Pancreas Surgery Club.
Results: Mean age of the patients was 42-years-old and
male to female ratio was 1:3.8. Abdominal pain was the
most common symptom (n = 605; 74.9%), and 100 pa-
tients (12.4%) were asymptomatic. Type I was most
common (n = 499; 68.2%) followed by type IVa
(n = 208; 28.4%), type IVb (n = 9; 1.2%), type II
(n = 7; 0.9%), type V (n = 5; 0.7%) and type III
(n = 4; 0.5%). APBDU was identiﬁed in 472 patients
(58.4%), with 293 C-P type (62.1%), 99 P-C type (21%),
and 80 complex type (16.9%). In 644 patients (79.7%)
choledochal cyst excision and choledochojejunostomy
was performed. Biliary tract malignancy was associated
in 86 patients (10.8%) which being 44 bile duct cancer
(51%), 37 GB cancer (43%), 3 periampullary cancer and
2 synchronous GB and bile duct cancer. Curative resec-
tion was performed in 70 patients (81.4%). Nineteen
patients (22.1%) recurred with a median survival of
38 months.
Conclusion: This study is the ﬁrst nation-wide survey on
choledochal cyst in adult and could be widely used as a
reference data for treatment of choledochal cyst.
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YIA-01
THE INTERLABORATORY VARIABILITY
OF LAB-MELD SCORES
M. Al-Saeedi1, T. Yassein1, A. Nickkholgh1, M. Zorn2,
U. Hinz1, M. W. Bu¨chler1, T. Ganten3 and P. Schemmer1
1Department of General and Transplantation Surgery,
Ruprecht-Karls-University, Heidelberg, Germany;
2Central Laboratory, Ruprecht-Karls-University,
Heidelberg, Germany; 3Department of Internal Medicine,
Ruprecht-Karls-University, Heidelberg Germany
Background: MELD-based organ allocation is estab-
lished by Eurotransplant since December 16th, 2006. This
concept prioritizes organ distribution to the sickest
patients. Since laboratory values for MELD score cal-
culation can be measured with various methods this
study was designed to asses the interlaboratory variabil-
ity of calculated labMELD scores.
Methods: Bilirubin, creatinine and INR of 10 patients
with liver disease were measured in different laboratories
(n = 6). The labMELD score was calculated (www.u-
nos.org/resources) and compared between laboratories.
Results: A substantial and clinically relevant difference
of the calculated labMELD scores was observed between
laboratories. The maximal difference accounted in the
labMELD score was 5 points. The highest difference of
measured bilirubin levels of the same patient was 4.6 mg/
dL which is equivalent of 4 labMELD points. The largest
difference in INR was 1.24 which is equivalent to 5 lab-
MELD points. The biggest difference in creatinine levels
was 0.9 mg/dL which did not have an impact on the
labMELD calculation. The pairwise comparison of the
laboratory values has shown a signiﬁcant difference
(P < 0.05).
Conclusion: There is a substantial and clinically relevant
variation between laboratories by the assessment of the
MELD scores. This variation is especially pronounced in
the INR.
YIA-02
HYPOXIA DEPLETES NAD+ WHICH
MAY PROMOTE DEVELOPMENT OF
COLORECTAL LIVER METASTASES
A. Young1,2, M. Hull2 and G. Toogood1
1St James’s University Hospital, Leeds; 2Leeds Institute of
Molecular Medicine, Leeds University
Background: Blocking Prostaglandin (PG) E2 produc-
tion using COX inhibitors has proven beneﬁt in treating
cancer patients. NAD± dependent-15-PG dehy-
drogenase (15-PGDH) represents another level of control
over PGE2 levels as it controls the rate-limiting step in
PGE2 breakdown. The hypoxic tumour micro-environ-
ment may affect PGE2 levels, promoting cancer cell in-
vasion and metastasis [epithelial-mesenchymal transition
(EMT)]. We investigated control of PGE2 levels in hy-
poxia with relation to EMT.
Methods: Paired central (relatively more hypoxic) and
peripheral samples from 20 CRC liver metastases
(CRCLM) were collected to assess PGE2, NAD+ and
15-PGDH expression. Similar studies were performed on
a model of EMT in LIM1863 CRC cells.
Results: PGE2 levels are higher in the centre of CRCLM
(95%CI: 1%-52%; p = 0.045) by a mean of 26% despite
increased 15-PGDH protein levels (immunoreactivity:
p = 0.036 and (3H)-PGE2 catabolism: p = 0.016).
There was no difference in COX-2 immunoreactivity
(p = 0.792). NAD+ levels are decreased by 59% in the
centre vs. periphery of CRCLM (p = 0.015). In vitro
experiments mirrored these ﬁndings and in addition
showed 15-PGDH enzyme activity had a dose-dependent
relationship with NAD+ levels (P < 0.001). PGE2
promotes EMT in LIM1863 cells (p = 0.008). Further-
more in CRCLM the relationship between 15-PGDH
levels and an EMT marker changes with tumour location
which may be due to differing enzyme function depend-
ing on oxygen related NAD+ levels.
Conclusion: We present a new mechanism whereby the
hypoxic tumour microenvironment increases PGE2 levels
through depletion of NAD+, preventing 15-PGDH
function. Modulation of factors controlling pro-tumori-
genic PGE2 represents a novel therapeutic strategy
against processes like EMT in CRC liver metastases.
YIA-03
LONG TERM TREATMENT RESULTS
AND PROGNOSTIC FACTORS OF HILAR
CHOLANGIOCARCINOMA
C-S. Lim, J-Y. Jang, S. E. Lee, M. J. Kang and
S-W. Kim
Seoul National University College of Medicine
Background: Surgical treatment of hilar cholangiocarci-
noma is difﬁcult and log-tem outcome is still unsatis-
factory. We aimed to analyze the outcome of hilar
cholangiocarcinoma according to the type of surgery,
and to inspect prognostic factors.
Materials and methods: Between 1981 and 2008, 710
patients with hilar cholangiocarcinoma were treated at
our institute. There were 490 male (69.0%) and 220 fe-
male (31.0%). Resection with curative intent was per-
formed in 225 patients (31.8%). Type of resection were
hepatobiliary resection (HBR, n = 151), bile duct
resection (BDR, n = 56), pancreatoduodenectomy (PD,
n = 9), and hepatopancreatoduodenectomy (HPD,
n = 9).
Results: R0 resection was done in 142 patients (63.1%);
98 HBR (64.9%), 33 BDR (58.9%), 6 PD (66.7%), 5
HPD (55.6%). Overall 5 year survival rate was 21.0%;
19.0% in HBR, 29.1% in BDR, 13.3% in PD, and 0% in
HPD. Recurrence of tumor occurred in 131 patients
(58.2%). Recurrence site was loco-regional in 53 patients
(40.5%) and remote site in 94 (71.8%). In multivariate
analysis, lymph node metastasis (P = 0.013) and histo-
logic grade (P = 0.014) were signiﬁcant prognostic fac-
tors. Eighty-three patients (36.9%) had positive resection
margin. Forty-four patients (53.0%) of them recurred;
loco-regional recurrence in 18 patients (21.7%), and re-
mote site in 35 (42.2%). In patients with positive resec-
tion margin, concurrent chemoradiation (P = 0.47) and
chemotherapy (P = 0.001) were signiﬁcant prognostic
factors.
Conclusion: Radical resection is mandatory for
long-term survival of hilar cholangiocarcinoma. Poor
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long-term outcome can be anticipated in patients with
lymph node metastasis or poorly differentiated carci-
noma. Adjuvant chemoradiation therapy can improve
survival in patients with positive resection margin.
YIA-04
CT-BASED CONSENSUS GUIDELINES
ARE SUPERIOR TO ENDOSCOPIC
ULTRASOUND (EUS) IN PREOPERATIVE
EVALUATION OF INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASM
(IPMN)
M. Cone, J. Rea, B. Diggs and B. Sheppard
Oregon Health & Science University, Portland, Oregon
Background: Published guidelines for resection of IPMN
include tumor, pancreatic duct, and patient characteris-
tics. While several imaging modalities are commonly
performed during work-up of IPMN, these guidelines do
not suggest the use of any one imaging technique.
Objective: Evaluate tumor and duct measurements by
computed tomography (CT) and EUS and their ability to
predict high grade dysplasia (HGD) and cancer within
pancreatic IPMN.
Methods: Patients with IPMN between 2001 and 2009
who had undergone pre-operative CT and EUS were
selected. Data were gathered retrospectively from elec-
tronic medical records and analyzed.
Results: Fifty-two patients were included. Overall 33%
(17/52) had HGD or cancer. On ﬁne needle aspirate
(FNA), neither carcinoembrionic antigen (CEA) >200
nor cytologic analysis, correlated with malignancy. Only
2/10 patients with CEA > 200 had HGD or cancer
(P = 0.768) and cytology was negative in 29% (5/17) of
patients with HGD or cancer. In multivariate analysis,
male gender (P = 0.045) and diameter on CT scan
(P = 0.050) were the only variables that predicted HGD
or cancer. Furthermore, 72% (34/47) of the lesions were
smaller when measured by CT than on EUS (P = 0.020).
A lesion diameter of ‡ 2.5 cm was associated with car-
cinoma on CT scan (odds ratio 3.962). All patients with
HGD or cancer had a lesion diameter ‡ 2.5 cm and/or
duct diameter ‡ 1 by CT scan.
Conclusion: EUS +/) FNA may be unnecessary during
pre-operative evaluation of IPMN. Using CT criteria of
lesion ‡ 2.5 cm and/or pancreatic duct ‡ 1 cm, all tumors
in this cohort with HGD or cancer would be resected.
YIA-05
PANCREATECTOMY RISK
CALCULATOR: AN
ACS-NSQIP RESOURCE
P. Y. Parikh1, M. Shiloach2, M. E. Cohen2,
K. Y. Bilimoria3, C. Y. Ko4, B. L. Hall5 and
H. A. Pitt1
1Indiana University School of Medicine; 2American
College of Surgeons; 3Northwestern University;
4University of California Los Angeles; 5Washington
University
Background: The morbidity of pancreatoduodenectomy
remains high and the mortality may be doubled or tripled
in high-risk patients. However, a method to predict
postoperative adverse outcomes based on readily avail-
able clinical data has not been available.
Objective: To create a ‘‘Pancreatectomy Risk Calcula-
tor’’ using the American College of Surgeons-National
Surgical Quality Improvement Program (ACS-NSQIP)
database.
Methods: The 2005-2008 ACS-NSQIP data on 7,571
patients undergoing proximal (n = 4,621), distal
(n = 2,552), total pancreatectomy (n = 177) or enucle-
ation (n = 221) were analyzed. Preoperative variables
(n = 31) were assessed for prediction of postoperative
mortality, serious morbidity, and overall morbidity using
a logistic regression model. Statistically signiﬁcant vari-
ables were ranked and weighted to create a risk model for
all three outcomes.
Results: Twenty preoperative variables were statistically
signiﬁcant predictors of postoperative mortality (2.5%),
serious morbidity (21%), or overall morbidity (32%).
Ten of 20 signiﬁcant preoperative variables were em-
ployed to produce a mortality and morbidity risk model
(see Table).
Table. Pancreatectomy Risk Calculator
Variable
30-Day
Mortality*
Serious
Morbidity*
Overall
Morbidity*
ASA Class 3 2.33 1.18 1.19
Functional Status 3.27 1.73 1.75
Preop Sepsis 2.26 2.26 2.10
Surgery Extent 1.62 1.29 1.36
Age > 74 2.28 1.30 1.26
Dyspnea § 1.72 1.38 1.36
BMI > 40 2.32 1.83 1.60
Cardiac SurgeryD 1.18* 1.20 1.36
Gender – Male 1.16* 1.22 1.13
Bleeding Disorder 1.15* 1.43 1.68
*Odds Ratios all P < 0.05 except three forced variables
indicated
Proximal vs. distal pancreatectomy
§With moderate exertion D Prior major procedure
Conclusions: The ACS-NSQIP ‘‘Pancreatectomy Risk
Calculator’’ employs ten easily assessable clinical
parameters to assist patients and surgeons in making an
informed decision regarding the advisability of under-
going pancreatic resection. This model will become
available as on online ACS-NSQIP resource.
YIA-06
UNRESECTABLE PANCREATIC
ADENOCARCINOMA: DO WE KNOW
WHO SURVIVES?
M. Jamal1, S. Doi2, M. Hasanain, P. Chaudhury,
P. Metrakos and J. Barkun1
1Department of Surgery, McGill University Health
Center, Montreal, QC, Canada; 2School of Population
Health, University of Queensland, Brisbane, Australia
Background: The choice of endoscopic versus surgical
methods of palliation in unresectable pancreatic adeno-
carcinoma (UPA) is controversial and depends on their
predicted survival. This study attempts to deﬁne clinical
predictors thereof.
Method: We conducted a retrospective study of 94 con-
secutive patients diagnosed with (UPA) from 2001 to
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2006. We obtained complete follow up until death in all
patients using a populational database. (i) Bedside pre-
dictors of survival were used to devise a symptom score
through a forward stepwise Cox proportional hazards
model based on four weighted criteria: (Weight loss
greater than 10%, pain, jaundice, and smoking). (ii) The
clinical score was subsequently validated in a distinct
cohort of 32 other patients diagnosed with (UPA) in
2007. (iii) Overall predictors of survival beyond 9 months
were then determined via logistic regression.
Results: (i) Overall median survival was 9 months. It was
11.5 months (7.4–15.6) for patients with locally advanced
disease, and 5.3 months (2.5–8.1) for patients with dis-
tant metastasis. The median survival for patients with a
low symptom score (LS) group was 14.6 (95% CI 13.1–
16.1) months and 6.3 (95% CI 4.1–8.5) months in pa-
tients with a high symptoms score (HS) groups. 69% of
LS group patients survived beyond 9 months compared
to only 34% HS patients. (ii) There was an excellent
coefﬁcient of agreement (kappa) between expected and
observed survival of 0.8 in the validation cohort. (iii).
Though Age [Odds Ratio (OR) = 0.926 (95% CI–
0.1355–-0.0185)], tumour size [OR = 0.607 (95% CI
0.418–0.883)], and chemotherapy [OR = 3.25 (95% CI
1.09–9.68)] all predicted survival at 9 months, the
symptom score was the most signiﬁcant predictor of
survival OR = 0.834 (95% CI 0.74–0.94).
Table 1. Survival of different subgroups with palliative
pancreatic adenocarcinoma. The symptom score was a
better discriminator of median survival than the presence
of local invasion or distant metastasis
Subgroups
Median
survival
95% conﬁdence
interval
Lower Upper
Local invasion 11.5 7.4 15.6
Distant metastasis 5.3 2.5 8.1
HS Group 6.3 4.1 8.5
LS Group 14.6 13.1 16.1
Conclusion: We have developed and validated an effec-
tive clinical model to predict survival in UPA patients
which is useful in planning their palliation strategy.
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MELD EXCEPTIONS COMMITTEE
ACTIVITY IN ARGENTINA: DOES IT
PROVIDE JUSTICE AND EQUITY
AMONG ADULT PATIENTS WAITING
FOR A LIVER TRANSPLANT?
L. McCormack1, A. Gadano2, J. Lendoire3,
E. Quin˜ones1, O. Imventarza4, O. Andriani5, L. Toselli6,
O. Gil7, G. Gondolesi8, L. Bisigniano9 and
E. de Santiban˜es2
1Hospital Aleman of Buenos Aires; 2Hospital Italiano of
Buenos Aires; 3Sanatorio Trinidad Mitre; 4Hospital
Argerich; 5Hospital University Austral; 6CRAI Norte;
7Sanatorio Allende of Cordoba; 8Favaloro Fundation;
9INCUCAI
Background: Since July 2005, the MELD-based alloca-
tion system was adopted in Argentina for elective
patients requiring liver transplantation. For patients in
whom the MELD score was thought to inaccurately
estimate their need of LT, each center could request
priority points to an Experts Committee.
Aim: To revise the activity of the National MELD
exceptions Committee in Argentina under the MELD
system.
Methods: Between July 2005 and April 2009, 1623 adult
patients were included in the national liver waiting list. A
speciﬁc regulation provides additional MELD points in
three situations: Amyloidosis, Hepatopulmonary syn-
drome (HPS) and T2 hepatocellular carcinoma (T2HCC).
Centers could also request priority points to the Com-
mittee for other situations not included in this regulation.
Using a prospective collected national database, we
identiﬁed each adult patient in whom priority points were
requested. Pathology reports of explanted livers were
analyzed for those with T2HCC.
Results: A total of 258/ 1623 (15.8%) requests were re-
viewed. The overall approbation rate among all MELD
exception requested was 54% (141/258) including: 2
Amiloidosis, 6 HPS, 111 T2HCC and 22 non-regulated
clinical situations. Among the 111 patients with T2HCC,
6 died on waiting list (5.4%), 8 had tumor progression
(7.2%), 94 were transplanted (84.2%) and 3 are still
waiting. Pathology reports were available in 92/94 cases.
Each preoperative diagnosis was correlated with the
pathological reports showing incorrect diagnosis of HCC
in 20/92 (21%) cases and a correct T2HCC in only 41/ 92
(44%) being T1HCC in 9 and T3HCC in 22 cases.
Conclusions: MELD exceptions are frequently requested
due to the fact that MELD score does not always accu-
rately determinate the need of LT. Unfortunately, most
receiving priority points for T2HCC were beneﬁted just
by medical mistake or imaging limitations. An intense
review process is urgently needed for maintaining equity
and justice in the allocation system.
PA-02
MALIGNANT TRANSFORMATION OF
HEPATOCELLULAR ADENOMAS INTO
HEPATOCELLULAR CARCINOMAS: A
SYSTEMATIC REVIEW INCLUDING
MORE THAN 1000 ADENOMA-CASES
J. H. M. B. Stoot1,2, R. J. S. Coelen1, M. C. De Jong1 and
C. H. C. Dejong1,3
1Department of Surgery, Maastricht University Medical
Centre, Maastricht, The Netherlands; 2Department of
Surgery, Orbis Medical Centre, Sittard, The Netherlands;
3Department of Surgery, NUTRIM School for Nutrition,
Metabolism and Toxicology, Maastricht University
Medical Centre, Maastricht, The Netherlands
Background: Hepatocellular adenomas (HCAs) are un-
common benign liver tumours that occur predominantly
in women taking oral contraceptives (OCs). Malignant
transformation of HCAs into hepatocellular carcinomas
(HCCs) has been reported repeatedly but its actual risk
and precise mechanism are currently unknown.
Objective: To provide an overview of the current insights
into the frequency, aetiology and risk factors of the
malignant transformation of HCAs.
Methods: A literature search was conducted using the
following databases: The Cochrane Hepatobiliary Group
Controlled Trials Register, The Cochrane Central Reg-
ister of Controlled Trials (CENTRAL), PubMed,
MEDLINE and EMBASE.
Results: Fifty-two relevant series (1238 HCAs) and 15
case reports were retrieved, reporting an overall fre-
quency of malignant transformation of 5.3%. When
HCAs are divided into four subtypes based on genotype/
phenotype features, b-catenin activated HCAs show a
higher risk of malignant alteration. Liver cell dysplasia
might be an early stadium in the progression of HCAs
into HCCs. Prolonged and continuous use of OCs may
speed up this process. Other established risk factors for
malignant transformation are glycogen storage diseases,
use of androgens or anabolic steroids and male sex. The
current search showed only three cases of malignant al-
teration in a tumour smaller than 5 cm in diameter,
providing evidence that this phenomenon is unlikely in
small tumours. However, the recommendation to only
treat HCAs larger than 5 cm in diameter is under debate.
Conclusion: Malignant transformation of HCAs into
HCCs remains a rare phenomenon with a probable fre-
quency of 5.3%. Although progress has been made in our
understanding of the underlying mechanism, the exact
causes are still unknown. A more proper study design
and a larger HCA registry are necessary to determine the
true frequency, risk factors and the relationship between
tumour size and risk of malignant transformation.
 2010 The Authors
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PA-03
SINGLE-PORT LAPAROSCOPIC LIVER
RESECTION: INITIAL HUMAN
EXPERIENCE
Y. K. You1, T. H. Hong2, S. K. Lee2, K. H. Lee2,
J. H. Park2, Y. C. Yoon2, W. S. Nam2, B. S. Son2,
S. J. Kim2, K. W. Kim2, I. Y. Park2, S. Lee2, D. G. Kim2
and E. K. Kim2
1The Catholic University of Korea, HBP Surgery and
Liver Transplantation; 2The Catholic University of Korea,
HBP Surgery
Introduction: Surgeons have rapidly adopted single-port
laparoscopic surgery for many abdominal operations.
The aim of the present study was to assess our initial
experiences with single-port laparoscopic liver resec-
tion.
Methods: Between December 2008 and Sep 2009, 14
patients underwent single-port laparoscopic liver resec-
tion for hepatocellular carcinoma (5 patients), liver
metastases (4 patients), cholangitis associated with an
intrahepatic duct stone (3 patients) or focal nodular
hyperplasia (2 patients). Of these single-port liver sur-
geries, ﬁve were laparoscopic left hepatectomies, 6 were
laparoscopic right partial liver resections, 2 were lapa-
roscopic right hepatectomies and one was a laparoscopic
left lateral sectionectomy.
Results: Median operating time and blood loss were
260 minutes (range, 155–546 minutes) and 521 mL
(range, 50–800 ml), respectively. Two procedures were
converted to multi-port laparoscopic hepatectomy due to
instrument length limitations. Conversion to laparoscopy
assisted hepatic resection took place in one of the right
hepatectomies because of technical failure. There was no
serious intraoperative or postoperative complication in
this series. Median postoperative stay was 9 days (range,
7–21 days).
Conclusions: Our selected series has demonstrated the
feasibility and safety of single-port laparoscopic liver
resection in a variety of hepatocellular carcinoma lesions,
secondary liver tumors and benign hepatic lesions.
However we need more cases and randomized studies for
evaluation of role of this challenging technique whether it
is applicable or not in the liver resection.
PA-04
QUALITY OF LIFE AFTER PALLIATIVE
SURGERY FOR ADVANCED DUCTAL
ADENOCARCINOMA OF THE
PANCREATIC HEAD
J. Walter, A. Nier, T. Schulte, J. H. Egberts, T. Ku¨chler,
D. C. Broering and B. Schniewind
Clinic for General and Thoracic Surgery, University
Hospital of Schleswig-Holstein, Campus Kiel
Background: As treatment for advanced carcinoma of
the pancreatic head, palliative resection (PR) is pre-
ferentially performed compared to double loop bypass
(DLB) surgery by some centers. This prospective study of
a single center compares the outcome after PR and DLB
focusing on the patients‘quality of life (QoL).
Methods: Between 01/1998 to 01/2008, a total of 198
patients were subjected to palliative surgery for advanced
pancreatic cancer at the University Hospital of Kiel and
were prospectively analyzed. Forty-three patients un-
derwent PR while 155 were treated with DLB. The DLB
group was further divided into one locally advanced
disease (LAD-subgroup; n = 86; 55.48%) and meta-
static disease (MD-subgroup; n = 69; 44.52%). The
EORTC QLQ-C30 was used to assess QoL. QoL data
collection was done preoperatively and for up to
12 months after surgery.
Results: Median survival after PR was 7.0 months (95%
CI 4.09; 9.91) and 6 months after DLB (95% CI 5.39;
6.61). There was no signiﬁcant difference in mortality
and morbidity rates with 7.8% and 58% for PR and
2.6% and 42% for DLB, respectively. In terms of QoL,
patients after DLB showed less decrease of QoL levels
compared to patients after PR with shorter anastasis time
and less impairment on time of discharge. No difference
Table 1 for PA-03: Clinical characteristics of patients performed single-port laparoscopic liver resection.
No Age Gender Diagnosis Cirrhosis Location
Operation
title
Operation
time
(min)
Blood
loss
(ml)
Transfusion
(packed
red cell) Conversion
Transumbilical
route
Length of
incision
(cm)
Tumor
Size/Margin
(cm)
1 65 Female IHD stones no Left IHD Left hepatectomy 546 700 2 units no no 3.5 -
2 62 Male HCC yes Segment VI Partial hepatectomy 185 400 2 units no yes 4.0 2.5 / 0.2
3 47 Male HCC yes Segment VI Partial hepatectomy 268 500 - no yes 4.0 1.0 / 2.8
4 66 Male HCC yes Segment II II, III segmentectomy 190 600 1 unit no no 4.0 2.5 / 1.7
5 31 Female FNH no Segment III Left hepatectomy 215 150 - no no 5.0 -
6 65 Female IHD stones no Left IHD Left hepatectomy 195 800 1 unit no yes 5.0 -
7 47 Male HCC yes Segment VI Partial hepatectomy 155 700 3 units yes (3 port)# yes - 5.5 / 1.3
8 52 Female Metastatic
lesion*
no Segment II Left hepatectomy 360 800 5 units yes (2 port)% no - 6.5 / 0.4
9 73 Male Metastatic
lesion*
no Segment VI Right hepatectomy 212 700 3 units no no 5.0 5.0 / 2.0
10 61 Male Metastatic
lesion*
no Segment VI Right hepatectomy 345 500 - yes (open) no - 4.5 / 0
11 57 Male FNH no Segment VI Partial hepatectomy 205 50 - no no 5.0 -
12 49 Female IHD stones no Left IHD Left hepatectomy 385 500 - no yes 4.5 -
13 66 Male HCC yes Segment VI Partial hepatectomy 160 100 - no no 5.0 4.5 / 1.5
14 62 Male Metastatic
lesion*
Yes Segment I, VI Partial hepatectomy 222 800 1 unit no no 5.0 3.0 / 2.0
*Primary colon carcinoma.
#Additional two ports were needed for hepatic parenchymal dissection and traction.
%Additional one port was required for hepatic parenchymal dissection.
IHD; intrahepatic duct.
HCC; hepatocellular carcinoma.
FNH; focal nodular hyperplasia.
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between QoL levels of LAD- and MD-subgroup was
observed.
Conclusion: While there was no difference in survival and
morbidity after PR and DLB, patients who underwent
DLB showed an advantage in QoL over patients after
PR. Therefore, application of PR for patients with ad-
vanced pancreatic cancer should be carefully proven.
PA-05
INVASIVE INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM: ADJUVANT
THERAPY AND TREATMENT OF
RECURRENCE
O. Turrini1, J. A. Waters2, C. Yiannoutsis3,
T. Schnelldorfer4, K. D. Lillemoe2, M. B. Farnell5,
M. G. Sarr5 and C. M. Schmidt2
1Institut Paoli-Calmettes, CRCM, Marseille; 2Indiana
University Department of Surgery; 3Indiana University
School of Medicine; 4Thomas Jefferson University
Department of Surgery; 5Mayo Clinic Department of
Surgery
Introduction: Adjuvant treatment for pancreatic adeno-
carcinoma has been shown to improve survival. An in-
creasingly recognized ‘‘sub-type’’ of pancreatic
adenocarcinoma is invasive intraductal papillary muci-
nous neoplasm (IPMN). It is unclear whether adjuvant
treatment for invasive IPMN improves survival.
Aim: To determine the impact of adjuvant treatment for
invasive IPMN.
Methods: A retrospective analysis of a clinical database
of 412 patients who underwent resection for IPMN at
two academic institutions between 1989 and 2006.
Results: Of 412 patients with IPMN, 98 were invasive.
Median survival of invasive IPMN was 32 months. Ad-
juvant treatment did not affect median survival in node
positive or node negative invasive IPMN subgroups.
Biopsy-proven recurrence of invasive IPMN occurred in
45 patients (46%). Median disease-free interval of these
patients from resection to recurrence was 27 months.
Treatment of recurrences with or without chemotherapy/
radiation therapy was not associated with a difference in
survival. (Table 1).
Table 1.
Patient Groups
Adjuvant Treatment
Median Survival
(Mo)
P valueYes No
All (N = 98) 23 41 0.07
LN (-) (N = 52) 63 48 0.98
LN (+)*(N = 46) 17 22 0.67
Recurrence
Treatment N
Survival
(Mo)
P value
(vs. none)
None 13 5 NA
Chemo/RT 19 6 0.06
Re-Resection** 3 72* < 0.005
*includes margin positive (R1) resections; Mo = months;
LN = lymph node; (-) = negative; (+) = positive
**2 patients remain alive at 72 and 120 months (6 and
10 years); Chemo/RT = chemotherapy, radiotherapy or
combination.
Conclusions: Invasive IPMN is a distinct ‘‘sub-type’’ of
pancreatic adenocarcinoma that remains poorly under-
stood. Adjuvant therapy in invasive IPMN demonstrated
no survival beneﬁt. Invasive IPMN recurrence after re-
section is associated with poor survival; however, a sub-
group of patients with recurrence in the remnant pan-
creas have more favorable outcomes with re-resection.
PA-06
OUTCOME OF LIVER
TRANSPLANTATION USING
SUPER-AGED (‡ 80-YEAR) GRAFTS. A
EUROPEAN LIVER TRANSPLANT
REGISTRY STUDY
R. Adam1, V. Karam1, V. Delvart1, J. Buckels2,
J. O’Grady3, D. Castaing1, N. Jamieson4, P. Neuhaus5,
J. Lerut6, S. Pollard7, M. Salizzoni8, L. Fischer9,
J. Garcia Valdecasas10, F. Muhlbacher11, J. Mir12,
A. Burroughs13, All ELTR centers are listed at14
1Centre He´patobiliaire, Hopital Paul Brousse, Villejuif,
France; Centre He´patobiliaire, Hopital Paul Brousse,
Villejuif, France; 2The Queen Elizabeth Hospital, Queen
Elisabeth Medical Center, Birmingham, United Kingdom;
3Liver Transplantation - 9th Floor Surgery, Royal Free
Hospital, London, United Kingdom; 4Addenbrooke’s
Hospital, Department of Surgery, Cambridge,
United Kingdom; 5Klinik fu¨r Allgemein-Viszeral- und
Transplantationschirurgie, Charite´- Campus - Virchow
klinikum, Berlin, Germany; 6Cliniques Universitaires Saint
Luc, Catholic University of Louvain, Brussels, Belgium;
7St Jame’s & Seacroft University Hospital, Department of
Surgery, Leeds, United Kingdom; 8Centro de Trapianti di
Fegato, Azienda Ospedaliera S. Giovanni Battista, Torino,
Italy; 9Department of Hepatobiliary Surgery,
Universitatskrankenhaus Eppendorf, Transplantation
Center, Hamburg, Germany; 10Gastrointestinal Surgery
Department, Hospital Clinic I Provincial de Barcelona,
Barcelona, Spain; 11Klinishe Abteilung fu¨r
Transplantation, Transplantationszentrum Allgemeines
Krankenhaus, Wien, Austria; 12Hospital Universitario LA
FE, Servicio de Medicina Digestiva, Valencia, Spain
Introduction; 13Liver Transplantation and Hepatobiliary
Medicine, Royal Free Hampstead NHS Trust, London
NW3 2QG, UK; 14www.eltr.org
We assessed the use of super-aged liver grafts
(‡ 80 years) and their inﬂuence on the recipient’s out-
come.
Patients and methods: From January 1988 to December
2008, 69185 ﬁrst LT have been performed in Europe.
First, ELTR data of ‡ 80 years donors (n = 464) were
compared to those < 80 years. Thereafter, ‡ 80 years
donors’ data were analyzed in order to identify risk fac-
tors of recipients’ death or graft loss.
Results: Whereas ‡ 80 years aged donors represented
overall 0.7% of all LT, this rate has increased to 2.2% in
2008. By comparison with < 80 years, there was more
females (58 vs. 40%, P = 0.007). Grafts of ‡ 80 years
donors were more frequently used in ‡ 60 years aged
recipients (33 vs. 17%), in HBsAg+ (18 vs. 12%), An-
tiHCV+ (34 vs. 26%) recipients, in malignancies (27 vs.
14%), Alcoholic (37 vs. 33%) or viral (45 vs. 38%) cir-
rhosis (mainly HCV), non urgent LT (93 vs. 88%), ABO
isogroup (96 vs. 92%), full size LT (99.8 vs. 87%), with
ischemic time < 12 hours (96 vs. 83%), Celsior preser-
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vation solution (30 vs. 7%), and LT with vena cava
preservation (41 vs. 33%) (all P < 0.01). Graft and pa-
tient 5-year survival were decreased with ‡ 80 years
grafts, 52% vs. 66% and 55% vs. 71%, respectively
(P < 0.001). Regarding the cause of death or graft fail-
ure after LT, recipients with ‡ 80 years grafts had more
non-tumor disease recurrence (18 vs. 9%, P < 0.001),
and less cardiovascular failure (1.6 vs. 6%, P < 0.05). At
univariate analysis, survival of recipients with ‡ 80 years
grafts was impaired in: HBsAg-, AntiHCV+, urgent LT,
UNOS status < 3 and ischemic time ‡ 12 hours
(P < 0.05). Multivariate analysis showed that only
UNOS < 3 (RR = 2.2) and AntiHCV+ (RR = 1.7)
were independent risk factors of death or graft loss.
Conclusion: Aged donors are increasingly used in LT
affording a 55% 5-year patient survival. However one of
two grafts is lost at long term with HCV+ and pre-
transplant recipient hospitalization as independent risk
factors. Avoidance of urgent LT and long ischemic time
may further improve the results.
PA-07
REAPPRAISAL OF R1 RESECTION FOR
COLORECTAL LIVER METASTASES IN
THE ERA OF MODERN
CHEMOTHERAPY
C. Eveno1, M. Karoui1, C. Tayar1, E. Gayat2,
A. Laurent1 and D. Cherqui1
1Department of GI and HPB Surgery, Hospital Henri
Mondor, Cre´teil, France; 2Biostatistics and Epidemiology
Unit, Hospital Saint-Louis, Paris, France
Background: Complete resection with negative margins
is the gold standard in the surgical treatment of color-
ectal liver metastases (CLM). It has been suggested by
some authors that long-term outcomes after R1 resection
were similar to those of R0.
Objective: To compare long-term outcomes and study
predictors of R0 (margin > 1 mm) vs. R1 (margin < 1
mm) resections for CLM.
Methods: All resected CLM between 2000 and 2005 were
evaluated. Exclusion criteria were: macroscopic in-
complete (R2) resections, use of other local treatment
modalities (RFA), and presence of extra hepatic disease.
R0/R1 status was based on pathological study of the
specimens. All patients had peri or postoperative Folfox
chemotherapy.
Results: Of 81 patients eligible, 60 (74%) had R0 re-
section, and 21 (26%) R1 resection. The R1 group had a
higher number of metastasis (3 vs. 2; P < 0.05); which
were more frequently bilobar (50% vs. 20%, P < 0.01);
and had more frequently a non anatomic resection (52%
vs. 27%, P < 0.05). After a mean follow-up of
44 months, 5-year OS was 48% and 38% for R0 and R1
patients (NS). Five-year disease-free survival was 42% in
the R0 group vs. 38% in the R1 group (NS). Intrahepatic
recurrences were more often observed in the R1 group,
(52% vs. 27%; p = 0.02) and occurred more frequently
in the vicinity of the surgical margin (P < 0.001). Eleven
(41%) intrahepatic recurrences were treatable, eight
(50%) in the R0 group and three (19%) in the R1 group
(NS).
Conclusion: R1 resections occurred more frequently in
cases of multiple lesions, bilateral disease and atypical
resections. They were associated with a higher risk of
intrahepatic recurrence and a trend towards slightly re-
duced survival. However, half of R1 patients did not
have intrahepatic recurrence and a satisfactory 38% 5-
year survival was observed in conjunction with modern
chemotherapy. R0 resection should remain the reference
but patients with potential R1 resection should not be
contraindicated for surgery.
PA-08
THE RESULTS OF LIVING DONOR
LIVER TRANSPLANTATION FOR HCC
SATISFYING MILAN CRITERIA AFTER
DOWON-STAGING IN PATIENTS
INITIALLY OUTSIDE MILAN
D-B. Moon, S-G. Lee, S. Hwang, K-H. Kim,
C-S. Ahn, T-Y. Ha, G-W. Song, D-H. Jung,
G-C. Park, Y-D. Yu, Y-I. Choi and P-J Park
Hepato-Biliary Surgery and Liver Transplantation, Asan
Medical Center, University of Ulsan College of Medicine,
Seoul, Korea
Aims: The extension of the selection criteria such as
UCSF, Kyoto, and Asan Medical Center criteria also
revealed comparable results, but still Milan criteria has
been believed to guarantee excellent results. As a result,
when HCC is initially outside Milan selection criteria,
down-staging effort to within Milan criteria has been
tried by using various locoregional treatment. Though
our institution do not have established down-staging
program of HCC for liver transplantation, we intended
to review our experiences corresponding to down-stag-
ing.
Methods: Adult liver transplantation was performed in
1,806 patients from July 1992 to April 2008, and the
number of adult LDLT was 1,575 cases. 553 patients
(35.1%) undergone LDLT had HCC. 65 patients was
diagnosed for HCC before LDLT but not treated pre-
viously and belonged to Milan criteria, classiﬁed as De
novo Milan group. Twenty two HCC patients did not
meet Milan criteria initially, but subsequently satisﬁed
the criteria after down-staging with loco-regional treat-
ment, classiﬁed as Artiﬁcial Milan group. The evaluation
of down-staging was based on pre-operative CT scan and
explanted liver biopsy, and excluded the patients having
unclear treatment history on analysis.
Results: Artiﬁcial group showed signiﬁcantly less Child
C patients (25%) than De novo group (64.5%) (0.037).
Tumor characteristics between Artiﬁcial and De novo
group had signiﬁcant differences in maximal tumor size
(2.5 ± 1.2 vs. 2.2 ± 0.95 cm), sum of tumor diameter
(3.4 ± 1.4 vs. 2.4 ± 1.0 cm), number of nodules
(1.8 ± 0.9 vs. 1.2 ± 0.5) and AFP level (438 vs.
133 ng mL-1) respectively. 5-year cumulative survivals
were not different between Artiﬁcial and De novo group
(83.9% vs. 93.9%), but 5-year disease free survival were
signiﬁcantly different (71.1% vs. 96.5%) (P = 0.0016).
Conclusion: Survival rates after LDLT were good in both
groups. However, more strict follow-up is necessary in
Artiﬁcial group considering higher recurrence rate than
De novo group.
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PA-09
SEVERE ACUTE PANCREATITIS – ROLE
OF EARLY LAPAROSCOPIC
PANCREATIC COMPARTMENT
DECOMPRESSION
R. Pareek and S. Pareek
Pareek Hospital and Research Center, Agra – India
Mortality in Severe Acute Pancreatitis is 15 to 40 percent
in pancreatic units around the world. Recently the
consensus has moved from early surgical intervention
to aggressive intensive care. End results have improved,
but have plateaued at one level. Laparoscopic decom-
pression of the pancreatic compartment during ﬁrst week
has shown to further reduce the mortality and morbidity.
Method: A prospective randomized study was performed
over 6 years (2003–2009). 92 patients with severe pan-
creatitis were divided in two groups.
(A) Early Laparoscopic decompression.
(B) No decompression.
The criteria for patient entry were Ransons score of four
or more at admission and at 48 h. Patients were entered
to the groups at random after informed consent. Forty
seven patients were in the decompression group and 45
were in the conservative group. All patients were treated
in ICU. The decompression group underwent laparo-
scopic decompression of pancreatic compartment
through the Gastro-colic ligament on 4th or 5th day.
The endpoint was incidence of mortality, morbidity &
duration of ICU and hospital stay.
Results: (a) The mortality was 3/47 Patients in decom-
pression group and 14/45 in non decompression group.
(b) Morbidity ﬁgures including need for assisted ventila-
tion, necrosectomy, development of SIRS, MODS and
pancreatic infections were signiﬁcantly lower in Decom-
pression group.
(C) ICU stay was shorter in the decompression group
(10/17 days). There was no difference in the total
duration of hospital stay.
Conclusion: Although recently there is a move away
from early surgical intervention in severe acute pan-
creatitis, early pancreatic compartment decompression,
preferably laparoscopic, signiﬁcantly reduces the mor-
tality, morbidity, and stay in ICU and in the hospital.
The procedure is practiced in patients who deteriorate
despite 72 h of ICU care.
PA-10
LIVER REGENERATIVE NODULAR
HYPERPLASIA CONSECUTIVE TO
PREOPERATIVE CHEMOTHERAPY:
IMPACT ON OUTCOME OF LIVER
SURGERY FOR COLORECTAL
METASTASES
D. Wicherts, R. DE Haas, M. Sebagh, O. Ciacio, F. Le´vi,
B. Paule, D. Azoulay, H. Bismuth, D. Castaing and
R. Adam
Hoˆpital Paul Brousse - Centre He´pato-Biliaire
Background: Liver regenerative nodular hyperplasia
(RNH) represents the worst evaluative stage of vascular
lesions induced by chemotherapy. Its impact on the
outcome of resection for colorectal liver metastases
(CLM) is however unknown.
Objective: We evaluated the effect of RNH on post-
operative morbidity and assessed its evolution in time at
repeat hepatectomy.
Methods: All patients that underwent hepatectomy for
CLM between January 1990 and November 2006 after
one line of chemotherapy of more than six cycles were
included. Detailed histopathologic analysis of the non-
tumoral liver was performed at ﬁrst and repeat hepatec-
tomies.
Results: From a total cohort of 856 consecutive patients
resected of CLM, 146 were included: 24 (16%) received
5-ﬂuorouracil (5-FU) and leucovorin (LV) alone, 92
(63%) had 5-FU/LV and oxaliplatin, 18 (12%) had 5-
FU/LV and irinotecan, and 12 (8%) were treated by 5-
FU/LV, oxaliplatin and irinotecan. RNH occurred in 22
of 146 patients (15%). Patients treated by oxaliplatin
more often had RNH compared to oxaliplatin-naı¨ve
patients (22%vs.4%) (P = 0.003). None of the RNH
patients died within 60 days postoperatively. However,
the presence of RNH was associated with increased
postoperative hepatic morbidity (23%vs.11%)
(P = 0.05). Preoperative levels of gamma-glutamyl-
transferase > 80 U/L and total bilirubin > 15 lmol/L
were independent predictors of RNH at ﬁrst hepa-
tectomy. Two of 22 patients with RNH underwent repeat
hepatectomy. RNH disappeared at second hepatectomy
in both patients following interruption of oxaliplatin and
prolonged treatment with irinotecan.
Conclusions: Patients with CLM that receive prolonged
courses of preoperative oxaliplatin have an increased risk
of RNH and associated postoperative hepatic morbidity.
Upfront treatment with short courses of highly effective
regimens may therefore be most appropriate. In addition,
the continuation of oxaliplatin should be discouraged in
case of RNH to avoid its negative effects on further
surgery.
PA-11
PROTECTIVE EFFECT OF LPS
PRECONDITIONING IN HEPATIC
ISCHEMIA REPERFUSION INJURY
T. Sano, K. Izuishi, R. Takebayashi, S Akamoto,
T. Inoue, K. Kakinoki, M. Hagiike, K. Okano, H. Usuki
and Y. Suzuki
Department of Gastroenterological Surgery, Kagawa
University
Background: Preconditioning is the procedure prior to
ischemia to reduce ischemia/reperfusion injury (IRI).
Preconditioning using Lipopolysaccharide (LPS), one of
the Toll-like receptor 4 (TLR4) ligand, has been dem-
onstrated in heart and kidney against IRI, but not been
sufﬁciently elucidated in the liver.
Aim: We examined the preconditioning effect of LPS
treatment in liver IRI, and elucidated the mechanism of
LPS preconditioning through nuclear factor (NF) jB
regulation.
Methods: BALB/c and C3H/HeJ (TLR4 deﬁcient) mice
underwent 90 min of 70% hepatic ischemia (n = 6). LPS
preconditioning was performed by intraperitoneal LPS
injection (1–1000 lg kg-1) 20 hours before ischemia. To
evaluate the liver damage after reperfusion, serum ALT
Abstracts 11
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
and tumor necrosis factor (TNF) a were examined.
NFjB activation was determined by ELISA kit. The
expression of feed back inhibitor; suppressor of cytokine
signaling (SOCS)1, and a signaling mediator to NFjB
activation; Interleukin-1 receptor-associated kinase
(IRAK)1, in TLR4 signaling pathway were evaluated by
western blotting.
Results: Protective effect of LPS preconditioning was
observed only with 100 lg kg-1 LPS. Serum ALT level
and tissue necrosis were signiﬁcantly decreased in LPS
group compared with control group 6 hours after rep-
erfusion. Especially, level of serum proinﬂammatory
cytokines, TNFa, was inhibited from 23.5 ± 3.2 to
9.8 ± 1.4 pg ml-1. Also tissue NFjB activation and
IRAK1 phosphorylation were suppressed signiﬁcantly.
The anti-IRI effect of LPS by the induction of SOCS1
was seen before ischemia (20 hours after LPS adminis-
tration). These LPS preconditioning was not observed in
TLR4 deﬁcient mice.
Conclusion: The mechanism of hepatic LPS precondi-
tioning is associated with the induction of SOCS-1 in pre-
ischemic period as a priming effect. However, preopera-
tive modulation of this pathway may be an important
strategy against IRI in liver.
PA-12
GENEXOL INHIBITS PRIMARY TUMOR
GROWTH AND METASTASIS IN
GEMCITABINE RESISTANT
PANCREATIC DUCTAL
ADENOCARCINOMA
J. Shea, K-H. Nam, N. Rapaport and C. Scaife
University of Utah
Background: Pancreatic ductal adenocarcinoma (PDA)
remains one of the most poorly controlled solid organ
malignancies in the United States. Gemcitabine, the
current standard of care for PDA, has a less than 10%
partial response rate and imparts a progression-free
survival interval of less than six months. Additionally,
acquired gemcitabine resistance is a common occurrence
in pancreatic cancer. Genexol-PM, a modiﬁed form of
paclitaxel, has been shown to have antitumor effects in
clinical trials of metastatic breast and small-lung-cell
carcinoma.
Aims: The aim of the current study was to determine if
Genexol would be a beneﬁcial treatment for gemcitabine
resistant PDA.
Methods: We initially determined the IC50s of gemcita-
bine and genexol in cell lines sensitive and resistant to
gemcitabine. In vivo, animals with orthotopic implanted,
gemcitabine resistant, red ﬂuorescent protein (RFP)
transfected, pancreatic tumors were treated with PBS
(control), gemcitabine, genexol, or gemcitabine+genexol.
Tumor progression was monitored on a weekly basis
using red ﬂuorescent protein imaging.
Results: In vitro, we demonstrated equivalent IC50s for
gemcitabine sensitive and gemcitabine resistant cell lines
when treated with genexol. In vivo treatment with Gen-
exol resulted in a greater percent reduction in tumor size,
less metastatic spread, and longer survival compared with
treatment with gemcitabine.
Orthotopic Tumor Model Treatment Related Tumor
Size, Survival, and % Metastases.
Treatment
Group
% Change in
size, 2 weeks
treatment
(RFP area
change)
Survival
(days)
% of
animals
with
metastases
Control +57% +/-17%* 43 +/-5* 100*
Gemcitabine +57% +/-9%* 46 +/-4* 100*
Genexol -64% +/-38% 107 +/-32 71
Genexol +
Gemcitabine
-84% +/-17% 103 +/-15 84
*P < 0.05 compared to Genexol groups
Discussion: Genexol proved to be an effective anti-tumor
agent to treat pancreatic tumors resistant to gemcitabine.
This in vitro and in vivo data suggests Genexol maybe an
effective treatment for pancreatic cancer, speciﬁcally for
those patients resistant to gemcitabine.
PA-13
COMPARING RESULTS IN PEDIATRIC
PATIENTS WITH < 10 KG IN LDLT.
MONOSEGMENTS VERSUS FULL LEFT
LATERAL SEGMENTS
M. Enne1, L. Pacheco-Moreira1, J. Alves1, E. Balbi1,
M. Valladares2, G. Santallucia2, R. Fernandes1,
K. Stenibruck1 and J. M. Martinho1,3
1Hospital Geral de Bonsucesso - Ministe´rio da Sau´de -
Hepatobiliary and Liver Transplantation Unit; 2Hospital
Geral de Bonsucesso - Ministe´rio da Sau´de - Pediatric
Unit; 3Department of Surgery, Antonio Pedro University
Hospital - Fluminense Federal University
Background: The development of pediatric liver trans-
plantation has been associated with the introduction of
some techniques to solve the problem of disparity be-
tween available donors and the exponential increase of
patients on the waiting list. Almost all of these techniques
use the left lateral segment (Couinaud’s segments II and
III) of the liver; but this graft may be too large for infants
under 7 kg. To overcome a size discrepancy from donor
to recipient a further reduction to a monosegment may
be necessary.
Objective: Our aim is to describe our results in pediatric
LDLT, under 10 kg, comparing full left lateral (Couin-
aud’s Seg II and III) and reduced left laterals (Mono-
segment III) grafts.
Methods: From March 2002 to September 2009, we
performed a total of 367 liver transplantations. Among
these, 27 cases were less than 10 kg patients who received
a graft from a living related donor. Left lateral segment
was used for 14 transplantations (Group 1) and a
monosegmental graft in the remaining 13 (Group 2). We
analized the incidence of surgical complications and
mortality between these two groups according with
Fisher’s exact test.
Results: During the early postoperative period, any he-
patic arterial thrombosis was identiﬁed, biliary compli-
cation was detected in three patients. In two patients,
portal vein thrombosis was identiﬁed. At the time of this
writing, 23 alive patients (85%) exhibited good graft
function at median follow up of 30 months (range,
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3–84 months). Four patients died during the follow-up.
Group 1 and 2 data is showed at table 1.
Results Comparing Group 1 and 2
Full Left Lateral
Segment Group 1
n = 14
Monosegment
Group 2
n = 13 P value
Age (months) mean 14 12
Weight (Kg) mean 7 5.7
PVT none 2 (15%) P = 0.2
HAT none none
Biliary Complication 3 (21%) none P = 0.2
Mortality none 4 (30%) P = 0.09
Conclusion: In conclusion, our data conﬁrmed that liv-
ing-related donor, especially in this age group, provides a
reliable source for the organ pool. Satisfactory results can
be achieved despite the graft type, mortality was higher at
monosegmental group.
PA-15
CLINICAL SIGNIFICANCE OF
HISTOLOGICALLY PROVEN PORTAL
VEIN INVASION IN PANCREATIC HEAD
CANCER
S-S. Han, Y-K. Kim, S. Y. Cho, S. H. Kim, K-W. Lee
and S-J. Park
Center for Liver Cancer, National Cancer Center, Korea
Background: Implication of portal vein (PV) invasion as
prognostic factor in patients who underwent curative
pancreatoduodenectomy (PD) for pancreatic adeno-
carcinoma is unclear.
Objective: To determine the signiﬁcance of PV invasion
on survival in patients who underwent curative PD for
pancreatic adenocarcinoma.
Methods: Of the 68 patients who underwent PD with/
without pylorus preserving procedure for pancreatic
ductal adenocarcinoma from August 2001 to December
2007, we reviewed the medical records of 60 patients who
underwent curative surgery (R0). PV resection was per-
formed in patients with suspicion of tumor invasion
during operation and the depth of vessel invasion was
investigated by one pathologist. Clinicopathologic data,
survival and prognostic factors were analyzed retro-
spectively.
Results: PV resection was performed in 19 patients
(31.7%); Fifteen patients (78.9%) had histologically true
invasion, and the other four had ﬁbrous adhesion. Depth
of vessel invasion was categorized into three groups; tu-
nica adventitia (three patients), tunica media (seven pa-
tients), tunica intima (ﬁve patients). Overall 3-year
survival of the 60 patients was 33%. When we compared
the clinicopathologic factors of the PV invasion group
(15 patients) with non-invasion group (45 patients),
median survival time showed signiﬁcant difference
(9 months vs. 14 months, P < 0.05). Univariate and
multivariate analysis of the total 60 patients showed that
tumor differentiation and PV depth of invasion were
signiﬁcant prognostic factors.
Conclusion: Intraoperative suspicion of PV invasion is
not a contraindication for PD because about 20% of
patients have no true invasion after PV resection. But,
invasion to the level of tunica intima is a poor prognostic
factor of survival after curative PD for pancreatic ade-
nocarcinoma.
PA-16
ROBOTIC VERSUS LAPAROSCOPIC
RESECTION OF THE LIVER TUMORS
H. Akyildiz, F. Aucejo, G. Gunasekaran, S. Chalikonda,
J. Fung and E. Berber
Cleveland Clinic
Background: Various techniques for minimally invasive
liver surgery have been described over the last decade.
There are scant data in the literature regarding the role of
robotic approach.
Objective: The aim of this study is to develop techniques
for robotic liver tumor resection with comparison to
laparoscopic resection.
Methods: Within a year, eight patients underwent ro-
botic resection of peripherally located malignant lesions
< 5 cm in the liver. These patients were compared to 23
patients who underwent laparoscopic resection of similar
tumors at the same institution. Statistical analyses were
performed using t-test, chi-square test and Kaplan Meier
survival. All data are expressed as mean +/) SEM.
Results: Tumor type included colorectal liver metastasis
(n = 4), hepatocellular cancer (n = 3) and sarcoma
metastasis (n = 1) in the Robotic versus colorectal liver
metastasis (n = 14), hepatocellular cancer (n = 6) and
other tumor types (n = 3) in the Laparoscopic group
(P = 0.8). Tumor size was 3.2 +/) 1.3 cm in the Ro-
botic, versus 2.9 +/) 1.3 cm in the Laparoscopic group
(P = 0.6). Skin-to-skin operative time was 258.5 +/)
27.9 minutes in the Robotic versus 233.6 +/)
16.4 minutes in the Laparoscopic group (P = 0.4).
There was no difference between the 2 groups regarding
age, gender and resection margin (P = NS). Conversion
to open was necessary in 1 patient in the Robotic and
none in the Laparoscopic group. The patients were fol-
lowed up for a mean of 14 months and DFS was
equivalent in both groups (P = 0.6). Subjectively, it was
felt that the Robotic approach was most similar to open
hepatectomy by enabling a crush-clamp technique and
individual vessel ligation due to 3-D visualization and
improved dexterity.
Conclusion: The results of this initial study suggest that,
for selected liver lesions, robotic approach provides
similar peri-operative outcomes compared to the lapa-
roscopic liver resection.
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ISOLATION OF CIRCULATING TUMOR
CELLS FROM HEPATIC VEIN BLOOD
OF PATIENTS UNDERGOING LIVER
SURGERY FOR COLORECTAL CANCER
METASTASES
F. Schwenter1, C. Ash1, S. Selvarajah1, P. Wegrynowski2,
G. Zogopoulos3, C. O’Brien3, C-A. Moulton3 and
S. Gallinger1,3
1Mount Sinai Hospital, Samuel Lunenfeld Institute,
Toronto; 2Mount Sinai Hospital, Department of
Pathology, Toronto; 3Toronto General Hospital, HPB
Surgery, Toronto
Background: The prognostic value and biology of cir-
culating tumor cells (CTC) detected in blood of color-
ectal cancer patients with liver metastases remains
controversial. Moreover, it is not known whether CTC
possess cancer stem cell (CSC) properties.
Aim: To identify CTC in hepatic vein blood from pa-
tients undergoing liver resection of colorectal cancer
metastases, and to characterize them in vitro.
Methods: Hepatic vein blood draining the metastatic li-
ver segment(s) was analyzed by the CellSearch system
for immunocytochemical detection of CTC. Blood was
also ﬁltered through polycarbonate membranes, and
placed in culture in enriched medium to stimulate growth
of CTC.
Results: In pilot studies, the CellSearch system was
used to detect 4–40 CTC in 7.5 mL of hepatic vein blood
from ﬁve patients. Future experiments will be performed
to compare CTC numbers in peripheral blood compared
to hepatic vein blood from the same patients. Blood ﬁl-
tration was performed to eliminate most blood mono-
nuclear cells and cultured membranes have demonstrated
growth of adherent cells, which will be characterized for
CTC and CSC surface markers and tumor initiating
potential.
Conclusion: This study demonstrates the capability to
isolate CTC from hepatic vein blood of colorectal cancer
liver resection patients. The growth of adherent cells
from cultured ﬁlters is encouraging in ongoing studies to
characterize the in vitro properties of CSC among CTC.
These cells will also be used to initiate tumor growth by
xenografting in immunodeﬁcient mice.
FP-02
REOVIRUS ACTIVATES HUMAN
INNATE IMMUNE CELL KILLING OF
COLORECTAL METASTASES IN VITRO
R. A. Adair1, A. E. Merrick2, A. A. Melcher2 and
G. J. Toogood1
1Department of HPB/Transplant Surgery, St James’s
University Hospital, Leeds. UK; 2Targerted and Biological
Therapies Group, Welcome Trust Brenner Building,
St James’s University Hospital, Leeds. UK
Introduction: Reovirus is a double-stranded RNA-con-
taining virus that selectively replicates and destroys cells
with an activated Ras Pathway. In vitro studies have
shown that reovirus infection causes direct oncolysis in
SW480 and SW620 human colorectal cancer cell lines.
Previous studies have also shown that reovirus directly
activates isolated human dendritic cells and that upon
coculture with autologous natural killer (NK) cells, re-
ovirus-activated DC up-regulates IFN-g production and
increases NK cytolytic activity.
Methods: Peripheral blood mononuclear cells (PBMC)
isolated from whole blood were incubated with one pla-
que forming unit (pfu) reovirus for 12 h in 7.5% human
serum. Non adherent virus was washed off and the
PBMC co-cultured with SW480 and SW620 targets for
4 h. The level of effector cell degranulation was measured
using a CD107 assay and ﬂow cytometric analysis. Direct
cell mediated killing was assessed using a Chromium re-
lease assay.
Results: Overnight incubation of PBMC with reovirus
led to upregulation of CD69 a marker of NK cell acti-
vation. Signiﬁcant levels degranulation of CD56+ve/
CD3–ve effector cells were seen after reovirus incubation
compared to controls. Up to 100% of SW620 and 80%
of SW480 targets underwent NK mediated cytolysis.
Conclusion: Intratumoural NK cells have been asso-
ciated with improved prognosis in a range of different
tumour cell types. This data suggests that reovirus acti-
vates NK cells within PBMC in vitro. These activated NK
cells are cytotoxic to SW480 and SW620 colorectal cell
lines. In vivo studies are needed to asses the role of re-
ovirus in augmenting the innate anti tumour immune
response against advanced colorectal cancer.
FP-03
TWO-STAGE STRATEGY FOR PATIENTS
WITH EXTENSIVE BILATERAL
COLORECTAL LIVER METASTASES
M. C. De Jong1, S. Tsai1, H. P. Marques2, P. Mira2,
V. Ribeiro2, M. A. Choti1, R. D. Schulick1, E. Barroso2
and T. M. Pawlik1
1Department of Surgery, Division of Surgical Oncology,
The Johns Hopkins University School of Medicine,
Baltimore, Maryland, Unites States; 2Hepato-Biliary-
Pancreatic and Transplantation Centre, Curry Cabral
Hospital, Lisbon, Portugal
Background: Two-stage hepatectomy has been proposed
for patients (pts) with bilateral colorectal liver metastases
(CRLM). We sought to assess feasibility and outcome of
two-stage approach for the treatment of CRLM.
Methods: From 2000–2008, 720 pts underwent CRLM
resection at two institutions. A two-stage approach was
planned in 45 pts. Therapeutic, operative and outcome
data were collected and analyzed.
Results: Of 45 pts considered for a two-stage approach,
35 (78%) completed both stages. Failure to undergo the
2nd stage included disease progression (n = 7), poor
performance status (n = 1) or death after 1st stage
(n = 2). Most pts underwent hepatic resection alone
(64%) without RFA. Compared with pts who completed
both stages, pts who failed to undergo the 2nd stage did
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not have a difference in tumor size (largest lesion: 5.0 cm
vs. 3.0 cm; p = 0.1), receipt of RFA (34% vs. 40%;
p = 0.7) or presence of extrahepatic disease (6% vs.10%;
p = 0.6). However, pts who completed both stages did
have fewer lesions vs. pts who failed to undergo the 2nd
stage (5 vs. 8; p = 0.02). Overall morbidity (24% vs.
26%; p = 0.9) and mortality (4% vs. 5%; p = 0.8) were
similar following the 1st vs. 2nd stage. While overall
median survival was 16 months, median survival of pts
who complete both stages was 39 months. Three-year
survival was 18% for pts who failed to undergo the 2nd
stage vs. 58% for pts who completed both stages
(P < 0.001). In fact, pts who completed the two-stage
approach had a similar survival as pts who were treated
with a planned single-stage hepatectomy (58% vs. 53%;
p = 0.3).
Conclusion: A two-stage strategy for CRLM can be
performed safely with acceptable morbidity and mortal-
ity. The 2nd stage will not be in feasible in 20–25% of pts.
However, for those pts who are able to complete the
two-stage, long-term survival is possible and may be
comparable to pts treated with a planned single-stage
hepatectomy.
FP-04
OUTCOMES FOLLOWING REPEATED
LIVER RESECTIONS FOR RECURRENT
COLORECTAL METASTASES
D. Czarnevicz, J. Vicente, O. Maglione, A. Mendez,
G. Andreoli and S. Cubas
Department of Surgery of IMPASA and Centro
Asistencial of Soriano (CAMS), Uruguay
Background: Hepatic resection is the only treatment that
can offer long-term survival in patients with colorectal
liver metastases, however nearly half of the patients will
develop recurrent disease.
Aims: Report the results and evaluate the risks, the
beneﬁts, the prognostic factors and the survival of repeat
hepatectomy for recurrent colorectal metastases.
Method: Retrospective review of our prospective data-
base identiﬁed 363 patients with liver resections due to
metastases of colorectal cancer from 1979 to 2008; 76 had
recurrence disease suitable for a repeat hepatectomy.
These 76 patients cumulated 104 hepatectomies (76 sec-
ond, 23 thirds, and 5 fourths). All repeated hepatic re-
sections were compared with the ﬁrst and between them
in terms of outcomes; prognostic factors were determined
by univariate and multivariate analysis.
Results: Morbidity was higher in repeat hepatectomies,
22.1%, as compared to ﬁrst hepatectomies, 6.8%
(p = 0.018). One patient died in the postoperative of the
fourth hepatectomy, but mortality showed no signiﬁcant
differences. Five years overall and disease-free survivals
after a repeat hepatectomies were 41% and 38%,
respectively; but when estimated from the time of ﬁrst
hepatectomy, overall survival was 49% and disease-free
survival 43%. Factors of prognostic value on multi-
variate analysis were, an interval between the two pro-
cedures of more than 1 year (p = 0.003), the number
of recurrent tumors (p = 0.021), and the size of the
metastases greater of 3 cm (p = 0.019).
Conclusion: Repeat liver resection because of recurrent
liver metastases from colorectal cancer is safe and
provides a survival beneﬁt similar to that with single
hepatectomy.
FP-05
DISSEMINATED TUMOR CELLS
NEGATIVELY INFLUENCE SURVIVAL
AFTER RESECTION OF COLORECTAL
LIVER METASTASES
S. Hinz1, J. Bockhorst1, C. Roeder2, T. Kuechler1,
H. Kalthoff2 and D. Broering1
1Department of General and Thoracic Surgery, University
Hospital Schleswig-Holstein, Campus Kiel; 2Insitute for
Experimental Tumor Research, University Hospital
Schleswig-Holstein, Campus Kiel
Aims/Objectives: Aim of this study was to analyse
prognostic factors for overall survival in patients with
resected colorectal liver metastases (CRLM). Special fo-
cus was set on the detection of disseminated tumor cells
(DTC) prior to resection of the metastases and quality of
live (QOL) after liver metastases resection.
Methods: One hundred and eight patients with a poten-
tially curative resection of CRLM (R0 or R1 resection)
were included in this study. Prior to the operation blood
and bone marrow blood was drawn and DTC were de-
tected with CK20 RT-PCR. For statistical analysis uni-
variate and multivariate testing was applied. Quality of
live (QoL) was measured using the EORTC QLQ-C30
questionaire.
Results: In 97/108 patients a R0 resection was achieved.
In 43/108 patients DTC were detected in the blood, but
only in 19/78 patients bone marrow specimen showed
DTC. Univariate analysis showed that detection of DTC
are a negative predictor for overall survival (OS)
(P = 0.05). In patients with > 1 CRLM, detection of
CRLM was highly signiﬁcant for a worse OS
(P = 0.0028). Furthermore, negative predictors for re-
duced OS were: postoperative transfusions (P = 0.04);
metastases size > 5 cm (P = 0.028); major liver resec-
tion (P = 0.001) and intensive care unit stay > 4 days
(P = 0.002). These factors did inﬂuence QOL (inter-
group differences > 10 points) without being statistically
signiﬁcant.
Conclusions: Detection of DTC in the blood is an
important factor for OS after resection of CRLM. This
supports the strategy to perform adjuvant chemotherapy
after R0 resection of CRLM to ﬁght ‘‘minimal residual
disease’’.
FP-06
THE IMPACT OF PORTAL VEIN
EMBOLIZATION ON LONG-TERM
SURVIVAL OF PATIENTS WITH
EXTENSIVE COLORECTAL LIVER
METASTASES
D. Azoulay, D. A. Wicherts, R. De Haas, S. De La
Serna, E. Vibert, C. Salloum, R. Adam and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Background: Portal vein embolization (PVE) increases
the resectability of patients with initially unresectable
colorectal liver metastases (CLM).
Aim: This study was to evaluate long-term survival in
patients with CLM that underwent hepatectomy follow-
ing PVE.
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Methods: All patients that underwent major hepatec-
tomy for CLM between January 1990 and January 2006
were selected for analysis. Patients treated by PVE before
hepatectomy were compared with PVE naı¨ve patients.
Results: Of 364 included patients, 67 (18%) underwent
PVE before hepatectomy and 297 (82%) were resected
without previous PVE. Thirty-two other patients treated
by PVE did not undergo resection. Resected PVE pa-
tients more often had > 3 liver metastases (68%vs. 41%)
(P < 0.001), that were more frequently bilobar (78%vs.
56%) (P < 0.001). PVE patients underwent more ex-
tended hepatectomies (63%vs. 19%) (P < 0.001). Post-
operative mortality rate was 2% (1/67) in the PVE group,
and morbidity occurred in 55% compared to 41% in the
control group (P = 0.035). Overall 3- and 5-year sur-
vivals were 44% and 21% for resected PVE patients, and
61% and 47% for resected PVE naı¨ve patients
(P = 0.001). All 32 PVE patients that did not undergo
hepatic resection died within 3 years.
Conclusion: PVE increases the resectability rate of pa-
tients with advanced CLM by 18%. Together with a
signiﬁcantly higher long-term survival than for nonre-
sected patients, these results conﬁrm the important value
of PVE in the multimodality treatment of patients with
extensive CLM.
FP-07
SPLENIC VOLUME AND AST-
PLATELETS-RATIO TO PREDICT
CHOTHERAPY-ASSOCIATED
HEPATOTOXICITY IN PATIENTS WITH
ADVANCED COLORECTAL CANCER
H. Nakano1, K. Yamada2, N. Miyajima3 and T. Otsubo1
1St. Marianna University Hospital/Department of
Gastroenterological Surgery; 2Kawasaki Tama Hospital/
Department of Surgery; 3St. Marianna University Toyoko
Hospital / Department of Surgery
Background: Advances of chemotherapy extended the
indication of hepatectomy in patients with colorectal
cancer (CRC) liver metastases. However, chemotherapy-
associated hepatotoxicity (CAH) cannot be disregarded
due to its higher incidence of postoperative complications
after major hepatectomy.1,2 Splenomegaly may indicate
portal hypertension due to CAH.
Aim: To elucidate chemotherapy-naı¨ve patients with li-
ver damage, splenic volume (SV) and AST-platelets-ratio
(APR) was investigated.
Methods: Patients receiving chemotherapy due to
advanced or recurrent diseases of CRC were selected.
Patients receiving FOLFIRI, FOLFOX, or FOLFOX +
Bevacizumab as the ﬁrst-line chemotherapy were in-
cluded. SV measurement was performed by Helical CT
volumetry, and SV index (SVI) was calculated (SV 6-
cycle-after-chemo / SV-before-chemo). AST-platelets-ra-
tio (APR) was used as the indicator of CAH and APR
index (APRI) was calculated (APR-6-cycle-after-chemo /
APR-before-chemo).
Results: There were 71 patients, including 16 of FOLF-
IRI, 40 of FOLFOX, and 15 of FOLFOX+Bev-
acizumab. SVI was signiﬁcantly higher in FOLFOX
group than in FOLFIRI group (1.17 +/- 0.34 vs. 0.98
+/- 0.21; P < 0.01, 1.09 +/- 0.21 in FOLFOX plus
Bevacizumab group). APRI was signiﬁcantly higher in
FOLFOX group than in FOLFIRI group (2.93 +/- 2.25
vs. 1.69 +/- 0.51; P < 0.01). A signiﬁcant correlation
between SVI and APRI was not found, but higher APR
before chemotherapy (> 0.15) was associated with
greater SVI, especially in patients with FOLFOX
(P < 0.05). The incidence of chemotherapeutic adverse
effects of Grade 3 or more was signiﬁcantly higher in
cases of SVI > 1.3 (P < 0.05).
Conclusions: The present study showed that splenomeg-
aly due to CAH can be predicted by APR before che-
motherapy (> 0.15), and that adverse events were
associated with higher SVI particularly in FOLFOX
group.
References:
1. Vauthey JN, et al. J Clin Oncol 2006; 24: 2065–2072.
2. Nakano H, et al. Ann Surg 2008; 247: 118–124.
FP-08
OBESITY RATHER THAN
NEOADJUVANT CHEMOTHERAPY
PREDICTS FOR LIVER INJURY IN
PATIENTS WITH COLORECTAL
METASTASIS
M. Bower, R. Brown, C. Scoggins, R. Martin and
K. McMasters
University of Louisville
Background: Neoadjuvant chemotherapy has been
associated with increased risk of surgery due to chemo-
therapy associated liver injury (CALI). Obesity has been
suggested as a predictor of CALI. The aim of the current
study was to assess for predictors of CALI, and to
determine the role of obesity in liver injury in patients
with colorectal liver metastasis (CLM).
Methods: An IRB-approved prospectively maintained
data base of patients who underwent hepatic procedures
for CLM from 2001 to 2009 was reviewed. All patients
with pathologic analysis of non-tumor bearing liver
parenchyma were included. Univarariate and multivari-
ate analysis were used to determine predictors of steatosis
and steatohepatitis. Patients who received 5-FU, oxa-
liplatin, bevacizumab, or irinotecan preoperatively were
included in the chemotherapy group.
Results: A total of 208 patients were included in the
analysis: 156 who received neoadjuvant chemotherapy
and 52 who did not. The rate of pathologically-assessed
steatosis or steatohepatitis was similar between the group
that received neoadjuvant chemotherapy and the group
that did not (23% vs. 17%, respectively, P = 0.223. The
rate of obesity [Deﬁned as body mass index (BMI)
>30 kg m-2] was 36% overall, and among obese patients
the rate of steatosis or steatohepatitis was 39%. Steatosis
or steatohepatitis was seen in 40% of obese patients
receiving chemotherapy and 37% of obese patients not
receiving chemotherapy (P = 0.652). On multivariate
analysis, BMI was the only predictor of steatosis or ste-
atohepatitis; neoadjuvant chemotherapy, diabetes, sleep
apnea, alcohol use, tobacco use, age, and gender were not
signiﬁcant predictors.
Conclusions: Obesity is the strongest predictor of stea-
tosis and steatohepatitis in patients with CLM, and this
risk is independent of the use of neoadjuvant chemo-
therapy.
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LAPAROSCOPIC RESECTION FOR
COLORECTAL LIVER METASTASES:
DIFFERENCE IN OBSERVED OVER
PREDICTED (FONG’S AND BPI SCORES)
SURVIVAL
A. M. Kazaryan1,2, I. Pavlik Marangos1, B. I. Røsok2,
A. R. Rosseland2, T. Mala3, O. Villanger2, E. Fosse1,
Ø. Mathisen2 and B. Edwin1,2
1Interventional Centre, Rikshospitalet, Oslo University
Hospital; 2Division of Surgery, Rikshospitalet, Oslo
University Hospital; 3Surgical Department, Aker
Hospital, Oslo University Hospital
Background: Laparoscopic liver resection has been re-
ported safe and feasible and improves postoperative
course. The oncologic outcomes following resection of
colorectal metastases are poorly reported.
Objective: Analyze oncologic outcome following lapa-
roscopic resection of colorectal liver metastases and dif-
ference between observed and predicted survival.
Methods: Patients with colorectal liver metastases
undergoing laparoscopic resection between August 1998
and July 2009 at Rikshospitalet were included. The pa-
tients had mean Fong’s and BPI scores of 1.8 ± 1.2 and
6.9 ± 3 as laparoscopically completed cases and
1.8 ± 1.2 and 7 ± 3.6 as intent to treat. Follow up was
median 24 (0–100) months.
Results: One-hundred and ﬁfty one liver resections were
performed in 107 patients during 118 procedures. The
resection margin was free of tumor tissue in 141/151
(93%) specimens, and the distance between resection
margin and tumor tissue was median 6 (0–40) mm.
During follow-up 21 patients received repeat liver resec-
tion of recurrences (11 by laparoscopy and 10 by lapa-
rotomy). The 5 year overall actuarial survivals were
51%, as laparoscopically completed cases and 47% as
intent to treat. The observed actuarial survival values
surpasses the values expected by Fong’s and BPI scores
on 10% and 7% as laparoscopically completed cases and
4% and 2.5% as intent to treat.
Conclusion: Laparoscopic resection is associated with
favourable long-term oncologic outcome if compared
with values expected by preoperative patient scoring.
FP-10
THE ACCORDION GRADING SYSTEM
OF SURGICAL COMPLICATIONS
PREDICTS OUTCOME FOLLOWING
RESECTION OF COLORECTAL LIVER
METASTASES. THE SURGEON DOES
MATTER!
C. Spiro, T. Ramacciotti, J. Choi, J. S. Samra and
T. J. Hugh
Royal North Shore Hospital
Multi-modal therapy, including liver resection, offers
long-term survival and even cure in selected patients
with colorectal liver metastases. Recently, the Accor-
dion severity grading system was proposed to standard-
ise deﬁnitions of post-operative complications
(Strasberg et al, 2009). An analysis of our prospective
database of 195 consecutive liver resections was under-
taken to determine whether the Accordion Severity
Grading System could predict long-term outcome
following resection. All clinical and pathological data
were evaluated by univariate and multivariate analysis
using Cox’s proportional hazard model. Over an eight
year period (1999 to 2007), 435 patients with colorectal
liver metastases were referred to our unit and 195
subsequently underwent a potentially curative liver
resection. The median age was 65 years (27–87 years)
and 51% of patients had a major liver resection (‡ 3
Couinard segments). The overall major post-operative
morbidity (Accordian grade 3, 4 or 5) in this group was
18.5% (36/195). Of these, two patients had grade 3, nine
had grade 4, and 25 had grade 5 complications. Only
13.8% (27/195) of patients in this study received a peri-
operative blood transfusion. The overall in-hospital
mortality was only 2% (4/195). Patients were followed
up for a mean period of 29 months (0–96 months) and
the 5-year overall and disease-free survivals were 52%
and 25%, respectively. Only an elevated pre-resection
serum CEA level (P < 0.017), male sex (P < 0.032),
involved liver resection margins (P < 0.03), and severe
(grades 3, 4, or 5) post-operative complications
(P < 0.017) were independent predictors of poor long-
term survival. The results of this study conﬁrm the
negative impact of adverse post-operative outcomes on
long-term survival following liver resection. Achieving
clear microscopic resection margins is also important
and, together, these factors highlight the critical role of
the surgeon in treating this disease.
FP-11
CONCOMITANT EXTRAHEPATIC
DISEASE IN PATIENTS WITH
COLORECTAL LIVER METASTASES:
WHEN IS THERE A PLACE FOR
SURGERY?
R. De Haas, D. Wicherts, D. Azoulay, D. Castaing and
R. Adam
Hoˆpital Paul Brousse, Centre He´pato-Biliaire
Background: Although recognized as poor prognostic
factor, concomitant extrahepatic disease (EHD) is no
more considered an absolute contraindication to surgery
in patients with colorectal liver metastases (CLM).
However, the impact of the location of EHD on survival
and the real beneﬁt in patient outcome is still diversely
appreciated.
Aim: To determine the impact of EHD on survival and
patient outcome in a consecutive series of patients treated
by an oncosurgical approach, combining repeat surgery
and chemotherapy.
Methods: From 840 patients resected for CLM between
1990 and 2006, 186 (22%) also had resectable EHD.
Sequential surgery was routinely combined with periop-
erative chemotherapy. Survival was compared with that
of patients without EHD, prognostic factors were iden-
tiﬁed, and a predictive model was designed to better se-
lect surgical candidates.
Results: Patients resected for CLM with concomitant
EHD experienced a lower 5-year survival than those
without EHD (28% vs. 55%, P < 0.001). Five poor
prognostic factors were identiﬁed at multivariate analy-
sis: EHD-location other than lung metastases (5-year
survival: 23% vs. 33%, P = 0.02), EHD concomitant to
CLM recurrence (14% vs. 34%, P < 0.001), CEA-level
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> 10 ng ml-1 (16% vs. 37%, P = 0.02), > 6 CLM (9%
vs. 32%, P = 0.02), and right colon cancer (P = 0.02).
Five-year survival ranged from 64% (0 factors) to 0%
(> 3 factors). In the EHD group, patients with an EHD-
recurrence experienced better outcomes when resected
than those treated by chemotherapy alone (5-year sur-
vival: 38% vs. 21%, P = 0.05).
Conclusion: While sequential surgery is warranted for
patients with < 5 CLM with isolated lung metastases,
low CEA-levels, and no right colon primary tumor, it
should be questioned in the presence of more than three
of these prognostic factors.
FP-12
DRAIN DATA TO PREDICT CLINICALLY
SIGNIFICANT PANCREATIC LEAK
D. Moskovic, S. Hodges, M-F. Wu, S. Hilsenbeck,
F. C. Brunicardi and W. Fisher
The Elkins Pancreas Center at Baylor College of Medicine
Background: Postoperative pancreatic leak (POPL) is a
common and potentially devastating complication of
pancreas resection. Management of this complication is
important to the pancreas surgeon.
Objective: To determine whether drain data accurately
predicts clinically signiﬁcant POPL.
Methods: A prospectively maintained database with
daily drain amylase concentrations and output volumes
from 177 consecutive pancreatic resections was analyzed.
Drain data, demographic, and operative data were cor-
related with POPL (ISGPF Grade: A – clinically silent, B
– clinically evident, C – severe) to determine predictive
factors.
Results: Twenty-ﬁve (44.6%) of 56 patients who under-
went distal pancreatectomy and 47 (38.8%) of 121 pa-
tients who underwent a Whipple procedure developed a
POPL (Grade A-C). POPLs were classiﬁed as A (24,
42.9%), and C (1, 1.8%) after distal pancreatectomy
while they were graded as A (30, 24.8%), B (13, 10.8%),
and C (4, 3.3%) after Whipple procedures. Drain data
analysis was limited to Whipple procedures because only
one patient developed a clinically signiﬁcant leak after
distal pancreatectomy. The daily total drain output did
not differ between patients with a clinical leak (Grades
B&C) and patients without a clinical leak (no leak &
Grade A) on postoperative day (POD) 1–7. The median
of amylase concentration was signiﬁcantly higher on
POD 1–4 (P < 0.05, Wilcoxon rank sum test) but not
different on POD 5–7 between the two groups. Although
POD1 amylase concentration, but not POD2–7, predicts
clinical leak better than chance (maximum POD1 accu-
racy = 83.3%, expected accuracy by chance = 77.0%,
kappa = 27.5%), it is not more accurate than classifying
all patients as ‘no leak’ (accuracy = 82.6%).
Conclusion: Drain amylase data in the early postopera-
tive period is not a sensitive or speciﬁc predictor of which
patients will develop clinically signiﬁcant POPL after
pancreas resection.
FP-13
DELAYED GASTRIC EMPTYING AFTER
PYLORUS-PRESERVING
PANCREATICODUODENECTOMY:
VALIDATION OF ISGPS
CLASSIFICATION AND ANALYSIS OF
RISK FACTORS
G. Malleo, S. Crippa, S. Partelli, G. Butturini, R. Salvia,
R. Rossini, M. Bacchion, M. Paini and C. Bassi
G.B. Rossi Hospital, University of Verona, Verona, Italy
Background: Delayed gastric emptying (DGE) is a major
complication after pancreaticoduodenectomy (PD), and
leads to patient discomfort, prolonged hospitalization
and increased costs. Its incidence, clinical presentation
and risk factors widely varied in past studies due to the
lack of an objective deﬁnition.
Aim: To evaluate our experience with DGE after PD
employing the ISGPS consensus deﬁnition, and to clini-
cally validate the deﬁnition itself and the grading system.
Methods: Demographic, pathological and surgical de-
tails from 260 consecutive patients undergone PD be-
tween November 2007 and October 2009 were analyzed.
Clinical presentation and grading of DGE, postoperative
parameters associated with DGE and risk factors were
evaluated with uni- and multivariate models.
Results: Perioperative mortality was nil, surgical mor-
bidity was 41.5%. The incidence of DGE was 13.8%.
Among DGE patients, 44% were grade A, 50% grade B
and 5.6% grade C. Discontinuation of nasogastric in-
tubation (P < 0.0001), resumption of a solid diet
(P < 0.0001), time to passage of stool (p = 0.002) and
hospital discharge (P < 0.0001) occurred signiﬁcantly
later in DGE patients. Total parenteral nutrition was
mostly required in grades B/C. In the univariate analysis,
abdominal collections (p = 0.0001), pancreatic ﬁstula
(P < 0.0001), biliary ﬁstula (p = 0.002), pulmonary
complications (P < 0.0001), and sepsis (p = 0.002),
were associated with DGE. Only abdominal collections
(p = 0.009), pancreatic ﬁstula (P < 0.0001) and sepsis
(p = 0.024) were associated to clinically relevant DGE.
There was no association with the route of duodenojeju-
nal anastomosis (antecolic vs. retrocolic). In the multi-
variate analysis, pancreatic (p = 0.004) and biliary ﬁstula
(p = 0.039) were independent risk factors for DGE.
Conclusions: ISGPS classiﬁcation and the grading system
well correlate with clinical course and are feasible for
patients management. Main risk factors for DGE seem to
be pancreatic and biliary ﬁstulas.
FP-14
LAPAROSCOPIC RESECTION OF LEFT
SIDE PANCREATIC TUMORS
UTILIZING TRANSCOLLATION
TECHNOLOGY TO MINIMIZE
PANCREATIC COMPLICATIONS
K. N. Lau and K. Watkins
Stony Brook University Medical Center
Background: Laparoscopic pancreatic tumor resections
have become mainstream procedures as surgeons become
more familiar with laparoscopic techniques. Complica-
tion rates remain relatively high with improvement in
length of stay. Approaches to laparoscopic resection have
not yet been standardized.
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Objectives: We chose to evaluate our initial experience
with laparoscopic distal pancreatectomy in terms of
operative results and short term outcome utilizing a
single approach.
Methods: A retrospective review of all patient charts
from 1/1/2005 to 9/1/2009 was conducted. All patients
with planned laparoscopic left pancreatic resection for
tumor were evaluated for operative time, blood loss,
length of stay and complications on an intention to treat
basis. All procedures were performed by a single surgeon
(KTW) and the pancreatic stump was managed solely
with the use of saline enhanced radiofrequency energy
(Transcollation) sealing of the pancreatic ducts.
Results: Thirty ﬁve patients were identiﬁed who were
taken for laparoscopic resection. Seven were spleen
sparing resections. Fifteen had solid tumors and 20
cystic lesions. Seven tumors were near the neck and
required transection of the pancreas to the right of the
portal vein. In hospital and 30 day morbidity and
mortality were 11.4% (4/35) (see table) and 0%
respectively. No pancreatic ﬁstulae were encountered.
Intraoperative drain was placed in only one patient.
Median (range) blood loss was 50 (5–500) ml, operative
time 206 (137–370) min, and length of stay 2 (1–7)
days.
Morbidity
Tumor Type Procedure Complication Intervention
Adenocarcinoma Distal Pancreatico-
Splenectomy
Atrial Fibrillation,
Hyperthyroidism
None
Adenocarcinoma Extended Left
Pancreatico-
Splenectomy
with Partial Portal
Vein resection
Portal Vein
thrombosis,
bleeding on
anticoagulation
Embolization
of bleeding
vessel
Adenocarcinoma Distal Pancreatico-
Splenectomy with
en Bloc Left
Adrenalectomy
Passage of kidney
stone,
possible pneumonia
None
IPMN Extended Left
Pancreatico-
Splenectomy
Readmission for
pain and nausea
None
Conclusions: The use of transcollation technology to
cause collagen shrinkage and occlude the pancreatic
ducts has promising initial results. Further investigation
is required to see if this technique can help to stan-
dardize an approach for laparoscopic distal pancreatic
resections.
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THE BENEFITS OF EARLY ENTERAL
NUTRITION AFTER PANCREATICO-
DUODENECTOMY: A RANDOMIZED
PROSPECTIVE STUDY
J. S. Park1, H. K. Chung2, H. K. Hwang1, J. K. Kim1,
S. I. Cho1, D. S. Yoon1 and H. S. Chi1
1Department of Surgery, Gangnam Severance Hospital/
Yonsei University Health System; 2Department of
Nutrition Service, Gangnam Severance Hospital/Yonsei
University Health System
Background: Pancreatoduodenectomy performed has
become increasingly safe and more efﬁcient, however, the
morbidity rate remains high. Recently, early postopera-
tive enteral feeding (EN) has been proposed as the novel
method for nutritional support after surgery. Neverthe-
less, pancreatic surgeons often prefer postoperative TPN
because of concerns about the possible adverse effects of
early feeding and increased risk of anastomotic leak. The
aim of this study was to evaluate whether early postop-
erative enteral feeding reduced the incidence of compli-
cations and length of hospital stay in patients following
pancreaticoduodenectomy.
Methods: This study has been conducted between May
2007 and December 2008. Patients were randomized to
received early enteral nutrition (n = 20) via nasojejunal
feeding tube or TPN (n = 20). Anthropometric param-
eters were checked on the pre and post operative day as
scheduled. PG-SGA was conducted on the pre and pos-
toeprative day as scheduled to assess the nutritional
status of the subjects.
Results: The general characteristics were not different
between two groups. The NPO period of EEN group was
shorter than the TPN group (2.1 days vs. 4.0 days,
P < 0.0001). The average period of EEN was 5.6 days
and the average period of TPN was 6.0 days. The mean
of weight loss was -4.0 kg in EEN group and –4.8 kg in
TPN group between pre-operation and POD 21. The
proportion of PG–SGA rating was less aggravated in
EEN group (11.1%, 1 of 9) than in TPN group (42.9%, 3
of 7) between pre-operation and POD 21, but not sta-
tistically signiﬁcant. Postoperative surgery related com-
plication was similar between both group, however the
rate of infections complications was lower in EN group.
The costs of EEN and PPN were about 8.2 USD/day and
53.2 USD/day, respectively.
Conclusion: EEN after PD decreased the cost of nutri-
tion support effectively. We could conclude that EEN
may replace TPN in patients undergoing PD safely and
effectively.
FP-16
PANCREATOGASTROSTOMY OR
PANCREATICOJEJUNOSTOMY AFTER
PANCREATODUODENECTOMY –
SINGLE-CENTER PROSPECTIVE
RANDOMIZED TRIAL
T. Keck, U. Wellner, F. Makowiec and U. Hopt
Department of General and Visceral Surgery, University of
Freiburg, Germany
Introduction: Retrospective analysis of pancreatoduo-
denectomies (PD) of over 200 patients at our institution
recently demonstrated a signiﬁcantly reduced postoper-
ative pancreatic ﬁstula (POPF) with pancreatogastros-
tomy PG) compared to pancreaticojejunostomy (PJ). A
prospective randomized trial was initiated in 2005 to
conﬁrm these results.
Materials and methods: Inclusion criteria were planned
pancreatoduodenectomy for malignancy or chronic
pancreatitis and age over 18 years. Exclusion criteria
were preoperative radiation or chemotherapy, cortico-
steroid therapy and liver cirrhosis grade Child B or C.
PG was performed as a double-layer inverted suture and
PJ employed the Warren Cartell technique with duct-
mucosa-anastomosis. Primary endpoint was the occur-
rence of POPF Grade B and C according to the ISGPS
deﬁnition. For statistical analysis, two sided Fisher’s
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exact test, binary logistic regression and Mann-Whittney-
U-Test of SPSS Version 15.0 were used.
Results: Since 2005, 59 patients were randomized. One
drop-out was excluded from the analysis. Histopatho-
logic examination revealed pancreatic carcinoma in
45% and chronic pancreatitis in 12% of cases. In
Interim analysis POPF grade A/B/C and grade B/C
occurred in 31% and 12% of patients and was signiﬁ-
cantly associated with ‘‘soft’’ pancreas (P < 0.001).
There was no signiﬁcant difference in the rate of POPF
Grade B/C between PG and PJ (10% and 14%). In the
subgroup of cases with soft pancreas (n = 30), the rate
of POPF Grade B/C was lower with PG compared to
PJ (11% vs. 36%, P = 0.16), constituting a non-sig-
niﬁcant trend.
Conclusion: The interim analysis of our prospective
randomized trial showed a trend, however not signiﬁcant,
toward a lower rate of POPF Grade B/C with PG,
especially in the subgroup of cases with a ‘soft’ pancreatic
remnant. We will continue the trial to the statistically
calculated endpoint of 110 included patients.
FP-17
THE BRIDGE-STENT TECHNIQUE FOR
SALVAGE OF PANCREATICOJEJUNAL
ANASTOMOTIC DEHISCENCE
T. Kent, M. Callery and C. Vollmer
Beth Israel Deaconess Medical Center/Harvard Medical
School, Boston, MA
Background: While infrequent, Grade C post-operative
pancreatic ﬁstulae (POPF) following pancreaticoduode-
nectomy (PD) are morbid and potentially lethal.
Traditional management of a disrupted pancreatico-
jejunostomy (PJ) anastomosis consists of either wide
external drainage or completion pancreatectomy.
Aims/Objectives: To describe an alternative management
approach to PJ dehiscence after PD.
Methods: A bridge-stent technique is employed in the
setting of a disrupted PJ anastomosis. Upon re-explora-
tion, a 5 or 8 F silastic feeding tube stent is placed across
a gap between the jejunal enterotomy and the pancreatic
duct, and secured with absorbable suture at both ends.
Depending upon the degree of local inﬂammation, this
may be externalized by coursing the stent down-stream
through the pancreaticobiliary drainage limb in a Witzel
fashion.
Results: Over eight years and 357 PD with duct-to
mucosa PJ reconstruction, 7 Grade C ISGPF ﬁstulas
occurred (2%). Two patients ultimately expired sec-
ondary to POPF (neither anastomosis was dehisced).
The described technique was used in the other ﬁve pa-
tients, all of whom had evidence of a dehisced PJ ana-
stomosis. All originally had at least two or three
recognized risk factors for POPF development (pathol-
ogy, soft gland, and PD £ 3 mm, EBL ‡ 1000 mL).
Table 1 illustrates the clinical presentation and technical
details of the reoperations. All patients survived this
complication, and were discharged from the hospital.
There have been no long-term external ﬁstulas, nor any
recognized PJ strictures or remnant atrophy (23 months
mean F/U).
Table 1. Patients managed with bridge-stent technique
for Grade C POPF
Diagnosis
Patient 1
Ampullary
Adenoma
Patient 2
Pancreatitis
Patient 3
Ampullary
Adenoma
Patient 4
Duodenal
Adenoma
Patient 5
Renal Cell
Metastasis
Gland texture Soft Soft Soft Soft Soft
Duct size 6 mm 2–3 mm 2 mm 2 mm 4 mm
EBL
(original
operation)
400 mL 600 mL 550 mL 500 mL 200 mL
Timing of
reoperation
POD 11 POD 6 POD 16 POD 13 POD 7
Symptoms Sepsis Sepsis Sepsis Change in
drain
output
character
Abdominal
Pain after
Drain
Removal
Gap 1.5 cm None 1 cm 2 cm 0.5 cm
Type of
Stent-Bridge
8 Fr
Internal
5 Fr
Externalized
5 Fr
Internal
8 Fr
Externalized
5F
Externalized
LOS 41 51 77 8 21
Conclusion: When the pancreas and jejunum cannot be
safely re-approximated, or when they can be apposed but
a duct-to-mucosa anastomosis cannot be accomplished,
the bridge-stent technique is a safe and effective man-
agement alternative contributing to diminished mortality
and salvaged pancreatic function.
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DOES POSITIVE BILE CULTURE
PREDICT POST-OPERATIVE
MORBIDITY IN PANCREATICO-
DUODENECTOMY?
T. C. W. Huey, A. W. C. Kow, B. Wang, C. Y. Chan,
C. K. Ho and K. H. Liau
Digestive Disease Center, Tan Tock Seng Hospital
Singapore
Background: Obstructed biliary system may lead to
bacterial overgrowth in a usually sterile bile. Presence of
bacteria in bile has also been postulated to lead to greater
risk of morbidity in pancreatic surgery. We study the
ﬂora of bactebilia in patients who underwent pancreati-
coduodenectomy (PD) in our institution.
Methods: We analysed 47 patients who had bile speci-
men collected between May 2005 to August 2008. We
deﬁned Group A as patients with positive bile culture
and Group B as sterile bile culture. The primary aim was
to study the bacterial ﬂora in the bile specimen. Sec-
ondary aim was to look for predictors of morbidity in
these patients in relation to positive bacterial growth.
Results: The mean age of this cohort was 63.5 ±
10.9 years. Majority of patients presented with jaundice
(72.3%) but only ten required biliary decompression pre-
operatively (21.3%). Eight of them had ERCP while
three required PTC for biliary drainage. One-third of
patients (32%) had positive bile culture (Group A), 40%
of them (n = 6) were monomicrobial and the remaining
nine (60%) had polymicrobial bile culture. Klebsiella
pneumonia was the most common organism. Prior
instrumentation did not increase the risk of polymicro-
bial growth in the bile (P = 0.09). The predictors for a
positive bile culture in Group A were prior instrumen-
tation like ERCP (P < 0.001) and higher pre-op biliru-
bin level (P = 0.01). There was no difference between
the two groups in terms of age, gender, race, pre-op
haemoglobin, AST, ALT, ALP level, type of anastomo-
sis. There was no statistical difference in the morbidity
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rate between the two groups (P = 0.55). Pre-op instru-
mentation (P = 0.85) and presence of bacteria in the bile
culture (P = 0.42) did not increase risk of Surgical Site
Infection (SSI) in this study.
Conclusion: Although pre-op biliary drainage and bili-
rubin level predisposes to positive bile culture, it has not
resulted in signiﬁcant increased risk of post-op
morbidity.
FP-19
PERIOPERATIVE BLOOD
TRANSFUSION AND OPERATIVE TIME
ARE QUALITY INDICATORS FOR
PANCREATICODUODENECTOMY
C. Ball1, H. Pitt1, M. Kilbane1, E. Dixon2, F. Sutherland2
and K. Lillemoe1
1Indiana University Hospital/Indiana University;
2Foothills Hospital/University of Calgary
Background: Allogenic blood transfusions increase the
risk of infection, acute lung injury, immunosuppression
and potentially cancer recurrence. Minimization of blood
loss during pancreaticoduodenectomy requires precise
dissection and careful surgical technique. Therefore,
packed red blood cell (PRBC) transfusions and operative
time are potential surgical quality indicators for pan-
creaticoduodenectomy.
Objective: To identify the associations between both
perioperative PRBC transfusion and operative time with
30-day outcomes following pancreaticoduodenectomy.
Methods: All patients who underwent a pancreatico-
duodenectomy were identiﬁed using the American Col-
lege of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP) database. PRBC transfusions
(within 72 hours) and operative time were correlated with
30-day morbidity and mortality. Correlation coefﬁcients
(R) were calculated.
Results: Pancreaticoduodenectomy was completed in
4817 patients. PRBC transfusions were given in 1559
(32%) patients (range: 1–35 units). Most (59%) operative
times were between 4 and 7 hours. Overall morbidity and
mortality rates were 37% and 3%, respectively. Overall
30-day morbidity increased in a stepwise manner with the
number of PRBC transfusions (R = 0.69, P < 0.01).
Although PRBC transfusions and operative times were
not statistically linked (P = 0.87), longer operative times
were linearly associated with increased 30-day morbidity
(R = 0.79, P < 0.001) and mortality (R = 0.65,
P < 0.01). Patients who were not transfused also dis-
played less morbidity (33%) and mortality (1.9%) than
patients receiving any volume of PRBCs (P < 0.05).
Discussion: Perioperative PRBC transfusion following
pancreaticoduodenectomy is associated with 30-day
morbidity in a stepwise manner. Longer operative time
also correlates with increased morbidity and mortality.
Therefore, avoidance of blood transfusions and pro-
longed operative time should be considered quality
indicators for pancreaticoduodenectomy.
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THE UNPREDICTABLE NATURE OF
PANCREATICOJEJUNOSTOMY
ANASTOMOTIC STRICTURES
A. Demirjian1,2, T. Kent1,2, M. Callery1,2 and
C. Vollmer1,2
1Beth Israel Deaconess Medical Center; 2Harvard Medical
School
Background: While early morbidity after pancreatico-
duodenectomy (PD) is well studied, less is understood
regarding long-term sequelae, including structural com-
plications like anastomotic strictures.
Aim: To describe our experience with the diagnosis,
management, and outcomes of post PD pancreaticoje-
junostomy strictures (PJS).
Methods: Patients treated for PJS were identiﬁed from
all PD (n = 357) performed in our practice. Technical
aspects of the original operation, as well as the pre-
sentation and management of the resultant stricture, were
assessed.
Results: Seven patients developed a PJS for an incidence
of 2%. Surgical indications for the original PD varied
(table). PJA was typically performed in a two-layer, duct-
to-mucosa fashion. Four glands were ‘‘ﬁrm’’, and three
were ‘‘soft’’. In just three patients was the duct noted to
be small (£ 3mm). An internal PJ stent was employed in
2/7. Pancreatic ﬁstula occurred in three patients. The
latency period from original resection to presentation
averaged 41 months. Patients presented with abdominal
pain (n = 7) and/or documented pancreatitis (n = 5).
Diagnosis of PJS was most commonly secured by secretin
MRCP. In four patients, therapeutic ERCP was at-
tempted – each was unsuccessful. All patients required
operative revision of their PJA by takedown/revision of
the original PJA (n = 4), ± a modiﬁed Puestow (n = 2).
The revised anastomosis was performed in one or two
layers, and a stent was used in four instances. One pa-
tient’s PJS was completely inaccessible due to dense ad-
hesions. Another’s stricture recurred and was successfully
revised with a stricturoplasty. At a mean follow-up of
25 months, all are alive, but only 4/7 are pain-free.
Table 1. Seven patients with PJS
Patient
Original
Diagnosis
Stricture
Presented
Operative
Intervention Follow-up Outcome
1 Serous Cyst
adenoma
120 months Revision of PJ
Anastomosis
39 months Persistent
Abdominal
Pain
2 Pancreatic NE
Tumour
16 months Revision of PJ
Anastomosis
34 months Symptom
Free
3 Chronic
Pancreatitis
8 months Revision of PJ
Anastomosis
56 months Persistent
Pancreatitis
4 Ampullary
AdenoCA
34 months Revision of PJ
Anastomosis –
Modiﬁed
Puestow
13 months Symptom
Free
5 Chronic
Pancreatitis
62 months Revision of PJ
Anastomosis –
Modiﬁed
Puestow
17 months Symptom
Free
6 GIST 17 months Exploration
with Intraop
ERCP-Pancreas/
Stricture
Inaccessible
11 months Persistent
Abdominal
Pain
7 Duodenal
Fibrosis
29 months Revision of PJ
Anastomosis
18 months Stricture
Recurrence,
Pancreatitis
(Same
Patient)
Pancreatitis 18 months Stricturoplasty 16.5 months Symptom
Free
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Conclusion: Occurrence of PJS appears to be indepen-
dent of original pathologic, glandular or technical fea-
tures. Secretin MRCP provides a useful, non-invasive
tool to identify these strictures, while ERCP has proven
therapeutically ineffective. Durable resolution of symp-
toms after surgical revision is unpredictable.
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SURGICAL TREATMENT OF CHRONIC
PANCREATITIS WITH FREY´S
PROCEDURE: ANALYSIS OF 73 CASES
(16 YEARS EXPERIENCE OF A
BRAZILIAN INSTITUTION)
M. A. Gestic, F. Callejas Neto, E. A. Chaim,
M. P. Utrini, E. Cazzo and J. C. Pareja
Clinical’s Hospital of State University of Campinas
(UNICAMP)
Background: Surgical treatment of chronic pancreatitis is
indicated for failure in clinical management of pain or
development of complications of the disease, like chole-
stasis secondary to compression of the bile duct. Frey´s
surgery (anterior enucleation of the pancreatic head
associated with longitudinal pancreatojejunostomy) is
one of the techniques available for intervention in this
process.
Objectives: Demonstrate the experience of 16 years (73
cases) of Clinical´s Hospital of State University of
Campinas (UNICAMP) in the treatment of chronic
pancreatitis using the technique of Frey.
Materials / Methods: Retrospective analysis of all pa-
tients underwent a Frey´s procedure for the treatment of
chronic pancreatitis from 1991 to 2007, with at least
1 year of follow-up. It have been studied the proﬁle of the
population, indications, perioperative complications and
late results in the control of pain and complications.
Results: The male sex was predominant (97.3%), with a
mean age of 40.7 years, body mass index (BMI) of
19.2 kg m-2. All patients had abdominal pain of daily
(46.6%) or weekly (35.6%) frequency and moderate/se-
vere (98.8%) intensity. Obstructive jaundice was present
in 41.1% of cases. The etiology of alcohol was predom-
inant (95.9%). The surgical morbidity rate was 41.1%,
and pulmonary complications were more frequent; there
were no deaths. Mean follow-up of patients was
77.0 months. 91.4% of patients became asymptomatic
and only one patient had recurrence of intense pain
symptoms. Operated patients showed on follow-up
higher rates of steatorrhea, diabetes mellitus and
improvement in BMI (P < 0.001).
Conclusion: Frey´s procedure showed a safe and effective
therapeutic option for the surgical treatment of patients
with intractable pain or biliary compression caused by
chronic pancreatitis.
FP-22
DRAIN FLUID ANALYSIS POST
PANCREATICODUODENECTOMY –
ARE WE ANY WISER? A 10-YEAR,
RETROSPECTIVE ANALYSIS OF 558
PATIENTS
P. T. Cherian1, C. Coldham2, S. R. Bramhall2,
D. F. Mirza2, J. Buckels2 and D. Mayer2
1Kings College Hospital; 2University Hospital,
Birmingham
Aim: Many units monitor drain amylase (DA) levels to
detect anastomotic leaks after pancreaticoduodenectomy
(PD) despite its unproven beneﬁt. We re-explore this
dogma with data from a high volume center.
Methods: Our prospective pancreatic database was re-
viewed to identify all patients who had undergone PD,
their complications and outcome. Clinical records of all
patients with a raised DA were retrieved and relevant
details collated and analyzed.
Results: From 1998 to 2007, 558 PDs were performed at
our centre. DA was routinely measured on the 5th post-
operative day. A DA greater than twice the upper limit of
the serum reference range was considered elevated. There
were 101 (18%) such patients, median age 62 years but
data was missing in 27. Amongst the 558 patients, there
were 60 (10.7%) clinical leaks (CL). Overall median
survival was 25.5 months, compared to 14.7 in those with
a CL (P < 0.001). Of the 74 with a raised DA, we de-
tected 37 (50%) patients who had suffered a CL (9 nee-
ded operative intervention), leaving 23 CL with a DA less
than 200. Median Survival in those with raised DA was
20.0 months compared to 26.4 in those without. The leak
rate in whom the pancreas was documented to be soft
was 80% compared to 43% in the others (OR 5.6; 95%
CI 1.39–22.7). The leak rate in patients with DA < 1000
was 34% vs. 62% in those with DA > 1000. Many pa-
tients (61%) who had drain volume > 200 mL/s had a
CL. Except for a bleed from a drain site on removal, no
drain caused signiﬁcant morbidity.
Conclusions: Post-PD the accuracy; positive and negative
predictive value of raised DA is 86%; 50% and 95%
respectively, suggesting drain ﬂuid analysis is potentially
corroborative in diagnosis despite a low positive pre-
dictive value. As of low morbidity we would recommend
its routine use. The prognosis is worse for patients with a
raised DA. There is a positive association between an
anastomotic leak and a ‘‘soft’’ pancreas.
FP-23
MOLECULAR MECHANISM OF
DIFFERENT 18F-FLUORODEOXY-
GLUCOSE UPTAKES IN
HEPATOCELLULAR CARCINOMA AND
METASTATIC LIVER TUMORS
K. Izuishi, T. Sano, R. Takebayashi, S. Akamoto,
T. Inoue, K. Kakinoki, M. Hagiike, K. Okano, H. Usuki
and Y. Suzuki
Department of Gastroenterological Surgery, Kagawa
University
Background: Positron emission tomography with 18F-
ﬂuorodeoxyglucose (FDG-PET) is widely used for
detecting malignant tumors and liver metastases from
Abstracts22
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
colorectal cancer (LMC), whereas FDG uptake is low in
hepatocellular carcinoma (HCC).
Aim: To examine molecular mechanisms underlying
detection of FDG-PET in liver tumors, we compared
gene expressions of glucose metabolizing proteins in
HCC and LMC.
Methods: We examined 18 patients (10 HCC and 8
LMC) undergoing FDG-PET and hepatectomy. To
examine relationships between maximal standardized
uptake values (SUV) in tumors and glucose metabolizing
protein expressions, mRNA expressions of Hexokinase
(HK)-1 and -2, Glucose transporter (GLUT)-1, and
glucose-6-phosphatase (G6Pase), were determined in
snap-frozen hepatectomy specimens by real-time poly-
merase chain reaction (RT-PCR).
Results: The detection rate was lower in HCC (7/10) than
LMC (8/8). The SUV was also lower in HCC (5.7) than
LMC (8.1) (means). Expressions of HK-1 and GLUT-1
(rate limiting enzyme or transporter for FDG uptake)
were lower in HCC (0.42) than LMC (2.46) (mean, can-
cer/normal tissue ratio). However, G6Pase (enzyme
eliminating FDG) expression was higher in HCC (0.90)
than LMC (0.02). Interestingly, two poorly differentiated
HCC showed quite different FDG uptakes (SUV, 14.0 vs.
3.6) and mRNA expressions (G6Pase expression, 0.01 vs.
1.11) compared with moderately differentiated HCC.
Conclusion: Variations in FDG uptake and expressions
of glucose metabolizing enzymes in HCC and LMC are
attributable to differences in origin. In HCC, low GLUT-
1 expression, and high G6Pase expression contributed to
low FDG uptake. High FDG accumulation in poorly
differentiated HCC might reﬂect decreased G6Pase
expression.
FP-24
NEW THERAPEUTIC AND DIAGNOSTIC
POTENTIAL OF CARBON DIOXIDE-
INSUFFLATED CHOLANGIO-
PANCREATOGRAPHY FOR ACUTE
CHOLANGITIS AND PANCREATITIS
M. Sugimoto1,2, T. Sanuki1, T. Azuma1 and H. Yasuda2
1Kobe University Gastroenterology; 2Teikyo University
Chiba Medical Center Surgery
Background/Aim: We evaluated new therapeutic and
diagnostic potential of carbon dioxide insufﬂation and
irrigation for acute cholangitis and pancreatitis in carbon
dioxide enhanced cholangiopancreatography.
Method: In 75 cases that were undergone biliary or
pancreatic external drainage, carbon dioxide enhanced
MDCT cholangiopancreatography was performed
under percutaneous or transpapillary infusion of carbon
dioxide. 3-D reconstruction was incorporated using
OsiriX imaging application. The capability of carbon
dioxide to delineate the biliary and pancreatic system
was evaluated.
Result/Discussion: All procedures showed complete
technical success; complications including cholangiitis,
pancreatitis, or pain never occurred. All infected cho-
langitis immediately recovered after carbon dioxide irri-
gation (100%). The incidences of visible third- and
fourth-order biliary branches were 100% and 86.0%. The
capability of carbon dioxide to pass an obstruction
through an occluded hilar bile duct malignancy was
80.0%; it provided feasible drainage and information on
additional bile duct segments. The main or second-order
pancreatic ducts were visible in 100% and 83.3% of the
studies, respectively. Carbon dioxide enabled the
replacement of the bile, mucin, and pancreatic juice and
facilitated the irrigation and detection of cystic lesions of
IPMN in 75.0% of the studies. We succeeded in achiev-
ing 3D spatial recognition of vascular structures in the
cholangiopancreatic region, through the fusion 3DCT
angiography in a single image scanning, and radiation
time was decreased. This combined modality proved to
be feasible for preparing and planning operations and for
image-guided navigated surgery in the resection of a
malignancy.
Conclusion: To our knowledge, this is the ﬁrst investi-
gation of carbon dioxide insufﬂation for cholangitis and
pancreatitis. Carbon dioxide possesses many advantages
over conventional iodinated contrast agents, and it might
replace more invasive diagnostic measures.
FP-25
ARRAY COMPARATIVE GENOMIC
HYBRIDIZATION IDENTIFIES NOVEL
POTENTIAL THERAPEUTIC TARGETS
FOR CHOLANGIOCARCINOMA
S. McKay1,2, K. Unger1, S. Pericleous1,2, D. Spalding1,
R. Hutchins2, G. Thomas1 and G. Stamp1
1Hammersmith Hospital, Imperial College; 2Barts and The
London, University of London
Introduction: Cholangiocarcinoma is a rare tumour with
a dismal prognosis. Conventional medical management
alone offers minimal survival beneﬁt. Cholangiocarci-
noma is a devastating malignancy, with surgery presently
offering the only chance of cure. Conventional chemo-
therapy is ineffective. We evaluated DNA copy number
alterations between intrahepatic (ICC), perihilar
(PHCC), and extrahepatic (ECC) cholangiocarcinoma
(CC), to identify novel therapeutic targets.
Method: We evaluated DNA copy number alterations
between intrahepatic (ICC), perihilar (PHCC), and
extrahepatic (ECC) cholangiocarcinoma (CC), to identify
novel potential therapeutic targets. Thirty ﬁve cases were
analysed (9 ICC, 13 PHCC, 13 ECC) using DNA ex-
tracted from sections of FFPE tissue. BAC array Com-
parative Genomic Hybridization (aCGH) was performed
to identify copy number alterations (CNA). ArrayCGH
was performed using an Agilent platform, with micro-
array slides containing 3400 BAC clones covering the
whole human genome. Analysis was with R-Package.
Results: CNAs were least frequent among ECC. Gains at
17q12, 17p13.3-q21.33, 17q22-q25.3, and 22q11.1-q13.3
were found in all cases and differing proﬁles were found
between tumours from different anatomical sites. ICC
and PHCC showed common regions of CNA at 11q12.2-
q13.4, 19p13.11-p13.3, 19q13.11-q13.43. The common
alterations seen on 17q12, 11q12.2-q13.4, which repre-
sent potential ampliﬁcation of the Her2 and VEGF-B
genes, respectively suggest that agents targeted to these
two factors may be clinically useful in some CC. A lower
frequency of gain of 7p11.2, which harbours the EGFR
gene may also suggest the possible use of EGFR inhibi-
tors. Interestingly, gain of this region was not identiﬁed
in ECC.
Conclusion: This study illustrates the genetic variability
of CC, highlights several potential therapeutic targets,
and indicates the need for molecular stratiﬁcation of
these patients prior to treatment.
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NOVEL 3D LAPAROSCOPIC MAGNETIC
IMAGE GUIDANCE MAKES LESION
TARGETING CHILD’S PLAY
D. Sindram, K. N. Lau, I. H. Mckillop, J. B. Martinie
and D. A. Iannitti
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, NC
Introduction: Laparoscopic liver lesion targeting for
biopsy or ablation depends on the surgeons’ ability to
merge laparoscopic and ultrasound images with propri-
oceptive positioning of instruments. This is a difﬁcult
skill, acquired by extensive experience. Currently, no
laparoscopic guidance system is available. Using mag-
netic positional tracking we can provide 3D real-time
guidance during laparoscopic needle placement.
Hypothesis: 3D magnetic guidance improves hit rates
during laparoscopic needle placement.
Methods: Directional sensors were embedded into a
needle and laparoscopic ultrasound transducer. These
sensors interrupted the magnetic ﬁelds produced by a
electromagnetic ﬁeld generator, allowing for real-time 3D
guidance on a stereoscopic monitor. 5 mm egg-whites
were embedded 4 cm deep in agar and placed inside a
laparoscopic trainer box. Two novices (college student
and intern) and two experts (HPB surgeons) targeted the
lesions out of plane using either traditional or 3D guid-
ance in randomized fashion. One attempt per lesion was
permitted without change of needle course once com-
mitted to angle of approach. Hit rates were determined
with two-plane ultrasound conﬁrmation. A chi-square
test was used for analysis.
Results: Each subject targeted 22 lesions, 11 with the
novel guidance (n = 88). 14/44 (32%) hits were observed
with the traditional approach vs. 44/44 (100%) with the
3D magnetic guidance. Novices were essentially unable
to hit targets traditionally, but did not miss using the
system, experts improved from 13/22 (59%) to 22/22
(100%) (P < 0.0001).
Conclusions: The novel magnetic 3D laparoscopic ultra-
sound guidance results in perfect targeting of 5 mm
lesions, even by surgical novices.
FP-27
ASSESSMENT OF LIVER FUNCTION IN
PRIMARY BILIARY CIRRHOSIS USING
GD-EOB-DTPA-ENHANCED LIVER MRI
H. Nilsson1, A. Nordell2, L. Douglas2, L. Blomqvist3,4
and E. Jonas1
1Karolinska Institutet; Department of Clinical Sciences,
Danderyd Hospital, Division of Surgery, Stockholm,
Sweden; 2Department of Medical Physics, Karolinska
University Hospital, Stockholm, Sweden; 3Department of
Diagnostic Radiology, Karolinska University Hospital
Solna, Institution for Molecular Medicine and Surgery
Karolinska Institutet, Stockholm, Sweden; 4Department of
Diagnostic Radiology, Danderyd Hospital, Stockholm
Sweden
Background: To date, we lack a method to reliably
monitor liver function, global or segmental, in patients
with liver cirrhosis. Gd-EOB-DTPA is a gadolinium-
based contrast agent developed for Magnetic Resonance
Imaging (MRI), and is in clinical use for detection and
characterization of focal liver lesions. About 50% of the
administered dose is extracted by the hepatocytes with
subsequent elimination by biliary excretion. The
remaining 50% is eliminated through the renal pathway.
Due to this hepatocyte-speciﬁc property, dynamic Gd-
EOB-DTPA enhanced MRI has previously been tested in
animal models to evaluate hepatic dysfunction.
Aim/Objective: The aim of this study was to assess if the
uptake of Gd-EOB-DTPA differs between patients with
Primary Biliary Cirrhosis (PBC) and healthy controls,
and if this difference can be quantiﬁed using MRI.
Methods: T1-weighted dynamic Gd-EOB-DTPA-en-
hanced liver MRI was performed on 20 healthy volun-
teers and 12 patients with PBC. Informed consent was
obtained prior to inclusion and the study was approved
by the Regional Ethical Review Board. The hepatic
extraction fraction (HEF) of Gd-EOB-DTPA was cal-
culated as described by Nilsson et al (J Magn Reson
Imaging 2009;29(6):1323-1331) using truncated SVD for
deconvolutional analysis.
Results: The mean Child-score for the patients was 5.67
(range 5 to 7). Median HEF decreased by 20% in pa-
tients compared to controls (0.161 vs. 0.201, Mann-
Whitney U-test P < 0.01) and median HEF decreased
with increasing Child-score (P for trend < 0.001).
Conclusion: Even though the 12 patients had relatively
mild disease, a difference in hepatocellular function be-
tween healthy subjects and patients with PBC was iden-
tiﬁed using Gd-EOB-DTPA-enhanced liver MRI. We
therefore believe that dynamic hepatocyte-speciﬁc con-
trast – enhanced MRI (DHCE-MRI) has a potential role
as an imaging based liver function test. Due to the spatial
resolution of MRI, hepatic function can be assessed on a
local or segmental level.
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VIRTUAL HEPATIC SURGERY USING
NAVIGATION TECHNIQUES
G. A. Stavrou1, S. Weber2, N. Wendt3 and
K. L. Oldhafer1
1Department of General, Visceral and Thoracic Surgery,
Celle General Hospital; 2Artorg Center for Biomedical
Engineering Research; 3Fraunhofer MeVis, University of
Bremen, Bremen
Background: Modern imaging techniques, especially 3D
analysis of vascular territories have led to advances in
understanding functional anatomy of the liver. We can
actually perform the resections virtually and understand
the consequences of different resection strategies on the
vasculature of the liver remant, therefore allowing more
advanced and complex resections without risking post-
operative liver failure. With the implementation of ste-
reotactic navigation techniques into soft tissue surgery
transferring the virtual plan into the operation site be-
comes possible today.
Methods: Current research focuses on transferring the
virtual plan to the operation site. This is made possible
by using stereotactic navigation techniques combined
with dynamic intraoperative ultrasound. Landmark
structures in the liver are identiﬁed and stereotactically
registered into the virtual plan. After registering a ste-
reotactic dissection device resections can be performed
according to the virtually planned resection plane.
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Results: During this study conducted by a research
consortium* we have performed 6 successful resections in
our department using the method. The plan could be
followed in all patients, resulting in R0 resections. Post-
operative course was uneventful in all cases, no liver
insufﬁciency occured. Resections ranged from segmen-
tectomies and multipfocal atypical resections (8 in one
case) to hemihepatectomies. In one case, we managed to
resect a non-visible, non palpaple tumour that could not
have been resected otherwise.
Conclusion: Intraoperative navigation in liver surgery is
one of the most challenging ﬁelds today. Though some
issues as the dynamic deformation of the organ during
the operation and the simplifaction of the registration
process have not been completely solved yet, we can
present a working solution for the implementation of
virtual resection planning into the actual operation.
*Project Somit-Fusion funded by the German BMBF.
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WORKLOAD VERSUS WORKFORCE IN
HPB SURGERY: DETERMINING THE
NEED OF HPB FELLOWS
N. Rehil, G. Subhas, M. Jacobs and V. Mittal
Providence Hospital and Medical Centers, Southﬁeld, MI,
USA
Background: According to the National Hospital Dis-
charge Survey, 800,000 HPB surgeries were performed in
a year in U.S. The IHPBA, currently shows 18 HPB
fellowships which train 25 fellows annually and have
trained 121 total fellows since 1986.
Objective: This study was designed to determine whether
a need exists for more HPB fellows.
Methods: An electronic survey was created to collect
information regarding the training, practice type, and
case volume of HPB surgeries being performed by cur-
rently practicing surgeons. The survey was sent to a total
of 120 U.S. surgeon members of the IHPBA.
Results: Thirty six surgeons responded resulting in a
30% response rate. Of these, 58.3% practice at university
programs, 27.8% at community programs, and 13.9% at
both. 52.8% were formally trained in an HPB fellowship,
and 22.2% are currently training HPB fellows. The
majority perform 101-200 HPB cases per year (38.9%),
where as 30.6% perform < 100, 16.7% perform 201–300
cases, 11.1% perform 301–400 cases and 2.8% perform
> 400. including Of the 800,000 HPB surgeries, there are
118,000 operations on the liver, 649,000 surgeries of the
biliary tree and gallbladder (398,000 cholecystectomies),
and 30,000 pancreatic surgeries. According to the AC-
GME, general surgery residencies perform 8623 liver
cases, 10,336 pancreas cases and 112,074 biliary cases
annually. On average, each HPB surgeon performs 217
surgeries per year. This means available HPB surgeons
would only be able to cover about 53,000 cases annually,
which falls well below the U.S. workload of HPB surgery.
Conclusions: Based on current numbers, we feel the
workload for HPB surgeons outweighs the current
workforce in HPB surgery. Excluding the 130,000 resi-
dency cases and 398,000 cholecystectomies, the case load
for HPB surgeons is still not well met. As HPB surgery
numbers increase, so will the demand for surgeons
trained in this specialty. The best way to meet such trends
in HPB surgery is to train more HPB fellows.
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ULTRASOUND ELASTICITY IMAGING
FOR MONITORING OF THERMAL
ABLATION IN PATIENTS WITH LIVER
CANCER
M. C. Van Vledder, L. Assumpcao, H. Rivaz,
E. M. Boctor and C. A. Michael
Johns Hopkins University
Background: Thermal ablation is an accepted therapy for
small unresectable liver cancer. However, the reliability
of thermal ablation is limited by the inability to accu-
rately monitor and conﬁrm completeness of therapy in
real time. We have developed an ultrasound based elas-
ticity imaging method (USEI) which relies on the quan-
titative measurement of tissue elasticity.
Objectives: Capitalizing on the known reduction in
elasticity that occurs with protein denaturation and
dehydration during thermal therapy, we sought to
investigate the accuracy of USEI for real-time monitor-
ing of liver tumor ablation.
Methods: A model for hepatic tumors was developed
and elasticity images of ablated lesions were acquired in
multiple ex-vivo and in-vivo animal studies, comparing
to post-ablation CT scan and pathologic assessment. A
clinical pilot study was then conducted in patients
undergoing radiofrequency ablation for hepatic malig-
nancies using the USEI system during surgery. The size
of the thermal lesions on elasticity images was com-
pared to the lesion size on conventional B-mode ultra-
sound and post-ablation CT using a paired sample
t-test.
Results: In both in-vivo and ex-vivo animal studies as well
as in the clinical trial, the boundary of thermal lesions
were signiﬁcantly more conspicuous on USEI when
compared to B-mode imaging. Animal studies demon-
strated good correlation between the diameter of ablated
lesions on USEI and that on postoperative CT. More-
over, high quality strain images could be generated real-
time during therapy. There was good correlation between
the size of thermal lesions on USEI and postoperative CT
(± 5 mm).
Conclusions: The size of post-ablation thermal lesions on
USEI shows strong correlation with the lesion size on
postoperative CT-scanning and the actual size of the le-
sion on histopathologic examination. USEI could be a
valuable tool for the accurate monitoring and real-time
veriﬁcation of successful thermal ablation of liver
tumors.
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TRANSFORMING GROWTH FACTOR-
BETA DEPENDENT SUPRESSION OF
HEPATIC METASTASIS FROM COLON
CANCER
C. Are1, N. Simms1, A. Rajput2 and M. Brattain1
1Eppley Cancer Center, University of Nebraska Medical
Center, Omaha, Nebraska; 2University of New Mexico
Health Science Center, Albuquerque, New Mexico
Background: The role of transforming growth factor-
beta (TGF-beta) in the development of hepatic meta-
stasis from colon cancer is not clearly elucidated.
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Aim: The aim of this study was to determine the role of
TGF-beta in the development of hepatic metastasis from
colon cancer.
Methods: We have previously developed an athymic
orthotopic mouse model to study the process of metas-
tasis in colon cancer. Three human cell lines derived from
colon cancer were utilized: (a) FET-alpha cells (intact
TGF-beta inhibitory response), (b) GEO cells and (c)
CBS cells (defects in TGF-beta inhibitory response due to
deﬁciency in expression of Type I and II receptors
respectively). All three cell lines are known to form
invasive tumors at the primary colonic orthotopic site in
100% of implanted animals. The ability of these cell lines
to metastasize after development of primary colonic
tumor was analyzed.
Results: FET-alpha cells did not metastasize to the liver
but showed lung metastasis in 10%, whereas GEO and
CBS cells gave rise to prominent metastasis in greater
than 50% of the animals. Following elimination of TGF-
beta activity by transfection and overexpression of
dominant negative Type II receptor, FET-alpha cells
demonstrated liver and lung metastasis in 70% of the
animals. Similarly, following restoration of Type I and II
receptor activity by ectopic expression, GEO and CBS
cells formed metastasis in < 5% of the animals.
Conclusion: The results of our study demonstrate for the
ﬁrst time that, TGF-beta displays a selective metastasis
suppressor activity. This activity persists despite the loss
of tumor suppressor activity as noted by the uniform
formation of invasive primary colonic tumors. These
abnormal pathways can serve as selective targets for
future development of targeted therapies in the man-
agement of hepatic metastasis from colon cancer.
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METASTATIC/RESECTED LYMPH
NODE STATUS IS AN IMPORTANT
PROGNOSTIC FACTOR IN PANCREATIC
DUCTAL ADENOCARCINOMA
A. Rahman, S. Robinson, G. Sen, M. Jacob, R. Saif,
D. M. Manas, B. C. Jaques, R. M. Charnley and
S. A. White
Department of HPB/Transplant Surgery, Freeman
Hospital, Newcastle upon Tyne, UK
Background: Lymph node status is a recognised predic-
tor of survival in those undergoing pancreaticoduoden-
ectomy for ductal adenocarcinoma. The majority of
patients undergoing resection have T3 N1 disease but this
covers a broad spectrum of patients and therefore the
aim of this study was to identify other factors to assess
patient prognosis.
Methods: A prospective database of all patients under-
going pancreaticoduodenectomy between April 2002 and
June 2009 was analysed to identify patients with proven
pancreatic ductal adenocarcinoma. Patients with peri-
ampullary tumours, duodenal adenocarcinoma and
neuroendocrine carcinomas were excluded from analysis.
The histology reports for these patients were obtained
and characteristics of the resected tumour recorded. Uni-
variate and Multi-variate survival analysis was utilised to
identify factors useful in predicting long-term outcome.
Results: One hundred and thirty four patients [74
Male:54 Female; mean age 64 years (range 34–80)]
underwent pancreaticoduodenectomy for ductal adeno-
carcinoma over this time period. Overall 5 year survival
in this series was 18.6%. Univariate analysis identiﬁed
nodal status, metastatic to resected lymph node ratio,
vascular invasion and resection margin status as predic-
tors of survival. T stage was not a predictor of survival.
Cox regression analysis revealed only nodal status or
metastatic to resected lymph node ratio as independent
predictors of survival (P < 0.001). Metastatic to resected
lymph node ratio is better able to stratify prognosis than
nodal status alone with 5 year survival of those with N0
disease being 55.6% and 12.9% for N1 disease, however
for those with < 15% resected nodes positive 5 year
survival was 21.7% compared to 6.6% with > 15%
nodes positive (P = 0.0017).
Conclusion: The metastatic/resected lymph node ratio
can provide signiﬁcant prognostic information in those
with node positive disease after pancreaticoduodenecto-
my for ductal adenocarcinoma.
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ISCHEMIA/REPERFUSION INJURIES
AND EXPRESSION OF GENES
INVOLVED IN ANGIOGENESIS IN THE
RAT LIVER: EFFECTS OF ISCHEMIC
PRE- AND POSTCONDITIONING
A. R. Knudsen1, A-S. Kannerup1,
P. Funch-Jensen1, M. Kruhøffer2 and F. V. Mortensen1
1Department of Surgical Gastroenterology L, Aarhus
University Hospital, Aarhus, Denmark; 2Molecular
Diagnostic Laboratory, Aarhus University Hospital,
Skejby, Denmark
Background: Angiogenesis is an important part of liver
regeneration after hepatectomy. On the other hand a
strong proangiogenetic stimuli may theoretically pro-
mote the growth of hepatic micro metastases, as sug-
gested in several studies.
Aims: To assess how ischemia and ischemic pre- and
postconditioning affects the expression of pro- and an-
tiangiogenetic genes in the rat liver.
Methods: Fourty-eight male Wistar rats were random-
ized into ﬁve groups: (C) control; (I/R) ischemic; (IPC)
ischemic preconditioning; (IPO) ischemic postcondition-
ing; and (IPC+IPO) combined ischemic pre- and post-
conditioning. All rats except the control group were
subjected to 30 min of liver ischemia. Ischemic precon-
ditioning consisted of 10 min of inﬂow occlusion and
10 min of reperfusion. Ischemic postconditioning con-
sisted of three cycles of 30 sec inﬂow occlusion and 30 sec
of reperfusion. Liver biopsy and standard liver parame-
ters were sampled after 30 min of reperfusion. Total
RNA was extracted from the biopsy and used for
microarray analysis.
Results: ALAT increased signiﬁcantly in all ischemic
groups compared to group (C) (P = 0.010). Using
ingenuity pathway database a search for genes involved
in rat angiogenesis was performed and a total of 98 genes
were identiﬁed. When comparing the I/R group to group
C eight genes were signiﬁcantly affected (P £ 0.05).
When IPC was applied the number of genes of signiﬁ-
cance increased to 16 (P £ 0.05). The strongest angioge-
netic stimuli were detected in the IPO group where 44
genes were affected (P £ 0.05), 27 of these were up reg-
ulated. IPC+IPO affected 34 genes (P £ 0.05), with 27
up regulated. For further details, see table 1.
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Table 1. Describing the number of genes signiﬁcantly
(P £ 0.05) up (*) or down (¤) regulated under the
different forms of ischemia. Pro and anti angiogenetic
genes are genes known to up or down regulate the
formation of new blood vessels. Genes with different
modulating effects on angiogenesis is combined in the
last group ‘‘modulating genes’’
Group
vs. I/R
Pro angiogenetic
genes
Anti angiogenetic
genes
Modulating
genes
Up* Down¤ Up* Down¤ Up* Down¤
IPC 1 1 2 0 10 2
IPO 5 4 6 0 22 7
IPC+IPO 4 3 6 0 17 4
Control 2 0 0 1 1 4
Conclusion: Ischemic conditioning and especially ische-
mic postconditioning are potent activators of angioge-
netic genes and may in this sense affect the growths of
micro metastases.
FP-34
TUMOR MARKER EVOLUTION:
COMPARISON WITH IMAGING TO
ASSESS RESPONSE TO
CHEMOTHERAPY IN PATIENTS WITH
COLORECTAL LIVER METASTASES
R. De Haas1, D. Wicherts1, E. Flores1, M. Ducreux2,
F. Le´vi2, B. Paule2, D. Azoulay1, D. Castaing1,
A. Lemoine3 and R. Adam1
1Hoˆpital Paul Brousse, Centre He´pato-Biliaire; 2Hoˆpital
Paul Brousse, Department of Medical Oncology 3Hoˆpital
Paul Brousse, Department of Biochemistry
Background: The real clinical signiﬁcance of carcinoem-
bryonic antigen (CEA) and carbohydrate antigen 19.9
(CA19.9) evolution during preoperative chemotherapy
for colorectal liver metastases (CLM) is still unknown.
Aim: To explore the correlation between biological and
radiological response on chemotherapy, and their com-
parative impact on outcome after hepatectomy.
Methods: All patients resected for CLM at our hospital
between 1990 and 2004 with the following eligibility
criteria were included in the study: (i) preoperative
chemotherapy; (ii) complete resection of CLM; (iii) no
extrahepatic disease; (iv) elevated baseline tumor marker
values. A 20% change of tumor marker levels while on
chemotherapy was used to deﬁne biological response
(decrease) or progression (increase). Correlation between
biological and radiological response at CT-scan, and
their impact on overall (OS) and progression-free
survival (PFS) after hepatectomy were determined.
Results: Among 119 from 695 consecutive patients re-
sected for CLM who fulﬁlled the inclusion criteria, serial
CEA and CA19.9 were available in 113 and 68 patients,
respectively. Of patients with radiological response or
stabilization, 94% had similar biological evolution for
CEA and 91% for CA19.9. In patients with radiological
progression, similar biological evolution was observed in
95% of cases for CEA and in 64% for CA19.9. At
multivariate analysis, radiological response (but not
biological evolution) independently predicted OS. How-
ever, progression of CA19.9, but not radiological re-
sponse, was an independent predictor of PFS.
Conclusion: In patients with CLM and elevated tumor
markers, biological response is as accurate as CT-imag-
ing to assess ‘clinical’ response to chemotherapy. With
regards to PFS, CA19.9 evolution has even a better
prognostic value than radiological response. Assessment
of tumor markers could be sufﬁcient to evaluate che-
motherapy response in a palliative setting, limiting the
need of repeat imaging.
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A PHASE I TRIAL OF THERMODOX IN
PATIENTS UNDERGOING
RADIOFREQUENCY ABLATION (RFA)
OF LIVER TUMORS
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Background: RFA is accepted treatment for unresectable
liver tumors, but local recurrence is high.
Objective: We investigated the safety and pharmacoki-
netics of ThermoDox, a unique thermosensitive liposo-
mal formulation of doxorubicin. ThermoDox may
potentially augment local control by release of cytotoxic
drug at tumor margins during RFA.
Methods: In this phase I study, 12 liver cancer patients [3
hepatocellular carcinoma (HCC), 9 metastatic] received a
30 min intravenous infusion of ThermoDox, [30 mg m-2
(3 subjects), 40 mg m-2 (6 subjects) or 50 mg m-2 (3
subjects)]during RFA. Patients were assessed for safety,
pharmacokinetics (plasma PK) and tumor response.
Results: PK: The area under the concentration vs.. time
curve (AUC0-inf) for total doxorubicin is composed of
68.9% liposomal doxorubicin and 31.1% free doxorubi-
cin, indicative of high circulating concentrations of
liposomes. The geometric mean (Gmean) of AUC0-inf of
liposomal doxorubicin is 317 hr.ng ml m-1 per mg m-2 of
dose, Gmean of Cmax is 236.4 ng ml-1. per mg m-2 and
clearance is low at 3.15 L hr-1 m-2. The AUC of the
liposomal drug in the ﬁrst 6 hours (AUC0-6h) constitutes
almost 88% of the entire liposomal AUC (to inﬁnity)
suggesting adequate liposomal doxorubicin in the plasma
during the period in which RFA was performed.
Toxicity: There were no grade IV toxicities and 1 patient
had grade III toxicity. Grade I/II toxicities included
transient alopecia, pancytopenia, fatigue, nausea, diar-
rhea, and elevated LFT’s (n = 6).
Tumor response: Two complete responses (1HCC, 1
metastasis) and four partial responses were observed.
Conclusions: These PK data show that high plasma
concentrations of ThermoDox are available for thermal
release during the time of tumor RFA but thereafter
the overall exposure is minimized as the liposomes are
removed from the circulation. The excellent toxicity &
tumor response proﬁles of Thermodox have resulted in
the initiation of Phase III trial for HCC.
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HUMAN PILOT TRIAL OF NOVEL
REAL-TIME 3D AND VIRTUAL REALITY
(VR) GUIDED ULTRASOUND (US)
TARGETING SYSTEM DURING OPEN
MICROWAVE ABLATION (MWA) OF
LIVER TUMORS
D. Sindram, K. N. Lau, J. B. Martinie and D. A. Iannitti
Introduction: Accurate targeting of liver tumors for abla-
tion procedures or biopsy is critical. Intraoperative US is a
precise technique to identify tumors in the liver, however
subsequent insertion of an ablation or biopsy needles can
be challenging. It requires the surgeon to render the 2DUS
images, the position of the ultrasound probe and the po-
sition of the needle to plan the course of the needle through
the tissue into the tumor.We developed a systemaiding the
surgeon in this process by combining 3D positional
information obtained by stereoscopic infrared cameras
from reﬂectors on the ultrasound probe and ablation
needle, with aVR representation of theMWAantenna and
its projected course on a true 3D stereoscopic screen. The
US and VR images are fused in 3D in real-time. Preclinical
studies had demonstrated a statistically signiﬁcant
improvement in accuracy. We present the preliminary re-
sults of a pilot human trial of this system for open micro-
wave ablation procedures.
Method: An IRB approved pilot study including 10
consecutive patients undergoing open hepatic MWA is
ongoing. The targeting system was used to target lesions.
Accuracy data was accumulated by the surgeon and
conﬁrmed by a radiologist based on stored US images.
Tumor size, MWA system, and accuracy data was re-
corded, as well as any adverse events.
Results: Thus far, six patients have been enrolled in the
study to date. Twenty tumors with a mean size of 1.83 cm
(range 0.4–8 cm) were targeted. All lesions were hit with
100% accuracy in one pass. The location of the tumors
under the rib cage in two patients resulted in transient
line-of-sight issues for the system.
Conclusion: When the advanced image guidance system
was used, lesions were targeted with 100% accuracy for
microwave ablation, particularly in small tumors. There
were no system related adverse events. Line-of-sight is-
sues may require development of novel 3D positioning
modalities obviating the need for light reﬂection and
cameras.
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PROSPECTIVE STUDY ONMICROWAVE
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On behalf of the International Microwave Tumour
Ablation Group (IMTAG).
Background: Microwave ablation is now an established
and accepted modality for the treatment of hepatic
malignancy.
Aims: To assess the safety and efﬁcacy of a new 2.45GHz
microwave system for the treatment of liver tumours. The
preliminary results of a prospective trial including 250
liver tumours in 135 patients from 17 centres around the
world are presented.
Methods: Patients were chosen for ablation based on
accepted criteria and entered into this study. Patients
were treated with a new 2.45GHz microwave system
(Acculis, UK). Patients were treated either laparoscopi-
cally or at laparotomy; the majority were treated with
100 Watts. Most patients underwent ablation alone; 20%
had a concomitant liver resection. All patients were fol-
lowed up with standard cross-sectional imaging. Data
from all international centres was prospectively collected
onto a centralised UK database.
Results: One hundred and thirty ﬁve patients (94 males),
age 41–82 years were treated. Tumour aetiology included
colorectal metastases (58%), hepatocellular carcinoma
(32%) and others 10%. Average tumour diameter was
26 mm (range 5–70 mm). Mean follow up was 4 months
(1–21 months). The major complication rate was 1.5%
(n = 2); one patient bled and returned to theatre. An-
other had an oesophageal perforation secondary to av-
astin chemotherapy unrelated to the ablation. 30-day
mortality was 0.7% (n = 1) secondary to multi-organ
failure. The minor complication rate was 5.0% (n = 7).
The local recurrence rate was 5.0%.
Conclusion: 2.45GHz microwave is well tolerated and is
effective in ablating liver tumours. It is associated with
low local recurrence and mortality rates. Further follow
up is required to determine long-term outcomes.
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PREDICTORS OF RESPONSE TO
YTTRIUM-90 RADIO-EMBOLIZATION
(THERASPHERE) TREATMENT FOR
NEURO-ENDOCRINE LIVER
METASTASIS
M. Hassanain1, T. Cabrera2, P. Chaudhury1,
S. Dumitra1, M. Aljiffry1, I. Feteih2, S. Leduc1,
J. Rivera3, M. Jamal1, D. Valenti2 and P. Metrakos1
1McGill University Health Center, Department of General
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Background: Neuro-endocrine tumors (NET) frequently
metastasize to the liver. Most patients have diffuse dis-
ease and therefore are not curable. NET liver metastases
have been shown to respond to yttrium-90 microsphere
therapy. This study aims to deﬁne factors that predict
response to radio-embolization.
Method: All patients with NET liver metastasis who
underwent radio-embolisation at McGill University
Health Centre from January 2006 to March 2009 were
reviewed. Patients were radio-embolized with Thera-
Sphere (glass microspheres). Patients were followed
with triphasic CT-scans prior to, and 4 weeks after
treatment. Response was determined by measuring the
change in percentage of necrosis (DN%) after the ﬁrst
radio-embolization. Univariate and multivariate analyses
were carried out with the following variables: age, sex,
size of lesions, liver involvement (<33%, 33–66%,
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> 66%), WHO staging, extra-hepatic metastasis, oc-
tereotide treatment, and previous operative (surgery and
RFA) and non-operative treatments (chemo-emboliza-
tion and bland-embolization).
Results: Twenty ﬁve patients were identiﬁed, with a
median follow-up of 15.4 months. The average age was
63, 28% had extra-hepatic metastasis, and 82% were
WHO stage 1. Post treatment, the mean DN% was 41%,
and 63% had > 30% DN%. WHO staging, previous
surgical therapy, and bilateral disease were the signiﬁcant
predictors of response. Patients who had a previous
operative intervention had a higher response rate of 78%
vs. 31% (P 0.001), liver involvement of less than 66% had
a higher response rate of 63% vs. 35% (P 0.004), and
bilateral disease was associated with a decreased rate of
response 46% vs. 63% (P 0.02).
Conclusion: Radio-embolization increased necrosis of
NET liver metastasis. The beneﬁt is mainly seen in pa-
tients with less bulky disease. This data warrants a larger
prospective study using aggressive surgical debulking in
combination with radio-embolization in patients with
multiple NET liver metastases.
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2250 CONSECUTIVE HEPATECTOMIES
FOR LIVER TUMORS AT A SINGLE
CENTER: THE REVERSED VOLUME –
OUTCOME RELATIONSHIP
D. Azoulay, G. Pascal, C. Salloum, S. De La Serna,
E. Vibert, R. Adam and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Aim: To assess the changes in hepatectomy over the last
20 year period.
Methods: From 1985 to 2005, 2250 consecutive hepa-
tectomies (1831 ﬁrst, 333 second, 72 third, 13 fourth, 1
ﬁfth) were performed. Operative morbidity and mortality
were analyzed from a prospective database. Trends over
the study period were analyzed.
Results: The diagnosis were colorectal metastases
(n = 1100, 49.3%), primary hepatic or biliary cancers
(n = 625, 27.9%), miscellaneous malignant disease
(n = 355, 15.8%), and benign disease (n = 169, 7.1%).
The liver parenchyma was normal in 1756 cases (78.0%),
cirrhotic in 237 cases (10%), ﬁbrotic in 106 cases (5%),
steatotic in 110 cases (5%), cholestatic in 41cases (2%).
Resections were performed without vascular clamping in
475 cases (21.1%) and needed in 1775 cases (78.9%)
some form of clamping ranging from triad clamping to
total vascular exclusion. Blood transfusion ranged from 0
(771 cases, 34.3%) to 76 RPC (mean = 1.7 + 4.5 RPC).
Morbidity rate was 29% and mortality rate was 2.4%.
With experience, indications for liver resection were
widened to signiﬁcantly more severe patients, and/or
signiﬁcantly more complex procedures. This was realized
at the price of signiﬁcantly increased morbidity and
mortality rates (from 1985–1995 vs. from 1995–2005,
morbidity and mortality rates were 21.6% vs. 34.4%
P < 0.0001) and 0.9% vs. 2.9% (P = 0.01) respectively.
Mortality and morbidity rates were similar when com-
paring patients of similar severity and/or resections of
similar complexity.
Conclusion: As liver resection is the only chance of cure
for most liver tumors we have favored the use experience
as a mean to extend the indications for resection. This
was possible ‘‘at the price’’ of increased morbidity and
mortality rates still acceptable. We consider this attitude
preferable to the one using experience to favor early re-
sults by a stringent selection excluding high risk patients
and/or procedures.
FP-40
SURGICAL TREATMENT OF
NEUROENDOCRINE METASTASES
YIELDS AN ALMOST 10 YEAR MEDIAN
SURVIVAL
E. S. Glazer1, J. F. Tseng2, K. A. Willborn1, P. Liu1,
W. Al-Refaie3, E. K. Abdalla1, J. N. Vauthey1 and
S. A. Curley1
1M.D. Anderson Cancer Center; 2University of
Massachusetts Medical School; 3University of Minnesota
Medical School
Background: The liver is the most common visceral site
for neuroendocrine metastases. Patients not treated sur-
gically have reported median survival of 24 to 40 months.
Objective: To asses the survival of patients with surgi-
cally resected neuroendocrine hepatic metastases.
Methods: A prospective database was queried for surgi-
cally treated neuroendocrine hepatic metastases. Demo-
graphic, operative, and outcome data were collected.
Univariate and multivariate analysis was performed from
the time of ﬁrst treatment.
Results: One hundred and seventy two patients were
identiﬁed. The mean age was 56.1 ± 12.7 years (SD).
Median follow up was 50.8 months (range 3.0 to
274.5 months). 60.5% of resections were synchronous
with the primary lesion. 41.3% of patients underwent
unilateral or extended hepatectomy while 37.2% patients
underwent partial resections. The rest had radiofre-
quency ablation. Twenty-one patients (12.2%) had two
metachronous hepatic resections while seven patients
(4.1%) had three resections. The median overall survival
was 9.6 years. There were no perioperative deaths. The
only primary site that conferred a statistically signiﬁcant
decrease in survival was pulmonary (P < 0.0001). He-
patic complications and intra-abdominal ﬂuid collections
were associated with hazard ratios of 9.9 (P~0.0002) and
3.8 (P~0.0009) for early death, respectively. Neither the
type of resection nor the margin status was signiﬁcantly
associated with survival (P > 0.05).
Discussion: These results suggest that carcinoid metas-
tases can be resected with minimal surrounding liver
parenchyma. Control of symptoms is an important goal,
but a survival beneﬁt of an R0 resection over an R1
resection was not found.
Conclusion: Resection or ablation of neuroendocrine
hepatic metastases is very well tolerated in most patients.
Extensive resection does not necessarily offer better sur-
vival, suggesting that controlling most of the tumor
burden is the most important aspect of surgical care.
Abstracts 29
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
FP-41
INTRA-HEPATIC CHOLANGIO-
CARCINOMA: A CHALLENGING
SURGICAL PROBLEM
M. C. Ellis1, M. A. Cassera2, J. Ma2, C. R. Thomas3,
P. D. Hansen2 and K. G. Billingsley4
1Department of General Surgery, Oregon Health Sciences
University; 2Hepatobiliary and Pancreatic Surgery
Program, Providence Portland Medical Center;
3Department of Radiation Medicine, Oregon Health
Sciences University; 4Department of Surgical Oncology,
Oregon Health Sciences University
Background: Although the incidence is increasing, intra-
hepatic cholangiocarcinoma (ICC) remains a rare tumor,
and surgical resection is the mainstay of treatment. There
is little data regarding prognostic factors and patient
selection.
Objective: To determine the clinicopathologic char-
acteristics of resectable ICC tumors and outcome fol-
lowing surgical treatment.
Methods: Retrospective review of prospectively collected
clinical data. Patients were identiﬁed through institu-
tional tumor registry and billing databases. Factors
analyzed included patient demographics, pathological
features, interventions, and outcomes. Survival was
analyzed using the Kaplan–Meier method. Multivariate
analysis of survival was performed using the Cox pro-
portional hazards model.
Results: The study group included 31 surgically treated
patients. Macroscopically curative resection (R0 n = 16,
51.6%; R1 n = 13, 41.9%) was achieved in 93.5% of
patients and portended a 3-year overall survival (OS) of
44.5%. The median survival was 31 months with a
median follow-up period of 17 months (1–98 months).
Three-year OS was 40.8%. Five-year OS was 39%, 20%
and 0% for N0, N1, and N2 patients, respectively. The
postoperative complication rate was 58%. Two patients
died of post-operative liver failure within 30 days. Of the
factors examined, only preoperative albumin was sig-
niﬁcantly associated with the improved survival.
Conclusions: ICC is inﬁltrative and aggressive cancer,
however surgical therapy is associated with long term
survival in the subset of patients with node negative
disease. Patients with favorable nutritional status at the
time of resection have a survival advantage. The overall
rate of microscopic and macroscopic margin involvement
is high, and the surgeons need to respect the inﬁltrative
nature of the disease in operative planning.
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RESECTABILITY OF COLORECTAL
LIVER METASTASES: AN IMAGING
BASED SURVEY OF CONCORDANCE
BETWEEN HEPATIC SURGEONS IN
CANADA
W. Mohammad, R. Mimeault, R. Fairfull-Smith,
R. Auer and F. Balaa
The Ottawa Hospital / University of Ottawa
Background: In the absence of contraindications,
resectability of colorectal liver metastases is based mainly
on surgeon’s assessment of cross-sectional imaging. We
believe that there is a large element of subjectivity when
determining resectablity.
Objective (S): To assess the concordance between
Canadian hepatic surgeons regarding resectability of
colorectal liver metastases when presented with a stan-
dardized case scenario and CT images.
Methods: Fourty-six hepatic surgeons across Canada
were invited to participate. Those were presented with a
standardized clinical scenario. The patient was described
to be otherwise healthy, with biologically favorable dis-
ease, and treated with modern neoadjuvant chemother-
apy. The clinical scenario was then matched with ten
different abdominal tri-phasic CT scans representing
maximum response after six cycles of chemotherapy.
Surgeons were requested to offer an opinion on resect-
ability based on the images, as well as the role for ad-
juncts such as radiofrequency ablation, portal vein
embolization and staged hepatectomy.
Results: A total of twenty-six responses received (56.5%
response rate). Twenty of those were complete. All par-
ticipants but one were attending surgeons at academic
institutions, and 60% have been in practice for at least
5 years. Half of the participants worked in groups of
three to ﬁve surgeons, and HPB surgery represented more
than 50% of the workload for 90% of participating
surgeons.
Two control cases demonstrated 100% concordance.
Signiﬁcant lack of concordance was demonstrated for the
test cases. Agreement on resectability was as low as 50%
in some cases. Even in the four out of 10 cases that
trended towards a higher concordance rate for resect-
ability, eight different combinations of adjuncts to
hepatic resection were utilized.
Conclusion: There is signiﬁcant lack of concordance of
surgeons’ opinion on resectability and use of adjuncts in
the treatment of colorectal liver metastases.
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TWENTY-THREE INFERIOR VENA CAVA
RESECTIONS FOR RADICAL
TREATMENT OF MALIGNANT AND
BENIGN TUMORS
E. Vicente, Y. Quijano, H. Dura´n, E. Esteban,
M. Marcello, R. Conradi, P. Galindo, C. Loinaz,
M. Pringles, N. Sa´nchez-Ferna´ndez, M. Idrovo and
I. Fabra
Hospital Madrid-Norte-Sanchinarro. Centro Integral
Oncolo´gico Clara Campal (CIOCC). Universidad San
Pablo CEU, Facultad de Medicina. Madrid, Spain
Background: Regional invasion or compression of the
inferior vena cava (IVC) are often associated with tumors
of the liver, biliary tract, pancreas, retroperitoneum and
kidney.
Aim: Our experience, technical considerations and
results for IVC resections in selected cases of locally
advanced tumors are presented.
Patients: Twenty three patients underwent IVC resec-
tions (17 circumferential and 5 partial) to obtain R0
surgery. Primary diseases: liver metastasis from colon
cancer (8), intrahepatic cholangiocarcinoma (1), hydatid
cyst (2), renal carcinoma (4), IVC tumoral thrombosis
after renal carcinoma relapse (3), tumoral thrombus into
IVC + liver inﬁltration (segment VI) (1), IVC primary
tumors (2), adrenal carcinoma (2). Locations: level I
(renal veins) (10), level II (retrohepatic IVC) (4), level III
Abstracts30
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
(hepatic veins and atrium) (9). Associated resections:
right hepatectomy (5), right hepatectomy extended to
segment IV (4), hepatic segmentectomy (segment VI) (1),
nephrectomy (4), nephrectomy + adrenalectomy (2), and
total cystopericystectomy (2) one of them with IVC and
atrium trombectomy and nephrectomy. Hepatic veins (8)
and renal veins bifurcation (8) were resected when
necessary. Prosthetic replacement was performed in 14
patients with reimplantation of left hepatic vein in one
patient.
Results: General and vascular resection-related morbid-
ity, early and late graft patency, graft thrombosis inci-
dence, mortality and survival are presented. Techniques
of venous control, hepatic vascular exclusion, hepatic
and renal veins reconstruction, prosthetic replacement
and arterio-venous ﬁstulae are also analyzed.
Discussion: IVC resection can be performed in selected
cases with low risk of morbimortality. Pre and intraop-
erative evaluation to determine the extent of tumor are
imperative.
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OUTCOMES AFTER HEPATIC
RESECTION FOR COLORECTAL
METASTASES IN YOUNG PATIENTS
D. Azoulay, R. De Haas, D. A. Wicherts, S. De La
Serna, E. Vibert, R. Adam and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Background: Long-term outcomes after hepatectomy for
colorectal liver metastases (CLM) in relatively young
patients are still unknown. The aim of the current study
was to evaluate long-term outcomes in patients <40
years, and to compare them with patients > 40 years.
Methods: All consecutive patients who underwent hep-
atectomy for CLM at our hospital between 1990 and
2006 were included in the study. Patients < 40 years
were compared with all other patients treated during the
same period. Overall (OS), progression-free (PFS), and
disease-free survival rates (DFS) were determined, and
prognostic factors were identiﬁed.
Results: In total, 806 patients underwent hepatectomy
for CLM, of whom 56 (7%) were aged < 40 years.
Among the young patients, more CLM were present at
diagnosis which were more often diagnosed synchro-
nous to the primary tumor. Five-year OS was 33% in
young patients, compared with 51% in older patients
(P = 0.12). Five-year PFS was 2% in young patients,
compared with 16% in older patients (P < 0.001).
DFS were comparable between both groups (17%vs.
23%, P = 0.10). At multivariate analysis, age
< 40 years was identiﬁed as an independent predictor
of poor PFS.
Conclusion: In young patients, CLM seem to be more
aggressive with a trend to lower OS, more disease
recurrences, and a signiﬁcantly shorter PFS after hepa-
tectomy. However, DFS were comparable between
young and older patients, owing to an aggressive mul-
timodality treatment approach, consisting of chemo-
therapy and repeat surgery. Therefore, physicians should
recognize the poor outcome of CLM in young patients
and should consider an aggressive approach to diagnosis
and early treatment.
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NEW PREDICTIVE FACTORS OF
MORTALITY IN PYOGENIC LIVER
ABSCESS
C. Dufay1, B. Alkofer1, S. Dargere2, V. Lepennec3,
E. Salame´1 and L. Chiche1
1Department of hepatobiliary surgery, CHU Caen,
France; 2Department of infectious diseases, CHU Caen,
France; 3Department of radiology, CHU Cean, France
Background: Pyogenic liver abscess is a rare disease with
a high rate of mortality up to 19% in recent series. Al-
though the modern treatment associating antibiotics,
percutaneous drainage and surgery is more and more
efﬁcient, patients still die of this condition. Some factors
predictive of mortality have previously been described
but mostly in American or Asian series, the most com-
mon being, severe sepsis, APACHE score > 15, cirrho-
sis, diabetes and hypoalbuminemia.
Aim: the aim of this work was to analyse in a mono-
centric French series, factors associated with mortality in
patients presenting a pyogenic liver abscess.
Methods: During the last 18 years, 103 patients with a
pyogenic liver abscess were treated in our center, and
reviewed retrospectively.
Results: There were 55% of male patients with a mean
age of 64.4 year old. Symptoms at presentation were
studied. 45.6% were of biliary origin, 25.2% of portal
origin among which 9.7% had a neoplasic cause. 16.5%
were treated with antibiotics alone, 52.4% with percu-
taneous management and 41.7% ﬁnally needed surgery.
The overall mortality was 8.7%. Nine patients died with
a mean age of 72 year old. Factors found to be predictive
of death on a univariate analysis were a high ASA score,
a neoplasic cause and a right pleural effusion
(P = 0.018). Indeed, 77% of patients presenting with a
right pleural effusion died. Looking at biological criteria,
albumin level < 21 g L-1 and a haemoglobin level below
9.5 g L-1 can predict death with a sensibility and speci-
ﬁcity of 60% and 80% and 40% and 90% respectively.
Conclusion: To conclude, in our experience, pleural
effusion should be considered as a bad prognostic factor
as well as a high ASA score. Albumin and haemoglobin
levels should also be carefully followed. Presence of these
different factors should be indicators for urgent and
aggressive therapy in pyogenic liver abscesses.
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ARE THROMBOPHILIA STATES IN
NON CIRRHOTIC PORTAL VEIN
THROMBOSIS FAMILIAL?
S. Shah1, S. Khodaiji1, D. Desai1, A. Joshi1,
P. Abraham1, V. Ganjevar2 and S. Bhatia2
1PD Hinduja Hospital, Mumbai 400 016, India; 2KEM
Hospital, Mumbai 400 012, India
Background and aims: Spontaneous portal vein throm-
bosis (PVT) is associated with many thrombophilic
conditions. It is unclear whether these are hereditary or
acquired. This study aims to evaluate thrombophilic
conditions in parents of patients with non cirrhotic portal
vein thrombosis.
Methods: Sixteen consecutive patients of non cirrhotic
portal vein thrombosis with no other etiological factors
[Median age 14 (6–30 years)] whose parents were avail-
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able for testing were subjected to thrombophilia screen
consisting of Protein C, S, antithrombin levels, Factor
VIII assay, Factor V Leiden mutation, Lupus anticoag-
ulant (LA), homocysteine levels, anticardiolipin antibody
levels and tests for paroxysmal nocturnal hemoglobinu-
ria. Fasting sample was also collected from both parents.
Analysis of thrombophilic conditions was carried out in
children as well as the parents.
Results: Of the 16 patients, 13 had a thrombophilic
condition. Five of these showed the same anomaly in a
parent (Factor V Leiden 1 heterozygous in parent, Pro-
tein C deﬁciency in 1 parent, protein S deﬁciency in one
parent, severe hyperhomocysteinemia in both parents of
one child, severely elevated Factor VIII levels in both
parents of one child. Of the three children with no
thrombophilic condition, no parent demonstrated any
anomaly. Elevated protein S and Factor VIII levels were
seen in two families without the same deﬁciency in the
child. One parent was LA positive with the child being
normal.
Conclusions: Factor V Leiden and hyperhomocystein-
emia are hereditary thrombophilic conditions. For the
others, the role of heredity is unclear.
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THE SURGICAL TREATMENT OF
HYDATID DISEASE: CONSERVATIVE
OR RADICAL?
S. Kilicturgay, E. Ozturk, A. Ozer and O. Isik
Uludag University School of Medicine, Department of
General Surgery
Background: The ease of performance and superiority in
safety related to conservative surgical procedures in the
treatment of hydatid disease when compared to radical
procedures is counterbalanced by the higher recurrence
rates and morbidity. We compared the short and long
term results of patients who underwent conservative or
radical surgery for hydatid disease.
Methods: Patients who underwent surgery for hydatid
disease at the Uludag University School of Medicine
Department of General Surgery were determined from a
prospectively maintained Hydatid Disease database. Pa-
tients were divided into two groups based on whether
they underwent conservative or radical surgery. Conser-
vative surgical procedures were regarded as cystotomy
procedures with or without drainage. Radical surgical
procedures were considered as pericycstectomy and he-
patic resections. The demographics, data related to the
hydatid disease, operative morbidity, mortality, length of
hospital stay (LOS) and recurrence rates were compared
for both groups of patients. Student test was used to
compare continuous variables and categorical values
were compared using chi square test.
Results: There were 349 patients of whom 241 underwent
conservative methods and 108 received radical surgery
for hydatid disease. There was no signiﬁcant difference in
demographics and disease related variables between both
groups. The mortality (P = 0.68), morbidity (P = 0.33)
and LOS (P = 0.05) were comparable between both
groups. The mean follow-up time was 64.35 ±
34 months. The recurrence rate was signiﬁcantly lowered
in radical group (1.9% vs. 20.3%; P = 0.003).
Conclusion: The radical procedures are associated with
less recurrence rates with similar short term results to
conservative methods.
FP-48
HEPATECTOMY FOLLOWING HEPATIC
ARTERIAL THERAPY WITH EITHER
YTTRIUM-90 OR DRUG-ELUTING BEAD
CHEMOTHERAPY: IS IT SAFE?
R. Brown1, M. Bower1, T. Metzger1, C. Scoggins1,
K. McMasters1, M. Hahl2, C. Tatum3 and R. Martin1
1Division of Surgical Oncology; Department of Surgery;
University of Louisville; Louisville, Kentucky;
2Department of Radiology; Norton Healthcare; Louisville,
Kentucky; 3Department of Radiation Oncology; Norton
Cancer Institute; Louisville, Kentucky
Background: Recently, the use of hepatic arterial therapy
(HAT) with either Yttrium-90 or drug-eluting bead
therapy has risen signiﬁcantly. With this rise and the
effectiveness of these treatments, surgeons are called
upon to perform hepatic resections on patients who have
been previously treated with HAT.
Objective: The purpose of this analysis was to compare
the overall morbidity and the liver-speciﬁc morbidity of
patients undergoing hepatectomy following HAT.
Methods: We identiﬁed 840 patients undergoing hepa-
tectomy for primary or metastatic lesions. Forty pa-
tients underwent HAT prior to hepatectomy (pre-
HAT). A 4:1 case-matched analysis compared three
groups: (i) pre-HAT and preoperative chemotherapy;
(ii) preoperative chemotherapy; (iii) no preoperative
therapy. Controls were matched for age, resection type,
ASA class, maximal tumor size, body mass index
(BMI), histology, and tumor location. Univariate and
multivariate analyses were used to identify factors
associated with increased overall or liver-speciﬁc mor-
bidity.
Results: There were no signiﬁcant differences among
groups with regard to age, ASA class, BMI, maximal
tumor size, location of tumor(s), or number of tumors.
There were no differences in postoperative complica-
tions, liver speciﬁc complications, or bile speciﬁc com-
plications among groups (4% vs. 8% vs. 7%: P =
0.20). Operative characteristics and perioperative com-
plications were also compared (Table). A proportional
hazards model for all patients did not demonstrate any
association between increased complications and either
pre-HAT or preoperative chemotherapy when com-
pared to patients without preoperative therapy
(P = 0.7).
Operative and Perioperative Comparisons
Group (n)
Right
Hepatectomy
(%)
Median
EBL
(mL)
Need for
Blood
Transfusion
(%)
Complications
(%)
30-day
Mortality
(%)
Pre-HAT (40) 35% 550 25% 31% 0%
Preop Chemo
(160)
56% 400 48% 35% 4%
No Preop
Chemo (650)
44% 375 30% 23% 5%
P-value 0.3 0.4 0.04 0.7 0.7
Conclusions: Pre-HAT demonstrated similar morbidity,
liver speciﬁc morbidity and intra-operative complications
when compared to patients undergoing preoperative
chemotherapy alone or without preoperative chemother-
apy. These results suggest that pre-HAT is safe and should
not preclude hepatectomy in well-selected patients.
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T CELL INFILTRATE PREDICTS
OUTCOME FOLLOWING RESECTION
OF INTERMEDIATE GRADE PRIMARY
NEUROENDOCRINE NEOPLASMS AND
LIVER METASTASES
S. Katz1,2, C. Donkor2, V. Pillarisetty2, M. Gonen2,
D. Klimstra2, M. D’Angelica2, P. Allen2, W. Jarnagin2,
R. Dematteo2, M. Brennan2 and L. Tang2
1Roger Williams Medical Center; 2Memorial
Sloan-Kettering Cancer Center
Background: Tumor inﬁltrating lymphocytes (TIL) have
been shown to predict survival in numerous malig-
nancies, however the importance of TIL in primary
neuroendocrine tumors (NET) and liver metastases
(NETLM) has not been deﬁned.
Objective: To determine if TIL density predicts oncolo-
gic outcome following resection of NET or NETLM.
Methods: We studied 87 patients with NET and 39
with NETLM who underwent resection. Immuno-
histochemistry was performed to determine TIL density
based upon median cell counts/10 HPF. Correlation
between TIL and recurrence- free (RFS) or overall sur-
vival (OS) was determined with the log-rank test.
Results: The median follow-up time was 62 months for
NET and 48 months for NETLM. The majority of NET
was low grade (57%), and the remainder intermediate
grade (43%). Histologic grade was the only independent
predictor of outcome for NET and NETLM. Analysis of
intermediate grade NET indicated that a dense (n = 22)
T cell (CD3+) inﬁltration was associated with a median
RFS of 128 months compared to 61 months for those
with a low (n = 14) level of intratumoral T cells
(p = 0.05). TIL density did not correlate with outcome
in patients with low grade NET. Examination of
NETLM revealed the median OS time for patients with a
low (n = 25) level of inﬁltrating regulatory T cells (Treg,
FoxP3+) was 108 months compared to 47 months for
patients with a high (n = 14) density of Treg (P < 0.01).
CD4+ or CD8+ TIL density did not correlate with
outcome for either NET or NETLM.
Table 1. Correlation of TIL density with outcome
following resection of neuroendocrine tumors
NET INT*
5 year
RFS (%)
10 year
RFS (%)
MEDIAN
RFS P
CD3 HIGH 80 66 128 0.046
LOW 50 50 61
CD8 HIGH 83 58 128 .28
LOW 67 60 61
CD4 HIGH 88 71 106 .19
LOW 50 40 60
FoxP3 HIGH 78 53 106 .66
LOW 78 61 72
NETLM**
5 year
OS (%)
10 year
OS (%)
MEDIAN
OS p
CD3 HIGH 60% 42% 67 0.53
LOW 38% 25% 30
CD8 HIGH 54% 31% 47 0.21
LOW 54% 38% 67
CD4 HIGH 56% 38% 61 0.78
LOW 56% 38% 67
FoxP3 HIGH 36% 7% 47 0.009
LOW 68% 52% 108
*NET INT = intermediate grade primary neuroendocrine tumors.
**NELM = neuroendocrine tumor liver metastases.
Conclusions: A robust T cell inﬁltrate is associated with
improved RFS following resection of intermediate
grade NET, while the presence of more Treg correlated
with shorter OS after treatment of NETLM. T cell
inﬁltrate does not predict outcome in those with low
grade NET. Further study of the immune response to
intermediate grade NET and NETLM is warranted.
FP-50
THE SPECIFIC RISK OF ISOLATED
SEGMENT VIII RESECTION
J. Agostini, S. Dokmak, B. Aussilhou, O. Farges and
J. Belghiti
Beaujon Hospital
Background: Surgical resection of segment VIII (S8) is
rarely performed and few series described this challeng-
ing procedure. The aim of our study was to evaluate the
outcomes of a the largest series of patients who under-
went a surgical resection of S8 in comparison with right
hepatectomy (RH).
Patients and methods: From 2001 to 2008, among the
1470 elective hepatic resections performed at Beaujon
hospital, 24 (1.6%) patients with a mean age of 61 years
underwent a S8 resection for colorectal metastasis
(n = 14), hepatocellular carcinoma (n = 8) and benign
tumors (n = 2). No patient with HCC had major vas-
cular invasion. This group was retrospectively compared
with 24 matched patients who underwent a RH for tu-
mors located in segment VIII.
Results: The comparison of S8 vs. RH showed a similar
age 61 vs. 59 years; the number and size of tumors was
lower in the S8 group (1.08 vs. 2.54) and (28 vs. 51 mm)
respectively. Blood loss was similar (566 vs. 600 mL) but
pedicular clamping was more frequent (87 vs. 60%,
P = 0.04) and longer (60 vs. 37 mn, P = 0.008) in the
S8 group. The mortality (5% vs. 0%) and overall mor-
bidity rates (41% vs. 35%) were similar in both groups.
However, there was signiﬁcantly more subphrenic col-
lections (42% vs. 4%, P = 0.002) in S8 group, necessi-
tating percutaneous drainage in 40% of cases mainly due
to biliary ﬁstula (21% vs. 4%) which was more frequent
in S8 resection group.
Conclusion: This study conﬁrmed that segment VIII
resection was technically more difﬁcult than RH with a
higher rate of subphrenic collections mainly due to
biliary ﬁstula. Isolated segment VIII resection should
be restricted to patients requiring parenchymal preser-
vation.
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EVALUATION OF ISCHEMIC
PRECONDITIONING IN PATIENTS
UNDERGOING MAJOR HEPATECTOMY
WITH INTERMITTENT PEDICULAR
CLAMPING A PROSPECTIVE
RANDOMIZED TRIAL
O. Scatton1,2, S. Zalinski1,2, D. Jegou1,2, M. Lesurtel2,3,
P. Compagnon4, J. Belghiti2,3, K. Boudjema4,
C. Lentschener1,2 and O. Soubrane1,2
1Hopital Cochin; 2Assistance Public - Hoˆpitaux de Paris;
3Hoˆpital Beaujon; 4Hoˆpital Pontchaillou
Objective: To evaluate the accuracy of ischemic precon-
ditioning (IPC) as a protective maneuver against ische-
mia/reperfusion lesion in patients undergoing major liver
resection with intermittent portal triad Clamping (IPTC).
Summary Background Data: For sake of safety and to
avoid excessive blood loss during parenchymal transec-
tion, vascular inﬂow occlusion is an effective trick but
may cause ischemic damage to the remnant liver. IPTC
has been proven to be superior to continuous hepatic
pedicle clamping as it preserve liver remnant from severe
ischemia/reperfusion lesion, so does IPC. Yet, if IPC is
beneﬁcial if liver resection is performed under IPTC has
never been demonstrated in a randomised controlled trial
(RCT). We designed a RCT to assess the impact of IPC
in patient undergoing major liver resection with inter-
mittent vascular inﬂow occlusion.
Methods: A total of 87 patients undergoing major liver
resection with intermittent vascular inﬂow occlusion were
randomised, intraoperatively, to either receive IPC
(10 min inﬂow occlusion followed by 10 min of reperfu-
sion). Follow-up was 3 months and an intention to treat
analysis was performed. Primary endpoint was postop-
erative day one (POD 1) serum ALT.
Results: Both groups were comparable considering
demographic data, preoperative ASA status, and extent
of liver resection. Intra operative morbidity and post-
operative outcomes were also similar. Transaminase
levels (ALT) on postoperative day 1 (POD 1) one was not
decreased by IPC (537.6 ± 358.5 UI mL-1 vs.
525.0 ± 400.6 UI mL-1, P = 0.88). Finally, liver bio-
chemistry tests from POD 1 to POD 7 had the same
evolution in both groups.
Conclusion: This RCT is the ﬁrst to demonstrate that
IPC does not improve outcomes of patients undergoing
major liver resection with IPTC.
FP-52
DEVELOPMENT OF A COMPOSITE
ENDPOINT FOR RANDOMIZED
CONTROLLED TRIALS IN LIVER
SURGERY
M. A. Van Den Broek1, R. M. Van Dam1,
G. Van Breukelen2, L. I. Mpabanzi1, M. H. Bemelmans1,
C. H. C. Dejong1,3, N. Freemantle4 and S. W. M. Olde
Damink1,3,5
1Department of Surgery, Maastricht University Medical
Centre, Maastricht, the Netherlands; 2Department of
Methodology and Statistics, Maastricht University,
Maastricht, the Netherlands; 3NUTRIM School for
Nutrition, Toxicology and Metabolism, Department of
Surgery, Maastricht University, Maastricht, the
Netherlands; 4Department of Primary Care and General
Practice, University of Birmingham, Birmingham, United
Kingdom; 5Department of Surgery, University College
London, London, United Kingdom
Background: The feasibility of adequately powered ran-
domized controlled trials (RCTs) in liver surgery using
surgery related morbidity or mortality is low as the
sample size would be very large. A liver surgery speciﬁc
composite endpoint (CEP) could solve this problem.
Aim: To design and validate a liver surgery speciﬁc CEP
to be used as primary endpoint in RCTs.
Methods: Dichotomous variables used as endpoint in
RCTs in liver surgery between 2004 and 2008 were
identiﬁed by a literature search. A web-based survey was
developed based on these endpoints and sent to 54
leading HPB surgeons worldwide in order to reach con-
sensus on deﬁnitions and components of a liver surgery
speciﬁc CEP. Major complications (Dindo grade ‡ 3)
with a preference rate ‡ 66% were considered as com-
ponents. A prospective database with 321 patients who
have undergone a partial hepatic resection in our institute
was used to determine the incidence of the liver surgery
speciﬁc CEP. Sample sizes were calculated with the
assumption that a = 0.05 and b = 0.8.
Results: Twelve endpoints mostly used in 47 RCTs in
liver surgery formed the basis of the survey. Thirty-one
responses were collected (57%); all respondents were
interested to use a liver surgery speciﬁc CEP. Compli-
cations selected as components of the liver surgery spe-
ciﬁc CEP were post-resectional liver failure (incidence
4.0%), bile leakage (11.8%), ascites (2.8%), intra-
abdominal hemorrhage (1.6%), intra-abdominal abscess
(11.8%) and operative mortality (4.7%). Internal vali-
dation showed an incidence of the liver surgery speciﬁc
CEP of 20.9%. An RCT aiming to show a 50% relative
reduction in any of the components would need to in-
clude between 726 and 5808 patients; when using the liver
surgery speciﬁc CEP as primary endpoint, this RCT
would need 380 patients.
Conclusion: A liver surgery speciﬁc CEP increases the
event rate up to 20.9%. When used as primary endpoint,
it increases the feasibility and comparability of RCTs in
liver surgery.
FP-53
LAPAROSCOPIC MAJOR HEPATIC
RESECTION: A NEW STANDARD OF
CARE?
R. Cannon1, M. Marvin1, M. Thomas2, G. Brock1,
S. Rudich3, T. Doty3, K. Bilinski4, K. Ravindra1,
S. Barve1, G. Neff3, A. Barve1, L. Marsano1,
C. McClain1, K. McMasters1 and J. Buell1
1University of Louisville; 2Bethesda North Hospital;
3University of Cincinnati; 4Jewish Hospital
Initial experiences with laparoscopic liver resection were
limited to peripheral wedge resections. Now with a wide
experience, has major hepatic resection, become standard
of care in specialty centers?
Methods: Retrospective analysis of a prospectively
database was performed after IRB approval. Multivari-
ate analysis was performed between major and minor
resections.
Results: Seventy seven resections (6 Trisegmentectomies,
44 R lobes, 27 L lobes) were identiﬁed in our ﬁrst 300
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patients. 200 resections were performed open during this
same period. Major resections were performed ﬁrst in
benign tumor and eventually expanded into malignancy.
Lobar resections sparingly performed in cirrhotics
(n = 3) and for re-operative procedures (n = 3). The
median follow up was 30 months with a 90 day mortality
rate of 1%. Despite a conservative approach, larger tu-
mors were addressed, with correspondingly higher
transfusion and complication rates, while mortality re-
mained at 1%. Notably, resection margins increased
when compared to segmental.
Conclusions: Laparoscopic major resection has achieved
acceptance in several experienced centers. Major resec-
tions, addressing larger tumors can be performed, albeit,
with increased operative times and complication rates.
Despite an increase in morbidity, mortality in larger
resections remains equivalent to smaller resections.
FP-54
MODERN MANAGEMENT OF
PYOGENIC LIVER ABSCESS: IS THERE
STILL A ROLE FOR SURGERY?
C. Dufay1, B. Alkofer1, S. Dargere2, V. Lepennec3,
E. Salame1 and L. Chiche1
1Department of hepatobiliary surgery, CHU Caen,
France; 2Department of infectious diseases, CHU Caen,
France; 3Department of radiology, CHU Caen, France
Background: Pyogenic Liver abscess is a rare disease
with a high rate of mortality up to 19%. The manage-
ment of these lesions has changed with a higher use of
percutaneous drainage associated with antibiotic ther-
apy. Surgery still plays a role in the treatment but its
indications are not clear.
Aim: To study the place of surgery in the management of
liver abscess and to ﬁnd predictive factors of surgical
recourse.
Methods: We retrospectively analyzed our monocentric
series of 103 pyogenic liver abscesses and studied their
clinical presentation, their causes, treatment and factors
associated with a need for a surgical treatment.
Results: From January 1990 to December 2008, 103
patients presenting a liver abscess were referred and
treated in our center. 55% were male with a mean age of
64.4 year old. Overall mortality was 8.7%. Main symp-
toms at presentation were fever and abdominal pain,
with 100% of patients having a CRP > 6 mg L-1 and
94.3% a low albumin level (< 37 g L-1). Most abscesses
were large (> 5 cm) and unique. 16.5% of patients were
treated with antibiotics alone, 52.4% with percutaneous
drainage and antibiotics. 26% of patients treated with
percutaneous techniques needed a surgical therapy, and
28.1% of patients were initially operated on. Finally,
41.7% underwent surgery for the abscess and 59.7% of
patients needed surgical treatment of the cause of the
liver abscess. Univariate analysis of factors associated
with failure of medical and percutaneous treatment were
gas forming abscess, septic shock at initial presentation
and biliary origin (P < 0.05).
Conclusion: Medical and percutaneous treatment is still
the standard management of liver abscess. However,
surgery remains today the therapy after failure of
initial treatment but should also be indicated as an
initial approach especially in case a gas forming liver
abscess of biliary origin with a septic shock at pre-
sentation and when treatment of the cause is imme-
diately required.
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CHANGES IN LIVER MITOCHONDRIAL
FUNCTION INDUCED BY A PUFA-RICH
DIET ARE ASSOCIATED WITH
REDUCTION OF HEPATIC LESION
AFTER ISCHEMIA/REPERFUSION
INJURY
A. M. M. Coelho1, S. N. Sampietre1, H. Takahashi2,
J. T. Stefano1, L. A. C. D’albuquerque1, R. Curi2 and
M. C. C. Machado1
1Department of Gastroentrolgy/University of Sa˜o Paulo;
2Institute of Biomedical Sciences/University of Sa˜o Paulo
Background/Aims: Studies have demonstrated that
polyunsaturated fatty acids (PUFA)-rich diet has a pro-
tective effect on the liver. The aim of this study was to
determine the effects of PUFA-rich diet on hepatic
mitochondrial functions and hepatic disturbances asso-
ciate with hepatic ischemia/reperfusion (I/R) injury.
Methods: Wistar male rats were fed a standard diet (SD)
or a high-fat diet enriched with x-6 and x-3 PUFA
(HFD) for 4 weeks and evaluated in pre and post-ische-
mia/reperfusion (I/R) conditions. In pre-I/R condition
livers were collected for determination of fatty acid
composition, liver mitochondrial function, expression of
peroxisome proliferator-activated receptor alpha (PPAR-
a) gene, malondialdehyde (MDA) content and histolog-
ical analysis. In post-I/R condition rats were submitted to
partial liver ischemia during an hour. Four hours after
liver reperfusion serum activities of AST and ALT, serum
levels of TNF-a, IL-6, IL-10, and PGE2, liver mito-
chondrial function, MDA content, and histology were
evaluated.
Results: The HFD group showed a signiﬁcant liver
mitochondrial uncoupling compared to the SD group
and this condition remains even after I/R injury. A
reduction of liver damage with decrease in serum activi-
ties of AST and ALT, in liver mitochondrial dysfunction
and in histological analysis, and a marked reduction of
systemic inﬂammation were found in the HFD group
when compared to the group SD.
Table 1 for FP-53
Cancer Cirrhosis
Prior
Procedure Age Size EBL
OR
time Tx Comp Margin Mortality
Major
n = 77
26% 4% 4% 53 7.8 cm 200 cc 3.0 12% 30% 1.1 cm 1%
Minor
n = 223
54% 16% 6% 56 4.3 cm 150 cc 2.5 5% 14% 0.9 cm 1%
P-value <0.001 <0.008 NS 0.09 <0.001 <0.01 <0.001 <0.05 <0.001 <0.07 NS
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Conclusion: High-fat diet enriched with x-6 and x-3
PUFA protected the liver from ischemia/reperfusion in-
jury probably by a mechanism associated to mitochon-
drial function changes and should be object of future
clinical trials.
FP-56
EFFECTS OF A PRECONDITIONING
ORAL NUTRITIONAL SUPPLEMENT
(PONS) ON PIG LIVERS AFTER WARM
ISCHEMIA
A. Nickkholgh1, Z. Li1, X. Yi1, E. Mohr1, R. Liang1,
M. Saulius1, L. Mikalauskiene1, M-L. Gross2, M. Zorn3,
S. Benzing4, H. Schneider5, M. W. Bu¨chler1 and
P. Schemmer1
1Department of General Surgery, Ruprecht-Karls
University, Heidelberg, Germany; 2Department of
Pathology, Ruprecht-Karls University, Heidelberg,
Germany; 3Central Laboratory, Ruprecht-Karls
University, Heidelberg, Germany; 4Fresenius Kabi, Bad
Homburg; 5HealthEcon AG, Basel, Switzerland
Background: Polyphenolic constituents of Green tea
(Camellia sinenesis) have been shown to be potent scav-
engers of reactive oxygen species. This study was de-
signed to evaluate the effects of a preconditioning Oral
Nutritional Supplement containing carbohydrates, glu-
tamine, antioxidants and green tea extract on hepatic
warm ischemia/reperfusion injury in pigs.
Methods: pONS (70 g/serving, Fresenius Kabi, Ger-
many), dissolved in 250 mL tap water was given to pigs
(German Landrace) at 24, 12 and 2 h before warm
ischemia of the liver. A 4th dose was given 3h after
reperfusion. Controls were given the same amount of
cellulose with the same volume of water. All animals were
treated with humane care and were fasted over night.
Two hours after administration of the 3rd dose of pONS,
both the portal vein and the hepatic artery were clamped
for 40 min. At 0.5, 3, 6, and 8 h after reperfusion, pulse
rate (PR), mean arterial pressure (MAP), central venous
pressure (CVP), portal venous ﬂow (PVF), hepatic arte-
rial ﬂow (HAF), bile ﬂow, and transaminases were
measured. Liver tissue was taken at 8 hrs after reperfu-
sion for histology (H&E) and immunohistochemistry
(TNF-a, myeloperoxidase, caspase-3). Analysis of vari-
ance (ANOVA) or Mann-Whitney rank sum test was used
as appropriate. Results are presented as mean ± SEM.
Results: PR, MAP, CVP, HAF, and PVF were compa-
rable between the two groups. pONS signiﬁcantly in-
creased bile production at 8h after reperfusion. ALT and
AST were signiﬁcantly lower after pONS (35 ± 3 vs.
49 ± 3 at 6 h and 33 ± 4 vs. 50 ± 3 at 8 h for ALT and
57 ± 13 vs. 112 ± 38 at 8 h for AST). Histology showed
more severe necrosis and neutrophil inﬁltration in con-
trols. pONS signiﬁcantly decreased the index of immu-
nohistochemical expression for TNF-a, MPO, and
caspase-3 (P < 0.001).
Conclusion: pONS dose before and after tissue damage
protects the liver from warm ischemia/reperfusion by
decreasing oxidative stress, lipid peroxidation, apoptosis,
and necrosis.
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HEPATIC EPITHELOID
HEMANGIOENDOTHELIOMA: IS
TRANSPLANTATION THE ONLY
TREATMENT OPTION?
T. Grotz1, D. Nagorney1, J. Donohue1, F. Que1,
M. Kendrick1, M. Farnell1, S. Harmsen1, D. Mulligan2,
J. J. Nguyen3, R. Charles1 and K. M. Reid-Lombardo1
1From the Division of Gastroenterologic and General
Surgery, *Division of Biomedical Statistics and
Informatics, §Division of Transplantation Surgery at
Mayo Clinic, Rochester MN, USA; 2Department of
Transplantation at Mayo Clinic, Scottsdale AZ, USA;
3Department of Transplantation at Mayo Clinic,
Jacksonville FL, USA
Background: Hepatic Epithelioid Hemangioendotheli-
oma (HEH) is a rare vascular neoplasm that can range
from an indolent hepatic hemangioma to a rapidly pro-
gressive angiosarcoma. HEH may present as a discrete
hepatic nodule or a coalescing and diffuse tumor
involving a signiﬁcant portion of the hepatic paren-
chyma. Because of the large amount of liver parenchyma
replaced by tumor, orthotopic liver transplantation
(OLT) has been historically the chosen treatment option.
Liver resection (LR) when feasible has not been aggres-
sively pursued, as there are reports of rapid tumor
growth following resection.
Aim: To compare overall survival (OS) and disease-free
survival (DFS) between nonoperative, operative resec-
tion (LR) and OLT for the treatment of HEH.
Methods: A retrospective analysis of 30 patients treated
at Mayo Clinic from 1984–2007 based on medical record
and follow-up survey. Survival was analyzed by Kaplan
Maier and Cox proportional hazards regression.
Results: Median age was 45 with a female predominance
of 2:1. The most common presentation was RUQ pain
(67%). Treatment modalities included LR in 11, OLT in
11 and chemotherapy alone in 5 patients. The remaining
3 patients did not receive any medical/surgical therapies.
Although 37% of patients had metastatic disease at
diagnosis this did not impact survival, P = 0.5. Impor-
tant predictors of a favorable OS and DFS was largest
Impact of Disease speciﬁc variables on survival (for
FP-57)
Variable
Survival – Years
(%)
P-value1 3 5
Treatment
Option
Transplant 91 73 73 0.1
Resection 100 86 86
Palliative 57 43 29
Metastasis at
diagnosis
Yes 94 80 73 0.5
No 70 50 50
Nodules
(Number)
£10 100 91 91 0.01
>10 73 51 44
Nodules
(Size)
£5 100 89 89 0.0001
6-10 100 87 87
‡10 50 25 12.5
Disease
Type
Nodular 100 92 92 0.0015
Diffuse 67 42 33
Line missing
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tumor < 10 cm and multifocal disease with < 10 nod-
ules. Patients who underwent OLT had a 1, 3 and 5- year
OS and DFS of 90.9%, 72.7%, 72.7%, and 63.6%,
45.5%, 45.5%, respectively. Patients undergoing LR had
a similar 1, 3 and 5- year OS and DFS of 100%, 85.7%,
85.7% and 77.8%, 62.2%, 62.2%, respectively.
Conclusion: Tumor size < 10 cm, < 10 nodules and
multifocal disease pattern were favorable predictors of
OS and DFS. LR is at least as effective as OLT. LR
should be the initial treatment in resectable patients.
OLT should be considered in patients with diffuse or
extensive bilobar disease.
FP-58
RISK ASSESSMENT OF LIVER
DONATION FOR PATIENTS WITH
FAMILIAL AMYLOID
POLYNEUROPATHY IN DOMINO LIVER
TRANSPLANTATION: 100 CASES FROM
A SINGLE CENTER
D. Azoulay, G. Tincani, S. De La Serna, C. Salloum,
E. Vibert, R. Adam, D. Samuel and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Background: The shortage of cadaveric organs for livers
grafts led to the development of new techniques to ex-
pand the donor pool including domino liver transplan-
tation. The question of additional risk for patients with
familial amyloid polyneuropathy (FAP) transplanted in
domino program compared to those transplanted with-
out this procedure has not been addressed so far.
Aim: This study has evaluated the feasibility and safety
of domino liver transplantation in FAP patients com-
pared to the group of FAP patients transplanted without
this procedure.
Materials: From March 1993 to January 2007, 100 pa-
tients with FAP were transplanted with a cadaveric
whole liver: 39 patients underwent standard liver trans-
plantation (group D-); 61 were transplanted with domino
procedure (group D+). Morbidity, mortality, graft and
patient survival were compared in the two groups.
Results: Post-operative mortality within 60 days of
transplantation was comparable in the two groups (4
cases in D+ group vs. 3 cases in D- group; P = 1).
Morbidity was comparable in the two groups. No dif-
ferences were found between the two groups when com-
paring the rates of arterial, portal, biliary and out-ﬂow
complications. No speciﬁc complications were found in
D+ group. The 1-, 5- and 10-years patient and graft
survivals were 84.8%, 75.4% and 66.2% respectively. No
signiﬁcant differences were found between D+ and D-
group (P = 0.7).
Conclusion: Domino liver transplantation in FAP
patients is a safe and reproducible procedure. Domino
procedure does not increase the risk of liver transplan-
tation compared to standard liver transplantation for
FAP.
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INHERITED THROMBOPHILIA: A
POSSIBLE CONTRIBUTOR TO HEPATIC
ARTERY THROMBOSIS AFTER
ORTHOTOPIC LIVER
TRANSPLANTATION
I. Pereboom1,2, J. Adelmeijer2, G. Van Der Steege3,
A. Van Den Berg4, T. Lisman1,2 and R.T Porte1
1Hepatobilairy Surgery and Liver Transplantation,
University Medical Center Groningen, The Netherlands;
2Surgical Research Laboratory, University Medical
Center Groningen, The Netherlands; 3Medical Biology,
University Medical Center Groningen, the Netherlands;
4Gastroenterology and Hepatology, University Medical
Center Groningen, the Netherlands
Background: Thrombotic complications of the hepatic
vessels are an important cause of graft failure after
orthotopic liver transplantation (OLT). Various gene
polymorphisms have been associated with an increased
risk of thrombo-embolic. The aim of this study is to as-
sess the inﬂuence of seven different thrombophilic genetic
factors on the risk of hepatic vessel thrombosis after
OLT.
Methods: In a series of 421 transplant procedures DNA
was available for genotyping in 381 donors (91%) and
382 recipients (91%). G1691A Factor V Leiden (FVL)
mutation, G20210A prothrombin polymorphism, and
V34L Factor XIII polymorphism were identiﬁed in both
donors and recipients; C677T MTHFR polymorphism,
C807T Glycoprotein Ia polymorphism, C1565T Glyco-
protein IIIa polymorphism, and A387P Thrombospon-
din 4 polymorphism were identiﬁed in recipients.
Clinical data was obtained from a prospectively main-
tained database and medical records. All recipients
underwent protocolized Doppler ultrasonography of the
hepatic vessels postoperatively. In case of an abnormal
or absent Doppler signal, catheter or CT angiography
was performed to exclude or conﬁrm thrombotic com-
plications.
Results: FVL mutation in the donor was associated with
an almost 5-fold increased risk of hepatic artery throm-
bosis (HAT) more then seven days after liver transplan-
tation (HR 4.78, 95% CI 1.04–21.8, P = 0.04). The
overall contribution of FVL on development of HAT
was low: of the 14 patients who developed HAT more
than seven days after OLT, two (17%) patients received a
liver graft with FVL. None of the other thrombophilic
gene mutations were associated with liver graft-related
vascular thrombosis.
Conclusions: FVL in the donor liver is associated with a
5-fold increased risk for development of HAT after OLT.
However, since the prevalence of FVL is low, the overall
impact of this mutation on the incidence of HAT is
marginal and does not justify routine screening for this
mutation.
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RESCUE POLICY OF DISCARDED LIVER
GRAFTS: SINGLE-CENTER EXPERIENCE
TRANSPLANTING LIVERS THAT
NOBODY WANTS
L. McCormack1, E. Quin˜ones1, P. Capitanich1,
N. Goldaracena1, J. Kerman Cabo1, M. M. Rios2 and
N. Mezzadri1
1Hospital Aleman of Buenos Aires; 2INCUCAI
Background: Although there is a worldwide need to ex-
pand the donor liver pool, many livers are still discarded
for liver transplantation (LT).
Objective: To report a consecutive series of patients
transplanted using ‘‘livers that nobody wants’’ (LNW)
under the MELD allocation system in Argentina.
Methods: Between August 2006 and April 2009, each
patient receiving a LNW (i.e. rescued liver group) was
analyzed and compared with a control group using a
prospective collected database. We deﬁned as LNW as
that liver discarded by others but ﬁnally accepted by us
for candidates having a position on the waiting list (WL)
> 30th. As a control group we used a consecutive series
of elective patients transplanted with a position on the
WL of < 30th. Primary endpoints were primary graft
non-function (PNF), mortality and graft and patient
survival.
Results: We accepted and subsequently transplanted 26
LNW. The median recipient position on the national WL
of the rescued livers group was 71th (r: 31st–432nd). All
26 rescued livers were consecutively discarded by 298
transplant centers (median number of rejecting centers
per organ: 12, r: 9–14) before our ﬁnal acceptance. A
total of 2.666 refusals have been ofﬁcially documented
being the most frequent: 1.229 bad donor history, 521
poor donor ICU condition, 398 inadequate transplant-
center conditions, 194 size mismatch and 136 prolonged
cold ischemia time. The incidence of PNF (3.8% vs. 4%)
was equal in rescued livers and control group. In-hospital
mortality rate was higher in the control group (8 vs.
3.8%), but not signiﬁcantly. One-year patient (84% vs.
84%) and graft survival (84% vs. 80%) were comparable
in both groups.
Conclusions: Transplantable livers are unnecessarily dis-
carded by the transplant community. Internal revision of
all reason for donor refusal should be urgently performed
in each transplant center to reduce mortality in their
waiting list.
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LIVING DONOR LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA: THE
OUTCOME OF 240 HCC CASES
I. Marwan1, T. Ibrahim1, M. Elmeteny2, A. Fayez2,
A. Hosny3, R. R. KAMEL2, O. Elmalt3, Y. Hatata3,
K. Amer4, I. Moustafa5, A. Youssry3, I. Waked1 and
M. Abd-Elwahab6
1National Liver Institute, Menoufeya University; 2Ain
Shams Univeristy; 3Cairo University; 4IMC; 5Tudoor
Belhars Institute; 6Mansoura University
Background: Despite the wide spectrum of selection cri-
teria used by centers using living donor liver transplan-
tation (LDLT) procedures, LDLT for hepatocellular
carcinoma (HCC) can achieve an acceptable outcome
comparable to the outcome for deceased donor liver
transplantation (DDLT) for HCC.
Aim: Is to present the outcome of LDLT for 239 HCC
adult patients and one case of hepatoblastoma in eight
years in ten centers in Egypt.
Patients and methods: From August 2001 to August
2009, 239 adult patients having hepatitis C viral infection
(HCV) and HCC and one pediatric case of hepato-
blastoma received LDLT in ten centers in Egypt. HCV
was proved by PCR in 98.8% of adult patients and HCC
was diagnosed by tumor marker AFP and triphasic spiral
CT portography. The mean recipient’s age was
53.56 years, while the mean MELD score was 18. Acci-
dentally diagnosis of HCC where found in 26 patients
(10.87%). Regarding Milan criteria, 207 (86.61%) of the
adult recipients were within Milan at the time of trans-
plantation. Downstaging was performed in 32 (13.39%)
cases by liver resection, radiofrequency ablation and/or
transarterial chemoembolization. As regards the hepa-
toblastoma case, the girl’s age at presentation was
18 months and she was at level IV pre-transplantation
(central) with AFP level 5 500 000 ng/mL. She received
chemotherapy pre-transplant and post-transplantation
for 6 months.
Results: As regards the girl with hepatoblastoma, she
received the graft from her mother October.2004 and she
is doing will with no recurrence to date. For the adult
recipients, ﬁrst year recurrence occurs in 24 recipients
(10.04%) while 3 years recurrence was 15.06% with
5 years long term survival was 58%.The mortality rate
due to tumor recurrence 13.65%.
Conclusion: The long term survival and disease free
survival rate between patients with HCC transplanted by
LDLT procedure is comparable with those using diseased
donors specially when there is no law for using diseased
donors like in Egypt.
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LIVER TRANSPLANTATION FOR HIV
POSITIVE RECIPIENTS:
PROCOAGULANT AND REQUIRING
PROPHYLAXIS?
P. T. Cherian, F. S. Dar, M. Heneghan, J. O’Grady,
M. Rela and N. D. Heaton
King’s College Hospital, London
Aim: It is recognised that HIV positive individuals are
prothrombotic as a result of their disease. We analysed
our cohort of liver transplantation recipients to review
the incidence of post transplant arterial complications.
Method: We reviewed our patient cohort of 2658 adult
patients transplanted between 1989 to Feb 2009 and
identiﬁed 25 HIV positive liver transplant adult re-
cipients. These were analysed in terms of their transplant,
post-operative course with speciﬁc regard to their vas-
cular complications, and long-term outcome.
Results: Of the 25 HIV positive liver transplant re-
cipients [Median age 40 years; all whole liver grafts ex-
cept one (Reduced left lobe graft)], there were ﬁve
‘‘arterial’’ complications. Aetiology was HBV (9), HCV
(11), Seronegative (2), Alcohol related (2) and drug in-
duced (1) liver failure. These included three with hepatic
artery thrombosis (HAT) (One in a DCD liver) at 3, 8
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and 218 months, one with generalised arteriopathy on
angiography at 2 months) and one with endoarteritis at
3 weeks on liver biopsy although ﬂow was present in the
HA. Of note 8 out of 25, had more than one arterial
anastomoses (including a left accessory HA) and all of
the HATs occurred within this cohort. Outcome after
HAT included re-transplantation in one, biliary stenting
for ischemic cholangiopathy and re-exploration and re-
vascularisation with an iliac conduit in one, respectively.
Analysis of donor details revealed no unusual char-
acteristics, or recurrent patterns.
Conclusion: The prothrombotic state associated with
combined HIV and liver disease increases the risk of
HAT (14%), when compared to the non HIV (3.8%)
cohort (p = 0.029). Complex arterial anastomoses might
increase the risk of HAT especially within the HIV co-
hort, and should be taken into account in recipient se-
lection. Prophylactic anti-coagulation with heparin in the
early post –operative period and either Aspirin or War-
farin later, may help avoid some of these complications
and should be evaluated.
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EARLY BILIARY COMPLICATIONS
AFTER LIVER TRANSPLANTATION
F. Ausania, M. Dawwas, A. Gimson, N. Jamieson and
R. Praseedom
Transplant Unit, Addenbrooke’s Hospital, NIHR
Comprehensive Biomedical Research Centre, Cambridge,
UK
Introduction: Biliary complications occur in about 20%
of liver transplants sometimes causing loss of graft or
even death. The aim of this study is to determine the
incidence and risk factors of biliary complications within
three months after liver transplantation.
Methods: A prospectively held database of all patients
who underwent liver transplantation from 1994 to 2007
in the United Kingdom and Ireland was reviewed. Biliary
complications were deﬁned as following: biliary stric-
tures, biliary leak requiring treatment, and graft loss due
to unspeciﬁed biliary complication. Risk factors were
evaluated through univariate and multivariate analysis
(P < 0.05).
Results: A total of 7368 liver transplants were considered
for this analysis. The number of all biliary complications
was 725 (11.2%); 345 leaks (5.3%), and 380 strictures
(5.9%). 76 patients with biliary leak not requiring treat-
ment were excluded from the study (1.1%) and in 53
patients (0.8%) both leaks and strictures occurred. Thus,
601 (9.3%) cases were identiﬁed for analysis. Multivari-
ate analysis revealed recipient albumin, recipient biliru-
bin, biliary stent, cold ischaemic time, donor-recipient
age difference, donor rhesus antigen, donor haemoglo-
bin, donor urinary infection, living donor, split grafts and
transplant centre as signiﬁcant factors related to the
occurrence of biliary complications.
Conclusions: This is the largest study ever performed on
biliary complications after liver transplantation. We
identiﬁed several risk factors that could be helpful to
stratify the risk of biliary complications in patients
undergoing liver transplantation, although some of them
require further investigations.
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GRAFTS LARGER THAN 2% OF THE
RECIPIENT’S BODY WEIGHT: IMPACT
ON EARLY POST-OPERATIVE
OUTCOME FOLLOWING LIVER
TRANSPLANTATION
E. Levesque, E. Vibert, C. Salloum, A. Benkabbou,
L. Gorden, R. Adam, D. Castaing, D. Samuel and
D. Azoulay
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Introduction: Size matching between recipients and donor
livers is an important factor in organ allocation. Little
information is available on the consequences of large size
graft on the outcome after liver transplantation (LT).
Aim: To evaluate the impact on early post-operative
outcome following LT of grafts larger than 2% of the
recipient’s body weight (GW/RW).
Methods: A prospective study of 75 consecutive patients
admitted to the ICU after LT from January 2009 to
September 2009. Mean age was 50 ± 12 years (68%
male). The reason for LT was cirrhosis (n = 35), cancer
(n = 24), familial amyloid polyneuropathy (n = 10) or
other (n = 8). Of these, 29 had GW/RW > 2% and 46
had GW/RW < 2%. The baseline patient demographics
were similar. No patient in the GW/RW > 2% group
had macrosteatosis > 30%.
Results: Measures of graft function during the ﬁrst days
post-LT were not signiﬁcantly different between the two
groups. The peak AST and ALT values were higher in
the GW/RW > 2% group (AST: 1689.7 ± 1593.5 vs.
802.7 ± 714.8 IU/l, P = 0.014, ALT: 1115.6 ± 1302.3
vs. 592.2 ± 547.2 IU/l, P = 0.01). Among the early
post-operative complications, the rate of bronchopneu-
monia was higher in the GW/RW > 2% group (38% vs.
17%, P = 0.04) than the number of patients requiring
reventilation (38% vs. 11%, P = 0.01). The length of the
intensive care unit stay for the GW/RW > 2% group
was slightly longer (11.0 ± 6.1 vs. 8.0 ± 6.7 days,
P = 0.06). The rates of others complications (infection,
hemorrhage, vascular thrombosis or acute renal failure)
were not different between the two groups. Primary non-
function developed in two patients requiring re-LT (one
in each group). Two patients died during the ICU stay
due to multi-organ failure secondary to a sepsis.
Conclusion: Larger liver grafts do not demonstrate im-
paired liver function in the early postoperative period.
However, GW/RW > 2% appears to be a determining
factor for respiratory morbidity (bronchopneumonia,
need for reventilation) following LT.
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VALGANCICLOVIR IS AN EFFECTIVE
PROPHYLAXIS FOR CYTOMEGALO-
VIRUS IN LIVER TRANSPLANT
RECIPIENTS
S. A. Fayek1, W. Manitpisitkul2, F. Rasetto2,
R. Munivenkatappa1, R. Barth1 and B. Philosophe1
1Department of Surgery, University of Maryland School
of Medicine, Baltimore, Maryland, USA; 2Department of
Pharmacy, University of Maryland, School of Medicine,
Baltimore, Maryland, USA
Background: Cytomegalovirus (CMV) infection is
responsible for signiﬁcant morbidity and mortality
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among solid organ transplant recipients. Optimal pro-
phylaxis in orthotopic liver transplant (OLT) recipients is
still unknown. Prophylaxis using valganciclovir in OLT
recipients is controversial and not approved by Food and
Drug administration.
Aim: To evaluate the effectiveness of valganciclovir in
CMV prophylaxis in OLT recipients.
Method: Retrospective, single center study, including all
OLT in 2007 and 2008. Patient with early death or follow
up £ 30 days were excluded. The overall incidence of
CMV disease was compared in patients receiving pro-
phylaxis with valganciclovir (VGCV) versus oral ganci-
clovir (GCV). Sub analysis of high risk recipients (CMV
sero+ve donors / CMV sero -ve recipients) was con-
ducted.
Result: Seventy seven patients met inclusion criteria.
High risk recipients were ﬁrst given intravenous ganci-
clovir (5 mg Kg-1 daily) for 14 days or until discharge (if
before 14 days) then transitioned to oral therapy (VGCV
or GCV). Low risk patients were given oral therapy from
the start. At discharge 66 patients were on VGCV
(900 mg daily) and 11 on GCV (1 gm every 8 hours). All
doses were adjusted to renal function. Groups had sim-
ilar demographics, primary disease, MELD, operative
factors (type of liver, ischemic time, simultaneous / redo
transplants), immunosuppressive regimens, prophylaxis
duration and rejection episodes. Five CMV cases oc-
curred, all after completion of prophylaxis, without
affecting patient’s survival. There was no difference in the
overall occurrence of CMV disease in VGCV or GCV
groups (6.1% vs. 14.3%; P = 0.55). In the high risk
recipients, none in the VGCV developed CMV disease
compared to 25% in the GCV group.
Conclusion: Valganciclovir is a reliable method for CMV
prophylaxis in liver transplant recipients. Our data sup-
port its use in high risk OLT patients.
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WAITING FOR TRANSPLANTATION IN
HEPATOCELLULAR CARCINOMA: THE
EXPERIENCE OF TWO CHILEAN
CENTERS
M. Vivanco1,2, M. Gabrielli3, N. Jarufe3, R. Humeres1,
H. Rios1, J. M. Palacios1, R. Zapata1,2, E. Sanhueza1,2,
J. Contreras1,2, G. Rencoret1,2, R. Rossi1,2, J. Martı´nez3,
R. M. Perez3, J. Guerra3, M. Arrese3, E. Figueroa3,
A. Soza3, R. Yan˜ez3 and J. Hepp1,2
1Liver Transplantation Program Clı´nica Alemana,
Santiago, Chile; 2Facultad de Medicina Clı´nica Alemana-
Universidad del Desarrollo, Santiago, Chile; 3Liver
Transplantation Program, Facultad de Medicina Pontiﬁcia
Universidad Cato´lica de Chile
Background: Liver Transplantation (LT) is currently an
established therapy for small, early stage hepatocellular
carcinoma (HCC) within the Milan criteria. Long waiting
time due to the shortage of donor organs can result in
tumor progression and drop out from LT candidacy.
There for is necessary a wide variety of procedures before
LT. The aim of this retrospective study is to review our
experience in relation to bridge therapy prior LT for
HCC.
Methods: Retrospective Database review of all the
patients transplanted in Clinica Alemana Santiago and
Hospital Clinico Universidad Catolica between January
1993 until June 2009. Patients with diagnosis of HCC in
the explants were analyzed.
Results: Twenty nine patients were selected, of these 12
were diagnosed at the explant and 17 were diagnosis
previously to the transplant, in this group, 88% under-
went bridge therapies, the mean waiting time for LT was
12 months, the total procedures number was 23, 1.5
procedures per patients, from which chemoembolization
was the most frequent (48%), followed by alcohol abla-
tion (30%), radiofrequency ablation (13%) and surgery
(9%). Thirty-three percent were within Milan criteria in
the explants. In our series 5 year survival for patients
transplanted for HCC was 86%, and in the bridge ther-
apy group is 73%.
Conclusions: The percentage of patients that underwent
bridge therapy (88%) is similar with other reported
experiences, but the Milan Criteria fulﬁllment in the ex-
plants is lower. In relation to survival in the bridge
therapy group, is slightly lower, probably explained be-
cause this group have a more advanced disease.
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LIVER GRAFTS FROM SELECTED OLD
DONORS DO NOT HAVE
SIGNIFICANTLY MORE ISCHEMIA
REPERFUSION INJURY THAN GRAFTS
FROM YOUNGER DONORS
P. N. Martins, B. Mahadevappa, S. Chang,
A-B. Martins, C. Rochon, M. Rodriguez,
B. Bhattacharya, M. Facciuto and P. Sheiner
Department of Hepatobiliary Surgery and
Transplantation. New York Medical College
Background: Livers from old donors have been increas-
ingly used for transplantation. However, aging is con-
sidered a risk factor for ischemia reperfusion injury.
Goal: The aim of this study was to correlate donor age
and the patterns of ischemia reperfusion injury and
synthetic function early and later after liver transplan-
tation.
Methods: We performed a retrospective study of ﬁrst
transplant using a single-center electronic database.
Pattern of liver injury, synthetic function, and 1-week-
graft survival in recipients receiving liver grafts from
donor older than age 65 (group I, n = 50) were
compared with matched cohort of recipients trans-
planted with grafts from donors younger 65 (group II,
n = 50).
Results: Older grafts were more likely to be allocated
to low MELD recipients (18.02 ± 7.34 vs. 25.77 ±
10.55, P < 0.0001). There was no signiﬁcant difference
in transaminase levels from day 0 to day 6 after
transplantation, and at day 30 and 60. However, at
day 7, recipient of older grafts presented higher AST
(98.125 ± 97.97 vs. 62.84 ± 39.43, P = 0.02) and also
signiﬁcant elevation of total bilirubin (7.32 ± 6.44 vs.
4.14 ± 3.92, P = 0.0007). There was no difference in
synthetic function during the ﬁrst week, and at day 30
and 60. In addition, 1-year survival rate (older 76% vs.
younger 88%, P = 0.19), retransplant rate (older 4%
vs. younger 2%, P = 0.5), total bilirubin (older
1.46 ± 2.3 vs. younger 1.49 ± 3.1, P = 0.95), GGT
(older 164.22 ± 209.02 vs. younger 170.21 ± 283.48,
P = 0.9) and albumin (older 3.8 ± 0.6vs. younger
3.95 ± 0.6, P = 0.21) at 1-year post transplant were
not different.
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Conclusions: Based on biochemical parameters, we could
not ﬁnd in our series that selected old liver donors have
increased susceptibility to cold ischemia injury. This im-
plies that chronological age per se may not be a major
risk factor for ischemia reperfusion injury. Judiciously
selected old liver grafts can provide similar short-term
results and should be used to expand the liver donor
pool.
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LIVER TRANSPLANTATION FOR
RECIPIENTS ‡ 70 YEARS: IS IT
WORTHWHILE?
R. Adam1, V. Karam1, V. Delvart1, J. Buckels2,
J. O’grady3, D. Castaing1, J. Klempnauer4,
N. Jamieson5, P. Neuhaus6, J. Lerut7, S. Pollard8,
M. Salizzoni9, L. Fischer10, J. Garcia Valdecasas11,
F. Muhlbacher12, J. Mir13 and A. Burroughs14, All
ELTR Centers are listed at15
1Centre He´patobiliaire, Hopital Paul Brousse, Villejuif,
France; Centre He´patobiliaire, Hopital Paul Brousse,
Villejuif, France; 2The Queen Elizabeth Hospital, Queen
Elisabeth Medical Center, Birmingham, United Kingdom;
3Liver Transplantation - 9th Floor Surgery, Royal Free
Hospital, London, United Kingdom; 4Klinik fu¨r Viszeral-
und Transplantationschirurgie, Medizinische Hochschule
Hannover, Hannover, Germany; 5Addenbrooke’s Hospital,
Department of Surgery, Cambridge, United Kingdom;
6Klinik fu¨r Allgemein-Viszeral- und
Transplantationschirurgie, Charite´- Campus - Virchow
klinikum, Berlin, Germany; 7Cliniques Universitaires Saint
Luc, Catholic University of Louvain, Brussels, Belgium;
8St Jame’s & Seacroft University Hospital, Department of
Surgery, Leeds, United Kingdom; 9Centro de Trapianti di
Fegato, Azienda Ospedaliera S. Giovanni Battista, Torino,
Italy; 10Department of Hepatobiliary Surgery,
Universitatskrankenhaus Eppendorf, Transplantation
Center, Hamburg, Germany; 11Gastrointestinal Surgery
Department, Hospital Clinic I Provincial de Barcelona,
Barcelona, Spain; 12Klinishe Abteilung fu¨r
Transplantation, Transplantationszentrum Allgemeines
Krankenhaus, Wien, Austria; 13Hospital Universitario LA
FE, Servicio de Medicina Digestiva, Valencia, Spain
Introduction; 14Liver Transplantation and Hepatobiliary
Medicine, Royal Free Hampstead NHS Trust, London
NW3 2QG, UK; 15www.eltr.org
Background: Sixty-ﬁve years represents the upper age
limit of recipients for liver transplantation (LT). An in-
creased number of patients exceeding this age limit are
presently transplanted.
Aim of study: To evaluate the long-term outcome of
‡ 70 years LT recipients in a large multicenter European
cohort.
Patients and methods: From January 1988 to December
2008, 74334 patients have been transplanted in Europe.
Donor, recipient, surgical procedure and outcome data
of ‡ 70 years aged recipients (n = 302) were compared
to those < 70 years. Moreover, data of ‡ 70 years aged
recipients were analyzed by uni- and multivariate analysis
to identify risk factors of death or graft loss.
Results: Compared to < 70 yrs, ‡ 70 yrs recipients were
more frequently transplantedwith‡ 60 aged donors (31 vs.
16%, P < 0.001) and, differed for the following charac-
teristics: HBsAg+ (5 vs 12%), AntiHCV+ (33 vs. 26%),
malignancies (26 vs. 14%), Alcoholic (12 vs. 33%), HCV
cirrhosis (83 vs. 62%), elective LT (94 vs. 88%), ABO
isogroup (94 vs. 92%), (‡ 70 years vs. < 70 years, all
P < 0.01). Graft and patient 5-year survival were 61%
and 65%, compared to 62% and 71%, respectively for
< 70 years (P = 0.06). Regarding the cause of death or
graft failure, aged recipients had signiﬁcantly less technical
complications (5 vs. 12%, P < 0.05), and more cardio-
vascular failure (12 vs. 6%, P < 0.05). At univariate
analysis, survival of ‡ 70 years recipients was statistically
impaired in case of: male recipient, donor age ‡ 55 years,
combined transplantation (all P < 0.05). Multivariate
analysis showed that living donor (RR = 4.2), UNOS
status< 4 (RR = 2.1) and donor age ‡ 55 (RR = 1.7),
were independent risk factors of death or graft loss.
Conclusion: Although still scarce in Europe, LT of aged
recipients leads however to almost 65% patient 5-year
survival. This survival is obtained despite the high level
of malignancies or HCV among those patients and the
higher use of aged donor grafts in this population.
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INTERFERONS AUGMENT THE
ANTITUMORAL ACTIVITY OF
SORAFENIB IN HUMAN PANCREATIC
CANCER CELL LINES
N. R. Billimoria1, A. A. Arora1, S. S. Galoforo2,
B. Marples2, G. D. Wilson2 and M. J. Jacobs1
1Department of General Surgery, William Beaumont
Hospital, Royal Oak, Michigan; 2Department of
Radiation Oncology, William Beaumont Hospital, Royal
Oak, Michigan
Background: Interferons (IFNs) may be beneﬁcial for
pancreatic cancer therapy. Previous studies showed
that their cytotoxic effects are mediated through IFN
receptors.
Objectives: Determine whether IFNs augment anti-
tumoral activity of sorafenib in human pancreatic cancer
cell lines by activating signal transduction pathways to
increase apoptosis.
Methods: Four human pancreatic cancer cell lines with
disparate receptor expressions were investigated (BxPc3,
Capan1, MiaPaCa2, Panc1). Cell survival was measured
after exposure to three chemotherapy agents [5FU, gem-
citabine (Gem), sorafenib] and IFNs alone followed by
combinations of IFNs + chemotherapy agents. Cellular
viability was assessed by the methylthiazol tetrazolium
assay; apoptosis assayed by caspase activation.
Results: IFNs mediated cytotoxic activity only in cell
lines expressing the corresponding receptor. Of the che-
motherapeutic agents, sorafenib had the most signiﬁcant
decrease in cell viability compared to 5FU and Gem
(P < 0.05) in three cell lines (MIAPaCa2, Capan1, and
Panc1). The addition of IFN-alpha to sorafenib sig-
niﬁcantly decreased cell survival compared to sorafenib
alone (P < 0.05) in MIAPaCa2 and BxPc3. In Capan1,
the combination of sorafenib and IFN-alpha had the
lowest cell survival, but it was not signiﬁcant compared
to sorafenib alone. There was no survival difference by
adding IFN-alpha to the Panc1, which was expected
since these cells do not express the interferon receptor.
Similar results were observed when IFN-alpha was re-
placed with IFN-beta, and IFN-gamma. Apoptosis cor-
related with cell survival; there was increased cell death
with the combination treatment compared to the single
agent.
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Conclusions: Addition of IFN to each chemotherapy
agent augmented the antitumoral effects of the drug in
IFN-receptor positive cell lines. Furthermore, the IFN-
sorafenib combination caused the lowest cell survival by
increasing apoptosis when compared to the IFN combi-
nations with 5FU and Gem.
FP-72
PREOPERATIVE CT MEASUREMENT
OF PANCREATIC STEATOSIS AND
VISCERAL FAT- PROGNOSTIC
MARKERS FOR DISSEMINATION AND
LETHALITY OF PANCREATIC
ADENOCARCINOMA
A. Mathur1, J. Hernandez1, F. Shaheen2, M. Shroff3,
S. Dahal1, C. Morton1, R. Kedar2 and A. Rosemurgy1
1Department of Surgery, University of South Florida;
2Department of Radiology, University of South Florida;
3University of South Florida
Introduction: Increased visceral steatosis has been shown
to amplify the risk of development of pancreatic cancer.
Moreover, in patients undergoing pancreatoduode-
nectomy for pancreatic adenocarcinoma, increased pan-
creatic fat correlates to positive lymph nodes and
decreased survival. However, a correlation between pre-
operative CT adipose measurements and patient out-
comes remains ill deﬁned.
Aim: We aim to determine the utility of preoperative CT
measurement of pancreatic steatosis and visceral fat as
prognostic indicators for patients with pancreatic ade-
nocarcinoma.
Methods: Patients undergoing resections for pancreatic
adenocarcinoma and having high resolution CT imaging
available for review were identiﬁed from our pro-
spectively maintained database. CT attenuation of the
pancreas, liver and spleen were measured in Hounsﬁeld
units and scored by two blinded investigators, with de-
creased units corresponding to increased fatty inﬁltra-
tion. Perirenal adipose tissue (indicator of visceral
obesity) was measured in mm. Additionally, histologic
slides were reviewed for tumor differentiation and inva-
sion. Data is presented as mean, ± SD.
Results: CT imaging was reviewed for 42 patients under-
going pancreatic resections. Lymphatic metastases were
absent (N0) in 18 patients and present (N1) in 24 patients.
Age (67 ± 3 vs. 66 ± 2), sex (male-61% vs. 50%), tumor
size (3.4 ± 0.5 vs. 3.6 ± 0.2), resection status (RO-69%
vs. 100%) were similar in both groups. Outcomes for
patients with and without lymphatic metastases and peri-
renal fat pad < 10 and > 10 mm are depicted in table 1.
Table 1.
Lymphatic
Invasion
Perirenal
fat pad
(mm)
% Patients
with
peripancreatic
fat invasion
Panc-
Body
(HU)
Panc-
Tail
(HU)
Liver
(HU)
Survival
(months)
Tumor-%
Poor
Differen-
tiation
N0 13 ± 2 53 35 ± 4 34 ± 4 58 ± 4 21 ± 4 12
N1 18 ± 1* 90* 23 ± 2* 21 ± 2* 50 ± 2* 11 ± 2* 52*
N1 &
fat pad
< 10 mm
9 ± 1 80 27 ± 2 27 ± 2 53 ± 4 16 ± 2 10
N1 &
fat pad
> 10 mm
21 ± 1 91 25 ± 2 20 ± 2 48 ± 2 7 ± 1 50
*P < 0.01 vs. N0, P < 0.01vs. N1 & fat pad < 10 mm.
Conclusions: In patients with pancreatic adenocarcinoma
undergoing pancreatoduodenectomy 1) lymphatic inva-
sion is associated with increased pancreatic steatosis and
visceral fat and 2) increased visceral fat stores are asso-
ciated with a decreased survival. Therefore, we conclude
that CT measurement of pancreatic steatosis and visceral
fat are important prognostic indicators of dissemination
and lethality of pancreatic adenocarcinoma.
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COMPARISON OF THE LONG-TERM
OUTCOMES OF UNCINATE PROCESS
CANCER AND NON-UNCINATE
PROCESS PANCREAS HEAD CANCER
M. J. Kang, J-Y. Jang, S. E. Lee, C-S. Lim, K. U. Lee
and S-W. Kim
Department of Surgery, Seoul National University College
of Medicine
Background: The embryologic and anatomic peculiarity
of the uncinate process may result in distinct clinical
features, but few studies have addressed the uncinate
process cancer. The purpose of this study was to compare
the clinicopathologic characteristics of pancreatic head
cancer by tumor location.
Objective: The authors sought to ﬁgure out the long-
term outcomes and identify the prognostic factors that
affect the survival and recurrence of pancreatic head
cancer by tumor location.
Methods: Between January 2002 and December 2008,
453 patients (161 with uncinate and 292 with non-unci-
nate process cancer) were treated for pancreatic head
cancer. Clinicopathologic variables were analyzed by
tumor location.
Results: Invasion into the superior mesenteric artery
(SMA) occurred more frequently (P < 0.001), and
overall resectability (P = 0.003), curative resection
(P < 0.001) and R0 resection rates (P = 0.003) were
lower for uncinate process cancer. Furthermore, overall
survival after R0 resection was lower for uncinate process
cancer (median 21 vs. 26 months; P = 0.018), and this
was accompanied by more frequent (P = 0.038) and
earlier (median 13 vs. 52 months; P < 0.001) locore-
gional recurrence. Concurrent chemoradiation increased
overall (median, 26 vs. 13 months; P < 0.001) and dis-
ease free survival (median, 15 vs. 6 months; P < 0.001)
of uncinate and non-uncinate process cancer, respec-
tively, after curative intended resection.
Conclusion: In uncinate process cancer, frequent inva-
sion into the SMA led to lower resectability. Further-
more, lower survival after R0 resection was accompanied
with frequent and early locoregional recurrence. Strate-
gies to improve surgical and perioperative locoregional
control are required for uncinate process cancer.
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SOCIOECONOMIC STATUS IMPACTS
THE VOLUME-OUTCOME
RELATIONSHIP FOR RESECTION OF
PANCREATIC ADENOCARCINOMA
J. Carroll, J. Smith, M. Murphy, J. Simons, S. C. Ng,
Z. Zhou and J. Tseng
University of Massachusetts Medical School, Surgical
Outcomes Analysis & Research
Background: The volume-outcome relationship for
complex operations such as pancreatectomy has been
described, with lower-volume surgeons producing infe-
rior survival. However, the effect of socioeconomic status
(SES) on this volume-outcome relationship has not been
elucidated.
Objective: To examine the impact of SES on overall
survival in the context of surgeon volume (SV) following
resection for pancreatic adenocarcinoma (PC).
Methods: The linked SEER-Medicare databases (1991–
2002) were queried for patients undergoing resection for
PC. Patients were grouped into socioeconomic strata
based on census tract and zip code data. SV was
dichotomized into two groups based on unique surgeon
identiﬁers. Univariate, trend, and Kaplan-Meier (KM)
analyses were used to characterize associations between
patient characteristics, SES, and SV. Logistic regression
models were constructed to assess the adjusted effect of
SV on overall survival.
Results: One thousand nine hundred and four patients
underwent surgical resection for PC, including 330 with
low SES. Univariate analysis showed that the low SES
group tended to be older (P < 0.001), female
(P < 0.016), of non-white race (P < 0.001), unmarried
(P < 0.001), and had more comorbidities (P = 0.025).
Trend analysis demonstrated low SES patients were sig-
niﬁcantly less likely to receive therapy from high-volume
surgeons when compared to higher SES patients
(P = 0.026). KM survival analysis showed a survival
beneﬁt for high SES patients (P = 0.007) and for pa-
tients receiving therapy from high-volume surgeons
(P < 0.0001). On multivariate analysis, high-volume
surgeons had better 60-day mortality [Odds Ratio (OR)
0.54, 95% Conﬁdence Interval (CI) 0.36–0.75], but did
not confer superior overall survival than their lower-
volume peers (OR 0.94, CI 0.63-1.4).
Conclusions: Socioeconomic differences are associated
with both surgeon volume and survival following resec-
tion for pancreatic cancer and are a potential confounder
of volume-outcome analyses.
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DOES HYSTOPHATOLOGIC TYPES
INFLUENCE THE OUTCOME AFTER
RESECTION IN AMPULLA OF VATER
ADENOCARCINOMA?
L. Haddad, R. Patzina, W. Andraus, A. Matheus,
E. Abe, S. Penteado, A. Montagnini, J. E. Da Cunha,
M. Machado and J. Jukemura
Department of Gastroenterology. University of Sa˜o Paulo
School of Medicine
Background: Intestinal and pancreatobliliary types of
Vater’s ampulla adenocarcinoma present a different
biologic behavior and prognosis. The aim of the present
study was to determine the best immunohistochemical
panel for tumor classiﬁcation and analyze the survival of
these histological types.
Method: Ninety-seven resected ampullary adenocarci-
nomas were histologically classiﬁed and the prognosis
factors were analyzed. The expression of MUC1, MUC2,
MUC5AC, MUC6, CK7, CK17, CK20, CD10 and
CDX2 was evaluated by using immunohistochemistry.
Results: Forty three Vater’s ampulla carcinomas were
histologically classiﬁed into intestinal type, forty seven
into pancreatobiliary and seven into other types. The
intestinal type had a signiﬁcantly higher expression of
MUC2 (74.4%vs. 23.4%), CK20 (76.7%vs. 29.8%),
CDX2 (86%vs. 21.3%) and CD10 (81.4%vs. 51.1%);
while MUC1 (53.5%vs. 82.9%) and CK7 (79.1%vs.
95.7%) were higher in pancreatobiliary adenocarcino-
mas. The most accurate markers for the immunohisto-
chemical classiﬁcation were CDX2, MUC1 and MUC2.
Survival was signiﬁcantly affected by pancreaticobiliary
type (P = 0.021); but only lymph node metastasis,
lymphatic invasion and stage were independent risk fac-
tor for survival in a multivariate analysis.
Conclusion: The immunohistochemical expression of
CDX2, MUC1 and MUC2 allows a reproducible classi-
ﬁcation of ampullary carcinomas. Although intestinal
type have shown better survival in the univariate, nor
histological classiﬁcation nor immunohistochemistry
were independent predictors of poor prognosis.
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PREDICTIVE FACTORS FOR
RECURRENCE AND SURVIVAL FOR
RESECTED INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM (IPMN):
IMPACT OF RESECTION MARGIN
STATUS
J. Choi, D. J. Han, Y-J. Lee, S. H. Shin, K-M. Park,
Y. H. Kim, J. Park, D. W. Hwang and S. C. Kim
Asan Medical Center, Seoul, South Korea
Background: Surgical resection is the only curative
treatment option for malignant Intraductal Papillary
Mucinous Neoplasm (IPMN). The risk factors for re-
currence and survival for resected IPMN have not been
clearly deﬁned.
Aims: We aim to evaluate prognostic factors for recur-
rence and survival after pancreatic resections for IPMN.
Methods: The retrospective review of 204 patients with
IPMN following resection was performed including pa-
tient demographics, tumour characteristics, surgical
treatments and outcomes. The median follow-up was
48 months.
Results: The proportion of patients with each type of
IPMN was as follows: adenoma (77, 38%), borderline
(77, 38%), carcinoma in-situ (9, 4%) and invasive carci-
noma (41, 20%). One hundred and eighty patients (88%)
underwent frozen sections with 35 (19%) having re-ex-
cision intra-operatively. The rate of recurrence and 5-
year disease free survival rate (DFSR) for invasive and
non-invasive IPMN were: 41% vs. 11% for recurrence
(P < 0.001) and 60.3% and 93.6% for 5-year DFS
(P < 0.001) respectively. The rate of recurrence for the
margin positive and the margin negative group was 31%
(13/42) and 14% (22/162) respectively (P = 0.012). The
5-year DFSR for invasive and non-invasive IPMN with
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the positive and the negative resection margin were:
50.8% and 63.9% in invasive (P = 0.333) vs. 82.3% and
96.3% in non-invasive IPMN (P = 0.023) respectively.
The signiﬁcant risk factors for recurrence on the multi-
variate analysis were the resection margin status
(P < 0.001) and the histology of IPMN (P = 0.024).
The histology of IPMN (P < 0.001, HR 2.506) and the
resection margin status (P = 0.018, HR 3.977) were
signiﬁcant predictors for DFS.
Conclusions: We have identiﬁed the margin status and
the IPMN histology as signiﬁcant predictors for long-
term outcomes following resection. The routine use of
frozen section is recommended to achieve resection
margin free of IPMN. The patients with positive resec-
tion margin need a close long-term follow up, even in
those with benign IPMN.
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THE USE OF SCORING SYSTEMS TO
RATIONALISE STAGING
LAPAROSCOPY IN PANCREATIC
MALIGNANCY
C. Macutkiewicz, M. Manu, D. Sherlock and D. O’Reilly
Department of Hepato-Pancreatico-Biliary Surgery,
North Manchester General Hospital, Manchester, UK
Background: Staging laparoscopy (SL) is currently con-
troversial for staging of intra-abdominal malignancies
due to the accuracy of high resolution computed
tomography (CT) scans. Platelet-lymphocyte ratio (PLR)
and carbohydrate antigen 19-9 (CA19-9) have been used
to determine patient selection for SL in pancreatic can-
cer. The Glasgow Prognostic Score (GPS) is an inﬂam-
mation-based scoring system.
Aims: The aim of this study was to use a scoring system
to allow targeting of SL to the highest risk groups.
Methods: A prospectively maintained pancreatic data-
base was reviewed and patients identiﬁed who underwent
pancreatoduodenectomy. Preoperative CA19-9, C-Reac-
tive protein (CRP), carcinoembryonic antigen (CEA),
and PLR values were obtained and used to stratify
patients into low-risk and high-risk groups based on
CA19-9 and PLR values.
Results: From 130 patients: 12 were found to be inop-
erable at laparoscopy, 36 were inoperable at laparotomy
and 82 underwent pancreatoduodenectomy. The median
CA19-9 was signiﬁcantly raised in the unresectable group
(363 vs. 94kU/l, P = 0.005). The median PLR was sig-
niﬁcantly higher in the unresectable group (223.0 vs.
172.0, P = 0.0027). The CEA and CRP were not sig-
niﬁcantly different in either group. The GPS was signif-
icantly higher in the unresectable group (1.621 vs. 1.089,
P = 0.004). Combining CA19-9 and PLR £ 150 in-
creased both positive predictive value (90%) and speci-
ﬁcity (94.7%) for resectability. Patients in the low-risk
group would have avoided 21 out of 110 (19%) of la-
paroscopies.
Conclusions: CA19-9 and PLR are signiﬁcantly raised in
advanced pancreatic malignancy and are therefore useful
markers in preoperatively assessing the need for SL. GPS
is signiﬁcantly raised in unresectable patients and war-
rants further evaluation in pancreatic cancer. Stratifying
patients into low- and high-risk groups has the potential
of sparing patients the need for SL, decreasing hospital
Trust expenditure and increase cost-effectiveness.
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NEOADJUVANT THERAPY FOR
ADVANCED PANCREATIC CANCER
MAY POTENTIATE SUCCESSFUL
RESECTION: RESULTS FROM A
NATIONAL STUDY
J. K. Smith, S. C. Ng, J. P. Simons, S. A. Shah,
T. P. McDade and J. F. Tseng
Surgical Outcomes Analysis & Research, University of
Massachusetts Medical School
Background: Potentially curative treatment of pancreatic
cancer necessitates surgical resection and adjuvant ther-
apy; however, pancreatic cancer is often diagnosed at late
stages when no longer resectable. Recent advances in
neoadjuvant therapy have introduced the possibility of
downstaging these cancers, increasing opportunities for
resection.
Objective: To use large national databases to examine
patterns and outcomes of neoadjuvant therapy for ad-
vanced (stage III or IV) pancreatic cancer.
Methods: The Surveillance, Epidemiology, and End Re-
sults (SEER)-Medicare linked databases (1991–2007)
were used to identify all Medicare-eligible patients
‡ 65 years with a diagnosis of pancreatic cancer. Treat-
ment patterns for patients with advanced cancer were
examined using univariate and survival analyses.
Results: Among 23,840 patients with pancreatic cancer,
905 (3.8%) were diagnosed at stage III, while the
majority, 14,329 (67.8%) were diagnosed at stage IV. Of
these with stage III or IV pancreatic cancer, 8406 had no
treatment, 4363 underwent chemotherapy alone, 602
underwent radiation alone, 1642 underwent chemoradi-
ation, 206 underwent resection alone, and 180 underwent
resection followed by adjuvant therapy. A minority of
patients (43, 0.3%) underwent neoadjuvant therapy fol-
lowed by resection. Survival analyses demonstrate that
patients who underwent neoadjuvant therapy followed
by resection had longer median survival than those who
underwent resection alone or even resection followed by
adjuvant therapy (13.2 months vs. 4.2 and 9.8 months,
respectively; P < 0.0001). Patients who underwent neo-
adjuvant therapy were more likely to be younger
(P = 0.038) and have fewer comorbidities (P = 0.012).
Conclusions: Patients with advanced (stage III or IV)
pancreatic cancer, traditionally considered unresectable,
may beneﬁt from neoadjuvant therapy followed by
resection if possible. Further investigation is warranted in
order to identify the best candidates for neoadjuvant
treatment.
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PREDICTORS OF PERIOPERATIVE
MORBIDITY AND MORTALITY AFTER
PANCREATICODUODENECTOMY FOR
PERIAMPULLARY CANCER
V. Kakarla, A. Annamalai, S. Nurkin, K Nandipati and
T. Addasi
New York Hospital Queens
Background: Pancreaticoduodenectomy is one of the
most complex surgical procedures today, and as such, is
associated with signiﬁcant risks of postoperative mor-
bidity and mortality.
Abstracts44
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Methods: Using the American College of Surgeons-Na-
tional Surgical Quality Improvement Project’s (ACS-
NSQIP) participant-use ﬁle, patients who underwent
Pancreaticoduodenectomy (WP) for Periampullary can-
cer at the 240 participating hospitals were identiﬁed.
Several peri-operative variables including 30-day mor-
bidity and mortality were collected. Variables are com-
pared between mortality and survival groups, and an
attempt was made to identify the mortality predictors.
Results: Our study included a total of 3072 patients from
2005 to 2008. We found that the 30 day mortality after
pancreaticoduondenectomy was 3% (92/3072).The sig-
niﬁcant predictors of mortality included: Age > 55 years
(OR 2.65, P = 0.005), pre-operative co-morbidities
including NIDDM (OR 1.7, P = 0.0423), dyspnea at
rest (OR 7.14, P = 0.013) and with moderate exercise
(OR 2.4, P = 0.0037), COPD (OR2.8, P = 0057), asci-
tes (OR 4.3, P = 0.0411), CHF (OR 33.8, P < 0.0001),
hypertension (OR 1.8, P = 0.0076), acute renal failure
(OR 16.53, P = 0.0123); Pre-operative lab variables
including Albumin < 2.5, High BUN, elevated PTT and
INR; and also operative time. Also signiﬁcantly, there
were speciﬁc postoperative complications that were
associated with a higher likelihood of mortality. These
included: Organ space infection, pneumonia, septic
shock, unplanned intubation, renal failure, and myocar-
dial infarction.
Conclusion: Our study identiﬁes the perioperative vari-
ables that signiﬁcantly affect patient outcome after pan-
creaticoduodenectomy. These risk-adjusted ﬁndings may
facilitate patient selection for this high risk procedure
that may be applicable in small and large healthcare
systems.
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THE VALUE OF PROPHYLACTIC
PANCREATICODUODENECTOMY WITH
PANCREATIC HEAD SURROUNDING
LYMPH NODES DISSECTION IN
ADVANCED GALLBLADDER CANCER
R. Higuchi, T. Ota, T. Araida, M. Hamano,
N. Takeshita, H. Kajiyama, T. Yazawa, Y. Yagawa and
M. Yamamoto
Department of Surgery, Institute of GAstroenterology,
Tokyo Women’s Medical University
Background: The necessity of prophylactic pancreatico-
duodenectomy (p-PD) with lymph nodes dissection sur-
rounds pancreatic head in gallbladder cancer remains
controversial.
Objective: Under the consideration of its necessity we
analyzed the post-operated advance gallbladder cancer
patients’ clinical data.
Method: We analyzed 213 cases of advanced gallbladder
cancer.
Result: Within 213 cases of advanced gallbladder cancer,
hepato-pancreaticoduodenectomy was performed in 93
cases (43.7%), pancreatico duodenectomy was performed
in 6 cases (2.8%), hepatectomy was performed in 88 cases
(41.3%) (63 cases with bile duct resection) and others
operation was performed in 26 cases (12.2%) (19 cases
with bile duct resection). A signiﬁcant difference in sur-
vival rate was found in those with curative resections
(n = 123, 5-year survival rate P = 36.2%) and those
without (n = 90, 5-year survival rate = 5.0%) (P <
0.001). In N1Binf (-) cases of curative resection, the sur-
gical outcomes of p-PD signiﬁcantly higher in those
without p-PD (p-PD = 19 cases, 5-years survival rate
69.9%; without p-PD = 19 cases, 5-years survival rate
20.9%; P = 0.0021). However, no signiﬁcant differences
were found in patient’s surgical outcome with or without
p-PD in N0 Binf (+), N0Binf (-) and N1Binf (+) patients.
There were signiﬁcant differences in morbidity (with p-PD
74.7%, without p-PD 61.4%: P = 0.038) and mortality
(P = 0.027: with p-PD 19.2%, without p-PD 9.6%) rates
in those cases with or without p-PD. Nevertheless, mor-
bidity and mortality rate gradually improved (morbidity
after p-PD 5/5 (100%) in 1970’s, 59/81 (72.8%) in 1980’s,
49/72 (68.1%) in 1990’s, 31/55 (56.4%) in 2000’s, mor-
tality after p-PD 2/3 (67%) in 1970’s, 9/48 (18.8%) in
1980’s, 8/40 (20%) in 1990’s, 0/8 (0%) in 2000’s.
Conclusion: Although, curative resection is important for
gallbladder cancer, p-PD seem to be considered as an
effective procedure in patients with N1Binf (-) cases.
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PROGNOSTIC VALUE OF LYMPH NODE
RATIO AFTER RESECTION OF PERI-
HILAR CHOLANGIOCARCINOMA
A. Guglielmi, A. Ruzzenente, T. Campagnaro,
S. Pachera and C. Iacono
Division of General Surgery ‘A’, GB Rossi Hospital,
University of Verona, Verona, Italy
Background: Lymph node (LN) metastasis is a major
negative prognostic factor for peri-hilar cholangiocarci-
noma (PCC). Prognostic signiﬁcance of the extent of LN
dissection and of the number of metastatic LN is still
under debate. Moreover, the prognostic signiﬁcance of
lymph-node ratio (LNR) had not been investigated in
PCC.
Aims: The aims of this study are to evaluate the prog-
nostic value of LNs status, of the total number of LNs
evaluated and of LNR in PCC.
Methods: Patients with PCC submitted to surgical re-
section with curative intent between 1990 and 2008 were
retrospectively evaluated. Number and status of har-
vested LN were recorded.
Results: Sixty-two patients underwent to surgical resec-
tion with curative intent. Survival after a mean follow-up
of 19 months was 22 months (95% CI 18–26).
In 53 patients (85%) regional lymphadenectomy was
performed. Median number of LNs examined was 7.3
(range 1–25). LNs were positive (N+) in 21 patients
(40%).
Median survival was signiﬁcantly longer in N0 patients
compared to N+, 42 and 23 months respectively
(P = 0.03). Mean survival was signiﬁcantly related with
the number of LN harvested: mean survival for patients
with 0 LNs retrieved, between 1–3 and more than three
LNs was 3, 18 and 28 months, respectively (P < 0.001).
Further statistical analysis identiﬁed a LNR cut-off value
of 0.25, survival analysis identiﬁed that 5-year survival
for patients above and below LNR of 0.25 was of 0 and
22%, respectively (p = 0.03).
Conclusion: LN metastasis is a major prognostic factor
for survival after surgical resection of PCC. Number of
LN harvested and LNR showed prognostic value. Like-
wise of other gastrointestinal tumors, our study identiﬁes
the prognostic role of LNR also in PCC.
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THE ROLE OF FDG-PET-CT AND
STANDARDIZED UPTAKE VALUE (SUV)
IN PRIMARY DIAGNOSIS AND STAGING
OF HILAR CHOLANGIOCARCINOMA
A. T. Ruys1, R. J. Bennink2, H. L. Van Westreenen1,
O. R. C. Busch1, D. J. Gouma1 and T. M. Van Gulik1
1Department of Surgery, Academic Medical Centre,
Amsterdam; 2Department of Nuclear Medicine, Academic
Medical Centre, Amsterdam
Introduction: The diagnosis and staging of hilar cholan-
giocarcinoma (HCCA) remains a challenge despite recent
advances in imaging. PET-CT is a non-invasive imaging
technique that is frequently applied in the staging of
different types of cancer, however little is known about
its use in HCCA. The level of FDG uptake (metabolism)
on PET-CT can be quantiﬁed by the assessment of the
standardized uptake value (SUV).
Aim: To evaluate accuracy of FDG-PET-CT and the
additional value of SUV in patientswith suspectedHCCA.
Methods: Between February 2006 and August 2009,
PET-CT was performed in 30 patients with suspected
HCCA who were all deemed resectable after conven-
tional staging methods including laparoscopy. The re-
sults of PET-CT and SUV were compared with
intraoperative and histopathological ﬁndings. Student’s
T-test was used to analyse relationship between patient
and tumour characteristics and SUV.
Results: Of 30 patients, 4 (13%) had benign, inﬂamma-
tory strictures diagnosed in the resection specimen. Sen-
sitivity of primary tumour detection was 89%. Sensitivity
and speciﬁcity for detection of regional lymph node
metastases and distant metastases were 67%/68% and
33%/96% respectively. Median SUV in the primary tu-
mor was signiﬁcantly (P < 0.05) higher in patients with
distant metastases (8.88) compared to patients without
distant metastases (mean 5.84). SUV in patients with
benign disease (n = 4) showed a trend towards lower
values than in patients with cholangiocarcinoma, al-
though this was not signiﬁcant.
Conclusion: PET-CT may improve accuracy of diagnosis
and staging of hilar cholangiocarcinoma. SUV can be
used to predict distant metastases and can potentially
help to differentiate HCCA from benign disease.
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ANALYSIS OF RECURRENCE PATTERN
PT2 GALLBLADDER CANCER THAT
UNDERWENT CURATIVE RESECTION
S.-G. Kim, G.-S. Kim, H.-J. Kwon, J.-M. Chun,
Y.-J. Hwang, Y.-G. Yoon and I.-C. Song
Kyungbook National University Hospital
Background: Clinical course after curative resection of
pT2 is diverse. Analysis of recurrence pattern of pT2
Gallbladder (GB) cancer may enable us to choose opti-
mal treatments for both original tumor and recurrent
tumors.
Aims and objectives: In this study, we analyzed the re-
currence pattern of pT2 GB cancer.
Methods: One hundred and one patients who underwent
surgery for pT2 GB cancer from 1992 to 2009 at KNUH
were selected. Clinico-pathologial features were studied
retrospectively by review of medical records. Mean follow
up period was 38 months. Recurrence was determined by
imaging studies and CA19-9. Kaplan–Meier method
(SPSS) was used for the overall and disease free survival.
Results: The patients included 44 males and 57 females.
Average age was 64.25 ± 10.5 and 64.9 ± 9.9 respec-
tively. Coexisting malignancies were present in 9.9%. R0,
R1, and R2 resections were performed in 87.1% (88/101),
4.0% (4/101), and 8.9% (9/101), respectively. Among the
88 patients of R0 resection, 17.6% (15/88) had re-
currences. Overall and disease free-5-year survival rate
was 77.9% and 78.7%. Disease free-5-year survival rate
was higher in lymph node dissection group and lymph
node negative group than the other groups but the dif-
ference was not statistically signiﬁcant. Among 15 re-
current cases, the frequency of local recurrences only,
regional lymph node recurrences only, distant metastasis
only, and combined recurrence was 26.7%(4/15),
6.7%(1/15), 26.7%(4/15), and 40% (6/15).
Conclusion: Only R0 resection provided favorable long
term survival. Because local recurrence only, which can
be surgically re-resected, occurs in considerable fre-
quency, development of surgical strategy is required.
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NEW HILAR CHOLANGIOCARCINOMA
RESECTION GUIDELINES BASED ON
ANATOMIC VARIATIONS
D. W. Hwang, J. M. Choi, S.-H. Chon, K.-M. Park and
Y.-J. Lee
Asan Medical Center University of Ulsan College of
Medicine
Objective: The rates of curative resection for hilar cho-
langiocarcinoma remain unsatisfactorily low. Thus, we
devised new guidelines for curative resection, based on
correlation between the anatomy of the bile duct, hepatic
artery (HA) and portal vein (PV) and the surgical
pathology.
Methods: A total of 101 patients underwent surgery for
hilar cholangiocarcinoma by a single surgeon at the Asan
Medical Center. Clinical, radiological, and pathological
data were analyzed retrospectively. Concomitant hepatic
resection was performed in 64 patients, of whom 39
underwent conventional resection (period I; 2004-2006),
and 25 underwent surgery using the new guidelines
(period II; 2007-2008). The new guidelines were: a left
hepatectomy for right-sided HA variations such as a re-
placed RHA from the superior mesenteric artery, an
accessory RHA, and an early dividing HA; a right hep-
atectomy for left-sided HA variations such as a replaced
LHA from the left gastric artery, an accessory LHA, and
an early dividing HA; a right hepatectomy for type I PV,
and a left hepatectomy for PV types II, III and IV; a right
hepatectomy for type A bile ducts; and a right hepatec-
tomy or left trisectionectomy for types B and C bile ducts
(Seyama’s bile duct classiﬁcation).
Results: There was no signiﬁcant difference in the clinical
and radiological outcomes between the groups. The po-
sitive proximal margin rate was lower in period II than
period I patients [8% (2/25) vs. 31% (12/39)].
Conclusions: New hilar cholangiocarcinoma resection
guidelines were developed based on a thorough preop-
erative assessment of the anatomy of hilar bilio-vascular
structures. Application of these guidelines resulted in an
improved proximal R0 resection rate.
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RESECTION FOR KLATSKIN TUMORS:
CURATIVE OR PALLIATIVE?
R. Cannon1, M. Thomas2, K. Bilinski3, R. Kaikaus3,
K. Ravindra1, S. Rudich4, S. Appana1, A. Barve1,
T. Doty4, T. Shaqour4, G. Brock1, M. Marvin1,
S. Barve1, C. McClain1, W. Jones3, K. McMasters1 and
J. Buell1
1University of Louisville; 2Bethesda North Hospital;
3Jewish Hospital; 4University of Cincinnati
Objectives: The management of hilar cholangiocarcino-
mas (Klatskin tumors) remains challenging, with con-
ﬂicting reports on the value of resection.
Methods: Retrospective analysis of prospectively col-
lected database was approved by the IRB. Multivariate
analysis and Cox Regression Modeling was performed
for tumor resectability, tumor recurrence and patient
survival.
Results: One hundred consecutive pts with median fol-
low-up of 31 mos was studied. 58% were males, 92%
Caucasians, with median age of 63 years. Presentation:
jaundice (85%), wt loss (50%), abdominal pain (21%).
Bilirubin 6.2 mg dL-1, Alk Phos 475 IU L-1, and Ca 19–9
of 258. 32/89 pts (36%) had positive ERCP cytology. 82
explored, 51 (62%) resected: 31 with R0 and 20 with R1
resections. Lobar resection was performed in 43 (84%).
The 30-day mortality was 11%; complication rate was
52%. In the second 50 pts resectability (34% vs. 68%:
P < 0.001) and R0 resections (35% vs. 73%: P = 0.008)
increased. Nineteen (37%) pts recurred. On Cox regres-
sion analysis, factors associated with improved survival:
resection, negative margins, negative lymph nodes, lobar
resection and second era of resection. (P < 0.05).
Table 1.
N
1-yr
survival
3-yr
survival
5-yr
survival
HR (95% CI)
p-value
Resected 51 63% 36% 33% 0.23 (0.1–0.5)
< 0.001
No
Resection
49 10% 2% 0%
R0 31 73% 60% 52% 2.98 (1.4–6.2)
< 0.001
R1 20 50% 10% 10%
Conclusions: Despite a low RO rate these patients have a
reasonable chance of long-term survival. Encouraging
has been the rise of RO resections over the last decade.
FP-87
GEMCITABINE PLUS RAD001 CONFER
THE BEST RESPONSE FOR
CHOLANGIOCARCINOMA CELLS WITH
OR WITHOUT K-RAS MUTATION
C-H. Cheng and T.-S. Yeh
Surgical Lab, Department of Surgery, Chang Gung
Memorial Hospital, Taipei
Backgrounds: Although gemcitabine-based cytotoxic
drugs are currently considered the standard chemother-
apeutic regimen in management of advanced or meta-
static cholangiocarcinoma based on phase II clinical
trials, however, the response rate is disappointing.
Addition of novel target therapy to the standard regimen
is thus desirable.
Materials and Methods: Three k-ras mutant cholangio-
carcinoma cell lines (HuCCT1, SSP-25, and RBE) and
three k-ras wild-type cholangiocarcinoma cell lines (YS-
CCC, TGBC, TFK-1) were tested for different thera-
peutic regimens including oxaliplatin (OX), gemcitabine
(GEM), ceftuximab (Erb), Ox+ Gem, Ox+Gem+Erb,
everolimus (Rad001), and Gem+ Rad001. The prolifer-
ation index of tested cell lines was determined using MTT
test. Expression of Akt, GSK-3, p38MAPK, p70 and
mTOR were determined using Bio-Plex kits.Further,
SCID mice were implanted with HuCCT1 subcutane-
ously and tested for different therapeutic regimens. Tu-
mor size, TUNEL assay, Ki-67, VEGF, and eIF4E of the
excised tumors were determined. Finally, thioacetamide-
induced cholangiocarcinoma rat model was employed to
test the therapeutic efﬁcacy of different regimens using
microPET.
Results and conclusions: Gem+Rad 001, through the
effect on Akt-mTOR signaling, exhibited the best thera-
peutic response in management of cholangiocarcinoma
irrespective to the presence of k-ras mutations. Increased
apoptosis, decreased Ki-67, VEGF and eIF4E of the
tumors treated by Gem+ Rad 001 were phenotypically
remarkable compared to those of other regimens.
FP-89
POSTOPERATIVE MORBIDITY
RESULTS IN DECREASED SURVIVAL
AFTER RESECTION FOR HILAR
CHOLANGIOCARCINOMA
M. House, A. Chauhan, A. Nakeeb, N. Zyromski,
T. Howard, K. Lillemoe and H. Pitt
Department of Surgery, Indiana University School of
Medicine
Introduction: The prognosis for patients with hilar cho-
langiocarcinoma (HCCA) remains poor despite aggres-
sive operative approaches, including major hepatectomy,
to accomplish complete resection. This study examines
the postoperative morbidity (PM) associated with resec-
tions for HCCA and its association with short- and long-
term patient survival.
Methods: Between 1998 and 2008, 51 patients with a
median age of 66 years underwent resection for HCCA.
Associations between survival and clinicopathologic
factors, including peri- and postoperative variables, were
studied with univariate and multivariate models. PM was
classiﬁed according to the Clavien grading system. Grade
III-V complications were considered major PM.
Results: 76% of patients underwent major hepatectomy
with resection of the extrahepatic bile ducts. Operative
mortality was 10%. The overall incidence of PM was
71%, with 64% of all PM as major. There was no dif-
ference in operative blood loss for patients with major
versus minor PM. Patients with major PM received
adjuvant chemotherapy less frequently than patients with
minor or no complications 26% v. 54%, P = 0.08. The
overall median patient follow-up was 20 months (30 mos
for survivors). The 1-, 3-, and 5-year overall survival (OS)
rates were 57%, 25%, and 20%. On univariate analysis,
margin status (24% R1), nodal metastasis (22% N1),
histologic grade (20% high grade), and major PM were
associated with OS, P < 0.05. Multivariate Cox regres-
sion analysis revealed major PM as an independent factor
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associated with OS and DSS (H.R = 2.2 and 1.9,
respectively, P = 0.02). The median OS for patients with
major PM was 7.5 mos compared to 25 mos for patients
who experienced minor or no PM, P = 0.018.
Conclusion: Extensive operations for HCCA can pro-
duce substantial postoperative morbidity. In addition to
causing early mortality, major postoperative complica-
tions are associated with decreased long-term cancer-
speciﬁc survival after resection of HCCA.
FP-90
ENDOSCOPIC MANAGEMENT OF
PANCREATIC PSEUDOCYSTS
P. Kumar1, N. Palaniappan2, N. Mohan1 and
A. Ramesh1
1Meenakshi Mission Hospital and Research Centre,
Madurai; 2Global Hospitals, Chennai
Introduction: Pancreatic pseudocysts arise as a con-
sequence of pancreatic injury, which results in disruption
of the pancreatic duct or side branches. Endoscopic
therapy is directed at drainage of the ﬂuid collection
using a transmural approach and/or transpapillary ap-
proach. Hereby we present our data on endoscopic
drainage of pancreatic pseudocyst and outcomes.
Materials and methods: Retrospective analysis of pro-
spectively collected data base from January 2000–De-
cember 2008 was analysed and proposal of a treatment
algorithm.
Results: Total number of pancreatic pseudocyst during
the study period was 108. Endoscopic drainage was at-
tempted in 46 (42.5%). Aetiologies were acute pancrea-
titis in 82%, pancreatic trauma in 8%, chronic
pancreatitis in 6%, recurrence following open surgery
4%. Mean age was 28.4 years, male: female ratios were
1.8:1. Mean cyst size was 9.5 cm (7–20 cm). Endoscopic
drainage was successful in 34 (73.9%). Transmural
drainage was done in 80% (Cystogastrostomy, Cysto-
duodenostomy), transpapillary in 12% and combined
in 8%. EUS was used in later half of series. About
28% of cases had solid necrotic material removed, and
52% required more than one double pig tail stent
placement. Overall morbidity was 18%. No mortality.
Major morbidities were recurrence in 5%, bleeding in
4%, and aspiration in 2%. Mean hospitalisation was
3.5 days.
Conclusion: Endoscopic drainage of pseudocyst is
feasible with accepted morbidity and EUS guided
drainage is preferred for better outcome. Transmural
drainage is the most common method of drainage.
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PANCREATICOJEJUNOSTOMY VERSUS
PANCREATICOGASTROSTOMY IN
RECONSTRUCTION FOLLOWING
PANCREATICODUODENECTOMY: A
RANDOMIZED CONTROLLED TRIAL
M. Gandhi, A. Venugopal and M. Bedi
Lakeshore Hospital & Research center, Cochin, Kerala,
India
Background: There continues to be controversy about
the relative efﬁcacy of anastomotic techniques after
Whipple resection.
Aim: Prospective randomized controlled trial of PJ vs.
PG after Whipple resection. Period of study 2004 to
2009.
Patients: Two hundred and thirty four patients were
screened, and 201 patients were randomized. Four pa-
tients were removed from the study owing to surgeon
preference. 99 patients underwent PJ and 101 underwent
PG. Patient characteristics were similar in both groups.
In both cases, a Duct-to-mucosa technique was used.
Methods: The following parameters were analyzed:
mortality, major complications, pancreatic ﬁstula as de-
ﬁned by high drain amylase at Days 1, 3, 5 and 10, intra
abdominal collections, postoperative bleeding, hospital
stay, time to resumption of oral intake, and need for
postoperative intervention (endoscopy, interventional
radiology or surgery). Data was analyzed using SPSS v
11.0.
Results: Six patients died (4 PJ, 2 PG). Postoperative
pancreatic ﬁstula rates were higher following PJ than PG.
See Table. Patients had fewer episodes of postoperative
bleeding after PG, shorter hospital stay, and less post-
operative interventions. Oral intake was resumed earlier
following PJ.
Parameter
PJ
(n = 99)
PG
(n = 98)
P
Value
High amylase in drain Day 3 38 24 0.06
High amylase in drain Day 5 25 14 0.03
High amylase in drain Day 10 12 2 0.008
Intra abdominal collection 18 13 NS
Delayed gastric emptying 23 24 NS
Bleeding 5 1 0.09
Intervention 14 7 NS
Hospital stay (days) 14.5 13 0.03
Mortality overall 4 2 NS
mortality due to POPF 2 1 NS
Conclusion: Postoperative pancreatic ﬁstulas occur more
commonly following pancreaticojejunostomy. Intra
abdominal collections, hemorrhagic complications, and
hospital stay were more in the PJ group, although mor-
tality rates are similar.
FP-92
GASTRIC ACIDITY AFTER
PANCREATODUODENECTOMY:
INFLUENCE OF SURGICAL TECHNIQUE
AND PERI-OPERATIVE MEDICAL
TREATMENT
M. J. M. Morak, K. Tran, M. J. Bruno, W. C. J. Hop,
G. Kazemier, J. De Jonge and C. H. J. Van Eijck
Erasmus Medical Center Rotterdam
Background: Gastric acid at the anastomotic site after
pancreaticoduodenectomy might cause peptic ulcers.
This study was performed to compare gastric acidity
after pylorus-preserving pancreatoduodenectomy
(PPPD) and classical Whipple’s resection, in addition we
assessed the effect of proton pump inhibitors (PPIs) and
somatostatin analogues.
Methods: In a prospective cohort study, 50 (69%)
patients underwent a PPPD and 22 a classical Whipple’s
resection. Patient received intramuscular Sandostatin
long acting release (LAR) (n = 48; 67%) or sub-
cutaneous octreotide (n = 23; 32%). Esomeprazole was
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started following operation if not used pre-operatively.
Gastrin levels were measured before and on day 2 after
surgery together with gastric acidity.
Results: Multivariate analysis showed that the type of
somatostatin analogue and pre-operative PPI were in-
dependent determinants of gastric acidity two days
postoperatively. The type of resection or post-operatively
started PPIs had no effect on gastric acidity. There was a
positive relation between serum gastrin levels and gastric
pH. The type of resection, type of somatostatin analogue
or PPIs had no inﬂuence on serum gastrin.
Table IV. Multivariate analysis (multiple regression) of
relations between post-operative gastric acidity (pH) and
various factors. Data shown are adjusted differences of
means
Factors Effect 95% conﬁdence interval p-value
Type of pre-operative
somatostatin analogue
LAR vs. octreotide s.c.
)1.7 )2.8 to )0.7 0.002
Pre-operative PPI
Yes vs. no
1.2 0.1 to 2.3 0.031
Surgical resection
technique Whipple
vs. PPPD
0.2 )0.9 to 1.3 0.737
Post-operative
administration of a
PPI Yes vs. no
0.6 )0.4 to 1.7 0.241
Conclusion: There is no difference between PPPD or
classical Whipple’s resection on post-operative gastric
acidity. Pre-operative use of PPIs and the administration
of subcutaneous octreotide resulted in diminished gastric
acidity on day 2 postoperatively, which may prevent
anastomotic ulcers. Sandostatin LAR resulted in sig-
niﬁcantly higher gastric acidity.
Multivariate analysis of factors possibly inﬂuencing post-
operative gastric acidity (pH).
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APPLICATION OF THE LEFT VEIN AS
A PRACTICAL CONDUIT IN SUPERIOR
MESENTERIC VEIN RECONSTRUCTION
Y. Xie and J. Dong
Hospital and Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: Pancreatectomy combined with en bloc vas-
cular resection represents a potentially curative treatment
inpatientswithpancreatic cancer inﬁltratingmajor vessels.
Objectives: This report evaluates our experience in
reconstruction of portal-superior mesenteric vein using
autologous left renal vein after en bloc vascular resection
for locally advanced pancreatic cancer.
Methods: Between 2006 and 2009, four patients with
pancreatic cancer underwent extended pancreaticoduo-
denectomy combined with en bloc resection of portal-
superior mesenteric vein. The vascular reconstruction
was performed using a conduit derived from autologous
left renal vein.
Results: The average operating time was 290 ± 20 min,
and the blood loss was 400 ± 30 mL. The mean time of
portal vein obstruction was 25 ± 3 min. None of four
patients developed hepatic and renal dysfunction after
extended pancreaticoduodenectomy. The average hospi-
tal stay was 17 ± 2 days. There were no portal vein
thrombosis and anastomotic stricture in all patients after
a follow-up period of 3 months.
Conclusion: The reconstruction of portal-superior me-
senteric vein with autologous left renal vein is a safe and
feasible procedure in extended pancreaticoduodenectomy
combined with en bloc vascular resection.
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EARLY LOW VOLUME ORAL
SYNBIOTIC/PREBIOTIC
SUPPLEMENTED ENTERAL
STIMULATION OF THE GUT IN
PATIENTS WITH SAP: RANDOMIZED
DOUBLE BLIND PROSPECTIVE STUDY
H. Plaudis, V. Boka and G. Pupelis
Department of Surgery, Riga Eastern Clinical University
Hospital
Background: Experience with administration of Prebiot-
ics/Probiotics (Synbiotics) in patients with severe acute
pancreatitis (SAP) has demonstrated immunomodula-
tory capacity of this treatment modality.
Aim: Evaluation of the feasibility, effectiveness and
perspective of the clinical application of early low volume
oral Synbiotic/Prebiotic supplemented enteral stimula-
tion of the gut in patients with SAP.
Methods: During the period from 2005 to 2008 totally
90 SAP patients with signs of SIRS and/or MODS were
prospectively enrolled in to the double-blind clinical
trial. Patients were randomised according the feeding
mode. Group I (n = 32) have received standard whole
protein feeding formula. Group II (n = 30) and Group
III (n = 28) have received early Synbiotic or Prebiotic
supplements. Synbiotic consisted of four bioactive lactic
acid bacteria and four bioactive plant ﬁbres. Prebiotic
consisted of ﬁbres only. Oral administration of Syn-
biotics or Prebiotics mixed with standard enteral nutri-
tion formula was commenced when patients were able
to sip water.
Results: Statistically signiﬁcantly differed average vol-
umes of orally administered blends as well as number of
calories between Groups I/II and I/III, P = 0.001. Early
oral administration of Synbiotic/Prebiotic supplements
was associated with lower infection rate comparing to the
Group I, (P = 0.03, P = 0.001), lower rate of surgical
interventions, P = 0.005, as well as shorter ICU (P =
0.05) and hospital stay (P = 0.03). Finally Synbiotic
supplemented enteral stimulation of the gut resulted in
reduced mortality rate comparing to the Group I,
P = 0.02.
Conclusion: Early low volume oral Synbiotic/Prebiotic
supplemented enteral stimulation of the gut seems to be
perspective complement to the routine treatment proto-
col of SAP. Positive therapeutic effect can be partially
explained by the possible improvement of the gut barrier
function.
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CYST ASPIRATION ANALYSIS: MUCIN
OR CARCINOEMBRYONIC ANTIGEN
(CEA) – WHICH IS BETTER?
G. Morris-Stiff, G. Lentz, S. Chalikonda, M. Johnson
and R. M. Walsh
Department of Hepato-Pancreato-Biliary Surgery,
Cleveland Clinic Foundation, Cleveland, Ohio
Background: Differentiation between the various
pathologies presenting as a cystic pancreatic lesion is
clinically important but often challenging. We have pre-
viously advocated the performance of endoscopic ultra-
sound (EUS) with aspiration and determination of mucin
and carcinoembryonic antigen (CEA) content.
Aims: To report the results of this ongoing protocol and
determine the relative importance of mucin and CEA
within these cysts in the diagnostic process.
Methods: The institutions prospectively maintained
pancreatic cyst database was accessed to identify patients
who had undergone pancreatic EUS and cyst aspiration
as part of their evaluation. Only those patients who had
subsequently undergone resection were selected, with
histopathology being the gold-standard for comparison.
Results: During the period January 2000 to July 2009,
174 patients with pancreatic cystic disease underwent
surgery of which 121 had an EUS with aspiration at-
tempted at our institution with specimens sent for mucin
and CEA. Based on histopathology, 79 mucinous lesions
were identiﬁed including 44 cystadenomas and 35 intra-
ductal papillary mucinous neoplasms (IPMN), and 42
non-mucinous lesions. The median cyst CEA levels were
signiﬁcantly higher in the mucinous lesions group at 826
vs. 2.7 ng mL)1 (P = 0.001). The results are summarised
in the Table 1.
Table 1. Relative importance of mucin and CEA in cyst
analysis
Sensitivity Speciﬁcity PPV NPV PDLR NDLR
Mucin 0.62 0.60 0.74 0.45 1.55 0.63
CEA 0.52 0.85 0.87 0.49 3.47 0.56
Mucin or CEA 0.87 0.5 0.77 0.68 1.74 0.26
Mucin & CEA 0.27 0.95 0.91 0.41 1.80 0.77
PPV = positive predictive value
NPV = negative predictive value
PDLR = positive diagnostic likelihood ratio
NDLR = negative diagnostic likelihood ratio
Conclusions: It would appear that assessment of mucin
and CEA are complementary, with the best proﬁle ob-
tained when the results are assessed together, with a high
sensitivity and NPV, and a low NDLR. However, the
low sensitivity, PPV means that the combination is not
optimal and further studies are ongoing to deﬁne a more
reliable combination of markers.
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IT IS IMPORTANT TO ESTABLISH AN
ACCUTRATE DIAGNOSIS IN CASES OF
PRESUMED CHRONIC PANCREATITIS
G. Morris-Stiff, N. Jardine and M. C. A. Puntis
Department of Pancreato-Biliary Surgery, University
Hospital of Wales, Cardiff, Wales
Background: CP is a diagnosis with a stigma because of
the aetiological link to excess alcohol consumption. It is
therefore critical that an accurate diagnosis is established
such that patients with other causes for chronic epigastric
pain are not mislabelled.
Aims: To review diagnostic data of all patients with a
discharge diagnosis of CP as attributed by clinical coding
staff, and determine the number in whom the diagnosis
was accurate.
Methods: All patients with a diagnosis of CP based on
discharge coding during a 12 month period were identi-
ﬁed. In all cases, the computerised hospital radiological
database was analysed to determine whether or not a
diagnosis of CP had been established at either the time of
admission or during a previous hospitalisation/clinic visit.
The biochemical database was also interrogated to
determine those with endocrine and/or exocrine insufﬁ-
ciency as a result of CP. In patients in whom a diagnosis of
CP was not established, alternate diagnoses were sought.
Results: One hundred and nine patients were identiﬁed
with a discharge diagnosis of CP consisting of 79 males
and 30 females with a mean age of 51.9 ± 16.1 years.
Review of the radiological database revealed only 59
patients had conﬁrmed CP based on imaging studies. Of
the remainder, 11 had acute pancreatitis, 18 had recur-
rent acute pancreatitis, and 21 had no established diag-
nosis but investigations were in progress and CP was
suspected. In those with conﬁrmed CP, evidence of
endocrine insufﬁciency had been sought in 58/59 patients
of which 34 demonstrated impaired glucose tolerance but
exocrine function had been investigated in only 38 cases
being abnormal in 28 individuals.
Conclusions: Many patients diagnosed with CP based on
discharge coding classiﬁcations have either an alternative
diagnosis or no formal diagnosis established. Further-
more, a number of patients with a diagnosis of CP have
not had an assessment of exocrine function and as such
may not be optimally treated.
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OUTCOMES FROM PANCREATO-
DUODENAL TRAUMA IN THE UK
1989–2009
A. Kausar1, O. Bouamra2, F. Lecky2 and D. O Reilly1
1North Manchester General Hospital; 2Trauma Audit and
Reasearch Network
Introduction: The aim of this population-based study
was to assess the incidence, mechanisms of injury, man-
agement and outcome of patients who sustained pan-
creatoduodenal (PD) trauma in the UK over the period
1989-2009.
Methods: The Trauma Audit and Research Network
(TARN) database was searched for details of any patient
with blunt or penetrating trauma to the pancreas, duo-
denum or both.
Results: Six hundred and ﬁfty seven of 267,000 (0.246%)
trauma cases or of 13,513 (4.86%) cases with abdominal
trauma sustained PD trauma. Median age was 27 (IQR:
17–45) for blunt trauma and 28 (IQR: 21–38) for pene-
trating trauma. The Male:Female ratio was 3:1. The In-
jury severity scores (ISS) were 26 (IQR: 17–36) for blunt
trauma and 16 (IQR: 9-25) for penetrating trauma. The
ratio of penetrating: blunt injury was 17:83. Road trafﬁc
collision was the commonest mechanism of injury,
accounting for 393 (59.8%) of cases. 63.6% of cases
underwent an initial operation for trauma in blunt PD
trauma; 72.6% in penetrating PD trauma. For blunt
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trauma, mortality rates for pancreatic, duodenal, both
and total were 25.4%, 16.1%, 27.3%, 22.2%. For pene-
trating trauma, mortality rates for pancreatic, duodenal
and total were 18.5%, 9.5% and 13.3%. Age, Glasgow
Coma Scale and ISS were associated with mortality,
Mann-Whitney test, all < 0.001.
Conclusion: Pancreatic trauma is rare in the UK. The
high proportion of cases due to blunt trauma differs from
that of series from the USA and South Africa. Mortality
is high in the UK but comparison with surgical series is
difﬁcult because of selection bias in the latter.
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INFLUENCE OF ABERRANT RIGHT
HEPATIC ARTERY ON PERIOPERATIVE
COURSE AND LONG TERM SURVIVAL
AFTER PANCREATODUODENECTOMY
W. J. Eshuis, K. Olde Loohuis, O. R. C. Busch,
T. M. Van Gulik and D. J. Gouma
Academic Medical Center
Background: An aberrant right hepatic artery, mostly
arising from the superior mesenteric artery (replaced or
accessory RHA), is the most frequent vascular anomaly
encountered in patients undergoing pancreatoduode-
nectomy. Preservation of an aberrant RHA may be
challenging when aiming at radical oncologic resections.
Aim(s)/Objective(s): To investigate the relation between
presence of aberrant RHA and perioperative course and
long-term survival after pancreatoduodenectomy.
Methods: In a consecutive series of 790 patients from our
prospective pancreatoduodenectomy database, patients
with aberrant RHA were identiﬁed by reviewing opera-
tion reports. Hospital course and follow-up were re-
corded prospectively. Patients with and without aberrant
RHA were compared. Outcome measures were perio-
perative course and long term survival (oncologic pa-
tients only).
Results: Sufﬁcient data was available for 757 patients, of
which an aberrant RHA (aRHA) was found in 136 pa-
tients (18%). In six patients the aberrant artery had to be
sacriﬁced to enable resection; in ﬁve cases, it was da-
maged or ligated because of late recognition. Mean op-
erative time was 295 min in the aRHA group, vs. 300 min
in the group without aRHA (p 0.53). There was no dif-
ference in hepaticojejunostomy leakage (no aRHA: 3%,
aRHA: 2%, p = 0.24) or post-pancreatoduodenectomy
hemorrhage (both groups 7%). Kaplan Meier survival
curves of oncologic patients (n = 666) showed no dif-
ference between patients with and without aRHA (log
rank test, p = 0.91).
Conclusion: Aberrant right hepatic artery was found in
18% of our patients. Its presence did not prolong
duration of operation and did not inﬂuence the
incidence of hepaticojejunostomy leakage or post-
pancreatoduodenectomy hemorrhage. Long term sur-
vival of oncologic patients was not compromised.
Surgeons must always be aware of an aberrant right
hepatic artery. Early recognition helps to prevent
intraoperative complications.
FP-99
AQUAPORINS PLAY A CENTRAL ROLE
IN APOPTOTIC CELL DEATH IN
HUMAN HEPATOCELLULAR
CARCINOMA
D. Sindram, M. A. Pallilonis, M. A. Mattocks,
J. B. Martinie, D. A. Iannitti and I. H. McKillop
Section of HPB Surgery, Carolinas Medical Center,
Charlotte, NC
Objectives: Determine the role of AQPs during apoptotic
cell death in human HCC cells and characterize AQP8/9
expression in human HCC tissue-non-tumorigenic liver
(NTL).
Methods: Human HuH7 cells were cultured and stimu-
lated to undergo apoptosis with apicidin in the presence
or absence of HgCl2, an AQP channel inhibitor. Im-
muno-histochemistry (IHC) was performed on human
HCC-NTL tissue using antibodies speciﬁc against AQP 8
or 9.
Results: Western blot analysis demonstrated AQP8 and
AQP9 expression in HuH7 cells. Fluorescent-cell acti-
vated sorting (FACS) analysis identiﬁed rapid, AQP-
dependent water movement in HuH7 cells in response to
osmotic challenge (210mOsm), an effect inhibited by
HgCl2 pretreatment (10 lM, 15 mins). In a parallel ser-
ies of studies apicidin (2 lM, 24 hour) stimulated
apoptosis in 69.1 ± 3.9% of HuH7 cells (as detected by
FACS). In contrast, pretreatment of cells with HgCl2
(10 lM) signiﬁcantly inhibited apicidin-induced apop-
tosis in Huh7 cells (48.7 ± 5.3%, P < 0.05 versus ap-
icidin alone, n = 4 separate experiments) to a level not
signiﬁcantly different to that of cells treated with HgCl2
alone (34.4 ± 5.4%). Using archived human HCC-NTL
tissue IHC analysis demonstrated expression of AQP8
and 9 were signiﬁcantly lower in HCC tissue than
adjacent NTL tissue in 8/15 specimens (53%). Further-
more, signiﬁcant differences in AQP expression, and
intracellular localization, were identiﬁed between cir-
rhotic and non-cirrhotic NTL in which HCC arose al-
though, no signiﬁcant correlation could be made
between underlying liver pathology and pattern(s) of
AQP8 and/or 9 expression.
Conclusions: AQP-dependent water movement is re-
quired for apoptotic progression in human HCC cells in
vitro. A signiﬁcant number of Human HCC specimens
are characterized by decreased AQP 8/9 expression as
compared to NTL. These data may explain, at least in
part, the increased resistance to pro-apoptotic agents in
HCC and, may provide a target for future therapeutic
development.
FP-100
EXPERIMENTAL STUDY OF LIGHT
GENE TRANSFECTION FOR
TREATMENT OF HEPATOCELLULAR
CARCINOMA
X-Y Yin, X. Hou, Y. Wang and L-J. Liang
Department of Hepatobiliary Surgery, The First Afﬁliated
Hospital, Sun Yat-Sen University, Guangzhou 510080,
China
Background: LIGHT (TNFSF14) is a recently-identiﬁed
member of TNF superfamily. Expressed primarily by
Abstracts 51
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
immune cells, it can induce maturation of dendritic cells,
promote activation and expansion of T lymphocytes,
enhance secretion of various cytokines and trigger cell
apoptosis. It was found that LIGHT played an important
role in building up anti-tumoral immunity. However, the
therapeutic signiﬁcances of up-regulation of LIGHT on
hepatocellular carcinoma (HCC) have not been well-
documented.
Aims: To investigate the therapeutic efﬁcacy of plasmid-
mediated transfection of LIGHT gene on HCC using
murine tumor model.
Methods: Stable LIGHT-expressing murine HCC cell
line Hepa1-6 (Hepa-LGH) and blank plasmid-transfect-
ed Hepa1-6 (Hepa-NEO) were generated by plasmid-
mediated gene transfection and G418 selection. Growth
of Hepa-LGH, Hepa-NEO and Hepa1-6 was assessed
and compared in vitro, and on C57Bl/C mice by subcu-
taneous inoculation.
Results: RT-PCR conﬁrmed that Hepa-LGH expressed
high-level LIGHT, while both Hepa-NEO and Hepa1-6
had no expression of LIGHT. In vitro titration showed
no signiﬁcant differences in cell growth rate among
Hepa-LGH, Hepa-Neo and Hepa1-6 (p>0.05). C57Bl/C
mice tumor model revealed that Hepa-LGH tumor grew
markedly slower than both Hepa-Neo and Hepa1-6
(P < 0.01), and the latter two had no signiﬁcant differ-
ences (P > 0.05). Hepa-LGH tumor-bearing mice sur-
vived much longer than Hepa-Neo and Hepa1-6 tumor
bearing mice (P < 0.01).
Conclusions: Up-regulation of LIGHT gene on HCC via
gene transfection helps to inhibit tumor growth in vivo
and prolong the survival of tumor-bearing mice. It might
become a promising therapeutic approach for HCC.
FP-101
IMPACT OF ANTIVIRAL THERAPY ON
THE SURVIVAL OUTCOME AFTER
HEPATECTOMY FOR HEPATITIS
B-RELATED HEPATOCELLULAR
CARCINOMA
A. Chan, S. H. Chok, W. K. Yuen, S. C. Chan,
K. K. C. Ng, R. T. P. Poon, C. M. Lo and S. T. Fan
Queen Mary Hospital, University of Hong Kong
Background: Although the therapeutic beneﬁt of antivi-
ral treatment in the management of chronic hepatitis B
infection (HBV) is well-known, its impact on the survival
outcome after hepatectomy for HBV-related hepatocel-
lular carcinoma (HCC) remains unclear.
Aim: To evaluate the impact of post-hepatectomy an-
tiviral treatment on the prognosis of HBV-related HCC.
Methods: From September 2003 to December 2007, 42
patients were given Lamivudine (n = 39) or Entecavir
(n = 4) after hepatectomy (i.e. treatment group) due to
abnormal liver function. Their preoperative data, tumour
characteristics and survival outcome were compared with
94 patients who did not receive any antiviral treatment
after hepatectomy (i.e. control group). Univariate and
multivariate analyses were performed to identify prog-
nostic factors for survival.
Results: Patient demographics, preoperative liver func-
tion and tumour characteristics were comparable be-
tween the two study groups. The liver function reserve at
the time of tumour recurrence in the treatment group was
also comparable with the control group. There was no
signiﬁcant difference in tumour recurrence rate (47.6%
vs. 65%, P = 0.28) and disease-free survival (69.8 vs.
9.2 months, P = 0.05) between the two study groups.
Nonetheless, the overall survival was signiﬁcantly im-
proved in the treatment group (72.3 vs. 33.2 months,
P = 0.005). Multivariate analysis identiﬁed use of an-
tiviral treatment to be a prognostic factor for prolonged
overall survival. Subgroup analysis stratiﬁed against tu-
mour stage and portal vein status showed that the sur-
vival beneﬁt of antiviral treatment was more pronounced
in AJCC stage I/II tumours or HCCs without portal vein
invasion.
Discussion: Antiviral therapy may improve the prognosis
of HBV-related HCC by inhibition of hepatitis activity in
the liver remnant.
Conclusion: Antiviral treatment should be considered
after hepatectomy for HBV-related HCC especially in
early stage tumours.
FP-102
REPEAT HEPATECTOMY FOR
RECURRENT HEPATOCELLULAR
CARCINOMA AFTER PREVIOUS
CURATIVE RESECTION: IS IT
WORTHWHILE?
K-F. Lee, B. Chui, J. Wong, P. Ip, S. Bhange, D. Ngo,
M. Tam and P. Lai
Prince of Wales Hospital
Background: Intrahepatic recurrence after curative
resection of hepatocellular carcinoma (HCC) is common.
Repeat hepatectomy is only feasible in selected patients
with intrahepatic recurrence. Outcomes of this selected
group of patients are seldom addressed and the role of
repeat hepatectomy needs to be clearly deﬁned.
Objective: To assess the value of repeat hepatectomy in
patients with intrahepatic recurrence of HCC.
Method: Between July 2001 and September 2009, 304
liver resections for HCC were performed in our centre of
which 15 (4.9%) patients underwent a repeat hepatec-
tomy for recurrent HCC. The data, including those of
previous hepatectomy, of these 15 patients were retrieved
and analysed.
Results: There were 12 males and three females with a
median age of 59 years (33–74). All had Child’s A
grading and 60% of them had liver cirrhosis on histol-
ogy. The median time interval between the two hepa-
tectomies was 22.8 months (7.8–60.3). There was no
operative mortality. No signiﬁcant difference was de-
tected between ﬁrst and second hepatectomy in terms of
complication rate, blood loss, transfusion rate and
postoperative length of stay, though the duration of
operation was signiﬁcantly longer for second hepatec-
tomy. All patients had no extrahepatic metastasis before
second hepatectomy. With a median follow-up of
30.5 months (0.8–97.5) after the second operation, ﬁve
patients developed intrahepatic recurrence of which one
patient also had extrahepatic recurrence. An additional
patient developed extrahepatic recurrence only. The 1, 3,
5-year overall and disease-free survival for this group of
patients after second hepatectomy was 100, 71.3, 71.3
and 85.1, 56.7 and 42.6% respectively.
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Sites of tumor and types of hepatectomy in the study
patient group
Case No.
1st Hepatectomy 2nd Hepatectomy
Sites of tumor
Operation
Sites of tumor
Operation
1st
lesion
2nd
lesion
1st
lesion
2nd
lesion
3rd
lesion
1 Seg 1 Seg 4 BS Seg 8 Seg 7 BS
2 Seg 5/6 Seg 7/8 RH Seg 4 NR
3 Seg 2/3 LLS Seg 5/6 S
4 Seg 7 S Seg 6 RH
5 Seg 5/8 RH Seg 3 NR
6 Seg 2/3 LLS Seg 6/7 BS
7 Seg 4 S Seg 5 S
8 Seg 7 S Seg 2 NR
9 Seg 6 S Seg 2 Seg 3 Seg 7 BS+NR
10 Seg 2/3 LLS Seg 6 NR
11 Seg 8 S Seg 2/3 NR
12 Seg 6/7 BS Seg 4 NR
13 Seg 5/6 BS Seg 2/3 NR
14 Seg 2/3 LLS Seg 4/5 NR
15 Seg 2/3 NR Seg 8 NR
S: Segmentectomy
BS: Bisegmentectomy
NR: Non-anatomical resection
RH: Right hepatectomy
LLS: Left lateral sectionectomy
Conclusion: This study shows that no extra operative
risks are encountered for repeat hepatectomy for recur-
rent HCC in selected patients, while it can convey a
survival as good as those after single hepatectomy only.
FP-103
PREDICTORS OF PERIOPERATIVE
MORBIDITY AND LIVER DYSFUNCTION
AFTER LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA IN
PATIENTS WITH CHRONIC LIVER
DISEASE
E. Greco1, S. Nanji2, I. Bromberg3, S. Gallinger1 and
S. Cleary1
1Toronto General Hospital, University of Toronto;
2Queens University; 3Mount Sinai Hospital
Background: Hepatic resection in patients with chronic
liver disease (CLD) is associated with increased risk of
post-operative liver failure and morbidity. There is no
universal risk stratiﬁcation scheme for CLD patients
undergoing resection.
Objectives: Our aim was to determine factors associated
with post-operative liver dysfunction and prolonged
length of stay (LOS) in CLD patients undergoing liver
resection and to evaluate the ability of pre-operative
Model for End-Stage Liver Disease (MELD), Indocya-
nine Green retention at 15 min (ICG15) to predict post-
operative outcomes.
Methods: A retrospective review of patients undergoing
resection for Hepatocellular carcinoma (HCC) at The
Toronto General and Mount Sinai Hospitals was per-
formed. Pre-operative liver function, ICG15, surgical
data and post-operative outcomes were assessed.
Adjusted Odds ratios (AOR) were calculated by multi-
variate logistic regression adjusting for patient age and
number of segments resected.
Results: Hundred and twenty nine CLD patients under-
went resection for HCC between 1998 and 2005. Oper-
ative procedures included 51 (40%) resections of £3
segments, 52 (40%) lobectomies and 25 (19%) extended
hepatic resections. 30 and 90-days post-op mortality was
1.6 and 4.1%, respectively. Prolonged (>10 days) LOS
was independently associated with ICG15 ‡15% (AOR
(95%CI) = 8.5 (1.4–51) and INR >1.2 (AOR
(95%CI) = 5.0 (1.4–18.6). If lab components of MELD
are excluded from the analysis, ICG15 ‡15% and MELD
score were independent predictors of prolonged LOS.
ICG15 >15% was associated with a MELD score >20
on post-operative day 3 (AOR (95%CI) = 24.3 (1.8–
319).
Conclusions: Elevated ICG retention is associated with
post-operative liver dysfunction and prolonged LOS.
Elevated MELD and ICG15 are independently associ-
ated with increasing LOS following liver resection. The
utility of ICG retention in combination with other bio-
chemical measures (MELD score) to predict outcomes
following hepatic resection in CLD patients requires
further study.
FP-104
INCOMPLETE THERMAL ABLATION
OF HEPATOCELLULAR CARCINOMA
LEADS TO ENHANCED CELLULAR
VIABILITY AND RESISTANCE TO
PROGRAMMED CELL DEATH
R. Brown, Y. Li, X. Li, C. Scoggins and R. Martin
Division of Surgical Oncology, Department of Surgery,
University of Louisville, Louisville, Kentucky
Background: In hepatocellular carcinoma (HCC), ther-
mal ablation is used as either deﬁnitive treatment or as
‘‘bridging therapy’’ prior the hepatic transplantation.
Tumor recurrence after thermal ablation is common and
problematic.
Objectives: We hypothesized that HCC recurrence after
ablation is related to inadequate heat exposure and
sought to deﬁne the thermal parameters and cellular
changes associated with incomplete ablation.
Methods: Human, rodent and murine cell lines were used
in an established in vitro model of HCC. Viable cells were
exposed to temperatures ranging from 37C (control) to
51C for 30 min in an isothermic water bath. After
exposure to heat, equivalent cell concentrations were
incubated at 37C for 24, 48 and 72 hours After incu-
bation, viability and metabolic activity was assessed by
colorimetric assay (MTT). Apoptosis was measured in
situ using immunohistochemistry (TUNEL). The proto-
col was repeated in quadruplicate.
Results: In each species, cells treated at 45C and higher
were more likely to die and were morphologically distinct
from those treated at lower temperatures, demonstrating
contracture, loss of adhesion and fragmentation. Com-
pared with higher temperatures, treatment at tempera-
tures below 45C, was associated with a statistically
signiﬁcant increase in cell viability (P < 0.001) (Table),
which persisted after 3 days. TUNEL assays demon-
strated increasing DNA fragmentation with increased
heat exposure.
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Cell Viability by MTT: Increasing OD Indicates Increas-
ing Cell Viability
Control (37C) 42C 45C 48C
Endpoint Mean [95% CI] Mean [95% CI] Mean [95% CI] Mean [95% CI]
24 hours 0.941 [0.895–0.987] 0.847 [0.811–0.883] 0.197 [0.188–0.206]** 0.141 [0.133–0.149]**
48 hours 1.158 [1.12–1.196] 1.071 [1.051–1.091] 0.309 [0.301–0.317]** 0.033 [0.031–0.035]**
72 hours 1.304 [1.218–1.390] 1.165 [1.113–1.217] 0.220 [0.208–0.232]** 0.028 [0.026–0.030]**
** indicates P < 0.05 compared with immediately preceding temperature
Conclusions: Cellular viability and resistance to apopto-
sis are signiﬁcantly increased after incomplete ablation.
The margin of error between viability and cell death
occurred over a relatively narrow temperature differen-
tial (3oC), underscoring the importance of a complete
wide-margin thermal ablation in the treatment of HCC
to prevent recurrence.
FP-105
LAPAROSCOPIC HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA: A
EUROPEAN EXPERIENCE
I. Dagher1, G. Belli2, C. Fantini2, A. Laurent3, C. Tayar3,
P. Lainas1, H. Tranchart1, D. Franco1 and D. Cherqui3
1Department of General Surgery, Antoine Beclere
Hospital, AP-HP, University of Paris-Sud, Clamart,
France; 2Department of General and Hepato-Pancreato-
Biliary Surgery, S.M. Loreto Nuovo Hospital, Naples,
Italy; 3Department of General Surgery, Henri Mondor
Hospital, AP–HP, Paris 12 University, Creteil, France
Background: Few series suggested that laparoscopy is
beneﬁcial for the resection of hepatocellular carcinoma.
This has to be conﬁrmed in larger series.
Aim and objective: To analyse the results of three Eur-
opean surgical centers on laparoscopic liver resections for
hepatocellular carcinoma.
Methods: Prospective databases of three European cen-
ters involved in the development of laparoscopic liver
surgery were combined. Between 1998 and 2008, 163 liver
resections for hepatocellular carcinoma were performed.
Liver parenchyma was cirrhotic in 120 (73.6%) patients.
Liver resection was anatomical in 107 (65.6%) patients
and was a major resection (> 3 segments) in 16 (9.8%).
A totally laparoscopic approach was used in 155 (95.1%)
patients.
Results: Surgical duration was 180 ± 84 min. Operative
blood loss was 250 ± 375 mL and sixteen (9.8%) pa-
tients received blood transfusion. Conversion to open
surgery was required in 15 (9.2%) patients. Tumour size
was 3.6 ± 2.6 cm and the surgical margin was
12 ± 10 mm. Liver-speciﬁc and general complications
occurred in 19 (11.6%) and 17 (10.4%) patients, respec-
tively. Hospital length of stay was 7 ± 8 days. A further
analysis of early (n = 75) and recent (n = 88) experience
showed improved results in the latter group. Overall and
recurrence free survival rates at one, three and ﬁve years
were 92.6%, 68.7%, 64.9%, and 77.5%, 47.1%, 32.2%
respectively.
Discussion: This study demonstrates that laparoscopic
resection for hepatocellular carcinoma is feasible in
selected patients with good operative and oncologic
results. Laparoscopy should be routinely considered in
centers experienced in liver surgery and advanced
laparoscopy.
FP-106
LEPTIN INHIBITS HEPATOCELLULAR
CARCINOMA PROLIFERATION VIA
P38-MAPK-DEPENDENT SIGNALING
D. Sindram, K. N. Lau, J. B. Martinie, D. A. Iannitti and
I. H. McKillop
Section of HPB Surgery, Carolinas Medical Center,
Charlotte, NC
Background: Obesity is a signiﬁcant risk factor for many
liver diseases including hepatocellular carcinoma (HCC).
Previous studies have identiﬁed a central role for leptin
(Lep) in regulating appetite and fat storage. However, the
role of Lep in HCC development and/or progression
remains poorly understood.
Objectives: Determine the effect of Lep on HCC cell
proliferation, and identify the signaling pathway(s)
through which Lep may exert these effects.
Methods: Rat H4IIE HCC cells and H4IIE-derived HCC
tumors were analyzed for Lep receptor (Ob-R) expres-
sion. Cells were then treated with Lep (0–100 ng/mL) in
the absence or presence of speciﬁc inhibitors of ERK
(PD98-059, 10 lM), p38-MAPK (SB202190, 100 nm) or
JAK-STAT (AG490, 10 lM) signaling. Markers of cell
proliferation and speciﬁc signal pathway activity were
then analyzed.
Results: Western blot and IHC identiﬁed Ob-R
expression in HCC in vitro and in vivo. In serum-de-
pleted culture medium Lep alone did not signiﬁcantly
affect H4IIE cell number. However, in the presence of
serum Lep signiﬁcantly inhibited FBS-stimulated H4IIE
cell proliferation. Western blot analysis demonstrated
Lep signiﬁcantly stimulated ERK, p38MAPK and
STAT3 activity in a dose and time dependent manner,
effects that were abrogated using pathway-speciﬁc
inhibitors. Pre-treatment of H4IIE cells with PD98-059
or AG490 signiﬁcantly inhibited FBS-stimulated H4IIE
proliferation, an effect not altered by pretreatment with
Lep. In contrast, inhibition of p38MAPK (SB202190,
100 nm) abrogated Lep-dependent inhibition of H4IIE
proliferation.
Conclusions: Leptin inhibits HCC cell growth in vitro via
a p38MAPK-dependent signaling pathway. Identifying
similar effects on tumor growth in vivo may provide an
attractive therapeutic target for slowing the rate of HCC
progression.
FP-108
IS THERE ANY DIFFERENCE BETWEEN
RIGHT HEPATECTOMY AND LEFT
LATERAL SEGMENTECTOMY FOR
LIVING DONORS? AS MUCH YOU CUT,
AS MUCH YOU HURT?
K. Steinbru¨ck, R. Fernandes, M. Enne, J. M. Martinho,
J. Alves and L. Pacheco-Moreira
Liver Transplantation Unit, Bonsucesso General Hospital/
MS, Rio de Janeiro, Brazil
Background: The world wide rising demand for deceased
donors in the liver transplantation scenario is an
important incentive for development of alternative
transplantation options, such as living donors. A precise
evaluation of surgical complications is therefore consid-
ered to be an important issue in this setting. Data from
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publications report donor morbidity range from 13 to
75%, especially for right hepatectomy.
Aim: Present a retrospective analysis of 126 living donors
hepatectomies operated in our center.
Methods: From December 2002 to August 2009, 126
living donors were submitted to hepatectomy in our
center. The charts of these patients were analyzed to
stratify the complications according to Clavien´s score
system and comparing the morbidity of right hepa-
tectomy (Group 1) and left lateral segmentectomy
(Group 2).
Results: The majority of donors (n = 91) didn’t suffer
any complications. Thirty-eight complications were
observed in 35 patients. According to the Brisbane
classiﬁcation, we carry out 60 left lateral segmentecto-
mies, three left and 63 right hepatectomies. Conforming
to Clavien, the complications were classiﬁed as: grade 1
– 12 (9.5%), grade 2 – 12 (9.5%), grade 3A – 12 (9.5%),
grade 3B – 1 (0.8%) and grade 4A – 1 (0.8%). We had
no death (grade 5) and the most common complication
was biliary leaks, like in others series. Only one donor
experienced a life-threatening complication, called
hemoperitoneum, and needed to be reoperated. When
we compare Group 1 (63 patients) and Group 2 (60
patients), there was no signiﬁcant difference between the
number of complicated patients: 20 (31%) and 14
(23%), respectively (P > 0.3).
Conclusion: In our series, hepatectomy for LDLT was a
safe procedure with low morbidity, regardless of the type
of liver resection undertaken. More than this, we found
no difference in morbidity between right hepatectomy
and left lateral segmentectomy, which suggests that
complications may occur despite of how much liver is
harvested.
FP-109
ASSESSMENT OF LIVER
REGENERATION IN LIVING RELATED
DONOR
S. Saleh
National Liver Institute, Menouﬁya University, Egypt
Background: Donor is the ﬁrst priority during the pro-
cedure of living donor liver transplantation (LDLT).
Hepatic regeneration is critical to the success of the
procedure and allows the various lobes or segments of
liver remaining in the donor or transplanted into the
recipient to return to normal size.
Aim: An evaluation to the extent of liver regeneration
after donor surgery, and the inﬂuence of preoperative
variables.
Methods: Twenty ﬁve live liver donors (15 males and 10
females) operated at the National Liver Institute,
Menouﬁya University, Egypt. Serial monitoring was
done regarding serum bilirubin and liver enzymes. Also
computerized tomography and volumetric assessment of
the liver were done preoperatively as well as at 30 days
postoperatively.
Results: The mean preoperative total liver volume was
1386.9 cm3. The discrepancies between estimated graft
volume and actual graft weight ranged from -300 to
+167 cm3. The mean remained liver volume after har-
vesting was 496 cm3. It increased to 1191 cm3 at post-
operative day 30 (POD 30), which was 88.9% of
preoperative liver volume. Serum level of ALT and AST
peaked at POD 1, whereas total bilirubin peaked at POD
5. And declined thereafter and ﬁnally returned to pre-
operative level at POD 30. The regeneration was signiﬁ-
cantly different by age and size of the grafts.
Postoperative morbidities of the donors were mainly
biliary complications (26%) in the form of bile collection
and biliary stricture, wound problems (17.4%), pleural
effusion and delayed biochemical recovery of liver func-
tions (13%). All were managed by conservative and in-
terventional means except of one case of biliary stricture,
which required operative management.
Conclusion: Donor liver regeneration occurred promptly
after one month. Meticulous operative and post opera-
tive care was done to minimize postoperative complica-
tions.
FP-110
EFFECTS OF ISCHEMIC
PRECONDITIONING OF THE GRAFT IN
ADULT LIVING RELATED RIGHT LIVER
TRANSPLANTATION
D. Azoulay, P. Andreani, S. De La Serna, E. Vibert,
C. Salloum, R. Adam and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Ischemic preconditioning of the liver graft in the donor
has not yet been studied in clinical adult to adult living
related right liver transplantation (LRRLT).
Aim: To compare the results of LRRLT with and with-
out ischemic preconditioning of the liver graft in the
donor.
Method: Alternate patients were transplanted with right
liver grafts from living donor that had (n = 22,
GroupPrecond) or had not (n = 22, GroupControl) been
subjected to IPC of the graft in the donor. Liver ische-
mia-reperfusion injury, liver and kidney function, mor-
bidity and in-hospital mortality rates were compared in
the two groups of recipients. The outcome of the two
groups of donors was compared.
Results: In the recipients, the postoperative peaks of AST
(IU/L) and ALT (IU/L) were similar (307 + 189 and
437 + 302, P = 0.8, vs. 290 + 146 and 496 + 343,
P = 0.6, respectively) in Group Precond and Group Control.
In univariate analysis, only the preoperative value of
AST in the recipient was signiﬁcantly associated with the
postoperative peak of AST. The rate of technical mor-
bidity and the incidence of acute rejection were similar in
both groups. Primary non function occured in 1 and 0
case of Group Precond and Group Control respectively
(P = 0.9). Hospital mortality rates were similar in the
two groups. Ischemic preconditioning had no impact in
the donor on postoperative peak of AST, liver and kid-
ney function tests, morbidity and duration of hospital
stay.
Conclusion: Compared to standard LRRLT, ischemic
preconditioning of the liver graft in the donor does
trigger any beneﬁt neither for the recipient nor for
the donor. Until further studies are available, the
clinical value of preconditioning liver grafts remains
uncertain.
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FP-111
GENE POLYMORPHISMS AND THE
RISK OF CLINICALLY SIGNIFICANT
INFECTIONS AND IN-HOSPITAL
MORTALITY IN LIVING DONOR LIVER
TRANSPLANT RECIPIENTS
M. A. Van Den Broek1, S. W. M. Olde Damink1,2,
M. Adamzik3, R. Matthijsen1, C. E. Broelsch4, A. Paul4,
M. Malago2,4 and F. H. Saner4
1Department of Surgery, Maastricht University Medical
Centre, Maastricht, the Netherlands; 2Department of
Surgery, University College London, London, United
Kingdom; 3Department of Anaesthesiology and Intensive
Care Medicine, University Hospital Essen, Essen,
Germany; 4Department of General, Visceral and
Transplant Surgery, University Hospital Essen, Essen,
Germany
Background: Clinically signiﬁcant infections (CSIs) are
life threatening after living and deceased donor liver
transplantation (LTx). Polymorphisms in genes encoding
key molecules of the innate immune response are asso-
ciated with higher risks of CSIs in deceased donor LTx
recipients.
Aim: To test whether polymorphisms in genes encoding
key molecules of the innate immune response also inﬂu-
ence the risk of CSIs or in-hospital mortality in living
donor LTx recipients.
Methods: Sixty-one consecutive adult living LTx donors
and recipients, operated in a single University Hospital
between January 2004 and July 2007, were included.
Their clinical course was studied prospectively. CSIs
comprised pulmonary, blood stream and intra-abdomi-
nal infections. Polymorphisms in the promoter of
NFjB1 (-94 insertion/deletion ATTG) and TNFa (-
857C/T) and the exon of mannose binding lectin (MBL;
-54 G/A) were analysed in living LTx donors and
recipients using pyrosequencing. Differences in CSIs
and in-hospital mortality were calculated using Pear-
son’s Chi squared test. P-value <0.05 was considered
statistically signiﬁcant.
Results: Twenty-six LTx recipients (43%) experienced a
CSI and 17 (28%) died. LTx recipients with a CSI had a
6-times higher risk of mortality (54% vs. 9%;
P < 0.001). Polymorphisms in NFjB or MBL in the
LTx recipient were not related with CSIs, whereas a
TNFa-857TT genotype was (83% vs. 38%; P = 0.031).
There was a trend towards a higher in-hospital mor-
tality in LTx recipients with a NFjB homozygous ins
genotype (47% vs. 20%; P = 0.056). Donor genotypes
were not associated with increased risks of CSIs or
mortality.
Conclusion: The -857C/T polymorphism in the TNFa
promoter inﬂuenced the risk of CSIs and the ins/del
polymorphism in the NFjB promoter tended to
inﬂuence the risk of in-hospital mortality in living
donor LTx recipients. Based on these data, standard
screening for the presence of polymorphisms in either
NFjB, TNFa or MBL in living liver donors seems not
justiﬁed.
FP-112
EXTENDED CRITERIA FOR LIVING
DONOR LIVER TRANSPLANTATION IN
PATIENT WITH ADVANCED
HEPATOCELLULAR CARCINOMA
D. G. Kim, Y. C. Youn, J. G. Hwang, J. I. Kim,
I. S. Moon and M. D. Lee
Department of Surgery, Catholic University of Korea
Background: Milan criteria has known to be a gold
standard on the selection criteria of hepatocellular car-
cinoma (HCC) in liver transplantation. But there have
been many debates on extension of selection criteria for
HCC from Milan criteria.
Objectives: This study was to evaluate the possibility of
expanding the indication in living donor liver trans-
plantation (LDLT) for HCC beyond the Milan criteria
without compromising patient’s survival.
Methods: The 52 patients (36.4%) who underwent
LDLT beyond Milan criteria among 143 patients with
HCC from October 2000 to May 2008 at Department of
Surgery, Catholic University of Korea were reviewed
retrospectively. We evaluated the survival curve, prog-
nostic factors for survival and compared survival be-
tween our new criteria and Milan criteria.
Results: The prognostic factor affecting to disease free
survival included serum AFP level, tumor size, vascular
invasion, tumor cell differentiation and pretransplant
treatment. The prognostic factors affecting to survival
included serum AFP level, tumor size, vascular invasion
and tumor cell differentiation on univariate analysis. In
multivariate analysis, AFP (200 ng/mL), tumor size
(7 cm) and vascular invasion had signiﬁcant inﬂuenced
on survival and disease free survival. So according to our
new criteria (size, <-7 cm, AFP, <200 ng/mL), 88.1%
of our patients were included compare to 63.6% in Milan
criteria. The survival, meet two factors in our new criteria
was comparable to survival on Milan criteria (63.7% on
our news criteria and 78.2% on Milan criteria on 5 years
survival rate) (P = 0.103). Survival on 3, 5 years that
was meet one factor was 44% and 29.3% and no survival
on 3 years over two factors.
Conclusion: Tumor size <7 cm and AFP <200 ng/ml
appeared the useful cut-off value in beyond Milan crite-
ria. Analysis according to our criteria showed acceptable
survival outcome. Further veriﬁcation by large volume or
prospective study is required for proposal of the new our
criteria.
FP-113
CLINICAL OUTCOMES AND
ECONOMIC IMPACT OF OBESITY IN
LIVER TRANSPLANTATION
M. Montenovo, A. Cantaﬁo, K. Macleod, A. Dick,
J. Halldorson, R. Bakthavatsalam, J. Reyes, J. Perkins
and P. Salvalaggio
Division of Transplantation, University of Washington,
Seattle, WA
Background: It is estimated that direct costs of obesity
represent 5.7% of the National Health Expenditure in
the US. Our objective was to evaluate the impact of
obesity on the ﬁnal cost and outcomes of liver trans-
plantation.
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Methods: Between January 1st 2000 and May 31st 2008,
795 adult patients underwent liver transplantation in our
institution. Cost was measured assessing the readmis-
sions during the 1st year post-transplant, whereas out-
comes were analyzed looking at both patient and graft
survival during the same study period. Patients were
stratiﬁed into two groups; obese (OB) (BMI ‡ 30,
n = 293) and non-obese (NOB) (BMI < 30, n = 502).
Results: OB and NOB patients were similar in age and
sex. Twenty-three percent of the patients experienced a
clinical event at transplantation and this rate was equally
distributed between both groups. OB and NOB patients
were also similar in LOS and total charges at trans-
plantation. Approximately 68% of the patients had a
hospital re-admission within the study period. The rate of
readmission at 1 year post-transplantation was similar in
both groups. OB readmission patients were more likely to
have surgical (13% vs. 6%; P < 0.01) and cardiac events
(10% vs. 3%; P < 0.001). One year post-transplant, OB
patients had higher health resource utilization (total
average LOS 20.7 vs. 15.5 days; P < 0.05 and total
average ICU LOS 2.7 vs. 1.4 days respectively;
P < 0.05) and total charges (U$S97,000 vs. U$S71,000,
P < 0.05). Despite these differences, either patient and
graft survival were similar between both groups.
Conclusion: Obesity does not affect clinical outcomes
after liver transplantation; nonetheless it seems to have
major economic impact on the health system.
FP-114
CHRONOLOGICAL ANALYSIS OF
ADULT-TO-ADULT LIVING DONOR
LIVER TRANSPLANTATION
OUTCOMES: A 10-YEAR SINGLE
CENTER EXPERIENCE
T. Kim, K.-S. Suh, Y. M. Jeon, W. Y. Shin, N.-J. Yi and
K. U. Lee
Seoul National University College of Medicine
Background: Recent advances in operative techniques
and perioperative management have resulted improved
results of adult-to-adult living donor liver transplanta-
tion (ALDLT).
Objectives: The aim of this study is to investigate the
changes of survival rates (SR) and complication rates for
different periods within a decade in a single center and
also to assess the various factors associated with the SR.
Methods: We reviewed the data of 375 consecutive
ALDLT patients from January 1999 to December 2008
in Seoul National University Hospital. We divided
10 year into period 1 (1999–2001), period 2 (2002–2004)
and period 3 (2005–2008). We investigated the differences
of overall SR, tumor recurrence rates in hepatocellular
carcinoma (HCC) patients, Hepatitis B reinfection rates
and complication rates for three consecutive periods.
There were 291 Hepatitis B virus (HBV) related cirrhosis
patients. HCC was diagnosed in 165 patients (44.0%).
Results: There were 59 ALDLT cases in period 1, 111
cases in period 2 and 205 cases in period 3. One year SR
of period 1, period 2 and period 3 were 76.3%, 85.6%
and 97.5% respectively. Three years SR of period 1,
period 2 and period 3 were 71.2%, 77.4% and 90.4%
respectively. In multivariate analysis, HCC recurrence,
the period in which ALDLT was performed and acute
rejection episode treated with steroid pulse therapy were
statistically associated factors with overall patient SR. In
HCC patients, HCC recurrence after ALDLT occurred
in 30 patients. In HBV related cirrhosis patients, Hepa-
titis B reinfection occurred in 29 patients. Biliary com-
plications which needed intervention occurred in 26.7%.
Biliary complication rates in period 1, period 2 and
period 3 were 33.9%, 27.0% and 24.4% respectively.
Discussion: The patients who underwent ALDLT in
period 3 showed 97.5% 1 year SR. ALDLT has shown
quantitative growth and signiﬁcant improvement of re-
sults in last decade. ALDLT have gained ground as a safe
treatment modality.
FP-115
VALIDATION OF MELD AND MELDNA
FOR PATIENTS LIVING IN RURAL
AREAS
P. Renfrew, M. Walsh, I. Alwayn and M. Molinari
Dalhousie University
Background: MELD has been used in the USA and
Europe. Validation of MELD for patients living in rural
areas has no been done yet. We assessed the performance
of the model to predict 90-day mortality in patients living
in rural East Canada.
Methods: Patients listed for OLT at a tertiary university
Canadian hospital from January 1st 2004 until December
31st 2008 was included. MELD and MELDNa scores
were calculated at the time of listing and predicted and
observed survival probabilities were compared at
90 days. Performance of MELD was assessed by mea-
surement of model discrimination and calibration.
Results: Hundred and ﬁfty eight patients were included:
101 were males (63%) and 57 females (37%) with mean
age of 51.7 years (SD = 11). Among them 25 (16%) died
during the ﬁrst 90 days after being listed. Median MELD
(Mayo), MELD (UNOS) and MELDNa scores of the
study population at the time of listing were; 13, 14 and 18
respectively. Mortality rate at 90-day was signiﬁcantly
higher than predicted by both the MELD (UNOS) and
MELDNa models: 16% vs. 10% (P = 0.017) and 16%
vs. 11% respectively (P = 0.026). Discrimination (ROC)
for the three models was equivalent: 0.73 (95%CI, 0.65–
0.83) for the MELD (Mayo) model; 0.74 (95%CI, 0.65–
0.84) for the MELD (UNOS) model and 0.75 (95%CI,
0.65–0.85) for the MELDNa model. These results
showed ‘‘adequate’’ model discrimination but inferior
performance in comparison to previously published
studies (MELD UNOS and MELDNa models c-statis-
tics: 0.87 and 0.88 respectively). Subset analysis of our
population showed that MELD (UNOS) and MELDNa
had lower predictive mortality rate values for patients
with listing MELD scores between 15 and 22.
Conclusions: Although ROC of the MELD models in
this study was 0.74–0.75 (acceptable values), MELD
(UNOS) and MELDNa models underperformed in pre-
dicting 90-day mortality in comparison to published
data. The use of MELD score for prioritization of organ
allocation in populations living in rural areas warrants
further validation.
 2010 The Authors
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ISCHEMIC PRECONDITIONING LIMITS
NECROSIS IN FATTY LIVER GRAFTS
BY INDUCING AUTOPHAGY
D. Degli Esposti1,2,3,4, M. Sebagh5,6,7, B. Yan Min8,
A. Lemoine1,2,3,4 and D. Azoulay2,3,8
1AP-HP Hopital Paul Brousse, Service de Biochimie et
Biologie Moleculaire, Villejuif, France; 2INSERM, U602,
Villejuif, France; 3Univ Paris-Sud, UMR-S602, Villejuif,
France; 4Institut Andre´ Lwoff-IFR89, Villejuif, France;
5AP-HP Hopital Paul Brousse, Laboratoire Anatomie
Pathologique, Villejuif, France; 6INSERM, U785,
Villejuif, France; 7Univ Paris-Sud, UMR-S785, Villejuif,
France; 8AP-HP Hopital Paul Brousse, Centre Hepato-
Biliaire, Villejuif, France
Background: Ischemic preconditioning (IP) was shown
to reduce ischemia/reperfusion (I/R) injury, notably in
fatty livers. These results are based on animal models
and the few clinical studies showed controversy results
without describing mechanisms. Therefore, we have
compared the results of cadaveric liver transplantation
with and without liver IP in the donor in two inde-
pendent cohorts according to the presence or not of
steatosis.
Methods: Liver donors with steatosis (n = 23) or not
(n = 29) were submitted or not to IP before graft har-
vesting. Clinical data of the recipient and histological
characteristics of liver graft biopsies performed at the end
of the reperfusion were analyzed. Immunohistochemistry
was performed to assess expression of death (apoptosis
and necrosis) markers in a subset of steatotic or non
steatotic patients. As recent studies suggest a role of
autophagy as a cell strategy of defense upon cell damage
by eliminating damaged proteins/organelles and pre-
serving ATP levels, we investigated the presence of
autophagy markers in liver biopsies.
Results: IR had more deleterious effect on recipients of
non-IP steatotic livers (11/11) than non-IP normal liv-
ers (8/15) by increasing incidence of post-reperfusion
necrosis of the graft (P < 0.01). When submitted to
IP, patients receiving a non steatotic liver exhibit lower
levels of transamisases (P < 0.01) and no change in
the incidence of necrosis (P = 0.16). Indeed, patients
receiving an IP fatty liver exhibited a reduction of
necrosis (P = 0.056), although that was not associated
with a clearcut decreased transaminases levels. The
increased expression of beclin-1 in IP steatotic livers (in
80% of IP biopsies compared to 0% in non-IP biop-
sies) suggests an induction of autophagy that could be
the mechanism triggered by IP to preserve ATP
intracellular levels in fatty livers and favouring apop-
tosis instead of the inﬂammatory death by necrosis.
Mechanisms of cell death linked to IP are different in
normal human livers.
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RESULTS OF A MULTIDISCIPLINARY
APPROACH FOR BILIARY SYMPTOMS
FOLLOWING FAILED PRIMARY
HEPATICOJEJUNOSTOMY IN THE
SETTING OF BENIGN DISEASE
A. Benkabbou, E. Vibert, P. Bucur, L. Gorden,
C. Salloum, G. Pascal, R. Adam, D. Azoulay and
D. Castaing
AP-HP Hoˆpital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Background: Bile duct injury (BDI) following cholecys-
tectomy is a complex problem associated with signiﬁcant
morbidity and mortality. Management of recurrent bili-
ary symptoms following primary surgical repair requires
careful treatment planning.
Aim: Evaluate results of a multidisciplinary approach
combining percutaneous biliary access and surgical
revision of failed hepaticojejunostomy in a hepatobiliary
referral center.
Methods: Retrospective single center study of 45 con-
secutive patients (13 males and 32 females) referred for
management of failed primary hepaticojejunostomies
following cholecystectomy. Patients had symptoms of
cholangitis (40 patients) and jaundice (six patients.). All
patients underwent biliary imaging and had a hepatic
vascular evaluation. Patients underwent revision of hep-
aticojejunostomy (23 patients), hepatic resection (four
patients), and revision of roux limb (12 patients). Eigh-
teen patients had initial percutaneous therapy; dilation of
stenosis (12 patients), stone extraction (six patients),
lithotripsy (four patients), and portal vein embolisation
(one patient). Results were classiﬁed as ‘‘good’’ with
improvement of symptoms and as ‘‘excellent’’ with
complete resolution of symptoms.
Results: Overall morbidity following surgery was 30%
and mortality was 2.2% (one death due to suicide).
Morbidity following percutaneous procedures was 44%
with no mortality. One patient was placed on the liver
transplant waiting list due to secondary biliary cirrhosis.
18 patients required an additional treatment (four sur-
gical treatment and four patients percutaneous patients)
for recurrent biliary symptoms (average time to recur-
rence: 12 months). Results were considered ‘‘good’’ in
40% and ‘‘excellent’’ in 49%.
Conclusion: Symptoms related to failure of primary hep-
aticojejunostomy for benign disease are bestmanagedwith
a combination of surgical and percutaneous intervention
(89% favorable outcome). Multiple interventions may be
required (18%). Risk of recurrent symptoms in these
complex patients mandates a long and careful follow-up.
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CONCOMITANT VASCULAR AND
BILIARY DUCTS INJURIES (BDI) AFTER
CHOLECYSTECTOMY: A SINGLE
CENTRE EXPERIENCE
G. Sarno, A. A. Al-Sarira, B. A. Al-Sarireh, S. Pathak,
R. Acharya, H. Z. Malik, S. W. Fenwick, P. Ghaneh,
A. Wu and G. J. Poston
University Hospital Aintree Liverpool
Introduction: Vascular injuries are associated with BDI
during laparoscopic cholecystectomy (LC). We evaluated
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the impact of combined vascular and BDI injuries on
outcome after repair.
Method: Between 1992 and 2008, patients referred for
bile duct reconstruction following BDI after LC at our
Institution were identiﬁed. Patients were divided in two
groups: those with BDI and those with vasculo-biliary
injuries. The two groups were compared accordingly to
type of injury and the outcomes. Evaluation was based
on a clinical symptom grading system and re-interven-
tion.
Results: Major BDI were identiﬁed in 61 patients
(41F:20M), median age 53 years. Using the Strasberg
classiﬁcation, injuries were stratiﬁed: four patients E2
(6.6%), 42 E3 (68.9%), 11 E4 (18%), 4 E5 (6.6%).
Hepaticojejunostomy was performed in all patients apart
from three who were managed endoscopically. 15
(24.6%) had a concomitant vascular injury, 14 having
angiogram conﬁrmation. During a median follow-up of
88 (1–237) months, overall biliary complications (BC)
were observed in 21 patients (34.4%). Vasculo-biliary
injuries were associated with worse outcome. BC rate in
the combined injuries was 66.7% (10/15) vs. 26% (12/46)
in patients with BDI (P = 0.002). 9 (14.7%) developed
anastomotic strictures. 6 (66.6%) underwent revision and
3 (33.3%) managed radiologically. Excellent and good
outcomes, according to Mayo Clinic classiﬁcation
achieved in 42 (69%) patients while 19 (31%) patients
had fair or poor outcome. seven died during the follow
up, three from BC and the other four died from other
causes.
Conclusions: Combined vascular and BDI are associated
with poor outcomes. Patients with major BDI should be
evaluated for concomitant vascular injury.
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EXPERIENCE USING LIVER
TRANSPLANTATION FOR THE
TREATMENT OF SEVERE BILE DUCT
INJURIES OVER 20 YEARS
V. Ardiles1, J. Pekolj1, L. McCormack2,
N. Goldaracena2, E. Quin˜ones2, J. Mattera1,
M. Ciardullo1 and E. De Santiban˜es1
1Hospital Italiano de Buenos Aires; 2Hospital Aleman
Background: Bile duct injury (BDI) is a severe compli-
cation that may arise during the surgical treatment of a
benign disease. Only few patients will develop end-stage
liver disease requiring a liver transplant (LT).
Objective: To analyze the experience using LT for the
deﬁnitive treatment of BDI in Argentina.
Patients and methods: Between January 1988 and August
2009, 2323 liver transplantation have been performed in
18 centers in Argentina. Retrospective analysis of all
patients included in the waiting list for liver transplan-
tation with diagnosis of BDI.
Results: Only 2/18 centers have performed LT for the
treatment of BDI. Twenty two patients were included in
the waiting list but only 18 were ﬁnally transplanted
(overall incidence of LT for BDI 0.8%). Mean age was
45 years (SD 10.4) and nine were female. The BDI oc-
curred during cholecystectomy in 15 being the main
mechanism of lesion partial duct section (=7) and
resection (=5). Six patients have associated vascular in-
jury (two right hepatic arteries, three right portal veins +
right hepatic artery and one left hepatic artery). One
patient presented with fuliminant liver failure and the
others with chronic end stage liver disease. All but one
received some surgical treatment (median: two proce-
dures) prior to LT. Transplantation was performed with
full-size cadaveric donors in all cases with a median time
between BDI and LT of 72.11 months (SD 47 (min 0.17–
Max 157). The explants showed cholestasis and liver
gangrene in one and secondary biliar cirrosis in all the
others. Four patients died in the postoperative period
(mortality rate: 22%) and nine had major postoperative
complications. Mean follow-up was 72 months (SD 5,
min: 8–162). One, 3, and 5-year survival rates were 81%,
75% and 75%.
Conclusions: Complex bile duct injuries are a rare indi-
cation of LT. In those patients presenting with chronic
end stage liver disease, the use of LT as a last step option
provides good quality of life and long- term survival.
FP-120
BISMUTH TYPE V BILIARY STRICTURE
– A HETEROGENOUS GROUP!
A. K. Agarwal, S. Singh, A. Yadav, V. Gupta,
S. Agarwal and H. H. Nag
GB Pant Hospital & MAM College, Delhi University
Background: Bismuth Type V Biliary stricture include
both isolated sectoral duct injury with & without the
main duct stricture.
Aims and objectives: To analyze our experience of sec-
toral duct injuries.
Materials and methods: Retrospective analysis of the
prospective database of post cholecystectomy bile duct
injuries at our centre, a tertiary referral teaching unit,
between January 2000 and December 2008.
Results: During the period of the 393 patients of bile
duct injuries managed by us 12 (3.4%) were those with
a right sectoral bile duct injury. Of these 12 patients, 4
(33%) had an isolated right sectoral duct injury, eight
patients (66%) had a right sectoral combined with a
main duct injury. All four patients with an isolated
sectoral duct injury had an external biliary ﬁstula
(n = 2 following the index surgery, n = 2 following
drainage at our centre). The external ﬁstula in these
patients closed over a mean duration of 248 ± 107 days
and none of these patients needed a further surgical
intervention, all these patients had a normal bilirubin
level and a mean alkaline phosphatase of 305 IU/L
(n £ 117 IU/L) following the closure of the ﬁstula. All
eight patients with a combined injury had an external
biliary ﬁstula following the index surgery which closed
in seven patients over mean duration of 262 days; all
these eight patients needed a deﬁnitive biliary repair for
jaundice and recurrent cholangitis. None of these pa-
tients needed a concurrent hepatectomy/ hepatotomy
during the deﬁnitive repair.
Conclusions: While, the sectoral duct injury with main
duct stricture needs surgical management & poses a
major challenge, most isolated sectoral duct injury
(without main duct stricture) can be managed without
surgery. Isolated sectoral duct stricture (as Type V) is
perhaps a misﬁt in bismuth biliary stricture classiﬁcation!
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MANAGEMENT OF BILE DUCT INJURY
COMPLICATING CHOLECYSTECTOMY
– A SINGLE CENTRE EXPERIENCE
G. Sen,R. Saif,M. Jacob S.D.Mansﬁeld, R.M.Charnley,
J. J. French, B. C. Jaques, S. A. White and D. M. Manas
Hepato-Pancreatico-Biliary Unit, Freeman Hospital,
Newcastle upon Tyne, United Kingdom
Background: Bile duct injuries (BDI) are a devastating
complication after laparoscopic cholecystectomy and
often require biliary reconstruction.
Aim: To assess the management and outcome of BDI
referred to a specialist HPB unit in the UK.
Methods: All patients referred to a regional HPB centre
for iatrogenic BDI over the last 12 years were identiﬁed
from a prospectively maintained database. Investiga-
tions, treatment and outcome were analyzed.
Results: Seventy one patients were identiﬁed. 45 injuries
occurred during laparoscopic cholecystectomy, 16 fol-
lowing converted laparoscopic cholecystectomy and 10
during open procedures. Median time to diagnosis was
5 days (0–180). Twenty four were diagnosed intra-oper-
atively. Presenting problems included intra-abdominal
collections, cholangitis, jaundice, biliary ﬁstulae and
abdominal pain. After laparoscopically initiated proce-
dures, Strasberg classiﬁcations of severity were; types A
to D - 17, Types E1 to E5 - 44. For open procedures: two
were types A to D, while seven were types E1 to E5. Eight
patients had associated vascular injuries with three hav-
ing complete transaction of portal structures. Sixty pa-
tients (86%) underwent surgery, 16 procedures were done
at the time of primary surgery. Further 21 procedures
were performed within 7 days (early repair). Four
underwent major vascular reconstruction. One patient
underwent a successful liver transplant. Two patients
died of severe sepsis following late recognition of injury.
Early complications of surgery occurred in 15 cases (8
major). Late complications occurred in 8. Patients
undergoing early repair had less overall morbidity when
compared to late repair but it does not reach statistical
signiﬁcance (P = 0.23). Overall morbidity was 32% and
mortality was 2.8%.
Conclusion: The treatment of BDI is demanding and
carries high risk of morbidity. Minority of the injuries
was recognized during cholecystectomy. Early recogni-
tion of Injury and referral to HPB team is like to reduce
morbidity and improve outcome.
FP-122
SINGLE-PORT LAPAROSCOPIC
CHOLECYSTECTOMY: COMPARATIVE
STUDY IN INITIAL 106 CASES
Y. K. You1, S. K. Lee2, T. H. Hong2, K. H. Lee2,
J. H. Park2, Y. C. Yoon2, W. S. Nam2, B. S. Son2,
S. J. Kim2, K. W. Kim2, I. Y. Park2, S. Lee2, D G. Kim2
and E. K. Kim2
1The Catholic University of Korea, HBP Surgery & Liver
Transplantation; 2The Catholic University of Korea, HBP
Surgery
Purpose: Laparoscopic cholecystectomy has been the
standard of care for gallbladder diseases since the late
1980s. Not a few surgeons have rapidly adopted single-
port laparoscopic cholecystectomy for gallbladder
pathologies. The aim of present study was to analyze
clinical outcome in initial single-port laparoscopic cho-
lecystectomy.
Methods: Data of 106 consecutive single-port laparo-
scopic cholecystectomies between May 2008 and April
2009 were analyzed retrospectively. We divided two group
as the early group (group I,n = 56) and the late one (group
II, n = 50) according to consecutive series and the clinical
outcomes between both groups were compared each other.
Only one longitudinal transumbilical 1.5 to 2.0 cm in
length incision was made for accessing the abdominal
cavity and a multichannel port system was assembled with
existing devices. Standard laparoscopic instruments were
used for the performance of cholecystectomy.
Results: Patient’s demographics were not different be-
tween the two groups. Among eight conversion cases to
conventional laparoscopic technique, seven cases were
included in the group I (P = 0.063). Mean operation
time for single-port laparoscopic cholecystectomy was
signiﬁcantly shorter in the group II (58.2 vs. 71.6 min,
P = 0.004). There were two operative complications in
the group I, which were successfully managed with lap-
aroscopic surgery. There was no statistical difference in
occurrence of operative complication and hospital stay
between the two groups.
Comparative study of single-port laparoscopic cholecys-
tectomy between the early group (group I, n = 56) and
the late group (group II, n = 50) according to consec-
utive series.
Group I (n = 56) Group II (n = 50) P
Age (year) 43.2 ± 10.6 48.9 ± 14.2 0.021*
Male: Female 19: 37 (34: 66%) 16: 34 (32: 68%) 0.833
BMI (kg/m2) 23.1 ± 3.4 22.8 ± 2.7 0.696
Conversion 7 (12.5%) 1 (2%) 0.063
Male: female
in conversion
5:2 1:0 0.015**
Operation time§
(minutes)
71.6 ± 25.2 58.2 ± 19.9 0.004***
Gallbladder
perforation
13 (23.2%) 12 (24%) 0.924
Operative
complication
2 (mesenteric tearing,
right hepatic
duct injury)
0
Postoperative
hospital stay
(days)
2.5 ± 1.3 2.3 ± 0.7 0.309
BMI: Body mass index
Conversion indicates the addition of one or more trocars, since no
conversion to laparotomy occurred.
*Mean age of the group I was signiﬁcantly younger than in group II.
**Conversion was signiﬁcantly prevalent in male patient than female in
these 106 cases.
***Mean operation time in group II was signiﬁcantly shorter than in
group I.
Conclusion: Single-port laparoscopic cholecystectomy
can be safely performed for various gallbladder lesions in
selected cases and the operation time improved with
accumulation of cases.
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SURGICAL TREATMENT OF CAROLI’S
DISEASE: ANALYSIS OF A
MULTICENTER STUDY FROM
ARGENTINA
J. Lendoire1, G. Rafﬁn1, J. Grondona2, R. Bracco2,
R. Russi3, V. Ardiles4, G. Gondolesi5, J. Defelitto6,
E. De Santiban˜es4 and O. Imventarza1
1Hospital Dr Cosme Argerich; 2UNACIR HPB; 3Hospital
Naval Pedro Mallo; 4Hospital Italiano; 5Fundacio´n
Favaloro; 6Instituto del Diagno´stico de La Plata
Background: Caroli’s Disease (CD) is a rare congenital
disorder characterized by cystic dilatations of the intra-
hepatic bile ducts.
Objective: Analyze the results of the surgical treatment
and outcome of CD in a multicenter study.
Methods: Between 1991 and 2009, 24 patients with CD
were operated on at six HPB centers. Diagnosis was
performed by US, CT, ERCP and MRI. In all patients
the diagnosis of CD was conﬁrmed by histology.
Demographic, clinical, surgical and pathological vari-
ables were analyzed.
Results: 17 (70.8%) patients were female, average age
was 48.7 years (20–71). 95.5% symptomatic. Cholangitis
was the main presenting symptom (96%). The left
hemiliver was involved in 75%. Mean interval time from
the onset of symptoms was 951 days. According to CD
extension surgical procedures performed were: A)
Hemiliver disease: left lateral sectionectomy 9, left hep-
atectomy 8 and right hepatectomy 4 B) Bilobar disease:
right hepatectomy 1 and hepaticojejunostomy 2. Vascu-
lar Control was by ischemic preconditioning in 3 (13%)
and intermittent Pringle maneuver in 7 (30%). Blood
transfusion was required in 16.7%. Average hospitaliza-
tion was 7 days (4–21) Morbidity was 27.3% (Dindo-
Clavien type 1 and 2, type 2 and 1 and type 3A and 1.
Mortality: 0%. After a median follow-up of 166 months
all patients are alive and free of symptoms. In all patients
the diagnosis of CD was conﬁrmed by histology (Biliary
hamartomas – Biliary ramiﬁcations – Granulomatous
reaction). Congenital hepatic ﬁbrosis was present in two
patients (8.3%) and cholangiocarcinoma in one patient
(4.2%).
Conclusion: CD in Argentina is more common in females
with left hemiliver involvement. Surgical resection is the
best curative option in unilateral disease with long term
survival free of symptoms and complications. In cases of
bilateral disease hepaticoyeyunostomy could be an op-
tional treatment prior to liver transplantation.
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LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION: FIFTEEN YEARS
EXPERIENCE
R. Sanchez Claria, D. Fernandez, J. Salceda, O. Mazza,
E. De Santiban˜es and J. Pekolj
Hospital Italiano de Buenos Aires
Background: The indications for laparoscopic bile duct
exploration are similar to those for open surgery Con-
traindications are patient’s poor general condition and
severe acute cholangitis Most of the common bile duct
stones can be resolved though the one-step laparoscopic
approach.
Aim: Present the feasibility of the one step laparoscopic
approach in order to treat patients with common bile
duct stones.
Material and methods: From September 1991 to
December 2007 we performed 8283 laparoscopic chole-
cystectomy; 865 (10.4%) patients had common bile duct
stones. We performed systematic intraoperative cholan-
giography (IOC), with a cannulation rate of 98%.
Results: In 588 (67%) we suspect the lithiasis and in 277
(33%) the lithiasis was unsuspected. We performed the
transcystic approach in 752 (86.9%) patients, choledo-
chotomy was done in 93 (10.7%), 13 (1.5%) we con-
verted to an open surgery and in 7 (0.8%) we decided to
performed a laparoscopic bilio digestive anastomosis. In
the transcystic group the success rate was 91.6% (689
patients) and in the choledochotomy group the success
rate was 96.3% (131 patients, due to 43 patients came
from the transcystic group). In the transcystic group the
mean hospital stay was similar to those patients without
bile duct exploration (1 day) and in the choledochotomy
the mean hospital stay was 3 days. Morbidity in the
transcystic group was 0.3% and in the choledochotomy
group was 3% Mortality between the two groups was
0.3%
Conclusion: In a high volume center, with well trained
surgeons and with all the equipment in the OR, common
bile duct stones are resolved frequently with low morbid-
mortality and elevated applicability and efﬁcacy; being a
safe and cost effective procedure.
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THE SIMULTANEOUS LAPARO-
ENDOSCOPIC ‘‘RENDEZ VOUS’’ FOR
PATIENTS WITH CHOLECYSTO-
CHOLEDOCHOLITHIASIS: 120
CONSECUTIVE CASES
G. La Greca, F. Barbagallo, M. Soﬁa, A. Ricotta,
S. Gagliardo, A. Chisari, S. Latteri, R. Lombardo,
M. Di Blasi and D. Russello
Department of Surgical Sciences and Transplantation
University of Catania -Cannizzaro Hospital Catania, Italy
Background: The management of patients affected by
gallstones and common bile duct stones is still a challenge
as there are different options. An alternative to both
sequential approach and totally laparoscopic treatment
consists of the simultaneous laparo-endoscopic ‘‘Rendez-
Vous’’ (RV) procedure which combines laparoscopic
cholecystectomy with ERCP-ES.
Aim: The authors report their experience with the RV in
120 consecutive patients.
Method: The records of the patients were analyzed con-
cerning main clinical data, the relevant technical features
and the results concerning feasibility, effectiveness,
morbility and mortality. Postoperative amilase levels
were monitored to analyze iatrogenic relevant hyperam-
ilasemia (3· n.v) and risk of pancreatitis.
Results: The diagnosis of common bile duct stones was
certain preoperatively in (58.7%), in (41.2%) the diag-
nosis was not given. The RV procedure was feasible in
97.7% of the patients. The effectiveness was 98.8%
concerning the clearance of CBD stones, sludge, and/or
resolution of problems at the papilla. Minor morbidity
affected 2.9% of the patients. Pathologic increase of
amylase affected 5.8% but clinical acute pancreatitis
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never occurred, mortality was 0.8%. The operating time
for the RV was prolonged by a mean of 17 min. The
mean hospital stay was 3.8 days. Only one patient (0.8%)
referred a recurrence of a stone.
Conclusions: This simultaneous laparo-endoscopic RV is
related to a very high feasibility and effectiveness that
seems to be better than those reported for the other
available options. Moreover the morbidity and the
mortality of this combined approach suggests that the
procedure is extremely safe and also the risk of iatrogenic
pancreatitis minimal. The laparoendoscopic RV needs a
mandatory collaboration between surgeons and endos-
copists. In many cases this option can be the preferable
for the patient and the hospital but also to simplify the
work of both the endoscopis and the surgeon.
FP-126
SPLENECTOMY WITH SUBSEQUENT
ANTIVIRAL TREATMENT IS
BENEFICIAL FOR HEPATITIS C,
COMPENSATED CIRRHOTICS WITH
THROMBOCYTOPENIA
I. S. Sheen and C. Y. Lin
Chang-Gung Memorial Hospital, Linkou Medical Center/
Division of HepatoGastroenterology
Background: Combination therapy of pegylated inter-
feron and ribavirin is the current best choice for chronic
hepatitis C patients. Thrombocytopenia is one of the
limiting factors for combination therapy. There are sev-
eral measures can raise the platelet counts, such as
thrombopoitein receptor agonist (Eltrombopag), splenic
embolization and splenectomy.
Aim: To assess the beneﬁt of splenectomy with sub-
sequent combination treatment for hepatitis C cirrhotics.
Method: Splenectomy was suggested to those who were
hepatitis C compensated cirrhotics with platelet counts
<100*103/mL and had strong intention for combination
treatment. The combination treatment was pegylated
interferon a-2a or a-2b and ribavirin 1000–1200 mg/day
for 24–48 weeks. HCV genotyping and quantiﬁcation of
HCV-RNA were checked. Sustained virological response
(SVR) was deﬁned as non-detectable HCV-RNA at
24 weeks after completion of treatment. The response
was compared with other non-splenectomy cirrhotics
who had combination therapy (186 of genotype 1 and
129 of genotype 2).
Results: There were 16 patients (eight males, eight fe-
males) with a median age of 55.2 years (46–66 years),
received splenectomy and combination treatment subse-
quently. Their post-operative courses were uneventful.
Eight patients were genotype 1b and eight patients were
genotype 2a or 2b. The median counts of platelet, WBC
and hemoglobin was 49.1 · 103/mL, 3.42 · 103/mL and
12.1 g/dL before splenectomy, and 26.3 · 103/mL,
6.87 · 103/mL and 12.9 g/dL after splenectomy. The
SVR was 62.5% (5 of 8) of genotype 1 and 87.5% (7/8) of
genotype 2. There were one patient in each group of
genotype developed HCC after SVR, 24 months (geno-
type 1) and 15 months (genotype 2). The SVR rate of
non-splenectomy cirrhotics was 35.5% (66 of 186) in
genotype 1 and 75.9% (98 of 129) in genotype 2.
Conclusion: Splenectomy is safe in selected patients of
hepatitis C compensated cirrhotics. Combination treat-
ment can achieve a good SVR in these patients.
FP-127
SOX9-ASSOCIATED OVER-EXPRESSION
OF IFIT3 LEADS TO PANCREATIC
CANCER PROGRESSION BY
ACTIVATION OF ‘‘PSEUDO-
INFLAMMATORY’’ PATHWAYS
P. Camaj, I. Ischenko, A. Renner, H. Seeliger,
M. Angele, K.-W. Jauch and C. J. Bruns
Department of Surgery, University of Munich, Klinikum
Großhadern
Inﬂammation plays an important role in tumour initia-
tion and progression in different solid tumor systems.
Here we report the role of the transcription factor Sox9
for regulation of IFIT3 (interferon-induced protein with
tetratricopeptide repeats 3), an inﬂammation-related and
tumour-promoting protein in pancreatic cancer. To
analyze primary tumor growth and metastases in vivo
we injected the following human pancreatic cancer cell
lines in the pancreas of nude mice: low metastatic FG,
highly metastatic L3.6pl, and stably transfected FG-
IFIT3. The VEGF depending angiogenic capacity was
analyzed by ELISA in vitro. By One STrEP technology
we identiﬁed IFIT3-binding partners. To investigate
Sox9-depending expression of IFIT3 we used stably
transfected L3.6pl-Sox9-shRNA cells under control of
the Tet-CMV promoter in presence or absence of
tetracycline, respectively. IFIT3 is up-regulated in
L3.6pl compared to FG cells analyzed by gene array
technology. Results of in vivo and in vitro experiments
clearly demonstrated tumor-promoting, pro-metastatic
and pro-angiogenic features of IFIT3. RT-PCR revealed
that treatment with IFna and NFjB led to up-regulation
of IFIT3-RNA expression. One STrEP experiment iden-
tiﬁed JNK and STAT1 as binding partners of IFIT3. By
Western Blot and RT-PCR we demonstrated that
reduced Sox9 expression in stably transfected L3.6pl-
Sox9-shRNA cells led to a signiﬁcant down-regulation of
IFIT3 epression. The inﬂammation-related protein IFIT3
is up-regulated in L3.6pl cells. This gene is up-regulated
by IFna and NFjB. Interestingly Sox9 binds to the
IFIT3P and activates its expression. Since L3.6pl cells
constitutively overexpress Sox9, IFIT3 is up-regulated
independent on the presence of IFna. Therefore, the pro-
inﬂammatory IFna-signaling pathway is activated even
in absence of pro-inﬂammatory cytokines. The activation
of such a ‘‘pseudo-inﬂammatory pathway’’ seems to be in
part responsible for pancreatic cancer progression.
FP-128
XIGRIS (HUMAN RECOMBINANT
ACTIVATED PROTEIN C) ATTENUATES
EXPERIMENTAL ACUTE
PANCREATITIS VIA REGULATION OF
NF-jb AND APOPTOTIC PATHWAYS
B. Idicula Babu1, T. Genovese2, E. Mazzon2,
A. K. Siriwardena1 and S. Cuzzorea2
1Hepatobiliary Surgery Unit, Manchester Royal
Inﬁrmary, Manchester UK; 2Experimental Pharmacology
Dept, University of Messina, Italy
Introduction: Microvascular thrombosis occurs in severe
acute pancreatitis (AP). Exploiting this knowledge, we
used Human recombinant activated protein C (Xigris; Eli
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Lilly, USA) known to preserve microvascular patency, in
evaluating the role of Xigris in experimental AP.
Methods: In accordance with EU experimentation regu-
lations AP was induced by 6 hourly injections of cerulein
50 lg/kg body weight. Male rats of median (range) weight
231 (176–312) g were allocated at random into groups:
Group 1 Control (n = 5); Group 2 vehicle (n = 5);
Group 3: AP (n = 10); Group 4 Cerulein + xigris at
induction of AP & sacriﬁce at 24 hour (n = 10); Group 5
Cerulein + Xigris 24 hours after induction& sacriﬁce at
48 hours (n = 10). In addition tomorphology,markers of
apoptosis and endothelial injury were assessed by quan-
titative Immunohistochemistry, apoptosis by TUNEL
and western blot quantiﬁed by densitometry was used to
assess marker of apoptosis and endothelial injury.
Results: Cerulein administration induced acute necrotis-
ing pancreatitis. Xigris did not modify coagulation
parameters. The xigris post-treatment group (group 5)
showed signiﬁcant reductions in myeloperoxidase and
malondialdehyde together with reduction in histological
evidence of injury. There was a signiﬁcant reduction in
densitometric levels of ijb, Nf- jb 65, icam-1, P-selectin,
Bax and BCL2 in this group compared to AP.
Conclusion: This study demonstrates that Xigris ame-
liorates the effect of experimental cerulein-induced pan-
creatitis through the apoptotic and NF- jb pathways
without causing pancreatic haemorrhage.
FP-129
NOVEL SEMI-SYNTHETIC FLAVONOID
MONOHER PREVENTS
MONOCROTALINE-INDUCED
SINUSOIDAL OBSTRUCTION
SYNDROME IN RATS
M. Van Den Broek1, S. Olde Damink1,2, T. M. Ezzat2,
N. Davies3, A. Bast4, K. Dejong1, D. Dhar2 and
M. Malago2
1Department of Surgery, Maastricht University Medical
Centre, Maastricht; 2HPB Research Group, Department
of Surgery, University College London, London, UK;
3Liver Failure Group, Institute of Hepatology, University
College London, UK; 4Department of Pharmacology,
Maastricht University Medical Centre
Background: Sinusoidal obstruction syndrome (SOS) is a
frequent complication of oxaliplatin treatment for colo-
rectal liver metastases. It is associated with a higher risk
of morbidity after partial liver resection. Depletion of
glutathione in sinusoidal endothelial cells is central in its
pathophysiology.
Aim: To assess the protective effect of the antioxidant
monoHer on the development of monocrotaline (MCT)
induced liver injury in rats.
Methods: Male Sprague Dawley rats (n = 7 per group)
received a single gavage of MCT (160 mg/kg b.w) to
induce SOS. The intervention group was treated with
monoHer (500 mg/kg b.w. i.p) and the control group
with monoHer vehicle (NaOH i.p. in equivalent amount),
starting 24 hours before MCT gavage and continuing
once daily for 72 hours. After 24 and 72 hours, animals
were sacriﬁced. Primary endpoints were liver injury
[alanine aminotransferase (ALT0)] and portal pressure.
The effect of monoHer combined with oxaliplatin or
MCT on proliferation of two colorectal cancer cell lines
(LoVo & LS174T) was studied by MTS assay. Data are
mean ± SD.
Results: ALT was signiﬁcantly lower in monoHer-trea-
ted rats when compared with controls (24 hours:
47 ± 15 vs. 73 ± 7, P = 0.004, and 72 hours: 103 ± 96
vs. 327 ± 171, P = 0.029). Also, there was a signiﬁcant
difference in portal pressure between intervention and
control rats (24 hours: 7.43 mmHg ± 0.94 mmHg vs.
9.17 mmHg ± 0.71 mmHg, P = 0.003, and 72 hours:
8.57 mmHg ± 1.26 mmHg vs. 11.73 mmHg ± 2.78
mmHg, P = 0.018). Oxaliplatin had a dose dependent
growth inhibitory effect on colorectal cancer cells,
whereas MCT had no effect. MonoHer had no effect on
cell proliferation when used either alone or in combina-
tion with oxaliplatin or MCT (MTS-assay £10% differ-
ence between groups).
Conclusion: The ﬂavonoid monoHer signiﬁcantly pre-
vented MCT induced hepatic injury in rats and may serve
as a novel preventive strategy for SOS. MonoHer could
be used safely along with oxaliplatin without interfering
with its cytotoxic effect.
FP-130
HEME ARGINATE AMELIORATES
HEPATIC ISCHAEMIA REPERFUSION
INJURY THROUGH MODIFICATION OF
MACROPHAGE PHENOTYPE
S. J. McNally1,2, A. Dane2, E. Y. H. Tang1,
O. J. Garden1, D. C. Kluth2 and S. J. Wigmore1,2
1Divison of Clinical and Surgical Sciences (Surgery),
University of Edinburgh; 2MRC Centre for Inﬂammation
Research, University of Edinburgh
Background: Ischaemia reperfusion injury (IRI) is a
major contributor to the mortality and morbidity of he-
patic surgery and transplantation. It currently has no
treatment. Induction of Heme Oxygenase-1 (HO-1) can
reduce IRI; however, the lack of a suitable pharmaco-
logical agent has prevented its clinical application.
Aims: This study investigated the ability of heme argi-
nate to induce HO-1 and to treat IRI.
Methods: A murine model of lobar ischaemia-reperfu-
sion was used. Injury was assessed by ALT, histology and
immunostaining. Bone marrow derived macrophage
(BMDM) phenotype was determined by ﬂow cytometry
(CD11b, CCR2, Gr1, F480), Greiss and ELISA (TNF
and IL10). Biological effect of macrophage phenotype
was assessed in a co-culture model utilising either
BMDMs or precision cut tissue slices of murine liver or
human monocytes with human liver slices.
Results: In vivo heme arginate induced HO-1 expression
in murine liver, predominantly in Kupffer cells. Systemic
pretreatment signiﬁcantly reduced hepatic IRI and al-
tered inﬂammatory cell recruitment (P < 0.05). In vitro
it readily induced HO-1 in BMDMs. Heme arginate al-
tered macrophage phenotype, increasing IL10, reducing
NO production, and lowering CCR2 expression
(P < 0.01). Pretreatment of macrophages led to a
reduction of injury in both the murine and human tissue
slice co-culture models (P < 0.05).
Conclusions: Heme arginate readily induces HO-1 and
protects from hepatic ischaemia reperfusion injury. This
is mediated through modiﬁcation of macrophage phe-
notype. Heme arginate also leads to a protective pheno-
type in human monocytes. Heme arginate has clinical
potential to reduce ischaemia-reperfusion injury in hu-
mans undergoing liver surgery and is now under assess-
ment in a clinical trial.
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MO-01
ADJUVANT PEFG (CISPLATIN,
EPIRUBICIN, 5-FLUOROURACIL,
GEMCITABINE) OR GEMCITABINE IN
PANCREATIC CANCER: A
RANDOMIZED PHASE II TRIAL
M. Reni1, G. Balzano2, S. Cereda1, A. Zerbi2,
V. Durastante3, M. Montorsi4, A. Passardi5, P. Passoni1,
P. Saletti6, V. Di Carlo2 and E. Villa1
1Department of Oncology, S. Raffaele Scientiﬁc Institute,
V. Ogettina 60, 20132 Milan, Italy; 2Pancreas Unit,
Department of Surgery, San Raffaele Scientiﬁc Institute,
Via Olgettina 60 20132, Milan, Italy; 3University
Hospital, Udine, Italy; 4Istituto Clinico Humanitas,
Rozzano-Milan, Italy; 5Massa Carrara City Hospital,
Localita` Monterosso, Carrara, Italy; 6Oncology Institute
of Southern Switzerland, Bellinzona, Switzerland
Background: PEFG regimen signiﬁcantly improved pro-
gression-free and overall survival (OS) as compared with
gemcitabine (G) in stage III and IV pancreatic adeno-
carcinoma (PA).
Aim: We assessed the impact upon disease control of G
or PEFG in the adjuvant setting as well.
Methods: Patients with resected PA, stage IB-III, aged
18–70 years, Karnofsky >60 were randomized within
8 weeks from surgery to receive either G 1 g/m2/weekly
Q3 every 4 weeks (Arm A), or PEFG (cisplatin and
epirubicin at 40 mg/m2 each on day one, gemcitabine at
600 mg/m2 on days 1 and 8 and 5-FU at 200 mg/m2/day
on days 1 to 28) every 4 weeks (Arm B). In both arms
chemotherapy was administered for 3 months and fol-
lowed by radiotherapy (54–60 Gy in 27–30 fractions)
with concurrent 5-FU 250 mg/m2/day. The primary
endpoint was the probability of being disease-free at
1 year (DFS1y) from surgery. The Fleming design was
used for the sample size. Assuming P0 = 35% and
P1 = 55%, a (.05 and b.10, the study was to enroll 51
patients per arm. The treatment regimen had to be con-
sidered of interest with >23 patients being DFS1y.
Results: From August 2003 to August 2008, 102 patients
were enrolled, stratiﬁed by center and margins and ran-
domized (51 per arm). An intent-to-treat analysis on
eligible patients (50 arm A, 49 arm B) was performed.
Patients’ characteristics were (A/B): median age 61/60,
median PS 90/90, stage IB-IIA 25/15%; stage IIB 63/
78%; stage III 12/7%; grade 3 29/46%; R1 35/29%.
DFS1y in arm A was 24 patients (48%) and in arm B 34
patients (69.4%). Median DFS was 11.5 and 15 m,
respectively. After a median follow-up of 22 m, 10/50
patients in arm A and 13/49 patients in arm B are dis-
ease-free, with a 2y OS of 50% and 64%, respectively.
Main G3-4 toxicity was: neutropenia in 15/58% and
thrombocytopenia in 0/11% of cycles.
Conclusions: This is the ﬁrst randomized trial on single
agent or combination chemotherapy as adjuvant treat-
ment of PA. PEFG fulﬁlled the primary endpoint and
warrants further study.
MO-02
INVASIVE INTRADUCTAL PAPILLARY
MUCINOUS CARCINOMAS OF THE
PANCREAS: PREDICTORS OF
SURVIVAL AND THE ROLE OF LYMPH
NODE RATIO
S. Partelli1, C. Fernandez Del-Castillo2, C. Bassi1,
W. Mantovani3, S. P. Thayer2, S. Crippa1, C. Ferrone2,
M. Falconi1, P. Pederzoli1, A. L.Warshaw2 andR. Salvia1
1University of Verona, Department of Surgery;
2Massachusetts General Hospital, Department of Surgery;
3University of Verona, Department of Public Health
Background: Intraductal papillary mucinous neoplasms
(IPMNs) are being increasingly recognized, and often
harbour cancer. Lymph node metastases are an impor-
tant prognostic factor for patients with invasive intra-
ductal papillary carcinoma (I-IPMC), but the role of
lymph node ratio (LNR) in predicting survival after
surgery for I-IPMC is unknown.
Methods: The combined databases from the Surgical
Department of Massachusetts General Hospital of Bos-
ton and the University of Verona were queried. We ret-
rospectively reviewed clinical and pathological data of all
patients with resected, pathologically conﬁrmed, I-IPMC
between 1990 and 2007. Univariate and multivariate
analysis were performed.
Results: I-IPMCs were diagnosed in 104 patients (55
males and 49 females), median age was 69 years.
Recurrent disease was identiﬁed in 49 patients (47.1%)
and the median 5-year disease speciﬁc survival (DSS) was
60.1%. The median number of resected/evaluated nodes
was 15 (range 5–60). There were 60 (57.7%) patients who
had negative lymph nodes (N0), whereas 44 (42.3%) had
lymph node metastases (N1). Patients with lymph node
metastases had a shorter 5-year DSS (28.9%) compared
with patients with negative lymph nodes (80.3%;
P < 0.05) As the LNR increased, 5-year DSS decreased
(LNR = 0, 86.5%; LNR > 0 to 0.2, 34.4%; LNR >
0.2, 11.1%; P < 0.05). On multivariate analysis, LNR,
the presence of a family history of pancreatic cancer and
a preoperative value of Ca 19.9 > 37 U/L were signiﬁ-
cant predictors of survival (P < 0.05.).
Conclusions: Lymph node ratio is a strong predictor of
survival after resection for invasive intraductal papillary
mucinous carcinoma.
MO-03
OPPOSITE EFFECTS OF TWO BH3-
ONLY PRO-APOPTOTIC BCL-2
MEMBERS IN PANCREATIC CANCER
M. Erkan1, T. Samkharadze1, C. Reiser-Erkan1,
T. Deoliveira1, I. Esposito2, H. Friess1 and J. Kleeff1
1Department of General Surgery, Technische Universita¨t
Mu¨nchen, Munich, Germany; 2Institute of Pathology,
Technische Universita¨t Mu¨nchen, Munich, Germany
Background & Aims: BNIP3 and BNIP3L are BH3-only
pro-apoptotic Bcl-2 proteins. Both are induced by
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hypoxia and share 80% homology in their transmem-
brane domains. While loss of BNIP3 leads to apoptosis
resistance and worsened prognosis in pancreatic cancer,
the role of BNIP3L in pancreatic cancer is unknown.
Methods: cDNA-microarray, quantitative RT-PCR, and
immunoblot analyses were used to evaluate BNIP3L
expression. Correlation of BNIP3L positivity with the
p53-status of tumors and patient survival was analyzed
by semiquantitative immunohistochemistry using PanIN
tissue-microarrays (n = 188) and tissues of the normal
pancreas (n = 20), chronic pancreatitis (n = 20) and
pancreatic cancer (n = 75). Modulation of BNIP3L
expression was achieved using two different siRNA
molecules and by hypoxia. The effects of chemothera-
peutic agents on pancreatic cancer cells were assessed
utilizing MTT assay.
Results: Independent of the disease, linear regression
analysis revealed a signiﬁcant reciprocal expression of
BNIP3 and BNIP3L mRNAs in pancreatic tissues of 69
patients (P < 0.0001, F = 27.74). Compared with the
normal pancreas, the expression of BNIP3 mRNA de-
creased 80% in pancreatic cancer while BNIP3L
expression increased 14-fold (P < 0.001). Interestingly,
there was a signiﬁcant reduced expression of BNIP3 in
p53-mutated tumors (P = 0.004). Median survival of
BNIP3L positive patients was signiﬁcantly shorter than
BNIP3L negative patients (17 months, 95%CI 13.4–
20.6 months vs. 34 months 95% CI 12.3–55.7 months,
P = 0.009). In pancreatic cancer cell lines, BNIP3L was
induced up to 9-fold by hypoxia. Silencing of BNIP3L
did not inﬂuence apoptosis resistance in these cells.
Conclusion: Expression of BNIP3 and BNIP3L is in-
versely correlated in pancreatic tissues. Unlike BNIP3,
higher expression of BNIP3L in pancreatic tumors is a
signiﬁcant negative prognostic factor.
MO-05
PAIN AND DEPRESSION RELATE TO
TUMOR EXTENT IN RESECTED
PANCREAS CANCER PATIENTS
B. I. Carr, L. Pujol and C. J. Yeo
Thomas Jefferson University
Background: Psychological tools have been used to as-
sess pain and depression in cancer and their impact on
patient quality of life (QoL). Little is known about such
factors in pancreas cancer, especially the correlations of
QoL with disease extent or outcomes.
Methods: We prospectively examined QoL using Fact-
Hep and CES-D scores in resected pancreas cancer pa-
tients and correlated initial scores with pathologically-
proven baseline disease extent.
Results: Ninety nine patients were evaluated. There were
63% males and 37% females. Pain was a presenting
symptom in 38% each in both genders and jaundice in
10% females and 14% males. Patients were compared for
Pain or No Pain on presentation. Patients with pain had
more metastases than patients with no pain (52% vs.
27%). An ANOVA found higher CEA (P < 0.02) and
depression scores (CES-D; P < 0.01) and lower Physical
(P < 0.01) and Functional well-being (FACT-HEP,
P < 0.01) for patients with pain than those no pain. No
differences were found between groups on serum biliru-
bin or CA19-9 levels, or social or emotional well-being
FACT-HEP subscales. For individuals with the worst
depression (CESD ‡ 26, the worst 33% category), 36%
had tumors ‡2 cm and 33% <2 cm; 43% had vascular
invasion vs. 26% without; 42% had neural invasion
vs.25% without, P < 0.05 (Chi Square), 36% had local
invasion (fat) vs. 25% without and 56% had positive
margins vs. 27% without, P < 0.04 (Chi Square).
Conclusions: This is the ﬁrst study in pancreas cancer to
ﬁnd statistically signiﬁcant differences between patients
with pain and no pain in psychological dimensions and
tumor invasiveness. The results highlight the importance
of depression as a correlate of both pain and tumor
extent.
MO-06
NEOADJUVANT THERAPY IN
PANCREATIC CANCER: A SYSTEMATIC
REVIEW OF RESPONSE AND
RESECTION RATES
S. Gillen1, T. Schuster2, C. Meyer Zum Bu¨schenfelde3,
H. Friess1 and J. Kleeff1
1Department of Surgery, Technische Universita¨t Mu¨nchen,
Munich, Germany; 2Institute of Medical Statistics and
Epidemiology, Technische Universita¨t Mu¨nchen, Munich,
Germany; 3Department of Hematology and Oncology,
Technische Universita¨t Mu¨nchen, Munich, Germany
Background & Aims: There is a strong rationale for a
neoadjuvant approach in pancreatic cancer, since a rel-
evant percentage of patients present with non-metastatic
but unresectable disease and microscopic incomplete
resections are common.
Methods: A systematic review according PRISMA
guidelines of studies investigating preoperative chemo-
and/or radiotherapy for pancreatic cancer was per-
formed. A total of 107 studies including 42 phase I and II
trials were analyzed for percentages of response, resec-
tion and survival fractions.
Results: In studies considering initially resectable tumors
(group 1), resectability was estimated to 74.1% (95% CI
66.7–80.8%) compared to 28.3% (CI 21.2–36%) in
studies of locally advanced/unresectable tumors (group
2). Averaged complete/partial response probabilities were
4.1% (CI 2.2–6.6%)/34.9% (CI 24.6–46.0%) and 5.7%
(CI 4.1–7.4%)/28.9% (CI 23.6–34.4%) for group 1 and 2,
respectively. Estimated median survival following resec-
tion was 22.7 (range 12–54) months for group 1 and 19.4
(range 9–83) months for group 2. Combination chemo-
therapies resulted in higher estimated response and
resection probabilities for initially unresectable patients
(30.5%, CI 20.3–41.9% vs. 20.7%, CI 13.6–29.0%)
compared to monotherapy.
Conclusion: In the group of initially resectable patients,
resection frequencies and survival after neoadjuvant
therapy are similar to the ones observed in primarily
resected tumors and adjuvant therapy. In patients ini-
tially staged unresectable, approximately one fourth are
expected to be resectable following neoadjuvant therapy
with comparable survival as patients who were initially
staged as resectable. Thus, patients with locally ad-
vanced/unresectable tumors should be included in neo-
adjuvant protocols and subsequently re-evaluated for
resection.
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MO-08
ROLE OF SIRS SCORE ON ADMISSION
AND INITIAL CONCENTRATION OF IL-6
IN PREDICTION OF OUTCOME IN
SEVERE ACUTE PANCREATITIS
P. Gregoric1, D. Bajec1, N. Ivancevic1, D. Radenkovic1,
A. Karamarkovic1, A. Sijacki1, S. Stankovic2,
B. Karadzic1 and M. Pandurovic3
1Clinic of Emergency Surgery, Clinical Center of Serbia
and School of Medicine, University of Belgade, Serbia;
2Institute for Medical Biochemistry, Clinical Center of
Serbia and School of Medicine, University of Belgade,
Serbia; 3Institute for Anesthesiology, Clinical Center of
Serbia and School of Medicine, University of Belgade,
Serbia
Background: Early recognition of severe form of acute
pancreatitis is important because these patients need
more aggressive diagnostic and therapeutical approach
an can develop systemic complications such as: sepsis,
coagulopathy, Acute Lung Injury (ALI), Acute Respi-
ratory Distress Syndrome (ARDS), Multiple Organ
Dysfunction Syndrome (MODS), Multiple Organ Fail-
ure (MOF).
Aims: To determine role of the combination of Systemic
Inﬂammatory Response Syndrome (SIRS) score and
serum Interleukin-6 (IL-6) level on admission as predic-
tor of illness severity and outcome of Severe Acute
Pancreatitis (SAP).
Methods: We evaluated 234 patients with ﬁrst onset of
SAP appears in last twenty four hours. A total of 77
(33%) patients died. SIRS score and serum IL-6 con-
centration were measured in ﬁrst hour after admission.
Results: In 105 patients with SIRS score 3 and higher,
initial measured IL-6 levels were signiﬁcantly higher than
in the group of remaining 129 patients (72 ± 67 pg/mL,
vs. 18 ± 15 pg/mL). All non-survivals were in the ﬁrst
group, with SIRS score 3 and 4 and initial IL-6 concen-
tration 113 ± 27 pg/mL. The values of C-reactive Pro-
tein (CRP) measured after 48 hours, Acute Physiology
and Chronic Health Evaluation (APACHE II) score on
admission and Ranson score showed the similar corre-
lation, but serum amylase level did not correlate signiﬁ-
cantly with Ranson score, IL-6 concentration and
APACHE II score.
Conclusion: The combination of SIRS score on admis-
sion and IL-6 serum concentration can be early, predictor
of illness severity and outcome in SAP.
MO-10
DIAGNOSIS AND TREATMENT OF
VIPOMA IN CHINA (41 CASES REVIEW)
J. Li1, H. Q. Fang1, Z. Tang1, X. L. Liu1, R. Ma1,
L. Y. Zhang1, G. J. Tian1, B. H. Lou1, Y. B. Liu2,
X. B. Wang3 and S. Y. Peng1
1Second afﬁliated Hospital, Zhejiang University; 2Xinhua
Hospital, Shanghai Jiaotong University; 3Zhejiang Cancer
Hospital
Background: Vasoactive intestinal peptide-secreting-tu-
mors (VIPoma) is a rare endocrine tumor with compli-
cated symptoms. We report a rare case of pancreatic
VIPoma with liver metastasis who was survival for
68 months. In addition, the experience of diagnosis and
treatment for VIPoma was discussed by summarizing
clinical informations of 41 patients with VIPoma in
China.
Methods: To analyze clinical manifestations, laboratory
examinations, imaging features, operation, pathological
ﬁndings and follow up survey of 41 patients, among them
one case was from our hospital and the other 40 cases
were reported in Chinese literature from 1977 to 2008.
Results: Thirty seven cases were performed operation
(90%), The mean serum value of VIP before operation
decreased markedly after the operation (943.7 pg/mL vs.
116.4 pg/mL) among 15 cases, 33 cases were malignant
VIPoma (80%), Liver metastasis were presented in nine
cases (21%), The tumor immunohistochemistry staining
of 34 cases for VIP (82%), nodal metastasis was 7%.
Follow-up survey were achieved in 15 cases, the course is
2–68 months. Two cases with embolization via hepatic
artery all died after 6 months. The patient which we
treated died after 68 months combined therapy with
pancreatoduodenectomy, two cycles (5 times) radiofre-
quency ablation treatment and somatostatin analogues.
Conclusion: VIPoma is rare. Typical symptoms and the
serum value of VIP are keys to diagnosis before opera-
tion; surgical resection is the most effective means for
cure. RF was effective for liver metastasis, surgical deb-
ulking of the tumor, somatostatin analogues can be used
for good palliation.
MO-11
CORRELATION BETWEEN EXPRESSION
OF TYPE IV COLLAGEN AND
VASCULARITY IN HEPATOCELLULAR
CARCINOMA
C.-H. Cheng1, M.-C. Yu1,2, K.-M. Chan1, W.-C. Lee1,
Y.-Y. Jan1 and M.-F. Chen1
1Chang Gung Memorial Hospital, Linkou; 2Guaduate
Institiute of Clinical Medical Sciences, Chang Gung
University
Background: Despite studies conﬁrming the association
between type IV collagen and ﬁbrosis score in hepato-
cellular carcinoma (HCC), no studies has been published
to investigate the relationship between type IV collagen
and vascularity in HCC.
Aim: The purpose of this study was to explore the cor-
relation between the expression of type IV collagen and
vascularity in HCC. In addition, survival outcomes with
respect to type IV collagen expression were examined.
Materials and Methods: The samples of cancerous and
non-cancerous paired tissue were taken from 100 patients
with HCC who underwent hepatectomy. Immunohisto-
chemistry (IHC) staining for type IV collagen was then
performed in 100 paired samples to demonstrate the
vascularity of tumor. Histologic examination for vascu-
larity and radiologic determination of vascularity in
cancerous tissue was carried out to investigate the asso-
ciations between type IV collagen and vascularity. The
clinicopathologic factors, tumor recurrence, and survival
were analyzed to study the inﬂuence of type IV collagen
expression. The data were analyzed using paired t test,
independent t test, chi-square tests, and log-rank test.
Results: Microarray analysis demonstrated that the
expression of type IV collagen gene was up-regulated in
cancerous tissue compared with non-cancerous tissue
with a P-value <0.001. The IHC staining also demon-
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strated a signiﬁcant result in terms of collagen type IV
concentration in cancerous tissue (P < 0.05). Histololgic
and radiologic examinations found that type IV collagen
expression is correlated with the vascularity of HCC.
Survival analyses revealed that HCC with higher type IV
collagen expression had shorter overall survival
(P < 0.001).
Conclusion: This study revealed that type IV collagen
expression correlates with the vascularity and prognosis
of HCC. Since HCC is a hypervascular tumor, novel
anti-angiogenic therapy involving anti-type IV collagen
expression warrants further investigation.
MO-12
PREDICTION OF HEPATOCELLULAR
CARCINOMA TUMOR GRADE AND
MICRO-VASCULAR INVASION BY
MEANS OF ARTIFICIAL NEURAL
NETWORK: A PILOT STUDY
A. Cucchetti1, M. Cescon1, G. L. Grazi1, G. Ercolani1,
M. Ravaioli1, M. Del Gaudio1, G. Vetrone1,
M. Zanello1, A. D’errico-Grigioni2, G. Stacchini1 and
A. D. Pinna1
1Department of General Surgery and Transplantation,
University of Bologna; 2Department of Hematology,
Oncology and Laboratory Medicine, University of Bologna
Background: Hepatocellular carcinoma (HCC) progno-
sis strongly depends on nuclear grade and presence of
microscopic vascular invasion (MVI). Aim of this study
was to develop an artiﬁcial neural network (ANN) able
to predict tumor grade and MVI on the basis of non-
invasive variables.
Methods: Clinical, radiological and histological data
from 250 cirrhotic patients resected (n = 200) or trans-
planted (n = 50) for HCC were analyzed. ANN and
logistic regression models were built on a training group
of 175 randomly chosen patients and tested on the
remaining testing group of 75. Receiver operating char-
acteristics (ROC) curve and k-statistic were used to
analyze model accuracy in the prediction of the ﬁnal
histological assessment of tumor grade (G1–G2 vs. G3–
G4) and MVI (absent vs. present).
Results: Pathologic examination showed G3–G4 in
69.6% of cases and MVI in 74.4%. Preoperative serum
AFP, tumor number, size and volume were related to
tumor grade and MVI (P < 0.05) and were used for
ANN building, whereas, tumor number did not enter in
the logistic models. In the training group, ANN area
under ROC curves (AUC) for tumor grade and MVI
prediction were 0.94 and 0.92, both higher (P < 0.001)
than those of logistic models (0.85 both). In the testing
group, ANN correctly identiﬁed 93.3% of tumor grades
(k = 0.81) and 91.0% of MVI (k = 0.73); logistic
models correctly identiﬁed 81.0% of tumor grades
(k = 0.55) and 85.0% of MVI (k = 0.57).
Conclusion: ANN identiﬁes HCC tumor grade and MVI
on the basis of preoperative variables more accurately
than the conventional linear model and should be used
for tailoring clinical management.
MO-13
IMPACT OF CHEMOTHERAPY AND
MEDICAL COMORBIDITIES ON THE
HEPATIC VOLUME HYPERTROPHY
AFTER PORTAL VEIN EMBOLIZATION
(PVE)
A. Begin, D. Bourdonnais, F. Vandenbroucke-Menu,
M. Plasse, R. Letourneau, A. Roy, M. Dagenais and
R. Lapointe
Unit of Hepatobiliary Surgery and Liver Transplantation -
Hopital Saint Luc - CHUM - Montreal, QC
Introduction: Some studies have showed that diabetes,
chemotherapy, age, dysplipidemia and obesity could re-
straint the degree of hypertrophy of the liver after PVE.
The aim of this study was to analyze the impact of these
factors on the liver hypertrophy after preoperative PVE.
Material and methods: This was a retrospective study of
47 patients (27 males and 20 females) with a mean age of
59-years old, which have undergone a preoperative PVE.
Total and future remnant liver volumes and tumor vol-
ume were calculated before and one month after PVE.
Mann-Whitney test was used for statistical analysis.
Results: There was no mortality and ﬁve minor compli-
cations after PVE. Average length of hospital stay was
1.8 days (one-day procedure in 19 patients (41%)). Per-
centage of future remnant liver volume hypertrophy was
12%. This volume hypertrophy was not statistically
modiﬁed by: sex (male (13%) vs. female (10.4%)), age
(360-years old (12%) vs. <60-years old (12%)), body
mass index (330 (16.1%) vs. <30 (10.6%)), diabetes (yes
(15.1%) vs. no (10.9%)), dyslipidemia (yes (11.3%) vs. no
(12.3%)), type of chemotherapy (folﬁri (13.9%) vs. folfox
(7.6%); P = 0.05), number of cycles of chemotherapy
(£6 (13.2%) vs. >6 (7.2%); P = 0.05).
Conclusion: PVE is secure and could be performed as a
one-day procedure. No studied factors restraint the de-
gree of future remnant liver volume hypertrophy. In our
experience, the number of chemotherapy cycles (more
than six) and the type of chemotherapy need to be more
studied to deﬁne exactly their impact on liver volume
hypertrophy.
MO-14
HEPATOCELLULAR CARCINOMA
(HCC) ARISING FROM LIVER CELL
ADENOMAS (LCA): A CLINICO-
PATHOLOGICAL ANALYSIS
O. Farges, N. Ferreira, S. Dokmak, M. Ronot,
J. Belghiti, P. Bedossa and V. Paradis
Beaujon Clichy
Background: Alcohol ingestion, viral infection or the
metabolic syndrome are the main risk factors of HCC.
HCC may also arise through the malignant transforma-
tion of LCA but this sequence is considered anecdotical,
especially in men. In surgical series of LCA patients, the
majority of which are women, the proportion of those
with malignant transformation ranges between 5 and
10%. Nevertheless, the number of malignant LCA re-
ported in the literature is overall limited (41 in the past
20 years).
Methods: All patients who had undergone complete
resection of a tumor between 1995 and 2008 with a
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pathological code of LCA were retrieved from our hos-
pital database. The search yielded 218 patients (184 wo-
men and 34 men) of whom 23 had associated histological
features of HCC (dysplasia was not considered as
malignancy). Immunohistochemistry was used to cha-
racterise the LCA subtype, identify beta-catenin muta-
tion and map the malignant transformation.
Results: The 23 patients were seven women and 16 men
and accounted for 4% and 47% of female and male
patients with LCA. Although this proportion remained
constant during the study period in women, it increased
in men from 1 in 4 before 2000 to 15 in 30 since 2000.
None of the seven female patients with malignant LCA
had associated conditions other than contraceptive pill
consumption. In contrast, among the 16 male patients 12
had associated conditions including six (all managed
since 2000) with a metabolic syndrome. The median
diameter of the adenoma was not different in male and
female (10 vs. 8 cm). However male patients more fre-
quently had LCA with cell atypias (7/16 vs. 1/7 in fe-
males) and beta-catenin mutation (13/16 vs. 2/7).
Conclusion: Liver adenoma is increasingly recognised in
male patients. Approximately 1 in 2 has evidence of
malignant transformation and carcinogenesis appears
different than in women. The increasing prevalence of
HCC associated with the metabolic syndrome may, at
least partly, result from the transformation of LCA.
MO-15
LONG-TERM SURGICAL OUTCOME OF
HEPATOCELLULAR CARCINOMA –
10 YEARS FOLLOW-UP
M.-C. Yu1,2, H.-H. Chou1, K.-M. Chan1, T.-J. Wu1,2,
C.-F. Lee1, W.-C. Lee1 and M.-F. Chen1
1Chang Gung Memorial Hospital, Linkou; 2Graduate
Institute of Clinical Medical Sciences
Background: Surgical treatment remained the ﬁrst choice
for earlier stage of hepatocellular carcinoma (HCC).
Several pathologic factors were predictive in the long-
term outcome. However, few papers were studied on
long-term follow-up for 8 years or longer.
Materials and Methods: 20/100 from 1982 to 2005, 1948
patients underwent hepatectomies at our institute. The
mean age is 55.1 + 11.1 years old and the hospital
mortality rate was 5.8%. The HBV was positive in 1194,
whereas the HCV was positive in 519 patients. The
clinicopathological data were collected for large scale
analysis. The data were analyzed using paired t test,
independent t test, chi-square tests, and log-rank test.
Results: Patients with stage I were 45%, stage II were
19%, and stage III were 36%. The survival data were
compatible with our previous study that tumor status
was the most important factors for long-term outcome.
Tumor differentiation, vascular invasion, especially
thrombus formation, and satellite lesions were poor
prognostic factors (P-value <0.01). But the impact oc-
curred at the ﬁrst ﬁve years. The staging of the AJCC
edition was effective in clinical practice to predict out-
come. The 10-year overall survival rate was 62.8, 53.1,
and 24.8% for stage I, II and III respectively, and the 10-
year disease-free survival rate was 41.1, 32.2, and 16.7%
respectively.
Conclusion: This study revealed that most patients with
HCC had relative good outcome in the second 5 years
follow-up though some population had recurrence. Sur-
gical resection can offer greater beneﬁt for patients with
stage I HCC and the result was comparable with HCC
for liver transplantation.
MO-16
LAPAROSCOPIC RESECION OF
HEPATOCELLULAR CARCINOMA:
ONCOLOGICAL SAFETY
Y.-P. Yeung, J. Hui, K.-C. Cheng and A. Yip
Department of Surgery, Kwong Wah Hospital
Background: Oncological safety, with regards resection
margin and anatomical resection, is a great concern for
hepatectomy in hepatocellular carcinoma (HCC). Onco-
logical resection of HCC is an important determinant for
recurrence and long-term survival.
Aim: To examine whether anatomical resection and
adequate resection margin can be achieved in patients
with HCC treated with laparoscopic hepatectomy.
Method: During a 3-year period, 24 consecutive patients
with solitary HCC of less than 5 cm were treated with
laparoscopic hepatectomy. Non-anatomical resection
was performed for 16 patients with tumour size <3 cm
and anatomical resection for eight patients with tumor
size ‡3 cm. For anatomical resection, inﬂow pedicle
control was ﬁrst exercised to delineate the involved seg-
ment(s) hence the resection plane, leaving segmental bile
duct control during or after parenchymal dissection. All
specimens were examined for margin immediately after
resection and sent for parafﬁn section. Patients were
followed regularly in outpatient clinic at intervals of 2 to
3 months.
Results: Anatomical resection can be achieved in all
patients with tumour ‡3 cm, but one operation needed
conversion to open because of bleeding. The median
resection margin for all resections (anatomical and non-
anatomical) was 9 mm (range 1–25 mm). Two of our
patients were found to have close resection margin
<5 mm when the specimen examined. In both patients,
the close margin was further treated with radiofrequency
ablation. At a median follow-up of 18 months, four pa-
tients had recurrences, two systemic and two local. Both
local recurrences occurred distant from the primary le-
sions at other hepatic segments.
Discussion: Oncological resection can be achieved by
laparoscopic hepatectomy in selected HCC patients.
Longer duration of follow-up is required to delineate
whether laparoscopic hepatectomy is a safe option in the
treatment of HCC.
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MO-18
SIGNAL TRANSDUCTION BY THE
TYROSINE KINASE PATHWAY IS
INVOLVED IN THE DEVELOPMENT OF
MULTI-DRUG RESISTANCE IN
HEPATOCELLULAR CARCINOMA
K. Hoffmann1, C. Franz1, X. Zhi1, C. Falk2,
M. W. Bu¨chler1 and P. Schemmer1
1Department of General- and Transplantation-Surgery,
Ruprecht-Karls-University, Heidelberg, Germany;
2National Center of Tumor Diseases, Heidelberg, Germany
Background: Recent studies indicate an involvement of
tyrosine kinases (TK) in the development of ABC
transporter mediated multi-drug resistance (MDR) in
cancer cells. The expression of MDR proteins as well as
an activation of the TK pathway is important prognosis
limiting factors in hepatocellular cancer (HCC).
Objective: Aim of the study was to investigate the
interaction of MDR proteins and tyrosine kinases in
HCC with regard to potential targets for new therapeutic
approaches.
Methods: Multi-drug resistance was induced by gemcit-
abine treatment of HUH7 and HEPG2 cells. Real-time
RT PCR and western blot were used for quantiﬁcation of
MDR protein (MRP1-3, P-Glycoprotein) and tyrosine
kinases (RAF1, MEK, ERK, MAPK14) expression. The
functional activity of TKs was measured by phospho-
kinase multiplex analysis. SiRNA was used for silencing
of the EGF receptor (EGFR).
Results: Expression of MDR proteins was signiﬁcantly
increased by chemotherapy compared to untreated con-
trols. Chemotherapy signiﬁcantly induced RAF1, ERK
and MAPK14 mRNA and protein expression. Multiplex
analysis revealed an increased RAF1 and ERK phos-
phorylation after chemotherapy. Gemcitabine induced
EGFR expression and EGF secretion. Application of
EGF enhanced the MRP2 and MRP3 as well as RAF1,
ERK and MAPK14 expression. In contrast, after
silencing of EGFR no changes in protein expression were
detectable. Treatment with the tyrosine kinase inhibitor
sorafenib restored chemosensitivity.
Conclusion: A simultaneous induction of MDR protein
and tyrosine kinases expression by chemotherapy in HCC
was demonstrated for the ﬁrst time. Chemotherapy
induced activation of the TK pathway via EGFR seems to
be involved in resistance development. The data support
an inhibition of tyrosine kinases as new option for resto-
ration of chemosensitivity in highly resistant tumors.
MO-19
THE IMPACT OF RADIOFREQUENCY
ABLATION AND LIVER RESECTION ON
PATIENTS WITH CIRRHOSIS AND
EARLY AND VERY EARLY
HEPATOCELLULAR CARCINOMA
E. Opocher1, M. Barabino1, M. Costa1, M. Zuin2,
P. Carnevali1 and R. Santambrogio3
1HPB Surgical Unit San Paolo Hospital Milan;
2Hepatology Unit San Paolo Hospital Milan; 3HPB
Surgical Unit San Giuseppe Hospital Milan
Background: On the basis of Barcelona Clinic Liver
Cancer (BCLC) staging system, an algorithm for the
treatment of hepatocellular carcinoma (HCC) has been
proposed. However, external validation studies, which
demonstrate the usefulness of this methodology, still
lack.
Aim: Of this non–randomized retrospective cohort study
was to assess in a large series of patients the impact of
radiofrequency ablation (RFA) and liver resection (LR)
on survival and HCC recurrence.
Methods: A database was set-up including all cirrhotic
patients with a diagnosis of HCC admitted in a single
center and treated by RFA (laparoscopic or laparotomic)
or by LR from January 1997 to December 2008. Out-
comes included morbidity; HCC recurrence and overall
survival were evaluated.
Results: In a set of 387 patients, 326 were retrospectively
classiﬁed as ‘‘very early’’ (group A, 21%) or ‘‘early’’
HCC (group B, 79%). 64% of them were treated by RFA
and 36% by LR. No differences were found in gender,
age, etiology of cirrhosis, while both the rate of Child
class A (100% group A, 64% group B, P = 0.0001) and
the proportion of BCLC classiﬁcation (A1: 82% group
A, 48% group B, P = 0.0001) was different between
groups. In group A, 23 patients (34%) were treated by
RFA and 45 (66%) by LR. Moreover, after a mean
follow-up time of 28 ± 21 (median 22) months, no dif-
ference was found for global HCC recurrences (45%
group A, 56% group B) and local recurrences (13%,
group A, 15% group B). Patients with ‘‘very early’’ HCC
had signiﬁcantly longer 5-year survival in comparison to
subject with ‘‘early’’ HCC (group A 57%, group B 35%,
P = 0.005). HCC recurrence rate in group A was sig-
niﬁcantly lower in patients treated with LR (table).
Outcome according to very early (group A) and early
(group B) HCC patients.
5-year survival HCC recurrence
Group A LR 68% 26%
RFA 50% 55%
P 0.247 0.026
Group B LR 44% 53%
RFA 30% 57%
P 0.073 0.558
Conclusion: The risk of HCC recurrence and of 5-year
survival was similar among patients with cirrhosis and
HCC treated with either LR or ‘‘surgical’’ RFA. More-
over, they suggest that LR should be adopted as a ﬁrst-
line option in the treatment of cirrhotic patients with
‘‘very early ‘‘HCC.
MO-20
LAPAROSCOPIC LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
IN CIRRHOTIC PATIENTS: A CASE
CONTROL STUDY
B. Menahem, C. Dufay, L. Chiche, G. Lebreton,
B. Alkofer, G. Samama and E. Salame
CHU Cote de Nacre 14000 CAEN FRANCE
Introduction: Liver resection (LR) is indicated for HCC
in patients with Child A cirrhosis and moderate portal
hypertension. Laparoscopic liver resection (LLR) was
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evaluated retrospectively and compared to conventional
liver resection (CLR) at the same period.
Materials and methods: Between 2004 and 2009, 82 LLR
and 663 CLR were performed in our institution. We
analyzed retrospectively LR in cirrhotic patients. 21 LLR
(Group 1) were matched to 46 CLR (Group 2): <3
segments. Mean age was 64 and 67 years in Group 1 and
2 respectively. Sex ratio was 14/3 (Group 1) and 36/10
(Group 2). Operation were monosegmentectomies
n = 10 in Group 1, n = 22 in Group 2, bisegmentecto-
mies n = 11 in Group 1, n = 15 in Group 2, triseg-
mentectomies none in Group 1 and n = 9 in Group 2.
Results: Mortality was 6% in Group 2 and none in
Group 1. Morbidity was 40% in Group 2 and 5% in
Group 1. Mean duration of stay was signiﬁcantly higher
in CLR comparatively to LLR (12.23 vs. 6.22 days).
Mean duration of drainage was signiﬁcantly higher in the
CLR as compared to LLR (5.19 vs. 0.55 days). There was
no difference in surgical margin between the two groups
(7.64 mm in Group 1, 9.26 mm in Group 2). A cost
effectiveness analysis showed signiﬁcant difference
favouring the LLR group (Group 1 = 8400€; Group
2 = 14222€).
Discussion: In cirrhotic patients LLR is feasible and safe
as compared to CLR. Oncological results in LLR were
comparable to CLR. LLR had lower mortality and
morbidity, and offered signiﬁcant beneﬁts in terms of
hospital stay and cost-effectiveness as compared to CLR.
MO-22
SYSTEMATIC REVIEW ON THE
SURGICAL TREATMENT FOR T1
GALLBLADDER CANCER
S. E. Lee, J-Y. Jang, C-S. Lim, M. J. Kang and
S.-W. Kim
Department of Surgery, Seoul National University College
of Medicine
Background: Because T1 Gallbladder (GB) cancer
showed better prognosis than advanced GB cancer, some
authors have considered it is amenable to perform only
cholecystectomy. However, owing to lack of evidence,
there has been controversy regarding the optimum
management.
Aim: The aim of this study is to evaluate the effectiveness
of simple cholecystectomy and extended cholecystectomy
options in patients with T1a or T1b GB cancer.
Methods: Electronic searches of the MEDLINE (Pub-
Med) database (1966–2008), Cochrane Library (1996–
2008), EMBase (1970–2008), and Cancerlit (1970–2008)
were performed to identify original published studies of
surgery for T1 GB cancer.
Results: Among 2312 potentially relevant publications,
252 publications were potentially eligible and reviewed
for full text after review of title and abstract. Of these, 29
studies met eligibility criteria, speciﬁcally assessing the
outcome of surgery in patients with T1a and T1b GB
cancer. Of the 1266 patients with T1 tumors, 706 patients
(55.8%) had T1a and 560 patients (44.2%) had T1b tu-
mor. Simple cholecystectomy was performed in 590 pa-
tients (83.6%) with T1a and in 375 patients (67.0%) with
T1b tumor (P < 0.01). In most series, the treatment of
choice for T1a GB cancer was simple cholecystectomy
with 5-year survival of 100%. Lymph node metastasis
was present in 10.9% in T1b and 1.8% in T1a
(P < 0.01). Eight patients (1.1%) with T1a and 52 pa-
tients (9.3%) with T1b tumor died of recurrence
(P < 0.01).
Conclusion: For T1a tumor, simple cholecystectomy
would be adequate. For T1b tumor, there was no deﬁnite
evidence of priority of extended cholecystectomy to
simple cholecystectomy. However, considering recur-
rence rate after radical cholecystsectomy was lower than
simple cholecystectomy, radical cholecystecotmy could
be recommended for the patients with low risk of oper-
ation. And because lymph node metastasis rate was
considerable, regional lymphadenectomy should be per-
formed for the purpose of the treatment and staging.
MO-23
AGGRESSIVE SURGERY TO
GALLBLADDER CANCER – IS
HEPATECTOMY FOR GALLBLADDER
CANCER ONLY FOR NEGATIVE
MARGIN?
T. Niguma, T. Mimura and T. Kojima
Okayama Saiseikai General Hospital
Advanced gallbladder (GB) cancer with liver metastasis
is usually given up operating radically because of poor
prognosis. Although the beneﬁt of resection is contro-
versial, there are some reports that the liver of GB’s
venous drainage region may be the primary lesion of the
liver metastasis of GB cancer. The aim of this study was
to report the result of radical operation for advanced GB
cancer with liver metastasis. From 1980 to 2008, 202
patients underwent laparotomy for GB cancer in Okay-
ama Saiseikai General Hospital. 190 patients underwent
radical resection, while 12 patients were palliative.
Median survival of palliative surgery is 4.4 months. In
the resection group, 104 patients were pathologically
curative, but 64 patients were non-curative. 5 year
survival rate of curative resection is 95.8% in pT1,
62.4% in pT2, and 29.1% in pT3 and pT4 (UICC
classiﬁcation). Median survival of non-curative operation
is 6.7 months. 16 patients were found metastasis in the
excised liver, and were classiﬁed in non-curative opera-
tion. Of the 16 patients, ﬁve patients had other non-
curative factors such as aortocaval lymph node involve-
ment or peritoneal dissemination. These patients died
within 7 months. Eleven patients were found small
metastasis in the excised liver as the only factor of non-
curative operation. Of the 11 patients, ﬁve patients
underwent extended lobectomy, four patients underwent
central lower segmentectomy (Couinaud’s S4a and S5),
and two patients underwent peri-GB partial hepatec-
tomy. Median survival of the 10 patients (exclude one
because of complication death) is 17.2 months. Two
patients (one extended left lobectomy + partial resec-
tion, one central lower segmentectomy) are still alive
more than 10 years without recurrence. One of the
patients received adjuvant hepatic arterial infusion che-
motherapy, and the other was treated surgery alone.
These results suggest that extended liver resection
including limited liver metastasis may have the beneﬁt
for highly selected patients.
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MO-24
THE BENEFIT OF INTRA-OPERATIVE
ULTRASOUND IN THE MANAGEMENT
OF SUSPECTED GALLBLADDER
CANCER
A. Sasson, E. Kim, Q. Ly and C. Are
University of Nebraska Medical Center
Background: Gallbladder cancer is often discovered as
an incidental ﬁnding following cholecystectomy.
Obtaining the diagnosis of gallbladder cancer prior to
cholecystecomy is often difﬁcult and requires a high in-
dex of suspicion. The optimal management of localized
gallbladder cancer involves a radical cholecystectomy.
The same surgical treatment applies to patients with
suspected gallbladder cancer.
Aim: Purpose is to determine the value of intra-operative
ultrasound in the management of patients with suspected
gallbladder cancer and its ability to discriminate between
benign and malignant pathology.
Methods: We reviewed clinical and pathologic data of
patients, from 2001 to 2009, referred to the surgical ser-
vice of a tertiary referral center with suspected gallblad-
der cancer.
Results: We identiﬁed 12 patients with pre-operative
imaging studies with radiographic abnormalities suspi-
cious for gallbladder cancer. Pre-operative imaging
modalities included a transcutaneous abdominal ultra-
sound as well as computed tomography or magnetic res-
onance imaging in all patients. The cohort contains seven
males and ﬁve females with a median age of 61 years
(range 31–78). A gallbladder mass was detected in nine
patients, with a median size of 3.2 cm (range 1.2–9.5). All
patients underwent evaluation with an intra-operative
ultrasound. A lack of a gallbladder mass, presence of
gallbladder sludge, or non-speciﬁc gallbladder wall
thickening was present in 9 (75%) patients. These nine
patients underwent simple cholecystectomy, ﬁve of them
laparoscopically, with no malignancy identiﬁed in the
specimens. Three patients had features worrisome for
malignancy and underwent radical cholecystectomy, with
two patients having carcinoma and one patient with
hemorrhagic necrotizing cholecystitis.
Conclusion: Intra-operative ultrasound successfully
identiﬁed benign gallbladder pathology in 75% of patient
suspected of harboring a malignancy and altered the
management thus avoiding an unnecessary radical cho-
lecystectomy.
MO-25
ANALYSIS OF POSTOPERATIVE
COMPLICATIONS FOLLOWING
SURGICAL TREATMENT OF HILAR
CHOLANGIOCARCINOMA: A SPECIAL
REFERENCE TO HEPATIC
INSUFFICIENCY
S. Hirano, S. Kondo, E. Tanaka, T. Tsuchikawa,
K. Kato, J. Matsumoto, R. Kawasaki and T. Shichinohe
Hokkaido University Graduate School of Medicine
Background: Radical resection for hilar cholangiocarci-
noma is still associated with signiﬁcant morbidity or
mortality. Especially, hepatic insufﬁciency after hepa-
tobiliary resection is one of the serious complications
which may lead to mortality.
Aims/objectives: The aim of this study was to analyze the
short-term outcome of radical resections especially for
postoperative hepatic insufﬁciency and to validate our
strategies including preoperative management and selec-
tion of operative procedure.
Methods: We surgically treated 146 consecutive patients
with hilar cholangiocarcinoma with a management
strategy consisting of preoperative biliary drainage,
portal vein embolization, and selection of operative
procedure based on tumor extension and hepatic reserve.
Major hepatectomy was conducted in 126 patients, and
caudate lobectomy or hilar bile duct resection in 20 pa-
tients. The data on all of the patients were analyzed to
identify the factors that might affect the occurrence of
postoperative hepatic insufﬁciency.
Results: Overall in-hospital mortality rate was 3.4% and
the morbidity rate was 44%. Hyperbilirubinemia (total
bilirubin >5 mg/dL, persisted for >7 postoperative
days) and liver failure (total bilirubin >10 mg/dL) were
occurred in 11 and nine patients. All the patients with
hyperbilirubinemia were recovered, whereas the ﬁve pa-
tients with liver failure encountered in-hospital mortality.
Four mortality patients suffered circulatory impairment
of the liver due to other complications. Univariate and
multivariate analysis revealed a single independent sig-
niﬁcant predictive factor for postoperative hepatic
insufﬁciency, intraoperative blood loss (odds ratio, 1.001,
95% conﬁdence interval, 1.00–1.001, P = 0.02).
Conclusions: Aggressive resection for hilar cholangio-
carcinoma, performed in accordance with strict man-
agement strategy, achieved acceptable low mortality.
Much intraoperative blood loss was a risk for postoper-
ative hepatic insufﬁciency.
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CLINICAL APPLICATION OF 3D-
CHOLANGIOGRAPHY IN BILIARY
TRACT CARCINOMA
A. Nanashima, T. Syuuichi, T. Abo, M. Kunizaki,
S. Hidaka, H. Takeshita, T. Yasutake, T. Sawai and
T. Nagayasu
Nagasaki University Hospital, Division of Surgical
Oncology
Background: The 2D-cholangiography requires changes
in body position and large X-ray exposure. Experience of
the radiologist might inﬂuence the quality of images.
Recent developments in X-ray imaging facilitate 3D
reconstruction of angiography or cholangiography. We
examined the usefulness of 3D cholangiography applying
C-arm CT or Multidetector row-CT (MDCT).
Methods: CT-like reconstructed images by C-arm CT
were automatically constructed by the workstation. 3D
cholangiography could be obtained using only a single
scan for 8 seconds. Using MDCT, 3D-cholangiography
was obtained by direct infusion of low concentration of
contrast media in a single scan.
Results: Between 2006 and 2009, 3D-cholangiography
was performed in 19 patients with bile duct carcinoma
including 14 exposed by C-arm CT and ﬁve by MD-CT.
Thirteen patients had bile duct carcinoma, four intrahe-
patic cholangiocarcinoma and two gall bladder carci-
noma. Ten patients underwent surgical resection and
nine underwent biliary stent. Excellent 3D-cholangio-
grams were obtained using low concentrations of con-
trast media; the stenotic lesions could be viewed from
Abstracts 71
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
various angles. The extent of tumor involvement on 3D
cholangiography was similar to that detected by 2D-
cholangiography. Comparison of MRCP and DIC-CT
showed better detection of peripheral branches of bile
duct by C-arm CT although direct cholangiography by
MDCT was more remarkable. The C-arm CT allowed
quick and accurate positioning of multiple biliary stents
in a non-resectable case with stenosis at multiple tumor
sites.
Conclusions: C-arm CT provided accurate information
on bile duct status and extent of tumor invasion, which
would be helpful for treatment by interventional radiol-
ogy. MDCT also provides precise and remarkable 3D-
cholangiography and simultaneously helps deﬁne the
relationship with surrounding major vessels. 3D-cholan-
giography is a useful diagnostic modality particularly for
pre-treatment evaluation of the extent of biliary carci-
noma.
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MANAGEMENT AND OUTCOMES
AFTER RESECTION OF HILAR
CHOLANGIOCARCINOMA – A FRENCH
NATIONWIDE PROSPECTIVE STUDY
J.-M. Regimbeau1,2, D. Fuks1,2, F. R. Pruvot2,3,
Y. P. Le Treut2,4, D. Castaing2,5, J. Belghiti2,6,
P. Bachellier2,7, K. Boudjema2,8, G. Nuzzo2,9,
D. Cherqui2,10, J.-F. Gigot2,11, O. Boillot2,12,
J. Baulieux2,13 and O. Farges2,6
1Amiens North Hospital; 2Department of Digestive
Surgery; 3Lille Universitary hospital - Claude Huriez
hospital; 4Marseille Universitary hospital - Conception
hospital; 5Paul Brousse hospital; 6Beaujon hospital;
7Strasbourg Universitary hospital - Hautepierre hospital;
8Rennes Universitary hospital - Pontchaillou hospital;
9Roma hospital; 10Henri Mondor hospital; 11Brussels
Universitary hospital - St Luc hospital; 12Lyon
Universitary hospital - Edouard Herriot hospital; 13Lyon
Universitary hospital - Croix Rousse hospital
Introduction: Surgical resection is the only possibility of
long term survival in patients with hilar cholangiocarci-
noma (HC). The aim of this study was to assess the safety
and outcomes of these procedures.
Methods: From January 1st to December 31st 2008, 56
patients operated were prospectively collected into a
nationwide database focusing on preoperative manage-
ment, surgical procedures and morbimortality.
Results: There were 40 men and 16 women with a med-
ian age of 63 ± 11. Tumors were classiﬁed Bismuth-
Corlette I (n = 6), II (n = 8), IIIa (n = 18), IIIb
(n = 18) and IV (n = 4). Nine patients (16%) under-
went laparoscopic evaluation. Four patients had neoad-
juvant chemotherapy/radiation therapy. A biliary
drainage was decided in 81% of jaundiced patients and
18 (32%) had portal vein embolization prior to surgery.
Resection with curative intent was performed in 39
(70%) patients: major hepatectomy (>3 segments) with
main bile duct resection was done in 100%. Fourteen
patients (36%) had portal vein resection and one patient
required pancreaticoduodenectomy. Vascular clamping
was required in 69% and 16 (41%) had intraoperative
transfusion. Negative surgical margins were obtained in
75%. Overall mortality and morbidity were 3.8 and 60%
respectively. The two major complications were sepsis
(30%) and biliary ﬁstula (21%). Seven patients required
re-operation and 13 patients had percutaneous drainage
of abdominal collection. Median length of stay was
20 ± 13 days. 75% of patients had clear resection mar-
gins.
Conclusion: With an aggressive peri-operative manage-
ment, resection for HC still carries the risk of signiﬁcant
morbidity but with low mortality.
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EFFICACY OF PORTAL VEIN
EMBOLIZATION IN PATIENTS WITH
HILAR CHOLANGIOCELLULAR
CARCINOMA
Y. K. Hong1, S. B. Choi2, K. H. Lee3, S. W. Park4,
Y. N. Park5, J. S. Choi1, W. J. Lee1 and
K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of Surgery,
Kuro Hospital, Yonsei University College of Medicine;
3Department of Radiology, Severance Hospital, Yonsei
University College of Medicine; 4Department of Medicine,
Severance Hospital, Yonsei University College of
Medicine; 5Department of Pathology, Severance Hospital,
Yonsei University College of Medicine
Introduction: An extended hepatectomy is occasionally
necessary for the radical surgery of hilar cholangiocel-
lular carcinoma (CC), to minimize complications after
extended hepatectomy for hilar CC; preoperative portal
vein embolization was introduced.
Materials and Methods: To compare outcomes with and
without PVE before hepatectomy for hilar CC, a retro-
spective cohort study was conducted with 35 patients
who underwent right extended hemihepatectomy for hi-
lar CC from 2001 to 2008.
Results: Preoperative PVE was performed in 14 patients
(EM group) and not in 21 patients (non-EM group). The
groups did not differ in terms of sex, age, operative time,
transfusion, postoperative serum bilirubin level, pro-
thrombin time, and length of intensive care unit (ICU)
stay. Although blood loss was higher in the EM group
than in non-EM group (P = 0.009), no major compli-
cations were observed after embolization before resec-
tion. At presentation, future liver remnant was smaller in
the EM group (19.8%, range 16–35%) than in non-EM
group (28.3%, 15–47%; P = 0.001). After embolization,
future liver remnant increased signiﬁcantly to 27.2%
(range, 23–42%; P = 0.001). Preoperative future liver
remnants were similar in both groups (P > 0.99). There
was no signiﬁcant difference in terms of the rate of
morbidity and in hospital mortality. No statistically sig-
niﬁcant differences were observed in disease-free survival
(P = 0.66) and overall survival (P = 0.33).
Conclusion: PVE don’t increase the rate of morbidity, in
hospital mortality, the local recurrence and system
metastasis, therefore it will be safe and effective for pa-
tients with small future liver remnants. Especially in pa-
tients with marginal future liver remnants, embolization
can lessen postoperative liver failure and widen the
indication of the surgical resection.
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QUALITY OF LIFE FOLLOWING LIVER
TRANSPLANTATION IN PATIENTS
WITH LIVER METASTASES FROM
COLORECTAL CARCINOMA – LONG
TERM FOLLOW-UP
A. Foss1, M. H. Andersen1, S. Dueland2, M. Hagness1,
T. Vidnes1, E. Drolsum Finstad1 and A. Klopstad Wahl3
1Oslo University Hospital-Rikshospitalet; 2Oslo University
Hospital-Radiumhospitalet; 3Oslo University
Background: Life expectancy in patients with unresec-
table liver metastasis from colorectal cancer is limited
(mean, 25 months). In a liver transplantation (Ltx) study,
using mTOR-inhibitor as immunosuppression, we as-
sessed survival and quality of life (QOL) in patients
transplanted for liver metastases from colorectal carci-
noma.
Methods: In a prospective pilot study, selected patients
with unresectable liver metastases were treated with Ltx
and sirolimus (mTOR inhibitor) as maintenance immu-
nosuppression. Major inclusion criteria were liver only
metastases determined by CT-, PET- scans and colo-
noscopy, chemo-response, ECOG 0–1 and ineligibility
for liver resection. QOL was assessed by the EORTC-
C30 questionnaires at baseline, and 3, 6 and 12 months
after Ltx.
Results: Median age at time of Ltx was 56 years (50–
63 years). Overall survival at one year was 90% (one
patient died due to recurrent disease at 6 months post
transplantation). Physical Function Score at baseline, 3,
6 and 12 months post transplantation was 87 (47–100),
87 (40–100), 93 (28–100) and 87 (47–100), respectively.
Global Health Score at the same time points was 70 (33–
100), 75 (33–83), 83 (50–100) and 83 (25–100), respec-
tively.
Median EORTC-C30 scores at baseline and at 3, 6 and
12 months
Baseline
(n = 10)
3 months
(n = 10)
6 months
(n = 9)
12 months
(n = 9)
Global QoL 70 (33.3–100) 75 (33.3–83.4) 83.3 (50–100) 83.3 (25–100)
Functional scales
Physical 86.7 (46.7–100) 86.7 (40–100) 93.3 (28.5–100) 86.7 (46.7–100)
Cognitive 91.7 (33.3–100) 100 (66.6–100) 100 (33.4–100) 86.7 (50–100)
Emotional 87.5 (25–100) 79.2 (8.3–100) 91.7 (25–100) 91.7 (33.3–100)
Social 75 (0–100) 83.4 (16.7–100) 66.7 (0–100) 83.4 (0–100)
Symptom scales
Fatigue 22.2 (0–66.7) 22.2 (0–77.8) 22.2 (0–44.4) 33.3 (0–88.9)
Pain 0 (0–83.4) 16.7 (0–83.4) 16.7 (0–50) 0 (0–83.4)
Single items
Dyspnoea 0 (0–33.3) 33.3 (0–66.7) 33.3 (0–33.3) 33.3 (0–66.7)
Insomnia 0 (0–100) 0 (0–66.7) 33.3 (0–66.7) 33.3 (0–100)
Diarrhoea 0 (0–33.3) 33.3 (0–33.3) 33.3 (0–66.7) 33.3 (0–100)
Conclusion: Nine out of 10 patients with liver metastases
from colorectal carcinoma treated with Ltx and sirolimus
as immunosuppression was alive at one year post trans-
plantation and with improved QOL compared to base-
line.
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RESULTS OF LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA IN
HIV INFECTED CIRRHOTIC PATIENTS
E. Vibert1,2,3, J.-C. Duclos-Vallee1,2,3, D. Azoulay1,
M. R. Ghigna1, C. Guettier2,3,4, E. Hoti1, D. Samuel1,2,3,
D. Castaing1,2,3 and R. Adam1,5,6
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France; 2INSERM, U785, Villejuif, France;
3Univ Paris-Sud, UMR-S 785, Villejuif, France; 4AP-HP
Hopital de Biceˆtre, Laboratoire Anatomie Pathologique,
Le Kremlin Bicetre, France; 5INSERM, U 776, Villejuif,
France; 6Univ Paris-Sud, UMR-S 776, Villejuif, France
Introduction: Liver disease is a major cause of mortality
in HIV infected patients. While liver transplantation (LT)
has become a accepted therapy for end-stage liver disease
in this population, this treatment is debatable for hepa-
tocellular carcinoma (HCC).
Aim: We report here long-term results of LT for HCC in
HIV+ patients.
Methods: From 2003 to 2008, 21 HIV+ patients with
HCC were listed for LT. Characteristic of patients at
listing and at transplantation, rate of drop-out; patho-
logical features and long-term results were compared to
that of 65 HIV- patients. Pathological features of the
HCC were analyzed by two pathologists. Uni- and mul-
tivariate analysis for overall survival (OS) after LT and
for recurrence free survival (RFS) were made to identify
the impact of HIV infection.
Results: At listing, HIV+ were younger than HIV-
(49 ± 5 vs. 56 ± 8 years, P < 0.001) with a higher AFP
(436 ± 1552 lg/L vs. 55 ± 105 lg/L; P = 0.04). No
other differences were noted. There was a trend for
higher drop-out in HIV+ (5/21–23%) vs. (6/65–9%);
P = 0.08. After waiting-times of 6.8 ± 8.4 vs.
3.8 ± 4.3 months (P = 0.18), 16 HIV+ and 57 HIV-
patients were transplanted with similar rate of pre-
transplant AFP (248 ± 622 lg/L vs. 547 ± 1649 lg/L;
P = 0.73). Two-month post-operative (po) mortality
was similar (1/15 vs. 2/53, P = 0.2). No signiﬁcant dif-
ference was seen concerning pathological feature of
HCC. With a mean of follow-up of 32 ± 21 vs.
39 ± 21 months (P = 0.24), OS after LT at 1 and 3 year
was 81% and 74% in HIV+ vs. 92% and 85% in HIV-
(P = 0.07) respectively. RFS at 1 and 3 year was 68%
and 68% in HIV+ vs. 89% and 84% in HIV- (P = 0.10)
respectively. At uni- and multivariate analysis, none
preoperative or histological parameters were retrieved as
prognostic factor for OS or RFS, notably HIV status.
Conclusion: A trend for higher rate of drop-out and
lower survival rate were observed in HIV+ patients.
While the reasons need further evaluation, there is pres-
ently no objective argument to contraindicate LT in these
patients.
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EXTENDED-RIGHT SPLIT LIVER
ALLOGRAFTS OFFER EXCELLENT
OUTCOMES IN CAREFULLY SELECTED
DONORS
T. M. Earl, N. Vachharajani, C. D. Anderson,
M. B. Doyle, J. A. Lowell, S. Shenoy, J. R. Wellen,
S. L. Logan and W. C. Chapman
Washington University/Barnes-Jewish Hospital, St. Louis
Background: Split liver transplantation is a widely ac-
cepted practice to increase the pediatric donor pool and
provide quality grafts to pediatric recipients. The out-
comes of adult recipients of split grafts, however, remain
controversial.
Aims: Evaluate the outcomes of adult recipients of
cadaveric split liver allografts.
Methods: Retrospective analysis of all adult recipients of
whole organ and cadaveric split liver allografts at a sin-
gle-center from 2003 to 2009.
Results: During the study period 482 adult liver trans-
plants were performed. Seventeen of these utilized a split
allograft all of which were extended-right grafts. Mean
age of the split graft recipients was 52 ± 11 years with
an average MELD of 18.8 ± 3.4. There was no pre-
dominant etiology of liver disease noted. Arterial con-
duits were utilized in 4/17 (23.5%) split graft recipients.
The mean donor age of split allografts was
22.1 ± 11.1 years and the average donor BMI was
22.3 ± 3.0. One and three year patient survival for split
vs. whole-organ grafts was 93.3% vs. 90.0% (one-year)
and 93.3% vs. 84.6% (three-year) respectively (P = 0.29,
log-rank test). One and three year graft survival for split
vs. whole-organ grafts was 93.3% vs. 87.4% (one-year)
and 93.3% vs. 80.8% (three-year) respectively (P = 0.19,
log-rank test). Bile leak occurred in 11.8% of split allo-
grafts vs. 9% of whole organ grafts (P = 0.65, Fisher’s
exact). Biliary strictures occurred in 6% of whole organ
recipients and none were noted in the recipients of split
grafts. There were no instances of hepatic artery throm-
bosis or hemorrhage requiring re-exploration in split
graft recipients.
Conclusion: Despite the need for complex arterial
reconstruction, extended-right split liver allografts in
carefully selected donors can offer excellent outcomes
and similar biliary morbidity when compared to whole
organ transplants.
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SPLIT-LIVER TRANSPLANTATION IN
ARGENTINA: A MULTICENTER STUDY
G. R. Bianco1,2, E. De Santiban˜es3, F. J. Mattera3,
L. G. Podesta4, G. Gondolesi4, J. Lendoire5, V. Garay5,
O. C. Andreani6, M. Fauda6, A. Casavilla2,
L. McCormack7 and O. C. Imventarza1,5
1Hospital J. P. Garrahan; 2Instituto Argentino de
Diagno´stico y Tratamiento; 3Hospital Italiano de Bs As;
4Fundacion Favaloro; 5Hospital Argerich; 6Hospital
Universitario Austral; 7Hospital Alema´n
Background: Split-livers transplantation (SLT) expands
donor pool while organ demand continues unsatisﬁed.
Aim: Multicenter experience in SLT in our country with
a long follow-up is presented.
Methods: Descriptive, retrospective and observational
study: We analyzed donors and recipients proﬁle, wait-
ing-list status, graft’s types, vascular and biliary compli-
cations, patients and graft survival.
Results: From January 1988 to July 2009 2323 patients
were transplanted: 96 (4%) with SLT from 48 cadaveric
donors. Mean follow-up: 56 months (1 day–
208 months). Donor’s mean age: 21 years (14–45 years),
weight 75kg (35–120 kg). 90% of livers (43) were divided
into left lateral segment (LLS) + extended right lobe
(ERL), four LLS + right lobe (RL) and one RL + left
lobe. "Ex-situ’’ technique: 28 (58%) cases and ‘‘in-situ"
20. No ABO incompatible livers. Recipient’s mean age
11 years (4 months–67 years), mean weight: 32kg (5.8–
90 kg): 56 (58%) were pediatrics (PED) and 40 adults
(AD). Donor to recipient weight ratio: 4.6 (0.7–12). Were
36 (38%) patients in emergency and 60 in elective/
MELD-PELD status. Complications: Hepatic artery
thrombosis (HAT) in 12 patients (12.5%): ﬁve AD and
seven PED; portal vein thrombosis in 4 (4%): one AD
and three PED. One PED patient developed hepatic vein
thrombosis. Biliary complications were 28 (29%): 17
(18%) ﬁstulas and 11 (12%) stenosis, both with pre-
dominance in the PED group: 18 vs. 10. The association
with HAT was seen in ﬁve cases: four ﬁstulas and one
stenosis. Retransplantation (ReTx) rate was 9.4% (9/96):
vascular complications were the most common cause 6/9.
Actuarial patient survival at 1, 5 and 10 years was: 81, 74
and 69% respectively, while graft’s survival was: 74, 66
and 59%.
Conclusion: Overall actuarial survival of SLT patients
and grafts was comparable with other series and with
full-size liver transplantation. Vascular and biliary com-
plications had a higher incidence and represented the
most common cause of graft loss. SLT is safe with good
results, and effective to increase the donor pool.
Abstracts74
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
MO-37
EVOLUTION OF COMPLICATIONS AND
MORTALITY OF LIVING LIVER
DONATION IN EUROPE
R. Adam1, V. Karam1, V. Delvart1, L. Fischer2,
M. Kilic3, J. Lerut4, P. Neuhaus5, P. Kalicinski6,
D. Castaing1, B. De Hemptinne7, O. Boillot8, Y. Tokat9,
J. Klempnauer10, J. O’grady11, Y. Revillon12,
J. Belghiti13, A. Burroughs14, All ELTR centers are listed
at15
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France; 2Universitatskrankenhaus Eppendorf,
Transplantation Center, Dept. of Hepatobiliary Surgery,
Hamburg, Germany; 3Ege University Medical School,
Department of Surgery - Division of Hepatobiliary and
Liver Transplantation, Izmir, Turkey; 4Catholic
University of Louvain, Cliniques Universitaires Saint Luc,
Brussels, Belgium; 5Charite´- Campus - Virchow klinikum,
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Transplantation - 9th Floor Surgery, Royal Free Hospital,
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Chirurgie Digestive, Hospital Beaujon, Paris, France;
14Liver Transplantation and Hepatobiliary Medicine,
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Background and Aim: Because donor hepatectomy-re-
lated complications or mortality are critical issues of
living donor liver transplantation, we performed an
analysis of European Liver Transplant Registry data to
provide information from a large multicenter cohort of
living donation.
Patients and methods: From October 1991 to December
2008, 3115 LDLT were performed in 76 European cen-
ters. We compared from two chronological periods
(1991–2000 and 2001–2008) the evolution of the inci-
dence of two-month post-hepatectomy donor mortality
and complications according to the Clavien grading
system (Grade I–II: complication requiring either no
treatment or symptomatic; Grade III–IV: complication
requiring interventional treatment; Grade V: death of
donor). The type of graft (RLV: right liver, LLV: left
liver) was also considered in the analysis.
Results: Overall, donor mortality has declined after 2000
(0.1 vs. 1%, P < 0.03). Six of the 7 donors’ deaths have
occurred after a RLV donation. No donor mortality was
reported for a LLV donation after 2000. Early compli-
cations have similarly declined after 2000 (12 vs. 19%,
P < 0001). This decline was highly signiﬁcant in RLV
(15 vs. 29%, P < 0.001), mainly for biliary complica-
tions (5 vs. 11%, P < 0.002). The same decline was ob-
served for LLV (7 vs. 14%, P < 0.002) but not for
biliary complications. According to the Clavien grading
system, the incidence of Grade III-IV complications has
not changed after 2000, neither in RLV, nor in LLV
donors. However, the incidence of Grade I-II complica-
tions has dramatically decreased for RLV (11 vs. 23%,
P < 0.001) and for LLV (5 vs. 12%, P < 0.001).
Conclusion: Donor mortality have signiﬁcantly de-
creased from 2000 to only 0.1% overall, and none for the
left liver. This improvement could be attributed partially
to a better management of surgical complications,
including reoperation and transplantation as the last
solution. More improvements are still necessary to fur-
ther reduce complications in RLV.
MO-38
ENDOSCOPIC FEATURES OF
HYPERACUTE REJECTION IN
MULTIVISCERAL
XENOTRANSPLANTATION
F. H. Galva˜o, A. R. Teixeira, D. Waisberg,
R. Castro-Galva˜o, A. Queiroz, F. J. Carrilho and
L. A. Carneiro D’Albuquerque
University of Sa˜o Paulo
Aims/Background: Interspecies transplantation is a po-
tential solution for the shortage of organs donors, mainly
in multivisceral transplantation; however, hyperacute
rejection limits this practice. We recently described a
model of multivisceral xenotransplantation. This report
describes the endoscopic ﬁnds of hyperacute rejection in
stomach, small bowel and large bowel.
Method: We removed from rabbits a cluster with the
distal esophagus, stomach, intestine, colon, liver, pan-
creas and the kidneys in a common vascular pedicle and
implanted heterotopically in the abdomen of pig (exper-
imental group, n = 6) or rabbit (control group, n = 4).
We performed serial endoscopy in the stomach, jejunum
and ascending colon in four periods: at the back table
after graft vascular perfusion with cold Lactate Ringer,
10, 60 and 180 after reperfusion. We graduate the lesion
in mild (edema of mucosa, petechias and inﬂammation)
mild (the previous features plus mucosal hematoma and
thrombosis) and severe, where hemorrhage and necrosis
is observed.
Results: At 10 min the stomach presented mild hyper-
acute rejection, while jejunum and colon achieved normal
appearance. At 60 min we observed moderate hyperacute
rejection in stomach and mild in jejunum and colon. At
120 min the stomach presented severe hyperacute rejec-
tion, while jejunum and colon achieved moderate degree.
Histopathology of the viscera conﬁrmed the diagnosis of
hyperacute rejection. Differently, grafts from group two
animals presented absence of endoscopic diagnosis of
hyperacute rejection.
Conclusion: The present model is a new relevant instru-
ment to study the endoscopic ﬁnds of hyperacute rejec-
tion in stomach, small bowel and large bowel. The
stomach appears to be more sensitive to rejection in this
model of xenotransplantation.
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MANAGEMENT OF COLORECTAL
LIVER METASTASES IN THE ELDERLY
PATIENT: A DECISION ANALYSIS
S. Yang1, S. Alibhai2, E. Kennedy2, N. Coburn1 and
C. Law1
1Sunnybrook Health Sciences Centre, Toronto, Canada;
2University Health Network, Toronto, Canada
Background: Our population is aging rapidly and the
incidence of liver metastases (LM) from colorectal cancer
(CRC) is on the rise. When invasive strategies are con-
sidered, elderly patients are frequently subject to under-
treatment both due to perceived risks of therapy and
under-representation of the elderly in clinical trials.
Commonly employed alternative strategies to hepatic
resection (HR) are best supportive care (BSC), systemic
chemotherapy (SC), and radiofrequency ablation (RFA).
Objective: The present study aims to develop a decision-
analytic model to quantify outcomes associated with
common treatment strategies for LM in elderly patients.
Methods: A Markov decision model was built to exam-
ine the effect on quality-adjusted life expectancy (QALE)
and life expectancy (LE) of four strategies – BSC, SC,
RFA, and HR. The baseline cohort included healthy 70-
year old patients presenting with LM following primary
resection for CRC potential treatable by all strategies. All
event and transition probabilities as well as utilities were
derived from a comprehensive review of the literature.
Deterministic and probabilistic sensitivity analyses were
performed on all study parameters to assess the strength
of the model.
Results: In the base case analysis, BSC, SC, RFA, and
HR yielded QALE of 7.9, 15.3, 27.9, and 34.5 months,
and LE of 11.3, 25.9, 38.0, and 40.1 months, respectively
(Table 1). The model was sensitive to the probability of
recurrence after hepatic resection, with RFA becoming
the preferred strategy if monthly probability of recur-
rence is greater than 6.1%. In probabilistic sensitivity
analysis, HR is preferred 70.1% of the time and RFA is
preferred 29.9% of the time.
Table 1. Expected value from base case deterministic
analysis
Treatment Strategy LE (months) QALE (months)
Best supportive care 11.3 7.9
Systemic chemotherapy 25.9 15.3
Radiofrequency ablation 38.0 27.9
Hepatic resection 40.1 34.5
Conclusion: The present model suggests that hepatic
resection is the optimal treatment strategy for elderly
patients with liver metastases. However, in older patients
who have less favorable tumour characteristics, RFA
may provide better QALE then other strategies.
MO-44
ROLE OF LIVER RESECTION IN
SUCCESSFUL LONG-TERM SURVIVAL
OF PATIENTS WITH CANCERS
DEVELOPING LATE HEPATIC
METASTASIS
M. Caralt1, J. Martı´2, I. Bilbao1, G. Sapisochin1,
R. Rodriguez1, L. Blanco1, C. Dopazo1, J. L. Lazaro1,
J. Fuster2, C. Fondevila2, J. C. Garcia-Valdecasas2 and
R. Charco1
1HBP Surgery and Transplants Department, Hospital
Universitari Vall d’Hebron, Barcelona, Spain; 2Liver
Surgery and Transplant Unit. IMDiM. Hospitla Clı´nic,
Barcelona, Spain
Background: Certain tumors such as melanoma or breast
cancer may develop metastases late after the primary
treatment and are classically considered incurable.
Therefore, these cancers are likely to develop metastases
to the liver over the years. Surgery has an important role
in the case of melanoma due to little response of systemic
therapies and is an essential part in the oncosurgical
treatment of breast cancer liver metastases (BCLM).
Aims: To analyze the outcome of patients undergoing
liver resection for melanoma and BCLM.
Patients and methods: Patient selection criteria were:
good performance status, the feasibility of a complete
and safe surgical procedure, and absence of uncontrolled
extrahepatic metastases. Data was collected prospectively
and analyzed retrospectively.
Results: Between 1988 and 2007 26 patients underwent
liver resection for BCLM and melanoma metastases.
Patients with BCLM and melanoma metastatic to the
liver
BCLM MELANOMA
Number of patients 12 14
Median follow-up 35.9 months
(r 12–113.4)
26.6 months (r 0.5–103.5)
Median age 58.4 years (r 36–76) 49.5 years (r 25–68)
Synchronous metastases 2 2
Major hepatectomy 6/12 (50%) 9/14 (64.3%)
Postoperative morbidity 2/12 (16.6%)
(biliary leak)
5/14 (35.7%) (biliary leak,
pneumothorax, pneumonia,
urinary infection)
Postoperative mortality 0% 1/14 (7.1%) (cerebral
vasular accident)
Recurrence
Liver – Systemic
7/12 (58.3%)–3/12 (25%) 46.2%–76.9%
Actuarial Survival
1-, 3- 5-year
100%, 79%, 33% 77%, 49%, 49%
Conclusions: Resection of breast cancer and melanoma
metastasis to the liver may improve survival in selected
patients.
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DETECTION OF CELL-FREE TUMOR
DNA IN PLASMA AS A BIOMARKER OF
PRESENCE OF LIVER METASTASES IN
COLORECTAL CANCER PATIENTS
L. Lipska1, L. Benesova2, B. Belsanova2,
P. Minarikova3,4, G. Veprekova3,4, S. Suchanek3,4,
V. Visokai1, M. Levy1, M. Zavoral3,4 and M. Minarik2
1Thomayer University Hospital/Department of Surgery,
Videnska 800, CZ14059 Prague 4; 2Genomac
International/Center for Applied Genomics of Solid
Tumors, Bavorska 856, CZ15541 Prague 5; 3Institute for
postgraduate medical education/Department of
gastroenterology, Ruska 85, CZ10005 Prague 10; 4Charles
University/Internal Clinic, 1st Faculty of Medicine,
U Vojenska nemocnice 1200, CZ16902 Prague 6
Background: Metastatic liver disease from colorectal
cancer progression is a signiﬁcant oncologic problem
with hepatic resection as the main form of treatment.
Non-invasive screening of molecular biomarkers may
enable effective surgical intervention through an early
diagnosis of the disease.
Aims: To investigate presence of cell-free tumor DNA
and its correlation to clinical status of the patient, espe-
cially metastatic liver disease.
Methods: In a prospective study cohort of 46 patients we
have initially acquired a tissue samples from primary
tumor (n = 46) where available, additional tissue was
collected from nodes and liver metastases. For each pa-
tient, multiple plasma samples (n = 100) were acquired
over a period covering (i) initial examination, (ii) imme-
diately preceding the surgery, (iii) at the surgery, (iv)
post-surgery and (v) during a subsequent follow-up. We
have used the most frequent colorectal somatic mutations
(APC, TP53 and KRAS) detected in primary tumors to
trace cell-free tumor DNA in plasma samples.
Results: A total of 20 patients (20/46, 43.5%) had so-
matic mutation in primary tumor, of which nine were
diagnosed with liver metastases (9/20, 45%). Where
available, mutation from primary tumor was also con-
ﬁrmed in the metastatic liver tissue (4/4, 100%). Cell-free
tumor DNA was detected in plasma of 8 out of 9 patients
with liver metastases (88.9%). None of the patients with
non-metastatic disease had positivity in any of the plas-
ma samples (0/11, 0%). In two patients positivity was
detected in subsequent plasma samples, following the
course of the disease development.
Conclusion: Our results indicate a potential for the
detection of cell-free tumor DNA as a non-invasive test
of metastatic liver disease. Somatic mutations in addi-
tional genes (BRAF, PIK3CA) are now being explored as
markers to increase the number of patients that can be
evaluated from cell-free tumor DNA. Supported by
Czech Ministry of Health grant no. NS9809.
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SAFETY OF ADDITION OF BIOLOGICAL
AGENTS TO STANDARD
CHEMOTHERAPY PRIOR TO LIVER
RESECTION
K. Bowers, G. Bond-Smith, D. O’reilly and R. Hutchins
Royal London Hospital
Background: In the USA 150 biological agents are cur-
rently licensed with over 500 in development. It is still
contentious as to what degree pre-operative chemother-
apy affects the morbidity and mortality of liver resection.
Chemotherapy is known to cause chemotherapy-associ-
ated liver injury. As larger numbers of patients receive
biological agents in conjunction with standard chemo-
therapy regimens prior to liver resection, the effect on
morbidity and mortality post operatively, needs to be
established.
Aim: To assess the safety of the addition of biological
agents to standard chemotherapy prior to liver resection.
Method: Data was analysed from a prospective database
of 220 consecutive liver resections by a single HPB con-
sultant surgeon between 2004 and 2009. Twenty two
patients received a biological agent, in addition to con-
ventional chemotherapy prior to liver resection (group
A). This group was compared to 58 patients who received
conventional chemotherapy alone (group B).
Results: The median age was group A 62 years (range
55–75) and group B 58 years (range 40–84). The F:M
ratio was group A 9:13 and group B 23:35. 10/22 patients
(45.5%) underwent major liver resections (three or more
segments) in group A and 26/58 patients (44.8%) in
group B (P = 1.00). Inﬂow occlusion was used in only
one patient in group A and 10 patients in group B.
Median operative time was group A 195 min (range 60–
420) and group B 210 min (range 30–510). Median blood
loss was group A 225 mL (range 0–3000) and group B
300 mL (range 0–3000). Median blood transfusion in
both groups was 0 units (range 0–5). Morbidity in group
A was 36% and in group B 24% (P = 0.28). 90-day
mortality was zero. Median length of stay was group A
11 days (range 5–27 days) and group B 10 days (range 5–
26 days).
Conclusion: The addition of biological agents to con-
ventional chemotherapy, appear not to affect the early
outcome of liver resection.
MO-47
LONG-TERM RESULTS OF SURGICAL
TREATMENT OF LIVER AND LUNGS
COLORECTAL METASTASES
A. Vishnevsky, V. Vishnevsky, D. Ionkin and
M. Pikynov
A.V. Vishnevsky Institute of Surgery
Aim: Improvement the results of treatment of patients
with liver and lungs colorectal metastases.
Methods: Seventy nine patients (25–69 years) with colo-
rectal metastases were operated on. Primary bowel tumor
was surgically removed. In 20% lungs and liver metas-
tases were detected in one stage with large intestine tu-
mor, at 80% in 6 and more months after operation on
large intestine. All patients had polychemotherapy; 42 –
surgically procedures about secondary combined lungs
and liver lesions, from them colorectal metastases were in
30 cases in liver and in one lung; in liver and in both lungs
– 12.
The sequence of operations:
1. one-stage removal of metastases from liver and lung
[6 (14.4%) patients];
2. Liver metastasectomy, in 2–3 weeks from one lung
[25 (59.5%)];
3. Liver metastasectomy, in 2–3 weeks from both
lungs in one-stage [8 (19%)];
4. Liver metastasectomy, in 2–3 weeks from one lung
and through 2-3 weeks contrlateral lung [3 (7.1%)].
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The extent liver resection: 21 (50%) hemihepatectomies;
9 (21.4%) extended hemihepatectomies; 6 (14.2%) tri-
sectionectomies; 6 (14.2%) bisectionectomies. The extent
lung resection: 21 (53.8%) precision (laser, coagulation)
metastasectomy; 14 (36.9%) marginal or atypical sublo-
bar machine lung resection; 2 (5.1%) lobectomy; 2
(5.1%) videothoracoscopic lung resection.
Results: The survival median – 24 months Life expec-
tancy: 1 year–80%; 3–21%; 5–45%.
Conclusion: The best results of treatment of liver and
lungs colorectal metastases were in group underwent liver
resection and metastasectomy from lungs in 2–3 weeks,
especially at those patients when the secondary tumors
have been detected only after 6 and more months after
surgically removal of a primary.
MO-48
TREATMENT OF BREAST CANCER
LIVER METASTASES: IS SURGERY A
SUITABLE OPTION?
D. Czarnevicz, G. Andreoli, F. Estallano, J. Zeballos
and S. Cubas
Department of Surgery IMPASA, Montevideo, Uruguay
Background: Hepatic resection is an established modality
of treatment for colorectal cancer metastases, but resec-
tion of breast cancer liver metastases remains contro-
versial.
Aims: Asses the outcome and prognostic factors of liver
surgery for breast cancer metastases.
Method: Twenty one patients with liver metastases from
previously treated breast cancer were referred for hepatic
resection between 2001 and 2008. All patients complete
systemic therapy before hepatic resection. The median
follow-up was of 48 months. Statistical analysis was
made by means of v2 test, Kaplan-Meier method for
survival probabilities, log-rank test to compare different
prognosis factors and a stepwise Cox proportional haz-
ard regression model to assess independent factors.
Results: We performed 12 major and nine minor hepa-
tectomies with no mortality or major morbidity (onr
patient with perihepatic collection). 29% of the patients
had positive resection margins (R1 in 4 and R2 in 2) and
9 patients had recurrence within 24 months. The median
survival was 37.6 months, and the overall 2- and 5-year
survival rates were 67% and 38%, respectively, whereas
the median and the 2- and 5-year disease-free survival
rates were 20 months and 52% and 19%, respectively.
Study variables independently associated with poor sur-
vival were failure to respond to preoperative chemo-
therapy (P = 0.007), and positive resections margins
(P = 0.002).
Conclusion: Hepatic resection for breast cancer liver
metastases is a safe procedure with low morbidity and
mortality, and must be considered as one part of a
multimodal treatment of the metastatic disease. Surgery
is not only a suitable option but rather a compelling
option. If preoperative chemotherapy response and the
achievement of a curative resection represent ﬁtting cri-
teria to select patients for liver resection must be clarify
by further investigations.
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THE SIGNIFICANCE OF
PERIOPERATIVE TUMOR MARKERS
SERUM LEVELS FOR THE PROGNOSIS
OF PATIENTS WITH LIVER
METASTASES
V. Treska1, O. Topolcan2, V. Liska1, L. Holubec2,
J. Vrzalova2 and T. Skalicky1
1Department of Surgery, University Hospital Pilsen;
2Department of Immunoanalysis, University Hospital,
Pilsen
Background: Recurrence of tumor process develops in
various organs in almost 60% of patients after liver
surgery for colorectal (CLM) and non – colorectal liver
metastases (NCLM). Unfortunately the diagnosis of tu-
mor recurrence is late in majority of patients.
Aim: To assess the signiﬁcance of preoperative and
immediate postoperative tumor markers serum levels for
early detection of tumor recurrence and patient survival
after surgery for liver metastases.
Methods: In the prospective non-randomized study pre-
operative and immediate postoperative serum levels of
carcinoembryonic antigen -CEA, CA 19–9, CA 72–4,
thymidine kinase (TK), tissue polypeptide antigen (TPA)
and tissue polypeptide speciﬁc antigen (TPS) were eval-
uated in 175 patients operated on for CLM and NCLM.
Results: Preoperative levels of CEA (P < 0.01), CA 19–
9 (P < 0.04), CA 72–4 (P < 0.01), TPS (P < 0.0002),
TPA (P < 0.0001) in patients operated on for CLM and
preoperative levels of CEA (P < 0.07), TPS (P < 0.009)
and TPA (P < 0.03) in patients operated on for NCLM
were important for patients survival. The signiﬁcant
relation between tumor markers and DFI in patients with
CLM was only in TK (P < 0.007). In patients with
NCLM there was signiﬁcant relation between DFI and
TPA and TPS (P < 0.03, P < 0.04).
Conclusion: For early detection of CLM, as well as
NCLM recurrence only preoperative TK, respectively
TPS and TPA and postoperative CEA levels are impor-
tant. All preoperative tumormarkers inCLM, respectively
CEA, TPS and TPA in NCLM and postoperative CEA
levels in both groups are important for patients survival.
Sponsored by Research Project IGA MZ NS 9727-4 and
NS 9723-4.
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SIMULTANEOUS LIVER AND
COLORECTAL ONCOLOGIC
RESECTIONS: SAFE ALTERNATIVE FOR
THE TREATMENT OF SYNCHRONOUS
COLORECTAL LIVER METASTASIS
E. Norero, E. Figueroa, J. Martinez, J. F. Guerra,
R. Funke, G. Pinedo, M. E. Molina, A. Zun˜iga,
C. Bambs, S. Guzman and N. Jarufe
Hospital Clinico Pontiﬁcia Universidad Cato´lica de Chile,
Department of Digestive Surgery
Background: Simultaneous colonic and liver resection is
controversial in patients with synchronous colorectal li-
ver metastases (CRLM).
Aim: To compare the postoperative outcomes after
simultaneous and staged colorectal and hepatic resec-
tions for CRLM.
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Methods: Postoperative outcomes of patients who
underwent simultaneous or staged colorectal and hepatic
resections for CRLM between 1990 and 2009 were ret-
rospectively reviewed. Resections were performed by two
surgical teams. Results were compared according to
number of liver segments resected; divided in three
groups; wedge resection, resection of 1–2 segments and 3
or more segments.
Results: Ninety three liver resections were included (men
64, age 61 ± 13 years). A simultaneous surgery was
performed in 31 cases and staged in 62. In patients with
simultaneous surgery we performed 12 liver wedge
resections, resections of 1–2 segments in 10 cases and
resections of 3 or more segments in 9. The simultaneous
surgery group was associated with a greater number
resections of less than three segments (71% vs. 48%;
P = 0.03). Patients with postoperative complications
after simultaneous surgery had more liver segments re-
sected (3.7 vs. 1, P = 0.0001) and more red blood cell
transfusions (1.2 vs. 0.2, P = 0.013). When comparing
simultaneous and staged surgery we did not ﬁnd any
difference in morbidity (32 vs. 40%), mortality (0%),
intensive care unit stay (27 vs. 29%), red blood cell
transfusions (24 vs. 30%), post-operative liver function
test nor in the proportion of R0 resections (84 vs. 84%).
In resections of 3 or more segments operative time (303
vs. 241 min; P = 0.02) and hospital stay (23 vs. 12 days;
P = 0.03) was greater in the simultaneous surgery group.
Conclusions: Morbidity and mortality is similar between
simultaneous and staged liver resection. Simultaneous
resection of colorectal primary and synchronous CRLM
is a safe alternative with the beneﬁt of only one lapa-
rotomy and should be the procedure of choice in spe-
cialized centers.
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VALIDATION OF PROGNOSTIC
SCORING SYSTEMS FOR PATIENTS
UNDERGOING RESECTION OF
COLORECTAL CANCER LIVER
METASTASES
M. Koch, C. Reissfelder, M. W. Bu¨chler, N. N. Rahbari
and J. Weitz
Department of General, Visceral and Transplantation
Surgery, University of Heidelberg, Germany
Background: Several prognostic scoring systems have
been proposed for patients undergoing resection of
colorectal cancer (CRC) liver metastases. While these
scoring systems have mostly been developed at single
institutions, it has remained uncertain, if their prognostic
value also applies to external patients.
Aims/Objectives: To assess the predictive value of ﬁve
published scoring systems in an independent patient co-
hort for the purpose of external validation.
Methods: The predictive value of the Nordlinger score,
MSKCC score, Iwatsuki score, Basingstoke Index and
Mayo scoring system were assessed in 281 patients who
underwent liver resection for CRC liver metastases at our
institution. Variables included in the individual scoring
systems were analyzed in this cohort by univariate and
multivariate analyses.
Results: The disease-speciﬁc survival rates at 1-, 3-, and
5-years were 94.6%, 61.8% and 33.7%, respectively. The
MSKCC score (P = 0.006) and the Iwatsuki score
(P = 0.01) were the only classiﬁcations that provided a
statistically signiﬁcant stratiﬁcation of patients regarding
survival. The predictive value was particularly evident for
patients grouped within the high-risk categories. While
none of these patients was alive at three years after sur-
gery, the 3-year survival rates for high-risk patients in the
remaining three scoring systems exceeded 50%.
Conclusions: In the present validation analysis using an
independent patient population, survival was predicted
only by the MSKCC score and the Iwatsuki score.
Additional studies should assess the prognostic value of
available scoring systems in further independent cohorts
to achieve higher levels of validation.
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NATIONAL TRENDS IN DISCHARGE
DISPOSITION FOLLOWING HEPATIC
RESECTION FOR MALIGNANCY
B. Shah1, F. Ullrich2, P. Leiphrakpam1, Q. Ly1,
A. Sasson1 and C. Are1
1Eppley Cancer Center, University of Nebraska Medical
Center, Omaha, Nebraska; 2Department of Biostatistics,
College of Public Health, University of Nebraska Medical
Center, Omaha, Nebraska
Background: There is a paucity of data on the trends in
discharge disposition for patients undergoing hepatic
resection for malignancy.
Aim: The aim of this study was to analyze the national
trends in discharge disposition following hepatic resec-
tion for malignancy.
Methods: The National Inpatient Sample database was
queried (1993 to 2005) to identify patients that underwent
hepatic resection for malignancy. The status of patients
at discharge (routine, home health or other facility) was
noted.
Results: A weighted total of 74,520 patients underwent
hepatic resection of whom, 53,770 patients had a prin-
cipal diagnosis of malignancy. The overall mortality
improved from 6.3% to 3.4% over the period of the
study. After excluding patients that died in the post-
operative period and those with incomplete discharge
National trends in discharge dispostion following hepatic
resection for malignancy
Year
Patient Disposition
Routine Other Facility Home Health Care
1993 89.2% 2.0% 8.9%
1994 87.2% 3.0% 9.8%
1995 81.8% 3.9% 14.3%
1996 80.3% 4.2% 15.6%
1997 85.0% 4.3% 10.8%
1998 78.3% 5.6% 16.1%
1999 85.2% 6.1% 8.8%
2000 81.4% 6.0% 12.6%
2001 82.2% 5.7% 12.1%
2002 85.2% 4.3% 10.5%
2003 74.9% 6.3% 18.8%
2004 80.0% 5.6% 14.5%
2005 80.5% 5.7% 13.8%
*‘‘Other facility’’ includes short-term hospital, skilled
nursing facility, intermediate care facility or another type
of facility.
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status, 45,583 patients were included. The proportion of
patients that had acute care needs preventing them from
being discharged home without assistance increased from
10.9% in 1993 to 19.5% in 2005. While there was an
increase in the number of patients discharged to home
health care during this time, there was a larger increase in
the proportion of patients that were discharged to a sub
acute facility. Despite a decrease in the mortality rates,
there was no improvement in rate of patients discharged
home without assistance over the period of the study.
Conclusion: The results of our study demonstrate that
following hepatic resection, a signiﬁcant proportion of
patients will need assistance upon discharge. This infor-
mation needs to be included in the patient counseling
during pre-operative risk and beneﬁt assessment.
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EXPERIENCE WITH SIR-SPHERES
YTTRIUM-90 MICROSPHERE
RADIOEMBOLIZATION FOR LIVER
METASTASES FROM
NEUROENDOCRINE TUMORS
J. Peterson1, L. Vallow1, D. Johnson2, M. Heckman1,
N. Diehl1, A. Gale1, K. Tzou1, S. Kim1, N. Brown2,
R. Paz-Fumagalli1 and S. Buskirk1
1Mayo Clinic Florida; 2Baptist Medical Center
Background: SIR-Spheres Yttrium-90 microsphere ra-
dioembolization has been used to improve survival in
patients with colorectal liver metastases but limited data
exists regarding its use for treatment of neuroendocrine
liver metastases.
Objectives: To assess initial response rates, overall sur-
vival, and complications in 21 patients treated with SIR-
Spheres for neuroendocrine liver metastases.
Methods: Twenty-one patients treated with SIR-Spheres
for neuroendocrine liver metastases from 2 institutions
were retrospectively reviewed. Patients underwent initial
follow up imaging with PET, CT, or MRI at a median of
73 days following SIR-Spheres. Subsequent imaging was
performed every 2–4 months. Assessment of response
was determined at the time of each imaging. The Kaplan-
Meier method was used to estimate time to occurrence of
various endpoints after SIR-Spheres. Complications were
graded according to Common Terminology Criteria for
Adverse Events, v3.0.
Results: Median length of follow up was 13.1 months.
Median prescribed dose was 41 mCi, with all patients
receiving between 91% and 112% of the prescribed dose.
Based on the initial imaging following treatment, 16 pa-
tients (76%) experienced a complete or partial response
and 3 (14%) had progressive disease. Of the patients who
achieved a complete or partial response, 17% (95% CI
[conﬁdence interval]: 0%-35%) developed progressive
disease by 6 months after treatment. At 12 months after
SIR-Spheres, the estimated overall survival was 83%
(95% CI: 66–100%). Seventeen patients (81%) experi-
enced acute post-embolization symptoms. Long term
complications included gastrointestinal ulceration (19%),
cholecystitis (5%), and liver dysfunction (5%).
Conclusions: Our results suggest SIR-Spheres Yttrium-
90 microsphere radioembolization is an effective treat-
ment for liver metastases from neuroendocrine tumors
with a good initial response rate and acceptable
toxicity.
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NEOADJUVANT CHEMOTHERAPY FOR
LIVER METASTASES FROM GASTRIC
ADENOCARCINOMA
L. Vigan1, M. Vellone2, A. Ferrero1, F. Ardito2,
A. Muratore1, F. Giuliante2, G. Nuzzo2 and
L. Capussotti1
1HPB and Digestive Surgery, Ospedale Mauriziano
Umberto I, Torino, Italy; 2Department of Surgery,
Hepatobiliary Unit, Catholic University of the Sacred
Heart School of Medicine, Roma, Italy
Background: Results of surgery in patients with liver
metastases from gastric adenocarcinoma are debated.
The role of neoadjuvant chemotherapy (NeoCTx) has
never been evaluated.
Aim: To analyse the impact of NeoCTx on outcomes of
these patients.
Methods: Data of 25 patients undergoing liver resection
for metastases from gastric adenocarcinoma between
1990 and 2008 at the Ospedale Mauriziano in Torino
and Policlinico ‘‘Gemelli’’ in Roma have been reviewed.
Patients with primary cardiac tumor have been
excluded.
Results: Gastric tumor was T4 in 5 patients and N+ in
17. Liver metastases were synchronous in 11 patients and
multiple in 7. Nine patients received NeoCTx: Oxalipla-
tin in 4, ECF in 3, PELF in 3, and Irinotecan in 1
(multiple lines in 1). Median number of cycles was 6.
Three patients had tumor progression while on NeoCTx.
Tumor characteristics were similar between NeoCTx and
non-NeoCTx groups. Simultaneous gastric and hepatic
resection was performed in 10 cases and major hepatec-
tomy in 12. Resection was radical in 23 patients (2 po-
sitive margin). Mortality was nil and morbidity was 36%
(9). Morbidity was not increased in the NeoCTx group.
After a median follow-up of 30 months, 3- and 5-year
survival rates were 61.3 and 46.7%. Three- and 5-year
disease-free survival rates were 35.1% and 35.1%. Dis-
ease-free survival was similar between patients of Neo-
CTx and non-NeoCTx groups. Patients of NeoCTx
group whose disease did not progress experienced sig-
niﬁcantly improved disease-free survival as compared to
patients of non-NeoCTx group (3-year 80.0% vs. 23.8%,
P = 0.014). Early recurrence (within 1 year) occurred in
no patient of NeoCTx group without progression, in all
patients of NeoCTx group with progression, and in 56%
of non-NeoCTx group.
Conclusions: NeoCTx is useful in selecting candidates to
liver resection for metastases from gastric adenocarci-
noma. In patient without progression, NeoCTx is asso-
ciated with improved disease-free survival.
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NEOADJUVANT TRANSARTERIAL
CHEMOEMBOLIZATION IRINOTECAN
BEADS (DEBIRI) FOR RESECTABLE
LIVER METASTASES FROM
COLORECTAL CANCER (CRC)
S. Fenwick1, H. Malik1, E. O’grady1, C. Byrne1,
P. Ghaneh1, M. Rees2, J. Figueras3, R. Adam4 and
G. Poston1
1Aintree University Hospital, Liverpool; 2North
Hampshire Hospital, Basingstoke; 3Hospital Tauli,
Girona; 4Hopital Paul Brousse, Villejuif
Background: The standard treatment for primarily
resectable livermetastases fromCRC is surgery. However,
67–85% of such patients subsequently develop hepatic
recurrence. The EORTC trial recently showed beneﬁt for
perioperative chemotherapy versus surgery alone in terms
of progression-free survival, however potential surgical
complications related to liver toxicity remains a concern.
Objectives: The purpose of this study is to evaluate safety
and efﬁcacy of DEBIRI as neoadjuvant therapy before
resection of CRC liver metastases. The primary endpoint
is percentage of patients with R0 resection. Additional
endpoints: safety; tumor response by imaging; patholog-
ical evaluation of the resected tissue; recurrence rates.
Methods: Multicentre, open label, single arm, phase II
study. Patients received DEBIRI 4 weeks prior to the
planned liver resection. All patients have metachronous
metastases following complete resection of the primary
tumour. Pathological evaluation of the resected liver was
performed.
Results: 19/20 patients have been included to date, 12
have undergone DEBIRI using an average of 100 mg of
Irinotecan per treatment. From the 12 patients included,
1 had >1 tumour. Complications observed following
embolisation included pain and post-embolization syn-
drome. All patients underwent R0 liver resection with no
associated morbidity/mortality. Pathological results
showed R0 in all patients. No chemotherapy-associated
liver toxicity was observed by pathology. Data on tumor
necrosis responses will be presented.
Conclusions: Neoadjuvant DEBIRI is both feasible and
safe in patients undergoing hepatectomy for CRC
metastases. The value of this approach to neoadjuvant
therapy versus systemic neoadjuvant therapy needs to be
tested in a prospective randomised trial.
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EFFICACY OF INTRAOPERATIVE
RADIOFREQUENCY ABLATION
COMBINED OR NOT WITH RESECTION
TO TREAT UNRESECTABLE
COLORECTAL METASTASES. THE
ARF2003 STUDY
S. Evrard1, S. Mathoulin-Pe´lissier2, M. Rivoire3,
J.-P. Arnaud4, A. Ayav5, A. Sa Cunha6, M. Fonck2,
Y. Be´couarn2, R. Brunet2 and C. Bellera2
1Institut Bergonie´ and Universite´ de Bordeaux; 2Institut
Bergonie´; 3Centre Le´on Be´rard and Universte´ de Lyon;
4CHU and Universite´ d’Angers; 5CHU and Universite´ de
Nancy 6CHU and Universite´ de Bordeaux
Background: Only few patients suffering from colorectal
metastases (CRM) can have surgery and thus hope for a
40% 5-year survival rate. Adding intra-operative
radiofrequency ablation (IRFA) to resection may im-
prove the efﬁcacy of surgery.
Aims: The primary objective was to evaluate the efﬁcacy
of IRFA combined or not with resection in terms of 3-
month complete hepatic response (CHR) in patients with
unresectable CRM. Secondary endpoints were overall
survival (OS), disease-free survival (DFS), morbidity and
quality of life.
Methods: A phase 2 study (NTC 00210106) based on a
Simon’s two-stage design was conducted in 6 university
French hospitals. Number of subjects estimated was 53,
with 19 for the 1st stage. At the end of the 1st stage, 12
CHR were required to continue recruiting. At the end of
2nd stage, 37 CHR would be required to claim efﬁcacy.
Results: Mean age 60.5 years; 7 had RFA alone (14%),
43 had RFA & resections (86%), 3 could not be treated
(5.7%). Median number of CRM was 5 (1-13). All had
chemotherapy pre-op and 21 post-op (42%). The median
follow-up was 15 months.
Mortality: One patient died of septic shock on the 3rd
week following intervention. Global morbidity was 40%,
none were reoperated on. Scans were independently
reviewed. 40 patients had CHR (75.5%; IC95% = 63.9,
87.1). One-year OS and DFS rates were 94.9% and
29.9% respectively.
Discussion: These preliminary results suggest that IRFA
combined or not to resection may be efﬁcient in treating
unresectable diseases despite their more aggressive pat-
tern. This corroborates the EORTCC CLOCC Trial
ﬁndings which demonstrated IRFA superiority upon
chemotherapy alone. IRFA could thus be valuably
associated to resection in treating patients with colorectal
metastases that resection alone could not handle.
MO-58
SURGICAL OUTCOME OF REPEAT
HEPATECTOMY FOR RECURRENT
HEPATOCELLULAR CARCINOMA
H.-J. Kim, S.-H. Park, D.-W. Hwang, D.-S. Lee and
S.-S. Yun
Yeunnam university hospital, department of surgery
Background/aims: Curative surgical resection is the most
effective treatment for hepatocellular carcinoma (HCC).
However, the long term prognosis after curative resection
remains unsatisfactory because of a high rate of intra-
hepatic recurrence. Therefore, effective treatment of int-
rahepatic recurrent HCC is very important in prolonging
prognosis after resection of HCC. The purposes of this
study were to evaluate the clinicopathologic characteris-
tics and to clarify the outcome of the patients after repeat
hepatectomy for recurrent HCC.
Materials: From March 1991 to August 2009, 33 pa-
tients underwent repeat hepatectomy for recurrent HCC
at the Yeungnam university hospital. The clinicopatho-
logic and follow-up data were evaluated retrospectively.
Results: Four hundred and seven patients underwent a
ﬁrst hepatectomy for HCC, 33 and 6 patients respectively
had a second and third hepatectomies for recurrence.
There was no signiﬁcant difference in the average of ICG
R15 between primary (11.2 ± 1.8%) and repeat hepa-
tectomy (18.2 ± 2.8%). A signiﬁcant difference was seen
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in the average of tumor size between ﬁrst (3.6 ± 0.5 cm)
and repeat hepatectomy (2.9 ± 1.9 cm). The average of
tumor number for both ﬁrst and repeat hepatectomy was
equal (1.3 ± 0.6). The mean interval between the ﬁrst
and repeat hepatectomy was 48.0 ± 33.0 months (13–
136 months). The mean survival time after ﬁrst hepa-
tectomy was 83.6 ± 36.3 months. The cumulative 1, 3, 5,
and 7 year disease-free survival rates after ﬁrst hepatec-
tomy were 100%, 62.5%, 25%, and 12.5%, respectively.
The cumulative 1, 3, 5, and 7 year survival rates after ﬁrst
hepatectomy were 100%, 100%, 85.9%, and 75.3%,
respectively.
Conclusion: The repeat hepatectomy leads to satisfactory
outcomes for selected patients with recurrent HCC.
MO-59
HEPATIC ARTERY
PSEUDOANEURYSMS: VARIED
PRESENTATION
A. K. Agarwal, S. Agarwal, M. Nayeem, M. Gupta,
H. H. Nag, S. Tyagi, V. Trehan and S. Naik
GB Pant Hospital & MAM College, Delhi University
Background/Aim: Hepatic artery pseudoaneurysm is an
uncommon cause of hemobilia. The diagnosis may be
difﬁcult due to its varied presentation. The clinical pre-
sentation and management of 7 patients with hepatic
artery pseudoaneurysm is described.
Materials and methods: Prospectively collected data of
seven consecutive patients of hepatic artery pseudoan-
eurysms who presented to us between 2002–2008 were
studied.
Results: Male: female ratio was 4:3. Median age was
24 years (range 9–50 years). The etiology was post cho-
lecystectomy bile duct injury (2) patients, liver abscess (2)
patients, blunt trauma abdomen, hydatid disease liver,
and chronic pancreatitis in one patient each. Clinical
presentation was with obstructive jaundice in 2 patients,
melena with mild jaundice in 2 patients, hematemesis/
melena without jaundice in 3 patients. Endoscopic con-
ﬁrmation of hemobilia as demonstrated by bleed from
papilla of Vater was present in 2/7 (28%) patients.
Conventional selective angiogram was performed in 6/7
patients which were all successfully embolized. One pa-
tient with proper hepatic artery pseudoaneurysm rup-
turing into the duodenum causing massive hematemesis
underwent surgery. Two patients with progressive
obstructive jaundice were successfully treated with
endoscopic biliary stenting following angioembolization.
There was no procedure related mortality.
Discussion: Hepatic artery pseudoaneurysm is an
uncommon cause of hemobilia and can rarely present
with jaundice alone. Trans-arterial embolization has
been shown to be successful in controlling the bleed in
all cases and is the procedure of choice. Surgery is
reserved for patients with hemodynamic instability or
with failure of embolization. Patients in whom jaundice
is not relieved following angioembolization require bil-
iary drainage. Endoscopic biliary stenting is highly
effective in relieving the biliary obstruction following
angioembolization.
MO-60
RECURRENCE OF LIVER HYDATID
CYST
H. O. El Malki1,2,3, A. Benkabbou1, A. Souadka1,
R. Mohsine1, L. Ifrine1, R. Abouqal2,3 and A. Belkouchi1
1Surgery Departement ‘‘A’’ Ibn Sina Hospital, Rabat
Morocco; 2Medical Center of Clinical Trials and
Epidemiological Study (CRECET), Medical School,
University Mohammed Vth Souissi, Rabat, Morocco;
3Biostatical, clinical research and epidemiological
laboratory (LBRCE), Medical School, University
Mohammed Vth Souissi, Rabat, Morocco
Background and aims: Hydatid disease continues to be a
major health problem in sheep-raising areas. Surgery is
the basic treatment for liver hydatid cyst (LHC).
Recurrences can occur after all therapeutic. Surgery for
recurrence of LHC becomes technically more difﬁcult
and. The aim was to ﬁnd perfective factors associated to
hepatic recurrence after LHC surgery and to propose and
to discuss postoperative follow-up schedules.
Methods: A retrospective cohort study of 672 patients
with liver hydatid cyst treated at the surgery department
‘‘A’’ at Ibn Sina University Hospital, Rabat Morocco.
Recurrence rates have been analyzed by the Kaplan-
Meier method for patients undergoing surgery.
Results: Fifty-six patients (8.5%) had a recurrence of
LHC after surgery represented in 34 females (60.7%) and
22 males (39.3%). The median duration of recurrence
diagnosis was 24 months (IQR: 10 months; 48 months).
Recurrence’s risk was 2.3% ± 0.6 at one year and
9.1% ± 1.3 at the 10th year. The past history of LHC
OR = 2 (95% CI 1.13–3.59) and three cysts or more
OR = 3.8 (95% CI 2.07–6.98), were an independent risk
factors for recurrence.
Conclusion: We think that the surgeon’s practice and
experience are the most important to success the surgical
treatment. Its prevent complications and recurrences.
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MASSIVE HEMOBILIA: DIAGNOSTIC
AND THERAPEUTIC CHALLENGES
P. G. Shanthanam, V. Velayutham, J. Sathyanesan,
R. Prabhakar, S. Ramasami, S. Eswaran,
G. Rajarathinam, J. Damodaran, R. Palaniappan,
R. Shanmugasundaram and S. Rajagopal
Government Stanley Medical College Hospital
Introduction and objectives: Hemobilia is deﬁned as
bleeding into the biliary tract due to a communication
between a blood vessel and the bileducts. Massive he-
mobilia is a rare but potentially life-threatening cause of
upper gastrointestinal hemorrhage. This retrospective
analysis evaluated the challenges in diagnosis and man-
agement of massive hemobilia.
Materials and methods: Between 1998 to 2008 Twenty
consecutive patients (14 male, 6 female) who were re-
ferred to our department for severe or recurrent hemo-
bilia were included in the study and the records were
retrospectively analysed.
Results: Causes of hemobilia were blunt liver trauma
(n = 9), following liver biopsy (n = 4), post lap chole-
cystectomy hepatic artery pseudoaneurysm (n = 3), he-
patobiliary tumors (n = 3) and vascular malformation
(n = 1). Malena, pain abdomen, Haemetemesis and
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jaundice were the leading symptoms. All patients
underwent ultrasound and CECT abdomen. Angiogram
and therapeutic embolisation was done in 12 patients and
it was successful in 9 patients and 3 patients in whom it
failed required surgery. Surgical procedures performed
were Rt hepatectomy in 4, Rt extended hepatectomy in 1,
segmentectomy in 1, extended radical cholecystectomy in
1, repair of the Pseudoaneurysm in 3 and R hepatic ar-
tery ligation in 1.
Conclusion: Massive Hemobilia is a diagnostic and
therapeutic challenge. The therapeutic options consist of
surgery and embolization. Endovascular treatment can
control an unstable hemodynamics and can be sufﬁcient
in the some cases. However, in patients with recurrent
bleeding or failed embolization, surgery is required.
MO-62
VIRTUAL LIVER SURGERY. IMPACT ON
PREOPERATIVE PLANNING
P. Sisco1, N. Perrone2, J. Vallejos3 and G. Pagliarino2
1Pirovano Hospital; 2Pirovano Hospital; 3Diagnostico
Maipu
Background: The increase of liver resections has
encouraged the development of imaging technology
which has improved the preoperative assessment. The
advent of multidetector CT (MDCT) allows to realize 3D
vascular reconstruction, liver volume (LV) and virtual
hepatectomy (VH) which permits the surgeon to identify
anatomical repairs, determine the resection planning and
calculate the hepatic volume specially in extended resec-
tions where an insufﬁcient remnant liver could trigger
hepatic failure.
Objective: To show the MDCT effectiveness for plan-
ning a better and more accurate preoperative strategy as
compared with the ﬁndings of previous studies.
Methods: From May 2008 to October 2009, 16 patients
were reevaluated with 64-row MDCT. Nine presented
metastatic disease, six primary liver tumors and one
polycystic disease. The liver was assessed pre- and post-
contrast administration, analyzing in each case the arte-
rial, portal venous and late parenchymal phase. At the
workstation, the radiologist and the surgeon calculated
the LV, performed 3D vascular reconstruction and ﬁnally
completed the VH.
Results: MDCT proved effective in 15 of the 16 patients
studied (93.7%), allowing in 14 cases to achieve the
preoperative strategy. One patient was excluded of sur-
gery and, in another one, extrahepatic disease was dis-
covered intraoperatively.
No mortality was reported.
Conclusions: The radiologist´s preoperative MDCT
assessment advised by the surgeon produced a positive
impact on the postoperative results of liver resections.
This virtual method contributed to safe and curative
techniques with no postoperative hepatic failure and no
mortality.
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COMPARISON OF ANATOMIC AND
NON-ANATOMIC HEPATIC RESECTION
FOR HEPATOCELLULAR CARCINOMA:
A PROSPECTIVE RANDOMIZED TRIAL
J. Dong1, Y. J. Su2, X. W. Li3, S. G. Wang3 and
S. Z. Yang4
1Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China; 2Institute of
Hepatobiliary Surgery, Southwest Hospital, Third
Military Medical University, Chongqing, China; 3Institute
of Hepatobiliary Surgery, Southwest Hospital, Third
Military Medical University, Chongqing, China; 4Hospital
& Institute of Hepatobiliary Surgery, Chinese PLA
General Hospital, Beijing, China
Introduction: Anatomic liver resection is thought to be a
reasonable treatment option for hepatocellular carci-
noma (HCC); however, its clinical signiﬁcance remains to
be conﬁrmed. The aim of this study was to evaluate the
prognostic impact of anatomic versus non-anatomic liver
resection on HCC patients through randomized control
trial in a single center.
Methods: Curative hepatic resection was performed in
133 patients with HCC. The patients were randomly
classiﬁed into the anatomic resection (n = 67) and non-
anatomic resection (n = 66) groups. The mean follow-up
time was 19 months (8–27 months).
Results: The intraoperative blood loss in the anatomic
resection group was signiﬁcantly less than that in the non-
anatomic group (744.8 ± 539.0 ml vs. 952.3 ± 634.1 ml,
P = 0.044). Number of micrometastatic foci removed in
anatomic resection group was signiﬁcantly more than that
in non-anatomic resection group (78 vs. 58, P = 0.043).
By Kaplan-Meier survival analysis, the 1-year disease-free
survival rate in the anatomic resection group was signiﬁ-
cantly better than that in the nonanatomic resection
group (75.5% vs. 48.2%, P = 0.003). Anatomic resection
was conﬁrmed to be an independent favorable factor of
disease-free survival by multivariate analysis.
A group B group Z value P value
micrometastatic foci (n) 79 57 )2.028 0.043D
portal vein tumor thrombus (n) 51 32 )3.735 0.000D
tumor satellite micronodules (n) 10 8 )0.039 0.969
hepatic vein tumor thrombus (n) 10 11 0.000 1.000
Other tumor thrombus (n) 8 6 0.000 1.000
Conclusions: Anatomic resection for HCC yields more
favorable results rather than non-anatomic resection,
which might because anatomic resection has the potential
to remove undetected metastatic foci. The further long
term follow-up is needed to conﬁrm the conclusion.
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A SYSTEMATIC REVIEW AND META-
ANALYSIS OF THE CLAMP-CRUSHING
TECHNIQUE IN ELECTIVE
HEPATECTOMY
N. N. Rahbari1, M. Koch1, E. Motschall2,
M. W. Bu¨chler1 and W. Ju¨rgen1
1Department of General, Visceral and Transplantation
Surgery, University of Heidelberg, Germany; 2Institute of
Medical Biometry and Medical Informatics, University of
Freiburg, Germany
Background: Various techniques have been introduced to
reduce intraoperative blood loss and improve perioper-
ative outcome after elective hepatectomy. It is unclear, if
these techniques are superior to the rather simple clamp-
crushing technique.
Aims/Objectives: To compare effectiveness and safety of
the clamp-crushing technique to alternative transection
techniques in elective hepatectomy.
Methods: The Medline, Embase, Clinical Trials (The
Cochrane Library Database CENTRAL), and Science
Citation Index databases were systematically searched for
randomized controlled trials (RCT). Relative risks (RR)
were chosen as effect measures and reported together with
their 95 per cent conﬁdence intervals (CI). Meta-analyses
were carried out using a random effects model.
Results: A total of seven RCT including 554 patients
were eligible for meta-analyses. There were no signiﬁcant
differences between the clamp-crushing and alternative
transection techniques in the meta-analyses of biliary
leakage RR 1.03 (95% CI, 0.50 to 2.13), transfusion rates
RR 0.69 (95% CI, 0.31 to 1.51), overall morbidity RR
0.89 (95% CI, 0.63 to 1.25) and mortality RR 0.20 (95%
CI, 0.02 to 1.65). None of the identiﬁed studies demon-
strated a signiﬁcant beneﬁt of an alternative transection
method regarding blood loss, parenchymal injury, tran-
section time, and hospital stay.
Conclusions: Currently available evidence from RCT
does not indicate a beneﬁt of any alternative transection
technique on perioperative outcome after hepatectomy
compared to the clamp-crushing technique. The clamp-
crushing technique remains the reference technique for
transection of the parenchyma in elective hepatectomy.
MO-65
LAPAROSCOPIC VERSUS OPEN LEFT
LATERAL SECTIONECTOMY: A
COMPARATIVE CASE-MATCHED
STUDY
A. Kausar1, R. Deshpande1, M. Manu1, D. O’Reilly1,
D. Sherlock1 and B. J. Ammori1,2
1North Manchester General Hospital; 2Manchester Royal
Inﬁrmary
Background: Laparoscopic left lateral sectionectomy
(LLS) of the liver is now an established practice. How-
ever, signiﬁcant advantages over the open approach have
not been conclusively demonstrated. The aim of this
study was to compare the laparoscopic and open ap-
proaches to elective LLS.
Methods: Consecutive patients undergoing laparoscopic
LLS over a 5-year period were matched to a control
group who underwent open resection. All laparoscopic
resections were performed by a single surgeon. The out-
come measures were tumour clearance, postoperative
complications and length of stay.
Results: Between 2003 and 2009, 41 patients underwent
21 laparoscopic and 20 open LLS. There were no con-
versions to open surgery. The laparoscopic and open
groups were comparable for age (66 vs. 61.5 years,
P = 0.121), sex distribution, number (1 vs. 1,
P = 0.429) and size of lesions (4.0 vs. 4.0 cm,
P = 0.525), frequency of malignant pathology (90.5%
vs. 75%, P = 0.238) and need for additional segmental
resection (29% vs. 35%, P = 0.744). The operating time
(172.5 vs. 190 minutes, P = 0.245) and frequency of R0
resection (89.5% vs. 86.7%, P = 1.000) were compara-
ble. Laparoscopic surgery was associated with signiﬁ-
cantly lower morbidity (4.8% vs. 24%, P = 0.045) and
shorter postoperative hospital stay (3 vs. 10 days,
P < 0.0001).
Conclusions: Laparoscopic approach to left lateral sec-
tionectomy should become the gold standard as it
achieves oncologic clearance comparable to open surgery
and offers the advantages of lower morbidity and more
rapid recovery.
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DIABETES MELLITUS INCREASES
MORBIDITY AND MORTALITY IN
LIVER SURGERY
J. Wang, J. Dietrich, D. Ga¨rtner, J. Jenkner, S. Mu¨nch,
A. Scho¨ttler, M. Kapps and M. R. Scho¨n
Department of Visceral Surgery, Sta¨dtisches Klinikum
Karlsruhe, Germany
Background: Postoperative outcome in elective liver
surgery has improved signiﬁcantly over the last decade.
Aims: For this study risk factors related to perioperative
morbidity and mortality were evaluated. Multivariate
analysis was conducted in 265 elective liver resections.
127 parameters affecting postoperative outcome were
determined; parameters included: demographic, diag-
nostic, therapeutic, laboratory and operative data. After
liver resections cases were divided in three groups: no or
minor complications (wound infection, pleural effusions)
(n = 224), major complications (liver failure, biliary
leakage or operative revision) (n = 23) and death within
30 days (n = 8).
Results: All groups compared were similar in demo-
graphic data, diagnosis and operative data. In univariate
analysis age, ﬁbrosis, ASA and chronic obstructive pul-
monary disease were associated with more and more se-
vere complications (table 1). In multivariate analysis only
diabetes mellitus and simultaneous procedures were
independently assisted to more morbidity and mortality.
Table 1.
Group 1
n = 224
Group 2
n = 23 Signiﬁcance
Group 3
n = 8 Signiﬁcance
Age in years 58 ± 13 64 ± 10 P < 0.05 66±11 n.s.
Fibrosis/Cirrhosis 15.6% 33.3% P < 0.05 16.7% n.s.
ASA 39.5% 40.7% n.s. 83.3% P < 0.05
COPD 3.0% 3.7% n.s. 33.3% P = 0.05
Diabetes mellitus 14.3% 21.7% P < 0.05 66.7% P = 0.005
Simultaneous
procedure
17.4% 51.9% P < 0.001 33.3% n.s.
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Conclusion: Diabetes mellitus is an independent and of-
ten underrated risk factor for increased postoperative
morbidity and mortality in liver resection.
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LIVER RESECTION WITHOUT PEDICLE
CLAMPING: FEASIBILITY AND SAFETY
IN 512 CONSECUTIVE PATIENTS
L. Vigan, A. Jaffary, A. Ferrero, N. Russolillo, E. Sgotto
and L. Capussotti
HPB and Digestive Surgery, Ospedale Mauriziano
Umberto I, Torino, Italy
Background: The use of pedicle clamping (PC) in liver
resections (LR) is debated. A randomized control trial
(RCT) demonstrated no beneﬁts from systematic PC, but
some authors still consider LR without PC unsafe.
Aims: To assess feasibility and safety of ‘‘non-PC’’ policy
in a large clinical series. To analyze outcomes of ‘‘salvage
PC’’ (clamping in case of bleeding) and its predictive
factors.
Methods: Five hundred and forty seven patients under-
went LR between April 2004 (after the RCT) and April
2009. 35 (6.4%) underwent LR with PC because of vas-
cular resection or tumor location. The remaining 512
underwent LR without initial PC and represented our
study group.
Results: Four hundred and sixty two (90.2%) patients
completed LR without PC, while 50 (9.8%) required
salvage PC (SPC). In SPC group blood loss and trans-
fusion rates were higher than in non-PC group (500 vs.
125.5 cc, P < 0.0001 and 22% vs. 13.4%, P = 0.099),
while mortality, morbidity, liver dysfunction and renal
dysfunction rates were similar.
At multivariate analysis, arterial hypertension
(P = 0.012), cirrhosis (P = 0.014), transection along
the right portal scissure (RPS) (P < 0.0001), and resec-
tion of segments 7/8 (P = 0.003) were independent
factors predicting the need for SPC, while resection of
antero-lateral segments (Sg2-6) was a negative predictive
factor of SPC (P = 0.002). SPC rate and median blood
loss were 2% and 60 cc in Sg2-6 resections, 21.0% and
200 cc in Sg7/8 resections and 19.7% and 300 cc in RPS.
Neither coagulation parameters, nor pathologic data, nor
neoadjuvant treatments inﬂuenced SPC.
Conclusions: LR can be safely performed without PC in
the majority of cases. Salvage PC should be promptly
used whenever major bleeding occurs. In resections of
antero-lateral segments (Sg2-6) systematic PC is useless
and salvage PC is rarely required. In resections of seg-
ment 7/8 or those conducted along the right portal scis-
sure, the role of PC has to clarify: systematic PC or early
salvage PC should be considered, especially in cirrhotic
patients.
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EVALUATION OF PET/CT, EUS AND
LAPAROSCOPIC ULTRASONOGRAPHY
IN THE PREOPERATIVE ASSESSMENT
OF RESECTABILITY IN PATIENTS
WITH LIVER TUMORS
A. Ainsworth, T. Pless, H. Petersen, B. Svolgaard,
P.-F. Hoeilund-Carlsen and H. Nielsen
Odense University Hospital
Background: It is not settled which diagnostic procedures
should be made as a supplement to CT scan in the pre-
operative assessment of resectability in patients with
primary and secondary liver cancer.
Aim: To evaluate the diagnostic yield of positron emis-
sion tomography/CT scan (PET/CT), endoscopic ultra-
sonography (EUS) and laparoscopic ultrasonography
(LUS) in the preoperative assessment of resectability in
patients with liver cancer.
Methods: Patients with suspected liver cancer, who were
referred for assessment of resectability, were prospec-
tively registered. In each patient, PET/CT, EUS and LUS
were performed in addition to standard CT scan to be-
fore the decision of liver surgery was made.
Results: Sixty four patients (36 men/28 women) were
included. The mean age was 62 years (range 19–
77 years). Referral diagnoses were: metastases from
colorectal cancer (n = 40), hepatocellular carcinoma
(n = 12), metastases from other malignant diseases
(n = 4) and other diagnoses (n = 8). Curative resections
were performed in 19 patients. The sensitivity and spec-
iﬁcity of EUS, PET/CT and LUS in predicting non-
resectability were: 0.40/0.96, 0.51/0.86 and 0.65/1.00. If
decision regarding referral for curative liver surgery had
been taken after each test investigation, the impact of
EUS, PET/CT and LUS would have been: 0.21, 0.28 and
0.36, respectively. Final diagnoses were: metastases from
colorectal cancer (n = 38), non malignant disease
(n = 11), hepatocellular carcinoma (n = 7) and miscel-
laneous malignant diseases (n = 8).
Conclusion: EUS and PET/CT can be used in the pre-
operative assessment of respectability by selecting which
patients should not be referred for liver surgery. How-
ever, the most accurate supplementary diagnostic pro-
cedure regarding judgement of resectability is
laparoscopic ultrasonography.
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PROGNOSTIC FACTORS FOR THE
TRANSECTED SURFACE
COMPLICATIONS AFTER LIVER
RESECTION
F. Duek, J. Lendoire, P. Barros, G. Rafﬁn, V. Garay,
L. Gil, C. Quarin, A. Oks and O. Imventarza
Liver Transplant Unit. Hospital Dr Cosme Argerich
Background: Hepatic resection has evolved into the
treatment of choice for selected patients with benign and
malignant hepatobiliary disease. Despite improvement in
the safety of hepatic resection, the procedure is still
burdened by mortality and postoperative complications.
Bile leakage, bleeding and cut liver abscess are secondary
complications after an hepatectomy. The presence of any
of these, can alter the evolution of the patients who
underwent an hepatectomy.
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Objective: Identify the prognostic factors for cut surface
complications after liver resection.
Method: Two hundred and seventy one consecutive liver
resections were performed between January 2001 and
December 2008. Complications were staged by Dindo
classiﬁcation. Only patients with primary and secondary
tumours were included. In patients with transected sur-
face (TS) complications variables analized were: demo-
graphic data, surgical techniques, introperative variables
and outcome.
Results: Surface complication rate was 11% (30 patients).
Biliary ﬁstulas 22, abscess 4, necrosis 2 and hemorrhages 2.
Complications were ranked according to Dindo classiﬁ-
cation: grade 1 = 10, grade 2 = 8, grade 3a = 1, grade
3b = 10 and grade 5 = 1. Eleven patients required at
least one reoperation. Fistula drainage output was 141 cc
(±124 cc) and closed spontaneously on the 4th post
operative day (r 1-11). The univariate analysis showed that
reresection (P 0.048), parenquimal section of the major
caesura (P 0.001), resection of more than 3 segments and
the need of a transfusion (P 0.003) were signiﬁcantly
associated with the incidence of TS complications. In the
multivariate analysis only the need for blood transfusion
(P 0.036) showed a statistical signiﬁcance.
Conclusions: The results indicates that the type of liver
resection and the transfusion requirements are factors
associated with TS complications. Nevertheless, the liver
TS complications are still justiﬁed by an aggressive
approach in liver resections.
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ROBOTIC-ASSISTED LAPAROSCOPIC
PRECISE HEPATECTOMY IN CHINA:
INITIAL EXPERIENCE
J. Dong, W. Ji and H. Wang
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: Robotic-assisted minimally invasive sur-
gery represents the third generation of surgery, and the
repertoire of procedures is increasing steadily.
Objectives: In this study, we report our initial experience
in robotic-assisted laparoscopic precise hepatectomy in
13 patients.
Methods: Between April and July 2009, 13 patients
underwent robotic-assisted laparoscopic anatomic hepa-
tectomy for benign and malignant hepatic diseases with
Da Vinci surgical system.
Results: Major hepatectomy was performed in 9 patients
(1 right hepatectomy, 1 right hepatectomy and simulta-
neous enucleation of lesion in segment IV, 6 left hepa-
tectomy and 1 left hepatectomy and caudate
segmentectomy, Roux-en-y hepaticojejunostomy for
radical resection of hilar cholangiocarcinoma), and left
lateral sectionectomy in 4 patients. All the procedures
were performed anatomically with precise hilar dissec-
tion. Eight major hepatectomies were for malignant dis-
ease, and 5 hepatectomies (1 left hepatectomy and 4 left
lateral sectionectomies) for benign disease. No conver-
sion to laparotomy occurred in all 13 patients. The
median operating time was 338 min (range, 150–
720 minutes). The mean blood loss was 280 ml. None of
13 patients required intraoperative or perioperative
blood transfusion. Bile leakage developed in the only one
patient with hilar cholangiocarcinoma. The median
hospital stay was 6.7 days (range, 2–13 days).
Conclusions: Da Vinci robotic system enables surgeons
to perform precise laparoscopic liver resection with fewer
complications as compared with conventional laparo-
scopic surgery. Large multicenter studies are required to
evaluate the potential advantages of the robotic-assisted
laparoscopic hepatectomy over conventional laparo-
scopic and open surgery.
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AUTOTRANSPLANTATION AND
ANTE-SITUM PROCEDURES ON THE
LIVER. A SINGLE CENTER EXPERIENCE
P.-D. Line1, A. Foss1 and Ø. Mathisen2
1Oslo University Hospital, Section for Transplant Surgery;
2Oslo University Hospital, Section for Hepatobiliary
Surgery
Background: Tumors involving the liver vasculature or
the vena cava can be difﬁcult to handle with conventional
resection techniques. Autotransplantation or ante-situm
mobilization of the livers provide unique access to the
liver under prolonged tolerance for ischemia.
Aim: We wish to present our own experience with these
methods and demonstrate alternative surgical techniques
for special problems.
Material: From 2001 to 2009 we have operated 5 men
and 5 women, average age 49,8 years (29-67) Eight had
malignant tumors (3 leiomyosarcomas of the retrohepatic
v. cava, 2 cholangiocarcinomas, 1 adrenal carcinoma with
invasion of v.cava, 2 colorectal cancer metastases) and
two patients had giant hemangiomas with compression of
hepatic venous drainage. Seven autotransplantations and
3 ante-situm resections were performed. In all cases, at
least one major vascular reconstruction was done.
Results: There was no perioperative mortality. Anhe-
patic times for the autotransplantations ranged from 1.5
to 6 hours Four patients experienced major complica-
tions (Clavien grade ‡ 3) consisting of reoperation for
bleeding, arterial stenosis requiring stenting, postopera-
tive liver failure and vascular prosthetic infection. Nine
patients are currently alive with mean observation time
37.6 months (0.7-101 months) Five of the patients with
malignant tumors are currently tumor free.
Conclusion: These procedures are demanding and asso-
ciated with increased risks for complications, and there-
fore only indicated in a small number of selected cases.
The utilization of liver transplantation and vascular
surgical techniques can offer surgical treatment to pa-
tients that would otherwise be judged as inoperable. In
the setting of a liver transplat program the operations can
be performed with acceptable perioperative morbidity
and satisfactory long term results.
MO-72
CHEMOEMBOLIZATION IN PATIENTS
WITH LIVER METASTASES OF
NEUROENDOCRINE TUMORS
R. Garcia Monaco, O. Peralta, R. Rostagno and F. Petra
Angiography and Endovascular Therapy Department,
Italian Hospital of Buenos Aires. Buenos Aires University
Background: NET liver metastases are uncommon and
usually no surgical treatment is feasible when diagnosed.
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Transarterial chemoembolization (CE) is ﬁrst choice
treatment in these cases.
Objectives: To evaluate symptomatic, humoral and
morphological response of CE in patients with liver
metastases of NET.
Materials and methods: Between 1991 and 2008, 238 CE
procedures were performed in 102 patients with liver
metastases of NET. Primary tumors were located in bo-
wel (n = 40), pancreas (n = 24), stomach (n = 3) and
unknown (n = 35). Type of tumor founded was carci-
noid (n = 68), islet cell tumors (n = 20), undetermined
(n = 10), gastrinomas (n = 3), and mixed (n = 1).
Ninety-ﬁve (93%) patiens were symptomatic, while 7
(7%) were not. Clinical and humoral response were
qualiﬁed in Complete (CR), Partial (PR), Stable (EE)
and progression (PR). Morphological response was
evaluated according to the EASL and complications
according to the SCVIR criteria.
Results: Previous treatments consisted in octreotide
(n = 70), primary tumor resection (n = 41) metastasic
resection (n = 9), systemic chemotherapy (n = 25) and
radiotherapy (n = 2). Clinical response was CR in
51.2%, PR 36.6% and EE in 12.2%. Humoral response
was CR in 75% and PR 25%. Morphological response
was RC in 18.6%, PR 69.8% and EE in 11.6%. Median
survival rate was 56.6 months from diagnosis and
31.46 months from treatment. Seven (5.8%) mayor
complications (3 hepatic abscesses, 2 confusional syn-
dromes, 1 liver failure and 1 death) and seventeen (21%)
minor complications were observed.
Conclusion: CE is an effective and safe procedure for the
treatment of unresectable liver metastases of NET, pro-
viding high symptomatic, humoral and morphological
responses.
MO-73
OUTCOME FOLLOWING HEPATIC
RESECTION FOR METASTATIC
MALIGNANT MESENCHYMAL
TUMOURS
R. Marudanayagam, B. Sandhu, T. Perera, P. Taniere,
C. Coldham, S. Bramhall, D. Mayer, J. Buckels and
D. Mirza
Queen Elizabeth Hospital, University Hospital of
Birmingham NHS Foundation Trust, Birmingham, UK
Background: Malignant mesenchymal tumours (MMT)
are a heterogenous group of sarcomas with a propensity
for haematogenous spread. For patients with hepatic
metastasis, surgical resection is viewed as the only viable
option to improve the otherwise poor prognosis.
Aim: To analyse the outcome following hepatic resection
for metastatic MMT and to identify factors predicting
survival.
Methods: All the patients who underwent hepatic resec-
tion for metastatic MMT between August 1997 and April
2009 were included in the study. The data was obtained
from the prospectively maintained liver unit database
and pathology database. Patients’ demographics, clinical
and histopathological parameters, overall survival and
the factors predicting survival were analysed.
Results: Thirty six patients underwent hepatic resection
for metastasis. The predominant site of primary tumour
was gastro-intestinal tract (50%). Leiomyosarcoma was
the most common histological type (54%). The median
interval between the primary and metastatic resections
was 17 months. Thirteen patients (36%) had synchro-
nous tumours. 24 patients (66.7%) had major liver
resections and 10 patients (27.8%) had bilobar dis-
ease.The median number of liver lesions resected was 1
(range: 1–6) and the median maximum diameter of the
metastasis was 11 cm. R0 resection was performed in 31
patients (86%). The 1-, 3- and 5-year overall survival
from the time of metastasectomy was 90.3%, 48.0% and
31.8% respectively, with a median survival of 24 months.
Factors predicting poor survival were the presence of
high grade tumours (P = 0.042), primary leiomyosar-
coma (P = 0.017) and positive resection margin
(P = 0.05). The 5-year survival improved to 35.3% for
R0 resection compared with 20% for R1 resection.
Conclusion: Hepatic resection for metastatic MMT
appears to be valuable in carefully selected patients with
acceptable long-term survival. The aim of surgery must
be a R0 resection to offer a chance of cure.
MO-74
ISCHEMIC PRECONDITIONING PRIOR
TO LIVER RESECTION – A
RANDOMIZED CONTROLLED STUDY
A. Winbladh1, L. Trulsson1, B. Bjo¨rnsson1,
K. Offenbartl2, E. Svartholm3, P. Gullstrand1 and
P. Sandstro¨m1
1Department of Surgery, the University Hospital of
Linko¨ping; 2Department of Surgery, Ho¨glandssjukhuset,
Eksjo¨; 3Department of Surgery, Ryhov Hospital,
Jo¨nko¨ping
Introduction: Intermittent inﬂow occlusion (15 min
ischemia/5 min reperfusion, 15/5) during liver resection
causes less ischemia reperfusion injury (IRI) than con-
tinuous occlusion. Previous studies have shown that
ischemic preconditioning (IP) also protects from IRI. No
previous study has compared 15/5 with IP + 15/5.
Method: Thirty two consecutive patients with malignant
liver disease had liver resections (minimum 2 segments)
performed with inﬂow occlusion 15/5. 16 were random-
ized to receive IP (10/10). The patients were stratiﬁed
according to volume of resection. No patient had chronic
liver disease. The patients were followed for 5 days with
microdialysis (lD).
Results: There were no differences between the groups
regarding demographics or operative parameters (bleed-
ing, duration of ischemia, resection volume). Two pa-
tients had postoperative complications (stroke and
abscess) and there were no deaths. lD revealed lower
levels of lactate in the IP group from day 3 and onwards
(1.4 vs. 2.4 mM, P < 0.001). There were no differences
between the groups when glucose, pyruvate, glycerol
levels were analyzed, nor between large and small resec-
tions. Immediately postop S-Lactate was lower (2.6 vs.
5.0 mM) and from day 2 the albumin levels were higher
(33 vs. 27 g/L) in the IP-group (both P < 0.05). AST,
ALT or bilirubin levels were not different between the
groups. Patients with complications had a clearly ele-
vated glycerol curve.
Conclusion: IP reduces the levels of Lactate locally in the
liver as well as in serum, indicating that IP increases
aerobic metabolism. lD can detect complications early.
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INHIBITION OF TRANSFORMING
GROWTH FACTOR BETA-1 AUGMENTS
LIVER REGENERATION AFTER
PARTIAL PORTAL VEIN LIGATION IN
PORCINE EXPERIMENTAL MODEL
V. Liska1, V. Treska1, H. Mirka2, J. Kobr3, R. Sykora4,
T. Skalicky1, A. Sutnar1, O. Vycital1, J. Bruha1, P. Pitule1,
A. Chlumska5, J. Racek6, L. Treﬁl6 and J. Benes7
1Department of Surgery, Charles University Prague,
Medical School and Teaching Hospital Plzen;
2Department of Radiology, Charles University Prague,
Medical School and Teaching Hospital Plzen;
3Department of Pediatrics, Charles University Prague,
Medical School and Teaching Hospital Plzen; 4First
Department of Medicine, Charles University Prague,
Medical School and Teaching Hospital Plzen; 5Institute of
Pathology, Charles University Prague, Medical School
and Teaching Hospital Plzen; 6Department of
Biochemistry, Charles University Prague, Medical School
and Teaching Hospital Plzen; 7Department of
Anaestesiology, Charles University Prague, Medical
School and Teaching Hospital Plzen
Introduction: TGF-b1 is a pleiotropic cytokine that is
overexpressed in terminal phase of liver regeneration and
decrease the proliferation activity of hepatocytes.
Aim: Our aim was to increase liver regeneration by
prolongation of proliferation of hepatocytes by neutral-
izing monoclonal antibody against TGF-b1 in large
animal experimental model.
Methods: Twenty four hours after partial portal vein
ligation monoclonal antibody against TGF-b1 (TGF-b1
group, 7 piglets) or physiological solution (control group,
9 piglets) were applied into the central venous catheter.
The biochemical parameters (bilirubin, urea, creatinine,
alkaline phosphatase, gammaglutamyltransferase, cho-
linesterase, aspartate aminotransferase, alanine amino-
transferase and albumin) were assessed. The
compensatory hypertrophy of the non-occluded liver
lobes was evaluated by periodic ultrasonography during
the next fourteen days and by histological examination.
Results: The acceleration of growth of the hypertrophic
liver lobes was maximal between 3rd and 7th postoper-
ative days in comparison with the control group
(P < 0.05). No important differences in the biochemical
or histological parameters studied were proved.
Conclusion: The present study describes a new usage of
monoclonal antibody against TGF-b1 in large animal
experimental model of partial portal vein ligation.
This experimental study was supported by grants IGA
MZ CR NS 9731/4 and NS 10230/3 and Research project
MSM 0021620819 (Replacement of some vital organs).
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QUALITY OF LIFE IN A RANDOMIZED
CONTROLLED TRIAL OF ENDOSCOPIC
SCLEROTHERAPY VERSUS
EMERGENCY PORTACAVAL SHUNT
TREATMENT OF BLEEDING
ESOPHAGEAL VARICES
M. Orloff1, J. Isenberg1, H. Wheeler1, K. Haynes1,
H. Jinich-Brook1, R. Rapier1, F. Vaida1, R. Hye1 and
S. Orloff2
1University of California, San Diego; 2Oregon Health and
Sciences University
Background: Emergency treatment of bleeding esopha-
geal varices (BEV) is of paramount importance because
of the high mortality rate surrounding acute bleeding.
Nevertheless, there is a paucity of randomized controlled
trials of emergency surgical therapy and no reports on
quality of life (QOL).
Objectives: QOL was examined in a randomized con-
trolled trial that compared emergency and long-term
endoscopic sclerotherapy (EST) to emergency direct
portacaval shunt (EPCS) in cirrhotic patients with acute
BEV.
Methods: Two hundred and eleven unselected, consecu-
tive patients with biopsy-proven cirrhosis and endo-
scopically-proven, acute BEV were randomized to EST
(n = 106) or EPCS (n = 105). Diagnostic workup was
completed within 6 hours and treatment was initiated
within 8 hours. Criteria for failure of EST or EPCS were
clearly deﬁned and crossover rescue treatment was ap-
plied when primary therapy failed. 96% underwent over
10 years follow-up, or until death. QOL was measured
repeatedly by assessing 9 factors.
Results: Ten-year survival rate was 8% in the EST group
versus 51% in the EPCS group (P < 0.001). EPCS had
signiﬁcantly better indices in 6 determinants of QOL (see
below). There were no differences between EST and
EPCS in rates of return to work (43% vs. 51%), absti-
nence from alcohol (55% vs. 61%), and rescue PCS pa-
tency vs. EPCS patency (100% vs. 98%). Overall QOL
score was signiﬁcantly lower (i.e., better) following
EPCS.
Quality of Life Indices
EST EPCS P Value
Liver function improvement
(Child’s class)
+++ <0.001
Liver function worsening
(Child’s class)
+++ <0.001
PSE incidence – % 36 15 <0.001
PSE episodes – n (n/person) 179 (1.97) 94 (1.06) 0.003
PRBC transfusion units – n (mean) 1005 (10.81) 320 (3.81) <0.001
Hospital readmissions – n (mean) 387 (1.39) 292 (0.60) <0.001
Hospital readmission days – n (mean) 2682 (9.6) 2272 (4.7) <0.001
Conclusions: EPCS resulted in a markedly better QOL
than EST, even when failure of EST to control bleeding
was treated by rescue PCS. When added to the signiﬁ-
cantly higher survival rate, better control of bleeding, and
lower incidence of PSE, these results indicate that EPCS
is an effective ﬁrst-line emergency treatment of BEV,
superior to EST.
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PROGNOSTIC MOLECULAR IMAGING
IN PANCREATIC CANCER THROUGH
ANALYSIS OF THE STROMAL ACTIVITY
M. Erkan1, A. Fingerle2, C. Reiser-Erkan1,
T. Samkharadze1, Z. Pan1, I. Esposito3, Y. Tekant4,
J. Gaa2, H. Friess1 and J. Kleeff1
1Department of General Surgery, Klinikum r. d. Isar,
Technische Universita¨t Mu¨nchen, Munich, Germany;
2Department of Radiology, Klinikum r. d. Isar, Technische
Universita¨t Mu¨nchen, Munich, Germany; 3Department of
Pathology, Klinikum r. d. Isar, Technische Universita¨t
Mu¨nchen, Munich, Germany; 4Department of General
Surgery, Istanbul Medical Faculty, Istanbul University,
Istanbul, Turkey
Aims and background: To identify tumor speciﬁc stromal
changes in pancreatic cancer using MRI-imaging coupled
with quantitative image analysis and immunohisto-
chemistry. Stromal tissue forms more than 80% of the
pancreatic cancer mass and inﬂuences patient prognosis
signiﬁcantly.
Methods: Postoperative high resolution MRI imaging of
the resected specimens using standard and diffusion-
weighted sequences was carried out in 6 patients with
chronic pancreatitis and 12 patients with pancreatic
ductal adenocarcinoma undergoing resection. Stromal
activity was assessed by immunohistochemistry and
quantitative image analysis in terms of a-smooth muscle-
actin, CD31, collagen and periostin expression of the
stromal tissue. Prognostic value of the identiﬁed stromal
factors was tested separately on a cohort of 113 pancre-
atic cancer patients. Survival analysis was performed
using the Kaplan–Meier and Log-Rank analyses. Prog-
nostic factors were determined in a multivariable analysis
using a Cox proportional hazards model.
Results: Postoperative high resolution T2-scanning cor-
related accurately with the histomorphological data.
Among analyzed factors only periostin expression was
signiﬁcantly different in pancreatic cancer tissues com-
pared to chronic pancreatitis tissues (lower in cancer,
P = 0.01). Collagen expression correlated negatively
(P = 0.03) whereas periostin expression correlated pos-
itively (P = 0.002) with the microvessel density of the
tumors. Pancreatic cancer patients with higher periostin
expression survived signiﬁcantly longer than the ones
with low expression (29.7 months vs. 15.8 months,
P = 0.01). High periostin expression was an independent
prognostic marker among pancreatic cancer patients
(P = 0.017, 95% CI: 1.1159–4.563).
Conclusions: MRI imaging is a promising method to
assess the stromal activity in pancreatic cancer, thereby
providing an important tool in the differential diagnosis
and in the estimation of the prognosis of pancreatic
cancer patients.
MO-78
IPMN; ASSOCIATED CANCERS, FAMILY
HISTORY AND GENETIC
PREDISPOSITION
N. Lubezky, R. Nakache, J. Klausner and M. Ben-Haim
Tel Aviv Sourasky Medical Center
Background: Increased rates of extrapancreatic malig-
nancies (EPM) in patients with IPMN of the pancreas are
recently reported. Occurrence of IPMN in patients with
familial history of pancreatic cancer, and in a patient
with Hereditary Nonpolyposis Colon Cancer syndrome
(HNPCC) has also been reported.
Materials and Methods: Analysis of a prospective data-
base of 73 patients with proved IPMN. Interview of all
patients to obtain personal and familial cancer history.
Comparison with a cohort of 120 patients with pancre-
atic ductal adenocarcinoma (PDAC). Evaluation of the
common germline mutations in the BRCA 1 and 2 genes
in available patients.
Results: Rate of EPM in patients with IPMN was higher
than in patients with PDAC (17% vs. 6.8%, P = 0.04).
Malignancies in ﬁrst degree relatives were more common
among patients with IPMN than patients with PDAC
(56% vs. 40.6%, P = 0.048). Patients with IPMN who
had additional EPM, had a higher rate of ﬁrst degree
relatives with cancer compared with patients without
EPM (84% vs. 36%, P = 0.0015). This was most evident
regarding colorectal cancer in ﬁrst degree family mem-
bers (38% vs. 3%, P = 0.0015). 2 patients, both with
family history of pancreatic cancer, were tested positive
for the BRCA2 gene mutation (5% of tested patients, 8%
of tested Ashkenazi patients, 33% of tested patients with
family history of pancreatic cancer). One patient fulﬁlled
all Amsterdam criteria for HNPCC.
Conclusions: Patients with IPMN have an increased risk
of EPM, and a high rate of family members with cancer,
compared to patients with PDAC. Screening patients
with IPMN and a personal or familial history of pan-
creatic or breast cancer for the BRCA 2 gene mutations is
appropriate. Patients with IPMN and EPM have a high
rate of malignancies in ﬁrst degree relatives, especially
colorectal cancer. This, and the fact that IPMN is found
in patients with HNPCC, point to a possible role of the
mismatch repair (MMR) genes in IPMN pathogenesis.
MO-79
SIGNIFICANCE OF BIOELECTRICAL
IMPEDANCE DURING ISCHEMIA AND
REPERFUSION IN RAT LIVER AND
WHAT IT CAUSES?
S. S. Yun, D. S. Lee, H. J. Kim, M. L. Choi, S. W. Park
and D. W. Hwang
Yeungnam University Hospital, Department of Surgery
Background: Ischemia and reperfusion (I/R) injury is a
major cause of hepatic failure after liver surgery, but
there is no direct method to monitor or predict it in a
real-time manner during surgery.
Aims: We measured bioelectrical impedance (BEI) to
assess the usefulness of BEI during I/R in rat liver and
evaluated the mechanism underlying BEI changes.
Methods: A 70% partial liver ischemia model was used.
BEI was measured at various frequencies. ATP contents,
palmitic acid oxidation rate, cation changes in extracel-
lular ﬂuid (ECF; determined using an in vivo intracellular
microdialysis technique), hepatocyte sizes, and histolog-
ical changes were examined to investigate the liver cell
viability and mechanism of BEI change.
Results: BEI increased gradually during 60 minutes of
ischemia and had a tendency to plateau thereafter. The
ATP content decreased below 20% of the baseline level.
[Na+] in ECF decreased from 150.4 ± 3.8 to
97.8 ± 10.6 mmol/L, and [K+] in ECF increased from
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7.5 ± 0.3 to 34.3 ± 5.5 mmol/L during the ﬁrst
60 minutes of ischemia. Hepatocyte diameter increased
by ~20% during the ﬁrst 60 minutes of ischemia. After
24 hours of reperfusion, the ATP contents decreased to
below 50% in 30, 60 and 120 minutes of ischemia and the
palmitic acid metabolic rates decreased to 91%, 78%,
and 74%, respectively, compared with normal liver.
Conclusions: BEI may be a good tool for monitoring I/R
during liver surgery. BEI changes during hepatic ische-
mia are probably caused by sodium and potassium con-
centration changes in the ECF due to reduced
intracellular ATP contents.
MO-81
HUMAN ISLET TRANSPLANTATION:
THE STATE OF THE ART
B. Silveira1,2, E. Chaib2, T. Gananc¸a1,2, I. Siqueira2,
C. Pariz1,2, F. Almeida1,2, F. Galva˜o2 and
L. D’albuquerque2
1Universidade Nove de Julho; 2Transplantation Surgery
Unit, Department of Gastroenterology, University of Sa˜o
Paulo School of Medicine
Background: The results of islet transplantation is
improving; nevertheless, it still faces major challenges,
specially related to the site of cell implantation, deterio-
ration during cell isolation, poor islet functional after
implant, allorejection and autoimmunity.
Aim: Discuss progresses regarding islet cell culture,
cryopreservation systems, islet immortalization, innova-
tion on sites for islet engraftment, stem cell differentia-
tion and fusion into islet cell and current clinical trials.
Material and method: We systematically reviewed seven
hundred and forty seven articles related to the theme
throughout The Cochrane Metabolism and Endocrine
Disorders Review Group, Cochrane Library, MEDLINE
and EMBASE.
Results: Clinical islet transplantation needs to be evalu-
ated using the most clinically relevant endpoints such as
glucose stabilization and severe hypoglycemia preven-
tion. The cumulative results of the registry conﬁrm the
inarguably positive impact of islet transplantation on
metabolic control in T1 diabetes.
Human islet transplantation literature review
Study Year
n of
recepients
outcome
insulin-independent
Largiader et al 1980 1 recipient 9.5 months
Scharp et al 1990 1 recipient 22 days
Tzakis et al 1990 9 patients
with cancer
Warnock et al 1991 1 recipient 3 months
Scharp et al 1991 9 recipients 3 patients – failed
4 patients – 10 months
2 patients – 1–5 months
Warnock et al 1992 4 recipients 1 patient – 1 year
3 patients – 1–8 months
Gores et al 1993 2 recipients 1 patient C-peptide +/
9 months
1 patient – 8 months
Soon-Shiong et al 1994 1 recipient 9 months
Carrol et al 1995 1 patient
with cancer
3 years
Luizi et al 1996 15 recipients 8 patients C-peptide +
4 patients, 1–8 months
Alejandro et al 1997 8 recipients 2 patients – 1 month
2 patients – 6 years
Secchi et al 1997 20 recipients 9 patients C-peptide +
6 patients, 3–11 months
1 patient, 48 months
Keymeulen et al 1998 7 recipients 3 patients C-peptide +,
1 year
2 patients, 1 year
Oberholzer et al 2000 13 recipients 5 patients C-peptide +,
1 year
2 patients, 4–36 months
Shapiro et al 2000 7 recipients 7 patients, 4–15 months
Shapiro et AL 2005 47 recipients 44 patients, 15 months
Sutherland et al 2008 173 recipients
(Auto-tx)
85% patients, 1 year
69% patients, 5 years
Gangemi et al 2008 10 recipients 80% patients, 15 months
Froud et al 2008 3 recipients 2 patients, 24 months
Islet Transplant
Registry
1999-2008 325 recipients 23% recip. insulin
independent
29% insulin dependent
with C-peptide after
3 years
Discussion: There are good reasons to believe islet cell
transplantation will become the standard treatment for
type 1 diabetes. Its advantage over whole-organ
replacement are: (1) the procedure to infuse the islets into
the portal blood stream is much simpler than a complex
surgical intervention; (2) it may be possible to induce
tolerance of the engrafted islets by pre-treating them in
culture or by pre-treating the recipient with donor anti-
gen; (3) the islets can be cryopreserved for future use.
Conclusion: The challenge is to obtain similar clinical
success with single-donor grafts and to assess which is the
critical islet mass to achieve insulin-independence and
what are the detrimental effects of transplanting islets in
an ectopic site.
MO-82
EARLY OUTCOMES IN A NOVEL
TECHNIQUE OF PORTAL-ENDOCRINE
AND GASTRIC-EXOCRINE DRAINAGE
IN PANCREATIC TRANSPLANTATION
D. F. Doumite, M. J. Mazoch, H. Shokouh-Amiri,
S. LaRoux, R. W. McMillan, V. K. Rao, D. Dies and
G. B. Zibari
Lousiana State University Health and Sciences Center -
Shreveport
Background: Pancreas transplant (PTx) is an established
treatment for patients with complicated diabetes mellitus.
Diagnosis of rejection has continued to be problematic
for allograft surveillance. In 1992, a technique of porto-
enteric PTx introduced a new physiologic technique of
pancreas transplant and addition of venting jejunostomy
to this technique has given us a noninvasive technique to
monitor rejection. In October 2007, a new technique of
portal endocrine and gastric exocrine drainage was ﬁrst
performed at our institution.
Aim: To report the early outcomes of patients receiving
PTx with portal-gastric drainage.
Methods: Twenty-two patients underwent PTx between
2007 and 2009. Arterial inﬂow was from right common
iliac artery. Allograft portal vein was anastomosed to the
side of superior mesenteric vein of recipient. The end of
allograft jejunum was anastomosed to the anterior aspect
of the stomach.
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Results: This technique was applied for 22 patients (12
males;16 Caucasians). Nineteen patients underwent
simultaneous pancreatic-kidney (SPK) transplant and
three patients underwent solitary PTx. Mean recipient
age was 40.5 (range 24–58) and mean donor age was 20.7
(range 9–35). Mean hospital stay was 10.2 days (range 7–
22) with an average ICU stay of 3.4 days (range 2–6) and
mean follow-up was 11 months (range 1–23 months). All
patients achieved euglycemia and were free of hemodi-
alysis. Three patients underwent pancreatectomy due to
vessel thrombosis; of these, two were diagnosed with
hypercoagulable state. Two patients died with function-
ing pancreatic and kidney allografts. Two patients with
CMV duodenitis and three patients with rejection were
diagnosed with endoscopy and successfully treated.
Conclusion: Early results with this technique have proven
to be safe with good patient and allograft survival. Ac-
cess to donor duodenum and pancreas allograft via
endoscopy is unique to this technique and provides the
added advantage of life-long easy access to duodenum
and pancreas allograft.
MO-83
N-ACETYLCYSTEINE PROTECTS THE
PIG LIVER AGAINST SEGMENTAL
ISCHEMIA-REPERFUSION INJURY
A. Winbladh, L. Trulsson, B. Bjo¨rnsson, P. Gullstrand
and P. Sandstro¨m
Department of Surgery, University Hospital of Linko¨ping
Introduction: N-Acetylcystein (NAC) is known to have
antioxidant effects and have been used in various models
of ischemia-reperfusion injury (IRI). The primary aim of
this study was to see the effects of NAC on both the
perfused and the ischemic segment in segmental liver IRI
in vivo.
Method: Eight pigs [NAC(+)] received an infusion of
NAC 50 mg/kg/h. Another 8 pigs [NAC(-)] served as
controls. Liver segment 4 was selectively clamped for
80 min. Reperfusion was followed continuously for
6 hours with laser Doppler Flowmetry and microdialysis
(lD). Blood and tissue samples were obtained hourly.
Results: NAC(+) showed higher levels of ATP (0.62 vs.
0.40 M/g) and glycogen (13.8 vs. 3.3 lg/mg) during rep-
erfusion (both P < 0.05). lD showed lower levels of
lactate (5.2 vs. 7.6 mM), glucose (11.9 vs. 15.6 mM) and
pyruvate (4 vs. 21 mM) in the NAC(+) vs NAC(-) (all
P < 0,05). In all animals total antioxidative capacity
from 0.4 to 1.4 mM (P < 0.01) and oxidative stress de-
creased (4.0 to 2.3 mM P < 0.01), but no differences
were seen between the groups, nor regarding glutathione
levels. NO2/NO3 in serum remained unchanged in both
groups but tended to be lower in the NAC(+) group
(1.21 vs. 0.85, P = 0.054). Similarly, The NAC(+) had
lower levels of NO2/NO3 in the lD than the NAC(-)
group, 0.58 vs.1.29 and 0.62 vs. 1.27 mM (both
P < 0.01) in the non-ischemic and ischemic segment
respectively. DNA-fragmentation increased in the ische-
mic segment (no differences between groups). The density
of leukocytes increased over time and more so in the
NAC(-) group, (P < 0.05).
Conclusion: The main effect of NAC seems to relate to
its effect as a scavenger of reactive nitrogen species rather
than oxygen species or by increasing endogenous gluta-
thione. Higher levels of ATP and improved aerobic glu-
cose metabolism improves the energy status in liver
parenchymal cells, thereby reducing oncotic necrosis
and reducing the recruitment of leukocytes to the injured
liver.
MO-84
SULFORAPHANE DOSEDEPENDENTLY
INHIBITS PROLIFERATION OF HUMAN
COLON CARCINOMA CELLS AND HAS
SYNERGISTIC PROAPOPTOTIC
EFFECTS WITH STANDARD
CHEMOTHERAPY
D. Simcikas, H. Bruns, D. Schultze, G. Kallifatidis,
I. Herr, M. W. Bu¨chler and P. Schemmer
Ruprecht-Karls-University Heidelberg, Department of
General-, Visceral- and Transplantation Surgery
Background: Standard chemotherapy for primary and
metastatic colorectal cancer is associated with hepato-
toxic side effects. Thus, novel therapeutic agents and
regimens are needed. Sulforaphane (SF), a natural iso-
thiocyanate has anti-proliferative and pro-apoptotic ef-
fects. Thus, this study was designed to evaluate its effect
with or without chemotherapy on human colorectal
carcinoma cells.
Methods: CX-1 cells were cultured and SF (0-25lM)
with or without chemotherapy (leucovorin, ﬂuorouracil
and oxaliplatin) was added to the culture media. Un-
treated cells were used as controls. Cell growth was as-
sessed with MTT-assay while the Bax/Bcl-2 ratio
revealed differences in apoptosis.
Results: SF signiﬁcantly decreased growth of CX-1 cells
in a dose dependent manner (r2 = 0.93 for up to 25 lM
SF; P < 0.05). Moreover, SF in combination with che-
motherapy signiﬁcantly decreased proliferation com-
pared to chemotherapy alone (70% and 50% of controls
for chemotherapy and combination, respectively), while
apoptosis almost doubled (Bax/Bcl-2 ratio 1.5 vs. 3 for
chemotherapy vs. combination after 24 hour).
Conclusion: SF has pro-apoptotic and anti-proliferative
effects on human colorectal carcinoma cells being syn-
ergistic to standard chemotherapy. Thus, SF might fur-
ther increase cytotoxic effects of standard chemotherapy
on colorectal cancer cells.
MO-85
LAPAROSCOPIC TREATMENT FOR
RIGHT-SIDE INTRAHEPATIC DUCT
STONES
Y.-S. Yoon, H.-S. Han, J. Y. Cho and K. S. Ahn
Department of Surgery, Seoul National University
Bundang Hospital, Seoul National University College of
Medicine
Background: Reports on laparoscopic surgery for intra-
hepatic duct (IHD) stone to date, although rare, have
been mainly limited to left-side stones.
Aim/Objective: The aim of this study is to analyze our
experiences of laparoscopic surgery for right-side IHD
stones and evaluate its usefulness.
Methods: From March 2004 to August 2009, 51 cases of
laparoscopic surgery for IHD stone were performed in
our hospital. Among them, 15 patients who underwent
Abstracts 91
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
laparoscopic surgery for right-side IHD stones were ret-
rospectively analyzed.
Results: There were 4 men and 11 women, with a mean
age of 60.3 years. The performed operative procedures
were laparoscopic IHD exploration (LIHDE) (n = 6)
and laparoscopic hepatectomy (LH) (n = 9) including
right hemihepatectomy (n = 7) and right posterior sec-
tionectomy (n = 2). In 2 patients of the LIHDE group
and one patient of the LH group, laparoscopic Roux-en-
Y hepatico-jejunostomy was additionally carried out.
There was no open conversion. The mean operation time
(LIHDE vs. LH) was 252.5 and 398.5 min, and estimated
amount of blood loss during operation was 125.0 mL
and 815.5 mL, respectively. Postoperative complications
occurred in one patient (16.6%) in the LIHDE group and
two patients (22.2%) of the LH group. All the compli-
cations were improved by the conservative management.
The mean postoperative hospital stay was 11.0 and
14.6 days, respectively. The initial success rate of
removing the stones, as conﬁrmed by cholangiography or
abdominal CT before discharge, was 80.0% (12 of 15);
50% (3 of 6) in the LIHDE group and 100% in the LH
group. The ﬁnal rate of stone clearance after postopera-
tive choledochoscopic removal was 93.3% (14 of 15).
Conclusions: In this study, laparoscopic surgery for
right-side IHD stones showed a good result in clearance
of the stones, despite of the technical difﬁculty. However,
to establish the safety of this procedure, more accumu-
lation of experiences and technical reﬁnements will be
required.
MO-86
IS GENOTYPE ANALYSIS OF LIVER
ADENOMA USEFUL FOR THE
HEPATOBILIARY SURGEON? FROM A
SERIES OF 78 CONSECUTIVE PATIENTS
B. Alkofer1, C. Bazille2, E. Salame´1, P. Rousselot2,
L. Chiche1
1Department of hepatobiliary surgery, CHU Caen,
France; 2Department of pathology, CHU Caen, France
Background: Liver adenoma (LA) is a common benign
epithelial tumor of the liver. Its management remains a
challenge. A classiﬁcation has been proposed based on
the genotype: mutations of the hepatocyte nuclear factor
1 alpha in 35% of LA, associated with adenomatosis,
highly steatotic and usually asymptomatic, activating
beta catenin mutation in 10% of LA often associated
with a risk of malignant transformation, inﬂammatory
LA observed in 40% of cases and unclassiﬁed LA in
10%. This genotype classiﬁcation is not clearly linked to
clinical presentation.
Aim: We wondered if immunohistochemistry could be
helpful in the management of LA.
Methods: From 1994 to 2008, we studied all consecutive
patients operated on for LA. Final pathology and
immunohistochemistry were reviewed and compared
with clinical presentation to determine the help of a
preoperative biopsy in such lesions.
Results: Seventy eight patients were operated on. 16%
were unclassiﬁed. 48.6% were inﬂammatory, 3 of which
were associated with a Betacatenin mutation and one of
which was a hepatocellular carcinoma (HCC). Among
the 3 with the mutation, 1 was a HCC of fortuitous
discovery. 50% of patients were asymptomatic and 50%
experienced pain or bleeding. The evolution of all lesions
was stable after initial treatment in all cases. One patient
had a betacatenin mutation but was not associated with
malignant transformation. 31% were steatosic. 48%
presented with pain or bleeding whereas 44% were
asymptomatic. None were HCC, but among these LA, 5
(mostly adenomatosis) had an increase in lesion size and
appearance of new lesions.
Conclusion: Bcatenin mutation is not always associated
with malignant transformation. Inﬂammatory adenomas
can be associated with HCC even without the betacatenin
mutation. But HNF1alpha mutation is not synonymous
with asymptomatic or uncomplicated adenoma and can
be associated with evolutive forms of LA. Therefore
preoperative genotyping of LA should not be the main
factor of decision.
MO-87
MINIMAL RESIDUAL DISEASE IN
PANCREATIC CANCER - PILOT STUDY
D. Klos1, M. Lovecek1, J. Srovnal2, M. Kesselova2,
L. Radova2, M. Hajduch2, C. Neoral1 and R. Havlik1
1University Hospital Olomouc, Department of Surgery I;
2Palacky University Olomouc, Department of Pediatrics,
Laboratory of Experimental Medicine
Introduction: As the minimal residual disease (MRD) in
patients with pancreatic cancer we understand the pres-
ence of isolated tumor cells in the patient´s body, in which
the primary tumor was removed and is currently without
clinical signs of disease. These isolated tumor cells we can
describe as the precursors of micrometastases. Assess-
ment of MRD in patients with this highly malignant
disease could eliminate burdensome implementation of
surgery in patients with systematic dissemination of
molecular disease and more precise prognosis.
Material and methods: The study to date included 72
patients operated on with curative intent for carcinoma
of the pancreas. The method of real-time PCR to mea-
sure the expression of hTERT (telomerase), EGFR1
(epidermal growth factor receptor) and CEA (carcino-
embryonic antigen) examined samples of peripheral and
portal blood, bone marrow, and peritoneal lavage and
the tumor. Readings expression of markers tested were
correlated of with clinicopathological characteristics and
survival parameters.
Results and conclusion: We found a statistically signiﬁ-
cant association between EGFR expression levels in the
portal blood and clinical stage (patients with advanced
disease have a higher expression of EGFR in the portal
stream and the peritoneal lavage in contrast to patients
without the presence of metastases). Unfortunately, we
failed to demonstrate a signiﬁcant dependence between
the other tested markers (hTERT, CEA) and other
compartments (systematic blood, bone marrow). Fur-
thermore, EGFR positivity and CEA in pre-operative
peritoneal lavage means shorter overall survival of pa-
tients with pancreatic cancer. The results of our pilot
study conﬁrm the adequate sensitivity and speciﬁcity RT-
PCR method for detection of circulating tumor cells in
patients with pancreatic cancer. For the ﬁnal certiﬁed
prognostic value of MRD is necessary to monitor a lar-
ger group of patients.
Work on this project is supported by grant IGA MZ CR
9937-4.
Abstracts92
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
MO-88
ANTI-INFLAMMATORY EFFECTS OF
PERITONEAL LAVAGE IN ACUTE
PANCREATITIS
L. J. Souza1, A. M. M. Coelho1, S. N. Sampietre1,
J. O. Martins2, J. E. M. Cunha1 and M. C. C. Machado1
1Department of Gastroenterology/University of Sa˜o
Paulo; 2Institute of Biomedical Sciences/University of Sa˜o
Paulo
Background: Previous studies have demonstrated that
trypsin injection into the peritoneal cavity stimulates the
production of cytokines from peritoneal macrophages.
Therefore removing the pancreatitis-associated ascitic
ﬂuid from the peritoneal cavity may decrease the systemic
inﬂammatory response in acute pancreatitis (AP).
Aims: To investigate the effect of peritoneal lavage (PL)
on the systemic inﬂammatory response in a rat model of
AP.
Methods: AP was induced in Wistar rats by intraductal
injection of 5% sodium taurocholate. PL was performed
by infusion of 200 ml of warm peritoneal dialysis ﬂuid at
constant ﬂow (50 ml/h) for 4h after AP. Animals were
divided in: Group I (n = 10): Sham-operated rats, with
PL, Group II (n = 16): No treatment after the induction
of AP, and Group III (n = 16): PL after induction of
AP. After 4 hours of AP induction serum samples were
assayed for amylase TNF-a, IL-6 and IL-10. Expression
of pancreatic COX-2 and iNOS were analysed. Liver
mitochondria oxidation and phosphorylation and pul-
monary myeloperoxidase (MPO) activities were deter-
mined in hepatic and pulmonary tissues.
Results: A decrease in TNF-a and IL-6 serum levels, and
an increase of IL-10 serum levels were observed in PL
treated animals when compared to no treated animals.
The AP group with PL had signiﬁcant reduction of liver
mitochondria dysfunction when compared to group
without PL. There were no differences on serum amylase
levels and pulmonary MPO between groups with AP.
Conclusion: Peritoneal lavage has an anti-inﬂammatory
effect in AP and should be used to decrease the severity
of the disease.
MO-89
COMBINATION OF FEG AND
GALANTIDE AMELIORATES
CAERULEIN-INDUCED PANCREATITIS
IN MICE
S. G. Barreto1, C. Carati2, A. Schloithe1, R. Mathison3,
J. Davison3, J. Toouli2 and G. Saccone1
1Flinders University and Flinders Medical Center;
2Flinders University; 3University of Calgary
Background: We have shown that galantide, a galanin
receptor antagonist, ameliorates mild acute pancreatitis
(AP) induced in mice. We have also shown that the sal-
ivary tripeptide analogue feG ameliorates in a mouse
model of severe AP.
Aims: To compare the efﬁcacy of combining galantide
and feG in the treatment of AP.
Methods: Mild AP was induced in mice (7 hourly intra-
peritoneal (i.p.) injections of caerulein at 50 lg/kg).
In separate groups of mice, galantide (30 nmol/kg) was
co-administered with each caerulein injection, feG
(100 lg/kg) as a single dose i.p with the ﬁrst caerulein
injection and the combination of the two peptides as
indicated above. Control animals received galantide, feG,
or saline alone. Pancreata were harvested for histological
examination (% abnormal acinar cells) and estimation of
myeloperoxidase (MPO) activity. Plasma amylase and
lipase activity were measured. Statistical analysis used the
Mann-Whitney U test.
Results: Galantide signiﬁcantly reduced AP-induced hy-
perenzymaemia by 41–49%. Administration of feG alone
did not signiﬁcantly alter hyperenzymaemia. Combina-
tion of the two peptides signiﬁcantly reduced AP-induced
hyperenzymaemia by 39–40%. Plasma enzyme activity in
the controls was comparable with pre-treatment activity.
Galantide, feG, and their combination signiﬁcantly re-
duced MPO activity and % abnormal acinar cells.
Conclusion: Treatment with galantide alone ameliorates
all indices of mild AP whereas treatment with feG re-
duces pancreatic MPO and acinar cell damage. The
combination of the two peptides, however, offers no
further beneﬁt to treatment with only galantide. There is
a need to explore the combination of the two agents in
other, more severe models of AP.
MO-90
CC CHEMOKINE RECEPTOR 5D32 IS
ASSOCIATED WITH SURVIVAL AND
THE DEVELOPMENT OF
NONANASTOMOTIC BILIARY
STRICTURES AFTER LIVER
TRANSPLANTATION
S. Op den Dries1, C. I. Buis1, J. Adelmeijer1, E. J. van der
Jagt2, E. B. Haagsma3, T. Lisman1 and R. J. Porte1
1Department of HPB Surgery and Liver Transplantation,
University Medical Center Groningen, Groningen, The
Netherlands; 2Department of Radiology, University
Medical Center Groningen, Groningen, The Netherlands;
3Department of Hepatology, University Medical Center
Groningen, Groningen, The Netherlands
Background: Nonanastomotic bile duct strictures (NAS)
are a major cause of morbidity and graft failure in pa-
tients after orthotopic liver transplantation (OLT). A 32-
bp loss-of-function deletion in the chemokine receptor
CCR5 (CCR5-D32) in recipients has been associated with
improved survival after kidney transplantation. Para-
doxically, it has also been associated with the develop-
ment of NAS after OLT.
Aim: To study the impact of the CCR5-D32 mutation on
outcome after OLT.
Methods: In 384 liver transplantations we assessed
CCR5 genotype and correlated this with outcome vari-
ables.
Results: Of all patients, 2 (0.5%) were homozygous and
63 (16.4%) were heterozygous for the CCR5-D32 allele.
The 5-year patient survival rate was signiﬁcantly higher
in patients with CCR5-D32, compared with the CCR5
wild type (Wt) group (90.8% vs. 76.5%; P = 0.010).
The greater patient survival in recipients carrying
CCR5-D32 seemed to be explained by lower infection-
related mortality in this group (P = 0.082). Despite
improved patient survival, retransplantation rate within
the ﬁrst year after OLT was signiﬁcantly higher in
recipients carrying CCR5-D32 compared with CCR5 Wt
recipients (10.8% vs. 2.5%; P = 0.002). Retransplan-
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tation for NAS was observed in 4.6% of the recipients
carrying CCR5-D32 versus 0.6% in recipients with
CCR5 Wt (P = 0.010). In uni- and multivariate logistic
regression analysis, the overall risk of developing NAS
was 4-fold higher in recipients with CCR5-D32
(P = 0.002). The highest risk of NAS was seen in
patients transplanted for primary sclerosing cholangitis,
who also carried CCR5-D32.
Conclusion: While patient survival after OLT is signiﬁ-
cantly higher in patients with CCR5-D32, these recipients
have a 4-fold higher risk of developing NAS, compared
with CCR5 Wt recipients. NAS was a major indication
for retransplantation in patients with CCR5-D32. These
data suggest that immunological factors play an impor-
tant role in development of NAS after OLT.
MO-91
HEPATOCELLULAR CARCINOMA LESS
THAN 3 CM: RESECTION IS BETTER
THAN ABLATION: SINGLE CENTER
EXPERIENCE
M. Massani, C. Ezio, B. Luca, C. Ruffolo, M. Antoniutti
and N. Bassi
IV Department of Surgery, Regional center for HPB
Surgery, Regional Hospital Treviso
Abstract: Hepatocellular is a major worldwide problem
accounting for 80 to 90% of primary liver cancer, its
incidence ranging between 500.000 and 1.000.000 new
cases per year. Many treatments are now available but
Transplantation or Resection is the treatment of choice.
Unfortunately most patients are not suitable for surgery
and the only chance for cure for these patients is
ablation. We retrospectively reviewed data regarding
two groups of patients with lesions less than 3 cm. The
aim was to compare Resection to Ablation (radiofre-
quency or alcol injection). The two groups, 49 resected
and 51 ablated were all with a single naı¨ve hepatocellular
carcinoma less than 3 cm. The two groups were compa-
rable for age, sex, etiology of the cirrhosis. In the resected
group lesions in the posterior segment were 15 and 26 in
the ablated group, Child A was slightly higher in the
resected group. Outcomes were considered in terms of
overall survival and recurrence rate. Median survival in
the resected group was 40.6 months, while in the ablated
26.3, recurrence rate in ablated was 40% with a median
of 1.9 treatment for patient. Recurrence in the resected
was 15%, two patient were transplanted after recurrence.
Perioperative mortality was 0% in both groups, while
morbidity was higher in the resected group. It seems that
liver resection is the best treatment even for small HCC,
also as a bridge to liver transplantation.
MO-95
TOWARD 3D IMAGE-GUIDED
PANCREATIC SURGERY
S. Jayaraman, M. Gonen, P. Allen, M. Brennan,
M. D’Angelica, R. Dematteo, Y. Fong and W. Jarnagin
Memorial Sloan Kettering Cancer Center
Introduction: The Pathﬁnder image-guided liver surgery
system provides accurate 3D tumor and vascular delin-
eation. This software was modiﬁed for application to the
pancreas.
Aim: To demonstrate that preoperative planning 3D
images (segmentations) are accurate representations of
the conventional CT scans from which they are derived; a
required ﬁrst step for developing image-guided surgery.
Methods: Using a prospective database, we identiﬁed 20
patients with pancreatic head adenocarcinoma who had
CT scans and surgery at MSKCC. All were considered to
have potentially resectable tumors prior to operation.
Ten had unresectable, locally advanced tumors, while the
remaining 10 were resectable. Five pancreatic surgeons
blinded to resection outcome compared conventional
preoperative computed tomography scans (CT) to the
Pathﬁnder generated three dimensional (3D) images, in
random order. Each image was evaluated using a 5-point
scale as to resectability, vascular involvement, and need
for venous reconstruction. The ability to predict resect-
ability was compared using ROC curves. Vascular
involvement and the need for vein reconstruction were
assessed for agreement using Kappa.
Results: No difference in ROC area was found between
3D and CT (0.72 vs. 0.76, P = 0.5) conﬁrming that 3D
reconstruction accurately replicated the ﬁndings on the
CTs from which they were derived. There was only fair
agreement regarding vein involvement (K = 0.23,
P < 0.001) and the need for vascular reconstruction
(K = 0.24, P < 0.001). Arterial involvement was in
poor agreement (K = 0.09, P = 0.09).
Conclusions: The Pathﬁnder liver system can be adapted
to pancreas images with accurate and user friendly 3D
image reconstruction. Future work should focus on
improving the relationship of pancreatic tumors to mes-
enteric vasculature toward the goal of enhanced preop-
erative assessment of tumor resectability and facilitating
a study of intraoperative image registration.
MO-96
THE EFFECT OF SURGEON VOLUME
ON THE OUTCOME OF
PANCREATICODUODENECTOMY IN A
HIGH-VOLUME INSTITUTION
G. Balzano, G. Capretti, M. Braga, N. Pecorelli, A. Zerbi
and V. Di Carlo
Pancreas Unit, Dept. of Surgery, San Raffaele Scientiﬁc
Institute, Via Olgettina 60, 20132, Milan, Italy
Background: The contribution of surgeon volume on
pancreaticoduodenectomy (PD) outcome is controver-
sial. Moreover, multinstitutional reviews do not allow the
reliable comparison of single complications.
Aim: To clarify the effect of surgeon volume on the
outcome of PD in a single high-volume institution.
Methods: We analyzed prospectively collected data on
610 patients who underwent PD from August 2001 to
August 2009. Cut-off value between high and low-vol-
ume surgeons (HVS and LVS) was chosen upon the
median value of PD/year/surgeon (18/year). Primary
endpoint was operative mortality (death within 30-day
post-discharge); secondary endpoints were morbidity
(graded by Clavien-Dindo classiﬁcation), pancreatic ﬁs-
tula (PF) (ISGPF deﬁnition) and postoperative stay.
Demographic, pathologic and intraoperative data
(including pancreas consistency and duct diameter) were
recorded. Uni- and multivariate analysis was performed
(logistic regression models).
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Results: Mortality was 4.1% morbidity was 61.4%, with
27.3% PF occurrence (grade A 14.2%, B 8%, C 5.4%).
Two HVS performed 358 PD (58.6%) (26 and 18 PD/
year, respectively) while LVS performed 252 PD (41.4%)
(range 1–10). Mortality was similar for both HVS and
LVS (3.9% vs. 4.3%), but morbidity was lower for HVS
(56.6% vs. 67.7%, P = 0.03). Severe complications
(grade 3b-5) were similar in HVS and LVS (9.8% vs
10.4%), whereas mild complications (1-3a) were higher
for LVS (46.8% vs 57.4%, P = 0.01). PF rate was higher
for LVS as well (24.1% vs 32.4%, P = 0.03); grade A PF
were 12.6% and 16.6% (P = 0.20) and grade B-C PF
were 11.5% and 15.8% (P = 0.14). Median postopera-
tive stay was 13 vs 14 days (P = 0.04). At multivariate
analysis, risk factors for PF were duct diameter
(P < 0.001), pancreas consistency (P < 0.001) and LVS
(P = 0.01).
Conclusion: Surgeon volume has an impact on the rate of
PF and overall morbidity. However, this does affect
neither mortality nor severe morbidity, for the protective
effect of hospital volume.
MO-97
PROSPECTIVE STUDY GASTRIC
EMPTYING AND NUTRITIONAL
STATUS AFTER PYLORUS-PRESERVING
VERSUS SUBTOTAL STOMACH-
PRESERVING PANCREATICODUO-
DENECTOMY
K. Chijiiwa, M. Hiyoshi, J. Ohuchida and N. Imamura
Miyazaki University School of Medicine Department of
Surgery 1
Background: Pylorus-preserving pancreaticoduodenec-
tomy (PPPD) is a standard surgical procedure for treat-
ment of periampullary diseases. Delayed gastric
emptying (DGE) is a speciﬁc, worrisome complication
after PPPD, whereas subtotal stomach-preserving pan-
creaticoduodenectomy (SSPPD) that excises the pylorus
ring seems to be effective in reducing DGE. This study
compared gastric emptying and nutritional status be-
tween PPPD and SSPPD over 1 year.
Methods: From June 2003 to December 2007, 41 patients
(PPPD: 33, SSPPD: 8) were enrolled in this study to
evaluate clinical DGE after pancreaticoduodenectomy.
Clinical DGE was deﬁned as (i) the need for nasogastric
tube decompression for ‡ 10 days (DGE10) or (ii) the
inability to take a solid meal until 14 days after surgery
(DGE14). Gastric emptying was evaluated by 13C-acetate
breath test before and at 1, 3, 6, 9, and 12 months
postoperatively. Nutritional status (body weight, serum
levels of total protein, albumin, and total cholesterol) was
similarly assessed.
Results: Clinical DGE at DGE10 was absent in the
PPPD and SSPPD groups, but DGE14 was observed
without statistical signiﬁcance in 33.3% and 50.0% of
patients, respectively. Gastric emptying evaluated at T1/2
(half-emptying time) showed function signiﬁcantly better
preserved at 3, 6, and 12 months after PPPD than after
SSPPD. Body weight recovery was signiﬁcantly better at
6 and 12 months after PPPD than after SSPPD. Other
nutritional parameters were better preserved in the PPPD
group during 1-year follow-up.
Conclusions: PPPD and SSPPD showed similar inci-
dences of clinical DGE. Long-term, however, PPPD is a
more suitable surgical procedure than SSPPD in regard
to gastric emptying and nutritional status.
MO-99
THE PANCREATICO-JEJUNAL
ANASTOMOTIC STENT: FRIEND OR
FOE?
T. E. Sachs1, T. S. Kent1, M. P. Callery1, W. B. Pratt2
and C. M. Vollmer1
1Beth Israel Deaconess Medical Center, Harvard Medical
School; 2Harvard Medical School
Background: Despite common use in clinical practice,
the efﬁcacy of pancreato-jejunal (PJ) anastomotic stents
in preventing clinically relevant ﬁstulas (CR-POPF) after
pancreatic resection is poorly understood.
Aim: To compare the outcomes of stented & non-stented
patients in light of known risk factors for CR-POPF
development.
Methods: Three hundred and forty seven patients
underwent proximal or central pancreatic resection w/ PJ
reconstruction from 2001–09. At the surgeon’s discretion
a PJ stent (5 or 8 Fr silastic tube) was placed in 60 pa-
tients (46 short internal, 14 external). Demographics, co-
morbidities & adjusted outcomes were studied b/w co-
horts. Risk factors for CR-POPF (ISGPF Grade B or C)
development have previously been deﬁned as soft gland,
small duct size, high risk pathology or excessive blood
loss (> 1000 mL). Risk factor proﬁle refers to number of
accrued risk factors (0–4).
Results: Demographics of age, sex, BMI, ASA class &
POSSUM score were equivalent b/w cohorts. The CR-
POPF risk factor proﬁle was higher in patients w/ stents
(P < .01). Stented patients actually had signiﬁcantly
higher rates of CR-POPF (30 vs. 12%), overall (72 vs.
54%) & major (30 vs. 14%) complications, greater LOS
(9 vs. 8 d) & total costs ($24,027 vs. $20,617) (all
P < .05). When examined by risk factors, the use of a PJ
stent did not confer protection from ﬁstula development.
In fact, CR-POPF was more common when stents were
employed (Table). There were no differences b/w internal
& external stents. Extended post-op imaging was avail-
able for 23 stented patients. Of these, one-third of stents
were retained past 6 wks, & one-fourth beyond 6 month.
Stents migrated to the PB drainage limb (n = 4), the
biliary tree (n = 3) & the peritoneum (n = 1). Four
patients required stent removal by endoscopy or surgery.
CR-POPF Development based on deﬁned risk factors
Factor No Stent Stent P-Value
Small Duct 11 / 45 (24.4%%) 14 / 46 (30.4%%) 0.785
Soft Gland 26 / 130 (20%%) 18 / 45 (40%%) 0.058
High Risk Pathology 21 / 106 (19.8%%) 12 / 27 (44.4%%) 0.054
EBL >> 1000 4 / 12 (33.3%%) 3 / 6 (50%%) 0.627
0 Risk Factors 2 / 107 (1.9%%) 0 / 3 (0%%) 0.95
1 Risk Factor 10 / 95 (10.5%%) 3 / 15 (20%%) 0.133
2 Risk Factors 16 / 67 (23.9%%) 4 / 19 (21.1%%) 0.798
3 Risk Factors 4 / 19 (21.1%%) 7 / 19 (36.8%%) 0.652
4 Risk Factors 2 / 2 (100%%) 4 / 4 (100%%) 1
Conclusion: The use of PJ stents does not decrease the
incidence of CR-POPF after proximal or central pan-
creatic resection. In fact, in some patients PJ stents may
lead to short & long term adverse outcomes.
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IMPACT OF BODY MASS INDEX AND
PREOPERATIVE HYPERGLYCEMIA ON
MORBIDITY AFTER PANCREATICO-
DUODENECTOMY
J. Liles, C. Shubert and J. Christein
University of Alabama at Birmingham
Background: Malignant pathology is associated with a
higher rate of operative complications after pancreati-
coduodenectomy (PD). Few series have evaluated the
impact of both obesity and preoperative hyperglycemia
(PHG) on morbidity in these patients.
Aim: To evaluate the impact of obesity and PHG on
perioperative complications in patients undergoing PD
for malignancy.
Methods: Patients undergoing PD by the senior author
between 2006 and 2009 were retrospectively analyzed.
Complications included, but were not limited to, leak,
delayed gastric emptying (DGE), hemorrhage, and
infection (abscess, wound, urinary, bacteremia, pneu-
monia). We deﬁned PHG according to ADA deﬁnition of
diabetes (fasting glucose > 126 mg dL-1). The chi square
test was used for comparisons.
Results: One hundred and sixteen patients underwent
PD for malignant pathology (77% pancreatic ductal
adenocarcinoma, 15% ampullary, 8% cholangiocarci-
noma). Twenty seven were obese (BMI > 30) and these
patients did not demonstrate a higher rate of overall
(P = 0.46) or infectious complications (P = 0.54).
Among the 42 patients with PHG, obesity was not
associated with more complications (P = 0.41). Patients
with PHG were signiﬁcantly more likely to have DGE
(P < 0.05) and infectious complications (P < 0.01),
speciﬁcally, wound and intra-abdominal infections
(P < 0.01). Additionally, these patients demonstrated a
trend toward more readmissions (0.3 vs. 0.5 readmis-
sions; P = 0.08) and longer post-operative hospitaliza-
tions (9.4 vs. 11.2 days; P = 0.09). On multivariate
analysis, PHG was the strongest predictor of morbidity
(P < 0.05). Furthermore, well-controlled diabetics
(< 126 mg dL-1) had signiﬁcantly fewer infectious com-
plications than poorly controlled diabetics (P < 0.05).
Conclusions: In patients undergoing PD for malignant
pathology, PHG is a stronger predictor than obesity of
perioperative morbidity, especially infections. Therefore,
we recommend aggressive control of hyperglycemia in
the preoperative setting to minimize overall and infec-
tious complications.
MO-102
PANCREATICODUODENECTOMY FOR
DUODENAL POLYPOSIS IN FAMILIAL
ADENOMATOUS POLYPOSIS: IS IT
THE RIGHT PROCEDURE?
F. Paye1, F. Caillie1, B. Desaint2, N. Mourra3,
P. Balladur1, Y. Parc1 and E. Tiret1
1Department of Digestive and Hepato-Biliary Surgery,
Saint Antoine Hospital 75012 Paris; 2Department of
Gastroenterology, Saint Antoine Hospital 75012 Paris;
3Department of Pathology, Saint Antoine Hospital 75012
Paris
Background: Pancreas sparing duodenectomy (PSD) has
been recently proposed for radical treatment of severe
duodenal polyposis in Familial Adenomatous Polyposis
(FAP) as an alternative of pancreaticoduodenectomy.
Objective: To assess the results of pylorus preserving
pancreaticoduodenectomy (PPPD) for severe duodenal
polyposis in Familial Adenomatous Polyposis (FAP) and
those of endoscopic follow-up of proximal jejunum.
Methods: Nineteen FAP patients among 122 followed
for duodenal polyposis underwent PPPD for severe
duodenal polyposis (17 Spigelman IV, 1 Spigelman III, 1
invasive carcinoma). All were previously treated for
colorectal lesions. Reconstructive procedure enabled
post-operative endoscopic access to proximal jejunum.
Results: Post-operative mortality was nil. Global mor-
bidity rate was 42%, including one acute pancreatitis
requiring completion pancreatectomy, 4 pancreatic ﬁst-
ulae (21%) which were treated medically and 2 delayed
gastric emptying (10.5%). The mean hospital stay was
27 days. Pathological examination found 7 invasive car-
cinomas, of which only one was known before resection.
After a mean follow-up of 58 months, 16 patients were
alive and well and 3 were deceased (2 of tumorous
recurrence and 1 of suicide). Thirteen patients underwent
endoscopic follow-up and new adenomas were found in
31% within a mean of 71 months. They were not located
in the vicinity of the biliary-jejunal anastomosis All were
treated successfully during the same endoscopic proce-
dure. PPPD did not modify the functionnal result after
coloproctectomy.
Conclusions: PPPD remains a safe and efﬁcient thera-
peutic option for severe duodenal polyposis in FAP pa-
tients. PSD reported results are not better than those of
PPPD and might be not the right procedure in case of
occult carcinoma. Endoscopic follow-up of proximal
jejunum is mandatory.
MO-103
THE ROBOTIC WHIPPLE: INITIAL
EXPERIENCE AND TECHNICAL
CONSIDERATIONS
S. Mackenzie, K. Kosari and T. Sielaff
Virginia Piper Cancer Institute
Background: Advances in robotic surgery have allowed
the expansion of minimally invasive surgery in pancre-
aticobiliary surgery. Our initial experience with robotic
Whipple is presented.
Objective: To prospectively evaluate our initial experi-
ence with the robotic Whipple.
Methods: Over a one-year period, after initiating our
robotic pancreatic program, 10 patients were prospec-
tively evaluated. Five patients had a completed totally
robotic Whipple procedure, including pancreaticojejun-
ostomy duct-to-mucosa anastomotic reconstruction. The
remaining 5 patients were converted from the robotic
procedure to a standard open Whipple procedure, due to
technical difﬁculties related to body habitus or inﬂam-
mation related to acute on chronic pancreatitis.
Results: The 5 totally robotic Whipple procedure pa-
tients were carefully selected for premalignant peri-
ampullary disease (2 IPMNs, ampullary carcinoid, and
head dominant pancreatitis) and a small-localized
ampullary adenocarcinoma. Average robotic operating
time was 8.3 hour (range 5.8–11 hour), with robotic
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docking less than 10 min in each case. Pancreatic duct
leak occurred in 1 of the 5 patients. Average blood loss
per operative case was 125cc, with no patients requiring a
blood transfusion. The median length of hospitalization
was 5.75 days (compared to 7.8 days for open Whipples
during a similar time period). There were no 30-day
mortalities and no major complications.
Discussion: The magniﬁcation and wrist articulation of
the robot, allow safe dissection and microsurgery
reconstruction during the Whipple procedure.
Conclusions: Our initial experience with the robotic
Whipple appears to have a similar outcome proﬁle, when
compared to the open Whipple procedure during a sim-
ilar time period.
MO-105
LOCALLY ADVANCED MALIGNANCIES
OF THE PANCREATIC BODY: CELIAC
AXIS RESECTION AND SUBSEQUENT
LIVER REARTERIALIZATION
TECHNIQUES
E. Vicente, Y. Quijano, R. Conradi, C. Loinaz,
P. Galindo, M. Marcello, H. Dura´n, E. Esteban,
M. Idrovo, N. Sa´nchez-Ferna´ndez, M. Pringles and
I. Fabra
Hospital Madrid-Norte-Sanchinarro, Centro Integral
Oncolo´gico Clara Campal (CIOCC), Universidad San
Pablo CEU, Facultad de Medicina, Madrid, Spain
Introduction: Pancreatic body tumors are associated with
a low resectability, mainly due to major vessels involve-
ment.
Aim: To present our experience in radical pancreatec-
tomy with en bloc resection of the celiac axis and dif-
ferent liver rearterialization techniques.
Methods: Seven patients with pancreatic carcinoma of
the body (3) or head-body (4) and arterial involvement
underwent radical resections. Encasement of the celiac
axis (5), common hepatic artery (7) and splenic artery (4)
was found. Complete resection (R0) was achieved by
corporocaudal (4) and total pancreatoduodenectomy (3)
with en bloc resection of the celiac axis and its branches.
Combined resection of superior mesenteric vein was re-
quired (4). Two patients showed no necessity of revas-
cularization because of preserved hepatic arterial ﬂow
through the pancreatoduodenal arcade (Appleby opera-
tion). Four patients underwent arterial reconstruction:
end-to-end anastomosis (common hepatic artery-celiac
axis stump) (2) or PTFEt grafting (1).
Results: Operative time: 350–820 min. Intraoperative red
blood transfusions: 3-8 units. AST-ALT postoperative
day one: 210–620 and 130–590 (arterial reconstruction);
1200 and 1080 (Appleby). Abdominal pain was relieved
after surgery in all cases. Mortality (30 days): 1/7 (no
vascular or digestive complications demonstrated). Four
patients are alive and disease free 3, 8, 20 and 24 months
after surgery. One patient is alive 43 months after surgery
with tumoral recurrence. One patient died 2 months after
surgery.
Conclusions: An extremely selected population of pa-
tients could beneﬁt from radical pancreatectomy with
celiac axis resection in terms of quality of life (relief of
pain). Late outcome should be further studied.
MO-106
THE USE OF THE COMPRESSION
ANASTOMOSIS CLIP (CAC) IN
PANCREATIC SURGERY– OUR
PRELIMINARY EXPERIENCE
P. Lampe1, K. Kusnierz1 and D. Zhavoronkov2
1The Department of Gastrointestinal Surgery, Medical
University of Silesia, Katowice, Poland; 2The Department
of Gastrointestinal Surgery, Central Teaching Hospital,
Katowice, Poland
Background: Gastrointestinal surgery, such as pancreas
surgery, requires searching new and safe methods of
anastomosis, which will also be time-saving during sur-
gical procedures.
Aim: Current study was designed to evaluate the role of
a new type of tissue compression anastomosis performed
with a reversible, temperature-dependent memory-shape
device: the CAC (Compression Anastomosis Clip).
Methods: We performed 11 pancreatoduodenectomies
(6Whipple, 3Traverso and 2Flautner reconstructions)
with 13 CAC anastomoses. Pancreatoduodenectomies
were performed because of head of the pancreas cancer.
The CAC is a double-ring made of Nitinol (an alloy
containing a mixture of nickel and titanium), elliptical
device with a diameter of 30mm. The CAC is placed in
ice water (0C) to open the rings. It then becomes ﬂexible
with an opening angle of 30 to 40. The CAC is placed
directly on the tissue to exert strong local pressure and
thereby induce local necrosis. The device has the ability
to recover its original closed shape when it senses a
change in ambient temperature (in contact with body
temperature). The continuous compression of the tissue
entrapped by the CAC leads to full tissue necrosis after
7–10 days and detaches from the tissue to be expelled
with the stool.
Results: Our experience: 13 anastomoses: hepaticojejun-
ostomy-2, gastrojejunostomy-6, jejunojejunostomy-5
(Brown anastomosis). No complications up today.
Conclusion: CAC is a safe, easy to apply, superior to
conventional anastomoses with regard to operative time
and a fully no-touch technique type of anastomosis.
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SURGERY REMAINS THE BEST OPTION
FOR MANAGEMENT OF PATIENTS
WITH CHRONIC PANCREATITIS
C. Kyriakides1, A. E. Frampton1, P. Limongelli1,
D. Westaby2, P. Vlavianos2 and L. R. Jiao1
1Division of Surgery, HPB Surgery Unit, Hammersmith
Hospital, Imperial College London, UK; 2Department of
Gastroenterology, Hammersmith Hospital, Imperial
College London, UK
Objective: Controversy related to endoscopic or surgical
management of patients with chronic pancreatitis (CP)
remains due to a lack of adequately powered randomised
control trials. A systematic review of the published data
was carried out to address issues related to the outcome
and choice of treatment for CP.
Methods: Search of published articles on endoscopic or
surgical treatment of chronic pancreatitis from January
1994 to December 2008 using the search engines of
Medline, Embase and the Cochrane Collaboration
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database was carried out. Keywords such as CP, endo-
scopic, stenting, surgical, drainage, resection, pancreat-
icojejunostomy and Whipple’s were used in various
combinations. Meta-analysis was performed on studies
fulﬁlling the selection criteria with data on morbidity,
mortality and pain control.
Results: A total of 18 articles that fulﬁlled the selection
criteria were included in the statistical analysis. Only two
articles were randomised trials (RCT). Analysis of these 2
RCTs (n = 180) revealed that surgical treatment was
signiﬁcantly better than the endoscopic option for either
complete pain resolution or partial pain resolution
(P < 0.0001).
Sixteen non-RCT publications with a total of 2109
patients were identiﬁed. The results showed that the
complete and partial pain control was achieved in 50.2%
and 74.1% patients respectively in the surgical group,
whilst 49.8% and 25.9% respectively in the endoscopic
group.
Complications were higher (17.8%) in the surgical group
compared to the endoscopic group (2.7%) including
cholecystitis, pancreatitis, bleeding, leakage, infection
and death.
Conclusion: Surgery remains the most effective treatment
for CP, with a higher proportion of patients achieving
lasting pain relief.
MO-108
BILIARY DRAINAGE PRIOR TO
PANCREATICODUODENECTOMY FOR
CANCER: LOCATION COUNTS
M. Duxbury1, E. Scott1, A. Miller2 and E. Hidalgo1
1Hepatobiliary & Pancreatic Surgery Unit, Royal
Inﬁrmary of Edinburgh; 2Endoscopy Unit, Royal
Inﬁrmary of Edinburgh
Background: Preoperative endoscopic biliary drainage
(PEBD) before pancreaticoduodenectomy (PD) remains
controversial.
Objective: To determine the effects of PEBD on short-
term outcome of patients undergoing PD for pancreatic
adenocarcinoma in a regional HPB Surgery unit.
Methods: 100 consecutive initially hyperbilirubinaemic
patients undergoing PD for histologically conﬁrmed
pancreatic adenocarcinoma were identiﬁed from a pro-
spectively maintained database. Patient demographics,
serum bilirubin, complications (Clavien classiﬁcation),
length of stay, in-hospital mortality, use of PEBD,
location in which PEBD was performed, and time from
PEBD to PD were ascertained. Three groups were de-
ﬁned:
1. No-PEBD,
2. PEBD in HPB surgery unit (PEBD-HPB).
3. PEBD in non-HPB surgery unit (PEBD-nHPB).
Patients undergoing primary preoperative percutaneous
transhepatic biliary drainage (PTBD) were excluded.
Results: Mean patient age was 66 years (SD=11.9),
M:F=56:44. 74 patients underwent PEBD prior to PD,
of whom 53 (72%) patients underwent PEBD-HPB and
21 (28%) underwent PEBD-nHPB. In-hospital mortality
did not differ signiﬁcantly between the 3 groups. Mean
preoperative serum bilirubin was signiﬁcantly higher in
No-PEBD (P < 0.01). Mean length of stay and occur-
rence of infective wound complications were signiﬁcantly
higher in PEBD-nHPB, vs. PEBD-HPB and No-PEBD
patients (P = 0.035). Mean PEBD to PD interval was
higher in the PEBD-nHPB vs. the PEBD-HPB group
(P = 0.045). 6 patients required PTBD following at-
tempted PEBD: 5 PEBD-nHPB and 1 PEBD-HPB pa-
tient.
Conclusion: PEBD prior to PD did not improve short-
term perioperative morbidity and mortality. Pre-
operative PEBD may be detrimental when performed in
non-HPB units, where increased PEBD to PD interval
and PTBD requirement have been identiﬁed. The role of
PEBD prior to PD warrants further prospective clinical
evaluation.
MO-109
SYNDECAN2 PROMOTES PERINEURAL
INVASION AND COOPERATES WITH
KRAS TO INDUCE AN INVASIVE
PANCREATIC CANCER CELL
PHENOTYPE
T. De Oliveira, W. Michalski Christoph, I. Abiatari,
D. Sauliunaite, H. Friess and J. Kleeff
Surgery Department of Klinikum rechts der Isar –
Technische Universita¨t Mu¨nchen. Munich, Germany
Background: Using a recently developed in vitro model,
we have identiﬁed syndecan-2 as a protein potentially
involved in perineural invasion of pancreatic adenocar-
cinoma (PDAC) cells.
Methods: Syndecan-2 (SDC-2) expression was analyzed
in human normal pancreas, chronic pancreatitis and
PDAC tissues by immunohistochemistry, western blot,
quantitative real time PCR and immunoprecipitation.
Functional in vitro assays were carried out to determine
its role in invasion, migration and signaling. Differences
in survival were analyzed using the Kaplan-Meier
method.
Results: SDC-2 was expressed in the majority of the
tested pancreatic cancer cell lines while it was upregu-
lated in nerve-invasive PDAC cell clones. There were two
distinct expression patterns in PDAC tissue samples: in
approximately one third of the cases, there was SDC-2
positivity in the cancer cell cytoplasm and in two thirds
of the tissues, a peritumoral expression pattern was
found; the latter correlated with longer survival following
cancer resection. Though SDC-2 silencing (using speciﬁc
siRNA) did not affect anchorage-dependent growth, it
signiﬁcantly reduced cell motility and invasiveness. This
was also reﬂected on a transcriptional level where
migration- and invasion-associated genes were down-
regulated following SDC-2 RNAi. Furthermore, SDC-2
silencing reduced K-ras activity, binding of p120-GAP to
SDC-2 and – further downstream – phosphorylation of
ERK2.
Conclusion: Peritumoral SDC-2 is related to survival
following pancreatic cancer resection. SDC-2 is a novel
(perineural) invasion-associated gene in PDAC which
cooperates with K-ras to induce a more invasive pheno-
type.
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CAN A MULTIDISCIPLINARY TEAM
APPROACH CORRECTLY IDENTIFY
THE NATURE OF PANCREATIC CYSTIC
LESIONS REQUIRING RESECTION?
G. Morris-Stiff1, G. Lentz1, S. Chalikonda1,
M. Johnson1 and M. R. Walsh1
1Department of Hepato-Pancreato-Biliary Surgery,
Cleveland Clinic Foundation, Cleveland, Ohio
Background: Pancreatic cystic lesions can be notoriously
difﬁcult to characterise. We have developed an algorithm
for these lesions based on symptoms, size, symptoms and
cyst ﬂuid analysis.
Aims: To determine if the protocol accurately identiﬁes
pre-operative pathology and is able to identify lesions in
need of excision based on risk of malignancy.
Methods: The pancreatic cyst database which was ac-
cessed to identify patients that had undergone resection.
Details of pre-operative investigations including cyst
ﬂuid analysis were recorded. The ﬁnal pre-operative
diagnosis was then compared to the histopathological
ﬁndings. Lesions with malignant potential (IPMN,
mucinous cystadenoma, neuroendocrine) were grouped.
As a secondary analysis, symptomatic lesions were added
to this cohort.
Results: 174 patients were identiﬁed. Diagnostic work-up
included: CT (n = 174); MRCP (n = 69); ERCP
(n = 38); EUS (n = 135); and cyst ﬂuid analysis (mucin,
CEA, cytology) at EUS (n = 121). A ﬁnal pre-operative
of malignant or pre-malignant condition was established
in 132 cases. Of the remaining 42 cases, 32 reported cyst-
related symptoms and the remainder were asymptomatic.
The sensitivity, speciﬁcity, positive and negative predic-
tive values for the ﬁnal diagnosis the corresponding val-
ues were 85.6%, 67.2%, 91.9% and 62.7%, and for the
combination of ﬁnal diagnosis and symptoms were
99.4%, 100%, 100% and 90%. The kappa statistic for
ﬁnal diagnosis in relation to malignant or pre-malignant
lesions was k = 0.58 (P £ 0.05) and when symptomatic
cases were included, this improved to k = 0.94
(P £ 0.05). Only one patient, an individual with a neu-
roendocrine tumour, was incorrectly classiﬁed as benign
based on an assessment of symptoms and evaluation.
Conclusions: Selecting patients for resection based on
our algorithm to detect those with malignancy/malignant
potential, and supplementing with symptomatic patients
identiﬁes those who should undergo resection.
MO-111
PET/CT USING 18F-FLUOROMETHYL-
CHOLINE TO DIFFERENTIATE FOCAL
NODULAR HYPERPLASIA FROM
HEPATOCELLULAR ADENOMA;
PRELIMINARY RESULTS
J. Van Den Esschert1, M. Bieze1, R. Bennink2 and
T. Van Gulik1
1Department of Surgery, Academic Medical Center
Amsterdam; 2Department of Nuclear Medicine, Academic
Medical Center Amsterdam
Background: It is important to differentiate Focal Nod-
ular Hyperplasia (FNH) from Hepatocellular Adenoma
(HCA) because of the therapeutic consequences. Unlike
FNH, HCA>5cm should be resected because of the
potential risk of bleeding and malignant transformation.
Diagnosis based on radiological studies remains difﬁcult
and when the diagnosis is unclear, a tumor biopsy is
ultimately performed. Therefore, there is a need for
accurate non-invasive diagnostic imaging techniques. A
recent report suggests PET/CT using the tracer 18F-ﬂu-
oromethylcholine (FCh) to be able to differentiate be-
tween FNH and HCA.
Objective: To evaluate the accuracy of PET/CT using the
FCh tracer in differentiating FNH from HCA.
Methods: This study is part of a large clinical trial and
supported by the local ethics committee. Informed con-
sent was obtained of all patients. Twelve patients with a
lesion in the liver suspected of FNH or HCA underwent
a FCh PET/CT. Fifteen minutes after intravenous
injection of the FCh, a PET and a low dose CT scan were
performed. The FCh PET/CT was found positive if the
ratio between the maximum standardized uptake value
(SUV) of the tumor and the mean SUV of the normal
surrounding liver parenchyma was above 1.15. Imaging
results were compared with histological outcome ob-
tained by either liver biopsy or resection specimen.
Results: Twelve women were included with histologically
proven FNH (n = 6) and HCA (n = 6). All FNH lesions
showed increased uptake of FCh (mean SUV ratio
1.78 ± 0.09 SD). In contrast, none of the HCAs showed
increased uptake (mean SUV ratio 0.92 ± 0.06 SD).
Conclusion: FCh PET/CT is a promising diagnostic tool
to differentiate FNH from HCA. In contrast to HCA,
FNH shows increased uptake of FCh.
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MINIMALLY INVASIVE STEP-UP
APPROACH VS. OPEN
NECROSECTOMY IN NECROTIZING
PANCREATITIS: A RANDOMIZED
CONTROLLED MULTICENTER TRIAL
H. Van Santvoort1, M. Besselink1, O. Bakker1,
S. Hofker2, M. Boermeester3, C. Dejong4, H. Van Goor5,
S. Alexander6, C. Van Eijck7, T. Bollen8,
B. Van Ramshorst8, V. Nieuwenhuijs2, R. Timmer8,
J. Lameris3, P. Kruyt9, E. Manusama10,
E. Van Der Harst11, G. Van Der Schelling12,
T. Karsten13, E. Hesselink14, L. Cornelis V.15,
C. Rosman16, K. Bosscha17, R. De Wit18, A. Houdijk19,
M. Van Leeuwen1, E. Buskens20 and H. Gooszen1
1University Medical Center Utrecht; 2University Medical
Center Groningen; 3Academic Medical Center
Amsterdam; 4Maastricht University Medical Center;
5St. Radboud University Medical Center Nijmegen;
6Leiden University Medical Center; 7Erasmus Medical
Center Rotterdam; 8St. Antonius Hospital Nieuwegein;
9Gelderse Vallei Hospital Ede; 10Medical Center
Leeuwarden; 11Maasstad Hospital Rotterdam; 12Amphia
Hospital Breda; 13Reinier de Graaf Hospital Delft; 14Gelre
Hospitals Apeldoorn; 15St. Elisabeth Hospital Tilburg
(currently St. Radboud University Medical Center
Nijmegen); 16Canisius Wilhelmina Hospital Nijmegen;
17Jeroen Bosch Hospital Den Bosch; 18Medisch Spectrum
Twente Enschede; 19Medical Center Alkmaar;
20University Medical Center Utrecht (currently University
Medical Center Groningen)
Background: Infected necrotizing pancreatitis is asso-
ciated with high morbidity and mortality. Current
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standard treatment is open necrosectomy. Outcome may
be improved by a minimally invasive step-up approach.
Methods: In this multicenter study, we randomly as-
signed 88 patients with (suspected) infected necrotizing
pancreatitis to primary open necrosectomy or a step-up
approach. The step-up approach consisted of percuta-
neous drainage followed, if necessary, by minimally
invasive retroperitoneal necrosectomy. The primary
endpoint was a composite of major morbidity (new onset
multiple organ failure, perforation of a visceral organ or
enterocutaneous ﬁstula, bleeding) and mortality during
admission and 3 months follow-up. Secondary endpoints
included other morbidity and total costs at 6 months
follow-up.
Results: The primary endpoint occurred in 31 of 45 pa-
tients (69%) assigned to open necrosectomy and in 17 of
43 patients (40%) assigned to the step-up approach (risk
ratio 0.57, 95% conﬁdence interval 0.38 to 0.87,
P = 0.006). In the step-up approach group, 35% of
patients were successfully treated with percutaneous
drainage only and did not require necrosectomy. New
onset multiple organ failure occurred less often in the
step-up approach group (12% vs. 40%; P = 0.002). At 6
months follow-up, patients in the step-up approach
group had a lower rate of incisional hernias (7% vs. 24%;
P = 0.03), use of pancreatic enzymes (7% vs. 33%;
P = 0.002) and new onset diabetes (16% vs. 38%;
P = 0.02). Mean total costs per patient were $15,963
(12%) lower in the step-up approach group.
Conclusions: A minimally invasive step-up approach, as
compared to open necrosectomy, reduced the rate of the
composite endpoint of major morbidity and mortality as
well as long-term morbidity and costs in patients with
(suspected) infected necrotizing pancreatitis. In these
patients, percutaneous drainage should be considered as
the ﬁrst step of treatment.
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IMAGING MODALITIES BEFORE LIVER
RESECTION FOR COLORECTAL
METASTASES: WHICH, WHEN AND
HOW MANY?
P. Banghui1, L. Chiche1, B. Alkofer1, E. Salame´1,
N. Bouvard2 and V. Lepennec2
1Department of hepatobiliary surgery, CHU Caen,
France; 2Department of radiology, CHU Caen, France
Background: Surgery remains the sole curative option
for colorectal liver metastases (CRLM’s), if a R0 resec-
tion can be achieved. Hence accurate pre operative
staging is mandatory. Multi detector row computed
tomography scan (MDCT) has been proposed as the
imaging modality of choice for pre-resection staging.
Super paramagnetic iron oxide-enhanced MR imaging
(SPIO-MRI) and contrast enhanced ultrasound (CEUS)
are emerging as high performance and perhaps more
accurate investigations. The optimal pre operative stag-
ing strategy is yet to be deﬁned.
Aims: To prospectively compare the accuracy of 2D
ultrasonography (USG), CEUS, MDCT, dynamic gad-
olinium-enhanced magnetic resonance imaging and
SPIO-MRI in pre operative staging of CRLM’s, and to
develop a staging algorithm for better patient selection
for resection.
Methods: Prospective and systematic evaluation of 37
patients with CRLM’s was carried out with 5 imaging
modalities. The results were correlated with intra oper-
ative ultrasonography and histopathology.
Results: The accuracy of imaging modalities for all le-
sions (n = 130), in patients with upto 3 liver lesions and
in patients with more than 3 liver lesions are shown in the
table. Sensitivity of CEUS, MDCT and SPIO-MRI in
patients with upto 3 lesions and more than 3 lesions
respectively were: 0.75 and 0.61, 0.95 and 0.79 and 0.95
and 0.86. Operative surprises, poor correlation with his-
topathology, and short recurrence free interval were
more frequent in patients with more than 3 lesions on
initial imaging. All imaging modalities were less sensitive
for lesions with a maximum diameter of less than 1 cm,
SPIO-MRI having the best sensitivity.
Accuracy (Acc) and sensitivity (Sen) of investigations
USG
Acc Sen
CEUS
Acc Sen
MDCT
Acc Sen
Gd-MRI
Acc Sen
SPIO
Acc Sen
All lesions (n = 130) 0.59 0.58 0.66 0.67 0.76 0.82 0.82 0.85 0.83 0.86
Patients with up to
3 lesions (n = 25)
0.74 0.75 0.74 0.75 0.86 0.95 0.88 0.93 0.89 0.95
Patients with more
than 3 lesions
(n = 12)
0.48 0.45 0.62 0.61 0.74 0.79 0.81 0.86 0.82 0.86
Conclusion: SPIO-MRI is the most accurate pre opera-
tive investigation for CRLM’s. In a patient with upto 3
lesions on initial imaging, MDCT with CEUS are sufﬁ-
cient. However, presence of more than 3 lesions or poorly
characterized sub-centimetric lesions warrants the
performance of SPIO-MRI before planning surgical
resection.
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COMPARISON OF UNENHANCED AND
CONTRAST-ENHANCED
ULTRASONOGRAPHY IN THE
DIAGNOSIS OF FOCAL LIVER LESIONS
F. Loria1, G. Loria1, G. Crea1, S. Basile1, L. Frosina2
and S. Cantoni3
1Department of Radiology Palmi Hospital ASP 5 Raggio
Calabria; 2Facolta` di Medicina Universita` di Messina;
3Department of Radiology Ospedale S. Martino Genova
Background: The purpose of this study was to compare
the diagnostic accuracy, conﬁdence level and recom-
mended management of focal liver lesions after contrast-
enhanced ultrasonography (CEUS) compared with
unenhanced ultrasonography alone.
Methods: One hundred sixty-seven patients were referred
for CEUS to characterize a focal liver lesion. A 2-person
blind read determined benignancy or malignancy, com-
parative diagnosis and accuracy on both baseline
sonography and CEUS.
Results: The 2 readers could not determine benignancy
or malignancy in 77 (46%) and 46 (27.5%) of 167 un-
enhanced scans compared with 2 (1.2%) and 1 (0.6%)
of 167 CEUS scans. The conﬁdence level increased from
0 responses in the 2 highest grade (4-5) on the unen-
hanced scans to 135 (81.8%) and 132 (79.5%) of 167 at
level 5 for CEUS. Regarding the diagnosis, the conﬁ-
dence level was lowest (grade 1) on the unenhanced
scans in 128 (82.1%) and 79 (65.3%) of 167 for the 2
readers and improved to the highest (grade 5) in 110
(65.9%) and 113 (68.8%) of 167. Regarding diagnostic
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accuracy, the unenhanced scans agreed with the correct
diagnosis in 85 (50.9%) and 63 (37.7%) of 167, and
CEUS agreed with the correct diagnosis in 133 (79.6%)
and 142 (85%) of 167 for readers 1 and 2 respectively.
Recommendations for further imaging decreased from
166 (99.4%) and 147 (88%) of 167 on the unenhanced
scans to 30 (18%) and 5 (3%) of 167 on CEUS for
readers 1 and 2.
Conclusions: CEUS improves the accuracy and conﬁ-
dence of diagnosis of focal liver lesions and reduces
recommendations for further investigations.
MO-116
DETECTION OF LIVER METASTASES
IN PATIENTS WITH MALIGNANT
PANCREATIC TUMORS BY DIFFUSION-
WEIGHTED MR IMAGING
C. Reiser-Erkan1, M. Erkan1, A. Fingerle2,
K. Holzapfel2, J. Gaa2, H. Friess1 and J. O¨rg Kleeff1
1Department of General Surgery, Klinikum r. d. Isar,
Technische Universita¨t Mu¨nchen, Munich, Germany;
2Department of Radiology, Klinikum r. d. Isar, Technische
Universita¨t Mu¨nchen, Munich, Germany
Introduction: Diffusion-weighted imaging (DWI) is one
of the best diagnostic techniques to detect focal liver le-
sions and to characterize their nature.
Aim: We evaluated the usefulness of diffusion-weighted
MR imaging (DW-MRI) for the detection of liver
metastases in patients with newly diagnosed pancreatic
tumors and compared it to multidetector-row CT
(MDCT), intraoperative and histopathological ﬁndings.
Methods: In 31 patients with newly diagnosed pancreatic
tumor, preoperative DW-MRI and MDCT were per-
formed. Both methods were evaluated by a senior radi-
ologist blinded to the diagnosis. Standard reference for
detecting hepatic metastases was intraoperative US and/
or histology result. Sensitivity, speciﬁcity and accuracy
for detection of hepatic metastases were calculated.
Results: Correlated with intraoperative US and histology
results, the sensitivity, speciﬁty and accuracy of detecting
liver metastases was 86.7%, 97.5% and 93.2% respec-
tively in DW-MRI whereas, 53.3%, 77.8% and 69.4%
respectively in MDCT. DWI-MR may have inﬂuenced
the therapy in 4 out of 31 patients (12.9%).
Conclusion: DWI-MR performs signiﬁcantly better in
detection of liver metastases than MDCT. DWI may help
to optimize the therapeutic management in patients with
pancreatic cancer.
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HAPLOTYPES IN MELANOMA
INHIBITORY ACTIVITY 2 CORRELATE
WITH SURVIVAL AND
CHEMORESISTANCE IN PANCREATIC
CANCER
C. Michalski, B. Kong, N. Valkovskaya, X. Hong,
H. Friess and J. Kleeff
TU Munich, Dept. of Surgery
Background: Response rates of pancreatic ductal ade-
nocarcinomas (PDAC) to chemotherapy are low; iden-
tiﬁcation of a subgroup of patients who are more likely to
beneﬁt from a particular chemotherapy might constitute
a rational approach to improve overall prognosis.
Methods: Expression and polymorphisms of melanoma
inhibitory activity 2 (MIA2) were determined in pancre-
atic tissues and cancer cells. Following site-directed
mutagenesis in PDAC cell lines, proliferation and
chemoresistance assays were performed in vitro and in
vivo (using a mouse model of PDAC).
Results: Seventy one percent of PDACs stained moder-
ately to strongly positive for MIA2. Sequencing of MIA2
exons in MIA2-expressing cell lines ASPC-1, Capan-1
and Colo-357 revealed a GG and CC genotype at the 617
and 1833 loci in Colo-357, whereas the other two cells
lines carried the AA and GG genotypes at the corre-
sponding loci. These two polymorphisms result in the
replacement of 141Ile and 547Asp to 141Met and 547His on
the MIA2 protein sequence, respectively. Characteriza-
tion of these polymorphisms in pancreatic diseases
(chronic pancreatitis (n = 18), pancreatic neuroendo-
crine tumors (n = 38) and PDAC (n = 258)) and heal-
thy donors (n = 26) revealed that the 617 genotype
correlated with the 1833 genotype (P < 0.0001) and was
thus termed a haplotype. PDAC patients with 617AA/
1833GG survived signiﬁcantly longer than patients with
617AG & GG/1833GC&CC (median survival,
21 months vs. 15 months). Silencing of MIA2 (617AA/
1833GG) rendered Capan-1 cells more resistant to gem-
citabine, while silencing of MIA2 (617GG/1833CC) in
Colo-357 had no such effect. Overexpression of the
MIA2 haplotype 617AA/1833GG in Su86.86 signiﬁ-
cantly decreased proliferation and increased sensitivity to
gemcitabine in vitro and in a PDAC mouse model.
Conclusion: Haplotypes in MIA2 are associated with
survival and chemoresistance. The MIA2 haplotype
617AA/1833GG might serve as a novel predictive marker
for chemosensitivity in PDAC.
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ONCOLOYTIC ACTIVITY OF A NOVEL
CONDITIONALLY REPLICATIVE
ADENOVIRUS (CRAD) AGAINST PANC-1
PANCREATIC ADENOCARCINOMA
CELLS
Q. Chu, G. Sun, B. Li and M. Mathis
Louisiana State University Health Sciences
Center-Shreveport
Background: Cancer virotherapy using conditionally
replicative adenoviruses (CRAds) represents a promising
novel therapeutic approach for pancreatic adenocarci-
nomas. Low efﬁciency of viral transduction into targeted
cancer cells and lack of speciﬁcity are drawbacks with the
CRAds. To circumvent these problems, we replaced the
ﬁber gene of the Ad serotype 5 vector with an Ad sero-
type 3 ﬁber to increase infectivity. We also placed the
CXCR4 chemokine receptor gene promoter to regulate
Ad E1A gene expression, thus restricting oncolytic
activity only to those cells that over express CXCR4 (i.e.
pancreatic cancer cells).
Aims: We tested this novel modiﬁed CRAd against the
PANC-1 human pancreatic cancer cells.
Methods: Human pancreatic cancer line PANC-1 was
obtained from ATCC. Overexpression of CXCR4 was
conﬁrmed by Western blot analysis. PANC-1 was in-
fected with viruses with various modiﬁed ﬁber proteins
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(Ad5-CMV-GFP, Ad5/3-CMV-GFP, Ad5-CMV-GFP-
RGD). Multiplicity of infection (m.o.i) was determined
via ﬂow cytometry. Transcriptional controls were tested
using an oncolytic assay. Percentage of adherent live cells
was evaluated by crystal violet staining.
Results: PANC-1 demonstrated overexpression of
CXCR4. The modiﬁed 5/3 chimeric CRAd was most
efﬁcient in infecting PANC-1 cells when compared to the
wildtype and other modiﬁcations. Adding the CXCR4
promoter to the chimeric Ad5/3 (i.e. Ad5/3-CXCR4)
resulted in a highly effective oncolysis of PANC-1 cells.
Conclusion: Bymodifying the protein ﬁber and restricting
viral transcription with the CXCR4 promoter, we dem-
onstrated that our novel CRAd (Ad5/3-CXCR4) had a
marked increase in infectivity and oncolytic potential
against human PANC-1 pancreatic adenocarcinoma cells.
MO-119
RAPID WHOLE EXOME SEQUENCING
OF PANCREATIC ADENOCARCINOMA
USING NIMBLEGEN CAPTURE CHIP
AND A HIGH THROUGHPUT
SEQUENCING PLATFORM
M.-C. Gingras, D. Wheeler, S. Hodges, L. Nazareth,
D. Muzny, R. Gibbs, C. Brunicardi and W. Fisher
The Elkins Pancreas Center and Human Genome
Sequencing Center, Baylor College of Medicine
Background: Rapid assessment of an individual patient’s
germ line and tumor DNA alterations will advance per-
sonalized genomic therapy. New custom arrays that
contain 204,000 exons, allow the entire exonic coding
genome to be captured and sequenced on a high
throughput sequencing platform.
Objective: To rapidly sequence the exome of an indi-
vidual patient and their pancreatic cancer using Nim-
bleGen array and 454 pyrosequencing.
Methods: Tumor and blood DNA was fragmented
hybridized to the NimbleGen high density oligonucleo-
tide microarray and the speciﬁcally bound material was
eluted. The 454 universal primers were added; the DNA
was ampliﬁed by emulsion PCR and sequenced.
Sequences were analyzed with the SNP calling software
ATLAS SNP and annotated. SNPs present in both
sequencing directions, with a p value threshold < 0.01,
and adequate coverage in blood and tumor samples were
kept. Germline SNPs, those found in the tumor and
normal were set aside; mutations, SNPs found only in the
tumor, were further analyzed.
Results: Nearly 4 million (3–454 runs) and over 1 million
(1–454 run) reads of about 290 bases were obtained from
the tumor and blood samples respectively. 64 non syn-
onymous (ns) somatic mutations resulting in an amino
acid shift or a STOP codon were identiﬁed in 56 genes.
Based on analysis with ‘‘Polyphen’’, a program that
predicts the effect of amino acid change on protein
function, at least 26 (40%) of these genes had a mutation
that was likely damaging to protein function. This per-
centage of possibly damaging mutations is similar to re-
sults with lung adenocarcinoma but greater than the
percentage in a healthy person’s germline.
Conclusion: Novel chip sequencing technology can be
used to rapidly identify an individual patient’s unique set
of genes with somatic ns damaging mutations. This is an
important step toward personalized genomic therapy.
MO-120
EFFECT OF HUMAN ADIPOSE-TISSUE
DERIVED-MESENCHYMAL STEM CELL
ON STREPTOZOTOCIN-INDUCED
DIABETIC NUDE MICE
T. Ikemoto, M. Shimada, M. Komatsu, T. Utsunomiya,
S. Imura, Y. Morine, H. Mori, J. Hanaoka, Y. Saito and
Y. Kawata
University of Tokushima
Background: Type 1 Diabetes Melinus (T1DM) is an
autoimmune disease, caused by the islet cell destruction
with lymphocytes inﬁltration (autoimmune insulitis). The
radical therapy of T1DM is exogenous insulin supple-
ment. Recently, stem cells are considered as effective for
beta cell replacement therapy for T1DM, however, the
mechanism is still unknown. Thus, we use human Adi-
pose-tissue derived-mesenchymal stem cell: hAT-MSC)
for induction of B cell after pancreas injury and investi-
gate the possibility for B cell replacement therapy.
Materials and methods: 160 mg Kg-1 Streptozotocin
(STZ) are injected intraperitonially to 8 weeks male nude
mice for islet injury model (induction of diabetic state).
1.0·106 hAT-MSC are transplanted into peri-pancreatic
lesion 2 days after STZ injection (STZ+MSC group).
Body weight, fasting blood glucose (FBS), OGTT are
measured and immunohistology are undergone and
compared to control group (STZ injection only).
Results: Parenchyma of the pancreas were signiﬁcantly
thick in STZ+MSC group 14 days after hAT-MSC
transplantation. FBS in all mice of STZ + MSC group
were within normal limit (below 200 mg dL-1), tolerance
of OGTT were kept normal pattern (below 110 mg dL-1.
250 mg dL-1 at 60 min in control group). Signiﬁcant anti-
human insulin positive islet cells were observed in
STZ + MSC group in immunohistology.
Conclusions: hAT-MSC transplantation to nude mice
improved STZ induced diabetic state. Our data suggested
that hAT-MSC administration was useful to treat
T1DM.
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DEREGULATION OF THE RB/E2F
PATHWAY VIA LOSS OF P16
EXPRESSION IN PANCREATIC
ADENOCARCINOMA
J. M. Hernandez1, A. Elahi2, S. Brantley1, C. Morton1,
L. Humphries1, M. A. Timmel1, S. Ross1, S. C. Jhanwar3
and A. S. Rosemurgy
1University of South Florida Department of Surgery;
2Mofﬁtt Cancer Center and Research Institute; 3Memorial
Sloan-Kettering Cancer Center
Background: Deregulation of pathways governing cell
cycling via chromosomal deletion or mutational inacti-
vation may predict clinical outcomes for patient with
pancreatic adenocarcinoma.
Aim: We aim to interrogate relationships between tumor
genetics and clinical outcomes.
Methods: Cytogenetic analysis was undertaken on ten
cell lines, four of which were established in the labora-
tory. PCR analysis, single-strand conformation poly-
morphism (SSCP) analysis, and northern blotting were
used to determine the status of CDKN2A (p16), as well
as other regulators of the Rb/E2F pathway. Immuno-
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histochemical staining for p16 was performed on FFPE
tissues, and correlated with clinical outcomes. Data is
presented as median, mean ± SD where appropriate.
Results: Pancreatic adenocarcinoma cell lines frequently
possessed chromosomal abnormalities in the following
locations; 3p, 6p, 8p, 9p, 17p, and 18q. Given the high
frequency of deletions involving chromosome 9p, we se-
quenced the 3 exons of CDKN2A and found homozy-
gous deletions for 7/10 cell lines. DNA sequence
mutations were detected in each of the three cell lines
expressing CDKN2A mRNA. In order to determine the
clinical signiﬁcance of p16 protein expression, immuno-
histochemical staining was performed on 26 patients who
underwent resections for pancreatic adenocarcinoma
(AJCC Stage IB (3), IIA (8), and IIB (15)) and completed
adjuvant gemcitabine-based chemotherapy. Overall sur-
vival for 26 patients was 20 months, 27 months ± 17.5.
p16 protein expression was absent in 25/26 (96%) of
patients. Pan-INs were identiﬁed with adenocarcinoma in
two patients; both were p16 negative (adenocarcinoma)
and p16 positive (Pan-IN).
Conclusions: Deregulation of the Rb/E2f pathway, spe-
ciﬁcally via deletions or mutations of the tumor sup-
pressor gene CDKN2A (p16), appears to be a ubiquitous
ﬁnding among pancreatic adenocarcinomas. Although
prognostic ramiﬁcations may therefore be limited, p16
may play an integral role in the tumorigenesis process.
MO-122
HEPATO-PANCREATICO-BILIARY
SURGERY IN ELDELRY PATIENTS: IS
THERE A DIFFERENCE IN OUTCOME?
R. Saidi1, V. Mittal2 and M. Jacobs2
1University of Massachusetts; 2Providence Hospital
Background: Early and long-term outcome of hepato-
pancreatico-biliary (HPB) surgery in elderly adults has
been a subject of controversy and debate.
Method and Methods: Clinical information was reviewed
for patients undergoing HPB surgery for HPB malig-
nancies during a 14-year period (1990-2003). Patient
demographics, tumor characteristics, operative mortality
and morbidity, survival, and length of hospitalization
were reviewed.
Results: Eighty ﬁve (85) patients underwent HPB sur-
gery; 50 (58.8%) pancreatectomy and 35 (48.1%) liver
resections. Forty six (54.1%) were over 70 years old
(group 1)and 39 (45.9%) under 70 years old (group 2).
Hepatic resections were primarily performed for meta-
static colorectal cancer (45.7%), hepatocelluar carcinoma
(17.1%), and cholangiocarcinoma (11.4%). Pancreatic
resection was mainly performed for pancreatic carci-
noma. There was no signiﬁcant difference between the
group 1 and 2 comparing their tumor size, stage, com-
orbidities, intraoperative blood loss, length of hospital
stay (11.3 vs. 11.0 days), or readmission (32.6% vs.
28.2%). Overall mortality and morbidity of HPB surgery
was 3.5% and 25.6%, respectively; 4.3%, 28.2% in group
1 and 5.2%, 23.6% in group 2 which was not statistically
signiﬁcant. Mean surival in group 1 ad 2 were 20 vs.
22 months which was not statistically signiﬁcant.
Conclusion: This study suggests that HPB surgery can be
carried out safely in elderly patients. The early and long-
term outcomes in elderly patients (over age 70) are com-
parable to younger patients (under age 70). Age alone
should not preclude HPB surgery in elderly patients.
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VENOUS INVASION IN PANCREATIC
CANCER: AGGRESSIVE MESENTERIC
VENOUS RESECTION RESULTS IN
EQUIVALENT OUTCOMES TO CASES
WITHOUT VENOUS INVOLVEMENT
M. Porembka, W. Hawkins, D. Linehan and S. Strasberg
Washington University in Saint Louis
Introduction: Our purpose was to determine whether an
aggressive policy of mesenteric venous resection (MVR)
was successful in achieving R0 status at the vein and
whether achieving R0 status by MVR affected outcome.
Methods: Three hundred and forty four patients with
pancreatic adenocarcinoma had PD from 1998 to 2008.
MVR was performed when there was radiologic or
intraoperative evidence of vein involvement. After
resection, margins were inked by the surgeon using a
four-color system. 101 patients (29%) had PD with MVR
and 243 patients (71%) had standard resection (SR).
Results: Forty-one patients (41%) undergoing MVR
required sleeve resection or reconstruction with graft; the
remainder had more minor resections. Overall R0 status
at all margins was achieved in 76 patients (75%) who had
MVR and in 178 patients (75%) who had SR. However,
R0 status at the mesenteric vein was achieved in 98% of
patients in both groups. Median survival rates with MVR
and SR were 20 months and 19 months, respectively. R1
status in the MVR group (25 patients) resulted in sig-
niﬁcantly reduced survival (14 months) compared to R0
status (76 patients, 22 months, P = 0.007). The same
was true for SR (R0: 178 patients, 22 months; R1: 64
patients, 14 months; P = 0.0006).
Conclusions: R1 resection is associated with inferior
outcome. Aggressive MVR in which 30% of PD are done
with MVR can achieve negative margin resection at the
vein in 98% of cases, which is equivalent to patients
without vein involvement. Centers performing PD should
have surgeons facile with these techniques.
MO-124
HEPATOID CARCINOMA OF THE
PANCREAS
R. Andersson1, S. Dawiskiba2 and P. Leveau1
1Department of Surgery, Clinical Sciences Lund, Lund
University Hospital; 2Department of Pathology, Clinical
Sciences Lund, Lund University Hospital
Background: Due to a recent case of ours, we have re-
viewed the literature and found another 10 cases.
Aim: Summarize the experience as described on hepatoid
carcinoma of the pancreas, management and outcome.
Methods and results: Including our own case, totally 11
patients with hepatoid carcinoma of the pancreas have
been described. The median age has been 53 years
ranging from 28 to 80 years with an even sex distribution.
Histopathological examination demonstrates clear simi-
larities with hepatocellular carcinoma and the expression
of alpha-feto-protein (AFP). AFP is, however, in less
than half of the cases increased in blood. In 1/3 of the
cases, a neuroendocrine component has been found to-
gether with hepatoid carcinoma in the pancreas. Liver
metastases are frequent, occurring in 5/11 patients and
associated with a poor prognosis (median survival
3.5 months). In patients without liver metastases, 4/6
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have been reported alive at follow-up after 7–48 months.
One patient without liver metastases was inoperable due
to locally advanced disease and died after 14 months.
Conclusion: Hepatoid carcinoma of the pancreas is an
infrequent type of pancreatic cancer, mostly seen in pa-
tients about 50 years of age, without sex difference, and
histologically with an appearance of hepatocellular car-
cinoma, staining positive for AFP. An increase in AFP in
blood is not obligatory. Liver metastases are frequent
and associated with a poor prognosis, while patients that
are resectable seems to do fairly well, at least during the
in general short follow-up time as reported. The exact
origin still remains unclear, though both pancreas and
liver both evolve from a common foregut endoderm,
making e.g. stem cells a potential cause.
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SURGICAL VERSUS NON-SURGICAL
APPROACH FOR THE MANAGEMENT
OF PANCREATIC CANCER WITH
VENOUS OR PLEXUS INVASION
A. Sawaki1, K. Yamao1, K. Hara1, S. Hijioka1,
N. Mizuno1, H. Imamura1, Y. Senda2, T. Sano2,
Y. Shimizu3 and Y. Nimura4
1Department of Gastroenterology, Aichi Cancer Center
Hospital; 2Department of Gastroenterological Surgery,
Aichi Cancer Center Hospital; 3Department of
Gastroenterological Surgery, Aichi Cancer Center
Hospitalenter Hospital; 4Aichi Cancer Center Hospital
Background: Pancreatic cancer sometimes invades the
portal vein (PV) or neural plexus (PL). Pancreatectomy
combined with PV and/or PL resection represents a
potentially curative treatment in these cases but is still a
controversial procedure. The purpose of this retrospec-
tive study is to evaluate the signiﬁcance of pancreatec-
tomy with PV/PL invasion diagnosed by computed
tomography.
Methods: We compared survival associated with pan-
createctomy (Group 1), non surgery: palliative che-
moradiotherapy (Grou2) and chemotherapy (Group 3).
Patients, who were treated at Aichi Cancer Center
Hospital, with locally advanced pancreatic cancer with
PV/PL invasion, were retrospectively enrolled from
April 2001 to December 2007. Pancreatic cancer pa-
tient with PV/PL invasion were recruited from data
base in our hospital and all clinical parameters were
collected from medical record: treatment regimens, sex,
age, PV, PL, arterial invasion to celiac artery or
superior mesenteric artery, tumor size, Carcinoembry-
onic Antigen, carbohydrate antigen 19-9 and second
line treatment. Patients with distant metastases were
excluded.
Results: A total of 103 patients were enrolled in this
study. 26, 45 and 32 patients were categorized to Group
1, 2 and 3, respectively. Arterial invasion and age were
statistically signiﬁcant differences among three groups.
The MST of overall survival in each group was 21, 13
and 10 months, respectively. Overall survival of Group 1
vs. Group 2 plus Group 3 was signiﬁcantly difference.
Multivariate analysis didn’t show the statistically signif-
icant factor for overall survival.
Conclusions: Surgical resection may confer a survival
advantage over palliative chemoradiotherapy and che-
motherapy in select patients with pancreatic cancers with
presumed local venous invasion.
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BILIARY DISEASE DURING
PREGNANCY. 9 YEARS OF EXPERIENCE
OF A CHILEAN CENTER
M. Vivanco1,2, I. Turu1,2, G. Rencoret1,2, F. Macan3,
J. T. Gantz1,2, A. Valle1,2, G. Wiedmaier1,2,
M. Bustamante2,4, F. Carrillo2,4, E. Paiva2,4 and
A. Ovalle2
1Department of Surgery, Hospital Padre Hurtado,
Santiago, Chile; 2Facultad de Medicina Clı´nica Alemana-
Universidad del Desarrollo, Santiago, Chile; 3Hospital
Mutual de Seguridad, Santiago, Chile; 4Department of
Obstetrics and Gynecology, Hospital Padre Hurtado,
Santiago, Chile
Background: Symptomatic gallstone disease is the second
most common abdominal emergency in pregnant women.
The reported incidence is 0.5 to 0.8%. Acute Pancreatitis
is indeed a more rare condition with a reported incidence
of 0.09%. Current literature is controversial in relation to
the management of these patients.
Objective: Show the results of management of this dis-
ease within our institution.
Methods: Retrospective review of the clinical records of
all pregnant patients admitted in our institution between
January 2000 and June 2009, with the diagnosis of
symptomatic cholelithiasis (SC), acute cholecystitis (AC)
and acute pancreatitis (AP). Demographics, ethiology,
clinical characteristics, management and perinatal-
maternal results were evaluated.
Results: Thirty eight patients were selected. The average
age was 25.5 years (range 17–31), the average gestational
age was 27 weeks (range 7–33), 47% AC at admission,
29% AP and 24% SC. Thirty two patients undergo
laparoscopic cholecystectomy during pregnancy and 6
after delivery. Four patients had choledocolythiasis de-
tected intraoperative, 2 were converted to a open proce-
dure and 2 were solved laparoscopically, of the AP group
the most frequent etiology was gallstone disease (91%),
10 patients got a mild evolution and respond to initial
medical therapy. There was no maternal morbidity or
mortality; there was 1 fetal death 6 weeks after surgery.
Conclusions: Biliary disease during pregnancy is a rela-
tive infrequent complication. Laparoscopic approach of
this disease is safe and in our series is associated with a
good perinatal and maternal result. The medical man-
agement of AP in pregnant patients is also safe if the
evolution of it is mild.
MO-127
ATTAINING THE CRITICAL VIEW OF
SAFETY IN SINGLE INCISION
LAPAROSCOPIC CHOLECYSTECTOMY
(SIL-C)
A. R. Ferreres1,2, A. Ronda´n2, M. E. Gime´nez1 and
V. P. Gutie´rrez1
1Division of Gastrointestinal Surgery, Department of
Surgery, University of Buenos Aires; 2Department of
General Surgery, ‘‘Dr. Carlos A. Bocalandro’’ Hospital
Background: Iatrogenic bile duct injuries increased with
the advent of laparoscopic cholecystectomy and repre-
sent a concern for the development of NOTES and SIL
approaches for cholecystectomy. Several methods have
been described for the prevention of this adverse event
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(infundibular technique, reversed cholecystectomy, in-
traoperative cholangiography and recognition of cystic
duct and common bile duct junction) but the critical view
of safety technique of dissection (CVS) is considered the
one offering the highest protection.
Aim: To assess the achievement of CVS during the per-
formance of SIL-C.
Methods: Retrospective review by 2 independent
observers of the video recordings of the ﬁrst 60 consec-
utive SIL-Cs performed between August 2008 and July
2009.
Results: CVS was achieved in 55 of the 60 cholecystec-
tomies performed (91.66%). The ﬁndings in the ﬁve pa-
tients in which the CVS could not be achieved included
huge inﬂamed gallbladders. Mean operative time was
62 min +/- 17.5 min and intraoperative cholangiogra-
phy was performed in 37 patients (61.66%). In 3 cases the
additional placement of a right subcostal 2 mm forceps
was required. Intraoperative complications included:
bleeding from the gallbladder bed (1 case) and opening of
the gallbladder with stone spillage (2 cases). Postopera-
tive complications included 2 surgical site infections. No
bile duct injuries were produced in this series.
Conclusions: a) Dissection of the critical view of safety
technique of dissection can be achieved during SIL-C
using adequate instrumentation, b) prevention of bile
duct injuries and patient safety are a must for the
development of alternative approaches to traditional
laparoscopic cholecystectomy.
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ACUTE LAPAROSCOPIC
CHOLECYSTECTOMY IN A TERTIARY
REFERRAL CENTRE: DELAYS IN ACUTE
SURGERY AND COST ANALYSIS OF A
PROPOSED NEW SERVICE
A. Cockbain, A. Young and G. Toogood
St James’ University Hospital, Leeds, UK
Background: Acute Laparoscopic Cholecystectomy
(ALC) is the management of choice for patients admitted
with symptomatic gallstone disease. We believed that
patients waiting for ALC in our tertiary referral centre
were suffering excessive delays on the acute theatre list,
which could be improved by service reconﬁguration.
Aims: To audit 12 months of patient admissions with
acute gallstone disease, and identify the number of ALCs
performed and delays along the patient pathway. Sec-
ondly, to assess the patient beneﬁt and cost-effectiveness
of service reconﬁguration by introducing a weekly semi-
acute day-case ALC list to facilitate discharge of asymp-
tomatic patients, but with an imminent date for surgery.
Methods: All patients admitted with acute gallstone
disease in a 12 month period, and those who had ALC
were identiﬁed from hospital admission records and a
manual trawl of theatre logbooks. Patient diagnosis,
length of stay and intra-operative data were retrieved.
Cost analysis of current and proposed services was per-
formed based on 2008/2009 Healthcare Resource Group
(HRG) tariffs.
Results: Two hundred and sixty four patients had 280
acute admissions. Forty two patients were unﬁt or
unsuitable for ALC. One hundred and sixty one of the
remaining 222 patients (73%) had an ALC, with a
median hospital stay of 8 days vs median stay of 4 days
without ALC. The median delay between admission and
booking for acute theatre was 3 days, and between
booking and operation was 2 days. Mean operating time
was 1hr 32 min. Conversion rate was 7.4%. The pro-
posed new service would save the trust £200,000 annually
by reducing length of acute hospital stays, covering the
cost of the new semi-acute lists.
Conclusions: Patients awaiting ALC are delayed by the-
atre availability, with associated unnecessary fasting,
prolonged hospital stays, and a signiﬁcant cost to the
trust. Reconﬁguration of service is at least as cost effec-
tive, would improve patient care, and would reduce
pressure on acute bed capacity.
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SINGLE-INCISION LAPAROSCOPIC
CHOLECYSTECTOMY: THE FIRST
COMPARATIVE STUDY OF POST-
OPERATIVE PAIN WITH THE
STANDARD LAPAROSCOPIC
CHOLECYSTECTOMY
S. K. Y. Chang, C. W. Tay, R. A. Bicol, Y. Y. Lee and
K. Madhavan
National University Hospital, Singapore
Background: Single-incision laparoscopic (SILS) chole-
cystectomy has recently been performed, mainly in pa-
tients with uncomplicated gallbladder pathology.There is
currently no comparative study on the beneﬁts of SILS
against standard 4-ports laparoscopic cholecystectomy
(SLC).
Objective: Our study aims to compare the post-operative
pain, site of pain, number of days requiring analgesia and
number of days required to return to normal activity
between patients underwent SILS and SLC.
Methods: Twenty eight patients who had SILS chole-
cystectomy over 6 months period in a university hospital
were included and matched (sex, age group, race) with 28
patients who underwent SLC. All patients were pre-
scribed paracetamol 6 hourly as analgesia. Verbal pain
score (VPS) on post-op day (POD) 1, 2, 3 and 5, pain site,
days of analgesia required, period of return to normal
activities, were recorded and compared with the control
patients.
Results: There were 4 acute cholecystitis in the SILS and
3 in the SLC group. Average VPS on POD 1, 2, 3 and 5
of SILS and (SLC) cholecystectomy patients were 4.61
(5.26) (P = 0.065), 3.43 (3.81) (P = 0.20), 2.11 (2.48)
(P = 0.40) and 1.11 (1.22) (P = 0.73) respectively. 26
(93%) patients had umbilical pain and 2 (7%) patients
had epigastric pain in the SILS group, whereas 25 (89%)
patients had umbilical pain, 2 (7%) patients had epigas-
tric pain and 1 (4%) patients had right upper quadrant
pain in the SLC group. The SILS and the SLC required
3.96 and 4.78 days (P = 0.13) of regular paracetamol
respectively. Number of days required to return to nor-
mal activity in the SILS and SLC were 6.07 days and
7.81 days (P = 0.01) respectively.
Conclusions: There was no statistical signiﬁcant differ-
ence in post-operative pain, pain site and analgesia
requirement, however, patients who underwent SILS re-
turned to their normal activity 1.74 days earlier than the
SLC patients. We recommend SILS cholecystectomy to
those who wish to return to their normal activity as soon
as possible. Larger studies are needed to further evaluate
other outcomes.
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MO-130
SAME ADMISSION LAPAROSCOPIC
CHOLECYSTECTOMY FOR PATIENTS
ADMITTED WITH ACUTE BILIARY
SYMPTOMS
A. Young, A. White, A. Hood, A. Cockbain, K. Menon
and G. Toogood
St James’s University Hospital, Leeds
Background: Acute laparoscopic cholecystectomy (ALC)
is the treatment of choice for patients admitted with
biliary symptoms but is performed in less than 15% of
these admissions in the UK with a perceived increased
complication rate one suggested explanation for this. We
analysed our results for ALC within a specialist hepa-
tobiliary centre.
Methods: A prospectively maintained database of all
cholecystectomies carried out under the care of the two
senior authors from 1998 to 2008 was interrogated.
Demographics, pre-operative and post-operative investi-
gations and interventions, operative details, histology
and outcomes were analysed for differences between
those operated on acutely and those electively then as-
sessed for factors predictive of complications and need to
convert to an open procedure.
Results: One thousand seven hundred and ten patients
underwent cholecystectomy of which 439 (26%) were
ALC. Patients operated on acutely did not have a sig-
niﬁcantly different complication rate (P = 0.279) with
the rate in elective operations 3% and acute operations
4%. Factors predicting complications were abnormal
ALP, dilated CBD, cholangitis and absence of on table
cholangiography (OTC). There were no bile duct injuries.
Only 10% of patients undergoing ALC required con-
version to open procedure but this was signiﬁcantly more
than the elective group (P < 0.001). The proportion of
complicated disease was higher in the ALC group
(P < 0.001). Only complicated disease, absence of OTC
and age greater than 65 were predictive of conversion on
multivariate analysis.
Conclusions: Laparoscopic cholecystectomy can be per-
formed safely in patients with acute biliary symptoms
and should be considered the gold standard for man-
agement of these patients thus avoiding avoidable read-
missions and life threatening complications. A higher
conversion rate to an open procedure must be accepted
when treating more complicated disease.
MO-131
PROSPECTIVE OBSERVATIONAL
STUDY OF SINGLE PORT
CHOLECYSTECTOMY VS STANDARD
LAPAROSCOPIC CHOLECYSTECTOMY
M. Lawenko1, A. Lee-Ong1, J. Lopez-Gutierrez1,
S. Chan2, I. S. Ganpathi3 and D. Lomanto1
1Minimally Invasive Surgical Centre, Department of
Surgery, National University Hospital; 2Department of
Sociology, Singapore Management University; 3Division
of Hepatobilliary and Pancreatic Surgery, National
University Hospital
Background: Single port cholecystectomy (SPC) reduces
the aggression of surgery to a single incision. The fun-
damental idea is to have a single port to hold all of the
instruments into the abdominal cavity.
Aim: We are attempting to ascertain the safety, feasi-
bility of SPC and to compare the outcomes with standard
laparoscopic cholecystectomy.
Methodology: From May to September 2009, 14 patients
with chronic calculous cholecystitis, 7 for single port
cholecystectomy (SPC) and 7 patients for laparoscopic
cholecystectomy (LC). For the SPC, gallbladder retrac-
tion was achieved by suture traction of the gallbladder
fundus transabdominally or by magnetic retraction. Pa-
tient demographics, operating time, complications intra
and postoperatively length of hospital stay were noted.
Statistical analysis using the independent T-test was
done.
Results: The median age was 53 (35–75) with eight fe-
males. The single port devices used in the SPC group
were 4 Triport (Olympus, Japan) and 3 SILS port
(Coviden, USA). Mean operating time for the SPC group
was 114.43 min (SD 23.68), 68.29 min (SD 9.06) for
LC (P 0.001). No conversion to LC was done in the SPC
group. Intraoperative complications of bile spillage were
due to the suture retraction of the gallbladder occurred in
four patients. One patient had a minor cystic artery bleed
intraopertively but was quickly clipped. No intraopera-
tive complications occurred in the LC groups. No post
operative complications occurred in both groups. The
mean postoperative stay was 28.86 hours (SD 23.14) for
the SPC group and 21.43 hours (SD 6.02) for the LC
group (P 0.42).
Conclusion: Operating time was longer in the SPC group
due to the learning curve present. SPC is feasible and safe
if favourable retraction can be achieved. Further evalu-
ation with randomization and a larger sample population
is necessary.
MO-132
INTRAPERITONEAL 0.5% BUPIVACAINE
INSTILLATION IN TRENDELENBURG
POSITION FOR POSTOPERATIVE PAIN
RELIEF IN LAPAROSCOPIC
CHOLECYSTECTOMY
J. Razman1, R. Ramasamy2, Y. W. Yan2 and
K. Muthupalaniappan2
1Department of Surgery, Universiti Kebangsaan Malaysia
Medical Centre, Kuala Lumpur; 2Hospital Tengku Puan
Afzan, Kuantan
Introduction: Laparoscopic cholecystectomy has become
the procedure of choice in the treatment of symptomatic
gallstone disease. However there are signiﬁcant numbers
of patients presented with abdominal pain related with
pain at the incision site and stretching of abdominal wall
following pneumoperitoneum. Therefore this study was
conducted to evaluate the efﬁcacy if instilling 0.5%
bupivacaine intraperitoneally in Trendelenburg position
during cholecystectomy for reduction of postoperative
pain as compared to placebo.
Method: This is a randomized double blind controlled
study performed at our centre. The patients were ran-
domly assigned to receive 20ml of 0.5% Bupivacaine with
200,00 units of Epinephrine (Group A) or 20ml of 0.9%
saline (Group B) in Trendelenburg position. All the pa-
tients will receive 10ml of 0.5% Bupivacaine at the port
site. The pain score will be assessing using visual ana-
logue score (VAS) at speciﬁed time.
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Results: Sixty patients (n = 30) were recruited with 30
patients in each group. The mean score of VAS at the
ﬁrst hour after surgery for group A and B was 6 and 5.8
respectively (P > 0.05). There was a rapid deceleration
of pain score in group A as compared to group B.
However it was statistically not signiﬁcant. The mean
score of VAS after 48 hours were 1.9 for group A and 1.8
fro group B (P > 0.005). There was a statistically sig-
niﬁcant usage of analgesia (NSAID) between group A
and group B at day 1after the surgery.
Conclusion: In conclusion, although there was a signiﬁ-
cant reduction of analgesia usage after the surgery, the
intraperitoneal instillation of 0.5% bupivacaine in
Trendelenburg position during cholecystectomy does not
produce a signiﬁcant reduction in abdominal pain after
the surgery. Therefore the routine use of this method for
reduction of postoperative analgesia cannot be recom-
mended.
MO-133
CHOLEDOCHAL CYST PRESENTING
LATE
G. R. Bora, P. Parmanand, S. Singh, R. Gondal and
A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Background: Choledochal Cyst (CDC) presenting in
Adulthood are known to have a higher rate of compli-
cations. However whether the complications increase
with increasing age has not been studied.
Aim: To analyze the late presenting (over 50 years)
Choledochal Cysts and comparison with pediatric &
adult CDC.
Material and Methods: Three hundred and ninety oper-
ated CDC patients of different age groups were retro-
spectively analysed from prospectively collected data,
between 1994 to October 2009. Divided into three
groups; paediatric age group (0–18 years) n = 98, mid-
dle age group (19–49 years.) n = 207 and older age
group (> 50years.) n = 85 and rate of complications
were compared between respective groups.
Result: Three hundred and ninety, operated CDC
patients with M:F ratio was 1 : 3.5 (M = 85, F = 305).
According to Todani’s classiﬁcation – type I in 199
(51.02%), type IV a in 172 (44.10%), type IVb in 5
(1.28%), type II in 1 (0.25%), type III in 1 (0.25%) and
type V in 3 (0.76%). Proportion of type Iva was higher in
adults. The preoperative complication rate was higher in
older age group (Cholangitis 22.35%, Portal hyperten-
sion 3.5%, and Malignancy 14.11%) compared to middle
age (17.87%, 2.41% & 4.34% respectively) and paediat-
ric age (17.34%, 2.04% & 0% respectively). Prior biliary
surgery was also more commonly performed in older age
group (27.05%) compared to middle age (22.22%) and
paediatric age (8.16%) patients. Cystolithiasis was more
common in older age group (45.88%) compared to
middle age (33.81%) and paediatric age (17.34%).
Conclusion: CDC in older age group (> 50 years) pres-
ent with a higher rate of complications, both benign and
malignant. Early CDC excision can help prevent com-
plications.
MO-134
ELECTROMYOGRAPHY OF SPHINCTER
OF ODDI, FROM LABORATORY TO
CLINIC
J. Dong1 and F. Chen2
1Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China 2Institute of
Hepatobiliary Surgery, Southwest Hospital, Third
Military Medical University, ChongQing, China
Background: Sphincter of Oddi manometry (SOM) is the
gold standard for assessing sphincter of Oddi dysfunction
(SOD), but is considered a diagnostic sensitivity of 30–
80% and associated with signi?cant complications of
pancreatitis. Electromyography of sphincter of Oddi
(EMSO) using a Mucous Contact Electrode (MCE) may
be useful in improving diagnostic accuracy and reducing
complications.
Methods: (a) With the application of MCE, we record
myoelectric activity of SO in rabbits to compare with the
needle electrode (NE). (b) Developing same-phase mon-
itoring catheter aiming to simultaneously measure the
electrophysiological and kinetic output, investigating the
correlation between EMSO and SOM. (c) To study the
properties of EMSO in human beings, and to collect the
basic data of EMSO and SOM in 34 health volunteers.
(d) We collected 97 clinical SOD-suspectable cases and
performed EMSO and SOM in these patients.
Results: Simultaneous recording by the MCE and the
Needle Electrodes (NE) showed that MCE was compa-
rable to NE in terms of recording efﬁcacy, but easy to
operate, little trauma, higher reliability, and anti-inter-
ference (NE). Simultaneous study of EMSO and SOM
indicated Subtotal SO Spike Burst (SOSB) corresponded
to pressure wave, but 10-30% of SOSB had no pressure
changes. EMSO in 34 health volunteers experienced
interrupted and regular SOSB, duration 5.3 ± 0.9 sec,
amplitude 132.7 ± 15.6 lV, frequency 6.4 ± 1.2 min-1.
Sensitivity of EMSO for diagnosis of SOD was 70%,
speciﬁcity 44%, positive predictive value 68%, negative
predictive value 47%.
Conclusion: EMSO is quantitative, safe, reliable and re-
ﬂect the movement functional state of SO. EMSO is
comparable to SOM and combination of EMSO and
SOM show high sensitivity for diagnosis of SOD.
MO-135
COMMON BILE DUCT POSTERIOR
FLAP: A NOVEL TECHNIQUE FOR
HIGH, DIFFICULT, BILIOENTERIC
ANASTOMOSES
M. Uribe1,2, F. Catan1, S. Uribe-Echevarrı´a1,
J. Ormazaval1, W. Martı´nez1 and R. Rebolledo1
1Servicio y Departamento de Cirugı´a, Hospital del
Salvador, Universidad de Chile. Santiago-Chile;
2Departamento de Cirugı´a Clı´nica Las Condes,
Santiago-Chile
Background: High bilioenteric anastomoses represent a
technical challenge due to the difﬁculties in visualizing
the posterior wall of the common bile duct. Additional
complexity is added when important ﬁbrosis is encoun-
tered.
Aim: The of this study is to present our experience with a
novel technique that can ameliorate long term results for
these anastomoses.
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Technique: A posterior ﬂap of the common bile duct is
‘‘tailored’’, cutting an inverted U at the anterior common
bile duct wall for at least 1 cm. Arterial supply at 3 and 9
o’clock should be preserved. Dissection of the liver
parenchyma is performed as needed. The bilioenteric
anastomosis is ﬁnished with running long term absorb-
able suture in an anterior/superior wall and a posterior/
inferior wall, in two different planes. Cholangiography is
performed through a trans-anastomotic catheter. A drain
is left in the perianastomotic area.
Results: Eighteen patients aged 5 to 76 years old were
treated. Six due to malignancies and 12 to benign ste-
nosis; 8 iatrogenic and 4 post liver transplantation. Fol-
low up is between 6 and 78 months. No strictures were
developed, even in cases where anastomoses were per-
formed in ﬁbrotic tissue.
Conclusions: The posterior common bile duct ﬂap allows
excellent visualization of the posterior wall of the bile
duct. Because the anastomosis is done in two different
planes, the presence of ﬁbrosis in the posterior wall does
not interfere with healing, preserving the anastomosis
diameter. This technique represents a good therapeutic
option for high, difﬁcult, highly risky bilio-enteric anas-
tomoses.
MO-136
NOVEL RECONSTRUCTION
TECHNIQUE OF THE EXTRAHEPATIC
BILIARY TREES WITH A
BIOSYNTHETIC ABSORBABLE GRAFT
P. Nau, E. C. Ellison, J. Hazey, V. Narula and
W. S. Melvin
The Ohio State University Medical Center
Background: The standard reconstruction of the extra-
hepatic biliary tree is considered a Roux-en-Y hepati-
cojejunostomy. This procedure is not without
complications, both acute and long term, and may not
be feasible in some patients.
Objectives: This project seeks to evaluate a novel ap-
proach for repairing common bile duct injuries with a
biosynthetic graft, reconstructing the anatomy without
an intestinal bypass.
Methods: Utilizing an open approach, the common bile
duct was isolated using minimal dissection and sharply
transected in eleven mongrel hounds. A 1 cm tube graft
of a synthetic bioabsorbable prosthetic was individually
fashioned for biliary reconstruction. The graft was
interposed over a 5 French pancreatic stent and secured
with 6-0 absorbable suture. Intra-op cholangiograms and
monthly liver function tests were completed.
Results: Five animals are long-term survivors without
evidence of graft stenosis. Biliary stents were removed
endoscopically (2) or veriﬁed that they had passed (2)
eight weeks post-op. The ﬁfth is 6 weeks post-op with a
stent in place. The mean alkaline phosphatase and total
bilirubin at 8 weeks were normal at 194 U/L and
0.2 mg dL-1 respectively. The animals will be sacriﬁced at
three (1), six (2), and twelve months (2) for histologic
analysis and assessment of ductal anatomy. One animal
developed obstructive symptoms and was sacriﬁced on
post-op day 14. At necropsy, an intact anastomosis with
dilated hepatic ducts and stent migration into the duo-
denum were noted. Histology showed complete replace-
ment of the graft with native collagen. The ﬁrst ﬁve
animals were removed from the protocol early and sac-
riﬁced for acute surgical complications during protocol
development. The next ﬁve animals are the long-term
suvivors.
Conclusion: Biliary reconstruction using a synthetic bio-
absorbable prosthetic as an interposition tube graft is
feasible based on our early initial results. Further study is
needed.
MO-137
PNEUMOPERITONEUM PRESSURE IN
LAPAROSCOPIC CHOLECYSTECTOMY
INFLUENCES THE OUTCOME –
PRELIMINARY DATA
M. Almeida, A. Taveira-Gomes and J. Costa-Maia
HBP Surgical Unit, Hospital S. Joa˜o, Porto Medical
School
Background: Laparoscopy is the standard procedure in
cholecystectomy. Randomized studies report less bio-
logical aggression and pain in the post-operative period,
when compared to laparotomy. Some issues, however,
still remain unclear.
Objectives: To compare the clinical outcome of patients
submitted to Standard pneumoperitoneum Pressure (SP)
vs. patients submitted to Minimal pneumoperitoneum
Pressure (MP) laparoscopic cholecystectomy.
Methods: Prospective, randomized study in 27 consecu-
tive patients comparing two options: Standard Pressure
(12 mmHg) and Minimal Pressure (8–10 mmHg,
according to surgeon’s preference). Patients were evalu-
ated at 6 hour (stage 1), 12 hour (stage 2) and 24 hour
(stage3) of the postoperative period. Pain was evaluated
according to the visual pain scale (Eur J Clin Pharmacol
(1983) 24: 475–478).
Results: Thirteen patients were operated under MP and
14 patients under SP. Patients were similar in both
groups according to age, sex, ASA classiﬁcation, BMI.
At stage 1, 80% of the MP had small intensity pain vs.
40% in the SP group; furthermore, 20% of the patients in
the SP group had severe pain vs. none in the MP group.
This difference disappeared at stage 2 and stage 3. This
difference did not achieve statistical signiﬁcance. The
presence of nausea and vomiting at stage1 was 27% in SP
vs. 40% in MP. At stage 2 and stage 3 the results were
identical in both groups. At stage 1 the presence of
intestinal motility was 50% in MP vs. 7% in SP
(P = 0.01). At stage 2, 90% of the patients in MP had
intestinal motility vs. 60% of the patients in SP. The
presence of intestinal motility was statistically different at
stage 2 (P = 0.04). The mean postoperative period
lenght was 1.4 days.
Conclusion: Pneumoperitoneum pressure inﬂuences
symptoms in the postoperative period with greater
inﬂuence (P < 0.05) in the regain of intestinal motility in
MP group.
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SURGERY MANAGEMENT OF HILAR
CHOLANGIOCARCINOMA – THE
FRENCH EXPERIENCE ABOUT 710
PATIENTS
J.-M. Regimbeau1,2, D. Fuks1,2, F. R. Pruvot2,3,
Y. P. Le Treut2,4, D. Castaing2,5, J. Belghiti2,6,
P. Bachellier2,7, K. Boudjema2,8, G. Nuzzo2,9,
D. Cherqui2,10, J.-F. Gigot2,11, O. Boillot2,12,
J. Baulieux2,13 and O. Farges2,6
1Amiens North Hospital; 2Department of Digestive
Surgery; 3Lille Universitary hospital - Claude Huriez
hospital; 4Marseille Universitary hospital - Conception
hospital; 5Paul Brousse hospital; 6Beaujon hospital;
7Strasbourg Universitary hospital - Hautepierre hospital;
8Rennes Universitary hospital - Pontchaillou hospital;
9Roma hospital; 10Henri Mondor hospital; 11Brussels
Universitary hospital - St Luc hospital; 12Lyon
Universitary hospital - Edouard Herriot hospital;
13Lyon Universitary hospital - Croix Rousse hospital
Introduction: Surgical resection is the only possibility of
long term survival in patients with hilar cholangiocarci-
noma (HC). The aim of this study was to review the
French experience with HC.
Methods: From 1988 to 2008, 710 patients treated sur-
gically for HC were collected into a nationwide retro-
spective database. Demography, preoperative
management, histopathology reports, postoperative out-
comes and survival were analyzed.
Results: There were 456 men and 245 women with a
median age of 61 ± 10. Tumors were staged Bismuth-
Corlette I (n = 71), II (n = 99), IIIa (n = 169), IIIb
(n = 191) and IV (n = 40). Seventy-two patients (10%)
underwent laparoscopic evaluation (contraindication to
surgery: 39%). A biliary drainage was done in 66% of
jaundiced patients and 99 (14%) had portal vein embo-
lization (PVE). Bilirubin serum level was > 50 lmol L-1
before resection in 60% although biliary drainage.
Median liver volume after PVE was 30%. Out of 710
patients, 595 (84%) had resection with curative intent
(liver resection with bile duct resection n = 527): major
hepatectomy was performed in 97%. One hundred and
eight patients (18%) had portal vein resection and 18
patients required pancreaticoduodenectomy. The cau-
date lobe was excised in 68%, vascular clamping was
required in 54% and 255 (43%) had intraoperative
transfusion. Negative surgical margins were obtained in
54%. Overall mortality and morbidity were 10 and 57%
respectively. The only risk factor of 30-days postopera-
tive death was hypertension in multivariate analysis.
Overall survival at 1, 3 and 5 years for patients who
underwent a resection was 77%, 56 and 45% including
postoperative deaths. The surgical margins was found to
be the only independent factor affecting the survival time
producing a hazard ratio of 1.7 (P = 0.002, 95% conﬁ-
dence interval 1.23–2.53).
Conclusion: Radical surgical resection is the best treat-
ment for hilar cholangiocarcinoma. R0 resection pro-
vides acceptable 5-year survival.
MO-140
SHORT AND LONG TERM OUTCOMES
AFTER FREY PROCEDURE FOR
CHRONIC PANCREATITIS: A 15 YEAR,
400 CASE EXPERIENCE
H. Ramesh, M. Gandhi and A. Venugopal
Lakeshore Hospital, Cochin, Kerala, India
Background: Data regarding long term outcomes after
surgery for chronic pancreatitis are lacking.
Aim: Determine long term outcomes after Pancreat-
icojejunostomy with head coring (Frey Procedure) for
chronic pancreatitis over the period 1993-2008.
Patients: Four hundred patients (257 male, 143 female,
age range 8–71 years, median 42.5 years) underwent Frey
procedure for intractable pain (n = 157), complications
(n = 219), or asymptomatic pancreatic calculi (n = 24).
Methods: Early outcomes studied were mortality/ mor-
bidity rates, and long term outcomes studied – pain relief,
changes in exocrine/endocrine status (both subjective and
objective), and quality of life. Follow up was 1–15 years
(median 98 months).
Results: Five patients died, all during 1993–2000 (pan-
creatic leak = 2, intra-abdominal sepsis (n = 1), ARDS
(n = 1) and unexplained (n = 1). Postoperative com-
plications occurred in 21% (intra abdominal collection,
chest infection, fever, pancreatic leak, bleed, and wound
complications). Eleven patients died due to intercurrent
and related illnesses during follow up. Pain relief oc-
curred in 336 patients (84%) at 1 year follow up. At
5 years, the pain relief ﬁgure was 94%. 43 patients
underwent reoperation/reinterventions. Endocrine status
improved in 18%, worsened in 16% and remained con-
stant in 66% of survivors. On univariate analysis, acute
presentation, alcohol dependence, residual head calculi,
pancreatic head mass affected outcome. On Multivariate
analysis, residual head calculi was the only signiﬁcant
factor (OR 3.14, 95% CI 1.09–6.87). On QOL assess-
ments, 92% had excellent or good quality of life.
Conclusion: a) Surgery relieves pain and provides quality
of life in over 90% of patients in the long term (against
the myth that long term results are poor). b) pancreatic
function is maintained following Frey procedure, c) a
signiﬁcant number of patients required postoperative
interventions, or died due to both related and intercur-
rent illness.
MO-141
IS PROGRESSION WHILE ON
NEOADJUVANT CHEMOTHERAPY
ALWAYS A CONTRAINDICATION TO
LIVER RESECTION FOR COLORECTAL
METASTASES?
L. Vigan1, L. Capussotti1, C. Laurent2, E. Barroso3,
G. Mentha4, G. Nuzzo5, J-F. Gigot6, D. Jaeck7,
G. Poston8, P. Colombo9, T. Gruenberger10,
A. Frilling11, E. Ramos12, J. Figueras13, D. Mirza14,
D. Elias15, F. Castro Sousa16, J. Herrera17, I. Popescu18
and R. Adam19
1Department HPB and Digestive Surgery, Ospedale
Mauriziano Umberto I, Torino, Italy; 2Department of
Surgery, Hoˆpital Saint Andre´, Bordeaux, France;
3Department HPB surgery and transplantation, Curry
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Cabral Hospital, Lisboa, Portugal; 4Department of
Visceral and Transplantation Surgery, University
Hospitals of Geneva, Gene`ve, Switzerland; 5Department of
Surgery, Hepatobiliary Unit, Catholic University of the
Sacred Heart School of Medicine, Roma, Italy; 6Unit of
HPB Surgery, Cliniques Universitaires Saint-Luc,
Universite´ Catholique de Louvain Brussels, Belgium;
7Department of Visceral and Transplantation Surgery,
Hoˆpital de Hautepierre, Strasbourg, France; 8Department
of Surgery, University Hospital Aintree, Liverpool, UK;
9Department of Surgery, CRLC Val d’Aurelle,
Montpellier, France; 10Department of Surgery, Medical
University of Vienna, Vienna, Austria; 11Department of
Surgery, Essen University Hospital, Essen, Germany;
12Department of Surgery, University Hospital Bellvitge,
Barcelona, Spain; 13Department of Surgery, ‘‘Josep
Trueta’’ Hospital, Girona, Spain; 14Liver Unit, Queen
Elizabeth Hospital, Birmingham, UK; 15Department of
Surgery, Institute Gustave Roussy, Villejuif, France;
16Department of Surgery, Surgery 3, Coimbra University
Hospital, Coimbra, Portugal; 17Department of Surgery,
Navarra Hospital, Pamplona, Spain; 18Department of
General Surgery and Liver Transplantation, Fundeni
Clinical Institute, Bucharest, Romania; 19AP-HP Hoˆpital
Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background: Tumor progression while on neoadjuvant
chemotherapy (PD) has been associated with poor out-
come and is considered by some authors a contraindi-
cation to liver resection.
Aim: To clarify, in a large multicentric setting, if PD is
always a contraindication to surgery.
Methods: Data have been analyzed from the LiverMet-
Survey international registry. Patients who developed
colorectal liver metastases without extra-hepatic disease,
undergoing resection after neoadjuvant chemotherapy
between 1986 and 2008 have been reviewed.
Results: Among 1850 patients, PD occurred in 10.5% of
cases (195). 5-FU and Irinotecan regimens were more
commonly used in the PD group (29.8% vs 14.0%,
P < 0.0001, 25.7% vs 15.8%, P = 0.001), while oxa-
liplatin in the non-PD one (40.9% vs 29.8%, P = 0.005).
Progression rarely occurred in case of combined targeted
therapy (1-3%). Prognosis was lower in the PD group (5-
year survival 34% vs 48%, P < 0.0001). At multivariate
analysis, PD was an independent prognostic factor of
survival (P = 0.0009) together with CEA value ‡ 200
(P = 0.0003), major hepatectomy (P = 0.0005), and
> 3 metastases (P < 0.0001). In the PD group, 3 inde-
pendent prognostic factors were identiﬁed: CEA value
>=200 (P = 0.038), >3 metastases (P = 0.0024), and
tumor diameter ‡ 50 mm (P = 0.0011). A risk model
was created assigning one point for each prognostic
factor: 5-year survival was 66% for patients with 0
points, 27–30% for patients with 1, and 0–2.5% for pa-
tients with 2–3.
Conclusions: PD is a negative prognostic factor, but it is
not an absolute contraindication to liver resection. Fur-
ther chemotherapy is recommended in patients with 2 or
more negative prognostic factors, while for the others,
surgery can be considered.
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MAIN-DUCT AND COMBINED IPMNS
ARE THE SAME CLINICAL ENTITY AND
DISTINCT FROM BRANCH-DUCT IPMNS
S. Crippa1, C. Fernandez-Del Castillo2, R. Salvia1,
I. Dominguez2, C. Bassi1, S. P. Thayer2, M. Falconi1,
M. Mino-Kenudson2, M. Paini1, P. Capelli1,
G. Lawrence2, S. Partelli1, P. Pederzoli1 and
A. L. Warshaw2
1Policlinico GB Rossi University of Verona, Verona;
2Massachusetts General Hospital, Boston, USA
Background: Intraductal papillary mucinous neoplasms
(IPMNs) of the pancreas comprise main-duct (MD),
branch-duct (BD) and combined types. It is unclear if
BD- and MD- represent two distinct diseases, and where
combined-IPMNs ﬁt. The aim of this study was to
evaluate the clinico-epidemiological characteristics and
prognosis of a large series of patients with IPMNs, to
elucidate differences among the three types.
Methods: Three hundred and eighty nine patients who
underwent pancreatic resection for IPMN were identi-
ﬁed. Surgical specimens and histological slides were re-
reviewed and eventually reclassiﬁed according to the
WHO and IAP diagnostic criteria.
Results: One hundred and ﬁfty nine (41%) patients had
BD-IPMNs, 149 (38%) combined-IPMNs, and 81 (21%)
MD-IPMNs. MD- and combined IPMNs occurred more
frequently in males (56%) while BD-IPMNs in females
(57%) (P < 0.05). All IPMNs subtypes were generally
located in the proximal pancreas. Incidental diagnosis
was more common in BD-IPMNs (34.5%) than in MD-
(13.5%) and combined (19%) ones (P = 0.001). Preva-
lence of adenoma was 44% in BD-, 11% in MD- and 8%
in combined-IPMNs (P = 0.0001). The rate of invasive
cancer was 11% in BD-IPMNs but 42% and 48% in
combined- and MD-IPMNs (P = 0.0001). Patients with
combined and MD-IPMNs with invasive cancer were
older than those with noninvasive tumors -suggesting
tumor progression- while this age difference was not
found in BD-IPMNs. 5-year DSS was 100% for patients
with noninvasive BD-IPMNs and combined-IPMNs and
95% for patients with noninvasive MD-IPMNs; 5-year
DSS was 56%, 51%, and 64%, for BD-IPMNs, MD-
IPMNs, and combined-IPMNs with invasive cancer.
Conclusion: BD-IPMNs have a speciﬁc proﬁle, likely
representing a speciﬁc entity. Combined-IPMNs show
close overlapping in regard to clinico-pathological-epi-
demiological characteristics with MD-IPMNs, and
should be considered an extension of MD-IPMNs to the
branch-ducts. These two subtypes show a more aggres-
sive biological behavior.
MO-143
CHANGING’S IN THE DIAGNOSIS AND
TREATMENT OF SEROUS CYSTIC
TUMORS OF THE PANCREAS:
OBSERVATIONS FROM 260 PATIENTS
G. Malleo, S. Partelli, S. Crippa, R. Rossini,
M. Massignani, M. Paini, C. Bassi and R. Salvia
G.B. Rossi Hospital, University of Verona
Background: Serous cystic tumors (SCTs) are mostly
incidentally diagnosed, but local growth can result in
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symptoms. Indications for surgery include an unclear
differential diagnosis with potentially-malignant cystic
tumors and the presence of symptoms. A diameter
> 4 cm has been proposed as an additional criterion for
recommending surgery.
Objective/Methods: To review SCTs observed from 1990
to 2008 at our centre and to investigate epidemiologic/
morphologic features, indications to surgery and how
management changed in three time periods (1990–1995,
1996–2001, 2002–2008).
Results: 260 pts (212F/81.5%, 48M/18.5%) were found
with SCT (61.5% incidentally, 38.5% symptomatic).
Incidental diagnoses increased over years (P < 0.0001).
Median diameter (US) was 32.0 mm (4–160), greater in
symptomatic pts than in asymptomatic ones (32.5 (4–
160) vs. 31.0 (4–150), P = 0.0495). 83.9% of SCTs were
microcystic, 11.5% oligocystic, 4.6% could not be dif-
ferentiated from IPMNs. Main symptoms were abdom-
inal pain/discomfort, and jaundice. There was no
association between symptoms and gender, symptoms
and tumor location, and gender and tumor location. 139
pts (53.5%) were operated, 121 (46.5%) are in follow-up.
In the resected group [median tumor diameter 50 mm
(30–160)], 60.3% were operated within 6 months from
diagnosis because of symptoms (70.7%), an unclear dif-
ferential diagnosis with MCNs (14.8%) and tumor size.
The remaining 39.7% was initially submitted to follow-
up and then operated due to occurrence of symptoms
(55.5%), tumor growth (77.7%), and an unclear differ-
ential diagnosis with MCNs (14.8%). Median interval
between diagnosis and surgery was 18.0 months (6-120).
The proportion of operated patients has diminished over
years (P < 0.0001).
Changing’s in the diagnosis and management of pancre-
atic SCTs
1990–1995 1996–2001 2002–2008 P
Total Cases 37 77 146
Incidental
diagnosis
13 38 109 < 0.0001
Symptomatic 24 39 37
Surgery 31 55 53
Observation 6 22 93 < 0.0001
Conclusions: If a SCT is asymptomatic and well charac-
terized at imaging, a conservative approach is feasible.
Tumors > 50 mm are more likely to cause symptoms
and may require resection, although no evidence emerges
from current literature.
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RESUME OF WORK AFTER DISTAL
PANCREATECTOMY FOR BENIGN
LESIONS: LAPAROSCOPY IS BETTER.
A SINGLE INSTITUTION
COMPARATIVE STUDY ON 116
PATIENTS
S. Partelli1, G. Butturini1, S. Crippa1, G. Malleo1,
L. Casetti1, G. L. Melotti2, M. Piccoli2, C. Bassi1 and
P. Pederzoli1
1University of Verona, Department of Surgery; 2Ospedale
Boggiovara, Department of Surgery
Background and aim: An increasing number of patients
with pancreatic neoplasms can now be managed by lap-
aroscopic distal pancreatectomy. Aim of this study was
to compare perioperative and long-term outcomes of
laparoscopic distal pancreatectomy (LDP) with open
distal pancreatectomy (ODP).
Methods: Between 2000 and 2006, all patients with be-
nign neoplasms of the pancreatic body/tail were ad-
dressed to LDP or ODP according to the choice of two
experienced pancreatic surgeons (CB and PP). All the
procedures were performed at Pancreatic Unit of Verona.
The laparoscopic resections were executed by two sur-
geons (GLM and GB). All perioperative data were pro-
spectively collected and patients were followed up.
Multivariate analysis was performed using binary logistic
regression.
Results: Seventy-three (62.9%) patients underwent ODP
and 43 (37.1%) LDP. Overall mortality was nil. In the
comparison there were no differences between ODP and
LDP group in median operative time (180 vs.. 180 min-
utes), overall complications (45.2% vs. 48.2%), pancre-
atic ﬁstula rates (13.7% vs. 27.9%), ﬂuid collections
(16.4% vs. 18.6%), re-explorations (9.6% vs. 9.3%),
length of hospital stay (9 vs. 8 days), postoperative dia-
betes (30% vs. 22.5%) and incisional hernia (17.4% vs.
5%). LDP patients had a higher incidence of spleen-
preserving procedures (44.2% vs. 11%, P < 0.0001), a
shorter median time to resume work (3 vs. 6 weeks,
P < 0.0001) and postoperative exocrine insufﬁciency
(0% vs. 10.3%, P < 0.05). By multivariate analysis,
LDP was an independent factor for shorter resume to
work (odds ratio 0.05, 95% conﬁdence interval 0.01–
0.25).
Conclusions: Overall morbidity and pancreatic ﬁstula
rates are similar for LDP and ODP. LDP is associated
with a shorter time to resume work and this should be
considered in the cost effectiveness analyses in future
clinical trials.
MO-148
PARENCHYMA-PRESERVING
RESECTIONS FOR SMALL
NON-FUNCTIONING PANCREATIC
ENDOCRINE TUMORS
S. Crippa1, M. Falconi1, A. Zerbi2, G. Balzano2,
L. Boninsegna1, V. Capitanio2, C. Bassi1, P. Pederzoli1
and V. Di Carlo2
1Policlinico GB Rossi University of Verona; 2San Raffaele
Hospital, Vita e Salute University, Milan
Background: Parenchyma-preserving resection (PPRs)
including enucleation and middle pancreatectomy (MP)
Abstracts 111
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
are accepted procedures for insulinomas, but their role in
the management of non-functioning pancreatic endocrine
tumors (NF-PETs) is debated. Aim of this study is to
evaluate perioperative and long-term outcomes after
PPRs for NF-PETs.
Methods: All patients who underwent PPRs for NF-
PETs between 1990 and 2005 were included. Patients
with multiple endocrine neoplasia-type 1 were excluded.
Results: Overall, 50 patients (23 males, 27 females,
median age 59 years) underwent 26 enucleations and 24
MP. 58% of NF-PETs were incidentally discovered.
Median size of the tumors was 13.5 mm with no preop-
erative suspicion of malignancy in all patients. Overall
morbidity and pancreatic ﬁstula rates were 58% and
50%, respectively. Reoperation rate was 4%, with no
mortality. Postoperative complications were higher in
MP group. At pathology there were 34 (68%) benign
lesions, 13 (26%) neoplasms of uncertain behavior and
three (6%) well-differentiated carcinomas. Forty-one
patients (82%) had a tumor size £ 2 cm. Only 8 patients
(16%) had at least one lymph node removed. After a
median follow-up of 58 months no patient died of dis-
ease. Overall, four patients (8%) experienced tumor
recurrence after a mean of 68 months. The incidence of
exocrine/endocrine insufﬁciency was 8%.
Conclusion: PPRs are generally safe and effective pro-
cedures for treating small NF-PETs. However, better
selection-criteria must be identiﬁed, and lymph-node
sampling should be routinely performed in order to avoid
under-staging. Long-term follow-up evaluation
(> 5 years) is of paramount importance given the pos-
sible risk of late recurrence.
MO-149
THE IMPACT OF LIVER
TRANSPLANTATION TIME ON
FOLLOW UP. DO NOCTURNALS
TRANSPLANTATIONS INCREASED
POSTOPERATIVE COMPLICATIONS?
O. Maillet, A. Herrero, M. Hamoui, H. Bouyabrine and
F. Navarro
Saint Eloi hospital, CHU de Montpellier, France
Background: Since the ﬁrst orthotopic liver transplanta-
tion (OLT) performed by Starlz, this activity has evolved
over the years. Despite the marked increase in the num-
ber of OLT, the organization of surgical teams did not
change and most OLT are often conducted at night time.
However, many studies have revealed decreased alterness
based on circadian rhythm and the negative impact of
tiredness on medical care.
Aim: To study the role of night operations on short-term
follow up for liver transplantation.
Methodology: We analysed restrospectively a serie of 124
patients (mean age: 52 years old, sex ratio 4/1) operated
between the 1st of January 2005 to the 31st of December
2007. Excluded criterias were re-transplantation (n = 6)
and incomplete medical ﬁles (n = 11).Two groups were
deﬁned based on incision time: group 1 (n = 68) in-
cluded incision time between 7:00am to 8:00 PM, group 2
(n = 54) included incision time between 8:01 PM to 6:59
am. We realized a comparative study between these two
groups and univariate and multivariate analysis of vas-
cular complication.
Results: Upon decryption of parameters, group II pre-
sented a number of upper GI tract procedures prior to
transplantation higher than group I (16% vs. 13%,
P = 0.01). Per-operative parameters showed an in-
creased duration of operation (group I = 390 min vs.
group II = 450 min, P = 0,002) and a longer duration
of warm ischemic (group = 55 min vs. group II = 67,
P = 0,02) in group II. Complications were more severe
in group II: global complication (group I = 44% vs.
group II = 60%, P = 0.07) and vascular complication
(group I = 17% vs. group II = 39%, P = 0.006).
Univariate and multivariate logistic regression analysis
revealed that group II was a risk factor of vascular
complication.
Conclusion: Night time transplantation has a negative
impact on follow up with an increased rate of vascular
complications. OLT timing is a new factor that should be
considered for optimizing the outcomes of OLT.
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PHASE II TRIAL OF CETUXIMAB GEM
AND OXALI, FOLLOWED BY XRT WITH
CONCURRENT CAPE, AND CETUXIMAB,
FOR LOCALLY ADVANCED
PANCREATIC ADENOCARCINOMA
(LAPC)
C. Crane1, G. Varadhachary1, M. Javle1, H. Safran2,
S. Krishnan1, J. Fleming1, P. Das1, J. Lee1,
J. Abbruzzese1 and R. Wolff1
1University of Texas MD Anderson Cancer Center,
Houston TX; 2Brown University Oncology Group,
Providence, RI
Background: This trial was designed to assess the efﬁcacy
and safety of 2 cycles of cetuximab (CET), gemcitabine
(GEM) and oxaliplatin (OX) followed by CET, capecit-
abine (CAP) and radiation (RT) in LAPC.
Methods: Treatment naive eligible patients (n = 69)
with LAPC and ECOG PS 0 or 1 were enrolled between
10/05 and 06/09. GEM (1000 mg/m2) and OX (100 mg/
m2) were given IV (q2 weeks for 4 doses). Patients
without progression of disease on restaging CT scan,
then received RT (50.4 Gy to the gross tumor only) and
concurrent CAP (825 mg/m2 twice daily on days of
radiation). CET was started on day 1 of chemotherapy
(500 mg/m2) and every 2 weeks (during chemo and
chemoradiation). The primary endpoint was 1-year OS
with the statistical hypothesis that this treatment would
result in a 1-year OS greater than 45%. Response and
safety were secondary endpoints.
Results: After a median FU is 12.5 months, median,
1 year and 30 month actuarial OS is 19.0 months (95%
CI 14.3–23.7), 66.7%(95% CI 60.2–73.2%) and 18.4%
(95% CI 10.4–26.4). response measured 6 weeks after the
completion of CXRT was partial response in 19%, minor
response in 17%, stable disease in 48%, and progressive
disease in 15% (2 local after CTX, 2 distant after CTX,
and 6 distant after CXRT). Worst acute toxicity during
any part of therapy (G2/G3) was: gastrointestinal (30%/
7%); fatigue (25%2%); paresthesias (12%/2%); acne-
iform rash: (60%/2%) and hematologic (14% G 3/4).
Eighteen SAEs were reported in 16 patients (5 cholan-
gitis, 4 dehydration requiring admission); no SAEs were
unexpected or treatment related. Four patients with
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borderline resectable tumors underwent R0 surgical
resection.
Conclusions: This regimen appears to be effective with
acceptable toxicity. The primary endpoint was met with
encouraging survival duration, suggesting this regimen
should be studied further. Correlative tumor and serum
marker studies under way to evaluate predictors of out-
come.
MO-151
PATTERNS OF RECURRENCE AFTER
RESECTION FOR PANCREATIC
ADENOCARCINOMA
G. Capretti1, G. Balzano1, A. Zerbi1, M. Reni2,
S. Cereda2, N. Pecorelli1 and V. Di Carlo1
1Pancreas Unit, Department of Surgery, San Raffaele
Scientiﬁc Institute, Milan, Italy; 2Department of
Oncology, San Raffaele Scientiﬁc Institute, Milan, Italy
Aim: To deﬁne the pattern of recurrence in resected
pancreatic cancer, possibly identifying prognostic factors
for recurrence site.
Background: The great majority of patients undergoing
resection of pancreatic cancer will die of the disease. The
analysis of recurrence pattern after resection could help
deﬁne the adequate strategy of adjuvant treatment.
Methods: From 1997 to 2007, 192 patients who under-
went resection for ductal carcinoma were followed-up at
our Institution with scheduled clinical evaluation, Ca 19-
9 assessment and CT scan every 3 months. Log-Rank
and Cox regression were used for statistical analysis.
Results: Median overall survival (OS) of the study group
was 23.7 mo, 5-year OS was 18%. 158 pts (82.3%)
developed recurrence (range 2–73 mo); local relapse was
detected in overall 73 pts (46.1%), and distant metastases
in 114 pts (72.1%); of these, 29 (18.2%) had both local
and distant recurrence. Median disease-free (DF) sur-
vival was 12.7 mo. Three out of 8 actual 5-year DF
survivors recurred after 5 years (1 liver, 1 lung, and 1
lung + local). No difference was observed in survival
after detection of local and distant recurrence (9.4 and
11.1 mo. respectively). A number of factors were evalu-
ated, searching for prognostic determinants of recur-
rence. At multivariate analysis, signiﬁcant factors were:
nodal status (OR 2), nodal ratio (OR 4.41), diameter (OR
1.13) and adjuvant therapy (OR 0.47). As regards site of
recurrence, no factor (including margin status) signiﬁ-
cantly predicted local relapse, whereas nodal ratio (OR
6.46) and adjuvant therapy (OR 0.43) were signiﬁcant
determinants for distant metastases.
Conclusions: Distant metastasis is the most frequent
recurrence site, suggesting the adequacy of a chemo-
therapy-ﬁrst strategy in adjuvant therapy. Local relapse
was not related to margin status, indicating that the role
of R-factor should be reconsidered. Recurrence may
occur even after a prolonged DF survival.
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GALLBLADDER CANCER WITH
JAUNDICE – RESULTS OF A FRENCH
NATIONWIDE STUDY ON
CHOLANGIOCARCINOMA
J.-M. Regimbeau1,2, D. Fuks1,2, F. R. Pruvot2,3,
P. Bachellier2,4, Y. P. Le Treut2,5, A. Ayav2,6,
F. Navarro2,7, B. Descottes2,8, C. Partensky2,9,
M. Rivoire2,10, C. Letoublon2,11 and O. Farges2,12
1Amiens North hospital; 2Department of Digestive
Surgery; 3Lille Universitary hospital - Claude Huriez
hospital; 4Strasbourg Universitary hospital - Hautepierre
hospital; 5Marseille Universitary hospital - Conception
hospital; 6Nancy Universitary hospital - Brabois hospital;
7Montpellier Universitary hospital; 8Limoges Universitary
hospital; 9Lyon Universitary hospital - Edouard Herriot
hospital; 10Lyon Universitary hospital - Leon Berard
hospital; 11Grenoble Universitary hospital; 12Beaujon
hospital
Introduction: The presence of jaundice in patients with
gallbladder cancer (GBC) is an indicator of advanced
disease with poor resectability. This study reports of the
clinical impact of jaundice in these patients.
Methods: Patients with gallbladder cancer managed
from 1988 to 2008 were collected into a nationwide ret-
rospective database. Clinicopathologic, surgical proce-
dures, morbimortality and survival correlates were
analyzed.
Results: One hundred and ten (26%) of 429 patients with
gallbladder cancer presented with jaundice. Jaundiced
patients were more likely to have preoperative weight loss
(P < 0.0001), T3-T4 stage disease (72 vs. 62%,
P = 0.04), hepatic resection (45 vs. 64%, P < 0.0001),
major resection (> 3 segments) (53 vs. 18%,
P < 0.0001), portal vein resection (14 vs. 1%,
P < 0.0001), main bile duct resection (49 vs. 35%,
P = 0.02) and lymph node involvement (63 vs. 45%,
P = 0.02) than non jaundiced patients. Mortality and
morbidity were higher in jaundiced patients (15 vs. 3%,
P < 0.0001 and 50 vs. 30%, P < 0.0001 respectively).
There was no difference in negative surgical margins (63
vs. 76%, P = 0.08) and in recurrence (43 vs. 42%,
P = 0.48). The median survival in patients with jaundice
was 6.8 months and was signiﬁcantly lower compared
with 26.2 months in patients without jaundice
(P < 0.0001). There were survivors at 3 and 5 years in
the group with jaundice.
Conclusion: Even if biliary obstruction is an important
indicator of advanced malignancy, jaundice does not
preclude resectability. An aggressive management with
extended procedures can bring prolonged survival in
highly selected patients.
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COMPARISON BETWEEN RIGHT AND
LEFT HILAR CHOLANGIOCARCINOMA
– RESULTS OF A FRENCH STUDY
ABOUT 399 PATIENTS WITH BISMUTH
III CHOLANGIOCARCINOMA
J-M. Regimbeau1,2, D. Fuks1,2, F.-R. Pruvot2,3,
Y. P. Le Treut2,4, D. Castaing2,5, J. Belghiti2,6,
P. Bachellier2,7, K. Boudjema2,8, G. Nuzzo2,9,
D. Cherqui2,10, J.-F. Gigot2,11, O. Boillot2,12,
J. Baulieux2,13 and Olivier Farges2,6
1Amiens North Hospital; 2Department of Digestive
Surgery; 3Lille Universitary Hospital; 4Marseille
Universitary Hospital; 5Paul Brousse Center; 6Beaujon
hospital; 7Strasbourg Universitary Hospital; 8Rennes
Universitary Hospital; 9Roma hospital; 10Henri Mondor
Hospital; 11St Luc Hospital – Brussels; 12Lyon
Universitary Hospital - Edouard Herriot hospital; 13Lyon
Universitary Hospital - Croix Rousse hospital
Introduction: Surgical resection is the only possibility of
long term survival in patients with hilar cholangiocarci-
noma (HC). Tumours staged Bismuth-Corlette III can be
left-sided or right sided. The aim of this study was to
compare right and left HC.
Methods: Patients with HC managed from 1988 to 2008
were collected into a nationwide retrospective database.
Clinicopathologic, surgical procedures, morbimortality
and survival correlates were analyzed.
Results: There were 144 right-sided HC (RHC) and 155
left-sided HC (LHC). Patients with RHC were more
likely to have preoperative biliary drainage (64 vs. 47%,
P = 0.003), portal vein embolization (36 vs. 2%,
P < 0.0001), 30-days mortality (17 vs. 8%, P = 0.009),
morbidity (71 vs. 58%, P = 0.01) and positive surgical
margins (66 vs. 31% P < 0.03) than patients with LHC.
There was signiﬁcantly more liver failure (22 vs. 7%) in
patients with RHC. There was no difference in major
(> 3 segments) hepatectomy (98 vs. 98%), portal vein
resection (22 vs. 30, P = 0.07), intraoperative transfu-
sion (45 vs. 52, P = 0.35), recurrence (44 vs. 40%,
P = 0.28) and lymph node involvement (55 vs. 60%,
P = 0.24). Survival at 1, 3 and 5 years for patients with
LHC (82, 59, 51% respectively) was signiﬁcantly better
(P = 0.01) than in RHC (73%, 49 and 33%).
Conclusion: Despite the retrospective design of this
study, left-sided hilar cholangiocarcinoma seems to have
a better outcomes and better prognosis than right-sided
HC. These results are to take in consideration in Bis-
muth-Corlette II HC.
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PASSIVE DILATATION OF THE MAIN
PANCREATIC DUCT IN IPMN: AN
ANALYTIC STUDY
F. Paye1, J. The´reaux1, P. Balladur1, M. Svreck2,
M. Bennis1, L. Azzizi3 and E. Tiret1
1Department of digestive and hepato-biliary surgery. Saint
Antoine Hospital 75012 Paris, France; 2Department of
Pathology. Saint Antoine Hospital 75012 Paris, France;
3Department of Radiology. Saint Antoine Hospital 75012
Paris, France
Background: Passive dilatation of the main pancreatic
duct (MPD) in Intra ductal papillary mucinous neo-
plasms of the pancreas (IPMN) induces overestimation
of the disease extent leading to exessive pancreatic
resections.
Aims: This study aims to assess the characteristics of
passive dilatation and the risk of detectable recurrence
according to the last pancreatic margin’s histology.
Methods: Forty two patients whose IPMN was resected
from 1996 to 2008, were retrospectively reviewed. All
dilated parts of the MPD diagnosed preoperatively were
at least partially resected in a surgical procedure guided
by frozen section examination of pancreatic resection
margins.
Results: IPMN was malignant in 25 patients and in-
volved the MPD in 33. Dilatation of the MPD preoper-
atively diagnosed in 27 patients was passive on ﬁnal
histopathologic evaluation in 14 (2 benign IPMN, 12
malignant IPMN) and localized in 10 upstream to
IPMN, 2 downstream and 2 both (respectively: 0, 1, 1 in
benign IPMN and 10, 1, 1 in malignant IPMN;
P = 0.05). Presence of mass or mural nodule in IPMN
was signiﬁcantly associated with passive dilatation and
malignancy. Branch-duct type IPMN were not associated
with passive dilatation of the MPD. Only 3 of 11 patients
with adenoma on the last pancreatic margin developed
recurrence of IPMN, asymptomatic, located on branch
ducts and did not require to be resected.
Conclusions: In case of suspected IPMN without preop-
erative element suggestive of malignancy, any part of the
dilated MPD should be considered as pathological in its
entirety, informing the patient of the risks of extensive
surgery guided by repeated frozen section. Deliberately
microscopically uncomplete resection of adenoma ap-
pears, in some patients, more reasonable than total
pancreatectomy.
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EPIDEMIOLOGICAL AND CLINICAL
CHANGES IN PANCREATIC CYSTIC
NEOPLASMS: A 24-YEAR SINGLE-
INSTITUTION EXPERIENCE WITH 1226
PATIENTS
S. Partelli, R. Salvia, M. Paini, A. Esposito, S. Crippa,
M. Falconi, P. Pederzoli and C. Bassi
University of Verona, Department of Surgery
Background: The appropriate management of pancreatic
cystic neoplasms is often a demanding issue for pancre-
atic surgeons.
Methods: All patients evaluated at our institution be-
tween January 1985 and January 2009 with a diagnosis of
pancreatic cyst were reviewed. Analysis was performed to
analyse differences between patients, cyst characteristics
and selection of operative or non-operative management
over three time periods (1985–1993, 1994–2001 and
2002–2009).
Results: Pancreatic cysts were evaluated in 1226 patients.
In all, 636 (52%) were IPMNs, 332 (27%) serous cystic
tumors (SCTs), 207 (17%) mucinous cystadenoma/cy-
stoadenocarcinoma and 54 (4%) solid pseudopapillary
tumours. The median age (54 vs. 65 years) and the Ca
19.9 value (10 vs. 41 U/L) as well as the incidence of non-
incidental diagnosis (75.7% vs. 55.8%) were higher in
malignant neoplasms (P < 0.0001). Median age at
diagnosis (59 vs. 58 vs. 60 years), male/female ratio (3.1
vs. 2.1 vs. 1.9) and incidence of malignant neoplasms
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underwent resection (26.8% vs. 24.9% vs. 21.7%) were
similar between the three time periods. Incidence of
incidental diagnosis (30% vs. 41.5% vs. 73.8%) was sig-
niﬁcantly higher in the last two time periods respect of
the ﬁrst one (P < 0.0001). Between 2002 and 2009, 323
(38.7%) patients underwent surgery respect of 225
(74.8%) and 82 (91.1%) who were operated between
1994–2001 and 1985–1993, respectively (P < 0.0001).
The median diameter of the cystic lesions signiﬁcantly
decreased over the three time periods (45 mm vs. 35 mm
vs. 25 mm, P < 0.0001).
Conclusion: Since the development and the widespread
use of new imaging techniques over the last two decades,
pancreatic cystic neoplasms are ever more early recog-
nized. The improved awareness of this lesions dramati-
cally increased the number of conservatively managed
patients over the years.
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OUTCOME AND COSTS OF
CONVENTIONAL VERSUS RESTRICTED
BLOOD PRODUCT TRANSFUSION
PROTOCOLS IN LIVER
TRANSPLANTATION
C. S. Van Der Hilst1, A. J. C. Ijtsma1, M. J. H. Slooff1,
G. Kazemier 2, T. H. N. Groenland2, J. Ringers3,
Y. Sarton E.3, A. P. Van Den Berg1, H. G. D. Hendriks 1,
M. T. De Boer1, T. Lisman1 and R. J. Porte1
1University Medical Center Groningen, University of
Groningen; 2Erasmus University Medical Center; 3Leiden
University Medical Center
Background: Retrospective studies have indicated that
usage of blood products during liver transplantation is
associated with increased postoperative complication
rates and lower graft and patient survival. Based on this,
some centers have adopted a restrictive blood transfusion
protocol. The safety and efﬁcacy of a restrictive trans-
fusion policy in liver transplant recipients, however, has
not been demonstrated.
Objective: In a prospective study, we aimed to compare
a restricted transfusion protocol with a conventional
transfusion protocol.
Methods: A total of 240 patients undergoing a ﬁrst liver
transplantation in one of the three Dutch liver transplant
centers between 2004 and 2007 were included in this
study. In two centers a conventional transfusion protocol
was used (n = 162 patients), whereas a restrictive
transfusion protocol was used in one center (n = 78
patients). Data on patient and graft survival as well as
recipient-related costs and complications were prospec-
tively collected.
Results: There were no signiﬁcant differences in preop-
erative patient characteristics, including the MELD-
score. In the restricted transfusion group, signiﬁcantly
less blood products were used and a larger proportion
of patients could be transplanted without any blood
products. Overall postoperative complication rate was
similar in both groups. One year graft survival, how-
ever, was better in the restricted transfusion group,
compared to the conventional group (94% vs. 78%;
P < 0.007). Costs for blood product transfusions were
signiﬁcantly less in the restricted transfusion group, but
overall hospital costs were not different among the two
groups.
Conclusion: The use of a restricted transfusion protocol
in liver transplant recipients is safe and is associated with
a better one-year graft survival rate. In the current study
restrictive transfusion was not associated with lower
overall costs.
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THE NEWMELD ALLOCATION SYSTEM
FOR LIVER TRANSPLANTATION SAVES
LIVES BUT INCREASES MORBIDITY
AND COST. A PROSPECTIVE OUTCOME
ANALYSIS
P. Dutkowski1, C. Oberkoﬂer1, M. Bechir2,
B. Mu¨Llhaupt3 and P. A. Clavien1
1Hepato-Pancreatico-Biliary (HPB) and Transplant
Center, University Hospital Zu¨rich, Switzerland;
2Department of Intensive Care, University Hospital
Zu¨rich, Switzerland; 3Department of Hepatology and
Gastroenterology, University Hospital Zu¨rich, Switzerland
Background: There is currently an intense debate on
whether liver grafts should be offered directly to a patient
(the sickest one) or rather to a center with the freedom to
use an organ for the patient of their choice. In our
country, a disease oriented graft allocation policy by
MELD score was implemented in July 2007, while organs
were previously allocated solely to centers. This has
caused major controversies and claim about increased
cost with poorer patient outcome, as in many other
countries.
Objectives: To test how a newly implemented MELD
(Model of End stage Liver Disease) allocation policy
affects mortality and morbidity before and after trans-
plantation, as well as cost.
Methods: We prospectively analysed the ﬁrst 75 patients
transplanted by MELD allocation, and compared out-
come of patients on the waiting and after OLT, including
cost, with the last 75 patients transplanted prior to the
introduction of the MELD system.
Results: MELD resulted in decreased waiting list mor-
tality (25 vs. 13%, p = 0.03), and transplantation of
sicker recipients (uncorrected median MELD score 15 vs.
22, p = 0.03). Recipient post transplant morbidity was
signiﬁcantly higher, mainly caused by increased percen-
tage of renal failure requiring renal replacement therapy
(15 vs. 41%, p = 0.01). However, kidney function
recovered in most cases within 6 months after OLT. The
number and severity of other complications, and mor-
tality (7%) were similar in both groups. Cost, in contrast,
was signiﬁcant higher after introduction of the MELD
policy (37.900 vs. 55.600€, 47% increase, p = 0.02) with
a strong correlation with the individual MELD score
(P < 0.0001).
Conclusions: The MELD system addresses the goal of
fairness well. However, the postoperative course appears
more difﬁcult in the MELD era with increased ﬁnancial
burden, but similar patient and graft survival. This is the
inevitable price to balance justice and utility in liver graft
allocation.
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MO-158
NOVEL AND SIMPLE PREOPERATIVE
SCORE PREDICTING OUTCOME
FOLLOWING LIVER RESECTION
M. L. De Oliveira, S. Breitenstein, D. Raptis,
K. Slankamenac, P. Kambakamba, J. Nerl and
P. A. Clavien
Swiss HPB (Hepato-Pancreato-Biliary) Center,
Department of Surgery, University Hospital of Zurich
Background: Liver surgery is associated with a sub-
stantial rate of complications. Early identiﬁcation of
patients at risk of serious complications is important to
adjust therapeutic strategies, improve quality, and to
evaluate cost.
Objective: To develop and validate a simple score to
predict complications following liver resection using
preoperative risk factors.
Methods: Complications were prospectively assessed in
615 consecutive non-cirrhotic patients undergoing liver
resection (2002–2008). In randomly selected 60% of the
population, multivariate regression analysis was used to
develop a predictive score of severe complications (grade
III, IV, V). The new score was validated by calibration
within the remaining 40% of the patients.
Results: Serious complications occurred in 159 of the 615
patients (26%) after liver resection, 90 (15%) grade III,
48 (8%) grade IV, and 21 (3%) grade V. Four pre-
operative parameters were identiﬁed as independent
predictors such AST, ASA, major liver resection and
hepaticojejunostomy. The prediction score was devel-
oped involving 369 patients (60%) based on the 4 pre-
dictors and ranged from 0 to 10 points. The risk to
develop serious postoperative complications was 16% in
the ‘‘low risk’’ group (0–2 points), 37% in the ‘‘inter-
mediate risk’’ group (3–5 points) and 60% in the ‘‘high
risk’’ group (6–10 points). The predicted mean absolute
risk for serious complications was 27% in the validation
population (n = 246), while the observed risk was 24%.
Predicted and observed risks were similar (p = 0.8). The
score was signiﬁcantly associated with hospital and ICU
stay. Costs of the procedure doubled in the high risk
group.
Conclusions: This novel and simple score accurately
predicts postoperative outcome and cost in patients
undergoing liver resection. The use of this score allows
early identiﬁcation of risk of complications and may
impact not only on decision-making for surgical inter-
vention but also on quality assessment and reimburse-
ment.
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FV-01
RENAL VEIN: A CONDUIT FOR PORTAL
VEIN RECONSTRUCTION
G. Gunasekaran, F. Aucejo, C. Quintini, K. Hashimoto,
C. Winans, J. Fung and C. Miller
Cleveland Clinic Foundation, Cleveland, OH
Introduction: We report a case of hilar cholangiocarci-
noma with portal vein (PV) invasion where a renal vein
(RV) was used for reconstruction of the portal vein.
Patient and methods: A 38 year old female with hilar
cholangiocarcinoma involving the portal vein bifurcation
was referred to our institution. Preoperative evaluation
revealed a completely thrombosed right PV and a
thrombus in the proximal left PV. Endoscopic ultrason-
ogram and computerized tomogram showed no evidence
of lymphadenopathy. We performed a right trisegmen-
tectomy with PV resection. The distal main PV along
with the proximal left PV was transected. The left hepatic
artery was preserved. The distal portion of left renal vein,
extending from IVC to the point where the gonadal and
adrenal veins drain, was transected. The transected renal
vein was then used as a conduit for reconstructing the
main PV to the transected left PV. The patient recovered
from surgery without any complications. Patient had
good ﬂow across the conduit. No renal dysfunction was
seen postoperatively.
Conclusion: The easy access and length of the left RV
makes it a reasonable conduit for reconstructing the PV.
In addition, the diameter of the RV approximately
matches the PV. The left gonadal and adrenal veins serve
as alternative routes of venous drainage for the left
kidney.
FV-02
PORTO-GASTRIC PANCREAS
TRANSPLANT, A NOVEL TECHNIQUE
H. Shokouh-Amiri and G. B. Zibari
Louisiana State University Health Sciences Center -
Shreveport
Background: Portal drainage of pancreas allograft (PA)
was performed by Calene in 1980’s. Shokouh-Amiri et al
perfected and popularized the technique of portal enteric
(PE) pancreas transplantation (PTX). In 2007 Zibari et al
added a venting jejunostomy to it and showed an
improvement in the result of PTX. Zibari and Shokouh-
Amiri further perfected the technique of PE PTX by
anastomising jejunum of PA to stomach.
Aim: To show our new technique of PTX.
Methods: Arterial supply of PA is reconstructed. An
arterial conduit is anastomosed to common iliac artery
and brings it up through the mesentery of the small bowel
toward the superior mesenteric vein (SMV). The portal
vein (PV) is dissected and in this technique it is necessary
to have a few inches longer of proximal jejunum of the
PA to facilitate anastomising it to stomach. At this point
SMV in the recipient is dissected. An end to side anas-
tomosis between the PV of PA and SMV of the recipient
is performed. Reconstructed Y graft is anastomosed to
arterial conduit and PA is reperfused. Hereafter terminal
part of the jejunum of PA is anastomosed to anterior
aspect of the stomach.
Results: Twenty-two patients have been transplanted in
our center by this technique. Three grafts have been lost,
2 in patients with hypercoagulable state. Gastrojejunos-
tomy of PA has proven useful in 5 patients to diagnose
rejection, and CMV disease.
Discussion: By incorporating this novel addition to PE
technique of transplantation, exocrine secretions of the
PA will be diverted to G.I. tract, no ﬂuid and electrolyte
will be lost and irritative complications will not occur.
Furthermore there will be no need for taking down of
venting jejunostomy and there will be a permanent access
for studying the PA if it becomes necessary either by
endoscopy or contrast study. This technique will be even
more useful for solitary PT.
Conclusion: Porto-gastric pancreas transplant is a safe
and easy technique with good short term results.
FV-03
USE OF LEFT RENAL VEIN AS PORTAL
VEIN INFLOW IN LIVER TRANSPLANT
RECIPIENTS WITH PORTAL VEIN
THROMBOSIS
K. Saeb-Parsy, A. Jah, N. Jamieson and R. Praseedom
University of Cambridge
A number of approaches including thrombectomy and
porto-caval transposition have been described to allow
patients with portal vein thrombosis to receive a liver
transplant. This video describes the orthotopic liver
transplant (OLT) in a patient with portal vein thrombosis
in whom the left renal vein was used for portal inﬂow to
the liver graft. A 48 year old patient with end-stage
alcoholic liver disease and extrahepatic portal vein
thrombosis presented with intractable haemorrhage from
oesophageal and gastric varices unresponsive to banding
or a transjugular intrahepatic porto-systemic shunt
(TIPSS). At laparotomy the inferior mesenteric vein
(IMV) was anastomosed end-to-side to the left renal vein
as a non-selective central shunt. Pre- and post-shunt CT
images are shown in the video. The patient made a good
recovery and ﬁve months later underwent an OLT. The
video shows the patent IMV-left renal vein porto-
systemic shunt at the time of the transplant. The OLT
was performed with the patient on extra-corporeal veno-
venous bypass and using the classical technique of caval
replacement. The video shows dissection of the left renal
vein, its division from the recipient inferior vena cava and
anastomosis to the donor portal vein. Removal of the
vascular clamps and reperfusion of the liver graft is also
shown. The patient made a good recovery and was
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discharged three weeks post-operatively. Post-operative
doppler ultrasound traces are shown in the video,
demonstrating a patent reconstructed portal vein. Anas-
tomosis of the left renal vein to the donor portal vein is
an effective method of obtaining portal inﬂow in patients
with extensive portal thrombosis found at laparotomy.
The choice in this case of a central decompressive shunt
to the left renal vein at the time of the variceal
haemorrhage allowed use of the left renal vein to give
full portal inﬂow to the grafted liver without the
additional operative risk and complexity of dismantling
the shunt.
FV-04
RESECTION OF PORTAL AND
SUPERIOR MESENTERIC VEIN
ANEURYSM WITH RECONSTRUCTION
USING PTFE
M. Abouljoud1,2
1Henry Ford Hospital; 2Transplant and Hepatobiliary
Surgery
Background: Portal (PV) and superior mesenteric vein
(SMV) aneurysms present technical challenges for
resection and reconstruction. They can be complicated by
thrombosis with risk for adverse outcomes. Avoiding
resection is considered while aneuysmorraphy and
resection with primary repair have been advocated. In
this instance, we present a video of resection with
reconstruction of the PV, SMV and splenic veins using 12
ringed PTFE.
Case History: A 54 year female who was referred for
abdominal pain. CAT scan showed evidence of chronic
pancreatitis and an aneurysm of the PV and SMV,
involving the splenic vein. The aneurysm measured 9 cm
in the craniocaudal dimension and 6 · 3.5 cm at its
largest section. Resection of the aneurysm with recon-
struction was offered and informed consent obtained.
Procedure: Patient was taken to the operating room and,
after proper anesthesia and preparation, a low Mercedes
incision was performed. The SMV was dissected and
aneurysm identiﬁed. Small branches were tied and di-
vided, SMV proximal to aneurysm was isolated and
splenic vein was also dissected were it entered the aneu-
rysm. Portal vein was dissected at the hilum and was fully
mobilized. Retropancreatic segment of PV was also dis-
sected circumferentially and pancreatic branches divided.
Patient was systemically heparinized, clamps applied to
PV, SMV and splenic vein and aneurysm resected. A
12 mm ringed PTFE was fashioned and anastomosed to
PV and SMV in end-end fashion with running 6-0 PTFE
suture. A side graftotomy was performed with excision of
a button and splenic vein was anastomosed in end-side
fashion. Clamps were removed and ﬂow restored with
excellent doppler and ﬂow. Patient is now 1 year fol-
lowing repair with excellent imaging and patency of
graft.
Conclusion: Reconstruction after resection of combined
PV and SMV aneurysms can be complex. Technique with
successful outcome using PTFE is presented and dis-
cussed.
FV-05
PARTIAL SPLENECTOMY WITH
BIPOLAR RADIOFREQUENCY DEVICE
M. Pai, C. Kyriakides, A. Frampton, O. Kornasiewicz,
D. Spalding, L. Jiao and N. Habib
HPB Surgery, Hammersmith Hospital, Imperial College,
London, UK
Background: Over the years various resection techniques
have been used for spleen preservation with unsatisfac-
tory results, due to uncontrollable intra-operative
bleeding. A bipolar Radiofrequency (RF) device has been
used routinely for liver surgery in our unit with good
results over the last 5 years and its role has been ex-
panded successfully for partial splenectomy. We present
here a patient undergoing spleen preservation surgery
with this technique.
Materials and method: A 40 year old male patient pre-
sented with left upper quadrant pain over a period of
4 weeks. Imaging revealed a solid lesion in the lower pole
of the spleen. It was difﬁcult characterise this lesion on
imaging and we decided to do partial splenectomy after
discussing with the patient. Following mobilization of
spleen, ablation of tissue to induce coagulative desicca-
tion was carried out, along an intended line of division
with the bipolar RF device. Subsequently the splenic
parenchyma was divided with a scalpel.
Results: The operative time was 90 min and blood loss
was minimal. The postoperative course was uneventful
and the patient was discharged on the 7th postoperative
day. The histology conﬁrmed this to be a hemartoma. A
CT scan one month postoperatively showed normal
enhancement of the porto-splenic venous system and the
splenic artery.
Conclusions: This technique, with increasing experience,
may allow surgeons to perform splenic preservation
surgery with minimal intra-operative bleeding.
FV-06
LAPAROSCOPIC SPLENECTOMY
C. Salas, G. Moriconi, N. Bucich, F. Bersano, J. Pekolj
and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Laparoscopic splenectomy is internation-
ally considered the standard procedure in surgical treat-
ment of diseases of the spleen. The procedure requires
expertise in laparoscopic surgical techniques and metic-
ulous dissection of the spleen. The patient should un-
dergo preoperative vaccination against meningococcal,
pneumococcal, and Haemophilus inﬂuenzae type B
infections.
Methods: A 43-year old male patient with abdominal
pain. Past surgical history: cholecystectomy. Abdominal
CT scan: in the anterior sector of the splenic superior
pole there is a nodular hypodense formation of
26 · 27 mm of diameter. The operation included dif-
ferent phases: Trocar placement, lower pole dissection,
exposing spleen hilum, spleen vessel clipping and sec-
tion.
Results: The operating time was 160 min. with no blood
transfusion. Histopathological report: Granulomatous
foreign body reaction. The hospital stay was 48 hour.
Conclusions: Laparoscopic splenectomy seems to be a
safe and favourable procedure for elective splenectomy,
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except in cases of distinct splenomegaly. The feasibility
and safety for diagnosis and treatment of both benign
and malignant tumors of the spleen have been demon-
strated.
FV-07
ONE-STAGE LAPAROSCOPIC
BISEGMENTECTOMY 7–8 AND
BISEGMENTECTOMY 2–3 FOR
BILATERAL COLORECTAL LIVER
METASTASIS
M. A. Machado, F. Almeida, F. Makdissi, R. Surjan and
G. Cunha Filho
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Bisegmentectomy 7–8 is feasible even in the
absence of a large inferior right hepatic vein. To our
knowledge this operation has never been performed by
laparoscopy. AIM: To present a video of totally lapa-
roscopic bisegmentectomy 7–8 and bisegmentectomy 2–3
in one-stage operation for bilateral liver metastasis.
Method: A 67-year-old male suffering from metachro-
nous bilobar colorectal liver metastasis was referred for
surgical treatment after neoadjuvant chemotherapy. CT
scan disclosed two liver metastasis: one located between
segments 7 and 8 and another one in segment 2. At liver
examination another metastasis was found on the surface
of segment 3. We decided to perform a bisegmentectomy
7–8 along with bisegmentectomy 2–3 in a single proce-
dure. Operation began with mobilization of the right liver
with complete dissection of retrohepatic vena cava.
Inferior right hepatic vein was absent. Right hepatic vein
was dissected and encircled. Upper part of right liver,
containing segment 7 and 8, was marked with cautery.
Selective hemi-Pringle maneuver was performed and
right hepatic vein was divided with stapler. At this point,
liver rotation to the left allowed direct view and access to
the superior aspect of the right liver. Liver transection
was accomplished with harmonic scalpel and endoscopic
stapling device. Bisegmentectomy 2–3 was performed
using intrahepatic Glissonian approach. The specimens
were extracted through a suprapubic incision. Liver raw
surfaces were reviewed for bleeding and bile leaks.
Results: Operative time was 240 min with minimum
blood loss and no need for blood transfusion. Recovery
was uneventful and the patient was discharged on the 5th
postoperative day.
Conclusion: Bisegmentectomy 7–8 may increase resect-
ability rate in patients with bilateral lesions. This oper-
ation can safely be done by laparoscopy. Preservation of
segments 5 and 6 permitted simultaneous resection of
segments 2 and 3 with adequate liver remnant.
FV-08
LAPAROSCOPIC LEFT
HEMIHEPATECTOMY BY CURETTAGE
AND ASPIRATION
X. J. Cai, H. Yu, X. Liang and Y. F. Wang
Sir Run Ruin Shaw Hospital, College of Medicine,
Zhejiang University
Background: By using the instrument of laparoscopic
multifunctional operative dissector (LMOD) and the
technique of Selective liver inﬂow/outﬂow occlusion,
laparoscopic left hemihepatectomy was performed safely
in our institution.
Aim: To introduce laparoscopic left hemihepatectomy
by curettage and aspiration.
Method: From August 1998 to July 2009, 315 laparo-
scopic hepatectomies were performed by authors in Sir
Run Run Shaw Hospital (including 46 laparoscopic left
hemihepatectomies).In the video, a patient with hepato-
lithiasis have laparoscopic left hemihepatectomy. The
technique of hepatectomy by curettage and aspiration
(LHCA) was used and laparoscopic multifunctional
operative dissector (LMOD) was used as the main
instrument for liver transection. Left hepatic artery, left
portal vein, and left hepatic vein was occluded (Selective
liver inﬂow/outﬂow occlusion) before liver transection to
decrease blood loss and to prevent gas embolism.
Results: The operation was completed successfully. The
operating time was 135 min and blood loss was 200 mL.
Postoperative hospital stay was 7 days. There was no
blood transfusion and no complication.
Conclusions: Laparoscopic left hemihepatectomy by
curettage and aspiration is an alternative procedure for
liver lesions.
FV-09
LAPAROSCOPIC RIGHT
HEPATECTOMY
M. Scho¨n
Department of Surgery Klinikum Karlsruhe, Academic
Teaching Hospital Universtity of Freiburg
Major anatomic liver resections, initially considered to be
unsuitable for laparoscopy, are increasingly reported by
several centers worldwide. It is widely accepted that
standards of open liver surgery should not be compro-
mised during laparoscopic interventions. The video
describes a totally laparoscopic right hepatectomy in an
adipose patient (BMI: 44). Patient history: Twenty four
months after sphincter preserving radical rectal resection
with TME [ypT3, ypN 0 (0/20), M0], metastasis of the
right liver were diagnosed on routine follow up. Accord-
ing to MRI scans, endoscopy and PET-scan, metastasis
were limited to the right liver. The HD-Video includes
the following steps: Positioning of the adipose patient,
intermittent pneumatic calf compression for prevention
of DVT, trocar placement, explorative laparoscopy,
intraoperative diagnostic ultrasound, cholecystectomy,
mobilisation of the right liver, preparation of the hepto-
duodenal ligament without Pringle manoeuver, dissection
and ligation of the right hepatic artery, right portal
branch, and right hepatic duct, parenchymal dissection
with ultrasonic surgical aspirator, a bipolar vessel sealing
device, vascular stapler only for larger vessels, ligation of
right hepatic vein, sealing of the resection surface with
bipolar coagulation, argon-beamer and ﬁbrin glue,
extraction of the resectate. No blood transfusions were
given and the post operative course was uneventful.
Pathology conﬁrmed metastasis of an adeno carcinoma
with a maximal diameter of 6 cm and clear resection
margins. The patient was discharged 8 days after resec-
tion. Laparoscopic right hepatectomy was carried out
without compromising on surgical principles established
in open surgery. Laparoscopic equipment such as intra-
operative ultrasound, ultrasonic surgical aspirator, bipo-
lar and argon beamer coagulation and ﬁbrin glue sealing
can be used to its fullest extend. However, proﬁciency in
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both open liver surgery and advanced laparoscopy is
compulsory.
FV-10
LAPAROSCOPIC RIGHT
HEPATECTOMY USING A PEDICLE
STAPLING TECHNIQUE AND
WATERJET DISSECTION
M. Porembka, D. Linehan, W. Hawkins and S. Strasberg
Washington University in Saint Louis
Introduction: Laparoscopic major liver resection is an
innovative procedure which is in continuing develop-
ment. The major steps in liver resection are control of
vascular inﬂow and outﬂow and parenchymal transec-
tion. This video shows a controlled method for per-
forming the procedure by right pedicle division, waterjet
dissection of the parenchyma and intrahepatic control of
major hepatic veins.
Methods: The patient was a 67 year old male with 5
colorectal metastases in the right liver. There was no
extrahepatic disease. The procedure was performed with
the patient rolled up to 45 degrees on the left side using a
handport placed in the midline and four other ports. The
right liver was mobilized, the gallbladder was removed
and the liver was opened in the midplane until the right
pedicle was isolated. The pedicle was divided with a
stapler. Waterjet dissection combined with a sealer-cut-
ter, locking clips and vascular stapler were used to divide
the parenchyma and vessels.
Results: The patient had two postoperative complica-
tions, ascites and C. difﬁcile colitis which delayed his
discharge for 10 days. He has been well in the 12 months
since surgery.
Conclusions: The technique provides a controlled meth-
od for performing laparoscopic right hepatectomy.
FV-11
LAPAROSCOPIC LEFT LATERAL
SEGMENTECTOMY
N. G. Bucich, C. F. Salas, F. V. Bersano, G. F. Moriconi,
E. De Santiban˜es and J. Pekolj
Hospı`tal Italiano de Buenos Aires
Background: Liver resection is the deﬁnitive treatment in
cystic tumors located in the left lobe. Access to posterior
lesions of the right lobe (segments VII and VIII) and
performing major regulated hepatectomies (more than 3
segments) are at present difﬁcult for liver surgeons.
Objective: To show that laparascopic liver resection can
be performed safely.
Method: A left hepatectomy was performed in an 81-
year-old woman with recurrent cholangitis. MRI showed
left lateral segment biliary duct dilatated, with defect
suggestive of lithiasis. The operation followed four dis-
tinct phases: placement of trocar, abdominal cavity
examination, liver mobilization and repair of hepatic
hilus (Pringle maneuver). Dissection of the hepatic artery
and the portal vein was performed between ligations.
Parenchymal transection with harmonic shears and linear
staplers for left hepatic vein was also performed.
Results: The operating time for left hepatectomy was
240 min, with no morbidity and mortality. Length of
hospital stay was 7 days. Histopathological report
showed malignant mucinous hepatobiliary cystic tumor.
Conclusion: Laparoscopic liver resection is safe to be
performed, with low morbidity and mortality and with
the advantages of laparoscopic surgery. And malignant
mucinous hepatobiliary cystic tumor can resemble an
intrahepatic biliary disease.
FV-12
TWO-STAGE TOTALLY LAPAROSCOPIC
HEPATECTOMY FOR BILOBAR
COLORECTAL LIVER METASTASIS
R. Surjan, F. Makdissi, G. Kappaz, N. Yamaguchi and
M. Autran Machado
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Hepatectomy may prolong survival of
colorectal cancer patients with liver metastases. Two-
stage liver surgery is a valid option for the treatment of
bilobar colorectal liver metastasis.
Aim: To present a video of two-stage laparoscopic liver
resection for bilobar liver metastasis.
Method: A 54-year-old male suffering from right colon
cancer and synchronous bilobar colorectal liver metas-
tasis underwent laparoscopic right colon resection fol-
lowed by oxaliplatin-based chemotherapy. The patient
was then referred for surgical treatment of liver metas-
tasis. Liver volumetry showed a small left liver remnant.
Surgical planning was a totally laparoscopic two-stage
liver resection. First stage: laparoscopic resection of
segment 3 and ligature of right portal vein. Postoperative
pathology disclosed high-grade liver steatosis. After
4 weeks the left liver had regenerated and volumetry of
left liver was 43%. Second stage: Laparoscopic right
hepatectomy using intrahepatic Glissonian approach.
Intrahepatic access to the main right Glissonian pedicle
was achieved with two small incisions and an endoscopic
vascular stapling device was inserted between these inci-
sions and ﬁred. Line of liver transection is marked along
following ischemic area. Liver transection was accom-
plished with harmonic scalpel and endoscopic stapling
device. The specimen was extracted through a suprapubic
incision. Falciform ligament was ﬁxed to maintain the
left liver in its original anatomical position, avoiding
hepatic vein kinking and outﬂow syndrome.
Results: Operative time was 90 and 240 min, respec-
tively. Recovery after the ﬁrst and the second operations
were uneventful and the patient was discharged on the
2nd and 7th postoperative day, respectively.
Conclusion: Two stage liver resections can safely be done
by laparoscopy. Intrahepatic Glissonian approach is a
useful tool for pedicle control of the right liver, especially
after previous dissection of the hilar plate.
FV-13
EX VIVO LIVER AND MAIN HEPATIC
VEINS/RETROHEPATIC VENA CAVA
RESECTION FOR CHOLANGIO-
CELLULAR CARCINOMA IN CAUDATE
LOBE
J. Dong, W. Ji, W. Duan, Y. Liang and H. Wang
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: Liver resection is technically challenging
for cholangiocellular carcinoma in the caudate lobe due
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to tumor invasion of major hepatic veins and inferior
vena cava (IVC). However, ex vivo liver resection and
autotransplantation is theoretically a treatment option.
Objectives: This video will show the technical aspects of
ex vivo liver resection and autotransplantation.
Methods: A 38-year-old female patient with cholangio-
cellular carcinoma in caudate lobe was referred for sur-
gical treatment. The ex vivo liver resection and
autotransplantation was attempted for this patient be-
cause of tumor inﬁltration into major hepatic veins and
IVC. Protection of the liver parenchyma against pro-
longed ischemia was obtained through cold portal per-
fusion with HTK solution. An atypical hepatectomy with
ex vivo R0 resection of tumor and resection of left portal
vein, 3 major hepatic veins and retrohepatic vena cava
were performed followed by liver remnant autotrans-
plantation. The temporary portacaval shunt was per-
formed instead of veno-venous bypass. The IVC, 3
hepatic veins and left portal vein were reconstructed with
cryopreserved venous allografts.
Results: The operating time was 15 hours. The blood
loss was 5500 ml, and blood transfusion 4760 ml. The
anhepatic period was 6 hours, while duration of hypo-
thermic ischemia was 5 hours. The patient recovered
uneventfully with a hospital stay of 20 days.
Conclusions: Ex vivo liver resection and autotransplan-
tation is a safe and feasible procedure for the caudate
tumor with invasion both of major hepatic veins and IVC.
FV-14
PANCREATODUODENECTOMY FOR
PANCREATIC HEAD CANCER WITH
CELIAC ARTERY OBSTRUCTION BY
MEDIAN ARCUATE LIGAMENT
COMPRESSION
A. Nakao, S. Takeda, S. Nomoto, H. Sugimoto, T. Fujii
and G. Nakayama
Gastroenterological Surgery, Nagoya University Graduate
School of Medicine
Background: When performing pancreatoduodenectomy
(PD) for pancreatic head tumor with celiac artery
obstruction by median arcuate ligament (MAL) com-
pression, special problems concerning arterial blood
supply to the liver, stomach, pancreas and spleen must be
addressed. If we do not know this situation before or
during the operation, dangerous postoperative ischemic
damage or necrosis of the stomach, pancreas, spleen or
liver will occur.
Aims: In this video presentation, we present two types of
MAL compression. One is celiac artery obstruction by
MAL. However, celiac arterial blood ﬂow was recovered
by the dissection of MAL. Therefore conventional PD
was performed. The other is celiac blood ﬂow that was
not recovered by the dissection of MAL, so PD combined
with arterial reconstruction was performed.
Method: MAL compression can be diagnosed before
operation by dynamic MDCT. The ﬁrst step of PD is the
exposure of the proper hepatic, gastroduodenal, common
hepatic and splenic arteries. Then, the MAL is dissected
on the celiac artery. Usually, the MAL dissection obtains
celiac arterial blood ﬂow and conventional PD can pro-
ceed. This procedure is presented in the ﬁrst case. If the
blood ﬂow of the celiac artery is not recovered, arterial
reconstruction is necessary. In the second case, arterial
reconstruction between the gastroduodenal artery and
arterior inferior pancreatoduodenal artery was per-
formed. This procedure is presented in the second one.
Conclusion: Preoperative diagnosis of the celiac artery
obstruction by MAL compression is important to per-
form PD safely and arterial reconstruction is necessary in
some cases.
FV-15
EXTENDED LEFT HEPATECTOMY
WITH RESECTION OF 3 HEPATIC VEINS
AND RECONSTRUCTION USING LEFT
RENAL VEIN GRAFT UNDER TVE AND
HYPOTHERMIC LIVER PERFUSION
J. Figueras1, S. Lopez-Ben1, A. Codina-Barreras1,
M. Albiol1, L. Falgueras1, E. Castro1, P. Planellas1,
C. Garcia-Jimenez1, B. Pardina1, S. Torres-Bahı´1 and
V. Sanchez2
1‘‘Josep Trueta’’ Hospital, IDiBGi, Girona, Spain;
2Hospital Vall Hebro´, Barcelona, Spain
Background: The application of skills of OLT to liver
surgery has raised the threshold of resectability to limits
previously unexpected.
Aim: We present the case of LM successfully resected
using ‘‘extreme liver surgery’’ techniques.
Case: A 48-years old man was send to our unit with
unresectable LM of CRC. The patient was treated with
12 cycles of Folfox+bevacizumab and 11 cycles of
Folﬁri+bevaczumab and a ‘‘wallstent’’ prosthesis was
placed in the primary tumor. CEA levels dropped from
964 to 5 ng mL-1. However, the CT scan showed huge
LM involving the left liver, segment VII-VIII and the 3
hepatic veins. There was not inferior right hepatic vein.
An extended left hepatectomy enlarged to segments VII-
VIII with resection of the 3 hepatic veins was performed
under TVE of 105’, veno-venous by-pass of 140’ and
hypothermic perfusion of the liver with UW solution of
85’. The right hepatic vein was reconstructed using
autologous graft from the left kidney. Histological study
demonstrated 90% tumoral necrosis.
Discussion: New chemotherapy for CRC has achieved
high objective response. TVE longer than 60’ produces
severe homodynamic disturbances and promotes liver
insufﬁciency due to ischemia. The use of veno-venous by-
pass allows performing extended hepatic resections and
complex vascular reconstructions. Conversely the use of
hypothermic perfusion minimizes the ischemia reperfu-
sion injury of prolonged liver clamping. Our case com-
bines modern technical reﬁnements with new oncological
concepts such as neoadjuvant chemotherapy and ‘‘re-
verse approach’’ in the treatment of synchronous colo-
rectal LM to offer a treatment with curative intent to
otherwise unresectable patients.
FV-16
THREE CASES OF LAPAROSCOPIC
HILAR CHOLANGIOCARCINOMA
RESECTION WITH HEPATICOJEJUNAL
RECONSTRUCTION AND PORTAL
LYMPH NODE DISSECTION
J. Weaver, E. Paul, E. Lin and J. Sarmiento
Emory University
Background: Laparoscopic techniques are in the fore-
ground of hepatobiliary and pancreas surgery. Three
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cases of hilar cholangiocarcinoma were excised laparo-
scopically with laparoscopic hepaticojejunal reconstruc-
tion incorporating our existing protocols for
laparoscopic anatomic hepatectomy and laparoscopic
hand sewn biliary-enteric anastomosis.
Objectives: To examine and display the laparoscopic
technique used in the excision of hilar cholangiocarci-
noma with hepaticojejunostomy and to analyze intraop-
erative and post-operative surgical complications,
technical feasibility, tumor margins and clinical out-
comes.
Methods: During 2008-2009, three patients underwent
extended right hepatectomy for hilar cholangiocarcino-
ma (Bismuth IIIa), radical portal lymphadenectomy and
roux-en-Y hepaticojejunostomy using laparoscopic
techniques.
Results: No intraoperative complications occurred dur-
ing the procedures. Tumor margins were clear in all pa-
tients, but positive lymph nodes were discovered in one
patient. All patients were given an oral diet post-opera-
tive day 1 and discharged day 3–4. No blood transfusions
were necessary. Cholangiograms were performed 10–
14 days after surgery demonstrating patent hepaticojej-
unal anastomoses.
Discussion: Compared with standard open hepatic
resections, laparoscopic-assisted extended right hepatec-
tomy for hilar cholangiocarcinoma with laparoscopically
hand sewn hepaticojejunal anastomosis can be achieved
with superior visibility, shorter length of stay and equal
biliary-enteric patency rates.
FV-17
BILE DUCT DETECTABILITIES OF
FLUORESCENT CHOLANGIOGRAPHY
DURING LAPAROSCOPIC
CHOLECYSTECTOMY
T. Ishizawa1,2, Y. Bandai2, N. Harada1,2, A. Muraoka1,2,
M. Ijichi2, K. Kusaka2, M. Shibasaki2, K. Yamamoto1,
J. Kaneko1, K. Hasegawa1 and N. Kokudo1
1Hepato-Biliary-Pancreatic Surgery Division, Department
of Surgery, Graduate School of Medicine, University of
Tokyo; 2Department of Surgery, Central Hospital of
Social Health Insurance
Background: Although intraoperative cholangiography
(IOC) has been recommended for avoiding bile duct in-
jury during laparoscopic cholecystectomy (LC), radio-
graphic IOC is time-consuming and the procedure itself
may cause bile duct injury. We have developed a novel
ﬂuorescent cholangiography technique using preopera-
tive intravenous injection of indocyanine green (ICG).
Methods: In 45 patients undergoing LC, ICG (2.5 mg)
was intravenously injected before surgery. We utilized
ﬂuorescent imaging system (Hamamatsu Photonics Co.,
Japan) comprised of a xenon light source and a laparo-
scope with a charge-coupled device camera, which can
ﬁlter out light wavelengths below 810 nm. Fluorescent
cholangiography was performed before and during the
dissection of the triangle of Calot by changing from color
images to ﬂuorescent images using a foot switch. The
ability of ﬂuorescent cholangiography to detect the bile
duct anatomy was evaluated.
Results: Fluorescent cholangiography delineated the
cystic duct in all 45 patients and the cystic duct - common
hepatic duct (CHD) junction in 43 patients prior to the
dissection of the triangle of Calot. This technique also
identiﬁed all the accessory bile ducts that were preoper-
atively diagnosed in 8 patients. The cystic duct – CHD
junction were classiﬁable into the following three types:
normal (n = 35), parallel (n = 6), and spiral junction
(n = 4).
Conclusions: Fluorescent cholangiography enables real-
time identiﬁcation of the bile duct anatomy during dis-
section of the triangle of Calot. This safe and simple
technique has the potential to become a standard practice
for avoiding bile duct injury during LC, replacing con-
ventional radiographic IOC.
FV-18
FIRST CASE OF ROBOTIC-ASSISTED
LAPAROSCOPIC RADICAL RESECTION
WITH MAJOR HEPATECTOMY FOR
HILAR CHOLANGIOCARCINOMA IN
CHINA
W. Ji, H. Wang and J. Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: Hilar cholangiocarcinoma remains techni-
cally challenging for laparoscopic surgery due to difﬁcult
radical resection and hepaticojejunostomy. However, the
robotic system made the difference, allowing the perfor-
mance of procedure with complex manipulative maneu-
vers.
Objectives: This video shows technical aspects of the ﬁrst
case of robotic-assisted laparoscopic anatomic left hep-
atectomy and caudate segmentectomy, Roux-en-y hepa-
ticojejunostomy for radical resection of hilar
cholangiocarcinoma in China.
Methods: The robotic-assisted laparoscopic anatomic
left hepatectomy and caudate segmentectomy, Roux-en-y
hepaticojejunostomy for radical resection of hilar cho-
langiocarcinoma was performed in a 54-year-old male
patient with hilar cholangiocarcinoma.
Results: The operation followed several distinct phases:
liver mobilization, skeletonized hepatoduodenal liga-
ment, dissection and division of the left hepatic artery
and left portal vein, parenchymal transection, plasty of
the right bile ducts and Roux-en-y hepaticoenterostomy.
The operating time was 600 min, and the blood loss was
600 mL. No blood transfusion was required. Resection
margin were free of tumor. The transient bile leakage was
observed, and was cured with percutaneous drainage
3 days postoperatively. The hospital stay was 12 days.
Conclusions: Robotic-assisted laparoscopic anatomic left
hepatectomy, caudate segmentectomy, and Roux-en-y
hepaticojejunostomy is a safe and feasible procedure for
hilar cholangiocarcinoma.
FV-19
EXTENDED RIGHT HEPATECTOMY
WITH RESECTION OF THE PORTAL
BIFURCATION USING THE ‘‘NO
TOUCH’’ TECHNIQUE FOR HILAR
CHOLANGIOCARCINOMA
D. Cherqui, L. Vigano, A. Laurent and C. Tayar
Hopital Henri Mondor, Creteil
The video shows a right hepatectomy extended to
segment 4 and 1 with systematic resection of the portal
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bifurcation using the ‘‘no touch’’ technique in a 57-year
old patient with hilar cholangiocarcinoma. In the original
technique described by Neuhaus, portal division and
anastomosis are performed at an early stage of the
procedure. In the present technique it is performed as the
ﬁnal step of the liver resection. In June 2008, the patient
presented with jaundice. Imaging showed typical stage
IIIa hilar cholagiocarcinoma without macroscopic vas-
cular invasion. The patient underwent left sided percu-
taneous biliairy drainage followed by percutaneous right
portal vein embolization. Future liver remnant volume
after portal vein embolization was measured at 30%. The
patient was operated on, 6 weeks after diagnosis. The
steps of the procedure were as follows:- lymphadenecto-
my - common bile duct division - division of the right
branch of the hepatic artery - dissection of the root of the
portal vein - dissection of the left branch of the portal
vein - complete mobilization of the liver including
segment 1 - liver transection with division of segment 4
pedicles - division of the left bile duct ﬂush with the
transection line - division of segment 1 pedicles - division
of middle and right hepatic veins using linear staplers -
clamping and division of the portal trunk and left portal
branch - portal reconstruction by end to end anastomosis
of the portal trunk to the left portal branch - Roux en Y
hepaticojejunostomy on the left bile duct stump. The
operation lasted 6 hours. No clamping was used, blood
loss was 400 mL and no transfusions were required. The
specimen included the portal bifurcation and at no time
was the hilar region dissected. Patholological staging was
pT2N0 with a proximal biliary margin of 2 mm. Post-
operative course was uneventful. No adjuvant treatment
was used and the patient is alive and disease free as of
October 2009 (14 months).
FV-20
STANDARD LEFT HEMIHEPATECTOMY
FOR HILAR CHOLANGIOCARCINOMA
AT A JAPANESE CANCER CENTER
T. Sano1, Y. Shimizu1, Y. Senda1, K. Shimada2 and
Y. Nimura1
1Aichi Cancer Center Hospital; 2National Cancer Center
Hospital
Background and aim: Hepatobiliary resection for hilar
cholangiocarcinoma (HC) remains a technically
demanding procedure. We present our standard surgery
for HC by the left hemihepatectomy with caudate
lobectomy.
Methods: At ﬁrst, Kocher’s maneuver and retropancre-
atic lymphadenectomy are performed. Simultaneously,
the distal bile duct is isolated and resected at the intra-
pancreatic portion. During hilar preparation the left and
middle hepatic artery are divided. The main portal vein is
skeletonized and encircled by a vessel loop. Tiny caudate
branches around the portal bifurcation should be care-
fully dissected; thereafter the left portal vein is divided at
its origin. Complete mobilization of the left liver followed
by complete detachment of the caudate lobe from the
inferior vena cava (IVC). The short hepatic veins (SHV)
are then carefully divided.
Results: Liver parenchymal transection is performed
during intermittent inﬂow occlusion. The middle hepatic
vein (MHV) appears on the transection plane, and the
root of the left hepatic vein is divided with suture closure.
The left lateral aspect of the MHV is exposed, and the
liver parenchymal transection progresses to the right edge
of the IVC. Also, division between the caudate process
and posterior section progresses in the cranial direction.
The bile duct is ﬁnally transected just beneath the MHV
or the expected point determined preoperatively. Bile
duct transection starts from the caudo-ventral border to
the cranio-dorsal border. Frozen sections of the proximal
bile duct margins should be submitted to conﬁrm the
absence of cancer invasion.
Conclusion: After completing hemostasis, hepaticoplasty
prior to bilio-enterostomy is advisable to reduce the
number of anastomoses and simplify the procedure. Bi-
lio-enteric continuity is reestablished by bilio-enteros-
tomy using a Roux-en-Y jejunal limb.
FV-21
ISOLATED CAUDATE LOBECTOMY
COMBINED WITH BILE DUCT
RESECTION FOR TYPE II HILAR
CHOLANGIOCARCINOMA
D.-W. Choi, W-S. Kim and C.-Y. Ho
Samsung Medical Center/Sungkyunkwan University
school of Medicine
Background: Isolated caudate lobectomy combined with
bile duct resection for type II hilar cholangiocarcinoma is
a challenging surgical procedure for which safe and
reliable techniques have yet to be developed.
Methods: Isolated caudate lobectomy combined with
bile duct resection was performed by initial distal com-
mon bile duct dissection and inﬂow control to the cau-
date lobe, full mobilization of the caudate lobe from the
inferior vena cava by dividing all draining hepatic veins,
and parenchymal division from right hemi-liver, and
both hepatic duct dissection.
Results: One patient with type II hilar cholangiocarci-
noma underwent this procedure successfully without in-
traoperative hemodynamic instability or postoperative
liver dysfunction. All pathologically negative bile duct
resection margin could be obtained.
Conclusion: This parenchyma preserving technique could
offer safe and radical resection for type II hilar cholan-
giocarcinoma without substantial parenchymal volume
loss.
FV-22
SURGICAL TREATMENT OF HILAR
CHOLANGIOCARCINOMA WITH
VASCULAR RESECTION
J. Costa-Maia, R. Bessa De Melo, M. Almeida and
H. Cristino
HBP Surgical unit, Hospital S. Joao, Porto Medical
School
Hilar Cholangiocarcinoma remains one of the greatest
challenges in liver oncology. Recent advances including
‘‘no-touch’’ techniques and systematic vascular resection,
have contributed to better outcomes, achieving higher
resectability rates and R0 resections. The authors present
a left hepatectomy with caudate lobectomy and arterial
and venous resections, in a 70 year-old female with a type
3b Klatskin tumor, with thrombosis of the left portal
branch.
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FV-23
APPLICATION OF LIVER HANGING
MANEUVER AND USE OF LIGASURE
FORCEPS FOR RIGHT TRISECTION-
ECTOMY IN BILIARY CARCINOMA
A. Nanashima, S. Tobinaga, M. Kunizaki, T. Abo,
S. Hidaka, H. Takeshita, T. Sawai, T. Yasutake and
T. Nagayasu
Nagasaki University Hospital, Division of Surgical
Oncology
Background: Liver hanging maneuver (LHM) is a useful
surgical technique for major hepatectomy, as it can re-
duce blood loss and time of transection, and provide
adequate cut-planes. The latest vessel sealing devices are
helpful for this purpose. We report a modiﬁed technique
of LHM with combined use of forceps fracture and
LigaSure forceps for right trisectionectomy in 2 cases of
biliary carcinomas.
Methods: A small nasogastric tube is placed between
right and middle hepatic veins and then the tube is
repositioned between the conﬂuence of the middle and
left hepatic veins after transection of Arantius ligament.
At the hepatic hilum, the spaces between Glisson’s ped-
icle and hepatic parenchyma are dissected using a right-
angled clamp. The tube was positioned in this space using
‘‘tape-repositioning technique’’ adjacent to the umbilical
Glisson’s pedicle for right trisectionectomy. The tube is
placed along the border of Spiegel lobe and left lateral
sector and, eventually, the cut-plane of right trisection-
ectomy could be lifted up. The hepatic bile duct is usually
cut after hepatic transection in hilar bile duct carcinomas.
During transection, we apply forceps fracture method
using short LigaSure forceps and remnant branches are
sealed with this forceps. The combination procedure re-
duces blood loss and transection time. CASE 1, A 56-
year-old female had 9 cm gall bladder carcinoma
expanding in the right hemi-liver and segment 4, which
severely compressed hilar Glisson’s pedicle. Right tri-
sectionectomy was completed without biliary recon-
struction by above method. Blood loss = 1180 ml,
transection time = 45 min. CASE 2, A 76-year-old fe-
male with large hilar bile duct carcinoma. Trisectionec-
tomy was conducted using above method. Blood
loss = 780 ml, transection time = 26 min.
Conclusion: LHM can be applied for right trisectionec-
tomy in patients with biliary carcinoma. It helps have an
appropriate transected plane and reduces the time for
hepatic transection and blood loss.
FV-24
LEFT HEPATECTOMY COMBINED
WITH RESECTION AND
RECONSTRUCTION OF PORTAL VAIN
AND RIGHT HEPATIC ARTERY FOR
INTRAHEPATIC
CHOLANGIOCARCINOMA
T. Ota, N. Takeshita, R. Higuchi, T. Yazawa,
H. Kajiyama, K. Onuki, Y. Yagawa and M. Yamamoto
Tokyo Women’s Medical University Institute of
Gastroenterology
Introduction: Despite the recent advances of surgical
technique, major hepatectomy combined with vascular
resection and reconstruction has not yet been established
as a safe and secure procedure.
Case: The patient was a 58-year-old female, who
underwent extrahepatic bile duct resection and recon-
struction 23 years ago for congenital biliary dilatation. In
a medical checkup, a liver tumor was detected and she
was referred to our institute. CT demonstrated a tumor,
4 cm in diameter in the left lobe of the liver. The tumor
invaded the bifurcation of the portal vein and the right
hepatic artery at the hepatic hilum and combined vas-
cular resection was mandatory for tumor resection.
Fortunately, no jaundice was observed and the liver
function was normal. Left hepatectomy and caudate
lobectomy, combined with resection of the hilar bile duct,
portal vein and right hepatic artery, was performed. The
gastroduodenal artery was used for reconstruction of the
right hepatic artery. The operative time was 10 hours and
29 min. No blood transfusion was performed. There was
no postoperative complication and the patient was dis-
charged in 14 post operative days.
Conclusion: Aggressive vascular resection and recon-
struction may achieve a better prognosis to a patient with
a tumor invading the hepatic hilum.
FV-25
DUODENOPANCREATECTOMY WITH
VASCULAR RESECTION IN THE
PRESENCE OF ‘‘SITUS INVERSUS
TOTALIS’’
L. Ferna´ndez-Cruz1, R. Garcı´a1, M. Acosta2,
M.-A. Lo´pez-Boado1 and J. Samame´1
1Hospital Clı´nic de Barcelona; 2Hospital Universitario
Austral
Since 1966 until 2008 four cases of pancreatic cancer,
three cholangiocarcinomas and three periampullary can-
cers with associated situs abnormalities have been
described. In this video is presented a pylorus-preserving
pancreaticoduodenectomy with vascular resection on a
73 years old patient with situs inversus and adenocarci-
noma of pancreatic head. The occurrence of situs
inversus must not deter the surgeon from sound onco-
logic principles of pancreatic surgery: standard regional
lymphadenectomy, including complete dissection of the
retropancreatic soft tissues. No postoperative complica-
tions occurred and this patient was discharged home
17 days after surgery.
FV-26
‘‘FIVE VESSEL CLEARANCE’’ FOR
PANCREATODUODENECTOMY
D. Chhabra, S. Vaze, R. Shah and P. Jagannath
Department of Surgical Oncology, Lilavati Hospital and
Research Centre, Bandra (W), Mumbai, India
Background: R1 resection for pancreatic cancer has been
shown to be detrimental to survival. R1 resections are
better deﬁned by a standardized histopathological
examination introduced by the Leeds Pathology Protocol
(LEEPP). Posterior and medial margins are the most
frequently reported positive resection margins especially
in pancreatic adenocarcinomas and distal bile duct car-
cinomas. Anatomically these margins correspond to
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major vascular structures which form boundaries on
medial and posterior sides.
Aim: To deﬁne postero-medial limits of resection in
pancreatoduodenectomy.
Methods: We introduce a ‘‘Five vessel clearance’’ con-
cept that was developed to ensure an adequate clearance
by exposing all vessels forming the medial and posterior
boundaries of the pancreas and the uncinate process. The
ﬁve vessels that need to be exposed for an adequate
clearance are IVC and the left renal vein posteriorly,
superior mesenteric vein (SMV) and portal vein medially
and hepatic artery going on to celiac artery and superior
mesenteric artery with aortic window postero-medially.
Results: The uncinate process shows one of the three
variations stopping short sometimes on the right border
of SMV or extending under the SMV and sometimes
under the border of superior mesenteric artery. A clear
deﬁnition of boundaries of resection increases the rates of
R0 resection. We could achieve R0 resections for 15
consecutive pancreatic head resections with this tech-
nique.
Conclusion: The video demonstrates the ‘Five vessel
clearance’ as our method adopted for ensuring an ade-
quate clearance of uncinate and retropancreatic tissues
which are at higher risk for microscopic margin positivity.
FV-27
CELIAC AXIS AND PORTAL VEIN
RESECTION FOR LOCALLY ADVANCED
PANCREATIC CANCER
S. Celinski, H. Zeh, S. Hughes and K. Lee
University of Pittsburgh
Purpose: To present a case of celiac axis and portal vein
resection for locally advanced pancreatic cancer.
Patient: The patient is a 61-year-old man who presented
with left ﬂank pain. On CT scan he was found to have a
pancreatic body mass with encasement of the celiac axis
as well as abutment of the spleno-portal conﬂuence.
There was no evidence of distant disease. Endoscopic
ultrasound conﬁrmed the CT ﬁndings and a biopsy
showed adenocarcinoma. He underwent neoadjuvant
chemoradiation without progression of his disease.
Operation: An extended Kocher maneuver was per-
formed, and a tunnel was developed anterior to the
portal vein at the pancreatic neck to establish resect-
ability. The common hepatic artery was involved with the
mass up to the takeoff of the gastroduodenal artery
(GDA), which was dissected free. The spleen and distal
pancreas were mobilized upward to expose the celiac
axis, which was dissected free at the aorta. The celiac axis
and common hepatic artery were clamped. The liver re-
mained well perfused and the proper hepatic artery was
found to have Doppler ﬂow as well as a palpable pulse.
The celiac axis then was ligated and divided at the aorta.
The common hepatic artery was ligated and divided
proximal to the GDA takeoff. The pancreas was divided
at the neck and the splenic vein was widely resected at the
spleno-portal conﬂuence. The portal vein was found to
be narrowed after repair. The narrowed portion of the
portal vein was resected and then reconstructed in an end
to end fashion. Pathology revealed a 2.5 cm adenocar-
cinoma with negative margins of resection. One of 19
nodes was involved by direct invasion.
Conclusion: Resection of the celiac axis and portal vein is
feasible for the treatment of locally advanced pancreatic
cancer. We believe this technique is appropriate in highly
selected patients with patent collateral arterial circulation
who do not exhibit disease progression after neoadjuvant
chemoradiation.
FV-28
ILIAC-HEPATIC ARTERIAL BYPASS FOR
COMPROMISED COLLATERAL FLOW
DURING MODIFIED APPLEBY
OPERATION FOR ADVANCED
PANCREATIC CANCER
F. Makdissi, R. Surjan, K. Nishinari, M. C. Machado
and M. A. Machado
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Involvement of the celiac trunk is the most
common form of vascular invasion by tumours of the
distal pancreas, and until recently was considered a
contra-indication to resection. Modiﬁed Appleby opera-
tion consists of en bloc resection of the celiac trunk with
distal pancreatectomy.
Aim: To present a video of a modiﬁed Appleby opera-
tion for locally advanced distal pancreatic cancer with
compromised hepatic collateral ﬂow that needed hepatic
arterial revascularization.
Methods: A 71-year-old male with pancreatic body can-
cer was referred for surgical treatment. Abdominal CT
scan showed a locally advanced tumour. The ﬁrst step
was to assess the common hepatic artery and the gas-
troduodenal artery. When the common hepatic artery
was temporally clamped, the pulse of the proper hepatic
artery became remarkably weak, indicating that the col-
lateral ﬂow by pancreaticouodenal branches was insufﬁ-
cient to guarantee adequate hepatic arterial ﬂow and the
need for arterial revascularization, that was successfully
accomplished by left external iliac-hepatic arterial bypass
with Dacron prosthesis.
Results: Patient recovery was uneventful and he was
discharged on the 10th postoperative day. Patient is well
and asymptomatic 13 months after operation. At the
time of this writing, postoperative CT scan showed no
evidence of disease and CA 19–9 level is normal.
Conclusion: Modiﬁed Appleby procedure can safely be
performed, has oncological advantages to palliative
procedures and provides relief of pain but is reserved for
selected patients. Preservation of hepatic arterial ﬂow has
utmost importance to avoid hepato-biliary complica-
tions. In this case, hepatic revascularization was suc-
cessfully accomplished by left external iliac-hepatic
arterial bypass. To our knowledge this type of arterial
bypass has never been described so far in the English
literature and its description may be important for sur-
geons dealing with advanced pancreatic cancer.
FV-29
SPLEEN-PRESERVING DISTAL
PANCREATECTOMY OF A LARGE
MUCINOUS CYSTIC NEOPLASM
Y. Zak, S. Perryman, L. Pasche and B. Visser
Stanford University Medical Center
Background: Laparoscopic distal pancreatectomy offers
all the advantages of the minimally invasive approach,
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but has largely been used for small lesions due to the
technical complexity of the operation.
Aims: A 33-year-old woman was incidentally found to
have a complex cystic distal pancreatic lesion measuring
13 · 12 cm. Endoscopic ultrasound with ﬁne needle
aspiration suggested it was a mucinous neoplasm. We
demonstrate a laparoscopic, spleen-preserving distal
pancreatectomy for this large and potentially malignant
tumor.
Methods: Laparoscopic resection with distal pancrea-
tectomy was performed through four ports (three 5 mm
ports and a single 12 mm port in the umbilicus). A ﬂex-
ible laparoscope (Stryker) was used for the dissection of
the splenic hilum behind the large tumor. The splenic
vessels were divided in the hilum (before the proximal
dissection of vessels and body of pancreas) for better
exposure, anticipating that the large tumor would pre-
clude access to the hilum once mobile. The splenic vessels
were then divided proximally before division of the body
of the pancreas. Once the specimen was secured in a bag
(intact), it was completely deﬂated by aspiration, allow-
ing it to be removed from the umbilical port. Pathology
revealed a mucinous cystadenoma. The patient had an
uneventful post-operative recovery.
Discussion: A minimally invasive approach to spleen-
preserving distal pancreatectomy is challenging but fea-
sible even in the case of large cystic tumors.
FV-30
PANCREATICODUODENECTOMY WITH
REPLACED HEPATIC ARTERY AND
VASCULAR RECONSTRUCTION
L. Ferna´ndez-Cruz1, R. Garcı´a1, M. Acosta2,
M.-A. Lo´pez-Boado1 and J. Samame´
1Hospital Clı´nic de Barcelona; 2Hospital Universitario
Australia
Aberrant arterial anatomy is a common ﬁnding during
foregut surgery. Anomalies to the right hepatic lobe are
especially relevant during pancreaticoduodenectomy
(PD) and their recognition serves to protect the blood
supply to the liver and bile ducts. Recognition of
aberrant vasculature to the liver before PD is important.
In this video is presented the management of the presence
of the replaced right hepatic artery (RRHA) involved by
a distal cholangiocarcinoma. Operative management
included pylorus-preserving pancreatoduodenectomy,
transection of the RRHA and reconstruction with
interposition graft with cadaveric iliac artery. No com-
plications occurred and the patient was discharged home
2 weeks after surgery.
FV-31
ROBOTIC HYDATID CYSTECTOMY:
A SAFE TECHNIQUE
G. Gunasekaran, F. Aucejo, G. Morris-Stiff, J. Fung,
C. Miller and S. Chalikonda
Cleveland Clinic Fondation
Introduction: Surgery remains the treatment of choice in
management of hydatid cyst. With improvement in
minimally invasive technique, several cases of successful
treatment of hydatid cysts by laparoscopy have been
described. We describe a case of hydatid cyst of the liver
which was managed successfully by robotic cystectomy.
Patient and methods: A 65-year-old female presented
with 4 cm asymptomatic cystic lesion in segment 5/8 of
the liver. Computerized tomographic features were con-
sistent with a hydatid cyst. Despite negative serological
studies, a decision was made to proceed with surgical
resection based on imaging diagnosis. We performed a
hydatid cystectomy using the da Vinci Surgical System
(Intuitive Surgical, Sunnyvale View, CA, USA). The
blood vessels on the wall of the cyst were circumferen-
tially dissected, clipped and then transected. The cyst was
removed by clamp fracturing parenchyma circumferen-
tially. The angle provided by the robotic arm was helpful
in dissecting the superior aspect of the cyst. The cyst was
then placed in an endobag and safely removed. The pa-
tient tolerated the procedure well and was discharged on
post-operative day 1. The ﬁnal pathology was conﬁrmed
to be hydatid cyst.
Conclusion: The enhanced precision and the angle of
dissection provided by the robotic arm can be helpful in
performing complete removal of hydatid cyst from the
liver. Robotic technique may be a safe alternative for
treatment of hepatic hydatid cyst.
FV-32
FIRST CASE OF ROBOTIC-ASSISTED
LAPAROSCOPIC ANATOMIC RIGHT
HEPATECTOMY IN CHINA
W. Ji, H. Wang and J. Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: The robotic surgical system is superior to
traditional laparoscopy in regards to 3-dimensional
images and better instrumentations. Robotic surgery for
hepatic resection has not yet been extensively reported.
The ﬁrst case of robotic-assisted laparoscopic anatomic
right hepatectomy in China was performed at our insti-
tution in July 2009.
Objectives: This video will show the pertinent steps to
perform a robotic-assisted laparoscopic anatomic right
hepatectomy.
Methods: A 53-year-old man with right intrahepatic
cholangiocarcinoma was referred for surgical treatment.
The robotic-assisted laparoscopic anatomic right hepa-
tectomy was performed. Liver mobilization and chole-
cystectomy were performed in the usual fashion. After
dissection and division of the right hepatic artery, right
portal vein and right hepatic duct, parenchymal tran-
section was performed with harmonic curved shears and
bipolar electrocautery. The branches of the middle he-
patic vein to segments V and VIII were either ligated
intraparenchymally with Hem-o-lock clips or controlled
by suture ligation with monoﬁlament suture. Right he-
patic vein and connective liver tissue were transected with
an endoscopic stapling device. The specimen was ex-
tracted through a suprapubic incision using an endobag.
A single abdominal drainage was placed in the sub-
phrenic space. No Pringles’ maneuver was used.
Results: The operating time was 600 min, and the blood
loss was 500 ml. No blood transfusion was required. The
resection margin was free of tumor. The patient recov-
ered uneventfully, and discharged at day 6 after opera-
tion. No intrahepatic recurrences or port-site metastases
have been observed after a follow-up of 4 months.
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Conclusions: Robotic-assisted laparoscopic anatomic
right hepatectomy is a safe and feasible procedure, which
should be performed by surgeons with expertise in lap-
aroscopic and hepatobiliary surgery.
FV-33
DA VINCI ROBOT-ASSISTED RIGHT
HEPATECTOMY IN PATIENT WITH
HEPATOCELLULAR CARCINOMA
C. Gi Hong, H. Woo Jin, K. Dong Hyun, K. Chang
Moo, C. Jin Sub and L. Woo Jung
Department of Surgery, Yonsei University Health System,
Seoul, Korea
Background: The da Vinci Robotic system provides a
high quality three-dimensional image and seven degrees
of freedom as the human wrist. We reported our ﬁrst
experience of right hepatectomy using da Vinci Robotic
system.
Methods: A 56-year-old male was admitted for hepato-
cellular carcinoma (HCC) in the right liver. The liver
function corresponded to Child-Pugh class A. Dynamic
imaging studies showed a 4.5 cm sized nodular HCC in
Segment V. The patient was placed in a supine position
with reverse Trendelenburg (15). We used ﬁve ports
altogether; four for the robotic arms and one for the
assistant surgeon. The left portal vein and hepatic artery
were ligated by hem-o-lok clip. After full mobilization of
right liver, several short hepatic veins were ligated by
clipping. The parenchymal transection was performed by
harmonic scalpel along the demarcation line. For the
better exposure of the dissected parenchymal plane,
additional two 2 mm trocars were used to retract both
liver edges by rubber bands. The branches of Glisson’s
sheath and hepatic vein were ligated by clipping. The
right bile duct was ligated by hem-o-lok clipping during
the parenchymal transection. The right hepatic vein was
divided by endo-GIA. The specimen was pulled out
through the suprapubic incision.
Results: The amount of intraoperative bleeding was
400 ml, including the weight of the soaked gauze. The
total operating time was 735 min and the surgeon’s
console time was 575 min. The CT at postoperative ﬁve
days showed a small amount of bilateral pleural effusion
and minimal ﬂuid collection in the operative site. The
patient was discharged from the hospital on postopera-
tive nine days without any signiﬁcant complication.
Conclusions: Robot-assisted right hepatectomy is tech-
nically feasible. The further experiences should be needed
to standardize the surgical technique.
FV-34
LAPAROSCOPIC BISEGMENTECTOMY
6-7 USING INTRAHEPATIC GLISSONIAN
TECHNIQUE
M. Autran Machado, R. C. Surjan, F. F. Makdissi,
V. Santos and M. Barros
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Anatomical segmental liver resection is not
currently performed due to technical difﬁculties to con-
trol segmental Glissonian pedicles laparoscopically. We
have recently described a technique of laparoscopic
posterior approach for segmental liver resections.
Aim: To present a video of totally laparoscopic biseg-
mentectomy 6-7 using intrahepatic Glissonian technique.
Method: A 33-year-old female presenting a liver cell
adenoma located between segments 6 and 7 was referred
for surgical treatment. Operation begins with mobiliza-
tion of right liver and dissection of retrohepatic vena
cava. Control of the posterior right sheath pedicle is
achieved with two small liver incisions: ﬁrst on the right
edge of the gallbladder and another on the right edge of
caudate lobe. A large laparoscopic vascular clamp is
introduced through those incisions and closed. Ischemic
delineation of the right posterior sector (segments 6 and
7) is achieved and is marked along liver surface. Vascular
clamp is replaced by a stapler and, if ischemic delineation
is coincident with previous demarcation, the stapler is
ﬁred. All this steps are performed without the Pringle
maneuver and without hand assistance. Liver transection
was accomplished with harmonic scalpel and endoscopic
stapler. The specimen was extracted through a suprapu-
bic incision. Liver raw surface was reviewed for bleeding
and bile leaks.
Results: Operative time was 160 min, with no need for
blood transfusion. Recovery was uneventful and patient
was discharged on the 4th postoperative day.
Conclusion: Bisegmentectomy 6-7 can safely be done by
laparoscopy and intrahepatic technique, based on small
incisions following speciﬁc anatomical landmarks, allows
a straight forward control of Glissonian pedicle from
right posterior sector, without hilar or parenchymal dis-
section and no need for ultrasound or cholangiography
guidance.
FV-35
LAPAROSCOPIC CLOSED CYST-
PERICYSTECTOMY IN A PATIENT
WITH LIVER HYDATID DISEASE
C. Loinaz, A. Garcı´a-Sesma, M. Ramos, F. Ochando,
M. Jime´nez, P. Herna´ndez, L. Vega, P. Dujovne,
J. M. Ferna´ndez and A. Quinta´ns
General Surgery Unit, Hospital Universitario Fundacio´n
Alcorco´n, Madrid, Spain
Introduction and aim: Laparoscopic approach in the
treatment of liver hydatid disease is very much debated.
In this ﬁlm we try to show the technique of closed total
cyst-pericystectomy.
Patient and methods: Fifty-year-old male patient, with
symptomatic cholelithiasis and a 5 cm in diameter left
liver lobe hydatid cyst seen by ultrasonography and then
studied by CT. Scheduled for cholecystectomy and cyst
removal.
Results: Exploratory laparoscopy. Standard cholecys-
tectomy. The cyst was considered suitable for closed
pericystectomy. Adhesions were removed by electrocau-
tery with scissors and hook, and pericystic dissection was
done by 5 mm Ligasure. The specimen was retrieved by
an endobag. Patient was discharged on POD 1.
Conclusions: Laparoscopic cyst-pericystectomy may be
safe in moderate size cysts on accessible sites. Enables a
minimally invasive approach in hydatid disease, allowing
a sooner recovery due to the smaller incision need.
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FV-36
TOTALLY LAPAROSCOPIC RIGHT
TRISECTIONECTOMY USING
INTRAHEPATIC GLISSONIAN
APPROACH
R. Surjan, F. Makdissi, A. Oliveira, V. Pilla, A. Teixeira
and M. Autran Machado
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Laparoscopic right liver trisectionectomy is
a very complex procedure with few technical descriptions
so far in the English literature.
Aim: To present a video of a totally laparoscopic right
trisectionectomy.
Method: Operation begins with control of venous out-
ﬂow. Main right hepatic vein is divided with vascular
stapler and main trunk (containing middle and left he-
patic veins) is encircled. Temporary clamping allows
complete outﬂow control of the liver, minimizing bleed-
ing during transection. Due to previous right portal vein
embolization, hepatic pedicle is not fully dissected. Int-
rahepatic access to the main right Glissonian pedicle is
achieved with two small incisions and an endoscopic
vascular stapling device is inserted between these inci-
sions and ﬁred. Glissonian pedicle from segment 4 is di-
vided within liver substance. Line of liver transection is
marked along the liver surface and to avoid possible
damage to pedicles from segments 2 and 3, the line of
transection is placed at 1 cm right from falciform liga-
ment. Liver transection is accomplished with harmonic
scalpel and endoscopic stapling device. The specimen is
extracted through a suprapubic incision. Falciform liga-
ment is then ﬁxed to the abdominal wall in order to
prevent remnant liver to rotate spontaneously and cause
left hepatic vein kinking.
Results: Operative time was 360 min and hospital stay
was 7 days. Apart from self-limited biliary leakage,
postoperative recovery was uneventful.
Conclusion: A totally laparoscopic right trisectionectomy
is safe and feasible in selected patients and should be
considered for patients with benign or malignant liver
neoplasms. The intrahepatic Glissonian technique and
control of venous outﬂow may facilitate laparoscopic
extended liver resections by reducing the technical difﬁ-
culties in pedicle control and may diminish bleeding
during liver transection.
FV-37
RIGHT TRISECTIONECTOMY IN SITU,
EX VIVO AND CAVAL RESECTIONWITH
VENOVENOUS BYPASS AND THE
CAVAL RECONSTRUCTION WITH A
GORE-TEX INTERPOSITION GRAFT
J. Pekolj, E. De Santiban˜es, F. Bersano, N. Bucich,
V. Ardiles and M. Ciardullo
Hospital Italiano de Buenos Aires
Background: Male patient, 54 years old. History: an
abdominal mass was found in right liver during a routine
exam.
Diagnostic work-up: -Laboratory: tumor markers whi-
thin normal limits
-MDCT: expansive formation that involves rigth hepatic
lobe.
The right portal vein, the rigth and middle hepatic veins
pass through the formation. This mass is in contact with
ICV.
Methods: -Pre-op Portal Right Embolization was per-
formed
-Bilateral subcostal incision with a middline extension
-Hepatic movilization
-Intraoperative ultrasound
-The left femoral vein is cannulated
-Cannulation of the inferior mesenteric vein and the left
axilliary vein
-Total vascular exclucion while the liver is perfussed
-The retrohepatic vena cava is resected
-Liver is put in ice while ﬂushing left lobe
-Transsection of liver parenchyma
-Reconstruction is accomplished with a Gore-tex inter-
position graft
-Anastomosis between left hepatic vein and the graft is
performed
-Anastomosis is performed with an end to side hepati-
coyeyunostomy
Results: Histo-Pathological report
Intrahepatic Cholangiocarcinoma.
Complications: -Relaparotomy due to abdominal com-
partimental sindrome
- Bilateral pleural effusion, chest tubes were placed.
-Renal failure, requiring dialysis.
-Lower GI bleeding, requiring ileocolic artery emboliza-
tion
-POD+22 transferred to general ward
-Eleven months later the patient is in good condition
Conclusio´n: This Radical major hepatectomy, ex vivo, in
situ with techniques of Vascular Exclusion and Caval
Resection was performed to reduce blood loss during
parenchymal dissection, to dissect in proximity of major
vascular structures and because the tumour had invaded
the Vena Cava or all hepatic veins The surgery is indi-
cated because the Intrahepatic Cholangiocarcinoma has
no absolute contraindication in Vascular invasion and
there is a long-term survival in R0- resection. In rare
cases, with recurrence conﬁned to the liver, repeated
resection may be indicated.
FV-38
RECONSTRUCTION OF HEPATIC VEIN
IN HEPATECTOMY – INDICATION AND
TECHNICAL ASPECT
Y. Iso, T. Sawada, J. Kita, M. Kato, M. Shimoda and
K. Kubota
Dokkyo Medical University/Second Department of
Surgery
Because liver carcinoma often invades hepatic vein,
reconstruction of hepatic vein has been paid an attention.
Simple resection of invaded main hepatic vein results in
congestion of remained hepatic parenchyma where blood
efﬂux enters the resected hepatic vein. Thus, the indica-
tion and the technical aspect of the hepatic vein recon-
struction is a crucial matter for surgeons. In this study,
we present our experiences of patients with liver cancer
who underwent hepatic vein reconstruction. Between
April 2000 and September 2009, there were 832 patients
who underwent hepatectomy at our department. There
were 4 cases of patients with liver carcinoma who
underwent reconstruction of hepatic vein. There were 3
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males and 1 female with a mean age of 61.5 years.
Invaded hepatic vein was right hepatic vein in one, and
middle hepatic vein in three. In all cases, invasion to
hepatic vein was conﬁrmed by intraoperative ultrasound.
Preoperatively, the volume of liver parenchymas which
was drained by the hepatic vein was estimated using 2D-
CT. If the volume was considered big (20–40%), indica-
tion for reconstruction of hepatic vein was determined by
Doppler ultrasound. That is, we dissected the affected
hepatic vein and clamped it temporally. If Doppler
ultrasound reveals the reversed ﬂow of the hepatic vein
with reversed ﬂow in the corresponding portal vein, we
reconstruct the vein. If not, it indicates the presence of
alternative drainage vein of remained hepatic paren-
chyma, and we do not perform reconstruction and simply
remove the invaded hepatic vein. In all cases, the
reconstructions were performed with great saphenous
vein graft, by end to end anastomosis. Median operation
time was 375 min, blood loss was 386 ml, and Pringle
time was 56 min. Postoperative patency of reconstructed
hepatic vein was successfully conﬁrmed by ultrasound.
At the conference, we will present our techniques with
video.
FV-39
ISOLATED CAUDATE LIVER
RESECTION WITH MODIFIED
HANGING MANEUVER
M. Enne1, L. Pacheco-Moreira1, J. Alves1 and
J. M. Martinho1,2
1Hospital Geral de Bonsucesso - Ministe´rio da Sau´de -
Hepatobiliary and Liver Transplantation Unit;
2Department of Surgery, Antonio Pedro University
Hospital - Fluminense Federal University
Background: Isolated resection is a challenging technical
procedure because of its location in contact with major
vessels. Belghiti and cols. proposed the liver hanging
maneuver for right hepatectomy using a tape passed be-
tween the anterior surface of the inferior vena cava (IVC)
and the liver parenchyma. A safe cutting plane of the
liver can be obtained with tape pulls, providing better
control of blood loss, and protection of the IVC to avoid
unnecessary bleeding. Kim and cols were the ﬁrst to
introduce the hanging maneuver applied to the isolated
caudate lobectomy with safety.
Objective: Our objective is to show an isolated caudate
liver resection with the modiﬁed hanging maneuver
proposed by Kim and cols.
Methods: An isolated caudate liver resection was carried
out in a 61-years-old man with methacronous colorectal
metastasis.
Results: Operative time was 320 min, resection time was
30 min. The patient didn’t required blood transfusion
and was discharged at 8th postoperative day.
Conclusion: The modiﬁed hanging maneuver for isolated
caudate liver resection can be achieved with safety and is
a helpful tool for this challenging resection.
FV-40
RIGHT TRISECTIONECTOMY,
CAUDATE LOBECTOMY AND INFERIOR
VENA CAVA (IVC) RESECTION FOR
COLORECTAL LIVER METASTASES
H. Z. Malik, G. Sarno, S. W. Fenwick, A. A. Al-Sarira
and G. J. Poston
Hepatobiliary Surgery Unit, University Hospital Aintree,
Liverpool UK
Introduction: A 61-year-old female was referred with
metastatic colorectal cancer. A right trisectionectomy
with segment I resection combined with resection of the
IVC was performed.
Surgical technique: A laparotomy through reverse L
incision revealed no evidence of extrahepatic disease.
Due to the suspicion of IVC involvement we elected not
to attempt the Hanging maneuver. The right lobe of the
liver was mobilized. We attempted mobilisation of the
liver from the IVC dividing short hepatic veins however
due to IVC encasement this was abandoned. The supra
and infra hepatic IVC was slung. Right hepatic artery
and portal vein were divided. CUSA was used to split the
liver (under intermittent Pringle maneuver) in the plane
between the left lateral and segments 1 and 4. In doing so
we divided the middle hepatic vein at its origin as well as
the right biliary pedicle. This maneuver enabled us to
swing the remnant liver away and expose the hole of the
retrohepatic Cava. The Caudate lobe was mobilised from
the left until the specimen was attached by the right he-
patic vein and the origin of the IVC involvement. The
origin of the IVC involvement was controlled by Satinski
clamp and a cuff of IVC was resected. The IVC was over-
sutured 3/0 Prolene. Finally the right hepatic vein was
also divided.
Conclusion: In the absence of veno-venous by-pass, tu-
mour involvement of the hepato-caval conﬂuence can be
dealt with safely by control of the IVC. However such
techniques should be limited to high volumeHPBCentres.
FV-41
LEFT TRISECTIONECTOMY WITH
TOTAL VASCULAR EXCLUSION
HEPATOCELLULAR CARCINOMA IN
HEALTHY LIVER
C. Salas, E. De Santiban˜es, F. Bersano, N. Bucich,
G. Moriconi and M. Ciardullo
Hospital Italiano de Buenos Aires
Background: Male patient, 54 years old.
Antecedents: Healthy man. No signiﬁcant past medical
history.
History: complains of gradual weight loss in last months.
Diagnostic work-up: Laboratory: alfa-fetoprotein 145
(1.7), Fal 144, AST 70, ALT 80.
PET/CT total body: expansive hepatic mass with
increased Fluoro Deoxi-Glucose uptake.
Diagnosis: Hepatocellular carcinoma.
Surgical Treatment. Surgical risk ASA II.
Methods: -Bilateral subcostal incision with a middline
extension.
-Liver movilization.
-Intraoperative ultrasound (conﬁrmation of the
resectability).
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-Pringle Maneuver is prepared (by opening the
hepatogastric ligament).
-The infrahepatic Vena Cava is isloted with a band.
-The suprahepatic Vena Cava is isloted with a band,
too.
-Pringle Maneuver is performed.
-Demarcation of the liver surface.
-Transsection of the liver parenchyma.
-Total Vascular exclusion 20 min.
-Transsection left hepatic vein and bile duct.
-The tumour mass is removed.
-The left hepatic vein is segurate by running prolene
suture.
-The left portal vein is segurate by suture ligation.
-Open hepatic outﬂow and inﬂow by releasing the
band on the suprahepatic and infrahepatic vena cava.
-Intraoperative cholangiography.
Results: -POD 1-2: critical care unit, 48 hours for
observation and transfered to the general ward.
-POD 3-7: patient in good condition starts clear
liquids on pod 2. Early movilization.
-Discharge at 8th post-op day.
-Uneventful post-operative course.
-Histo-pathological report: Hepatocellular carcinoma.
EDMONDSON 2 (high differentiation).
Conclusions: A greater progress in the diagnosis, staging
and treatment of Hepatocellular carcinoma has taken
place over the last 20 years. Early diagnosis, better
evaluation and staging of the disease and more structured
treatment decision algorithms have led to signiﬁcant
improvements in the survival rate.
FV-42
RIGHT HEPATECTOMY WITH CAVAL
THROMBECTOMY AFTER
NEOADJIUVANT THERAPY (TACE AND
SORAFENIB) FOR HCC WITH CAVAL
THROMBOSIS
A. Guglielmi, A. Ruzzenente, A. Valdegamberi,
T. Campagnaro and C. Iacono
Division of General Surgery ‘‘A’’, GB Rossi Hospital,
University of Verona, Verona, Italy
Case report: This video shows a clinical case regarding a
HCV chronic hepatitis patient affected by hepatocellular
carcinoma (HCC) with caval thrombosis who underwent
radical resection after neoadjuvant treatment with tran-
sarterial chemoembolization (TACE) and sorafenib. The
patient was a 55-year-old man with HCV-related chronic
hepatitis classiﬁed in class A5 according to Child-Pugh
classiﬁcation. The CT scan revealed three nodules of
HCC in the right lobe of 42, 36 and 23 mm with neo-
plastic thrombus into the right hepatic vein extended to
the inferior vena cava; serum alpha-fetoprotein (AFP)
level was 36200 lg L-1. The patient was initially consid-
ered not resectable and was submitted to TACE in right
hepatic artery with Lipiodol and Mitomicin C, followed
by two cycles (8 weeks) of chemotherapy with sorafenib
200 mg twice a day. After 3 months, re-evaluation with
chest and abdominal CT scan documented no lung
metastases and reduction in size of the nodules and no
changes of the extension of the caval thrombosis. AFP
decreased to 3.7 lg L-1. Due to good response to treat-
ment surgical resection was planned. The patient was
submitted to right hepatectomy with anterior approach
and en bloc caval thrombectomy under total vascular
exclusion with intrapericardial clamping of inferior vena
cava. The postoperative course was uneventful and the
patient was discharged on 10th postoperative day. The
surgical specimen revealed complete necrosis of the tu-
mor and of neoplastic thrombus. Three months follow up
CT scan did not showed intra or extra hepatic recurrence.
Conclusion: To our knowledge, this is the ﬁrst reported
case in literature of combination therapy with TACE and
sorafenib with neoadjuvant intent, conﬁguring as inno-
vative approach in selected case of patients with initially
non resectable HCC.
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ROBOTIC ASSISTED LAPAROSCOPIC
WHIPPLE’S OPERATION FOR
CARCINOMA OF AMPULLA
E. C. H. Lai, C. N. Tang, G. P. C. Yang,
O. C. Y. Chan and M. K. W. Li
Department of Surgery, Pamela Youde Nethersole Eastern
Hospital, 3 Lok Man Road, Chai Wan, Hong Kong SAR,
China
Introduction: The surgical robotic system is superior to
traditional laparoscopy in regards to 3-dimensional
images and better instrumentations. The aim of this video
was to report a patient who underwent a robotic assisted
laparoscopic Whipple’s operation for carcinoma of am-
pulla.
Methods and procedures: Case report for video presen-
tation.
Results: A 45-year-old lady presented with an episode of
acute cholangitis. She was found to have carcinoma of
ampulla with biliary obstruction. Endoscopic biliary
stent insertion was done. After preoperative assessment,
robotic assisted laparoscopic Whipple’s operation was
performed for her. Resection margins were clear. The
operating time was 11 hour and 32 min. The blood loss
was 300 ml. The patient had an uneventful postoperative
recovery. The pathological staging was T1N0.
Conclusion: Robotic assisted laparoscopic Whipple’s
operation is safe and feasible in patients with carcinoma
of ampulla.
FV-44
ROBOTIC ASSISTED LAPAROSCOPIC
PUESTOW PROCEDURE FOR CHRONIC
PANCREATITIS
N. Agee, K. N. Lau, D. Sindram, D. A. Iannitti and
J. B. Martinie
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, NC, USA
Background: Chronic pancreatitis is currently without
deﬁnitive treatment. Non-surgical modalities include
behavioral modiﬁcations, pharmacologic interventions
and endoscopic procedures to palliate symptoms. These
are often ineffective when the disease progresses and a
pancreatic stricture occurs, at which point surgery has
been proven to be the modality of choice. Originally re-
ported in 1958 by Puestow, the longitudinal pancreat-
icojejunostomy (LPJ) aims to decompress the pancreatic
duct, relieving pancreatic ductal obstruction.
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Objective: The majority of complex liver, pancreas and
biliary surgery is still performed with open surgical
techniques. The reasons for this are many, but include
the challenging nature of the procedures and minimal
margin for error. We demonstrate the advantages of a
surgical robot in performing a totally laparoscopic HPB
procedure.
Case presentation: A 54-year-old male was referred with
a history of chronic pancreatitis, alcohol abuse, diabetes
mellitus and obstructive jaundice secondary to chronic
biliary strictures. The patient had multiple prior episodes
of cholangitis and had developed pancreatic enzyme
insufﬁciency. Previous interventions included medical
therapies, behavioral modiﬁcations and multiple ERCP’s
for biliary decompession. A computed-tomography scan
demonstrated dilated biliary and pancreatic ducts with
multiple pancreatic stones present. A robotic assisted
laparoscopic LPJ and duodenojejunostomy was per-
formed without complications. The patient was dis-
charged post-operative day ﬁve and is doing well on
follow-up.
Conclusion: A laparoscopic approach affords the patient
the potential for decreased morbidity. The surgical robot
facilitates procedures which are often too complicated or
technically demanding for HPB surgeons using tradi-
tional laparoscopic techniques. Our case demonstrates
the feasibility and safety of this procedure.
FV-45
ROBOTIC ASSISTED LAPAROSCOPIC
TRANSGASTRIC PANCREATIC
NECROSECTOMY
K. N. Lau, N. Agee, P. Q. Bao and K. T. Watkins
Division of UGI and General Oncological Surgery,
Department of Surgery, State University of New York at
Stony Brook, Stony Brook, NY, USA
Background: Infected pancreatic necrosis is associated
with signiﬁcant morbidity and mortality. Surgical inter-
vention is required. This video presents our technique of
transgastric pancreatic necrosectomy utilizing the da
Vinci system.
Objective: Demonstrate a minimally invasive pancreatic
surgery for infected necrosis.
Case presentation: The patient is a 38-year-old Hispanic
female presenting with pancreatic necrosis of biliary
origin. She was maintained on the medical service on
antibiotics and total parenteral nutrition. Gastroenter-
ology was consulted and biliary stent was placed for
choledocholithiasis. A percutaneous gastrostomy tube
was placed with J extension for enteral nutrition because
of her inability to tolerate oral intake. She developed a
large pancreatic ﬂuid collection that was internally
drained with endoscopic cyst gastrostomy approximately
two months into her course. The patient developed fevers
and abdominal pain with gas and debris in the collection
on computed tomography after her initial stent place-
ment. A second stent was placed and thick debris was
noted. At this time the HPB surgical service was con-
sulted and the patient was taken to the operating room
for pancreatic debridement. A transgastric necrosectomy
was done with robotic assistance. The necrosectomy was
performed through an anterior gastrotomy and then cyst-
gastrostomy. A retroperitoneal drain was placed through
the gastrostomy site. The patient tolerated the procedure
well and was able to tolerate oral intake. Antibiotics were
stopped post operative day 5 when her WBC count
normalized. The patient was discharged on post opera-
tive day 7 and had an uneventful recovery.
Conclusion: Robotic system greatly enhances surgeons’
capacity to perform pancreatic surgery by providing
superior dissection capacities and three-dimensional vis-
ibility.
FV-46
ROBOT-ASSSISTED ENUCLEATION
FOR PANCREATIC CYSTIC TUMOR
D. S. Yoon, H. K. Hwang, J. K. Kim, J. S. Park,
S. I. Cho and H. S. Chi
Department of Surgery, Gangnam Severance Hospital/
Yonsei University Health System
Background: According to the development of diagnostic
tools, it is increasing to diagnosis pancreas cystic tumor
with asymptomatic patients. For low malignancy pan-
creas cystic tumor of pancreas head, enuculation yields
the higher outcome beneﬁt than PD and organ preserving
pancreatic head resection. The application of robotic
surgery was proven to be one of the best cutting-edge
technologies for successful minimally invasive surgery by
providing solutions to the many drawbacks of laparo-
scopic surgery. However, the application of robotic
pancreas surgery is relatively limited because of techni-
cally complex, difﬁcult, and time consuming procedures
and serious postoperative complications. We present in
our initial experience with pancreas surgery using da
Vinci surgical system (Intuitive Surgical, Sunnyvale, CA)
to evaluate the technical feasibility, effectiveness, and
safety of robot assisted pancreas surgery.
Methods: Between January 2009 and September 2009,
we performed 3 cases of robotic-assisted enucleation for
pancreatic cystic tumor in Gangnam Severance hospital,
Yonsei University Health System, Seoul, Korea. Clini-
copathologic characteristics, intraoperative and surgical
outcomes were reviewed.
Results: All operations were performed successfully
without open conversion. The mean total operation time
and docking time were 300 min (270–330 min) and
12 min (10–13 min), respectively. There were no serious
postoperative complications. The ﬁrst ﬂatus was noted
on postoperative day 2.9, soft diet was started on post-
operative day 4, and the mean postoperative hospital stay
was 8 days.
Conclusion: In this early and small experience, robot-
assisted enucleation for pancreatic cyst could be applied
safely and effectively for pancreatic surgery and could
overcome the limitations of conventional laparoscopic
pancreatic surgery in selected patients.
FV-47
TECHNICAL REFINEMENTS DURING
ROBOT-ASSISTED MINIMALLY
INVASIVE PANCREATODUODEN-
ECTOMIES (WHIPPLE PROCEDURE)
K. Turaga1,2, D. Bartlett2, A. J. Moser2 and III H. Zeh2
1H.Lee Mofﬁtt Cancer Center, Tampa, Florida;
2University of Pittsburgh Medical Center, Pittsburgh, PA
Background: Despite the common application of mini-
mally invasive surgery to many oncologic operations,
there has not been widespread adoption of this approach
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for complex pancreatic surgery. This is mainly due to
complexity of the reconstructive component of the
procedure and limited dexterity offered by ﬁrst genera-
tion minimally invasive technology. Utilizing the FDA
approved DaVinci S robotic platform, we have now
demonstrated the feasibility of robot-assisted complex
pancreatic resections. Here we provide examples of the
more technically demanding components of a Robot
assisted pancreatoduodenectomy, which is virtually
identical to its open counterpart in oncological princi-
ples.
Methods: Twenty ﬁve patients with varied pancreatic
and ampullary pathologies (adenocarcinoma, IPMNs
and cystic neoplasms) have undergone minimally inva-
sive robot assisted pancreatoduodenectomy. Following
pneumoperitoneum and laparoscopic mobilization of the
right colon and stomach, the Da Vinci S  robotic system
was used to complete the procedure. Final port place-
ment required 5-5 mm ports, one 12 mm camera port at
the umbilicus, and a 15 mm extraction port in the right
lower quadrant. We reviewed and edited the video from
available teaching ﬁles to create short video clips high-
lighting the advantages of the minimally invasive robotic
assisted approach.
Results: We have successfully navigated technical com-
plexities such as aberrant arterial anatomy; small biliary
duct (< 5 mm) and intra-operative bleeding from the
portal vein and gastroduodenal artery without convert-
ing to an open procedure. We describe techniques to
address each of these clinical scenarios.
Conclusions: Minimally Invasive Robot Assisted Pan-
creatoduodenectomies are technically feasible and can
successfully recreate the technical complexities of the
open procedure. Larger cumulative experience will be
necessary to determine differences in outcomes from the
open procedure.
FV-48
LAPAROSCOPIC RESECTION FOR
PANREATIC CYSTIC TUMOR
J. A. Salceda, D. L. Fernandez, R. Sanchez Claria,
O. Mazza, J. Pekolj and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Laparoscopicapproach for the treatment of
pancreatic tumors is feasible option, however this tech-
nique remains controvertial, most in malignancy
pathology.
Methods: We present the case of a 54-year-old woman,
who was refered to us after 2 years of epigastric pain.
Ultrasound and MRI were performed and both shown a
7 · 6 cm cystic pancreatic tumor with increased wall
thickness located at pancreatic body. Tumoral merkers
were negatives. resection was planned and laparoscopic
approach was elected.
Results: Laparoscopic left pancreatectomy with esplen-
ectomy was performed. Patient has a normal post oper-
ative course and was discharged at fourth postoperative
day with no complication. Pathologist analyse informed
mucinous cystic neoplasm with carcinoma in situ. Re-
mains with no complications after 8 months.
Conclusion: Laparoscopic surgery for left pancreatic tu-
mors is a safe option in trained hands with an adeccuate
patient selection.
FV-49
BILE DUCT INJURY: CONSIDERATIONS
TO PERFORM A SUCCESSFUL
ANASTOMOSIS
P. Sisco, N. Perrone, M. Cisneros, G. Pagliarino,
N. Mosna, F. Carballo and P. Gomez
Pirovano Hospital
Background: While many laparoscopic surgeries con-
verted to an open procedure may seem to be uneventful,
there may be undetected damage due to the use of dia-
thermy causing progressive stenotic lesions to the bile
duct.
Objective: The video shows the timing and the technique
for preparing the stump of the proximal bile duct after
injury.
Method: A 61-year-old woman was admitted to the
hospital by cholangitis four months after converted lap
cholecystectomy and T-tube drainage due to a Mirizzi´s
syndrome with a bleeding at Calot´s triangle controlled
with monopolar electrocautery. The patient developed a
bile duct stenosis evidenced by MR cholangiography.
The plan was to perform Hepp-Couinaud operation
when the diathermy ﬁbrotic process was over.
Results: After cholangitis episode, the patient received
medical treatment aimed to delay the surgery till ﬁbrosis
was established. The strategy was effective and the
interval time could be extended to eight months. Lapa-
rotomy conﬁrmed the biliary stenosis with total lumen
compromise and the presence of spontaneous biliary-
duodenal ﬁstula. The ﬁbrotic tissue was removed and a
biopsy was obtained to evaluate the inﬂammatory
activity. An accurate dissection was accomplished to
prepare the bile stump. The hilar plate was approached
through the liver parenchyma to avoid damage on the
vascular network. The opening of the bile duct was ex-
tended on the left hepatic duct as the Hepp-Couinaud
technique and a satisfactory Roux-en Y hepatoyeyun-
ostomy could be performed.
Conclusions: The ﬁrst key-factor to achieve the best tis-
sular conditions for preparing bile duct stump is the
interval time between injury and repair, and the second
the use of the appropriate technique.
FV-50
TOTALLY LAPAROSCOPIC RADICAL
SURGERY FOR GALLBLADDER CANCER
E. Figueroa1,2, M. Gabrielli1,2, F. Crovari1,2,
J. Martinez1,2 and N. Jarufe1,2
1Department of Digestive Surgery; 2Pontiﬁcia Universidad
Cato´lica de Chile
The development of laparoscopic surgery has led us to
add this technology for the treatment of several pathol-
ogies. Gallbladder cancer is frequent in Chile. In selected
cases a radical surgery is indicated. It involves the
resection of the gallbladder bed plus lymphadenectomy
of the hepatoduodenal ligament, celiac axis, retropan-
creatic area and para-aortic zone. The present video
shows a totally laparoscopic radical surgery for gallblad-
der cancer. This is a 61 years old female patient with a
recent cholecystectomy for a 12 mm polyp. The histology
revealed a well differentiated adenocarcinoma that
extended to the muscular layer with absence of the cystic
lymph node. The dissemination study was negative. We
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did a resection of the gallbladder bed and lymphaden-
ectomy. The patient was discharged at second postoper-
ative day with no complications. Pathological analysis
showed no tumor at gallbladder bed and negative lymph
node spread (0/12).
FV-51
SINGLE INCISION
CHOLECYSTECTOMY USING THE GEL
PORT DEVICE
R. Matteotti, E. Chouillard, Z.El Rassi and
A. A. Gumbs
Department of Surgical Oncology, Fox Chase Cancer
Center, Philadelphia, USA
Introduction: Laparo-Endoscopic Single-Site (LESS)
surgery has emerged as a viable and widely applicable
minimally invasive technique. Presented here are the
steps necessary to perform Single Incision Laparoscopic
(SIL) cholecystectomy using a ready available gel port
device.
Methods: To perform SILS cholecystectomy we make a
2 cm incision through the umbilicus until the fascia is
identiﬁed. The fascia is opened 2 cm and a wound pro-
tector is inserted. Through the gel port we insert a 10 mm
trocar with a ballon tip for the camera and 2 5 mm
trocars as working ports. All the trokars are placed in the
lower third in a semilunar conﬁguration prior to
mounting the gel port onto the wound protector. After
that a pneumoperitoneum to 15 torr is obtained with the
insufﬂation attached to the 10 mm trocar. Intra-
abdominal visualization is obtained with a regular
10 mm straight laparoscope. Because only 2 other
instruments are used, it is imperative to grasp the gall-
bladder high on the fundus to enable the exposure of
both the Triangle of Calot and retract the cystic duct off
of the common bile duct.
Results: At our institution 28 patients have undergone
SILC. One patient required a second trocar site. Proce-
dures average 81 minutes (range = 49–137) all patients
were discharged home in less than 20 hours. To date, one
wound infection and no hernias have developed.
Conclusion: SILC is feasible and safe. The use of a
deﬂecting scope and an articulating instrument could
greatly reduce the ‘learning curve,’ of this procedure and
should be used in the beginning of one’s experience, in
particular. The Gel Port allows widespread use of this
exciting technology even in non specialized centers.
FV-52
ANATOMIC LIVER RESECTION OF
SEGMENTS I, II, III, IV, VIII AND ROUX-
EN-Y HEPATICOJEJUNOSTOMY FOR
TYPE? A CONGENITAL BILIARY
DILATATION
J. Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, China
Background: Complete lesion excision with Roux-en-y
hepaticojejunostomy is the treatment of choice for con-
genital biliary dilatation. However, major hepatectomy
for type IVa congenital biliary dilatation remains tech-
nically challenging.
Objectives: This video will show the pertinent steps to
perform an anatomic liver resection of segments I, II, III,
IV, VIII and Roux-en-y hepaticojejunostomy for type
IVa congenital biliary dilatation.
Methods: A 21-year-old female patient with type IVa
congenital biliary dilatation was referred for surgical
treatment. The anatomic liver resection of segments I, II,
III, IV, VIII and Roux-en-y hepaticojejunostomy was
performed. The parenchymal transection was performed
with CUSA and electrocautery, and the transection plane
was identiﬁed with intraoperative ultrasonography.
Results: Segments V, VI, VII were normal, and severe
ﬁbrosis developed in the other segments. The operating
time was 240 min, and the blood loss was 200 ml. No
blood transfusion was required. The bile ducts of seg-
ments V, VI, VII were normal according to intraopera-
tive choledochoscope. The hospital stay is 6 days. The
patient recovered uneventfully, and is free of clinical
symptoms after a follow-up period of 10 months.
Conclusion: The precise liver resection and Roux-en-y
hepaticojejunostomy is the preferred therapeutic option
for type ?a congenital biliary dilatation.
FV-53
SEGMENTAL CAROLI’S DISEASE:
RIGHT HEPATECTOMY IN A PATIENT
WITH BILIARY MALIGNANT
TRANSFORMATION
G. Rafﬁn, J. Lendoire, V. Garay, F. Duek and
O. Imventarza
Programa de trasplante hepa´tico y cirugı´a hepa´tica -
hospital dr. Cosme argerich, Argentina
Background: Caroli’s disease is a congenital, benign en-
tity, characterized by segmental, unilobar or bilobar
cystic dilatations of the intrahepatic biliary tract. The left
hemi liver is most commonly affected in the unilateral
disease Treatment options range from percutaneous ap-
proach, hepaticoyeyunostomy, liver resection up to liver
transplantation in advanced bilateral involvement.
Patient and methods: 52-year-old female with intrahepatic
biliary tree dilatations in segments 5 and 8 compatible
with Caroli’s disease. Diagnoses made by ultrasound and
MRI cholangiography. Right hepatectomy with inter-
mittent Pringle maneuver was performed. Pathological
report demonstrated biliary hamartomas – biliary ram-
iﬁcations – granulomatous reaction compatible with
Caroli’s disease and a 2 mm cholangiocarcinoma with
perineural invasion.
Comment: Caroli’s disease is a dysplastic lesion caused
by bile stasis and chronic inﬂammation of the epithelium.
Development of a cholangiocarcinoma has been reported
from 5 to 14%. Liver resection is the most used alter-
native treatment for unilateral Caroli’s disease with long-
term success.
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FV-54
INTRADUCTAL PAPILLARY
CHOLANGIOCARCINOMA OF THE
LEFT HEPATIC DUCT – LEFT
HEPATECTOMY WITH RESECTION OF
THE BILIARY CONFLUENCE
P. J. Sisco1, N. Perrone1, G. Pagliarino1,
M. O. Gianatiempo1, C. Perez2 and N. Mosna1
1Pirovano Hospital; 2Alvarez Hospital
Background: Intraductal papillary cholangiocarcinoma
is a low-grade malignancy neoplasm, accounting for 8–
18% of intrahepatic cholangiocarcinoma. Often, it ap-
pears as a partial obstructive lesion of small size. This
tumor type is associated with cure.
Methods: A 35-year-old female was referred with
uncertain diagnosis of Klastkin tumor. She had been
operated 30 days before because of cholestatic jaundice.
Preoperative evaluation had included CT scan, MRI,
MR cholangiography and ERCP with papillotomy due
to biliary stones. Intraoperative severe haemobilia had
made the surgeon ligate a hepatic artery. Cholecystec-
tomy and T-tube drainage were carried out. Intrac-
holedocal biopsy had reported an adenocarcinoma. At
admission, a T-tube cholangiography and an angiogra-
phy were performed.
Results: Cholangiogram revealed a partial obstructive
lesion in the left hepatic duct. Angiography showed a
well supplied liver, a right hepatic artery ligated, a per-
meable left hepatic artery and an accessory left one. Left
hepatectomy was proposed and different strategies were
planned dependant on intraoperative left hepatic artery
clamping and assessment of the right liver repercussion:
1) right hepatic artery repermeabilization; 2) portal ar-
terialization. Intraoperative choledocoscopy demon-
strated a polypoid lesion in the left hepatic duct without
involvement of the biliary conﬂuence. Left hepatic artery
clamping did not affect the right liver blood supply and
left hepatectomy could be performed. The resection in-
cluded the biliary conﬂuence at second-order right ducts.
Roux-en-Y anastomosis was accomplished. The histo-
pathology reported an intraductal cholangiocarcinoma
minimally invasive with negative lymph nodes. No
complications.
Conclusions: Choledocoscopy proved useful to reach the
precise diagnosis. Alternative collateral circulation due to
hepatic artery ligation demonstrated to maintain an
effective liver blood supply to allow left hepatectomy.
FV-55
RIGHT HEPATECTOMY EXTENDED TO
SEGMENT 4A FOR HEPATOCELLULAR
CARCINOMA
D. Cherqui1, L. Vigano, A. Laurent and C. Tayar
1Hospital Henri Mondor, Creteil
The video shows a right hepatectomy extended to
segment 4a for hepatocellular carcinoma in a 50 year-
old woman with HBV+ chronic hepatitis A2F1. In 03/
08, screening abdominal US and MRI showed a 4 cm
HCC in segment 8 in contact with the right and the
middle hepatic veins. AFP was 26.9 ng mL-1 and liver
function tests were normal. J-shaped incision was
performed. The conﬂuence of the hepatic veins was
dissected and a tape was passed between the liver and the
IVC for a hanging maneuver. Right portal branch and
right hepatic artery were divided. Ischemic demarcation
along the Cantlie’s line was obtained. Transection began
at the upper right part of the falciform to expose and
encircle the termination of the middle hepatic vein.
Transection line was then conducted along the Cantlie’s
line between segments 5 and 4b, and then transversally
between segment 4a and 4b to reach transection line
along falciform ligament previously marked. In the
horizontal part of transection plane, the middle hepatic
vein was identiﬁed and divided between ligatures. The
right hepatic duct and the portal pedicles of segment 4a
were divided. The scissural vein was exposed along
transection line and preserved. At the end of parenchy-
mal transection the middle and the right hepatic veins
were divided by linear stapler. Right hepatectomy was
completed by mobilisation of the specimen.
Operative time was 210 min. A single session of pedicle
clamping (20 min) was needed during the ﬁnal part of
parenchymal transection. Blood loss was 250 mL and no
transfusions were required. Postoperative course was
uneventful and the patient was discharged on postoper-
ative day 10. Pathology: HCC inﬁltrating the right
hepatic vein. Surgical margin 2 mm.
As of October 2009 (19 months), the patient is alive and
disease free.
FV-56
INSTALLATION OF ISOLATED
SEGMENT6 IN A CLOCKWISE
ROTATION IS EFFECTIVE FOR
AVOIDING INSTABILITY AND
CONGESTION
Y. Tanahasi, A. Sugioka, C. Takeura, K. Amano,
Y. Sakurai, K. Sakabe, T. Kagawa, Y. Okabe, T. Tokoro
and Z. Morise
Department of Surgery, Fujita Health University, Aichi,
Japan
Background: In some cases with isolated Segment6, we
are confronted with difﬁculties such as instability and
congestion.
Aim: The aim of this paper is to demonstrate the sig-
niﬁcance of installation in a clockwise rotation of isolated
Segment6.
Case: A 70-year-old-male was referred to our institute
for hepatocellular carcinoma in the Segment5 and
Segment7 with liver cirrhosis due to hepatitis C. We
performed systematic Segmentectomy5 and Segmentec-
tomy7 leaving isolated Segment6 with the right hepatic
vein. The isolated Segment6 was instable and easily
congested with kinking of the right hepatic vein. There-
fore, we adopted an installation of the Segment6 in a
clockwise rotation in the right subphrenic space. The
Segment6 was well ﬁt to the space and congestion was
avoided.
Conclusion: Installation of the isolated Segment6 in a
clockwise rotation is effective for avoiding instability and
congestion.
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FV-57
A CASE OF BILE DUCT CARCINOMA
WITH OBSTRUCTION OF CELIAC
TRUNK TREATED PREOPERATIVELY
BY INTERVENTIONAL MODIFICATION
OF HEPATIC ARTERIAL FLOW
A. Nanashima, T. Abo, T. Syuuichi, M. Kunizaki,
S. Hidaka, H. Takeshita, T. Sawai and T. Nagayasu
Nagasaki University Hospital, Division of Surgical
Oncology
Background: The median arcuate ligament and athero-
sclerosis can cause narrowing of celiac artery trunk
(SCA). However, hepatic arterial ﬂow is maintained in
such cases via small arteries of the pancreatic arcade. In
pancreaticoduodenectomy (PD), cutting the arcuate lig-
ament or insertion of tube stent in SCA can prevent
ischemia of upper abdominal organs.
Methods: We present a video of a patient with bile duct
carcinoma and obstruction of celiac trunk, who was pre-
treated by coil embolization in the gastroduodenal artery
before PD to preserve arterial ﬂow via collateral dorsal
pancreatic artery.
Case: A 79-year-old male had a lower bile duct carci-
noma. Abdominal CT showed obstruction of celiac trunk
accompanied by collaterally extended dorsal pancreatic
artery (DPA). Abdominal angiography showed another
collateral ﬂow from the gastroduodenal artery (GDA)
via pancreatic head arcade. To increase collateral ﬂow to
hepatic ﬂow via DPA, preoperative coil embolization of
GDA was performed and increased ﬂow via DPA was
conﬁrmed immediately after embolization. At 5 days
after embolization, PD preserving collateral DPA was
conducted and hepatic arterial ﬂow was well preserved by
intraoperative Doppler ultrasonography. Postoperative
CT also showed sufﬁcient hepatic and splenic arterial
ﬂow and blood test did not show upper organ injury in
acute postoperative period.
Conclusion: Preoperative enhancement of arterial ﬂow
by coil embolization secures adequate hepatic arterial
ﬂow in patients with SCA narrowing scheduled for
pancreatic resection.
FV-58
RIGHT TRISECTIONECTOMY (AND
SEGMENTECTOMY 3) IN SITUS
INVERSUS TOTAL
N. Bucich, E. De Santiban˜es, F. Bersano, V. Ardiles,
G. Pfaffen and M. Ciardullo
Hospital Italiano de Buenos Aires
Background: Female patient, 61-years old.
Antecedents: Hypothyroidismo and situs inversus total.
Complains of gradual abdominal pain, nauseous and
sickness.
Diagnostic work-up: Laboratory: Alfa-fetoprotein 112
(VN 1.7), FAL 134, AST 100, ALT 90.
MDCT: Situs inversus total. Expansive tumour mass of
149 · 143 mm in right hepatic lobe. This mass involves
the right portal vein, the right and middle hepatic veins.
And another tumour mass of 35 · 30 mm in Sg 3.
Diagnose: Hepatocellular carcinoma.
Surgical treatment. ASA II.
Methods: -Bilateral subcostal incision with a midline
extension
-Liver mobilization
-Dissection of hepatic hilum
-Identiﬁcation and transsection of the right hepatic
pedicle
-The hepatoduodenal ligament is divided
-Demarcation of the hepatic surface
-Pringle maneuver
-Transsection of the liver parenchyma
-Total Vascular exclusion is performed
-Identiﬁcation and ligation of the right hepatic vein
-The tumour mass is removed
Results: POD 1-2 (ICU): the patient shows a satisfactory
recovery. Transferred to general ward.
POD 3-6: the patient starts clear liquids. Early mobili-
zation.
Abdominal drains are removed, and the patient is
discharge from hospital.
Histo-pathological report: Hepatocellular carcinoma.
EDMONDSON 2 (Angiomatoid type).
Conclusions: Hepatic resection is considered the treat-
ment of choice for Large Hepatocellular Carcinoma. In
western countries between 10 and 49% of patients with
HCC present a non-cirrhotic liver. The tumour size in
healthy livers is bigger than in cirrhotic livers. The right
trisectionectomy includes resection of segments IV-V-VI-
VII and VIII.
This procedure should only be performed if the remnant
liver (segments II and III) provides sufﬁcient liver
function. This is feasible in patients with situs inversus
total.
FV-59
CENTRAL HEPATIC
BISECTIONECTOMY, CAUDATE
LOBECTOMY FOR A
HEPATOCELLULAR CARCINOMA
ORIGINATING IN THE CAUDATE LOBE
T. Sano1, Y. Shimizu1, Y. Senda1, K. Shimada2 and
Y. Nimura1
1Aichi Cancer Center Hospital; 2National Cancer Center
Hospital
Aim: To report a central hepatic bisectionectomy and
caudate lobectomy for a hepatocellular carcinoma
(HCC) originating in the caudate lobe (S1).
Case: A 51-year-old HB antigen-positive woman pointed
out a liver tumor. CT demonstrated a hyper-vascular
tumor 10 cm in diameter originating in the caudate lobe.
CT-volumetry showed 30% of the right anterior section,
31% of the right posterior section, 9% of the left medial
section, and 29% of the left lateral section, respectively.
Although the ICG retention rate at 15 minutes was 2.2%,
the resection liver volume through the right trisection-
ectomy was calculated as 71%; this would be a heavy
burden considering the underlying liver disease. Thus a
central hepatic bisectionectomy, caudate lobectomy was
selected for the radical surgery.
Results: A reverse T-shaped thoracoabdominal incision
through the 9th intercostal space was made. The middle
and left hepatic artery were transected; the left medial
and the right anterior branch of the portal vein were
ligated. After complete mobilization of the whole liver
including the detachment of the caudate lobe from the
IVC, liver parenchymal dissection was started using
intermittent pedicle occlusion. Liver resection along the
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falciform ligament followed by the right portal ﬁssure
was performed. Meticulous manipulations for exposing
the hilar plate and division of tiny caudate glisson are
advisable to prevent postoperative intractable bile leak-
age. Operation time was 640 min and intraoperative
blood loss was 1016 mL. Postoperative recovery was
uneventful, and the patient is alive 52 months after the
operation.
Conclusions: Surgery for HCC originating in S1 should
be selected in terms of the tumor extension and the
functional reserve of the future remnant liver.
FV-60
LEFT HEPATECTOMY EXTENDED TO
S 1-5-8 FOR SYMPTOMATIC GIANT FNH
WITH BUDD-CHIARI SYNDROME
F. Ardito, F. Giuliante, M. Vellone, I. Giovannini and
G. Nuzzo
Catholic University-Hepatobiliary Surgery Unit-Rome
Background: Liver resection for focal nodular hyperpla-
sia (FNH) is indicated for large symptomatic lesions, or
lesions indistinguishable from adenoma/malignancies.
Objective: The case of a 35-year-old female patient with
right upper quadrant abdominal pain is reported. CT
scan and MR showed giant FNH (14 cm) occupying the
whole left hemiliver (S 2-3-4), extended to S 1-5-8,
invading left and middle hepatic veins, compressing and
dislocating right hepatic vein, partly obstructing venous
outﬂow with initial Budd-Chiari syndrome, and causing
hilar compression with initial cholestasis. Left hepatec-
tomy extended to S 1-5-8 was performed.
Methods: After right subcostal incision extended to the
xiphoid along the midline, the left hepatic artery and left
portal vein, dislocated by the tumor, were encircled with
loops. Liver mobilization was obstacled by the mass size.
Supra-hepatic and infra-hepatic inferior vena cava were
encircled with loops to permit total vascular exclusion, if
needed. Caudate lobe isolation proceeded from the left
and the right side. Right dorsal caval and Acranius lig-
ament were divided. Right hepatic vein and common
hepatic trunk were encircled with loops. Liver resection
was performed by kellyclasia, bipolar forceps, and
ultrasonic dissector. Left portal vein and left hepatic ar-
tery were extraparenchymally divided, reducing tumor
size. The common hepatic trunk was extraparenchymally
divided, the tumor was enucleated from right hepatic
vein, hepatic vascular exclusion with preservation of ca-
val ﬂow was intermittently applied (total ischemia
210 min).
Results: On postoperative day 1 alanine-aminotransfer-
ase was 3010 U L-1 (n.v. < 45), progressively decreasing
to 89 U L-1 (day 7). Complications included mild tran-
sient liver failure and a percutaneously drained sub-
phrenic abscess.
FV-61
RESECTION OF GIANT HEMANGIOMA
OF THE LIVER
C. Rowe, A. Gonzalez Campan˜a, P. Ferreira Mongelos,
L. G. Podesta and O. Andriani
Hospital Universitario Austral
Background: Hemangiomata are the most frequent form
of benign liver tumors. In most cases they are asymp-
tomatic and require no treatment. Giant hemangiomata
may sometimes become symptomatic; however there is
still controversy on the indication for surgery in these
tumors.
Objective: To show the procedure for hemangiectomy
preserving non-tumoral liver tissue.
Methods: A 39 year old male complained of abdominal
pain and an abdominal mass he described as rapidly
growing in the months prior to admission. The mass was
clearly evident at sight upon examination and occupied
most of the abdominal cavity as showed on CT-scans.
Liver function tests, viral serologic testing and tumoral
serologic markers were normal. An extended midline
incision was required due to tumoral size. The lesion
showed to be free from adhesions to the surrounding
abdominal organs. Hemangiectomy preserving normal
liver was performed. Intraoperative ultrasound demon-
strated several non-complicated small hemangiomata
scattered among the remaining liver.
Results: The patient recovered from the surgery without
complications and was discharged from the hospital at
postoperative day 5.
Conclusion: Giant hemangiomata are rarely subject to
surgical treatment but when required, surgery should be
performed with the intent of preserving as much func-
tional normal liver tissue as possible.
FV-62
RADICAL SURGERY OF RECURRENT
LIVER METASTASES INVOLVING
HEPATIC VENOUS OUTFLOW
E. Vicente, Y. Quijano, C. Loinaz, P. Galindo,
E. Esteban, H. Dura´n, M. Marcello, R. Conradi,
L. Co´rdoba, A. Muro, J. Rodrı´guez Pascual and
J. A. Martı´nez Roma´n
Madrid-Norte-Sanchinarro Hospital/Clara Campal
Oncologic Center (CIOCC)/Faculty of Medicine, San
Pablo CEU University, Madrid, Spain
Introduction: Resection of recurrent liver tumors
involving the hepatic venous outﬂow remains contro-
versial. Adequate surgical clearance can require resection
and reconstruction of the hepatic veins.
Methods: A 32-year-old man was referred to our hospital
with a history of an elective low anterior resection in May
2001 because of distal rectal cancer. At that time he was
found to have multiple liver metastases occupying the
right lobe and segment IV. A low anterior resection was
performed. Preoperative percutaneous transhepatic
embolization of the right portal vein plus the left medial
portal branch was performed to initiate compensatory
hypertrophy in the remnant segments II and III. During
surgery, the liver metastases were judged to be unresec-
table and he received adjuvant chemotherapy. In Sep-
tember 2002, we carried out an elective right hepatic
trisegmentectomy and nonanatomic metastasectomy
from the central part of segments 2 and 3. Fourteen
months postoperatively a recurrence developed within
the liver remnant. A CT scan and venography reveals a
4 cm liver mass in the left liver remnant, which appeared
to be closely apposed to the left hepatic vein. A positron
emission tomography with 18 FDG showed the evidence
of solitary liver metastatic disease.
Results: The preoperative diagnosis was a recurrence of
colorectal liver metastases involving the hepatic venous
outﬂow and surgical treatment was indicated; nonan-
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atomic metastasectomy with resection and reconstruction
of the intrahepatic venous outﬂow with vascular graft of
cadaveric donor.
Conclusion: The vascular grafts of cadaveric donor offer
an excellent alternative for hepatic venous outﬂow
reconstruction.
FV-63
RETROGRADE HEPATECTOMY WITH
LIVER HANGING MANEUVER FOR
HEPATOCELLULAR CARCINOMA
S. Y. Peng1, F. Hong De2, Y. B. Liu3 and
J. T. Li1
1Second Afﬁliated Hospital, School of Medicine, Zhejiang
University; 2Sir Run Run Shaw Hospital, School of
Medicine, Zhejiang University; 3Afﬁliated Shanghai
Xinhua Hospital, Shanghai Jiaotong University
Background: When a wide area of diaphragm is inﬁl-
trated by hepatocellular carcinoma, it would be very
difﬁcult to perform a resection of the tumor, especially
when at the same time a large piece of pericardium is also
involved. In such situations retrograde resection of the
liver is indicated. It has been debatable whether liver
hanging maneuver is good for retrograde resection of the
liver.
Aim: To introduce retrograde hepatectomy with liver
hanging maneuver for hepatocellular carcinoma inﬁl-
trating diaphragm.
Methods: A tunnel along anterior surface of retrohepatic
inferior vena cava was created by ﬁngers. The hanging
tape passed along the tunnel and taped the left lobe.
Retrograde hepatectomy was performed using peng’s
multifunctional operative dissector (PMOD).
Results: The two cases of hepatectomy were performed
successfully. Blood loss was 900/700ml and operating
time was 250/195 min. No complication occurred.
Conclusions: Liver hanging maneuver is very helpful in
carrying out retrograde resection of right or left liver.
FV-64
LAPAROSCOPIC APPROACH FOR
PANCREATIC PSEUDOCYST AND
GALLBLADDER STONES
J. A. Salceda, D. L. Fernandez, R. Sanchez Claria,
O. Mazza, J. Pekolj and E. De Santiban˜es
Hospital Italiano de Buenos Aires
The treatment of pancreatic’s pseudocyst involves several
ﬁelds such as endoscopic, percutaneous, laparoscopic
and conventional surgery. Each of these ﬁelds must be
taken on account for the HPB surgeon in order to choose
the best option for each case.
We present the case of 56-year-old women who presented
a large and symptomatic pancreatic pseudocyst after one
ﬁrst episode of biliary acute pancreatitis. CAT scan and
MRI were performed. Laparoscopic approach was
decided in order to solve both problems. The etiologic
factor (gallbladder stones) and the complication (pan-
creatic pseudocyst).
Laparoscopic Cysto-gastric anastomosis and cholecys-
tectomy with intraoperative cholangiogram were done at
the same procedure and both problems were solved in the
same operative time. Patient underwent an uneventful
postoperative course with no further complications.
FV-65
LAPAROSCOPIC DISTAL PANCREATO-
SPLENECTOMY AND SPLEEN
PRESERVING DISTAL
PANCREATECTOMY WITH
CONSERVATION OF THE SPLENIC
ARTERY AND VEIN
G. Belli, C. Fantini, A. D’agostino, P. Limongelli,
L. Ciofﬁ, G. Russo and A. Belli
Department of General and Hepato-Pancreato-Biliary
Surgery
Background: Laparoscopic distal pancreatectomy is
progressively gaining popularity and its feasibility and
safety has been demonstrated by many series.
Aim: The aim of this video is to focus on the technical
aspects and differences between laparoscopic distal pan-
creato-splenectomy (indicated in case of aggressive
malignant neoplasms) and spleen preserving distal pan-
createctomy with conservation of the splenic artery and
vein. (Indicated in case of benign or borderline malignant
tumors).
Methods: A case of pancreatic adenocarcinoma and a
case of pancreatic insulinoma both localized in the tail of
the pancreas are compared analyzing the differences in
the surgical techniques.
Results: The postoperative course was uneventful and
the patients were discharged on postoperative day 10.
Conclusions: Laparoscopic distal pancreatectomy is fea-
sible and safe. Both pancreato-splenectomy and spleen
preserving procedures are technically demanding. In the
case of adenocarcinoma it is necessary to pay attention to
inﬁltrations to adjacent organs or vascular structure as
the celiac axis; when preservation of the splenic vessels is
performed preventive control at the origin is suggestible
and a meticulous and ﬁne dissection is mandatory to
avoid massive bleeding.
FV-66
LAPAROSCOPIC RESECTION OF
UNCINATE PROCESS OF THE
PANCREAS
F. Makdissi, R. C Surjan, M. C. Machado and
M. A. Machado
Department of Gastroenterology, University of Sa˜o Paulo,
Brazil
Background: Solid pseudo papillary neoplasm of the
pancreas is an uncommon but distinctive pancreatic
neoplasm with low metastatic potential. There are only
few cases of laparoscopic resection for solid pseudo
papillary neoplasm of pancreas published in the English
literature and, to our knowledge, laparoscopic resection
of uncinate process of the pancreas has never been re-
ported so far.
Aim: To present a video with technical aspects of a to-
tally laparoscopic resection of the uncinate process of the
pancreas in a patient with solid pseudo papillary neo-
plasm.
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Methods: A 26-year-old woman with a 4 cm solid pseu-
do papillary pancreatic neoplasm was referred for treat-
ment. According to preoperative echo endoscopy, there
was a safe margin between neoplasm and main pancre-
atic duct. Patient was placed in supine position with
surgeon standing between her legs. Four trocars, one
10 mm and three 5 mm, were used. At inspection, infe-
rior vena cava, transverse colon, duodenum and pancreas
are clearly identiﬁed. Kocher maneuver was performed
with complete exposure of pancreatic head and uncinate
process. The uncinate process was dissected off from
superior mesenteric blood supply of the duodenum was
maintained by ligature of small pancreatic branches
preserving inferior pancreatoduodenal artery. Transec-
tion of pancreatic parenchyma was performed using
laparoscopic coagulation shears, which is an effective
tool for cutting the pancreas. A hemostatic absorbable
tissue was placed in the cutting pancreatic surface and
one round 19F Blake abdominal was left in place. Sur-
gical specimen was removed through a suprapubic inci-
sion inside a retrieval bag.
Results: Operative time was 180 min with minimum
blood loss. Hospital stay was 4 days and recovery was
uneventful.
Conclusion: Laparoscopic resection of uncinate process
of the pancreas is safe and feasible and should be con-
sidered for patients suffering from pancreatic neoplasms.
FV-67
TOTALLY LAPAROSCOPIC WHIPPLE
PROCEDURE: TECHNICAL ASPECT
S. Teh
Sacred Heart Medical Center
A totally laparoscopic Whipple procedure is technically
challenging and demanding. This video presentation
focuses on the technical aspect of a totally laparoscopic
Whipple procedure. This video demonstrates patient
positioning, trocar set up, laparoscopic Cattell-Braasch
maneuver, lesser sac dissection, portal hepatis exposure
maneuver, kocherization, inferior pancreatic dissection,
portal vein and supraduodenal dissection, ligation of
gastrodoudenal artery and right epiploic pedicle, periad-
ventitial superior mesenteric artery dissection, intracor-
poreal reconstruction of pancreatico-jejunostomy
(mucosa to mucosa), choledocho-jejunostomy and a
gastro-jejunostomy. This video also demonstrated the
important of intracorporeal needle rotation and suturing
technique with right and left hand in order to accomplish
the delicate anastomosis.
FV-68
TRANSMESOCOLIC APPROACH FOR
LAPAROSCOPIC DISTAL
PANCREATECTOMY WITH SPLEEN
PRESERVATION IN RARE TUMOR
A. L. M. Meyer1, M. A. Pedroso2, E. Berger1,
M. A. A. Ranoya1, O. JR Monteiro1, P. A. Alonso1,
L. M. V. Guimara˜es1 and D. Bellandi1
1Professor Edmundo Vasconcelos Hospital, Department
of Surgery, Sa˜o Paulo; 2Lubeck Institute, Itu
Background: Minimally invasive techniques have been
revolutionary and provide clinical evidence of decreased
morbidity and comparable efﬁcacy to open surgery.
Indications in the ﬁeld of pancreatic surgery should be
limited considering the technical difﬁculties and the
characteristics of pancreatic diseases. Intraductal papil-
lary mucinous neoplasm of the pancreas (IPMN) is a rare
pancreatic cystic neoplasm. These tumors, even when
malignant, are often resectable and have a more favor-
able prognosis than do ductal adenocarcinoma and
classic mucinous cystadenocarcinoma of the pancreas.
Objective: Describe the utilization of an alternative ap-
proach for laparoscopic distal pancreatectomy.
Case report: A 37-year-old man was admitted in emer-
gency with uncharacteristic abdominal pain. Abdominal
CT-scan reported a solid-cystic tumor of 45 X 30 mm in
the pancreatic body suggesting a mucinous cystadenoma
of the pancreas. Laparoscopic distal pancreatectomy
with spleen preservation was performed by transmeso-
colic approach. Pathological examination of surgical
specimen revealed a 60 x 40 mm tumor, showed intra-
ductal papillary mucinous neoplasm of the pancreas. The
resection margins were free of tumor. The postoperative
course was uneventful and the patient was discharged on
post operation day 4.
Conclusion: This case demonstrated that mesocolic ap-
proach is a safe and effective way to properly access the
pancreas. This approach is more direct and accurate and
with rapid recovery and short hospital stay provide by
laparoscopy.
FV-69
LAPAROSCOPIC SPLEEN-
PANCREATECTOMY, FOR MUCINOUS
PANCREATIC-CYST
J. Nefa, P. Omelanczuk, M. Masrur and S. Bustos
Hospital Italiano de Mendoza-Argentina
Background: Among pancreatic cysts, mucinous cystad-
enoma, and intraductal papillary mucinous neoplasms
have the potential for malignant transformation. Differ-
entiation between benign and potentially malignant cysts
remains difﬁcult at the preoperative time. Majority of
these tumors must be resected and the laparoscopic ap-
proach is nowadays a valid option.
Objective: To show in a video the laparoscopic excision
of a multiple pancreatic mucinous cyst. In this was nec-
essary the simultaneous splenectomy.
Methods: A 54 year-old female was diagnosed for Pan-
creatic mucinous Cyst by CT-Scan (Computer tomogra-
phy), NMR (Nuclear Magnetic Resonance), PET-Scan
(Positron Emission Tomography) and Tumor Markers.
Using four trocars the spleen and pancreatic Cysts were
successfully removed. Pancreatic section was carried out
using stapler. Both splenic artery and vein were occluded
by ligature and clips.
Results: The operating room time was 4 hours, transfu-
sion of 500 mL of Red Cells was necessary. Hospital stay
was 5 days. Pathologic study informed Adenocarcinoma
mucinous of the pancreas.
Conclusions: Simultaneous resection of pancreas and
spleen is possible by Laparoscopy as many authors have
reported. On the other hand, neither laboratory exams
nor Imagines were able to conﬁrm the malignant condi-
tion of the tumor at the preoperative time.
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COMPLETION OF PANCREATECTOMY
FOR IPMN RECURRENCE AND FOR
ANASTOMOTIC FAILURE AFTER
PANCREATICOGASTROSTOMY WITH
GASTRIC PARTITION
L. Ferna´ndez-Cruz1, R. Garcı´a1, M. Acosta2,
M.-A. Lo´pez-Boado1 and J. Samame´1
1Hospital Clı´nic de Barcelona; 2Hospital Universitario
Austral
Pancreaticogastrostomy with gastric partition (GP) after
pylorus preserving pancreatoduodenectomy (PPPD) is
associated with less complication than PPPD with
pancreaticojejunostomy anastomosis (Ann Surg 2008,
248:930–938). In addition, PPPD-GP allows in patients
requiring completion of pancreatectomy the en-block
resection of the pancreas and the segment of the stomach
involved in the anastomosis.
In this video is presented completion of pancreatectomy
years after PPPD-GP, in one case for IPMN local
recurrence and in another case for pancreatic anasto-
motic failure. There were no complications and oral
feeding was started 48 hours after the operation.
FV-71
PANCREATIC HEAD RESECTION WITH
DUODENAL PRESERVATION: A VIDEO
PRESENTATION
A. E. Frampton1, J. J. Bong2, C. Kyriakides1 and
L. R. Jiao1
1Division of Surgery, HPB Surgery Unit, Hammersmith
Hospital, Imperial College London, UK; 2Department of
Surgery, National University of Malaysia, PPUKM,
Malaysia
Background: Aggressive surgery such as pancreatico-
duodenectomy (PD) is called into question in patients
with indolent disease.
Objective: We describe a surgical procedure for duodenal
preservation in a patient with a non-invasive tumour at
the head of pancreas.
Case History: A 37-year-old female presented with
recurrent right-upper-quadrant pain. Computed tomog-
raphy scans showed a 2cm hypervascular lesion lying
between the head of pancreas and 2nd part of duodenum.
The patient underwent an exploratory laparotomy with a
view to local resection rather than PD.
Surgical Technique: The duodenum was extensively mo-
bilised. Hilar dissection was then performed and the
gastroduodenal artery was then ligated and divided. The
gallbladder was removed and the common bile duct ex-
posed. The portal vein was exposed and the ‘‘tunnelling’’
of the pancreatic neck was completed. A limited en bloc
resection of the 2nd part of duodenum was performed
with the head of pancreas, in order to preserve the 1st
part, a small amount of the 2nd part, and the 3rd and 4th
parts of the duodenum.
Reconstruction was carried out by performing a pan-
creatico-gastrostomy; a Roux-en-Y loop was fashioned
and anastomosed to the distal bile duct and a duodeno-
duodenal anastomosis was then performed with a
tension-free anastomosis. Postoperatively she had an
uneventful recovery and was discharged home after 15
days. Examination of the specimen showed a 1.5cm
supra-ampullary cystic mass in the duodenum. The ﬁnal
histology was duodenal GIST with complete excision.
Conclusion: Pancreatic head resection with segmental
duodenectomy is technically feasible and appears safe in
our hands.
FV-72
PANCREATOGASTROSTOMY WITH
GASTRIC PARTITION AFTER
PYLORUS-PRESERVING PANCREATO-
DUODENECTOMY: THE
FERNANDEZ-CRUZ OPERATION
G. Belli, C. Fantini, A. D’agostino, A. Belli, L. Ciofﬁ,
P. Limongelli and G. Russo
Department of General and Hepato-Pancreato-Biliary
Surgery
Background: In 2008 the promising results of a prospec-
tive randomized study presented by Fernandez-Cruz (FC)
L. et al showed that Pancreatogastrostomy with gastric
partition after pylorus preserving pancreatoduodenecto-
my (PPPD-GP) is associated with less postoperative
complications comprised pancreatic ﬁstula when com-
pared to conventional pancreatojejunostomy (PPPD-PJ).
Aim: The video shows the technique of PPPD-GP pro-
posed by Fernandez-Cruz L.
Methods: After the completion of a standard PPPD
performed for a duodenal tumour, good vascularization
of the stomach and residual duodenum is checked. An
opening is made in an avascular area in the upper part of
the body of the stomach and gastric partition is accom-
plished by 2 ﬁring of endo-Gia placed in the lateral
border of the stomach 2 to 3 cm from the gastroepiploic
arcade which has been carefully preserved. A third ﬁring
of endo-Gia follows the same line reaching the body-
antrum junction. Pancreatogastrostomy is carried out
juxtaposing the segment of the stomach to the pancreatic
stump that has been minimally mobilized to preserve
blood supply. An end-to-side and duct-to-mucosa anas-
tomosis with an internal stent (subsequently externalized)
is than performed. A retrocolic duodenojejunostomy and
a single layer hepatojejunostomy are ﬁnally performed
using the same jejunal loop. In our practice we usually
externalize the pancreatic stent in case of high risk
anastomosis.
Results: The postoperative course was uneventful and
the patient was discharged on postoperative day 9.
Discussion: FC operation with the use of gastric parti-
tion makes the pancreatogastrostomy easy to perform
and effective.
FV-73
THE ‘WHIP-STOW’ PROCEDURE: AN
INNOVATIVE MODIFICATION TO THE
PANCREATICOJEJUNAL
ANASTOMOSIS
D. R. Jeyarajah1, A. Khithani1, J. Barton1,
C. Galanopoulos2, D. Curtis3 and R. Rassadi4
1Methodist Dallas Medical Center, Dallas, Texas;
2Renown Institute for Cancer, Reno, Nevada; 3HPB
Surgery, Division of General Surgery, Connecticut
Surgical Group, Hartford; 4John C. Lincoln Hospital
North Mountain, Phoenix, Arizona
Introduction: Pancreaticoduodenectomy (PD) is the
standard of care in the treatment of pre-malignant and
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malignant diseases of the head of the pancreas. Vari-
ability exists in the method of anastomosis with the
pancreatic remnant. This work describes, for the ﬁrst
time, a safe and easy modiﬁcation for the pancreatic
anastomosis after PD.
Methods: Medical records of 22 consecutive patients,
who underwent the ‘Whip-Stow’ procedure for the
management of the pancreatic remnant at a high volume
non university tertiary care center (NUTCC) were ana-
lyzed. PD combined with a Peustow (LPJ-lateral pan-
creaticojejunostomy) - The ‘Whip-Stow’ procedure
(WSP), was performed on the pancreatic remnant using a
running single layer, 4–0 prolene obeying a duct-to-mu-
cosa technique. The records were reviewed with respect
to intraoperative and postoperative data, thirty-day
mortality and morbidity.
Results: Twenty-two patients underwent WSP after a
PD. The Whip-Stow was completed without loops or
microscope while achieving a duct-to-mucosa anasto-
mosis. Completing the anastomosis with a 4-0 single layer
suture decreased the time and complexity of the anasto-
mosis. Average time was 12 min, as compared to the
50 min of a 5 or 6-0, interrupted, multilayered duct –
mucosa anastomosis. Beneﬁts included a long segment
LPJ.
Conclusion: The Whip-Stow procedure has proven to be
a safe and simple approach to the pancreatic anastomosis
in selected patients. This new technique provides the
beneﬁt of technical ease while obeying the age old prin-
ciples of obtaining a wide duct to mucosa anastomosis.
FV-74
A NEW TECHNICAL METHOD OF
PANCREATOGASTROSTOMY USING AN
ISOPERISTALTIC GASTRIC TUBE
FOLLOWING A PYLORUS PRESERVING
PANCREATODUODENECTOMY
R. M. Costa, P. C. Brandao, G. Cunha and L. L. Pereira
Hospital de Base do Distrito Federal
Background: Pancreatoduodenectomy is the standard
treatment for most of the malignancies regarding the
periampullary region.
Aim: Describe a new surgical technique for a safer pan-
creatogastrostomy, which thus far has been performed
with three leaks and no other signiﬁcant complications.
Methods: Our series consisted of twenty- seven men and
twenty- four women, with age ranging from 34 to
84 years. Twenty nine of them presented with carcinoma
of the head of the pancreas, nineteen with carcinoma of
the papilla of Vater, two with chronic pancreatitis, and
one with a single metastasis to the head of the pancreas
from a primary gallbladder tumor. All patients under-
went a pylorus-preserving pancreatoduodenectomy. Two
of them underwent a simultaneous resection of the right
lobe of the liver. Following removal of the specimen, a 75
mm long and 50 mm wide isoperistaltic gastric tube was
created along the greater curvature of the stomach
without ligation of the left gastroepiploic vessels. A
length of approximately 4 to 5 cm of the pancreatic body
was dissected, intussuscepted into the gastric tube, and
ﬁxed to it with a 2.0 Prolene purse-string suture.
Results: Leakage was detected in three patients. One
patient presented with amylase-rich ﬂuid drainage re-
stricted to the ﬁrst two post-operative days, 355 and
267 I.U dL-1, respectively. The nasogastric tube was used
for delayed gastric emptying and a feeding jejunostomy
was performed in four patients. Subsequently, we have
replaced jejunostomy with a nasoenteral feeding tube for
early feeding.
Conclusion: In this group of patients, the intussusception
of the remnants of pancreas into a short isoperistaltic
gastric tube following a pancreatoduodenectomy was
shown to be a simple, effective and useful technical
alternative to avoid the disruption of the pancreatoga-
strostomy.
FV-75
SURGICAL TECHNIQUES OF HEPATO-
PANCREATODUODENECTOMY
K. Kubota
Department of Gastro-enterological Surgery, Dokkyo
Medical University
Background: Hepato-pancreatoduodenectomy (HPD),
which consists of pancreatoduodnectomy (PD) with right
or left hepatectomy, still presents high postoperative
morbidity and mortality rates. Liver failure and intra-
abdominal hemorrhage caused by pancreatic ﬁstula are
considered associated with the poor outcome.
Aim: I report my surgical technique in 14 cases of HPD.
Methods: Between April 2000 and September 2009, 830
hepatectomies were performed at my department. 14 of
the 830 patients underwent HPD under diagnoses of
biliary malignancies (Bile duct cancer: 11, gallbladder
cancer: 3). There were 7 males and 7 females with a
median age of 70 years (34–79). Their median ICG15 was
8% (3–16). HPD was indicated to patients with gall-
bladder cancer invading the duodenum or wide-spread
bile duct cancer. When RHPD was considered necessary,
portal embolization was performed irrespective of the
size of the future remnant left liver. Extended right or left
hepatectomy was preceded by PD. Thereby two-staged
PD including exteriorization of the pancreatic juice,
covering of the major vessels by omental graft and sec-
ond-look pancreatico-jejunostomy, was employed. Pan-
creatico-jejunostomy was performed 3 months after
HPD.
Results: 9 RHPDs and 5 LHPDs were performed suc-
cessfully. Their median operation time, Pringle time and
bleeding amount were 790 min (660–1205), 46 min (36–
61) and 1136 mL (596–2500), respectively. In two pa-
tients, rupture of pseudo-aneurysm developed postoper-
atively and was successfully treated by TAE. There was
no postoperative mortality within one month. Second-
look anastomosis was performed successfully in 10 pa-
tients. In 4 patients, the intra-hepatic duct stumps were
positive for cancer and 7 patients died of cancer. The
cancer-speciﬁc one-year and 3-year survival rates were
60% and 30%, respectively.
Conclusion: By employing portal embolization and two-
staged PD, HPD can be performed safely as an estab-
lished procedure in selected patients with biliary cancers.
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HEPATIC CAVERNOUS HEMANGIOMA:
WHEN SHOULD BE RESECTED?
J. P. Grondona, R. A. Bracco, M. A. Duhalde,
P. J. Angiolini, R. A. Sarquis and J. P. Rastrilla
Associated Units of Hepato-Pancreato-Biliary Surgery
(UNACIR HPB) San Isidro and Mar del Plata, Buenos
Aires, Argentina
Background: Hepatic cavernous hemangioma (HCH) is a
congenital vascular malformation and is the most fre-
quent solid hepatic benign tumor. Because the use of
cross-sectional imaging studies HCH are frequently
encountered. Surgeons and Physicians have to be familiar
with the appropriated diagnostic method, management
and outcome.
Aim: To asses surgical indications and outcome of re-
sected patients.
Method: Between January 1989 and July 2009 out of 439
patients with imaging studies suspected of HCH were
evaluated and only 36 (10 males and 26 females) were
resected (8.2%). The surgical indications were: pain
(52.8%); pain plus other symptoms and/or signs (30.5%);
uncertain diagnosis (13.9%) and spontaneous rupture
(2.8%). The imaging studies employed were: Ultraso-
nography (US) in all patients; US plus dynamic com-
puted tomography scan (CT-scan) in 94.4% and US plus
CT-scan plus magnetic resonance imaging in 16.7%. A
total of 15 hemangiectomies (41.7%) and 21 hepatecto-
mies (58.3%) were carried out.
Results: No postoperative mortality was observed and
the morbidity rate was 22.2%. Thorough follow-up was
achieved in all the resected patients and all of them re-
main symptoms free after surgery.
Conclusions: Surgical treatment is only indicated in a
select group of patients. The correlation between clinical
ﬁndings and the imaging studies obtained have to be
accurate. Resection therapy should accomplish complete
removal of the lesion while maximizing preservation of
the normal hepatic parenchyma. As HCH is a benign
liver tumor surgery must be done by HPB Surgeons with
no mortality and low morbidity rate.
P-002
DIFFERENTIATION BETWEEN FOCAL
NODULAR HYPERPLASIA AND
HEPATOCELLULAR ADENOMA; THE
DIFA-TRIAL
M. Bieze1, J. Van Den Esschert1, S. Phoa2, Y. Nio2,
U. Beuers3, O. Van Delden2, V. Terpstra4, R. Bennink5,
D. Gouma1 and T. Van Gulik1
1Department of Surgery, Academic Medical Center
Amsterdam; 2Department of Radiology, Academic
Medical Center Amsterdam; 3Department of Hepatology,
Academic Medical Center Amsterdam; 4Department of
Pathology, Academic Medical Center Amsterdam;
5Department of Nuclear Medicine, Academic Medical
Center Amsterdam
Background: Differentiating focal nodular hyperplasia
(FNH) from hepatocellular adenoma (HCA) is impor-
tant because of the therapeutic consequences. FNH can
be treated conservatively while HCA> 5 cm should be
resected because of the potential risk of bleeding and
malignant transformation. Diagnosis based solely on
imaging studies remains difﬁcult whereas the gold stan-
dard still is histological biopsy. Several imaging tech-
niques are available to characterize liver lesions, but no
large studies are available which clearly show us which
imaging modality can be used best to differentiate FNH
from HCA.
Objective: To assess the accuracy of the MRI with
Primovist, multiphase CT-scan, contrast enhanced
ultrasound and F18 ﬂuoromethylcholine PET/CT-scan,
in differentiating FNH from HCA.
Methods: Prospective clinical trial in a referral center.
The trial is supported by the local medical ethical com-
mittee. All patients, after informed consent, undergo a
multiphase CT scan, MRI with Primovist, PET scan
with ﬂuoromethylcholine and a contrast enhanced
ultrasound with guided liver biopsy. The diagnosis based
on the different imaging studies is compared with histo-
logical outcome (biopsy and/or resection specimen).
Conclusion: We introduce a prospective clinical trial, the
DiFA trial, to assess the accuracy of several imaging
modalities for the differentiation of FNH and HCA.
P-003
MAJOR HEPATIC RESECTIONS FOR
THE TREATMENT OF BILE DUCT
INJURIES
J. Pekolj, V. Ardiles, F. Bersano, R. Sanchez Claria´ and
E. de Santiban˜es
Hospital Italiano de Buenos Aires
Background: Hepatic resections are an infrequently
indication in the management of common bile duct injury
(CBDI). Usual indications for resection are irreversible
pathology generated by a vascular and/or biliary injury.
Objective: To analyse our series of mayor hepatic
resections to treat CBDI.
Methods: Retrospective review of a prospective collected
database of 213 patients with CBDI was treated between
January 1988 and August 2009.
Results: Eleven patients (5.1%) required mayor hepatic
resections. 4 were men, mean age was 41.9 (DS 16.6), 6
open surgery and 5 laparoscopic surgery were the causes
of the CBDI. Probable mechanism of the injury was:
ligatures in 3 patients, section in 2, and resection with
thermal injury in 2, burning in 2, and unknown mecha-
nism in 2. Five patients had associated arterial injury and
1 right portal injury. The median time between injury and
hepatic resection was 87.3 (SD136, min 2, max 408). 10
patients had previous surgeries (mean 1.9 (SD 1.1)).
Main indications to perform the hepatic resection were
unilateral intrahepatic stenosis with lobar atrophy in 3,
unilateral stenosis with failure of percutaneous treatment
in 3 and complex bile duct injury with associated arterial
lesion in 3. We performed 7 right hepatectomies and 4
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left. Mean operative time was 305 min (r: 270–360). Post-
operatory morbidity was 63% (2 grade I, 1 grade II and 3
grade IIIa). Mortality was nil. With a mean follow-up
was of 48.8 month (SD 44.7, r: 4–129) all patients are free
of symptoms.
Conclusions: Hepatic resection is an unusual but effective
treatment for complex CBDI with intrahepatic strictures
and/or lobar atrophy.
P-004
COMPLEX BILIARY CYSTIC LESIONS:
15 YEARS OF SURGICAL
MANAGEMENT
J. Pine, R. Kaddaba, A. Aldouri, R. Prasad, J. P. Lodge
and G. Toogood
Department of HPB Surgery, St James’s University
Hospital, Leeds, UK
Background: Biliary cystic tumors, such as cystadenoma
and cystadenocarcinoma, are rare cystic tumors of liver
accounting for fewer than 5% of all intra-hepatic cysts of
biliary origin. They have potential for malignant trans-
formation and therefore should be surgically excised.
Aim: To review our experience with these lesions to
determine if radiological appearance correlated sufﬁ-
ciently with histological diagnosis to warrant aggressive
surgical management.
Methods: Data were collected retrospectively from our
institutions radiological and surgical databases. Patients
who underwent surgical intervention for complex hepatic
cysts (septated and/or nodular on MRI) were identiﬁed
and their clinical records were reviewed.
Results: From October 1994 to December 2008 at our
institution, 36 patients had surgical intervention for
complex hepatic cystic lesion. The median age was 56
years at time of surgery. Complaints included abdominal
pain in 42%, abdominal distension in 17%, abdominal
mass in 11% and nausea/ vomiting in 11%. Four patients
presented with an incidental ﬁnding. All patients had
MRI scan for characterization of the hepatic cyst.
Deﬁnitive operative intervention consisted of hepatic
resection in 31 patients, and fenestration in 5 patients.
Histology conﬁrmed the diagnosis of biliary cystadeno-
ma in 12 patients, simple biliary cyst in 18 and malignant
cystic lesions in two cases. Another 2 patients had mes-
enchymal hamartoma. Follow up range from 7 to
78 months (median 16 months). Postoperative compli-
cations included bile leak in 3 cases, incisional herniae in
3 cases and recurrence in 6 cases.
Conclusion: Our data demonstrates that 50% of radio-
logically complex cysts were simple cysts on histology
whilst 38.9% where cystadenoma/cystadenocarcinoma.
Therefore our analysis suggests that an aggressive ap-
proach to complex cysts is justiﬁed.
P-005
AMOEBIC LIVER ABSCESS – REVIEW
OF 313 CASES FROM NORTH INDIA
A. K. Sarda, S. Neogi, N. Talwar, R. Mittal and
N. Malhotra
Maulana Azad Medical College
Background: Amoebiasis involves the liver in 3%-9%.
The treatment of amoebic liver abscess (ALA) has been
changed dramatically; however, aspiration with anti-
amebicidals of uncomplicated ALA is still not widely
accepted.
Aims: To study the effectiveness of early abscess drain-
age in improving outcome of the disease.
Methods: All patients were started on antiamoebic drugs
and a broad-spectrum antibiotic and in patients with
abscesses with volume > 400 mL, left lobe abscesses,
with abscesses < 400 mL size not responding clinically
to medical management within 48 hours or abscesses
with signs of pre-rupture drainage by USG guided aspi-
ration and, since 2005, pigtail insertion was carried out.
The abscess was considered cured when the patient re-
mained asymptomatic and there was no residual ﬂuid in
the cavity.
Results: Of the 313 patients with ALA, 217 were males,
the mean age was 37.4 years and 186 had history of
alcohol intake. In 250 patients the abscesses were solitary
(212 in the right lobe). The mean volume of the solitary
ALA was 302.9 ± 278.3 mL and in multiple ALA it was
219.4 ± 140.6 mL of the largest abscess. One hundred
and fourteen patients required drainage (22 ALA with
failed medical treatment); 41 cases had needle aspiration
and in 161 patients a pigtail was inserted. There were no
complications of the drainage procedure. The mean
hospital stay of the patients under the study was
13.6 ± 8.9 days (range: 5 to 57 days); the mean duration
of hospital stay in patients undergoing drainage proce-
dure was 10.7 ± 5.2 days.
Conclusion: In patients with uncomplicated ALA, com-
bination of aspiration with antiamebicidals improved
symptoms more rapidly and decreased the length of
hospital.
P-006
CENTRAL BILE DUCT INJURY
COMPLICATING PARTIAL LIVER
RESECTIONS: RISK FACTORS AND
IMPACT ON OUTCOME
E. A. Boonstra, M. T. De Boer, E. Sieders,
P. M. J. G. Peeters, K. P. De Jong, M. J. H. Slooff and
R. J. Porte
Department of Surgery, Division Hepatobiliary Surgery
and Liver Transplantation, University Medical Center
Groningen, University of Groningen, Groningen, the
Netherlands
Background: Bile duct injury in patients undergoing a
liver resection is a serious complication. Very few studies
have differentiated between leakage from small periph-
eral bile ducts at the parenchymal surface and central bile
duct injuries (CBDI), deﬁned as an injury leading to
leakage or stenosis of the common bile duct, common
hepatic duct, right or left hepatic duct.
Aim: To study the incidence, risk factors and conse-
quences of CBDI in liver resections.
Methods: A total of 462 patients undergoing a liver
resection were included in this study. Patients undergoing
resection for bile duct-related pathology, trauma, or after
liver transplantation were excluded. Characteristics and
outcome variables were prospectively collected.
Results: CBDI was observed in 19/462 patients (4.1%).
One third of the patients with CBDI required a surgical
reintervention and construction of a hepatico-jejunosto-
my. Overall one-year mortality rate was signiﬁcantly
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higher in patients with CBDI versus those who did not
(26.3% vs. 9.3%; P = 0.015). In univariate analysis,
resection type (P = 0.002), previous portal vein ligation
(P = 0.026), previous liver resection (P = 0.003) and
intra-operative blood loss (P = 0.002) were associated
with an increased risk of CBDI. After multivariate
analysis the only two variables that were identiﬁed as
independent risk factors for CBDI were previous liver
resection (P = 0.009) and extended left hemihepatecto-
my (P = 0.02).
Conclusion: Patients undergoing extended left hemihep-
atectomy or repeat liver resection are at increased risk of
developing CBDI. Conservative management is the
treatment of ﬁrst choice, but surgical repair and con-
struction of a hepatico-jejunostomy is needed in 10% of
the patients. In high risk procedures, surgeons must be
aware of the increased risk of CBDI and intra-operative
imaging of the biliary tree should be considered at a low
threshold in these patients.
P-007
HYDATID DISEASE OF LIVER: PAIR,
DRAIN OR RESECT?
N. Gupta, S. Kumar, S. Singh, S. Agarwal, H. H. Nag,
P. K. Mishra, S. Puri and A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Background: Treatment options for Hepatic Echinococ-
cosis include PAIR, Drainage & resection in form of
cystopericystectomy (CP).
Aim: To evaluate our experience of Hydatid cyst man-
agement.
Materials and methods: 136 patients of hydatid cyst of the
Liver managed during 2000–2009. M : F ratio was
0.5 : 1. Mean age was 39 years (11–62 years). Gharbi
type I and II were assessed by radiologist for PAIR.
Cysts unsuitable for PAIR were assessed for Cyst peri
cystectomy. Liver resection was preferred when cyst
occupied most of Liver lobe. Laparoscopic cystopericys-
tectomy / resection were considered in favorably located
cysts. In Cysts unsuitable for resection, drainage was
performed, preferably laparoscopic in recent years.
Results: Radiological treatment PAIR was successfully
performed in 42 of 52 patients. 26 hydatid cysts with
large cyst (> 8 cm) were subjected to percutaneous
alcohol ablation and catheter drainage. 94 patients were
taken up for surgical management. Various surgical
procedures performed on hydatid cyst like cystopericys-
tectomy (Laparoscopic/open) in 52/94), partial cystecto-
my in 10, drainage (23/94)- lap (8) or open (15), formal
liver resection (9/94)- laparoscopically in 3. Six were left
lateral, 2 left with caudate & 1 Right hepatectomy.
Indication for Drainage included proximity to major
vessels, underlying cirrhosis, pleural rupture.
Conclusion: In our series of 136 hepatic hydatid diseases,
PAIR was performed in 31% (42) & surgical manage-
ment in 69% (94) patients. Cystopericystectomy and
hepatectomy were performed in 64.9% (61/94), partial/
subtotal cystectomy in 10.6% (10/94) while drainage in
24.5% (23/94). The three treatment options for hydatid
cyst management ranging from PAIR to surgical (con-
servative and radical procedures) needs to be tailored,
with PAIR for type I and II Gharbi hydatid cysts and
cystopericystectomy as the surgical procedure of choice
and drainage (preferably laparoscopic) for unsuitable
cases.
P-008
COMPLEX HYDATID CYSTS OF THE
LIVER: A SINGLE CENTER’S EVOLVING
APPROACH TO SURGICAL TREATMENT
I. Botrugno1, S. Gruttadauria1, S. Li Petri1,
D. Cintorino1, M. Spada1, F. Di Francesco1, D. Pagano1,
F. Crin2, D. Anastasi1 and B. Gridelli1
1Department of Abdominal and Transplantation Surgery,
Mediterranean Institute for Transplantation and Advanced
Specialized Therapies (IsMeTT), Palermo; 2Department
of Radiology, Mediterranean Institute for Transplantation
and Advanced Specialized Therapies (IsMeTT), Palermo
In humans, approximately 75% of hydatid disease cases
involve the liver, 15% involve the lungs, and 10% involve
other organs. It is extremely rare to ﬁnd patients with
symptomatic hydatid disease of the liver presenting with
very large cysts that cause compression of the neighbor-
ing organs. The complex hydatid cysts include the giant
cysts of the liver as either cysts with a diameter ‡ 10 cm,
and complicated cyst as multiple, recurrent, abscessed
cysts, or those resistant to conservative treatment. We
retrospectively analyze a series of 38 consecutive patients
who underwent surgery for complex hydatid cysts, over a
period of 9 years, at the same institute, in order to
determine the evolution of the surgical treatment, and the
risk factors for recurrence. Fourteen (36.8%) of these
patients were women and 24 (63.2%) men (median age
48.1, range 16–71 years). The mean postoperative follow-
up was 24 ± 10.8 months. All patients were treated
prophylactically with albendazole (10 mg Kg-1day-1) for
15 days preoperatively, and for 2 months postopera-
tively. Partial cystectomy was performed in 2 cases
(5.26%) and radical pericystectomy in 20 cases (52.63%).
In the remaining 15 cases, the patients underwent liver
resection (39.47%): left hepatectomy was performed in 8
cases (21.05%), and right hepatectomy in 7 cases
(18.42%). In one case, both wedge resection and pericis-
tectomy were performed. There were no deaths and only
one patient (2.63%) showed signs of recurrence at follow-
up. Radical surgery is the most effective treatment for
complex hydatid cysts. In our experience, partial or total
pericystectomy virtually eliminated, over time, the need
for hepatic resection.
P-009
A MISSENSE TCF1 MUTATION IN A
PATIENTWITHMODY-3 DIABETES AND
LIVER ADENOMATOSIS
A. M. Lerario, L. P. Brito, B. M. Mariani,
M. C. Fragoso, B. B. Mendonc¸a, M. A. Machado and
A. R. Teixeira
University of Sa˜o Paulo-USP
Aims and hypothesis: Maturity-onset diabetes of the
young type 3 (MODY-3) is a non-ketotic form of dia-
betes mellitus with an autosomic dominant inheritance
caused by germline mutations of the TCF1 gene. Also,
somatic TCF1 mutations have been described in hepa-
tocellular adenomas, a benign liver neoplasm that usually
develops as a solitary nodule and has been associated to
oral contraceptives (OCs) use. Rarely, these hepatocel-
lular adenomas can be multiple and disseminated, a
condition known as liver adenomatosis (LA), which has
been described in sporadic and familial forms. The latter
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has been recently described in association with TCF1
germline mutations and MODY-3. In all of the cases, the
germline mutations described were nonsense or frame-
shift. Here, we report a case of LA in a patient with
MODY-3 associated to a missense germline TCF1
mutation. This patient had a 5-year history of OC use.
She underwent an extended right hepatectomy with total
vascular exclusion, since the bulky tumor was very close
to IVC. Methods: The coding sequence of the entire
TCF1 from peripheral blood and from a resected hepatic
nodule was ampliﬁed by PCR and directly sequenced.
Results: Sequencing analysis of TCF1 identiﬁed a germ-
line missense mutation (R263L) in peripheral blood. A
second (somatic) mutation (P291fsInC) was identiﬁed in
the hepatic nodule.
Conclusions/interpretation: This is the ﬁrst report of LA
associated to a missense germline TCF1 mutation in a
patient with MODY-3. OC should be used with care in
MODY-3 patients, considering these drugs may be a risk
factor for the development and/or progression of LA.
P-010
RECURRENT PYOGENIC CHOLANGITIS
– MANAGEMENT STRATEGIES &
OUTCOMES AT A TERTIARY REFERRAL
CENTRE
K. Raman, H. Singh, L. Kin Foong and
S. Sachithanandan
Selayang Hospital, Kuala Lumpur
Background: Recurrent pyogenic cholangitis (RPC) is a
clinical entity with diverse descriptions, pathogenesis and
clinical presentation. Management is complex and
fraught with high incidence of recurrent cholangitis.
Aim: To evaluate the effectiveness and outcomes of
management strategies of RPC at a tertiary referral centre.
Methods: One hundred ten patients with RPC who were
managed at Hospital Selayang, Kuala Lumpur between
January 2000 and June 2009 were studied retrospectively.
The results of the various procedures and long term
outcomes were analysed.
Results: 64.5% of patients presented with cholangitis.
Initial management included antimicrobial therapy and
biliary drainage. All patients were evaluated with CT
imaging & cholangiography. Ninety three patients (82%)
underwent surgery - 21 Roux-en-Y hepaticojejunosto-
mies and 62 hepatic resections with or without hepatico-
jejunostomies were performed. Five (5.4%) patients had
undiagnosed metastatic cholangiocarcinoma at the time
of surgery. Operative mortality was 2%. Eight patients
(7.2%) had endoscopic removal of the intrahepatic
stones by ERCP or choledochoscopy via a PTBD tract
while nine patients (8%) had advanced secondary biliary
cirrhosis. Mean follow-up was 36 (range 12–60) months.
80% of those who had hepatic resection and 65% of
those who had non-resectional surgery remained disease
free. 21% of patients developed recurrent cholangitis &
stones during the follow-up period.
Conclusions: No single therapeutic strategy is effective in
providing a long term cure for hepatolithiasis. The
management of each patient has to be individualised
depending on the site & extent of the stones and the
severity of secondary changes such as hepatic atrophy,
secondary biliary cirrhosis and structuring of the biliary
ductal system.
P-011
SURGICAL TREATMENT OF HYDATID
LIVER DISEASE AND ALVEOLAR
HYDATID LIVER DISEASE: STUDY
BASED ON THE DATA OF LITHUANIAN
ECHINOCOCCOSIS REGISTER
K. Strupas1, M. Paskonis1, J. Jurgaitis1, V. Sokolovas1,
A. Marcinkute2, A. Samuilis3, D. Rutkauskaite3,
A. Barakauskiene4, V. Brimiene1 and G. Brimas1
1Vilnius University Medical faculty, Clinic of
Gastroenterology, Urology and Abdominal Surgery,
Vilnius, Lithuania; 2National Tuberculosis and Infectious
Disease University hospital, Vilnius, Lithuania;
3Department of Radiology, Vilnius University Hospital
Santariskiu Klinikos, Vilnius, Lithuania; 4National Centre
of Pathology, Vilnius, Lithuania
Background: Surgery remains the main radical treatment
modality for hydatid disease or alveolar hydatid liver
disease. The short preoperative chemotherapy with me-
bendazole/albendazole as well as the postoperative che-
motherapy treatment according to guidelines of
European Echinococcosis register is very important for
prophylaxis of recurrences of liver echinococcosis.
Objective: This study is based on the data of Lithuanian
Echinococcosis Register which was founded in 2003 and
has tide relations with European Echinococcosis Regis-
ter.
Methods: In prospective study data were collected from
2003 06 to 2009 02. Totally 93 patients were included in
Lithuanian Echinococcosis Register. 26 cases of Echi-
nococcus granulosus (hydatid disease) and 67 cases of
Echinococcus multilocularis (alveolar hydatid disease).
In all cases diagnosis was obtained using serology test
(ELISA), radiological modalities (US, CT, MR) and in
rare cases - biopsy. Chemotherapy with mebendazole/
albendazole received all patients. Patients suitable for
operation chemotherapy received preoperatively and
postoperatively.
Results: From entire series, 38 (41%) patients were fea-
sible for radical operation. Two types of radical opera-
tions were performed: atypical resection or radical
hepatectomy. Others 55 (59%) received only palliative
treatment and chemotherapy or chemotherapy alone.
There were no operative and postoperative mortality in
the radically operated group. There were 6 (16%) post-
operative complications after radical operations.
16 (17%) patients dead during observation period. There
were no mortality and relapses after radical surgery.
Conclusion: Radical surgery with preoperative and
postoperative chemotherapy is the ﬁrst choice treatment
for hydatid disease and alveolar hydatid liver disease.
P-012
PARTICULARITIES IN THE
DISTRIBUTION OF ECHINOCOCCIASIS:
665 CASES ANALYSIS
A. Michalopoulos, V. Papadopoulos, T. Papavramidis,
S. Netta and G. Basdanis
AHEPA Hospital, Aristotle’s University Thessaloniki,
Greece
Background: Of all cysts in the liver, 50%–70% are
caused by Echinococcus. Most of these cysts are unique
and settle in the right lobe of the liver.
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Aim: The aim of the present study is to examine the
presence of a distribution pattern concerning hydatid cyst
localization in the liver parenchyma.
Material and Methods: This is a retrospective analysis of
665 patients operated for liver echinococciasis. There
were 284 males and 381 females. The mean age was
49.04 years. The localization of the cysts was conﬁrmed
intraoperatively.
Results: Of the 665 patient, 194 (29.17%) had multiple
echinococcal cysts located in both lobes. For the rest 471
patients the localization of the hepatic cysts was as fol-
lows: left lobe 94 (19.96), right lobe 377 (80.04%). Wo-
men were more affected by the disease in the earlier years.
Conclusions: From the observed differences in the
localization of the echinococcal cysts between the two
lobes, we can conclude that not only the difference of the
volume of the involved parenchyma plays a role, but also
other factors like blood ﬂow and sex.
P-013
PREDICTIVE MODEL OF BILIOCYSTIC
COMMUNICATION IN LIVER HYDATID
CYSTS USING CLASSIFICATION AND
REGRESSION TREE ANALYSIS
H. O. El Malki1,2,3, A. Benkabbou1, A. Souadka1,
R. Mohsine1, L. Ifrine1, R. Abouqal2,3 and A. Belkouchi1
1Surgery Departement ‘‘A’’ Ibn Sina Hospital, Rabat
Morocco; 2Medical Center of Clinical Trials and
Epidemiological Study (CRECET), Medical School,
University Mohammed Vth Souissi, Rabat, Morocco;
3Biostatical, Clinical Research and Epidemiological
Laboratory (LBRCE), Medical School, University
Mohammed Vth Souissi, Rabat, Morocco
Background and aims: Incidence of liver hydatid cyst
(LHC) rupture range from 15 to 40% of cases, and most
of them concern bile duct tree. Patients with biliocystic
communication (BCC) have speciﬁc clinic and thera-
peutic features. The purpose of this study was to deter-
mine patients with LHC that may develop BCC using
classiﬁcation and regression tree (CART) analysis.
Methods: A retrospective study of 672 patients with liver
hydatid cyst treated at the surgery department ‘‘A’’ at
Ibn Sina University Hospital, Rabat Morocco. Fourteen
risk factors for BCC occurrence were submitted into a
CART analysis to build an algorithm for a better pre-
diction of BCC occurrence.
Results: Incidence of BCC was 24.5%. Two high risk
Subgroups were deﬁned: ﬁrst one where patients having
jaundice associated to a thick pericyst, the risk was 73.2%.
The second subgroup containing patients with thick
pericyst, with no jaundice, 36.5 years-old and younger
with no past history of LHC, the risk was 40.5%. Our
developed CART model has sensitivity at 39.6%, speci-
ﬁcity at 93.3%, positive predictive value at 65.6%, and a
negative predictive value at 82.6% and accuracy at 80.1%.
Discriminating ability of the model was good 82%.
Conclusion: We developed a simple classiﬁcation tool to
identify LHC patients with high risk to have BCC. This
classiﬁcation tool identiﬁed patients during a routine
clinic visit (clinical history and ultrasonography). Pre-
dictive factors were based on pericyst aspect, jaundice,
age, past history of liver hydatidosis and morphological
Gharbi cyst aspect. This classiﬁcation will be useful for
an efﬁcient orientation of the patients to the appropriate
medical structures.
P-014
HEPATIC RESECTION FOR PYOGENIC
LIVER ABSCESS: NOT SO LEFT FIELD
J. Koea
Auckland Hospital, Private Bag 92024, Auckland, New
Zealand
Introduction: Pyogenic liver abscess (LA) is a common
condition and is usually managed by hepatobiliary sur-
geons. Historically LA has been managed with either
radiological or surgical drainage in addition to intravenous
antibiotic therapy, oftenwith prolonged hospital stays and
requiring multiple drainage procedures. We report a series
of patients managed with limited hepatic resection.
Methods: Outcome data on 28 consecutive patients pre-
senting with LA between 2002 and 2009 managed with
either percutaneous, radiologically guided drainage
(n = 17), open hepatic resection (n = 7), or laparo-
scopic liver resection (n = 4) was compared.
Results: All patients presented with signs of sepsis and
CT scan evidence of a pyogenic abscess. Amoebic serol-
ogy was negative in all patients and E coli (11 patients)
and S. milleri (6 patients) were the commonest infective
agents. Seventeen patients were managed with percuta-
neous, ultrasound guided drainage for abscesses affecting
segments 2/3 (3), 5 (4), 6 (3), 7 (5), 8 (2) and 4 patients
required secondary procedures (3 further drain place-
ments, 1 operative drainage). Seven patients were man-
aged with open, limited resection for abscesses affecting
segments 2/3 (4), 5 (2), 4 (1). No secondary procedures
were required while 4 patients underwent laparoscopic
resection for abscess affecting segments 2/3 (table 1).
There was no patient mortality and no signiﬁcant oper-
ative morbidity.
Table 1.
% Fall
c-reactive
protein
day 1 post
procedure
% Fall
white cell
count
day 1 post
procedure
20 Procedure
required
Median
hospital
stay
(range)
Perc drain 17% -15% 4 13 days (8–19)
Open resection 93% 78% 0 6 days (5–8)
Lap resection 91% 89% 0 4 days (3–6)
Conclusion: Limited hepatic resection, either open or
laparoscopic, can be undertaken safely for accessible LA.
Resection is a deﬁnitive treatment is associated with
rapid resolution of sepsis, normalization of inﬂammatory
markers, and early hospital discharge.
P-015
STRATEGIC ALTERNATIVES IN
HEPATIC HIDATID DISEASE
TREATMENT. A LESS AGGRESSIVE
ACTUAL APPROACH
G. Secondo, G. Sanchez, G. Massaferro, M. Moldes and
J. Rodriguez
Department of Surgery, Maciel Hospital. Surgical Clinic
‘‘2’’ from the Uruguayan State University, Montevideo,
Uruguay
Background: Since we presented, as Dr. Torterolo’s co-
workers in the 3rd World I.H.P.B. Congress (1998), an
amount of 218 patients, throughout 6 years in which we
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performed 95% cistoadventicial radical resections, on
our current work we present the last 5 years perspective
with 63 patients where the actual approach was less
invasive. Although it is commonly accepted that the total
cistoadventicectomy is the ideal treatment for the hepatic
hidatid disease, the morbidity and mortality could be
high in relation with other less invasive and equally
effective procedures. This has actually diminished the
total cistoadventicectomy procedures.
The goal for this study was compared with the actual
approach.
Objectives: We review a prospective database, with 63
identiﬁed patients who underwent Hepatic Hidatic Dis-
ease.
Methods: Complication data were entered into a vali-
dated postoperative complication database, morbidity
and mortality.
Results: Since 2005 we have treated 63 patients with
different procedures: Total and partial cistoadventicec-
tomy, percutaneous procedures, and treatment for the
main different complications like suppuration, intrabil-
iary rupture, thoracic transit and peritoneal spread.
The total mortality was 1.61%, with 1 dead in the
hepato-bronchial complication. We performed 43% of
Total cistoadventicectomy and in the other 57% the
procedures were different with good outcomes.
Conclusion: The hepatic hidatid disease is an endemic
pathology in Uruguay. The total cistoadventicectomy
remains as the ideal treatment for avoiding residual
cavity complications, but the less aggressive approach
can be equally effective in well selectioned cases.
P-016
TREATMENT OF PYOGENIC LIVER
ABSCESS: EXPERIENCE IN A SOUTH
EAST ASIAN TERTIARY CENTRE
K. F. Lim1, K. Raman1, H. Singh1 and R. Strong2
1Selayang Hospital; 2Princess Alexandra Hospital,
Brisbane
Background: Management of pyogenic liver abscess can
be a challenging HPB experience, particularly in com-
plicated abscesses, abscesses with underlying hepatobil-
iary disorders or which have failed non-operative
treatment. Not many studies have addressed current
experiences with this disease.
Objective: This study aims to present and review the
experience and results of a South East Asian tertiary
HPB surgical centre in managing pyogenic liver abscess,
in both operative and non-operative therapy.
Methods: A retrospective review was performed on all
patients with pyogenic liver abscess referred to the
Department of HPB Surgery in Selayang Hospital,
Malaysia from 2004 to 2008. The data was analysed
using SPSS for Windows.
Results: Of 103 patients treated, 66 had non-operative
therapy (percutaneous drainage and antibiotics) while 37
underwent hepatic resection. There is no statistical dif-
ference between the two groups in patient demographics,
age, sex, ethnicity, abscess location, comorbidities or
causative microbial organism. The operative treatment
group had a higher proportion of patients with multil-
oculated abscesses (81.1% vs. 39.4%) and also abscesses
of a biliary origin (21.6% vs. 6.1%). Overall mortality
rate was 1.9% (2 of 103). Mortality did not differ be-
tween the two groups. However, the failure rate and
double treatment rate were signiﬁcantly higher in the
non-operative group (13.5% vs. 0% and 14.9% vs. 0%),
as was the length of hospital stay (25.1 days vs. 8.3 days)
and the duration of antibiotic use (41.3 days vs.
10.0 days). Success rates were 85.1% (non-operative) and
100% (operative).
Discussion: The results show good treatment success
rates, in keeping with published experiences of centres
worldwide. It also highlights that there is a signiﬁcant
proportion of patients with complicated, multiloculated
abscesses and underlying biliary problems who would
beneﬁt from surgical resection, perhaps even as a ﬁrst-
line treatment option.
P-017
BENIGN LIVER TUMOURS (BLT) – IS
THERE A PLACE FOR HEPATIC
RESECTION?
S. Aroori1, C. Coldham1, J. Isaac1, A. D. Mayer1,
S. Oliff2, J. Buckels1 and D. F Mirza1
1Department of HPB and Liver Transplant Surgery,
Queen Elizabeth Hospital, Birmingham, United Kingdom;
2Department of Radiology, Queen Elizabeth Hospital,
Birmingham, United Kingdom
Background: Frequent imaging has resulted in an in-
creased identiﬁcation of liver lesions. Most do not require
treatment, unless symptomatic or if a diagnostic dilemma
exists. We analysed patients with BLT in the setting of a
busy tertiary liver cancer service.
Material and methods: Of 4010 referrals (1988-8/2009)
with liver lesions, BLT were diagnosed in 595 patients
(median age 58 years, 509 females) comprising the fol-
lowing: haemangioma (n = 170), focal nodular hyper-
plasia (FNH, n = 98), liver cell adenoma (LCA,
n = 71), biliary cystadenoma (BCA, n = 26), and liver
cysts (LC, n = 230). Of these, 134 (22.5%, 130 open, 4
laparoscopic, females 98, median age 43, 18–77 years)
underwent resection. This prospective data was analysed
for indications for surgery, resection rates, and correla-
tion with pre-operative diagnosis.
Results: Indications for resection were: suspected malig-
nancy in 61 (46%, colorectal metastases 18, hepatoma 11,
cholangiocarcinoma 5, other malignancy 27), spontane-
ous rupture in 12 and abdominal pain in 5 patients.
Procedures included: hemi-hepatectomy (n = 64, 48%),
extended hepatectomy (n = 16, 12%), left lateral hepa-
tectomy (n = 25, 19%), and segmental/non anatomical
resections (n = 29, 22%). The median hospital stay was
11 (range: 3–58) days. Post-operative mortality was 1.5%
(n = 2) and morbidity was 15% (n = 20). The histo-
pathological diagnosis was haemangioma in 37 (27%),
FNH in 24 (18%), LCA in 28 (21%), BCA in 14 (10.5%),
LC in 10 (6%), pseudotumours in 6 (4.4%), and others in
15 (13%). At 26.6 (0.5–154.4) months median follow-up,
125 patients are alive/well.
Conclusions: BLTs are common and seen on investiga-
tions performed for non-speciﬁc symptoms. A minority
of these require resection usually for haemorrhage or for
a preoperative diagnosis of suspected cancer.
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P-018
INFLAMATORY HEPATIC
PSEUDOTUMOR: AN INFREQUENT
PATHOLOGY
R. Sanchez Claria, C. Salas, G. Morricone, F. Bersano,
D. Fernandez, M. Palavecino, O. Mazza, J. Pekolj and
E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: The inﬂammatory hepatic pseudotumor
(IPT) is a rare benign infrequent lesion with very few
reported cases in the literature.
Patients with IPT commonly have symptoms and labo-
ratory ﬁndings suggestive of inﬂammation, but a deﬁn-
itive diagnosis is often difﬁcult to establish in the absence
of clinical abnormalities.
Objective: To review the current management options in
inﬂammatory pseudotumor via analysis of nine cases
from an referral center which has a large number of pa-
tients undergoing hepato-bilio-pancreatic surgery.
Material and method: From January 1980 to December
2003, 1070 hepatectomies were performed, 9 of them
were performed in order to treat IHP. The average age of
these patients was 40 years (r 6–66).
Results: The most common clinical expression of the
pathology was abdominal pain and fever. These patients
showed a high sedimentation rate and negative tumor
markers.
6 right and 3 left hepatectomies were performed. The
average size of the tumors was 10 cm (r 5–19). When
macroscopically examined, the tumors seemed to be
malignant, with areas of haemorrhagic necrosis. The
pathology reports diagnosed IHP in all the 9 cases. The
morbility was 22%. One of the patients (11%) died due
to post surgery complications. Two patients died long
after surgery: one due to a lymphoma, 7 years after
surgery, and the other one due to a gastric cancer 3 years
after surgery. The other 6 patients are still alive, one of
them with tumoral recurrence but responding well to a
treatment with corticoids.
Conclusions: It is largely a self-limiting entity and has
favorable prognosis; it is thus important to preoperatively
distinguish this lesion from malignancy, but the low
indices of suspicion prior to surgery and the limitations
within complementary methods sum up to the fact that
the diagnosis is often made through surgical resection.
P-019
SURGICAL MANAGEMENT OF
CAROLI’S DISEASE AND SYNDROME:
A SINGLE CENTRE EXPERIENCE
G. Morris-Stiff, D. Vogt, J. M. Henderson, J. J. Fung
and C. Miller
Departments of Hepato-Pancreato-Biliary and Transplant
Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
Background: Caroli’s disease is a rare congenital condi-
tion characterised by non-obstructive dilatation of larger
intrahepatic ducts. In Caroli’s syndrome there is associ-
ated congenital hepatic ﬁbrosis and in addition cystic
renal disease may occur.
Aims: To review a single centre experience with the
management of these conditions.
Methods: The histopathology database was accessed to
identify patients with Caroli’s disease/syndrome. The
mode of presentation, type of resection, surgical pathol-
ogy and follow-up was noted. The presence of extra-he-
patic manifestations of the syndrome was recorded.
Results: Eight patients were identiﬁed, 7 males and 1
female, with a mean age of 44.3 ± 19 years. Final
pathological diagnoses included 5 cases of disease and 3
of syndrome. Of those with Caroli’s disease, presentation
included: deranged liver function (n = 1); cholangitis
(n = 1); cholangiocarcinoma [CCA] (n = 1); pain
(n = 1); and incidental in a transplant work-up for
Hepatitis C cirrhosis [HCV] (n = 1.). Four underwent
resection and the HCV patient transplantation. 1 patient
subsequently underwent transplantation for recurrent
cholangitis due to anastomotic stricture. Of 3 patients
with Caroli’s syndrome, 1 had polycystic kidney disease
and was diagnosed on follow-up of renal disease and the
remaining 2 were asymptomatic being diagnosed during
work-up of cirrhosis. 2 patients died during follow-up at
26.2 and 7.8 months, those with CCA at presentation
(recurrence) and HCV (liver failure) respectively. The
median survival of the remaining patients was
30.1 months (range: 1.7–66.1). The patient who under-
went transplantation following resection had a CCA in
the resection specimen. The remaining patients have been
asymptomatic during follow-up.
Conclusions: Caroli’s disease/syndrome has a varied
presentation with CCA being a risk. Most individuals
with Caroli’s may be adequately treated by resection but
transplantation is required for the syndrome due to the
associated hepatic ﬁbrosis.
P-020
SURGICAL TREATMENT OF LIVER
HYDATID CYSTS: A CHALLENGING
EXPERIENCE FROM A NON-ENDEMIC
COUNTRY
A. Begin, S. Ismail, F. Vandenbroucke-Menu,
R. Letourneau, M. Plasse, A. Roy, M. Dagenais and
R. Lapointe
Unit of Hepatobiliary Surgery and Liver transplantation -
Hopital Saint Luc - CHUM - Montreal, Qc
Background: Hydatid cyst is a rare infectious liver dis-
ease in North American countries. Its management is a
considerable challenge, considering its rarity and ten-
dency to recur. There is still a debate about conservative
surgery as opposed to radical surgery in which the cyst is
totally removed by either pericystectomy or liver resec-
tion.
Objective: The aim of this study was to review the results
of surgery obtained in a country outside the endemic
area.
Methods: This retrospective study over a twenty-year
period (1988–2008) included 33 patients (20 males, 13
females) with a mean age of 43. Surgical treatment was
performed in a tertiary medical center. Clinical presen-
tation, investigation, management and long term follow
up were evaluated.
Results: Twenty-six patients (78.8%) were immigrants
from endemic countries, and 7 originating from Quebec
(21.2%). Twenty-ﬁve patients (75.8%) were symptom-
atic. The investigations included: ultrasound in 24 pa-
tients (84.8%), abdominal CT-Scan in 31 (93.9%) and
MRI in 16 (48.5%). Cysts were mainly located in the
right lobe (48.5%) and mostly solitary in 2/3 of cases.
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The average cyst size was 9.04 cm (1–23 cm). Treatment
was a radical surgery in 22 cases (66.7%) with 7 minor
and 15 major liver resections, a conservative surgery in 8
(5 marsupialisations and 3 external drainages) and a
combined surgery for bilateral disease in 3 with liver
resection and marsupialisation. There was no operative
mortality and major complications observed in 5 patients
(4 bile leaks and 1 subphrenic abscess). Albendazole was
given perioperative in 91% of patients. Mean follow-up
time was 35.6 months with recurrence in 3 cases in the
conservative surgery group at 4, 9 and 12 months.
Conclusion: The management of liver hydatid cyst is a
challenging experience in our hands. Liver resection
combined with perioperative albendazole should be
considered whenever it is feasible because of a higher risk
of recurrence with conservative surgery.
P-021
TRENDS IN TREATMENT OF HYDATID
DISEASE IN THE NETHERLANDS
H. M. B. Stoot Jan1,2, R. J. S. Coelen1, I. Limantoro1,
L. Kortbeek3, A. De Bruine4 and C. H. C. Dejong1,5
1Department of Surgery, Maastricht University Medical
Centre, Maastricht, the Netherlands; 2Department of
Surgery, Orbis Medical Centre, Sittard, the Netherlands;
3RIVM, The national institute for Public Health and the
Environment, Bilthoven, The Netherlands; 4Department of
Pathology, Viecurie Hospital, Venlo, the Netherlands;
5Department of Surgery, NUTRIM School for Nutrition,
Metabolism and Toxicology, Maastricht University
Medical Centre, Maastricht, the Netherlands
Background: Human cystic echinococcosis remains en-
demic in the world but is almost always imported in the
Netherlands. Up till now, no reliable incidence and
prevalence numbers are available, nor is there any con-
sensus about the best treatment.
Objectives: To explore the opinions of experts concern-
ing treatment of hepatic echinococcosis in a low endemic
country like the Netherlands.
Methods: A questionnaire concerning incidence, diag-
nosis, therapy and follow-up, was sent to gastro-intesti-
nal surgeons in 20 hepato-pancreato-biliary centres in
The Netherlands to get an overview of their opinions on
echinococcosis. Secondly, the national database of
pathology (PALGA), containing all individual reports of
resected specimens, was investigated and compared with
results from serological testing.
Results: Seventeen (85%) of twenty hospitals responded
to the questionnaire. Seven (41%) centres stated they had
treated hydatid disease of the liver. Six (86%) of them
saw one to ﬁve patients per year. Diagnosis was in most
cases based on clinical criteria, computed tomography
and serology. ELISA was used to conﬁrm the diagnosis.
Four (57%) of seven hospitals followed a protocol for the
treatment of hydatid liver disease. Primary treatment
strategy varied between the hospitals. The mean inci-
dence of echinococcosis decreased from 2002 onwards, to
an incidence to 33 patients/year. Moreover, a decrease
was seen in the amount of resected specimens from 2003
onwards.
Conclusion: The incidence of hydatid disease in the
Netherlands is decreasing in the last decade. Since this
remains a rare disease in non-endemic areas and primary
treatment strategy differs between specialised centres, a
guideline might improve the uniformity in treatments.
P-022
LIVER RESECTION FOR POLYCYSTIC
NEOTROPICAL ECHINOCOCCOSIS.
INITIAL EXPERIENCE IN BRAZILIAN
EASTERN AMAZONIA
A. Rodrigues1,2, P. Soares1, L. N. Moura1,
A. Magalha˜es1, I. Lima1, R. Sousa1, L. Meguins3 and
M. Soares4
1Hospital Ophir Loyola; 2Hospital de Clı´nicas Gaspar
Vianna; 3Universidade Federal do Para´; 4Instituto
Evandro Chagas. Bele´m, Para´, Brazil
Introduction: The hepatic polycystic Neotropical echi-
nococcosis (HPNE) is an emerging infectious disease in
the Brazilian Amazonia.
Aim: The aim is to describe and evaluate the initial
experience of the surgical treatment of HPNE. Methods:
We evaluated the reports of patients with HPNE
surgically treated. We assigned the data of the patients
according to the place of living, age, gender, initial
diagnosis, clinical staging (according to the classiﬁca-
tion of Kern et al.), and type of surgery performed, pos-
operative complications and disease free survival.
Results: From May 2006 to June 2009, seven patients
underwent surgery for the treatment of HPNE; ﬁve of
them were from the countryside of the state of Para´,
Brazil; ﬁve of them were female; the mean age was
60 years-old (47–77); four of them had as initial diagnosis
liver cancer. According to the classiﬁcation of Kern et
al., two patients were classiﬁed as stage I, four as III b
and one as IV. According to the surgical procedure
performed, one patient underwent left hepatectomy, one
underwent bis segmentectomy of the III and IV, one
underwent enucleation, one left lateral segmentectomy,
one left lateral segmentectomy plus peritoneal cyst
resection, one underwent segmentectomy of the III and
one underwent segmentectomy of the V. Pos-operative
complications were note in two patients: one evolved
hepatic failure and died at the ﬁfth pos-operative day and
one evolved subphrenic abscess due to biliary leakage ten
months after surgery and was treated with percutaneous
drainage and endoscopic papilotomy. After a follow up
ranging from 30 days to 2, 5 years, six patients are in
good clinical conditions and free of disease (no recur-
rence was noted so far).
Conclusion: The surgical treatment of HPNE is effective
and allows a disease free survival during a medium per-
iod of follow up. However, liver transplantation may be
considered as an alternative approach.
P-023
HEPATECTOMY FOR BENIGN LESIONS
OF THE LIVER
V. Velayutham, J. Sathyanesan, S. Ramaswami,
P. G.santhanam, J. Damodaran, S. Eswaran,
R. Palaniappan, G. Rajarathinam and S. Rajagopal
Department of surgical gastroenterology, Government
Stanley Medical College Hospital, Chennai, India
Background and aims: Benign lesions of the liver are
increasingly being diagnosed and continue to represent a
management challenge. Benign tumors and certain other
benign conditions constitute a substantial component of
hepatic neoplasms evaluated and resected at a tertiary
referral center. We reviewed our experience with resec-
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tion for benign liver lesions (that included benign tumors
and certain other benign conditions) to clarify the safety
and effectiveness of this treatment and also to assess the
long-term results of partial liver resections for benign
liver lesions.
Methods: Between January 1998 and January 2009, 45
patients with benign hepatic lesions were identiﬁed from
a cohort of 448 hepatic resection patients. Demographic
characteristics, operative management, morbidity, mor-
tality and follow-up were retrospectively analyzed.
Results: The mean age in our patients was 38 years [10–
66 years]. The most common presenting symptom was
abdominal pain in 32/45 (71%). The indications for
resection were suspicion of malignancy - 27/45 (60%),
Haemobilia 4/45 (8%), Bronchobiliary ﬁstula – 1/45
(2%), Complications (Intratumoral bleeding, impending
rupture and rupture) – 6, potential for malignant change
– 7.The distribution of pathology in case of benign tu-
mors was haemangioma 19/45 (42%), adenoma 10/45
(22%), benign ﬁbrous tumour 2/45 (4%), mesenchymal
tumour – 1/45 (2%) and FNH 6/45 (13%). Mean length
of stay was 12 days (range 8-46 d). Complications were
encountered in 6 patients there was no mortality in this
series. Follow-up ranged from 6 months to 10 years.
Conclusion: The management of clinically relevant be-
nign conditions of the liver comprises a signiﬁcant pro-
portion of our resectional practice. Our data suggests
that anatomically based resections can be performed
safely in these patients with no mortality and minimal
morbidity. Resection of these lesions was highly effective
in long-term relief of symptoms.
P-024
MANAGEMENT HEPATIC
HEMANGIOMAS (OURS EXPERIENCE)
F. Bersano, G. Moriconi, V. Ardiles, N. Bucich, C. Salas,
R. Sanchez Claria, E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Hepatic hemangiomas are the most com-
mon benign mesenchymal hepatic tumours. Hemangio-
mas are often solitary, but multiple lesions may be
present in both the right and left lobe of the liver in up to
40 percent of patient. They range in size from a few
millimeters to over 20 cm. Most patients with hepatic
hemangiomas are asymptomatic and have an excellent
prognosis. The aim of this study was to evaluate the
management hepatic hemangiomas.
Methods: Between June 2000 and June 2009, a total of
256 patients with hepatic hemangiomas were retrospec-
tively reviewed.
Results: The sex ratio was F/M = 188/68 with a mean
age of 44 years (range 2–81). Diagnosis was performed
whit ultrasound and MDCT (208 patients), MRI (48
patients). Asymptomatic patients 174 (68%) can be ob-
served, and Symptomatic patient 82 (32%) underwent
hepatic resection.
The type hepatic resection were enucleation (63 patients),
liver resections (17 patients; right hepatectomy 9, left
hepatectomy 3, left lateral segmentectomy 5), Radiofre-
quency (1 patient), and liver transplantation (1 patient).
The morbility rate was 20% (51 patients) and there was
no mortality.
Conclusion: In the absence of symptoms, the risk of
bleeding is too low to justify prophylactic resection.
Patients who have pain or symptoms suggestive of
extrinsic compression of adjacent structures and when
the nature of the liver lesion is doubtful; should be con-
sidered for surgical resection. Liver resections for benign
hepatic lesion performed in specialized centers are safe
and efﬁcient, with low morbidity and mortality.
P-025
SURGICAL TREATMENT OF LIVER
CYST WITH BILIARY FISTULA
Y. Shindo, H. Andoh, Y. Tanaka, Y. Saito, A. Hattori,
K. Fukuda, T. Takahashi, N. Yokoyama and
M. Nakamura
Nakadori General Hosipital/Gastrointestinal Surgery;
Ogachi Chuo Hospital/Gastrointestinal Surgery
Background: When the patient with liver cyst (LC) has
sometimes anorexia, abdominal pain, something symp-
tom with LC, any treatment should be necessary for these
patients. Treatment of LC is often performed the per-
cutaneous transhepatic cyst drainage or surgical treat-
ment. But surgical treatment is best treatment to LC with
connection to biliary tract.
Methods: At our hospital, 14 patients were performed
surgical treatment for LC from January 2004 to Sep-
tember 2009. Patients proﬁles were Male/Female: 3/11,
average age 65.4 years old (range46–78), simple LC/
multiple LC: 9/5, average diameter of cyst (max) 13.8 cm
(range5–25). We think that standard therapy for LC is
fenestration but intraoperative cystography or cholangi-
ography or cholangioscopy are necessary.
Results: Two patients among nine patients had the cyst-
biliary ﬁstula. Twelve patients were performed fenestra-
tion (Laparo/Open: 10/2) of LC. One patient was
performed cyst-jejunostomy and one patient was per-
formed fenestration with simple closure to ﬁstula because
of cyst-bilal ﬁstula. Average operation time was 180 min
(range100–324). Cyst-jejunostomy case was recognized
connection to the bile duct by cholangiography. So we
selected cyst-jejunostomy or simle closure of ﬁstula with
fenestration not fenestration only.
Conclusions: Intraoperative cystography or cholangiog-
raphy or cholangioscopy was necessary at operation of
liver cyst, because of the presence of the patients with the
cyst-biliary ﬁstula, and cyst-jejunostomy was effective for
those patients.
P-026
LIVER TRAUMA MANAGEMENT: OUR
EXPERIENCE
E. Colangelo, A. Ricci, M. Basti, M. Nardi,
E. Monteferrante, E. Liberatore, N. Pitrelli and
G. Colecchia
Department of Surgery III unit general surgery Spirito
Santo Hospital Pescara Italy
Background: For the patients hemodynamically stable
the non operative management (NOM) is the treatment
of choice with 70\80% rate. High grade liver injuries with
hemodynamic instability requires immediate surgery.
Materials and methods: We reviewed retrospectively 59
patients with blunt liver trauma managed in our unit
from 1999 to 2009 (tertiary centre for emergency).
Results: Forty-eight (81%) patients were treated non
operatively for hemodynamic stability with low grade
injury (LJS 1–2) and only 2 with high grade injury (LJS
3). All of these had an uneventful course with an average
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discharge of 12 days. 11 (11.6%) patients were operated
immediately for hemodynamic instability and high LJS
(3–4) .5 of these with associate intraabdominal injuries (3
spleen and 2 kidney+spleen). 6 patients were treated
with hemostatic matrix (Floseal) on the liver lacerated
surface, 3 with liver resection and 2 with perihepatic
packing. 3 patients died but of which one for concomi-
tant head injury.
Conclusions: In the absence of hemodynamic instability
and others abdominal injuries the non operative man-
agement is the treatment of choice with surveillance in
the intensive care unit. Immediate laparotomy is man-
datory for instable patients and for those with complex
intraabdominal injuries.
P-027
A CASE OF PERCUTANEOUS DRAINAGE
IN A GAS-FORMING PYOGENIC LIVER
ABSCESS: IT IS SURGERY NECESSARY?
F. Pereira, Y. Venales, A. Salazar and L. Lapadula
Unidad de cirugı´a de mı´nimo acceso. Hospital universitario
‘‘DAr. Luı´s razetti’’
Background: In diabetic patients, the gas-forming pyo-
genic liver abscess (PLA) is considered a surgical urgency
due to their reserved prognosis. Frequently, the surgical
drainage (open or laparoscopic) is employed, however
some complications are observed.
Objective(s): To describe the technique employed and
the results obtained with the percutaneous drainage of a
gas-forming PLA.
Methods: We describe and illustrate the clinical case of a
male, diabetic type-2 patient, who complains of fever, a
mass and pain in the right upper quadrant. The X-Ray,
the abdominal ultrasound and the abdominal computed
tomography demonstrated a gas-forming abscess into the
liver. The percutaneous drainage was employed as min-
imally access surgical strategy, obtaining 1300 cc of a
purulent ﬂuid. The pus culture was positive for Klebsiella
pneumoniae.
Results: The clinical course was satisfactory. The patient
was discharged on the 4th day post-drainage. There was
not associated morbidity and the patient was highly
satisﬁed with the outcome. During the follow-up (6-
months), he has been normal.
Conclusion: In this patient, the percutaneous drainage of
a gas-forming PLA results an adequate therapeutic op-
tion, without associated morbidity. In this case, the sur-
gical drainage was not necessary.
P-028
GIANT HEPATIC HEMANGIOMA:
REPORT OF 4 CASES SUCCESSFUL
OPERATIONS
V. Carrillo-Maciel, J. E. Carrillo-Maciel, A. L. Acosta-
Saludado, J. A. Leal-Martinez, S. Ramos-Linaje,
D. E. Fernandez-Madinaveitia, O. M. Solorzano-Pineda,
M. Sanchez and Y. Jaramillo
Social Security # 71, Torreon, Coah, Mexico
Background: The hepatic hemangioma is the most com-
mon benign liver tumor is a true angioma, characterized
by hyperplasia of blood vascular tissue. Frerich told this
in 1861 in ‘A Clinical Treatise on Disease of the Liver’.
When 4 inches in diameter or more are are considered
giants, the incidence is 0.4 to 7.3%. Of mesenchymal
origin are asymptomatic and nonspeciﬁc symptoms In
1954 Kasabach and Merritt described the Kasabach-
Merritt syndrome. On physical examination a palpable
liver tumor, sometimes collects a breath at the heman-
gioma. For image are hyperechoic lesions, hypo dense
and well deﬁned. In the selective abdominal arteriogra-
phy, there are the hepatic arteries, hepatic veins, portal
displaced by the hemangioma, after 2 to 3 seconds.
Injection of contrast material, there are dense patches
and its appearance is ﬂuffy like cotton bud. The density
increases from 8 to 12 sec. A radiopaque image is visible
even 25 or 30 seconds.
The ideal treatment is surgical removal, Pfannenstiel in
1898, mentioned that the selection of surgical technique
for resection should be considered: the volume of the
lesion, anatomic location and surgeon experience.
Objective: To report 4 cases of giant hepatic hemangi-
oma successfully operated in the past 10 years in High
Specialty Hospital of Torreon, Mexico.
Material and methods: We report epidemiological, study,
management and surgical procedure used in the resolu-
tion of 4 cases.
Conclusions: The study and treatment of such patients
should be in highly specialized hospitals and by surgeons
experienced in liver surgery.
P-029
LAPAROSCOPIC RESECTION OF LIVER
ANGIOMYOLIPOMA
J.-M. Ramia, R. De La Plaza, M. D. Sanchez-
Tembleque, J. Quin˜ones, P. Veguillas, F. Ruiz,
A. Caminoa and J. Garcia-Parren˜o
Hospital Universitario de Guadalajara
Introduction: Liver angiomyolipoma (AML) is an
unfrequent benign mesenchymal neoplasm of the liver.
To date, only 200 AML have been reported. The tumor
consists of 3 components: smooth muscle cells, adipose
tissue and vessels. HMB45 positivity is always present.
The etiology is unknown. Some authors include AML in
PEComa family. We present a liver AML treated by
laparoscopic liver resection and discuss etiology, diag-
nostic methods and treatments options.
Case report: A 66 years-old male came to our depart-
ment due to severe epigastric pain. Clinical examination
and blood analysis were normal. The patient had no
remarkable past medical history. In abdominal US and
CT a 5 cm mass was detected between segment II and III.
Radiological diagnosis was liver AML. No other masses
were present in kidney or lung. Due to symptoms, a three
port atypical laparoscopic left lateral sectionectomy was
performed. Postoperative course was uneventful and was
discharged on second postoperative day. Histology: non
encapsulated mesenchymal lesion with several tissues
(adipose, vascular, muscle) there were HMB45 positive
epithelioid cells around vessels. Immunohistochemistry:
AE1-AEÆ3, CD117 negative, s-100, HMB45, desmin and
actin positive. No relapse has been detected in follow up.
Conclusions: Liver AML is unfrequent benign liver tu-
mor. Although conservative treatment is adequate,
resection could be recommended when symptoms are
present or the diagnosis is not clear. Besides, a few
malignant cases have been described. Laparoscopic
resection is the best option for benign tumors especially
in peripheral locations.
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P-030
A RARE CAUSE OF LIVER ABSCESS
R. Bessa De melo1,2, A. Pinho1,2, C. Paredes1,2,
A. Gouveia2,3, J. Costa-Maia1,2 and A. Pimenta2,4
1Unidade de Cirurgia Hepato-Bilio-Pancreatica, Servico
de Cirurgia Geral, Hospital de Sao Joao – Porto;
2Faculdade de Medicina da Universidade do Porto;
3Unidade de Cirurgia Esofago Gastrica, Servico de
Cirurgia Geral, Hospital de Sao Joao – Porto; 4Servico de
Cirurgia Geral, Hospital de Sao Joao - Porto
Introduction: Gastrointestinal stromal tumors (GIST)
represent less than 1% of all tumors of the digestive tract
and are located most often in the stomach (60–70%).
They usually present with abdominal pain, gastrointes-
tinal bleeding, or palpable mass, 10–30% of cases being
asymptomatic. Invasion of adjacent structures may cause
atypical presentations.
Case report: Forty-nine year-old male, previously heal-
thy, without infectious epidemiological risk factors pre-
sents at Hospital with 12 day-evolution fever (39.5C)
responding to antipyretics, with no accompanying
symptoms. Laboratory tests showed leukocytosis with
neutrophilia and elevated C-reactive protein. Abdominal
ultrasonography revealed a hypoechoic heterogeneous
mass in the left hepatic lobe. CT scan was suggestive of
an 8 cm liver abscess. Percutaneous drainage was per-
formed. In control CT the image of the abscess remained
unchanged and a gastric ﬁstula was suspected. Gastros-
copy conﬁrmed the ﬁstula and showed a submucosal
gastric tumor.
The patient was proposed for surgical exploration. At
operation a 10 cm tumor depending on the lesser gastric
curvature/posterior surface, with extension/invasion of
hepatic segments II and III was found. A Bilroth type II
distal gastrectomy and en-bloc liver bisegmentectomy (II/
III) were performed. Pathology revealed a high risk
gastric GIST (pT2bN0MxR0) with liver abscess and
ﬁstulization due to intratumoral necrosis. The patient
was discharged at day 6, after an uneventful post-
operative course.
Conclusion: The preoperative diagnosis of GIST is
challenging, especially when manifested by atypical
symptoms related to invasion of adjacent structures. A
multidisciplinary involvement in diagnosis, treatment
and follow-up of GIST patients is of paramount impor-
tance.
P-031
CAROLI’S DISEASE WITH
INTRAHEPATIC STONES: A CASE
REPORT
C. Yere´n, E. Cordero, O. Becerra, V. H. Torres and
E. Anchante
Hepatobiliary Service Department of Surgery Guillermo
Almenara Hospital. EsSalud Lima-Peru´
Background: Caroli’s disease is a rare congenital
pathology of the liver characterized by cystic dilation of
the intrahepatic bile duct. The disease may diffusely af-
fect the entire liver or be localized to one lobe or segment.
Less than 20% of all reported cases of Caroli’s disease
are monolobar type. Surgical resection has been used
successfully in patients with monolobar disease. We re-
port a case of simple type Caroli’s disease with intrahe-
patic lithiasis conﬁned to left lobe of the liver in a 41-
year-old man.
Material and methods: A 41-year-old man was admitted
to our hospital with sepsis for acute cholangitis for about
seven days. The patient had undergone a choledochoto-
my and T tube drainage in 2002 and choledochojejun-
ostomy in 2008 by common duct stones and cholangitis.
Also two endoscopic sphincteroplasty procedures in 2003
and 2006 years.
Results: On the admission his laboratory values showed
elevated white blood count, liver function tests with
cholestatic patron, viral hepatitis serology and Ca 19-9
were negatives. CT scan and percutaneous transhepatic
cholangiography revealed marked left bile duct dilatation
After control de acute episode with ceftriaxone and met-
ronidazole. The treatment used was segmentectomy II
and III of the liver. Macroscopic examination of the
resected specimen revealed cystic dilatation of the intra-
hepatic bile ducts and intrahepatic lithiasis. Histologically
there was dilated bile duct and no evidence of malignancy.
Conclusion: Liver resection is the treatment of choice for
Caroli’s disease conﬁned to a single lobe or segment,
eliminating the potential risk for lithiasis, cholangitis and
carcinoma. This congenital entity, despite its rarity must
be considered in the circumstances described.
P-032
LONG-TERM OUTCOME OF PATIENTS
WITH INTERMEDIATE
HEPATOCELLULAR CARCINOMA.
WHERE IS THE ROLE OF LIVER
RESECTION?
G. Sapisochin1, C. Dopazo1, E. Ferna´ndez De Sevilla1,
R. Rodriguez1, L. Blanco1, L. Caralt1, L. Castells2,
H. Allende3, J. Balsells1, I. Bilbao1 and R. Charco1
1HBP Surgery & Transplantation Department, Hospital
Universitario Vall d¢Hebron, Barcelona, Spain;
2Hepatology Department, Internal Medicine Department,
Hospital Universitario Vall d¢Hebron, Barcelona. Spain;
3Pathology Department, Hospital Universitario Vall
d¢Hebron, Barcelona, Spain
Background: According BCLC staging, arterial chemo-
embolization is the treatment of choice in patients with
hepatocellular carcinoma (HCC) in intermediate stage.
However, liver resection (LR) could play a role in this
stage.
Aims: To study the feasibility and beneﬁt of LR for
intermediate HCC.
Material and methods: From 1988 to 2008, 146 cirrhotic
patients underwent LR owing HCC at our department.
Of these, 47 (32%) had a preoperative single tumor
> 5 cm or multiple tumors > 3 cm.
Surgical criteria: Non-decompensated liver cirrhosis, no
portal hypertension, good performance status and tech-
nically feasible. We performed a retrospective study of
our prospective database. Median follow up was
35 months (r: 1–191).
Results: Median age of patients was 67 years (r: 30–84)
and 96% were male.
Major hepatectomy was performed in 49% of cases with
postoperative mortality and morbidity of 4.3% and 38%,
respectively. Median survival was 35 months (r: 1–191).
Actuarial patient survival at 1-, 3- and 5-years was 79%,
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50% and 32%, respectively. Recurrence was observed in
83% of patients, however disease-free survival at 1-, 3-
and 5-years was 67%, 20% and 15%, respectively.
Actuarial patient survival at 1-, 3- and 5-years in patients
with tumors < 7 cm and > 7 cm were 88%, 76%, 36%
and 71%, 36%, 21% respectively, P = 0.08.
Extrahepatic invasion, resection margin < 1 cm, more
than 3 nodules, tumor > 7 cm and age > 65 years were
independent predictors of survival.
Conclusions: LR as a treatment of non-early HCC can be
effective and safe with an accurate patient selection.
P-033
RESULTS OF LIVER RESECTION IN
PATIENTS WITH PORTAL VEIN TUMOR
THROMBUS COMPLICATING
HEPATOCELLULAR CARCINOMA
E. Vibert, M. Khalfallah, C. Salloum, L. Gorden,
S. De La Serna, R. Adam, D. Castaing and D. Azoulay
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Median survival of patients with hepatocellular carci-
noma (HCC) complicated by macroscopic portal vein
tumor thrombus (PVTT) is inferior to 3 months.
Aim: This study analyses the results of surgical treatment
in this situation.
Methods: From 1992 to 2009, 31 patients (pts) (ages:
57 ± 10 years, 10 females/21 males, 27 ASA I-II, 4 ASA
III) were operated upon, 15 (48%) pts were cirrhotic
(Child A-B), 7 (22%) had a hepatopathy and 9 (29%) a
normal liver. Mean number and diameter of HCC was
2.2 ± 2.3 and 8.3 ± 4.6 cm, respectively, with bilobar
extension in 10 (32%) pts. PVTT involved a sectorial
branch in 6 (19%) pts, a pedicular branch in 21 (67%) pts
and the portal trunk in 4 (12%) pts. Mean bilirubin was
15 ± 9 mmol L-1, PT was 75 ± 14%, creatinine
75 ± 25 lmol L-1 and platelet count: 241000 ±
143000 mm-3. Median level of AFP was 375 lg L-1 (Min
2-Max 1245377). Uni- and Multivariate analysis were
done for overall survival with preoperative data.
Results: These 31 pts have been treated with 3 minor and
28 major hepatectomies that required liver vascular
exclusion in 8 (25%) pts and vascular reconstructions in 2
pts. Rate of transfusion was 3.1 ± 4.0 units of packed
red cells. Resection were R0, R1 and R2 in 8 (25%), 16
(51%) and 7 (22%) pts, respectively. Two-month post-
operative mortality was 3/31 (9%). Morbidity rate was
17/31 (51%). Length of hospitalization was
17 ± 10 days. The median survival was 5.7 months. 6-
month, 1 and 2 year OS were 62%; 48%, 35% (5 pts at
risk). In multivariate analysis, preoperative bilirubin rate
was the only independent predictive factor of OS. In pts
with normal bilirubin (£ 17 lmol L-1) (n = 22), 6-
month, 1 and 2 year OS were 68%; 68% and 50% (5 pts
at risk), respectively. In pts with bilirubin > 17 lmol L-1
(n = 9), 6 month OS was 31% (2 pts at risk) with no 1-
year survivors (log rank, P = 0.003).
Conclusions: Liver surgery in patients with portal vein
tumor thrombus complicating HCC can be performed
with satisfactory OS rate in patients with strictly normal
liver function.
P-034
IMPACT OF POSTOPERATIVE
COMPLICATIONS ON LONG TERM
OUTCOMES AFTER SURGICAL
RESECTION FOR HCC
S. Farid, P. Goldsmith, I. Rajput, G. Toogood, P. Lodge
and R. Prasad
St James University Hospital, Leeds, United Kingdom
Introduction: We present a single centre experience
investigating the impact of postoperative complications
on long-term outcomes following resection for hepato-
cellular carcinoma (HCC).
Methods: All patients undergoing curative intent resec-
tion for HCC between February 1994 and August 2007
were reviewed and divided into groups with or without
postoperative complications (POCs). Pearson’s chi-
squared test was used for categorical variables and
Mann-Whitney U test where variables did not follow a
normal distribution. The Kaplan and Meier method was
performed to analyse the overall (OS) and disease-free
survival (DFS). Patients who died within 30 days of
operation were excluded.
Results: In total there were 96 patients undergoing sur-
gical resection. Median follow up was 30 months.
Operative mortality occurred in 3 (3.1%) and POC’s
occurred in 38 (39%) patients. Major resection and tu-
mour size > 5 cm were observed factors associated with
POC’s. No signiﬁcant difference in age, parenchyma
status, AFP expression, neutrophil/lymphocyte ratio
> 5, use of blood transfusion, and resection margin
involvement were observed between study groups.
Overall 1 & 5 year DFS and OS was 73%, 52%, 80%
and 55% respectively. No signiﬁcant difference observed
in DFS and OS at 5-years between patients with and
without POC’s respectively: 48% vs. 51% and 49% and
53%. Only multiple and involved resection margins were
independent prognostic factors for poor long-term out-
comes in multivariate analysis.
Conclusions: Extent of surgery and tumour size is asso-
ciated with postoperative complications. However the
occurrence of postoperative morbidity did not impact
either long term DFS or OS.
P-035
EXPANDING THE TREATMENT
OPTIONS FOR PATIENTS WITH HCC
GREATER THAN 5 CM. COMBINING
THERAPY WITH TACE AND RFA
JR. Ribeiro, A. F. Marcelo1,2, F. Papaiordanou1,
A. Sakamoto1 and E. Chaib3
1Unicid; 2Unisa; 3HC-FMUSP
Background: The range of treatment options for Hepa-
tocellular carcinoma (HCC) is fairly wide, and the choi-
ces are not always easy, giving the number of variables to
be assessed. The main limitation for RFA is the size of
the lesions. Tumors greater than 3 cm can be treated by
transcatheter arterial chemoembolization (TACE) with
the aim to control tumor growth as well as some times
down stage the lesions.
Aim: To evaluate results of the treatment combined
therapy with TACE and RFA in HCC greater than 5 cm.
Methods: Among 140 cases of liver tumors treated by
RFA, 7 were single HCC nodules not eligible initially
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neither for surgical or single ablative treatment due to the
size of the tumor.
Results: The mean size of the lesions was 6.4 cm of
diameter. There were 4 child A and 3 Child B patients
with a mean age of 53 years. After the TACE all patients
were discharged and return to the unit after two weeks
for radiological control and RFA. 3 cases the percuta-
neous route was used and in the other four due to the
localization, size or proximity to other organs the surgi-
cal approach was performed. The mean follow-up time is
9.1 months, so far only one patient die due to progres-
sion of the liver disease, levels of alpha-fetoprotein pre-
sented with a mean value before procedure of
2140 ng mL-1 to 78 ng mL-1 after it. There was no
mortality related to the procedure.
Conclusion: The addition of RFA to TACE improves
survival in patients with unresectable HCC. RFA with
TACE should be in the armamentarium of surgeons
caring for patients with malignant liver lesions.
P-036
IMPROVED SURVIVAL IN
HEPATOCELLULAR CARCINOMA
PATIENTS WITH LOW CLIP SCORES
AND LIVER-DIRECTED THERAPIES:
RETROSPECTIVE SINGLE INSTITUTION
STUDY
S. Cole1, R. Uﬂacker2, M. Shabbir1, M. Goodman1,
L. Costa1, E. Garret-Mayer3 and M. Thomas1
1Division of Hematology/Oncology, Medical University of
South Carolina (MUSC), Hollings Cancer Center;
2Department of Interventional Radiology, Medical
University of South Carolina; 3Department of Biostatistics
and Epidemiology, Medical University of South Carolina
Background: Hepatocellular carcinoma (HCC) is the
ﬁfth most common cause of cancer death worldwide with
few patients (pts) eligible for curative treatments. Loco-
regional treatments include percutanteous ablation,
transarterial chemo-embolization (TACE), and radio-
frequency ablation (RFA). Few adequately powered
prospective controlled trials have been conducted. Large
cohort studies can provide insight into the effect of
treatment.
Objectives/Aims: To evaluate the impact of CLIP scores
and liver targeted treatments in pt outcome.
Methods: Systematic medical record audit was per-
formed on pts treated at MUSC between 06/02 and 10/
09. Demographics, clinical measures and outcomes were
collected. Overall survival (OS) was described using
Kaplan-Meier methods. Log-rank tests were used to test
for differences in categorical variables. Hazard ratios
were estimated by Cox regression and the proportional
hazards assumption was assessed using graphical meth-
ods. Statistical signiﬁcance was deﬁned by a two-sided
alpha of 0.05.
Results: Seventy-two of 73 pts treated with TACE or
RFA were available for analysis. Median age was
63 years (range 20–86), 71% male, 73% Caucasian, 20%
African–American, 5% Asian, 2% Hispanic. 68% had
Hepatitis C cirrhosis. By multiple regression analysis, pts
with CLIP score 0–2 had statistically improved median
OS (35.3 mos, P = 0.0136) vs. CLIP score 3–6
(20.3 mos) and improved median OS (40.6 mos,
P = 0.0341) with ‡ 2 RFA procedures vs. < 2
(21.3 mos). Entire cohort OS was 26.7mos (95% CI: 21.0,
40.9). Tumor diameter, age, etiology of cirrhosis, number
TACE procedures, and sequence of intervention were not
statistically signiﬁcant for OS. Nine of 128 interventions
(7%) resulted in grade 3-4 adverse events (AE) requiring
hospitalization.
Conclusions: Patients with low CLIP scores beneﬁt
greatly from aggressive liver directed therapy with
marked improvement in OS.
P-037
HEPATIC VENOUS PRESSURE
GRADIENT IS A PREDICTIVE FACTOR
OF LIVER FAILURE AND MORTALITY
AFTER RESECTION FOR
HEPATOCELLULAR CARCINOMA ON
CIRRHOSIS
E. Boleslawski1, G. Petrovai1, S. Dharancy2, S. Truant1,
L. Sulaberidze1, O. Delhaye3 and F.-R. Pruvot1
1Service de Chirurgie Digestive et Transplantations,
Hopital Huriez, CHRU de Lille; 2Clinique des Maladies
de l’Appareil Digestif, Hopital Huriez, CHRU de Lille;
3Departement d’Anesthesie-Reanimation, Hopital Huriez,
CHRU de Lille
Background: In this era of organ shortage, liver resection
(LR) returns as a mainstay of treatment for uninodular
hepatocellular carcinoma (HCC). However, the role of
portal hypertension on postoperative outcome remains
controversial.
Aim of the study: The aim of this prospective study was
to assess the predictive value of hepatic venous pressure
gradient (HVPG) on postoperative liver failure and
mortality.
Patients and methods: Since January 2007, all consecu-
tive cirrhotic patients candidate for LR underwent sys-
tematic screening prior to surgery including transjugular
measurement of HVPG. Both indication for LR and
choice of surgical technique were determined indepen-
dently of HVPG values. Postoperative liver failure (PLF)
was deﬁned as jaundice or ascites or encephalopathy. A
composite endpoint was deﬁned as PLF and/or death
within the ﬁrst 3 postoperative months.
Results: From January 2007 to October 2009, 40 patients
(37M 3F, mean age 60.2 years) with uninodular HCC
were included in the study. Cirrhosis was alcoholic in
85% of cases. The median value of HVPG was 9 mmHg
(3–19). Resections were major in 22% of cases; wedge in
40%, unisegmentectomies in 18% and left lobectomies in
20%. In univariate analysis, factors associated with the
composite endpoint were preoperative serum creatinine
(0.97 vs. 0.80 mg dL-1, P = 0.01), preoperative HVPG
(10.5 vs. 7.4 mmHg; P < 0.01), a major hepatectomy,
intraoperative blood losses (925 cc vs. 275 cc;
P < 0.001) and duration of surgery (287 vs. 208 min;
P = 0.02). In multivariate analysis, only preoperative
HVPG>= 10 mmHg (P = 0.026, OR = 4.9) and pre-
operative serum creatinine (P = 0.025, OR = 0.85 by
0.1 mg dL-1 increase) were independent predictors of
PLF and/or death.
Conclusion: Preoperative measurement of HVPG is a
valuable and useful tool for predicting PLF and/or
mortality after LR for HCC in cirrhotic patients. Alter-
native therapies should be preferred in patients with
HPVG>= 10 mmHg and increase in serum creatinine.
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P-038
IN INTENTION TO TREAT, IS PARTIAL
LIVER RESECTION FOR HCC ON
CIRRHOSIS A WASTE OF CHANCE FOR
PATIENTS THEORICALLY
TRANSPLANTABLES?
A. Herrero, M. Hamoui, K. Gazzane, O. Maillet,
G.-P. Pageaux, J. M. F. Fabre and F. Navarro
Saint Eloi Hospital
Introduction: Liver transplantation (LT) is the best
treatment of HCC on cirrhosis, but the number of grafts
available is inferior to the number of patients who could
revive this treatment. Alternative like partial liver resec-
tion (LR) in patients with good liver function are used.
The aim of this study was to compare in intention to treat
the outcome of patients who were resected to those who
were transplanted.
Patients and methods: Retrospective study on patients
treated for HCC on cirrhosis by either LT or LR between
1998 and 2008. A sub-population of patients aged less
than 69 years, with a tumor less than 5 cm, classiﬁed
Child A was analysed: the group LT and the group LR
compared in terms of overall survival (OS) and disease
free survival (DFS).
Results: Among 209 patients who had LT or LR, 80
corresponded to the sub-population (n = 30 for LT,
n = 50 for LR). The causes of cirrhosis were not dif-
ferent in both groups: 42% HCV, 14% HBV, 34%
alcohol and 8% metabolic syndrome. MELD score was
< 12 in both groups. Mortality and morbidity rates
were: 7% LT vs. 3.5% LR, 37% LT vs. 33% LR. There
was no signiﬁcant difference on 5 year’s OS in both
groups (80% for LT vs. 73% for LR, P = 0.24). The 5
year’s DFS was signiﬁcantly more elevated in LT than
LR (85% vs. 55%, P = 0.05). In the LR group, 24 pa-
tients (48%) had recurrence, 15 could be transplanted
and 5 had reresection. Only 4 patients (8%) could not
receive any treatment. Moreover, OS after salvage
transplantation was not signiﬁcantly different compared
to ﬁrst intention LT (80% vs. 78%).
Conclusion: This study shows that in selected patients,
ﬁrst intention LR gives good results in terms of OS with
low morbi-mortality rates. It allows histologic analyse for
a better selection of patients for LT. DFS remains infe-
rior to LT but aggressive treatment of recurrence with
salvage transplantation and reresection had good results.
It’s an interesting therapeutic strategy for a better attri-
bution of grafts.
P-039
THE EFFECT OF METABOLIC FACTORS
IN HEPATOCELLULAR CANCER IN US
BORN ASIANS COMPARED TO ASIAN
IMMIGRANTS
L. Wong1,2 and B. Hernandez3
1Hawaii Medical Center-East; 2Department of Surgery/
University of Hawaii School of Medicine; 3Cancer
Research Center of Hawaii
Background: Hepatocellular cancer (HCC) is a distinctly
different malignancy in various geographic regions. Viral
risk factors may differ, but the effect of the environment
on HCC as a population migrates from one country to
another is not understood.
Objective: To characterize and compare two groups of
Asians with HCC: those born in the US (n = 185) vs. in
Asia (n = 191).
Methods: A retrospective review of 376 HCC cases from
1991–2009 was performed. Data collected included:
demographics, risk factors, tumor characteristics, treat-
ment, and survival.
Results: Asians born in Asia (AbA) were more likely to
be female (37.7 vs. 20%, P = 0.001) and have hepatitis B
(62.8 vs. 34.6%, P < 0.001). Asians born in the US
(AbUS) were more likely to have alcohol history (41.6 vs.
24.6%, P = 0.001), smoking history (56.8 vs. 45%,
P = 0.03), diabetes (38.9 vs. 18.8%, P < 0.001),
hyperlipidemia (25.4 vs. 12.6%, P = 0.003), another
malignancy (13.0 vs. 6.8%, P = 0.045), higher weight
(71.8 vs. 64.1 kg, P < 0.001) and higher BMI (26.2 vs.
24.1, P < 0.001). More AbUS had no viral/alcohol risk
factors (26.5 vs. 6.8%, P = 0.0001). There was no dif-
ference in age, hepatitis C, cirrhosis, HCC screening,
tumor size, stage, or treatment. Median survival was
similar in AbA (811 days) and AbUS (686 days) and Cox
regression indicated that hyperlipidemia, tumor size,
albumin and treatment (transplant/resection) were the
main predictors of survival.
Conclusion: The presence of hepatitis B and metabolic
factors differ between Asians born in the US and Asian
immigrants who developed HCC. Metabolic/environ-
mental factors may play a larger role in development of
HCC in the US as more patients had no viral or alcohol
risk factors. Despite these differences, optimal treatment
with resection/transplant and survival were not affected
by birthplace.
P-040
PROGNOSTIC FACTORS AFTER EARLY
RECURRENCE IN THE PATIENTS WHO
UNDERWENT CURATIVE RESECTION
FOR HEPATOCELLULAR CARCINOMA
J. M. Chun, Y. J. Hwang, G. S. Kim, S. G. Kim,
Y. K. Yun, K. S. Han, K. K. Lee and H. J. Kwon
Department of surgery, Kyungpook National University
College of Medicine
Background: Most effective therapy for hepatocellular
carcinoma is surgical resection. However, after curative
resection, recurrence developed in up to 70% of the pa-
tients and is the main cause of death in HCC patients. In
case of early recurrence, the prognosis of the patients is
more dismal.
Aim: We analyzed the prognostic factors after early
recurrence in the patients who underwent curative
resection for HCC.
Method: One hundred seventy seven patients underwent
curative resection for HCC in Kyungpook National
University Hospital from Jan.2002 to Dec.2006. We de-
ﬁned early recurrence as recurrence within 2 years after
curative resection and analyzed the overall survival and
relating risk factors of survival after early recurrence.
Results: Early recurrence developed in 79 patients
(44.6%) and risk factors of early recurrence were tumor
size (P = 0.02) and micrometastasis of tumor
(P < 0.001). 1 year/2 year overall survival after early
recurrence was 55.6%/37.5% and recurrence patterns,
preoperative AFP, PIVKA-II, CRP, tumor size, macro-
scopic vascular invasion, and Edmondson-Steiner grade
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had inﬂuences on survival through univariate analysis.
Preoperative CRP (£ 1.0 mg dL-1 vs.> 1.0 mg dL-1),
recurrence patterns (intrahepatic nodular recurrence vs.
extrahepatic recurrence, intrahepatic with major vessel or
massive form recurrence) and preoperative AFP
(£ 100 ng mL-1 vs. > 100 ng mL-1) showed statistical
signiﬁcance on multivariate analysis. (P = 0.028,
P = 0.011, P = 0.008 respectively).
Conclusion: The prognostic factor after early recurrence
is different with the risk factor of early recurrence and
preoperative CRP, AFP, and recurrence patterns can
predict the aggressiveness of recurred HCC.
P-041
RESULTS OF PORTAL VEIN METALLIC
STENT PLACEMENT IN PATIENTS
WITH PORTAL VEIN TUMOR
THROMBUS COMPLICATING
HEPATOCELLULAR CARCINOMA
E. Vibert, F. Perdigao Cotta, M. Khalfallah, C. Salloum,
L. Gorden, S. De La Serna, R. Adam, D. Castaing and
D. Azoulay
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire
Background: Median survival of patients (pts) with
hepatocellular carcinoma (HCC) complicated by mac-
roscopic portal vein tumor thrombus (PVTT) is inferior
to 3 months.
Aim: This study analyses the results of treatment with an
uncovered metallic stent (MS) extending from portal
trunk to an uninvolved portal branch to maintain portal
patency.
Methods: From 1998 to 2008, 54 pts (age: 60 ± 11
years, 4 females/50 males) were treated. 50 (92%) pts
were cirrhotic. 30 (60%) pts were Child A and 20 (40%)
pts were Child B-C. Mean number and diameter of HCC
was respectively 3.1 ± 2.3 and 7.5 ± 3.5 cm. PVTT in-
volved a sectorial branch in 7 (12%), a pedicular branch
in 34 (62%) pts and partially invaded the portal trunk in
13 (24%) pts. Bilirubin was > 30 lmol L-1 in 13 (24%)
pts. Open surgical insertion (via ileal vein accessed by a
McBurney incision) as an alternative to a percutaneous
approach was used in 14 (24%) pts.
Results: Early mortality (< 30 days) was 7% (4/54 pts).
Mortality was attributable to MS placement in 2 pts
(hemoperitoneum and early MS and portal thrombosis).
Mean hospital stay was 8 ± 6 days. Following MS
deployment, a TACE was performed in 26 (48%) pts.
After MS, overall survival at 6, 12 and 24 months were
47% (15 pts at risk), 44% (11 pts at risk) and 36% (4 pts
at risk), respectively. Jaundice (bilirubin > 30 lmol/L)
and open surgical insertion were predictive of short-term
mortality (< 3 months) despite MS deployment.
Conclusions: In the absence of jaundice, the deployment
by a transhepatic approach of uncovered MS improves
overall survival of patients with HCC complicated by
PVTT and allows subsequent additional palliative treat-
ments.
P-042
SURGICAL RESECTION OF HCC ON
CIRRHOSIS: PROGNOSTIC VALUE OF
PORTAL HYPERTENSION
A. Ruzzenente, A. Guglielmi, S. Pachera,
T. Campagnaro, G. Piccirillo and C. Iacono
Division of General Surgery ‘‘A’’, GB Rossi Hospital,
University of Verona, Verona, Italy
Background: EASL/AASLD guidelines consider the
presence of clinical portal hypertension (PH) as a con-
traindication to liver resection for HCC in patients with
liver cirrhosis.
Aims: The aims of this study were to analyze the out-
come of resection in patients with or without PH, and the
relationship between PH, extent of hepatectomy and long
term survival.
Methods: Retrospective analysis of 135 patients with
HCC in cirrhosis radically resected between 1995 and
2008. Grade of cirrhosis was classiﬁed according to
Child-Pugh (C-P) score; the presence of PH was deﬁned
as the presence of esophageal varices or splenomegaly
associated with platelet count < 100000 mm-3.
Results: One-hundred-ten patients were class C-P A and
25 were C-P B; 91 patients had single HCC and 44 had
multi-nodular (range 1-5). PH was present in 44 (32.5%)
patients. Overall mortality and morbidity were 2.2% and
33.7%, respectively; the complication rate in patients
with or without PH was 37% and 32%, respectively.
Mean follow up was of 38.3 months; 3- and 5-years
survival was of 58 and 46%, respectively. Median
survival time in patients with or without PH was of
31.6 and 64.9 months, respectively (P = 0.04). In sub-
group of C-P A patients, median survival was of 65.1 and
60.5 months, respectively. Patients submitted to wedge
resection (WR) or segmentectomy, with and without PH
had a median survival of 60.5 and 64.9 months respec-
tively. On the contrary, patients who underwent resection
of 2 or more segments, with or without PH showed a
mean survival of 34.4 and 116 respectively (P = 0.03).
Conclusion: PH is not an absolute contraindication to
hepatectomy in cirrhotic patients. In Child–Pugh A pa-
tients submitted to WR or segmentectomy long term
survival was not signiﬁcantly different in patients with or
without PH. On the contrary, surgical resection of 2 or
more segments in patients with PH showed signiﬁcantly
shorter survival and should not be recommended.
P-043
AGONIST ANTI-CD40 ANTIBODY
REVERSES CENTRALLY MEDIATED
TOLERANCE IN PERIPHERALLY
EXPRESSED TUMOR ANTIGENS IN A
MURINE MODEL FOR
HEPATOCELLULAR CANCER
D. Avella-Patino, H. Tagaram, E. Kimchi, N. Gusani
and K. Staveley-O’carroll
Penn State University
Background: Hepatocellular cancer (HCC) is one of the
most common malignancies worldwide. Tumor antigen-
speciﬁc immune response has been well studied for other
malignancies however; in vivo models for immunologic
studies of HCC are scarce.
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Aim: In this study we characterized the endogenous T
cell response-speciﬁc for one of the most immunogenic
epitopes of a liver tumor associated antigen and dem-
onstrated that treatment with anti-CD40 reverses cen-
trally-induced immune tolerance to peripherally
expressed liver tumor antigens.
Methods: We studied the CD8+-speciﬁc immune re-
sponse against the epitope-I of the large T antigen (T-ag)
in the MTD2 murine line. In MTD2 mice hepatocyte
transformation occurs as a consequence of tissue-speciﬁc
expression of the T-ag from the major urinary protein
promoter. T-ag is simultaneously expressed in some
apocrine glands without malignant transformation. Im-
mune response was studied by ﬂow cytometry after
immunization, adoptive transfer of epitope-I-speciﬁc
naive CD8+ T cells, and treatment with anti-CD40
molecule.
Results: In MTD2 model CD8+ T cell tolerance to T-ag
is centrally mediated. Adoptively transferred naive T cells
become tolerant to peripherally expressed T-ag. Treat-
ment with anti-CD40 reverses tolerance to peripherally
expressed T-ag in untransformed tissues. In mice that
simultaneously expressed T-ag in peripheral untrans-
formed tissue and liver tumors treatment with anti-CD40
reversed tolerance only in nontumoral tissue. In tumor
draining lymph nodes treatment with anti-CD40 induced
a signiﬁcant accumulation of TCR-I cells but failed to
induce IFN-c production. Conclusion: Treatment with
anti-CD40 reverses CD8+ T cell tolerance to tumor-
associated antigens expressed peripherally in untrans-
formed tissues.
P-044
THREE DOMAINS OF PROGNOSTIC
FACTORS FOLLOWING RESECTION OF
HEPATOCELLULAR CARCINOMA:
CRITICAL IMPORTANCE OF SURGICAL
TREATMENT
J. Choi, Y.-J. Lee, D. W. Hwang, S.-H. Chon, B. Jung
and K.-M. Park
Asan Medical Center, Seoul, South Korea
Background: Hepatocellular carcinoma (HCC) is one of
three leading causes of cancer deaths in Korea. Treat-
ment outcomes for HCC depend on patient factors, tu-
mour biology and treatment factors.
Aims: The present study aims to explore these three
domains of risk factors for recurrence and survival for
HCC.
Methods: A retrospective review of 418 liver resections
(males, 21.5%; females, 78.5% with mean age of
54.5 +/- 9.9) for HCC at a tertiary institution was per-
formed between January 2004 and December 2006.
Results: One hundred and forty-two patients (34%) were
symptomatic with 8 cases (1.9%) of ruptured HCC. The
mean tumour size and number were 5.6 cm +/- 3.9 and
1.3 +/- 0.92 respectively. Three hundred and fourteen
(75.1%) anatomical hepatic resections were performed
using the Glissonian pedicle transection method with
intra-operative transfusion rate of 11.5%. The resection
margin status was R0 (380, 90.9%), R1 (33, 7.9%) and
R2 (2, 0.5%). The 60-days morbidity and mortality rate
was 17% (71/418) and 0.2% (1/418) respectively. 257
patients recurred (61.5%) and 137 died of the disease
(32.8%) during follow-up (minimum of 24 months). The
3-year and 5-year overall (OS) and disease free survival
rates (DFS) were; 72.5% vs. 64.3%; and 57.1% vs. 57.2%
respectively. The 5-year OS rate for stage I, II, IIIA and
IIIB/C /IV were 69.7%, 53.6%, 22.1% and 34.3%
respectively. The risk factors for recurrence on multi-
variate analysis were lack of preoperative treatment
(P = 0.007), high-grade of tumour (P = 0.016) and
macrovascular invasion (P = 0.046). The presence of
symptoms (P = 0.020), intra-operative transfusion
(P = 0.002), microvascular invasion (P = 0.028) and
positive resection margin (P < 0.001) were poor prog-
nostic factors for overall survival on Cox regression
analysis.
Conclusion: The prognosis of HCC following resection
predominantly follows the tumour biology. However,
surgeons have important role in the treatment of HCC by
ensuring negative resection margin status with the mini-
mal intraoperative blood loss.
P-045
SELECTIVE INTRAHEPATIC PORTAL
OCCLUSION TECHNIQUE VERSUS
STANDARD LAPAROSCOPIC
RADIOFREQUENCY ABLATION IN THE
TREATMENT OF HEPATOCELLULAR
CARCINOMA
E. Opocher1, M. Barabino1, A. Pisani Ceretti1,
M. Costa1, R. Scalzone1 and R. Santambrogio2
1HPB Surgical Unit San Paolo Hospital Milan; 2HPB
Surgical Unit San Giuseppe Hospital Milan
Background: Although radiofrequency ablation (RFA)
has now been worldwide accepted as an alternative
curative treatment for early-stage hepatocellular carci-
noma (HCC) with a signiﬁcant impact on long term
survival, the local tumour recurrence still remains a more
considerable problem than with surgical resection. Based
on the well-known concept of tumour spreading along
tributary portal vein, we thus compared the standard
laparoscopic RFA technique with a novel LRFA proce-
dure with selective portal occlusion (obtained by the
ablation at ﬁrst of the tributary HCC vessel), in terms of
postoperative outcome, survival and recurrence rate.
Aim: To compare two homogeneous groups of patients
submitted to laparoscopic radiofrequency ablation
(LRFA) with or without selective intrahepatic vascular
occlusion (SIHVO) for the treatment of early-stage HCC.
Methods: Between January 2005 and July 2009, we en-
rolled 129 cirrhotic patients out of 228 cases consecu-
tively evaluated for HCC, amenable to LRFA. In 54
cases, it was possible to identify the primary portal
branch of the lesion, thus the modiﬁed SIHVO technique
was carried out. In the remaining 75 patients the stan-
dard LRFA was performed. All patients were then fol-
lowed for similar durations and outcomes included
morbidity, HCC recurrence and overall survival were
evaluated.
Results: There were no statistical differences between the
two groups in baseline pre-operative features, morbidity
rate and length of admission. SIHVO-LRFA was better
than standard procedure in terms of complete tumour
necrosis (100% vs. 90.1%) and recurrence rate either
local (7.4% vs. 18.1%, P = 0.0195) or early (27.8 vs.
31.9%). Distant intrahepatic recurrence rate (SIHVO
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48.2% vs. LRFA 45.8%) and overall survival was similar
for all groups.
Conclusion: This preliminary report demonstrated vas-
cular occlusion LRFA predominance comparing with
standard LRFA procedure, even if local recurrence rate
still remains sensibly higher to surgical resection.
P-046
FAMILY HISTORY DOES NOT AFFECT
SURVIVAL FROM HEPATOCELLULAR
CARCINOMA
L. Wong1 and N. Grace2
1Hawaii Medical Center – East; 2John A. Burns School of
Medicine
Background: A family history of hepatocellular cancer
(HCC) in a ﬁrst-degree relative has been shown to be a
risk factor for development of HCC, especially in Asian
countries related to hepatitis B. little is known if a family
history of HCC affects survival.
Objective: To compare HCC patients with a family his-
tory of HCC (FH+) to HCC patients without a family
history (FH-).
Methods: In a prospectively-collected database of 581
HCC patients (1993–2009), 47 patients had a family
history of HCC. Tumor characteristics, liver function,
treatment, and survival were compared between FH+
and FH-.
Results: In FH+, 19 had a sibling, 19 had a parent, and
1 had both with HCC. Eight patients had second-degree
relatives and 3 had more than one relative with HCC.
FH+ was more likely to be female, non-diabetics, hep-
atitis B+, and have higher albumin (all P < 0.05). FH+
was as likely to be screened for HCC and the treatments
did not differ. Median survival in FH+ was 1322 days
(95%CI 569–2074 days) compared to FH- at 643 days
(95%CI 518–767 days) and was not quite signiﬁcant
(P = 0.051). Cox regression showed that tumor size,
MELD score, and albumin were the best predictors of
survival. The presence of a family history of HCC did not
affect survival.
Conclusions: Only 8% of HCC is familial-related and the
association is likely related to hepatitis B transmission.
The presence of family history of HCC does not confer a
worse prognosis as tumor characteristics and underlying
liver function were more important.
P-047
APPRAISAL OF STAGED
HEPATECTOMY FOR RUPTURED
HEPATOCELLULAR CARCINOMA
H.-J. Kim, S.-H. Park, D.-W. Hwang, D.-S. Lee and
S.-S. Yun
Yeungnam university hospital, department of surgery
Background: Spontaneous rupture causing massive he-
moperitoneum is a potentially life-threatening complica-
tion of hepatocellular carcinoma (HCC). Hepatic
resection provides the only hope of cure for patients with
a ruptured HCC. So we reviewed our clinical experience
with surgical treatments for ruptured HCC.
Materials and Method: Between October 1990 and July
2009, 22 cases were treated with liver resection for rup-
tured HCC at our department. The clinical records were
reviewed retrospectively.
Results: Twenty-two patients underwent hepatectomy.
Ages ranged from 26 to 70 years with a mean age of
53.4 years, and sex ratio was 17 : 5 with a male pre-
dominance. Mean tumor size was 6.3 cm (2.5–15 cm).
Liver cirrhosis was presented in 15 cases (68.2%). 17
cases of them underwent staged hepatectomy; the other 5
underwent emergency hepatectomy. Time from admis-
sion to operation was 10.2 days (0–50 day). 7 patients
were treated by transcatheter arterial chemoembolization
(TACE) before elective hepatectomy. 14 patients under-
went intraperitoneal hyperthermic chemotherapy. Post-
operative mortality was 2 patients, these patients
underwent emergency hepatectomy. The median survival
time were 36 (1–105) months, and overall 1, 3 and 5-year
cumulative survival rates were 83%, 61.3% and 51.1%,
respectively.
Conclusion: Due to high morbidity and mortality in
emergency hepatectomy, staged hepatectomy is strongly
recommended to obtain favorable outcome for patients
with ruptured HCC.
P-048
LONG TERM RESULTS OF SURGICAL
RESECTION FOR TREATMENT OF
HEPATOCELLULAR CARCINOMA IN
THE SETTING OF NORMAL LIVER
J. Agostini1, E. Vibert1,2,3, L.-A. Veilhan1, L. Gorden1,
E. Hoti1, D. Azoulay1, D. Castaing1,2,3, H. Bismuth1 and
R. Adam1
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France; 2INSERM, U785, Villejuif, France;
3Univ Paris-Sud, UMR-S785, Villejuif, France
Hepatocellular carcinoma (HCC) developed in the set-
ting of healthy liver (A0F0) is a rare entity for which
surgical resection is the standard treatment. This study
reports long-term results of hepatic resection to deter-
mine long-term prognostic factors.
Methods: From 1967 to 2008, 132 pts were operated on
for HCC in the setting of normal underlying liver
(A0F0). After exclusion of pts who had viral disease,
major steatosis, ﬁbro lamellar HCC or salvage liver
transplantation after resection, 77 pts were selected for
the study. Uni- and multivariate analysis for factors
affecting overall survival (OS) and recurrence-free sur-
vival (RFS) was done for preoperative variables includ-
ing: sex-ratio (42M/35F), age (51 ± 17 years), No. of
tumors > 1 [17 (22%) pts], diameter £ 6 cm [18 (24%)
pts], macroscopic portal vein invasion [12 (16%) pts] and
AFP > Normal [40 (54%) pts].
Results: The 77 pts were treated with 42 major (‡ 3
segments) and 14 limited hepatectomies. Two-month
operative mortality was 2.5%. With a median follow-up
of 46 months, 1-, 5-, 10-year OS and RFS was 88%,
53%, 46% and 70%, 45% and 41%, respectively. Among
48 pts who recurred (62%), 12 (34%) were reoperated
and 25 (52%) pts had strictly intra-hepatic recurrence. A
preoperative diameter > 6 cm was the only independent
predictive factor of OS and RFS. The 10-year OS and
RFS was 70% and 70%, respectively, up to 6 cm tumor
diameter vs. 36% (log rank, P = 0.009) and 27% (log
rank, P = 0.004), respectively, for tumor larger than
6 cm. Of note, up to 6 cm diameter, no pts have pre-
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sented extra-hepatic recurrence versus in 20/38 (52%) in
larger tumor.
Conclusion: A rate of 46% 10-year overall survival is
observed after resection of HCC with strictly normal li-
ver. While portal vein invasion and number of nodule(s)
were not prognostic factors, a tumor diameter 6 cm or
less is strongly predictive of good long-term outcome.
P-049
ROLE OF HEPATIC RESECTION IN
SUCCESSFUL LONG-TERM SURVIVAL
OF PATIENTS WITH METASTATIC
MELANOMA
M. Caralt1, J. Marti2, G. Sapisochin1, J. Fuster2,
I. Bilbao1, C. Fondevila2, L. J. Lazaro1,
J. C. Garcia-Valdecasas2 and R. Charco1
1HBP Surgery and Transplants Department. Hospital
Universitari Vall d’Hebron, Barcelona, Spain; 2Liver
Surgery and Transplant Unit. IMDiM. Hospitla Clı´nic,
Barcelona, Spain
Background: The prognosis of patients with melanoma
has not improved in recent years and the presence of
distant metastases confers very poor prognosis. Recent
studies suggest liver resection for melanoma metastases
may improve survival. The aim of this study was to
analyze the outcome of patients undergoing hepatic
resection for melanoma liver metastases.
Patients and methods: Patients undergoing liver resection
for melanoma metastases at the Hospital Vall d’Hebron
and Hospital Clinic, Barcelona were reviewed. Selection
criteria were: good performance status, feasibly complete
and safe resection and absence of non-visceral extrahe-
patic metastases.
Results: Between 1994 and 2007, 14 liver resections were
performed for melanoma liver metastases. Primary tu-
mor was cutaneous in 8 patients and ocular in 6. Two
patients had synchronous and 12 metachronous metas-
tases. Two patients underwent urgent liver surgery due to
tumor bleeding. In these patients, complete melanoma
staging was not performed and extrahepatic metastases
(suprarenal gland and brain) were found during surgery
or the postoperative course. Three patients had biliary
leak and one died of a brain hemorrhage in the postop-
erative course. Six patients (46.2%) developed liver
recurrence during follow-up. One-, 3-, and 5-year actu-
arial patient survival was 77%, 49% and 49%, respec-
tively. Excluding patients who underwent urgent liver
surgery, 1-, 3-, and 5-year actuarial patient survival in
primary ocular and cutaneous melanoma was 83%, 56%
and 56% and 80%, 60% and 60%, respectively.
Conclusions: Liver resection should be performed as part
of oncosurgical treatment in patients with melanoma
liver metastases since long-term survival was achieved.
P-050
HEPATOCELLULAR CARCINOMA
DURING PREGNANCY: IS
HEPATOCELLULAR CARCINOMA IN
PREGNANT PATIENTS MORE
AGGRESSIVE?
Y. J. Hong1, K. K. Choi1, S. B. Choi2, Y. N. Park3,
J. S. Choi1, W. J. Lee1 and K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of Surgery,
Kuro Hospital, Korea University College of Medicine;
3Department of Pathology, Severance Hospital, Yonsei
University College of Medicine
Background: Hepatocellular carcinoma (HCC) during
pregnancy is a very rare condition and is believed to have
a poorer prognosis than HCC outside of pregnancy.
With increasing popularity of HCC surveillance pro-
grams and more frequent early detection, the therapeutic
outcomes of HCC have recently improved. Here, we
evaluate prognosis, diagnostic, and therapeutic strategies
through analysis of cases of HCC in pregnancy over
several decades.
Methods: Four of our patients and 44 cases since 1957
retrieved from Medline were enrolled. Retrospective
analysis was performed using available data from the
literature. In addition, we compared characteristics
of HCC in pregnancy in two periods, before and after
1995.
Results: The overall 6-month, 1-, 2-, and 3-year survival
rates were 50%, 29.5%, 18.2%, and 13.6% respectively
(n = 44). Overall median survival was 18 months. The
mean age of cases before and after 1995 were 31.4 ± 7.2
and 28.9 ± 4.4 respectively (P = 0.113). There were
signiﬁcant differences in the number of pregnancies,
presence of advanced symptoms, treatment or no treat-
ment, surgery, and 6-month, 1-year, 2-year, and 3-year
survival between the two groups. Median survival of
groups before and after 1995 was 18 and 25.5 months
respectively (P < 0.001).
Conclusions: HCC during pregnancy does not have the
morbid outcome described in past reports. Early diag-
nosis and proper treatment is important in HCC during
pregnancy. For early screening, careful history taking
and early abdominal U/S is essential. If possible, imme-
diate curative surgery is the best approach but we must
provide the patient with enough information about the
possible unfavorable fetal outcome. Even in an advanced
case, more aggressive treatment results in a more favor-
able outcome.
P-051
MICROWAVE ABLATION (MWA) OF
HEPATOCELLULAR CARCINOMA (HCC)
D. Sindram, N. Lau Kwan, J. D. Whitﬁeld,
J. B. Martinie and D. A. Iannitti
Introduction: Microwave is an emerging ablation tech-
nology in the treatment of HCC. We have used MWA for
treatment of HCC with curative intent or as a bridge to
transplantation since 2003 clinically. Currently, there are
two MWA systems commercially available in the US. We
here report our recent experience and short-term follow
up.
Method: A retrospective analysis in our MWA database
was performed. All patients undergoing microwave
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ablation for HCC were included. Ablations were per-
formed with a 915 MHz (ValleyLab, Boulder, CO) or a
2.45 GHz (Microsulis D., UK) MWA system.
Results: Thirty-two patients (28 M, 4 F, mean age 59.6
(range 46–83) underwent MWA for HCC from 3/2007
until 9/2009. The 2.45 GHz system was used in 19 pa-
tients, the 915 MHz system in 12 patients. Both systems
were used in 1 patient. 28 (88%) cases were performed
laparoscopically and 4 open. Average tumor size was
3.24 cm (range 0.7–8 cm). Using the 2.45 GHz system,
26 tumors were ablated with 51 applications, mean tumor
size 3.3 cm, averaging 1.9 applications/tumor. The
915 MHz system was applied 32 times to 14 tumors,
mean tumor size 3.1 cm, averaging 2.3 applications/tu-
mor. One patient, undergoing a combination of liver
resection and ablation died from a transection bed bleed.
There was no other signiﬁcant morbidity or mortality.
Follow-up was obtained through 10/2009. Mean follow-
up was 7.5 months (range 1–20 months). One patient was
lost to follow-up. One local recurrence was noted at
15 months, and was re-ablated percutaneously. There
were 4 regional recurrences at an average of 9.7 months.
2 patients were transplanted, 2 and 3 months respectively
after ablation. The explants did not contain any viable
tumor. Six patients died at an average of 5.5 months,
without evidence of HCC.
Conclusion: Microwave ablation is a safe and effective
modality in the treatment of HCC, with limited mor-
bidity in a high-risk patient population. Most patients
can be treated with minimally invasive techniques.
P-052
ELEVEN YEARS OF A SINGLE CENTRE
EXPERIENCE IN LIVER RESECTION OF
NON-CIRRHOTIC HEPATOCELLULAR
CARCINOMA (HCC)
V. Yip, G. Sarno, S. Fenwick, H. Malik, P. Ghaneh,
A. Wu and G. Poston
Univeristy Hospital Aintree, Liverpool, United Kingdom
Background: HCC is uncommon in Western countries. It
is even more uncommon in non-cirrhotic livers. The
purpose of this study was to evaluate outcomes and
prognostic factors after hepatectomy in our centre.
Material and methods: Between 1997 and 2008, patients
undergoing hepatectomy for HCC were identiﬁed from a
prospectively maintained database. Pre-operative bio-
chemical and haematological factors, intra-operative and
post- operative clinical details, and tumour pathological
ﬁndings, were analysed against overall and disease-free
survival.
Results: Forty-nine patients underwent hepatectomy for
HCC during the study period. 4 had micro-cirrhotic
nodules, 2 died post-operatively, and there were insufﬁ-
cient data on 2.
Of the 41 eligible patients, overall median survival is
30 months, with a 3- and 5- year survival post resection
of 46% and 33% respectively. After a median follow-up
of 21 months, 54% (n = 22/41) had recurrent disease. In
univariate analysis, pre-operative bilirubin [P < 0.01
(survival), P = 0.03 (recurrent)] and aspartate amino-
transferase (AST) [P < 0.01 (survival), P < 0.02 (recur-
rent)] levels are independent predictors for both survival
and tumour recurrence, whereas the percentage of
neutrophil count (P = 0.04) is an independent predictor
for long term survival. Social deprivation, type of
hepatectomy, tumour size and its histopathological
characteristics did not have any bearing in both long
term outcomes and the recurrent of the disease.
Although there was no statistical difference of survival
outcomes between poor, moderately and well differenti-
ated HCC (P = 0.06), no patient survived longer than
70 months in the poor histological grade category.
Conclusions: Surgery is an option for HCC arising from
non-cirrhotic livers. The characteristic of the tumour did
not predict long term survival beneﬁt, whereas the
functional elements of the pre-operative liver might
contribute to the outcome and recurrent of HCC.
P-053
ABLATE, RESECT, OR TRANSPLANT?
THE ART OF TREATMENT FOR
HEPATOCELLULAR CANCER
C. Hammill1 and L. Wong2,3
1Hepatobiliary & Pancreatic Surgery, Providence Portland
Medical Center, Portland, Oregon, United States;
2Surgery, University of Hawaii, Honolulu, Hawaii, United
States; 3Surgery, Hawaii Medical Center - East,
Honolulu, Hawaii, United States
Background: Studies comparing liver resection to trans-
plant for hepatocellular cancer (HCC) have shown im-
proved survival with transplant and more recent studies
have suggested that radiofrequency ablation is as effec-
tive as resection. How does the surgeon select the optimal
treatment for a patient with HCC?
Objective: To characterize and compare HCC patients
treated with radiofrequency ablation, resection, or trans-
plant.
Methods: A retrospective review of 267 HCC cases from
1991 to 2009 who underwent ablation (n = 100), surgical
resection (n = 114), or transplant (n = 53) was per-
formed. Data was collected on demographics, risk fac-
tors, tumor characteristics, treatment, and survival.
Analysis was performed using chi-square, analysis of
variance, and Kaplan-Meier.
Results: Patients who underwent ablation or transplant
had similarly-sized tumors (3.1 vs. 3.0 cm), bilirubin,
albumin, protime, and MELD score (11.6 vs. 11.1),
however transplant patients were more likely to be
younger (mean age 55.9 years vs. 64.0 for ablation and
60.7 for resection), Caucasian (35.8% vs. 18.0% for
ablation and 11.4% for resection patients) and male
(88.7% vs. 69% of ablation and resection patients).
Resection patients had larger tumors (6.8 cm), lower
BMI, better liver function (bilirubin, albumin, protime,
and MELD score) and higher platelet counts. Mean
survival was signiﬁcantly better in transplant patients
(8.57 years) and similar in ablation (4.28 years) and
resection patients (5.07 years).
Conclusion: Liver transplant offers the best survival for
HCC and is the optimal treatment when possible. Abla-
tion and resection offer similar results; however the
treatment a patient ultimately undergoes is driven by age,
BMI, liver function, and tumor size.
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P-054
RECENT IMPROVEMENT OF OUTCOME
OF HEPATIC RESECTION FOR
HEPATOCELLULAR CARCINOMA
S. Woo Young, S. Kyung-Suk, K. Taehoon,
J. Young-Min, Y. Nam-Joon and L. Kuhn Uk
Seoul National University College of Medicine,
Department of Surgery
Introduction: Hepatic resection for hepatocellular carci-
noma is old standard treatment. Recently surgical skill,
surgical instrument, perioperative management and
diagnostic tools developed and surgical outcome also
improved. Hence, we analyzed recent outcome of hepatic
resection for HCC and investigated the prognostic fac-
tors relating to this.
Methods: Between January 2001 and December 2006,
399 patients who underwent hepatic resection were ret-
rospectively reviewed. Mean age was 53.8 year (17–81).
There were 329 (82.5%) men and 70 (17.5%) women.
Among these, 13 palliative cases were excluded. Median
follow-up duration was 28 months (0.2–96.1). The
chronological comparison was based on 2003.
Results: Overall 5-year survival and disease-free survival
rate were 59.4% and 33.5% respectively. According to
chronology, 3-year survival rate, 3-year survival rate
before and after 2003 were 65.7% and 78.8% respectively
(P = 0.002). In-hospital mortality (3 months) and major
morbidities after 2003 were signiﬁcantly lower than be-
fore 2003 (4.8% vs. 0.4%, P = 0.004, 15.9% vs. 5.4%,
P < 0.001). On multivariate analysis, preoperative AFP
(HR = 1.66, P = 0.021), tumor size (HR = 2.49,
P < 0.001), microvascular invasion (HR = 2.94,
P < 0.001), and intraoperative transfusion (HR = 2.45,
P = 0.003) were independent prognostic factors for
survival. According to subgroup analysis using tumor
size £ 5 cm and microvascular invasion (mvi), survival
rate of group with £ 5 cm & mvi(-),> 5 cm & miv(-),
5 cm & miv(+), and > 5cm & miv(+) were 79.0%,
59.0%, 60.9%, and 28.1% respectively (P < 0.001), 5-
disease-free survival rate of each group were 54.0%,
34.4%, 20.1%, and 9.5% respectively (P < 0.001).
Especially, 5-year survival rate of BCLC A1 patients with
tumor size £ 5 cm was 83.7%.
Conclusion: Recently the rate of operative mortality and
morbidity is getting lower. Hepatic resection should be
considered as the treatment of choice in patients with
small HCC and good liver function.
P-055
PREDICTORS OF MICROVASCULAR
INVASION FOLLOWING POTENTIALLY
CURATIVE RESECTION FOR HCC
S. Farid, R. Adair, A. Young, G. Toogood, P. Lodge and
R. J. Prasad
St James University Hospital, Leeds, United Kingdom
Introduction: Macroscopic vascular invasion is a poor
prognostic factor in hepatocellular carcinoma (HCC).
We present a single centre experience reporting on clinic-
pathological predictors for microvascular invasion fol-
lowing potentially curative HCC resection.
Methods: All patients undergoing curative intent resec-
tion for HCC between February 1994 and August 2007
were reviewed. Patients with macro vascular invasion
were excluded. Logistic regression models were used to
identify predictors for microvascular invasion (MVI).
The Kaplan and Meier method was performed to analyse
the overall (OS) and disease-free survival (DFS).
Results: A total of 96 patients underwent curative
resection for HCC. Macrovascular invasion occurred in
30 (31%) patients and excluded from the analysis. Out of
66 patients, MVI was reported in 20 (30%) of cases.
Tumour size > 5 cm, multiple (> 1) tumours, and tu-
mour size > 5 cm + multiplicity were signiﬁcantly
associated with MVI. However in multiple logistic
regression analysis only tumour size> 5 cm + multi-
plicity (P = 0.03, HZ 4.5 (0.249–81.6) remained an
independent risk factor for MVI. In a multivariate
model, MVI, tumour > 5 cm, multiplicity failed to re-
main independent prognostic factors for DFS and OS.
The 3 year DFS and OS for patients with and without
MVI were 46% vs. 54% (P = 0.453) and 51% vs. 59%
respectively (P = 0.654).
Conclusions: The presence of tumour size greater than
5 cm + multiple tumours was highly signiﬁcant for the
associated presence of microvascular invasion. Our small
series study failed to show a statistically signiﬁcant DFS
and OS difference between patients with and without
MVI. Studies with large patient numbers are required to
evaluate utility of preoperative classiﬁcation models for
predicting MVI in HCC.
P-056
AGGRESSIVE APPROACH OF
SURGICAL TREATMENT OF THE
HEPATOCELLULAR CARCINOMA WITH
THE PORTAL VEIN AND INFERIOR
VENA CAVA INVASION
O. Kotenko, A. Grinenko and A. Korshak
National Institute surgery and transplantology
Background: The invasion of a hepatocellular carcinoma
(HCC) in a portal vein or inferior vena cava (IVC) makes
known technical difﬁculties at a tumor resection.
Aim: To develop new methods of a resection and
reconstruction of a portal vein and IVC at surgical
treatment of a HCC for improvement of results.
Material and methods: Ninety-one patients with a HCC
undergoing liver resection from January 2003y till
December 2008y was included in research. Seventy-six
patients underwent radical liver resections (R0). Twenty-
three patients with a PV thrombosis have made the basic
group. Sixty-eight patients were included in control
group with a tumor thrombosis of branches of a PV 2-5
order. Results of a resection and reconstruction of the
retrohepatic segment of the IVC was analyzed at 9 pa-
tients with tumoral invasion. In all cases the size of a
tumor exceeded 10 sm.
Results and discussion: At patients of the basic group are
executed 13 expanded (more than 3 segments) and 10
extended (more than 5 segments) liver resections. In all
cases of the basic group the total caudal lobectomy was
executed. A resection of a PV was made in 2–3 mm from
visible border of a tumoral thrombus. We used 4 meth-
ods reconstruction of PV. At patients of control group
was executed 38 extensive, 15 expanded resections of a
liver and 15 resections of two segments of a liver. Char-
acter and quantity of complications were similar in both
groups except small for size syndrome, which authenti-
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cally met in the basic group. The postoperative mortality
till 30 days in the basic group was 8.7% (2 patients), in
control group – 6.6% (5 patients). Average life expec-
tancy of patients after a resection and reconstruction IVC
has made 30 months.
Conclusion: Aggressive surgical approach for HCC pa-
tients with a tumoral PV thrombosis and IVC invasion
allows obtaining satisfactory results with comprehensible
level of a mortality and survival rate.
P-057
OUTCOMES FOLLOWING RE-
RESECTION FOR RECURRENT
HEPATOCELLULAR CARCINOMA
S. Farid, J. Pine, G. Toogood, P. Lodge and R. Prasad
St James University Hospital, Leeds, UK
Introduction: Surgical resection remains the main cura-
tive treatment for hepatocellular (HCC) but recurrence
rates are high. We present the ﬁrst UK single centre
experience on outcomes following re-resection for
recurrent hepatocellular carcinoma.
Methods: A retrospective analysis of the departmental
database of patients undergoing curative resection for
HCC between February 1994 and August 2007. Clini-
copathological characteristics and early- and long-term
outcomes of patients who had a ﬁrst and repeat hepa-
tectomy were compared.
Results: In total there were 96 patients undergoing ﬁrst
hepatic resection for HCC and 14, 2 and 1 received sec-
ond, third and fourth repeat hepatectomies respectively.
Non-anatomical resections were the most frequent form
of repeat resection. Median follow up was 30 months. In
the 14 patients undergoing repeat resection 9 (65%) had
underlying abnormal liver parenchyma (ﬁbrosis/cirrho-
sis). There were no signiﬁcant differences in postopera-
tive mortality and morbidity after ﬁrst and repeat
resections. The 5-year disease free and overall survival
rates after the ﬁrst and second hepatectomies were 52%
and 32% (P = 0.099), and 55% and 49% respectively
(P = 0.876).
Conclusions: Repeat resection for recurrence of HCC
provides important long-term outcomes and did not
show statistically signiﬁcant difference to those under-
going ﬁrst hepatectomy in our series.
P-058
HAS TACE MADE A DIFFERENCE IN
MANAGEMENT OF HEPATOCELLULAR
CARCINOMA? AN INTENTION TO
TREAT ANALYSIS
M. Gandhi, A. Venugopal, H. Ramesh and M. Bedi
Lakeshore Hospital, Cochin, Kerala, India
Background: Hepatocellular carcinoma is often ad-
vanced at presentation, and treatment options are lim-
ited, and outcomes poor.
Aim of study: Retrospective analysis of the outcomes of
patients of hepatocellular carcinoma (HCC) who under-
went transarterial chemoembolization (TACE) during a 5
year period.
Materials and methods: Forty-eight patients underwent
84 sessions of TACE during the period June 2004 to
2009. Patients were divisible into 4 groups: I: palliative
TACE: 40 patients, II: TACE with intention to down-
stage a borderline resectable tumour: 4 patients, III:
TACE with portal vein embolization as a preoperative
measure: 2 patients, and group IV: patients unwilling for
surgery: 2 patients.
Results: In group I, 14/40 patients underwent down
staging, and three had complete disappearance of tu-
mour. One of these patients underwent R0 resection.
Median follow up was 1–48 months. None of the patients
in group II could achieve down staging. In group III, one
of two patients underwent complete resection. IN group
IV, one of the two patients later agreed to surgery and it
was performed with R0 margins. Complications occurred
in 8 patients (4 spontaneous bacterial peritonitis, 3 liver
failure and 1 hepatorenal syndrome).
Conclusion: Although TACE resulted in some down
staging disease, results were poor in the majority of cases.
Resectable tumours and long term survival were only
achieved in a few.
P-059
NON-CIRRHOTIC PATIENTS WITH
HCV REPRESENT A SIGNIFICANT
PERCENTAGE OF THOSE RESECTED
FOR HCC: A SINGLE CENTER
EXPERIENCE
C. K. Enestvedt, M. Yin, J. Schwartz, A. Zaman,
S. Naugler and S. Orloff
Oregon Health & Science University
Background: The incidence of hepatocellular carcinoma
(HCC) in cirrhotic patients is well established. Several
studies report occurrences of HCC in non-cirrhotic pa-
tients, but few Western series have documented this
previously rare entity.
Aims: The aim of this study was to evaluate the risk
factors for HCC in non-cirrhotic patients who underwent
liver resection.
Methods: All patients who underwent liver resection for
HCC at an academic liver transplant center were retro-
spectively reviewed for years 2005–2009. Demographics,
preoperative biopsy, hepatitis C virus (HCV) status,
HBV status, environmental exposures, alcohol (EtOH),
hemochromatosis, hypertension, diabetes, hyperlipid-
emia, obesity, and surgical pathology were analyzed.
Results: Twenty-eight patients underwent formal liver
resection during the study period and 17 (60.7%) had no
cirrhosis on ﬁnal pathology. Six patients (35.3%) in this
subgroup had HCV, 2 HCV+EtOH. One had hemo-
chromatosis. Among cirrhotics, 7 (63.6%) were HCV
positive. More non-cirrhotics had hypertension (88.2 vs.
54.5%, P = 0.04), but there was no difference in other
comorbidities. Few were HBV+ (5.9% in non-cirrhotic
vs. 27.3% of cirrhotic, P = 0.11). Median tumor diam-
eter was 5 cm (2 to 23 cm) in non-cirrhotics vs. 6 cm (2 to
10 cm) in the cirrhotic group (P = 0.87). There was a
trend toward more lymphovascular invasion in the cir-
rhotics compared to non-cirrhotics (45.5 vs. 17.6%,
P = 0.11).
Discussion: Non-cirrhotic patients with HCC represent a
substantial cohort of those undergoing liver resection in
this series. A high percentage of these patients (35.3%)
were HCV positive. While this group of non-cirrhotic
patients represents a small percentage of the total
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patients with HCC, it identiﬁes a potentially important
group that would not be identiﬁed with current screening
recommendations. Future investigation of genomic or
proteomic signatures may identify factors to help predict
HCC development in HCV positive non-cirrhotic
patients.
P-060
IS NON-ANATOMICAL RESECTION
NECESSARILY WORSE THAN
ANATOMICAL RESECTION FOR
HEPATOCELLULAR CARCINOMA?
Y. S. Cheung, C. N. Chong, K. F. Lee, J. Wong,
L. B. Chui, S. W. Wong and P. B. S. Lai
Department of Surgery, Prince of Wales Hospital, The
Chinese University of Hong Kong, Hong Kong
Background: Hepatectomy remains the curative treat-
ment of choice for hepatocellular carcinoma (HCC).
Anatomical (segmental) resection of liver has been
commonly accepted as the better procedure of choice.
However, its practice is frequently limited by the location
of tumour and the volume of functional liver remnant
after hepatectomy.
Objective: We hypothesize that as long as we can achieve
a negative resection margin, patients underwent non-
anatomical resections have a comparable survival to
those patients underwent anatomical resections.
Methods: We performed a retrospective study on a series
of 224 HCC patients undergoing hepatectomy at the
Prince of Wales Hospital from 2001 to 2007. Patients’
characteristics, operative outcome, time to recur-
rence and survival rates between anatomical resec-
tion (ANA group) and non-anatomical resection (NAT
group) were compared. Prognostic factors of overall and
disease-free survival were analysed by Cox regression.
Results: There were 96 patients in ANA group, whereas
128 patients in NAT group. Anatomical resection was
associated with signiﬁcantly larger tumour (P = 0.001)
and advanced AJCC staging (P = 0.001). However,
there was no signiﬁcant different between the two groups
in the median resection margin (P =0.067) and median
blood loss (P = 0.537). Time to recurrence (P = 0.85),
overall survival (P = 0.142) and disease-free survival
(P = 0.940) between the 2 groups were also comparable.
Child’s B cirrhosis and multifocal disease were indepen-
dent poor prognostic factors for both overall and disease-
free survival.
Conclusion: As long as a negative resection mar-
gin could be achieved, non-anatomical resection of-
fered a comparable recurrence and survival results
to anatomical resection.
P-061
ROLE OF LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS WITH SEVERE
GASTROESOPHAGEAL VARICES
C.-C. Wu, S.-B. Cheng, H.-Z. Yeh and C.-S. Chang
Taichung Veterans General Hospital
Background: The role of liver resection for hepatocellu-
lar carcinoma (HCC) in cirrhotic patients with portal
hypertension is controversial. Presence of severe gastro-
esophageal varices (GEV) is usually associated with se-
vere portal hypertension. No report regarding severe
GEV on liver resection for HCC has been reported.
Aims/Objectives: To evaluate the role of liver resection
for HCC in cirrhotic patients with severe GEV.
Materials and methods: A retrospective review of 1073
cirrhotic patients who underwent curative liver resection
from July 1991 to June 2009 was carried out. According
to preoperative endoscopic examination, these patients
were divided into 3 groups: group A (n = 861), no GEV;
group B (n = 184) low risk GEV (grade F1 or F2) and
group C (n = 28) severe GEV (grade F3 or presence of
red-colored sign). The patient clinicopathological char-
acteristics, early and long-term results of the 3 groups
were compared. Preoperative endoscopic ligation or
sclerotherapy were performed on 27 group C patients.
Concomitant Hassab procedure was performed on one
group C patients during liver resection. No additional
treatment for GEV was performed on group B patients.
Results: Group C patients had signiﬁcantly smaller tu-
mor size, higher incidence of thrombocytopenia and
poorer liver function higher indocyanine-green 15-min
retention rates (ICG R15) than the group A and B
patients. All except one who underwent concomitant
Hassab operation had no postoperative gastrointestinal
bleeding. Postoperative morbidity, mortality and 5-year
disease-free and overall survival rates of the three groups
did not differ. In cirrhotic patients with transplantable,
the 5-year disease-free and overall survival rates were
57.1 and 74.5% respectively.
Conclusion: Liver resection remains justiﬁed in selected
cirrhotic patients with severe GEV if preoperative liga-
tion and/or sclerotherapy are available.
P-062
LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
ARISING WITHIN A NON-CIRRHOTIC,
NON-FIBROTIC SERONEGATIVE LIVER
A. Young, S. Farid, R. Prasad, G. Toogood and
P. Lodge
St James’s University Hospital, Leeds
Background: HCC most commonly arises in patients
with chronic liver disease. Data on outcomes following
liver resection in patients with HCC arising in non-dis-
eased livers is limited. We present the largest reported
series of such patients.
Methods: One hundred and thirty eight patients were
identiﬁed who had undergone liver resection for HCC in
our unit of who 76 had no background liver disease. We
analysed clincopathological data from this sub-group,
comparing it with the group of patients who did have
chronic liver disease to assess its impact on outcomes.
Results: On multivariate analysis, patients with HCC in
‘normal’ livers were more likely to present with larger
tumours (P = 0.030). The overall and disease-free sur-
vival was 58% and 48% respectively at ﬁve years in pa-
tients with HCC in ‘normal’ livers. There was no
signiﬁcant difference in survival outcomes between pa-
tients who had HCC in ‘normal’ and ‘abnormal’ livers. In
patients with ‘normal’ livers, the only factor signiﬁcant at
predicting overall survival was blood transfusion
requirement (P = 0.041). Factors signiﬁcant at predict-
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ing disease free survival in this group were pre-operative
tumor biopsy (P = 0.041), presence of multiple tumors
(P = 0.020) and a positive resection margin
(P = 0.017).
Conclusion: Excellent outcomes can be achieved after
liver resection for HCC on the background of a normal
liver but success often requires the use of extensive
resections and advanced techniques. The presence of
multiple HCCs on a background of no liver disease was
particularly ominous.
P-063
A RESECTED CASE OF
HEPATOCELLULAR CARCINOMA
EXTENDING INTO THE RIGHT ATRIUM
AFTER TREATMENT WITH HEPATIC
ARTERIAL INFUSION CHEMOTHERAPY
T. Sano, Y. Shimizu, Y. Senda, K. Yamao, Y. Inaba and
Y. Nimura
Aichi Cancer Center Hospital
Objective: To report a resected case of hepatocellular
carcinoma (HCC) extending into the right atrium after
treatment with hepatic intraarterial infusion chemo-
therapy.
Case: An 81-year-old man presented with right hypo-
chondralgia. CT demonstrated a hyper-vascular tumor
12 cm in diameter extending into the right atrium
through the right hepatic vein, with a small amount of
pleural effusion and ascites. Angiography depicted a
solitary HCC showing the thread and streak sign corre-
sponding to the venous tumor thrombus. The ICG
retention rate at 15 min was 23%. The patient underwent
hepatic arterial infusion chemotherapy with 100 mg of
cisplatin particles 3 times every month. The tumor
showed a marked shrinkage and an involution of the
venous thrombus around the oriﬁce of the right hepatic
vein. Estimated liver resection volume calculated by CT-
volumetry was 27%, and the ICG retention rate at
15 min improved to 16%. The patients wished to un-
dergo resectional surgery.
Results: Right hemihepatectomy with tumor thrombec-
tomy was performed using a total hepatic vascular
exclusion technique. The operation time was 365 min and
intraoperative blood loss was 3010 mL.
Histologically, the tumors turned into diffuse necrosis
and ﬁbrosis, so viable tumor cells were not encountered
in either the main tumor or venous thrombus. The
therapeutic effect of chemotherapy was pathological
complete remission. Postoperative recovery was unevent-
ful and the patient is alive 13 months after the ﬁrst
presentation without evidence of the tumor recurrence.
Conclusions: Preoperative assessment of tumor viability
after chemotherapy is not deﬁnitive. Performance of a
safe operation must be the prime concern.
P-064
CHARACTERIZATION OF
HEPATOCELLULAR CARCINOMA (HCC)
CELL LINES ACCORDING TO THE
ADHESION MOLECULES
S.-B. Choi1,2, W.-B. Kim1,2, C.-Y. Kim1,3, S.-O. Suh1,3,
S.-Y. Choi1,2 and T.-J. Song1,4
1Korea University College of Medicine; 2Korea University
Medical Center Guro Hospital; 3Korea University Medical
Center Anam Hospital; 4Korea University Medical Center
Ansan Hospital
Background: There are many reports on the relation of
cancer cells and adhesion molecules in tumor invasion
and metastasis. Although the role and clinical usefulness
of adhesion molecules are investigated in many cancer
cell lines, reports on their roles in hepatocellular carci-
noma (HCC) cell lines are limited. In this study, the
expression status of the adhesion molecules, ICAM-1,
E-selectin, Integrin-a5 in HCC cell lines was analyzed.
Materials and methods: Eight human hepatocellular
carcinoma cell lines were used in this study. They were
incubated under the normoxic condition. We ﬁrst ana-
lyzed the expression of ICAM-1, E-selectin, and Integrin-
a5 of hepatocellular carcinoma cell lines by Western blot
analysis. Integrin-a5 on the surface of cells was analyzed
quantitatively with ELISA kit and performed immuno-
ﬂuorescence to deﬁne expression of Integrin-a5.
Results: The ICAM-1 was expressed in all the cell lines,
highly increased in SNU354, SNU368, SNU449,
SNU739, SNU886 and HepG2 but it was very low in
SNU398 and Hep3B. E-selectin was expressed in all HCC
cell lines used as well but higher in SNU354, SNU739,
hep3B and lower in SNU398, SNU886. For the Integrin-
a5 expression, it increased similarly in SNU354,
SNU398, SNU739, SNU886 and Hep3B in Western
blots. It was somewhat different but showed mostly
similar levels in its active forms in ELISA. It showed
same result in its visualized form in immunoﬂuorescence
staining. The level of the expression of the adhesion
molecules had no signiﬁcant relations with cellular
activity or morphology of HCC cell lines at any expres-
sion levels. The protein expression levels also had no
affects on tumorigenic activities.
Conclusion: The adhesion molecules, ICAM-1, E-selec-
tin, Integrin-a5 expression status may not affect the cel-
lular activity, morphology or tumorigenicity. Thus, HCC
cell lines that express the major adhesion molecules re-
main candidates for cellular target therapy.
P-065
CEUS OF HCC:CORRELATION
BETWEEN ENHANCEMENT PATTERN
AND TUMOUR CELLULAR
DIFFERENTIATION ON
HISTOPATHOLOGY
F. Loria1, G. Loria1, S. Basile1, G. Crea1, L. Frosina2
and S. Cantoni3
1Department of Radiology ASP 5 RC; 2Facolta` di
Medicina Univ. Messina; 3Department of Radiology Osp.
S Martino Genova
The objective of this study was to evaluate the enhance-
ment pattern of hepato-cellular carcinoma (HCC) on
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contrast-enhanced ultrasound (CEUS) and tumour cel-
lular differentiation on histopathology.
189 HCC patients were examined between March 2003
and September 2009. Among these 189 patients, 159 had
a solitary lesion, 24 had 2 lesions and 6 had multiple
lesions. Final diagnosis was obtained by histopatholog-
ical examination or percutaneous ultrasound-guided
biopsy. CEUS was performed with SonoVue and con-
trast pulse sequencing and were evaluated, with statistical
analysis, the correlation between enhancement time and
enhancement level of the lesions in different vascular
phases and tumour cellular differentiation. Histopatho-
logical diagnoses were made according to the Edmond-
son grading system.
The ﬁnal pathological diagnoses of all lesions were as
follows: grade I in 22 lesions, grade II in 114, grade III in
49 and grade IV in 4. Signiﬁcant differences were shown
between the time that the HCC become hypo enhancing
or remained echogenic in late phase and tumour cellular
differentiation (P = 0.006, P = 0.036) but not with the
time of commencement of hyper enhancing or com-
mencement of isoenhancing in arterial and portal phase
(P = 0.164, P = 0.113, P = 0.186, P = 0.070.
The timing of HCC becoming hypo enhancing was
correlated with tumour cellular differentiation, with
better differentiated HCCs washing out more slowly
than worse differentiated ones. With regard to the
enhancement level of HCC in different vascular phases,
we found that the echogenecity of lesions in late phase
correlated with tumour cellular differentiation.
In conclusion, the enhancement pattern of HCC by
CEUS correlates with the cellular differentiation. Well-
differentiated tumours fade out more slowly than poorly
differentiated ones. In late phase, hyperechoic lesions are
likely to be better differentiated, whereas hypoechoic
lesion are more likely to be worse differentiated.
P-066
COMPARISON OF RADIOFREQUENCY
ABLATION VERSUS RESECTION FOR
THE TREATMENT OF
HEPATOCELLULAR CARCINOMA
K. Sreenivasan, S. Roy and M. Subramaniam
Sri Ramachandra University, Chennai-116, India
Aim: Resection remains the gold standard of therapy for
hepatocellular carcinoma, but only selected patients can
undergo surgery because of the underlying liver disease
and the comorbidity. Radiofrequency ablation has
shown comparable results to resection for the treatment
of HCC. We compared the results of RFA and resection
for the treatment of HCC.
Methods: From August 2006 to September 2008, thirty
patients who had undergone resection or RFA were
analyzed retrospectively. 14 patients with HCC under-
went resection in our surgical unit (group A) and another
16 patients had RFA at the radiological unit (group B).
Those patients with a tumor size less than 5 cm in
diameter, with less than 3 tumors in number, with Child-
Pugh class A classiﬁcation and with no evidence of
extrahepatic metastasis were enrolled in this study. We
compared the complications, the recurrence patterns and
the survival rates between the two groups.
Results: The mean follow-up was 18 ± 6months. The
incidences of complications were similar between the two
groups. The local recurrence rate was 35.5% for resection
and 37.5% for RFA. In Group A: the operative mortality
were 7.1%, the mean hospital stay were 9 days, One- and
Two-year survival rates were 71% and 49.7% respec-
tively, One- and Two-year disease-free survival were
56.8% and 42.6% respectively. In Group B: There were
no mortality and the mean hospital stays were 2 days.
One- and Two-year survivals were 75% and 56.2%
respectively; One- and Two-year disease-free survival was
62.5% and 43.7% respectively.
Conclusions: Radiofrequency ablation shows compara-
ble results to resection for the treatment of HCC. RFA
should be considered for those patients who are not
candidates for resection. Intrahepatic recurrence after
RFA were more common than seen after resection and
also it takes shorter time to recur. RFA and resection
producing equivalent survival, remains to be proven. The
time has come for a randomized trial.
P-067
RADIOFREQUENCY ABLATION FOR
EARLY STAGE HEPATOCELLULAR
CARCINOMA; COMPARISON OF
LONG-TERM RESULTS AFTER
RADIOFREQUENCY ABLATION AND
SURGICAL RESECTION
I. Kirino1, H. Ikeda1, M. Okabe1, A. Tsuruta1, K. Sano1,
K. Kawamoto1, Y. Morimoto1, T.B Park1, Y. Yoshida1,
Y. Takuma2, N. Toshikuni2, T. Ito1, K. Ogasawara1 and
T. Fukuoka3
1Department of Surgery, Kurashiki Central Hospital;
2Department of Gastroenterology, Kurashiki Central
Hospital; 3Department of General Medicine, Kurashiki
Central Hospital
Background: Surgical resection is recommended most
frequently as the ﬁrst-line treatment for the early stage
hepatocellular carcinoma (HCC) among patients who are
not candidates for liver transplantation. Radiofrequency
ablation (RFA) is also considered for very early stage
HCC or for the patients with poorer liver function.
Aim: The aim of this retrospective study is to assess the
efﬁcacy of RFA for early stage HCC as the ﬁrst-line
treatment by comparing outcomes with surgical resection.
Methods: Fifty nine patients of Barcelona Clinic Liver
Cancer (BCLC) stage 0~A HCC who received RFA for
the ﬁrst-line treatment (RFA group) were compared to 88
patients who underwent surgical resection for the same
condition (surgery group) in terms of patient character-
istics, prognostic factors, as well as long term survival.
Results: The BCLC stage and back ground liver
pathology were almost identical in these two groups. The
RFA group included more patients with older age
(P = 0.0019), poorer hepatic function according to
Child-Pugh class (P = 0.0063) and less number of the
platelet count (P = 0.0063). The surgery group included
more number of patients with hepatitis B infection
(P = 0.021). The 1-, 3-, and 5-year overall survival were
96.3%, 89.6%, and 86.4% respectively in the surgery
group, and 94.5%, 85.8%, and 67.7% respectively in the
RFA group.
Conclusion: The long term survival for the RFA group is
less than that for the surgery group but is still acceptable
despite older age and poorer hepatic function of this
cohort compared to the surgery group.
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P-068
COMPARISON OF CLINICAL
OUTCOMES AFTER HEPATECTOMY
FOR HEPATOCELLULAR CARCINOMA
WITH OR WITHOUT CIRRHOSIS
E.-H. Cho1, S. B. Kim 1 and D. W. Choi 2
1Korea Cancer Center Hospital; 2Samsung Medical
Center, Sungkyunkwan University School of Medicine
Background and purpose: The presence of cirrhosis in
background liver may affect the clinical outcome after
hepatic resection. The purpose of this study is to inves-
tigate the difference of clinical outcome between patients
with or without cirrhosis after hepatectomy for HCC.
Patients and methods: Two hundred and thirty one pa-
tients underwent curative hepatic resection between
January 2001 and December 2007 at Korea Cancer
Center Hospital, Seoul, Korea. We collected clinical data
and investigated clinical outcome retrospectively. Hepa-
titis B virus infection was the most frequent etiology
(74.9%). Patients were divided into two groups according
to the presence of cirrhosis in postoperative pathologic
result, non-cirrhosis group (n = 115) and cirrhosis group
(n = 116). We compared clinical data of both groups.
Results: Postoperative complication rate was 33.2% in
all patients, and two in-hospital mortalities occurred
(0.9%). Overall ﬁve-year survival rate was 65.3% Inde-
pendent poor prognostic factors of all patients were ad-
vanced T-stage and occurrence of postoperative
complication. Cirrhosis was not a prognostic factor in
our series.
Hepatitis B infection was more frequent in cirrhosis
group. Postoperative complication rate was higher in
cirrhosis group (27% in non-cirrhosis group and 40.0%
in cirrhosis group, P = 0.047), and all hospital mortal-
ities occurred in cirrhosis group. Prognostic factors were
different between both groups. In non-cirrhosis group,
independent prognostic factors were T stage and histo-
logical grade. In cirrhosis group, occurrence of postop-
erative complication was independent prognostic factor.
Conclusion: In our series, the presence of liver cirrhosis
was not a prognostic factor, but further evaluation is
needed for longer period. When performing hepatic
resection for HCC with cirrhosis, more meticulous pro-
cedure to reduce the possibility of complication occur-
rence is needed.
P-069
SUCCESSFUL TWO-STAGED
OPERATION FOR RESECTION OF
MULTIPLE ADVANCED HCC WITH
PORTAL VEIN (PV) AND RIGHT
HEPATIC VEIN (RHV) TUMOR
THROMBI
T. Hoshino, T. Ishida, A. Odaka and H. Daijo
Saitama Medical University, Saitama Medical Center
Successful two-staged operation for resection of multiple
advanced HCCs with PV and RHV tumor thrombi is
presented.
Case: A 67-year-old female patient was admitted with
diagnosis of multiple HCCs. CT, and MRI demonstrated
three HCC tumors, (A) 7 cm in diameter located in S2-3,
(B) 2.5 cm in S4, and (C) 8 cm in S7–8. The tumor (A)
(in S2–3) was associated with tumor thrombus in left
main PV, and the tumor (C) was associated with RHV
stenosis. No distant metastasis was detected preopera-
tively. Considering bilobar advanced tumors and mod-
erately impaired liver function (ICG15 = 18%), surgical
resection was divided into two operations as follows.
Surgical Operations: (1) one month following TACE, the
tumors (A) and (B) were resected by the ﬁrst operation
(Left hepatectomy with resection of PV thrombus). (2)
1.5 months following left hepatectomy, when liver func-
tions were normalized and substantial liver regeneration
was observed, the second operation was performed. At
this time, tumor (C) was associated with tumor thrombus
in RHV as well as RHV stenosis. Therefore, resection of
S7 (total) and S8 (subtotal) together with resection of
RHV (including tumor thrombus) was performed. Post-
operative course was uneventful, and the patient was
disease-free at 15 months following surgery. Thereafter
small lung metastases were pointed out, which have been
treated by systemic chemotherapy. Tumor recurrence
was not observed in the remnant liver.
Conclusions: Two-staged operation (combined with
TACE) appears to be one good option for the treatment
of advanced multiple liver tumors.
P-070
THE TREATMENT OF THE ELDERLY
PATIENT WITH HEPATOCELLULAR
CARCINOMA
M. Hiroshi, K. Shigetomo, K. Kei, S. Junko, O. Mritaka,
K. Takeshi and S. Hironobu
Department of Surgery, Kasukabe Municipal Hospital
Background: As an increasingly aging society, an
increasing number of patients have surgery in the elderly.
In order to clarify how patient’ age may be involved in
the process which determine the treatment of the elderly
patients with hepatocellular carcinoma (HCC).
Methods: We analyzed among 126 patient with HCC
initially treated, 14 patient of 80-years old or over were
deﬁned as the elderly patients (the elderly) and 23 pa-
tients of under 60 years old as the young patients
(youth). They were examined their back ground factors
and the factors that determined the treatment.
Results: In the elderly, comparing with the youth, the
proportion of women was higher and the AFP positive
rate was not different. But the number of the patients
showing positive HBs antigen and that of the patient with
cirrhosis were smaller. There were no differences in
treatment methods between the two groups, indicating
that the propriety of the treatment depended on the
extent of the lesion and the functional reserve of the liver.
Conclusion: In the patient receiving medical treatment or
having periodical checks, it was found that HCC was
discovered earlier or at the time when the liver still
showed good functional reserve. It was also found that in
14.3% of the elderly, associated cardiac, pulmonary and
renal diseases were the factors which limited the treat-
ment methods.
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P-071
IS BCLC ALGORITHM USEFUL IN
CLINICAL PRACTICE? A
RETROSPECTIVE AND PROSPECTIVE
STUDY ON 144 HCC PATIENTS
M. A. Trovato, A. Pesce, M. Soﬁa, T. R. Portale,
G. La Greca and S. Puleo
Department of Surgical Sciences, Organ Transplantation
and Advanced Technologies, University of Catania,
Catania Italy
Background: The Barcelona clinic liver cancer (BCLC)
classiﬁcation has been validated as the best system for
treatment guidance for hepatocellular carcinoma (HCC),
but it does not properly consider liver dysfunction.
Aims: To evaluate the usefulness of BCLC for hepatic
surgeons comparing our treatment decision and the
BCLC algorithm indications.
Methods: One hundred and two patients affected by
HCC observed from 1991 to 2002 was analysed retro-
spectively. The choice of treatment was compared with
that proposed by BCLC. A second group of 62 pt ob-
served from 2000 to 2008 was analysed both retrospec-
tively and prospectively in comparison with the BCLC
classiﬁcation.
Results: Of 102 pt, in 44 (43.1%) our treatment agreed
with BCLC system, while the remnant 58 cases (56.9%)
revealed an under treatment in 47 pt (81.1%) and an
overtreatment in 11 (18.9%). Concerning the under
treatment cases we did not perform hepatic resection
such as BCLC suggested because of advanced age and/or
high level of Indocyanine Green Clearance (IGC); in pt
where BCLC would suggest chemoembolization, we as-
sumed this treatment as an high risk therapy. In the case
of the overtreatment we chose hepatic resection, because
of early Child B class and good liver functional status. As
regards the second group of pt, we agreed with BCLC in
43.5% of cases, while we believe that remaining data
should be compared to a more speciﬁc surgical algorithm
like that one recently designed by Torzilli.
Conclusions: Analysing our conduct in the treatment of
HCC in the decade prior to the introduction of BCLC
classiﬁcation and after its validation, although the dis-
agreement has not been neglected, the BCLC system
would have not changed our decision either in the past,
or in present days, especially in surgical indications. Even
if the decision making is affected by BCLC, actually that
process still needs both the support of the experience of
each clinical centre involved and the agreement with
consensus conferences reached in these last years.
P-072
OUTCOME OF PATIENTS WITH
HEPATOCELLULAR CARCINOMA IN
THE PRESENCE OR ABCENSE OF LIVER
CIRRHOSIS
C. D. M. Witjes1, R. A. De Man2, F. A. L. M. Eskens3,
R. S. Dwarkasing4, P. E. Zondervan5, T. Terkivatan1,
C. Verhoef6 and J. N. M. Ijzermans1
1Hepatobiliary and Transplantation Surgery, Erasmus
University Medical Center; 2Hepato-Gastroenterology,
Erasmus University Medical Center; 3Medical Oncology,
Erasmus University Medical Center; 4Radiology, Erasmus
University Medical Center; 5Pathology, Erasmus
University Medical Center; 6Surgical Oncology, Erasmus
University Medical Center
Background: Hepatocellular carcinoma (HCC) occurs in
cirrhotic and non-cirrhotic livers. We investigated whe-
ther the presence of underlying liver cirrhosis affected
clinical outcome of HCC.
Objectives: To compare patients with HCC having
undergone curative treatment in cirrhotic and non-cir-
rhotic livers.
Methods: Retrospective analysis of all diagnosed HCC
cases in a single reference center setting. Survival at 1 and
3 years after treatment and recurrence rates were assessed.
Results: Between 2000 and 2007, HCC was diagnosed in
461 patients. Underlying cirrhosis was present in 295
patients (64%) and absent in 166 (36%) patients. Treat-
ment with curative intent was pursued in 184 patients
through either partial liver resection, liver transplanta-
tion (OLT) or radiofrequency ablation (RFA). The
group of patients without cirrhosis contained signiﬁ-
cantly more females (38% vs. 19%) (P < 0.001), showed
less hepatitis B/C infection (26% vs. 55%) (P < 0.001)
and larger tumor size (median 80 mm (range 3–810) vs.
median 35 mm (range 8–900)) (P < 0.001). Patients
without cirrhosis were mainly treated by partial liver
resection (37% vs. 10%), vs. OLT (1% vs. 13%). Median
follow-up was 31 months (range 1–108). Overall 1 and 3-
year survival rates in patients with non-cirrhotic HCC
and cirrhotic HCC were 56, 30%, and 55, 32%, respec-
tively. Patients who had undergone potential curative
treatment of HCC in non-cirrhotic livers had 1 and 3-
year survival rates of 81 and 59%. Patients with potential
curative treatment of HCC in cirrhotic livers had 1 and 3-
year survival rates of 81 and 54%. One year recurrence
rate of HCC was 78% in patients with non-cirrhotic
livers and 63% in patients with cirrhotic livers (NS).
Conclusion: The presence or absence of underlying cir-
rhosis did inﬂuence treatment of choice, however did not
inﬂuence recurrence rate or 1 and 3-year survival rates.
P-073
LONG-TERM RESULTS AND
PROGNOSIS AFTER LIVER
RESECTIONS IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA (HCC)
V. Vishnevsky, M. Efanov, R. Ikramov, N. Nazarenko,
T. Shevchenko, D. Ionkin, I. Kozyrin and I. Kazakov
A.V.Vishnevsky Institute of surgery, Moscow
Background: HCC is one of the most common cancers
not only in Asia but in Western counties. Liver resection
is the only curative method for primary liver cancer.
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Aim: To estimate long term results and prognosis in
patients with HCC after liver resections.
Material and methods: From 1995 till 2007 57 patients
with HCC and 9 patients with CCC underwent curative
liver resections. Fifty one (77%) patients were followed
up. Major liver resections were applied in 47 patients
(71%). The most frequent was III stage according to
TNM classiﬁcation (UICC-6) – 57% for HCC and 50%
for CCC.
Results: Actuarial 5-year survival in patients with HCC
was 42%, with CCC – 20%. Univariant analysis revealed
that stage II-III vs. IV TNM UICC-6 (P = 0.0003),
multiple tumors (P = 0.009), number of affected liver
segments > 3 (P = 0.022), lymph node metastases
(P = 0.005), extrahepatic tumor spread (P = 0.0002),
vascular tumor invasion (P = 0.017), clear surgical
margin ‡ 1 cm (P = 0.007) had signiﬁcant impact on
survival in patients with HCC. Multivariant analysis
conﬁrmed signiﬁcant prognostic effect of stage II-III vs.
IV TNM UICC-6 (P = 0.025), multiple tumors
(P = 0.050), lymph node metastases (P = 0.021), clear
surgical margin ‡ 1 cm (P = 0.041). Five-year survival
in patients without the last four factors, with 1–2 and 3–4
factors was 100%, 26% and 0% respectively
(P = 0.0005).
Conclusion: Survival depends on factors that reﬂected
dissemination of the tumor. They should be considered as
the most signiﬁcant for long term results.
P-074
APPLICATION OF BCLC STAGING
SYSTEM FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA (HCC)
BEFORE 1999. DOES IT AFFECT
PROGNOSIS?
G. Sapisochin1, I. Bilbao1, C. Dopazo1, E. Ferna´ndez De
Sevilla1, M. Caralt1, L. Blanco1, R. Rodriguez1,
L. Castells2, J. L. Lazaro1, J. Balsells1 and R. Charco1
1HBP Surgery and Transplantation Department. Hospital
Universitario Vall d’Hebron. Barcelona; 2Hepatology
Department. Internal Department. Hospital Universitario
Vall d’Hebron. Barcelona
Introduction: BCLC Staging System for the treatment of
HCC on cirrhotic patients is one of the most worldwide
accepted.
Aim: To asses the efﬁcacy of the BCLC on the treatment
of early HCC over the time.
Material and methods: From 1988 to 2008 146 cirrhotic
patients underwent liver resection (LR) owing HCC a
department. According to BCLC staging application at
our centre two periods of study were designed; ﬁrst per-
iod from 1988 to 1999 (n = 68) (before BCLC) and
second period from 1999 to 2008 (n = 78) (after BCLC).
Median follow up was 35 months (r: 0.1–190). We per-
formed a retrospective study from our prospective data-
base.
Results: Actuarial patient survival at 1, 3 and 5-year for
the ﬁrst vs. the second period was 75%, 44%, 37% vs.
89%, 65%, 38% respectively, P = 0.3 however, post-
operative morbidity was higher in the ﬁrst period com-
pared with the second (48.5% vs. 24.7%, P < 0.04).
Patients fulﬁlling BCLC were lower in the ﬁrst period
compared with the second period (70.5% vs. 53%,
P < 0.05). When the BCLC was retrospectively applied
in the ﬁrst period 1, 3 and 5-year actuarial patient sur-
vival in patients fulﬁlling BCLC was 89%, 64%, 35%, in
the ﬁrst period vs. 83%, 56%, 53% in the second
(P = 0.6). No differences were observed between these
groups in postoperative morbidity (33% vs. 18%,
P = 0.1).
Conclusions: Our retrospective application of BCLC
conﬁrms the efﬁcacy of it for HCC on cirrhotic patients
and should be applied on all these patients.
P-075
A NOBLE METHOD TO DETERMINE
FREE RESECTION MARGINS DURING
SURGERY FOR LARGE
HEPATOCELLULAR CARCINOMA:
FLUORESCENT PORTOGRAPHY
W.-B. Kim1,2, H.-J. Han1,2, S.-O. Suh1,3, Y.-C. Kim1,3,
S.-Y. Choi1,2 and T.-J. Song1,4
1Korea University College of Medicine; 2Korea University
Medical Center Guro Hospital; 3Korea University Medical
Center Anam Hospital; 4Korea University Medical Center
Ansan Hospital
Background: It is sometimes difﬁcult to make out safe
resection margins for large liver tumors during surgery
with conventional intraoperative sonographic or direct
visual localization. This study is designed to determine
whether the authentic ﬂuorescent portography with
ﬂuorescein dye injection can facilitate the intraoperative
determination of the safe resection margins during the
liver surgery.
Methods: Fluorescent portographic imagings were col-
lected from three cases with large primary hepatocellular
carcinoma. After the exposure of the liver and the he-
patic hilum, the portal vascular structure was isolated
and hung on color rubber loops for identiﬁcation of the
vessels and bile ducts. Fluorescein injection mixed in 5%
albumin was intravenously injected to one of the two
sides of the vein for visualization of the liver parenchyme
drained by each side of portal branch. Wood’s lamp was
applied to the hepatic surface for identiﬁcation of the
ﬂuorescent parenchyme.
Results: The tumors were all primary hepatocellular
carcinomas in the ﬁnal pathologic diagnosis. All of these
tumors were demarcated from their parenchymal mar-
gins very well from the overlaying mass of tumors. The
ﬂuorescence was clearly localizing the resection line bet-
ter than vague visual estimated demarcations.
Conclusion: We have tried intraoperative portography
using a ﬂuorescein dye injection directly to exposed
portal vein. In all three tumors, the margins of the
hepatocellular carcinoma were well distinguished from
the healthy hepatic parenchyma by the aid of the ﬂuo-
rescent portographic images. The procedure is a novel
ﬂuorescent portography for safe liver surgeries. Fluo-
rescent portography of the liver facilitate identiﬁcation of
the tumor margin from the portal drained area of normal
parenchyme. This procedure is useful in the determina-
tion of the safe resection margins during the liver surgery.
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P-076
OUTCOMES OF NON-ANATOMIC LIVER
RESECTION FOR HEPATOCELLULAR
CARCINOMA IN PATIENTS WITH LIVER
CIRRHOSIS AND ANALYSIS OF
PROGNOSTIC FACTORS
G. Chen, Z. Y. Huang, X. P. Chen, Z. Y. Xiao, R. Y. Cai
and Y. F. Zhao
Hepatic Surgery Center, Tongji hospital, Tong ji medical
College, Huazhong University of Science and Technology
Background: It has been overwhelmingly reported that
anatomic resection achieves the best clinical outcomes for
treatment of hepatocellular carcinomas (HCC). As most
of HCC patients in the east countries are associated with
varied degrees of liver cirrhosis, however, the application
of anatomic resection is therefore largely limited. In re-
cent years, few authors reported the beneﬁt of non-ana-
tomic liver resection for HCC treatment.
Objective: The aim of this study was to determine clinical
values of non-anatomic liver resection for HCC treat-
ment in the patients with liver cirrhosis.
Methods: Between January 2003 and December 2006, 77
consecutive HCC patients with varied degrees of liver
cirrhosis underwent non-anatomic liver resection in
Tongji hospital. The clinicopathological and surgical
characteristics, survivals and prognostic factors were
evaluated.
Results: Univariate analysis revealed that statistically
signiﬁcant independent factors for overall survival were
Alfa-fetoprotein levels more than 400ng/ml, degree of
liver cirrhosis, multiple tumors, tumor diameter larger
than 5cm and vascular invasion. The 1-, 3-year overall
survivals and the disease-free survivals were 88%, 76%
and 70%, 54%, respectively. The perioperative motility
was zero, and mobility was 25.9%.
Discussion: Non-anatomic liver resection for HCC
treatment in patients with liver cirrhosis could yield
comparable outcomes with anatomic resection. Non-
anatomic resection preserves more liver parenchyma and
reduces postoperative complications.
Conclusions: Non-anatomical resection is a safe and
effective surgical strategy in treatment of HCC patients
with liver cirrhosis.
P-077
HEPATOCELLULAR CARCINOMA:
ANALYSIS OF LONG TERM SURVIVAL
RATE AND PROGNOSTIC FACTORS
BASED ON THE ONLINE LIVER CANCER
REGISTRY OF KOREA
Korean Liver Cancer Study Group,
K L C S G, Korea Central Cancer Registry, K C C R
Objectives: To investigate the long-term survival rate
and prognostic factors in patients with hepatocellular
carcinoma (HCC) based on the multi-institutional online
liver cancer registry of Korea.
Methods: The Korean Liver Cancer Study Group has
carried out the multi-institutional online registry of liver
cancer (http://www.plcr.or.kr) since 2003. The number of
online registration of primary liver cancer was 5392 from
January 1st, 2000 to December 31st, 2005. Among them,
4933 HCC patients were enrolled in this study. The vital
status of the patients was followed until December 31,
2007 using the data from Korea National Statistical
Ofﬁce. We analysed the long term survival rate of HCC
patients by Kaplan-Meier method and performed uni-
variate analysis by log-rank test. Numerous clinical fac-
tors and tumor factors were included in the statistical
analysis, and each survival curve according to each
prognostic factor was obtained.
Results: The 1-, 2-, 3-, 4-, and 5-year survival rates of
HCC patients of the online liver cancer registry of Korea
were 64.4%, 51.4%, 42.2%, 36.5%, and 31.8%. Child-
Pugh classiﬁcation modiﬁed TNM stage and their com-
ponent factors were all signiﬁcant prognostic factors on
the statistical analysis.
Conclusions: This multi-institutional online liver cancer
registry will be helpful in facilitating progress in research
and medical practice that will contribute to the treatment
of HCC.
P-078
EARLY PREDICTOR OF MORTALITY
AFTER LIVER RESECTION IN PATIENTS
WITH HEPATOCELLULAR CARCINOMA
S. H. Kim1, S. B. Choi2, K. H. Choi1, J. S. Choi1 and
K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of Surgery,
Kuro Hosptial, Korea University College of Medicine,
Introduction: The mortality rate after hepatectomy has
been declined to nearly zero. The postoperative liver
failure is a major cause of early death. The aim of this
study is to ﬁnd out an early predictor of postoperative
liver failure with biochemical parameters.
Materials and methods: The medical records of 248
patients were analyzed retrospectively from Mar. 2000 to
Dec. 2008. The various indices based on the biochemical
parameters were analyzed on postoperative days (POD)
1, 3, 5 and 7.
Results: Mortality rate was 4.4% (11/248). 7 patients of
11 were died with 1 month. The most signiﬁcant factor
was the operative time (P = 0.011). ‘‘50-50’’ criterion
and new criteria revealed a signiﬁcant difference in uni-
variate analysis. The various parameters were revealed
signiﬁcant results: Bilirubin with INR (0.811, P = 0.006)
on POD 3, bilirubin with INR (0.803, P = 0.007), bili-
rubin with cholesterol (0.775, P = 0.015), cholesterol
with INR (0.771, P = 0.017), bilirubin with INR &
MELD (0.838, P = 0.03), bilirubin with INR & MELD-
Na (0.908, P = 0.000) on POD 5, bilirubin with INR
(0.915, P = 0.000), bilirubin with cholesterol & INR
(0.763, P = 0.017), bilirubin with INR & MELD (0.895,
P = 0.000), bilirubin with INR & MELD-Na (0.947,
P = 0.000) on POD 7. The sensitivity and speciﬁcity of
bilirubin with INR, bilirubin with INR & MELD and
bilirubin with INR & MELD-Na criteria on POD 7 were
each 57.1% & 99.1%, 57.1% & 99.1% and 71.4% &
97.2%.
Conclusion: The criterion of bilirubin with INR and
MELD-Na revealed a high sensitivity and speciﬁcity and
will be helpful to predict poor outcome. The validation
with this index will be required in national wide base.
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P-079
RESECTION OF HEPATOCELLULAR
CANCER IN A NON-LIVER
TRANSPLANT TERTIARY REFERRAL
HOSPITAL
S. M. Schlichtemeier, J. S. Samra and T. J. Hugh
Royal North Shore Hospital, Upper GI Surgical Unit,
University of Sydney, NSW, Australia
Objective: To analyse the clinical, pathological and
immunohistochemical characteristics and outcomes of
patients who undergo liver resection for hepatocellular
carcinoma (HCC).
Introduction: HCC is a common cause of cancer death
worldwide. Resection offers the best chance of long-term
survival. Outcomes are inﬂuenced by patient selection
criteria, but may also depend on referral patterns and
frequency of chronic liver disease in the referred popu-
lation. This study documents our experience of treating
HCC as a non-liver transplant tertiary referral hospital in
a patient population with low levels of chronic liver
disease.
Methods: From January 1998 to February 2009, 108
patients with HCC were referred for surgical consider-
ation. Thirty-four patients underwent a potentially
curative liver resection. A retrospective analysis of clini-
cal, pathological, and immunohistochemical ﬁndings
(K67, CK-19, and p53) was performed on these patients
and correlated with patient outcomes.
Results: In our series of 22 males and 12 females (median
age 65 years), 62% of patients had pre-operative risk
factors for HCC and all had either Childs-Pugh A or B
liver status. Post-operative morbidity and in-hospital
mortality was 17.6% and 2.9% respectively. Overall 5-
year survival was 42% with a mean follow up period of
27 months. Tumour size, multicentricity or pre-operative
risk factors for HCC were not predictive of early recur-
rence or poor long-term survival. Only vascular invasion
by tumour predicted early recurrence (P < 0.004) and
poor long-term survival (P < 0.012).
Conclusion: Resection of HCC in a non-liver transplant
tertiary referral hospital can achieve similar outcomes as
units offering liver transplantation. In our patients, only
vascular invasion by tumour predicted early recurrence
and poor long-term survival. Further, these patients
might beneﬁt from routine postoperative adjuvant
treatment and an intensive follow up regime.
P-080
LAPAROSCOPIC HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
P. J. Park1, K. H. Kim1, S. G. Lee1, S. Hwang1,
C. S. Ahn, Moon D. B.1, T. Y. Ha1, G. W. Song1,
K. W. Kim1, Y. D. Yu1, G. C. Park1, N. K. Choi1,
Y. I. Choi1, D. H. Jung1 and D. S. Kim2
1Asan Medical Center, Seoul, Korea; 2Korea University
Anam Hospital, Seoul, Korea
Background: Laparoscopic liver resection has become an
increasingly popular operation but still limited and the-
oretical beneﬁts remain unproven. There are a few re-
ports of the advantages of laparoscopic liver resection of
hepatocellular carcinoma (HCC). The purpose of this
work was to evaluate the short-term results of laparo-
scopic liver resection.
Methods: From July 2007 to September 2009, 42 patients
with HCC who underwent laparoscopic liver resection in
Asan Medical Center. Data for all resections were re-
corded and analyzed retrospectively to assess sex, age,
pathology report, blood loss, hospital stay, tumor site,
mobidity and mortality.
Results: The mean age was 55.3 ± 9.72 (35–70) years
old and mean tumor size was 2.82 ± 1.19 (1.0–5.5) cm.
The tumors were located left lateral lobe (segment II or
III) 26patients, left medial lobe (segment IV) 4 patients
and right lobe 12 patients. The type of operations were 22
left lateral sectionectomy, 9 partial hepatectomy, 6 left
hepatectomy, 1 laparoscopic right hepatectomy, 1 lap-ass
right hepatectomy and 3 laroscopic assisted right pos-
terior sectionectomy. The median operative time was
222.40 ± 106.60 (95–720) min, and median blood loss
was 282.14 ± 120.88 (150–800) ml and two patients re-
quired intra-operative blood transfusion, but signiﬁ-
cantly blood loss was none. The mean resection margin
was 1.65 ± 1.16 (0–4.8) cm. There was no in hospital
mortality, and only one patient had postoperative com-
plication as wound seroma. Return to normal diet was
achieved on average at 1.87 days. The mean hospital stay
was 8.8 ± 2.34 (6–17) days.
Conclusion: Laparoscopic liver resection for HCC is
feasible and safe in our experiences. This procedure is
developing and safe technique in selected patients
including those with malignancies, resulting in short
hospital stays, rapid return to normal diet, full mobility
and minimal morbidity with acceptable oncological
parameter.
P-081
SURGICAL MANAGEMENT OF HCC
WITH PORTAL VEIN THROMBOSIS
H. E. Soliman and M. Osman
Departement of HBP surgery, National Liver Institute,
Menouﬁa University
Background: Portal vein tumor thrombosis (PVTT) is
common in hepatocellular carcinoma (HCC). PVT is one
of the conspicuous growth patterns of HCC. Survival of
those patients is usually 1–2 months.
Aim: We present our experience with liver resection for
HCC with macroscopic PVT.
Patients and methods: Between July 2004 and October
2009, 12 patients affected by HCC with gross PVTT were
reviewed. They were 10 males and two females. All had
all the routine workup was done for them. AFP was
elevated in all patients (mean 1745 ± 500).
Results: All the patients were operated using the same
technique with exctraction of the PVTT. Operations in-
cluded formal 2 Rt. hepatectomy and Thrombectomy 2
Lt. Lateral Segmentectomy and Thrombectomy 4 biseg-
ementectomy and Thrombectomy and 4 non anatomical
resctions. AFP decreased in all cases and started to re-
elevate in cases due to recurrence. Hospital Mortality
occurred in one case due to renal failure in a patient with
solitary kidney. Four cases are living free of tumors.
Overall 16 ± 5 months.Tumor free survival was 10 ± 6
months.Partial PVT thrombosis occurred in 3 cases and
resolved completely.
Conclusion: Aggressive surgical treatment of PVTT is
essential to improve the outcome of those patients.
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P-082
HEPATOCELLULAR CARCINOMA (HCC)
WITH NEOPLASTIC THROMBOSIS OF
THE HEPATIC DUCT (BDT)
M. Mirarchi1, E. De Raffele1, L. Calculli2, D. Santini3,
S. Vaccari1 and B. Cola1
1U.O. Chirurgia Generale. Policlinico S.Orsola-Malpighi,
Bologna, Italy; 2U.O. Radiologia, Policlinico S.Orsola-
Malpighi, Bologna, Italy; 3U.O. Anatomia e Istologia
Patologica, Policlinico S.Orsola-Malpighi, Bologna, Italy
Background: The biliary tract involvement in patients
with HCC usually occurs in advanced stages. Sometimes
however a tumour thrombus may grow into the biliary
ducts. Surgical treatment may be beneﬁcial in selected
cases.
Case report: A 69-year-old man was admitted in our
unit in May 2002 after repeated sessions of RFTA of 3
nodules of HCC. At admission the nodule in S5-S8 was
still viable and a BDT had invaded the right and the
common hepatic ducts. S5-S8 sub-segmentectomy, S6
wedge resection and removal of the BDT were per-
formed. 17 months later the BDT recurred in the hepatic
duct without evidence of intra-hepatic recurrence and
was removed. In June 2004, a metastatic lymph node
appeared at the hepatic hilum, without evidence of liver
or distant metastases, and the patient underwent lim-
phadenectomy. In June 2007, a new HCC appeared in
segment S8, along with a neoplastic seeding at the right
diaphragm, in the site of the previous RFTA. The patient
underwent S8 wedge resection and excision of the dia-
phragmatic nodule. He is at present alive without
recurrence.
Conclusions: The appearance of BDT in the natural
history of HCC does not necessarily involve an unfa-
vourable prognosis. Removal of BDT and curative
resection of the HCC car result in occasional long-term
survival. Also in presence of intra-biliary, hepatic or
limited extra-hepatic recurrence, surgical exeresis is the
best therapeutic choice in selected cases. Repeated ses-
sions of RFTA may predispose to malignant seeding,
which can develop also many years later.
P-083
THE STANDIZATION OF CLINICAL
INFORMATION FOR THE KOREAN
HEPATOCELLULAR CARCINOMA
REGISTRY
S. B. Choi1, K. S. Kim2, K. S. Song3 and H. J. Wang4
1Department of surgery, Kuro hospital, Korea University
College of Medicine; 2Department of surgery, Severance
hospital, Yonsei University College of Medicine;
3Department of Radiology, St. Paul’s hospital, Catholic
University College of Medicine; 4Department of surgery,
Ajou University School of Medicine
Obtaining the basic statistical data on cancer diseases is
essential to plan cancer research and to determine the
proper tools to use for diagnosing and treating cancer. By
using the national wide cancer registry, more accurate
data has been collected and more informative cancer
related statistical data can be calculated such as the
occurrence rate, the death rate, the survival rate and so
on.
In Korea, the primary liver cancer registry has been
active since 2003, and the clinical data from 10886
patients has been collected. Unfortunately there are time
and security limitations for recording and sharing this
data and so a more convenient system is required.
Therefore, we have revised the original primary hepa-
toma cancer registry to give a summary of research itself
and an analysis of patients’ data for the government’s
national wide evaluation and management of primary
hepatoma.
P-084
MANAGEMENT OF HEPATOCELLULAR
CARCINOMA: A POPULATION-BASED
STUDY
Y. Zak, K. Rhoads and B. Visser
Stanford University Medical Center
Background: Hepatocellular carcinoma (HCC) is man-
aged with a broad spectrum of surgical and nonsurgical
therapies. Indications for each treatment are hotly de-
bated, and their use varies widely between centers. Little
accurate population-based data is available describing
application of these modalities across the entire spectrum
of HCC patients.
Study design: Patients with primary HCC treated in
California’s (CA) general acute nonfederal hospitals were
identiﬁed in the CA Cancer Registry linked to Ofﬁce of
Statewide Health Planning and Development’s patient
discharge abstracts. These included patients of all ages,
races, geographical regions, and socioeconomic groups
within CA. ANOVA and Chi Square were used to
compare surgical and nonsurgical treatments by comor-
bidity score, race, and hospital characteristics (dispro-
portionate share of uncompensated care hospitals
(DSH), public vs. private, urban vs. rural, teaching vs.
nonteaching).
Results: 11480 HCC cases were recorded from 1996 to
2006. Among these, 1222 (10.6%) underwent resection,
742 (6.5%) ablation, and 294 (2.6%) liver transplanta-
tion. Predictably, patients with high Charlson Comor-
bidity scores were less likely to undergo transplant or
hepatectomy (P < 0.05). Notably, there were wide
variations in treatment by race and hospital type. African
Americans were less likely than Whites to get RFA or
transplant, Hispanics less likely to receive transplant or
resection, and Asian Americans less likely to undergo
hepatectomy (P < 0.05 for all). DSH and nonteaching
hospitals were less likely to offer any kind of surgical
treatment (P < 0.01), and rural hospitals less likely to
manage patients with liver resections than urban centers
(P < 0.01).
Conclusion: This analysis describes application of avail-
able HCC therapies within a large and diverse popula-
tion, and can serve as a yardstick for future population
studies. There are signiﬁcant racial, urban-rural, and
hospital type disparities in surgical treatment of HCC in
California.
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P-085
STAPLER HEPATECTOMY OF
HEPATOCELLULAR CARCINOMA:
PRESENCE OF LIVER CIRRHOSIS AND
OPERATIVE BLOOD LOSS
INDEPENDENTLY PREDICT OVERALL
SURVIVAL
K. Hoffmann1, C. Franz1, U. Hinz1, P. Schirmacher2,
M. W. Bu¨chler1 and P. Schemmer1
1Department of General and Transplantation Surgery,
Ruprecht-Karls-University, Heidelberg, Germany;
2Institute of Pathology, Ruprecht-Karls-University,
Heidelberg, Germany
Background: The development of new technical devises
for hepatic parenchymal transection has contributed to
an improved peri-operative safety and prolonged survival
after liver resection. The purpose of this study was to
determine the oncologic outcome and potential prog-
nostic factors for long-term survival after stapler hepa-
tectomy in HCC patients.
Methods: From our prospective database we identiﬁed 67
patients who underwent stapler hepatic resection for
HCC between 2001 and 2008. Overall survival and disease
free survival were assed using Kaplan-Meier estimate.
Clinicopathologic prognostic factors were identiﬁed by
uni- and multivariate Cox regression analyses.
Results: Twenty-six minor and 41 major hepatic resec-
tions were performed in 50 male and 17 female with a
median age of 64 years. The 30-day mortality rate was
7.5%. The median follow-up time was 32 months with an
estimated median survival of 54 months. Operating time
‡ 210 min and age ‡ 70 years were associated with in-
creased blood loss in multivariate analysis. An estimated
intraoperative blood loss ‡ 1.5l and the presence of liver
cirrhosis were independent predictors of overall survival
(P = 0.04 and P < 0.01). UICC stage 3/4 and estimated
intraoperative blood loss ‡ 1.5l independently predicted
HCC recurrence on multivariate analysis (P < 0.01 and
P = 0.09, respectively).
Conclusion: Stapler hepatectomy is a safe procedure in
patients with HCC. Substantial intraoperative blood loss
and presence of cirrhosis independently predict overall
survival. The association of substantial blood loss and
presence of cirrhosis with the overall survival highlights
the importance of meticulous preoperative patient selec-
tion and use of parenchymal transection techniques that
minimize intraoperative hemorrhage. Furthermore, since
intraoperative blood loss is also an independent prog-
nostic factor for disease free survival its reduction has
direct impact on oncological the long-term outcome of
HCC treatment.
P-086
HEPATOCELLULAR CANCER IN
NEUROLOGICAL WILSON’S DISEASE
S. Shah
PD Hinduja Hospital, Mumbai 400 016, India
Background: Hepatocellular cancer (HCC) in Wilson’s
disease with cirrhosis is extremely unusual. Liver copper
is supposed to be a protective factor against carcino-
genesis. Patients presenting with neurological Wilson’s
disease are rarely monitored for tumours.
Case report: A 30 year old male was diagnosed 4 years
previously with neurological Wilson’s disease on the
basis of clinical features, presence of a K-F ring, elevated
urinary copper levels and a positive penicillamine chal-
lenge test. His liver function tests were normal. He was
aggressively treated with D- penicillamine and Zinc with
signiﬁcant improvement in neurology and lightening of
the K-F ring. Six months prior he was investigated for
right upper quadrant discomfort. A hepatocellular cancer
measuring 10cm was detected in the right posterior sector
of the liver. HCV RNA, HBsAg, Anti HBc, HBV DNA,
ANA were all negative. We performed a segment VII/
VIII resection from which the patient recovered
uneventfully. A moderately differentiated HCC in the
setting of cirrhosis was conﬁrmed on histology. Inter-
estingly, the liver copper levels were very low, presum-
ably due to aggressive chelation therapy.
Discussion: Liver copper is protective in Wilson’s dis-
ease. Reports of HCC in Wilson’s disease are extremely
rare, especially in those presenting with neurological
Wilson’s disease and no hepatic manifestations. In pre-
vious reports, hepatits may co-exist, or has not been ru-
led out. In the present case, Hepatitis B and C were ruled
out. We postulate that aggressive chelation therapy
cleared the liver of protective copper leading to carci-
nogenesis.
P-087
ISCHEMIC PRECONDITION KEEPS IN
BALANCE NITRIC OXIDE
CONCENTRATION, AVOIDING LIVER
ISCHEMIA/REPERFUSION INJURY,
EXPERIMENTAL MODEL IN RATS
H. Almau1, I. Galdo´n1, M. Carretta1, R. Antequera2 and
T. Gledhill3
1Department of Surgery II, Hospital Vargas, Caracas,
Venezuela; 2Department of Biochemistry, Escuela de
Medicina J.M. Vargas, UCV, Caracas, Venezuela;
3Department of Pathology, Hospital Vargas, Caracas,
Venezuela
Background: The ischemic/reperfusion injury its one of
the principal causes of failure grafts. Understand the
mechanism how the ischemic preconditioning offers
protection to the liver it’s an essential part to comprise
how to avoid the liver ischemic/reperfusion injury.
Aim: Evaluate the relationship between nitric oxide lev-
els and the histological ﬁndings on livers rats, submitted
at liver ischemia/reperfusion injury, with or without
ischemic preconditioning.
Methods: Experimental investigation: 20 Spregue-Daw-
ley rats, divided in two groups. Control group: 45 min of
continues ischemia and 6 hours of reperfusion (left liver).
Study group: 10 min of ischemia and 15 min of reper-
fusion, as an ischemic preconditioning, and 45 min of
continues ischemia and 6 hours reperfusion (left liver). It
was measured Nitric oxide, TGO, TGP and histological
analysis.
Results: The control group presented an signiﬁcance
decrease concentration of Nitric oxide, P 0.00. Study
group did not present signiﬁcance variations on its con-
centration P 0.82. The Hepatocellular damage: 80% se-
vere in the control group; the study group was 70% light.
The Councilman bodies’: 80% diffuse for the control
group and 70% focal for the study group. The Coagu-
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lation Necrosis: 80% severe in control group; the study
group 20% did not present, 50% presented light.
Inﬂammatory Inﬁltration: control group 80% severe;
study group 70% light.
Conclusions: The low levels of nitric oxide can be related
with severe ischemia/reperfusion injury.
The ischemic preconditioning keeps in balance the
concentration of nitric oxide. The ischemic precondition-
ing is effective to prevent liver ischemia/reperfusion
injury.
P-088
ERYTHROCYTE RETENTION AFTER
WASH-OUT OF THE RAT LIVER USING
DIFFERENT PRESERVATION
SOLUTIONS
M. Dirkes1, R. Bennink2, K. De Bruin2 and
T. Van Gulik1
1Department of Experimental Surgery, Academic Medical
Centre Amsterdam; 2Department of Nuclear Medicine,
Academic Medical Centre Amsterdam
Background: Complete wash-out of donor livers for
transplantation is a major determinant of graft viability.
Histidine-tryptophan-ketoglutarate (HTK), University
of Wisconsin (UW) and Polysol (PS) are clinically used
wash-out solutions. Addition of colloids prevents edema,
but hydroxyl ethyl starch (HES) and polyethylene glycol
(PEG), in UW and PS respectively, also increase viscosity
and exert agglutinative properties.
Aim: This study was aimed at analyzing erythrocyte
retention after wash-out of the rat liver using different
solutions.
Methods: Rat livers (n = 5 per group) were ﬂushed
using 50 ml HTK, UW, PS or Ringerlactate (RL) at 4C
via the portal vein at 15 mmHg. The control group was
not ﬂushed. At start of the experiment Tc99m pertechnate
was injected to enable in-vivo labeling of erythrocytes.
After ﬂush, livers were removed, weighed and placed in a
scintillation analyzer. Erythrocyte retention was ex-
pressed as radiation per gram of liver relative to radiation
per gram of blood (weight percentage), after correction
for weight and Tc99m uptake. Statistics were performed
using a one-way ANOVA.
Results: No signiﬁcant differences were seen in erythro-
cyte retention after wash-out using the four ﬂush solu-
tions (P = 0.156, F = 1.99). The HTK-group averaged
9.87% (SD ± 1.48) of liver weight composed of erytro-
cytes after wash-out, UW 8.59% (± 1.77), PS 10.88%
(± 1.35), RL 9.83% (± 1.30) en Coˆ 19.39% (± 2.24).
Time of wash-out of 50 ml HTK was 4:15 minutes
(± SD 34 seconds), whereas wash-out times for equal
volumes of UW, PS and RL were 15:45 (± 30), 10:30
(± 34) and 4:00 (± 49), respectively. Wash-out times
were signiﬁcantly different (P = < 0.01), except for
HTK and RL (P = 0.937).
Discussion/Conclusion: These results show that colloids
in preservation solutions and erythrocyte agglutination
do not play a role in blood retention after wash-out of
the liver, but signiﬁcantly affect the time until complete
wash-out.
P-089
DONOR PRECONDITIONING WITH
GLYCINE AMELIORATES LIVER
INJURY AFTER EXPERIMENTAL
PARTIAL LIVER TRANSPLANTATION
R. Liang1,2, K. Hoffmann1, D. P. Schultze1, M. Zorn3,
M. Kern4, M. W. Bu¨chler1 and P. Schemmer1
1Departments of General Surgery, Ruprecht-Karls-
University, Heidelberg, Germany; 2Department of the
Second Afﬁliated Hospital Dalian, Dalian Medical
University, P.R. China; 3Departments of Internal
Medicine I, Ruprecht-Karls-University, Heidelberg,
Germany; 4Departments of Pathology, Ruprecht-Karls-
University, Heidelberg, Germany
Background: Partial liver transplantation (pLTx) is used
to increase the number of available grafts. In these cases,
both Kupffer cell-dependent regeneration and post-
transplant growth of the graft is of special importance.
Glycine, a non-essential non-toxic amino-acid, inacti-
vates Kupffer cells and protects from hepatic injury in
various animal models. Thus, this study was designed to
evaluate both its hepatoprotective effects and impact on
regeneration after experimental pLTx.
Methods: PLTx was performed in female Sprague-
Dawley rats (200–220 g). Ten minutes before organ
harvest, glycine was given to donors (1.5 ml / 300 mM;
i.v). Controls received the same volume of Ringer’s
solution. All grafts underwent cold storage in HTK
solution for 2 hours. Survival was compared one weak
after transplantation. Serum transaminases, histology
and immunohistochemistry were compared in samples
taken at 8 hours after reperfusion. Kupffer-cell activa-
tion and microcirculation were evaluated with in vivo
microscopy.
Results: Glycine signiﬁcantly increased survival from 0%
in controls to 40%. AST, ALT and LDH signiﬁcantly
decreased to about 40-60% of control values, while
necrosis decreased to about 50% of controls. Kupffer
cell-dependent expression of TNF-a signiﬁcantly de-
creased after glycine, while there was no difference be-
tween groups in expression of Ki-67. In vivo microscopy
showed increased sinusoidal blood ﬂow by 40–80% and
decreased leukocyte-adherence to endothelial lining cells
after glycine (P < 0.05).
Conclusions: Data presented here clearly demonstrate
that glycine protects grafts after pLTx without negative
effects on hepatic regeneration while Kupffer cells were
inactivated.
P-090
EDARAVONE PROTECTS HEPATOCYTE
FROM HEPATIC I/R INJURY AND
PROMOTES HEPATOCYTE
PROLIFERATION IN A PORCINE
HEPATECTOMY MODEL
M. Shimoda, I. Yoshimi, T. Okada, T. Sawada and
K. Kubota
Dokkyo Medical University, Second Department of
Surgery
The effect of Edaravon (Edv: 3-methyl-1-phenyl-2-
pyazolin-5-one), a free radical scavenger, on hepatic
ischemia-reperfusion (I/R) injury and liver regeneration
were examined in a pig hepatectomy model. At ﬁrst, one
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hour ischemia was induced by occluding of the hepatic
artery, the portal vein, and the bile duct of the right and
median lobes. About 40% hepatic resection (left lobe)
was performed after reperfusion of the right and middle
lobes. Six animals received Edv (3 mg kg-1 hour-1)
intravenously and six control animals received physio-
logical saline (3 mg kg-1hour-1) from just before reper-
fusion. Remnant liver volume, hemodynamics, blood
chemistry, including AST, ALT, LDH and lactic acid
(LA), were compared between the groups. Expressions
of TGF-b1 and TLR4 mRNA in hepatic tissues were
examined using RT-PCR. Apoptosis and cell prolifer-
ation in the hepatocytes were demonstrated by TUNEL
stainings. Serum AST (P = 0.022), and TLR4 level
(P = 0.043) were signiﬁcantly lower 3 hours in animals
receiving Edv. Also in Edr treatment pigs, TUNEL
staining was signiﬁcantly lower level than in saline
injection pigs. After one month, all factors were not
signiﬁcantly different in between two groups. We
conclude that Edv reduces hepatic injury in early stage
I/R injury in pig model.
P-091
CHANGES IN CHOLANGIOCYTE BILE
SALT TRANSPORTER EXPRESSION
AND BILE DUCT INJURY AFTER
ORTHOTOPIC LIVER
TRANSPLANTATION
H. Hoekstra, S. Op Den Dries, C. I. Buis, A. A. Khan,
A. S. H. Gouw, G. M. M. Groothuis, T. Lisman and
R. J. Porte
University Medical Center Groningen
Background: Bile salts have been shown to contribute to
bile duct injury after orthotopic liver transplantation
(OLT). Cholangiocytes modify bile composition by
reabsorption of bile salts (cholehepatic shunt) and con-
tribute to bile ﬂow by active secretion of sodium and
water via cystic ﬁbrosis transmembrane conductance
regulator (CFTR). We hypothesized that changes in
these transporters may be associated with the develop-
ment of bile duct injury after OLT.
Aim: To examine the expression of cholangiocyte trans-
porters in liver grafts and to correlate this with the
development of bile duct injury.
Methods: In 37 adult liver transplant recipients, liver
biopsies were taken during and after OLT. Changes in
the apical sodium-dependent bile salt transporter
(ASBT), the organic solute transporters (OSTalpha and
beta), and CFTR were assessed using real-time RT-PCR
and immunoﬂuorescence staining. Gene expressions were
correlated with bile salt concentration as well as with the
histological degree of bile duct injury.
Results: Compared to normal controls, OSTalpha
expression was signiﬁcantly down-regulated at the end of
cold storage and 3 hours after graft reperfusion, but
levels normalized at one week after OLT. OSTbeta
expression was more than 8-fold up-regulated at the time
of transplantation and levels increased further during the
ﬁrst week. There were no major changes in the expression
of CFTR. Expression of these transporters did not cor-
relate with changes in bile salt concentration or with the
development of bile duct injury after OLT.
Conclusion: Liver transplantation is associated with
changes in the expression of the bile salt transporters
OST alpha and OST beta, while CFTR expression
remains stable. Changes in OST alpha/beta do not cor-
relate with bile salt concentration or the degree of bile
duct injury, suggesting that the cholehepatic shunt does
not play a major role in the development of bile salt
induced bile duct injury after OLT.
P-092
THE EFFECTS OF THIOREDOKSIN AND
L-NAME ON LIVER INJURY IN THE
EXPERIMENTAL LIVER ISCHEMIA/
REPERFUSION MODEL
O. Akin1, B. Salman2, M. Serdar3, U. Yilmaz2 and
N. Kilic4
1Kecioren Research and Traning Hospital, Department of
Clinical Biochemistry-Ankara/Turkey; 2Gazi University
School of Medicine, Department of General Surgery-
Ankara/Turkey; 3Gulhane School of Medicine,
Department of Clinical Biochemistry-Ankara/Turkey;
4Gazi University School of Medicine, Department of
Clinical Biochemistry-Ankara/Turkey
Background: Although the physiopathology of ischemia/
reperfusion (I/R) injury hasn’t clear, the key role is
played by reactive oxygen products. Thioredoxin (Trx)
play important role for intracellular and intramitoc-
hondrial energy systems.
Aim: In this study, rats with partial liver I/R were given
Trx and L-name so as to analyse the effects of these
substances on liver injury.
Methods: Wistar rat hepatic artery and portal vein were
clamped and reperfusion was applied for 2 hours. He-
patic tissue blood ﬂow was measured before ischemia, at
the 5th, 15th, 30th and 60th minutes of ischemia and at
5th, 15th, 30th and 60th post-ischemia minutes. Serum
ALT, AST, LDH, GGT, NO, MDA, SOD, tGSH, GPx,
P-selectin, and Endotelin-1 and direct, total bilirubin
measures were made. Immunohistochemical method was
used for apoptosis evaluation.
Results: Trx application increased the hepatic blood ﬂow
in reperfusion while L-name had a decreasing effect.
ALT, AST, LDH, GGT, NO, MDA, P-selectin and
Endotelin-1 were increased in ischemia group and de-
creased in the group with Trx, L-name and Trx-L-name.
GPx and SOD enzymes and total glutathione were sig-
niﬁcantly reduced in ischemia group when compared to
sham group, and increased in groups with Trx, L-name
and Trx-L-name. ALP, ALT, AST and P-selectine levels
of L-name were signiﬁcantly decreased when compared
with I/R group. LDH, NO, MDA, Endotelin-1 levels and
apoptosis ratio in the group with L-name signiﬁcantly
decreased.
Discussion: Trx showed similar effects due to the block-
ing of excess NO production. Co-use of Trx and L-name
did not create a cumulative effect.
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P-093
PREVENTION OF AGGREGATION OF
MICROENCAPSULATED ISLETS IN THE
PERITONEAL CAVITY OF NON-HUMAN
PRIMATES BY LAPAROSCOPIC
IMPLANTATION AND USE OF PMCG
M. Qi1, I. Lacik2, B. Strand3, S. Wang1, Y. Wang1,
K. Formo1, G. Kollarikova2, D. Paushter1, S. Patel1,
A. Mele1, F. Gatti1, E. Marchese1, B. Barbaro1,
G. Braek3, D. Hunkeler4 and J. Oberholzer1
1Division of Transplantation, University of Illinois at
Chicago, Chicago; 2Department of Special Polymers and
Biopolymers, Polymer Institute of the Slovak Academy
of Sciences, Bratislava; 3Department of Biotechnology,
University of Science and Technology, Trondheim;
4AQUA+TECH, Geneva
Purpose: Our initial study with both alginate beads and
PMCG microcapsules using a random implantation of
microencapsulated islets via mini-laparotomy in non-
human primates (NHP) showed that the microcapsules
sedimented to the pouch of Douglas after transplantation
and formed large aggregates with foreign body reaction.
The purpose of the current study was to develop a new
transplantation approach to avoid capsule clumping, and
create a clinically relevant platform for biocompatibility
screening of various types of microcapsules in NHP.
Methods: Microcapsules were infused either random
implantation (n = 4) or laparoscopic implantation
(n = 13). Microcapsules were retrieved and the presence
and degree of overgrowth was assessed by optical
microscopy and immunohistochemistry.
Results: In all animals with random implantation (4 out
of 4), regardless of the capsule type, aggregation was
found at 1 week post-transplantation and the capsules
could not be ﬂushed out. After laparoscopic implanta-
tion, sedimentation to the Douglas space was prevented
in all animals (12 out of 13) except in one case in which
bleeding from the abdominal wall was observed when
inserting the trocar, and the capsules were contaminated
by blood. After one week of implantation, the capsules in
this animal adhered to surrounding tissue. Among all
capsule types tested, the PMCG microcapsules were the
most biocompatible.
Conclusion: Implantation of microcapsules by laparo-
scopic procedure could prevent aggregation, as long as
no bleeding was provoked. Our NHP model allowed for
identifying a microcapsule technology with superior
biocompatibility avoiding a foreign body reaction. Pre-
clinical trials with encapsulated islet transplantation in
NHP can now proceed.
P-094
THE FUNCTIONAL IMPORTANCE OF
NO/ENOS IN SURVIVAL OF HEPATOMA
CELLS UNDER STRESS
G.-Y. Chau, C.-W. Chi and H.-J. Lei
Departments of Surgery and Medical Research, Taipei
Veterans General Hospital, and College of Medicine,
National Yang-Ming University, Taipei 217, Taiwan
Background: Nitric oxide (NO) production and nitric
oxide synthase (NOS) may have effect on cancer growth.
Previous study demonstrated NO and endothelial NOS
(eNOS) expression has protective effect on hepatoma cell
under glucose depletion cytotoxic environment.
Aims: To investigate the protective effect and mechanism
of NO and eNOS on hepatoma cell under cytotoxic cir-
cumstances and evaluate the prognostic value of eNOS
expression on human hepatocellular carcinoma (HCC).
Methods: Sodium nitroprusside was used as NO donor
to human hepatoma cell (HepG2) under cytotoxic envi-
ronments (no glucose, hypoxia, chemotherapy agent) and
the protection effects were evaluated with sulforhod-
amine B methods. The change of eNOS expression on
HepG2 cell under above conditions was evaluated with
western blotting method. The relation between NO pro-
tection effect and eNOS expression was further evaluated
with eNOS knockdown by Si-RNA transfection. In
immunohistochemistry studies, eNOS expressions on
HCC of 96 patients were scored. The results were cor-
related to patient prognosis.
Results: In vitro studies, after NO was provided, the
number of tumor cell increased under cytotoxic condition
and demonstrated the protective effect. Increased eNOS
expression was detected synchronous with NO increase.
The protection effect diminished after eNOS expression
knockdown by Si-RNA even NO was given. HCC pa-
tients with strong eNOS expression on tumor have
marginal disease free survival beneﬁt (P = 0.054).
Conclusion: NO production and eNOS expression pro-
vide protection effect on hepatoma cell. The eNOS
expression level on HCC related to patient’s survival.
Manipulation of NO production and eNOS expression
may be a novel method for hepatoma treatment.
P-095
HEPATIC SUFFICIENCY IN CELLULAR
STRESS CONDITIONS IN CIRRHOTIC
RAT LIVER
L. Quadrelli1, M. Secchi2, E. Peralta3, M. Cantaberta1,
G. Zabala1 and J. M. Torre1
1Basic and Experimental Surgery- Medical School-
IUNIR-Rosario-Argentina; 2Clinical Surgery- Medical
School-IUNIR-Rosario-Argentina; 3Biology Department-
Medical School-IUNIR-Rosario-Argentina
Introduction: Our model of carbon tetrachloride (CCL4)
induced liver cirrhosis in rats is described in the British
Journal of Surgery 1998 Vol 85 Suppl 2 (July). And the
delayed micronodular cirrhosis model in rats by CCL4 is
described in Liver International, 2006 Vol 26, Suppl 1:46.
After a period of 5 and 7 months the inﬂammatory
activity is minimal but the cellular stress condition per-
sists. In 2008 and 2009 we studied hepatic sufﬁciency in
cellular stress conditions in a rat model of delayed cir-
rhosis.
Method: Male Wistar rats with delayed cirrhosis
(5 months) were used and divided into 3 Groups. A new
single dose of 0.20 mL of CCL4 by intragastric route was
administered a week before the procedure:
Group 1 (n = 7): rats with sham operation
Group 2: (n = 8): rats with 30% hepatectomy
Group 2: (n = 8): rats with 60% hepatectomy
Two weeks later all surviving animals were euthanized
after collection of a serology sample. Serum level of
ASAT, albuminemia, bilirubinemia and cholinester were
recorded. Relative hepatic volume was calculated and a
histological examination of liver samples was performed
and recorded for all animals.
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Results: Group 1: all animals survived at 2 weeks.
Group 2: 6 of 8 animals survived. Evidence of liver
regeneration in 5.
Group 3: 4 of 8 animals survived. Evidence of liver
regeneration in 3.
No signiﬁcant difference between G1 (n = 8) and G2
(n = 6) in serum level of ASAT, albuminemia, biliru-
binemia and cholinester was observed. A signiﬁcant
difference between G3 (n = 4) and G1-2 in serum level
of ASAT, albuminemia, bilirubinemia and cholinester
was found. Histological evidence of regeneration was
found in 8 cirrhotic livers.
Conclusion: After a longer period of experimental cir-
rhosis in rats with cellular stress (single dose of CCL4),
hepatic sufﬁciency could be demonstrated following 30%
and 60% hepatectomy, with 75% and 50% survival in
each group respectively and evidence of liver sufﬁciency
and regeneration.
P-096
THE FACTORS AFFECTING
TRANSPLANTED HEPATOCYTES
REPOPULATION IN RATS WITH LIVER
FIBROSIS
S. W. Lee1, S. O. Min1, S. B. Choi2 and K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of Surgery,
Kuro Hospital, Korea University College of Medicine
Background and aims: Recently cell therapy for various
diseases is widely accepted. Because the most of patients
with chronic liver failure have a mild to severe liver cir-
rhosis, there are many limitations to try clinical appli-
cations. We analyzed how to increase the cell
engraftment in rat with liver ﬁbrosis.
Materials and methods: We used analbuminemic SD rats
(NARs) as recipients of syngeneic CAG-EGFP SD he-
patocytes obtained by 2 perfusion method. The hepatic
ﬁbrosis was induced with thio acetamide in drinking
water for 6 weeks in the recipient NARs. NARs were
pre-treated with Gadolinium, Doxorubicin and Gliotoxin
before hepatocyte transplantation. We evaluated the de-
grees of cell engraftment by RT- PCR and immunoﬂu-
orescent staining for GFP and albumin. The transplanted
cells were detected by immunostaining for albumin and
the serum albumin was also measured.
Results: Although the detection for GFP by RT-PCR
was variable, the albumin was detected in all groups at
4 weeks after hepatocyte transplantation. The GFP and
albumin were also detected by immunoﬂuorescent
staining at 1 and 4 weeks after cell transplantation. In
control, the albumin production is maximal at 3 weeks
and after that it was rapidly decreased. In gadolinium
and doxorubicin treated group, the albumin productions
were increased up to 4 weeks. The albumin production of
gadolinium treated group was superior to that of doxo-
rubicin treated group.
Conclusion: The kupffer cells play the most important
role on cell engraftment in hepatic ﬁbrosis. Therefore the
perturbation to kupffer cells in hepatic ﬁbrosis should be
needed to increase the cell engraftment.
P-097
AUDIT OF LIVER REGENERATION OF
RODENT MODELS WITH HEPATIC
PARENCHYMA DISEASES AFTER
PORTAL VEIN LIGATION
Y.-Y. Jan1, T.-S. Yeh1, T.-C. Chen2 and
M.-F. Chen1
1Departments of Surgery, 1 Chang Gung Memorial
Hospital, Chang Gung University, Taiwan; 2Departments
of Pathology, 2 Chang Gung Memorial Hospital, Chang
Gung University, Taiwan
Background: Portal vein ligation (PVL) is increasingly
employed prior to major hepatectomy to enhance volume
of future liver remnant (FLR) to avoid post-hepatectomy
liver failure. The efﬁcacy of PVL on subjects with hepatic
parenchyma diseases substantially determines the fate of
ongoing hepatectomy.
Methods: Diabetic, cirrhotic and steatotic rodent models
were established, which underwent PVL and were sub-
sequently sacriﬁced at indicated time points.
Results: The restituted liver mass and redistributed vol-
ume ratio of FLR after PVL were lowest in steatotic rats,
followed by cirrhotic, diabetic and normal rats in
increasing order. ICG-R15 of steatotic rats after PVL
was most deteriorated than other groups. Both HEF and
TE1/2 of FLR after PVL detected by
99mTc-DISIDA
scintigraphy, representing hepatocyte function, were
most deteriorated in steatotic rats. Expression of cell-
cycle related genes (cyclin D1, cyclin B1, and TERT) was
most decreased in steatotic rats after PVL, while
expression of apoptosis-related genes (Bax and Daxx)
was most increased in steatotic rats after PVL. The basal
level of Kupffer cells, TNFa and IL-10 of diseased rats,
particularly steatotic rats, before PVL were strikingly
activated; while their Kupffer cells and TNFa expression
did not further boost in response to PVL as normal rats
did.
Conclusions: Steatosis, in addition to diabetes and cir-
rhosis, currently emerges as an important adverse factor
to inﬂuence liver regeneration after PVL with respect to
liver mass restoration and hepatocyte function of FLR,
which were orchestrated by cell cycling, apoptosis sig-
nalling and proinﬂammatory cytokines.
P-098
MITOCHONDRIAL FUNCTION AND
LASER AUTOFLUORESCENCE AFTER
70% HEPATECTOMY. AN
EXPERIMENTAL STUDY ON RATS
O. Castro e Silva, C. Kurachi, J. Ferreira,
T. Castro e Silva, A. K. Sankarankutty and V. Bagnato
Faculdade de Medicina de Ribeira˜o Preto
Objective: To evaluate the mitochondrial function of the
regenerating liver during the initial period after 70%
partial hepatectomy (PH).
Method: The remnant livers of 70 male Wistar rats (200
to 300 g) were studied at 5 minute intervals over a period
of 12 hours and then up to 12 days after 70% PH.
Mitochondrial respiratory rate, activated respiration
(state 3), basal respiration (state 4), mitochondrial
intumescence, membrane potential and hepatic regener-
ation were studied. Fluorescence was evaluated after
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stimulation with YAG laser at 532 nm using a Y probe
(Ocean Optics-USA) with 600 lm optic ﬁbers, one of
them releasing (excitation light) and six others capturing
light from the liver, and analyzed with a spectrophotom-
eter - IFSC-USP. Data were analyzed statistically by
nonparametric methods, with the level of signiﬁcance set
at 5%.
Result: There was a signiﬁcant reduction in the mito-
chondrial parameters studied 4 hours after PH
(P < 0.05). These values increased by 24 hours after PH
and remained at normal levels until the end of the study.
Laser autoﬂuorescence was signiﬁcantly reduced after 24,
36 and 72 hours (P < 0.05), increasing thereafter and
reaching control values by 10 and 15 days after PH.
Conclusion: Liver oxidative stress after 70% PH oc-
curred at higher intensity four hours after PH and the
process of liver regeneration evaluated by laser light was
signiﬁcantly increased between 24 and 72 hours, being
complete by 10 and 15 days after partial 70% hepatec-
tomy.
P-099
THE EXTRACELLULAR MATRIX (ECM)
AFFECTED PROLIFERATION AND CELL
ADHESION OF HUMAN ADIPOSE
TISSUE DERIVED MESENCHYMAL
STEM CELLS (HAD-MSCS) IN VITRO
S. O. Min1, S. W. Lee1, S. B. Choi2 and K. S. Kim1
1Department of surgery, Severance Hosp, Yonsei
University College of Medicine; 2Department of surgery,
Kuro Hosp, Korea University College of Medicine
Introduction: The human Mesenchymal stem cells
(hMSCs) have the potency of self-renewing and differ-
entiation into various kinds of cells. Extracellular matrix
(ECM) is an important factor that affects cell adherence,
growth, migration, apoptosis, and differentiation in vitro
and vivo.
Purpose: The Adipose-derived mesenchymal stem cells
(AD-MSCs) have CD29 (integrin) which is the receptor
for ECM-protein on the cell surface. The aim of this
study is to validate the efﬁcacy of ECM especially
ﬁbronectin and matrigel for cell expansions.
Materials and methods: AD-MSCs were obtained from
the abdominal fat of human. These cells were seeded
onto culture plates coated with ﬁbronectin-Human (FN),
matrigel basement membrane (M-BMM), collagen type I
and plates without ECM (control).
Results: hAD-MSCs in FN and M-BMM coated and
non-coated plate exhibited cytoplasm staining for inte-
grin-beta1. In all cultures, the extended ﬁbroblastic-
shaped cells that turned into rhomboid cells are most
frequently observed. The cell growth rates in non coated
culture plate were lower than those in FN and M-BMM
coated plates. Passage3 and passage5 at After 72 hour
culture under the different coated concentrations of FN,
M-BMM, collagen and non coated condition (control),
the control group has a lower growth rate. In a culture
with FN and M-BMM coated plate, a signiﬁcant change
was observed in comparison to the control group. We
observed an increase in cell proliferation with a maxi-
mum 140% at FN coated and 130% at M-BMM coated
by proliferation assays.
Conclusion: The cell morphology can be changed faster
in the FN, matrigel, collagen coated culture plates than in
not coated culture plates. Because proliferation and
adhesion with FN, matrigel can be enhanced for the
expansion, the culture within FN coated plate is needed
to encourage hAD-MSCs proliferation in vitro.
P-100
EFFECT OF NOVEL NECROSIS
MODULATOR, LC28-126 ON HEPATIC
ISCHAEMIA AND REPERFUSION
INJURY IN BEAGLE DOGS
J. Choi1, K.-M. Park1, S.-H. Kim2, S.-H. Chon1,
D. W. Hwang1 and Y.-J. Lee1
1Department of Surgery, University of Ulsan College of
Medicine, Asan Medical Center, Seoul; 2LG life science,
Daejun
Background: Liver is susceptible to ischaemia-reperfu-
sion (IR) injury during inﬂow occlusion for hepatectomy.
The extra-cellular release of high mobility group B1
(HMGB1) protein occurs following hepatic ischaemia
and necrosis. There is no effective pharmacological agent
available to prevent the release of HMGB1 or to ame-
liorate IR injury.
Aims: The current study aims to develop a hepatic IR
injury model in Beagle dogs and to test efﬁcacy of
necrosis modulator (LC 28-126, LG Life Science, Korea)
in prevention of IR injury in Beagle dogs.
Method: Following an approval from the institutional
review board, 6 male Beagle dogs were randomly as-
signed to the control (Group A, n = 3) and the treat-
ment group (Group B, n = 3). Under general
anaesthetics, the group B received intravenous infusion
of LC 28–126, (13mg kg-1 over 20 min) prior to 60 min
of left hepatic inﬂow occlusion and 60 minutes of rep-
erfusion. Both groups were tested for serum biochemis-
try, haematology, liver biopsy and plasma HMGB1 levels
for 48 hours.
Results: The maximum alanine transferase (ALT),
aspartate transferase (AST) and lactate dehydrogenase
(LDH) levels for the group A and B was: 868.3+/-
337.4 IU L-1 vs. 274.3+/-72.6 IU L-1 (P = 0.041, ALT);
1024.7+/-246.5 IU L-1 vs. 505.3+/-66.7 IU L-1
(P = 0.024, AST); and 962.7+/- 226.2 IU L-1 vs.
552.7+/-62.4 IU L-1 (P = 0.039, LDH). The left lobe
of the group B following inﬂow occlusion appeared less
congested and swollen than the group A. Histopatho-
logical ﬁndings at 60 minutes, 120 minutes and 48 hours
showed marked ischaemic necrosis in the control group,
where as the treatment group showed no evidence of IR
injury. Plasma HMGB1 levels according to ELISA
demonstrated signiﬁcantly lower HMGB1 levels in the
group B compared to A.
Conclusion: We have developed a hepatic IR injury
model in Beagle dogs. The present study demonstrated
that LC 28–126 reduced hepatic necrosis secondary to IR
injury in large animal settings.
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P-101
TRANSPORTERS INVOLVED IN THE
HEPATIC UPTAKE OF 99MTC-
MEBROFENIN AND INDOCYANINE
GREEN
W. De Graaf1, S. Hausler2, M. Heger1, R. J. Bennink3,
T. M. van Gulik1 and B. Stieger2
1Department of Surgery, Academic Medical Center,
Amsterdam; 2Division of Clinical Pharmacology and
Toxicology, Department of Medicine, University Hospital,
Zurich; 3Department of Nuclear Medicine, Academic
Medical Center, Amsterdam
Background: 99mTc-mebrofenin hepatobiliary scintigra-
phy (HBS) and the indocyanine green (ICG) clearance
test are used for the assessment of liver function before
and after liver surgery. The hepatic uptake of both
99mTc-mebrofenin and ICG is considered similar to the
uptake of organic anions such as bilirubin and bile acids.
However, little is known regarding the hepatic uptake
mechanisms of both substances. Recent evidence suggests
that the speciﬁc hepatic transporters for ICG and
99mTc-mebrofenin are distinct. A better understanding of
the hepatic uptake mechanisms of 99mTc-mebrofenin and
ICG is necessary for the interpretation of both tests in
patients with liver diseases.
Aim: To identify the human hepatic transporters of
99mTc-mebrofenin and ICG.
Methods: The uptake of 99mTc-mebrofenin was investi-
gated in cRNA-injected X. laevis oocytes expressing
human OATP1B1, OATP1B3, OATP2B1, and human
NTCP. Chinese hamster ovary (CHO) cells expressing
OATP1B1, OATP1B3, OATP2B1, and human NTCP
were used to determine the uptake kinetics of 99mTc-
mebrofenin and ICG. ICG uptake was additionally
visualized by confocal microscopy.
Results: OATP1B1 and OATP1B3 are involved in the
transport of 99mTc-mebrofenin. OATP1B1 showed an
approximately 1.5-fold higher afﬁnity for 99mTc-
mebrofenin compared to OATP1B3 with similar maxi-
mal transport rates. ICG is transported by OATP1B3
and NTCP.
Conclusion: The transporter speciﬁcity of 99mTc-
mebrofenin and ICG partially overlap with both
substances being transported by OATP1B3. Whereas
99mTc-mebrofenin is also taken up by OATP1B1, ICG is
additionally taken up by human NTCP.
P-102
DYNAMICS OF THE GLUTATHIONE-
OPHTHALMATE REDOX SYSTEM IN
THE VX2 RABBIT MODEL OF
SECONDARY LIVER TUMORS
R. Abbas1, K. Subramanian2, H. Brunengraber1,2 and
J. Sanabria1,2
1University Hospitals Case Medical Center; 2Case
Western Reserve University
Background: Available tumor markers have low sensi-
tivity/ speciﬁcity for the diagnosis of liver tumors. The
purpose of the present study was to evaluate the oxido-
reductive status of the liver and its metabolites as sur-
rogates of tumor subsistence and growth.
Methods: a-feto protein (AFP), Glutathione species
(GSH-GSSG), and Ophthalmic acid (OA) concentrations
and their turn over were measured by ELISA and LC-
MS/MS, respectively in the plasma of rabbits (n = 8) in
their healthy state and in the state of tumor growth after
implantation of the VX2 tumor. Animals were loaded
with 2H2O at 5% of their total body water. Enrichment
began 14 days prior to tumor implantation and 11 days
after tumor implantation. Daily blood draws were taken
on three consecutive days after enrichment. The tumor
growth was allowed for a period of 14 days when rabbits
were sacriﬁced. Livers were removed and liver tissue from
experimental and sham animals was submitted for
pathological studies.
Results: Tumor growth was found in 100% (6/6) of the
rabbits. AFP concentrations were similar in experimental
animals before and after tumor implantation and to AFP
levels from sham animals. GSH and GSSG concentra-
tions were similar in experimental animals before and
after tumor implantation and to sham animals. Labeling
of glutathione species and OA was similar in rabbits in
their healthy status when compared to their tumor
growth status and to sham animals. In contrast, a sig-
niﬁcant increase in ophthalmic acid concentration was
observed in experimental animals after tumor implanta-
tion when compared to animals prior to tumor implan-
tation (healthy status vs. tumor growth, P < 0.05) and
to sham animals (P < 0.05).
Conclusion: Ophthalmic acid concentration signiﬁcantly
differed in rabbits before and after tumor implantation
and growth. Alterations in the oxido-reductive state of
livers with subsequent increase in the ophthalmic acid
concentration appear to be a surrogate of tumor subsis-
tence and growth.
P-103
DOSE THE EXPRESSION OF MRNA OF
HH SIGNALING PATHWAY OF THE
HEPATOCELLULAR CARCINOMA/NON-
CANCEROUS LIVER TISSUE PLAYS A
ROLE IN PROGNOSTIC PREDICTION?
K. S. Jeng1, W. J. Jeng2, I. S. Sheen2 and J. C. Su3
1Far Eastern Memorial Hospital/Department of Surgery;
2Chang-Gung Memorial Hospital, Lin-Kou Medical
Center/Division of HepatoGastroenterology; 3Far Eastern
Memorial Hospital/Department of Medical Research
Background: Hepatocellular carcinoma (HCC) has a
high recurrence rate after resection. Up-regulated pro-
genitor cell proliferation induced by abnormal activation
of the hedgehog (Hh) signaling pathway may contribute
to carcinogenesis of the digestive tract tissues. It is
hypothesized that Hh activation is involved in the
recurrence of HCC.
Aim: To elucidate the correlation between the expres-
sions of Shh pathway (including PTCH-1, Shh, and Gli-
1) and the clinical outcomes of HCC.
Method: HCC and the noncancerous liver tissues were
obtained from 50 patients. Detection of mRNA included
extraction of RNA and reverse transcription, and
ampliﬁcation of cDNA of Shh, Gli1 and PTCH1 by real-
time PCR. The associations between clinical outcomes
and the mRNA ratio of Shh, Gli-1 and PTCH-1 were
analyzed.
Results: The expressions of Hh mRNA at HCC and non-
HCC are 3.55 ± 20.36 vs. 0.75 ± 0.74 in Shh (ratio:
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7.92 ± 44.29), 2.14 ± 4.69 vs. 2.17 ± 3.45 in Gli-1
(ratio: 1.84 ± 4.60), and 1.74 ± 4.56 vs. 1.03 ± 1.20 in
PTCH-1 (ratio: 5.43 ± 18.81). There were no associa-
tions between recurrence and mRNA ratio of Shh, Gli-1
and PTCH-1. Only PTCH-1 had a signiﬁcant association
with survival (P = 0.035). The clinicopathological
parameters that associated signiﬁcantly with mRNA
PTCH-1 were tumor size (P = 0.001), TNM stage
(P = 0.003), satellite nodules (P = 0.055), multinodu-
larity (P = 0.039), vascular permeation (P = 0.043),
and AFP value (P = 0.045). The Gli1 mRNA ratio had
association only with multicentric lesion (P = 0.013).
Conclusion: The ratio of mRNA PTCH-1 in HCC/non
HCC liver tissue is a signiﬁcant predictor of post resec-
tion survival.
P-104
DOES THE RATIO OF MRNA OF
LAMININ 5 SUBCHAINS OF
HEPATOCELLULAR CARCINOMA TO
NON CANCEROUS LIVER REMNANT
HAVE PROGNOSTIC VALUES? A
PROSPECTIVE STUDY
K. S. Jeng1, I. S. Sheen2 and J. C. Su3
1Far Eastern Memorial Hospital/Department of Surgery;
2Chang-Gung Memorial Hospital, Lin-Kou Medical
Center; 3Far Eastern Memorial Hospital/Department of
Medical Research
Background: Hepatocellular carcinoma (HCC) has a
high recurrence rate after resection. Laminins that are
extracellular matrix and localized mainly in basement
membranes, play roles in cell differentiation, adhesion,
and migration. Among them, laminin 5 (composed of the
a3, b3, and g2 chains, and the genes encoding these three
chains) is important in cancer invasion.
Aim: This prospective study was conducted to examine
different subchain mRNA of laminin 5 in HCC and the
noncancerous liver remnant, and to elucidate their ratios
in HCC recurrence.
Method: Twenty nine consecutive patients (19 men and
10 women, mean age: 53.7 ± 15.8 years) with HCC
undergoing curative hepatectomy were enrolled. Both
HCC and noncancerous liver tissues were obtained and
were examined for mRNA of laminin 5 subchains a3, b3
and g2.
Results: The mRNA of HCC and non-HCC was
1.23 ± 1.12 vs. HCC: 1.64 ± 1.08 (ratio: 1.55 ± 2.85)
for a3 subchain, 3.24 ± 9.30 vs. 0.87 ± 1.24 (ratio:
12.08 ± 30.80) for b3 subchain, and 0.13 ± 0.22 vs.
0.14 ± 0.27 (ratio: 7.02 ± 15.13) for g2 subchain. There
was no association of recurrence, or survival with any of
the laminin 5 subchains.
Conclusion: The ratios of mRNA of laminin 5 subchains
a3, b3 and g2 in HCC/non HCC tissue have no roles in
the prediction of post resection recurrence.
P-105
ANALYSIS OF THE ROLE OF IMATINIB
MESYLATE IN LIVER REGENERATION –
MICE MODEL
M.-C. Yu1,2, C.-N. Tsai2, K.-M. Chan1, W.-C. Lee1,
Y.-Y. Jan1 and M.-F. Chen1
1Chang Gung Memorial Hospital, Linkou; 2Graduate
Institiute of Clinical Medical Sciences, Chang Gung
University
Background: Liver regeneration is a compensatory
mechanism for the recovery of liver damage, liver resec-
tion, or hepatitis. Repeated inﬂammation would induce
liver cirrhosis, assumed of irreversible liver paranechymal
destruction with lower regeneration capacity.
Aim: We have proved that imatinib mesylate could
attenuate the ﬁbrotic status with imatinib mesylate. In
this study, the regeneratrion capacity of STI-571was
tested with the model of liver ﬁbrosis and liver resection.
Materials and methods: Four groups were set with/
without administration of CCL4 and STI-571 for C3H
mice. The intraperitoneal administration of CCL4 was
kept for 6 weeks and the STI-571 were kept for one week
and surgery was performed thereafter. The mice were
sacriﬁced at ﬁxed time interval and regeneration capacity
was checked.
Results: Elevation of AST occurred in CCL4 groups
whereas administration of STI-571 can decrease the de-
gree of liver damage. (P < 0.05) The IL-6 analysis
through ELISA and ﬂow-cytomix also showed higher
levels in the antiﬁbrotic groups. (P < 0.05) The prolif-
eration assay showed improved in the treatment.
(P < 0.05).
Conclusion: Administration can attenuate the degree of
ﬁbrosis and improve liver regeneration in mice model.
The mechanism is possibly through IL-6 pathway.
P-106
A CHARACTERISATION OF THE
LYMPHATIC PATTERNS OF
COLORECTAL LIVER METASTASES IN
A MURINE MODEL
A. Hadj, C. Malcontenti-Wilson and C. Christophi
Austin Hospital, Department of Surgery
Background: Studies on the development and dissemi-
nation of liver metastases have focused predominantly on
the haematogenous spread of tumour cells. There is little
information regarding the role of the lymphatic system in
this process with evidence of peri-tumoural lymphatics
enhancing the spread of liver metastasis.
Aim: The primary aim of this study was to assess the
degree of peri-tumoural lymphatics in liver metastases
and their possible contribution to tumour spread.
Immunohistochemistry for lymphatic markers (Podopl-
anin, LYVE-1) and a vascular marker (CD34) were em-
ployed. The study demonstrated the application of new
lymphatic markers in delineating lymphatic patterns in a
well established murine model of colorectal liver metas-
tases.
Methods: Harvesting of the murine livers occurred at
speciﬁc intervals (days 10–21) post induction of CRC li-
ver metastases. Livers were harvested and immunohis-
tochemistry was undertaken using the various antibodies.
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The lymphatic markers were used for their high sensi-
tivity for lymph vessels. Descriptive & quantitative
assessment was undertaken using digital microscopy &
image analysis. Statistical analysis was carried out using
ANOVA with post-hoc analysis.
Results: Both peri- and intra-tumoural lymphatic vessels
were identiﬁed in tumours. Podoplanin demonstrated
consistent positive staining patterns and signiﬁcant in-
creases in staining as the tumour size increased. Cross
sectional area of peri-tumoural lymphatics increased as
tumour size increased, displaying increased patency and
metastatic potential. The marker LYVE-1 displayed
variable staining patterns.
Conclusion: This study demonstrated the patency and
increase in the cross-sectional area of peri-tumoural
lymphatics in colorectal liver metastases over time. It
furthermore provided evidence for the spread of liver
metastases via the lymphatic pathway. These lymphatic
channels may be targeted in future research and provide
an avenue of treatment for the disease.
P-107
MESENCHYMAL STEM CELLS: THE
PROMOTION OF ENDODERMAL-
INDUCTION USING ACTIVIN A
S. W. Lee1, S. O. Min1, S. Y. Kim2, S. B. Choi3,
H. O. Kim4 and K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine, Seoul, Korea;
2Department of Laboratory Medcine, Kangnam Severance
Hospital, Yonsei University College of Medicine, Seoul,
Korea; 3Department of Surgery, Kuro Hospital, Korea
University College of Medicine, Seoul, Korea;
4Department of Laboratory Medcine, Severance Hospital,
Yonsei University College of Medicine, Seoul, Korea
Introduction: The most important consideration for
therapy using MSCs is the differentiation of target or-
gan’s cell type. In in-vitro hepatogenic differentiation of
MSCs, the main focus is to induct efﬁciently into endo-
derm stage. Activin A which is a similar signaling to
Nodal promotes the induction of deﬁnitive endoderm on
both of ES and MSCs.
Purpose: The protocols for induction into deﬁnitive
endoderm show different efﬁciency and reproducibility
depending on researchers or sources of MSCs. Thus, the
study on various conditions of Activin A is needed to
differentiate efﬁciently into deﬁnitive endoderm lineage
of MSCs.
Materials and methods: MSCs were isolated from human
adipose tissues and were cultured in MCM (MSCs Cul-
ture Medium) on human ﬁbronectin coated plate. At
70%~80% conﬂuence, the MSCs are harvested and cul-
tured in MCM supplemented with Activin A of 50 ng/
mL concentration and FGF4. The expression of genes
related with MSCs or primitive endoderm were analyzed
by RT-PCR. The changes of cell morphology were also
observed for differentiation by microscope & SEM.
Results: The expression of genes related with primitive
foregut endoderm was in groups using higher concen-
tration of Activin A. Morphology of differentiated cells
into deﬁnitive endoderm were not different to those of
undifferentiated MSCs. And, the expression of genes
related with functional primitive hepatocytes was in early
phase during hepatic differentiation. The cell morphol-
ogy was changed to similar cuboidal form in a time-
dependent manner.
Conclusions: Activin A promotes more rapid induction
of deﬁnitive endoderm. And, it makes an efﬁcient con-
dition of differentiation into primitive foregut endoderm
on higher concentration.
P-108
GENE EXPRESSION AND
POLYMORPHISMS RELATED TO
FOLFOX INDUCED HEPATIC INJURY
C. H. C. Pilgrim1,2, K. Brettingham-Moore1,
L. Satgunaseelan2, M. Michael1, B. N. J. Thomson1,3,
W. Phillips1 and R. Thomas1
1Peter MacCallum Cancer Centre, Melbourne, Australia;
2The Alfred Hospital, Melbourne, Australia; 3Royal
Melbourne Hospital, Melbourne Australia
Background: Chemotherapy induced hepatic injury
(CIHI) is an emerging and serious problem facing hepatic
surgeons resecting colorectal liver metastases. Steatosis,
steatohepatitis and sinusoidal obstruction syndrome fol-
lowing treatment with FOLFOX can increase morbidity
and mortality of hepatectomy. Although there is an
association between steatohepatitis and irinotecan, and
sinusoidal obstruction with oxaliplatin, there is currently
no way of predicting the development or extent of these
injury patterns.
Aims/Objectives: Correlations were sought between
clinical parameters; extent of CIHI as objectively graded
using a validated scoring system and genetic parameters.
Methods: Normal hepatic tissue stored in tissue bank
was accessed to grade extent of hepatic injury and med-
ical records reviewed to retrieve relevant clinical predis-
posing factors. Genetic polymorphisms and expression
level of key enzymes involved in the metabolism and
mechanism of action of 5-ﬂurouracil and oxaliplatin (key
components of FOLFOX) were investigated using
quantitative PCR and sequencing across exons contain-
ing known mutations associated with response to treat-
ment or toxicity in other organs.
Results: Preliminary data on 49 patients having under-
gone resection with tissue stored in the tissue bank is
presented.
Discussion: Prediction of CIHI based on genetic
parameters and clinical characteristics associated with
the development of injury may allow individualization of
therapy, minimizing morbidity of chemotherapy, while
maximizing potential beneﬁt of neoadjuvant therapy by
selecting those who are at lower risk of CIHI for che-
motherapy, and altering treatment regimen, timing or
order in those at higher risk of CIHI.
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P-109
EXPERIMENTAL STUDY OF HEPATIC
ARTERY SELECTIVE CLAMPING AND
ITS IMPACT ON HEPATOCELLULAR
FUNCTION
J. Tralhao1, A. Abrantes2, C. Gonc¸alves3, I. Portela1,
A. Sarmento3, F. Botelho4 and F. Castro-Sousa1
1Faculty of Medicine, Surgical III Department, HUC,
Coimbra, Portugal; 2Biophysics/Biomathematics Institute,
IBILI, Faculty of Medicine, Coimbra, Portugal;
3Biochemistry Institute, Faculty of Medicine, Coimbra;
4Biophysics/Biomathematics Institute, IBILI, Faculty of
Medicine, Coimbra, Portugal.
Aim: To study the impact of selective clamping of the
hepatic artery (HA) in hepatocellular function using an
animal model with normal liver.
Material and methods: 1) Forty Wistar rats (male,
2 months) were divided into four groups: three groups
were subjected to a HA clamping (HAC) ischemia period
for 60 min: group A (n = 13) submitted to a continuous
HAC; group B (n = 13) underwent to an intermittent
HAC for 30 min with 5 min of reperfusion; group C
(n = 6) underwent an Intermitent HAC for 15 min with
5 min of reperfusion and group D (n = 8) without HAC.
At the end of surgery a liver biopsy was performed.
2) Determination of liver blood markers three days and
hepatic extraction function (HEF) using 99mTc-mebrofe-
nin three days before and after surgery.
3) Isolation of hepatocytes from liver biopsy to evaluate
oxidative stress (DCFH2-DA); characterization of cell
death using Annexin-V/Propidium Iodide, Bcl-2, BAX
and TRAIL-Ligand and mitochondrial membrane po-
tential using JC-1 probe by ﬂow cytometry.
Results: 1) Mortality: G-A (7.6%), G-B, G-C and G-D
(0%);
2) There is signiﬁcant increase of blood markers before
and after HAC, but without differences between groups
A, B, C and D;
3) FEH maintained normal values without differences
between the four groups;
4) No signiﬁcant differences were observed in viability
and on the type of cell death, as well as in the production
of reactive oxygen species between groups (ns).
Conclusions: The selective HAC shows an increase of cell
viability with a decrease of hepatocyte necrosis and/or
apoptosis compared with Pringle maneuver. This ap-
proach used during laparoscopy hepatectomy is a po-
tential alternative to decrease per-operative bleeding
maintaining hepatocellular function.
P-110
COULD PRIOR SPLENECTOMY
MODULATE HEAT SHOCK PROTEIN 70
(HSP70) EXPRESSION DURING LIVER
REGENERATION?
M. Perini, F. Lopasso, E. Sobrozza, R. Sayao,
J. Requena, A. Cruz, M. Mazzurana, L. D’Albuquerque
and I. Cecconello
University of Sa˜o Paulo, School of Medicine, Dpt. of
Gastroenterology, Sa˜o Paulo, SP, Brazil
Background: Liver regeneration depends on the imbal-
ance between the amount of residual liver and the
inﬂammatory response that occurs after hepatectomy.
HSP70 is a chaperone over expressed in stress situations
like partial hepatectomies.
Objective: Analyze HSP70 expression in remain liver
tissue in rats during liver regeneration.
Method: Male Wistar rats were divided in two groups: 1-
hepatectomy (H+) 2- splenectomy and after 3 days
hepatectomy (S+). Animals were treated intravenously
with 20 mg/kg of deferoxamine and 20 mg/kg of n-ace-
tilcystein (NAC) 1 hour before surgical procedure. NAC
per os was also administered for 3 days before hepatec-
tomy. Each group was then divided according to post
operative (PO) day: 1, 3 and 7. Imunnohistochemistry for
HSP70 was performed and its expression in the liver was
evaluated according to its intensity (absent, mild, mod-
erate, high), percentage and localization (zone1, 2 or 3).
Splenic expression was also evaluated (intensity, cell type
and percentage).
Results: There were 51 rats and group H+ has 26 rats
and group S + 25 rats. In the H+ group, HSP70
expression in the spleen was different regarding intensity
(P = 0.04), cell type (P < 0.01) and percentage of cells
(P < 0.01). Also, HSP70 expression in the liver was
different regarding intensity (P = 0.05), percentage
(0.03) zone (P = 0.001). In the group S+, there was
difference regarding intensity (P = 0.03), percentual
(P = 0.06) and zone (P = 0.03) expression. When ana-
lyzed by linear regression regarding PO day and type of
surgery, prior splenectomy show decreased HSP-70
expression in the third PO day.
Conclusion: Prior splenectomy and NAC+DFX
administration does alter HSP-70 expression in the
remaining liver tissue.
P-111
ISCHEMIC PRECONDITIONING
INDUCES AUTOPHAGY TO PROTECT
STEATOTIC LIVER CELLS AGAINST
ISCHEMIA/REPERFUSION INJURIES
D. Degli Esposti1,2,3, M.-C. Domart1,2,3, A. Lemoine1,2,3
and D. Azoulay1,2,3
1AP-HP Hopital Paul Brousse, Service de Biochimie et
Biologie Moleculaire, Villejuif, France; 2Inserm U602,
Villejuif, France; 3Univ Paris-Sud, UMR-S 602, Villejuif,
France
Background: Autophagy is involved in the balance of
nutrient and energy metabolism, in the protein quality
control and endoplasmic reticulum stress mitigation and
in the maintenance of cellular homeostasis by engaging
in, organelle turnover. As a mechanism controlling cel-
lular homeostasis, autophagy is associated with the reg-
ulation of cell survival and cell death. In the liver, stress
signals could activate both cell death and autophagy and
it seems that autophagy could play a role in switching on/
off necrosis or apoptosis, depending on the cellular and
microenvironment context.
Aim: We provide data on autophagy involvement in
hepatocyte response to ischemia/reperfusion injury in
steatotic and peliotic livers altered by chemotherapy.
Methods: We have studied a series of 61 patients’ livers
treated with chemotherapy for colorectal cancer that
underwent ischemic preconditioning (n = 30) or not
(n = 31) before hepatectomy.
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Results: Our data show a signiﬁcant decrease of necrosis
in preconditioned livers (P = 0.038), associated with a
concomitant increase with Bcl-2 expression and an acti-
vation of autophagy. No change was observed in overall
apoptosis of hepatocytes or endothelial cells as assessed
by the TUNEL assay or by procaspase 3, 8 and 9
expression.
Conclusion: Our data suggest that Bcl-2 and beclin-1
could be major targets in the regulation of cell death
during ischemia/reperfusion injury. Therefore, auto-
phagy could be triggered by ischemic preconditioning in
steatotic livers to protect cells against necrosis by
allowing basal levels of ATP and amino-acids recycling.
P-112
ETHANOL EXPOSURE ATTENUATES
LIVER PATHOLOGY INDUCED BY BILE
DUCT LIGATION IN RATS
G. Wu1, Y. He2 and A. Klein1
1Comprehensive Transplant Center, Cedars-Sinai Medical
Center, Los Angeles; 2Department of Gastroenterology,
1st Afﬁliated Hospital of Zhongshan University,
Guangzhou
Introduction: Overconsumption of alcohol can lead to
alcoholic liver disease (ALD) while bile duct stones can
cause hepatic cholestatsis and secondary ﬁbrosis.
Objective: This study investigated the compounding ef-
fects of ethanol (Et) and bile duct obstruction in the
development of liver pathology.
Methods: A rat model of lobar hepatic cholestasis in-
duced by ligation of the right hepatic duct (rBDL) was
utilized to quantitatively discriminate the effects of eth-
anol on the development of liver pathology.
Results: Et dosed rats exhibited signiﬁcant increases in
blood ethanol and liver enzyme levels when compared
with animals not treated with Et dosing (P < 0.05).
Histological examination showed that Knodell scores
were signiﬁcantly higher in the Et dosed groups than in
the control group. In the rBDL model without Et dosing,
Knodell scores were also signiﬁcantly higher in the bile
duct ligated right hepatic lobes compared to the non-
ligated left lobes (P < 0.05). Et dosed livers displayed
up-regulated mRNA expression of genes relating to
inﬂammation (IL-1b, IL-6, MCP-1, MIP-1, TNF-a,
RANTES), ﬁbrogenesis, (TGF-beta1, and PDGF-A,
collagen 1a, aSMA, MMP-9 and TIMP-1) and liver
metabolism (ADH1, CYP2E1, GSTa2, and PPAPa)
when compared with control livers. Interestingly, the
severity of histological changes was signiﬁcantly reduced
in the right lobes of rBDL livers receiving Et dosing when
compared with the right lobes from the rBDL livers
without Et dosing (Knodell scores: 7.25 ± 2.99 vs.
11.5 ± 1.73, P < 0.05). Accordingly, mRNA expression
of selected pro-inﬂammatory cytokines, ﬁbrogenic
growth factors, ECM remodeling proteinases and liver
metabolism enzymes was signiﬁcantly lower in the right
lobes in Et + rBDL group compared to the rBDL group
(P < 0.05, respectively).
Conclusion: Et can induce ALD in rats. However, Et
appears to attenuate the severity of the liver damage in-
duced by bile duct ligation, suggesting that Et may have
anti-cholestasis properties.
P-113
DEFINE THE IMMUNOGENICITY OF
ESC-DERIVED CELLS OF HEPATIC
LINEAGE: EXPRESSION PROFILES OF
MHC CLASS I/II ANTIGENS
G. Wu, X. Zhao and A. Klein
Comprehensive Transplant Center at Cedars-Sinai
Medical Center, Los Angeles
Introduction: Embryonic stem cells (ESC) have the po-
tential to provide a renewable source of parenchymal li-
ver cells for treating liver diseases. A major foreseeable
hurdle in ESC-based cytotherapy, however, is the rejec-
tion reaction mounted by the host, presumptively
resembling that observed in allotransplantation.
Objective: This study investigated the expression proﬁles
of MHC class I and class II antigens by mouse ESC and
derivatives.
Methods: A mouse embryonic stem cell line (129) was
directed in differentiation cultures to provide cell deriv-
atives at different stages of hepatic lineage development.
Expression of mouse MHC class I and II was examined
by quantitative real-time PCR at mRNA levels and
immunocytochemistry at the protein levels.
Results: Undifferentiated mESC were directed to hepatic
lineage differentiation in vitro. At different stages cells
were identiﬁed by expression of stage speciﬁc markers,
including OCT-4 for undifferentiated ESC, FoxA2 and
Sax17 for deﬁnitive endoderm (DE); AFP and HNF4A
for hepatocyte progenitors, CYP7A1 and albumin for
mature hepatocytes. Expression of MHC class I (H2Kb)
and associated molecule B2M were detected at Day 5 of
ESC cultures, with co-expression of FoxA2 and Sax17.
ESC derivatives continued expressing MHC class I
throughout the hepatic lineage development. Low levels
of MHC class II molecule (H2D1 and H2Aa) were ob-
served in Day 5 cultures and their expression increased
by 2.5 fold at days 15 and 21 when the cells co-expressed
signiﬁcant levels of AFP, HNF4A, and low levels of
albumin and cytochrome P450 enzyme CYP7A1.
Expression of MHC I and II antigens were also demon-
strated by immunocytochemistry on ESC derivatives at
developmental stages.
Conclusion: The data demonstrate that MHC class I and
II molecules are differentially expressed by ESC deriva-
tives in the hepatic lineage, suggesting that these MHC
expressing ESC derivatives are potential targets for al-
loimmunity.
P-114
COMPARISON OF HEPATIC
DIFFERENTIATION POTENTIAL
BETWEEN HUMAN ES AND IPS CELLS
D. Choi1 and S. Thorgeirsson2
1Soonchunhyang University Hospital; 2Laboratory of
Experimental Carcinogenesis, CCR, National Cancer
Institute, National Institutes of Health, Bethesda, MD,
U.S.A.
Background: Human embryonic stem cells (hESC) and
induced pluripotent stem cells (hiPS) may provide func-
tional hepatocytes for drug discovery, developmental
biology, and therapeutic use. In this study, we aimed to
compare the capacity of hESC and hiPS to differentiate
towards hepatocytes.
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Method: Using sequential treatments of embryoid bodies
established from hESC and hiPS with various combina-
tions of cytokines and growth factors, we have developed
an optimal protocol permitting efﬁcient differentiation
towards hepatocytic lineage.
Results: After 4 weeks of treatment, both hESC and
hiPS acquired a polygonal shape and differentiated into
hepatocyte-like cells as judged by light and electron
microscopy, and quantitative RT-PCR analysis. Both
hESC- and hiPS-derived hepatocyte-like cells exhibited a
time-dependent upregulation of genes associated with
early- and late-stage hepatic differentiation, including a-
fetoprotein (AFP), CK8, CK18, albumin (ALB), asialo-
glycoprotein 1 (ASGPR1), tryptophan deoxygenase
(TDO), glucose-6-phosphatase (G6P), ornitine carbam-
oyl transferase (OCT), CYP1A2, CYP3A4, CYP3A7,
and CYP7A1. Increased expression of AFP, ALB and
ASGPR1 was conﬁrmed by immunostaining, western
blotting and FACS analysis. In addition, hESC- and
hiPS-derived hepatocytes accumulated glycogen secreted
high levels of albumin and showed signs of indocyanine
green uptake indicative of mature hepatocyte function.
Conclusion: hES and hiPS showed a comparable poten-
tial to differentiate towards hepatocytes in vitro. Trans-
plantation experiments using FACS-sorted ASGPR1-
positive cells derived from hES and hiPS cultures are
underway to formally test their ability to give rise to
differentiated hepatocytes in vivo.
P-115
OPTIMAL NON-THERMAL LIVER
ABLATION BY IRREVERSIBLE
ELECTROPORATION: RESULTS IN A
PRE-CLINICAL PORCINE MODEL
R. Brown1, M. Bower1, X. Li1, J. Zhang1, Y. Li1,
S. Sloan2, C. Scoggins1 and R. Martin1
1Div. of Surgical Oncology; Dept. of Surgery; University
of Louisville; Louisville, Kentucky; 2Dept. of Pathology
and Laboratory Medicine; University of Louisville;
Louisville, Kentucky
Background: Irreversible electroporation (IRE) has
emerged as a novel method of non-thermal tissue abla-
tion with potential applications in the treatment of he-
patic malignancies not amenable to standard thermal
ablation.
Objectives: We aimed to optimize the surgical technique
of hepatic IRE in the treatment of both a 2 cm and 3 cm
malignant lesion using an in vivo porcine model.
Methods: Multiple IRE ablations were performed in
three adult pigs (75–82 kg) via celiotomy. A pre-treat-
ment model was used to deﬁne the geometry and elec-
trical ﬁelds required for IRE ablations of 2 and 3 cm
diameter tumors with a 6 mm margin. Necropsies were
performed 24 hours after treatment. Samples were ob-
tained of each ablation margin and examined micro-
scopically by a collaborating pathologist.
Results: IRE was performed without technical difﬁculty,
intraoperative complication or cardiac arrhythmia.
Based on the pre-IRE model for treatment of a 2 cm
lesion, a 4-probe array of linear electrodes was deployed
in a 1.5 cm square conﬁguration with an active electrode
exposure of 2 cm. Ninety 100 lsec electrical pulses were
generated at 1500 V/cm and synchronized with the elec-
trocardiogram. For a 3 cm diameter treatment, the array
was applied four times by rotating the array at 90 degree
intervals about the center of the target. At necropsy,
gross hepatic tissue destruction was obvious at the
ablation sites without evidence of biliary leakage. Mea-
sured ablation sizes and volumes were signiﬁcantly larger
than predicted (P = 0.04) by the pre-IRE model (Table)
and non-viable margins were conﬁrmed by H&E staining
at all sites.
Post-Treatment Results of Hepatic Irreversible Electro-
poration
Location
Target
Size
Predicted
Treatment
Volume
(cm^3)
Measured
Treatment
Size
(cm)
Measured
Treatment
Volume
(cm^3)
Volume
Difference
(cm^3)
(Measured –
Predicted)
R Medial 2 cm 25.7 4.9 · 3.8 · 3.9 58.0 32.3
L Medial 2 cm 25.7 4.8 · 4.3 · 4.0 65.0 39.3
L Lateral 2 cm 25.7 4.4 · 3.6 · 3.8 47.8 22.1
R Medial 2 cm 25.7 3.3 · 3.9 · 3.9 39.7 14.0
R Lateral 2 cm 25.7 4.1 · 4.2 · 2.8 37.9 12.2
R Medial 3 cm 58.2 7.5 · 6.5 · 4.5 173.1 114.9
L Medial 3 cm 58.2 6.5 · 5.5 · 4.5 127.2 69.0
L Medial 3 cm 58.2 6.0 · 5.8 · 4.2 114.8 56.6
Conclusions: We demonstrate the optimal technique and
histologic success of hepatic IRE in a porcine model.
Further work is needed to reﬁne the model used for
electrical ﬁeld generation, to deﬁne the maximum toler-
ated ablation size, and to establish the longitudinal
effects of IRE. IRE holds promise as an effective non-
thermal modality in hepatic ablation.
P-116
REGULATING STUDY OF aPKC-i TO
EPITHELIAL-MESENCHYMAL
TRANSITION AND POLARIZATION
RECONSTRUCTION IN
HEPATOCELLULAR CARCINOMA
J. Wang, C. Ma, G. Du, J. Du and S. Zou
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology
Background: Previous studies have indicated that atypi-
cal protein kinase C-i (aPKC-i) was the core element of
the cell polarization regulation. It is pointed out that the
over-expression of aPKC-i may play an important role in
the loss of cell adhesion and invasion and metastasis of
hepatocellular carcinoma (HCC).
Objectives: The inﬂuence of aPKC-i was investigated on
polarization and invasion of tumor cells in the vitro EMT
(Epithelial-Mesenchymal transition) model. Inhibiting
carcinogenesis and progression, the treatment of drug for
aPKC-i signal pathway was studied and assessed.
Methods: The model of tumor cells with highly invasion
was established by EMT. The polarization of MMH-D3
cells was evaluated by immunoﬂuorescence of E-cadh-
erin, b-catenin and ZO-1. The comparison of distribution
and expression of aPKC-i was simultaneously tested in
pre-and post-EMT. The interaction of aPKC-i with Par6
and inhibiting effect of aurothiomalate (ATM) was
measured by GST pull down and co-immunoprecipita-
tion in prokaryocyte and eukaryon respectively.
Results: The vitro EMT model was successfully
constructed. In the polarized cells, the immunostaining
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pattern for E-cadherin and b-catenin remained restricted
to intercellular boundaries. The localization of ZO-1 at
cell borders was indicative of the presence of intact tight
junctions. On the contrary, it was revealed that the E-
cadherin and ZO-1 even declined to undetectable levels
and that the cytoplasmic redistribution of b-catenin in
ﬁbroblastoid cells. aPKC-i was high expression diffusely
in cytoplasm. aPKC-i can bind to Par6 through PB1-PB1
domain interaction. ATM is a highly selective inhibitor
of PB1-PB1 domain interactions between PKC-i and
Par6.
Conclusion: aPKC-i plays a critical important role in
polarization, invasion and metastasis of tumor cells. It
was determined that a small molecule inhibitor (ATM) of
the PKC-i/Par6 interaction would have potential as a
chemotherapeutic agent in the treatment of HCC.
P-117
LYMPHATIC PATTERNS OF
COLORECTAL LIVER METASTASES IN
A MURINE MODEL
A. Hadj, C. Malcontenti Wilson and C. Christophi
University Department of Surgery, Austin Hospital
Introduction: Studies on the development and dissemi-
nation of liver metastases have focused predominantly on
the haematogenous spread of tumour cells. There is little
information regarding the role of the lymphatic system in
this process. Recent evidence suggests that the spread of
liver metastases may be enhanced by the formation of
peri-tumoural lymphatics.
Aim: The primary aim of this study was to assess the
degree of peri-tumoural lymphatics in liver metastases
and their possible contribution to tumour spread.
Methods: Harvesting of the murine livers occurred at
speciﬁc intervals over days 10–21 post induction of CRC
liver metastases. Livers were harvested and immunohis-
tochemical staining was undertaken using the antibodies
Podoplanin, LYVE-1 and CD34. The lymphatic markers
were selectively used due to their high sensitivity for
lymphatic vessels. Descriptive and quantitative assess-
ment was undertaken using digital microscopy and image
analysis. Statistical analysis was carried out using
ANOVA with post-hoc analysis.
Results: Both peri- and intra-tumoural lymphatic vessels
were identiﬁed in tumours. Podoplanin demonstrated
consistent positive staining patterns and signiﬁcant in-
creases in staining as the tumour size increased. Cross
sectional area of peri-tumoural lymphatics increased as
tumour size increased, displaying increased patency and
metastatic potential. The marker LYVE-1 displayed
variable staining patterns.
Conclusion: This study demonstrated the patency and
increase in the cross-sectional area of peri-tumoural
lymphatics in colorectal liver metastases over time. It
furthermore provided evidence for the spread of liver
metastases via the lymphatic pathway. These lymphatic
channels may be targeted in future research to limit the
spread of CRC and provide an avenue of treatment for
the disease.
P-118
COMPARISON OF TWO HAEMOSTATIC
AGENTS IN A PORCINE LIVER TRAUMA
MODEL
K. Coenye1, C. Bourgain2, C. Keibl3, S. Nu¨rnberger3,4
and M. Van Griensven3
1Departments for Surgery and Emergency Medicine,
Kliniek Sint Jan, Brussels; 2Department for Pathological
Anatomy, University Hospital VUB, Brussels; 3Ludwig
Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna; 4Department of Traumatology,
Medical University of Vienna
Background: Surgical haemostasis in certain parts of the
body can be difﬁcult and hazardous. Commercial prod-
ucts are promoted to accomplish this task at a reasonable
cost.
Objectives: In this study we compared the effectiveness
of two topical gelatin-based haemostatic agents, Floseal
and Surgiﬂo in a porcine liver trauma model.
Methods: We compared the activity of Floseal (with
human or bovine thrombin), Surgiﬂo and Surgiﬂo
with added bovine thrombin in two porcine models. One
anesthetised piglet mimicked ‘‘normal’’ conditions, while
the other was kept in a status of hypotension, hypo-
thermia and haemodilution, necessitating inotropic sup-
port (‘‘critically ill’’). Laparotomy was performed, after
which we inﬂicted ﬁve identical stab wounds on each liver
lobe. Each wound was treated with one of the four
agents, while one wound was kept as a control. Hae-
mostasis was evaluated clinically. After euthanizing the
piglets, the pathologist performed a macroscopic,
microscopic and electron microscopic evaluation, blinded
for which agent was used in which wound.
Results: Clinically, Surgiﬂo was able to produce a clot
in some of its applications in the healthy piglet (‘‘normal’’
conditions), which was not the case in the critically ill
animal, not even with the added thrombin. Floseal in-
duced clotting in every wound. Both microscopic
(hematoxylin and eosin and Mallory stain) and electron
microscopic examination of the stab wounds conﬁrmed
that Floseal created a stable and dense agglomerate of
gelatin and ﬁbrin, ﬁrmly attached to the adjacent liver
tissue, whereas with Surgiﬂo, the gelatin contained
more air bubbles, there was a lot less ﬁbrin included in
the clot and the clot was not strongly adherent to liver
tissue.
Conclusion: It would seem that Floseal is a superior
haemostatic agent, creating a dense and stable blood
clot, even in a critically ill animal, hence ensuring
haemostasis.
P-119
INCREASED EXPRESSION OF IL-6
GENES DURING WARM ISCHEMIA AND
REPERFUSION WITH OR WITHOUT
PRECONDITIONING
A.-S. Kannerup1, A. Knudsen1, F.-J. Peter1,
M. Kruhøffer2 and F. V. Mortensen1
1Department of Surgery Gastroenterology L, Aarhus
University Hospital; 2Molecular Diagnostic Labarotory,
Aarhus University Hospital, Skejby
Background: Ischemia and ischemic preconditioning
(IPC) activates the pro- and anti-inﬂammatory cytokines.
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IL-6 stimulates the modulation of liver regeneration and
has a protective effect on liver ischemia-reperfusion in-
jury (I/R). From a previous study on pigs we know that
preconditioning increases IL-6 measured on EDTA
plasma.
Aims: In a rodent liver to investigate the inﬂuence of
ischemia and preconditioning on the expression of IL-6
genes.
Materials: Thirty-two male Wistar rats were randomized
into three groups: (A) control (n = 8); (B) I/R group
(n = 12); (C) IPC group (n = 12). A model of total in-
ﬂow occlusion was used. All rats except the control group
were subjected to 30 min of liver ischemia. Ischemic
preconditioning consists of 10 min of total inﬂow
occlusion and 10 min of reperfusion. Liver biopsy and
blood samples for standard liver parameters were col-
lected after 30 min of reperfusion. Total RNA was ex-
tracted from the biopsy and used for microarray analysis.
Results: The expression of IL-6 genes increased signiﬁ-
cantly in the IPC group compared to the control group
(P = 0.031). Compared to the I/R group the increase in
the IPC group were insigniﬁcant. No signiﬁcant increase
between the I/R group and the control group. ALAT
increased signiﬁcantly in both groups compared to the
control group (P = 0.010).
Discussion: Warm liver ischemia with or without ische-
mic preconditioning activates the expression of IL-6
genes. IL-6 increased signiﬁcantly in the IPC-group
compared to the control group and may be involved in
the hepatoprotective mechanism induced by IPC.
P-120
INTERRELATION BETWEEN
PERIPHERAL PLATELETS COUNT AND
PLATELETS ACTIVATION DURING AND
AFTER LIVER SURGERY IN PIGS
S. A. Kishta, A. Helmy and E. Khaled
Theodor Bilharz Research Institute
Background: Measures to ensure the safety of the do-
nors’ hepatectomy remain the main concern. Thrombo-
cytopenia can be related to liver cell mass and PVP.
Aims: Study of functions and ultra-structures of platelets
after mobilization and hepatectomy.
Methods: Fifteen healthy adult pigs were prepared for
hepatectomy by Rt. Tri-Segmentectomy. Peripheral
blood samples (15 mL) were collected as such, one pre-
operative, two intra-operative (one after the liver mobi-
lization and the other after resection) and two
postoperative (one after 7 days and the other after
14 days). Platelet count and markers of platelets activa-
tion, PF4 and b-TG, were measured. Separated platelets
from peripheral blood were examined by EM.
Results: Platelet count was decreased than preoperative
count signiﬁcantly after hepatic mobilization and resec-
tion (P < 0.05) & (P < 0.01) respectively. On 7th day it
remained signiﬁcantly (P < 0.05) lower. On 14th day it
increased and insigniﬁcantly different than preoperative
count. B-TG and PF4 were signiﬁcantly increased after
hepatic mobilization and resection (P < 0.05) &
(P < 0.01) respectively. On 7th day they increased but
insigniﬁcant to preoperative level. On 14th day they sig-
niﬁcantly increased (P < 0.01). EM examination of
platelets revealed all signs of activation after hepatic
mobilization & resection. These changes disappeared on
7th day and re-observed on 14th day.
Conclusion: Liver surgery causes an acute and profound
drop in platelet count and an increase in platelet activa-
tion. It is necessary to monitor platelet count and activity
and to give proper systemic coagulant therapy beside
platelets transfusion at the end of surgery for one week in
case of hepatectomy.
P-121
A RETROSPECTIVE ANALYSIS OF
BENZODIAZEPINE SEDATION VERSUS
PROPOFOL ANAESTHESIA IN 252
PATIENTS UNDERGOING ERCP
J. Lordan, J. Woods, P. Keeling and I. Paterson
Frimley Park Hospital, Surrey, UK
Introduction: Historically, HPB surgeons and gast-
roenterologists have undertaken endoscopic retrograde
cholangio-pancreatography (ERCP) using benzodiaze-
pine sedation (BS). This is poorly tolerated by a sub-
stantial number of patients leading to potential
premature abandonment, additional investigations and
therapeutics, thus, avoidable risk exposure to patients
and increased NHS cost. Furthermore, recent concerns
have been raised in the literature regarding safe sedation
techniques.
Aim: To compare the completion rates and safety of
ERCP using BS vs. light propofol anaesthesia (PA).
Patients and methods: This was a retrospective case
matched comparison analysis of consecutive patients
who underwent ERCP with BS vs. PA, with an anaes-
thetist present, over a 2-year period. Patients’ demo-
graphics, complications and completion rates were
recorded. Procedural monitoring included pulse oxime-
try, non-invasive blood pressure, ECG and end tidal
CO2. Statistical analyses included t-test to compare
continuous variables and v2 and Fisher’s exact test to
compare categorical variables. P < 0.05 was considered
signiﬁcant.
Results: Two hundred and ﬁfty two patients were in-
cluded in the study. 128 (50.8%) received BS and 124
(49.2%) received PA. The median age of the BS group
and the PA group was 69 years (range, 20–99 years) and
65 years (range, 26–98 years) respectively (P = 0.07).
The incidence of incomplete ERCP procedures in the BS
group and PA group was 14 (10.9%) and 5 (4%)
respectively (v2, P = 0.04, OR = 2.92, 95%CI, 1.02 to
8.38, Fisher’s exact test; P = 0.03).
Conclusion: Light propofol anaesthesia with an anaes-
thetist present for ERCP is safe and may signiﬁcantly
improve completion rates.
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P-122
COMPARATIVE MICROSURGICAL AND
REGULAR TERMINO-TERMINAL
COMMON BILE DUCT ANASTOMOSIS:
EXPERIMENTAL STUDY IN PIGS
M. Uribe1,2, M. Capelillo3, G. Guzman4, A. Godoy5 and
R. Rebolledo1
1Servicio y Departamento de Cirugı´a. Hospital del
Salvador, Campus Oriente. Facultad de Medicina.
Universidad de Chile. Santiago-Chile; 2Departamento de
Cirugı´a. Clı´nica Las Condes. Santiago-Chile; 3Servicio
Anatomı´a Patolo´gica Hospital del Salvador. Santiago-
Chile; 4Servicio de Medicina Nuclear Instituto de
Neurocirugı´a Asenjo. Santiago-Chile; 5Facultad De
Medicina Veterinaria Universidad de Chile, Santiago-
Chile
Bile duct repair due to intraoperative injuries has been a
complex subject for surgeons. Best results have been
obtained after immediately intraoperative termino-termi-
nal anastomosis. The most common long-term compli-
cations are ﬁbrosis and strictures. Factors related with
stenosis are suture material and surgical technique.
Aim: To compare two different common bile duct repair
techniques in an experimental model in pigs.
Methods: Twenty four Landrace-Largewhite pigs were
divided in two groups. Preoperative liver tests were ta-
ken. Under general anaesthesia a complete bile duct
transaction was performed. Immediate repair was done
with long term absorbable suture material using two
techniques. Group A: Interrupted stitches of 5-0 suture.
Group B: 9-0 running suture with microsurgical tech-
nique. Functional and biochemical studies were per-
formed at 90 days. A DISIDA Tc 99 test was done under
sedation. Animal were euthanatized. Radiological, macro
and microscopic ﬁndings were recorded. A Chi square
test was used for statistical purposes. P = 0.05 was
considered statistically signiﬁcant (SS).
Results: Eight pigs from group A presented with altered
liver test and none in group B. Median stenosis presented
was 29% of the original duct diameter in group A (range
10–63%) compared with 6% (range 0–28%) (SS). DIS-
IDA test was altered in 10/12 in group A and 0/12 in
group B (SS). Suture material was found in eight cases in
group A and none in group B (SS).
Conclusions: The incidence of bile duct stenosis post
surgical repair can be signiﬁcantly reduced using micro-
surgical technique in this experimental model.
P-123
DETERMINING PROBE ANGLE AND
INSERTION DEPTH AS SKIN BURN RISK
FACTORS DURING 915 MHZ
MICROWAVE ABLATION (MWA) IN A
PORCINE MODEL
D. Sindram, K. Haley, I. H. McKillop, J. B. Martinie
and D. A. Iannitti
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, NC
Introduction: Microwave antennae are placed transcuta-
neously with radiographic guidance or during laparos-
copy. Clustering of multiple 915 MHz antennae
expedites treatment of large tumors. We previously
reported safe inter-antennae distances to avoid skin
burns. However, clinically we observed skin burns when
antennae were angled inwardly. We hypothesized that
angulation, in addition to distance between antennae,
predicts occurrence of skin burns during liver ablations.
Methods: Three, cooled-shaft antennae were placed
percutaneously in a pyramidal conﬁguration with vary-
ing angles, inter-antennae distances and depths of pene-
tration, through the abdominal wall of a 25 kg pig into
explanted bovine liver. Serial MWAs were performed
(45 W, 915 Mhz, 10 min; Covidien Energy-based De-
vices, Boulder, CO). Insertion depth (ID) was determined
from antenna tip to liver surface and angulations were
regimented using hard-plastic molds. Thirty-six MWAs
were performed, with (n = 21) or without (n = 15) a
2 cm air-gap, simulating laparoscopy. Skin and perito-
neum temperatures were measured.
Results: Tissue temperatures >50C were noted to cor-
respond with skin burns. With a 2 cm air-gap between
abdominal wall and liver, antenna ID 2 cm or less re-
sulted in skin burns with parallel placement. Inward
angle (IA) augmented this effect and ID of more than
3.7 cm was required to prevent skin burns at all angles.
Without air-gap, an ID of ‡5 cm did not result in burns
using a parallel probe placement. However, IA resulted
in skin burns with any ID £ 7cm.
Conclusion: We recommend that when multiple antennae
are used simultaneously during laparoscopic MWA an
ID of >3.7 cm is observed with IA. During percutaneous
(non-laparoscopic) procedures, the antennae should be
inserted minimally 7 cm into the liver tissue when clus-
tered and inwardly angulated. A minimal inter-antenna
spacing of 1.5 cm should be observed.
P-124
A NEW SIMPLIFIED TECHNIQUE OF
PANCREAS TRANSPLANTATION IN
PORCINE MODEL
H. Fonouni, M. Tahmasbi Rad, M. Esmaeilzadeh,
M. Golriz, P. Jarahian, M. W. Buechler, J. Schmidt and
A. Mehrabi
Department of Surgery, University of Heidelberg
Introduction: The incidence of diabetes has increased
steadily. The only curative option is pancreas trans-
plantation (PTx). Experimental studies are important to
evaluate different aspects of PTx. Porcine model is
valuable due to anatomical and physiological resem-
blance to human.
Materials and methods: In landrace donor pigs (n = 32),
after median laparotomy, pancreas was mobilized; portal
and splenic veins were prepared. The common hepatic
and splenic arteries and bile duct were divided and li-
gated. The proximal part of duodenum at division of
right gastric branch was stapled. The third portion of the
duodenum was also freed up to the treitz ligament and
stapled. After systemic heparinization, pancreas was
perfused through abdominal aorta with HTK solution.
Portal and splenic veins were cut to evaluate the perfu-
sion sufﬁciency. The superior mesenteric artery and vein
were prepared at the border of duodenum and stapled.
Whole pancreato-duodenal graft was procured along
with portal vein and aortic jump graft containing both
mesenteric and celiac trunks. Pancreas was preserved in
HTK at 4C. In recipients, total pancreatectomy was
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done. IVC and aorta was prepared for vascular anasto-
mosis in an end-to-side manner. Pancreas was reperfused
and subsequently the duodenodoudenostomy was per-
formed end to side.
Results: The median cold and warm ischemia time were
10 hours (9–14) and 50 min (35–80), respectively. The
hemodynamic status of all pigs was stable throughout the
operation. The median follow-up period was 7 days (4–
10). There were no major intra- and postoperative com-
plications.
Conclusion: By using aortic jump graft there was no need
to perform additional arterial reconstruction resulting in
a short back-table and warm ischemia time. Further-
more, end-to-side portocaval and duodenoduodenal
anastomses makes this model of PTx more feasible than
other reported techniques offering a simpliﬁed, repro-
ducible experimental model of PTx.
P-125
ISLET TRANSPLANTATION IN THE
RAT: THE STATE OF THE ART
B. Silveira1,2, E. Chaib1, Y. Souza1,2, C. Pariz1,2,
F. Almeida1,2, L. Chen1, L. Marinucci1 and
L. D’Albuquerque1
1Transplantation Surgery Unit, Department of
Gastroenterology, University of Sa˜o Paulo, School of
Medicine; 2Universidade Nove de Julho
Background: The pancreatic islet transplantation is ex-
pected to be less invasive than a pancreas transplant
which is currently the most commonly used approach
and it consists of isolated islets from a donor pancreas
being inserted in another person.
Aim: Our aim is to give the reader broad overview of
current status of islet transplantation in the rat in the last
10 years.
Material and method: A literature search was conducted
using MEDLINE/PUBMED and SCIELO, using terms
for islet transplantation in the rat from 2000 to 2009.
Results: Out of 63 articles used, 58% were allografts and
42% were autografts. Analyzing both types of trans-
plantation the majority of the islets were implanted into
the liver through the portal vein. Furthermore the great
advantage of the liver as the site of islet transplantation is
its dual blood supply, which allows the total occlusion of
the portal venules, caused by embolization and the non-
infarted site of transplantation, which is nourished by
blood. Trying to increase the vascularization of the graft
soon after implantation, both vascular endothelial cells
and vascular endothelial growth factor could be used to
stimulate angiogenesis of the islet grafts.
Conclusion: While signiﬁcant progress has been made in
the islet transplantation ﬁeld, many obstacles remain to
be overcome. Three of the most important limitations are
the currently inadequate means for preventing islet
rejection, the limited supply of islets for transplantation
and also low tension of O2 in the site where the islets are
implanted.
P-126
IMMUNOHISTOCHEMICAL
EXPRESSION OF CARCINOGENIC
MARKERS FOR AMPULLA DE VATER´S
ADENOCARCINOMA
L. Haddad, R. Patzina, W. Andraus, A. Matheus,
E. Abe, E. Abdo, S. Penteado, A. Montagnini,
J. E. Da Cunha, M. Machado and J. Jukemura
Gastroenterology Department, Sa˜o Paulo University
School of Medicine
Background: The adenocarcinoma of Vater´s ampulla
(AVA) has two types of histological differentiation,
intestinal and pancreatobliliary. Each type has a different
biologic behavior and prognosis. The aim of the present
study was to analyze carcinogenic markers for this tumor
and the relationship between histopathological features
and prognosis.
Patients and methods: Clinical and histopathological
variables were analyzed in 97 resected ampullary ade-
nocarcinomas. The cases were histological classiﬁed into
intestinal and pancreatobliary types. The expression of
p53, p16, Ki67, CEA and CA19.9 was evaluated by
immunohistochemistry. Microsatellite instability was
evaluated by staining AVAs with antibodies against the
mismatch repair proteins (MMR): hMLH1, hMSH2 and
hMSH6.
Results: The positivity of p53, p16, Ki67, CEA and
CA19.9 were 36.1, 30.6, 37.1, 79 and 88%, respectively,
without any signiﬁcant difference between intestinal and
pancreatobiliary types. Positivity for p53 was signiﬁ-
cantly higher among poorly differentiated tumors
(P = 0.05) and AVAs with lymphatic invasion
(P = 0.006). Expression of Ki67 was associated with
short survival after resection (P < 0.001). Loss of MMR
proteins expression occurred in 14% of intestinal AVAs
and in 15.2% of pancreaticobiliary AVAs. It was asso-
ciated with prolonged survival (>5 years) (P = 0.03).
Survival was signiﬁcantly inﬂuenced by pancreaticobil-
iary type, tumor grade, nodal status and lymphatic
invasion. Immunohistochemical markers had no inﬂu-
ence on survival. Only regional lymph node involvement
and lymphatic invasion were independent risks factors
for survival in a multivariate analysis.
Conclusion: Immunohistochemical expressions of p53,
p16, Ki67, CEA, CA19.9 and MMR proteins showed no
difference between intestinal and pancreaticobliary types
of AVAs. Intestinal type tumors were associated with a
better prognosis, however only lymph node status and
lymphatic invasion were independent risk factors.
P-127
UTILIZING POLY-(A) RT-PCR TO
EVALUATE INDICATOR GENES IN
PANCREATIC AND PERI-AMPULLARY
CANCERS
M. Oliveira-Cunha1, A. Sheen1, R. J. Byers2 and
A. K. Siriwardena1
1Academic Hepatobiliary Unit, University of Manchester,
Manchester Royal Inﬁrmary; 2Department of
Histopathology, Manchester Royal Inﬁrmary
Background: Poly-(A) cDNA RT-PCR has been proved
to be a sensitive, cheap and robust technique in lym-
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phoma to evaluate potential tumour markers and may be
used as a platform for clinical measurement of prognostic
gene signatures.
Aim: To utilize Poly-(A) RT-PCR to measure expression
levels of 30 candidate Indicator genes, selected from
microarray studies.
Methods: With informed consent, sampling of fresh
pancreatic tissue sample was undertaken in 33 patients
undergoing pancreaticoduodenectomy. The RNA iso-
lated was then quantiﬁed by Nanodrop analysis. We
performed Poly-(A) PCR on RNA isolated using stan-
dard published protocols. Finally real-time PCR was
performed. Samples were normalized for two reference
genes (GAPDH and PSMB6) and tested for 30 Indicator
Genes that have been previously documented to be over
expressed in pancreatic cancer.
Results: Histopathology report demonstrated that 25
cases were pancreatobiliary malignancies and eight cases
chronic pancreatitis. The median RNA yield in pancre-
atic tissue samples was 132 ng/mL (range from 3.8 ng/lL
to 2594 ng/mL). The median purity ratio 260/280 was
2.09 (range from 1.41 to 2.15) for total RNA of pan-
creatic tissue. Poly-(A) cDNA was generated from
mRNA extracted from all samples. Analysis of 30 Indi-
cator genes demonstrated three genes, namely IGFBP3
(P < 0.035), PSCA (P < 0.001), and SPINK1
(P < 0.055), showed statistically different expression
between cancerous and benign pancreatic tissue samples.
Conclusions: These results demonstrate that Poly-(A)
cDNA technique is a feasible and is a sensitive technique
to RNA analysis of pancreatic tissue. These results sug-
gest that PSCA, SPINK1 and IGFBP3 may prove to be
valuable pancreatic cancer tumour markers.
P-128
IMMUNOHISTOCHEMICAL
EXPRESSION OF LH RECEPTOR IN
PANCREATIC SOLID
PSEUDOPAPILLARY TUMORS
I. Domı´nguez1, C. Chan1, F. Chable1, C. Ortiz-Hidalgo2,
J. Albores-Saavedra1, L. Uscanga1, G. Robles-Diaz1 and
M. Campuzano1
1Instituto Nacional de Ciencias Me´dicas y Nutricio´n
‘‘Salvador Zubira´n’’; 2The American British Cowdray
Medical Center/Universidad Panamericana School of
Medicine
Background: Solid pseudopapillary tumors (SPT) of the
pancreas are rare neoplasms mostly present in young
women, constituting 1–2% of all pancreatic exocrine
tumors. Several antibodies have been used in the evalu-
ation of these tumors. Recently, beta-catenin and E-
cadherin have been described as useful markers as well as
progesterone receptor and estrogen receptor beta sub-
type. No data exists regarding the expression of gonad-
otrophin receptors in SPT.
Aim: Determine the immunohistochemical expression of
LH receptor in solid pseudopapillary tumors of the
pancreas.
Methods: A retrospective review of 15 cases with SPT
from 2000 to 2007 was performed. Clinical, demographic
and follow up variables were recorded. Ten cases were
available for immunohistochemical study. A Lutropin-
choriogonadotropic hormone receptor (LHR) antibody
was used (GenWay Biotech Inc).
Results: Only one male patient was recorded among ten
cases reported. Median age at diagnosis was 28 years. Six
patients underwent pancreatoduodenectomy and four
distal pancreatectomy. Two patients required partial ve-
nous resection of the porto-mesenteric conﬂuence. The
median tumor size was 7.0 cm. Postoperative complica-
tions were present in 30% of patients, being delayed
gastric emptying and pancreatic ﬁstula the two most
common. Median follow up was 28 months (2–102). All
the patients showed cytoplasmatic and membranous
reactivity to LHR antibody.
Conclusion: SPT presents immunohistochemical reactiv-
ity to LHR. The clinical and pathophysiological impli-
cation of this ﬁnding needs to be elucidated.
P-129
A NOVEL DENDRITIC CELL (DC)
IMMUNOTHERAPY TRIAL FOR
LOCALLY ADVANCED PANCREATIC
CANCER (PC)
M. Shoup, S. Nagda, K. Micetich, M. Drakes, M. Borge,
D. Malhotra and P. Stiff
Loyola University Medical Center
Background: Locally advanced, unresectable PC is a
deadly disease despite aggressive local and systemic
therapy. Preclinical studies with other GI malignancies
have shown a synergistic response with radiation fol-
lowed by DC injection into the tumor. We developed a
trial for PC that includes three local injections of autol-
ogous DCs into the patients PC in an attempt to docu-
ment both safety and an immune response.
Methods: Patients with locally advanced PC underwent
leukapheresis with harvesting of their peripheral blood
mononuclear cells (PBMC) followed by chemoradiation
(CRT) with 5-FU and 50.4Gy. Some received gemcita-
bine-based therapy. The PBMCs were cultured in GM-
CSF and IL-4 and were pulsed with keyhole limpet
hemocyanin (KLH). The DCs were harvested and an
immature DC phenotype was conﬁrmed by FACS. After
CRT patients received three injections of 1–10 million
DCs into the treated PC. DTH skin testing and Elispots
were performed to determine the response to KLH
stimulation of PBMC before and after vaccine. Periph-
eral blood was analyzed with FACS for CD8+ as well as
CD4+CD25highFoxP3.
Results: From 2007 to 2009, 14 patients were enrolled
and 10 completed the course of DC injections. Patients
did not receive injections due to insufﬁcient cells (n = 3),
or complications from the CRT (n = 1). All 10 patients
tolerated the DC injections with no adverse events. The
median survival from signing consent was 14 months
(range 7–29). No DTH responses to KLH skin testing
were noted, nor were there any responses to KLH reac-
tivity as determined by IFN-c Elispot. No consistent
pattern of T cell alteration correlated with survival.
Conclusion: In this study, patients with pancreatic cancer
undergoing CRT followed by KLH pulsed DC injection
did not mount an immune response to KLH, and there
were no notable T cell alterations. This may be due to the
immunosuppressive effects of the pretreatment chemo-
therapy. Future studies will not include chemotherapy
prior to DC injection.
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EVALUATION OF THE LIPASE,
C-REACTIVE PROTEIN AND
LEUKOCYTES SERUM LEVELS
ACCORDING TO THE PANCREATIC
RECONSTRUCTION AFTER
PANCREATICODUODENECTOMY
M. Musiewicz, P. Lampe, S. Mrowiec and H. Palacz
Department of Gastrointestinal Surgery, Medical
University of Silesia
Background: Possible early complications or later secre-
tory insufﬁciency of the pancreas may be inﬂuenced by
the type of pancreatic reconstruction after pancreatico-
duodenectomy (PD).
Material and method: Sixty eight patients after PD per-
formed due to the pancreatic head cancer were analyzed.
Thirty seven patients after R0 and R1 resection were
enrolled – 21 men (57%) and 16 women (43%), the mean
age was 58.9 years (35–78). The patients were divided
into the 2 groups: PJ-pancreaticojejunostomy– 25
patients, PG-pancreaticogastrostomy– 12 patients. The
lekocytosis, lipase and C-reactive protein (CRP) serum
levels were examined before the surgery as well as on ﬁrst
and third day postoperatively.
Results: Intergroup analysis did not show any statistical
signiﬁcance as regards the lipase level before the operation
(P = 0.27) and the lipase level examined twice post-
operatively (P = 0.79, P = 0.31). The change dynamics
of the lipase level in both groups were statistically insig-
niﬁcant (PJ P = 0.17, PG P = 0.10). The CRP serum
level was statistically insigniﬁcant: before the operation
P = 0.12, two-time examination postoperatively P =
0.25, P = 0.36. The CRP serum level dynamics were
statistically signiﬁcant in both groups (PJ P < 0.0001,
PG P = 0.0024). Comparing the groups, the leukocytes
count changes, both before and after the operation, were
statistically insigniﬁcant (before the operation P = 0.43,
postoperatively P = 0.98, P = 0.93). The leukocytes
count dynamics were statistically signiﬁcant in both
groups (PJ P < 0.0001, PG P < 0.0001). Postoperative
complications were observed in 48% of cases of 1 group,
and in 41.2% of cases of 2 group, P = 0.2.
Conclusions: Variations in the leukocytes count, lipase
and CRP serum levels in the early postoperative period
are not depended on the pancreatic reconstruction. The
increase dynamics of CRP serum level and leukocytes
count in the both groups in the early postoperative per-
iod resulted from the surgery and were not depended on
the pancreatic reconstruction after PD.
P-131
NOVEL STRATEGIES FOR
LAPAROSCOPIC TREATMENT OF
STAGE IV (HEP) COLORECTAL
CANCER: SYNCHRONOUS, STAGED
RESECTIONS AND RADIOFREQUENCY
ABLATION
P. Sanjay, I. Tait and F. Polignano
Ninewells Hospital and Medical School
Background: There is minimal data regarding the role of
a totally laparoscopic approach for synchronous stage IV
(Hep) colorectal cancer (CRC).
Aims: This study aimed to analyse laparoscopic Syn-
chronous, Staged resections and synchronous resection
and Radiofrequency ablation (RFA) as treatment op-
tions for stage IV CRC.
Methods: All patients who underwent totally laparo-
scopic management of stage IV CRC between 2006 and
2009 were reviewed.
Results: Eighteen patients were identiﬁed. The median
age was 68 (range 44–85). Seven underwent a synchro-
nous colon and liver resection [three anterior resections
(AR) with left lateral liver sectionectomy (LLS) and one
AR with atypical Sg 4 resection, 2 right hemicolectomies
(RH) and atypical resection of Sg.4 lesion and 1 RH and
atypical resection of Sg.3 lesion]. Six underwent a re-
versed (‘‘liver ﬁrst’’) approach in two stages which in-
cluded one posterior sectionectomy, one LLS, 3 Sg.7
resection and one right hepatectomy followed by a co-
lectomy after a mean time period of 47 days (sd 27 days).
The colon resections in this group included ﬁve AR and
one RH. Five patients initially considered for a syn-
chronous resection were found unsuitable for it and
underwent synchronous colon resection and RFA of liver
metastasis. No difference was noted in the operating time
(420 vs. 372, P = 0.059) and cumulative postoperative
stay (15 days vs. 14 days, P = 0.5) between the syn-
chronous and staged resections. The mean operating time
and postoperative stay for the RFA group was 290 min
and 8 days. No in hospital mortalities were noted.
Conclusion: Totally laparoscopic resection of stage IV
CRC is feasible with low morbidity in selected cases.
Patients unsuitable for a synchronous resection, a staged
‘‘liver ﬁrst’’ approach is an alternative with no increase in
operating time and hospital stay. Laparoscopic syn-
chronous resection and RFA is a suitable alternative in
patients with unresectable liver metastasis.
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IMPROVED SHORT-TERM OUTCOMES
AFTER LAPAROSCOPIC LIVER
RESECTION COMPARED TO OPEN
LIVER RESECTION: A META-ANALYSIS
R. Mirnezami1, N. Berridge1, K. Chandrakumaran2,
A. Mirnezami3 and R. P. Sutcliffe4
1HPB Department Hammersmith Hospital, London;
2Department of Surgery, Basingstoke Hospital,
Hampshire, UK; 3Department of Colorectal Surgery,
Southampton General Hospital, UK; 4Department of
Hepatobiliary Surgery, Royal London Hospital, London,
UK
Background: There is increasing evidence that laparo-
scopic liver resection (LLR) may be equivalent or supe-
rior to open liver resection (OLR).
Aim: To compare, LLR and OLR with regard to short-
term outcomes by meta-analysis.
Methods: An electronic search using MEDLINE, EM-
BASE, CINAHL and Cochrane databases was con-
ducted to identify studies comparing outcomes after LLR
and OLR. Evaluated outcomes were operating time,
blood loss, postoperative complication rate and length of
hospital stay. A random-effects model was used and the
I2 test was used to assess study heterogeneity. Results are
expressed as either weighted standardized mean differ-
ence (WSMD) or odds ratio (OR) with 95% conﬁdence
intervals (CI).
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Results: Fourteen studies were included, reporting on
647 liver resections (284 LLR, 363 OLR). Eleven studies
(79%) were case-controlled series, where controls were
matched for tumour size, location and type of resection.
Methodological quality was variable, and there was sig-
niﬁcant study heterogeneity. Mean operating time was
longer for LLR (WSMD = 0.644, 95% C.I 0.41, 0.88,
P < 0.001). Blood loss (WSMD = -0.57, 95% C.I = -
0.77, -0.38, P < 0.001), length of hospital stay
(WSMD = -0.66, 95% C.I = -0.84, -0.47, P < 0.001)
and postoperative complications (OR = 0.46, 95%
C.I = 0.29, 0.73, P = 0.001) were signiﬁcantly reduced
after LLR compared to OLR.
Conclusions: In selected patients, laparoscopic liver
resection results in reduced blood loss, fewer complica-
tions and shorter hospital stay compared to open sur-
gery. With increasing expertise and technological
advances, the indications for laparoscopic liver surgery
will continue to expand, provided that long-term out-
comes are not compromised.
P-133
EVOLUTION OF LAPAROSCOPIC LIVER
RESECTION IN 300 PATIENTS:
OUTCOME ASSESSMENT
J. Buell1, R. Cannon1, G. Brock1, M. Marvin1,
M. Thomas2, S. Rudich3, T. Doty3, K. Bilinski4,
K. Ravindra1, S. Barve1, G. Neff3, L. Marsano1,
A. Barve1, C. McClain1 and K. McMasters1
1University of Louisville; 2Bethesda North Hospital;
3University of Cincinnati; 4Jewish Hospital
Laparoscopic liver resection evolved over the last decade,
from peripheral resections to major resections.
Methods: Retrospective analysis of a database approved
by the IRB, ANOVA and multivariate analysis was used
to assess successive cohorts.
Results: Out of ﬁve hundred, three hundred were (146
malignancy, 154 symptomatic) laparoscopically resected.
One hundred and eighty three female median age 54, and
median tumor size of 4.0 cm, 37 cirrhotic, 16 prior open
resections. Seventy seven major (6 trisegs, 44 R, 27 L)
resections. Pre op diagnosis: Colorectal n = 40, Non
colorectal n = 34, Hepatoma n = 62, cholangiocarci-
noma n = 10, hemangioma n = 52, adenoma n = 19,
FNH n = 26, cyst n = 39, other n = 23. Cirrhotics had
a higher mortality rate (8% vs. 1%; P < 0.01). Majors
for larger tumors (7.8 vs. 4.3 cm; P < 0.001) Median
follow up for this current series was 30 months. Local
recurrence was 1.6%. In ﬁeld and distant recurrences was
7.9%, and 4.7%. Complications increased with the
number of cirrhotic and redos.
Conclusions: During our experience, laparoscopic liver
resection realized improvements in operative times,
transfusion requirements, and surgical margins. The last
era witnessed a rise in patients with cirrhotics and re-
operative hepatectomies.
P-134
LAPAROSCOPIC LIVER RESECTION IN
THE PATIENTS WITH HISTORY OF
UPPER ABDOMINAL SURGERY
K. S. Ahn, H-S. Han, Y-S. Yoon and J. Y. Cho
Seoul National University Bundang Hospital
Purpose: Liver is the organ where most of cancers
including gastrointestinal malignancy can metastases.
Therefore, laparoscopic liver resection can be performed
frequently in patients with previous operation history.
The purpose of this study is to assess the feasibility and
clinical outcomes of laparoscopic liver resection in pa-
tients with previous operation history by reviewing our
experiences of laparoscopic liver resection.
Methods: We deﬁned upper abdominal surgery which
the scar extended above the umbilicus and the manipu-
lation was performed at upper part of abdomen. Out of
202 total laparoscopic liver resections, 47 patients
underwent laparoscopic liver resection after previous
upper abdominal operation between January 2004 and
July 2009. Total 55 operations in 47 patients were pre-
vious operation and included hepatobiliary and pancre-
atic operation (n = 29), radical subtotal gastrectomy
(n = 2) and surgery of colorectal malignancies (n = 24).
Results: The mean operation time was 312.3 min and the
mean blood loss was 481.0 mL. Transfusion was required
in seven patients (14.9%). There was one conversion to
laparotomy due to severe adhesion. Complication oc-
curred in 11 patients (23.4%) including ﬂuid collection
(n = 3), bile leakage (n = 5). The mean hospital stay
was 10.6 days. When we compare theses results with the
patients without history of previous operation, there were
no signiﬁcant differences. However, among patients with
previous upper operation history, patients with previous
hepatobiliary operation history showed longer operation
time and postoperative morbidity than those with non
hepatobiliary operation history.
Conclusion: Laparoscopic liver resection for patients
with previous upper abdominal surgery history is safe
and feasible. For patients of metastatic or recurred he-
patic tumor, with further study about oncologic safety,
laparoscopic liver resection can become an established
treatment modality in the era of laparoscopy.
P-135
SHORT-TERM OUTCOME FOLLOWING
OPEN AND LAPAROSCOPIC LEFT
LATERAL LIVER RESECTION
O. Villanger1, I. Pavlik Marangos2, A. Kazaryan2,
B. Røsok1, A. Rosseland1, Ø. Mathisen1 and B. Edwin1,2
1Division of Surgery, Oslo University Hospital,
Rikshospitalet, Oslo, Norway; 2The Interventional Centre,
Oslo University Hospital, Rikshospitalet, Oslo, Norway
Table 1. for P-133
Cancer Cirrhosis Major Prior Age Size EBL OR time Tx Comp Margin Mortality
100 47% 2% 25% 2 51 4.9 cm 150 cc 3.0 hours 8% 14% 0.9 cm 3%
200 49% 7% 24% 2 56 5.5 cm 150 cc 2.5 hours 8% 14% 0.8 cm 1%
300 50% 28% 28% 12 55 5.3 cm 150 cc 2.0 hours 4% 28% 1.3 cm 1%
P-value NS <0.001 NS <0.001 <0.01 <0.01 NS <0.001 <0.001 <0.01 <0.01 <0.01
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Background: Left lateral sectionectomy (LLS) is the
easiest anatomical resection suitable for laparoscopic
technique and has been our preferred method since 1998.
LLS is a standardized procedure appropriate for com-
paring conventional and laparoscopic technique. It may
however be difﬁcult to compare open and laparoscopic
liver resections due to additional procedures.
Aim: To compare, short-term outcome of the two
approaches.
Methods: Out of total 40 patients in the laparoscopic
group and 32 patients in the open group, there were 10
‘‘true’’ LLS by conventional surgery that were compared
to 27 LLS performed laparoscopically from December
1996 to October 2009. The median age was 68 years (27–
75) in the group with conventional approach (CG) and
65 years (23–81) in the laparoscopic group (LG). Median
ASA score were three in the CG and two in the LG. Our
material includes eight malign and two benign tumors in
the CG and 19 malign and eight benign tumors in the
LG.
Results: No perioperative mortality occurred. The med-
ian operation time was 190 min (95–270) in CG and
170 min (100–345) in LG. The median perioperative
bleeding was 450 mL (200–500) in CG compared to
170 mL (0–2000) in LG. We experienced three patients
with perioperative complications in CG and one patient
in LG. None of the laparoscopic procedures were con-
verted. The median postoperative stay in hospital was
6.5 days (3–29) in CG and 3 days (1–10) in LG. The
median follow up was 71 months (24–138) in CG and
45 months (0–90) in LG. Concerning combined LLS and
local resection, eight patients in CG were excluded from
the study due to non comparable technique. In LG (nine
patients) we found no difference concerning complica-
tions and hospital stay compared to ‘‘true’’ LLS. Median
operation time was 205 min (148–340) and blood loss
was median 300 mL (0–2000).
Conclusion: Laparoscopic LLS for lesions of the liver is
safe and feasible in experienced centres. Short-term out-
come of laparoscopic LLS is comparable to conventional
surgery.
P-136
LAPAROSCOPIC HEPATECTOMY FOR
CAUDATE HEPATIC TUMORS
K.-H. Chen, H.-A. Chen, J.-M. Wu, C.-C. Tu,
K.-H. Cheng and S.-H. Huang
Division of General Surgery, Department of Surgery, Far-
Eastern Memorial Hospital Pan-Chiao, Taipei, Taiwan
Background: Traditional indications for laparoscopic
hepatectomy include lesions in the segment 2, 3, 4, 5 and
6 of the liver. For S1 lesions, the left lateral section fre-
quently interfere the surgical exposure in traditional open
hepatectomy. In addition, the close relation to the great
vessels is another possible obstacle. For the particular
anatomical location, laparoscopic caudate hepatectomy
has been reported rarely.
Aim: To evaluate the feasibility and clinical outcome, we
retrospectively reviewed the patients received laparo-
scopic hepatectomy for caudate hepatic tumors in our
institute.
Methods: From February 2006 to October 2009, total
ﬁve patients were enrolled. There were four male and one
female aged from 43 to 67 years (mean 54.8 years). The
nature of the hepatic tumors was metastatic in three and
HCC in two patients. One patient also received laparo-
scopic wedge gastric resection for malignant gastric gas-
trointestinal stromal tumor (GIST). Laparoscopic S1
caudate hepatectomy was done through 4 port technique.
Under pneumoperitoneum, the patient was placed in
modiﬁed lithotomy position. After adequate hepatic hi-
lum retraction and exposure, the inﬂow vessels to the S1
were dissected and divided selectively. The liver paren-
chyma was transected by EndoCUSA (Cavitron Ultra-
sonic Surgical Aspirator).
Results: Except the patient with gastric GIST, all the
other patients resumed oral intake on the day after sur-
gery. The hepatic resection included laparoscopic cau-
date segmentectomy in four and left lateral
sectionectomy with caudate segmentectomy in one. The
postoperative hospital stay ranged from 4 to 11 days
(mean 6.6 days). All section margins were free of tumor
involvement.
Conclusion: Laparoscopic hepatectomy for caudate he-
patic tumor seemed feasible. The intrinsic illumination
and image system of laparoscopic approach provided an
addition beneﬁt to avoid the interference of the overlying
lateral section of liver in this particular region.
P-137
ELEVEN YEARS EXPERIENCE OF
LAPAROSCOPIC HEPATECTOMY BY
CURETTAGE AND ASPIRATION
X. J. Cai, Y. F. Wang, H. Yu, X. Liang, Z. Y. Zhu and
Y. Dai
Sir Run Run Shaw Hospital, College of Medicine,
Zhejiang University
Background: Laparoscopic hepatectomy is still per-
formed in a few institutions worldwide mainly for the
risk of massive bleeding and lack of efﬁcient instrument
for liver transection. In our institution, a special instru-
ment and some surgical techniques were developed to
facilitate laparoscopic hepatectomy.
Aim: To report the 11 years experience of laparoscopic
hepatectomy by curettage and aspiration.
Method: From August 1998 to July 2009, 315 laparo-
scopic hepatectomies were performed by authors in Sir
Run Run Shaw Hospital. The technique of hepatectomy
by curettage and aspiration (LHCA) was used in all cases
and laparoscopic multifunctional operative dissector
(LMOD) was used as the main instrument for liver
transection. Procedure included local resection, segmen-
tectomy, left lateral segmentectomy, combined resection
of caudate lobe, and left/right hemihepatectomy. A
technique of laparoscopic selective inﬂow occlusion was
used in hemihepatectomy to decrease blood loss.
Results: The operation of LHCA was completed suc-
cessfully in 305 patients. 10 patients had to be converted
to an open hepatectomy. Mean operating time was
158 min. The mean length of postoperative hospital stay
was range 1–18 days. There was no mortality. Compli-
cation occurred in nine patients. Selective inﬂow occlu-
sion was performed successfully in all cases of
hemihepatectomy and the mean blood loss of these cases
was 271 mL.
Conclusions: The technique of laparoscopic hepatectomy
by curettage and aspiration is a safe and effective tech-
nique for liver resection. The technique of selective inﬂow
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occlusion is also a safe technique which decreased in-
traoperative blood loss. With accumulated experience
and developed instrument, laparoscopic liver resection
will be an ideal procedure for liver lesion as well as open
procedure.
P-138
LAPAROSCOPIC MAJOR
HEPATECTOMY CAN BE SAFELY
PERFORMED WITH COLORECTAL
SURGERY FOR SYNCHRONOUS
COLORECTAL LIVER METASTASIS
H. Tranchart1, P. S. Diop1, P. Lainas1, G. Pourcher1,
D. Franco1,2 and I. Dagher1,2
1Department of General Surgery, Antoine Be´cle`re
Hospital, AP-HP, Clamart, F-92140, France; 2Univ Paris-
Sud, Orsay, F-91405, France
Background: The optimal strategy for resectable syn-
chronous colorectal liver metastases remains controver-
sial. Although some authors advocate a staged treatment,
an increasing number of studies have reported that
combined colorectal and liver resection is feasible and
safe. Laparoscopic combined colon and liver resection in
primary colorectal cancer with synchronous liver metas-
tases has been reported but there are no speciﬁc data for
major liver resections.
Aim and Objective: To evaluate the feasibility of a
simultaneous entirely laparoscopic procedure in the light
of the beneﬁts of laparoscopy in both colon surgery and
liver resection, and discuss the beneﬁts of this combined
strategy.
Methods: We present two cases of totally laparoscopic
major liver resections associated with laparoscopic colo-
rectal resection for synchronous liver metastases and give
emphasis to technical aspects. Duration of surgery, blood
loss and postoperative outcome were evaluated.
Results: We showed that laparoscopic colon resection
with synchronous right hepatectomy or left hepatectomy
for liver metastasis was feasible and safe with only one
suprapubic 5 mm trocar added to our usual trocar sites.
The mean duration of surgery was 327 min with a mean
estimated blood loss of 200 mL. The postoperative
course was uneventful. Patients left hospital at day four
and day six.
Conclusion: In selected patients, laparoscopic major
hepatectomies for unilobular synchronous metastases
can be safely performed simultaneously with colorectal
surgery.
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LAPAROSCOPIC LIVER RESECTION IN
PATIENTS WITH CIRRHOSIS: AN
AMERICAN EXPERIENCE
R. Cannon1, G. Brock1, M. Marvin1, M. Thomas2,
S. Rudich3, T. Doty3, K. Bilinski4, K. Ravindra1,
S. Barve1, A. Barve1, G. Neff3, L. Marsano1,
C. McClain1, K. McMasters1 and J. Buell1
1University of Louisville; 2Bethesda North Hospital;
3University of Cincinnati; 4Jewish Hospital
Laparoscopic liver resection has become commonplace in
selected centers. European groups have demonstrated a
mastery of laparoscopic resections in cirrhotic study was
to evaluate our experience with cirrhotic patients who
underwent laparoscopic resection.
Methods: Retrospective analysis of a prospectively col-
lected database was performed after IRB approval.
Multivariate analysis was performed between patients
with and without cirrhosis.
Results: Of 300 laparoscopic resections, 37 were cir-
rhotic. All patients were resected for presumed cancer.
Seven were later found to be regenerative nodules or
hamartomas. Median follow up for this series was
30 months. All mortalities were due to infection or liver
failure. The median MELD was 12, however, there was
no correlation between MELD and survival.
Conclusions: Laparoscopic liver resection can be per-
formed in patients with cirrhosis. Operative time and
blood was similar but an increased mortality was recog-
nized in cirrhotics. Currently, American centers are
acquiring experience essential to achieve equivalent sur-
vival between cirrhotic and non cirrhotic tumor patients.
P-140
A SAFE AND EFFICIENT PRINGLE’S
MANOEUVRE FOR LAPAROSCOPIC
LIVER RESECTION
R. Saif, S. Robinson, G. Sen, M. Jacob, D. Manas and
S. White
Department of Hepatopancreatobiliary and
Transplantation Surgery, Newcastle upon Tyne Hospitals
NHS Foundation Trust, United Kingdom
Background: Totally laparoscopic liver resection (TLLR)
is becoming an alternative to open liver resection in se-
lected patients. Even minor bleeding during TLLR can
signiﬁcantly affect visibility resulting in open conversion.
The Pringle’s manoeuvre can be usefully applied during
TLLR but this can be technically challenging. We present
a safe and efﬁcient technique that has evolved during our
series of TLLR.
Table 1. for P-139
Cirrhosis Cancer Major
Prior
Surgery Age Size
EBL
(median)
OR
time Transfused
ICU
Admission Morbidity Margin Mortality
Yes
n = 37
75% 8% 0% 58 2.5 cm 150 cc 2.5 hours 14% 24% 27% 0.8 cm 8%
No
n = 263
41% 29% 6% 54 4.5 cm 150 cc 2.5 hours 6% 9% 11% 1.0 cm 1%
P-value <0.03 <0.009 NS <0.03 <0.001 NS NS 0.09 <0.01 0.19 NS <0.001
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Methods: A tourniquet is routinely positioned around
the hepato-duodenal ligament for all TLLR. The
Goldﬁnger is a long instrument with a versatile tip
commonly used in bariatric surgery. A tape is prepared
with a vicryl ligature fashioned in such a way to loop
the tape in the receiver of the Goldﬁnger. The Gold-
ﬁnger is then introduced from the patient’s right side
using a port placed in the anterior axillary line. A
snugger is introduced into the peritoneal cavity and the
tape ends are brought out alongside a port in the pre-
ferred position.
Results: Twenty two patients were included in this series
(12M:10F), mean age 65 years (41–79 years). The main
indication for resection was for malignant disease (90%).
three patients were converted to an open operation
(concern over margin n = 2, adhesions n = 1). A fur-
ther patient was abandoned because of peritoneal dis-
ease. Types of procedure included metastectomy (n = 8),
left lateral segment (n = 5), left hepatectomy (n = 3),
right hepatectomy (n = 2). A Pringle’s manoeuvre was
intermittently used in seven patients (38%) for a total
mean duration of 35 min (15–56 min). Mean hospital
stay was 6 days (1–24 days). There were no complica-
tions relating to application of the tourniquet or con-
version to open surgery as a result of bleeding.
Conclusion: The technique of using the Goldﬁnger to
facilitate placement of a tape around the hepato-duode-
nal ligament for Pringle’s manoeuvre is an easy, safe and
efﬁcient technique. Although not always necessary it is an
important technique when training junior surgeons
TLLR.
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LAPAROSCOPIC LIVER SURGERY
R. Sanchez Claria, G. Morricone, F. Bersano, C. Salas,
N. Bucich, O. Mazza, J. Pekolj and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Laparoscopic liver resections are one of the
most complex procedures in hepatobiliary surgery.
During the last 20 years, laparoscopic liver surgery had
an important development in specialized centers.
Aim: To evaluate outcomes in the initial experience of
laparoscopic liver resections, in a Hepato-Pancreato-
Biliary Surgery Unit.
Material and methods: Records of 34 patients who
underwent laparoscopic liver resection between Novem-
ber 2000 and July 2009 were reviewed. Data regarding
preoperative management and postoperative outcomes
were analyzed.
Results: Thirty two liver resections were performed la-
paroscopically (22 purely laparoscopic, ﬁve hand-as-
sisted, ﬁve hybrid technique) and two were converted to
open surgery. The laparoscopic approach was attempted
in 7.5% (34 out of 459) of the liver resections carried out
in the analyzed period. Indications for resection were:
benign tumors in 28 (82%) patients and malignant tu-
mors in 6 (18%). Resections were minor in 31 (91%)
patients and major in 3 (9%). Pringle maneuver was
performed in 17 (50%) patients. Margins were negative
in all the oncological cases. Mean operative time was
170 min (range 70–350), and the mean length of stay was
3 days (range 1–6). Mortality rate was 0%. Only 2 (7%)
patients had post-operative minor complications (self-
limited bile leaks).
Conclusion: In selected patients with benign and
malignant liver tumors, laparoscopic liver resections can
be safely performed. This procedure must be carried
out by surgeons trained in both, hepatobiliary and
laparoscopy.
P-142
INITIAL EXPERIENCE WITH TOTALLY
LAPAROSCOPIC LIVER RESECTIONS
P. Herman, M. Perini, F. Coelho, L. D’Albuquerque and
I. Cecconello
Hospital das Clinicas, Sa˜o Paulo Medical School
Background: The term laparoscopic liver resection
(LLR) has been used to describe any interventional
procedure in which laparoscopy is used; even when hand
assisted procedures are performed. Pure laparoscopic
liver resection (PLLR) reports are not common and some
reports have dealing with this issue, deﬁning LLR only
when no hand assisted maneuvers are used. Surgeons
with experience in liver and expertise in advanced lapa-
roscopic surgery have increased the indications for
PLLR.
Aim: The aim of this study is to assess the feasibility,
safety and outcomes of pure laparoscopic liver resections
in a single tertiary center.
Material and methods: A prospective data collection of
laparoscopic liver resection was initiated in our center in
2006. The study population was a consecutive series of
patients who underwent pure laparoscopic liver resection
in a tertiary referral center. Benign and malignant dis-
eases were enrolled.
Results: Forty one patients with mean a age of 52 years
were evaluated. There were 5 (12.1%) right hepatecto-
mies, 12 (29.2%) left lateral segmentectomies, 2 (4.8%)
right lateral bi-segmentectomies (6–7), 12 (29.2%) seg-
mentectomies and 9 (21.9%) wedge resections. Three
(7.3%) patients required intra-operative transfusion and
conversion rate was 4.8% (2 patients) and were indicated
due to bleeding. Mortality rate was null. One patient
developed right pleural effusion complicated with
empyema, other had a benign biliary ﬁstula and
another had nosocomial pneumonia (complication rate
of 7.3%).
Conclusions: Laparoscopic resection is technically feasi-
ble and safe, even for major liver resections with low
morbidity and mortality rates. Laparoscopic liver resec-
tion should be considered for selected cases in the treat-
ment of benign and malignant diseases and should be
operated on by surgeons with laparoscopic and hepa-
tobiliary experience.
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THE ORANGE II-TRIAL: AN
INTERNATIONAL MULTICENTRE RCT
COMPARING OPEN VERSUS
LAPAROSCOPIC LEFT LATERAL
HEPATIC SECTIONECTOMY IN AN
ERAS-PROGRAMME
E. M. Wong-Lun-Hing, R. M. Van Dam, H. C. Dejong,
J. R. Van Der Vorst, F. Gillissen, M. H. A. Bemelmans,
S. W. M. Olde Damink, J. H. M. B. Stoot, B. Essers and
G. J. P. Van Breukelen
Maastricht University Medical Centre
Background: The optimization of postoperative recovery
by laparoscopic surgery and enhanced recovery pro-
grammes has been introduced into liver surgery recently.
Therefore, this is the subject of the international multi-
centre randomised controlled ORANGE II-trial: open vs.
laparoscopic surgery within an enhanced recovery pro-
gramme.
Aim(s)/Objectives(s): The added value of laparoscopy
compared to open liver surgery in left lateral liver sec-
tionectomy within an ERAS programme in terms of
functional recovery, hospital length of stay and postop-
erative morbidity has never been studied in a randomized
controlled setting.
Methods/Design: Patients eligible for left lateral hepatic
sectionectomy (LLS) will be recruited at the outpatient
clinic. The experimental design produces two randomi-
zation arms open LLS (a). laparoscopic LLS (b). Two
additional non randomized arms will be based on sur-
geons/patients that have a preference for the laparo-
scopic LLS (c).Or that have a preference for the open
LLS (d). The two primary endpoints of the ORANGE II
trial to be analysed are functional recovery and the total
postoperative length of hospital stay. Secondary out-
comes of this trial are readmission percentage, morbidity,
quality of life, body image and cosmesis, hospital and
societal costs during one year and the long term incidence
of incisional hernias. We assume that in patients under-
going LLS the LOS can be reduced by 2 days. We have
chosen to implement interim analysis by Snappin’s
method. This method enables us to detect 1-day reduc-
tion in hospital length of stay (n = 2 · 160, power 90%
and a = 0.05) or a 2-day reduction with a smaller sample
size (n = 2 · 40), with the extra beneﬁt to stop the trial
for non-signiﬁcance or futility reasons at interim analysis.
Discussion: The ORANGE-II trial is a multicentre RCT
that will provide evidence on the merits of laparoscopic
surgery in patients undergoing a left lateral hepatic sec-
tionectomy within an enhanced recovery programme.
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LAPAROSCOPIC LIVER RESECTIONS
IN CANCER PATIENTS: EXPERIENCE AT
A NATIONAL CANCER CENTER
R. Matteotti, A. A. Gumbs, E. Chouillard, V. Siripurapu
and J. P. Hoffman
Department of Surgical Oncology, Fox Chase Cancer
Center, Philadelphia, USA
Introduction: Oncological adequacy and safety of liver
resections is still uncertain. The aim of this retrospective
analysis was to examine intraoperative data with ﬁnal
pathology and short-term clinical outcome.
Methods: Patients undergoing laparoscopic liver surgery
were retrospectively analyzed using our tumor registry.
Results: Forty one consecutive liver resections were
analyzed, 2 converted (4.88%). Median age 62 (r 22–93),
median BMI 28.2 (r 21.6–37), ASA 2. Fourteen under-
went major (34.15%), 27 minor resections (65.85%).3
left, 8 right, 1caudate lobectomy, 2 wedges. 95% had
additional procedures like adhesiolysis, ablation or
additional wedge. 7 of 41 patients (17.95%) had intra-
operative complications, two requiring conversion; rea-
son for conversion were major bleeding and IVC injury.
23.53% (n = 8) had postoperative complications DVT
(n = 1), PE (n = 1) ileus (n = 3), exacerbation of
COPD (n = 1), A-ﬁb (n = 1) Renal Insufﬁciency
(n = 1). 1 post-operative bile leak. Lymph node dissec-
tion done in 26.47% (n = 9). Median EBL 100 cc (r 0–
3200 cc). Median OR time 219.5 min (r 38–591)).Frozen
sections positive in 30% (n = 9) requiring re-resection
during same surgery. Margins positive in 5 (16.13%). 26
patients were stage 4, n = 19 colorectal Ca, n = 3 gall-
bladder Ca, n = 1 renal Ca, n = 2 breast Ca, n = 1
neuroendocrine Ca. Specimen: Median Size (mm) 137 (r
5–215), Median Volume (cc) 901 (r 3.6–3370)), Median
Weight (gr) 653 (r 217–988), Median Distance tumor to
margin (mm) 7 (r 0–55) Median hospital stay 4 days (r 1–
17) 30-day mortality 0%.
Conclusions: Laparoscopic liver surgery at a major can-
cer center is safe and Median hospital stay and short term
mortality are comparable to similar series in the literature
reporting open procedures. Most importantly, a laparo-
scopic approach does not violate oncological principles
intraoperatively, tumor visualization is excellent and
adequate margins can be obtained. Many more cases and
Long-term follow up data will be needed to compare
laparoscopy to an open approach in terms of survival
and quality of life.
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LAPAROSCOPIC LIVER SURGERY IN
GERMANY-A SURVEY
M. Kleemann1,2, P. Hildebrand1, H. Wolken1,
U. Roblick1 and H. P. Bruch1
1University Hospital Schleswig-Holstein Campus Luebeck;
2Department of Surgery
To date the laparoscopic hepatic surgery is only common
in a few centres within a speciﬁc selected patient group.
Intention of this survey was to estimate the actual state of
affair about laparoscopic hepatic surgery in Germany at
2008.
Materials and methods: A questionnaire has been pre-
pared and sent out by e-mail to the members of DGAV
(German Society of General and Visceral Surgery) in
May 2009. Beside questions to status of the participating
hospitals (basic- and standard care/ specialized hospital/
hospital with maximum care/ university hospital) infor-
mation has been gained about frequency of laparoscopic
hepatic surgeries.
Results: Throughout we received 181 feedbacks until
July 31st 2009. With regard to the total number of sur-
gery hospitals this is a return rate of 15.9% in Germany.
Whereby, hospitals with maximum care 50% and uni-
versity hospitals had a return rate of 71.9%. The question
if laparoscopic hepatic surgery has been performed in
2008 was answered with YES by 125 (69.1%) and NO by
54 (29.8%) members. In 2008 frequency of laparoscopic
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ultra sonic during intraoperative staging to make evi-
dence of the diagnosis was two to maximum 250,
whereby 96.4% of the hospitals had less than 50 and only
two hospitals (2.7%) had respectively 211 and 250
examinations. From 50 hospitals which do laparoscopic
radiofrequency ablation (RFA) 36 answered the question
about frequency. Between 1 and maximum 20 laparo-
scopic RFA procedures have been performed. All of
these 36 hospitals performed a total of 238 laparoscopic
RFA procedures. By analyzing the details, 69 (38.1%) of
the interviewed hospitals indicate to do hepatic laparo-
scopic resections. On average each of the 69 hospitals
performed 7.9 laparoscopic resections in 2008. However
eight hospitals performed more than 15, ﬁve hospitals
more than 25 and only two hospitals performed more
than 40 laparoscopic hepatic resection. All in all from 69
hospitals a total of 551 laparoscopic hepatic resections
were done in 2008.
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SINGLE PORT ACCESS LAPAROSCOPIC
LIVER RESECTION
I. Y. Park, B. S. Sohn, S. J. Kim, S. K. Lee, Y. K. You,
K. H. Kim, D. S. Lee, S. Lee, D. G. Kim and E. K. Kim
Department of Surgery, Division of Hepato-Pancreato-
Biliary Surgery, The Catholic University of Korea
In 1992, Gagner et al. ﬁrst reported laparoscopic liver
resection (LLR) for focal nodular hyperplasia. The
development of new instruments and techniques has
enabled the surgical resection of various liver lesions.
Single-port access (SPA) surgery is regarded as a prom-
ising technique for reducing postoperative pain, decreas-
ing wound complications, and improving cosmesis. A 74-
year old female patient with a mass in the left lateral
segment of the liver was admitted to the hospital. The
preoperative alpha-fetoprotein (AFP) level was 66 ng/
mL. Computed tomography and magnetic resonance
imaging revealed exophytic mass and liver cirrhosis. We
performed SPA laparoscopic liver resection using a
surgical glove as the single port by making an incision
at the umbilicus. We used a ﬂexible laparoscope and
articulating instruments for dissection. The operative
time was 150 min, and the estimated blood loss was
400 cc. There were no complications and she was
discharged on the 15th postoperative day. We have
shown that SPA laparoscopic liver resection is a feasible
and safe method; however, further evaluation is needed
to establish the efﬁcacy of this method.
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LAPAROSCOPIC HAND-ASSISTED
(HYBRID) RIGHT HEPATIC
LOBECTOMY: AN INITIAL EXPERIENCE
AT A COMMUNITY HOSPITAL
K. Kosari, S. Mackenzie and T. Sielaff
Abbott Northwestern Hospital Virginia Piper Cancer
Institute
Background: Few centers are performing major hepatic
resections laparoscopically, especially in community
hospital settings.
Objectives: The goal of this study is to examine the
initial experience with laparoscopic hand-assisted
(hybrid) right hepatic lobectomies (lap-HA) in a com-
munity hospital.
Methods: We identiﬁed consecutive lap HA patients
(patients) that were performed at our community hospi-
tal since performing the ﬁrst case in May 2009. We col-
lected pt demographics, operative times (OP), blood loss,
complications, length of stay (LOS), and survival. We
compared completed lap-HA vs. those converted to open
(con-op).
Results: Since May of 2009, we have completed four
cases via lap-HA, and had three con-op cases for a total
of seven cases in 6 months. Majority of patients had
colon cancer metastasis. There were three women (W)
and one man (M) in the lap-HA with a mean age of
55 years (2 W and 1 M in con-op with mean age of
47 years). All patients except for 1 W in con-op had had
prior operations. Median OP was 362 min in the lap-HA
(440 min in con-op), median blood loss was 325 mL in
the lap-HA (900 mL in con-op), and median incision
length was 14 cm in the lap-HA (22 cm in con-op). One
patient in each group spent 2 days each in the ICU.
Median LOS was 5 days in the lap-HA, compared to
8 days in the con-op. One patient in lap-HA developed a
duodenal ulcer with bleeding, and one had transient
encephalopathy. In the con-op, one patient had small
remnant-for-size syndrome that persisted for approxi-
mately 4 months. All patients had an R0 resection and
there have been no deaths. Median follow up for both
groups is 3 months.
Conclusions: Laparoscopic hand-assisted right hepatic
lobectomy done by surgeons who are experienced in both
open hepatectomies and advanced laparoscopy appears
to be feasible and safe in the community hospital setting.
Possible decreased LOS compared to the open group will
need to be investigated further in larger studies.
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LAPAROSCOPIC LIVER RESECTION:
EXPERIENCE FROM THE FIRST 40
CONSECUTIVE CASES
G. Ayiomamitis1, A. Kausar2, A. Hamoudi1,
R. Desphande2, M. Manu2, D. O’Reilly2, D. Sherlock2
and B. Ammori1,2
1Department of Hepato-Pancreato-Biliary Surgery,
Manchester Royal Inﬁrmary; 2Department of Hepato-
Pancreato-Biliary Surgery, North Manchester General
Hospital
Background and aims: Advancements in surgical tech-
nique and technology have facilitated safe laparoscopic
liver resection (LLR) in selected patients. The aim of this
study is to describe our approaches and evaluate the
feasibility and outcome of LLR.
Methods: Patients with lesions situated in anterior and
posterior liver segments (segments 4A, 7 and 8) were
selected for laparoscopic resection. Right hepatectomy
and extended resections were excluded. Data were col-
lected prospectively. Results shown represent median.
Results: Between 2003 and 2009, 40 patients underwent
LLR. The resections included left hepatic lobectomy
(n = 19), two anterior segments (n = 13), segments
6 ? 7 (n = 5) and segment 8 (n = 3). All procedures
were completed laparoscopically. The operating time was
125 min. The estimated blood loss was 100 mL. Post-
operative complications were encountered in two patients
(5%), and there were no operative deaths. The post-
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operative hospital stay was 3 days. The histology re-
vealed that 34 resections were for malignant lesions
[metastasis from colorectal cancer (n = 29), other
metastases (n = 3), hepatoma (n = 2)] and 6 were for
benign disease. At a median follow up of 35 months, 8
patients had disease recurrence (23.5%).
Conclusions: In selected patients with lesions in any liver
segment including segments 7 and 8, and excluding right
hemihepatectomy and extended resections, LLR is fea-
sible and is associated rapid recovery and satisfactory
short-term oncologic outcomes. Long-term follow up
data are required.
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EARLY EXPERIENCE OF TOTALLY
LAPAROSCOPIC LIVER RESECTION
J.-I. Tanaka, H. Kasugai, Y. Deguchi, H. Kida,
Y. Kobayashi, M. Shunpei and S-E. Kudo
Showa University Northern Yokohama Hospital Digestive
Disease Center
Aim: The aim of this study was to report our early
experience and surgical technique of laparoscopic liver
resection.
Patients and methods: We started laparoscopic liver
resection including laparoscope-assisted procedure and
HALS procedure in 2005. This study focus on the feasi-
bility and short term results in recent 17 patients who
underwent totally laparoscopic liver resection. Liver
resection was performed by using ultrasonic surgical
aspiration apparatus, laparoscopic ultrasonic coagula-
tion shears, TissueLinkTM, and endoscopic linear stapler
for dissection of the Glisson’s sheath and left hepatic
vein.
Results: Postoperative diagnosis was metastatic liver tu-
mor from colorectal cancers in seven, HCC in three,
gallbladder cancer in two, gallbladder polyp in four and
one CCD. Non-anatomical liver resections were per-
formed in 9/17, segmental liver resection in 1/17, liver bed
resection in 7/17. In one patient who underwent lateral
segmentectomy, synchronous laparoscopic colon resec-
tion was performed. The mean operating time was
210 min (89288) for partial resection, 134 (79203) for
liver bed resection and mean blood loss 28mL (171), 9
(411), hospital stay was 9 days (411), 4 (37)
respectively. No postoperative complications were
observed.
Conclusions: Totally laparoscopic liver resection was
feasible and safe procedure in selected patients. Short
term results were promising. The main advantages
seem to be less pain, less blood loss and shorter hospital
stay.
P-150
COMPLICATIONS AND MORBIDITY OF
LIVER RESECTION ARE LOWER IN
LAPAROSCOPIC CASES COMPARED
TO MATCHED OPEN CASES FOR
SEGMENTAL RESECTIONS
D. Slakey, E. Simms, F. Yazdi, R. Brett and B. Drew
Tulane University
Objective: Minimally invasive surgery for liver resection
remains controversial. This study was designed to com-
pare open vs. laparoscopic surgical approaches non-
anatomic liver resection.
Methods: A single center retrospective chart review: We
deﬁned ‘‘laparoscopic’’ cases as both pure laparoscopic
and hand-assisted laparoscopic technique.
Results: Forty laparoscopic liver resections were mat-
ched with 17 open procedures having equivalent resec-
tions based on anatomy and diagnosis. Overall
complication rate was 22.8%. More open resection pa-
tients had complications (52.9% vs. 10%, P < 0.0016).
The conversion rate was 11.1%, and one complication
occurred prior to conversion. Morbidity was also more
common in open cases. Average blood loss in open cases
was 667.1 ± 1450 mL, vs. 47.8 ± 89 mL (P < 0.0001).
Measures of IV narcotic use, post-operative ileus, ICU
length of stay and hospital length of stay all favored the
laparoscopic group. The relative risk of having a com-
plication in the open group was 5.29 (CI = 1.89–14.86,
P < 0.0016), and the relative risk of having at least one
poor measure of outcome in the open group was 3.92
(CI = 1.70–9.07, P = 0.0014). Patients were more likely
to have complications or poor measures of outcome in
the open resection group than in the laparoscopic group
for both the anterolateral (P < 0.078) and posterosu-
perior (P < 0.002) resection subgroups.
Conclusion: In this series comparing matched laparo-
scopic and open liver resections there were fewer major
complications, more rapid recovery, and lower morbidity
in the laparoscopic group, even for those resections
involving the posterosuperior segments of the liver. The
experience of the surgeon and surgical judgment remain
the essential aspects of ensuring patient safety and
quality outcomes.
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HALF PRINGLE MANEUVER: A USEFUL
TOOL IN LAPAROSCOPIC LIVER
RESECTION
P. Herman, M. Perini, F. Coelho, W. Saad,
L. D’Albuquerque and I. Cecconello
Hospital das Clinicas, Sa˜o Paulo Medical School
Background: Laparoscopic liver resections are becoming
a routine procedure in many centers however bleeding
remains the major concern during parenchymal transec-
tion. Total vascular inﬂow occlusion can be performed
but ischemic reperfusion injuries can lead to postopera-
tive morbidity. On the other hand, hemi hepatic inﬂow
occlusion, leading to hemi-liver ischemia, decreases the
amount of liver parenchyma submitted to reperfusion
damage and offers the advantage of reduced blood loss.
Objective: Describe the authors’ experience with lapa-
roscopic half Pringle maneuver for segmentar or non
anatomical liver resections.
Patients and methods: Eight patients submitted to lapa-
roscopic liver resection in a single tertiary center.
Results: There were ﬁve women and three men with a
mean age of 40.2 years (26–54 years). There were three
liver adenomas, two hepatocellular carcinomas, one
metastatic melanoma, one metastatic colorectal carci-
noma and one peripheral colangiocarcinoma. Mean tu-
mor size was 4.1 cm (2.6–6.0). No postoperative
complications or mortality were observed. Mean hospital
stay was 3.1 days (1–5).
Conclusions: Laparoscopic liver resection with half
Pringle maneuver is feasible and safe and may be
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included in the technical armamentarium of laparoscopic
liver resections for a selected group of patients.
P-152
SINGLE INCISION LAPAROSCOPIC
LIVER RESECTION: FEASIBILITY
DEMONSTRATION IN TWO CASES
F. Cannizzo JR.1, J. R. Romanelli2, J. E. Meyer3,
R. M. Seshadri3 and R. B. Arenas1
1Division of Surgical Oncology, Department of Surgery,
Baystate Medical Center, Springﬁeld, MA, USA;
2Division of Bariatric Surgery, Department of Surgery,
Baystate Medical Center, Springﬁeld, MA, USA;
3Department of Surgery, Baystate Medical Center,
Springﬁeld, MA, USA
Background: Laparoscopic liver resection has suffered
from the need for incisions large enough to deliver the
specimen. Single incision laparoscopic liver surgery
(SILLS) allows the entire procedure to be performed
through intended extraction incision.
Aims/Objectives: To safely evaluate, image, and manip-
ulate the liver laparoscopically using existing instruments
entering through the same skin incision.
Methods: Two patients were selected on the basis of the
anatomy of their tumors to participate in this trial. Pa-
tient 1 is a 58-year old female with a 5.5 cm hepatocel-
lular carcinoma in the left lateral segment. Patient 2 is a
68-year old female with a 4.0 cm HCC in Reidel’s lobe.
Both patients were counseled as to the approach and our
intention to convert to standard laparoscopic or open
approaches for safety or oncologic concerns.
Results: Patient 1 underwent an uncomplicated left
lateral segmentectomy via a single incision, multi-port
approach. Her EBL was 500 cc. Her LOS was 4 days.
Pathology revealed a 5.0 cm moderately differentiated
HCC completely resected. Patient 2 underwent extensive
adhesiolysis and mobilization of Reidel’s lobe using a
SILS Port (Covidien, Inc). The case was converted to
minilaparotomy for oncologic concerns posteriorly, al-
though IOUS-guided parenchymal transection was suc-
cessful via the single port. Her EBL was 1700 cc,
requiring 1 unit PRBCs intraoperatively. Her LOS was
5 days. Pathology revealed a 4 cm moderately differen-
tiated HCC conﬁned to the right lobe but present on the
capsular surface. She has required readmission for pain
issues but has shown no signs of bleeding, infection or
hepatic insufﬁciency.
Discussion: SILLS is a feasible alternative to standard
laparoscopic liver surgery in patients with left lateral
segment and right lobe inferior margin lesions. Facility
with standard laparoscopic techniques and a low
threshold to convert to standard laparoscopic or open
technique will ensure patient safety throughout these
procedures.
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DA VINCI ROBOT-ASSISTED LEFT
HEPATECTOMY
C. Gi Hong, H. Woo Jin, K. Dong Hyun, K. Chang
Moo, C. Jin Sub and L. Woo Jung
Department of Surgery, Yonsei University Health System,
Seoul, Korea
Background: Since the minimally invasive surgery has
been developed in all surgical ﬁelds, laparoscopic liver
resection has been more frequently performed by many
surgeons. However, laparoscopy has the limitations such
as 2-dimensional imaging and restricted instrument mo-
tion. TheDaVinci Robotic systemprovides 3-dimensional
images and EndoWrist with a 360-degree range of motion.
Aim/Objective: To demonstrate the safety and feasibility
of Da Vinci robot-assisted left hepatectomy.
Methods: From January 2009, ﬁve patients underwent
robot-assisted left hepatectomy in Yonsei University
Health System, Seoul, Korea. The patient is placed in a
supine position with reverse Trendelenburg (15). We use
ﬁve ports altogether; four for the robotic arms and one
for the assistant surgeon. The camera port is placed just
above the umbilicus. Three 8 mm robotic ports are
introduced in the both sub-costal areas along the mid-
clavicular line and the left ﬂank area, respectively. The
assistant port (12 mm) is placed in the right para-
umbilical area, 5 cm apart from the umbilicus.
Results: Five patients (two hepatocellular carcinomas,
two cholangiocellullar carcinomas and one liver metas-
tasis from the rectal cancer) underwent robot- assisted
left hepatectomy. The mean age was 46.4 years (range:
32–62). There were one female and four males. The
average operating time was 542 min (range: 460–670).
The average estimated blood loss was 438 cc (range: 200–
900). The second case was converted to the mini-lapa-
rotomy due to the uncontrolled bleeding during the
parenchymal transaction. This patient received transfu-
sion and developed wound infection. In the remaining
four patients, there was no need for transfusion and no
postoperative complication. The mean days of hospital-
ization were 12 days (range: 7–22).
Conclusions: From our limited experiences, robot-as-
sisted left hepatectomy seems to be a feasible and safe
procedure.
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LAPAROSCOPIC HEPATECTOMIES –
FROM LAPAROSCOPY TO ROBOTICS –
ALBERT EINSTEIN EXPERIENCE, SAO
PAULO, BRAZIL
A. L. Macedo1 and V. Schraibman2
1Founding Member, Clinical Robotic Surgical Association,
Albert Einstein Hospital, Sa˜o Paulo, Brazil; 2Albert
Einstein Hospital, Sa˜o Paulo, Brazil
Reﬁnements in instrument design and advances in
surgical technique have prompted many surgeons to
extend the laparoscopic hepatectomies for the treatment
of liver disease. Resection of the liver using laparoscopic
techniques still presents a challenge to the surgeon,
mainly due to the difﬁculties associated with safe
parenchymal transection of the abundant vascular struc-
ture and the serious consequences of injury to major
adjacent vessels. Robotics has also added more precision
and better visualization for surgeons.
Objective: The aim of this study was to evaluate the
feasibility, safety, and long-term outcome of the laparo-
scopic and robotic approach.
Methods: Since 2004, 12 hepatectomies were performed
in our center. Location of tumor and its transection
margin were deﬁned by laparoscopic ultrasound and
conﬁrmed by intra-operative pathology. Liver resection
was performed using Ligasure without portal triad con-
trol in 80% of the cases, with the specimens obtained
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placed in a bag and removed directly via a Pfanenstiel
incision.
Results: Liver resections included ﬁve right and three left
major lobe hepatectomies and four segmental hepatecto-
mies (one robotic). Mean hospital stay was 3 days (2–5).
Mean operative time was 3.5 hours (3–8) Mortality and
morbidity rates were 0 and 33%, respectively. Mean sur-
gical margin was 20 mm (range, 5–47 mm). After a mean
follow-up of 2 years (range, 0.5–4.7) all patients are alive.
Final diagnosis were: colonic metastasis (7), hepatic ade-
noma (2), HNF (2) neuroendocrine tumor metastasis (1).
Conclusion: Our study shows that laparoscopic liver
resection and ultimately robotic assistance, in selected
patients, are safe procedures with very good short and
mid-term results.
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TOTALLY LAPAROSCOPIC
CHOLEDOCHAL CYST EXCISION WITH
ROUX-EN-Y HEPATICOJEJUNOSTOMY:
USING A CONVENTIONAL OR DA VINCI
SURGICAL SYSTEM
K.-H. Kim1, T.-H. Hong2, S.-K. Lee2, Y.-K. Yoo2,
I.-Y. Park3, S. Lee4, D.-G. Kim2 and E.-G. Kim5
1Uijeongbu St. Mary’s Hospital/The Catholic University
of Korea; 2Seoul St. Mary’s Hospital/The Catholic
University of Korea; 3Bucheon St. Mary’s Hospital/The
Catholic University of Korea; 4St. Paul Hospital/
The Catholic University of Korea; 5St. Mary’s Hospital/
The Catholic University of Korea
Background: Type I choledochal cyst is a rare saccular or
fusiform congenital dilatation of the extrahepatic biliary
tract. It is usually treated by laparotomy at which the cyst
is completely excised and a Roux-en-Y hepaticojejunos-
tomy is performed to establish biliary enteric drainage.
With increased familiarity with the laparoscopic anatomy
of the biliary tract and advances in minimally invasive
techniques, surgeons have ventured further to operate on
technically difﬁcult cases such as choledochal cyst that
were until recently managed by laparotomy.
Patients and methods: From September 2004 to July
2009, We present our experiences with 10 adult patients,
eight were female and two were male, aged 19 and
59 years (mean: 35 years) with choledochal cyst (type I
according to the Alonzo-Lej classiﬁcation except one type
IVa) that were successfully excised with construction of a
Roux-en-Y hepaticojejunostomy entirely laparoscopical-
ly by using a conventional laparoscopic procedure and
one of them was using Da Vinci Surgical System.
Results: The mean operative time was 528 min (range
320–660 min). On the contrary, Operative time of the
Robot assisted case was below than mean operative time
(420 vs. 528 min). All patients had an uneventful recov-
ery, with no major morbidity. One patient had a bile
leak, which was resolved over 5 days by conservative
treatment. And one patient had an acute pancreatitis.
The mortality rate was 0%. The mean hospital stay was
9.5 days (range 5–16 days).
Conclusion: Laparoscopic resection of congenital
choledochal cyst and hepaticojejunostomy in adult pa-
tient is feasible. Cosmetic result was good in all patients.
We feel that there is a considerable learning curve with
the technique. Operation time of hepatico-jejunal anas-
tomosis can be shortened by using Da Vinci surgical
system. In the near future, laparoscopic choledochal cyst
excision represents an alternative treatment option in
carefully selected patients.
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LAPAROSCOPIC BILIARY-ENTERIC
BYPASS: EXPERIENCE AND OUTCOME
A. Koffron, D. Niemeyer and J. Stein
Beaumont Hospitals
Background: Biliary-enteric bypass (BEB) is performed
as both deﬁnitive treatment and as a method of palliation
for a variety of benign and malignant processes. While
the majority of BEB is performed using open techniques,
the growth of minimally-invasive liver resection has led
to consideration of minimally-invasive techniques in BEB
in hopes of reduction of surgery-associated pain, com-
plications, and hospital stay. A total laparoscopic ap-
proach of BEB has been described in small series as a
viable albeit technically challenging alternative to an
open procedure.
Objective(s): Analyze clinical results as well as proce-
dural conduct for our experience in laparoscopic BEB.
Methods: Between January 2003 and September 2009 we
performed laparoscopic BEB in 53 patients. The mean
patient age was 52 (range 19–81). Diagnoses included
both benign and malignant processes. The procedures
performed included: hepaticojejunostomy to extrahepatic
(HJE) or intrahepatic (HJI) biliary ducts, choledocho-
duodenostomy (CD), and cholecystojejunostomy (CJ).
Results: See table. All procedures were completed en-
tirely laparoscopically.
Biliary complications occurred in 6/53 (11%), however
only one patient required operative intervention, and two
patients (4%) required percutaneous biliary dilatation for
recurrent strictures. The remaining patients were doing
well a mean follow-up period of 45 months (range, 1–80).
Clinical Data
PROCEDURE N
OR
TIME
(MIN)*
LOS
(DAYS)* COMPLICATIONS
HJE 39 244 5.3 9 (3 leak, 2 stricture,
anastamotic edema,
port site bleed,
pneum, prolonged
ileus)
HJI 5 156 6.2 1 (UTI)
CD 8 96 4.4 1 (leak)
CJ 1 67 3 –
*mean values, LOS (length of stay)
Conclusions: Laparoscopic BEB is feasible for a variety
of conditions, with favorable outcomes, acceptable
morbidity, and the advantages of a minimally-invasive
surgery. This approach to biliary surgery requires the
combination of experience in both hepatobiliary and
advanced laparoscopic surgery.
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LAPAROSCOPIC BILIODIGESTIVE
ANASTOMOSIS
R. Sanchez Claria, J. Pekolj, D. Fernandez, O. Mazza,
J. Salceda, M. Palavecino and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Bilio-enteric anastomosis has historically
been performed using an open technique. We describe
here a single experience with this procedure using lapa-
roscopic techniques in 15 consecutive patients.
Aim: The aim of this study is to present our experience
and show technical aspects in laparoscopic bilio digestive
anastomosis.
Materials and methods: During a 9-year period between
July 2000 and July 2009, the authors performed 20 bilio-
enteric reconstruction by a total laparoscopic approach.
Indications included benign primary intrahepatic lithia-
sis, common bile duct calculous, Mirizzy syndrome, iat-
rogenic stricture, choledochal cyst and malignant biliary
obstruction Operations performed included choledocho-
duodenostomy in ﬁve patients and in 15 patients we
performed hepaticojejunostomy and extraabdominal
Roux-en-Y anastomosis.
Results: The mean operation time was 180 min (r 140–
310).
There were no intraoperative complications and no
major complications associated with anastomosis leakage
or obstruction. No operative or post-operative transfu-
sion was required. Morbidity was 22% and there were no
deaths Oral food intake was started within 2 days and
tolerated well, the average length of hospital stay was
5 days. Median follow up was 15 months; all patients are
symptom free with no signs of stricture or recurrent
biliary obstruction.
Conclusion: Total laparoscopic biliary reconstruction is
feasible for a select group of patients, but requires ad-
vanced laparoscopic skills, including intracorporeal
suturing. It must be attempted only in centers well versed
in advanced laparoscopic surgery.
P-158
ROBOTIC ASSISTANCE MAY PROVIDE
THE TECHNICAL CAPABILITY TO
PERFORM A SAFE, MINIMALLY
INVASIVE PANCREATICO-
DUODENECTOMY
C. Hammill1, M. Cassera1, L. Swanstrom2 and
P. Hansen1
1Hepatobiliary and Pancreatic Surgery, Providence
Portland Medical Center, Portland, Oregon, United
States; 2Gastrointestinal & Minimally Invasive Surgery,
Legacy Health Systems, Portland, Oregon, United States
Background: Pancreaticoduodenectomy (PD) involves a
complex set of technical tasks, many of which are poorly
suited to a minimally invasive approach. While laparo-
scopic PD’s may have patient advantages and are
reported in the literature, there is concern that the pan-
creatic and biliary anastamoses are high-risk. Robotic
surgery has the advantages of miniaturized instruments
with signiﬁcantly increased dexterity and a three dimen-
sional view, which may make minimally invasive PD an
acceptable alternative to open approaches.
Methods: Between March 2009 and September 2009,
patients with a clinical indication for PD were offered the
option of robotic-assisted PD (RAPD). Perioperative
data was compared to open PD’s performed by the same
surgeon from April 2005 to April 2009.
Results: RAPD was attempted in nine patients with one
conversion to open secondary to adhesions. Indications
for completed RAPD included pancreatic cancer (2), in-
traductal papillary mucinous neoplasm (3), ampullary
adenoma (1), and chronic pancreatitis (2). Lymph node
harvest averaged thirteen with one positive superior
mesenteric artery margin. There were two non-leak re-
lated intra-abdominal abscesses. One patient was treated
with CT-guided drainage. The other was treated with
laparoscopic drainage because of an allergy to local
anesthetics and subsequently developed a wound
infection.
Open versus Robot-assisted Pancreatoduodenectomy
Open PD
(n = 69)
RAPD
(n = 8)
Age (years) 62.5 55.0
BMI 26.6 26.1
ASA 2.8 2.8
Operative Time (minutes) 398 648
EBL (mL) 450 256
Hospital Days 14 7
Complications 23% 25%
Mortalities 1.4% 0%
Conclusion: RAPD is technically feasible and in this
series there were no anastomotic complications.
Although operative times were longer, short-term out-
comes were comparable to both published series of open
PD and to our experience.
P-159
EARLY EXPERIENCE OF ROBOT-
ASSSISTED PANCREATIC SURGERY IN
GANGNAM SEVERANCE HOSPITAL,
YONSEI UNIVERSITY HEALTH
SYSTEM, KOREA
D. S. Yoon, J. K. Kim, H. K. Hwang, J. S. Park,
S. I. Cho and H. S. Chi
Department of Surgery, Gangnam Severance Hospital/
Yonsei University Health System
Background: Robotic surgery is rapidly replacing con-
ventional open or laparoscopic surgery in abdominal
procedures. The application of robotic surgery was pro-
ven to be one of the best cutting-edge technologies for
successful minimally invasive surgery by providing solu-
tions to the many drawbacks of laparoscopic surgery, yet
few reports have studied robotic surgery in pancreas
surgery. However, the application of robotic pancreas
surgery is relatively limited because of technically com-
plex, difﬁcult, and time consuming procedures and seri-
ous postoperative complications. We present in our
initial experience with pancreas surgery using Da Vinci
surgical system (Intuitive Surgical, Sunnyvale, CA) to
evaluate the technical feasibility, effectiveness, and safety
of robot assisted pancreas surgery.
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Methods: Between October 2007 and September 2009,
we performed 12 cases of robotic-assisted pancreatic
surgery in Gangnam Severance hospital, Yonsei Uni-
versity Health System, Seoul, Korea. Clinicopathologic
characteristics, intraoperative and surgical outcomes
were reviewed.
Results: All operations were performed successfully ex-
cept three open conversions because of high BMI. There
were three enucleations, six distal pancreatectomy and
three pylorus preserving pancreaticoduodenectomy. The
average setup tine was 24.5 min, with a precipitous de-
crease in the setup time as the case increased. The mean
operation times were longer than open surgery. The
postoperative recoveries were better than open surgery
and there were no serious surgical complication.
Conclusion: In this early and small experience, robot-
assisted pancreatic surgery could be applied safely and
effectively for pancreatic surgery and could overcome the
limitations of conventional laparoscopic pancreatic sur-
gery in selected patients.
P-160
LAPARASCOPIC DISTAL
PANCREATECTOMY: EXPERIENCE AND
RESULTS
R. L. Rossi1, R. A. Rossi1,2, X. De Aretxabala1 and
J. Leo´n1
1Clı´nica Alemana; 2Hospital Padre Hurtado
Introduction: Laparoscopic distal pancreatectomy (LDP)
is being used increasingly for the treatment of tumors
with low malignant potential.
Objective: To analyze the indications, surgical technique,
pathology and results of patients who underwent a LDP.
Material and method: Patients who underwent LDP be-
tween 2001 and 2009.
Results: Forty-nine patients underwent LDP. The indi-
cations were cystic lesions in 36 and solid tumors in 13.
LDP was performed in a right lateral decubitis position
with four trocars, the splenic ﬂexure of the colon was
mobilized, and the gastrocolic ligament and short gastric
vessels divided with ligasure. The inferior border of the
pancreas was dissected and the gland elevated from the
retroperitoneum, separating the pancreas from the sple-
nic vessels which were divided between clips or stapled
when including a splenectomy. The pancreas was divided
with a stapler and the specimen extracted through a mini-
laparotomy. Splenic preservation was performed in 10
patients. There were 4 (8%) conversions and 2 (4%)
reoperations. There were two external pancreatic ﬁstulas
which were managed with the surgical drains. Pathology
revealed that the solid tumors were neuroendocrine in 12
and solid pseudopapillary in one, the cystic lesions were
benign cystic tumors in 31, cystadenocarcinomas in three,
borderline cystic tumor in one, and a pseudocyst in one.
The median hospital stay was 5 days for the 43 non-
converted, non-reoperated patients, who were drinking
liquids at 24 hours after surgery, requiring only intrave-
nous non-steroidal anti-inﬂammatory medication for
pain control, and returning to their activities at 2 weeks.
There was no mortality in this series.
Conclusions: LDP can reproduce the open technique
with the beneﬁts of a minimally invasive procedure.
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MINIMALLY INVASIVE INTRADUCTAL
PAPILLARY-MUCINOUS CARCINOMA
OF THE PANCREAS
S. Choi, D. You, M. Kim, J. Heo and D. Choi
Samsung Medical Center, Sungkyunkwan University
School of Medicine
Background: Intraductal papillary-mucinous neoplasm
(IPMN) is a distinct entity of pancreas, which shows a
good prognosis than conventional ductal adenocarci-
noma. When IPMN accompanied invasive cancer, it is
known that IPMN follows similar clinical course with
ductal adenocarcinoma. However, the postoperative
outcomes of invasive intraductal papillary-mucinous
carcinoma (I-IPMC) showed various results.
Objective and methods: Recently non-aggressive sub-
group classiﬁcation of IPMC, as minimally invasive
IPMC (MI-IPMC) was introduced. We investigated the
clinicopathological characteristics of ﬁfty patients with
IPMC. The lesions were classiﬁed into ﬁve noninvasive
IPMC and 45 I-IPMCs on the basis of the WHO classi-
ﬁcation. I-IPMCs were divided further into 18 MI-IP-
MCs and 27 invasive carcinomas originating in IPMC
(IC-IPMCs) according to new diagnostic criteria pro-
posed by Satoshi et al.
Results: When analyzed according to histologic subtype,
23 were intestinal type, 26 were pancreatobiliary type,
and one was oncocytic type, respectively. Increased pre-
operative CA19-9 level was more frequent in IC-IPMCs
(17 out of 27) than in MI-IPMCs (3 out of 18). Lymph
node metastasis was noted in nine patients, and all of
them were IC-IPMC. The group of IC-IPMC show more
frequent recurrences such as lymph node or distant
metastasis (72%) than MI-IPMC (0%) during follow up
period.
Conclusion: These ﬁndings suggest that the category of
MI-IPMC is less aggressive entity and it should be dif-
ferentiated from IC-IPMC. Preoperative differentiation
of MI-IPMC from IC-IPMC can be beneﬁcial for
avoiding additional LN dissection.
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LAPAROSCOPIC CYSTGASTROSTOMY
VIA THE POSTERIOR APPROACH FOR
PANCREATIC PSEUDOCYST
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1, H. Miyake2 and S. Amano3
1Social Insurance Yokohama central Hospital / Surgery;
2Kasukabe Municipal Hospital/Surgery 3Nihon University
School of Medicine/Surgery
Background/Aims: The treatment of pancreatic pseudo-
cyst is still being debated. Laparoscopic treatment of
pancreatic pseudocysts enables deﬁnitive drainage with
faster recovery. Moreover, the best drainage technique
for pseudocysts located adjacent to the posterior gastric
wall is pseudocystgastrostomy. Although, drainage via
the anterior approach has been frequently reported, re-
ports on the posterior approach are rare. Here, we
evaluated the efﬁcacy of the posterior-approach tech-
nique for pancreatic pseudocyst drainage.
Method: We retrospectively studied 28 patients who
underwent cystogastrostomy for pancreatic pseudocysts:
they were divided into the conventional cystogastrostomy
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group (CCG group) and the laparoscopic cystogastros-
tomy via the posterior approach group (LCGP group).
Results: The mean operative time was signiﬁcantly
shorter, blood loss was signiﬁcantly lesser, and the
duration of hospitalization after surgery was signiﬁcantly
shorter in the LCGP group than in the CCG group.
Recurrence was observed in one patient (5.6%) in the
CGP group; it was an asymptomatic recurrence that did
not require additional treatment. In contrast, there was
no recurrence in the LCGP group patients.
Conclusion: We think that our technique of performing
laparoscopic cystogastrosotmy via the posterior ap-
proach is easy and feasible for pancreatic pseudocyst
drainage.
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LAPAROSCOPIC MODIFIED DEVINE
EXCLUSION WITH VERTICAL
STOMACH RECONSTRUCTION FOR
UNRESECTABLE PANCREATIC CANCER
T. Oida1, K. Mimatsu1, H. Kano1, A. Kano1, Y. Kuboi1,
H. Miyake2, S. Amano3 and N. Fukino1
1Social insurance Yokohama Central Hospital / Surgery;
2Kasukabe Municipal Hospital / Surgery; 3Nihon
University School of Mecicine / Surgery
Background/Aims: A loop gastroenterostomy is the most
commonly applied palliative procedure in patients with
gastroduodenal outﬂow obstruction (GOO) caused by
unresectable advanced gastric and pancreatic cancer. We
developed a laparoscopic modiﬁed Devine exclusion
(LMDE) with vertical stomach reconstruction for unre-
sectable pancreatic cancer.
Method: Five patients underwent LMDE with vertical
stomach reconstruction. Five ports were placed. Initially,
semi-transection was performed at the bottom of the
stomach 3 cm proximal to the obstructing antral tumor
by using an Endo-GIA, in which a 2-cm wide segment
near the lesser curvature was not transected, which served
as a drainage route for contents on the oral side of the
gastroduodenal constriction. Subsequently, the proximal
site of the semi-transected stomach was vertically stret-
ched, and the proximal stomach was re-resected hori-
zontally using the stapler. The resected part was small
and triangular. The proximal jejunum at approximately
40 cm from the ligament of Treitz was brought to the
stomach in an antecolic position. Then, a horizontal side-
to-side gastrojejunostomy was performed using the sta-
pler. Finally, Braun anastomosis was performed using
the stapler.
Results: No intraoperative complications were experi-
enced. The median operative time was 110 min, and the
median blood loss was 30 mL. The median time for
postoperative oral intake was 3.6 days and the median
postoperative length of the hospital stay was 11 days.
GOO did not recur in any of the patients until the time of
death.
Conclusion: We consider that our LMDE with vertical
stomach reconstruction is an easy and feasible technique
for GOO.
P-164
LAPAROSCOPIC ENUCLEATION OF
PANCREATIC NEOPLASMS
A. Rault, A. Dedieu, D. Collet, B. Masson and
A. Sacunha
CHU Bordeaux-Hopital Haut Le´ve´que
Background: Enucleation is an alternative procedure to
treat benign and borderline neoplasms of the pancreas,
which preserves healthy parenchyma and pancreatic
function. The aim of this study was to evaluate postop-
erative and long-term results after laparoscopic enucle-
ation.
Methods: Data collected prospectively from 23 consec-
utive patients who underwent laparoscopic pancreatic
enucleation were analysed.
Results: Laparoscopic enucleation was achieved suc-
cessfully in 21 (91.3%) patients. There was one (4%)
death. A postoperative pancreatic ﬁstula was observed in
3 (13%) cases which was clinically signiﬁcant in one case
(4%). Enucleation was performed for endocrine neo-
plasm in 15 (65%) patients and for cystic neoplasm in 8
(35%) patients. All patients had benign tumors at ﬁnal
histopathological diagnoses. After a median follow up of
53 months no patient developed tumor recurrence, or
new-onset exocrine or endocrine insufﬁciency.
Conclusion: Laparoscopic enucleation is a safe and
effective procedure for the radical treatment of benign
and borderline tumors of the pancreas. Laparoscopic
approach seems associated with a decreased in operative
time, hospital stay and pancreatic ﬁstula after enucle-
ation. Laparoscopy should become the standard ap-
proach in the future for enucleation of presumed-benign
lesions.
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LAPAROSCOPIC MANAGEMENT OF
CYSTIC PANCREATIC LESIONS
I. Pavlik Marangos1, A. M. Kazaryan1,
A. R. Rosseland2, B. I. Røsok2, O. Villanger2,
Ø. Mathisen2, T. Buanes3 and B. Edwin1,2
1Interventional Center, Rikshospitalet, Oslo Uneversity
Hospital; 2Surgical department, Rikshospitalet, Oslo
Uneversity Hospital; 3Surgical department, Ulleva˚l, Oslo
University Hospital
Background: Presently as a result of increasing use of
modern visual modality cystic lesions in the pancreas are
detected more often and it is important to ﬁnd optimal
treatment strategy for these patients. This topic remains
controversial because of the lack of ability to deﬁne type
of cyst and potential malignancy precisely. Implementa-
tion of minimally invasive technique in the management
of pancreatic cysts can become a good argument in favor
of radical resections in stead of long time follow up
including invasive and noninvasive investigations. The
present prospective observational study selected patients
with cystic lesions which could be removed by distal
resection or enucleating.
Aim: To evaluate surgical outcomes of laparoscopic ap-
proach, focusing on postoperative morbidity.
Methods: From November 1997 to October 2009 total 72
patients, of which 57 women and 15 men were operated
in our hospital for cystic neoplasm of the pancreas. All
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patients were exanimate with preoperative cross-sectional
imaging and intraoperative endoscopic ultrasound.
Results: Laparoscopic distal pancreatectomy with sple-
nectomy n = 43, spleen preserving n = 18, local enu-
cleating n = 9, pancreatojejunostomy n = 1 and
explorative laparoscopy with biopsy and devasculariza-
tion of the tumor n = 1. The median operative time was
190 (29–680) min. Median postoperative stay was 6 (0–
37) days. One patients required conversion (1.4%) to an
open procedure. In two cases we used hand assistant
approach. According to the histological report there were
13 Pseudocysts, 29 Serous cystoadenomas, 12 Mucinous
cystic neoplasms, 11 Solid-pseudopapillary tumors, four
Intraductal papillary mucinous neoplasmas, two Acinar
cell carcinomas and one Lymphoepitelial cyst. Postop-
erative morbidity was 15%: Fistulas 6.8%. It was no
postoperative mortality.
Conclusions: We think that all cystic lesions should be
operated and minimally invasive technique allows doing
it with no mortality and with acceptable rate of mor-
bidity.
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LAPAROSCOPIC VERSUS OPEN DISTAL
PANCREATECTOMY: A COMPARATIVE
CASE-MATCHED STUDY
A. Kausar1, T. Ajala-Agbo1, D. O’reilly1, D. Sherlock1
and B. J. Ammori1,2
1North Manchester General Hospital; 2Manchester Royal
Inﬁrmary
Background: The laparoscopic approach to distal pan-
createctomy (DP) for benign and malignant diseases is
replacing open surgery in some centres, though its
potential beneﬁts remain to be conﬁrmed. The aim of this
study was to compare the open and laparoscopic ap-
proaches to elective DP.
Methods: Patients who underwent DP laparoscopically
were matched to those who had open surgery for age, sex
and size of the tumour. One surgeon adopted the lapa-
roscopic approach for all comers while the others per-
formed open surgery. The two approaches were
compared on an intention-to-treat basis. Data shown
represent means.
Results: Between 2006 and 2009 some 32 patients
underwent 16 laparoscopic and 16 open DP. One lapa-
roscopic procedure was converted to open surgery. The
laparoscopic and open groups were comparable for age
(57 vs. 59 years, P = 0.590), sex distribution, and size
(4.6 vs. 4.4 cm, P = 0.751) and nature of tumour. Al-
though laparoscopic surgery was associated with longer
operating time (281 vs. 227 min, P = 0.064), it carried
signiﬁcantly higher spleen preservation rate (12.5% vs.
50%, P = 0.027) and shorter postoperative hospital stay
(6.7 vs. 24.2 days, P < 0.0001), but comparable mor-
bidity rates (43.7% vs. 50%).
Conclusions: The laparoscopic approach to elective distal
is associated with a higher rate of preservation of the
spleen and a more rapid recovery compared with open
surgery.
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LAPAROSCOPIC VERSUS OPEN
CYSTGASTROSTOMY FOR
RETROGASTRIC PANCREATIC
PSEUDOCYSTS: A COMPARATIVE
CASE-MATCHED STUDY
T. Ajala-Agbo1, A. Kausar1, N. Hamza2, M. Manu1,
D. O’Reilly1, D. Sherlock1 and B. J. Ammori1,2
1North Manchester General Hospital; 2Manchester Royal
Inﬁrmary
Background: Large retrogastric and symptomatic
pseudocysts require internal drainage, and this is tradi-
tionally accomplished by laparotomy but could be per-
formed laparoscopically.
Aim: The aim of this study was to compare the open and
laparoscopic approaches to cystgastrostomy.
Methods: Patients who underwent cystgastrostomy were
selected, and those who had the surgery performed la-
paroscopically were matched to those who had open
surgery for age, sex and size of the pseudocyst. One
surgeon adopted the laparoscopic approach for all
comers while others performed open surgery. The two
approaches were compared on an intention-to-treat ba-
sis. Data shown represent medians.
Results: Between 2000 and 2009 some 35 patients
underwent 37 cystgastrostomies (27 laparoscopic, 10
open). One laparoscopic procedure was converted to
open surgery. The laparoscopic and open groups were
comparable for age (52 vs. 59 years, P = 0.227), sex
distribution, and size of pseudocyst (12 vs. 13.3 cm,
P = 0.287). Although laparoscopic surgery was associ-
ated with signiﬁcantly longer operating time (95 vs.
60 min, P = 0.02), it carried a signiﬁcantly lower risk of
morbidity (0% vs. 60%, P < 0.0001) and shorter post-
operative hospital stay (2 vs. 8.5 days, P < 0.0001).
Conclusions: The laparoscopic approach to cystgastros-
tomy for large and persistent retrogastric pancreatic
pseudocysts is associated with a smoother and more ra-
pid recovery and a shorter hospital stay compared with
open surgery.
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LAPAROSCOPIC DISTAL
PANCREATECTOMY USING THREE
PORTS- TECHNIQUE AND OUTCOMES
N. Gupta, G. Subhas, E. Kansakar, V. Mittal and
M. Jacobs
Providence Hospital-St John Health, Southﬁeld, Michigan
Introduction: Laparoscopic distal pancreatectomy is a
complex procedure that may reduce pain, length of stay,
and improve cosmesis. Techniques described for this
procedure use 4–7 ports, with an average operative time
ranging from 180–308 min, estimated blood loss (EBL)
of 100–249 mL, and length of stay (LOS) of 4–10 days.
Herein, we present our initial data on feasibility, safety,
and outcome with the three-port laparoscopic distal
pancreatectomy.
Technique and methods: Patient is placed in a partial
thoracoabdominal position exposing the left ﬂank with a
bean bag in reverse-trendelenberg. A 10-mm Hassan
trocar is inserted through subcostal anterior axillary
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incision and pneumoperitoneum is achieved. A 5-mm
midclavicular and 10-mm posterior axillary line trocar
are placed. Specimen is retrieved from the anterior ax-
illary line port. Charts were reviewed for 13 patients who
underwent this procedure from January 2006 to July
2009.
Results: Six men and seven women, ages 26–88 years
(mean 60 years), were evaluated. The body mass index
ranged from 18–37 (mean 26). Pancreatic lesion size
ranged from 1.0–5.5 cm (mean 3.0 cm). Four patients
had previous abdominal surgeries. Operative time ranged
from 116–296 min (mean 173 min). In four patients, an
intraoperative ultrasonography was done. EBL was 10–
300 mL (mean 136 mL). Lesions of various pathologies
were identiﬁed (cystadenoma, invasive carcinoma,
IPMN, pancreatic intraepithelial neoplasm, and endo-
crine tumor). Harvested lymph nodes ranged from 0–18
(mean 4.5). An R0 resection was achieved in all cases. No
cases required conversion or additional trocar placement.
LOS ranged from 2–4 days (mean 3.3 days). Post-oper-
ative small collections in three patients were treated
conservatively without further sequellae. Follow-up ex-
tended through October 2009.
Conclusions: The 3-port technique has excellent results
based on our initial series. Operative time, EBL and LOS
are favorable compared with published data.
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APPLICATION OF GASLESS
LAPAROSCOPY-ASSISTED MINIMAL
INVASIVE PROCEDURE IN
PANCREATICODUODENECTOMY WITH
INNOVATED NTUH LIN’S RETRACTION
SYSTEM
C.-Y. Yang1,2, Y.-W. Tien1,2, P.-H. Lee1,2 and
M.-T. Lin1,2
1Department of Surgery, National Taiwan University
Hospital; 2College of Medicine, National Taiwan
University
Background: Pancreaticoduodenectomy (PD) is a com-
plicated surgery with high morbidity, and mortality.
The skill demanding is high, and the operation time is
longer. Therefore, the application time of minimal
invasive surgery (MIS) in PD is later than other
abdominal surgery.
Objectives: The purpose of this study is to prove the
feasibility, and safety of MIS pancreaticoduodenectomy
with gasless laparoscopy-assisted retraction system.
Methods: Prospectively case-series were collected since
November-2008. Selective patients with periampullary
tumor were included to use gasless laparoscopy-assisted
retraction system to perform PD. But we excluded pa-
tients with pancreatic head cancer that need more deli-
cate lymph node dissection.
Results: We totally have three patients, with average
69 years old, receiving the gasless MIS pancreatico-
duodenectomy. Two cases were ampulla vater cancer;
the third one is serous cystadenoma of pancreatic head.
All three cases received PPPD. The operation time was
between 9 hours 25 min to 11 hours. The average blood
loss was 800 cc. The average number of regional lymph
node dissection was 10, and no any lymph node
metastasis was noted in the pathologic exam. Postop-
eratively, all patients received jejunostomy feeding since
day 3, and oral feeding since day 5. There was no
mortality. Two cases has minor PJ leak without the
need of further intervention treatment. The hospital stay
was between 15–21 days. Currently, all these three
patients were regularly followed up at OPD with no any
recurrence.
Conclusion: This preliminary study revealed using gasless
laparoscopy-assisted minimal invasive procedure in PD
in selective patients was feasible and safe. This gasless
NTUH Lin’s method applied on complicated PD has
several advantages such as shorter learning curve, less
difﬁculty than pure-gas ﬁlling laparoscopic procedure,
less cardiopulmonary stress during long surgical time of
these operations.
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LAPAROSCOPIC MANAGEMENT OF
CYSTIC NEOPLASM OF PANCREAS
M. Narasimhan, K. Palaniappan and R. Ardhanari
1Meenakshi Mission Hospital and Research Centre,
Madurai, India
Introduction: Laparoscopic pancreatic resections for
cystic neoplasms of pancreas are limited to small retro-
spective case series as these neoplasms are rare. We
critically analyzed the indications for and outcomes after
laparoscopic resection of pancreatic cystic neoplasm a
tertiary referral centre in South India over 8-year period.
Methods: A retrospective analysis of data collected on
pertinent pre-operative factors, intraop & post operative
course with a short term follow up was done. Fifteen
selected cases were successfully completed laparoscopi-
cally.
Results: Majority of patients were females (86%) and all
were symptomatic at presentation. Abdominal Pain was
commonest symptom. Eleven cases of Mucious cystade-
noma and four Serous cystadenoma were operated. Ele-
ven Distal pancreatectomy with and without
splenectomy, two central pancreatectomy and two enu-
cleation were done. Mean operating time was 130 mins.
There were no conversions or blood transfusions. Mean
tumor size was 8.5 cm. Morbidity in ﬁve cases (three
cases of pancreatic ﬁstula and two intraabdominal col-
lections) were managed conservatively and with percu-
taneous techniques. Mean hospital stay was 6.4 days.
Conclusions: Laparoscopic pancreatic resections for
cystic pancreatic neoplasms are feasible and safe and can
be offered to selected patients. Morbidity of surgery re-
duces with surgical experience in advanced laparoscopic
techniques.
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LAPAROSCOPIC DISTAL
PANCREATECTOMY EXPERIENCE
WITH 33 CASES
R. Jureidini1,2, J. E. M. Cunha2, T. Bacchella2,
P. P. P. Caravatto2, U. Ribeiro Jr1,2, E. S. Abe2,
W. M. Pollara1,2 and I. Cecconello1,2
1Instituto do Cancer do Estado de Sa˜o Paulo;
2Departamento de Gastroenterologia – HCFMUSP
The feasibility of laparoscopic distal pancreatectomy
(LDP) has been demonstrated in the last decade. To
evaluate the indications, safety, and efﬁcacy of LDP we
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present our experience with this procedure in 33 patients
(23F, 10M average age 45) from 2006 to 2009.
Pathology showed 15 mucinous cystadenoma, 12 endo-
crine tumors, ﬁve serous cystadenoma, one IPMN and
one splenic artery aneurism. There was one convertion to
conventional laparotomy in the ﬁrst case (IPMN) for
adequate pancreatic transection after positive intraoper-
ative frozen section analysis. 18 patients (55%) had a
distal pancreatectomy with splenic preservation. The
other 15 patients had concomitant splenectomy. Median
operative time was 2.7 hours (range 3–6) and there was
no need for blood transfusions. There were no deaths.
Complications included 16 self-limited pancreatic leaks
(Grade A International Study Group on Pancreatic
Fistula), 1 Grade B pancreatic leak.
The median length of hospital stay was 5 days (range 4–
10), median diet resumption was 2 days. We observed
better results in terms of pancreatic ﬁstulas applying
larger clips staplers (green cartridges).
LDP is feasible and safe in benign-appearing pancreatic
tumors. Its indications in malignant tumors are still in
debate. The beneﬁts of minimally invasive surgery were
manifested in the short hospital stay, acceptable pan-
creas-related complications and better cosmesis.
P-172
LAPAROSCOPIC-ASSISTED
PANCREATICODUODENECTOMY WITH
PANCREATICOGASTROSTOMY
S. K. Lee1,2,3, T. H. Hong1,2,3, J. H. Park1,2,3,
S. J. Kim2,3,4, K. H. Kim2,3,5, Y. K. You1,2,3,
I. Y. Park2,3,6, S. Lee2,3,7, D. G. Kim1,2,3 and
E. K. Kim2,3,8
1Seoul St. Mary’s Hospital; 2The Catholic University of
Korea; 3Department of Surgery; 4Daejon St. Mary’s
Hospital; 5Uijongbu St. Mary’s Hospital; 6Buchon
St. Mary’s Hospital; 7St. Paul’s Hospital; 8St. Mary’s
Hospital
Background: Laparoscopic surgery has evolved to the
point that nowadays, almost all of the abdominal pro-
cedures are feasible to proceed by this modality. Pan-
creaticoduodenectomy, which is considered as one of the
most challenging procedure for the surgeon because of
high morbidity and mortality, is being approached la-
paroscopically in limited specialized centers. Our team
has performed ﬁve laparoscopic-assisted pancreatico-
duodenectomies, thus far.
Aim: The purpose of this study is to report our initial
experience with laparoscopic-assisted pancreaticoduo-
denectomy.
Methods: From March to September 2009, ﬁve patients
with periampullary tumors underwent laparoscopic-as-
sisted pancreaticoduodenectomy. Age ranged from 42 to
70 years, and there was one man and four women.
Diseases included were intraductal papillary mucinous
neoplasms (n = 2), early ampullary cancers (n = 2),
and pancreatic head cancer (n = 1). Five-port tech-
nique was used; most parts of the procedure were car-
ried out laparoscopically, except for the pancreatic
anastomosis, which was performed by means of a mini-
laparotomy made on upper abdomen, about 8.5 cm in
length. Pancreaticogastrostomy was carried out in all
ﬁve patients.
Results: Median operation time was 450 (410–610) mins
and median estimated blood loss, 300 (200–450) cc.
Intraoperative blood transfusion was required in only
one patient. Median upper midline mini-laparotomy
length was 8.5 cm and median hospital stay, 15 (14–
18) days. As complication, mild pancreatic leak occurred
in one patient, which was managed conservatively with
drains. In same patient suffered from delayed gastric
emptying requiring prolonged nasogastric decompres-
sion.
Conclusion: It would be premature to draw a conclusion;
however, laparoscopic-assisted pancreaticoduodenecto-
my is a feasible procedure with outcome not so different
from conventional open surgery. Careful patient’s selec-
tion is the key for success.
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LAPAROSCOPIC
PANCREATICODUODENECTOMY AND
DISTAL PANCREATECTOMY:
EXPERIENCE WITH 24 RESECTIONS
G. Ayiomamitis1, A. Kausar2, A. Hamoudi1,
D. O’reilly2, D. Sherlock2 and B. Ammori1,2
1Department of Hepato-Pancreato-Biliary Surgery,
Manchester Royal Inﬁrmary; 2Department of Hepato-
Pancreato-Biliary Surgery, North Manchester General
Hospital Background:
Advances in operative techniques and technology have
facilitated laparoscopic distal pancreatectomy (LDP) and
laparoscopic pancreaticoduodenectomy (LPD).
Methods: All distal pancreatectomies were attempted
laparoscopically, while selected patients underwent LPD.
Results shown represent median (range).
Results: Between 2002 and 2009, 24 patients aged 62.5
(32–79) years underwent LDP with (n = 9) and without
(n = 7) splenic preservation and LPD (n = 8). One LDP
was converted to open (6.3%). The tumours were 1–
12 cm in diameter. The median operating times for LDP
and LPD were 260 and 630 mins respectively with a
median blood loss of 300 mL in each group. In the LDP
group the morbidity, pancreatic ﬁstula, re-admission, re-
operation, and mortality rates were 31, 25, 25, 0 and 6%
respectively. The corresponding ﬁgures in the LPD group
were 25, 12, 12, 0 and 0%. The postoperative hospital
stays after LDP and LPD were 6.5 (4–14) and 9 (6–
23) days respectively.
Conclusions: The laparoscopic approach to distal pan-
createctomy can be considered the gold standard for both
benign and malignant diseases. In selected patients and in
the hands of an experienced laparoscopic HPB surgeon,
LPD is feasible and safe. Growth of experience, tech-
nique reﬁnements and long-term follow up data are
needed.
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CLINICAL OUTCOMES COMPARED
BETWEEN LAPAROSCOPIC AND OPEN
DISTAL PANCREATECTOMY FOR
BENIGN TUMOR
H. C. Kim and J. C. Chung
Soon Chun Hyang University Hospital
Introduction: Though laparoscopic distal pancreatec-
tomy for benign conditions was ﬁrst described in the
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early 1990s, there is limited information on the out-
comes of the laparoscopic surgery compared with open
surgery. Therefore, this study aimed to investigate the
clinical outcomes and to evaluate efﬁcacy of laparo-
scopic distal pancreatectomy compared with open distal
pancreatectomy in the benign or borderline malignant
tumors.
Methods: From June 2001 to December 2008, 17 patients
underwent laparoscopic distal pancreatectomy, and 26
patients underwent open distal pancreatectomy at our
institute. Among 17 patients who underwent laparo-
scopic distal pancreatectomy, ﬁve cases (malignancy
cases = 2, enucleation cases = 3) were excluded.
Among 26 patients who underwent open distal pancrea-
tectomy, 13 cases (trauma cases = 6, malignancy
cases = 7) were excluded.
Results: Laparoscopic distal pancreatectomy is equiva-
lent to open distal pancreatectomy in operation time, rate
of transfusion, rate of pancreatic leakage, and mortality.
But, laparoscopic distal pancreatectomy is superior to
open distal pancreatectomy in blood loss (P = 0.002),
time to oral intake (P = 0.013), and time to ﬁrst ﬂatus
(P = 0.003).
Conclusion: Laparoscopic distal pancreatectomy is a
clinically safe and effective procedure for benign and
borderline malignant pancreatic tumors.
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THE COMPARISON OF LAPAROSCOPIC
VERSUS OPEN APPROACH FOR DISTAL
PANCREATIC RESECTION – A REVIEW
OF THE LITERATURE
M. Esmaeilzadeh Moghaddam1, H. Fonouni1,
A. Mehrabi1, K. Daneshvar2, M. W. Bu¨chler1 and
J. Schmidt1
1Surgery Clinic; 2Radiology Clinic
Background: Laparoscopic distal pancreatic resection
(LDPR) has undergone signiﬁcant development and is
becoming an increasingly used modality in the surgical
treatment of pancreatic diseases. Since there are few
Randomised Clinical Trials and actual comparative data
between open surgery (OS) and LDPR, the precise ben-
eﬁt of the laparoscopic procedure on the outcome is
controversial.
Objectives: The purpose of this study is to compare
LDPR versus OS based on the review of literature.
Methods: All published papers containing case controls
or case series, which report patients who underwent ei-
ther laparoscopic or open distal pancreatectomy, were
reviewed and analyzed. The investigated parameters in-
cluded: demographic parameters, pathological diagnoses,
operation time, duration of hospital stay, intra and post
operative complications as well as mortality.
Results: From 1850 reported cases that underwent distal
pancreatectomy, 29.8% were operated with laparoscopic
and 70.2% with OS approach. Intra and postop data
could show a lower operation time, blood loss, abscess,
postop bleeding and shorter hospital stay in LDPR as
compared to OS. The pancreas ﬁstula rate was higher in
LDPR group. The overall mortality rate was 0.4% and
1.5% in LDPR and OS, respectively.
Conclusion: LDPR can be considered as a feasible,
standardized, safe and relatively fast procedure. Except
pancreas ﬁstula, the incidence of morbidity and mortality
were in LDPR lower as compared with OS. It can be
summarized that the laparoscopic approach for distal
pancreatectomy is a good option in selected cases and in
high volume case load and experienced laparoscopic
centers.
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MANAGEMENT OF THE PANCREATIC
STUMP AFTER LAPAROSCOPIC DISTAL
PANCREATECTOMY
S. M. Robinson, G. Sen, R. Saif, M. Jacob,
R. M. Charnley, J. J. French and S. A. White
The Department of HPB and Transplant Surgery,
Freeman Hospital, Newcastle upon Tyne, England, UK
Introduction: Laparoscopic distal pancreatectomy (LDP)
is increasingly recognised as a treatment option for
tumours in the distal pancreas. Potentially it shortens
hospital stay and analgesia requirements as compared to
open distal pancreatectomy. Patients remain at risk of
pancreatic leaks from the cut surface of the pancreatic
stump. Fibrin sealants are a two component biological
system consisting of ﬁbrinogen and thrombin, Tisseel
also contains a protease inhibitor Aprotinin which may
facilitate stump management by inhibiting exocrine en-
zyme activation. The aim of this study was to describe the
use of the Duplocath MIS systemTM for Tisseel appli-
cation during LDP.
Methods: A standard pneumoperitoneum is achieved
using a blunt 12 mm port at either the umbilicus or in a
supra-umbilical position. Three further working ports are
usually placed and a Pfannenstiel incision is used for
removal of the specimen. The neck of the pancreas is
divided with a 60 mm Echelon (Endo-Ethicon) linear
stapler. Once haemostasis is achieved the Duplocath MIS
system is used to seal the pancreatic stump.
Results: Fourteen patients have undergone LDP
(7F:7M) mean age 55 years (range 32–82). One patient
was converted to an open procedure due to concerns over
the tumour margin. Of the remaining 13 patients ﬁbrin
sealant was applied in six patients as in the early series
the Duplocath MIS system was not available. Three pa-
tients experienced complications two were due to pan-
creatic leaks. Both occurred in patients who did not
receive Tisseel ﬁbrin sealant. The mean hospital stay was
8 days (range 4–34). Pancreatic leaks resulted in a pro-
longed hospital stay.
Conclusion: As with open distal pancreatectomy, lapa-
roscopic distal pancreatectomy can be complicated by
pancreatic leak. There is no absolute method to prevent
this complication but the use of a ﬁbrin sealant con-
taining a protease inhibitor may facilitate stump man-
agement by sealing the pancreatic duct and potentially
preventing pancreatic enzyme activation.
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LAPAROSCOPIC DISTAL
PANCREATECTOMY-FEASIBILITY OF
MORE HIGH RISK AND MULTI-
VISCERAL RESECTIONS
R. Saif1, S. M. Robinson1, G. Sen1, M. Jacob1,
R. M. Charnley1, A. Horgan2, J. J. French1 and
S. A. White1
1The Department of HPB and Transplant Surgery,
Freeman Hospital, Newcastle Upon Tyne, England, UK;
2The Department of Colorectal Surgery, Freeman
Hospital, Newcastle Upon Tyne, England, UK
Introduction: Laparoscopic distal pancreatectomy has
emerged in the last decade as an alternative option for the
management of both benign and malignant lesions of the
distal pancreas. The reported conversion rate for this
procedure is as high as 17% in some series. The aim of
this study was to evaluate the feasibility of more high-risk
multi-visceral resections.
Methods: Over a 2-year period (2007–2009) all tumours
lying in the body or tail of the pancreas were discussed in
an HPB MDT and referred to surgeons with a laparo-
scopic resection in mind. As the series evolved more high
risk patients and those requiring multi-visceral resections
were also considered.
Results: During this time period 14 patients were iden-
tiﬁed (7F:7M) mean age (55 years) range 32–82 years).
All patients underwent a pre-operative, cross sectional
triple phase CT scan and when appropriate EUS ±
FNA. One patient had a previous AP resection with an
end ileostomy for a low rectal cancer. Further patients
required simultaneous bowel resections; a sigmoid co-
lectomy and repair of a colovesical ﬁstula (n = 1), sub-
total colectomy (n = 1) and cholecystectomy (n = 2).
Two other patients were considered high risk resections;
chronic liver disease with portal hypertension and varices
(n = 1) and Behcet’s disease with thromboembolic dis-
ease on warfarin and steroids (n = 1). From this series
one patient was converted to an open procedure. Three
patients experienced complications due to pancreatic
leaks (n = 2) and a chest infection (n = 1) with no post-
operative mortality. The mean hospital stay was 8 days
(range 4–34 days).
Conclusion: All patients with tumours in the body and
tail of the pancreas should be considered for laparoscopic
distal pancreatectomy. Even high risk patients and those
requiring multi-visceral procedures should also be con-
sidered and referred to specialist centres.
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MINIMALLY INVASIVE
PANCREATECTOMIES – FROM
LAPAROSCOPY TO ROBOTICS –
ALBERT EINSTEIN EXPERIENCE – SA˜O
PAULO, BRAZIL
A. L. Macedo1 and V. Schraibman2
1Founding Member, Clinical Robotic Surgical Association,
Albert Einstein Hospital, Sa˜o Paulo, Brazil; 2Albert
Einstein Hospital, Sa˜o Paulo, Brazil
Since the ﬁrst report with laparoscopic pancreatic resec-
tion of islet cell tumors in 1996, the experience worldwide
is still limited, with only short-term outcomes available.
Although the role of minimally invasive techniques in
pancreatic surgery remains controversial, resection of the
left pancreas for benign or endocrine lesions has been
universally adopted as a routine technique over the last
few years. Adoption of robotics in HPB surgery made
more feasible complex procedures as minimally invasive
duodenopancreatectomies.
Objective: The purpose of this study was to evaluate the
outcomes and feasibility of 15 laparoscopic and robotic
pancreatic surgeries.
Methods: Fifteen laparoscopic and robotic pancreatec-
tomies were performed at Albert Einstein Hospital since
2004. Operative time, adequacy of dissection, respect for
oncologic principles, morbidity, and short-term out-
comes were analyzed.
Results: Surgery was successfully performed in all pa-
tients. Pancreatic dissection and resection was done in a
totally laparoscopic way in 13 patients (left pancreatec-
tomies with spleen preservation in eight cases and with-
out preservation ﬁve cases). Two patients were submitted
to hybrid laparoscopic and robotic duodenopancreatec-
tomies. There were no conversions. Mean operative time
was 240 mins (from 210 mins to 10 hours). There was no
need for blood transfusion in all surgeries. Fistula rate
was 15%. Mean hospital stay was 6 days varying from 4
to 21 days. There was no mortality.
Conclusion: This series demonstrate that laparoscopic
and robotic pancreatic surgery is feasible and safe in
benign-appearing and malignant lesions of the pancreas,
when performed by experienced and skilled surgeons.
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A USEFUL RECONSTRUCTION
ARRANGEMENT FOLLOWING
WHIPPLE’S RESECTION
(PANCREATICO-GASTROSTOMY) FOR
PATIENTS WITH FAMILIAL
ADENOMATOUS POLYPOSIS
A. Rosich-Medina, L. Siong-Seng, A. Jah, E. Huguet,
N. Jamieson, R. Praseedom and S. Mohamed
HPB Unit, Department of Surgery, Addenbrooke’s
Hospital, Cambridge
Background: Periampullary carcinoma is the third lead-
ing cause of mortality in patients with familial adeno-
matous polyposis (FAP). Thus, they may require a
Whipple’s pancreaticoduodenectomy (WPD) as prophy-
lactic or curative measure. However, they are at risk of
further small bowel polyp formation, requiring life-long
surveillance with enteroscopy or contrast follow-through.
Traditional reconstruction following WPD, with or
without a Roux-en-Y loop, makes the subsequent sur-
veillance study difﬁcult due to part of the small bowel
loop being inaccessible. Similarly, the useful small bowel
absorptive length is reduced.
Aim: We describe a reconstruction technique, a pan-
creatico-gastrostomy (PG), which aims to facilitate sur-
veillance studies and conserve absorptive bowel length.
Method: Classical WPD is performed with extended
Kocherisation of duodenum and en-bloc resection of
pancreatic head, gastric antrum and duodenum. The cut
end of the pancreas is dunked into the stomach through a
posterior gastrostomy and sutured in place. A gast-
roenterostomy is then performed between the end of the
stomach and the side of the jejunum. Finally a hepati-
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cojejunostomy is performed 15 cm distal to the gast-
roenterostomy.
Results: We have so far performed PG on ﬁve patients
with FAP. The indications for PG were duodenal ade-
noma with dysplasia (n = 5). Three patients had pre-
viously had a total colectomy and ileoanal pouch and
two patients had a subtotal colectomy and ileorectal
anastamosis. There was no mortality, but two patients
had controlled pancreatic leak (amylase ‡500 IU/L at
day 5) which were managed conservatively. This
technique did not predispose to biliary reﬂux post-
operatively. Four patients subsequently underwent
endoscopic surveillance successfully with one further
due for surveillance.
Discussion: This technique facilitates surveillance studies
and conserves small bowel to avoid malabsorption in
FAP patients.
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WIRSUNGOSTOMY AS A SALVAGE
PROCEDURE AFTER
PANCREATICODUODENECTOMY
Q. Denost, A. Rault, J. Ewald, D. Collet, B. Masson and
A. Sacunha
CHU Bordeaux-Hopital HAut Le´ve´que
Aim: Postoperative peritonitis or haemorrage secondary
to pancreatic ﬁstula after pancreaticoduodenectomy
(PD) still has a high mortality rate. This study analysed
results of a new management of these complications by
wirsungostomy.
Patients and methods: From January 2004 to December
2007,171 patients underwent a PD. In the postoperative
course, 41 patients developed a pancreatic ﬁstula, 25
patients were treated medically and 16 patients required
relaparotomy for either wirsungostomy (n = 14) or
completion pancreatectomy (n = 2). We analysed ret-
rospectively patients who underwent wirsungostomy.
Causes of relaparotomy for these patients were heamor-
rhage (n = 9), peritonitis (n = 3), septic shock (n = 2).
During the operative course, we performed a dismantling
of the pancreaticodigestive anastomosis, a closure of the
jejunal stump, and the pancreatic duct remnant was
canulated by a thin polyethylene tube (Escat tube) passed
through the abdominal wall. Main outcome measures
were mortality, morbidity and long-term outcome which
were assessed by interview.
Results: In the postoperative course, ﬁve patients
(35.7%) died of liver failure (n = 3), refractory septic
shock (n = 1) and mesentery ischaemia (n = 1). Mor-
bidity was: acute kidney failure (n = 2) which did not
require hemoﬁltration, gastric delayed emptying
(n = 1), pleural effusion (n = 2), wound infection
(n = 1) and catheter displacement requiring a third
laparotomy (n = 1). The median length of hospital stay
was 42 days (34–60) and the polyetylene tube of the
pancreatic duct was removed at 5 months (2–6). Reci-
dive of neoplasm was responsible for the late death of
four patients. Two patients had diabetes mellitus during
the follow up.
Conclusion: Pancreatic ﬁstula is usually treated conser-
vatively with a high rate of success but needs reoperation
when complicated by uncontrolled haemorrage or peri-
tonitis. Completion pancreatectomy could be avoided by
wirsungostomy which appears to reduce overall operative
time performed with unstable patients.
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ATRIAL FIBRILLATION AND DELAYED
GASTRIC EMPTYING AFTER
PANCREATICODUODENECTOMY –
COINCIDENCE OR SHARED
MECHANISM?
I. C. Botwinick, R. J. Shonkwiler, G. Yu and
J. A. Chabot
Columbia University
Background: Atrial ﬁbrillation is one of the most com-
mon postoperative arrhythmias in noncardiac surgery.
Postoperative atrial ﬁbrillation is associated with in-
creased morbidity and mortality, as well as prolonged
hospital stays and subsequent drain on staff and re-
sources.
Objectives: We aimed to investigate whether any preop-
erative or intraoperative variables are associated with the
development of postoperative atrial ﬁbrillation after
pancreaticoduodenectomy (PD).
Methods: We performed a retrospective chart review of
170 patients who underwent PD at our institution be-
tween January 2000 and February 2007. Data was ana-
lyzed with alpha = 0.05 using Fisher exact test for
categorical variables and Mann-Whitney U or unpaired t
test for continuous variables, followed by multivariate
analysis.
Results: Approximately 6% of patients reviewed experi-
enced at least one episode of postoperative atrial ﬁbril-
lation. Mean age of patients with atrial ﬁbrillation was
74.2 years, compared with 63.6 years in patients without
atrial ﬁbrillation (P = 0.0036). Patients with atrial
ﬁbrillation were more likely to have a history of cardiac
disease (P = 0.0347) and to require treatment for an
infection over the course of their hospitalization
(P = 0.0199). Of note, 100% of the patients with atrial
ﬁbrillation suffered from delayed gastric emptying, de-
ﬁned as failure to tolerate a regular diet by postoperative
day 7, compared to 50% of patients without atrial
ﬁbrillation (P = 0.0017). This association held true
when controlling for age. A possible explanation linking
postoperative atrial ﬁbrillation and delayed gastric
emptying could be intraoperative injury to the peri-
esophageal vagal plexus or perioperative changes in ﬂuid
balance.
Conclusions: Age and a prior history of cardiac disease
are risk factors for postoperative atrial ﬁbrillation. Pa-
tients with postoperative atrial ﬁbrillation are more likely
to experience delayed gastric emptying.
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IS ROUTINE NASOGASTRIC TUBE
INSERTION NECESSARY IN
PANCREATICODUODENECTOMY FOR
PERIAMPULLARY LESIONS?
D. Choi, Y. Y. Choi, J. Kim, J. H. Kim, K.-J. Lee and
K. Y. Hur
Soonchunhyang University Hospital
Background: The need to use nasogastric decompression
after abdominal operations has been increasingly ques-
tioned for several years. Traditionally, nasogastric
decompression is a mandatory procedure after classical
Abstracts206
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
pancreaticoduodenectomy (PD). But, we still do not
know whether it is necessary for PD.
Objectives: To assess the clinical beneﬁt for routine
nasogastric decompression after PD, a prospective trial
was done.
Method: From July 2004 to May 2007, 41 consecutive
patients who underwent PD were enrolled in this study.
Eighteen patients were enrolled in nasogastric tube
(NGT) group and 23 patients in no NGT group.
Results: There were no differences in each group’s
demographics, pathology, co-morbid medical conditions
and preoperative laboratory values. In addition, passage
of ﬂatus (P = 0.963) and starting time of oral intake
(P = 0.951) were similar in both group. 61% of NGT
group complained discomfort related to the NGT.
Pleural effusions were frequent in NGT group
(P = 0.037), however, other postoperative complications
such as wound dehiscence, anastomotic leak occurred
similarly in both group. There was one case of NGT
reinsertion in NGT group.
Conclusions: Routine nasogastric decompression in PD
is not a mandatory procedure because it has no clinical
advantages and increase patient’s discomfort.
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LAPAROSCOPIC PANCREATIC
RESECTION FOR CANCER – IS IT
JUSTIFIABLE?
I. Pavlik Marangos1, A. M. Kazaryan1,
A. R. Rosseland2, O. Villanger2, B. I. Rosøk2,
Ø. Mathisen2 and B. Edwin1,2
1Interventional Center, Rikshospitalet, Oslo Uneversity
Hospital; 2Surgical department, Rikshospitalet, Oslo
Uneversity Hospital
Background: Surgical resection of malignant neoplasmas
of the pancreas is the most important part of the multi-
disciplinary cancer treatment. The success of surgery
determines the success of the whole treatment.
Aim: To evaluate short and long term results of laparo-
scopic resections in patients with pancreatic adenocarci-
nomas.
Methods: A retrospective study describing short term
outcome and long term survival following laparoscopic
resection for pancreatic carcinomas. From April 1997 to
October 2009, 190 patients were operated in curative
intent for pancreatic disorders. Thirty (16.7%) of these
underwent laparoscopic procedure for pancreatic ade-
nocarcinomas.
Results: Thirteen men and 17 women, median age
63 years (41–83) were included and 23 patients were
treated by following resections: distal with splenectomy
(n = 20), spleen preserving distal (n = 1), Whipple
procedure (n = 1) and resection of ectopic pancreatic
adenocarcinoma (n = 1). Seven patients (ductal type)
were inoperable. According to histological report there
were 15 ductal adenocarcinomas, two IPMN carcinomas,
two cystadenocarcinomas, one adenosquamous carci-
noma, one acinary cell carcinoma, one mixed type car-
cinoma and one periampullary carcinoma. Median
tumour diameter was 50 mm (4–180).Operative time was
median 227 mins (150–313). One resection was converted
and one was hand assisted. Most patients started with a
liquid diet on the ﬁrst postoperative day. Median post-
operative hospital stay was 5 days (1–30). One ﬁstula
(grade B) was observed. Four minor complications were
recorded. One patient died the 29th postoperative day.
Calculated 3 and 5 years survivals were 51 and 31% in
the total group, respectively 36% and 36% in the ade-
nocarcinoma (ductal type) group.
Conclusion: Laparoscopic resection in patients with car-
cinomas of the body and tail of the pancreas is safe and
feasible. Estimated survival shows to be at least as good
as open surgery.
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TOTAL PANCREATECTOMY:
INDICATIONS, DIFFERENT TIMING,
PERIOPERATIVE AND LONG-TERM
OUTCOMES
S. Crippa, T. Domenico, S. Germenia, R. Salvia,
S. Partelli, R. Rossato, C. Bassi, P. Pederzoli and
M. Falconi
Policlinico GB Rossi, University of Verona
Background: Total pancreatectomy (TP) was rarely per-
formed in the past because of its high morbidity and
mortality. Since outcome of pancreatic surgery as well as
management of pancreatic insufﬁciency has signiﬁcantly
improved, TP has had an increased reappraisal.
Aim: To evaluate the experience with TP at a single high-
volume, academic center.
Methods: Between 1996 and 2008, 65 patients (33 fe-
males, 32 males, median age 63 years) underwent TP at a
single, high-volume centre. Indications, timing, periop-
erative and long-term results were analyzed.
Results: Twenty ﬁve patients (38.5%) underwent a
planned elective TP, 25 patients had a single-stage un-
planned TP after an initial partial pancreatectomy that
turned into TP because of intraoperative haemorrhage
(n = 1) or positive pancreatic resection margin
(n = 24). The remaining 15 patients (23%) underwent a
two-stage pancreatectomy for tumor recurrence in the
remnant. No completion TP for postoperative compli-
cations was performed. There was no mortality; overall
morbidity was 38.5% and reoperation rate 4.5%.
Overall, 48% of patients had intraductal papillary
mucinous neoplasms (IPMNs), and 29.5% pancreatic
ductal adenocarcinoma (PDA). R1 resections rate was
12%. 4/23 patients (17%) who underwent single-stage
unplanned TP for positive resection margin had R1
resection (positive retroperitoneal margin). Median fol-
low-up was 30 months. Five-years overall survival was
71%. No deaths due to hypoglycaemia were observed.
Median insulin units/day was 32, median lipase units/
day 80,000.
Conclusions: TP can be performed safely with no mor-
tality and acceptable morbidity. Postoperative pancreatic
insufﬁciency can be well-managed nowadays. In order to
achieve an R0 TP, both the resection and retroperitoneal
margin should be evaluated intraoperatively. TP is an
effective operation is selected patients.
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RECONSTRUCTION FOLLOWING
PANCREATICODUODENECTOMY FOR
PATIENTS WHO HAVE PREVIOUSLY
UNDERGONE PARTIAL GASTRECTOMY
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1, H. Miyake2 and S. Amano3
1Social Insurance Yokohama Central Hospital/Surgery;
2Kasukabe Municipal Hospital/Surgery; 3Nihon
University School of Medicen/Surgery
Background/Aims: We compared the results of recon-
structive procedure following pancreaticoduodenectomy
(PD) with pancreaticojejunostomy in patients who have
undergone partial gastrectomy previously.
Method: Twenty-two patients who had previously
undergone partial gastrectomy with Billroth-? recon-
struction for gastric ulcer or gastric cancer had sub-
sequent PD and were available for this study. The
patients were divided into 2 groups: those who under-
went Billroth-? (Imanaga’s and Cattell’s) (n = 10)
reconstruction and those who underwent Billroth-?
(Child’s) (n = 12) reconstruction.
Results: One patient from each group developed a post-
operative pancreatic ﬁstula (grade B). Although without
signiﬁcant difference, the Billroth-? group required
nasogastric suction for a shorter duration than those of
the Billroth-? group. Diet initiation and oral ingestion of
solid foods could be safely resumed signiﬁcantly earlier in
the Billroth-? group. Delayed gastric emptying (DGE)
was observed 40% in the Billroth-?? group, and 8% in the
Billroth-? group. The duration of hospitalization was
signiﬁcantly shorter in the Billroth-? group.
Conclusion: We conclude that Billroth-? (Child’s)
reconstruction is an appropriate reconstructive proce-
dure for preventing DGE after PD in patients who have
previously undergone partial gastrectomy.
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BINDING
PANCREATICOGASTROSTOMY – A
NEW PROCEDURE TO MINIMIZE LEAK
RATE
S. Y. Peng1, D. F. Hong2, Y. B. Liu3, J. T. Li1, Z. J. Tan4,
F. Tao5, B. Xu2, Y. F. Wang2 and X. A. Wang1
1The second afﬁliated Hospital, School of Medicine,
Zhejiang University; 2Sir Run Run Shaw Hospital, School
of Medicine, Zhejiang University; 3Afﬁliated Shanghai
Xinhua Hospital, Shanghai Jiaotong University; 4The
Afﬁliated Guangdong Chinese Traditional Medicine
hospital, Guangdong Chinese Traditional Medicine
University; 5Shaoxing Hospital
Background: Binding Pancreaticojejunostomy (BPJ) has
been widely used in China, however when the stump of
the pancreas remnant is too large, it might be difﬁcult to
be inserted into the lumen of the jejunum. To solve this
problem, a new procedure called Binding Pancreaticog-
astrostomy (BPG) has been designed by the author.
Clinical use has proved it to be very effective, safe and
even easier than BPJ to perform.
Aim: To introduce the new technique – Binding Pan-
creaticojejunostomy (BPJ).
Method: 1. Isolating the stump of pancreas remnant for
2 cm;
2. Excising a piece of sero-muscular layer at the posterior
gastric wall, the size being equivalent and the location
being opposite to the pancreas stump. A small incision is
made at the mucosa layer to accommodate pancreas
stump;
3. Incising the anterior gastric wall or opening part of the
closed distal gastric stump;
4. Binding anastomosis: the pancreas remant is pulled
into the gastric lumen. The ﬁrst purse-string is tied (outer
binding) and then the second one is also tied (inner
binding). Biliojejunostomy and gastrojejunostomy is then
separately performed.
Results: From May 2008 to May 2009, 47 cases under-
went BPG. No mortality and anastomotic leakage oc-
curred. Postoperative complications included small
amount of Pleural Effusion in 1 case, delayed gastric
emptying in two cases and bile leakage in two cases,
cured conservatively in 2 weeks. No pancreatic duct
stricture caused.
Conclusion: Pancreaticogastrostomy can easily be estab-
lished simply by two purse-string sutures. The binding
technique is very helpful in minimizing the leak rate of
pancreaticogastrostomy.
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MICROSURGICAL DUCT-TO-MUCOSA
PANCREATICO-JEJUNOSTOMY TO
MINIMIZE LEAKAGES
G. La Greca, F. Barbagallo, M. Soﬁa, S. Primo,
S. Latteri, D. Russello, R. Portale, S. Puleo and
A. Di Cataldo
Department of Surgical Sciences, Organ Transplantation,
and Advanced Technologies, University of Catania,
Catania, Italy
Background: Morbility and mortality after pancreatico-
duodenectomy still remain mostly related to the leakage
of the pancreatic anastomosis. The duct-to-mucosa
pancreatico-jejunostomy is one of the most used tech-
nique and probably the ‘‘ﬁnest’’ technique beneath other
more ‘‘gross’’ techniques like pancreato-gastrostomy or
telescope pancreato-jejunostomy without duct anasto-
mosis. This technique is normally not performed with
microsurgical technique reporting a mean leakage of 6.2–
11% anyway lower than overall rate.
Aim: This study analyzed the results obtained with the
duct-to-mucosa pancreato-jejunostomy performed with
microsurgical technique.
Methods: All patients who underwent to duodeno-pan-
createctomy with pancreato-jejunal anastomosis were
prospectively evaluated. Time to perform the anasto-
mosis and post-operative amylase values in the surgical
drains were also recorded. The anastomosis was per-
formed end-to-side on a Roux en Y jejunal loop. A
posterior and anterior layer, between the pancreatic
capsule and the sero-muscular layer of the jejunum were
realized by a 3–0 absorbable suture; the duct-to-mucosa
anastomosis was realized by 8–10 interrupted 5–0/6–0
absorbable sutures with microsurgical magniﬁcation.
Results: 34 microsurgical pancreaticojejunostomy were
performed. The time required for anastomosis was
9 mins (7–15). Only in the ﬁrst 26 patients a trans-jejunal
external stent was left inside the pancreatic duct for
8 days. Morbility affected three patients 8.8% (two
bleeding, one leakage) and one mortality (2.9%) due to
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bleeding. A leakage rate of 2.9% (n = 1) consisted of a
subclinical ﬁstula which healed spontaneously in 13 days.
Conclusion: Our preliminary experience with the micro-
surgical duct-to-mucosa pancreaticojejunostomy re-
ported very encouraging results comparable to those
obtained by other authors and strongly underlying the
very important role a microsurgical technique to mini-
mize the rate of anastomotic leaks after pancreatoduo-
denectomy.
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ABERRANT HEPATIC ARTERIAL
ANATOMY AND THE WHIPPLE
PROCEDURE: LESSONS LEARNED
A. El-Sedfy1 and R. Chamberlain1,2,3
1St. George’s University, School of Medicine, Grenada,
West Indies; 2Department of Surgery, Saint Barnabas
Medical Center, Livingston, NJ; 3Department of Surgery,
University of Medicine & Dentistry of New Jersey,
Newark NJ
Objectives: Appreciation and study of hepatic arterial
anatomical variability is essential to the performance of a
pancreaticoduodenectomy. The objective of our study is
to provide a comprehensive review of the anatomic
arterial anomalies and discuss surgical strategies which
will equip the surgeon to deal with all anomalies which
may be encountered a priori or en passant during the
course of a Whipple procedure.
Methods: We conducted a comprehensive review of both
English and non-English literature focusing on all topics
relevant to reports of normal and aberrant hepatic arte-
rial anatomy, and/or novel surgical techniques for per-
forming a pancreaticoduodenectomy.
Results: A variety of classiﬁcation systems for hepatic
arterial variations have been published, and slight mod-
iﬁcations continue to be made based upon new anatom-
ical knowledge provided by autopsy and angiographic
studies. All classiﬁcations of the hepatic arteries are
based on the benchmark cadaveric study of Michels in
1966.
Conclusions: The study of hepatic arterial anatomical
variability is essential to the performance of a successful
pancreaticoduodenectomy by avoiding surgical compli-
cations such as bleeding, hepatic ischemia/failure, and
anastomotic leak/stricture. Awareness of variability per-
mits the surgeon to adapt surgical technique to deal with
anomalies identiﬁed pre-operatively or intra-operatively
thereby preventing unnecessary surgical morbidity and
mortality.
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COMPARATIVE ANALYSIS BETWEEN
RAMPS AND CONVENTIONAL DISTAL
PANCREATECTOMY FOR PANCREATIC
BODY AND TAIL CANCER
D. You, M. Kim, J. Heo, S. Choi and D. Choi
Samsung Medical Center, Sungkyunkwan University
School of Medicine
Background: Radical antegrade modular pancreato-
splenectomy (RAMPS) was described by Strasbergas as a
novel approach for resection of adenocarcinoma of the
body and tail of the pancreas because of its modular
dissection plane direct to anterior or posterior to the
adrenal gland and its ability to obtain negative tangential
margin rates.
Objective: To compare RAMPS, with the conventional
distal pancreatectomy (DP) through the clinicopatho-
logic reviews.
Methods: From 1995 to 2008, 50 patients underwent DP
and 11 patients underwent RAMPS for the same disease
in Samsung Medical Center. Perioperative factors were
retrospectively analysed.
Results: The median age was 61 years (37–79), 39 (64%)
male and 22 (36%) female patients were included. Pre-
operative CA19-9 level was increased in 39 patients
(64%). Intraoperative bleeding and transfusion, postop-
erative day to tolerate solid oral intake, postoperative
pancreatic ﬁstula and its severity, overall complication,
postoperative hospital stay were not different between
DP and RAMPS. However, the median operation time of
RAMPS was longer than that of DP (230 vs. 180 mins,
P = 0.048) because combined resection of other organs
was frequent in RAMPS. In pathologic factors, tumor
size, T stage, N stage, AJCC stage, curability was not
different between two groups. The number of retrieved
lymph nodes in RAMPS was 21.5 (11–52) and 9 (1–35) in
DP (P < 0.001).
Conclusion: RAMPS enable to effective dissection of
regional lymph nodes, more accurate tumor staging and
thereafter this procedure may increase chance of curative
resection for adenocarcinoma of the body and tail of the
pancreas.
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LONG TERM OUTCOME FOLLOWING
PANCREATICODUODENECTOMY IN A
TERTIARY HEPATOPANCREATICO-
BILIARY REFERRAL CENTRE
D. McArthur1, G. Oniscu2, A. Oniscu3, R. Parks1,
S. Wigmore1 and J. Garden1
1Department of Surgical Sciences, University of
Edinburgh; 2Department of Surgery, NHS Lothian;
3Department of Pathology, NHS Lothian
Introduction: Pancreaticoduodenectomy (PD) for pe-
riampullary lesions has become increasingly frequent as
postoperative mortality and survival have improved.
Aims: The aim of this study was to analyse the long-term
outcome from a specialist centre.
Methods: All patients undergoing PD between Novem-
ber 1989 and February 2006 were identiﬁed from the
Lothian Surgical Audit Database (prospectively collected
data). Patient outcome was updated in March 2009 to
ensure a minimum follow up period of 3 years and was
correlated with treatment speciﬁc survival data from the
NHS Scotland Information & Statistic Division.
Results: Three hundred and eighteen patients underwent
PD during the 16-year study period. Fifteen cases were
excluded as the dataset was incomplete. The median age
of the remaining 303 patients (165 males:138 females)
was 63 years (IQR 55–69). The median follow-up was
8.5 years (range 3–16). 279 PD (92%) were carried out
for malignancy (263 adenocarcinoma and 16 neuroen-
docrine tumours) and 23 (7.6%) for benign disease (10
chronic pancreatitis, seven benign pancreatic lesions and
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six benign CBD strictures). Of those patients with
malignancy, 124 (40.9%) had pancreatic cancer, 93
(30.7%) had ampullary cancer, 45 (14.9%) had cholan-
giocarcinoma and 18 (5.9%) had duodenal cancer. The
overall 30 day mortality rate following PD was 2.6% and
was similar for patients with malignant disease or benign
disease (P = 0.4735). The overall 5- and 10-year survival
rates for patients with malignancy were 27.7 and 13.8%
respectively. Tumour speciﬁc survival is given in the ta-
ble. Duodenal and ampullary cancer survivals were sig-
niﬁcantly better than pancreatic or cholangiocarcinomas.
Tumour Speciﬁc Survival
Tumour Type
5 Year
Survival
10 Year
Survival
Median
Survival
(months)
Duodenal 48.6% n/a 54
Ampullary 41.6% 22.5% 41
Pancreatic 15.9% n/a 16
Cholangiocarcinoma 10.4% 0.8% 18
Conclusion: Surgery with curative intent for patients
with periampullary malignancy can be undertaken with
acceptable post-operative mortality rates and is associ-
ated with favourable long term outcome, particularly in
patients with ampullary cancer or duodenal cancer.
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RISK FACTORS FOR PANCREATIC
LEAKAGE AND EFFICACY OF
PROPHYLACTIC OCTREOTIDE FOR
SOFT PANCREATIC TEXTURE
K. Taniguchi, R. Matsuyama, H. Takakura, K. Takeda,
T. Kumamoto, Y. Homma, Y. Ota, A. Yamada,
K. Nojiri, Y. Minami, M. Ueda, Y. Nagano, K. Tanaka,
H. Akiyama and I. Endo
Department of Gastroenterological Surgery, Yokohama
City University Graduate School of Medicine
Background: The efﬁcacy of prophylactic use of octreo-
tide for pancreatic surgery is still controversial.
Aim: To clarify risk factors for pancreatic leakage and
investigate the efﬁcacy of prophylactic octreotide.
Patients and methods: We analyzed 332 pancreatic sur-
gery (285 pancreaticoduodenectomy, 34 distal pancrea-
tectomy and 13 partial resection) at our institution
between May, 1992 and April, 2009. Risk factors for
pancreatic leakage were examined by univariate and
multivariate analysis. 50 lg of prophylactic octreotide
was administered subcutaneously twice a day for 5 days
after surgery in high risk group of pancreatic leakage.
Results: Risk factors for pancreatic leakage were soft
pancreatic texture, narrow main pancreatic duct and in-
creased amylase level of drainage ﬂuid until three days
after surgery in univariate analysis. Soft pancreatic tex-
ture was an independent risk factor for pancreatic leak-
age in multivariate analysis (95%CI, 2.62-37.5,
P = 0.001) Prophylactic octreotide was administered
after 27 surgery for soft pancreatic texture since 2005, but
pancreatic leakage was occurred in 12 cases (44%).
Pancreatic leakage was not signiﬁcantly reduced com-
pared to historical control group of soft pancreatic tex-
ture (46%) (P = 0.811). There was no signiﬁcant effect
on preventing pancreatic leakage evaluated by each type
of operation. The amylase level of drainage ﬂuid was not
decreased by the use of prophylactic octreotide.
Conclusion: Soft pancreatic texture was an independent
risk factor for pancreatic leakage. Prophylactic use of
octreotide dose not reduce pancreatic leakage after sur-
gery for soft pancreatic texture.
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ROUX-EN-Y DRAINAGE OF
PANCREATIC FISTULA FOR
DISCONNECTED PANCREATIC DUCT
SYNDROME FOLLOWING ACUTE
NECROTIZING PANCREATITIS
E. Pearson, S. Mulvihill, C. Scaife and R. Glasgow
University of Utah
Background: Following acute necrotizing pancreatitis
(ANP), a pancreatic ﬁstula may occur from disconnected
pancreatic duct syndrome (DPDS) where a segment of
pancreas no longer is in continuity with the main pan-
creatic duct. Roux-en-Y drainage is a parenchyma-pre-
serving method of internalizing pancreatic ﬁstula
drainage.
Aim: Study the outcome of patients treated by Roux-Y
pancreatic ﬁstula tract-jejunostomy for DPDS following
ANP.
Methods: Patients treated for DPDS from 2002–2009.
DPDS was identiﬁed by presence of non-healing pan-
creatic ﬁstula in the setting of MRCP documented main
pancreatic duct disruption with undrained viable pan-
creas.
Results: Seven patients with DPDS were treated. Mean
age was 62 years (range 49–77). 57% were men. The
cause of ANP was gallstones (3), alcohol (1), ERCP (1)
and idiopathic (2). Pancreatic necrosectomy was done in
ﬁve patients. Two patients had percutaneous drainage of
pancreatic ﬂuid collections. Time from onset of pancre-
atitis to ﬁstula drainage was 227 days (164-349). Pan-
creatic ﬁstulae arose from DPDS in the head/neck (5)
and body/tail (2). Patients had a mean ﬁstula output of
150 mL (70–200) per day prior to surgery. Mean opera-
tive time was 186 min (120–367) and estimated blood loss
was 225 mL (50–500). Patients began an oral diet on post
operative day 4 (3–6) and were hospitalized a mean of
7 days (5–12). Mean follow-up was 374 days (7–
1363).Complications were wound infection (2), ventral
hernia (2), recurrent pseudocyst remote from the site of
DPDS drainage (2), splenic artery pseudoaneurysm (1),
infectious colitis (1), and transient anastomotic leak
requiring brief external drainage (1). Internalization of
ﬁstula drainage was successful in 100% of patients.
Following surgery, three patients required oral anti-dia-
betics. No patients had pancreatic exocrine insufﬁciency.
Conclusion: Internal surgical drainage with Roux-en-Y
pancreatic ﬁstula tract-jejunostomy is a safe and deﬁni-
tive treatment for patients with DPDS.
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ROUTINE GASTROSTOMY TUBE (GT)
SHORTENS LENGTH OF STAY IN
PATIENTS WITH DELAYED GASTRIC
EMPTYING AFTER PYLORUS-
PRESERVING
PANCREATICODUODENECTOMY (PPD)
Y. L. Cheah, J. J. Pomposelli, J. Verbesey, M. Akoad,
K. Khwaja, W. D. Lewis, E. A. Pomfret and
R. L. Jenkins
Department of Transplantation & Hepatobiliary Surgery,
Lahey Clinic, Burlington, Massachusetts, United States
Background: Delayed gastric emptying (DGE) is a
common complication following PPD and often requires
prolonged uncomfortable nasogastric decompression.
Unlike most centers, we routinely insert GT for gastric
decompression after PPD.
Objective: To examine the impact of GT decompression
after PPD on hospital length of stay (LOS) in patients
who develop DGE.
Methods: One hundred and four patients who underwent
PPD with GT and feeding jejunostomy by a single team
of surgeons between 2003–2009 were evaluated. Patient
demographics, morbidity, mortality, rate of DGE and
hospital LOS were analyzed retrospectively. The Inter-
national Study Group of Pancreatic Surgery (ISGPS)
grading system was used to deﬁne DGE. Continuous
data were analyzed by ANOVA and t-test, survival data
by Kaplan-Meier. Signiﬁcance for all tests was P < 0.05.
Results: Fifty eight males and 46 females with mean age
of 64.6 years underwent PPD. 30-day operative mortality
was 1.9% and overall morbidity rate was 65%. 74% of
patients had cancer diagnosis. Overall 1-year survival
was 88%, including non-cancer diagnosis. The most
common complication was DGE (52.9%). The incidence
of DGE ISGPS Grade A (mild), B (moderate) and C
(severe) were 38.5%, 10.6% and 3.8% respectively.
Hospital LOS stratiﬁed by the presence or absence of
DGE is summarized in the table below. 40% of patients
with Grade B or C DGE were able to be discharged home
with GT and tube feedings prior to tolerating solid food.
There were no major complications from gastrostomy
tube insertion.
Hospital LOS stratiﬁed by presence or absence of DGE
No DGE DGE A DGE B DGE C
LOS (days) 8.9 14.5* 18.5*& 18.8*&
*P < 0.001 vs. No DGE & P < 0.05 vs. DGE A
Conclusion: Despite signiﬁcant morbidity, PPD can be
performed with low operative mortality and excellent 1-
year survival. The presence of DGE signiﬁcantly in-
creases hospital LOS but routine GT allowed for early
discharge in 40% of patients with moderate or severe
DGE. Routine GT after PPD may improve resource
utilization by shortening hospital LOS.
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BODY MASS INDEX AND THE RISK OF
COMPLICATIONS AFTER MINIMALLY
INVASIVE PANCREATECTOMY
K. Mekeel, A. Moss, K. Reddy, D. Mulligan and
K. Harold
Mayo Clinic Arizona
Background: Minimally invasive distal pancreatectomy
is rapidly becoming the standard of care for patients with
benign and even small malignant lesions of the pancreas.
As the incidence of obesity continues to climb in the
United States, more obese patients are being considered
for minimally invasive pancreatectomy. As in other sur-
gical procedures, complications may increase with the
body mass index (BMI).
Methods: This is a retrospective review of 36 minimally
invasive pancreatectomies (35 laparoscopic and one ro-
botic) at our institution from 2005 until the present. Of
the 36 patients, 13 (36%) had a BMI 30 or greater
(obesity), 6 (17%) had a BMI greater than 35, and 2 (6%)
had a BMI greater than 40 (morbid obesity).
Results: Outcomes including total complications, ﬁstula
formation, concomitant splenectomy, estimated blood
loss, operative time, and length of stay were analyzed.
The results are listed in Table 1. Patients with a BMI of
30 or greater had a signiﬁcant decrease in spleen preser-
vation, and patients with a BMI of 35 or greater had a
trend to increased complications, which was not signiﬁ-
cant. Two patients had a BMI > 40. One required
conversion to an open procedure to obtain a negative
margin, and then developed a pancreatic ﬁstula. The
other developed a pulmonary embolism requiring anti-
coagulation.
BMI < 30 (23) BMI > 30 (13) P-value
Complications 7 (6 patients) 7 (6 patients) 0.2859
Fistula 5 3 1.0000
Splenectomy 13 12 0.0311
Blood loss (mL) 25–400 (135) 50–350 (185) 0.1585
Operative Time (min) 138–437 (224) 140–515 (269) 0.1146
Length of Stay (days) 3–11 (4.7) 3–9 (5) 0.6928
BMI < 35 (30) BMI > 35 (6) P-value
Complications 10 (9 patients) 5 (4 patients) 0.0628
Fistula 5 3 0.1086
Splenectomy 19 6 0.1479
Blood loss 50–250 (167) 25–350 (150) 0.6166
Operative Time (min) 138–300 (231) 145–515 (288) 0.1215
Length of Stay 3–11 (4.7) 3–9 (2.1) 0.6928
Conclusions: Obese and morbidly obese patients should
not be excluded as candidates for minimally invasive
pancreatectomy.
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WHIPPLE PROCEDURE ASSOCIATED
TO VISCERAL, VASCULAR OR LIVER
RESECTION: IS IT REASONABLE?
M. Tavernier1, B. Alkofer1, E. Salame´1, J. Lequet1,
J-J. Parienti2 and L. Chiche1
1Department of hepatobiliary surgery, CHU Caen,
France; 2Department of statistics, CHU Caen, France
Background: Whipple Procedure (WP) is now a safe
procedure in high volume centers. However, to obtain a
R0 resection of the pancreatic neoplasm, WP may need
the resection of other organs.
Objective: To analyse the morbidity and mortality of
extended WP (EWP) and to compare them to simple WP.
Method: Retrospective monocentric cohort study of WP
and EWP performed between January 1993 and
December 2008. The two groups were compared using
the chi2 test.
Results: Two hundred and seventy seven patients
underwent WP: 251 WP and 25 EWP. Visceral associated
resections included: seven right hemicolectomies, four
small bowell resections, one gastrectomy, and one
resection of the tail of the pancreas. Five WP were
associated with a hepatectomy (at least a segmentecto-
my), and 11 with a vascular resection (including 3 vena
cava, 5 right hepatic artery, 3 splenomesenteric conﬂu-
ence resections). Four patients had more than one
resection associated. Patients who had only resection of
part of the portal or mesenteric vein were included in the
WP group. Overall postoperative mortality was 1.1%
and morbidity was 61.4%. In the EWP group, overall
morbidity was signiﬁcantly higher (59.4 vs. 82.6%,
P < 0.05). Moreover, if we assess morbidity with the
Clavien classiﬁcation, the most serious complications (33)
were more frequent in the EWP group (39.1% vs. 16.9%,
P < 0.05), while less severe complications were not dif-
ferent (43.5 vs. 42.6%, P = 0.9). No difference was
found between the two groups for mortality, haemor-
rhage, pancreatic or bile duct leakage, pneumonia,
wound infections and reoperation rates.
Conclusion: EWP is a safe and effective procedure and
should be performed to obtain a RO resection. A higher
complication rate is well balanced by a low mortality and
a good survival rate.
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ANTERIOR TRANSGASTRIC
PANCREATICOGASTROSTOMY (PG)
AFTER STANDARD WHIPPLE’S
PANCREATICODUODENECTOMY
(SWPD), A PILOT STUDY
M. Narasimhan, K. Palaniappan, M. Joshi and
R. Ardhanari
Meenakshi mission hospital and research centre, Madurai
Background: Management of the pancreatic stump fol-
lowing pancreaticoduodenectomy (PD) has always been
a main source of concern among pancreatic surgeons.
The present pilot study describes the reconstructive
technique of anterior transgastric pancreaticogastrosto-
my (PG) after standard Whipple’s pancreaticoduoden-
ectomy (SWPD).
Methods: From March 2008 to June 2009, 32 consecu-
tive patients underwent our novel reconstructive tech-
nique. The major modiﬁcation was anterior transgastric
approach for Pancreaticogastrostomy with utilization of
the same incision for performing GJ.
Results: Average duration of the procedure was 210 min
(range: 180–290); two patients needed intra operative
transfusion with 2 units of blood. The post op compli-
cations occurred in 6 cases (18.8%). In particular, two
patients developed pancreatic ﬁstulas (6.2%), which were
grade C in nature. Four patients (12.5%) had features of
delayed gastric emptying, of which two patient’s required
surgical exploration. Two patients developed (6.25%)
post operative bleeding. There was one death (4.5%).
The mean hospitalization time was 11.1 days (range, 8–
25 days).
Conclusion: Our modiﬁed reconstructive technique is
simple & safe. The results obtained in this pilot study
appear encouraging and merit further analysis in a ran-
domized comparative trial.
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IS BACTIBILIA A PREDICTOR OF
POOR OUTCOME FOLLOWING
PANCREATICODUODENECTOMY?
J. Damodaran, S. Sivanpillai Mahadevan,
V. Velayutham, J. Sathyanesan, R. Palaniappan,
R. Vennila and S. Rajagopal
Department of SGE, Government Stanley Medical College
Hospital, Chennai - 600001
Background: Although Bile infection has been proposed
to increase infectious complications following pancreati-
coduodenectomy its association with infective complica-
tions & non infective complications like pancreatic ﬁstula
is still controversial.
Methods and materials: Between July 2007 to December
2008, 76 patients who underwent pancreaticoduodenec-
tomy were included in a prospective database & ana-
lyzed. In all patients intraoperative bile culture from the
bile duct was done. Preoperative, intra operative & post
operative variables were recorded & analyzed.
Results: Bile culture showed growth in 35 patients
(46.1%).In the positive bile culture group, 20 patients
had undergone ERCP & stenting (57.1%). All the pa-
tients who underwent ERCP & biliary stenting had po-
sitive bile cultures. Patients in the positive bile culture
group had higher incidence of infective complications –
Intra abdominal abscess (P = 0.0002), wound infection
(P = 0.0148), Bacteremia (0.0043) & renal failure
(0.03746). There was no increase in the rate of non
infective complications of pancreaticoduodenectomy –
pancreatic ﬁstula (P = 0.69681), delayed gastric empty-
ing (P = 0.16742), post operative hemorrhage (P = 1).
The hospital stay was signiﬁcantly prolonged in the po-
sitive bile culture group (P = 0.0002).
Conclusion: Pre operative biliary drainage was signiﬁ-
cantly associated with bile infection, other preoperative
factors were not associated with Bile infection, and Bile
infection increased the overall complications, infective
complications & renal insufﬁciency.
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POSTOPERATIVE COMPLICATIONS
Complication Infected Bile (35) Sterile Bile (41) P value
Mortality 1 1 1
Pancreatic ﬁstula 4 3 0.69681
Hemorrhage 1 2 1
Delayed gastric emptying 6 3 0.16742
Infective complications 18 9 0.0148
Wound infections 18 9 0.0148
IAA 7 1 0.0002
Bacteremia 9 1 0.0043
Renal Insufﬁciency 8 2 0.03746
Pulmonary 1 2 1
Hospital stay 16 10 0.0002
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SURGERY FOR METASTASES TO THE
PANCREAS
S. Pericleous1, S. McKay1, P. Mezes1, N. Habib1,
R. Hutchins2 and D. Spalding1
1Department of HPB Surgery, Hammersmith Hospital,
Imperial College, London UK; 2Department of HPB
Surgery, The Royal London Hospital, London, UK
Background: Solitary metastases to the pancreas are rare
and thus the role of operative treatment remains poorly
deﬁned. The aim of this study was to assess the role of
surgery in patients presenting with metastases to the
pancreas based on the experience of two pancreatic units
in afﬁliated university hospitals.
Methods: Between 1994 and 2008 eight patients with
pancreatic metastases were identiﬁed. Their histology,
operations and clinical outcome were reviewed retro-
spectively.
Results: There were four men and four women of median
age 56 (range 24–75) years. One patient presented with a
synchronous renal cell carcinoma [RCC] metastasis,
whilst four patients had known primaries (RCC 2,
colorectal carcinoma [CRC] 2) and developed meta-
chronous metastases at a median of 44 (range 12–
48) months following their original surgery. Three pa-
tients were thought to have pancreatic primaries, sub-
sequent histology revealed these to be synchronous
metastases [lung cancer (LC) 2, primitive neuro ecto-
dermal tumour/Ewing family (pNET) 1]. Five patients
had pancreaticoduodenectomies (RCC 2, LC 2, CRC 1),
1 a distal pancreatectomy (pNET) and 2 palliative by-
passes (RCC 1, CRC 1). Four patients had adjuvant (LC
2, CRC 1, pNET 1) and 1 palliative (CRC) chemother-
apy. One RCC patient each had adjuvant and palliative
radiotherapy respectively. At a median follow-up of 26
(9–100) months, 5 patients had died of recurrent disease
(RCC 2, LC 1, CRC 1, pNET 1) two remained alive but
with evidence of recurrent disease (CRC 1, RCC 1) and
one patient with LC remained alive with no evidence of
recurrence.
Conclusions: As pancreatic surgery becomes safer,
resection of pancreatic metastases may offer prolonged
survival in selected patients.
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RESECTION OF INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASMS
(IPMNS) OF THE PANCREAS: THE ROLE
OF INTRAOPERATIVE
ULTRASONOGRAPHY (IOUS)
M. Mirarchi1, E. De Raffele1, L. Calculli2, D. Santini3,
S. Vaccari1 and B. Cola1
1U.O. Chirurgia Generale. Policlinico S.Orsola-Malpighi.
Bologna. Italy; 2U.O. Radiologia. Policlinico
S.Orsola-Malpighi. Bologna. Italy; 3U.O. Anatomia e
Istologia Patologica. Policlinico S.Orsola-Malpighi.
Bologna. Italy
Background and aim: IPMNs are neoplasms of the pan-
creas increasingly identiﬁed in the last decades, have
malignant potential and can be multifocal. Segmental
pancreatic resection are increasingly considered to be
adequate for lesions with low malignant potential. The
aim of the study was to deﬁne the role of IOUS in can-
didates to pancreatic resection for IPMNs.
Methods: Ten patients were included in the study; six
were males and four were females; mean age (±SD) was
71 (± 7) years (range: 61–84 years). All underwent pre-
operative CT-scan and MRCP for staging. Three patients
had invasive carcinoma and IPMNs, two had multifocal
and ﬁve had unifocal IPMNs, respectively. IOUS was
performed after division of the gastrocolic ligament and
exposure of the anterior aspect of the pancreas to explore
the parenchyma, the tumour and the peripancreatic ves-
sels, and then to deﬁne resection margins before pan-
creatic division. Resection margins were submitted for
intraoperative frozen section analysis.
Results: IOUS was useful to deﬁne resection margin in
patients with invasive carcinoma: in one patient with an
invasive carcinoma of the tail and multiple IPMNs,
IOUS showed a 20 mm tumour of the isthmus which was
included in the resected specimen and contained focal in-
situ carcinoma. In patients with multifocal tumours,
IOUS was useful to deﬁne the resection margins of the
dominant IPMN. In patients with unifocal tumour,
IOUS was useful to obtain negative margins: two pa-
tients underwent DCP, 1 underwent distal pancreatec-
tomy without splenic preservation for a concomitant
splenic lymphoma, 2 underwent IOUS-guided resection
of the tail with splenic preservation. Resection margins
were negative at intraoperative frozen section analysis in
all cases.
Conclusion: IOUS should be routinely used in selected
patients with IPMNs candidated to pancreatic resection
and should guide the surgeon, especially in patients with
multifocal neoplasms and in candidates to segmental
conservative pancreatic resection.
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P-200
PREVENTING DELAYED GASTRIC
EMPTYING IN PANCREATICO-
GASTROSTOMY BY MODIFIED
SUBTPTAL-STOMACH-PRESERVING
PANCREATICODUODENECTOMY
T. Oida1, K. Mimatsu1, K. Hisao1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1 and S. Amano2
1Social Insurance Yokohama Central Hospital / Surgry;
2Nihon University School of Medicine
Background/Aims: Delayed gastric emptying (DGE) is
one of the most troublesome complications of pylorus-
preserving pancreaticoduodenectomy (PPPD). In Japan,
since the 1990s, subtotal-stomach-preserving pancreati-
coduodenectomy (SSPPD) has been performed as an
alternative to PPPD. Here, we evaluated the efﬁcacy of
our modiﬁcation of the original SSPPD technique as
compared to PPPD with an aim to decrease the incidence
of DGE.
Methodology: We retrospectively analyzed 67 patients
who underwent PD with Pancreaticogastrostomy (PG).
They were divided into 2 groups on their basis of the
surgical treatment: the PPPD group and the modiﬁed
SSPPPD (MSSPPD) group. The incidence of DGE was
determined and compared between the 2 groups.
Results: In the MSSPPD group, 98%, 2%, and 0% of
the cases developed class A, class B, and class C DGE,
respectively: the corresponding values in the PPPD group
were 4%, 52%, and 44%, respectively. The incidence of
DGE differed signiﬁcantly between the 2 groups
(P < 0.0001).
Conclusions: We consider that our reconstruction pro-
cedure is useful for preventing DGE in patients who have
undergone SSPPD with PG.
P-201
ENHANCED RECOVERY AFTER
SURGERY PROGRAMME FOR
PANCREATIC SURGERY – AN
ASSESSMENT OF HOSPITAL STAY,
READMISSIONS AND COMPLICATIONS
L. J. H. Wersch Van1, R. M. Dam Van1,
A. M. E. H. Beelen1, P. B. W. Cox2, B. Telgenkamp1,
L. P. S. Stassen1 and C. H. C. Dejong1
1Department of Surgery, Maastricht University Medical
Centre; 2Department of Anesthesiology, Maastricht
University Medical Centre
Background: The Enhanced Recovery After Surgery
(ERAS) programme has been designed to accelerate
recovery and reduce length of hospital stay (LOS). The
ERAS programme has shown positive results after
colonic- and liver-resection. However, the feasibility
and efﬁcacy in pancreatic surgery remains largely
unknown.
Objective: After introduction of the ERAS protocol for
colonic and hepatic surgery in our unit, perioperative
care of all patients was inﬂuenced by the ERAS-envi-
ronment, leading to early resumption of oral intake and
mobilisation. This study was designed to assess whether
an ERAS-environment reduced LOS and readmissions
after pancreaticoduodenectomy (PD).
Methods: Between January 1992 and December 2008
patients undergoing PD were included in the study. Pa-
tients undergoing PD from 2007 to 2008 were treated
within an ERAS-environment (ERAS-environment
group). Patients undergoing PD before 2006 were man-
aged by classical standards in perioperative care (control
group). 2006 was excluded as transition period. LOS,
readmissions, mortality and complications of both
groups were compared. Chi-square was used for com-
plications, readmissions and mortality. Mann-Whitney U
was used for LOS.
Results: The control group (n = 106) and ERAS-envi-
ronment group (n = 34) showed no difference at base-
line. Mean LOS was 29.1 days for the control group
(SD ± 23, median 23 days, range 1–139) and 18.4 days
for the ERAS-environment group (SD ± 14.3, median
12.5 days, range 2–57) with P = <0.001. Other outcome
parameters showed no signiﬁcant differences.
Discussion: LOS is reduced in the ERAS-environment
group, which cannot be attributed to complications,
readmissions or mortality. The 34 most recent patients in
the control group and the ERAS environment group
were also compared and LOS still showed a difference
(P < 0.05).
Conclusion: Treatment within an ERAS-minded envi-
ronment leads to a reduction in total LOS. Enhanced
recovery programmes in PD should be designed and
implemented.
P-202
‘‘LAPAROSCOPIC DISTAL
PANCREATECTOMY’’ BECOMING
MUCH COMMON FOR BENIGN AND
PREMALIGNANT DISEASE
D. Fernandez, O. Mazza, J. Sakeda, R. Sanchez Calria,
M. Palavecino, J. Pekolj and E. de Santiban˜es
Hospital Italiano Buenos Aires
Background: Laparoscopic distal pancreatectomy
(LDP) is an emerging modality for managing benign
and premalignant neoplasms of the pancreatic body and
tail.
Aim: To show the efﬁcacy of LP, applicability, conver-
sion, morbidity and mortality rates.
Methods and patients: Retrospective analysis of pro-
spective database tracking peri-operative clinical
parameters for all patients presenting to our tertiary care
center Hospital Italiano Buenos Aires for treatment of
pancreatic disease between June 2005 and June 2009.
Preoperative, operative, and postoperative characteristics
were analyzed. Forty nine patients underwent distal
pancreatectomy. Thirty three underwent Open Distal
Pancreatectomy. Sixteen LDP were attempted and thir-
teen were completed laparoscopically. Mean age 53 years
(r: 31–75), 15 female vs. 1 male. Three LP were converted
to an open procedure because of tumor size and technical
difﬁculties. We included seven patients with solid tumors,
seven with cystic tumor and two with non detected
functioning insulin secreting tumor.
Results: We performed: seven spleen preserving distal
pancreatectomy and six LDP with splenectomy. Four-
teen tumors from 2, 5 to 10 cm size were resected and two
blind resection. Pathological ﬁndings: 3 insulinoma, 3
mucinous cystoadenoma, 2 pseudocyst, 2 nonfunction-
ing endocrine tumor, 2 nesidioblastosis, 1 autoinmune
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pancreatitis, 1 serous cystoadenoma, 1 GIST tumor and
1 cyst mucinous cystoadenocarcinoma. Mean operatory
time was 180 min, mean hospital length stay was 4 days,
spleen preserving was 43.75% (7 patients), conversion
rate was 18% (3 patients), applicability was 26.5 (13:49),
morbidity rate 18% (3 pancreatic ﬁstula; 2 grade A + 1
grade C according to ISGPF classiﬁcation) and there was
no mortality.
Conclusion: LDP is a safe, effective modality for man-
aging premalignant neoplasms of the pancreatic body
and tail, providing a morbidity rate acceptable and no
mortality.
P-203
SIDE-BRANCH IPMN OF THE
PANCREATIC HEAD/UNCINATE:
RESECTION OR ENUCLEATION
O. Turrini1, C. M. Schmidt2, J. Guiramand1,
J. R. Aguilar-Saavedra2, S. Aboudi2, H. Pitt2,
K. Lillemoe2 and J. R. Delpero1
1Institut Paoli Calmettes, Department of Surgical
Oncology, Marseille; 2Department of Surgery, Indiana
University School of Medicine, Indianapolis, IN
Introduction: Side branch intraductal papillary mucinous
neoplasms (SB-IPMN) of the pancreatic head/uncinate
are an increasingly common indication for pancreatico-
duodenectomy (PD). Enucleation (EN) of SB-IPMN
preserves pancreatic parenchyma and may be an alter-
native to PD in selected cases.
Aim: To determine perioperative outcomes in patients
with SB-IPMN of the pancreatic head/uncinate under-
going PD or EN compared to a cohort of patients with
pancreatic adenocarcinoma (PA) undergoing PD.
Methods: Retrospective review of a prospectively col-
lected, combined, academic institutional series from 2005
to 2008. Of 107 pancreatic head/uncinate IPMN, enu-
cleation was performed in seven (IPMN EN group) and
PD was performed in 100 (IPMN PD group) with 17 of
these radiographically amenable to EN (IPMN PDen
group). During the same time period, 281 patients
underwent PD for PA (Control PD group).
Results: Perioperative mortality and morbidity of all
IPMN groups (IPMN EN, IPMN PDen, and IPMN PD)
was comparable to the Control PD group (table). Overall
PF rate in the IPMN EN group was higher than in the
IPMN PDen and Control PD groups; however, the rate
of grade C pancreatic ﬁstulae was the same in all groups.
Operative time was shorter and blood loss was less in the
IPMN EN group compared to all other groups.
IPMN EN IPMN PDen IPMN PD Control PD
n (# cases) 7 17 100 281
EBL (mL) 120*§ 724 692 859
Op Time (min) 201*§ 321§ 309§ 382
LOS 12 13 14 14
Readmission (%) 14 12 12 14
Morbidity (%) 43 35 36 42
PF (%) 43*§ 12§ 25*§ 14
Grade C (%) 1 0 1 0
Mortality (%) 0 0 0 2
*P < 0.05 vs. IPMN PDen; P < 0.05 vs. IPMN PD; §P < 0.05 vs. Control
PD.
Conclusions: Pancreaticoduodenctomy for SB-IPMN
can be safely performed. Compared to PD, enucleation
for IPMN has less blood loss, shorter operative time and
similar morbidity, mortality, LOS and readmission rate.
Enucleation should be considered more frequently as an
option for patients with unifocal side-branch IPMN.
P-204
THE IMPACT OF BMI FOR SURGICAL
MORBIDITY AFTER PANCREATICO-
DUODENECTOMY IN ASIAN
H. K. Hwang, J. K. Kim, J. S. Park, S. I. Cho,
D. S. Yoon and H. S. Chi
Department of Surgery, Gangnam Severance Hospital/
Yonsei University health System
Background: Pancreatoduodenectomy performed in high
volume centers has become increasingly safe and more
efﬁcient, however, the morbidity rate remains high with
complication rates of around 40%. Obesity, whose inci-
dence is growing at epidemic rates in the general popu-
lation, has been considered a risk factor. The presence of
excessive fat tissue inside and outside the viscera has
often increased operative times and blood losses while
impairing surgical quality. The purpose of this study was
to evaluate the impact of obesity for surgical morbidity
after pancreaticoduodenectomy in Asian.
Materials and methods: We retrospectively reviewed the
medical records of 138 patients underwent pancreatico-
duodenectomy from October 2002 to July 2009. The
patients were divided according to the body mass index
(BMI; calculated as kg/m2) as obese (BMI ‡ 25), or non-
obese (BMI < 25) in WHO classiﬁcation. Correlation of
the variables was analyzed using Student t-test, Chi-
square test, and Fisher’s Exact Test (SPSS Window
14.0.). P-values less than 0.05 were considered as statis-
tically signiﬁcant.
Results: Forty one patients (29.71%) were obese patient
and 97 patients (70.28%) were normal weight. The rate
of pancreatic leakage (56.09% vs. 35.05%; P = 0.022)
was signiﬁcantly increased in obese patients. The other
surgical complications including delayed gastric empty-
ing, wound infections and postoperative bleeding were
not signiﬁcantly different between two groups. The
length of hospital stay (28.56 ± 14.24 vs. 26.46 ±
11.33 days; P = 0.360) and operation time (465 ± 90.57
vs. 455.27 ± 104.66 min; P = 0.601) were longer in
obese patients but there were no statistically differences.
Conclusion: Obese patients have increased risk for pan-
creatic leakage after pancreaticoduodenectomy. So spe-
cial warning and careful perioperative monitoring are
recommended in obese patients.
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P-205
ROLE OF INTERVENTIONAL
RADIOLOGY IN THE MANAGEMENT OF
POST-OPERATIVE COMPLICATIONS
AFTER PANCREATO-DUODENECTOMY:
AN INSTITUTIONAL EXPERIENCE
P. Sanjay, H. Leaver, C. Kulli, F. Polignano, I. Zealley
and I. Tait
Ninewells Hospital and Medical School
Background: In recent years, interventional radiology
(IR) has become the mainstay for managing post surgical
complications.
Aims: This study has evaluated the role of IR in the
management of post-operative complications after PD.
Methods: Radiology and surgical records of all patients
undergoing PD over a 7 year period were reviewed to
identify IR procedures performed for complications after
PD.
Results: Ninety three PD were performed. 26/93 patients
(28%) required further intervention for 12 post-PD
haemorrhage (PPH), 5 intra-abdominal collections, 2 bile
leaks, 1 pancreatic ﬁstula, 1 bowel ischaemia, and 5 bil-
iary strictures (3 recurrent disease & 2 benign strictures).
Overall 5/26 patients after PD required further surgery
and 21/26 (81%) patients with complications were man-
aged by IR. 3/12 PPH were intra-luminal haemorrhage
(ILH) and 9/12 were intra-abdominal (IAH). 2/3 ILH
were managed conservatively and 1 ILH required a re-
look laparotomy. All 9 IAH had CT angiograms with the
bleeding site identiﬁed in 7 and controlled with angio-
graphic stenting/embolisation. In 2/9 IAH the bleeding
site was not identiﬁed and settled with conservative
management. Overall 1/12 PPH required surgical man-
agement, 7/12 were managed with radiological therapy.
Five patients (5/93) required percutaneous drainage of an
intra-abdominal collection. No patient required a salvage
laparotomy following IR management of IAH or intra-
abdominal collection. After discharge 5 patients pre-
sented with jaundice. Three with recurrent nodal disease
were managed by PTC and stent, and 2 with benign
biliary stricture underwent surgical revision of anasto-
mosis.
Conclusion: In our experience, majority of (85%) early
complications including PPH and intra-abdominal col-
lections can be successfully managed by IR. Only 3/93
(3%) patients required early re-operation for compli-
cations. Interventional radiology is essential in the
management algorithms of patients that develop com-
plications after PD.
P-206
SHORT-TERM RESULTS OF EXTENDED
PANCREATICODUODENECTOMIES
WITH SUB- OR TOTAL PANCREATIC
BODY RESECTION
V. Egorov, O. Melekhina, V. Vishnevsky and
T. Shevchenko
The Vishnevsky Institute of Surgery, Moscow
Background: The possibility of endocrine function pres-
ervation during surgery for large or multiple pancreatic
tumors makes the study of sub- or total pancreatic body
resection (STPBR) during extended pancreaticoduoden-
ectomy (EPD) reasonable.
Objective: To assess the early postoperative course after
EPD with STPBR.
Methods: Twenty EPD with STPBR for IPMN (7),
cystadenoma with uncertain malignancy (2), cystadeno-
carcinoma (3), solid-papillary tumor (1), neuroendocrine
carcinoma (2) and ductal adenocarcinoma (5) had been
performed from 2006 to 2009. We have prospectively
compared short-term results of this procedure with 30
standard pancreaticoduodenectomies (SPD) and 25 EPD
without STPBR for pancreatic malignancy.
Results: The postoperative morbidity and mortality rate
accounted for 60% and 6.6% in SPDs, 60% and 5% in
EPD with STPBR, 56% and 4% in extended PDRs.
Blood loss in SPDs was 985 ± 818 mL, 1112 ± 960 –
in EPDs and 1008 ± 710 mL in EPDs with STPBR.
Vessel resection was performed in 3.3% of patients
during SPDs, in 35% during EPDs with STPBR and in
24% in EPD. Pancreatic ﬁstula has developed in 16.6%
of SPDs, in 5% of EPDs with STPBR and was not
noted in EPDs (P > 0.05). Intra-abdominal bleeding
was found in 3.3% of SPDs, in 12% of EPDs and was
not recorded in EPDs with STPBR. Delayed gastric
emptying was registered in 28% of patients after SPD,
in 16% after EPD and in 5% after EPDs with STPBR
(P > 0.05). The postoperative hospital stay following
SPD was 11.8 and 12.3 following EPD with and without
STPBR. Diabetis mellitus has developed in 20% of
patients after SPD, in 24% after EPD and in 30% after
EPDs with STPBR (P > 0.05).
Conclusion: EPD with STPBR is a procedure demanding
precision vessel dissection and thorough pancreatoent-
erostomy formation. It is not accompanied by an in-
creased morbidity and mortality rate, as compared with
SPD and EPD. The reasonable diabetes development
rate after EPD with STPBR can make it alternative to
total pancreatectomy.
P-207
TOTAL PANCREATECTOMY WITH
DUODENUM, BILE DUCT AND SPLEEN
PRESERVATION IN THE PIG:
ANATOMICAL ASSESSMENT AND
SURGICAL ASPECTS
E. Chaib1, F. Galva˜o1, J. Rocha-Filho1, B. Silveira1,2,
L. Chen1, M. Carvalho1, C. Pariz1,2, F. Almeida1,2,
D. Waisberg1 and L. D’albuquerque1
1Transplantation Surgery unit, Department of
Gastroenterology, University of Sa˜o Paulo, School of
Medicine; 2Universidade Nove de Julho
Background: Swine is an essential model to carry out
pre-clinic research and for teaching complex surgical
procedures.
Aim: Our aim is to describe step-by-step anatomical and
surgical aspects of total pancreatectomy with duodenum,
bile duct and spleen preservation in the pig.
Materials and methods: The experiments were performed
in ten white male swine weighing 27–33 kg. Animals were
pre-medicated with midazolan (0.4 mg/kg, im) and ke-
tamine (4 mg/kg, im). Anesthesia was induced with
propofol (1–2 mg/kg, iv) and was maintained with
propofol and fentanil (0.3 mg and 0.1 ug/kg/min,
respectively, iv). The surgical period ranged from 44 to
77 min. The pancreas anatomy, the main arterial, venous
and pancreatic duct anatomy were assessed.
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Results: The pancreas anatomy was composed of three
lobes: ‘‘splenic’’, ‘‘duodenal’’ and ‘‘connecting’’ lobe,
which is attached to the anterior portion of the portal
vein. The splenic artery and the junction of the splenic
vein and portal vein were divided. The left gastric artery
was dissected and separated from its origin from the
splenic artery. The head of the pancreas is disposed in a
C-shape. The pancreas was dissected and liberated from
the right portion of the portal vein and the infrahepatic
vena cava. The pancreas was separated from the duo-
denum preserving the pancreato-duodenal artery then we
performed the total pancreatectomy preserving duode-
num, the common bile duct and the spleen.
Conclusion: Total pancreatectomy with duodenum, bile
duct and spleen preservation in the pig is feasible and
an important instrument for teaching surgical tech-
nique.
P-208
DELAYED GASTRIC EMPTYING
ACCELERATES PANCREATIC
ANASTOMOTIC STRICTURE
FORMATION AFTER PANCREATICO-
GASTROSTOMY FOR SOFT PANCREAS
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1, H. Miyake2 and S. Amano3
1Social Insurance Yokohama Central Hospital / Surgery;
2Kasukabe Municipal Hospital / Surgery; 3Nihon
University School of Medicine / Surgery
Background/Aims: Pancreatic duct dilatation induced
anastomotic stenosis of the pancreatic duct is frequently
observed in patients who have undergone pancreatico-
duodenectomy (PD) with pancreaticogastrostomy (PG).
Patency of the pancreaticoenteric anastomosis is one of
the most important factors affecting the function of the
remnant pancreas and quality of life. Anastomotic ste-
nosis after PG is observed in some patients after
approximately 1 to 2 postoperative weeks and is attrib-
uted to acute inﬂammation and ﬁbrosis around the
anastomosis. We therefore evaluated the early postop-
erative changes in remnant pancreatic duct diameter after
PG in patients with soft pancreas in terms of delayed
gastric emptying (DGE).
Method: We retrospectively studied 42 patients with soft
pancreas who underwent PD with PG. They were divided
into two groups depending on the grade of DGE; without
or slightly DGE group (WS group) and moderate or se-
vere DGE group (MS group).
Results: The mean diameter of the pancreatic duct of the
remnant pancreas was signiﬁcantly smaller in the WS
group than in the MS group.
Conclusion: DGE accelerates pancreatic anastomotic
stricture development after PG in patients having soft
pancreas with a pancreatic duct with a mall diameter.
Hence, to maintain the pancreatic duct patency, pre-
venting DGE is important.
P-209
LEFT (DISTAL) PANCREATECTOMY
WITH MULTI-VISCERAL ADJACENT
ORGAN RESECTION (MVLP) – A SINGLE
INSTITUTION SERIES
N. Gusani, D. Morrow, S. Kavuturu, I. Deshaies,
D. Avella, J. Kaiﬁ, E. Kimchi and K. Staveley-O’carroll
Section of Surgical Oncology, Department of Surgery,
Penn State College of Medicine
Objectives: Left (distal) pancreatectomy is performed for
a variety of indications, including cysts or primary tu-
mors of the pancreas, but is often performed in combi-
nation with resection of adjacent organs for known or
suspected malignancies of the pancreas, stomach, or
retroperitoneum. We compared our institutional experi-
ence performing laparoscopic left pancreatectomy alone
(LLP), open left pancreatectomy alone (OLP), and left
pancreatectomy involving multi-visceral adjacent organ
resection (MVLP).
Methods: A retrospective chart review of all patients
undergoing left pancreatectomy at our institution be-
tween June 2002 and June 2009 was performed. Indica-
tions, peri-operative outcomes, pathology, complications
and mortality were compared among the three groups-
LLP, OLP, and MVLP.
Results: Eighty nine cases of left pancreatectomy were
performed during the study period (18 LLP, 34 OLP, and
37 MVLP). Mucinous cystic neoplasm (MCN) and neu-
roendocrine tumor were the most common indications
for OLP and LLP, respectively, and pancreatic adeno-
carcinoma for MVLP. Median follow up was
10.6 months. There were no peri-operative mortalities.
MVLP was associated with longer operative times, in-
creased blood loss, and longer hospital stay, but rates of
pancreatic ﬁstula and major complications were similar
to those seen in OLP and LLP. 2-year overall survival
rates were 68% in patients undergoing MVLP, 57% in
patients with pancreatic adenocarcinoma, 95% in pa-
tients with pancreatic neuroendocrine tumors, and 100%
in patients with GIST.
Outcomes of Laproscopic (LLP), open (OLP), and
multivisceral left pancreatectomy (MVLP)
LLP (n = 18) OLP (n = 34) MVLP (n = 37)
Age 62 60 59
Gender M:F 8:10 10:23 12:23
Surgical Time (mins) 349 283 481
Blood Loss (mL) 204 321 459
Specimen Length (cm) 8.1 9.7 8.2
Hospital Stay (days) 7.3 7.8 11.4
All Pancreatic ﬁstula 4 (22%) 11 (32%) 11 (30%)
Panc Fistula B or C 3 (17%) 4 (12%) 3 (8%)
Major Morbidity 6 (33%) 5 (15%) 8 (22%)
Conclusion: MVLP can be performed with similar mor-
bidity to OLP and LLP and can provide excellent sur-
vival outcomes in patients with locally advanced left
upper quadrant malignancies.
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CLINICAL VALIDATION OF ISGPF
CLASSIFICATION AND RISK FACTORS
OF PANCREATIC FISTULA FOLLOWING
DUCT-TO-MUCOSA PANCREATO-
JEJUNOSTOMY BY SINGLE SURGEON
D.-W. Choi, W.-S. Kim, C.-Y. Ho, S.-H. Choi and
J.-S. Heo
Samsung Medical Center, Sungkyunkwan University
School of Medicine
Background: Pancreatic anastomotic leakage remains a
major troublesome complication after pancreatioduo-
denectomy (PD). Many literatures suggest several factors
affecting pancreatic leakage after PD. On the other hand,
ISGPF criteria on the pancreatic ﬁstula were published
recently, but new criteria were validated substantially, so
far.
Aims: The aims of this study were to validate the ISGPF
classiﬁcation and to analyze the risk factors for pancre-
atic leakage after duct-to-mucosa pancreatojejunostomy
by single surgeon.
Methods: Prospectively collected clinical data and risk
factors for pancreatic ﬁstula were analyzed retrospec-
tively for 247 consecutive patients who underwent PD or
PPPD between June 2005 and March 2009 in Samsung
medical Center by single surgeon. A duct-to-mucosa
pancreaticojejunostomy was performed for every patient.
Postoperative pancreatic ﬁstula was deﬁned by ISGPS
criteria.
Results: Classical Whipple’s operation (PD) was per-
formed in 84 patients and pylorus preserving PD in 163
patients. Postoperative complications occurred in 144
(58.3%) patients, although there was no postoperative
in-hospital mortality. Pancreatic ﬁstula occurred in 105
(42.5%) patients (grade A; 82 (33.2%), grade B; 9
(3.6%), grade C; 14 (5.7%)). There is not any difference
between no ﬁstula group and grade A ﬁstula group,
including postoperative hospital stay (11days vs.
12 days, P = 0.332). The duration of hospital stay for
grade B and C ﬁstulas was 21days and 28.5 days,
respectively, which was signiﬁcantly longer duration of
stay than grade A ﬁstulas (P < 0.001). Soft pancreas
was the only risk factor inﬂuencing on pancreatic ﬁstula
(P = 0.003).
Conclusions: New ISGPF criteria seem to be good sys-
tem to compare the postoperative pancreatic leakage,
although Grade A ﬁstula lacks any clinical implications.
Soft pancreatic texture of the remnant pancreas is the
only risk factor affecting pancreas leakage.
P-211
INTEGRATION OF LAPAROSCOPIC
PANCREATICO DUODENECTOMY INTO
SURGICAL PRACTICE
R. M. Walsh, S. Chalikonda and D. Martin
Cleveland Clinic
Surgical innovations can be difﬁcult to incorporate for
advanced operations where the operative complexities
and known complication rates are both formidable. We
review our recent experience to demonstrate how rapidly
integration can be achieved and the lessons learned. In
5 months we have performed seven laparoscopic PDs.
The mean age of the patients was 66 (54–77) yrs. Final
pathology showed a 6.5 cm duodenal hemangioma,
noninvasive IPMN, low grade adenomatous polyp, 2
ampullary carcinoma (2 cm & 1 cm) and a pancreatic
carcinoma (2 cm + 1.85 cm). The ﬁrst three patients
had a classic PD that included distal gastrectomy, and
the last 4 pylorous-preserving PD. All resections were
performed laparoscopically, and there were no conver-
sions to open laparotomy. All reconstructions were
performed robotically. The mean operative time was
522 (454–727). The mean blood loss was 275 (100–400 cc)
and no patient was transfused. All patients had two
drains via port sites, and there were no anastomotic
leaks, despite normal gland texture and main pancreatic
duct diameter in all but one patient. Final pathology
showed an average of 15 (10–24) nodes examined. All
margins were negative. The median length of stay was 6.0
(4–30) days. One patient had hypercarbia from CO2
insufﬂation requiring overnight intubation but was
discharged on day 6. One patient had a complication of
gastroparesis post classic PD requiring laparoscopic
revision of the gastrojejunostomy and was hospitalized
30 days. We conclude that LPD can be introduced
rapidly and safely providing caution is exercised in
patient selection, routine use of robotic surgery for
reconstruction, and a double staff surgical team. We also
emphasize pylorous-preserving PD and a surgical team
equally well versed in laparoscopy, robotics and pancre-
atic surgery.
P-212
OCTREOTIDE IN PATIENTS WITH HIGH
RISK TO DEVELOP PANCREATIC
FISTULA AFTER PANCREATICO-
DUODENECTOMY: A PROSPECTIVE
RANDOMIZED TRIAL
A. Matheus, A. Montagnini, E. Abe, L. Haddad,
S. Penteado, E. Abdo, J. E. Cunha and J. Jukemura
University of Sa˜o Paulo
Background: A signiﬁcant fraction of patients undergo-
ing pancreaticoduodenectomy (PD) develop pancreatic
ﬁstula (PF). Previous randomized, placebo-controlled
trials have evaluated prophylactic octreotide in patients
undergoing PD. A high risk group for PF can be estab-
lished after PD and a special care as prophylactic use of
octreotide could reduce the incidence of PF and the
complications related with.
Objective: This study was conducted to determine whe-
ther the administration of octreotide decreases the inci-
dence of PF after PD in a high risk group.
Methods: Based in previous reports patients with amy-
lase level > 1000 UI/dL in the abdominal drain on
postoperative day 1 were considered as a high risk group.
Between January 2004 and July 2007, 97 patients were
recruited into this study. Patients who had amylase level
> 1000 UI/dL in the abdominal drain on postoperative
day 1 were randomized to control versus octreotide
100 mcg 3 times a day for 10 days. The primary post-
operative endpoints were PF, clinical classiﬁcation of PF,
and length of hospital stay. The deﬁnition of PF was a
drain output of any measurable volume of ﬂuid on or
after postoperative day 3 with amylase content greater
than three times the serum amylase.
Results: Thirty ﬁve patients underwent PD had amylase
level > 1000 UI/dL in the abdominal drain on postop-
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erative day 1 and were randomized to control vs octre-
otide. The 2 groups were comparable with respect to
demographics aspects. The PF rates were 62.5% in the
control group and 72.2% in the octreotide group. The
clinical classiﬁcation of PF were type A – 64%, type B –
27% and type C – 9% in the control group and type A –
54%, type B – 31% and type C – 15% in the octreotide
group. The median postoperative length of hospital stay
was 11 days in both groups.
Conclusions: These data demonstrate that the prophy-
lactic use of octreotide in a high risk group to develop PF
does not reduce the incidence of PF, ﬁstula related
complications, and hospital stay.
P-213
PANCREATICODUODENECTOMY IN
THE ELDERLY OVER 80 YEARS: 23
CASES
S. Saeki, W. Takiyama, N. Hirabayashi, K. Hisamatsu,
H. Mukaida, Y. Sugiyama, Z. Taomoto, T. Mimura,
Y. Hino, I. Yamakita, M. Hashimoto and E. Kano
Department of Surgery, Hiroshima city Asa Hospital,
Hiroshima, Japan
Background: During the last decade, the outcome after
pancreaticoduodenectomy (PD) for cancer showed a
continuous improvement. Therefore, an increasing
number of patients, especially elderly patients, have been
considered for this procedure. The decision to recom-
mend this operation for localized pancreatic cancer, bil-
iary cancer, periampullary cancer etc in a very elderly
patient is complicated by the frailty of the patient and the
poor prognosis of the disease.
Aims: The aim of this study was to analyze the impact of
age in mortality and morbidity after PD, setting of the
age 80 as a cut-off.
Materials and Methods: From 1999 to 2009, among the
patients who underwent pancreaticoduodenectomy, the
elder patients older than 80 years old were retrospectively
reviewed. Perioperative surgical outcomes, including
general clinicopathologic features, morbidity, mortality,
and overall survival were investigated based on available
medical records.
Results: One hundred ﬁfteen patients underwent, among
them Twenty-three (20%) were 80 years older. More
frequent incidences of morbidity, especially delayed gas-
tric emptying were observed and length of hospital stay
after operation was also longer in the elderly. However,
no signiﬁcant differences in mortality rate and survival
outcomes were noted when compared with those of
younger patients.
Conclusion: Pancreaticoduodenectomy (PD) can be per-
formed for the elderly with acceptable morbidity and
mortality rates and possible long-term survival. Age
alone should not be a contraindication for PD.
P-214
TOTAL LAPAROSCOPIC DISTAL
PANCREACTECTOMY: BEYOND
SELECTED PATIENTS
C. Boutros, K. Ryan, S. Katz, N. J. Espat and
P. Somasundar
Division of Surgical Oncology, Roger Williams Medical
Center
Background: Laparoscopic distal pancreatectomy (LDP)
has emerged as the procedure of choice for selected pa-
tients.
Aim: To evaluate the feasibility, procedural outcomes of
LDP in a series of consecutive non-selected patients.
Methods: All patients undergoing distal pancreatectomy
(DP) over 18 months (2007–2009) were identiﬁed from a
prospectively maintained HPB database, under IRB ap-
proval. Completely laparoscopic procedure was per-
formed using a 4 trochar technique with endoscopic
ultrasound guidance. Conversion, operative time (OR),
estimated blood loss (EBL), transfusion, postop length of
stay (LOS) and complications were assessed.
Results: Sixteen patients were identiﬁed; two patients
had DP as a component of other multi-organ open pro-
cedure. 14 patients (67 years ± 16, M:F 3:11) consented
for LDP. Conversion occurred in 4/14 cases (28.5%) due
to: adhesions (n = 2), bleeding (n = 1) and difﬁculty to
localize lesion (n = 1). Converted patients trended to-
wards increased OR, EBL and LOS (P = NS). No
mortalities occurred and overall morbidity included:
pancreatic ﬁstula (PF) (n = 2, 14%), splenic abscess
(n = 1) and pneumonia (n = 1). 3 of the 4 conversions
had postop morbidities including PF (n = 2), pneumo-
nia (n = 1). LDP-splenectomy (n = 3/14) was associ-
ated with increased EBL (683 mL ± 388 vs.168 ± 141,
P < 0.002) and transfusion rate (3/3 vs 3/11, P = 0.05)
compared to LDP-splenic preservation. LDP with splenic
artery preservation (SAP) was completed in 7/14 pa-
tients, with less OR (2 h, 29 m ± 53 m vs. 3 h,
40 m ± 1h, P < 0.05), transfusion rate (14% vs. 71%,
P = 0.05) and LOS (2.8 days vs. 6.8 days P = 0.002)
compared to LDP no SAP. Pathology was IPMN
(n = 5), ductal carcinoma (n = 3), high grade dysplasia
(n = 2), neuroendocrine tumor (n = 2) and pancreatitis
(n = 2).
Conclusion: Patients undergoing LDP with splenic pres-
ervation demonstrated superior peri-procedural out-
come. This consecutive series supports that LDP is
technically feasible with comparable procedural outcome
to the selected-patient literature, suggesting potentially
expanded indications.
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PANCREATIC SCHWANNOMA: REPORT
OF TWO CASES AND REVIEW OF THE
LITERATURE
H. Murakami, A. Urakami, Y. Hirabayashi, Y. Oka,
H. Okumura H. Matsumoto, K. Yamashita, T. Hirai and
T. Tsunoda
Department of Gastroenterological Surgery, Kawasaki
Medical School, Kurashiki, Japan
Background: Pancreatic schwannoma are a rare benign
mesenchymal neoplasm of the pancreas. They arise from
the epineurium of either autonomic sympathetic or
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parasympathetic ﬁbers, which course through the pan-
creas with the vagus nerve. We present two cases of
pancreatic schwannoma.
Case 1: A 38-year-old healthy woman was incidentally
discovered to have a hypoechoic mass in the body of the
pancreas by US. All laboratory data were normal,
including tumor markers. CT disclosed a round low-
density mass, 2 cm in size. MRI revealed a mass, with
hypointensity on T1-weighted images (WI) and hyperin-
tensity on T2WI. The laparotomy disclosed a cystic, well
encapsulated tumor that was located in the body of the
pancreas. We performed a segmental resection of the
pancreas. On microscopic examination, the lesion
showed spindle cells with Antoni A and B patterns. The
tumor cells were positive for S-100 and HMB-45 (mel-
anocytic marker). The tumor was histologically diag-
nosed as a melanotic schwannoma.
Case 2: A 65-year-old man was referred to us for further
investigation of a tumor in the body of the pancreas,
which was incidentally found 15 years ago. The size of
the tumor had grown from 2 cm to 4 cm during those
15 years. He was asymptomatic and all laboratory data
were within normal limits. CT showed a low density tu-
mor with a weak enhancement, which was 45 mm in size.
MRI revealed a mass, with hypointensity on T1WI and
hyperintensity on T2WI. We performed an enucleation of
the tumor, which was histologically diagnosed as a sch-
wannoma.
Discussion: Pancreatic schwannoma can be difﬁcult to
diagnose preoperatively. Patients usually present with
nonspeciﬁc symptoms and normal laboratory values.
Large pancreatic schwannoma often undergo cystic
change, which causes them to be often confused with
other more common cystic pancreatic neoplasms. Surgi-
cal excision and close radiological follow-up are the key
points in the treatment.
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NATURAL HISTORY OF BRANCH DUCT
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASM: SIZE INCREMENT
VELOCITY AND RISK OF MALIGNANCY
IN FOLLOW UP CASES
M. J. Kang1, J.-Y. Jang1, S. E. Lee1, C.-S Lim1,
J. K. Ryu2, Y.-T. Kim2, Y. B. Yoon2 and S.-W. Kim1
1Department of Surgery, Seoul National University
College of Medicine; 2Department of Internal Medicine,
Seoul National University College of Medicine
Background: Recently, reports about the clinicopatho-
logical characteristics of branch duct intraductal papil-
lary mucinous neoplasm (Br-IPMN) are increasing.
However, because it is almost impossible to obtain exact
pathologic information without surgical specimen, there
is no credible research about the natural history of
IPMN.
Objective: The authors investigated the natural history
of Br-IPMN on the basis of imaging and surgical
pathology in follow up cases.
Methods: Between January 2000 and March 2009, 385
patients were diagnosed as Br-IPMN at our institute.
Only 201 patients with initial cyst less than 30mm with-
out main pancreatic duct dilatation and mural nodule,
and those who were followed up for more than 3 months
with repeated CT at least twice were included.
Results: Median follow up was 27.9 months (range, 3.2–
109.5). Mean initial cyst size was 14.7 mm, and mean cyst
increment velocity was 1.1 mm/year (9.6%/year). Among
201 patients, 35 patients underwent operation dur-
ing follow up and 8 of them were pathologically con-
ﬁrmed as malignant. The operation group had larger
initial (18.0 vs. 14.0 mm; P < 0.001) and ﬁnal (23.2 vs.
15.9 mm; P < 0.001) cyst size, higher absolute increment
(5.2 vs. 1.9 mm; P < 0.001) and increment velocity (2.9
vs. 0.7 mm/year; P = 0.001). Actuarial 5-year risk of
malignancy in operation group was 41.6%, and when
regarding all of the observed patients to be benign,
actuarial 5-year risk of malignancy in overall patients
was 10.9%. Cysts increasing rapidly than 2 mm/year had
higher risk of malignancy (5-year risk 45.5% vs. 1.8%;
P < 0.001). Patients with initial cyst smaller than 20 mm
which grows less than 2 mm/year had 0.8% of 5-year risk
of malignancy.
Conclusion: Actuarial risk of malignancy of Br-IPMN
was estimated to be minimum of 10.9% to maximum of
41.6%, and rapidly growing cysts had higher risk of
malignancy. In combination with cyst size and mural
nodule, cyst increment velocity could be used as another
malignancy predictor for Br-IPMN.
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PANCREATIC CANCER – A TOTAL COST
ANALYSIS
B. Tingstedt, E. Andersson, A. Flink and R. Andersson
Department of Surgery, Institution for Clinical Sciences,
Lund University
Background: Pancreatic cancer is the fourth leading
cause of cancer related death and it is poorly investigated
regarding direct and indirect costs.
Aim: The present study aims to calculate the societal cost
for pancreatic cancer.
Methods: We performed a retrospective study of all pa-
tients with pancreatic cancer excluding endocrine cancer
in the primary catchment area of Lund University Hos-
pital, Sweden, during 2005–2007. Information of all
diagnostic and therapeutic investigations, interventions
and postoperative course and longterm follow-up was
collected as well as sick leave. Cost for loss of production
due to sick leave and premature death was calculated
through human capital method.
Results: Eighty three patients were included in the study
with an incidence of 9.9 patients/100 00 inhabitants.
Summary of costs expressed in Euro
All patients
n = 83
Per
patient
Sweden
Annually
Direct costs
Hospital care 1 356 082 16 338 1 4132 662
Radiology 310 335 3 739 3 234 211
Chemotherapy 146 891 1 770 1 530 856
Surgical 395 442 4 764 4 121 177
Outpatient 20 040 241 208 851
Long Term care 468 046 5 639 4 877 829
Sick leave 3 730 531 44 946 38 878 430
Indirect costs
Loss of production 10 039 455 120 957 104 628 064
Total 16 466 822 198 394 171 612 080
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Overall median survival was 7.3 months and resection
rate was 15%. Survival rate of resected was in median
20.4 months compared to 4.3 among the non-resected.
The total cost per patient was 198 394 Euro. Of this
amount direct hospital costs represented 14%, palliative
care 2.8%, sick leave 22.7% and loss of production
60.5% respectively. Extrapolated to national level the
cost for pancreatic cancer with 865 new cases per year the
cost in Sweden for pancreatic cancer will amount to 171
612 080 Euro/year (18 858 470 Euro/million inhabitants
annually).
Conclusion: The direct cost for pancreatic cancer is
considerable but due to premature death the indirect cost
is vast for any society, equalling 172 million Euro/year in
Sweden.
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RADIOFREQUENCY ABLATION IN
LOCALLY ADVANCED PANCREATIC
CANCER: PRELIMINARY RESULTS
R. Girelli
Pederzoli Clinic Peschiera del Garda - Verona
Background: There are no available data in literature
regarding survival after radiofrequency ablation (RFA)
in locally advanced pancreatic cancer (LAPC) associated
to adjuvant therapy.
Aim: The aim of the study is to evaluate survival and
progression free time after RFA and adjuvant therapy in
LAPC in a series related to a pilot study carried out for
studying feasibility and safety of the procedure.
Methods: Sixty eight patients with cytologically proven
LAPC were enrolled between February 2007 and June
2009. Variables were compared using the Chi Square and
Fisher test as appropriate. Differences were considered to
be statistically signiﬁcant at P < 0.05.
Results: Fifty six patients were eligible for a medium
term follow-up study (FU‡ 6 months). The median age
was 67 years with male/female ratio of 32/24. The tumor
was located in the head in 37 patients and in the body/tail
19 with median size of 40 mm in both. Eighteen pts
(32%) received neoadjuvant therapy whereas 38 had
RFA as ﬁrst treatment. Median survival was 12 months
(IQR 6.75-18.25), median follow-up after RFA was
7 months (IQR 4–13.25). Median survival after neoad-
juvant therapy followed by RFA was 16 months (IQR
12–23), which was signiﬁcantly higher when compared to
survival after RFA as ﬁrst treatment (8 months, IQR 5–
16, P = 0,008). Nowadays 22 out of 56 patients (39%)
are progression free, with median survival of 8.5 months
(IQR 5.25–16.5) and median FU after RFA of
6.5 months (IQR 4.25–11).
Conclusions: The association of RFA with neo-adjuvant
or postoperative chemo-radiotherapy may improve
overall survival in LAPC but RFA should not be used as
ﬁrst treatment. We need further studies to compare sur-
vival and progression free time in RFA + CT-RT vs
CT-RT alone.
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ANAPLASTIC CANCER OF PANCREAS:
REPORT OF TWO CASES
N. Michalopoulos1, T. Papavramidis1,
G. Karayannopoulou2, A. Cheva2,
K. Triantaﬁlopoulou1, N. Deligiannidis1 and
S. Papavramidis1
13rd Department of Surgery, Aristotle University, AHEPA
Hospital, Thessaloniki, Greece; 2Pathology Labatory,
Aristotle University, Thessaloniki, Greece
Anaplastic carcinoma of the pancreas is a rare undiffer-
entiated type of ductal adenocarcinoma. It is an aggres-
sive tumor with male predominance that accounts 2% of
all pancreatic cancers. A numbers of terms have been
used to describe this type of tumor including pleomor-
phic carcinoma, sarcomatoid carcinoma, anaplastic and
undifferentiated carcinoma. The authors report two
cases, a 65-years old male (case 1) and an 80-years old
male (case 2), who underwent surgery for tumors in the
head of the pancreas based on the preoperative labatory
and imaging examinations. Pylorus preserving pancre-
ateduodenectomy performed in case 1, while the tumor in
case 2 proved to be unresective at laparotomy and only
biopsies was taken. The pathology result was undiffer-
entiated carcinoma of pancreas in case 1 and primary
pancreatic anaplastic large cell lymphoma in case 2. The
outcomes were pure in both patients who died on the
postoperative period. Diagnosis of this tumor based on
pathology examination and may be challenging due the
lack of the grandular structures or others features that
indicate a direction or differentiation. These tumors
usually have reactivity to epithelial markers, indicating
an epithelial origin with dedifferentiation. Anaplastic
pancreatic carcinoma is an aggressive neoplasm with a
worse prognosis than poorly differentiated ductal ade-
nocarcinoma of the pancreas.
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PROGNOSTIC FACTORS IN RESECTED
PANCREATIC NEUROENDOCRINE
TUMOURS
R. A. Rossi1,2, J. Buckels3, D. Mayer3, D. Mirza3,
J. Isaac3, P. Muiesan3, T. Shah3, P. Taniere3 and
S. Bramhall3
1Clı´nica Alemana; 2Hospital Padre Hurtado; 3The Queen
Elizabeth Hospital
Introduction: Although pancreatic neuroendocrine tu-
mours (PNETS) are of relatively good prognosis, many
patients will succumb to the disease.
Objectives: To analyze patient and tumor characteristics
of resected PNETS, and evaluate prognostic factors for
survival.
Material Methods: Patients resected with a pathological
diagnosis of PNETS between 1988–2009.The World
Health Organisation (WHO) classiﬁcation was used for
tumor grading. Bivariate and multivariate analysis with
logistic regression was performed with STATA 9.0 soft-
ware.
Results: Seventy seven patients, 21 male, 56 female,
median age 55, underwent 79 resections for PNETS. Risk
factors were present in 11.Forty-two (55%) had func-
tional PNETS; 35 had non-functional (NF) PNETS.
Median tumor size was 20 mm. Tumours were located in
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the head (HOP) in 44, body 16, tail 11, and were multi-
centric in 3.Ten had distant metastases.Ki-67 was <2%
in 29 of 39 patients. A pancreatoduodenectomy was
performed in 31, total pancreatectomy 4, distal 23 with
spleen preservation in 7, central 1, enucleation 20.
Simultaneous resections of additional organs were per-
formed in 11 (14%). Morbidity occurred in 35%, 90-day
mortality was 2.5%. Seventy-ﬁve patients had well-dif-
ferentiated (WD) PNETS: 22 (28%) benign, 34 (45%)
uncertain behaviour and 20 (27%) carcinomas, whereas 2
were poorly differentiated. Sex, tumor size, margin sta-
tus, distant metastases and tumor grade were signiﬁcant
(P < 0.05) for survival on bivariate analysis. On multi-
variate analysis only tumor grade was signiﬁcant. Among
the WD PNETS, at 63 month median follow-up, 20
(95%) of benign tumors, 29 (85%) of tumors of uncertain
behavior and 11 (38%) of carcinomas are alive.
Conclusions: PNET resections were more frequently
performed in females, functional tumors slightly pre-
dominated, and PNETS were more commonly located in
the HOP. Morbidity and mortality of resections were
acceptable. Tumor grade was the only signiﬁcant pre-
dictor of survival on multivariate analysis, correlating
well in each subgroup of patients.
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CHANGES OVER TWO MONTHS IN
QUALITY OF LIFE MEASURES IN
PATIENTS WITH PANCREATIC
CANCER: A COMPARISON BETWEEN
PATIENTS WITH AND WITHOUT
SURGERY
T. Buanes and T. Heiberg
Oslo University Hospital, Ulleval
Background: Survival is an essential endpoint in the
evaluation of clinical outcome of surgical treatment for
pancreatic cancer1. However, quality of life might be
improved by removal of the tumor also when survival is
unchanged2, and patient reported outcomes should have
impact on management programs for these patients.
Aim: To examine changes in quality of life measures in
patients with pancreatic cancer with and without surgery
over the immediate time span of two months after diag-
noses.
Methods: All patients [n = 33, 51.5% females, mean age
65.3 (SD 9.8, range 40–85) years] completed Edmonton
Symptom Assessment System (ESAS) and EQ-5D (3
questions on physical functioning, one on pain and one
on anxiety) at baseline (Visit1) and after two months
(Visit2). Baseline values and changes from Visit1 to
Visit2 were compared between patients with (n = 18)
and without surgery (n = 15) with t-test after checking
for normality.
Results: Baseline ESAS and EQ-5D values were similar
except for appetite which was signiﬁcantly worse in the
‘‘no surgery’’ group (P = 0.03). Favorable numerical
change was observed in all symptoms except for appetite
in the surgery vs. no surgery group, and signiﬁcant dif-
ferences were observed for nausea, dyspnoea and dry
mouth. For anxiety, the difference between surgeries vs.
no surgery group was borderline signiﬁcant (Table).
Measures
ESASEQ-5D
Baseline values-visit1
Surgeryno surgery
(n = 1815)
Change Visit1-Visit2
Surgeryno surgery
(n = 1815) P-value
Pain at rest 2.943.07 1.350.29 0.27
Fatigue 3.893.93 )0.24)0.80 0.60
Nausea 2.111.27 0.240.00 0.04
Dry mouth 2.110.87 )0.35)2.13 0.04
Appetite 2.504.93 )0.180.20 0.78
Anxiety 4.113.00 2.060.00 0.06
Global 3.444.40 0.06)0.57 0.58
EQ-5D 0.650.68 )0.010.06 0.55
Conclusion: ESAS symptoms were improved during the
two ﬁrst months after diagnosis in patients with pancre-
atic cancer with surgery compared to no surgery.
References:
1. Gouma DJ et al. Treatment of Pancreatic Adenocar-
cinoma: A European Perspective. Surg Oncol Clin N Am
2008, 17(3): 569–86.
2. Crippa S et al. Quality of life in pancreatic cancer:
analyses by stage and treatment. J Gastrointest Surg
2008, 12(5): 783–93.
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WHAT ARE THE PATIENTS REPORTED
DIMENSIONS OF HEALTH WITH MOST
IMPORTANT IMPACT OF PANCREATIC
CANCER (PC)?
T. Heiberg and T. Buanes
Oslo University Hospital, Ulleval
Background: Dimensions of highest relevance and
importance to patients should be identiﬁed and addressed
both in clinical practice and research. Special attention
should be paid to dimensions where PC has highest dis-
ease speciﬁc impact.
Aim: To identify dimensions of health, reported by pa-
tients, where PC has highest impact.
Methods: Forty-nine patients [49% females, mean age
66.9 (SD 9.8) years] with recently diagnosed PC, con-
senting to participate, were examined at baseline and
after one and two months. All patients were asked to
report the 5–10 dimensions of health related to their PC
with highest impact on their health, and then rank them
according to importance. We examined impact over time
from 33 patients who completed all three visits.
Results: Twenty eight different dimensions were reported
as having important impact at baseline. The eight most
frequently reported dimensions were (percentage in
parentheses) pain (65.3), fatigue (65.3), appetite (44.9),
anxiety (40.8), dry mouth (34.7), nausea (32.7), consti-
pation (32.7) and itching (26.5). The most frequently
reported dimensions, ranked with highest impact at
baseline were pain (30.6), anxiety (16.3) and itching
(14.3). The proﬁle of important impact contained similar
dimensions over time, but ﬂuctuated towards lower fre-
quencies, especially for itching (30.3, 3.0 and 6.1%),
anxiety (36.4, 33.3 and 6.1%) and dry mouth (36.4, 18.2
and 15.2%).
Conclusion: Pain was consistently reported as the
dimension of health with most important impact and
itching was more important at baseline than at follow-up
in this study of patients with PC. This identiﬁcation of
important dimensions of health represent the ﬁrst step in
the development of an new outcome measure, the Pan-
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creatic Cancer Disease Impact (PACADI) score, follow-
ing the same approach as was done for the Rheumatoid
Arthritis Impact of Disease (RAID) score (Gossec et al.
Ann. Rheum Dis. 2009).
P-223
PREOPERATIVE C-REACTIVE PROTEIN
AND LYMPH NODE RATIO ARE
IMPORTANT PREDICTORS OF
SURVIVAL FOR PANCREATIC DUCTAL
ADENOCARCINOMA
P. Sanjay, H. Leaver, F. C., Polignano Kulli and I. Tait
Ninewells Hospital and Medical School
Background: Cancer speciﬁc systemic inﬂammatory re-
sponse has been shown to effect survival and prognosis
for various cancers. There is minimal data on the impact
of preoperative inﬂammatory response and LNR on
survival after PD for PDAC.
Aims: This study investigated the prognostic role of the
pre-operative inﬂammatory response, and lymph node
ratio (LNR) on survival after pancreatic-head resection
for PDAC.
Methods: All patients who underwent PD for PDAC
between 2002 and 2008 were reviewed retrospectively.
The impact of preoperative CRP level, White Cell Count
(WCC), Neutrophil count, Neutrophil /Lymphocyte ra-
tio (N/LR), preoperative lymphocyte count, Platelet /
Lymphocyte ratio (P/LR) and lymph node ratio (LNR)
on survival was assessed.
Results: Fifty one patients underwent potentially cura-
tive resection for PDAC during the study period. Ele-
vated preoperative CRP (>3) was found to be a
signiﬁcant adverse prognostic factor (P = 0.015) pre-
dicting a poor survival, whereas WCC (P = 0.27),
Neutrophil count (P = 0.85), N/L ratio (P = 0.27), P/L
ratio (P = 0.53) and lymphocyte count (P = 0.72) were
not signiﬁcant prognosticators on univariate analysis.
Presence of metastatic lymph nodes did not adversely
affect survival (P = 0.05), however a LNR > 0.2 pre-
dicted poor survival on univariate analysis (P = 0.001).
The median overall survival in patients with CRP <3
(n = 13) was 21 months compared to 13 months in those
with CRP >3 (n = 38). The median overall survival of
patients with a LNR of 0, < 0.2 and > 0.2 was
31 months, 16 months, and 9 months respectively. The
preoperative CRP retained signiﬁcance on multivariate
analysis (P = 0.01), along with LNR (P = 0.001) and
tumour size (> 20 mm, P = 0.008).
Conclusion: A pre-operative elevated CRP and LNR
> 0.2 represent signiﬁcant independent prognostic fac-
tors that predict poor prognosis in patients under going
resection for pancreatic ductal adenocarcinoma.
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EGFR AND KRAS MUTATIONAL
ANALYSIS AND THEIR CORRELATION
TO SURVIVAL IN PANCREATIC AND
PERI-AMPULLARY CANCER
M. Oliveira-Cunha1, A. K. Siriwardena1 and
W. Newman2
1Academic Hepatobiliary Unit, University of Manchester,
Manchester Royal Inﬁrmary; 2Department of Clinical
Genetics, St Mary’s Hospital
Background: Pancreatic and peri-ampullary cancers ex-
hibit a high incidence of activating KRAS mutations.
The RAS protein is involved in EGFR signaling. Studies
in lung cancer have demonstrated that EGFR mutations
and K RAS mutations are mutually exclusive. Muta-
tional statuses of KRAS and EGFR, and EGFR over-
expression analysis in pancreatic cancer can predict
sensitivity to EGFR inhibitor therapy.
Aim: To explore the presence of EGFR and KRAS
mutations and their relationship with survival in pan-
creatic and peri-ampullary cancers.
Methods: One hundred patients undergoing pancreati-
coduodenectomy or pancreatic biopsy for cancer were
recruited. Samples of formalin-ﬁxed parafﬁn-embedded
or fresh pancreatic tissue were obtained. EGFR mutation
was analyzed by DNA sequencing of exons 18–21.
KRAS mutation was analyzed by pyrosequencing of
codons 12, 13 and 61.
Results: EGFR mutations were found in 2 of 88 cases
(2.3%). The mutations detected were amino acid substi-
tutions, one in exon 18 (1966C > T, P.Q656X) and one
in 19 (2066A > G, P.E689G). SNPs in exon 20
(2361G > A, Q787) were identiﬁed in 57 out of 84 pa-
tients (67.8%) studied. Twenty eight of 68 cases (41.2%)
harboured a point mutation in codons 12 (26 cases) and
codon 61 (2 cases). The overall median survival was
308 days (range from 7 to 2623 days). The presence of
KRAS point mutations did not inﬂuenced median sur-
vival time (10.6 vs. 16.36 months), P = 0.789.
Conclusions: The incidence of somatic mutations of
EGFR in pancreatic and peri-ampullary cancer is low.
The incidence of KRAS mutation in this group is lower
than previous reports published in the literature. The
presence of KRAS mutation does not affect survival.
P-225
ADENOSQUAMOUS CARCINOMA OF
THE PANCREAS: SURVIVAL AFTER
SURGERY IN UICC IIA AND IIB
H. Komatsu, S. Egawa, F. Motoi, T. Onogawa,
T. Morikawa, N. Sakata, T. Rikiyama, Y. Katayose and
M. Unno
Division of Hepato-Biliary Pancreatic Surgery, Tohoku
University Graduate School of Medicine, Sendai, Japan
Background and aims: Adenosquamous carcinoma of the
pancreas is characterized by an admixture of adenoma-
tous and squamous cell elements and demonstrates
aggressive biologic behavior. To elucidate the biological
behavior of adenosquamous carcinoma, we compared
the prognosis of the adenosquamous carcinoma to the
other type of the carcinoma after curative resection in
UICC IIA and IIB.
Methods: From 1961 to 2009, surgical resection was
performed in 270 patients for pancreatic cancer at
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Tohoku University. Of 270 patients, 243 cases were
pathologically diagnosed as tubular adenocarcinoma, 12
cases as papillary adenocarcinoma, 10 cases as adeno-
squamous carcinoma, and others. Neuroendocrine tu-
mour including islet tumour were excluded. We
compared clinicopathological properties between adeno-
squamous carcinoma and the other type of carcinoma.
Results: The frequency of adenosquamous carcinoma
increased when the tumour size increase. According to
the UICC classiﬁcation, 6 patients with adenosquamous
carcinoma and 107 with the other type had stages IIA
and IIB disease. The median survival with adenosqua-
mous carcinoma was 5 months (3–25 months) while the
other type of carcinoma was 16 months (0–109 months,
P = 0.0345). Vascular inﬁltration in histological factors
tended to increase in adenosquamous carcinoma, while
lymphatic and perineural inﬁltration did not have sig-
niﬁcant difference.
Conclusion: Adenosquamous carcinoma of the pancreas
is biologically aggressive and have poor prognosis com-
pared with the other type of carcinoma. During tumour
progression, adenosquamous carcinoma can be gener-
ated as a heterogenous component of tubular carcinoma.
Multidisciplinary treatment including neoadjuvant and
molecular targeting therapy combined with surgery must
be needed when preoperative diagnosis suggests the
presence of adenosquamous carcinoma.
P-226
INCIDENTAL PANCREATIC
ADENOCARCINOMA: LACK OF
SYMPTOMS DOES NOT IMPROVE
RESECTABILITY RATE
L. Vargas, E. Kim, Q. Ly, C. Are and A. Sasson
University of Nebraska Medical Center
Background: Surgical resection is the only curative
treatment for pancreatic adenocarcinoma. Majority of
patients are unresectable due to metastases or locally
advanced disease. We hypothesize that if pancreatic
cancer is detected prior to the development of symptoms,
more patients would be candidates for surgical resection.
Aim: To compare the resectability rate and pathologic
features for incidentally detected pancreatic cancer (IPC)
and symptomatic pancreatic cancer (SPC).
Methods: Clinical and pathologic data were collected for
a cohort of patients with pancreatic adenocarcinoma
who were evaluated by the Surgical Oncology service
from August 2001 to July 2009.
Results: A total of 249 pancreatic cancer cases were
identiﬁed of which 27 patients (11%) were detected
incidentally. There was a statistically signiﬁcant differ-
ence in the location of the lesion in the head between IPC
and SPC (44 vs. 78%, P < 0.001). There was no differ-
ence in the incidence of metastatic disease (41% vs. 37%,
P = .73) and the rate of resectability (33% vs. 39%,
P = .55) between the patients with IPC and SPC. Final
histopathology in resected patients with IPC and SPC
revealed no differences in tumour size (3.3 vs. 3 cm,
P = .23) or nodal positivity rate (44 vs. 63%, P = .68).
We noted a trend towards greater margin positive
resections in patients with SPC when compared to IPC
(34% vs. 0, P = 0.06).
Conclusions: The results of our study demonstrate that
the beneﬁt of detecting pancreatic cancer incidentally
does not translate into a higher resectability rate.
P-227
SURGICAL MANAGEMENT OF NON-
FUNCTIONING NEUROENDOCRINE
PANCREATIC TUMOUR
M. Pai, M. Buick, R. Williamson and D. Spalding
HPB Surgery, Hammersmith Hospital, Imperial College,
London, UK
Introduction: The surgical treatment of non-functioning
neuroendocrine pancreatic tumour (NFNEPTs) has be-
come increasingly important for symptom palliation and
survival. The aim of this study was to assess the role of
surgery, adjuvant therapy and outcomes of NFNEPTs
based on the experience of two surgeons from a single
institution.
Methods: From 1994–2009, 50 patients were treated for
NFNEPTs. Their investigations, surgery, histology and
clinical outcome were reviewed retrospectively.
Results: There were 27 men and 23 women. Gut hor-
mone proﬁles were normal in all patients. Contrast-en-
hanced computed tomography localised the tumour in 48
patients (sensitivity = 97%), whilst the average tumour
size was 5.96 cm. Twenty nine patients underwent cura-
tive resection (pancreatoduodenectomy [PD] n = 16,
distal pancreatectomy n = 11 and laparoscopic enucle-
ation n = 2) and 13 palliative resection (PD n = 7, total
and distal pancreatectomy three each). Eight patients had
bypass procedures only. Eight patients had concomitant
liver resection. Twenty two patients received adjuvant
therapy (chemotherapy n = 12, embolisation n = 9,
targeted radionuclide therapy n = 4 and radiation
n = 6). Of the 29 patients who had curative resections,
follow-up was for a median of 84 (range 2–264) months
with a median disease free survival of 39 (2–142) months.
Twelve patients have died from disease a median of 72
(range 2–216) months after operation, whilst one patient
was lost to follow-up.
Conclusions: Although surgical cure is rare in NFN-
EPTs, long-term palliation can be achieved with an
aggressive surgical approach and adjuvant therapy.
P-228
IMPACT OF LEUCOCYTE-DEPLETED
BLOOD TRANSFUSION ON LONG-TERM
SURVIVAL AFTER RESECTION OF
PANCREATIC ADENOCARCINOMA
A. E. Frampton1, J.-J. Bong2, C. Kyriakides1, M. Pai1,
F. Regan3 and L. R. Jiao1
1Division of Surgery, HPB Surgery Unit, Hammersmith
Hospital, Imperial College London, UK; 2Department
of Surgery, National University of Malaysia, PPUKM,
Malaysia; 3Department of Haematology, Hammersmith
Hospital, Imperial College London, UK
Background: Blood transfusion may adversely affect
prognosis in cancer patients.
Aim: To investigate whether leucocyte-depleted blood
transfusion (LDBT) affects survival in patients following
pancreatic ductal adenocarcinoma (PDAC) resection.
Methods: A retrospective cohort study was performed
from 2001 to 2008. Clinical and transfusion data was
collected from our transfusion laboratory and anaes-
thetic charts. Patients who died within 30-days of oper-
ation were excluded. Survival was calculated using the
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Kaplan–Meier method. Univariate and multivariate
analysis was performed.
Results: A total of 269 pancreatic resections were per-
formed for benign and malignant lesions. Seventy-six
patients who had resection for PDAC were included in
the analysis. Median age was 64.4 years (range 29.9 to
79.5 years). R0 resection was achieved in 47.9%. Median
tumour size was 2.5 (range 0.9 to 5) cm. Lymph node
metastases were present in 69.4% and perineural invasion
in 68.9%. Thirty-nine (51.3%) patients received a blood
transfusion (median 3 units; range 1 to 8 units) and 32
(82.1%) were transfused intra-operatively. Median sur-
vival was 13.9 months for those who had a blood
transfusion compared to 18.3 months for those who did
not (P = 0.07). Twenty-six patients (34.2%) had a post-
operative complication and the median length of stay was
18 (range 8 – 96) days. Univariate analysis indicated that
sex, resection status, timing of blood transfusion (intra-
operative, post-operative or both) and tumour (T) stage
inﬂuenced survival. Multivariate analysis, gender and
resection status were the only predictors of survival.
Conclusion: LDBT would seem to have an adverse im-
pact on survival in patients with PDAC.
P-229
COMPARISON BETWEEN CONTRAST-
ENHANCED ULTRASONOGRAPHIC
AND PATHOLOGICAL FINDINGS OF
PANCREATIC CANCER
G. Akasu1, Y. Goto1, T. Sato1, R. Kawahara1,
H. Ishikawa1, H. Kinoshita1, S. Aoyagi1 and
M. Yasumoto2
1Department of Surgery, Kurume University School of
Medicine; 2Department of Pathology, Kurume University
School of Medicine
Background: Ultrasonography is routinely employed in
clinical practice as a diagnostic imaging method. It
facilitates the noninvasive, simple, and real-time evalua-
tion of cross sections, and is essential in daily practice,
especially regarding morphological diagnosis. Contrast-
enhanced ultrasonography (CE-US) with a low-acoustic-
pressure contrast medium enables a continuous real-time
observation of contrast enhancement.
Objective: To evaluate contrast-enhanced ultrasono-
graphic ﬁndings of pancreatic cancer.
Methods: In nine patients who were performed CE-US
with a low-sound-pressure contrast medium, Sonazoid
(Daiichi-Sankyo, Tokyo, Japan), before surgery were
pathologically diagnosed with pancreatic cancer after
resection, we prepared time-signal intensity curves of the
pancreatic cancer. The increment in the signal intensity
(ISI) before contrast enhancement to the maximum was
regarded as the degree of contrast enhancement. Using a
resected specimen, double immunostaining with anti-
CD34 and anti-SMA antibodies were conducted.
Microvessels showing a positive reaction were counted at
a 200x magniﬁcation, and regarded as the microvessel
density (MVD) (pathological parameter). We compared
the ISI on CE-US with MVD.
Results: The ISI was 7 to 143 dB. The MVD ranged
from 1.6 to 17.7. There was a correlation between the
MVD and ISI.
Discussion: MVD may be associated with metastases
from many malignant tumours and their prognoses. This
association is also suggested in patients with pancreatic
cancer. Sonazoid is distributed only in blood vessels after
infusion. Therefore, the signal intensity on CE-US may
reﬂect micro-blood ﬂow at the pancreatic cancer lesion
site. In this study, a correlation was noted between the
ISI and MVD, suggesting the usefulness of CE-US in the
evaluation of pancreatic cancer MVD.
P-230
LYMPH NODE METASTASIS IN
PANCREATIC ENDOCRINE TUMOURS:
SIZE DOES MATTER
D. Christian, A. Khithani, A. J. Saad, J. Barton,
P. Chahal, J. Linder, R. Patel and D. R. Jeyarajah
Methodist Dallas Medical Center
Background: Pancreatic endocrine tumours (PET) are
uncommon, but have shown an increase in prevalence
over recent years. They have a variable biological
behavior which can be predicted by the extent of disease
and by tumour characteristics such as size and mitotic
count.
Aims and objectives: To evaluate the signiﬁcance of tu-
mour size and mitotic counts with lymph node status in
PET.
Methods: Records of patients who underwent surgical
resection at our institution for PET from September 2005
to September 2009 by a single surgeon were reviewed.
Pathologic variables of interest were size (‡ 2 cm), mi-
totic count (‡ 2/10 HPF) and lymph node (LN) metas-
tasis.
Results: A total of 248 pancreatic resections performed
at our Non University Tertiary care center (NUTCC) of
which 24 (10%) were done for PET. Eighteen (75%) of
these were distal pancreatectomies and 6 (24%) were
pancreatoduodenectomies. PET was limited to the pan-
creas or regional lymph nodes in 23 (96%) patients
whereas 1 (4%) patient had distant metastatic disease.
Multifocal disease within the pancreas was found in 8
(32%) patients, 9 (36%) had lymph node metastasis,
vascular invasion was present in 8 (33%), 23 (96%) pa-
tients underwent R0 resection, 17 (71%) patients had
tumours of 2 cm or greater. The distribution of patients
as per tumour size and mitotic count is shown in table 1.
The positive predictive value for lymph node metastasis
with tumours sized ‡ 2 cm was 0.75 and with mitotic
count ‡ 2/10 hpf was 0.88. All patients who were LN
positive with size ‡ 2 cm had vascular invasion. The
patient with metastatic disease had a high mitotic count
and large tumour (5 cm).
Table 1.Distribution of patients as per size, mitotic count
and LN status
Total no
of pts (%)
Mitotic count
< 2/10 hpf
Mitotic
count ‡ 2/10 hpf
Tumour
size ‡ 2 cm
17 (71%) 7
2 LN + (29%)
10
6 LN + (55%)
Tumour
size < 2 cm
7 (29%) 7
1 LN + (14%)
0
Conclusion: PET are recognized and diagnosed with
greater frequency, likely due to advancements in
abdominal imaging modalities. Lymph node involvement
in PET appears to be associated with high mitotic counts
and larger tumour size. Additional studies are needed to
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investigate the exact correlation and predicative efﬁcacy
of this association.
P-231
INTRAPERITONEAL 5-FU AND IV
LEUCOVORIN VS. IV GEMCITABINE
FOR TREATMENT OF NON-
RESECTABLE PANCREATIC CANCER –
A RANDOMISED PHASE III STUDY
B. Ardnor1, M. O¨man1, I. Karlberg2, M. Sund1 and
P. Naredi1
1Umea university hospital/ Department of surgery; 2Umea
university hospital/ Department of oncology
Background: For non-resectable pancreatic cancer there
is no curative treatment and Gemcitabine is considered
standard treatment. We have earlier treated patients with
intraperitoneal (ip) 5-Fu and iv leucovorin and had
fourteen months median survival with only minor side
effects or complications.
Objective: To compare the efﬁcacy, as assessed by
overall survival, of ip 5-FU with iv leucovorin compared
with iv Gemcitabine in advanced pancreatic cancer.
Methods: Patients older than 18 years with histologically
or cytologically veriﬁed non-resectable adenocarcinoma
of the pancreas. Performance status was WHO 0 or 1.
Patients were randomised to either arm A; 5-Fu
1250 mg/m2 ip and leucovorin 100 mg/m2 iv days one
and two every third week or arm B; Gemcitabine
1200 mg/m2 iv weekly. Patients were followed by radi-
ology every eight weeks and by performance parameters
and blood tests. The sample size was calculated for a four
months survival beneﬁt for arm A (11 vs. 7 months) over
arm B. Cross-over when progressive disease was allowed.
Results: Fifty-four patients were randomised before an
interim analysis. Median age was 69 years. There was no
difference in median survival between arm A (n: 27,
114 days) and arm B (n: 27, 123 days) (P = 0.73). Six
patients in arm A and 5 ﬁve patients in arm B did not
receive treatment due to rapidly progressive disease. For
patients receiving at least one course the median survival
was 130 days and 146 days (P = 0.59) for arm A resp. B.
Two patients in arm A and four in arm B lived more than
one year. Both treatments were well tolerated.
Conclusion: In this study patients with non-resectable
pancreatic cancer had shorter median survival than ex-
pected. Ip 5-Fu with iv Leucovorin was well tolerated
and although not superior to iv Gemcitabine in overall
survival it is an alternative palliative treatment option.
P-232
EVALUATION OF THE GUIDELINES
FOR THE MANAGEMENT OF BRANCH-
DUCT IPMNS OF THE PANCREAS IN A
SERIES OF 57 RESECTED PATIENTS
S. Crippa, S. Partelli, M. Paini, G. Malleo,
D. Tamburrino, C. Bassi, P. Pederzoli and R. Salvia
Policlinico GB Rossi University of Verona
Background and aim: The 2006 Sendai Consensus
Guidelines recommended surgical resection for all bench-
duct intraductal papillary mucinous neoplasm (BD-
IPMN) of the pancreas with symptoms, size > 3 cm,
nodules. However size > 3 cm alone and the presence
of minor symptoms (i.e. vague abdominal pain) are
debated. Aim of the preset study was to retrospectively
evaluate these guidelines in a series of resected, patho-
logically conﬁrmed BD-IPMN.
Methods: All patients who underwent a pancreatic
resection at our Institution between 1990 and 2007 with a
ﬁnal histological diagnosis of BD-IPMN were identiﬁed.
The Sendai criteria for surgical resection (presence and
type of symptoms, cyst size, presence of nodules) were
retrospectively applied and correlated with pathology.
Results: Fifty seven patients (25 males, 32 females,
median age 64 years, range: 35–78) were identiﬁed.
Overall, 26 patients (45.5%) had BD-IPMN with ade-
noma, 17 with borderline neoplasms (30%), 5 with car-
cinoma-in-situ (8.5%) and 9 with invasive carcinoma
(16%). Factors associated with the presence of malig-
nancy were nodules and ‘major’ symptoms such as
jaundice. Cyst size > 30 mm and the presence of ‘minor
symptoms’ such as vague abdominal pain were not
associated with malignancy unless other worrisome fea-
tures were present. There were no cases of malignant BD-
IPMN in patients without symptoms who had a BD-
IPMN < 30 mm without nodules.
Conclusions: Cyst size and minor symptoms in the ab-
sence of other worrisome features should not be consid-
ered as absolute criteria for surgical resection.
P-233
SOCIODEMOGRAPHICS AND
COMORBIDITIES INFLUENCE
DECISIONS TO UNDERGO
PANCREATIC RESECTION FOR
NEOPLASTIC LESIONS
C. Sandroussi, C. Brace, E. Kennedy, N. Baxter,
S. Gallinger and A. Wei
Department of Surgery, Toronto General Hospital,
University of Toronto, Canada
Introduction: Pancreatic resection is being performedwith
increasing frequency and safety. Technical outcomes and
long term survival for neoplastic lesions are well known
however reasons why patients do not receiving surgery for
resectable lesions are notwell documented. Our aimwas to
determine the factors contributing to the decision not to
operate for resectable pancreatic neoplasms.
Methods: From 2004–2008 on all patients with resectable
primary and secondary pancreatic neoplasms at the
UHN (Toronto) were analyzed. The impact of sociode-
mographics, comorbidities (Charlson combined comor-
bidity index-CMI and CCI) preoperative tumour
characteristics and type of resection on the decision to
proceed to resection for pancreatic neoplasms was
determined using univariate and multivariate binary lo-
gistic regression analysis.
Results: Three hundred and seventy ﬁve patients with
resectable pancreatic lesions were identiﬁed. The median
age was 62 years (21–93), 203/375 (54.1%) were males.
Fifty ﬁve (14.7%) did not undergo resection. On uni-
variate analysis age (OR 1.116, P < 0.001), non English
speaking background-NESB (OR 4.276, P = 0.001),
underlying diagnosis (P = 0.001 increased for, IPMN
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and cystadenoma/carcinoma), CMI score (OR 1.239,
P = 0.001), CCI score (OR 1.433, P < 0.001) were
associated with an increased odds of not undergoing
resection. Gender, age, marital status, and urban resi-
dence were not predictive. On multivariate analysis a
NESB (P = 0.018), and the CCI (P = 0.002) remained
predictive of not undergoing resection. 15 (27.3%) were
not offered surgery and 25 (45.5%) patients refused.
Comorbidities (27.3%), age (21.8%), surgical risk
(29.1%), frailty (18.2%), and uncertain diagnosis (5.5%)
were cited as reasons for not proceeding with surgery.
Conclusion: Patients with a higher CCI and those from
a NESB have an increase in the odds of not under-
going surgery for resectable neoplastic lesions of the
pancreas.
P-234
COUNSELING WITH THE
PATHOLOGIST: IMPACTING NODE
RETRIEVAL IN PANCREATICO-
DUODENECTOMY FOR MALIGNANCY?
A. Khithani, A. J. Saad, J. Barton and D. R. Jeyarajah
Methodist Dallas Medical Center, Dallas, Texas
Background: Lymph node positivity in peri ampullary
cancers is a poor prognostic factor. Studies have cited
lymph nodes dissected for as a benchmark for assessing
adequacy of the resection. Nevertheless the lymph node
retrieval is a variable, and can be impacted by the patient,
the surgeon and the pathologist factor.
Aims and objectives: The study was done to asses the
impact of the pathologist after an intervention by a
surgeon, namely counselling on the retrieval of lymph
nodes on PD specimens. All the PDs were done by a
single surgeon.
Methods: Cohort of patients undergoing PD from
September 2005 to March 2009 was included in the
study. The cases were reviewed with respect to the
median no of lymph nodes dissected. The PDs from
September 2005 to March 2008 were designated as
group A. The pathologist was counseled by the surgeon
on 1st April 2008. The PDs done over the next one year
(April 2008 – March 2009) were designated as Group B.
The pathologist was unaware of the study till its ter-
mination. The median no of lymph in groups were
compared between both groups.
Results: A total of 147 PDs were performed, 98 for peri
ampullary malignancy and 49 for benign head masses.
PDs with multi organ resections were excluded. Sixty
three PDs were done for peri ampullary cancer from
September 2005 to March 2008 by a single surgeon.
Thirty ﬁve PDs were performed for peri ampullary can-
cers between April 2008 and March 2009. The median no
of lymph nodes retrieved in group A was 11 nodes
(Range 3–32). The median no of lymph nodes retrieved in
group B was 22 nodes (Range 12–29). Other comparisons
are as shown in the table.
Conclusion: An intervention with the pathologist namely
counseling led to an increment in the lymph node
retrieval with PD. The same effect was seen with Stan-
dard and Pylorus preserving PD (PPPD). There was no
effect on Lymph node ratio. Weather or not lymph node
retrieval can be used as a benchmark for assessing ade-
quacy of resection remains inconclusive.
Comparison of both groups pre and post intervention
Entire period
(Sept 2005 –
March 2009)
Median
Nodes
(Range)
Group A
Sept 2005 –
March 2008
Median Nodes
(Range)
Group B
April 2008 –
March 2009
Median Nodes
(Range)
Overall Median LN
retrieval (Benign +
Malignant)
11 (0–32) 11 (0–32) 19 (3–29)
Median LN node
retrieval for PPPD
10 (1–32) 10 (1–32) 15 (12–29)
Median LN retrieval
for Standard PD
11 (0–29) 11 (0–29) 22 (0–23)
Median LN retrieval
for N1 disease
15 (7–32) 14 (7–32) 22 (15–27)
LN Ratio 0.18 (0.03–1.0) 0.19 (0.04–1.00) 0.17 (0.03–0.62)
P-235
EARLY ONSET PANCREATIC CANCER –
COMPARISON AGAINST MATCHED
CONTROLS
B. Tingstedt, C. Weitka¨mper and R. Andersson
Department of Surgery, Clinical Sciences Lund, Lund
University Hospital
Background: Pancreatic ductal adenocarcinoma (PC)
represents the fourth cause of death in cancer and with a
5-year survival rate reported less than 1–2%. The median
age at diagnosis is usually in the range 68–70 years, but a
subgroup exists below 50 years of age, Early Onset
Pancreatic Cancer (EOPC), infrequently described.
Aim: The objective was to determine epidemiology,
demographic incidence and prognosis of EOPC and
identify characteristics that might distinguish EOPC
from matched controls.
Methods: Five hundred and seventy six consecutive pa-
tients diagnosed with PC January 1993–December 2008
at the University Hospital in Lund, Sweden, were in-
cluded. Sixty ﬁve different parameters were put into a
database and these were compared to matched controls
regarding resection, tumour size, chemotherapy, radia-
tion therapy, jaundice, and sex.
Results: Thirty three out of 576 patients (5.7%) with PC
were 50 years or younger. Median age at diagnosis was
46.5 (range 30–50) years, 7 being between 30 and
40 years and none younger than 30. There were 20 men
and 30 women. The overall median survival was 170 days
and for matched controls 240 days (NS). Laboratory and
histopathological differentiation did not differ as com-
pared to matched controls and neither did location or
size of the pancreatic tumour. Patients with EOPC were
diagnosed at a signiﬁcantly more advanced stage with 27
out of 33 (82%) presenting with metastases (liver – 17,
lymph nodes – 11, loco regional – 5), as compared to
matched controls (30%; P < 0.0001). This is also re-
ﬂected by the frequent ﬁnding of weight loss, reported in
76% and averaging 11.8 kg/person.
Conclusion: EOPC constituted 5.7% of all PC, present-
ing at an advanced stage with frequent metastases, ca-
chexia, and poor survival. No other discriminating
parameter was identiﬁed. The role of genetic alterations
and the potential inﬂuence of environmental factors for
EOPC are to be investigated.
Abstracts 227
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
P-236
CLINICAL FACTORS FOR
MALIGNANCY IN INTRADUCTAL
PAPILLARY-MUCINOUS NEOPLASMS
OF THE PANCREAS
S. Murayama, W. Kimura, N. Takasu and I. Hirai
Department of Gastroenterological and General Surgery,
Ymagata University of Medicine, 2-2-2 Iida-Nishi,
Yamagata City, Yamagata, 990-9585, Japan
Background: It is difﬁcult for us to predict the malig-
nancy of intraductal papillary-mucinous neoplasm
(IPMN). The aim of this study was to investigate the
clinical factors for malignancy in intraductal papillary-
mucinous neoplasms of pancreas, and to determine the
ﬁndings which suggest malignancy.
Methods: Sixty-eight cases of intraductal papillary-
mucinous neoplasm of pancreas that were treated be-
tween 1996 and 2008 were analyzed morphologically.
IPMN type was classiﬁed as main-duct or branch-duct,
and tumours were classiﬁed as either benign (adenoma)
or malignant (carcinoma in situ or invasive cancer).
Imaging ﬁndings were mainly analyzed as predictors of
malignant. In this study, volumetry of IPMN was espe-
cially added as the new clinical factor.
Results: Among 68 IPMN cases, 55 cases were branch-
duct type and 13 cases were main-duct type. 20 (36%) of
55 branch-duct type and 9 (69%) of 13 main-duct type
were malignant. Multivariate analysis identiﬁed three
independent factors (diameter, volume of tumour, and
mural nodules) for malignancy in branch-duct type, but
we can not have the independent factors in main-duct
type.
Conclusions: The ﬁndings of there factors in branch-duct
type IPMN are supported to be considered in the diag-
nosis of IPMN to facilitate the indication of operation.
P-237
DOES EGFR EXPRESSION IN
PANCREATIC ADENOCARCINOMA (PA)
AND LYMPH NODEMETASTASES HAVE
ANY IMPACT IN LONG TERM
SURVIVAL?
M. Perini1, A. Montagnini1, R. Coudry2, R. Patzina2,
J. Jukemura1, S. Penteado1, F. Coimbra2, E. Abdo1 and
I. Cecconello1
1Hospital das Clinicas, Sa˜o Paulo Medical School;
2A.C. Camargo Hospital, Sa˜o Paulo
Introduction: Five year survival rate after resection of PA
ranges from 10% to 29% and EGFR expression has been
related to its aggressiveness.
Aim: Analyze the expression of EGFR in pancreatic non
tumour tissue, tumour tissue and metastatic lymph node
tissue and correlate it with clinicopathological ﬁndings
and survival after resection for PA.
Method: Between 1990 and 2006, 88 patients with PA
were operated. Variables analysed were: gender, differ-
entiation, nodal status, neural and vascular invasion,
margin, TNM, membrane EGFR (M-EGFR) and cyto-
plasmatic EGFR (C-EGFR) expression in tumour tissue,
pancreatic non-tumour tissue and metastatic lymph
node. TMA technique was used for immunohistochem-
istry analysis.
Result: There were 47 females (53.4%) and 41 males
(46.6%) with mean age of 59.1y. Median survival and 5y
survival were 22.9 m and 18%. M-EGFR expression was
positive in 35.5% of cases on the tumour sample and in
23.8% of cases in metastatic lymph nodes. There were no
positive expressions in non tumour pancreatic tissue. M-
EGFR expression was different in pancreatic non tumour
tissue when compared to tumour (P = 0.004) and nodal
tissues (P = 0.02). There was no difference between tu-
mour and metastatic nodal tissues. Only male gender was
associated with positive M-EGFR expression in pancre-
atic tumour tissue.
C-EGFR was positive in 11.3% of the tumour and 4.8%
of the metastatic lymph nodes tissues. There were no
positive expressions in pancreatic non tumour tissue.
There were no differences in C-EGFR expression when
tumour, non tumour and metastatic lymph nodes were
compared.
Gender, nodal and margin status, neural and vascular
invasion, TNM, peri-pancreatic invasion and tumour
positive M-EGFR expression correlated with survival.
On multivariate analysis, gender, neural invasion and
portal vein resection were signiﬁcant.
Conclusion: Tumour M-EGFR expression has impact in
survival in patients operated for PA and is related to its
expression in the metastatic lymph node tissue.
P-238
THE PROGNOSTIC FACTORS IN
LOCALLY ADVANCED UNRESECTABLE
PANCREATIC CARCINOMA PATIENTS
TREATED WITH CHEMORADIATION
T. You, T. H. Kim, W. J. Lee, S. M. Woo, S.-S. Han and
S-J. Park
Center for Liver Cancer, National Cancer Center
Background: For poor prognosis of the pancreatic can-
cer, it is important to be able to predict prognosis pre-
cisely for consideration of intensity, duration and
frequency of chemotherapy and radiotherapy.
Aim: To evaluate the effect of clinicopathological factors
on disease progression-free survival (DPFS) in unresec-
table pancreatic cancer with deﬁnitive chemoradiation
(CRT).
Methods: Between August 2002 and August 2008, 90
pancreatic carcinoma treated with deﬁnitive CRT at
National Cancer Center from was included. The study
inclusion criteria were: 1) locally advanced unresectable
disease (stage III) evaluated using CT and/or MRI and
FDG-PET; 2) treated with deﬁnitive CRT; (3) age
> 18 years; 4) no previous abdominal operation due to
pancreatic cancer; and, 5) no previous or concurrent
malignancy. Median total dose of radiotherapy was
55.8 Gy (range, 45 – 55.8 Gy). Sixty-three (70%) of pa-
tients were treated with 5-ﬂuorouracil-based concurrent
chemotherapy, and 27 (30%) patients were treated with
Capecitabine.
Results: Of the 90 patients, 2-year overall survival rate
was 20.1% and the median follow-up time was
12.3 months (range, 2.2–34.3 months). Seventy four
(82%) showed disease progression; 2-year DPFS rate was
17.7% and the median follow-up time was 9.2 months
(range, 1.6 – 33.2 months) for patients free of disease
progression. On univariate analysis, pretreatment serum
CA19-9 (> 300 U/mL vs. £ 300 U/mL), clinical nodal
classiﬁcation (cN0 vs. cN1) and adjuvant chemotherapy
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were signiﬁcantly associated with DPFS rates
(P = 0.007, P = 0.019, P = 0.03, respectively). On
multivariated analysis, pretreatment serum CA19-9 level
and clinical nodal classiﬁcation were signiﬁcantly asso-
ciated with DPFS of pancreatic cancer patients treated
with CRT (P = 0.005, P = 0.002).
Conclusion: Among the locally advanced patients treated
with CRT, our study showed that high level (> 300 U/
mL) of pretreatment serum CA19-9 and negative nodal
involvement (cN0) predicted for disease progression.
P-239
INTRADUCTAL PAPILLARY-MUCINOUS
CARCINOMA OF THE GASTRIC TYPE
WITH A MURAL NODULE
S. Murayama, N. Takasu, W. Kimura, T. Moriya,
A. Takeshita and I. Hirai
Department of Gastroenterological General, Breast and
Thyroid Surgery, Yamagata University, Faculty of
Medicine, Yamagata, Japan
We report a rare case of intraductal papillary-mucinous
neoplasm with pancreatobiliary-type carcinoma in situ
that originated around a mural nodule formed in a
gastric-type adenoma. A 64-year-old man was admitted
to our hospital in December 2001 for dilation of the main
pancreatic duct, detected on abdominal ultrasonography.
Branch duct-type intraductal papillary-mucinous neo-
plasm (diameter: 25 mm) was diagnosed, and because
mural nodules were absent, the patient was annually
followed up for 5 years. In 2006, computed tomography
scans revealed the thickening of the tumour wall and
development of a mural nodule (diameter: approximately
6 mm); pancreatoduodenectomy with regional lymph-
node dissection was performed. Histopathologic exami-
nation showed an intraductal papillary-mucinous carci-
noma arising from an adenoma. Hematoxylin and eosin
staining revealed that most of the tumour components,
including the mural nodule, had adenomatous changes,
indicating the tumour to be of the gastric type. However,
immunohistochemistry showed positive MUC2 expres-
sion. Histologically, the tissues around the nodule,
including those showing a cribriform pattern, were
diagnosed as carcinoma in situ. These tissues were
classiﬁed as the pancreatobiliary-type on the basis of
the results of both hematoxylin and eosin staining and
immunohistochemistry. The patient remained disease-
free for 3 years after surgery.
P-240
STEREOTACTIC BODY RADIATION
THERAPY FOR NON-RESECTABLE
TUMOURS OF THE PANCREAS:
PRELIMINARY RESULTS
K. Goyal1, D. Einstein1, M. Yao1, C. Kunos1,
F. Barton1, D. Singh1, C. Siegel1, J. Hardacre1, J. Kim1,
J. Stulberg1 and J. Sanabria1,2
1University Hospitals Case Medical Center; 2Case
Western Reserve University, Cleveland OH
Background and aims: Stereotactic body radiation ther-
apy (SBRT) has emerged as a treatment option for local
tumour control of primary malignancies of the pancreas.
We report on our experience with SBRT in patients with
malignant tumours of the pancreas whom were found not
to be candidates for surgical resection.
Methods: The records of our ﬁrst eleven consecutive
patients (mean age 71.9 years) receiving SBRT for
non-resectable tumours of the pancreas under an IRB
approved protocol were reviewed. Prior to SBRT,
cylindrical solid gold ﬁducial markers were placed within
or around the tumour tissue endoscopically (n = 5),
surgically (n = 4), or percutaneously under CT-guidance
(n = 2) to allow for tracking of tumour during respira-
tion. Mean radiation dose was 25 Gray (range 22–30 Gy)
delivered over one to three fractions (Stanford protocol).
Chemotherapy was accepted by 60% of patients.
Results: Patients had a mean tumour volume of 57 cm3
(range 10–110 cm3) and a mean total tumour volume
reduction of 17% six months after SBRT (P < 0.05, one
side student t-test). All patients with pancreatic tumours
arrested local tumour growth with a median follow-up of
6.5 months (range 2–42 months). No patient had a
complication related to marker placement regardless of
modality. We noted the development of three gastroin-
testinal ulcers (two gastric, one duodenal), which re-
sponded to medical management.
Conclusion: Our results, albeit with small numbers,
showed SBRT is a safe and effective treatment modality
for local control of pancreatic malignancies with minimal
adverse events.
P-241
ORAL S-1 PLUS GEMCITABINE AND
CONCURRENT RADIOTHERAPY IN
PATIENTS WITH T3-4 AND M0 CANCER
OF THE PANCREAS
G. Honda and M. Kurata
Tokyo Metropolitan Cancer and Infectious Diseases
Center, Komagome Hospital
Objective: To evaluate the safety and feasibility, and to
determine recommended doses of both oral S-1 and
Gemcitabine (GEM) as part of a Chemoradiation regi-
men for patients with T3-4 and M0 cancer of pancreas.
Methods: Fourteen patients consented to receive this
treatment. The total dose of radiation was 50.4 Gy
(1.8 Gy · 28 fractions, 5 times per week) and was
administered in combination with oral S–1 (60–80 mg/
sq/day · 28 fractions, synchronized with radiation) and
GEM (200–300 mg/sq/week · 6 fractions). A restaging
evaluation was performed 4 weeks after the ﬁnal irradi-
ation.
Results: The treatment was completed for 13 patients,
excluding one patient in whom treatment was discontin-
ued after the 18th administration due to thrombocyto-
penia of Grade 3. Seven patients showed PR and seven
patients showed SD. Adverse effects of grade three or four
were neutropenia in eight patients, thrombocytopenia in
one and anorexia in six, nausea in two and pneumonitis in
three. After restaging, all eight patients with T3 cancer
underwent surgical resection and intraoperative radiation
therapy (IORT), while ﬁve patients with T4 cancer
underwent IORT. One of the patients who had undergone
resection died on POD 35 due to acute portal embolism.
Adjuvant chemotherapy could be started in three of eight
patients after resection and in all patients after IORT.
Conclusion: This treatment regimen demonstrated a high
response rate. However, because adjuvant chemotherapy
is an important therapeutic modality in patients with
pancreatic cancer, this treatment should be followed by
IORT or by resection in selected patients.
Abstracts 229
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
P-242
ADENOCARCINOMA ARISING IN
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASMS (IPMN): A DIFFERENT
BIOLOGICAL PROFILE AND CLINICAL
OUTCOME
G. Morris-Stiff, G. Lentz, S. Chalikonda, M. Johnson
and R. M. Walsh
Department of Hepato-Pancreato-Biliary Surgery,
Cleveland Clinic Foundation, Cleveland, Ohio
Background: The rate of malignant transformation in
patients with IPMN is high, in particular for disease
affecting the main pancreatic duct. There is however, little
data on the outcome of these tumours in comparison to
pancreatic adenocarcinoma arising in a normal gland.
Aims: To evaluate this subset of patients with pancreatic
adenocarcinoma arising in IPMN.
Methods: The institutions prospectively maintained
pancreatic cyst database was reviewed to identify patients
with a histopathological diagnosis of pancreatic adeno-
carcinoma arising within an IPMN. Their presentation,
histopathological characteristics and outcome were re-
corded. Patients with asymptomatic cysts were evaluated
with endoscopic ultrasound (EUS) and cyst aspiration.
Results: Eleven patients were identiﬁed including seven
females and four males with a mean age of
65.4 ± 9.3 years. The mode of presentation included:
asymptomatic (n = 4); pain (n = 3); pancreatitis
(n = 2); jaundice (n = 1) and pain and jaundice
(n = 1). Only one patient, who presented with pain, had
a pre-operative diagnosis of carcinoma, the rest being
histopathological ﬁndings. Seven patients had main duct
IPMN, two had side branch IPMN and two had com-
bined disease. Three had multiple foci of invasive carci-
noma and the remaining eight had mass lesions varying
from 1.5 to 4 cm. The stage of disease was: IA (n = 4);
IB (n = 4); and IIB (n = 3). Lymph vascular invasion
was seen in only three, and neural invasion identiﬁed in
four patients. Three patients have died, two of recurrent
carcinoma and one of an unrelated cause. The two
recurrences were identiﬁed at 9 and 11 months with
death at 14 and 23 months following recurrence respec-
tively. For the remaining eight patients, the median sur-
vival is 41 months (range 1–100 months).
Conclusions: Despite an intensive pre-operative work-up,
IPMN-related adenocarcinoma is rarely identiﬁed pre-
operatively. The data would support resection of all
symptomatic and asymptomatic main duct IPMN and
side-branch disease being followed very closely.
P-243
PREOPERATIVE INDICATORS FOR NON
– RESECTABILITY OF PATIENTS WITH
CARCINOMA OF THE HEAD OF THE
PANCREAS
T. Dorffman, R. Eshkenazy, E. Brauner, Z. Assi,
A. Ariche and Y. Kluger
Department of General Surgery, Rambam Health Care
Campus, Haifa, Israel
Background: Improvement in preoperative workup
reduced operations of non resectable (NR) tumours in
patients with tumours of the pancreatic head (HP). CT
scan is considered gold standard in pre operative evalu-
ation. Its accuracy in detecting vascular involvement,
liver or peritoneal metastases is limited. Exploratory
laproscopy is an important toll in these patients workup
but some investigator call for its selective use.
Purpose of study: To identify preoperative indicators for
non respectability in patients subjected to surgery after
multimodality workup.
Study design: Retrospective analysis of charts, radiology
ﬁndings, operative notes and pathology reports of pa-
tients admitted for tumour of HP.
Results: During four years 141 patients were admitted
for tumour of the pancreas. 31 (22%) had tumour of the
body or tail and were excluded. 110 had tumour of HP. 8
(7.3%) patients preferred treatment in another hospital.
21 (19%) had peri ampullary tumours other than the
head. 81 (73.6%) were diagnosed with Adenocarcinoma
of the HP. 35 (43.2%) were found NR according to the
preoperative workup. One received neo adjuvant treat-
ment. 45 (55.5%) were found eligible for surgery. 46 were
operated. 9 (19.5%) were found NR at surgery. 4 (44%)
due to vascular involvement and 5 (56%) due to liver
metastases. CA19-9 > 300 was recorded in 61% of the
NR and in 33.6% of those who completed surgery
(P = 0.26). When all NR patients are grouped and
compared to the resectable, CA19-9 > 300 reached sig-
niﬁcance (P < 0.009). Weight loss was signiﬁcant in the
NR group.
Conclusion: Multimodality workup of patients with HP
carcinoma improves operative NR ﬁgures. Weight loss
and CA19-9 levels > 300 can aid in selecting patients for
laparoscopy before Whipple operation.
P-244
CONTROVERSIES IN THE TREATMENT
OF ADENOMAS OF THE AMPULLA OF
VATER AND OF THE DUODENUM
G. Vasiliades, A. Koliopanos, D. Georgiadou,
N. Kopanakis, S. Avlonitis, A. Katopodi and
E. Margaris
General Hospital of Athens, ‘G.Gennimatas’
Background: Adenomas of the ampulla of Vater and of
the duodenum represents a challenge, as the appropri-
ate surgical treatment of this entity remains controver-
sial. An accurate preoperative diagnosis is very
important as therapeutic strategies range from Trans-
duodenal excision of the ampulla to a Whipple proce-
dure. In achieving a deﬁnitive diagnosis, endoscopic
retrograde cholangiopancreatography is of paramount
importance.
Methods: Between June 1996 and November 2009, six
patients (three male, three female, mean age 67.5 years,
range 45–77), underwent Trans duodenal excision of an
adenoma of the ampulla of vater and duodenum and
anastomoses of the common duct and pancreatic duct to
the duodenum in our department.
Results: No operative mortality occurred and postoper-
ative course was without complications in all cases. In
two of them (33.34%) the histopathological examination
showed adenocarcinoma of ampulla of Vater, whereas in
the remaining four patients histology revealed adenoma
of ampulla of Vater in two cases (33.34%) and adenoma
of duodenum in two cases (33.34%). One of the two
patients with adenocarcinoma of ampulla of Vater
underwent a second operation, a Whipple pancreato-
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duodenectomy, while the second one did not, as he was at
high operative risk and he had a local recurrence after
2 years and had a further resection.
Conclusion: Tranduodenal excision of the ampulla is
recommended as the ﬁrst-line treatment for the small,
benign tumours and, when technically possible, for
malignant tumours in patients at high operative risk. If
adenocarcinoma is diagnosed postoperatively Whipple
pancreatoduodenectomy is mandatory in patients at low
operative risk. Close postoperative follow-up with duo-
denoscopy and ERCP is recommended.
P-245
PANCREATIC METASTASIS OF RENAL
CELL CARCINOMA AFTER 19 YEARS:
A CASE REPORT
D. Chhabra, S. Vaze, R. Shah and P. Jagannth
Department of Surgical Oncology, Lilavati Hospital and
Research Centre, Bandra (W), Mumbai, India
Background: Pancreatic metastasis from renal cell carci-
noma (RCC) is extremely rare and occurs in 2.8% of
patients with metastatic RCC. The average time between
nephrectomy and the diagnosis of metachronous metas-
tases is reported to exceed 10 year. Therefore, the initial
diagnosis may be neglected in the cases of prolonged
disease-free interval. Less than 250 cases have been re-
ported in literature with resectability rates as high as 80%
and 5 year survival ranging from 43–88%.
Report: A 52-year-old asymptomatic female was referred
for evaluation of mass in the distal portion of pancreas
with tumour thrombus extending from splenic vein into
the MPV found on an ultrasound 19 years after a left
nephrectomy for renal cell carcinoma. A distal pancrea-
tectomy and splenectomy with excision of tumour
thrombus was performed. The histopathological analysis
revealed metastases from renal cell carcinoma. She was
subsequently treated with sunitinib. The patient is alive
and doing well 24 months after surgery despite a portal
vein margin positivity.
Conclusion: Late pancreatic metastases should be con-
sidered during a long term follow up for renal cell
carcinoma. Resection of RCC metastases to the pan-
creas offers a survival advantage. It is advantageous to
combine with sunitinib if there is portal vein involve-
ment.
P-246
THE NATURAL HISTORY OF RESECTED
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASMS (IPMN): SURVEILLANCE
IS REQUIRED
G. Morris-Stiff, G. Lentz, S. Chalikonda, M. Johnson
and R. M. Walsh
Department of Hepato-Pancreato-Biliary Surgery,
Cleveland Clinic Foundation, Cleveland, Ohio
Background: Although knowledge of the natural history
of IPMN is improving, no data exists on outcome fol-
lowing resection.
Aim: To report postoperative results of IPMN in terms
of symptom & disease recurrence, and to relate this to
pathology and treatment.
Methods: Patients were identiﬁed from the pancreatic
cyst database. Details of IPMN subtype, location, and
margin status were noted. Details of symptoms, ﬁndings
of imaging studies, interventions and outcome were re-
corded.
Results: Forty six patients were identiﬁed, 25 of which
had symptoms: pain (n = 12); pancreatitis (n = 11): and
jaundice (n = 4), and 21 were asymptomatic. Resections
included: PPPD (n = 22); distal (n = 14); total (n = 6);
central (n = 3) and subtotal (n = 1) pancreatectomy.
IPMN subtypes included 20 main ducts, 21 side branch
and 5 mixed IPMN. A carcinoma was present in 11 cases,
dysplasia in 30 [high (n = 11); moderate (n = 8); and
low (n = 11)] and ﬁve had no dysplasia. Resection
margins were negative in 25 patients and positive in 21
patients including 16 with dysplasia [high (n = 3);
moderate (n = 2); and low (n = 11)], four with no
dysplasia, and one with carcinoma on formal histopa-
thology. two patients developed symptoms: one with
carcinoma in side branch IPMN (negative margin) pre-
sented with jaundice due to recurrent carcinoma, and one
with main duct IPMN and low grade dysplasia (negative
margin) developed a carcinoma in the remnant. 11 pa-
tients developed radiological evidence of IPMN not
present on pre-operative imaging and subtypes were:
main (n = 3); side branch (n = 6); and mixed (n = 2).
Of these individuals, six had negative margins, one had
moderate and two had low grade dysplasia, and two had
no dysplasia in their margins. In 10 cases this was limited
to the pancreas but in one patient lung metastases were
detected.
Conclusions: The course of IPMN is unpredictable and a
decision to follow-up patients cannot be based simply on
IPMN subtype, degree of dysplasia or margin status. As
such, all patients with IPMN should be followed care-
fully with radiological imaging.
P-247
ELEVATED CA 19 – 9 LEVELS PREDICT
FOR A WORSE OUTCOME IN PATIENTS
WITH EARLY AND ADVANCED
PANCREATIC ADENOCARCINOMA
T. Bekaii-Saab, A. Majumber, E. Trolli and T. Patel
The Ohio State University
Background: Pancreas cancer is the 4th leading cause of
cancer mortality. Ca19–9 is a tumour associated antigen
and a sensitive serum marker for pancreatic cancer. We
hypothesized that elevated Ca19–9 levels will predict for
a worse outcome in patients with early and advanced
pancreatic adenocarcinoma.
Methods: Data was obtained from charts of 123 patients
with a diagnosis pancreatic adenocarcinoma at the Ohio
State University. We collected all pertinent data. Data
was analyzed using Kaplan–Meier survival curves.
Results: A total of 30 resected patients were analyzed.
Patients with normal Ca19-9 levels after surgical resec-
tion had a mOS of 36 months vs. 20.3 months for those
with elevated Ca19-9 levels (95% CI 11.3, 36; P = 0.27).
Patients with normal Ca19-9 levels after surgical resec-
tion had a mDFS of 16.5 months vs. to 7.6 months for
those with elevated Ca19–9 levels (95% CI
3,9.3;P = 0.0.21). We also analyzed data on 93 patients
with stage III/IV disease. For patients with elevated
Ca19-9 levels prior to treatment, mOS was 11.3 months
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(95% CI; 8.8, 16) whereas for patients with normal
Ca19–9 levels mOS was 32.3 months (95% CI; 18, NA).
A signiﬁcant difference (P = 0.0008) was found between
the two groups. Finally, we analyzed trends in Ca 19-9
levels on 73 patients who underwent Gemcitabine based
therapy. For patients with < 50% decrease in maximum
CA19-9 level, mOS was 8.5 months (95% CI 56, 11). For
patients with > 50% decrease in maximum CA19-9 le-
vel, mOS was 16 months (95% CI; 12, 23). A signiﬁcant
difference (P = 0.0078) between the two groups.
Conclusion: We showed that elevated Ca19-9 levels fol-
lowing resection will predict for a shorter DFS and OS.
We also showed that patients with advanced pancreas
cancer who present with elevated Ca19-9 levels will have
a worse outcome compared to those with normal levels.
Finally, we conﬁrmed that patients who experience a
decrease in their Ca19-9 levels to > 50% of pretreatment
levels will have signiﬁcantly improved survival.
P-248
THE PROGNOSTIC SIGNIFICANCE OF
MICROVESSEL DENSITY IN
PANCREATIC ADENOCARCINOMA
R. Jureidini1,2, J. E. M Cunha2, T. Bacchella2,
F. R. Takeda2, P. P. P. Caravatto2, U. Ribeiro Jr1,2,
W. M. Pollara1,2 and I. Cecconello2
1Instituto do Caˆncer do Estado de Sa˜o Paulo;
2Departamento de Gastroenterologia - Hospital das
Clı´nicas FMUSP
The prognostic signiﬁcance of microvessel density was
evaluated in this retrospective study. Between 1993 and
2006, 49 patients with pancreatic adenocarcinoma were
resected with curative intention. Specimens were stained
immunohistochemically with antibodies anti-CD34. Mi-
crovessel density (MVD) was assessed scanning ten areas
of the tumoural section and counted at a high power in
an adequate area. The MVD ranged from 21.2 to 54.2
vessels/mm2 (mean 46.2 vessels/mm2). The overall
median survival was 24.1 months after resection and
there was no difference in survival rates according to the
MVD positivity. There was also no relation between the
MVD and p53 expression. MVD expression could not
predict survival in these patients with pancreatic adeno-
carcinoma.
High MVD was associated with tumour size grater than
3.0 cm and positive margins.
P-249
PANCREATIC GANGLIOCYTIC
PARAGANGLIOMA: A RARE BUT
POTENTIALLY MALIGNANT TUMOUR
OF THE PANCREAS
E. Kansakar, D. Machado-Aranda, L. A. Ferguson and
M. J. Jacobs
Providence Hospital and Medical Centers, Southﬁeld,
Michigan, United States
Background: Paragangliomas are rare tumours that de-
rive from cells coming from the neuronal crests in the
embryo. They are most frequently found in the para-
aortic retroperitoneum, adrenal glands, carotid body or
along any areas where sympathetic chains are present.
More rarely they can be seen in the lung, larynx, thyroid,
bladder and pancreas. Their infrequency as pancreatic
tumour has not allowed them to be extensively studied.
Objective: To describe the ﬁndings and management of
two cases of pancreatic gangliocytic paragangliomas
treated at our hospital.
Methods: We report two cases of conﬁrmed pancreatic
gangliocytic paragangliomas. Both patients had shown
on CT-scan a hypervascular exophytic mass arising from
the head of the pancreas. The patient’s main complaints
were of abdominal pain and early satiety. Decision to
take to surgery was based of the potential malignancy
appearance seen on CT-scan.
Results: Both patients had surgical resections with
curative intent. Intra-operative ﬁndings showed an
encapsulated and highly vascularized mass with its blood
supply pedicle deriving from the pancreas. In none of
these cases a full Pancreatic-duodenectomy was required.
R0 resection was achieved satisfactorily. No further
adjuvant therapy was employed. Pathology showed a
highly-vascularized mass with staining positive for
chromogranins a, synaptophysin and neuron speciﬁc
enolase. One of our patients had single positive lymph
node metastasis. This patient has not exhibited recur-
rence based on surveillance studies.
Discussion and conclusion: The intimal relationship of the
pancreas with other retroperitoneum organs makes it
possible that aberrant migration of neuroendocrine cells
to occur and transform into tumours of the pancreas.
Surgery has insofar demonstrated to be the only effective
treatment of these tumours. However because of their
rare occurrence it is still debated which type of resection
should be performed, therefore close surveillance should
be instituted.
P-250
MUCINOUS CYSTADENOCARCINOMA
OF THE PANCREAS – OUTCOME
FOLLOWING DIFFERENT MODES OF
TREATMENT
R. Andersson and J. Bjo¨rk-Werner
Department of Surgery, Clinical Sciences Lund, Lund
University Hospital
Background: Cystic neoplasms of the pancreas represent
both benign and premalignant/malignant lesions. Prog-
nosis is good when non-invasive disease or disease con-
ﬁned to the pancreas alone, but less favourable when the
mucinous cystadenocarcinoma has started to metasta-
size.
Aim: To determine outcome in patients with mucinous
cystadenocarcinoma of the pancreas following different
modes of treatment including radiochemotherapy and
surgery.
Method: Seventeen patients, 10 female and 7 male, with
histologically veriﬁed cystadenocarcinoma were included.
The group conﬁned 4 patients without operation or
radiochemotherapy, 5 with surgical treatment and no
adjuvant chemotherapy, and 8 with radiochemotherapy.
The median age was 63 years tending to be somewhat
higher in patients without operation or chemotherapy
treatment 69 years.
Results: In the group without operation or radioche-
motherapy, metastases were found in 3/4 and 3/4 had a
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history of weight loss. 3/4 patients died after in median
2 months (ranging up to 19 months) during follow-up
(median 2 months from histopathological diagnosis).
Following surgical treatment (n = 5), only 1 had weight
loss to be compared with 6/8 in patients with radioche-
motherapy (P < 0.01). Metastases were seen in 5/8 pa-
tients with radiochemotherapy and none in the surgically
treated group (P < 0.01). 7/8 patients with radioche-
motherapy died after in median 18 (4–45) months as
compared to 1/5 of surgically treated patients. There was
no signiﬁcant difference in size of the tumour, being in
median 4.5 cm, and neither did histopathological differ-
ential grading differ.
Conclusion: Mucinous cystadenocarcinoma of the pan-
creas is when locally conﬁned and without metastases
associated with a fairly good prognosis after surgical
resection. In inoperable patients, outcome is poor in
patients not administered chemo radiotherapy, while this
treatment allows a substantial survival length even de-
spite the frequent occurrence of metastases.
P-251
STUDY OF ENDOCRINE TUMOURS OF
PANCREAS SINGLE INSTITUTIONAL
STUDY -RURAL PERCEPTIVE
S. Dasgupta, S. Matkari and P. Nichkaode
N.K.P Salve Institute of Medical Sciences and Lata
Mangeskar Hospital Nagpur
Endocrine tumours of Pancreas are common benign
tumours, 90% tumours are benign. Imaging modalities-
USG and CT scan Yields diagnosis. Malignant transfor-
mation with metastasis has been described, including
recurrence after surgical excision. Occasionally localiza-
tion of these tumours is difﬁcult. We present a series of 22
patients of ETP encountered and treated in last ﬁve
years.
Materials and methods: Twenty two pats, of either sex,
age 36–65 years were studied all pats came from rural
background. Presentation is after reviewing from series
doctors- Range of symptoms included spells of uncon-
sciousness, convulsions, and giddiness to increase weight.
All patients were subjected to USG and CT Abdomen,
and biochemical analysis- Sr. Insulin levels, C- Peptide
with Parallel Blood Sugars. MRI and Selective angiog-
raphy required in a few cases. Of 22 cases 15- Insulinoma,
1- Glucagonoma, 1- Gastrinoma, 5- Carcinoid tumours.
One Insulinoma Giant > 9 cm. All tumours were benign
except gastrinoma which turned malignant with Hepatic
Mets. One had recurrence All patients were subjected to
open surgery except malignant gastrinoma. All insuli-
noma were located in Head & neck region, Glucagonoma
located in tail. Enucleation was the operative procedure
done. Biochemical recovery was instant and clinical
recovery was early. Obese patient had wound infection-
with no mortality in our series.
Conclusion: Report stresses the importance of clinical
exam, with high index of clinical suspicion, ETP though
rare constitute bulk of benign tumours of Pancreas, A
subset of these of Patients are difﬁcult to localize & those
larger in size are usually malignant. Enucleation is
commonest surgical procedure with resection reserved in
difﬁcult and large tumours. We conclude that managing
these tumours by simple enucleation is justiﬁable &
possible to be carried out in rural medical setup with
average but safe facilities.
P-252
CROSS-SECTIONAL AND
LONGITUDINAL ASSOCIATIONS
BETWEEN SCORES OF EQ-5D AND ESAS
IN PATIENTS WITH PANCREATIC
CANCER (PC)
T. Heiberg and T. Buanes
Oslo University Hospital, Ulleval
Background: EQ-5D is the most widely used utility
instrument in economic evaluation of health care. It
comprises ﬁve items – three on physical functioning, one
on anxiety and one on pain. We had observed that EQ-
5D levels were surprisingly high in patients with severe
pancreatic cancer (PC).
Aim: We wanted to examine how symptom scores from
ESAS were associated to EQ-5D.
Patients and methods: Forty-nine patients with recently
diagnosed PC (mean (SD) age 66.9 (9.8), 49% females)
completed a booklet of questionnaires including ESAS
and EQ-5D at inclusion, and were followed at inclusion
and after two months. Longitudinal data (change
scores) were available from 33 patients. Pearson corre-
lation coefﬁcients were computed to examine associa-
tions between status scores at baseline and 8 week
change scores.
Results: Mean (SD)/median (IQR) EQ-5D at baseline
was 0.59 (0.29)/0.73 (0.40) with a range from -0.24 to
1.00. Mean (SD)/median (IQR) 2 month change in EQ-
5D was 0.03 (0.34)/0 (0.34) (range -0.69 to 0.68). Corre-
lation coefﬁcients between EQ-5D and ESAS symptom
scores for baseline status and 2 month change scores
were as follows: Pain at rest 0.53/0.31, pain at movement
0.46/0.20, fatigue 0.53/0.27, nausea 0.31/0.06, shortness
of breath 0.04/0.02, dry mouth 0.22/0.41, appetite 0.30/
0.01, anxiety 0.41/0.24, depression 0.50/0.08 and global
well being 0.46/0.48.
Conclusion: EQ-5D correlates weakly to gastrointestinal
symptoms as reﬂected by ESAS. These results may
indicate that EQ-5D has limited external validity in pa-
tients with PC.
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CARCINOSARCOMA OF THE
PANCREAS
F. Apodaca-Torrez, M. B. Trivin˜o, A. Goldenberg,
E. J. Lobo and T. Trivin˜o
Department of Surgical Gastroenterology, Sa˜o Paulo
Federal University - EPM
Background: Carcinosarcoma of the pancreas is a
malignant neoplasm composed of mixed epithelial and
mesenchymal elements, with structural and immunohis-
tochemical features well deﬁned. It has been given dif-
ferent names among the few papers published about this
disease. This cancer rarely affects the pancreas.
Objective: More one case report.
Methods: A 75-year-old white female was admitted to
our hospital suffering from abdominal pain for
6 months, weight loss of about 10 kg, nonspeciﬁc gas-
trointestinal symptoms and anorexia. One month before
the admission she experienced increased pain radiating to
the back. She had diabetes and arterial hypertension.
Tomography with a tumour of pancreatic body and tail.
Distal pancreatectomy and splenectomy were performed.
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Results: Histopathology: 1. Carcinosarcoma measuring
approximately 8.5 · 5.5 · 3.0 cm with angiolymphatic
invasion. 2. Surgical margins of external tumour surface
were compromised by the neoplasm. 3. Pancreatic sur-
gical margin free of neoplastic involvement. Immuno-
histochemistry complement conﬁrmed the presence of
epithelial cells (adenocarcinoma) and mesenchymal cells
(sarcoma).
Discussion: Carcinosarcoma of the pancreas is a neo-
plasm of peculiar features that according to the WHO
classiﬁcation of cancer belongs to the group of undif-
ferentiated carcinomas. It is widely known that pancre-
atic cancers arise fundamentally from ductal cells, acinar
and islet, however, this type of cancer is still a subject to
debate about what their true origin is. Although the
histopathologic diagnosis can be done by hematoxylin
and eosin, conﬁrmation must be made by immunohis-
tochemistry. Because it is a high-grade neoplasm, prog-
nosis is dismal, with one patient having survived for more
than one year in the literature. The histogens is unclear.
Some authors defend the theory of the same totipotential
cell originating the mixed tumour while others support
that it comes from two different cells.
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PANCREATIC CYSTIC NEOPLASM
F. R. Apodaca-Torrez1, M. B. Trivin˜o1, R. Artigiani
Neto2, J. F. M. Farah Jose´1, A. Goldenberg1, E. J. Lobo1
and T. Trivin˜o1
1Department of Surgical Gastroenterology, Sa˜o Paulo
Federal University – EPM; 2Department of Pathology,
Sa˜o Paulo Federal University – EPM
Introduction: Cystic neoplasms of the pancreas (PCN)
presents clinically nonspeciﬁc. The development of new
imaging methods have contributed to the increase of the
diagnosis. Surgery remains controversial, mainly in
asymptomatic lesions.
Objective: To describe our experience in the diagnosis
and treatment of PCN.
Methods: Retrospective analysis based on histopatho-
logic ﬁndings of a series of 24 patients undergoing sur-
gical treatment for PCN. Twenty-one patients were
female (87.5%) and age ranged from 19 to 73 years
(median 43.5 years). The most frequent symptom re-
ported by patients was increase in abdominal volume in
41% of cases, followed by abdominal pain of mild to
moderate intensity (29%). Twenty-ﬁve percent of pa-
tients reported signiﬁcant weight loss. All patients were
initially submitted to abdominal ultrasound followed by
CT scan. Cystic lesion or cystic-solid was conﬁrmed in
100% of patients. Other diagnostic methods such as
cross-endoscopy and MRI were performed in selected
cases.
Results: The body-tail pancreatectomy associated with
splenectomy was the procedure most frequently used
(75%). Two laparoscopic procedures were performed.
Histopathological diagnosis revealed the case of seven
serous cystadenomas, seven pseudo papillary tumours,
four mucinous cystadenomas, three cystadenocarcino-
mas and three endocrine cystic neoplasia. The most fre-
quently observed complication was pancreatic ﬁstula in
three patients. There was one death in a patient diag-
nosed with cystadenocarcinoma, due to a pulmonary
thromboembolism.
Conclusion: PCN affect more women than man and the
clinical picture is usually associated with the size of the
tumour. Topographic location most affected were body
and tail of the pancreas. The three patients diagnosed
with mucinous cystadenocarcinoma had abdominal pain
associated with signiﬁcant weight loss.
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THE CLINICAL CHARACTERISTICS OF
ACINAR CELL CARCINOMA IN
PANCREAS
H. U. Kim1, J. K. Ryu1, S. B. Choi2, H. K. Hwang3,
D. S. Yoon3, W. J. Lee1 and K. S. Kim1
1Department of surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of surgery,
Kuro Hospital, Korea University College of Medicine;
3Department of surgery, Kangnam Severance Hospital,
Yonsei University College of Medicine
Acinar cell carcinoma (ACC) is a very rare type of
pancreatic cancer, which occurs below 1% among
pancreatic cancers. The prognosis of ACC is very poor
and the mean survival interval is only 18–19 months. The
only best treatment is an early radical resection as
concerned until now.
Materials and methods: To ﬁnd out ACC‘s clinical
characteristics and treatment efﬁcacy, we have studied
the clinical characteristics, laboratories, pathologies and
treatment responses of 10 ACC patients among 3042
pancreatic cancer patients who were diagnosed in Sev-
erance Hospital and Kangnam severance Hospital of
Yonsei University, College of Medicine from 1988.01.01
to 2008.12.31, with retrospective chart review.
Results: The 10 ACC patients are six males and four
females. The mean age of 10 ACC patients is 53.2 years.
The most of patients (7/10) complained the pain on the
epigastric area and there was no jaundice in eight patients
(80%). Unfortunately regional or distant metastases were
founded among ﬁve patients (50%) at the time of ﬁrst
diagnosis. The initial median CA19–9 level was 10.4 U/
mL (range 0.1~350.0 U/mL). Six of 10 patients under-
went radical surgery and 4 of 10 including one with open
and closure were treated with conservative treatment.
The median survival interval was 22.4 months with
operative treatment and 1.5 months with conservative
treatment. The median overall survival interval was
19.4 months. The median disease free survival was
17 months. The liver is the most recurrent site on three
cases.
Conclusions: An early radical resection is the only best
treatment of ACC until now, but in rare cases, post-
operative adjuvant chemotherapy shows hopeful results
and so it needs more studies.
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IMMUNOTHERAPY FOR PANCREATIC
CANCER
M. Akada, S. Egawa, K. Shima, Y. Kitamura,
K. Nakagawa, H. Hayashi, F. Motoi, S. Ottomo,
T. Rikiyama, Y. Katayose and M. Unno
Division of Hepato-Biliary Pancreatic Surgery,
Department of Surgery, Tohoku University Graduate
School of Medicine
Background and aims: Pancreatic cancer is one of the
most lethal cancers because it is resistant to standard
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chemotherapy. Thus, new therapeutic methods are nee-
ded. We have been striving to develop immunotherapy
for pancreatic cancer. So far three clinical trials had been
carried out, as follow (I, II, III).
Methods: (I)We infused lymphokine-activated killer
(LAK) cells into the portal vein after curative resection
and intraoperative radiation therapy (IORT) on ad-
vanced pancreatic cancer (1989–1990). (II)Then we per-
formed intra tumour injection of autologous dendritic
cell (DC) after IORT 17 patients (2000–2001). (III)Cur-
rently, we are trying HLA–A*2402–restricted WT1 pep-
tide vaccination for the patients against chemo-resistant
pancreatic cancer (2008–2009). Tissue array and micro
dissected mRNA of various stage of pancreatic cancer
were examined about WT1 expression.
Results: There were no fatal or major side effects in all
trials. Though it was a retrospective data, the portal
injection of LAK had a signiﬁcant elongation of survival
in JPS Stage IV a disease. Within 17 patients who re-
ceived intra tumour injection of DCs, one patient had
clinical responsive. WT1 is more expressed during tu-
mour progression. WT1 peptide vaccine is showing a
marginal effect when combined with chemotherapy and
is on-going.
Discussion: Pancreatic cancer is evading from host-im-
mune system. Non-speciﬁc immunotherapy has a limited
anti-tumour activity. One of tumour associated antigen,
WT1, is promising, but its effect on pancreatic cancer
should be further determined.
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FIRST REPORTED SQUAMOUS CELL
CARCINOMA OF PANCREAS IN LATVIA
M. Pavars1, I. Melbarde-Gorkusa1, A. Vanags1,
I. Strumfa1 and J. Gardovskis2
1Paula Stradins Clinical University Hospital; 2Riga
Stradins University
Background: Primary pancreatic squamous carcinoma
(PPSC) is a rare morphological variant of pancreatic
neoplasms with a reported incidence 0.5 to 2%.
Aim: We present an extremely rare case of pure squa-
mous cell carcinoma of the head of pancreas showing
cystic characteristics. PPSC was diagnosed on histo-
pathological examination of the surgical biopsy and is
the ﬁrst such reported case in Latvia.
Case report: A 66-year-old woman was admitted to the
hospital with a 3 month history of dull upper abdominal
pain. On physical examination, there was palpable epi-
gastric fullness. Blood tests were normal. Computed
tomography demonstrated a cystic mass in the pancreatic
head. The mass measured 7 cm in diameter and slightly
compressed the celiac trunk. No abdominal lymphade-
nopathy or other focal lesions were present. The patient
underwent laparotomy, but the lesion was non-resectable
due to the invasion in the celiac trunk. A palliative cys-
tojejunastomy was performed and biopsy of cyst was
done. Histology revealed pure squamous cell cancer, by
immunohistochemistry cytokeratins (CK) 5/6+;CK7-;
CK20-;CK34bE12+;p63+. The patient received post-
operative radiation therapy, but the survival was only
2 months.
Discussion: The origin of PPSC remains unclear. The
clinical picture of squamous cell tumours of the pancreas
appears to be similar to the much more common ade-
nocarcinomas. According to the literature, the diagnoses
of PPSC often are based on evaluation of the surgical
biopsy specimens and tumours are non-resectable at the
time of initial evaluation in most cases. Median survival
is generally poor, regardless of whether or not surgical
resection is performed.
Conclusion: Despite the progress in oncological research
squamous pancreatic tumours still represents worse sur-
vival results. Strategies involving non-surgical treatment
such as chemotherapy and radiotherapy should be tested.
More detailed studies of the tumour biology could lead
to new treatment modalities.
P-258
IOUS-GUIDED RESECTION OF THE
PANCREATIC TAIL WITH SPLEEN AND
SPLENIC-VESSEL PRESERVATION FOR
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASMS (IPMNS)
M. Mirarchi1, E. De Raffele1, L. Calculli2, D. Santini3,
S. Vaccari1, G. M. Gaspare4 and B. Cola1
1U.O. Chirurgia Generale. Policlinico S.Orsola-Malpighi.
Bologna. Italy; 2U.O. Radiologia. Policlinico S.Orsola-
Malpighi. Bologna. Italy; 3U.O. Anatomia e Istologia
Patologica. Policlinico S.Orsola-Malpighi. Bologna. Italy;
4U.O. di Medicina Interna. Policlinico Madonna della
Consolazione. Reggio Calabria. Italy.
Background and aim: Intraductal papillary mucinous
neoplasms (IPMN) of the pancreas are a distinct entity
with malignant potential, which may recur after surgical
excision. Limited pancreatectomies have been recently
proposed for noninvasive tumours. We report our tech-
nique of IOUS-guided resection of noninvasive IPMN
located in the tail of the pancreas with spleen and splenic
vessel preservation.
Methods and results: Following an adequate exposure of
the distal pancreas, a thorough ultrasonographic
examination of the parenchyma is accomplished to de-
ﬁne the features of the neoplasia, its relationship with
the main pancreatic duct and splenic vessels and to
mark the transection line with electrocautery. Dissection
begins at the inferior edge of the pancreatic tail and
proceeds from a lateral to medial direction up to the
transection line. The main pancreatic duct is identiﬁed
and sutured, the parenchyma is then closed and the
suture line is reinforced with a ﬁbrinogen/thrombin-
coated collagen patch. Patient 1 was a 63-year-old male
who underwent IOUS-guided resection of the pancreatic
tail for a IPMN of the pancreatic tail measuring 28 mm
with moderate dysplasia at histology, and was dis-
charged 9 days after surgery. Patient 2 was a 60-year-
old male who underwent IOUS-guided resection of the
pancreatic tail for a IPMN of the pancreatic tail mea-
suring 30 mm with carcinoma in situ at histology, and
was discharged 9 days after surgery.
Conclusion: Limited distal pancreatic resection with
spleen and splenic vessel preservation is an adequate
surgical technique for noninvasive IPMN of the tail of
the pancreas. IOUS is crucial in planning ‘radical but
conservative’ pancreatic resection.
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PANCREATIC METASTASES FROM
UTERINE LEIOMYOSARCOMA WITH
VASCULAR INVOLVEMENT
D. Pagano, S. Gruttadauria, S. Li Petri, F. Di Francesco,
D. Cintorino and B. Gridelli
Department of Abdominal and Transplantation Surgery,
Mediterranean Institute for Transplantation and Advanced
Specialized Therapies (IsMeTT), Palermo
A 35-year-old woman, who underwent hysterectomy
and bilateral oophorectomy for high-grade leiomyosar-
coma of the uterus in February 2005, was admitted to
our institute in May 2009. She had a mass measuring
4.5 cm at the widest diameter in the head of the
pancreas, detected with an abdominal CT scan per-
formed during follow-up. She was asymptomatic. The
initial staging suggested venous involvement, and so
more detailed assessments of the degree of venous
narrowing were performed to determine the feasibility
of neoplasm excision. There was a clear plane between
the tumour and the superior mesenteric artery, and R0
resection was planned by a multidisciplinary team
without neo adjuvant chemotherapy. Consequently,
the patient underwent pylorus-preserving pancreatic
duodenectomy with en bloc superior mesenteric-portal
vein resection. The superior mesenteric-portal vein
resection was circumferential, extending about 4 cm in
length; reconstruction of the superior mesenteric-portal
vein was carried out utilizing a heterologous graft of the
iliac vein from an organ donor of the same blood type.
The diagnosis was consistent with metastatic leiomyo-
sarcoma of the pancreatic head with involvement of the
vessel wall reached the intima and without positive
lymph-nodes. At present, the patient is alive, well and
disease free at 6 months after surgery. She is undergoing
adjuvant therapy. To the best of our knowledge, only a
few cases of pancreatic metastases from uterine leio-
myosarcomas have been reported, and pancreatic resec-
tion seems to improve survival in these patients.
However, this is the ﬁrst case with vascular involvement
treated with vein resection. In view of the close
anatomical proximity of the head of the pancreas to
the portal/superior mesenteric vein conﬂuence, it is
logical for surgeons to seek to expand the pool of
patients who may beneﬁt from pancreatic duodenecto-
my by undertaking en bloc resection of the vein.
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LONG TERM SURVIVAL WITH
CARCINOMATOSIS FROM
ADENOCARCINOMA OF PANCREAS:
REPORT OF 2 CASES
A. L. M. Meyer, S. Penteado, L. B. P Haddad, E. S. Abe,
A. L. Montagnini, J. E. M. Cunha, A. S. Matheus and
J. Jukemura
University of Sa˜o Paulo School of Medicine, Department
of Gastroenterology, Sa˜o Paulo
Background: Ductal adenocarcinoma present at an ad-
vanced stage with a poor prognosis. No more than 5% of
all patients with pancreatic cancer will survive 5 years.
Patients with localized disease in whom a potentially
curative resection can be performed have the only real
chance of long-term survival.
Objective: Report two rare cases of pancreatic tumour
with carcinomatosis diagnosed at intraoperative and
long-term survival.
Case report: Case 1: A 77-years-old female patient re-
ferred to our hospital with mild abdominal pain, weight
loss and palpable abdominal mass. Upper digestive
endoscopy revealed extrinsic compression in the gastric
antrum. Computed tomography revealed solid mass le-
sion (9.0 cm) coming from the duodenal second portion
without cleavage plane with pancreatic head and trans-
verse colon. Duodena pancreatectomy and segmental
colectomy (transverse) was undertaken and the stage was
IIB (pT3N1Mx). Besides, ascitic ﬂuid positive for malig-
nancy was found during laparotomy. The patient is alive
at 8.5 years after the resection. Case 2: A 62-years-old
female patient presented with weight loss. Computed
tomography revealed solid mass lesion (4.0 cm) in the tail
of the pancreas. Distal pancreatectomy and splenectomy
was performed and the stage was IB (pT2N0Mx). Intes-
tinal obstruction occurs two months later and another
surgery was performed. Umbilical (Sister Mary Joseph’s
nodule) and peritoneal implants were found during this
surgery and intestinal bypass performed. Remains alive
6 years after the ﬁrst surgery. Both cases received adju-
vant chemotherapy with Gemcitabine and Oxaliplatin for
6 months.
Conclusion: Resection of pancreatic adenocarcinoma
indicates that pancreatectomy with curative intent offers
a real chance of long-term survival to patients with this
highly lethal disease.
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THE PROGNOSTIC SIGNIFICANCE OF
P53 EXPRESSION IN PANCREATIC
ADENOCARCINOMA
R. Jureidini1,2, J. E. M. Cunha2, T. Bacchella2,
F. R. Takeda2, P. Caravatto2, U. Ribeiro Jr1,2,
W. M. Pollara1,2 and I. Cecconello2
1Instituto do Caˆncer do Estado de Sa˜o Paulo;
2Departamento de Gastroenterologia - Hospital das
Clı´nicas FMUSP
The prognostic signiﬁcance of the p53 expression was
evaluated in patients with pancreatic adenocarcinoma.
Between 1993 and 2006, 49 patients with were ressected
with curative intention. Specimens were stained immu-
nohistochemically with antibodies anti-p53. Speciﬁc
nuclear staining for p53 was determined positive in 20
patients (40.8%). The overall median survival was
24.1 months after resection and there was no difference
in survival rates according to the p53 positivity. There
was no relation between p53 expression and response to
chemotherapy.
Positive lymphnodes presented a 100% correlation with
p53 positivity of the pancreatic related tumor. p53
expression could not predict survival in pancreatic
adenocarcinoma.
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THE CLINICAL UTILITY OF
CIRCULATING TUMOUR CELL
MEASUREMENT IN THE DIAGNOSIS OF
INDETERMINATE LESIONS OF THE
PANCREAS
A. Giakoustidis1, S. Mudan2, A. Thillainayagam3,
D. Giakoustidis4, J. Jacob5 and J. Stebbing5
1The London Clinic, London, UK; 2The Royal Marsden
Hospital and St George’s Hospital Medical School,
London, UK; 3Gastroenterology & Hepatology Unit,
Hammersmith Hospital, Imperial College Healthcare
Trust, London, UK; 4Department of Transplant Surgery,
Aristotle University of Thessaloniki, Greece; 5Department
of Oncology, Hammersmith Hospital, Imperial College
Healthcare Trust, London, UK
Introduction: The quantiﬁcation of circulating tumour
cells (CTCs) has been historically problematic due to
different methods applied to their measurement. Fol-
lowing the development of standardised technology,
they are now becoming well established prognostic and
predictive markers in patients with breast, colon and
prostate cancer. While they represent a real time non-
invasive test, their use in diagnostics has seldom been
reported.
Method- Results: The use of CTCs measurement in pa-
tients with pancreatic cancer has seldom been reported.
As pancreatic lesions are often difﬁcult to biopsy, we
report their use in an individual with an indeterminate
pancreatic mass to help conﬁrm the diagnosis of an epi-
thelial cancer.
Conclusion: The use of an automated CTC platform is
likely to have utility in facilitating diagnosis although
prospective studies will be required to ascertain its posi-
tive or negative predictive value, and determining the true
clinical beneﬁt of their measurement.
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PANCREATIC TUMORS IN CHILDREN
R. Rossi1, C. Franco2, X. De Aretxabala1, R. Rossi JR1,
J. Leon1, J. Herrera1 and F. Cassorla1
1Clinica Alemana; 2Clinica Santa Maria
Background: Pancreatic tumors in children are uncom-
mon and unique in types and behavior.
Aims: The purpose of this report is to show the experi-
ence of the authors in the management of a series of
young patients harboring a pancreas tumor.
Method: The series includes 11 patients younger than
17 years old, treated between 1995 and 2008.
Results: Ten patients were female and one male, while
age ranged between 1 month and 17 years old. A solid
pseudopapilar tumor was observed in four patients. Two
patients had endocrine tumors while one patient each had
a pancreatoblastoma, primitive neuroectodermal tumor,
seromucinous cyst, lymphangioma and a pseudocyst
respectively.
Diagnosis was suspected from image studies such as CT
scan and MR while ﬁnal diagnosis was performed from
the pathological exam of the resected specimen. All
patients underwent surgical resection, six a pancreatodu-
odenal resection and ﬁve a pancreatic distal resection.
Follow-up ranged between 14 years and 18 months. Of
the patients, one harboring an endocrine tumor devel-
oped recurrence and is being treated with chemotherapy.
The rest of patients are alive and free of disease.
Conclusion: Although pancreas tumors are uncommon
in children, diagnosis should be taken into account in the
differential diagnosis of patients with abdominal symp-
toms. Because its lower frequency, management should
be performed by multidisciplinary groups including sur-
geons with experience in pancreas surgery.
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POSITIVE SURGICAL MARGINS
FOLLOWING A WHIPPLE RESECTION
FOR PANCREATIC ADENOCARCINOMA
ADVERSELY AFFECT PATIENT
SURVIVAL
C. Scaife, K. Boucher, J. Christensen, R. Glasgow and
S. Mulvihill
Huntsman Cancer Institute University of Utah
Background: An unresolved issue in pancreatic cancer
(PA) treatment is whether margin status after resection
predicts outcome.
Aim: The purpose of this study was to review the margin
status of Whipple resections for PA and assess impact on
overall survival rates. We hypothesized that a positive
surgical margin following a Whipple procedure adversely
affects patient survival.
Methods: Utilizing our prospectively collected clinical
research database, we identiﬁed all Whipple resections
performed for PA, from January 2001 to August 2009.
Data were recorded in a standardized fashion. Kaplan-
Meier analysis and Cox proportional hazards models
were performed to compare margin status to overall
patient survival. We deﬁned surgically controllable
(SCM) margins as the pancreatic neck, bile duct, and
superior mesenteric vein (SMV) margins. The pancreatic
capsule anterior and posterior surface margins, as well as
the superior mesenteric artery margin (SMA) were con-
sidered uncontrollable margins (UM).
Results: We identiﬁed 104 patients in the study period.
Mean patient age was 64 years (range 35–82), 53% were
male. Positive UMmargins occurred in 22 patients (21%)
and any margin was positive (AM+) in 26%. Comparing
the all margins negative (AM-) vs. AM+ groups, there
were no statistical differences relative to patient age,
gender, nodal status, or use of adjuvant therapy. The
median survival of patients with AM- was 684 (95% CI
520–965) vs. AM+ 346 (292–620) days, P = 0.00092.
Median survival in UM- vs. + groups was 684 and
319 days, respectively (P = 0.0004). Margin status was
an independent predictor of survival after controlling for
age, gender, nodal status, or use of adjuvant therapy.
Conclusions: We conclude that, despite reports to the
contrary, an R1 resection negatively impacts overall
survival following a Whipple procedure. This study
emphasizes the need for accurate preoperative imaging
of surgically UMs for appropriate surgical patient
selection.
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GALLBLADDER CANCER SURVIVAL IN
HOSPITALS FROM HIGH AND LOW
RISK REGIONS. CHILE 2002–2005
M. Gabrielli1, S. Hugo2, C. Bambs1, S. Baez2,
A. Venturelli3, E. Figueroa1, M. Puga3, A. Diaz2,
N. Jarufe1 and C. Ferreccio1
1Pontiﬁcia Universidad Catolica; 2Hospital Dr Sotero del
Rio; 3Hospital Base Valdivia
Introduction: Chile has the highest Gallbladder cancer
(GC) mortality reported worldwide. GC has a highly
heterogeneous geographic distribution with higher mor-
tality in the Southern Chile. Our aim was to explore the
factors that explain these differences in mortality between
high and low risk areas of Chile for GC.
Methods: Cases were GC patients admitted between
2002 and 2005 to the Southern Hospital of Valdivia and
to two Hospitals from the Metropolitan Region (low risk
area) Hospital So´tero del Rı´o and the Clinic of the
Catholic University of Chile. Based on data from the
clinical records and the Registro Civil databases we
analyzed ethnicity, socioeconomic status (SES) and ru-
rality. Survival Curves were estimated using the Kaplan-
Meier method and compared using the long-rank test.
Results: Five hundred ninety eight GC patients were
hospitalized, mean age 63 years, 78.4% women, similar
among hospitals. At diagnosis 60% of cases were in stage
IV and only 28.6% in early stages (I or II). There was no
difference in three and ﬁve year stage-speciﬁc survival
between hospitals in low and high risk areas for GC.
Conclusion: Stage-speciﬁc survival was similar in hospi-
tals for southern and central regions, and not inﬂuenced
by SES, rurality or ethnicity, so tumor stage emerges as
the only risk factor in the survival of GC. That GC
mortality is higher in southern Chile is due to less
accessibility to health care and not to economic, ambient
and ethnic factors prevalent in this population.
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EXPRESSION OF N-ACETYLGLUCOS-
AMINYLTRANSFERASE V (GNT-V) IN
PATHOLOGICAL TUMOR STAGE 2
CARCINOMA OF THE GALLBLADDER
AND ITS CLINICAL SIGNIFICANCE
K. Onuki1, T. Kawamoto1, T. Ota1, M. Yamamoto1,
H. Sugiyama2, K. Ishige2, E. Miyoshi3, N. Taniguchi4
and J. Shoda2
1Department of Surgery, Institute of Gastroenterology,
Tokyo Women’s Medical University; 2Department of
Gasteoenterology, Institute of Clinical Medicine, The
University of Tsukuba; 3Department of Biochemistry,
Osaka University Medical School; 4Department of
Surgical Oncology, Osaka Medical Center for cancer
and Cardiovascular Diseases
Purpose: Little is known about the molecular events
leading to the development and progression of patho-
logical tumor stage 2 (pT2) gallbladder carcinoma. Al-
though the carcinoma is limited to the gallbladder wall,
postsurgical recurrence at distant sites occurs in some
cases. N-Acetylglucosaminyltransferase V (GnT-V) is an
enzyme that catalyzes b1-6 branching of N-acetylglu-
cosamine on asparagine-linked oligosaccharides of cel-
lular proteins. This enzyme enhances metastasis in an
experimental cancer model of mice. Metastatic potential
of various cancer cells has been shown to correlate with
an increase of GnT-V activity. In this study, we investi-
gated GnT-V expression to clarify the possible relation-
ship between clinicopathological ﬁndings and GnT-V
expression in human pT2 gallbladder carcinoma.
Method: Immunohistochemistry was performed to
determine the expression level of GnT-V in 90 cases
(curative 76 cases, non curative 14 cases) of pT2 gall-
bladder carcinoma using surgically resected specimens.
Result: Of 90 cases, 57 cases (63%) showed positive
expression and 33 cases (37%) showed negative expres-
sion. Positive expression was classiﬁed as granular-type
or diffuse-type. In 76 curative cases, post surgical sur-
vival was signiﬁcantly poorer in cases showing positive
expression than in those showing negative expression
(P = 0.028).In all 90 cases, post surgical recurrence of
distant organs and lymph nodes were more frequent in
cases showing positive expression than in those showing
negative expression (P = 0.09 for distant organs and
0.04 for lymph nodes).
Conclusions: In pT2 gallbladder carcinoma, the expres-
sion of GnT-V is correlated with the aggressiveness of the
disease.
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GB CANCER WITH JAUNDICE: IS IT
CONTRAINDICATION FOR SURGERY?
D. W. Hwang, J. M. Choi, S. H. Chon, K.-M. Park and
Y.-J. Lee
Asan Medical Center University of Ulsan College of
Medicine
Background: Presence of obstructive jaundice in patients
with gallbladder (GB) cancer indicates locally advanced
disease with invasion of the porta hepatis, which leads to
poor prognosis. Therefore, surgical resection has been
generally not recommended.
Methods: Between January 1998 and December 2008,
432 patients underwent surgical resection for GB cancer
at Asan Medical Center (AMC), Korea. Hyperbiliru-
binemia (>1.3 mg/dL) was identiﬁed in 104 patients and
clinical jaundice was present on initial examination at
AMC in 54 patients. The clinical data was analyzed ret-
rospectively.
Results: The preoperative mean total bilirubin was
9.94 ± 8.0 mg/dL. Surgical resection with curative in-
tent was performed in 16 patients (29.6%) and R0
resection was achieved in 10 patients (18.5%). T stage
was the only signiﬁcant predictor for R0 resection
(P = 0.001). The median survival of patients with locally
advanced GB cancer with jaundice was 9.4 (4.8–
14.0) months. The median survival in R0 group was 18.2
(14.8–21.6) months and was signiﬁcantly longer com-
pared with 8.6 (6.3–11.0) months in patients with non-
curative resection (P = 0.014).
Conclusion: R0 resection was possible in considerable
proportion of patients with locally advanced GB cancer
and statistically signiﬁcant survival gain has been
achieved with radical surgery. Surgical resection with
curative intent should be considered in GB cancer pa-
tients with obstructive jaundice.
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EXTENT OF SURGERY FOR GALL
BLADDER CANCER: AN ANALYSIS OF A
SINGLE CENTRE EXPERIENCE OF 513
OPERATED PATIENTS
R. P. Singh, S. Singh, S. Agarwal, P. K. Mishra,
P. Sakhuja and A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Aims/Objectives: Here we present a Single centre expe-
rience of the surgical management of Gall bladder cancer
(GBC) patients from January 2000 to April 2009 at a
tertiary referral teaching centre.
Methods: This study group: 513 patients of GBC taken
for resection during January 2000–April 2009. The pa-
tients were evaluated for assessment of resectability &
extent of resection.
Results: Of 513 patients taken for resections, 189 were
with SOJ (36.84%) and 324 were without SOJ (63.16%).
440 (85.77%) patients were taken up for resection with
curative intent (135/71.4% with SOJ & 305/94.14%
without SOJ). Of these patients, 229 (229/513 = 44.64%,
229/440 = 52.05%) had curative resections. Amongst
these 229 curative resections, 61 were in patients with
SOJ & 168 in patients without SOJ. The overall resect-
ability was 44.64% (32.28% for SOJ group & 51.85% for
non SOJ group). In patients undergoing curative resec-
tions, 207 patients underwent segment IVB+V resection,
three patients had segments IVb+V+VI resection &
Extended Right Hepatectomy was done in 19 patients
(9.18%). Adjacent organ was involved in 74 patients. In
these patients with adjacent organ involvement, duodenal
sleeve was resected in 21 patients, distal Gastrec-
tomy+D1 resection was done in 36 patients, segmental
colectomy in 32 patients, pancreaticoduodenectomy in
two patients, and vascular reconstruction/ligation was
done in 10 patients. The morbidity and mortality rates
were 19.8 and 8.91% respectively.
Summary and conclusion: Aggressive approach results in
better resectability in Gall bladder Cancer. The overall
resectability in our study was 52.05%. An extended right
hepatectomy was required in 19 (9.18%) patients &
adjacent viscera was resected in 74 patients.
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THE CLINICAL FEATURES AND
SURGICAL OUTCOME OF
ADENOSQUAMOUS CELL CARCINOMA
IN GALLBLADDER
D.-W. Choi, S.-H. Choi, C.-Y. Ho, J.-S. Heo and
W.-S. Kim
Samsung Medical Center, Sungkyunkwan university
School of Medicine
Background: Adenosquamous/ squamous cell carcinoma
(ASC/SCC) of the gallbladder accounts for 5.3–10.6% of
all GBC and have been considered as a lethal disease,
although adenocarcinoma (AC) is the most histologic
type of gallbladder carcinoma.
Aim: This study was conducted to compare clinico-
pathological features including survival outcome of ASC/
SCC with AC of the gallbladder.
Methods: Sixteen case patients who were diagnosed with
ASC/SCC of the gallbladder were reviewed retrospec-
tively. We chose 16 control patients who underwent
surgery for adenocarcinoma of the gallbladder among
348 patients that underwent surgery for gallbladder car-
cinoma from October 1994 to March 2009. The control
group was selected by matching 1:1 with the case patients
for age and gender. Clinicopathological features and
survival rates were analyzed.
Results: The mean age was 60.2 years and 50% were
male. No difference in serum level of total bilirubin and
CA19-9 was observed. Tumor stages of case group pa-
tients were signiﬁcantly advanced (P = 0.008) and case
group showed the tendency of lower R0 resection rate
(P = 0.063). The overall 1-year survival rate of the case
group was signiﬁcantly worse than control group (18.8%
vs. 72.9%, P = 0.005). However, there was no signiﬁcant
difference in the disease free survival rate after R0
resection between two groups (P = 0.149).
Conclusions: ASC/SCC of the gallbladder might have a
poorer prognosis than AC of the gallbladder because of
lower R0 rate. R0 resection for ASC/SCC of the gall-
bladder might lead to comparable disease free survival
rate with AC of the gallbladder.
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COMPARISON OF RESULTS BETWEEN
PRIMARY RADICAL RESECTION AND
SECOND COMPLETION RADICAL
RESECTION AFTER SIMPLE
CHOLECYSTECTOMY FOR T2
GALLBLADDER CANCER
S. Y. Cho, S.-J. Park, S. H. Kim, S.-S. Han, Y.-K. Kim
and K.-W. Lee
Center for Liver Cancer, National Cancer Center, Korea
Background: Gallbladder (GB) cancer may be discovered
incidentally by histopathologic examination following
simple cholecystectomy. Incidental GB cancer ‡T2N0M0
needs second radical resection. It is a matter of concern
whether the prognosis may be worse in patients with T2
GB cancer undergoing second radical resection than in
those undergoing primary radical resection.
Aim: The aim of this study was to compare clinical
outcomes according to the type of operations (one-step
vs. two-step operations) for T2 GB cancer.
Methods: Between March 2001 and March 2009, Twen-
ty-one patients underwent one-step operation (OSO
group), and 17 patients underwent two-step operation
(TSO group) for T2 GB cancer. We compared clinico-
pathologic factors and survival between patients in the
OSO group (n = 9) and those in the TSO group (n = 9)
with T2N0M0 GB cancer, and between patients in the
OSO group (n = 12) and those in the TSO group
(n = 8) with T2N1M0 GB cancer.
Results: Except for patient age, clinicopathologic factors
as well as disease-free survival were not signiﬁcantly
different between OSO group and TSO group in the
aforementioned stages. Patient age was signiﬁcantly older
in the OSO group than in the TSO group.
Conclusion: The results of this study suggest that second
completion radical resection following initial simple
cholecystectomy will provide similar survival beneﬁts as
primary radical surgery for patients with T2N0M0 or
T2N1M0 GB cancer.
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TUMOR MARKERS AS PROGNOSTIC
FACTORS OF GALL BLADDER, BILE
DUCT AND CHOLANGIOCELLULAR
CARCINOMAS – A PILOT STUDY
V. Liska1, V. Treska1, L. Holubec2, J. Vrzalova2,
T. Skalicky1, A. Sutnar1, J. Bruha1, O. Vycital1,
P. Pitule1, J. Finek2, M. Pesta3, L. Pecen3, S. Kormunda3
and O. Topolcan3
1Department of Surgery, Medical School and Teaching
Hospital Pilsen, Charles University Prague; 2Department
of Oncology, Medical School and Teaching Hospital
Pilsen, Charles University Prague; 3Central Isotopic
Laboratory, Medical School and Teaching Hospital
Pilsen, Charles University Prague
Background: The behaviour of tumor markers in gall
bladder carcinoma, bile duct carcinoma (Klatskin) and
cholangiocellular carcinoma is not commonly known and
could play important role in diagnostics and treatment
strategies. The authors present statistical analysis of tu-
mor markers (AFP, CEA, CA 19-9, CA72-4, TK, TPA,
TPS and CYFRA 21.1) in mentioned carcinomas.
Aims: The study tries to ﬁnd the role of tumor markers
at not properly studied diseases, where their importance
is often marginalized.
Methods: The authors studied 43 patients, who under-
went explorative laparotomy without any surgical treat-
ment or were treated by radical surgical procedures for
gall bladder carcinoma, bile duct carcinoma (Klatskin)
and cholangiocellular carcinoma (24, 8 and 11 patients
respectively) between years 2000 and 2007. The relation
between particular tumor markers after none or radical
surgical treatment in comparison with disease free sur-
vival (only for radical surgery) and overall survival was
studied. We used LogRank test and Wilcoxon test for
statistical evaluation. Overall survival rate (OS) and
disease free interval (DFI) was computed by Kaplan-
Meier method.
Results: The statistical analysis of tumor markers proved
TK as promising prognostic factors of early recurrence
(DFI) or poor prognosis (OS) for patients with gall-
bladder carcinoma. TPS was demonstrated as good
prognostic factor of OS for patients with gall bladder
carcinoma. CEA was proved as excellent prognostic
factor of poor perspective (OS) of patients after explor-
ative laparotomy for all cumulated studied diagnoses.
Conclusion: The results of study suggest the importance
of tumor markers for prediction of recurrence of disease
after radical surgery or poor prognosis after palliative
treatment or none surgery for patients with biliary tract
malignancies.
This project was supported by grants IGA MZ CR NS
9731/4 and NS 10230/3 and Research project MSM
0021620819 (Replacement of some vital organs).
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INCIDENTAL GALL BLADDER CANCER
R. P. Singh, S. Singh, S. Agarwal, P. Sakhuja, S. Mandal
and A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Background: Incidental Gall Bladder cancer (IGBC) is
reported in 0.2 to 1% of cholecystectomies.
Aim: To analyse our experience of Incidental Gall
bladder Cancer.
Methods: Study group consists of 148 cases of IGBC
managed from 2000 to 2008.
Results: Of 148 IGBC patients, 88 presented early with
the biopsy report, while 60 (including 15 with ignored
biopsy) presented later with symptoms. On biopsy, Stage
of the disease were, T1a in 2, T1b in 21, T2 in 57, T3 in
22, T4 in none, and benign 1 patient. Cystic duct margin
was reported positive in three.
Evidence of recurrence due to metastasis at presentation
was seen in nine patients, (SCLN in two, Scar metastasis
in ﬁve patients). Recurrence on imaging was present in 43
patients. Two patients refused surgery. 94 patients with
no preoperative evidence of recurrence were taken for
surgery with curative intent (63.51%, 94/148) of these 58
underwent curative R0 resection, with an operative
resectability of 61.70% (58/94), & overall resectability
39.19% (58/148).
Time between 1st surgery and 2nd surgery in patients for
surgery with curative intent was – median 31.5 days,
(mean 68.47 days & range of 1–660 days). Resectable
patients had a mean time to second surgery of
39.45 days, (median – 25) vs. to 133.2 & 79 days in
unresectable patients. Post operative morbidity was
36.21% & mortality was 3.19%. Completion radical
Cholecystectomy included Segmentectomy 4b/5 with
standard lymph node dissection in 55 patients, Extended
right hepatectomy in one, only lymph node dissection in
one & only wide local excision of scar in one. Adjacent
organs (colon/duodenum) were involved in 19 patients.
(Eight colon resection, 14 duodenal sleeve/ distal gas-
trectomy with D1 resection) Port site/scar excision of 1st
surgery was carried out in all. In addition, CBD excision
was done in 13, omental excision in one, and in two Right
hepatic artery reconstructions.
Conclusion: In IGBC, the time to deﬁnitive resection is
an important predictor of resectability.
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RADICAL SURGICAL APPROACH WITH
4B-5 LIVER RESECTION FOR
GALLBLADDER CANCER:
DETERMINANT FACTORS OF LONG
TERM SURVIVAL
J. Lendoire, L. Gil, G. Rafﬁn, P. Barros Schelotto,
F. Duek, C. Quarin, V. Garay, A. Oks and
O. Imventarza
Liver Transplant Unit - Hospital Dr Cosme Argerich
Background: Surgical management of gallbladder cancer
(GC) is still controversial. Therapeutic efﬁcacy and
appropriate extent of the liver resection still remains
unclear.
Objective: To analyze the results of 4b-5 liver resection in
patients with GC and determine factors associated with
long term survival.
Methods: A retrospective analysis of patients referred to
the Hospital Argerich with diagnosis of GC between June
1999 and March 2008 was performed. Patients were
identiﬁed from the Liver Transplantation and Surgical
Division prospective computerized database. Incidental
and non incidental tumors were included. Data covering
demographic features, clinical characteristics, local
pathological stage, surgical procedure, morbidity, histo-
logical features and factors for long term survival were
analyzed. Survival curves were estimated with the Kap-
lan-Meier method and compared using the log-rank test.
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Results: Fifty two patients with GC were identiﬁed: 41
females (79%). Median age: 59.3 years (range 37–78.)
Incidental GC: 35 (67%) and non incidental GC: 17
(33%). Local pathological stage in incidental GC was T1
(1), T2 (13), T3 (21). 22 patients were inoperable and one
was subjected to exploration and biopsy only. Out of 29
patients who underwent potentially curative surgical
procedures, 25 were treated by resection of segments 4b-5
and lymphadentectomy. There was no peri-operative
mortality, 32% morbidity (88% type I) and an 96% (24/
25) R0 resections. Histological examination revealed
adenocarcinoma in 96%. Overall 5-year survival and
disease free survival was 54% (stage AJCC 6th ed.: IB
88%, IIA 24%, IIB and III 0%). In the univariate and
multivariate analyses survival was signiﬁcantly associated
with T stage (P 0.002) and TNM stage (P 0.001).
Conclusions: A marked improvement in outcome was
achieved by the radical surgical treatment of patients
with GC by systematic resection of segments 4b-5. T
stage and TNM stage are determinant factors of survival.
P-274
NEUROENDOCRINE TUMORS OF THE
GALLBLADDER: AN EVALUATION AND
REASSESSMENT OF MANAGEMENT
STRATEGY
K. Eltawil1, B. Gustafsson2,3, M. Kidd1 and I. Modlin1
1Department of Surgery, Yale University School of
Medicine; 2Department of Gastroenterology, St Olavs
Hospital HF, Trondheim University Hospital;
3Department of Cancer Research and Molecular Medicine,
Faculty of Medicine, Norwegian University of Science and
Technology, N-7006 Trondheim, Norway
Background: Gallbladder neuroendocrine tumors (GB-
NETs) represent only 0.5% of all NETs. They are rarely
diagnosed preoperatively and little is known about their
biological behavior.
Aims/Objectives: We sought to provide an overview of
the current state of knowledge about GB-NETs and
provide a recommendation for management.
Methods: A PubMed search was undertaken using the
following criteria: primary gallbladder and carcinoid or
NET. We also interrogated the United States Surveil-
lance, Epidemiology and End Results (SEER) 9, 13 and
17 registries (1973–2005) and the Niigata registry (2003)
to assess the epidemiology and clinicopathological char-
acteristics. Finally, we compared the clinical presenta-
tion, management and prognosis of GB-NETs to that of
gallbladder adenocarcinoma.
Results: GB-NETs probably derive from either a multi-
potent stem cell or neuroendocrine cells in intestinal or
gastric metaplasia of the gallbladder epithelium, which
occurs consequently upon cholelithiasis/chronic inﬂam-
mation. Clinically and at surgery, GB-NETs are indis-
tinguishable from gallbladder cancer (GBC) and
‘‘carcinoid syndrome’’ is evident in only ~1%. The
median survival was only 9.8 months among 278 cases of
GB-NETs reported in SEER. The 5-year survival rate for
tumors classiﬁed as carcinoids/neuroendocrine carci-
noma or small cell cancer (SCC) was 36.9 and 0%,
respectively. Soga divided GB-NETs into typical and
variant carcinoids with 5 year survival rates of 60.4%
and 21.3%, respectively.
Conclusion: GB-NETs have an aggressive behavior, and
once diagnosed, extensive surgical management and
careful follow up with plasma chromogranin A levels and
somatostatin scintigraphy are mandatory to facilitate
early detection of recurrence. Since more aggressive sur-
gical management for GBC has shown increased survival
rates for these tumors, a similar strategy seems reason-
able for GB-NETs.
P-275
LONG-TERM RESULTS OF THE
SURGICAL TREATMENT OF
GALLBLADDER CANCER
H. Losada1,2,3, C. Mun˜oz1,2, L. Burgos San Juan1,2,3,
J. Silva1,2,3, J. Roa4 and J. Sarmiento5
1HPB surgery team, Hospital herna´n Henrı´quez Aravena,
Temuco; 2Surgery Department, Universidad de La
Frontera, Temuco; 3Surgery Department, Clı´nica Alemana
de Temuco; 4Pathology Department, Universidad de La
Frontera Temuco; 5Surgery Department, Emory
University
Introduction: Gallbladder cancer (GBC) in one of the
most frequent causes of mortality in Chile. The region of
Araucanı´a is one of the high risk areas for the GBC. Our
goal is to present the long term results in the treatment of
GBC with curative intent through extended cholecystec-
tomy (hepatic resection and lymphadenectomy).
Materials and methods: Study design: Cohort Study.
Study Period: January 2000–July 2009. Maneuver: Clin-
ical and imaging follow-up of patients with surgical
treatment and curative intent through extended chole-
cystectomy by GBC. During follow-up, operative mor-
bimortality and survival are registered. Statistical
analysis: The variables were grouped in qualitative and
quantitative. The results are presented in frequency,
central tendency and scatter measures. The variable
analysis is done in the statistical program STATA 9.0.
Results: During the study period, 25 patients were sur-
gically treated for GBC. The average age was
54.4 ± 8.5 years old. 84% were females. 95% of the
patients were surgically treated as a re-resection. Most
tumors corresponded to T2N0–1M0. Surgery was consid-
ered R0 (completed) in 70%. The 75% does not receive
co-adjuvant therapy. The operative morbidity is 30%,
and includes minor complications. There is no operative
mortality. The global survival is 50% in 55 months, and
greater for N0.patients.
Conclusion: Surgery for GBC treatment presents an
acceptable operative morbidity with a global survival
comparable to national and international numbers.
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ARE ALL INCIDENTAL GALL BLADDER
CANCER (IGBC) TRULY INCIDENTAL?
A. K. Agarwal, S Singh, R. P. S. Malhotra, S. Agarwal
and S. Mandal
GB Pant Hospital & MAM College, Delhi University
Background: Incidental gall bladder cancer (IGBC) is
deﬁned as Cancer detected for the ﬁrst time on histo-
pathological examination HPE) with no pre or per
operative (including inspection of the removed Gall
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bladder. However in the literature, IGBC term is applied
to all Cholecystectomy specimens diagnosed as Gall
bladder cancer (GBC).
Aim: A prospective study of IGBC patients to analyse
features suggestive of GBC on preoperative imaging and
preoperative details review.
Methods: The study was conducted prospectively on 69
patients of IGBC managed from 2005-2008. Review of
preoperative imaging/operative notes and other records
was done to ascertain any suspicion of malignancy in
retrospect.
Results: Of the 69 patients, USG reported a diffuse
thickening, not suspicious of malignancy in 5 patients
and suspicious thickening in 3 patients and highly likely
to be malignant in 1 patient. Focal thickening suspicious
of malignancy were present in 22 patients. Preop. CT/
MRI was called for in 10 patients for suspicion of
malignancy. In four patients, there were intraoperative
ﬁndings of very difﬁcult cholecystectomy and dense
inﬂammation/inﬂammatory adhesions, which in retro-
spect were mistaken as benign. Intraoperative ﬁndings
show focal thickening of GB in 8 patients and GB mass
in 16 patients. In the overall analysis in 31 patients pre-
operative imaging or intraoperative details would point
towards malignancy. In 38 patients (55.07%) patients
there was no evidence suggestive of malignancy and was
an unanticipated diagnosis.
Conclusion: Only 38 amongst 69 (55.07%) patients of
IGBC were found to be True IGBC i.e. had no preop-
erative or intraoperative suspicion of gall bladder cancer.
The remaining 31 (45%) patients include both Missed i.e.
those with preoperative imaging suggestive of GBC, but
ignored and Unsuspected/ unexpected i.e. those in whom
the intraoperative ﬁnding / gross GB examination was
ignored or misinterpreted.
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SURGERY FOR PATIENTS DIAGNOSED
AS UNRESECTABLE ADVANCED
GALLBLADDER CANCER AFTER
CHEMOTHERAPY WITH GEMCITABINE
T. Ajiki, I Yamada, K. Hirata, K. Ueno, I. Otsubo,
Y. Otowa, H. Morimoto, T. Okazaki, M. Kido,
I. Matsumoto, M. Shinzeki, H. Toyama, T. Fukumoto
and Y. Ku
Kobe University Graduate School of Medicine,
Department of Hepato-Biliary-Pancreatic Surgery
Background/Aim: Recently gemcitabine (GEM) was ap-
proved as the effective chemotherapeutic agent for gall-
bladder cancer. We present two patients who are
diagnosed as unresectable gallbladder cancer at the ﬁrst
examination and underwent surgery after chemotherapy
with GEM.
Methods: Case reports.
Results: Case 1: GEM was administered to a 69-year-old
man with gallbladder cancer with metastasis to liver S8.
Although GEM was effective for the liver metastasis, his
serum CEA level gradually increased after 12 cycles of
GEM administration. Because there was no distant
metastasis (other than manageable liver metastasis) on
detailed radiological examination, we performed chole-
cystectomy with resection of liver bed, lymph node dis-
section, and partial resection of the duodenum and T-
colon. The patient died of acute myocardial infarction
24 months after surgery without recurrence. Case 2: A
68-year-old woman with advanced gallbladder cancer
with invasion to right hepatic artery was admitted to our
hospital. Because remnant liver volume was too small
(34%), percutaneous transhepatic portal embolization
(PTPE) was planned, but it resulted in failure. Therefore,
chemotherapy with GEM and low dose CDDP + 5-FU
was performed. Three months later, the tumor was dis-
tinctly shrinking and we could perform cholecystectomy
with liver bed resection, bile duct resection, hepaticojej-
unostomy and re-construction of right hepatic artery.
Following surgery, we continued chemotherapy with
GEM + low dose FP, GEM or S-1, and the patient is
still alive 17 months after surgery.
Discussion: In selected patients, chemotherapy with
GEM may be effective against gallbladder cancer with
metastasis or invasion to other organs, and following
surgical procedure could be achieved with good results.
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LAPAROSCOPIC CHOLECYSTECTOMY
FOR EARLY GALLBLADDER
CARCINOMA AND INCIDENTAL
FINDING OF GALLBLADDER
CARCINOMA
Y. Naohiro, S. Yoshiaki, H. Akinori, A. Hideaki,
S. Yuri, O. Manabu, H. Kouji, T. Tetu and T. Yuichi
Nakadori General Hospital Gastroenterological Surgery
Introduction: With the increase of cholecystectomies due
to the wide acceptance of laparoscopic cholecystectomy,
polypoid lesion even if the early gallbladder carcinoma
were applied to laparoscopic cholecystectomy and the
incidental diagnosis of gallbladder carcinoma with chol-
ecystolithiasis is more frequent. Gallbladder carcinoma
has been reported in 0.3–1.5% of cholecystecties. In this
paper, to evaluate the laparoscopic cholecystectomy for
early and incidental gallbladder carcinoma.
Material and methods: Eight (2.1%) cases with gall-
bladder carcinoma were found among 371 patients who
underwent laparoscopic cholecystectomy from January
2006 to September 2009 in our hospital. Five cases of
eight that had amalgamated the gall bladder cancer were
discovered after the gallstone was removed and three
remainder cases admitted cancer after the operation for
the gallbladder polyps even if there was cancer cells, its
invasion was within mucous membrane. Three cases in
ten cases were early gallbladder carcinoma, and the
others ﬁve were advanced, the cancer invade for the tu-
nica serosa. Additional excision was enforced to two
cases of ﬁve advanced gallbladder carcinoma as the
lymph node dissection and partial hepatic resection. All
cases were not relapsed for 12 to 46 months.
Conclusions: Gallbladder cancer runs a short course,
with a poor prognosis. But for the early gallbladder
carcinoma, the use of a meticulous laparoscopic tech-
nique seems to be acceptable. In our cases, early gall-
bladder carcinoma was applied for laparoscopic
cholecystectomy, and even for advanced carcinoma,
suitable additional treatment was performed, ﬁrst lapa-
roscopic treatment did not effect for the prognosis.
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A CASE OF CHYLURIA, A RARE
COMPLICATION AFTER SURGERY FOR
CANCER OF THE GALLBLADDER
R. Higuchi, T. Ota, T. Araida, M. Hamano,
N. Takeshita, H. Kajiyama, T. Yazawa, Y. Yagawa and
M. Yamamoto
Department of Surgery, Institute of Gastroenterology,
Tokyo Women’s Medical University
A 58-year-old woman underwent right lobectomy with
resection and reconstruction of the bile duct and portal
vein after percutaneous transhepatic portal vein emboli-
zation for gallbladder cancer with inﬁltration to the right
hepatic artery, portal vein and bile duct. She was
discharged on postoperative day (POD) 26 without
major complications, but was readmitted for dehydra-
tion, electrolyte imbalance and chyluria on POD 50. The
patient was discharged once again after symptomatic
therapy, but was readmitted for shortness of breath and
appetite loss. Split renal function study showed normal
left kidney function but protein 2+/glucose 2+ in the
right pelvic urine, and cystoscopy revealed milky urine
ﬂowing from the right ureteral oriﬁce. Filarial antibodies
were negative. Based on a diagnosis of chyluria occurring
from lymphorrhea at the level of the right pelvis
associated with of surgery for gallbladder cancer, she
underwent unilateral stripping of the right renal pedicle.
Postoperatively, hyponatremia, proteinuria and cloudy
urine became normal, and ascites and edema improved.
To the best of our knowledge, reports on chyluria after
biliary and abdominal surgery in the literature are very
rare, and we therefore report this case.
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COMPARISON BETWEEN
INTRAOPERATIVE FINDINGS AND
BIOPSY RESULTS WITH CT SCANS IN
PATIENTS REOPERATED FOR
GALLBLADDER CANCER
I. Turu, X. De Aretxabala, J. Leon, N. Solano, I. Roa
and J. Hepp
Clinica Alemana, Santiago, Chile
Introduction: Gallbladder cancer (GC) is an important
problem in Chile. Radical surgical resection is a potential
curative treatment for this disease. As part of preopera-
tive staging an abdomen CT scan (ACTS) prior to this
second surgery.
Objective: Compare information obtained in ACTS with
intra-operative ﬁndings and biopsy results of patients
undergoing a second surgery for GC.
Method and material: A case series was obtained from
our data based containing all patients treated for GC
between January 2006 and March 2009. Patients treated
with a second radical tumor resection were selected.
Demographic data, depth in gallbladder wall compro-
mise with tumor, surgery ﬁndings, biopsy information
and ACTS ﬁndings were reviewed.
Results: Twenty-seven patients underwent a radical tu-
mor resection GC. 22 women, 5 men, average age
57.7 years old. Gallbladder wall compromise was: 3
muscle layer, 18 sub-serosa, 4 compromise the serosa, 1
fat tissue involvement and 1 unclassiﬁed. 18 patients did
not present dissemination, and radical tumor resection
surgery was done: 4 had lymph node metastasis and 2
had neighbour hepatic compromise. 8 patients had dis-
semination signs as intraoperative ﬁndings: 5 peritoneal
dissemination, 2 biliary duct compromise, 1 hepatic
metastasis. None of them underwent tumoral resection.
ACTS information in patients undergoing radical sur-
gery: 2 of 18 had images compatible with tumoral dis-
semination, one to lymphatic system and one peritoneal.
Of the patients with dissemination demonstrated during
surgery, only 1 patient was informed as highly possible
dissemination and 2 with unspeciﬁc ﬁndings compatible
with tumor metastasis in their ACTS.
Discussion: We believe that a patient with GC the ACTS
not demonstrating massive tumor dissemination deserves
de opportunity for a second surgical exploration. Further
investigation in this area is required to obtain more
conclusive data.
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GALLBLADDER CANCER (GC) AND
RADICAL CHOLECYSTECTOMY (RC)
A. A. Al-Sarira, G. Sarno, B. A. Al-Sarireh, H. M. Joshi,
P. Ghaneh, S. W. Fenwick, H. Z. Malik, A. Wu and
G. J. Poston
University Hospital Aintree Liverpool
Introduction: The outcome for GC may be improved
with radical surgery (RS). Conversely incidental ﬁnding
of GC (ICG) after laparoscopic cholecystectomy (LC) is
associated with a poor prognosis if R0 resection is not
achieved. We have adopted a modiﬁed RC where imag-
ing suspicious for GC.
Methods: Between 2002 and 2009, patients referred with
imaging suspicious for GC, or IGC were identiﬁed.
Outcomes assessed for two groups (GC after primary RC
(PRC), IGC).
Results: RC performed in 49 (33F:16M) on intention to
treat, median age 62 years. Six were carcinomas (12.3%),
TNM stages: TisN0M0, T2N0M0, T3N0M0, T3N1M0,
and two T4N2M0. Morbidity after RC 20.4%. Median
length of hospital stays 6 (IQR 4–11) days. 11 (8F:3M)
with IGC diagnosed, median age 70 years. 6 (54.5%)
performed laparoscopically, 3 converted. 5 had GB per-
foration during LC, 3 of whom had early stage so
denying potential cure. 1 had metastases on further
imaging. 4 offered further RS, of which 2 had early stage.
Only 1 patient had a potentially curative LC.
Overall median survival (MS) for the 17 with GC was 9
(IQR 6–26) months. MS was 14 (IQR 8–51) months in
the PRC versus 9 (IQR 3–10) months in the ICG
(P = 0.2). The MS for the 9 patients (3 ICG and 6
PRC) who had RS was 12 (IQR 8-38) months compared
to 8 (IQR 2-10) months in those who had no RS for ICG
(P = 0.091).
Conclusion: Despite small number of patients there is a
trend toward survival beneﬁt from RS in either ICG or
PRC. Morbidity associated with RC is acceptable.
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EFFICACY OF CHEMOTHERAPY IN
GALLBLADDER CANCER ACCORDING
TO LOCAL PROGRESSION
M. Iwamoto, Y. Inoue, K. Komeda, T. Shimizu,
M. Asakuma, F. Hirokawa, Y. Miyamoto, M. Hayashi
and N. Tanigawa
Osaka Medical College
Purpose: Gallbladder cancer is often rapidly progressive,
with poor prognosis due to postoperative recurrence and/
or metastases for which certain consensus of chemo-
therapy has not obtained yet. In this report, we will
present a study of the efﬁcacy of chemotherapy in gall-
bladder cancer based on local progression.
Subjects and methods: The subjects comprised 57 patients
with gallbladder cancer who underwent radical operation
at our department from 1985 to 2008, and were divided
into 3 groups according to the local progression, into
pT1, pT2, pT3 or 4.
Results: There were 13 subjects in pT1, 33 in pT2, and
11 in pT3 or 4. Chemotherapy was administered to 2
subjects in pT1, 25 in pT2, and 8 in pT3,4, using regi-
men of 5FU in 6, FP in 5, MMC+tegafur in 5, UFT in
5, S-1 in 2, FAM in2, FP+UFT in 1, CP in 1 cases
respectively. There were no cases of recurrence in pT1.
There were 5 cases of recurrence in pT2; none of whom
had undergone chemotherapy. Overall survival rate of
chemotherapy performing group (100%) was signiﬁ-
cantly higher than that of non-performing group
(61.5%). There were only 2 subjects of survival more
than 5 years in pT3 or 4, chemotherapy had been per-
formed for both cases.
Conclusion: Chemotherapy is not required for patients
with gallbladder cancer in pT1. It is needed in pT2, and
may contribute to the improved results for selected pa-
tients in pT 3 or 4; however, the development of more
effective ancillary therapy is needed.
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CARCINOMA OF THE GALLBLADDER:
20 YEARS EXPERIENCE
L. Smithson, C. Keto, L. Ferguson, S. Sumet, M. Jacobs,
R. Kolachalam and V. Mittal
Providence Hospital and Medical Centers, Southﬁeld, MI,
USA
Background: Gallbladder cancer (GBC) is a rare disease
of the hepatobiliary tract characterized by silent presen-
tation, poor prognosis, and limited therapy. In the USA
this year, the estimated new cases are 9760 and deaths
3370. Current imaging modalities, clinical symptoms and
laboratory values are of limited value. Long-term sur-
vival is 5–12%, or < 1 year. Early identiﬁcation and
extended cholecystectomy improve survival; adjuvant
therapy does not.
Objective: To evaluate GBC cases over 20 years for
presentation, imaging, intra- and post-operative identiﬁ-
cation, planned treatment and survival.
Methods: Patients who presented with GBC were retro-
spectively reviewed 1989–2009. Demographics, clinical
presentation and laboratory values were analyzed. Prev-
alence of pre-, intra- or post-operative diagnoses was
compared. Survival rates were assessed via tumor registry
data.
Results: Fifty-four patients with gallbladder cancer were
analyzed. Forty-three had primary GBC. Of these, 32
(74%) were female; 11 (26%) were male. Average age was
68 years. The most common presenting symptoms were
right upper quadrant pain (30%) and nausea (28%).
Nineteen (44%) presented with acute cholecystitis; only 5
were suspicious for a mass. Ultrasound (58%) and
computed tomography (54%) were most often used.
Preoperative diagnoses was made in only 6 (14%) cases
whereas 18 (42%) cases each were diagnosed intra- and
post-operatively. Adjuvant chemotherapy was offered in
10 (23.3%) cases. Average survival was 21 months
(Range 1–36 months).
Conclusion: Our results mirror what has been reported in
the literature. Most patients presented with acute chole-
cystitis, but a few were preoperatively diagnosed with a
gallbladder mass. US and CT scans confer images but are
not deﬁnitive. The use of imaging must be improved for
better treatment and oncologic outcomes. High preop-
erative suspicion, including tumor markers and presen-
tation, could permit curative cholecystectomies.
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RENAL CELL CARCINOMA
METASTATIC TO GALLBLADDER:
A CASE REPORT
H.-H. Kim, E.-K. Park, J.-S. Seoung, Y.-H. Hur,
Y.-S. Koh, J.-C. Kim, C.-K. Cho and H.-J. Kim
Department of Surgery, Chonnam National University
Medical School
Introduction: Renal cell carcinoma is well known to
metastasize to distant organs such as the lung, lymph
nodes, bone, liver, and adrenal glands. However, gall-
bladder involvement in patients with renal cell carcinoma
is extremely rare, being present in less than 0.6% of
autopsies. We herein present a report of a 66-year-old
man with renal cell carcinoma metastasis to the gall-
bladder presenting as an intraluminal poypoid mass.
Case: A 66-year-old man was referred to our hospital
with right upper quadrant abdominal discomfort. He
underwent radical left nephrectomy due to left renal cell
carcinoma ﬁve years ago. And he underwent mass exci-
sion with primary repair on metastatic renal cell carci-
noma to left cheek and left buttock four years ago.
Abdominal ultrasonography revealed 1.3 cm and 0.6 cm
polypoid lesions in the gallbladder. Under the diagnosis
of gallbladder polyps, the patient underwent a laparo-
scopic cholecystectomy. By the way, postoperative
pathologic ﬁndings of gallbladder polyps showed clear
cell adenocarcinoma conﬁned to mucosa. Enhanced
cholangiogram magnetic resonance imaging (MRI) re-
vealed no metastatic lesion in the liver and enlarged
lymph node in the abdominal cavity. He underwent
completion cholecystectomy again. The pathologic ﬁnd-
ings showed no remnant malignant cells in the bile duct
and pericholecystic lymph nodes. The patient was dis-
charged on the 9th postoperative day in stable condition.
The follow-up enhanced abdominal computed tomogra-
phy (CT) scans revealed 1.4 cm and 0.7 cm nodular
enhancing mass lesion in pelvic cavity. And PET scan
demonstrated metastatic hypermetabolic lesions in the
left retropancreatic, peri-renal area, and pelvic cavity. He
had received 6 times of chemotheraphy (Sutene? (suniti-
nib) 25 mg Q). He has been followed semiannually in the
Department of Urology with routine imaging and labo-
ratory studies.
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APPEARANCE OF NEW INTRAHEPATIC
FLUID FILLED CYSTIC LESIONS IN AN
ADVANCED CASE OF CARCINOMA
GALLBLADDER POST
CHEMOTHERAPY – AN UNCOMMON
PRESENTATION
D. Balsarkar1, J. Chemburkar2, K. Sharma1,
D. Adhikari1, V. Chemburkar2 and S. Jhakere2
1Department of General Surgery, B.Y.L.Nair Hospital &
T. N. Medical College, Mumbai Central, Mumbai, India;
2Department of Radiology, B. Y. L. Nair Hospital &
T. N. Medical College, Mumbai Central, Mumbai, India
Introduction: New ﬂuid ﬁlled cystic lesions developing in
liver post-chemotherapy in a diagnosed case of carci-
noma gall bladder with liver metastases is uncommon.
Cystic degeneration in a solid metastases, intrahepatic
biloma and abscess are the possible differential diagnosis.
We report one such patient of advanced carcinoma gall
bladder with liver metastases developing cystic liver le-
sion post 3 cycles of chemotherapy with Oxaliplatin and
Gemcitabine.
Case report: A 35-year-old female diagnosed case of
carcinoma gall bladder with multiple liver metastases
received 3 cycles of Oxaliplatin and Gemcitabine based
chemotherapy. Two-month post therapy patient pre-
sented with pain in right hypochondrium. Liver function
tests were within normal limit. USG, CT scan and
MRCP showed the development of one large new cystic
lesion with ﬂuid level and 2 small cystic lesions in the liver
along with increase in previous Gallbladder mass and
multiple solid metastases. A liver scan and a FNAC
study of the lesion were also performed.
Discussion: Cystic degeneration of the previously non-
visible liver metastases post chemotherapy is the possible
postulated hypothesis for appearance of the new cystic
lesion in the liver.
Conclusion: Cystic liver metastases are seen mostly from
primary cystic ovarian and intestinal malignancy. Post
chemotherapy cystic degeneration in solid liver metasta-
ses from carcinoma gallbladder is a possibility and
should be kept in mind.
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HEPATOID ADENOCARCINOMA OF
THE GALLBLADDER WITH
PRODUCTION OF ALPHA-
FETOPROTEIN
K. G. Lee, J. H. Lee, H. K. Park and K. S. Lee
College of Medicine, Hanyang University, Seoul, Korea
Background: Hepatoid adenocarcinoma is deﬁned as a
tumor with aberrant hepatocellular differentiation
occurring in extrahepatic organs, most commonly in the
stomach. Hepatoid adenocarcinoma of the gallbladder is
rare, and alpha-fetoprotein production case is extremely
rare.
Aim: To identify for difﬁcult diagnosis and poor prog-
nosis, we described clinical course of several operation
and pathologic features.
Method: Gallbladder hepatoid adenocarcinoma with al-
pha-fetoprotein production was seen in a 61-year-old
male. Radiologic, pathologic, and immunohistochemical
characteristics, and clinical course of the tumor are re-
viewed, and the relevant literatures are also reviewed.
Results: The patient was diagnosed with adenocarci-
noma of the gallbladder after laparoscopic cholecystec-
tomy and referred to our hospital. A radical operation
including resection of liver bed and lymph node dissec-
tion was performed, and no tumor cell was found.
However, on postoperative 19 months, he showed
lymphadenopathy of portocaval area and tumor thrombi
of the right portal vein with a high level of serum alpha-
fetoprotein. Right hemihepatectomy and porta hepatis
lymph node dissection was performd, and he was diag-
nosed with metastatic hepatoid adenocarcinoma. On
reviewing the gallbladder specimen with an immunohis-
tochemical study, the tumor demonstrated hepatoid
adenocarcinoma of the gallbladder as the primary origin.
He died 26 months after cholecystectomy due to multiple
metastasis.
Conclusions: For diagnosis of hepatoid adenocarcinoma
of the gallbladder, tumor location, radiologic features
and high alpha-fetoprotein, synthetically, are important
clues. Although hepatoid adenocarcinoma of the gall-
bladder is a very rare malignancy, awareness of its exis-
tence is critical to avoid misdiagnosis.
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SQUAMOUS CELL CARCINOMA OF
GALLBLADDER AFTER LAPAROSCOPIC
CHOLECYSTECTOMY
S. H. Park and S. J. Yang
National Medical Center
Although carcinoma of the gallbladder is rare tumor,
Gallbladder carcinoma is the most common primary
hepatobiliary carcinoma and the ﬁfth most common
malignancy of the gastroinstestinal tract. The tumor has
been reported in almost all age groups but is most often
found in ptients in their seventh and eighth decades.The
most common type of gallbladder carcinoma is adeno-
carcinoma. However, suqamous cell carcinoma is rare
and responsible for up to 12.7% of the gallbladder
tumors.
A 78-year-old man was incidentally suspected of having
gallbladder mass on the abdominal CT scan by routine
check -up and underwent laparoscopic cholecystectomy,
which revealed squamous cell carcinoma by a pathologic
report. We report one case of keratinizing squamous cell
carcinoma of the gallbladder with the review of litera-
tures.
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ISOLATED GALLBLADDER
METASTASIS OF CUTANEOUS
MELANOMA
T. Artis, B. Oz, H. Akyildiz, F. Mutlu and Z. Yilmaz
Erciyes University Medical School Department of General
Surgery
Isolated gallbladder metastasis of cutaneous melanoma is
rare. We report a case of metastatic melanoma of the
gallbladder. A 57–year-old man was referred to our
department with a diagnosis of a mass in the gallbladder.
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He was clinically asymptomatic. He had previously no
abdominal pain, weight loss, nausea, vomiting and rectal
bleeding. On examination, there was a painless mass with
palpation of the right upper quadrant. Laboratory tests
were within normal limits including tumor markers. An
abdominal US revealed a solid mass within the gallblad-
der measuring 13·10 cm. Abdominal CT revealed an
irregular lesion in the localization of gallbladder mea-
suring 15·10 cm, were no pathology in other abdominal
organs. Initially a laparoscopy was decided with the
diagnosis of gallbladder mass. A hydropic and solid
gallbladder was detected and converted to open surgery.
Gallbladder was diffuse hard, hydropic and ﬁlled with
tumor 20 cm in size. Intraoperative US showed no
presence of hepatic invasion. Cholecystectomy was per-
formed. Examination of the surgical specimen showed an
ulcerated black mass in the gallbladder and lumen was
ﬁlled with black sludge and necrotic material. Frozen
section of the gallbladder material revealed as metastasis
of malignant melanoma in the gallbladder Final patho-
logic was malignant melanoma of the gallbladder con-
ﬁned in the mucosa and no serosal invasion. When
patient was reexamined no other suspicious lesion for
malignant melanoma was detected. However patient
eventually recognized that, four years ago, he had a
history of a surgical removal of 1 cm lesion from his
scalp tissue which was diagnosed as malignant mela-
noma. But he neglected the further follow up. Patient was
discharged at postoperative day 5. He received chemo-
therapy and doing well 10 months after surgery. Altough
its rarity malignant melanoma metastasis of gallbladder
should be kept in mind in the differential diagnosis of
gallbladder masses.
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INTERRUPTED MICROSURGICAL
BILIARY RECONSTRUCTION:
EXPERIENCE IN 30 CONSECUTIVE
CASES
H. E. Soliman and T. Ibrahim
Departement of HBP surgerym National Liver Institute
Menouﬁa University
Background: Living donor liver transplantation is a good
alternative in areas without cadaveric transplants. Biliary
are common upto 40–50% of donors. The incidences of
biliary complications are high especially in living donor
and segmental transplantation.
Aim: We present our technique of biliary reconstruction
of living donor transplants using interrupted microsur-
gical technique.
Patients and methods: We had performed 30 consequa-
tive living donor liver transplantation in the department
of Surgery, National Liver institute, Menouﬁa University
starting from May 2007 to the end of December August
2009. They were 26 adult and 4 pediatric patients. We
used a magniﬁcation of 5.5· loupe with interrupted 6/0
prolene or PDS for the anastomosis. We reviewed graft
characteristics, operative data, postoperative details
including hospital stay, the in-hospital complications and
early follow up.
Results: Twenty-six duct to duct reconstructions and 4
hepaticojejunostomy were done. The mean anastomotic
time was 30 min for each duct. Early bile leak occurred in
4 cases. All were were in right lobe graft, 4 all resolved
with conservative treatement. Late strictures developed
in 5 cases all were successfully dilated by ERCP followed
by stenting. We used vein grafts in 14 out of 34 patients.
Conclusions: Microsurgical interrupted biliary recon-
struction dramatically minimized the incidence of biliary
complications in our center.
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DOUBLE DUCT DILATATION- WHAT
DOES IT MEAN IN THE ABSENCE OF A
PERIAMPULLARY MASS? A REVIEW
OF 737 PATIENTS
P. T. Cherian, H. Dent, P. Sreenivasan, A. Prachalias,
N. D. Heaton and M. Rela
Kings College Hospital, London
Aim: Simultaneous dilation of the pancreatic and biliary
duct or a ‘double duct sign (DDS)’ is often considered
pathogonomic for periampullary malignancy. The ab-
sence of a mass on imaging in these circumstances is
uncommon. To guide future practice, we studied a cohort
of such cases.
Methods: We searched hospital histology, radiology &
MDT records and pancreatic resection databases to
identify all such patients. Data on presentation, man-
agement and ﬁnal outcomes including national registry
data were collated and analysed.
Results: Of 737 patients referred from 2005–2008 with a
suspected hepatobiliary cancer, 82 fulﬁlled above inclu-
sion criteria [median age 64 years; Range 20–85; 35 fe-
male]. At resection, biopsy or last follow up (median f/up
11 months), 32 (40%) were benign and 50 malignant. Of
those ultimately malignant 87% were jaundiced at pre-
sentation, compared to 15% (5 of 32) of benign patients
(in whom pain or weight loss were predominant symp-
toms). Of 17 suspected to have chronic pancreatitis ini-
tially, the ﬁnal diagnosis was malignancy in 7 (41%)
excluding 1 patient with ampullary hyperplasia. Neither
MRCP nor ERCP proved reliable in this difﬁcult cohort
and only 30 of 43 EUSs done (69%) were accurate, with 8
(18%) false negatives. Despite being targeted, 44% of
pre-operative biopsies were un-representative in our
study. Eight (17%) of 48 operated patients (37 pancreatic
resections, 10 bypasses, 1 SB resection) had benign
specimens. In comparison, of 34 not operated on, 8 were
malignant (none survive), and 2 await further scans.
Conclusions: Upto 60% patients who have DDS without
an associated mass on imaging had malignant disease in
our patients. The proportion of malignancy increased to
87% if it is associated with obstructive jaundice. Amongst
those with concomitant DDS and evidence of chronic
pancreatitis, malignancy was found in 40%. Negative pre-
operative biopsies need interpretation with care.
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DIAGNOSTIC AND THERAPEUTIC
DILEMMAS IN DECIDING WHETHER
PERIAMPULLARY LESIONS ARE
MALIGNANT OR BENIGN
Y. M. Shyr, S. E. Wang and P. J. Tsai
Taipei Veterans General Hospital
Background: Periampullary lesions without histologic
proof often present diagnostic and therapeutic dilemmas
in terms of surgical risks and false positive rate with
resection and false negative rate without resection.
Abstracts246
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Objective: To clarify the justiﬁcation of pancreatico-
duodenectomy for the resectable periampullary lesion
without histological conﬁrmation of malignancy.
Methods: Clinical data for periampullary lesions with
presumed malignancy were retrieved from our prospec-
tively-collected computer database. The surgical risks
and test performance characteristics (sensitivity etc) in
diagnosis were determined. Clinical factors were com-
pared to discriminate between benign and malignant le-
sions,
Results: There were 636 patients undergoing pancreati-
coduodenectomy, including 572 patients (89.9% positive
predictive value) with malignancy and 64 patients (10.1%
false positive rate) with benign lesions. No resection was
attempted for 32 periampullary lesions, but 8 (25% false
negative rate) eventually turned out to be malignant. Our
data showed a sensitivity of 98.6% (572/580), a speciﬁcity
of 27.3% (24/88) and an accuracy of 89.2% (596/668) in
detecting periampullary malignancies. The surgical risks
after pancreaticoduodenectomy were signiﬁcantly lower
in the benign group, with 28.1% morbidity (vs. 43.7% in
the malignant group), no pancreatic leakage (vs. 11.5%
in malignant group), and no surgical mortality (vs. 7.3%
in the malignant group). No clinical parameters could be
identiﬁed to discriminate between benign and malignant
periampullary lesions.
Conclusions: Pancreaticoduodenectomy is justiﬁed for a
periampullary lesion without histological conﬁrmation
whenever malignancy is suspected. Moreover, a nihilistic
approach could be associated with a signiﬁcant false
negative rate (25%) if left unresected and might preclude
a patient with periampullary malignancy from cure.
P-292
SAFETY OF EARLY PRECUT
PAPILLOTOMY AND BALLOON
SPHINCTEROPLASTY
P. Kumar, N. Mohan and A. Ramesh
Meenakshi Mission Hospital & Research Center, Madurai
Aim: To analyze our experience with precut papillotomy
and balloon sphincteroplasty during ERCP for extrac-
tion of CBD stones.
Methods: From 1 January 2005 to February 2008, 254
patients presenting with clinical, biochemical and radio-
logical features suggestive of CBD stones were included
in the study & underwent ERCP for stone extraction.
Results: Of 254 patients with mean age of 45 years,
cannulation was successful in 96.8% (246 patients). Pre-
cut papillotomy was done in 59% (150 patients) and free
CBD access was obtained in 37.8% (96 patients).
Sphincterotomy was done in 82.1% (202 patients) of
successful CBD access. Balloon sphincter dilatation post
biliary sphincterotomy was done in 41.8% (103
patients).Balloon sphincter dilatation done without
sphincterotomy in 7% (18). ERCP was normal in 8%
(19), Stone clearance was successful in 85.8% (158/185).
Rest underwent surgery. Post ERCP Nasobiliary tube
was placed in 59.4%
(151) cases, residual stones found on NBD cholangio-
gram in 6.6% (17) Complications occurred in 5.1%
including mild pancreatitis 4, bleeding in 3 cases with 1
requiring transfusion, duodenal perforation 4 cases,
acute coronary event in 1 and sub acute intestinal
obstruction in 1 case. Mortality rate was about 1.96%
(5 patients).
Conclusions: Our results suggest that early precut pap-
illotomy for CBD access and balloon sphincter dilatation
following biliary sphincterotomy are safe and reliable
procedures with low complication rates in CBD clearance
of stones. Naso biliary tube placement helps in con-
ﬁrming successful clearance of stones.
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TWO-DIMENSIONAL
ELECTROPHORESIS FOR
COMPARATIVE PROTEOMIC ANALYSIS
OF HUMAN BILE
B. Chen and S. Zou
Department of General Surgery, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan 430030, China
Background: Proteomic analysis of bile ﬂuid holds
promise as a method to identify biomarkers of bile tract
diseases, especially for tumors. Two-dimensional elec-
trophoresis (2-DE) is a popular and proven separation
technique for proteome analysis, but using this strategy
for bile ﬂuid analysis is still not fully developed.
Objective: This study was undertaken to (a) establish a
reliable method for general clean-up to make bile ﬂuid
samples suitable for 2-DE; (b) obtain 2-D biliary maps
with high reproducibility and resolution; and (c) identify
protein patterns present in 2-D biliary maps for potential
tumor biomarker discovery, with the intention of dis-
tinguishing malignant from benign causes of bile duct
obstruction.
Methods: Bile ﬂuid samples were obtained from two
patients suffering from malignant and benign bile tract
obstruction (one with cholangiocarcinoma as the exper-
imental case, the other with cholelithiasis as control). A
variety of sample preparation options, including delipi-
dation, desalination and nucleic acid removal, were
adopted to remove contaminants that affect 2-DE results.
After that, each 350 microg puriﬁed sample was loaded
onto nonlinear IPG strips (18 cm, pH 3–10 and pH 4–7)
for ﬁrst-dimension isoelectric focusing, and 12.5% SDS-
PAGE electrophoresis for second dimension separation.
Then 2-D maps were visualized after silver staining and
analyzed with the Image Master 2-D software.
Results: A large number of protein spots were separated
in 2-D maps from the experimental and control groups,
with means of 250 and 216 spots on pH 3–10 IPG strips,
and 182 and 176 spots on pH 4–7 strips, respectively.
Approximately 16 and 23 spots were differentially ex-
pressed in matched pairs from the experimental and
control cases using pH 3–10 and pH 4–7 strips.
Conclusions: This study established a reliable sample
preparation process suitable for 2-DE of bile ﬂuid. By
this method, 2-D biliary maps with high reproducibility
and resolution were obtained.
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A REVIEW OF ENDOSCOPIC
RETROGRADE CHOLANGIO-
PANCREATIOGRAPHY (ERCP) AT
UKMMC, MALAYSIA
H. Othman, A.-L. Khaliffa and R. Jarmin
UKM Medical Center, Kuala Lumpur, Malaysia
Background: We conducted a retrospective study on
patients undergoing ERCP at UKMMC from January
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2005 until June 2009. A total of 1020 procedures were
performed on 704 patients during this period. Data on
patient’s demography, indication for ERCP, and inci-
dence of complications were analyzed. The success rate
for ampulary cannulation and bile duct stones extraction
were also computed.
Methods: Data were obtained from ERCP records and
patients’ charts. All cases were performed by surgeons
who are experienced with ERCP.
Results: A total of 1020 ERCP procedures were per-
formed on 704 patients. 351 patients had more than 1
ERCP procedures done (mean = 1.54; range = 7).
Choledocholithiasis was encountered in 446 (43.7%)
cases, periampulary & head of pancreas tumour (6.7%),
Klatskin and cholangiocarcinoma (4%) and choledochal
cyst (0.8%). Ampulary cannulation was successful in
91.3% (n = 931). 351 sphincterotomies were performed
(34.4%), 194 biliary stents were inserted (19%). Other
procedures performed include mechanical lithotripsy
(1.7%) and brush cytology (1.6%). The incidence of post
ERCP pancreatitis was reported in 28.8% (n = 203) of
patients but all resolved spontaneously with conservative
management. No instance of bile duct injury was re-
ported. The incidence of periampulary bleeding was
encountered in 5.2% (n = 53) of cases and all were se-
cured during the endoscopy. 1 patient (0.1%) developed
duodenal perforation and succumbed to mortality due to
sepsis.
Conclusion: ERCP is a relatively safe procedure in the
hands of surgeons specialized in Hepatobiliary. None-
theless, the low complication rates of pancreatitis, peri-
ampulary bleeding and duodenal perforation do occurs
despite the high standards of care.
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COMPARATIVE ANALYSIS OF SERUM
PROTEOMES TO DISCOVER
BIOMARKERS FOR CHOLANGIO-
CARCINOMA
S. Chen1 and S. Zou2
1Department of Gastrointestinal Surgery, The Afﬁliated
First Hospital, Fujian Medical University, Fuzhou 350005,
China; 2Department of General Surgery, Tongji Hospital,
Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430030, China
Background: At the present time, the early detection of
cholangiocarcinoma is still very difﬁcult. Most cholan-
giocarcinoma patients have poor prognosis. Therefore a
suitable serologic biomarker of cholangiocarcinoma is
urgently needed. The proteomic technic may be feasible
direction to ﬁnd the biomarkers related with cholangio-
carcinoma.
Objective: The purpose of this study was to screen and
identify novel serologic biomarkers using 2-dimensional
gel electrophoresis for diagnosing cholangiocarcinoma
early.
Methods: We collected serum from 10 cholangiocarci-
noma patients and cholangiolithiasis patients undergoing
surgery. A proteomics method based on 2-dimensional
gel electrophoresis was used to analyze these serums and
identify potential cholangiocarcinoma biomarkers. The
differential expressions proteins were chose by image
master 2D platinum analysis software and were identiﬁed
through matrix-assisted laser desorption/ionization-time
of ﬂight mass spectrometry.
Results: Twenty-ﬁve spots were differentially expressed
and 20 spots were successfully identiﬁed by mass spec-
trometry. Transferring, chain A of human serum
transferrin, PRO2619, PRO1400, PRO2675, human
serum albumin mutant R218p complexed with thyrox-
ine, similar to human albumin and hypothetical protein,
were down-regulated in cholangiocarcinoma serum,
whereas ﬁbrin beta, ﬁbrinogen gamma, ﬁbrinogen
gamma chain (partial, 212AA), Alpha-1-Antitrypsin,
chain A of human complement component C3, chain A
of T-To-Thigh quaternary transitions in human hemo-
globin and unnamed protein product, were up-regu-
lated.
Conclusions: Novel proteins associated with cholangio-
carcinoma probably included ﬁbrin beta, ﬁbrinogen
gamma, ﬁbrinogen gamma chain (partial, 212AA), Al-
pha-1-Antitrypsin, chain A of human complement com-
ponent C3, transferring, chain A of human serum
transferring and PRO2619. Assessment of cholangiocar-
cinoma may be performed with a combination of these
novel tumor biomarkers.
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SPONTANEOUS PERFORATIONS OF
THE EXTRAHEPATIC BILIARY TRACT
J. Damodaran, V. Velayutham, G. Rajarathinam,
G. P. Santhanam, S. Eswaran, S. Jothiprakasam,
J. Sathyanesan, R. Palaniappan and S. Rajagopal
Department of surgical gastroenterology, Government
Stanley medical college & hospital
Background: Spontaneous perforations of the biliary
tract especially of the bile duct are rare entities with few
cases being reported. In adults most cases reported are
associated with bile duct stones.
Materials and methods: Between Jan 2004 to June 2009, 5
patients with spontaneous perforation of the biliary tract
were managed. 4 out of the 5 patients had perforation of
the common bile duct. One patient presented with per-
foration of the gall bladder.
Results: Three patients had associated chronic pancrea-
titis and one patient had associated choledocholithiasis. 3
of the 4 patients with bile duct perforation presented with
peritonitis, one developed peritonitis during his admis-
sion. All patients with bile duct perforations were man-
aged at laparotomy with T tube drainage. One patient
died in the immediate post operative period. One patient
developed mid CBD stricture post operatively. The pa-
tient with gall bladder perforation was diagnosed 45 days
after onset of symptoms when an ERCP done showed
contrast leak from body of the gall bladder. He under-
went cholecystectomy successfully.
Conclusion: Perforations of the biliary tract is a fre-
quently mis- diagnosed entity leading to high morbidity
and mortality. High index of suspicion and early surgery
results in better outcomes. Common bile duct perfora-
tions although rare, should always be considered as one
of the differential diagnosis in a known case of chronic
pancreatitis presenting with acute abdomen.
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COAGULATION AND FIBRINOLYSIS IN
CHOLESTATIC PATIENTS AND THE
EFFECT OF PREOPERATIVE BILIARY
DRAINAGE
J. Kloek, M. Heger, N. Van Der Gaag, U. Beuers,
T. Van Gulik, D. Gouma and M. Levi
Academic Medical Center, Amsterdam
Background: Cholestasis due to an obstructive biliary
malignancy is associated with postoperative complica-
tions related to a pro-inﬂammatory state, an impaired
hepatic synthesis function, and a potential derangement
of hemostasis. Hence, preoperative biliary drainage
(PBD) is advocated for cholestatic patients undergoing
major surgery.
Aim: To evaluate the function of coagulation and ﬁbri-
nolysis in cholestatic patients before and after PBD.
Methods: Plasma coagulation and ﬁbrinolytic parame-
ters were assessed in 24 cholestatic patients and 10 con-
trol subjects. In 9 cholestatic patients, the parameters
were reassessed at least 4 weeks after PBD.
Results: Compared to controls, cholestatic patients
showed lower concentrations (P < 0.001) of plasma
vitamin K-dependent factors II and VII whereas pro-
thrombin time, activated partial thromboplastin time,
and factor V were unaltered. Thrombin generation was
increased in cholestatic patients as reﬂected by higher
plasma concentrations of thrombin-antithrombin (TAT)
complexes and D-dimers. Fibrinolysis was signiﬁcantly
impaired as evidenced by low plasminogen activator
activity (PAA), due to an increase in plasminogen acti-
vator inhibitor (PAI-1). Elevated markers for thrombin
generation (TAT) decreased after PBD from 10.7 ± 1.2
to 5.7 ± 0.7 ng mL-1 (P < 0.05). Additionally, impair-
ment of ﬁbrinolysis in cholestatic patients resolved after
PBD (PAI-1 levels decreased from 19 ± 1 to 10 ± 1 IU/
mL and PAA increased from 82 ± 3% to 110 ± 4%,
respectively). D-dimers remained unaltered after PBD,
likely due to normalization of coagulation and ﬁbrino-
lytic activity.
Conclusions: Obstructive cholestasis is associated with a
procoagulant state despite an impaired vitamin K-
dependent coagulation factor synthesis. Virtually all
alterations in coagulation and ﬁbrinolysis were reversed
by biliary drainage, indicating that cholestasis itself and
not the underlying malignancy is the cause of the coag-
ulopathy.
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ASSOCIATION BETWEEN APOPTOSIS
IN LIVER CELLS AND BLOOD LEVELS
OF BILIRUBIN, ALKALINE
PHOSPHATASE, AND ALANINE
AMINOTRANSFERASE IN
OBSTRUCTIVE JAUNDICE
F. Vasques1, J. G. Parreira1, T. De Campos1,2, R. Brasil3,
A. Moricz1, R. Silva1 and A. Pacheco Jr1
1Department of Surgery - Santa Casa School of Medical
Sciences - Sa˜o Paulo; 2University of Sa˜o Paulo - LIM 62;
3Department of Pathology - University of Sa˜o Paulo
Aim: The objective of this study was to evaluate the
correlation between blood levels of total and fractionated
bilirubin, alanine aminotransferase, and alkaline phos-
phatase and the rate of hepatic apoptosis using an
experimental model of obstructive jaundice in rats.
Methods: Adult Wistar rats underwent ligation and sec-
tioning of the bile duct and were euthanized three days or
seven days later. Control rats were subjected to a lapa-
rotomy only, without ligation, and were similarly
euthanized three or seven days after the procedure. We
evaluated laboratory data, histological changes and the
presence of apoptotic cells in the liver as evidenced by the
presence of active caspase-3 markers. P < 0.05 was
considered signiﬁcant.
Results: Relative to the controls, rats in the ligation and
sectioning groups exhibited an increase in the diameter
of the bile duct, an increase in blood levels of alkaline
phosphatase (AP), total (TB) and direct bilirubin (DB),
and alanine aminotransferase (ALT). Immunohisto-
chemical analysis also revealed a greater number of
apoptotic cells in the groups that underwent ligature of
the bile duct. None of the blood markers correlated
signiﬁcantly with the presence of hepatic apoptosis,
though the correlation coefﬁcient for AP was the
greatest.
Conclusions: There were a higher number of apoptotic
cells in the liver of animals with obstructive jaundice. The
blood levels of alkaline phosphatase had a closer rela-
tionship with hepatic apoptosis than other markers.
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DIFFERENTIAL DISEASE
SUSCEPTIBILITY OF BILIARY
EPITHELIAL CELLS (BEC) FROM
LARGE AND SMALL BILE DUCTS: IT IS
NOT JUST CELL SIZE
A.-X. Holterman1, M. Wang1, S. Glaser2, G. Alpini2 and
Y. Ueno3
1RUSH University Medical Center and RUSH Children’s
Hospital; 2University of TX A&M Health Sciences
Center; 3Tohoku University Graduate School of Medicine
Introduction: BEC from different biliary compartments
have distinct disease susceptibility (e.g biliary cirrhosis vs
sclerosing cholangitis). Since liver-enriched genes are
regulated by hepatocyte nuclear factors (HNF), speciﬁ-
cally HNF6 as shown by biliary malformations and le-
thal cholestasis in HNF6-null mice, we hypothesize that
differential transcriptional regulation of large and small
BEC leads to their functional differences.
Methods: The expression of the major HNF (HNF6,
HNF4a, HNF1a) and their downstream biliary transport
genes (Oatp1, Ntcp, Mrp2) were compared between
SV40Large and SV40Small BEC cell lines by qRT-PCR.
To examine HNF6 effect, cells were infected with re-
combinant adenovirus AdLacZ or AdHNF6 and mice
were injected with growth hormone to increase hepatic
HNF6 expression. Cholangiocytes were extracted from
bile ducts by collagenase perfusion and separated into
large and small cell size by elutriation.
Results: Constitutive expression of HNF1a and HNF4a
is 15+/-2.6 and 2.4+/-0.4 fold (P = 0.01, 0.02) respec-
tively higher in SV40Small than SV40Large BEC. This is
associated with higher baseline expression of HNF4a-
and HNF1a-regulated Oatp1 and Ntcp (3.6+/-1 and
2.7+/-0.4 fold (P = 0.01, 0.004) respectively. AdHNF6
increased HNF6 more in SV40Small than SV40Large (by
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3.9+/-0.4 fold (P = 0.02)). This parallels higher upreg-
ulation in AdHNF6-SV40Small than AdHNF6-
SV40Large of HNF6-target genes glucokinase (by 2-fold,
P = 0.02), bile transport genes Oatp1 (by 2.7-fold,
P = 0.005), and Mrp2 (by 2.3-fold, P = 0.02). In in vi-
tro cholangiocytes isolated from bile ducts of growth
hormone-treated liver, similar higher upregulation of
these genes in small BEC vs large BEC were seen.
Conclusion: The clinical phenomenon of divergent dis-
ease susceptibility of small and large bile ducts can be
mechanistically linked to differential molecular regula-
tion of BEC.
P-300
THE USEFULLNESS OF BOVINE
PERICARDIUM IN THE REPAIR OF
FULL THICKNESS BILE DUCT DEFECTS:
AN EXPERIMENTAL STUDY IN PIGS
R. Matteoti, A. Assalia, K. Ueda and M. Gagner
Department of Surgical Oncology, Fox Chase Cancer
Center, Philadelphia, USA
The utilization of bovine pericardium as a substitute for
different tissues in humans, mainly arterial blood vessels
and cardiac valves, was met with encouraging results.
Aim: To evaluate the usefulness of Bovine pericardium
in the repair of full thickness common bile duct defects in
a porcine model.
Materials and methods: Fourteen pigs were divided into
two groups: Group I (n = 7) 50% of the circumference
defect, group II (n = 7) 2 cm length whole circumference
defect. Through a midline laparotomy a cholecystectomy
was performed followed by repair of the defects with a
patch in group I, a tube graft in group II. The repair was
done with continuous 6/0 Prolene suture. Blood counts
and liver function tests were obtained preoperatively, on
postoperative day 1 and each week for 6 weeks. The
animals were monitored for signs of intra-abdominal
infection and jaundice. No drains were utilized. Upon
sacriﬁce a cholangiogram was performed, the CBD was
inspected for the extent of stenosis and the specimen and
a liver biopsy were histologicaly examined.
Results: One animal in group II died on POD 7 due to
mesenteric infarction. No biliary leak was observed. 3
animals died during the postoperative week 5 due to liver
failure. No bile leaks developed, inﬂammatory and ﬁ-
brotic response was noticed in all animals. The prosthesis
was not evident. Stenosis was more severe in group II.
The liver function tests showed progressive obstructive
pattern, signiﬁcantly more severe in group II
(P < 0.0001).Cholangiograms showed near total
obstruction in group II. Histopathology showed inﬂam-
matory and ﬁbrotic response with total resorption of the
prosthesis. A restoration of the diameter of the CBD
could be seen in group I.
Conclusion: Repair of full thickness CBD defects using
Bovine pericardium showed promising results especially
in the patch repair group. Further experiments using
anti-inﬂammatory agents and a T-tube could potentially
overcome the limitations of this study.
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LONG TERM RESULTS WITH MAJOR
HEPATECTOMY AND BILIARY
RECONSTRUCTION FOR HEPATIC
ALVEOLAR ECHINOCOCCOSIS
J. Lubrano1, E. Delabrousse1, N. Lamﬁchek1,
N. Halkic2, D. Vuitton1,3, S. Bresson-Hadni1,3, H. Wen4,
M. Gillet2, B. Heyd1 and G. Mantion1,3
1Besanc¸on University Hospital; 2Lausane University
Hospital; 3WHO-Collaborating Centre for the Prevention
and Treatment of Human Echinococcosis; 4Xinjiang
Medical University
Background: Hepatic alveolar echinococcosis (HAE) is a
parasitic disease due to the hepatic involvement by the
larva of Echinococcus multilocularis. Natural history of
the disease leads to pseudo-tumoral involvement of the
liver and the hepatic veins and even to a metastatic dis-
ease to the lungs and the brain. Without treatment, up to
80% of patients may die within 10 years of diagnosis.
Parasitostatic benzimidazole therapy allows only stabil-
ization of the disease without complete cure. Surgical
treatment is still controversial especially in case of
involvement of the biliary convergence.
Objectives: The aim of our study was to assess the ben-
eﬁts of enlarged hepatectomy with biliary reconstruction
in terms of overall and disease free survivals in case of
advanced liver disease with biliary convergence’s
involvement.
Methods: For the last 30 years, 115 patients have
undergone liver resection in our surgical unit for HAE.
Among them, 28 patients had enlarged hepatectomy with
biliary reconstruction due to involvement of the biliary
convergence.
Results: Patient’s median age was 55-years-old. Main
symptom was jaundice with cholangitis in 57% of the
cases. Major Hepatectomy with biliary reconstruction
was performed in all cases (right lobectomy in 75%) and
vascular reconstruction in 46% of the cases. Mortality
and morbidity rates were 3.5 (1/28) and 10% respectively.
There was no post operative liver failure. Median follow-
up was 11 years, with a 10-years overall and disease free
survivals of 82% and 78% respectively.
Conclusion: Enlarged hepatectomy with biliary recon-
struction in front of biliary convergence’s involvement
due to hepatic alveolar echinococcosis are possible and
lead to long term survival.
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EXTRA-HEPATIC PORTAL VENOUS
OBSTRUCTION: SURGERY AN
EFFECTIVE REMEDY
A. K. Agarwal, D. Sharma, R. Rajesh, S. Singh,
S. Agarwal, P. K. Mishra, A. K. Sachdev, A. Chaudhary
and R. C. Aranya
GB Pant Hospital & MAM College, Delhi University
Background: Extra hepatic portal vein obstruction
(EHPVO) is a common cause of portal hypertension in
India. Most gastroenterologists advocate endotherapy.
However problems of hypersplenism, ectopic varices and
portal biliopathy, growth retardation are not resolved
with endotherapy. Surgical management with shunt
procedures (lieno-Renal) is advocated as a safe, one time
procedure.
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Aim: Analyze our experience of surgical management of
EHPVO for its role in the management of variceal bleed
& other associated complications of EHPVO.
Material and methods: Retrospective analysis of pro-
spective data of 246 EHPVO patients surgically treated at
our institution during the period January 1990 to April
2009.
Results: Out of 246 patients, (155males, 91 females,
mean age 21.9 years), Indication of surgery were- acute
variceal bleed (22), elective deﬁnitive management of
variceal bleed (148), portal biliopathy (56), symptomatic
splenomegaly (21), and Symptomatic Hypersplenism (32)
and growth retardation. Many patients had more than
one indication of surgery. Of these 15 patients had ec-
topic varices. One hundred and thirty-nine patients
underwent prior endoscopic management. One hundred
and ninety-ﬁve patients underwent proximal splenorenal
shunt, devasularisation was performed in 42, mesocaval
shunts in 4, distal spleno renal shunt in 1 and splenec-
tomy alone in four patients. Surgical management con-
trolled acute variceal bleed and resoived hypersplenism in
all patients, ectopic varices in 14 patients (93%) and was
alone effective in portal biliopathy in 43 patients (77%)
and facilitated 2nd stage biliary decompression in the
remaining. Morbidity and mortality rates were low
(4.01% and 0.81% respectively).
Conclusions: A signiﬁcant proportion of EHPVO pa-
tients have problems, other than variceal bleed. Surgical
management is a safe, effective and one time therapy for
EHPVO as it takes care of esophageal varices as well as
its associated complications.
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MORBIDITY’S PREDICTIVE FACTORS
OF LIVER HYDATID CYST SURGERY
H. O. El Malki1,2,3, A. Benkabbou1, A. Souadka1,
R. Mohsine1, L. Ifrine1, R. Abouqal2,3 and A. Belkouchi1
1Surgery Departement ‘‘A’’ Ibn Sina Hospital, Rabat
Morocco; 2Medical Center of Clinical Trials and
Epidemiological Study (CRECET), Medical School,
University Mohammed Vth Souiss, Rabat, Morocco;
3Biostatical, clinical research and epidemiological
laboratory (LBRCE), Medical School, University
Mohammed Vth Souissi, Rabat, Morocco
Background: Operations are the mainstay of liver hyda-
tid cyst (LHC) treatment. Operations are still associated
with high morbidity and mortality because of speciﬁc
postoperative complications (bile leaks, bilomas, deep
bleeding, and deep suppurations) and deep abdominal
complications (DAC).
Aim: To identify the predictive factors of DAC after
LHC operation.
Study design: We conducted a retrospective study of 672
patients with LHC treated at the Surgery Department
‘‘A’’ at Ibn Sina University Hospital, Rabat, Morocco.
Speciﬁc morbidity (DAC) and 30 variables were assessed.
Univariate and multivariate logistic regression were
performed to identify predictive factors for DAC. An
associated risk scoring system was developed.
Results: Six hundred sixty-four patients underwent
operations. Mortality rate was 0.8% (n = 5) and DAC
rate was 18.4% (n = 121). Five independent predictive
factors of DAC after LHC operation were retained, ie,
presence of cyst preoperative complications (odds ratio
3.10, 95% CI, 1.85 to 5.17), 3 or more cysts in the liver
(OR 2.55, 95% CI, 1.42 to 4.59), thick pericyst (OR 2.59,
95% CI, 1.27 to 5.29), biliary ﬁstula (OR 2.27, 95% CI,
1.38 to 3.72), and capitonnage alone as residual cavity
management (OR 2.23, 95% CI, 1.12 to 4.44). Multi-
variate model showed a good ﬁt. Discriminating ability
of the model was fair. In theoretical risk, scores ranged
from 0 to 5. When the score was 2 or more, sensitivity of
the scoring model was 80.3%, speciﬁcity was 58.5%,
positive predictive value was 30.3%, and negative pre-
dictive value was 93%.
Conclusions: Identiﬁcation of these ﬁve factors will allow
more appropriate therapeutic care after LHC operation.
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DUCT TO DUCT RECONSTRUCTION
AFTER LIMITED BILE DUCT
RESECTION DURING MAJOR
HEPATECTOMY
R. Memeo1, A. Laurent1, C. Tayar1, A. Charachon2 and
D. Cherqui1
1HPB and Liver Transplant Unit, Hopital Henri Mondor,
Cre´teil, France; 2Interventional Endoscopy Unit, Hopital
Henri Mondor, Cre´teil, France
Objective: In case of biliary tract resection during hep-
atectomy, the typical reconstruction is Roux-en-Y hep-
aticojejunostomy. Experience in living donor liver
transplantation showed the value of duct to duct anas-
tomosis. The goal of this study is to evaluate the results
of duct do duct reconstruction in case of limited bile duct
resection in the hilar region in the context of liver
resection.
Methods: From 1990 to 2009, of 1150 hepatectomies, 9
(0.8%) were associated with limited bile duct resection
and a duct do duct reconstruction. Tumors were located
close to hepatic hilum or next to a Glissonian pedicle
which needed to be preserved. Biliary tract resection was
required to obtain R0 resection in 7 cases where t was
decided purposely during surgery, while it was unex-
pected in two cases. The tumors were 2 HCC, 5 colorectal
metastases, 1 intrahepatic cholangiocarcinoma and 1
adenoma. All tumors were treated with a major hepa-
tectomy: 5 extended left (to S1 in 3 and to S5 and S8 in
2), 2 extended right to S4, 1 right and 1 central. The
reconstruction used magniﬁcation and consisted of an
anastomosis of the stump of the common bile duct to one
or two intrahepatic bile duct stumps. A completion
cholangiography was performed in all cases and an
external biliary drainage was placed in eight patients.
Results: No postoperative death was observed. Two
patients developed anastomotic biliary ﬁstula requiring
percutaneous drainage and placement of an endoscopic
stent. All bile duct margins were R0 at histology. No
early or delayed cholangitis, anastomotic stricture or
jaundice occurred. Six patients developed tumor
recurrence but none at the site of the biliary anasto-
mosis.
Conclusions: Duct to duct biliary reconstruction is a safe
and efﬁcient alternative to hepaticojejunostomy in case of
limited bile duct resection during major hepatectomy. It
is simpler, avoids intestinal anastomosis and preserves
the endoscopic access to the biliary tract.
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INADEQUACY OF COUINAUD’S
HEPATIC SEGMENTATION FOR RIGHT
ANTERIOR SECTIONECTOMY
J. Choi, Y.-J. Lee, D. W. Hwang, S.-H. Chon and
K.-M. Park
Department of Surgery, University of Ulsan College of
Medicine, Asan Medical Center, Seoul, Korea
Background: Accurate preoperative localisation is
essential in planning of surgical treatment for hepato-
cellular carcinoma (HCC). However, preoperative liver
segmentation based on hepatic veins on CT scans is not
always consistent with portal inﬂow based hepatic seg-
mentation.
Aim: The present study examined a rate of mismatch
between hepatic vein based and portal vein based liver
segmentation, in patients following right anterior sec-
tionectomy for HCC.
Methods: One hundred and ﬁfty patients (118 males, 32
females; mean age, 53.4 years old+/-8.99) underwent
right anterior sectionectomy using Glisson transection
method for HCC between January 2004 and August 2009
at a tertiary teaching hospital. Preoperative multidetector
CT scan was analysed for location of HCC in terms of
hepatic vein based Couinaud’s segments and portal vein
based segments.
Result: The average size and number of HCC was 4.5 cm
(+/-2.60) and 1.09 (+/-0.326). The rate of hepatitis B,
hepatitis C and combined B and C was 127, 8 and 3
patients respectively. One hundred and forty-six patients
were Child Pugh class A and 4 were Child Pugh class B.
The rate of R0, R1 and R2 resection was in 137, 11, 2
patients respectively. The blood transfusion was required
in 16 patients (10.7%). There was no 60 days mortality
and 42 patients developed morbidity (28%). 15 patients
were initially diagnosed with HCC in segment 7 accord-
ing to outﬂow based Couinaud’s segment. When they
were re-analysed according to portal vein inﬂow, they
received portal inﬂow from a branch of anterior portal
vein.
Conclusion: Amongst patients with right anterior sec-
tionectomy, 10% of patients had inaccurate preoperative
localisation based on Couinaud’s segmentation. Inﬂow
(or portal vein) based liver segmentation should be con-
sidered prior to anatomical liver resection.
P-307
RESECTION OF RECURRENT HEPATIC
TUMOURS AFTER
TRISECTIONECTOMY
I. Rajput, O. Ziff, R.Adair , T. Igami, G. J. Toogood,
K. R. Prasad, and P.Lodge
St James’s University Hospital, Leeds, UK
Introduction: Hepatic trisectionectomy is the largest liver
resection performed for malignancy. We report a series of
29 patients who had redo resection following their he-
patic trisectionectomy.
Results: Twenty nine patients underwent hepatic trisec-
tionectomy (23 right, 6 left) of which 23 had colorectal
liver metastasis. Overall 1-, 3- and 5- year survival rates
were 96%, 56% and 39% respectively.
In the colorectal metastasis group 5 patients received
conventional right trisectionectomy whereas 14 patients
had an extended right trisectionectomy. The remaining 4
patients all had extended left trisectionectomy.
Following redo resection overall 1-, 3-, and 5-year
survival for the colorectal metastasis group was 67%,
37%, and 31%. Patients who received chemotherapy
after trisectionectomy (prior to redo) had a 1- 3- and 5-
year survival rate of 76%, 58%, and 48% vs. chemo-
therapy prior to trisectionectomy 56%, 11% and 0% (P
= 0.02). R0 resection vs. R1 resection showed a 1- 3- and
5-year survival rate 70%, 50%, 40% vs. 65%, 25% and
25% (P = 0.35). Patients with recurrent tumours
> 5 cm (n = 6) had 1-, 3-, and 5- year survival rates
of 64%, 42% and 21% vs. 67%, 38% and 38% for
tumours < 5 cm (n = 15)(not signiﬁcant).
Conclusion: Redo resection following hepatic trisection-
ectomy can yield good survival rates. Patients who re-
ceived chemotherapy adjuvant to the trisectionectomy
had better survival rates than those who had neoadjuvant
chemotherapy in relation to trisectionectomy.
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MULTIMODALITY MANAGEMENT OF
POST-HEPATECTOMY BILIARY
FISTULAE: A 10-YEAR EXPERIENCE
C. Woodall1,2, C. Scoggins1, N. Reuter1, M. Bower1,
K. Ravindra3, R. Martin1, K. McMasters1 and G. Vitale2
1Department of Surgery, Division of Surgical Oncology,
Louisville, Kentucky, USA; 2Department of Surgery,
Division of Surgical Endoscopy, Louisville, Kentucky,
USA; 3Department of Surgery, Division of
Transplantation, Louisville, Kentucky, USA
Background: Post-hepatectomy biliary ﬁstula (PHBF) is
a common complication of liver resection. The manage-
ment of PHBF involves additional interventions.
Objective: To describe the role of multimodality treat-
ment of PHBF at a large referral center.
Methods: Review of patients who underwent hepatec-
tomy for tumor from 1999 to 2009 at a single academic
center; consecutive patients with PHBF (bilious drainage
or a biloma) were identiﬁed. Clinicopathologic factors
were analyzed.
Results: One thousand and one hundred and seven pa-
tients had hepatectomy; 30 patients (2.7%) developed
PHBF. The median age was 58, 53% were female, and
86% were Caucasian. Hemostatic assist devices (41%),
staplers (10%), and crush-clamp (49%) techniques were
used for the hepatotomies. Metastatic colorectal cancer
was most common (32.3%), then cholangiocarcinoma
(20%), then hepatoma or other metastatic histologies
(13% each). 24 (80%) required image-guided percutane-
ous intervention; the median procedures was 2.5 and the
median duration was 35 (range 1–260) days. 9 (30%) had
an endoscopic retrograde cholangiopancreatogram
(ERCP) at a median of 15 days post-hepatectomy. ERCP
identiﬁed a leak in 66% of patients; these leaks were
equally divided between the divided lobar bile duct and
hepatotomy sites. Sphincterotomy was performed in 89%
and a stent placed in 100%. The median number of
ERCPs was 3 (range 2–4). 5 patients (16%) underwent re-
operation at a median of 4 days post-operatively with
identiﬁcation and closure of the leak in 3 of the 5 patients.
90% (28) of patients had resolution of their bile leak at a
median of 37.5 days (range 4–282). Hepatotomy type was
not associated with time to resolution (P = 0.14) of
PHBF. 3 (10%) had non-healing ﬁstulae; 2 of these died.
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Distribution of techniques utilized in the mangement of
PHBF
Technique n (%)
Percutaneous drainage 24 (80%)
Percutaneous transhepatic cholangiography 1 (3%)
Endoscopic retrograde
cholangiopancreatography
9 (30%)
Operative exploration 5 (16%)
Discussion: Multimodal management of biliary ﬁstulae
following hepatectomy was effective in most patients,
though 10% had non-resolution of their ﬁstulae and two
patients died, in part, due to their ﬁstula.
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PREOPERATIVE ASSESSMENT OF
PREDICTORS OF POSTOPERATIVE
HEPATIC COMPLICATIONS AND
USEFULNESS OF MEASURING
FUNCTIONAL HEPATIC VOLUME
A. Nanashima, S. Tobinaga, M. Kunizaki, H. Takeshita,
S. Hidaka, T. Sawai, and T. Nagayasu
Nagasaki University Hospital, Division of Surgical
Oncology
Background: We evaluated risk parameters in patients
who underwent hepatectomy in 1998–2003 and subse-
quently modiﬁed surgical indications. Using the modiﬁed
indications, we examined postoperative complications in
patients from 2004 to 2008. We also measured functional
liver volume (FLV) by SPECT-CT FUSION IMAGE of
99mTc-GSA liver scintigraphy and assessed the clinical
usefulness of this modality.
Methods: We examined 250 consecutive patients who
underwent hepatectomy, who were divided into subjects
of the early period (-2003, n = 149) and those of the late
period (2004-, n = 101). FLV of targeted liver areas was
measured in 70 patients including 20 undergoing preop-
erative portal vein embolization (PVE).
Results: In the early period, multivariate analysis identi-
ﬁed volume of resected liver (‡ 50%), intraoperative
blood loss (‡ 500 mL), prothrombin activity (< 70%),
hyaluronic acid level (‡ 200 ng mL-1) and LHL15
(< 0.85) as risk factors for hepatic complications, and the
latter three parameters were identiﬁed as predictors of
outcome. Since 2004, we used these three as indication
criteria for hepatectomy in addition to ICGR15. Com-
parisons with the early period showed reductions in
uncontrolled ascites (23 vs.38%, P = 0.03), hepatic fail-
ure (4 vs.11%, P = 0.12) and total hepatic complications
(17 vs.50%, P = 0.003) in patients of the late period.
FLV correlated with morphological volume by CT; but
patients with biliary tumor obstruction and those who
underwent PVE showed marked discrepancy in FLV
measured by the two methods. The 99mTc-GSA scintig-
raphy was useful for preoperative assessment when results
of ICGR15 were inﬂuenced by the injured part of liver.
Conclusion: Application of our modiﬁed criteria for
major hepatectomy in selection of surgical candidates
lessened postoperative hepatic complications. Further-
more, in the liver with biliary obstruction or PVE, mea-
surement of FLV by GSA scintigraphy provides useful
information for deciding operative indication.
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STUDY OF HUMAN LIVER
REGENERATION AFTER
HEPATECTOMY
J. Tralhao1, A. Abrantes2, B. Oliveiros2, M. Seroˆdeo1,
J. Oliveira1, A. Pereira1, D. Cardoso3, F. Botelho2, and
F. Castro-Sousa1
1Faculty of Medicine, Surgical III Department, Coimbra
University Hospital, Coimbra, Portugal; 2Biophysics /
Biomathematics Institute, IBILI, Faculty of Medicine,
Coimbra, Portugal; 3Nuclear Medicine Department,
Coimbra University Hospital, Coimbra, Portugal
Aim: To study human liver regeneration (HLR) after
hepatectomy evaluated by the hepatic extraction fraction
(HEF) calculation using radioisotopic methods.
Material and methods: Ninety ﬁve patients (32 W and 63
M; 63.2 ± 11.3-years-old) with colorectal metastases
(n = 69), hepatocellular carcinoma (n = 16) and other
tumors (n = 10) were included. Thirty-ﬁve (37%)
underwent major hepatectomy (MAHR) and 63% minor
hepatectomy (miHR). HLR was assessed after intrave-
nous bolus injection of 99mTc-N-(3-bromo-2,4,6-trim-
ethylphenylcarbamoilmethyl-1-iminodiacetic acid. We
evaluated the pre-operative HEF (T0) and in the 5th day
(T5) and one month after PH (T30).
Results: Overall patient population: the mean HEF val-
ues in our series were 97.3 ± 9.6% for T0, 97.5 ± 8.3%
for T5 and 98.7 ± 4.1% for T30 (ns). The mean Tmax
values were 15.6 ± 8.1 min for T0, 13.9 ± 5.7 min for
T5 and 14.1 ± 5.4 min for T30 (ns). The mean T1/2
values were 35.7 ± 22 min for T0, 86.4 ± 105.1 min for
T5 and 39.5 ± 19.2 min for T30 (P < 0.0001). In the
patients treated by Major MAHR there are signiﬁcant
differences only for the values of T1/2 in T5 when com-
pared with T0 (P < 0.035). For the 60 patients who
underwent miHR there are signiﬁcant differences only
for the values of T1/2 in T5 when compared with T0
(P < 0.04).
Conclusion: Our results strongly support the view that
the HLR is early enough to normalize the HEF at day 5
after HR. This rapid liver regeneration may allow adju-
vant chemotherapy is initiated earlier than the three
weeks dogma. Similarly, the same applies to liver resec-
tions following portal embolisation.
P-311
ENHANCED RECOVERY AFTER LIVER
RESECTION – IS THERE POTENTIAL
FOR ERAS PRINCIPLES TO BE
APPLIED?
J. Pine, R. Aggarwal, S. Farid, P. Goldsmith,
G. Toogood, J. P. Lodge and R. Prasad
Department of HPB Surgery, St James’s University
Hospital, Leeds, UK
Background: Enhanced recovery after surgery (ERAS)
aims to reduce post operative morbidity using a multi-
modal approach based on factors delaying discharge.
Hospital stay is decreased by optimising pain manage-
ment, early mobilisation and early feeding.
Aim: To assess current practice at a high volume liver
surgery unit to determine if ERAS principles could be
applied.
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Method: Data was collected prospectively from April,
2008 to August 2008. A pro-forma was completed for
each patient admitted for liver resection in the study
period. Data collected included: date/type of operation,
HDU stay, invasive devices, IV/oral ﬂuids, feeding, mo-
bilisation, blood/blood products, events that delayed
discharge, and biochemical markers.
Results: Seventy one patients were included – 21 major
resections, 48 minor resections. Median length of stay
was 9 days/6 days for major/minor resections. In major
resections the central venous catheter (CVC) and urinary
catheter (UC) were removed day 4, epidural day 5 and
drain day 6. For minor resections the CVC came out day
3, UC and drain day 4, and epidural day 5. Oral ﬂuids
were started day 1 in both groups. Diet was started on
day 2 in the minor group and day 3 in the major. Patients
were sat out day 2 in both groups and were independently
mobile by day 6/day 5 following major/minor resection.
Bloods had normalised by day5/day 3 in the major/minor
groups. Events that delayed discharge: pain (n = 17),
constipation (n = 5), pyrexia (n = 4), LRTI (n = 4),
and cardiac/UTI/SBO (all n = 1).
Conclusion: Many of the principles of ERAS are applied
in current practice but there are areas that could be im-
proved. We are slow to remove invasive devices and
patients could be fed and mobilised earlier. Factors
delaying discharge such as pain relief and constipation
could be managed more efﬁciently. The most effective
way of reducing hospital stay would be to produce a
multi-disciplinary structured care pathway for both ma-
jor and minor resections.
P-312
INTRA AND POSTOPERATIVE
CLINICAL OUTCOME FOLLOWING
REPEAT HEPATECTOMY FOR
PRIMARY OR METASTATIC LIVER
CANCER
M. Mirarchi, E. De Raffele, S. Vaccari, A. Cavallari and
B. Cola
U.O. Chirurgia Generale, Policlinico S.Orsola-Malpighi.
Bologna. Italy
Background and aim: Recurrence after hepatectomy for
liver cancer is frequent and may be conﬁned to the liver.
Repeat hepatectomy is indicated in selected cases. The
aim of this study was to clarify the perioperative outcome
of repeat hepatectomy.
Methods: Intra and postoperative parameters of 285 li-
ver resections (October 2000–September 2009) performed
by one of the authors were reviewed; 115 hepatectomies
were done for hepatocellular carcinoma or colangiocel-
lular carcinoma and 170 for colorectal metastases. Two
hundred and four were ﬁrst hepatectomies (FH) and 81
were repeat hepatectomies (RH), including 58 second, 19
third and 4 fourth hepatectomies. Chi-square and Stu-
dent’s t tests were used for statistics; signiﬁcance was
deﬁned as P £ 0.05.
Results: Group FH included 138 males and 66 females
aged 64.26 ± 11.21 (range 21–86) years; group RH in-
cluded 57 males and 24 females aged 64.39 ± 9.74 (range
39–85) yrs (P = ns). Intraoperative blood transfusions
were 216.31 ± 444.69 (range 0–3300) mL and
293.04 ± 468.41 (range 0–2250) mL in FH and RH,
respectively (P = 0.1967). Duration of surgical proce-
dure was 299 ± 121 (range 110–765) min and 358 ± 134
(range 195–800) min in FH and RH, respectively
(P = 0.0004). Postoperative complications were 15.2%
and 14.8% in the two groups, respectively (P = 1.000).
There was no postoperative death. Postoperative hospital
stay was 10.59 ± 6.31 (range 4–72) days and
10.84 ± 7.78 (range 4–68) days in FH and RH, respec-
tively (P = 0.7784).
Conclusions: Repeat hepatectomy had similar perioper-
ative results than ﬁrst resection in our experience, but
should be reserved to experienced liver surgeons because
is usually more challenging. Surgery should remain the
treatment of choice for selected patients with recurrent
liver cancer.
P-313
RIGHT HEPATECTOMY AS A MODEL
FOR ASSESSING THE RISK OF MAJOR
LIVER RESECTION:A COMPARISON
OVER TWO CONSECUTIVE DECADES
P. Bhangui, A. Laurent, C. Tayar and D. Cherqui
HPB and Liver Transplant Unit. Hospital Henri Mondor,
Cre´teil, France
Background: Previous studies have analyzed changing
trends in outcomes of hepatic resection but in unselected
patients in terms of type and extent of hepatectomy. Pure
right hepatectomy [PRH] represents a ‘model of ana-
tomical hepatectomy’ and could serve as an indicator of
the risk of major liver resection.
Aim: To study the evolution of PRH over 2 decades and
assess the impact of advancements in techniques,
instrumentation and a better understanding of liver
physiology on early postoperative outcomes.
Methods: From 1989 to 2008, of 1075 liver resections,
127 were PRH (extended resections, contralateral/extra-
hepatic associated procedures, thoracoabdominal or
laparoscopic approach were excluded).Studied criteria
included patient and tumour characteristics, intraopera-
tive variables and early post operative outcomes. 2 peri-
ods (1989–1998, 46 cases and 1999–2008, 81 cases) were
compared.
Results: The second decade saw a 2-fold increase in pa-
tients with hepatocellular carcinoma, a higher ASA grade
(P < 0.0001), larger tumour load (P < 0.01), increased
use of preoperative systemic chemotherapy (P = 0.025)
and portal vein embolization [PVE](P = 0.016). There
was a signiﬁcant decrease in the intraoperative blood loss
(P < 0.0001) and transfusion requirements (transfusion
rate 30% vs. 7%; P = 0.002) and introduction of the
anterior approach (0 vs. 44%). Morbidity (20%) and
mortality rates (2.2% vs. 3.7%) were similar in both
periods. The 3 recent deaths could be explained by an
extension of indications to patients with cirrhosis (2) or
major comorbidity (1).
Conclusion: Recent years saw an extension of indica-
tions of PRH to patients with more advanced tumors,
a functionally compromised liver or more comorbidi-
ties. Reduction of blood loss, adoption of newer
techniques like preoperative PVE and the anterior ap-
proach are instrumental in limiting post operative
morbidity and mortality. Attention should remain di-
rected to adequate balance between the cost of
extending the indications and achieving the goal of
cure by resection.
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P-314
PATTERNS OF RIGHT HEPATIC VEIN
EXPOSURE DURING RIGHT ANTERIOR
SECTIONECTOMY
Y.-J. Lee, J. Choi, D. W. Hwang, S.-H. Chon and
K.-M. Park
Department of Surgery, University of Ulsan College of
Medicine, Asan Medical Center, Seoul
Introduction: The anatomical resection of hepatocellular
carcinoma is important for long-term outcomes, which
can be achieved by either inﬂow or outﬂow guided sur-
gery. For the right anterior sectionectomy (RAS), the
middle hepatic vein (MHV) and the right hepatic vein
(RHV) should be exposed. However, the routine expo-
sure of RHV is not always possible because of its ana-
tomical variations. We described three clinically relevant
patterns of RHV during the RAS and described ana-
tomical basis for such variations.
Method: We analysed anatomical variations of RHV
during RAS between 2002 and 2008. The RAS was per-
formed using Takasaki’s Glisson transection method
with selective inﬂow occlusion.
Results: There were three patterns of the RHV. Firstly,
the full length of RHV was exposed from the periphery of
the liver to the IVC during RAS. Secondly, only the
short, cranial portion of RHV near the IVC was exposed.
In this case, a right inferior hepatic vein (RIHV) was
present or a branch from right posterior section drained
into the MHV. In addition, a large branch of hepatic vein
from segment 8 (V8), merging with a branch of right
anterior and posterior hepatic veins drained into the
cranial part of RHV. Thirdly, when only the cranial half
of RHV was exposed, either V6 drained into the MHV or
the segment 6 was over the RHV.
Conclusion: The full exposure of RHV during RAS was
not always possible because of described anatomical
variations. Thus, it is important to carefully study the
preoperative CT and anticipate anatomical variations
during the surgery.
P-315
SURGICAL ANATOMY OF HEPATIC
VEINS FOR HANGING MANEUVER
S. Cubas, E. Squarza, G. Andreoli and D. Czarnevicz
Department of Anatomy, Uruguay School of Medicine
(UDELAR)
Background: The liver hanging maneuver (LHM) facili-
tates the anterior approach (AA) which is one of the most
important innovations in the ﬁeld of mayor hepatic
resections. The avascular plane used in this technique has
been poorly described in the anatomical literature in spite
of the fact that knowing the anatomy for doing this
‘‘blind’’ maneuver is essential.
Aim: Evaluate the vascular drainage of the dorsal and
right segments of the liver by means of identify veins
bigger than 3 mm between two lines: A and B which are
disposed in the same axe of the cava vein. Line A pass
through the right border of the medial hepatic vein and
line B though the left border of the right hepatic vein.
Design: Observational study of 40 normal cadaveric liver
dissections.
Results: There is a vein, bigger than 3 mm, draining
segment 1 (caudate vein) in 72.5% of cases; draining
segment 9 in 23%. In 52.5% the segment 1 vein is close to
the line A but never passes that line. In 23% of cases
there is a vein draining segment 9 and is always medial to
the line B. The posterior inferior hepatic vein exists in
30% of the cases and never passes the line B.
Conclusion: For posterior liver resections with LHM left
border of middle hepatic vein, line B is suggested as
anatomic reference. When resection includes right part of
segment I teh reference line A must be considered as
reference. When a minor hepatic exists it is always on the
right of line B and doing the parenchyma transection in
this plane resection in this plane, avoids the hazard of a
lesion of left hepatic vein.
P-316
THE PROGNOSTIC SIGNIFICANCE OF
SURGICAL MARGIN ON OUTCOME
AFTER CURATIVE LIVER RESECTION
FOR INTRAHEPATIC
CHOLANGIOCARCINOMA
L. Capussotti1, D. Ribero1, G. Nuzzo2, M. Amisano1,
A. Ponti3, P. Berloco4, F. Bresadola5, M. Filauro6,
A. Frena7, S. Gruttadauria8, E. Iovine9, E. Opocher10,
G. Torzilli11 and A. D. Pinna1,2
1Ospedale Mauriziano Umberto I, Torino; 2Universita`
Cattolica ‘‘Sacro Cuore’’, Roma; 3Azienda Ospedaliera
San Giovanni Battista, Torino; 4Universita` La Sapienza,
Roma; 5Universita` di Udine, Udine; 6Ospedale Galliera,
Genova; 7Ospedale di Bolzano, Bolzano; 8ISMETT,
Palermo; 9Ospedale Maggiore, Bologna; 10Ospedale San
Paolo, Milano; 11Istituto Clinico Humanitas, Milano;
12Ospedale Sant’Orsola-Malpighi
Background: The inﬂuence of histologic involvement and
width of resection margin on long term outcome after
hepatectomy for intrahepatic cholangiocarcinoma (IHC)
remains unclear.
Objective: To evaluate the impact of the resection mar-
gin width and status on survival and tumor recurrence
after surgery for IHC.
Methods: Data from 434 consecutive patients who
underwent hepatectomy at 16 tertiary hepatobiliary
centres (1990 to 2008) were analyzed.
Results: At ﬁnal pathology, 54 patients (12.4%) had a
positive resection margin (Margpos). The width of tumor-
free margin was as follow: 0.5-9 mm, 131 patients
(median 4 mm); ‡ 1 cm, 159 patients (median 15 mm).
At a median follow-up of 37 months, the 1-, 3-, and 5-
year survival rates after R0-resection were 86%, 52% and
39%, respectively, with a median survival of 43 months.
Survival estimates in patients with a negative margin of
0.5 to 9 mm and ‡ 1 cm were similar (P = .637) and
signiﬁcantly better than those in Margpos patients (35.7%
at 3 years and 7.94% at 5 years) (P < 001). At multi-
variate analysis Margpos emerged as independent pre-
dictor of poor survival along with multiple tumors,
lymph node (LN) metastases, and an elevated preopera-
tive CA19.9 level (all P < 05). After a median of
10.5 months, 237 patients (54.6%) developed tumor
recurrence which was signiﬁcantly more likely to occur in
Margpos patients (73.58% vs. 53.9%, P = .02). In neg-
ative margin patients the width of resection margin did
not predict tumor relapse, nor the site of recurrence
(P > 05). Adverse biologic factors (tumor size > 5 cm,
an elevated preoperative CA19.9 level, perineural inva-
sion, and LN metastases) as well as the need of an
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extended hepatectomy or additional major intraabdom-
inal procedures were associated with an increased risk of
Margpos (all P < 05).
Conclusions: A positive margin after hepatectomy for
IHC heralds a poor prognosis while the width of a neg-
ative resection margin does not inﬂuence the long-term
outcome.
P-317
A NEW STRATEGY TO ACCELERATE
LIVER REGENERATION AFTER
HEPATECTOMY
K. Kuramitsu, E. Csizmadia, L. E. Otterbein and
D. W. Hanto
Harvard Medical School, Beth Israel Deaconess Medical
Center
Background: The liver has the remarkable ability to re-
store lost volume after surgery. Although the mechanism
of hepatocyte proliferation after hepatectomy is well
established, there are no therapeutics to accelerate the
regenerative process. Carbon monoxide (CO) is a potent
cytoprotective molecule that modulates cellular prolifer-
ation. In this study, we hypothesized that administration
of CO at low, non-toxic concentrations would accelerate
liver regeneration after hepatectomy.
Methods: C57BL/6 mice underwent 70% hepatectomy.
Bodyweight and remnant liver weight were measured.
Additionally, ALT, prothrombin time, cytokine, growth
factor expression and immunohistochemistry were per-
formed at selected time points to assess liver regenera-
tion. Mice were exposed to CO for one hour before
surgery at a concentration of 250 ppm. Air-treated mice
were used as controls.
Results: The regeneration ratio and the level of ALT
showed no difference between the two groups. Hepato-
cyte growth factor expression peaked earlier at 12 hour
in CO treated mice vs. 24 hour in controls. CO-treated
mice however showed earlier activation of DNA syn-
thesis, higher expression of cyclin D1, decreased level of
mitotic inhibitor p21, and inhibition in hepatectomy-in-
duced elevation in prothrombin times compared to con-
trols.
Conclusions: CO exposure may have beneﬁcial effects to
enhance liver regeneration following hepatectomy. Col-
lectively these data support the use of CO in patients
undergoing hepatectomy or liver transplantation from
marginal donors.
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THE EFFECT OF SURGICAL VOLUME
AND PROVISION OF SURGICAL AND
FELLOWSHIP TRAINING ON
MORBIDITY AND MORTALITY
FOLLOWING MAJOR HEPATIC
RESECTION
M. Nikfajram1, J. Galanko2 and G. Kohn3
1Department of Surgery, University of Melbourne, Austin
Health, Melbourne, Australia; 2Department of Medicine,
University of North Carolina at Chapel Hill, NC, US;
3Department of surgery, University of South California,
Los Angeles, CA, USA
Introduction: Positive volume-outcomes relationships
have been demonstrated for hepatic resection when using
an arbitrary cut-off to deﬁne a high volume center. The
association of surgical volume, as a continuous variable
and the inﬂuence of a surgical residency and a fellowship
program on outcomes after major hepatectomy is how-
ever undetermined.
Methods: The Nationwide Inpatient Sample was queried
from 1998 to 2006. Quantiﬁcation of patients’comor-
bidities were made using the Charlson Index. Using lo-
gistic regression modeling, institutions’ annual case
volumes were correlated with risk-adjusted outcomes
over time, as well as presence or absence of residency or
fellowship training program.
Results: A nationwide total of 26,396 major hepatecto-
mies we recorded. In-hospital unadjusted mortality for
the study period was 6%. Adjusting for comorbidities,
greater major hepatectomy volume was associated with
improvements in the incidence of most measured com-
plications, reaching a plateau in mortality of between 2 to
3% at approximately 50 cases per year. The mortality
rate increased once greater than approximately 70 cases
were performed per annum. Hospitals supporting a sur-
gical residency program had lower overall morbidity and
mortality. A fellowship program however was not asso-
ciated with overall lower morbidly and mortality and
appeared to result in a higher rate of speciﬁc complica-
tions.
Conclusions: Greater annual major hepatectomy volume
improves outcomes with reduced mortality up to a cer-
tain point. The presence of surgical residency program
but not a fellowship program is associated with reduced
predicted morbidity and mortality.
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LIVER RESECTION FOR MULTIMODAL
TREATMENT OF BREAST CANCER
METASTASES – IDENTIFICATION OF
PROGNOSTIC FACTORS
K. Hoffmann1, C. Franz1, U. Hinz1, P. Schirmacher2,
M. Eichbaum3, W. Bu¨chler Markus1 and P. Schemmer1
1Department of General- and Transplantation Surgery,
Ruprecht-Karls-University, Heidelberg; 2Institute of
Pathology, Ruprecht-Karls-University, Heidelberg;
3Department of Gynaecology, Ruprecht-Karls-University,
Heidelberg, Germany
Background: Liver resection (LR) within a multimodal
treatment concept of hepatic metastases (HM) secondary
to breast cancer is discussed controversially.
Aim: To evaluate the outcome of liver resection in pa-
tients with hepatic breast cancer metastases.
Methods: Prospectively collected data from 41 consecu-
tive patients who underwent LR for HM between 1999
and 2008 were analysed retrospectively. HM occurred
synchronous 10% and metachronous in 90% of patients.
Twelve patients presented with extrahepatic metastases in
a status of complete remission or stable disease before
LR. Survival rates were assed using Kaplan-Meier esti-
mates. Uni- and multivariate Cox regression analysis was
performed to assess potential prognostic factors.
Results: Nineteen minor and 22 major hepatic resections
were performed in 41 patients with a median age of
55 years. The postoperative mortality rate was 0%. At a
median follow-up of 34 months 26 patients were alive.
The median and 5-year overall survival rates after LR
were 58 months and 48%, respectively. The median and
5-year disease free survivals of patients without extra-
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hepatic metasases before LR were 34 months and 31%,
respectively. The intrahepatic recurrence free 5-year
survival was 62%. The median survival from time of
diagnosis of HM was 79 months. The median and 5-year
progression free survival of patients with extrahepatic
metases before LR was 14.5 months and 13%. Positive
resection margin as well as a disease free interval between
treatment of the primary tumor and the diagnosis of
HM < 1 year were independent predictors of overall
survival.
Conclusion: LR of hepatic breast cancer metastases
within a multimodal treatment concept is a safe proce-
dure in well selected patients. Both, a short time interval
to development of hepatic metastases and positive
resection margins after LR are signiﬁcantly associated
with impaired long-term survival.
P-320
EXTRACORPOREAL PORTAL VEIN
ARTERIALIZATION IN MAN AFTER
EXTENDED LIVER RESECTION
B. Nardo1,2, S. Vaccarisi1, V. Pellegrino1, M. Cannistra`1,
E. Barcellona1, M. Canonaco1, S. Rizzuti1,
M. Tortorella1, E. De Marco1 and G. Cavallari2
1Hepato-Biliary-Pancreatic and Transplant Organs Unit
(Head B. Nardo) Annunziata Hospital of Cosenza;
2Department of Surgery and Transplantations (Head
G. Martinelli) University of Bologna
Aim: To determine whether the physiologically oxygen-
ated arterial blood reversed in the portal system by
means of portal vein arterialization (PVA) through an
extracorporeal device is effective in treating man with
extended hepatectomy leading to acute liver failure
(ALF).
Methods: An obese 69-years-old man (BMI > 35) af-
fected by multiple metastases from colorectal cancer
underwent 80% liver resection; at laparotomy a steatotic
liver due to adjuvant chemotherapy was evident. More-
over a 20 min of hepatic ischemia was done during
resection. The patient at the end of resection received
PVA extracorporeal treatment. Blood was withdrawn
from the femoral artery and reversed in the portal venous
system through the umbilical vein. An extracorporeal
device was interposed between the outﬂow and the inﬂow
in order to monitor the hemodynamic parameters.
Starting from operative room each treatment lasted
6 hours per day, for a total of six treatment. Serum and
liver samples were collected daily. The extracoporeal
device was dismounted at 7-day p.o. The postoperative
course was assessed at 1 month.
Results: The PVA-extracorporeal treatment yielded
beneﬁcial effects for subtotal hepatectomy with decreased
serum ammonia, transaminases and total bilirubin. INR
recovered rapidly remaining signiﬁcantly lower during all
the postoperative period. The 10-day post-operative
period was uneventful. The patient was discharged in
good health status. He is alive and well at moment.
Conclusions: Arterial blood supply in the portal system
through the umbilical vein using an extracorporeal device
is easily applicable, efﬁcacious, safe and cost effective and
may represent a novel approach to treat patient with a
potential ALF induced by subtotal liver resection.
P-321
MORBIDITY AND MORTALITY OF
LIVER RESECTION FOR COLORECTAL
METASTASIS AFTER PREOPERATIVE
PORTAL VEIN EMBOLIZATION (PVE):
A CASE-CONTROL STUDY
F. Vandenbroucke-Menu, D. Bourdonnais, A. Begin,
M. Plasse, R. Letourneau, M. Dagenais, A. Roy and
R. Lapointe
Unit of Hepatobiliary Surgery and Liver Transplantation -
Hopital Saint Luc - CHUM - Montreal, Qc
Introduction: One of the prerequisites for hepatic resec-
tion is that there is remaining parenchyma to avoid
postoperative liver failure. PVE is a technique that in-
duces an atrophy of the liver to be resected, leading to a
compensatory hypertrophy of the remnant liver.
Aim: To evaluate the morbidity and mortality of liver
resection after PVE.
Material and methods: This was a retrospective case-
control study of 58 patients (36 males and 22 females)
with a mean age of 59 years. The matching criteria of the
PVE group (PVEG) and the control group (CG) were:
type of liver resection, year of surgery, age and gender.
Statistic analyses were Mann-Whitney test and Chi-
square test.
Results: The 2 groups (PVEG and CG) were similar for
body mass index (27.7 vs. 26.6), preoperative chemo-
therapy (19 vs. 14 patients), diabetes (5 vs. 2), dyslipide-
mia (6 vs. 8), extended hepatectomy (10 vs. 6). Operative
time (237 min vs. 186 min; P = 0014) and bleeding
volume (933 cc vs. 528 cc; P = 0,001) were signiﬁcantly
higher in PVE group, but blood transfusion units were
similar (3 vs. 4, P = NS). No mortality was observed
and the morbidity rate was similar between both groups
(PVEG: 5 vs. CG: 7, P = NS).
Conclusion: In patients with insufﬁcient future remnant
liver, preoperative PVE allows liver resection without
increasing morbidity, but longer operative time and more
blood loss were observed.
P-322
CHEMOTHERAPY INDUCED LIVER
INJURY AND ROLE OF PEROXISOME
PROLIFERATOR-ACTIVATED
RECEPTORS (PPAR a AND c) ON
SURGICAL OUTCOMES
J. Choi, T. Hugh, S. Calista and J. Samra
Department of Surgery, University of Sydney, Royal
North Shore Hospital
Background: Preoperative chemotherapy for colorectal
liver metastasis (CRLM) has been associated with che-
motherapy-associated steatohepatitis (CASH).
Aims and objectives: We investigated predictive factors
for complications following hepatectomy and assess the
impact of CASH on its outcome. In addition, role of
peroxisome proliferator-activated receptor (PPAR) a and
c in CASH was explored.
Methods: One hundred and four patients (70 males and
34 females, mean age 62.9+/-11.1) with CRLM, who
underwent hepatectomy, were randomly selected and
their outcomes were reviewed. H&E slides were analysed
for degree of background steatosis, lobular inﬂamma-
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tion, hepatocellular ballooning, sinusoidal dilatation and
Kleiner score (marker of steatohepatitis). For PPAR a, a
rabbit polyclonal antibody (cat ab 8934, Abcam, Cam-
bridge UK) and PPAR c, a mouse monoclonal antibody
(Clone E8 SC7273, Santa Cruz CA, USA) was used for
immunohistochemical (IHC) staining.
Results: Major hepatectomy was performed in 52 pa-
tients (50%) with R0 resection rate of 75%. 18 patients
(17.3%) required blood transfusion and 40 (38.5%)
developed post-operative complications. 58 patients had
preoperative chemotherapy (5FU, 34, FOLFOX 25,
FOLFIRI 3). Steatosis, lobular inﬂammation, balloon-
ing, ﬁbrosis and sinusoidal dilatations were present in
47%, 68%, 22%, 47% and 71% respectively. Nonalco-
holic steatohepatitis (Kleiner score ‡ 4) was present in
36 patients (34.6%). Male sex (P = 0.033), blood
loss > 500 mL (P = 0.035) and Kleiner score
(P = 0.038) were signiﬁcant predictors of complications.
PPAR a was a predictor of steatosis (P = 0.001).
Conclusion: Kleiner score and increased blood loss were
important predictors of surgical outcomes. The use of
ﬁbrate (PPAR a agonist) may ameliorate effects of stea-
tosis and improve outcomes.
P-323
ELECTIVE CONTROLLED PACKING
(ECP) DURING ELECTIVE LIVER
SURGERY
O. Farges, M. A. Allard, D. Sommacale, F. Dondero,
S. Dokmak, C. Paugam, J. Belghiti and B. Clichy
Background: During complex hepatic resections, inter-
ruption of hepatic veins within the remnant liver may be
required or may inadvertently occur. This, results in
signiﬁcant bleeding from the cut surface at the end of the
procedure, especially if blood inﬂow is increased (high
perfusion rates associated with prolonged surgery) and
outﬂow is decreased (high ventilation pressures in pa-
tients with raised BMI). Conventional methods of hae-
mostasis are poorly effective in this setting and may only
result in prolonged surgery and acidosis or hypothermia-
related coagulation disorders. We report our preliminary
experience of elective controlled packing (ECP) in this
setting.
Methods: ECP was performed in 7 patients who under-
went elective liver surgery in a University HPB unit.
Indication was persistent bleeding from hepatic veins
within the transection plan despite attempt at control. At
the time of ECP the mean duration of surgery was
540 min [390–695], blood loss was 5.3 L [2–14], pro-
thrombin time was 20% [5–28], body temperature
35.4C, pH 7.23 [7.08–7.28], lactates 6.3 mmole L-1 [4–
16] and all patients received vasoactive drugs (mean NA:
7 mg hour-1). A piece of glove was interposed between
the cut surface and the swabs and skin closure only was
performed.
Results: Unpacking was performed at a mean of
37 hours after surgery [26–60]. All patients had normal-
ized their temperature and biological parameters except
for blood pH and lacates that were at 7.33 and
4 mmole L-1 respectively in one patient each. Bleeding
had stopped, did not resume following removale of the
swabs and the abdominal wall could be closed in all.
Postoperative morbidity included one blood line sepsis
and two lung infections. With a follow up of 6 months all
patients are alive without wound dehiscence.
Conclusion: Packing is also a life saving procedure dur-
ing elective liver surgery and may prove more effective
than stubbornness attempt at immediate haemostasis
when outﬂow obstruction is present.
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PERIOPERATIVE OUTCOMES AND
FACTORS PREDICTING MORTALITY
AND MORBIDITY AFTER
HEPATECTOMY
V. Velayutham, J. Sathyanesan, P. Senthilkumar,
R. Shanmugasundaram, S. Ramasami, D. Jyotibasu,
G. P. Santhanam, S. Eswaran, G. Rajarathinam,
R. Palaniappan and S. Rajagopal
Government Stanley Medical College Hospital, Chennai,
India
Introduction and objectives: Evolution of surgical tech-
niques in partial hepatectomy has enabled the procedure
to be performed with operative mortality rate of less than
5% in high-volume centers in recent years. The current
study aims to analyze the trends in perioperative outcome
of 200 consecutive patients with hepatectomy for various
benign or malignant hepatobiliary diseases in a special-
ized hepatobiliary center.
Material and methods: Between June 2004 and May
2009, 200 consecutive patients underwent hepatic resec-
tion for benign or malignant hepatobiliary diseases. To
analyze the trends in perioperative variables and outcome
of hepatectomy in our institution over the 5-year study
period, Pre-, intra-, and postoperative data were recorded
prospectively in a computerized database and analysed.
Results: One hundred and ﬁfteen men and 85 women
underwent hepatectomy for benign or malignant he-
patobiliary diseases. The mean age was 47.1 years [14–
82 years]. 77% underwent major hepatic resection. The
overall morbidity and hospital mortality of the 200
patients were 20% (n = 40) and 3% (n = 6), respec-
tively. The mean hospital stay was 16.2 (10 = 40)
days. Concomitant comorbid illness, hyperbilirubin-
emia, hypoalbuminemia, prolonged prothrombin time,
major hepatic resection, concomitant extra hepatic
procedure, Pringles maneuver, blood loss of more than
one litre, need for perioperative blood transfusion and
fresh frozen plasma more than six units and presence
of intraoperative hypotension were associated with in-
creased morbidity, whereas presence of comorbid ill-
ness, prolonged prothrombin time, concomitant extra
hepatic procedures and operative blood loss of more
than one litre, was associated with increased hospital
mortality.
Conclusion: Reduced perioperative blood loss hence
reduction in transfusion requirement is a main contrib-
utory factor for the improved outcome, and further effort
should be directed toward improving surgical techniques
to achieve bloodless hepatic resection.
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SURGERY FOR HEPATOCELLULAR
CARCINOMA WITH A TUMOR
THROMBUS EXTENDING INTO THE
RIGHT ATRIUM
T. Komokata1, M. Kaieda1, M. Fukueda1,
Y. Shimamoto1, I. Kitazono1, T. Ueno1, Y. Iguro1 and
R. Sakata2
1Department of Cardiovascular, Thoracic, and Hepato-
Biliary-Pancreatic Surgery, Kagoshima University
Graduate School of Medical and Dental Science;
2Department of Cardiovascular Surgery, Kyoto University
Background: Hepatocellular carcinoma (HCC) with a
tumor thrombus extending into the right atrium has
generally been considered beyond surgical intervention.
This condition also poses the potential risk of sudden
death caused by pulmonary embolism and heart failure.
Only surgery may be an effective treatment to prevent
such a disaster and to prolong the survival.
Aim: To investigate whether surgical management for
HCC with a tumor thrombus extending into the right
atrium results in better operative and mid-term survival
outcomes.
Methods: Six HCC patients with a tumor thrombus
extending into the right atrium admitted to our hospital
between March 2007 and July 2009. Except for two
patients; one suddenly died before operation due to heart
failure and the other was diagnosed as inoperable due to
extra right atrial progression, we performed radical
resection of the tumor thrombus with (n = 3) or without
hepatectomy (n = 1) under an extracorporeal circulation
(ECC).
Results: Operative procedures and outcomes were de-
scribed in Table 1.
Table 1.
No Age/Sex Hepatectomy
Operation
Time
ECC
Time
C-P
Arrest Complications Outcomes
1 67/M Right hepatic
lobectomy
12 hour.
50 min.
124 min. Yes None 7 months/
dead
2 55/M Anterior
segmentectomy
16 hour.
30 min.
148 min. Yes Hepatic
failure
12 days/
dead
3 65/F None 2 hour.
45 min.
59 min. Yes None 24 months/
alive
4 54/M Left hepatic
lobectomy
10 hour.
38 min.
51 min. No Pleural
effusion
8 months/
alive
Conclusion: Surgery for HCC with tumor thrombus
extending to the right atrium is technically feasible and
may offer better mid-term outcomes for far advanced
HCC patients.
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LIVER RESECTION FOR NON-
COLORECTAL, NON-CARCINOID
METASTATIC DISEASE: A SINGLE
CENTRE EXPERIENCE
J. Pine, S. Farid, G. Toogood, J. P. Lodge and R. Prasad
Department of HPB Surgery, St James’s University
Hospital, Leeds, UK
Background: Surgical liver resection is beneﬁcial in
selected patients with colorectal or carcinoid liver meta-
stases. The role of resection in other types of hepatic
metastatic disease is less clear.
Aim: To review our experience of surgical intervention
for non-colorectal, non-carcinoid (NCRNC) liver
metastases.
Method: Patients who underwent liver resection for
NCRNC liver metastases were identiﬁed from a pro-
spectively maintained database. Data collected included:
patient demographics, tumour type, number/size/loca-
tion of hepatic metastases, type of operation and mor-
bidity. Overall and disease-free survival was calculated.
Results: Twenty-three patients underwent liver resection
for NCRNC liver metastases. The mean age of the group
was 54 years. It included 15 women and 8 men. The
primary disease was carcinoma of the breast (7), renal
clear cell cancer (5), squamous cell carcinoma of the anus
(3), leiomyosarcoma (2), melanoma (2), pancreatic ade-
nocarcinoma (1), cervical adenocarcinoma (1), oeso-
phagogastric adenocarcinoma (1), and parotid carcinoma
(1). Major resections (>3 segments) were performed in
52.2% of cases. Additional procedures included dia-
phragmatic resections in 2 cases, multiple peritoneal
resections in one case and an en-bloc pancreaticodu-
denectomy in one case. Further resections were per-
formed in 6 cases. Post-operative morbidity and
mortality was 13.3% and 3.3% respectively. Overall
survival for the cohort stands at 56.5% with a mean
follow-up of 2 years.
Conclusion: The role of resection for NCRNC hepatic
metastases is still unclear. The recurrence rates from
pancreatic cancer, oesophagogastric cancer and malig-
nant melanoma can be high. However, our experience
suggests that, provided all gross disease can be removed,
hepatic resection for NCRNC metastatic disease is
safe and may confer a survival advantage. All patients
should be carefully selected and discussed at an MDT
meeting.
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FIXATION OF THE ROUND LIGAMENT
AFTER HEPATIC LATERAL
SEGMENTECTOMY
N. Fukino, T. Oida, K. Mimatsu, H. Kano, A. Kawasaki
and Y. Kuboi
Social Insurance Yokohama Central Hospital / Surgery
Background and aim: Left-sided hepatectomy occasion-
ally leads to early delayed gastric emptying (EDGE). We
developed a new ﬁxation procedure of the round liga-
ment to the peritoneum to prevent EDGE after hepatic
lateral segmentectomy and evaluated its efﬁcacy.
Methods: We retrospectively studied 42 patients who
underwent hepatic lateral segmentectomy. They were
divided into 2 groups: a ﬁxation group (n = 15) and a
non-ﬁxation group (n = 27). The round ligament of the
liver was divided at the umbilicus and detached from the
abdominal wall from the umbilicus to the liver. The cut
surface of the liver was wrapped by the round ligament,
and the distal part of the round ligament was then ﬁxated
to the peritoneum.
Results: EDGE was found to be 0% in the ﬁxation
group versus 15% in the non-ﬁxation group.
Conclusions: Fixation of the round ligament to the
peritoneum is a useful technique to prevent EDGE after
hepatic lateral segmentectomy.
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INTRAHEPATIC GLISSONIAN
APPROACH – NEW ANATOMICAL
CONCEPTS AND RESULTS FROM 50
PATIENTS
ACA Martins1, ED Martins Filho1, F Kreimer1,
CH Lyra1, PM Andrade Lima1, C Lira Terceiro2 and
C Souza Lea˜o1
1Department of Surgery, Instituto de Medicina Integral
Prof. Fernando Figueira – IMIP; 2Department of
Anesthesiology, Instituto de Medicina Integral Prof.
Fernando Figueira – IMIP
Background: The intra-hepatic glissonian approach has
been considered an advance in the modern hepatic sur-
gery by allowing a safe resection, with minor bleeding
and maximum preservation of hepatic tissue. This ap-
proach relies on the anatomical opportunity created by
the presence of a sheath that envelops the portal triad
(portal vein, hepatic artery and biliary duct).
Aim: Report the preliminary results of the ﬁrst 50 he-
patic resections using the intrahepatic Glissonian ap-
proach and describe some anatomical landmarks that can
be used to localize the Glissonian pedicle.
Results: From August 2005 to September 2009 we
performed 50 liver resections using the glissonian int-
rahepatic technique. The mean age of the patients was
56.5 years and most was female (71%). The main indi-
cation was metastatic colon cancer (27 patients, 55%),
followed by cancer of the gallbladder and the benign
tumors (9% each). Diferent types of anatomical resec-
tions were performed, including: left hepatectomy
(24%), segmentectomy 6.7 (17%), right hepatectomy
(10%), segmentectomy 4b, 5 (10%) and left lateral
segmentectomy (10%). The mortality rate was 2.2% (1
case). Considering the most common segments surgi-
cally resected (6/7, 3 and 4b), relation of their pedicles
with anatomical landmarks on the visceral surface of
the liver have been seen in as much as 60–90% of the
patients.
Conclusion: The glissonian approasch is a versatile and
safe method of performing hepatectomies of all segments
and combined liver resections with maximum preserva-
tion of the parenchyma with low morbidity and mortal-
ity. Some anatomical landmarks on the visceral surface
of the liver indicates the location of the glissonian pedi-
cles and can add for the safety and precision during many
liver resections.
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LIVER RESECTION IN CIRRHOTICS VS
NON-CIRRHOTICS PATIENTS
R. A. Ibarra1,2, K. K. Goyal1,2, J. Rose1,2, F. Alonso2,
C. Siegel1,2, K. Wiegel1 and J. R. Sanabria1,2
1University Hospitals-Case Medical Center; 2Case
Western Reserve University
Background: The management of primary and secondary
liver tumors has changed in recent years due to the
development of new technical modalities of tumor con-
trol, i.e. ablation (RFA), embolization (TACE), Stereo-
tactic Body Radiation Therapy (SBRT), or to the
development of more effective forms of chemotherapy.
One of the most frequent medical reasons for delay or
avoid surgical therapy in patients with liver tumors is the
presence of advanced ﬁbrosis/cirrhosis. We hypothesized
that patients with resectable liver tumors and compensate
liver ﬁbrosis (Child-Pugh A, MELD < 10) may have
similar mortality and morbidity that patients with no li-
ver ﬁbrosis.
Methods: Between October 2004 and October 2008, a
total of 209 patients underwent liver resections in our
institution. The following table is a summary of our
ﬁndings including all types of resections and diagnosis
with and without RFA and other procedures. Statistical
analysis was performed using Fisher’s exact test and Chi-
square as appropriate. Cochran-Armitage test was used
to compare the distribution of complication grades be-
tween the groups. P < 0.05 was considered statistically
signiﬁcant.
Results: See Table.
Cirrhotics
(n = 17)
Non-cirrhotics
(n = 192)
P) 
value
Age (Mean + SD in years) 60 ± 9 60 ± 15 0.66 #
Gender (M:F) 14:3 96:96 0.01
Complications < 30 days 5 (29.4%) 48 (25%) 0.77
Complications 30–90 days 1 (5.9%) 17 (8.9%) 0.99
Complications any 6 (35.3%) 65 (28.7%) 0.58
Severity of complications*
I 1 (16.6%) 4 (6.1%) 0.49 
II 1 (16.6%) 18 (27.6%)
IIIa 1 (16.6%) 21 (32.3%)
IIIb 1 (16.6%) 19 (29.2%)
IVa 1 (16.6%) 1 (1.5%)
IVb 0 0
V (death) 1 (16.6%) 2 (3%)
Number of lesions
(Mean + SD)
2 ± 2 3 ± 2 0.50 #
Diameter of the lesions (cm) 4.6 ± 3.1 5.3 ± 3.6 0.44 #
Liver transplant 2 3
Minor resections 11 (64.7%) 96 (50%)
Complications in minor
resections only
3 (27.2%) 21 (21.9%) 0.78
Major resections** 6 (35.3%) 96 (50%)
Complications in major
resections only
3 (50%) 34 (35.4%) 0.66
*Clavien classiﬁcation, **more then 2 anatomical segments,
Fisher’s exact test, Cochran-Armitage test for trend (Z value),
# Chi Square
Conclusions: There were no statistically signiﬁcant dif-
ferences in the rate of complications in patients with or
without compensated cirrhosis after different types of
liver resection. Our results suggest liver resection should
be the treatment modality of choice for patients with
resectable liver tumors and compensate cirrhosis. Liver
transplantation is a complementary form of therapy in
patients with resectable liver disease in selected patients.
Liver resection in patients with and without cirrhosis.
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INTEGRATION OF A NAVIGATION
ENVIRONMENT (LAPASSISTENT)
INTO ULTRASOUND-ASSISTED
LAPAROSCOPIC LIVER RESECTION
M. Kleemann1, P. Hildebrand1, V. Martens2,
A. Besirevic1, A. Schweikard2, C. Buerk1, U. Roblick1
and H. P. Bruch1
1University Hospital Schleswig-Holstein-Campus Luebeck
Depatment of Surgery; 2Institut for Robotics and cognitive
Systems, University Luebeck
Introduction: In our interdisciplinary working group, we
are currently developing an image-guided surgery system
for oncological visceral surgery with focus on laparo-
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scopic liver treatments. Today laparoscopic liver resec-
tions are discussed controversial. The system is aimed to
help the surgeon performing laparoscopic liver resections
using preoperative planning data and tracked laparo-
scopic ultrasound (LUS) as well as a tracked dissection
instruments.
Materials and methods: The tracking hardware for the
prototype of the system consists of an optical and an
electromagnetical tracking system. In order to connect
the tracking system with these instruments and the LUS
different adapters have to be used. These adapters should
provide a reproducible, sterilisable, easy to handle and
save connection between the trackers and the instrument
respectively LUS. Another requirement is the simoulta-
nous view of the preoperative planning data, the navi-
gated and tracked intraoperative ultrasound picture and
the laparoscopic view. Our Lap Assistant integrated all
three qualities of visual data and offers a surgical system
to assist navigated laparoscopic liver resections. The
Navigation System has been tested in a Pilot Animal
Study.
Results: The Navigation System provides the fusion of
pre- and intraoperative Imaging data. The planning data
are overlain the real-time ultrasound B-Mode Picture
with an accuracy of 3-5 mm. Planning data may be ac-
tualised, if a new lesion will be found in the ultrasound
examination. In future the system will be tested in a
multicenter Study (ProNaviCI). The reasearch was fun-
ded by the german Federal Ministry of Education and
Research (Project: FUSION-FKZ 01 EQ 0401).
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PERI-OPERATIVE N-ACETYLCYSTEINE
IN MAJOR LIVER RESECTION – DOES
IT INFLUENCE OUTCOME?
R. Saif1, G. Sen1, M. Jacob1, S. Robinson1, D. Manas1,
C. Snowden2 and S. White1
1Department of Hepatobiliary & Pancreatic Surgery,
Freeman Hospital, Newcastle upon Tyne, United
Kingdom; 2Department of Anaesthesia, Freeman Hospital,
Newcastle upon Tyne, United Kingdom
Introduction: Ischaemic/reperfusion injury plays an
important role in postoperative liver dysfunction. N-
acetylcysteine (NAC) acts as a protective agent serving as
a precursor of glutathione replenishing intracellular
stores. Ischaemic/reperfusion injury occurs during liver
resection due to hepatic inﬂow clamping (Pringle’s
manoeuvre).
Aim: To assess the protective role of NAC in the peri-
operative period after major liver resection.
Methods: A consecutive cohort of patients undergoing
major liver resection (3 segments or more) was chosen for
analysis. The group of patients receiving NAC in the
immediate peri-operative period was matched for age, sex
and similar disease proﬁle to patients who did not. Pre-
operative & post-operative day 3, 5 and 7 prothrombin
time (PT) and alanine transaminase (ALT) were taken as
surrogate markers of liver function. Use of pre-operative
chemotherapy, duration of Pringle’s manoeuvre and de-
gree of steatosis in the resected specimen were also con-
sidered as confounding factors that may have inﬂuenced
outcome. Study end points were changes in liver function
(ALT) and coagulopathyc (PT), hospital stay, morbidity
and 30-day mortality.
Results: A total of 50 patients were included in the study.
25 patients (M:F = 21:4, mean = 66 years) who re-
ceived NAC in the peri-operative period were compared
with 25 patients (M:F = 20:5, mean = 67 years) who
did not. Mean pre-operative PT and ALT was similar in
both groups. There was no signiﬁcant difference between
the 2 groups in PT and ALT on day 3, 5 and 7 (P > 0.05,
Mann-Whitney U, ANOVA). There was no difference in
peri-operative morbidity or 30-day mortality between the
2 groups.
Conclusion: This retrospective study did not demonstrate
any protective role of NAC in the peri-operative man-
agement of patients having major liver resection. At
present there is insufﬁcient evidence to support the rou-
tine use of NAC after major liver resection.
P-332
ANATOMIC LIVER RESECTIONS FOR
THE TREATMENT OF INTRAHEPATIC
STONES, RESULTS OF ONE CENTRE
E. Figueroa1,2, M. Gabrielli1,2, F. Navarrete1,2,
F. Pimentel1,2, J. F. Guerra1,2, C. Sierralta1,
J. Valbuena1,3, J. Martinez1,2, S. Guzman1,2 and
N. Jarufe1,2
1Pontiﬁcia Universidad Cato´lica de Chile; 2Department of
Digestive Surgery; 3Unit of Pathology
Objectives: To evaluate clinical data, peri-operative and
long-term results of anatomic hepatic resections for Int-
rahepatic liver stones (IHS).
Patients and methods: Clinical data, immediate and long-
term outcomes of a cohort of 47 consecutive patients who
underwent anatomic hepatic resections for IHS between
November 1986 and May 2009 were analyzed. Immediate
outcomes included stone clearance rate, operative mor-
bidity and mortality. Long-term results were focused on
stone recurrence rate, with a median follow-up of 73.8
(range 6–274) months. Statistical analysis was made with
SPSS 15.
Results: Mean age was 48.9 years, 64%% were women.
Almost All patients (98%) were symptomatic, being
abdominal pain (89.3%), cholangitis (34.7%) and jaun-
dice (32.6%) the most frequent symptom. Abdominal
ultrasound was diagnostic in 76.1%. Endoscopic retro-
grade cholangiopancreatography (ERCP) was performed
in 73.9%, Magnetic Resonance Imaging in 98% after
year 2000. Twenty seven patients (57.4%) had litiasis in
the left biliary tree, 16 (34%) in the right biliary tree and
4 patients (8.5%) had bilateral disease. The most fre-
quent surgical procedure was left lateral segmentectomy
(43.5%). Seventeen of 19 patients (89.4%) with right IHS
had history of Cholecystectomy in contrast to 16 of 28
(55.2%) patient with left IHS P = 0.027. In uni and
multivariate analysis, previous cholecistectomy demo-
strate to be a risk factor for the development of right IHS
(OR = 5.7 [1.04–31.1]). The immediate stone clearance
rate was 97.8%. Morbidity was 36%. Recurrent stones
were found in 4 patients (8.5%). There was no mortality
in this series.
Conclusions: Anatomical hepatic resection is a safe and
effective surgical treatment for IHS with a low rate of
residual disease. There is a relationship between history
of biliary surgery and development of IHS in the rigth
biliary tree that may be explained by unsuspected right
artery lesion during cholecistectomy.
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BIOCHEMICAL LIVER FUNCTIONS
AFTER HEPATIC RESECTION WITH OR
WITHOUT PARTIAL HEPATIC
VASCULAR EXCLUSION
O. Castro E silva, E. D. Mente, A. K. Sankarankutty,
M. E. J. Souza, M. C. Jordani, S. Zucoloto and
L. Ziviani
Faculdade de Medicina de Ribeira˜o Preto da Universidade
de Sa˜o Paulo
Background: Vascular occlusion may be used to reduce
blood loss during liver resection surgery.
Aim: To assess the advantages and disadvantages (liver
dysfunction due to ischemia) of partial vascular occlusion
during liver resection.
Patients and methods: A total of 114 patients were sub-
mitted to partial hepatectomy (minor versus major
resections) during the period from 1998 to 2008, with
liver partial vascular exclusion (LPVE) being used in 57
of them but not in the remaining 57. Patient age ranged
from 35 to 73 years and 57% were women. Mitochon-
drial function was analyzed by the polarographic method
and was assessed 30 min after liver resection in the liver
remnant, and the proﬁle of serum aminotransferases was
determined before surgery and for seven days postoper-
atively. The hepatectomies were performed for the
treatment of malignant and benign tumors. LPVE time
ranged from 30 to 60 min. Data were analyzed statisti-
cally by the Student T test (5% level of signiﬁcance).
Results: In the minor and major liver resections the levels
of the hepatic respiratory control ratio ranged from
3.0 ± 1.2 to 3.9 ± 1.3 (P > 0.05), with no signiﬁcant
difference between groups with and without LPVE
(P > 0.05).The Mitochondrial Membrane Potential
(MMP) was similar in the two groups (P > 0.05). The
maximum postoperative aminotransferase peak was:
AST, 181 ± 28 to 275 ± 22 without LPVE and
208 ± 31 to 379 ± 58 with LPVE (P > 0.05); ALT,
162 ± 19 to 233 ± 27 without LPVE and 237 ± 43 to
291 ± 49 with LPVE (P > 0.05).
Conclusion: LPVE did not induce mitochondrial changes
in hepatic tissue in either type of surgery. Postoperative
serum aminotransferase levels were similar for patients
with and without LPVE. Thus, the results show that
LPVE is a safe procedure that does not induce signiﬁcant
changes typical of ischemia and reperfusion in the liver
remnant.
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RUPTURED LIVER TUMOURS –
OUTCOMES OF AMULTIDISCIPLINARY
APPROACH
V. Velayutham, J. Sathyanesan, R. Sukumar,
J. Damodaran, G. P. Santhanam, S. Eswaran,
G. Rajarathinam, R. Prabhakar,
R. Shanmugasundaram, R. Palaniappan and
S. Rajagopal
Government Stanley Medical College Hospital
Background: Spontaneous rupture of hepatic tumors
(which includes both benign and malignant liver tumors)
is a life-threatening presentation, with an incidence of 3%
to 14%, which carries signiﬁcant morbidly and mortality.
Aim: To report a single center’s experience of patients
with ruptured liver tumors during a ten year period.
Materials and methods: A retrospective review was per-
formed of all patients who presented with ruptured HCC
between 1999 and 2008. Data on clinical features, treat-
ment strategies, and survival outcomes were collected.
Results: A cohort of 24 patients (18 male and 6 female)
was identiﬁed. The median age at presentation was
48 years. 21 patients had malignant tumors, 3 patients
had benign lesions. Initial bleeding control was at-
tempted by transarterial embolization (TAE) in 8 (33%)
and it was successful in 7 patients. surgery was the pri-
mary modality of management in 16 patients. The pro-
cedures performed were Rt hepatectomy in 3, Lt
hepatectomy in 3 patients, Lt lateral segmentectomy in 2
cases, non anatomical resection in 2 patients and seg-
mentectomy in 1. Hepatic artery ligation was done in 2
and perihepatic packing in 2 patients. Morbidity ob-
served were bile leak in 2, intra abdominal sepsis in 2,
pulmonary complications in 2 and posthepatectomy liver
failure in 1. Mean hospital stay was 14 days. (10 to
28 days.). 8/24 (33.3%) died. The causes of death were
Coagulopathy in 4 patients, sepsis in 3 and post hepa-
tectomy liver failure in 1.
Conclusion: A ruptured liver lesion is a life threatening
event and requires a multidisciplinary approach. Primary
hemostasis, followed by emergency or staged hepatic
resection, is the treatment of choice. Patients who had no
underlying liver disease had better prognosis than those
who had cirrhosis.
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GLISSONEAN APPROACH DURING
ANATOMIC HEPATECTOMIES
D. Fuks1,2, F. Browet1,2, H. Hajji1,2, C. Sabbagh1,2,
O. Brehant1,2, T. Yzet1,3 and J.-M. Regimbeau1,2
1Amiens North Hospital; 2Department of Digestive
Surgery; 3Department of Radiology
Introduction: The glissonean approach (GA) is the sup-
port of anatomical liver resections facilitating selective
clamping. A randomized study showed that this was an
effective technique with low morbidity. The purpose of
this study was to analyze the safety of the AG during
anatomic hepatectomies.
Patients and methods: Between January 2009 and June
2009, 16 consecutive patients who underwent an ana-
tomical hepatectomy (minor or major) were entered into
a prospective database. The technical details, failures and
their causes and complications related to the GA were
analyzed.
Results: There were 11 men and 5 women with a median
age of 59.4 (17–86) years. The indications for hepatec-
tomy were metastases (n = 13) and HCC (n = 2). Ten
patients had a right hepatectomy, 2 a right lobectomy, 1 a
left hepatectomy, 1 a resection of segment II and 1 a
resection of segment VI. During the GA, the initial
control was incomplete in 4 (25%) patients due to ana-
tomical variations (right portal pedicle from the left
branch n = 2, trifurcation n = 2). During the proce-
dure, 1 minimal bleeding and 3 biliary ﬁstulas were ob-
served crossing at the vascular stapler. Three patients had
persistent biliary ﬁstula requiring radiological drainage
(n = 2) and an early interventional endoscopy (death by
severe cholangitis n = 1).
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Conclusion: The GA during anatomic hepatectomies
seems to have a speciﬁc morbidity rarely reported in the
literature. These failures and / or complications should be
prevented by careful analysis on the preoperative scan of
the biliary and portal anatomy.
P-337
LIVER PARENCHYMAL DISSECTION
WHITH A NOVEL LASER DISSECTION
DEVICE - EXPERIMENTAL RESULTS
H. Wolken1, D. Theisen-Kunde2, V. Danicke2,
H.-P. Bruch1 and M. Kleemann1
1Department of Surgery, University Medical Center
Schleswig-Holstein, Campus Luebeck, Germany; 2Institute
for Biomedical Optics, Luebeck, Germany
Introduction: Dissection of liver is performed by utra-
sound, mono and bipolar dissection, waterbeam dissec-
tion, by stapler or former by ﬁnger fracture techniques.
We developed a laser tool for open and laparoscopic
parenchymal dissection to prevent bleeding and bile
leakage.
Material and methods: Based on a 50 W Thulium ﬁbre
Laser System (IPG-Photonics, Burbach, Germany) the
Institute of Biomedical Optics and the Medical Laser
Centre Luebeck developed a surgical laser device (IRS
40, Medical Laser Centre Luebeck GmbH, Germany) in
accordance to the Medical Device Directive 93/42/EEC,
Annex VIII for use in clinical studies. In cooperation
with the Clinic of Surgery at the University Hospital
Schleswig-Holstein, Campus Luebeck this system is now
used for liver resection using 1.9 lm cw laser radiations.
In three animal experiments (pigs) we performed lapa-
rotomy and atypical laser resection of the liver. Early
outcome was detected by 2nd and 3rd week survival.
Clinical and histological results have been evaluated.
Animal experiments were performed in accordance with
the local ethic committee.
Results: We found out using laser radiation for liver
resection takes little time, no secondary bleeding oc-
cured, no bile leakage, and no death of animals. Histol-
ogy showed vascular olititeration upto 2.3 mm.
Conclusion: Laser dissection seemed to be safe in our
preliminary animal experiments.
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CARDIOPULMONARY EXERCISE
TESTING (CPX) FOR THE PRE-
OPERATIVE ASSESSMENT OF RISK IN
PATIENTS UNDERGOING HEPATIC
RESECTION
M. Junejo1, A. J. Sheen1, J. Moores2, P. Foster3,
D. Atkinson2, M. J. Parker2 and A. K. Siriwardena1
1Academic Hepatobiliary Unit, University of Manchester,
Manchester Royal Inﬁrmary; 2Critical Care Unit,
Manchester Royal Inﬁrmary; 3Department of Anaesthesia,
Manchester Royal Inﬁrmary
Introduction: Contemporary liver surgery practice must
assess operative risk in increasingly elderly populations,
with greater co-morbidity and in individuals who have
received chemotherapy. There is a need for objective peri-
operative risk assessment. Dynamic cardiopulmonary
exercise testing (CPX) provides a functional evaluation of
risk with patients who demonstrate either a low anaero-
bic threshold (AT) or a high VE/VCO2 at AT repre-
senting high risk groups. This study evaluates the role of
CPX in patients undergoing hepatectomy.
Methods: CPX was carried out over the 18-month period
to 31st March 2009. Protocol was to undertake pre-
operative CPX over 65 years. During this period 129
hepatectomies were undertaken of who 50 underwent
pre-operative CPX on protocol and constitute the study
population. Demographic data were: median age 71 (47–
84) years, 34 males, median BMI 26 (18.4–41.3), Modal
ASA score 2 (1–4), 16 (39% smokers), 9 (18% NIDDM)
20 (40%) hypertension, 12 (24%) IHD. 22 (44%) had
pre-operative chemotherapy. Median AT 11.55 [7.4–21].
Outcome data on complications, in-patient stay and
mortality were collected. Results are analysed by bi-
variate correlation between CPX and each end-point.
Results: There was 1 death (mortality 2%). Median
HDU stay was 3 (1–10) days; cardiac complications oc-
curred in 5 (10%); pulmonary complications in 22 (44%).
Median in-patient stay was 10.5 (range 3–37) days. There
was a signiﬁcant correlation between AT < 11 and car-
diac complications and VE/VCO2 35.1–41.9 correlated
with overall stay and cardiac complications. Pre-opera-
tive chemotherapy was signiﬁcantly associated with car-
diac complications (P < 0.05).
Conclusions: These preliminary data suggest that CPX is
an objective test of peri-operative risk in liver resection. It
accurately predicts risk of morbidity in a low-mortality
procedure. With further evaluation, CPX testing prom-
ises to become the standard of care for risk assessment
prior to hepatectomy.
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THE ROLE OF PRINGLE MANEUVER
IN THE INCIDENCE OF RED BLOOD
CELLS TRANSFUSIONS
V. Ardiles, S. G. Perez, J. Robin, C. Bonoﬁglio and
E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Intraoperative bleeding and the need of
blood products transfusions are directly correlated with
liver resection’s morbidity and mortality. Pringle
Maneuver is worldwide used to diminish blood loss
during surgery. Recently studies have questioned its
efﬁciency to reduce the number of transfusions.
Objective: To evaluate the relationship between the rel-
evance of the Pringle Maneuver during liver resection
and the number of red blood cells transfusions in peri-
operative period.
Methods: Cohort retrospective study of patients who
went through liver resection between December 2006 and
June 2009. Group A: liver resection without Pringle
Maneuver, Group B: liver resection with Pringle
Maneuver.
Results: One hundred and ninety-three patients (group
A: 64, Group B: 129). Both groups were comparable
taking into account surgeon, sex and age over 70 years.
Group A includes more patients with ASA I (26% (IC:
16.3–39) versus 5,4% (IC 2.2–10.9) P < 0.001, Mean
age: Group A: 49,8 (DS: 18.3) and Group B: 56.6 (DS
14.72) P = 0,006 Group A includes more minor liver
resections. (67.2% (IC 54.3–78.4) vs. 47.7% (IC 38.8–
56.7) P = 0.034) and more benign pathologies (38.5%
Abstracts 263
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
(IC 25–53) versus 15.5% (8.5–22) P = 0.001). There
were no signiﬁcant differences in surgery length and
anesthesia, CVP management, mean hematocrite and
mean hematocrite difference (P < 0.05). The number of
patients who received blood products was greater in
Group B (31 vs. 4) P = 0.0023, RR = 3.6.
Conclusions: Patients with liver resection in whom Prin-
gle Maneuver was used presented 3.6 times more risk to
received blood products. Although it is important to take
into account that these patients were elder, went through
greater percentage of mayor liver resections and included
oncological pathologies.
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Background: The identiﬁcation of glissonian pedicles is a
fundamental step to perform liver segmentectomies. The
relationship between diaphragmatic sulci and the posi-
tion of hepatic veins is well understood. However, on the
visceral surface, few landmarks, besides Gans incisura
(also called Rouvie`re sulcus), have been studied to this
date.
Aim: This study focuses on the identiﬁcation and topo-
graphical relationships of the anatomical landmarks on
the visceral surface of the liver and the glissonian pedicles
of each segment.
Methods: Twenty fresh livers of non-cirrhotic individu-
als, and 10, with macroscopic cirrhotic signs were used.
Results: On average, 2.3 ± 1.06 landmarks related to
pedicles were found per liver. Fewer landmarks were seen
on cirrhotic livers (1 ± 0.69, P < 0.001). Considering
the most common segments surgically resected (6/7, 3
and 4b), relation of their pedicles with anatomical land-
marks on the visceral surface of the liver have been seen
in as much as 60–90% of the specimens.
Conclusion: The anatomical landmarks on the visceral
surface of the liver help in locating the position of glis-
sonian pedicles and can add for the safety and precision
during segmental liver resections.
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Background: The intrahepatic approach and the indi-
vidualization of glissonian pedicles facilitate the selective
ischemia of the Couinaud segments. This technique
avoided the use of the Pringle maneuver especially in
cirrhotic livers with a limited functional parenchyma and
permits the surgeon to outline the segmentary anatomy
of the liver before the hepatic resection.
Aim: To describe the beneﬁts of the intrahepatic
approach technique of glissonian pedicles.
Method: Out of 502 hepatic resections carried out
between January 1990 and July 2009 a selective control of
glissonian pedicles was performed in 142 of them
(28.3%). Segments 2, 3, 4a, 4b, 5, 6, 7 and 8 were resected
individually or in pairs. The right branch of the portal
vein and its paramedian and/or lateral divisions; or the
left branch and its divisions, were dissected and isolated
with the subsequent selective ischemia of the respective
segments. This ischemia delimitation obtained was
ostensible and then the demarcation before the resection
was completed with a continuous cautery outline.
Results: In this select group of patients no postoperative
mortality was observed and the morbidity rate was
20.4%.
Conclusion: With this procedure there is certainly that
the parenchymal area to be resected corresponds to the
Couinaud segment/s previously selected. The results ob-
tained induce to continue with the use of this technique,
by adjusting the hepatic resection to the number and size
of the lesions. Therefore, with this technique the unnec-
essary ischemia of the remaining parenchyma will be
avoided.
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ON PATIENTS WITH HILAR VARICES
O. A. Jarral, R. Kumar, R. C. N. Williamson and
D. R. C. Spalding
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Hammersmith Hospital
Introduction: Given the underlying pathology of many
patients undergoing hepatopancreatobiliary (HPB) pro-
cedures, it is not uncommon to ﬁnd hilar varices as a
complicating factor. Bleeding in such patients is difﬁcult
to control and potentially poses a signiﬁcant operative
risk.
Aim: To identify the impact of hilar varices on planned
HPB procedures and their operative risk based on the
experience of a single institution.
Methods: Between 1995 and 2008, 19 patients with hilar
varices secondary to portal, superior mesenteric or sple-
nic vein occlusion that had undergone an HPB surgical
procedure were identiﬁed. Their operations and clinical
outcome were reviewed retrospectively.
Results: There were 14 men and 5 women of median
age 55 (range 34–86) years. The underlying pathology
was chronic alcoholic pancreatitis in 16 patients (hepa-
ticojejunostomy [HJ] 10, HJ and longitudinal pancre-
atojejunostomy 2, HJ and distal pancreatectomy 1,
abandoned HJ converted to cholecystojejunostomy 2,
abandoned HJ 1) and pancreatic cancer in 3 (pancre-
atoduodenectomy, HJ, and abandoned HJ 1 each).
There were no operative deaths. Although the overall
morbidity was low at 11% (acute respiratory distress
syndrome 1, bile leak 1), signiﬁcant blood loss second-
ary to hilar varices led to 21% (4) of planned proce-
dures being converted to lesser procedures or
abandoned altogether.
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Conclusions: The presence of hilar varices and potential
subsequent blood loss can have a signiﬁcant impact on
planned HPB procedures and should be taken into con-
sideration when identiﬁed prior to surgery.
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Background: The application of skills of OLT to liver
surgery has raised the threshold of resectability to limits
previously unexpected.
Aim: We present four cases of huge LM successfully
resected using ‘extreme liver surgery’ techniques.
Patients and methods: There were 2 men and 2 women.
Primary tumor was CRC 2 cases, apocrine tumor and
NET. Age was 59.5 ± 7.4 years. Two patients had been
operated of the primary but the CRC were still in place.
The CT scan showed bilateral, multiple (range 2–6), huge
(7.3 ± 3 cm) LMwith compromise of hepatic veins (HV)
and the vena Cava. POPE was performed in 3 cases.
Results: All patients underwent extended liver resections
with TVE, V-V by-pass and hypotermic liver perfusion.
Three patients underwent resection of the vena Cava and
replacement with Goretex and one resection of 3 HV and
reconstruction of the right HV with autologous renal
vein. V-V By-pass was 122 ± 15 min, TVE 101 ± 7 min.
Cold ischemia 86 ± 6 min. Normothermic ischemia
25.5 ± 5 min. Intraoperative transfusion was 12 ± 4.8
PRC. 30 days mortality was nil. However, one patient
was reoperated for hemorrhage, 2 presented biliary ﬁs-
tula, 2 intrabdominal abscesses and 2 wound infection.
Discussion: New chemotherapy for CRC has achieved
high objective response. The use of TVE, V-V by-pass
allows performing extended hepatic resections and com-
plex vascular reconstructions. Hypothermic perfusion
minimizes the ischemia reperfusion injury of prolonged
liver clamping. Our cases combine modern technical
reﬁnements with new oncological concepts such ‘reverse
approach’ in the treatment of LM to offer a treatment
with curative intent to otherwise unresectable patients.
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THE USE OF A VESSEL SEALING
SYSTEM IN HEPATIC RESECTION
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Background: Today, intraoperative severe blood loss re-
mains a major problem for surgeons operating on the
liver. Most of them occur during parenchymal transec-
tion. A variety of different surgical techniques such as
unipolar cautery, bipolar cautery, standard bipolar cau-
tery, harmonic scalpel, ultrasonic dissectors, water jet
dissection, stapling devices, laser systems, and the ﬂoat-
ing ball apparatus system have been described for limit-
ing blood loss.
Aim: In this study, we aimed to present our experience
with the bipolar vessel-sealing device (BVSD) during
hepatic resection with 25 patients.
Methods: Between May 2002 and December 2008, 25
patients underwent hepatic surgery for different surgical
pathologies. The Brisbane 2000 terminology of the
International Hepato-Pancreato-Biliary Association has
been used for liver anatomy and resection. Patient
characteristics, indications, surgical procedures and
complications were assessed.
Results: The patients were 17 females and 8 males.
Indications were as follows: 7 echinococcal cysts, 5
metastatic colorectal cancers, 4 metastatic gallblader
carcinomas, 3 hepatocellular carcinomas, 3 hemangio-
mas, and 1 each blunt hepatic trauma, metastatic gastric
carcinoma, cholangiocarcinoma. There were one intra-
operative and four postoperative complications. Vena
cava ruptures occured intraoperatively. Postoperatively,
hemorrhagia, incisional hernia, intrabdominal abscess
and right pleural effusions associated with pneumonia
occured. Mean intraoperative total blood loss was
200 min (range: 150–800 min).
Summary/Conclusions: We may say that the use of the
LigaSure vessel sealing system for hepatic surgery is an
effective and safe method.
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PRINGLES MANEUVER VERSUS
SELECTIVE VASCULAR EXCLUSION IN
MAJOR HEPATECTOMIES – IS THERE
A DIFFERENCE? – EXPERIENCE FROM
A DEVELOPING COUNTRY
A. Pathirana, T. Wijeratne, C. Wijesurendere and
S. Silva
University Surgical Unit, Colombo South Teaching
Hospital, Kalubowila, Sri Lanka
Background: Intra-operative blood loss (IBL) is an
important determinant of the outcome of hepatic resec-
tions. Method of transection and vascular control affects
IBL. Intermittent Pringle maneuver (IPM) and Selective
Hepatic Vascular Exclusion (SHVE) are widely adopted
methods of vascular control. IPM being technically less
demanding can be performed by surgeons with limited
experience in liver surgery. While some studies have
shown SHVE to be superior, there are others which have
not shown a difference in outcome.
Aim: To compare the IBL, total operative time (TOT)
and immediate outcome, in patients undergoing major
hepatectomy with either IPM or SHVE in a centre with
limited resources.
Methods: A comparative study. A total of 19 patients
underwent major hepatectomies (resection of 3 or more
anatomical segments) at the University Surgical Unit,
Colombo South Teaching Hospital from October 2003 to
June 2009. Thirteen underwent IPM and the others
SHVE. All selected patients had non-cirrhotic livers with
normal liver function tests preoperatively. The paren-
chymal transaction was done exclusively by Kelly clamp
crushing technique.
Abstracts 265
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Results: The mean age of the two groups were 50
(SHVE) and 39.2 years (IPM) (P = 0.42). The ASA was
similar in both groups. Mean IBL was 641.7 mL and
802.3 mL in the SHVE and IPM groups respectively
(P = 0.92). Average TOT was 4.75 hours (SHVE) and
4.69 hours (IPM) (P = 0.52). There was neither in hos-
pital mortality nor signiﬁcant morbidity in both groups,
except for a death on day 2 from myocardial infarction in
the IPM group.
Discussion: The results obtained from this study shows
that vascular control achieved from IPM is of equiva-
lence to SHVE, with regards to IBL, TOT and immediate
outcome in major hepatectomies.
P-346
THE MODIFIED ‘50-50 TRANSFUSION
[TR] CRITERIA’ IS SUPERIOR FOR THE
PREDICTION OF HEPATIC FAILURE
AND MORTALITY FOLLOWING
RESECTION OF CRLM
G. Morris-Stiff, D. Gomez, G. Toogood,
J. P. A. Lodge and K. R. Prasad
Department of Hepatobiliary and Transplant Surgery,
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Background: The ‘50-50 criteria’ on day 5 has been
advocated as a means of predicting the development of
liver failure and death following hepatectomy.
Aim: To validate these criteria’ in a contemporaneous
non-cirrhotic cohort undergoing resection for colorectal
liver resection (CRLM) and assess the additional
importance of blood transfusion.
Methods: Patients undergoing resection of CRLM from
2000 to 2005 were identiﬁed from a prospectively main-
tained database. Data collected included: peri-operative
factors (extent and complexity of resection, blood/plasma
transfusion); histopathological factors (degree of steato-
sis/ﬁbrosis); post-operative (morbidity rate, ICU stay,
mortality).
Results: During the study period 386 patients (246 male
and 140 female) with a mean age of 65.9 years underwent
resection. 28/386 (7.3%) of patients fulﬁlled the criteria.
The ‘50-50 criteria’ did not relate to any peri- or post-
operative factors or predict liver failure/death although
mortality was higher in the case of positive criteria
(P < 0.001). If peri-operative transfusion requirement
(blood or plasma) was excluded, the ‘50-50 criteria’ were
accurate in predicting morbidity (P < 0.001), hepatic
failure (P < 0.001) and mortality (P < 0.001). When
the need for transfusion was incorporated into the ‘50-50
criteria’, the ‘50-50Tr’, all mortalities were within this
cohort as were all cases of hepatic failure. The ‘50-50Tr’
had a superior sensitivity for both mortality (100 vs.
50%) and prediction of liver failure (100% vs. 9.5%) at
the expense of speciﬁcity. The negative predictive value
was 100% for both mortality and liver failure in the ‘50-
50Tr’ group.
Conclusions: The ‘50-50 criteria’ are not able to accu-
rately predict outcome in patients undergoing resection
of CRLM. The modiﬁed ‘50-50Tr’ criteria appear supe-
rior for CRLM and we would suggest that the need for
transfusion in the modern era of resection should be re-
garded as an additional indicator for the need of vigi-
lance.
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PROGNOSTIC FACTORS OF SURVIVAL
IN REPEAT LIVER RESECTION FOR
RECURRENT COLORECTAL
METASTASES
D. Brachet, E. Lermite, G. Desolneux, S. Mucci,
A. Hamy and J. P. Arnaud
University Hospital Center Angers
Purpose: Liver metastases develop in 50 percent of pa-
tients with colorectal carcinoma. Recurrent liver disease
is usual. Repeat liver resection remains the only curative
treatment. The aim of this study was to review our data
on repeat hepatectomy and to analyze potential prog-
nostic factors of survival.
Method: Patients who underwent repeat liver resection
for metastases of colorectal carcinoma between January
1992 and August 2007 were identiﬁed from a prospective
database and their medical records were analyzed.
Results: Of 62 patients who underwent a second hepa-
tectomy, 15 underwent a third hepatectomy, and two
underwent a fourth hepatectomy. There was no periop-
erative mortality. Morbidity was less than 20 percent for
the ﬁrst and second hepatectomies. Overall 5-year sur-
vival rate after ﬁrst hepatectomy was 40 percent. Uni-
variate analysis identiﬁed three risk factors conﬁrmed by
log-rank test and multivariate Cox regression analysis:
serum carcinoembryonic antigen concentrations
> 5 ng mL-1 at ﬁrst hepatectomy (HR = 2.265, CI =
1.140–4.497, P = 0.020), anatomic resection (HR =
2.124, CI = 1.069–4.218, P = 0.031), and tumors
‡ 3 cm at the second resection (HR = 2.039, CI =
1.013–4.103, P = 0.046).
Conclusion: Our study shows that repeat hepatectomy
for liver metastases of colorectal carcinoma may be
performed with low mortality and morbidity. Preopera-
tive concentration of carcinoembryonic antigen at ﬁrst
hepatectomy, tumor size, and type of anatomic resection
are independent prognostic factors.
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TRENDS IN LONG-TERM SURVIVAL
AFTER HEPATECTOMY FOR
COLORECTAL METASTASES OVER THE
LAST TWO DECADES AT A SINGLE
CENTER
M. Cescon, G. Vetrone, G. L. Grazi, G. Ercolani,
G. Stacchini, M. Ravaioli, M. Del Gaudio, A. Cucchetti,
A. Lauro, A. Dazzi, P. Di Gioia, F. Tuci, C. Zanﬁ and
A. D. Pinna
Department of General Surgery and Transplantation,
University of Bologna
Background: Long-term outcomes after hepatectomy for
liver metastases from colorectal cancer (CRC) have re-
cently improved. However, single-center evaluations of
trends in postoperative survivals in the last two decades
are lacking.
Methods: From 1990 to 2008, 468 patients underwent
hepatectomy for metastases from CRC with a curative
intent at our Institution. Two-hundred forty-eight (53%)
patients were operated on before the year 2000 (group
A), and 220 (47%) did afterwards (group B). Demo-
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graphic, clinical, tumor-related, and surgical and out-
come parameters were compared between the 2 groups.
Results: Group B patients were signiﬁcantly older, with a
higher number of co-morbidities and of liver metastases
vs. group A patients. Group B received more frequently
extended hepatectomies and simultaneous colon resec-
tions, but also less intraoperative blood transfusions vs.
group A. Postoperative morbidity and mortality were
18% vs. 27% (P = 0.03), and 1.2% vs. 2.3% (P = 0.3)
in group A vs. group B, respectively. Five-year overall
survival was 35% in group A and 44% in group B
(P = 0.01). Five-year disease-free survival was 25% in
group A and 30% in group B (P = 0.2). On multivariate
analysis, absence of intraoperative blood transfusions
(P = 0.05), the possibility of receiving repeated hepa-
tectomies for tumor recurrence (P = 0.01), and opera-
tions performed after the year 2000 (P = 0.05) were
independent predictors of better overall survival.
Conclusions: More complex patients and aggressive sur-
gical treatments were observed after 2000. Although the
recent longer survival of patients undergoing hepatec-
tomy for metastases from CRC can be partly ascribed to
the improvements of multidisciplinary approach and of
adjuvant treatments, advances in surgical techniques
played a fundamental role.
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QUANTIFICATION OF HEPATIC
STEATOSIS AND VOLUME IN
PREDICTING HEPATIC DYSFUNCTION
AND COMPLICATIONS AFTER LIVER
RESECTION FOR COLORECTAL
METASTASES
A. Young, D. Wilson, J. Ward, J. Biglands, A. Guthrie,
R. Prasad, G. Toogood and P. Lodge
St James’s University Hospital, Leeds
Introduction: Accurate prediction of the safe remnant
liver volume to minimize complications following liver
resection remains a challenge.
Aim: To assess whether quantiﬁcation of steatosis im-
proved the predictive value of pre-operative volumetric
analysis.
Methods: Thirty patients were recruited prospectively
who were planned to have a right hemi-hepatectomy for
colorectal metastases. MRI was used to carry out quan-
tiﬁcation of remnant liver steatosis and future remnant
volume. These values were then used to assess correla-
tions with hepatic insufﬁciency, complications and post-
operative stay. Correlations of remnant percentage,
remnant mass to patient mass and remnant mass to body
surface area with and without steatosis measurements
were assessed.
Results: In 10 patients the planned liver resection was
altered. Moderate-severe hepatic dysfunction was seen in
17 patients. Complications arose in 14 patients. Median
stay was 10 days. The median level of steatosis was
3.8% (1.2–17.6%), but was higher in the group of pa-
tients who had pre-operative chemotherapy (n = 10,
P = 0.057). The correlation of remnant liver mass to
patient mass was the strongest correlation (P < 0.001,
r = 0.77). However addition of steatosis quantiﬁcation
did not improve this correlation (P < 0.001, r = 0.76).
These results were consistent with the other outcome
measures.
Conclusion: Surgeons make pragmatic intra-operative
decisions regarding operative planning to balance risk to
beneﬁt ratio for each individual patient. This makes
studies such as this difﬁcult and open to bias. This is the
ﬁrst study to combine volumetric with steatosis quanti-
ﬁcations. No signiﬁcant beneﬁt was seen by adding
steatosis quantiﬁcation to volumetric analysis in this
small pilot however these techniques may be useful in
operative planning, particularly in patients receiving pre-
operative chemotherapy.
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HEPATIC RESECTION FOR
NON-COLORECTAL, NON-
NEUROENDOCRINE METASTATIC
TUMOURS – A SINGLE CENTRE
EXPERIENCE
R. Marudanayagam, B. Sandhu, T. Perera, P. Taniere,
C. Coldham, S. Bramhall, D. Mayer, J. Buckels and
D. Mirza
Queen Elizabeth Hospital, University Hospital of
Birmingham NHS Foundation Trust, Birmingham, U.K
Background: Hepatic resection is an accepted form of
treatment for patients with liver metastasis from colo-
rectal and neuroendocrine tumours. However, the role of
liver resection remains ill-deﬁned and controversial for
patients with metastasis from non-colorectal, non-neu-
roendocrine carcinomas (NCRNNE).
Aim: To analyse the outcome following hepatic resection
for non-colorectal, non-neuroendocrine metastatic tu-
mours and to identify factors predicting survival.
Methods: All the patients who underwent hepatic resec-
tion for NCRNNE metastatic tumours between Sep-
tember 1996 and June 2009 were included in the study.
Patients who had resection for metastatic sarcomas were
excluded from the study. Patients’ demographics, clinical
and histopathological parameters, overall survival and
the factors predicting survival were analysed.
Results: Sixty-ﬁve patients underwent hepatic resection
for metastasis, with a median age of 59 years. The most
common site of primary tumour was kidney (36.9%).
The median interval between resections of the primary
and metastatic tumours was 30 months. Fifteen patients
(23.1%) had synchronous tumours. 50 patients (76.9%)
had major liver resections and 22 patients (33.8%) had
bilobar disease. The median number of liver lesions re-
sected was 1 (range: 1–7) and the median maximum
diameter of the metastasis was 6 cm. R0 resection was
performed in 51 patients (78.5%). The 1-, 3- and 5-year
overall survival from the time of metastasectomy was
72.9%, 47.9% and 25.6% respectively, with a median
survival of 19 months. Presence of a tumour of > 6 cm
(P = 0.048) and positive resection margin (P = 0.04)
were associated with poor survival. The 5-year survival
improved to 32.1% following R0 resection, compared
with 16.7% for R1 resection.
Conclusion: Hepatic resection for metastasis from
NCRNNE tumours can offer acceptable long-term sur-
vival in selected patients. The aim of surgery must be a
R0 resection to offer a chance of cure.
Abstracts 267
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
P-351
REPEAT LIVER RESECTIONS IN
PATIENTS WITH COLORECTAL
METASTASES: INDICATIONS AND
SAFETY
V. Vishnevsky, M. Efanov, R. Ikramov, N. Nazarenko,
T. Shevchenko, D. Ionkin, I. Kazakov and I. Kozyrin
A.V. Vishnevsky Institute of Surgery, Moscow
Background: Repeat liver resections in patients with liver
malignancy seem to be safe and most effective thera-
peutic approach for recurrent hepatic tumors as it was
shown recently. Indications for repeat liver resections are
still the object for discussion.
Aim: To estimate short and long term results after repeat
liver resections in patients with recurrent colorectal
metastases in order to clarify indications for rehepatec-
tomy.
Material and methods: From 1995 to 2007 27 patients
with recurrent colorectal metastases underwent repeat
liver resections. The total number of primary and repeat
liver resections was 62. Six patients underwent third and
forth liver resections. Control group included 32 patients
with single liver resection.
Results: There were 56% of complications according to
Clavien: I–4%, II–44% (equally pleural effusion and li-
quid abdomen collection that required single puncture),
III–4%, IV–4%. Actuarial 5-year survival after primary
liver resection was 54%, 4-year survival after second liver
resection–40%. Morbidity did not differ signiﬁcantly
from control group but survival was signiﬁcantly better.
Univariate analysis revealed that tumor size > 70 mm
(P = 0.037), tumor vascular invasion (P = 0.005) and
tumor recurrence within 12 months (P = 0.034) were
negative factors for survival.
Conclusion: Indications for repeat liver resections are the
same as for primary liver resections and depend on
respectability of metastatic tumor. Early recurrence and
large tumors with vascular invasion should be considered
in order to optimize outcomes after repeat liver resec-
tions.
P-352
IMPACT OF NEOADJUVANT
CHEMOTHERAPY IN COLORECTAL
LIVER METASTASES ON LIVER
FUNCTION BEFORE HEPATECTOMY
J. F. Lock, T. Westphal, M. Malinowski, P. Neuhaus and
M. Stockmann
Department of General, Visceral and Transplantation
Surgery, Charite´ - Universita¨tsmedizin Berlin
Background: Recent literature has shown the beneﬁt of
neoadjuvant chemotherapy of colorectal liver metastases
on respectability and survival. However, the potential
hepatic injury due to chemotherapy has remained a
controversial issue.
Aim: Investigate the impact of preoperative chemother-
apy on liver function capacity.
Methods: A prospective study assessing liver function
capacity during the preoperative evaluation for hepatec-
tomy. Determination of liver function by the LiMAx test
as the primary outcome variable. The LiMAx determines
the metabolic capacity based on cytochrome P450 1A2.
Non-parametric analysis of chemotherapy regime, num-
ber of cycles and chemotherapy free interval vs. liver
function. Values provided in median (IQR).
Results: Eighty-two patients were analyzed yet. Forty-
eight patients (59%) received chemotherapy within
12 months prior evaluation (17% 5-FU, 33% FOLFOX,
35% FOLFIRI, 15% FOLFOXIRI), with 8 (5–14) cycles
and a chemotherapy free interval of 8 (5–25) weeks. Pa-
tients with chemotherapy had a LiMAx of 360 (286–
416) lg kg-1hour-1 vs. 348 (288–391) lg kg-1hour-1 for
control. The correlation between LiMAx and number of
cycles was r = -0.244 (P = 0.095), and for time interval
r = 0.279 (P = 0.055). When a factor consisting of
chemotherapy regime, number of cycles and chemother-
apy free interval was calculated, the correlation with
LiMAx was r = 0.398 (P = 0.005).
Conclusion: Chemotherapy does not necessarily impair
liver function capacity in patients with colorectal liver
metastases. However, the preoperative liver function is
directly associated with the individually applied chemo-
therapy regime, the number of cycles and the chemo-
therapy free interval. No negative impact was observed in
cases with a limited number of cycles and an appropriate
chemotherapy free interval.
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HEPATECTOMY FOR ISOLATED
MELANOMA METASTASES
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T. Selbach1,2 and J. Dembogurski1,2
1Santa Casa Hospital of Porto, Alegre; 2Federal
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Background: Hepatic metastases are more common than
primary liver tumors in most countries. In comparison
with the colorectal hepatic metastases, the resection of
non-colorectal tumors still is a growing ﬁeld. Hence there
are few articles over this situation and there is no con-
sensus over the resection of these metastases.
Methods: Between 1993 and 2007, 94 patients underwent
surgery for non-colonic, non-endocrine hepatic metasta-
ses in one center. From this group, ten (10.6%) presented
metastases of melanoma, which will be reviewed in this
article. The evaluation of the lesions was made with CT
scan or MRI. The resection was considered to be curative
when the margins were free of disease on the pathologic
examination. The follow-up and death rate of the out-
patients was made through research of the secretary of
health database. Survival was analyzed using Kaplan
Meier model.
Results: There were a total of six women in the group, the
average age was 52-years-old. In all patients the metas-
tases occurred after the diagnosis of the primary tumor,
with a minimum interval of one year. Three were sec-
ondary to ocular melanoma and seven to cutaneous le-
sions. Regarding the surgical procedures, there were three
major hepatectomies, and eight margin free resections
were obtained. In two patients, despite the intraoperative
US and previous image exam demonstrating a unique le-
sion, there were small implants on the surgical margin. In
four patients the portal vein clamping was necessary and
the bleeding estimative was 300 mL. In only one patient
who presented with intratumoral bleeding there was need
to transfusion of packed red blood cells. There was no
intraoperative mortality. On the follow-up, 18 months
after the surgery 70% of the patients were alive.
Conclusion: The resection of metastases of melanoma is
feasible, safe and improves survival. However, there is
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the need of more trials with more patients so we can
reach a consensus of the best approach to these patients.
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TWO-STAGE SURGERY AS AN
EFFICIENT METHOD OF THE
TREATMENT OF COLORECTAL LIVER
METASTASES
N. Bagmet, O. Skipenko, L. Polischuk, T. Tarasyuk and
R. Polyakov
Russian Research Center of Surgery
The small size of the remnant liver and chemotherapy
induced liver injury increase the risk of postoperative
hepatic insufﬁciency after major resection for colorectal
metastases. Two-stage hepatectomy with or without
portal vein embolization (PVE) or ligation (PVL) allows
treatment of multiple bilobar tumors without additional
morbidity or mortality.
We retrospectively reviewed 42 patients who had PVE
(n = 7) or PVL (n = 35). PVE was performed in 20
patients after chemotherapy (average 7.5 cycles). A
comparable cohort of 51 patients (control group) who
had a one-stage hepatectomy was selected on the basis of
demographic and liver volume characteristics. The FLR
at presentation was signiﬁcantly smaller in patients who
underwent PVE or PVL then in patients in control group
(27% vs. 36%, P = 0.00015). PVL was associated with
minor liver resection of future liver remnant (FLR) in 13
patients (31%). Preoperative FLR volumes were similar
in both groups (38% in PVE/PVL group vs. 36% in
control group).
There was no mortality from PVE or PVL. The mean
increase in standardized FLR was 12.3% (range 2–29%):
11.1% after PVE and 12.6% after PVL. Two-stage
hepatectomy procedure could be achieved in 32 of 42
patients (76.2%). Mortality after second stage occurred
in 1 patient (3.1%) in PVL group. No patient developed
postoperative hepatic insufﬁciency in PVL and PVE
groups. Liver failure was in 3 patients (5.9%) in the
control group. The 4-year survival after liver resection
with PVE or PVL was 51%, compared with 66% in
control group (P = 0.97). The 2-year disease-free sur-
vival was 18% post PVE/PVL and 28% without PVE
(P = 0.97).
In selected patients with initially unresectable colorectal
liver metastases, a major liver resection combined with
PVE or PVL can be achieved safely with long-term
survival similar to that observed in patients with initially
resectable liver metastases.
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METASTATIC DISEASE OF THE LIVER:
COMPARISON OF CEUS VS. US AND CT
IN THE EVALUATION OF DIAGNOSTIC
PERFORMANCE AND CONFIDENCE
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and S. Cantoni3
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S Martino Genova
The aim of this study was to compare contrast-enhanced
ultrasound (CEUS) to baseline US and multiphasic
contrast-enhanced computed tomography (CT) in meta-
static disease of the liver diagnosed or suspected by US
during presurgical staging or post-surgical follow-up for
primary malignancies.
Two hundred and ﬁfty-three patients considered suitable
for US due to complete explorability of the liver and with
one to ﬁve proven or suspected liver metastases at
baseline US were included. All patients underwent US
before and after microbubble injection of second gener-
ation contrast media and multiphase contrast-enhanced
CT. Independent panels of readers reviewed US and CT
scans and recorded liver metastases according to a 5-
grade scale of diagnostic conﬁdence. Sensitivity, speciﬁc-
ity (diagnostic performance) and area under the receiver
operating characteristics (ROC) curve (diagnostic conﬁ-
dence) were calculated.
Reference standards revealed no metastases in 57/253,
more than ﬁve in 59/253 and one to ﬁve in137/253
patients. In patients with one to ﬁve metastases CEUS vs.
baseline US revealed more metastases in 64/137 patients
and the same number in 73/137 patients while CEUS vs.
CT revealed more metastases in 10/137 patients, the same
number in 99/137 patients, and lower number in 28/137
patients. Sensitivity, speciﬁcity and area under ROC
curve of CEUS (83%, 84%, 0929 respectively) differed
from baseline US (40%, 63%, 0.579 respectively,
P < 0.01) while did not differ from CT (89%, 89%,
0.945 respectively; P > 0.05).
CEUS improved liver metastases diagnosis in compari-
son with baseline US while it revealed similar diagnostic
performance and conﬁdence to contrast-enhanced CT in
patients considered suitable for US and with proven or
suspected liver metastases at baseline US.
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PREDICTION AND EARLY DETECTION
OF POST-HEPATECTOMY LIVER
FAILURE BY PERIOPERATIVE USE OF
THE LIMON METHOD OF
INDOCYANINE GREEN ELIMINATION
N. De Liguori Carino, D. A. O’reilly, K. Dajani,
P. Ghaneh, G. J. Poston and A. V. Wu
University Hospital Aintree, Liverpool
Introduction: A non-invasive liver function monitoring
system, the LiMON, has been developed that measures
indocyanine green (ICG) elimination by pulse spectro-
photometry.
Aims: To assess the relationship between pre and post-
operative ICG plasma disappearance rate (ICG PDR %/
min) values and the onset of post-hepatectomy liver
dysfunction in non-cirrhotic patients.
Methods: Thirty seven patients scheduled for major liver
resections were selected. None had chronic liver disease.
IGC PDR was measured preoperatively and on days 1, 5
and 10 postoperatively. On the same day, serum liver
function tests were measured.
Results: The median preoperative and post-operative
day 1 ICG PDR for the patients who developed liver
dysfunction was signiﬁcantly lower compared to the one
of those who did not (P = 0.044, P = 0.014). Signiﬁ-
cant correlation was found between ICG PDR mea-
surement taken on postoperative day 1 and bilirubin level
on day 1 (P = 0.002), 5 (P = < 0.001) and 10
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(P = 0.001). The same was true for IGC PDR on post-
operative day 1 and albumin level on day 5 and 10
(P = 0.003, P < 0.001).
Discussion: Limon ICG PDR measured by pulse spec-
trophotometry is a quick, non-invasive and reliable liver
function test in patients undergoing liver resection that
aids in the prediction and early detection of post-hepa-
tectomy liver dysfunction.
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RADIOFREQUENCY ABLATION
INDUCES A LOCAL HYPOXIA-DRIVEN
CD95 DEPENDENT INVASION OF
COLORECTAL LIVER METASTASES
J. R. Nijkamp, F. J. H. Hoogwater, E. J. A. Steller,
B. F. Westendorp, M. W. H. Leenders,
T. van der Meulen, O. Kranenburg and
I. H. M. Borel Rinkes
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Utrecht, Utrecht
Background: Radiofrequency ablation (RFA) is an
alternative treatment option for patients with non-
resectable liver metastases. Recently, we have shown in a
murine model that RFA induces accelerated outgrowth
of pre-established micrometastases in the perinecrotic
transition zone, which is associated with hypoxia.
The CD95/CD95 ligand system is best known for its
ability to induce apoptosis. Under certain conditions,
however, it imposes pro-invasive effects. Here, we
hypothesize a role for the CD95/CD95 ligand system in
RFA-induced, hypoxia driven, accelerated outgrowth of
colorectal liver metastases.
Methods: In vitro experiments were performed to show
whether hypoxia induced CD95-dependent tumor cell
invasion. In a murine model, the early effects of RFA on
pre-established micrometasases in the perinecrotic tran-
sition zone were assessed in vivo using- Green Fluores-
cent Protein-expressing C26 tumor cells. To assess the
role of CD95/CD95L system in RFA induced invasive-
ness and outgrowth of tumor cells; we used CD95L
neutralizing antibody or CD95 knockdown cells using
shRNA-interference.
Results: Under hypoxic conditions, the CD95/CD95L
system was upregulated and activated, without inducing
apoptosis. Hypoxia resulted in in vitro invasion of tumor
cells, which could be abrogated by inhibiting the system
using MFL4 and CD95 knockdown cells. In vivo, RFA
induced a highly invasive phenotype of the micrometas-
tases located in the perinecrotic transition zone. Both
invasiveness and outgrowth of tumor cells following
RFA decreased by CD95L neutralizing antibody or
CD95 knockdown.
Conclusion: RFA induces a highly invasive hypoxia dri-
ven phenotype of metastatic colorectal tumor cells in the
transition zone. The CD95/CD95L system is as a key
regulator of the local invasive outgrowth following
RFA. Our results implicate that CD95L neutralizing
agents could be of therapeutic beneﬁt in patients with
non-resectable colorectal liver metastases treated with
RFA.
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ASSOCIATION OF PREOPERATIVE
CHEMOTHERAPY WITH
STEATOHEPATITIS IN SURGICAL
PATIENTS WITH HEPATIC
COLORECTAL METASTASES
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Background: The treatment of hepatic colorectal cancer
metastases is increasingly multi-modal. Preoperative
chemotherapy may be associated with steatohepatitis
(SH), which can increase operative morbidity. Our
objective was to determine if preoperative chemotherapy
is associated with SH and to determine which agents
confer the greatest risk.
Methods: One hundred and forty nine patients who had
undergone liver resection or biopsy for hepatic colorectal
cancer metastases were identiﬁed from an institutional
database. Surgical specimens were assessed for percent
steatosis and SH as deﬁned by the Kleiner score. The
medical record was reviewed for preoperative chemo-
therapy and post-operative course. The association of
preoperative chemotherapy with steatosis and SH was
assessed. Preoperative non-contrast CT scans were re-
viewed for evidence of steatosis as determined by the
radiographic liver/spleen (L/S) ratio. The association of
the L/S ratio with the presence of SH was determined.
Post-operative outcome was compared in patients with
and without SH.
Results: The mean age of the population was
60.8 ± 11.6 years, 56% of patients were male, and 37%
of patients had preoperative chemotherapy. SH was
identiﬁed in 45.7% of specimens. There was no statisti-
cally signiﬁcant difference in the rate of SH (59% vs.
50%, P = 0.49) or percent steatosis (37% vs. 32%,
P = 0.29) with or without preoperative chemotherapy.
No individual agent predicted a greater risk of SH or
steatosis. There was no signiﬁcant difference in the L/S
ratio in patients with or without SH (P > 0.05). In pa-
tients undergoing liver resection, there was no difference
in total ICU stay, blood loss, total surgery time or total
length of stay between the SH and non-SH groups.
Conclusions: Although steatohepatitis remains a poten-
tial complication of systemic chemotherapy in surgical
patients with hepatic colorectal metastases, the risk and
impact of chemotherapy associated steatohepatitis have
not been signiﬁcant in our patient population.
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UPFRONT HEPATIC RESECTION FOR
METASTATIC COLORECTAL CANCER
S. Nanji1, P. Ryan2, M. Guindi2, S. Selvarajah1,
P. Greig1, I. McGilvary1, B. Taylor1, A. Wei1,
C.-A. Moulton1, S. Cleary1 and S. Gallinger1
1Department of Surgery, University of Toronto, Toronto,
Canada; 2Department of Pathology, University of
Toronto, Toronto, Canada
Background: Hepatic metastasis from colorectal cancer
(CRC) is best managed with a multimodality approach.
However, the optimal timing of resection in relation to
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perioperative chemotherapy remains unclear. Our strat-
egy has been to offer upfront liver resection for patients
with resectable hepatic metastases, and post liver resec-
tion chemotherapy for chemo-naı¨ve cases.
Objective: To evaluate our surgical approach to CRC
liver metastases by describing overall and disease free
survival as well as to identify clinical predictors of sur-
vival.
Methods: A retrospective review of all patients under-
going liver resection for CRC metastases over a 5-year-
period (2002–2007) was performed. Median follow-up
was 35 (range 8–80) months. Clinical and pathologic
factors were evaluated using the Cox proportional haz-
ard method.
Results: Three hundred and thirty six patients underwent
liver resection with a median of 2 metastases (1–15). The
majority (n = 187, 56%) had synchronous disease and
most patients (n = 286, 85%) had a major hepatectomy
(> 3 segments). Thirty six (11%) patients received pre-
operative chemotherapy, predominantly for down stag-
ing unresectable disease. Ninety-day mortality was 2.1%
and perioperative morbidity occurred in 90 (27%) pa-
tients. Actual disease free survival at 3 and 5 years were
46.2% and 42%, respectively. Actual overall survival at 3
and 5 years were 63.7% and 55%, respectively. Multi-
variate analysis revealed size > 6 cm (HR (95% CI) =
2.5 (1.5–4.2)), positive lymph node status (2.2 (1.1–4.4))
and treatment with chemotherapy after liver resection
(0.46 (0.26–0.83)) correlated signiﬁcantly with overall
survival.
Conclusions: Results from this contemporary series sug-
gest that an upfront surgical approach for patients with
resectable CRC liver metastases, followed by chemo-
therapy, can lead to good long-term overall survival.
There remains a need for multicentre randomized trials
to compare perioperative and postoperative chemother-
apy for this common problem.
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TRENDS IN TREATMENT FOR
COLORECTAL SYNCHRONOUS LIVER
METASTASES: DIFFERENCES IN
OUTCOME BEFORE AND AFTER 2000
A. van der Pool, Z. Lalmahomed1, J. de Wilt,
A. Eggermont, J. Ijzermans and C. Verhoef
Erasmus University MC - Daniel den Hoed Cancer Center
Background: The traditional treatment for stage IV
colorectal cancer has changed from palliative chemo-
therapy toward an aggressive multimodality approach.
Objective: Outcome in patients who underwent surgery
for synchronous colorectal liver metastases in a single
center was evaluated.
Methods: From January 1991 to May 2008 all consecu-
tive patients with synchronous colorectal liver metastases
who underwent curative resection of both primary and
metastatic disease were included. Date of resection was
divided into two groups: date of hepatic resection before
and after the year 2000.
Results: Before 2000, 50 patients underwent resection
and after 2000, 142 patients. Patients who underwent
hepatic surgery after 2000 were older, had more
advanced metastatic disease and 64% of the patients
received neoadjuvant chemotherapy (CTx). After 2000,
more extra-anatomic resections (parenchyma-sparing
resections) were performed. The estimated 5-year disease-
free survival before and after 2000 was 9% and 27%,
respectively (P = 0.4). A higher percentage of patients
(62% vs. 28%) who underwent resection after 2000,
underwent resection or was treated with local therapy for
intra-hepatic recurrence. The estimated 5-year survival
before and after the year 2000 was 26% and 44%,
respectively (P = 0.001).
Conclusion: Survival rates in patients with colorectal
synchronous liver metastases have been increased in the
past decade. The introduction of new chemotherapeutic
drugs and a more aggressive treatment approach in pa-
tients with liver recurrence were major factors in this
progress.
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PREPARATORY CHEMOTHERAPY
WITH BEVACIZUMAB IN
UNRESECTABLE LIVER METASTASES
OF COLORECTAL CANCER. HIGH
RESPONSE AND RESECTABILITY RATE
J. Figueras1, S. Lopez-Ben1, J. Soriano2, M. Albiol1,
X. Hernandez-Yagu¨e3, M Alsina3, R. Guarden˜o3,
B. Queralt3, A. Codina-Barreras1, A. Maroto4,
L. Falgueras1 and E. Castro1
1Department of surgery ‘‘Josep Trueta’’ Hospital, Girona,
IDiBGi; 2IDI ‘‘Josep Trueta’’ Hospital, Girona, IDiBGi;
3ICO ‘‘Josep Trueta’’ Hospital, Girona, IDiBGi;
4Department of radiology ‘‘Josep Trueta’’ Hospital,
Girona, IDiBGi
Hepatectomy is the only possibility for long time survival
in patients with liver metastases (LM) of colorectal
cancer (CRC). However, only 15–20% present with
respectable LM.
Aim: Prospective study of resectability in patients with
stage IV unresectable CCR treated with chemotherapy
based on Avastin.
Patients: All patients (n = 120) received treatment che-
motherapy based on Avastin. They presented with un-
resectable LM and/or metastases in other locations: 101
(84%) presented with LM, 35 (29%) lung metastases, 44
(37%) with primary tumor or loco regional recurrence,
10 (8%) hilar adenopathies, 22 (18%) peritoneal carci-
nomatosis and 19 (16%) other tumoral localizations. 73
(61%) patients presented > 1 metastatic site. 71 (59%)
were treated with irinotecan based chemotherapy, 23
(19%) Oxalipaltin and 26 (22%) received > 1 line.
Results: Overall response rate was 29% and 72% pre-
sented control of the disease. Sixty one (50%) were
operated. Thirty three (48%) underwent major hepatec-
tomies, 33 (48%) minor hepatectomies, 3 (4%) were
unresectable and 8 underwent > 1 resection. Resect-
ability rate was 48 (49%) with 38 (32%) R0 resections.
Median follow-up was 31 months. Overall survival in
non-operated patients was 14 months (95%CI 11–25)
and NR in operated patients. Median overall disease free
survival in operated patients was 14 m (95%CI 11–24).
Median time to progression in non-operated patients was
15 m (95%CI 12–24). Morbidity > 3a in operated pa-
tients was 18 (27%).
Conclusions: Chemotherapy with bevacizumab has a
high disease control rate (72%) and surgical rescue rate
(48%). Overall 3-years survival in operated patients is
high (54%). In non operated patients median PFS is
15 m high. Results about morbidity probably depends of
others factors.
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THE RENIN ANGIOTENSIN SYSTEM
AND LIVER METASTASES
C. Christophi, J. Neo, V. Murali and E. Ager
University of Melbourne, Austin Hospital
Introduction: The Renin angiotensin system (RAS) is
expressed locally in the liver and plays a signiﬁcant role
in the development and growth of liver metastases.
Blockade of the RAS reduces the growth and number of
liver metastases in a murine model, through two peptides,
Angiotensin II (acting through AT1R and AT2R) and
Ang (1–7) and the MAS receptor. There is an increased
expression of various components of the RAS in the liver
and tumour during the development of liver metastases.
The underlying mechanisms are incompletely under-
stood.
Aim: To determine the effects of key RAS peptides on
CRC and endothelial cells on cell viability, migration and
angiogenesis in vitro and in vivo.
Methods: The effects of RAS peptides were assessed in
vitro on CRC mouse and DLD-1 cell lines. The effects
tested included cell viability (Thymidine assay), apoptosis
(caspase), proliferation (PCNA) and cell migration and
angiogenesis (HUVEC). CD34 staining was used to as-
sess in vivo angiogenesis.
Results: Angiotensin II increased tumour cell viability
and proliferation, increased cell migration and promoted
angiogenesis. Ang (1–7) had opposing effects and was
tumour inhibitory. Invivo blockade of ACE and AT1R
suppressed growth of liver metastases.
Conclusions: The RAS directly inﬂuences tumour growth
in colorectal liver metastases. It also indirectly regulates
angiogenesis. Blockade of various components of the
RAS may provide alternative or additional therapeutic
strategies in the treatment of colorectal liver metastases.
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SELECTIVE INTERNAL
RADIOTHERAPY (SIRT) FOR
CHEMOTHERAPY-REFRACTORY
COLORECTAL CANCER LIVER
METASTASES
J. R. Scho¨n1, M. Binnenhei2, I. Scheppers3, T. Jakobs4,
R.-T. Hoffmann4, A. Haug5, D. Warth5, P. Reimer3 and
K. Tatsch6
1Department of Surgery, Klinikum Karlsruhe, Academic
Teaching Hospital, Universita¨t Freiburg; 2Department of
Oncology, Klinikum Karlsruhe, Academic Teaching
Hospital Universita¨t Freiburg; 3Department of Radiology,
Klinikum Karlsruhe, Academic Teaching Hospital,
Universita¨t Freiburg; 4Department of Radiology, Ludwig-
Maximilians-Universita¨t Mu¨nchen; 5Department of
Nuclear Medicine, Ludwig-Maximilians-Universita¨t
Mu¨nchen; 6Department of Nuclear Medicine, Klinikum
Karlsruhe, Academic Teaching Hospital, Universita¨t
Freiburg
Introduction: Standard therapy for patients with irresec-
table liver metastasis of colorectal cancer consists of che-
motherapy. Unfortunately, most patients eventually will
progress to chemotherapy-refractory or recurrent status.
Methods: Retrospective review of data was conducted of
case ﬁles of patients with colorectal cancer liver metas-
tases in whom previous chemotherapy had failed,
prompting hepatic radioembolization administered as a
single-session, whole-liver treatment. Imaging and labo-
ratory follow-up results were available for 59 patients.
Response and toxicity were assessed by computed
tomography/magnetic resonance imaging with the re-
sponse evaluation criteria in solid tumors and the Na-
tional Cancer Institute’s Common Terminology Criteria
for Adverse Events, version 3.0.
Results: Sixty-four patients (mean age, 65 years; 47 men)
were treated with Y-90 SIR-Spheres (mean activity,
1.9 GBq). At a median interval of 3.1 months after ra-
dioembolization, partial response, stable disease, and
progressive disease were demonstrated in 15, 43, and 6
patients, respectively. Median overall survival was
9.6 months, with improved survival for patients with a
decrease in carcinoembryonic antigen level (18.1 months
vs. 4.9 months) and imaging response (27.3 months vs.
4.1 months; P = 0.0001). Except for 3 instances of
treatment-associated cholecystitis (grade 4 toxicity) and 2
gastric ulcers (grade 2 toxicity), no severe toxicities were
observed.
Conclusion: Hepatic radioembolization with yttrium-90
resin microspheres can be performed with manageable
toxicity in patients with colorectal cancer liver metastases
whose disease is refractory to chemotherapy. The antit-
umoral effect is supported by imaging and tumor marker
responses. Current clinical trials investigate the use of
this emerging therapeutic modality in combination with
state of the art chemotherapy protocols in earlier stages
of the disease and prior to liver resection.
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COMPLETE PATHOLOGICAL
RESPONSE OF AT LEAST ONE
COLORECTAL LIVER METASTASIS
INDUCED BY PREOPERATIVE
CHEMOTHERAPY: THE SENTINEL
METASTASIS CONCEPT
C. Eveno1, V. Paradis2, S. Faivre3, V. Vilgrain4,
E. Gayat5, A. Sauvanet1, O. Farges1 and J. Belghiti1
1Surgery and Liver Transplantation Unit, Beaujon
Hospital, 92110 Clichy; 2Pathology Unit, Beaujon
Hospital, 92110 Clichy; 3Medical Oncology Unit, Beaujon
Hospital, 92110 Clichy; 4Radiology Unit, Beaujon
Hospital, 92110 Clichy; 5Biostatistic Department,
INSERM UMR 717, Saint Louis Hospital, 75475 Paris
Background: Preoperative chemotherapy can lead to
complete pathological response of colorectal liver
metastasis (CRLM).
Aim: The aim of this study was to describe outcome of
this subgroup in terms of survival and potential clinical
and radiological predictive factors of metastasis sterili-
zation.
Methods: From January 2005 to December 2006, 79
consecutive patients received systemic chemotherapy be-
fore hepatic surgery for CRLM. Tumor Regression
Grade (TRG) was assessed on pathological specimen
analyzing a total of 251 metastasis. Sixteen patients
(20%), who had at least one sterilized liver metastasis
(SLM, TGR 1) were compared to the group with
incomplete pathological response (n = 63). Radiological
pattern off all metastasis were assessed on CT scan before
and after chemotherapy.
Results: The SLM group had more synchronous (94%
vs. 61% P = 0.01), more numerous (5 vs. 3 P < 0.05)
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and more frequently bilobar metastasis (75% vs. 34%,
P < 0.05). The mean initial size of CRLM which will be
sterilized is signiﬁcantly lower (19 mm vs. 28 mm,
P < 0.01). Percent of regression was higher and calciﬁ-
cation under chemotherapy was more frequent for SLM
(58% vs. 25%, P < 0.01 and 41% vs. 4%, P < 0.001).
SLM had a tumor microvessel density lower and was
accompanied with CRLM with lower TGR (P < 0.001).
One- and 2- year overall survival for patients with SLM
were 78% and 58%, respectively, as compared with 58%
and 22% for the control group (P = 0.004).
Conclusion: After preoperative chemotherapy, steriliza-
tion of at least one CRLM, which occurs in 20% of
cases, is associated with high overall survival after
resection. SLM is more likely to occur in small, with
morphological regression > 50% and calciﬁed under
chemotherapy CRLM; and can represent a sentinel
metastasis because of their association with other
CRLM with good response under chemotherapy. The
ﬁndings of this study may help selecting optimal patients
for long-term survival combining chemotherapy and
surgical approach.
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PORTAL EMBOLIZATION IS A USEFUL
TOOL FOR PREVENTING
POSTOPERATIVE HEPATIC FAILURE IN
PATIENTS UNDERGOING RIGHT
HEPATIC LOBECTOMY
J. Kita and K. Kubota
Dokkyo University Hospital, Second Department of
Surgery
Purpose: Portal embolization (PE) has been used to
prevent hepatic failure after right hepatic lobectomy. In
this study, we retrospectively reviewed our patients who
had undergone PE and evaluated the usefulness of PE.
Methods: Between April 2000 and September 2008, 29
PEs for patients with hepatocellular carcinoma (HCC)
and 69 PEs for patients with other diseases, such as hilar
cholangiocarcinoma, were performed. For the patients
with HCC, selective hepatic arterial embolization was
performed prior to PE to close arterial-portal shunt and
suppress the growth of tumor.
Results: In all cases, PEs was performed without com-
plications. There was no hepatic failure after PE. In
patients with HCC, operation was not performed in 2
cases because of prolonged hepatic dysfunction, and the
hepatectomy was avoided in one patient because of the
tumor invasion to hepatoduodenal ligament. In remain-
ing 26 patients, right lobectomy was performed in 17
patients, extended right lobectomy in 8 patients, and
right trilobectomy in one patient. Portal vein pressure
increased from16.7 to 22.0 cmH2O by PE. Mean increase
in the volume of the remnant liver was 23.1% (428.7 mL–
529.6 mL).
In patients with other than HCC, right lobectomy was
performed in 7 patients, extended right lobectomy in 41
patients, right trilobectomy in 2 patients, and un-resec-
tion in 19 patients. Portal vein pressure increased from
15.5 to 20.4 cm H2O by PE. Mean increase in the volume
of the remnant liver was 20.3% (375.3 mL–451.6 mL).
There was no postoperative hepatic failure in these 98
patients. The 5-year survival rate after hepatectomy in
patients with HCC, who underwent PE, was 38.2% and
the 3-year disease-free survival rate was 38.3%.
Conclusion: PE is a safe and powerful tool for preventing
postoperative hepatic failure in patients undergoing right
lobectomy.
P-367
SYNCHRONOUS SQUAMOUS CELL
CARCINOMA OF THE ESOPHAGUS AND
HEPATOCELLULAR CARCINOMA
N. Fukino, T. Oida, K. Mimatsu, H. Kano, A Kawasaki
and Y. Kuboi
Social Insurance Yokohama Central Hospital / Surgery
Background/Aim: Recently, an increasing number of
cases with synchronous double primary cancer of the
oesophagus and liver has been increasing, although, the
incidence of such cases is extremely rare. Here, we report
a rare case of synchronous squamous cell carcinoma of
the oesophagus and hepatocellular carcinoma.
Method: A 66-year-old male admitted to our hospital to
receive treatment for vomiting. Endoscopic ﬁndings re-
vealed advanced oesophagal cancer. Ultrasonography
and computed tomography showed a solid tumor in the
segment 5 of the right hepatic lobe. Hepatic arteriogra-
phy revealed hypervascular tumor vessels. Serological
test was positive for hepatitis C virus. The serum of a-
fetoprotein level was 85 ng mL-1. The patient’s liver
function was classiﬁed as Child’s B, with 15-min reten-
tion rates of indocyanine green of 22.5%. The patient
underwent transthoracic subtotal esophagectomy for the
treatment of oesophageal cancer; in addition, an arterial
infusion reservoir was simultaneously implanted to en-
able transarterial chemotherapy after the surgery for
hepatocellular carcinoma.
Conclusions: Simultaneous radical resection for syn-
chronous cancers of oesophagus and liver might be a
possible indication for patients with adequate liver
function. In patients with liver dysfunction, it may be
justiﬁable to perform at least a curative esophagectomy,
whereas transcatheter arterial chemotherapy is warranted
for hepatocellular carcinoma.
P-368
HOW TO OPERATE A LIVER TUMOR
YOU CANNOT SEE
J. R. Stavrou1, S. Weber2, H.-O. Peitgen3, N. Wendt3 and
K. J. Oldhafer1
1Department of General, Visceral and Thoracic Surgery,
Celle General Hospital; 2Artorg Center for Biomedical
Engineering Research; 3Fraunhofer Mevis, University of
Bremen, Bremen
Background: As recent chemotherapy regimens for met-
astatic colorectal cancer become more and more effective
in a neoadjuvant setting before liver surgery, a "com-
plete’’ clinical response is sometimes documented on
imaging. Without operation though, metastatic recur-
rence is likely to commence within 12 months. Surgeons
now face the problem to resect non-visualizable and non-
palpable lesions.
Materials and methods: Combining computer based vir-
tual surgery planning can be used to fuse pre- and post
chemotherapy CT data to develop an operative strategy.
This information is then intraoperatively transferred to
the liver surface using an image-guided stereotactically
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navigated ultrasound dissector. This enables the surgeon
to perform a resection that is otherwise not possible.
Results: During operation, detection of the lesion
through palpation or ultrasound was impossible. After
registering the virtual operation plan into the navigation
system through matched stereotactic ultrasound, the
resection was performed according to the virtual plan
without problems. Histopathologic workup showed vital
tumour cells in the specimen.
Conclusion: The new image guided stereotactic naviga-
tion technique combined with virtual surgery planning
can solve the surgeon’s dilemma and yield a successful
operation.
P-369
THE EFFECTS OF SHORT COURSE
NEO-ADJUVANT CHEMOTHERAPY ON
HEPATOCELLULAR INJURY,
MORBIDITY AND 90-DAY MORTALITY
FOR COLORECTAL LIVER
METASTASES
J. Lordan, N. Karanjia and S. de Sanctis
Royal Surrey County Hospital, Guildford, UK
Introduction: Neo-adjuvant chemotherapy for colorectal
liver metastases (CRLM) may beneﬁt long-term survival.
However, liver surgeons are reluctant to treat due to
potential hepato-cellular injury and adverse peri-opera-
tive outcomes.
Short course neo-adjuvant chemotherapy may maintain
survival beneﬁt without increasing peri-operative risk. A
12-year retrospective analysis was undertaken to corre-
late liver parenchyma histological changes with peri-
operative risk.
Methods: Consecutive liver resections for CRLM be-
tween 1996 and 2007 were identiﬁed (n = 359). Co-
morbidity, peri-operative morbidity, 90-day mortality
and histological analyses (Kleiner (2005), Vauthey
(2006)) were recorded. Patients were excluded if they
received adjuvant chemotherapy within 1 year prior to
hepatectomy (n = 119). Histological changes and peri-
operative outcomes were compared between the neo-
adjuvant chemotherapy and control (no neo-adjuvant
therapy) groups.
v2 and Kruskal-Wallis tests compared categorical and
continuous variables respectively. P < 0.05 was consid-
ered signiﬁcant.
Results: The cohort included 240 patients; 212 (88.3%)
received neo-adjuvant chemotherapy (median 6-cycles).
The median age, intra-operative blood loss and LOS
were 66.3 years, 200 mL and 9 days respectively. There
were 50 (20.8%) complications, 5 (2.1%) of which
were ‡ grade III. ninety-day mortality was 8 (3.3%).
Neo-adjuvant chemotherapy did not increase the inci-
dence of sinusoidal dilatation (P = 0.31, OR = 1.69,
95%CI, 0.61–4.66), steatohepatitis (P = 0.34, OR =
1.51, 95%CI, 0.59–3.92) or hepatic injury (P = 0.12,
OR = 1.87, 95%CI, 0.84–4.18). Furthermore, it was not
associated with increased morbidity (P = 0.28, OR =
0.62, 95%CI, 0.25–1.5), severe complications (P = 0.41,
95%CI, 1.00–1.05) or 90-day mortality (P = 0.94,
OR = 0.92, 95%CI, 0.11–7.78).
Conclusion: Short course neo-adjuvant chemotherapy
for CRLM does not increase hepato-cellular injury or
peri-operative risk associated with liver resection.
P-370
PATTERN OF RECURRENCE AFTER
SURGERY FOR COLORECTAL LIVER
METASTASES AND OUTCOMES AFTER
REPEAT CURATIVE-INTENT
TREATMENT
I. Deshaies, J. Gusani Niraj, E. T. Kimchi, J. T. Kaiﬁ,
M. Nikfarjam, D. Avella and K. F. Staveley-O’Carroll
Penn State Milton S. Hershey Medical Center
Background: Following liver resection/ablation of colo-
rectal liver metastasis (CRLM), the outcome after sub-
sequent curative-intent treatment for recurrence is not
widely reported.
Methods: A retrospective chart review of sixty-four
consecutive patients with CRLM treated in a single
institution was performed.
Results: Thirty seven patients developed a recurrence
after initial liver surgery. The disease was conﬁned to the
liver in 15 patients and extrahepatic-only in 9 patients. The
median time to recurrence after the initial liver surgery was
11 months [1–48]. Repeat curative-intent treatment was
possible in 16 patients. Compared to the palliative treat-
ment group, these patients were more likely to have liver-
only recurrence (11/16 vs. 4/21, P = 0.006). Four patients
underwent surgery for an extrahepatic recurrence and 12
underwent liver metastasis resection or ablation. Twelve
out of 16 patients recurred after repeat curative intent
treatment, with 6 patients recurring only in the liver. An
early recurrence was more likely to occur in patients
treated by ablation only. Six patients underwent a third
procedure and two a fourth procedure. Excluding percu-
taneous ablations, the complication rate and the length of
stay after an iterative liver surgery (n = 11) is similar to
the initial liver surgery (see table). At the end of the study,
six patients among the 16 patients treated by a repeat
curative-intent procedure for recurrences after liver sur-
gery were alive without evidence of disease (median f/u
36 months). The 1 and 3 year overall-survival for those 16
patients was respectively 100% and 84%.
Outcomes after initial vs. subsequent liver surgery for
colorectal liver metastasis
Initial
surgery
n = 64
Subsequent
surgery
n = 11
Type of surgery
Minor hepatectomy 34 4
Major hepatectomy 26 2
Open ablation only 3 5
Exploratory
laparotomy
1 0
Complication 27 6 P = 0.52
Complication grade
No consequence 5 0
Medical treatment 12 2
Invasive treatment 10 3
Death 0 1
Lenght of stay
Median
[min–max] jour
6.5 [2–10] 5 [4–51]
Conclusion: An aggressive approach to recurrence after
liver surgery for CRLM is safe and effective.
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P-371
CLINICAL CONSEQUENCES OF WORK
UP WITHOUT LAPAROSCOPY IN
PATIENTS WITH CRC LIVER
METASTASES
J. R. Andersen1, A.-S. Kannerup1, A. R. Knudsen1,
D. T. Nielsen2, L. S. Jensen1 and F. V. Mortensen1
1Department of Surgical Gastroenterology L, Aarhus
University Hospital, Aarhus, Denmark; 2Department of
Radiology, R, Aarhus University Hospital, Aarhus,
Denmark
Background and aims: Multi-detector computed tomog-
raphy (MDCT) has dramatically improved in recent
years. MDCT allows fast scanning with 3-dimesional
segmental anatomic presentation of the liver. In a pre-
vious study we found, that diagnostic laparoscopy (DL)
and laparoscopic ultrasonography (LUS) not necessarily
needs to be done as a daily routine prior to resection of
colorectal liver metastases. The aim of the present study
was to evaluate the clinical and economic consequences
of MDCT as the only preoperative work-up in patients
with colorectal liver metastases.
Methods: Seventy consecutive patients considered to
have resectable liver metastases after MDCT were ret-
rospectively analysed. A pre-operative treatment strategy
was in each case planned according to the result of the
MDCT-scan. Patients considered to have incurable dis-
ease during operation were recorded. Additionally, cases
where the operative strategy had to be altered during
surgery were analysed. Finally cost analyses were made in
order to investigate the economical consequences of the
above mentioned pre-operative work-up compared to a
work-up including DL and LUS.
Results: Seventy patients underwent surgery. Of these
seventy patients, three were considered incurable during
operation. In 15 cases the strategy had to be altered
during operation; thirteen cases were converted to larger
and two cases to smaller procedures. Cost analysis
showed a clear beneﬁt using this approach.
Conclusion: MDCT is sufﬁcient and cost-effective as the
only preoperative work-up in patients with colorectal li-
ver metastases.
P-372
LIVER FUNCTION RECOVERY AFTER
HEPATIC RESECTION OF
COLORECTAL METASTASES IN
PATIENTS TREATED WITH
BEVACIZUMAB
D. Wicherts, R. De Haas, D. L. Gorden, F. Le´vi,
B. Paule, D. Azoulay, D. Castaing and R. Adam
Hoˆpital Paul Brousse - Centre He´pato-Biliaire
Background: The inﬂuence of bevacizumab on postop-
erative morbidity after resection of colorectal liver
metastases (CLM) has been evaluated. However, its im-
pact on postoperative liver function recovery through a
potential inhibition of liver regeneration remains un-
known.
Objective: To evaluate postoperative recovery of liver
function after resection of CLM in patients treated with
bevacizumab.
Methods: From July 2005 to December 2007, we evalu-
ated a consecutive series of 107 patients resected of CLM,
37 of who treated with bevacizumab prior to hepatec-
tomy. Postoperative evolution of liver function variables
was compared with that of 70 bevacizumab-naı¨ve pa-
tients. Recorded parameters included prothrombin time,
serum aspartate and alanine aminotransferase levels,
serum gamma-glutamyltransferase and total bilirubin
levels.
Results: Most patients of the bevacizumab group re-
ceived only 1 line of chemotherapy (62%vs.54% in the
control group) (P = 0.43). Bevacizumab was combined
to 5-FU/LV and irinotecan or 5-FU/LV and oxaliplatin
in the last preoperative line, in 57% and 30% of cases,
respectively. Patients received a mean number of
10.4 ± 5.7 and 11.1 ± 6.2 cycles of preoperative che-
motherapy in the bevacizumab and control group
(P = 0.56). The median number of administered bev-
acizumab cycles was 6 (range: 3–25). Bevacizumab
administration was stopped at a median of 7.9 weeks
before surgery (range: 3.6–18.0). Major hepatectomies
were performed in 41% and 36% of bevacizumab and
control patients, respectively (P = 0.62). Baseline liver
function tests as well as postoperative liver function
recovery were similar in both groups (Table). Mortality
was nil and postoperative morbidity occurred in 35% of
bevacizumab patients and in 43% of control patients
(P = 0.44).
Evolution of liver function variables (mean ± SE) in
patients with CLM submitted to hepatectomy treated
with and without preoperative bevacizumab.
Serum
variable Day
Patients
with
bevacizumab
(n = 37)
Patients
without
bevacizumab
(n = 70) P
Prothrombin
time (%)
0 59.6 + 2.4 58.7 + 1.6 0.51
1 58.7 + 2.5 57.8 + 1.8
3 73.8 + 2.5 72.3 + 1.9
5 76.5 + 2.5 74.3 + 2.2
Aspartate
aminotransferase
(U/L)
0 448.6 + 59.9 454.3 + 65.9 0.37
1 467.4 + 44.9 578.3 + 88.0
3 137.4 + 12.4 153.6 + 16.6
5 62.1 + 5.7 64.1 + 4.3
Alanine
aminotransferase
(U/L)
0 331.2 + 40.8 352.7 + 49.5 0.50
1 459.6 + 43.6 543.4 + 67.0
3 270.9 + 26.9 312.9 + 39.3
5 148.7 + 15.1 154.8 + 18.1
Gamma-
glutamyltransferase
(U/L)
01 66.5 + 9.9 83.1 + 8.9
77.3 + 11.5 96.1 + 9.7
3 84.5 + 11.4 87.6 + 9.2 0.54
5 163.4 + 21.8 192.6 + 20.0
Total bilirubin
(lmol/L)
0 23.4 + 2.6 24.8 + 2.1 0.74
1 39.2 + 5.7 31.4 + 2.5
3 37.2 + 5.5 29.8 + 3.0
5 28.2 + 4.7 29.6 + 4.9
Conclusions: Preoperative bevacizumab treatment has no
impact on short-term liver function recovery after
resection of CLM and has no deleterious effect on the
incidence of postoperative mortality or morbidity.
Abstracts 275
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
P-373
PROGNOSTIC SCORES FOR
COLORECTAL LIVER METASTASES –
CLINICALLY IMPORTANT OR AN
ACADEMIC EXERCISE?
D. Gomez and I. Cameron
Nottingham University Hospitals NHS Trust,
Nottingham, United Kingdom
Background: Over the last decade, various groups have
proposed prognostic scoring systems for patients with
colorectal liver metastasis (CRLM) treated with hepatic
resection. The aim of the current study was to evaluate
the clinical importance and relevance of these prognostic
scoring systems and determine their clinical applicability.
Methods: Relevant articles were reviewed from the
published literature using the Medline database. The
search was performed using the keywords ‘colorectal
cancer’, ‘liver metastases’, ‘liver resection’ and ‘hepatec-
tomy’.
Results: Twelve prognostic scoring systems were identi-
ﬁed from 1996 to 2009, with six originating from Euro-
pean institutions, followed by three from both Asian
centres and USA. The median study sample was 288 (81–
1568) patients with a median follow-up of 35 (16–
52) months. All studies were retrospective in nature and
the proposed groups in the scoring system ranged from
three to six. All the studies used the Cox proportional
hazard model for their multi-variable analysis. None of
these prognostic systems identiﬁed chemotherapy as a
signiﬁcant variable. There was no consistency with re-
spect to surveillance programs.
Conclusion: There is no ‘ideal’ prognostic scoring system
for the clinical management of patients with CRLM for
hepatic resection. These prognostic scoring systems are
clinically relevant with respect to survival but have not
been used for risk stratiﬁcation for controversial topics
such as the administration of chemotherapy or surveil-
lance programs.
P-374
REPEATED RESECTIONS FOR
COLORECTAL LIVER METASTASES
V. Visokai, M. Mracek, M. Levy and L. Lipska
Thomayer Teaching Hospital, 1st Medical Faculty Charles
University, Prague
Background: Liver resection is the only today’s treat-
ment that offers long-term survival with possible cure in
patients with colorectal carcinoma metastatic to the liver
(CRLM). Approximately two-thirds of patients will
experience some form of recurrence.
Aim: To evaluate results of repeated liver resections for
CRLM.
Materials and methods: There were 134 patients operand
for CRLM between 1996 and 2008 at our surgery. Of
these 17 patients were operated repeatedly.
Results: Morbidity in all patients operated for CRLM
was 26.3%, mortality 2.6%, 5-year survival is 35%, 5-
year DFI is 22%. Relapse in this group occured in 60%,
from that isolated liver relapse was in 25% and from that
in 34.5% in the same liver segment, 65.5% of liver re-
lapses occured in other segments. Repeatedly operated
were 17 patients, 14 two times, 2 three times, one four
times, together 21 repeated operations were performed.
Limited resections were preferred (10 times); segmentec-
tomy was performed in 6 cases, bisegmentectomy in 3
cases and right hepatectomy in 2 cases. Morbidity in
group repeatedly operated was 30%, mortality 0%, mean
blood loos 835 mL.
Conclusion: Our results conﬁrmed that morbidity, mor-
tality, DFI and survival are similar in patients who
underwent repeated liver resections compared with those
with one resection. Indication for repeated liver resection
is the same as for ﬁrst resection. Patient should be well
aware of probability of repeated liver resection at the
time of ﬁrst hepatectomy. Liver preserving resection
should be preferred.
P-375
RESECTION OF HEPATIC
NEUROENDOCRINE METASTASES
(NETM) IMPROVES SURVIVAL AND
SYMPTOMS
J. R. Al-Sarira, B. A. Al-Sarireh, R. Jones, G. Sarno,
S. Pathak, M. Banks, P. Ghaneh, S. W. Fenwick,
H. Z. Malik, A. Wu and G. J. Poston
University Hospital Aintree Liverpool
Background: NET frequently metastasizes to lymph
nodes and liver. Liver metastases correlate with reduced
survival. Surgical resection is a safe and effective, can
reduce symptoms and improve survival. This may allow
discontinuation of long acting somatostatin analogue.
Aim: To conﬁrm that resection of hepatic NETM im-
proves symptoms and survival. Secondly, to asses the
health economic beneﬁt.
Method: Patients undergoing resection for hepatic
NETM were identiﬁed. Resections were either curative
(CR) or palliative (PR) (more than 90% de-bulking).
Main outcomes were operative morbidity and mortality,
survival and symptoms response.
Results: Twenty six (11M : 15F) patients underwent
resection of NETM; median age 57 (IQR 47–69) years.
Right hepatectomy performed in 8, left hepatectomy in 7
and the others underwent non-anatomical resections.
Histopathology was consistent with: 22 carcinoid, 1
gastrinoma, 1 phaeochromocytoma, whilst 2 were inde-
terminate tumours. Twenty four patients were symp-
tomatic; 17patients had NET syndrome, 2 had
mechanical symptoms and 5 had combined symptoms. 12
underwent CR while 14 underwent PR. No 30 day post-
operative mortality. Overall morbidity rate 18%. Median
follows up 66 (IQR 22–112) months. Overall 5 year
survival was 76% with signiﬁcant difference between CR
and PR (91% and 60% respectively, Log Rank
P = 0.033). Overall post resection symptomatic response
was 91.7%, median 21 (IQR 10–38) months. This was
equal to saving £20 000 per patient in somatostatin
analogue prescribing. This was more durable in patients
who had CR with median time of symptoms control 47
(IQR16–59) months.
Conclusion: Hepatic resection for NETM improves sur-
vival and is cost-effective for symptoms control and
palliation.
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P-376
LONG TERM RESULTS FOR LIVER
RESECTION AND TRANSPLANTATION
FOR PRIMARY CARCINOID TUMORS
OF THE LIVER
N. de Liguori Carino, S. Farid, G. J. Toogood,
K. R. Prasad, S. G. Pollard and J. P. A. Lodge
HPB and Transplantation Unit, the Leeds Teaching
Hospitals NHS Trust, Leeds, United Kingdom
Objective: To discuss the clinical course, management
and long term follow-up of primary hepatic carcinoid
tumor (PHCT) treated with liver resection and trans-
plantation.
Summary background data: This updated series remains
the largest reported and the only one to include both
cadaveric and living related liver donor transplantation
as treatment options.
Methods: A review of all PHCT cases between March
1994 and October 2009. Diagnosis was conﬁrmed with
light microscopy and immunohistochemistry in all cases
where an alternative primary site was not identiﬁed.
Clinical data and follow-up records were retrieved from a
prospectively maintained liver resection and transplant
registry.
Results: In the study period, 11 consecutive liver resec-
tions (LR), 4 orthotopic liver transplantation (LT) and 1
living related donor liver transplantation were performed
on a total of 13 patients with PHCT (5M/7F). One pa-
tient underwent both liver resection and transplantation.
Follow-up ranged from 2 to 179 months. Only one pa-
tient died of recurrent disease within 5 months and three
others suffered recurrence on longer follow-up. Nine
patients remain alive and disease free at 2, 4, 14, 15, 36,
122, 129, 134 and 134 months respectively.
Conclusions: Active exclusion of an extrahepatic primary
site and long-term follow-up is essential for the diagnosis
of primary carcinoid of the liver. Mainstay treatment
remains liver resection, although our experience high-
lights successful outcomes following cadaveric and live
related donor liver transplantation in the setting of
widespread hepatic involvement. A radical surgical ap-
proach is warranted in PHCT as it carries a better
prognosis than other primary hepatic tumors and sec-
ondary hepatic carcinoids.
P-377
ANATOMICAL OR NON-ANATOMICAL
LIVER RESECTION FOR COLORECTAL
LIVER METASTASES: IS THERE A
DIFFERENCE?
J. R. Lalmahomed1, A. E. M. Van Der Pool1,
L. F. C. Dols1, J. H. W. De Wilt2, A. M. M. Eggermont1,
J. N. M. Ijzermans1 and C. Verhoef1
1Erasmus MC; 2UMC St Radboud
Background: Non-anatomical liver resections have be-
come more common in the management of colorectal
liver metastases (CLM). Due to the increased use of
neoadjuvant chemotherapy and repeated liver resections
for local recurrence, sufﬁcient liver remnant is becoming
more important.
Objective: We sought to investigate the patterns of
recurrence and overall survival of patients with (CLM)
treated with anatomical and non-anatomical resection.
Methods: From January 2000 to June 2008, a retro-
spective review was performed of patients undergoing
either anatomical resection (AR) or non-anatomical
resection (NAR) for CLM. Patient, tumor and treatment
data were compared and actuarial disease free and
overall survival was determined.
Results: One hundred and ninety nine patients met
inclusion criteria, Median age was 65, 126 (63.3%) were
male. 109 (54.8%) patients received an AR and 90
(45.2%) patients a NAR. NARs were performed for
signiﬁcant smaller metastases (3 cm vs. 4 cm, P =
< 0.001) and had a signiﬁcant shorter hospital stay (7 vs.
8 days, P = < 0.001) compared to AR. There was no
signiﬁcant difference in, blood loss, complications, and
the rate of positive surgical margin and recurrence rate.
The disease free survival was 59%, 34% and 32% at 1, 3
and 5 years respectively. Overall survival was 95%, 50%
and 34% at 1, 3 and 5 years respectively. Type of
resection was not associated with signiﬁcant differences
in disease free survival or overall survival.
Conclusion: Our study showed no signiﬁcant difference
in recurrence rate, disease free survival and patient sur-
vival according to resection type. NAR can be used as a
save procedure to spare liver parenchyma.
P-378
PERIOPERATIVE TUMOR MARKERS
LEVELS IN LIVER RESECTION FOR
COLORECTAL METASTASES
L. Lipska1, M. Levy1, M. Mracek1, V. Visokai1,
O. Topolcan2 and J. Vrzalova2
1Thomayer Teaching Hospital, 1st Medical Faculty,
Charles University Prague; 2University Hospital Pilsen
Background: Surgical resection remains the only
potentially curative therapy for hepatic malignancies.
Tumor growth in the remaining liver may be accelerated
after resection. The mechanism of this enhanced tumor
growth remains unexplained, although growth factors
that are released after hepatic resection may play a role
in residual tumor growth. Recent data focus on growth
factors that may be released in response to surgery-
stimulating receptors of residual tumour cells. Liver
speciﬁc markers should be used also for liver regenera-
tion monitoring.
Aim: To evaluate levels of chosen growth factors, inter-
leukins and tumor markers during and after resection of
colorectal liver metastases.
Materials and methods: Blood samples were taken during
surgery, 24 hours, 48 hours and one week after surgery.
Levels of interleukins IL6, IL8, hepatocyt growth factor
(HGF) were measured using multiplex immunoassay;
levels of CEA, thymidinekinase (TK), insulin-like growth
factor 1 (IGF1), CA 242 and tissue speciﬁc polypeptide
antigen (TPS) were measured using routine immunoassay
methods.
Results: Level of HGF rises in ﬁrst 24 hours, subse-
quently falls down. Level of IL6 rises in ﬁrst 24 hours,
falling down slowly. Level of TPS rises intensely after
start of surgery and collapses 24 hours after operation.
Level of IL8 is elevated after operation, but has no
characteristic peak. Thymidinekinase rises one week after
surgery, probably as marker of DNA synthesis during
tissue regeneration. CA 242, CEA and IGF1 do not show
signiﬁcant changes.
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Conclusion: HGF and IL6 expression are increased after
hepatectomy which may result in an increase in tumor
growth in the residual liver. While hepatectomy is the
only curative option for patients with hepatic malignan-
cies, it may accelerate growth of microscopic residual
disease. The perioperative levels of HGF and IL8 seem to
be signiﬁcant for monitoring reaction of organism to liver
resection.
Supported by grant: GAAV IAA500200917.
P-379
MICROWAVE ABLATION (MWA) OF
COLORECTAL LIVER METASTASES: A
SINGLE INSTITUTION EXPERIENCE
J. R. Lau, D. Sindram, J. D. Whitﬁeld, N. Agee,
I. H. Mckillop, J. B. Martinie and D. A. Iannitti
Section of HPB surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, North Carolina
Background: Hepatic resection is considered the ‘gold
standard’ for treatment of liver-only metastases. Most
liver-only lesions are not amendable to resectional ther-
apy. Several modalities have been used to ablate lesions
that are not treatable by resection. Accumulation of
outcomes data for MWA as an ablative therapy for
colorectal liver metastases (CRLM) is ongoing.
Objective: Determine rate of effective ablation, local
recurrence, regional recurrence, and overall survival for
patients undergoing MWA for CRLMs.
Methods: A retrospective evaluation was performed on
all patients with CRLM using 915 Mhz and 2.45 Ghz
systems from February, 2007 to September, 2009. Patient
demographics, tumor size, presence of residual tumor,
local/regional recurrence, distant metastatic recurrence,
post operative complication(s), and survival were as-
sessed.
Results: Data from 29 patients (15 males/14 females)
with a mean age of 59 years (range, 33–81 years) were
analyzed. A total of 83 CRLM lesions were ablated, of
which 9 ablations were performed concomitantly with
liver resection. The mean tumor size ablated was 1.63 cm
(range 0.3–4.5 cm) and 17 patients received chemother-
apy preoperatively. There was no 30-day mortality or
major complications. There were 2 early complications
(< 30 days) (1 postoperative biloma and 1 wound
infection) and 1 late complication (liver abscess). There
were 2 incomplete ablations, 6 regional recurrences, 3
local recurrences, and 1 distant metastatic recurrence. All
patients had postoperative CT scans, and the average
follow-up was 5 months. Two patients expired during the
follow-up period, and overall survival was 9 months.
Conclusion: MWA for CRLM is effective with low
morbidity. A prospective study is needed to compare the
efﬁciency of MWA with other ablative modalities.
P-380
TWO STAGE FERE TOTALIS
HEPATECTOMY FOR METASTATIC
MALIGNANT ILEAL CARCINOID
V. Straka and M. Sabol
St. Elisabeth Cancer Institute, Department of Surgical
Oncology, Bratislava
Background: Intestinal carcinoid tumors can be found in
all parts of gastrointestinal tract with the highest inci-
dence being the distal ileum. Sixty per cent of patients
present hepatic metastases at the time of diagnosis. Two-
stage hepatectomy has been developed as a surgical
strategy for extremely difﬁcult cases of bilobar multino-
dular metastatic liver disease.
Patients and methods: Between January 1991 and august
2009, totally 62 patients with neuroendocrine tumors
underwent surgical treatment. Seven patients were oper-
ated on due to malignant carcinoid (4 ileal carcinoids, 1
carcinoid of appendix, 1 carcinoid of the coecum and 1
rectal carcinoid). From January 2003 to August 2009 we
performed 164 hepatic resections, among these 5 times
for neuroendocrine tumors hepatic metastases (1 right
hepatectomy, 1 fere totalis hepatectomy, 2 segmentecto-
mies, 1 caudatus lobectomy). Authors present a 55-years-
old female patient with metastatic malignant ileal carci-
noid. During establishment of the diagnosis and the ﬁrst
operation diffuse bilobar liver metastases were present.
At the ﬁrst procedure right hemicolectomy, S2 and S3 left
lateral bi-segmentectomy, metatarsectomy of S4a and
S4b and right portal branch ligature were performed.
Patient underwent postoperative chemotherapy. Five
months later metastasis from the right orbital roof was
removed. FDG-PET and MRI scans showed multiple
viable metastatic lesions of the right liver lobe. Hyper-
trophy of S4 and S1 segments enabled to perform right
hepatectomy keeping S4 and S1 of the liver. Moreover,
severe steatohepatitis was present. Postoperative course
was uneventful.
Conclusion: Portal vein occlusion has become an integral
part in the treatment algorithm of patients with inade-
quate future liver remnant. The strategy of two-staged
hepatic resection in selected group of patients makes
extensive hepatic resection possible.
P-381
SCORING INDEX OF PROGNOSTIC
FACTORS INFLUENCING LONG-TERM
SURVIVAL IN PATIENTS WITH
HEPATIC METASTASIS OF COLON
CANCER
J. R. Yu1,2, S. E. Hwang2, G. W. Ha2 and B. H. Cho1,2
1Chonbuk National University Medical School; 2Chonbuk
National University Hospital
Background: There is need for prognostic index related
to patient survival after hepatic resection for metastatic
colon cancer.
Aim: To contrive a scoring of prognostic factors that
may affect the survival of patients with hepatic metastasis
of colon cancer.
Methods: We reviewed the medical record of 150 patients
with hepatic metastasis of colon cancer from 1994 to
2009. The prognostic values considered included sex, age,
disease stage, differentiation grade, site and nodal
metastasis of the primary tumor, carcinoembryonic
antigen and carbohydrate antigen (CA) 19–9 level, tem-
poral relation, extrahepatic metastasis, site, number and
diameter of the lesions, and treatment methods.
Results: The univariate analysis revealed a signiﬁcant
difference (P < 0.05) in overall 5-year survival rates
depending on CA 19–9 level > 36 U mL-1 at hepatic
metastasis, time from primary to metastasis <
12 months, extrahepatic metastasis, distribution, num-
ber, diameter and total size of hepatic metastasis, and
treatment methods. The multivariate analysis showed
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signiﬁcance in two factors-distribution of hepatic
metastasis and treatment methods. Each variable was
scored from 0 to 1 point in univariate signiﬁcant factor.
Weighted score was added 1 point in case of multivariate
signiﬁcant factor. The median overall survival was 65
(score 0–3), 38 (score 4–7), and 15 months (score8–10)
respectively (P = 0.001). The 5-year survival rate was
48.7% with 59 months median survival of (score £ 5)
and 0% with 17 months median survival (score > 5)
respectively (P < 0.0001).
Conclusion: Our prognostic scoring index may offer an
easy, rapid, and reliable indicator of survival outcome
with hepatic metastasis from colon cancer.
P-382
SIZE OF TUMOUR PREDICTS
OUTCOME IN REDO RESECTION FOR
COLORECTAL LIVER METASTASES
J. R. Adair, A. L. Young, K. R. Prasad,
J. P. A. Lodge and G. J. Toogood
Dept. of HPB/Transplant Surgery, St James’s University
Hospital, Leeds, UK
Background: Seventy-ﬁve to 80% of patients undergoing
liver resection for colorectal liver metastases develop
recurrence. A signiﬁcant number of these can be con-
sidered for re-do liver surgery.
Aim: To determine the outcome of re-do liver resection
for the treatment of recurrent colorectal metastases
conﬁned to the liver.
Methods: Patients who underwent repeat liver resection
in a single, tertiary referral, Hepato biliary centre were
identiﬁed from a prospective database. The records were
reviewed retrospectively. Clinico-pathological variables
were analysed to assess factors predictive of survival
using univariate/multivariate analysis.
Results: A total of 173 patients underwent repeat resec-
tion between 1992 and 2009. Median age was 63 years
and the median interval between 1st resection to repeat
was 13.6 months. One, 3 and 5 year survival was 89%,
44% and 25%. Thirty day mortality was 2.3% and
morbidity 13.8%. Twenty-eight patients underwent
completion hemi-hepatectomy with the remainder
undergoing non anatomical or segmental resection. Tu-
mour size greater than 5 cm was the only independent
predictor of overall survival (P = 0.001, RR 2.32, 95%
CI 1.44–3.77). Neoadjuvant chemotherapy, bilobar dis-
ease and multiple metastases were among factors which
did not signiﬁcantly inﬂuence survival.
Conclusion: Surgery should be considered the gold
standard treatment for patients presenting with recurrent
metastatic disease conﬁned to the liver.
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UNDIFFERENTIATED EMBRYONAL
SARCOMA OF LIVER IN ADULT
C. Takeura, A. Sugioka, K. Sakabe, S. Mori, S. Aihara,
K. Amano, Y. Sakurai, T. Kagawa, Y. Tanahashi,
Y. Okabe, T. Tokoro and Z. Morise
Department of Surgery, Fujita Health University, Aichi,
Japan
Background: Undifferentiated embryonal sarcoma of the
liver (UESL) is a rare hepatic tumor that exclusively
affects children. Stocker ﬁrst described the tumor as
unclassiﬁed undifferentiated pediatric hepatic sarcoma.
Adult cases are extremely rare and only 36 cases have
been reported in the world literature.
Aim: We report an adult case of UESL and the aim of this
study is to clarify the signiﬁcance of adjuvant chemo-
therapy for this rare hepatic tumor from the reported
cases.
Case: A 27-year-old male was referred to our institute
due to a large hepatic multilocular cystic tumor occu-
pying the entire right lobe and Segment4. CT revealed
mural nodules with enhancement. The hepatic hilum was
markedly compressed by the tumor. The extended right
hepatetomy was performed. The resected specimen
weighed 3500 g. The tumor contained mucus and coag-
ula with brownish soft mural nodules. Histological study
including immuno histo-chemistry revealed UESL.
Postoperative course was uneventful and he is doing well
without recurrence for 6 months with no adjuvant che-
motherapy.
Discussion: The postoperative prognosis of the tumor
originally reported to be extremely poor as less than one
year. However, recent papers reported improving prog-
nosis for cases with complete resection as 2-year-survival
rate 55%. Although some authors claim an advantage of
adjuvant chemotherapy with complete resection, proto-
cols have not been established and the evidence of
adjuvant chemotherapy is obscure.
Conclusion: Complete resection would be expected to
afford good prognosis for this rare tumor and the sig-
niﬁcance of the adjuvant chemotherapy awaits further
investigation.
P-384
LIVER RESECTION FOR METASTASES
FROM BREAST CARCINOMA: IMPACT
OF CLINICOPATHOLOGIC FEATURES
AND EXPRESSION OF DIFFERENT
RECEPTORS ON SURVIVAL
G. Ercolani1, M. Zanello1, G. L. Grazi1, M. Cescon1,
M. Ravaioli1, M. Del Gaudio1, A. Lauro1, G. Vetrone1,
A. Cucchetti1, F. Tuci1, A. D’errico2 and A. D. Pinna1
1Hospital Sant’Orsola-Malpighi, Department of Surgery
and Transplantation, University of Bologna; 2Hospital
Sant’Orsola-Malpighi, Department of Pathology and
Oncology, University of Bologna
Background: The role of liver resections for non-colo-
rectal, non-neuroendocrine metastases is debated.
Aim: To analyze long term results and prognostic factors
in resected patients for hepatic metastases from breast
carcinoma.
Methods: From 1995 to 2008, 51 resected patients were
retrospectively reviewed. Mean age was 56.1 ± 10.8-
year-old. The median number of metastases was 2 (range
from 1 to 6); single metastases was present in 24 (47%)
patients. The median tumor diameter was 4 cm (varying
from 0.8 to 11). All patients received adjuvant chemo-
therapy after resection of primary tumor. Several clinico-
pathologic characteristics and immunohistochemistry
expression of estrogen (ER) or progesterone receptors
(PR), of human epidermal growth factor receptor 2
(HER2), or Ki67 were evaluated.
Results: Major hepatectomies were performed in 31
(61%) patients, while minor resections were performed in
the remaining 20 (39%). Operative mortality was 0.
Postoperative morbidity was 13.7%. The 1, 3 and 5-year
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overall survival rates were 91%, 71% and 35%, respec-
tively. The 1, 3, and 5-year disease-free survival rates
were 92%, 58%, 27%, respectively. Eleven (21.6%) pa-
tients survived longer than 5 years. At the univariate
analysis, tumor diameter, lymph node status, progester-
one receptor status, and triple positive receptors (ER+/
PR+/Her2+) were signiﬁcantly related to survival. At
the multivariate analysis, only tumor diameter and the
progesterone receptor status were signiﬁcantly related to
long term outcome; the 5-year survival rate was 58% in
PR+ vs. 15% in the PR- group.
Conclusions: Liver resection seems to be an effective
treatment for metastases from breast cancer and
encouraging long term survival can be obtained with
acceptable operative risk in selected patients. Tumor less
than 5 cm and positive receptors for progesterone are the
best prognostic factors showing satisfying outcome.
P-385
PROGNOSTIC FACTORS AFTER
HEPATIC RESECTIONS IN PATIENTS
WITH COLORECTAL LIVER
METASTASIS
A. N. Kalil, J. R. Torrez, G. Barum and E. Leite
Santa Casa Hospital of Porto Alegre; Federal University
of Health Sciences of Porto Alegre
Background: The liver is the organ most affected by
metastasis of colorectal cancer (CRC), those occurring in
up to 65% of patients, while liver resection is feasible in
only 25% of cases. Among the curative treatments, sur-
gery offers the best prognosis, with 30–60% ﬁve-year
survival.
Objective: Evaluate the prognostic factors and the sur-
vival of patients undergoing hepatic resection for
metastasis from CRC.
Methods: This is a historical cohort of 173 patients
operated between November 1993 and March 2008, at
the Cancer center of the Hospital Santa Casa from South
of Brazil. We excluded 36 patients (incomplete medical
records, patients with unresectable metastasis and those
who underwent radiofrequency ablation only). There-
fore, we considered the clinical, histopathological and
perioperative data of 137 patients. Analysis of survival
was performed using the Kaplan-Meier model, and cal-
culation of signiﬁcance by * log-rank *.
Results: The overall survival at 1, 3 and 5 years was
82%, 43% and 32.3% respectively, with an average of
31.7 months. Perioperative death was 3.6% and compli-
cations 23.4%. In univariate analysis, the statistically
signiﬁcant difference was noticed in gender, age, levels of
carcinoembryonic antigen (CEA), length of resection of
metastasis, neo-adjuvant chemotherapy, number of le-
sions, distribution of lesions in the liver, histological
grade, perioperative complications and decade of liver
resection. In a multivariate analysis, better survival was
associated with female gender (P = 0.007); serum level
of CEA less than 100 ng mL-1 (P = 0.031); metachro-
nous lesion (P = 0.011); neo-adjuvant chemotherapy
(P = 0.028); unilobar distribution; and no postoperative
complications (P = 0.0109).
Conclusions: Hepatic resection remains the therapy of
choice in patients with metastasis of CRC and offers a
good long-term survival, especially in females, in unilo-
bar distribution of lesions and in the absence of post-
operative complications.
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COMPARATIVE ANALYSIS OF
VASCULAR ENDOTHELIAL GROWTH
FACTOR-A, C, D EXPRESSION IN
COLORECTAL CANCER WITH LIVER
METASTASIS
K.-S. Chun and I.-S. Song
Department of Surgery, Research Institute for Medical
Sciences, College of Medicine; Chungnam National
University
Purpose: We aimed to investigate the correlations be-
tween expressions of angiogenic cytokines VEGF-A, C,
D of primary colorectal cancer and liver metastasis.
Method: We examined parafﬁn-embedded primary
colorectal cancer tissue from 45 patients who were per-
formed liver resection due to colorectal liver metastasis
(metastasis group) and 37 patients who were surgically
resected colorectal cancer only (control group). Control
group had not occurred local recurrence and distant
metastasis. Immunohistochemical staining for VEGF-A,
C and D was performed. We analysed the correlations
between expression of VEGF-A, C and D in primary
colorectal cancer tissues and clinicopathologic parame-
ters.
Result: VEGF-A expressions of primary colorectal car-
cinoma were not different between two group. VEGF-C
was more frequently expressed in metastasis group
(P = 0.008) but VEGF-D was more expressed in control
group. (P = 0.003) Patients with VEGF-C negative and
VEGF-D positive expression were predominant in con-
trol group. (P = 0.020). Tumor location, T stage, lymph
node metastasis and tumor differentiation were not re-
lated with the expressions of VEGF-A, C, D but only
preoperative CEA was positively correlated with VEGF-
A and C expression.
Conclusion: Expressions of VEGF-C in primary tumor
were more frequent in metastatic colorectal cancer and
expressions of VEGF-D were more frequent in nonmet-
astatic colorectal cancer. More large scale prospective
study for VEGF-C and D expression in colorectal cancer
is necessary.
P-387
NON-COLORECTAL NON-
NEUROENDOCRINE LIVER
METASTASES
E. Figueroa, M. Gabrielli, C. Gamboa, C. Sierralta,
J. F. Guerra, S. Guzman, J. Martinez and N. Jarufe
Department of Digestive Surgery, Pontiﬁcia Universidad
Cato´lica de Chile
Background: The role of liver resection for colorectal and
neuroendocrine liver metastases, are well established,
with prolonged survival and palliation. However, there is
controversy for metastases from other primary tumor.
Objectives: To describe the experience of one centre,
including indication, selection criteria and clinical out-
come of patients with liver resection for non-colorectal,
non-neuroendocrine liver metastases (NCNNLM).
Patients and methods: Clinical and surgical data, imme-
diate and long term outcomes of a prospectively collected
operative database of patients who underwent liver
resection for NCNNLM from January 2004 to July 2009
was studied. Kaplan-Meier survival analysis was done
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comparing patients with hepatectomy for colorectal liver
metastases in the same period.
Results: One hundred and seventy two hepatectomies
were done, 57 for colorectal metastases and 18 for
NCNNLM. Nine patients (50%) female, mean age
52 ± 15[22–78] years, 9 patients had Adenocarcinoma, 6
Sarcoma and 3 had other histology. The median time
between surgery for primary tumor and surgery for
metastases was 6 months. With a median of 2 liver
metastases per patient and 22 mm mean size, the most
frequent surgery was segmentectomy in 11 patients, right
hepatectomy in 3, left hepatectomy in 2 and two cases of
extended right (1) and extended left (1) hepatectomy.
Mean operative time was 229 ± 110[60–480] min. Three
patients had postoperative surgical complications. There
was no postoperative mortality. With a median follow up
of 19[6–56.2] months, 11 patients died because of meta-
static cancer. Overall survival was better in patients with
colorectal liver metastases. Overall survival at one year
and three years were 80% and 40%, respectively.
Discussion: Hepatectomy for NCNNLM is safe and
feasible and may prolong survival in selected cases.
P-388
AGGRESSIVE SURGICAL REMOVAL
AND DOWNSTAGING IN THE
TREATMENT OF LIVER METASTASIS
FROM COLORECTAL CANCER.
RESULTS OBTAINED IN 308 LIVER
RESECTIONS
J. R. Slim, M. Ghizzoni and L. G. De Carlis
Niguarda Ca’ Granda Hospital, Milan, Italy
Introduction: Our aggressive approach to liver metasta-
ses is described. A reference to the importance of cavitron
ultrasonic surgical aspirator (CUSA) in reducing the
blood loss and obtaining an easier resectability is ex-
plained. The role of surgery is rediscussed. Results ob-
tained in 308 liver resections are cited in support of the
importance of the down staging.
Background: The down staging may be associated with a
longer survival in patients affected by hepatocarcinoma.
The extent of hepatic resection remains controversial is-
sue in the management of metastases. A retrospective
study was performed to elucidate the appropriate liver
resection for metastases from colorectal cancer as well as
the exclusion criteria from surgery.
Methods: Clinical information was reviewed for patients
undergoing hepatic surgery for metastases from colo-
rectal cancer during a 32-year period at Niguarda Ca’
Granda Hospital in Milan. Metastasis features, periop-
erative treatments, mortality and morbidity, periopera-
tive blood transfusion and length of hospitalization were
reviewed. Quality of life was analysed in relation to
several clinical factors.
Conclusion: The down staging may improve the survival
in a large number of patients with liver metastasis from
colorectal cancer. The aim of the surgeon has to be
making patients eligible for liver resection. Individuate
the absolute contraindications to perform surgery is
important to improve the prognosis of a number of pa-
tients as big as possible. The impossibility to obtain a
deep free margin hasn’t been considerated a contraindi-
cation in our series. Predicting a residual liver allows
obtaining a larger number of lesions resected in one or
more stages.
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LIVER RESECTION FOR COLORECTAL
CANCER METASTASIS
E. Jafarimehr1, H. Dabbous, H. Shokouh-Amiri1,
S. Laroux1, R. McMillan1, A. Veluvolu2, A. Marsala3,
D. Dies4, R. Shi5 and G. B. Zibari1
1Department of Surgery, Louisiana State University
Health Sciences Center, Shreveport, Louisiana;
2Department of Medical Oncology, Willis Knighton
Health System, Shreveport, Louisiana; 3Department of
Radiology, Willis Knighton Health System, Shreveport,
Louisiana; 4Department of Medicine, GI Section, Willis
Knighton Health System, Shreveport, Louisiana;
5Department of Statistics, Louisiana State University
Health Sciences Center, Shreveport, Louisiana
Background: Colorectal malignancy is the fourth most
common cancer and almost half of patients develop liver
metastasis during life. Liver resection (LR) is associated
with 35–58% long term survival.
Aim: To explore the potential effect of use of hemodi-
lution technique, low CVP, Habib probe and vascular
stapler in LR for metastatic colorectal cancer (MCRC).
Method: Retrospective, IRB approved chart review, and
prospectively collected data of 466 LR performed by our
team from July 1993 to October 2009 was conducted, 343
were for malignant causes and 112 were for MCRC. Age,
sex, race, operation, blood transfusion (BT), morbidity,
mortality, length of stay (LOS), recurrence and survival
were collected. Student t test or Chi-Square test was used
where appropriate. Kaplan Meier method and log-rank
test were used to estimate and compare the survival
among factors. Cox-regression was used in multivariate
survival data analysis.
Result: Male patients were 47% and 79% were Cauca-
sian. Mean age was 62 and 51 patients had major LR.
Hemodilution technique, low CVP, Habib probe and
vascular stapler was used in 32%. Among this, signiﬁ-
cantly less BT was required during major LR
(P < 0.003). Ninety percent of resections have been R/
O. Average size of lesion was 4 cm (1–19) cm. There was
one perioperative mortality and 11% had complications.
Average LOS was 8.8 days. Death among patients with
R1 resection was signiﬁcantly more (P < 0.001). Fifty-
one patients developed recurrence and median survival
was 43 months with a follow up of 1–143 months.
Discussion: By using advanced technology the need for
BT during major LR has decreased. Furthermore, better
patient selection and perioperative care has resulted in a
slight improvement in patient survival.
Conclusion: Major LR for MCRC alone or in combi-
nation with other modalities can safely be performed
with excellent short and good long term results.
P-390
THE INFLUENCE OF SOCIAL
DEPRIVATION ON PATIENT OUTCOME
WITH COLORECTAL LIVER
METASTASES
J. R. Goldsmith, R. A. Adair, J. K. Pine, S. Farid,
G. J. Toogood, J. P. A. Lodge and K. R. Prasad
St James’s University Hospital
Background: Social deprivation has been linked with
poor survival in cancer patients.
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Aim: We aimed to assess the outcome of patient’s sur-
vival undergoing surgery in colorectal liver metastases
(CRLM) using the indices of multiple deprivation (IMD)
score which covers a range of economic, social and
housing issues, into a single deprivation score for each
area in England.
Method: All patients undergoing curative resection for
CRLM between 1993 and 2009 were analysed. Patients
were split into 2 groups. Group 1, patients from IMD
quintiles 1, 2 and 3 (more afﬂuent) and Group 2, patients
from IMD quintiles 4 and 5 (less afﬂuent). Kaplan-Meier
method was utilised to analyse overall survival (OS) vs.
deprivation score. Multivariate analysis was performed
by Cox regression for prognostic variables R0/R1 resec-
tion, synchronous/metachronous presentation, size and
number of tumours, anatomical or non-anatomical
resection, vascular invasion, lymph node involvement,
background liver disease and differentiation of tumours.
Results: Patients OS in group 1 was signiﬁcantly im-
proved when compared to those in group 2 on univariate
analysis (Chi-Square P = 0.042). When other prognostic
variables were factored in for multivariate analyses the
impact of group 1 vs. group 2 overall survival beneﬁts
became non-signiﬁcant.
Conclusion: Social deprivation based on national scoring
system has shown that OS in patients with CRLM is only
signiﬁcant on univariate analysis. When factors such as
tumour biology are factored into OS no survival increase
is seen in more afﬂuent patient groups. Whilst social
deprivation may have been a factor in clinical outcome
with primary cancer, this is not the case with patients
who have already developed metastatic disease.
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SECOND LIVER RESECTION FOR
COLORECTAL METASTASES: A SINGLE
INSTITUTION CASE-CONTROL STUDY
J. Martı´, J. Fuster, M. M. Modolo, J. Samame, J. Ferrer,
R. Garcia-Roca, D. Calatayud, S. Sanchez, C. Fondevila
and J. C. Garcia-Valdecasas
Hospital Clı´nic i Provincial de Barcelona Barcelona, Spain
Background: The only curative treatment for patients
with colorectal liver metastases (CLM) is surgical resec-
tion. Although some oncologic concerns still remain, re-
resection of liver recurrences in these patients has shown
to be feasible and safe.
Aim: To analyze the results of second liver resections for
CLM recurrences in our institution and to compare the
results with patients undergoing similar procedures.
Methods: From March 1995 to April 2008 33 patients
undergoing a second liver resection because of CLM
recurrence were analyzed. Patients were compared with
other 33 patients operated at a similar time period and
undergoing a similar procedure.
Results: Types of liver resections were: 6 right hepatec-
tomies, 2 left hepatectomies, 2 segmentectomies and 23
non-anatomical resections. There were no differences on
operative time, blood losses and transfusion rate between
the two groups. There was a non-signiﬁcant trend to-
wards higher number of patients with complications in
the re-resection group (61% vs. 42%), with higher post-
operative infection (58% vs. 33%, P = 0.048) and pul-
monary infections rates (12% vs. 0%, P = 0.039) but
with similar ICU and total hospital stay. Overall survival
in patients undergoing second liver resection was 97%,
55% and 20% at 1-, 3- and 5-years. Having more than 4
nodules and receiving adjuvant treatment after the sec-
ond liver resection were associated with poorer survival,
while more than 4 nodules, preoperative CEA over
30 ng dL-1 and tumor satellitosis in the resected specimen
were associated with higher neoplastic recurrence. The
two groups had similar recurrence rate, disease-free sur-
vival and patient survival.
Conclusion: Second liver resections for CLM recurrence
are safe and offer similar oncologic outcomes than ﬁrst
liver resections. Good patient selection and a wide
experience in liver procedures are crucial to offer to pa-
tients a chance to improve their survival.
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TREATMENT OF METASTATIC LIVER
CANCER
A. Shabunin1, V. Bedin2, D. Grekov3, M. Tavobilov4,
A. Lukin4, D. Shikov4 and K. Dalgatov4
1Botkin’s Memorial Hospital, Prof., head of surgery
department, Moscow, Russia; 2Botkin’s Memorial
Hospital, head of HPB - surgery unit, Moscow, Russia;
3Botkin’s Memorial Hospital, HPB - surgery unit,
Moscow, Russia; 4Botkin’s Memorial Hospital, HPB -
surgery unit, Moscow, Russia
Background: Improving results of treatment of patients
with metastatic liver cancer achieved a holistic approach
to this issue.
Methods: From 2007 to 2009 were treated 103 patients
aged 35–78 years with metastatic liver cancer (men-29,
women-74). Localization primary tumor: thick colon-64,
mammary gland-21, ovaries-12, pancreas-3, stomach-2,
kidney-1 cases.
Resective methods used in 32 patients: atypical liver
resection-13, left-side hemihepatectomy-3, right-side
hemihepatectomy-16. This group is made up mostly of
patients with colorectal cancer metastases (22 (69%)
cases). The Doxorubicin chemoembolisation of vena
cava right branch performed in 3 patients before the
right-side hemihepatectomy.
In 5 patient right-side hemihepatectomy was supple-
mented radio frequency ablation of left lobe solitary
metastasis. The Doxorubicin chemoembolisation of left
hepatic artery performed to same patients in the postop-
erative period.
Ultrasound guided radio frequency ablation of metasta-
ses from 18 to 49 mm in diameter applied to19 patients
(colorectal cancer-15 patients; breast cancer-3, ovarian
cancer-1).
In 52 patients used only selective chemotherapy because
with extensive bilobal lesions (regional chemoinfusion to
hepatic artery-21, chemoembolisation of right hepatic
artery-19, chemoembolisation of left hepatic artery-12).
Results: The 2.5 years of observation after radical oper-
ations. Survival was 90.6% (3 deaths).
Two years of observation in the second group. Percent-
age of survival-79 (4 deaths).
Twenty months of observation in the third group.
Percentage of survival-75 (13 deaths).
Conclusion: The combination of resective methods with
radio frequency ablation and selective chemotherapy
improves results of treatment of patients with metastatic
liver cancer.
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SURGICAL RESECTION OF LIVER
METASTASES IN PATIENTS WITH
PRIMARY OVARIAN CANCER
N. Zeff, E. Abalo, F. Perazzo, A. Garcı´a, G. Crimi and
R. Oddi
CEMIC (Center of Medical Education and Clinical
Research)
Background: Most of primary ovarian cancer cases
present in advanced stages, with a 5-year survival of
approximately 5–20%. Signiﬁcant risk factors for the
development of distant metastases are disease stage,
postoperative residual disease and tumor grade. Nearly
one half of the patients with ovarian cancer have liver
metastases at the time of death. Most of the literature on
resection of metastatic disease in the liver comes from
studies of colorectal cancer. It is considered a safe pro-
cedure, with a mortality rate of less than 5%. To date, it
is not yet considered the standard of care for metastases
from ovarian cancer.
Materials and methods: We present four cases of resec-
tion of liver metastases from primary ovarian cancer.
Results: See table 1.
Table 1.
Case 1 Case 2 Case 3 Case 4
Primary
surgery
Primary
cytoreduction
stage IIIC
Primary
cytoreduction
stage IIIB
Primary
cytoreduction
stage IIIC
Primary
(resection
of liver
segments
IV-V)
stage IV
Disease-free
survival
(months)
19 38 55 11
Secondary
cytoreduction
Resection of
liver metastases
(segments
VI-VII)
Resection of
liver segment
VII-VIII
Resection of
liver segments
VII -VIII
Overall survival
(months) until
10-01-2009
Alive without
clinical
disease
192 Alive without
clinical
disease
Alive without
clinical
disease
Discussion: Although the deﬁning optimal cytoreduction
is based on intraperitoneal disease, the same criteria may
apply to metastatic tumor elsewhere in terms of residual
disease. Literature based on case reports series show that
survival of patients who had surgical treatment of liver
metastases is similar to that of patients without liver
disease but with similar volumes of residual disease.
Secondary cytoreductive surgery is indicated in the cases
that gather the following conditions: 1. Disease conﬁned
to the abdomen, 2. Good performance status, 3. number
of liver metastases (some using fewer than four as a cut-
off while others contending that the number of metas-
tases does not affect prognosis), and 4. long disease-free
interval, being probably the most important factor
affecting treatment outcome. Despite there are very few
published studies regarding liver resection of metastases
from primary ovarian cancer, data suggest that it could
improve disease-free survival, not being able to conclude
about its impact on overall survival.
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MODIFIED PIGGYBACK TECHNIQUE
OF LIVER TRANSPLANTATION IN
CHILDREN
A. Mehrabi1, H. Fonouni1, M. Golriz1, G. Engelmann2,
G. F. Hoffmann2, M. W. Buechler1 and J. Schmidt1
1Department of Surgery, University of Heidelberg;
2Department of Pediatrics, University of Heidelberg
Purpose: In themodiﬁed piggyback technique (MPBLTx)
introduced by Belghiti a side-to-side cavocaval anasto-
mosis not only preserves partial caval ﬂow but also
decreases the risk of outﬂow disturbance. Our aim is to
report the experience of this technique in children at our
department.
Method: From 2003 till now a total number of 9 children
underwent MPBLTx. The evaluated parameters were:
demographic data, indications of LTx, cold ischemia
time, type of preservation solution, duration of opera-
tion, and blood loss. Furthermore, postoperative com-
plications, graft and patient survival were analyzed.
Results: There were 2 girls and 7 boys with median age of
10 year (range 3–15). LTx indications were: cirrhosis due
to chemotherapy (n = 1) and extrahepatic biliary atresia
(n = 1), biliary cirrhosis (n = 1), Wilson (n = 1) and
Byler disease (n = 1), chronic liver failure following LTx
(n = 1), acute liver failure (n = 1), mucoviscidosis
(n = 1), and citrullinemia (n = 1). The Child score was:
Child-A (n = 2), Child-B (n = 4) and Child-C (n = 3).
Seven liver grafts were preserved in histidine-tryptophan-
ketoglutarate and two in UW solution. The median
blood loss, duration of operation and cold ischemia time
were 600 cc (range200–5000), 5 hours (range 4–10) and
9 hours (range 6–14), respectively. There was one case of
reLTx after complicated piggyback LTx. Two stenoses of
bile duct anastomosis occurred which were managed
conservatively in one case and with a bilio-digestive
anastomosis in the other one. Except one child with no
follow-up after one year, the rest showed 100% graft and
patient survival.
Conclusion: We could show MPBLTx is feasible and
beneﬁcial in children with a promising rate of complica-
tion and graft survival. However the risk of caval stenosis
after several years as a result of visceral growth is an
important factor. Although we have not encountered this
complication so far, longer follow-ups are warranted.
Finally, this procedure should be performed in high case
load centers and by experienced transplant surgeons.
P-396
GENETIC VARIANTS OF MICRO-RNA
196A2 SEQUENCES CAN PREDICT
SURVIVAL OF
CHOLANGIOCARCINOMA
J. R. Ko, C.-I. Kwon, N. K. Kim and K. S. Rim
Department of Internal Medicine, CHA Bundang Medical
center, CHA University
Background: MicroRNAs (mir) are a new class of non-
protein-coding, small RNAs that has function of tumor
suppressors or oncogenes. They participate in diverse
biological pathways and function as gene regulators.
Only a few studies have been published about the asso-
ciation between microRNA polymorphism and malig-
nant tumor.
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Aim: We evaluated that the association between genetic
variants of MicroRNA and survival of patients with
cholangiocarcinoma.
Patients and methods: We enrolled 94 patients, who were
diagnosed with cholangiocarcinoma between Jan.1999 to
Nov. 2006 in Bundang CHA hospital, CHA University
and obtained blood sample. Using DNA extract from
white blood cell, we analyzed mir-196a2, mir-149, mir-499
and mir-146a expressions by PCR-RFLP and patients’
survival.
Results: Mean age of patients was 66.9 ± 10.7-years-old
and ﬁfty ﬁve was male and thirty nine was female. Median
survival was 210 days (18–1290 days) after diagnosis of
cholangiocarcinoma. According to genetic variant of
mir-196a2, wild type (TT) showed signiﬁcantly longer
survival than in variant type (CT, CC) (P = 0.018),
especially in male patients (P = 0.011). There was no
association between mir-149mir-499 and mir-146a poly-
morphism and survival of cholangiocarcinoma patients.
Conclusion: These ﬁndings suggest that genetic variants
of microRNA 196a2 sequence could be important to
predict survival of cholangiocarcinoma patients, but these
ﬁndings need to be validated in larger prospective study.
P-397
CLINICAL PRESENTATION AND
PROGNOSTIC FACTORS FOR
INTRAHEPATIC AND EXTRAHEPATIC
CHOLANGIOCARCINOMA IN A
TERTIARY CARE CENTER
J. R. Singal1, M. Rakoski1, R. Salgia1, S. Pelletier2,
T. H. Welling2, R. J. Fontana1, A. S. Lok1 and
J. A. Marrero1
1Department of Internal Medicine, University of
Michigan, Ann Arbor, USA; 2Department of Surgery,
University of Michigan, Ann Arbor, USA
Background: The incidence of cholangiocarcinoma
(CCA) is increasing. Predictors of survival have not been
well deﬁned for CCA.
Aims: To deﬁne prognostic factors at time of diagnosis
for CCA.
Methods: Consecutive patients diagnosed with CCA bet-
ween 1/03 and 4/08 were included. CCA was divided into
extrahepatic (ECC) and intrahepatic (ICC) CCA.Kaplan-
Meier and Cox regression were used for survival analysis.
Results: One hundred and thirty six patients were seen-
79 ICC and 57 ECC. Median age was 65 years, 57%
male, and median CA 19-9 was 140 U mL-1 with no
signiﬁcant differences between ICC and ECC. Median
bilirubin level was 9.4 mg dL-1 in ECC and 1.0 mg dL-1
in ICC (P < 01). Only 20% were stage I and 65% had
stage III-IV tumors. Treatment did not differ between
ECC and ICC (P = 0.27) with 29% of patients under-
going resection. Median survival was 27.3 months, with a
1- and 3-yr survival of 71% and 42%. Survival did not
differ between ICC and ECC (P = 0.51). On multivari-
ate analysis, predictors of mortality at diagnosis were
bilirubin level (HR 1.04, 95%CI 1.01–1.07), CA19–9 le-
vel > 100 U mL-1 (HR 1.90, 95%CI 1.17–3.08), and
stage of disease (HR 1.51, 95%CI 1.16–1.96). In subset
analysis, CEA (HR 1.01, 95%CI 1.00–1.02) and age (HR
1.04, 95%CI 1.00–1.08) were also prognostic factors in
ECC. No further prognostic factors were seen for ICC.
After adjusting for pre-treatment factors, surgery was
independently correlated with improved survival (HR
0.48, 95%CI 0.26–0.88). Patients with resection had a
median survival of 65.6 months and 3-year survival of
74%, compared to a 20.2-month median survival and
29% 3-yr survival with non-surgical therapy. Adjuvant
chemo radiation provided no survival beneﬁt to resection
(HR 1.19, 95%CI .57–2.47).
Conclusions: Survival for CCA is poor with no signiﬁ-
cant difference in outcomes between ICC and ECC.
Stage of disease, bilirubin level, and CA 19–9 level are
important prognostic factors at diagnosis. Surgical
resection remains the cornerstone of curative therapy.
P-398
LONG TERM PROGNOSIS OF MID-
DISTAL EXTRA-HEPATIC BILE DUCT
CANCER ACCORDING TO SURGICAL
METHODS AND CURABILITY
J. R. Kwon, S. G. Kim, J. M. Chun, K. S. Kim, J. Y. Kim,
Y. B. Kwon, C. Y. Lee, Y. J. Hwang and Y. G. Yun
Kyungpook National University Hospital
Background: Recently, the incidence and resection rate
of mid-distal extrahepatic bilde duct cancer (BDCA) are
increasing due to the increasing cases diagnosed at early
stages and improved surgical safety. Factors inﬂuencing
the long term prognosis of BDCA are not well known.
Objectives: We aimed to identify the factors inﬂuencing
long term prognosis of mid-distal extrahepatic BDCA.
Methods: From 1984 to 2009, 217 patients, pathologi-
cally proven to have mid-distal extrahepatic BDCA, were
selected. We analyzed the long-term survival rate
according to the surgical method, curability, and patho-
logical factors. The average follow up period was
132 months. Recurrences were determined by imaging
studies or biopsy. Kaplan-Meier method (SPSS) was used
for the analysis.
Results: Patients included 139 males (64.1%) and 78
females (35.9%) and mean age was 64.5 ± 10.2 and
66.6 ± 8.3 respectively. Resection methods included bile
duct resection (BDR, n = 46) and pancreaticoduodenec-
tomy (PD, n = 97). R0, R1, and R2 resection rate were
different between BDR and PD groups [50% (22/44),
43.2%(19/44), and 6.8%(3/44) vs. 91.8%(89/97), 8.2%(8/
97), and 0, P < 0.000]. However, overall and disease-free
survival rate of BDR and PD were not different (43.5%
and 41% vs. 52.6%and 39.1%,P = 0.6 and 0.78). R0 and
R1 resection showed higher overall 5-year survival rate
than R2 (50.2% and 27.4% vs. 0%, P < 0.000).
Conclusion: BDR can be performed selectively, when R0
can be achieved. R0 resection has the best survival but
R1 resection, in inevitable cases, can be performed
because it offers better survival than R2 or no resection.
P-399
ANALYSIS OF PROGNOSTIC FACTORS
FOR SURVIVAL AFTER RESECTION OF
EXTRAHEPATIC CHOLANGIO-
CARCINOMA
J. Kloek, N. van der Gaag, J. de Bakker, B. Musters,
R. Geskus, O. Busch, A. Bosma, D. Gouma and
T. Van Gulik
Academic Medical Center, Amsterdam
Background: Extrahepatic cholangiocarcinoma (CCA)
occur throughout the entire bile duct and are often des-
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ignated as proximal, mid and distal CCA, based on
surgical approach. Tumor node metastasis (TNM) stage
grouping predicts survival on the basis of pathological
tumor extension. Aim of the current study was to eval-
uate the role of tumor location on survival after resec-
tion, to analyze the predictive value of TNM staging, and
to compare different prognostic models.
Methods: Consecutive patients who had a potentially
curative resection of extrahepatic CCA were included.
We performed Cox regression analyses to examine the
association between risk factors and time to death (can-
cer-speciﬁc survival [CSS]) from (recurrent) CCA. The
concordance index, calculated after bootstrapping, was
used to measure accuracy of prediction of survival of the
different constructed prognostic models.
Results: Between 1992 and 2007 a consecutive series of
175 patients underwent resection for extrahepatic CCA.
Median length of follow-up was 19 months (IQR 10–37)
for deceased patients and 54 months (IQR 34–99) for the
36 patients (21%) alive at last follow-up. Overall CSS
rate was 83%, 58%, and 26% at 1, 2 and 5 years
respectively. Tumor location was not an independent
signiﬁcant predictive factor for CSS (P 0.06). A prog-
nostic model using all potential prognostic variables
outperformed TNM staging (concordance index 0.64 vs.
0.60). A reduced model containing only lymph node
status, microscopically residual tumor status and tumor
differentiation grade, also outperformed TNM staging
(concordance index 0.64).
Conclusions: Tumor location of extrahepatic CCA does
not independently predict CSS after resection. A prog-
nostic model with lymph node status, microscopically
residual tumor status at resection plane, and tumor dif-
ferentiation grade was superior to TNM staging.
P-400
LYMPH NODEMETASTASIS IN MIDDLE
AND LOWER BILE DUCT CANCER:
PROGNOSTIC IMPACT AND
DISTRIBUTION
A. Urakami, Y. Hirabayashi, H. Murakami, Y. Oka,
H. Okumura, H. Matsumoto, K. Yamashita, T. Hirai
and T. Tsunoda
Department of Gastroenterological Surgery, Kawasaki
Medical School, Kurashiki, Japan
Background: Lymph node (LN) metastasis is one of the
prognostic factors in middle and lower bile duct cancer.
Aim: To evaluate the prognostic signiﬁcance of clinico-
pathological factors and the distribution of LN metas-
tasis in middle and lower bile duct cancer.
Methods: We reviewed the medical records of 43 patients
of surgically treated middle and lower bile duct cancer
between 1993 and 2008. Age, gender, operative proce-
dure, depth of invasion, LN metastasis (n), tumor size,
pancreatic invasion, duodenal invasion (du), portal ve-
nous invasion, hepatic side ductal margin, radial margin
(rm), histological differentiation, tumor inﬁltration,
lymphatic invasion, venous invasion, and perineural
invasion were investigated. Accumulative survival rates
were calculated using the Kaplan-Meier method and log-
rank test for the univariate analysis, and Cox’s propor-
tional hazards model for multivariate analysis. The dis-
tribution of LN metastasis was classiﬁed, and the
frequency of metastasis was investigated.
Results: There were 34 male and 9 female. The overall 5-
year survival rate was 41.3% and the median survival
time was 37 months. Four factors; depth of invasion
(P = 0.0329), n (P = 0.0005), du (P = 0.0473), and rm
(P = 0.191), were analyzed to be signiﬁcant prognostic
factors by univariate analysis. Those four factors were
reanalyzed by multivariate analysis. One factor, n
(P = 0.0085, hazard ratio = 4.495) was found to be the
signiﬁcant prognostic factor. There were 14 (32.5%) LN
positive patients. LN#13 (posterior pancreaticoduode-
nal) showed the highest rate of metastasis (20.9%), fol-
lowed by LN#12 (hepatoduodenal ligament) (11.6%).
LN#8 (common hepatic artery) and LN#17 (anterior
pancreaticoduodenal) were third (7.0%).
Conclusion: The results of our analysis showed lymph
node metastasis to be the most signiﬁcant prognostic
factor for resected middle and lower bile duct cancer. LN
dissection for frequently metastatic sites might be nec-
essary to make a longer prognosis.
P-401
CLINICAL ANALYSIS OF THE PATIENTS
WITH AMPULLA OF VATER
CARCINIOMA AFTER CURATIVE
RESECTION
J. R. Kim, J. H. Park, Y. C. Youn and Y. K. You
Department of Surgery, Catholic University of Korea
Background: Ampulla of Vater cancer has known to
relatively favorable survival rate after curative resection
and demonstrated the importance of molecular biological
feature due to sequence adenoma to carcinoma. Objec-
tives:
This study is to ﬁnd the survival rate in patient with
ampulla carcinoma after curative resection and various
factors including biological markers affecting the patient
survival.
Methods: The record of 63 patients with ampulla of
Vater carcinoma that underwent pancreasticoduodenec-
tomy from 1994 to 2008 was reviewed retrospectively. We
analyzed survival curve, prognostic factor for survival,
compare the pathologic result and tumor size, survival
signiﬁcance of P53, epidermal growth factor receptor
(EGFR), cyclin D1, Ki 67 by tissue immunohistochemi-
cal staining.
Results: Perioperative mortality and morbidity were 3.17
and 38.1%, respectively. There was no signiﬁcant rela-
tionship between tumor size and tumor invasion to tissue.
5-year survival rate and 5-year disease free survival rate
were 40.9 and 53.8% respectively. Prognostic factors that
correlated with long term survival were lymphatic, bile
duct invasion and lymph node metastasis independently.
In immunohistochemical staining, only p53 but not
EGFR, cyclin D, Ki 67 immunoreactivity is shown to be
related to unfavorable survival. After recurrence, the
survival of the patient with aggressive treatment was
better result than that of conservative treatment.
Conclusions: The survival rate of ampulla of Vater can-
cer patient after pancreatoduodenectomy was favorable
and the major prognostic factors affecting long term
survival is lymphatic invasion, bile duct invasion, lymph
node metastasis, positive p53 immunoreactivity.
Aggressive approach to recurrent tumor could give sur-
vival beneﬁt.
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P-402
CYSTIC DUCT CARCINOMA –
OUTCOME AFTER RESECTION OF THIS
RARE DISORDER
Y. Iso, T. Sawada, J. Kita, M. Kato, M. Shimoda and
K. Kubota
Dokkyo Medical University / Second Department of
Surgery
Primary cystic duct carcinoma (PCDC) is a rare disease.
Here, we report our experiences of six cases of PCDC, in
terms of clinicopathological features and outcomes after
surgical resection. Between April 2000 and September
2009, there were six resected cases of PCDC with a mean
age of 66.8-years old. Clinicopathological features, such
as preoperative ﬁndings, operative data were reviewed.
And long-term outcome of PCDC was compared with
that of resected cases of middle bile duct carcinoma
(MBDC: n = 20). In patients with PCDC, there were no
characteristic symptoms. Operative methods included
hepato-pancreatoduodenectomy in two cases, central
segmentectomy of the liver in one case, and S4, S5
subsegmentectomy of liver in three cases. Median oper-
ation time was 604 min and median blood loss during
operation was 663 mL. Diagnosis of PCDC was made by
histology in all the cases. Tumor stages were stage I in
one case, II in one case, III in one case, and IV in three
cases. Vascular invasion was found in four cases,
invasion to bile duct in four cases, and lymph nodes
metastasis in ﬁve cases. The 5-year survival rates of
PCDC and MBDC were 30.0 and 35.6%, respectively
(P = 0.42). The median survival periods of PCDC and
MBDC were 13.7and 28.5 months, respectively
(P = 0.16). Median survival periods of PCDC were
38 months for stage I, 36 months for stage II, 11 months
for stage III, and 24 months for stage IV. A signiﬁcant
difference was found between stage I and stages III, ?
(P = 0.01 and 0.03, respectively). Five cases (83.3%)
developed lymph node recurrence, and one case in the
local area, liver, and distant organ. Deﬁnitive preoper-
ative diagnosis is difﬁcult and most patients are in
advanced stage at the time of operation. Surgical
resection is the only modality to prolong patient’s
survival with comparable outcome to that of MBDC.
P-403
PRONOSTIC FACTORS OF SURVIVAL
IN THE SURGICAL TREATMENT OF
INTRAHEPATIC CHOLANGIO-
CARCINOMA: MULTICENTER STUDY
FROM ARGENTINA
V. Ardiles1, V. Garay2, J. Pekolj1, J. Grondona3,
R. Bracco3, E. Murguia4, J. Lendoire2, O. Imventarza2
and E. de Santiban˜es1
1Hospital Italiano Buenos Aires; 2Hospital Argerich;
3UNACIR HPB; 4Hospital Houssay
Background: Intrahepatic cholangiocarcinoma (ICC) is
an uncommon primary malignancy and continues to be a
challenging entity for the liver surgeon. Surgical resection
is the only treatment that improves survival but the fac-
tors related are still poorly deﬁned.
Aim: Identify prognostic factors of survival in a series of
patients that underwent surgical treatment for ICC.
Methods: Between August 1996 and May 2009 a total of
28 patients underwent surgical resection (26) and liver
transplantation (2) for ICC. Retrospectively data was
analyzed with regard to demographic and preoperative
variables, surgical treatment, pathological ﬁndings, out-
come and prognostic factors of survival.
Results: Fifteen patients were male, median age 53.9-
years old (25–78). 71% were symptomatic, with pain as
the main symptom. Tumors were solitary in 71%. A
major resection was performed in 16/26, with bile duct
resection in 19% and vascular resection in 8%. R0
resections were achieved in 96%. Postoperative compli-
cations rate was 35% (Types I-II: 60%, IIIB 10%, IVA
10%, and IVB 20%. Pathological analysis showed: tu-
mor size >5 cm in 64% and vascular inﬁltration in 29%.
Recurrence rate was 40% (three liver, three bones, two
lungs, two peritoneal). 1, 3 and 5- year-survival rate was
76, 60 and 50% respectively. In the univariate analysis
age <50-years old (P = 0,026) and vascular invasion
(P = 0,003) showed predictive values in the Kaplan-
Meier survival method.
Conclusions: Radical resection gives the only opportu-
nity to achieve long term survival in patients with ICC.
Age and vascular invasion were determinant factors of
survival in this multicenter study with high prevalence of
R0 surgical procedures.
P-404
INITIAL EXPERIENCE WITH SIR-
SPHERES YTTRIUM-90 MICROSPHERE
RADIOEMBOLIZATION FOR
CHOLANGIOCARCINOMA
J. Peterson1, L. Vallow1, D. Johnson2, M. Heckman1,
N. Diehl1, A. Gale1, K. Tzou1, S. Kim1, N. Brown2,
R. Paz-Fumagalli1 and S. Buskirk1
1Mayo Clinic Florida; 2Baptist Medical Center
Background: SIR-Spheres Yttrium-90 microsphere ra-
dioembolization has been used to improve survival in
patients with colorectal liver metastases but little is
known about its effectiveness and toxicity in treating
other cancers, including cholangiocarcinoma.
Objectives: In an exploratory analysis, to assess initial
response rates, overall survival, and complications in
nine patients treated with SIR-Spheres Yttrium-90
microsphere radioembolization for cholangiocarcinoma.
Methods: Nine patients treated with SIR-Spheres Yt-
trium-90 microsphere radioembolization for cholangio-
carcinoma from two institutions were retrospectively
reviewed. Seven patients underwent initial follow up
imaging with PET, CT, or MRI at a median of 56 days
following SIR-Spheres. Subsequent imaging was per-
formed every 2-4 months. An assessment of response was
determined at the time of each imaging. The Kaplan-
Meier method was used to estimate time to occurrence of
various endpoints after SIR-Spheres. Complications were
graded according to Common Terminology Criteria for
Adverse Events, version 3.0.
Results: Median length of follow up was 4.4 months.
The median prescribed dose was 41 mCi, with all nine
patients receiving between 90% and 108% of the pre-
scribed dose. Of the seven patients with follow up
imaging, 4 (57%) had a partial response to SIR-Spheres
and 3 (43%) had progressive disease at the time of initial
imaging. Of the patients who achieved a partial response,
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33% developed progressive disease by 6 months follow-
ing treatment. At 9 months after SIR-Spheres, the esti-
mated overall survival was 89%. Eight patients (89%)
experienced post-embolization symptoms. Long term
complications included gastrointestinal ulceration (11%)
and cholecystitis (11%).
Conclusions: Our initial response rate, survival data, and
low toxicity suggest that SIR-Spheres Yttrium-90
microsphere radioembolization may be an effective
treatment for cholangiocarcinoma.
P-405
THE USE OF ADJUSTED CA 19-9 TO
PREDICT MALIGNANCY IN
OBSTRUCTIVE JAUNDICE: INFLUENCE
OF BILIRUBIN AND CRP: A
PROSPECTIVE SINGLE CENTER STUDY
A. Ricotta, M. Soﬁa, F. Barbagallo, S. Gagliardo,
S. Latteri, D. Russello, S. Puleo and G. La Greca
Department of Surgical Sciences, Organ Transplantation,
and Advanced Technologies, University of Catania,
Catania, Italy
Background: Discrimination between benign and malig-
nant obstructive jaundice could not be made on the basis
of a solitary elevated CA19-9 measurement. Inﬂamma-
tion and jaundice modify the accuracy. We analysed a
possible relation between inﬂammation and CA19-9 va-
lue to ﬁnd a ratio or a corrective factor for predictivity
and speciﬁcity.
Method: Patients with obstructive jaundice were re-
corded about all routine laboratory tests including bili-
rubin, CRP and CA19-9. The adjusted CA19-9 value was
obtained by dividing it by the values of bilirubin and
CPR.
Results: One hundred and three patients were studied, 52
(50.5%) had benign disease and 51 (49.5%) had a pan-
creaticobiliary malignancy. In malignancies the mean
value of bilirubin and CA19-9 were signiﬁcantly higher
than in benign (respectively P < 0.01 and P < 0.05), the
CRP was higher in the benign (P < 0.05). Sensitivity,
speciﬁcity, PPV of CA19-9 >32 U/mL were 82.3%,
44.2% and 59.1%; when the cut-off is CA19-9 >100 U/
mL they were respectively 68.6%, 63.4% and 64.8%,
when the CA19-9 value was adjusted by diving it by the
bilirubin or CRP they become 49, 76.9, 67.5 and 76.5,
67.3 and 69.6% respectively.
Patients’ characteristics
BENIGNE MALIGNANT P
N patients 52 51
M/F 30/22 24/27
Bilirubin serum
level (g/dL)
6.15 (2.12-24.03) 11.06 (4.07–24.25) P < 0.01
CA 19-9 serum
level
1215 (2–27019) 3490 (2.5–62974) P < 0.05
Positive 29/52 (55.7%) 42/51 (82.3%) P < 0.05
>100 U/mL 19/52 (36.5%) 35/51 (68.6%) P < 0.01
PCR 6,15 (0.1–30) 2,97 (0.1–13.2) P < 0.05
Positive 35/52 (67.3%) 25/51 (49%) NS
>5 U/mL 22/51 (43.1%) 7/51 (13.7%) P < 0.05
Conclusions: We conclude that 55.7% of patients with
benign jaundice had a pathological CA19-9, and using a
cut off of 100 U/mL, the speciﬁcity increased, with a
decrease in sensitivity. The most part of benign patients
have a CA19-9 value <100 U/mL, so by adjusting this
value with the CRP it is possible to increase the attend-
ibility of the test. Other studies concerning these markers
are needed to improve knowledge for diagnosis of
malignant tumors when jaundice is present.
P-406
SIGNIFICANCE ANALYSIS OF
HISTOLOGIC TYPE AND PERINEURAL
INVASION AS PROGNOSTIC FACTORS
AFTER CURATIVE RESECTION OF
AMPULLA OF VATER CARCINOMA
J. R. Lee, K. G. Lee, H. K. Park and K. S. Lee
College of Medicine, Hanyang University
Background: Periampullary adenocarcinoma has either
intestinal- or pancreatobiliary-type of differentiation,
and the type has been shown to have biological and
prognostic relevance. Perineural invasion is generally
associated with a worse prognosis for various malig-
nancies. The inﬂuences of histologic type and perineural
invasion on recurrence and survival in ampullar of Vater
carcinoma still need to be assessed.
Material and method: We reviewed and analyzed the
clinicopathologic data, surgical outcomes, and recurrence
and survival of 49 patients who received curative pan-
creatoduodenectomy for ampulla of Vater carcinoma at
Hanyang University Hospital between January 1994 and
June 2008.
Results: Twenty (41.7%) experienced recurrence, and the
3- and 5-year overall survival rates were 65.3 and 53.1%,
respectively. Perineural invasion as well as tumor grade,
T stage, lymph node metastasis, and lymphatic invasion
were signiﬁcant for both recurrence and 5-year survival
(P < 0.05). The group positive for perineural invasion
had a high recurrence rate (56.5% vs. 28.0%) and a low
5-year survival (39.1% vs. 68.0%) compared to those of
the negative group. Pancreatobililary-type (n = 12) had
a higher in recurrence rate (58.3% vs. 36.1%), lower 5-
year survival rate (33.3% vs. 61.1%) and median survival
time (31 months vs. 51 months) in comparison to intes-
tinal-type (n = 36). However, histologic type was not
statistically signiﬁcant factor (P > 0.1).
Conclusion: Perineural invasion is an important factor
for recurrence and survival. Histologic type has no sig-
niﬁcance as a prognostic factor despite differences in
recurrence and survival between the two groups. How-
ever, further study is needed with a larger patient group.
P-407
LAPAROSCOPIC
HEPATICOJEJUNOSTOMY IN THE
PALLIATIVE TREATMENT OF
IRRESECTABLE PANCREATIC HEAD
AND PERIAMPULLARY TUMOURS
J. Herrera, E. Murguia and H. Mayorga
Department of General Surgery, Bernardo A. Houssay
Hospital, Vicente Lopez, Buenos Aires, Argentina
Background: Decompression in obstructive jaundice due
to malignant tumours of the pancreatic head and pe-
riampullary tumours could be obtained by surgical,
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endoscopy or laparoscopy approach. This palliative
treatment must have minimal morbidity, mortality, short
hospital stay and long palliation of the jaundice and
pruritus.
Aim: In this presentation the authors showed the results
of laparoscopic hepaticojejunostomy in irresectable
pancreatic head and periampullary tumours.
Methods: Between August 2006 and January 2009 a total
of 28 patients underwent a laparoscopic hepaticojejun-
ostomy. In retrospect data was analyzed focusing on
morbidity, mortality, hospital stay, duration of palliation
of the jaundice and survival.
Results: Patients’ ages ranged between 65 and 88 years
with an average of 68 years. All patients had tumour
stadiﬁcation stage III and IV. All patients underwent
hepaticojejunostomy. None of the patients underwent
open convertions. Median operative time was 220 min.
Median hospital stay was 4 days. Major complications
occurred in two patients consisting of two bile leaks. No
patients presented gastric outﬂow obstruction. The
median survival time was 8 months.
Conclusions: Laparoscopic hepaticojejunostomy is not
only feasible but also highly effective in relieving biliary
obstruction and pruritus, with good postoperative results
in pancreatic head and periampullary malignant condi-
tions.
P-408
ENDOSCOPIC AND PERCUTANEOUS
PREOPERATIVE BILIARY DRAINAGE IN
PATIENTS WITH SUSPECTED HILAR
CHOLANGIOCARCINOMA
J. Kloek, N. van der Gaag, Y. Aziz, E. Rauws,
O. van Delden, J. Lameris, O. Busch and D. Gouma
Academic Medical Center, Amsterdam
Background: Obstructive jaundice diminishes liver func-
tional reserve and after resection, reduces the regenera-
tive capacity of the remnant liver. Jaundice, therefore, is
a risk factor in patients with hilar cholangiocarcinoma
(HCCA) requiring major liver resection. Although pre-
operative biliary drainage (PBD) is accepted in these
patients, controversy exists over the preferred technique,
being either endoscopic biliary drainage (EBD) or per-
cutaneous transhepatic biliary drainage (PTBD). The aim
of the present study was to compare outcomes of EBD
and PTBD in patients with resectable HCCA.
Methods: Between 2001 and 2008, 115 patients under-
went explorative laparotomy on the suspicion of HCCA.
In these patients, EBD and PTBD were compared as
primary procedures. Success rates and complications of
both biliary decompression procedures were scored from
ﬁrst attempt of drainage until laparotomy.
Results: Of the 115 patients, 101 (88%) underwent PBD;
90 patients underwent EBD and 11 PTBD. Age, gender,
tumor stage and mean pre-drainage bilirubin values were
not different in both groups. Technical success rate of
initial drainage was 81% in the EBD vs. 100% in the
PTBD group (P = 23). Stent dislocation was similar in
the EBD and PTBD groups (23% vs. 20%, P = 71).
Infectious complications (cholangitis and cholecystitis)
were more common in the EBD group (48% vs. 9%,
P = 02). Patients in the EBD group required signiﬁ-
cantly higher number of drainage procedures (2.8 vs. 1.4,
P < 01) and had a longer drainage period until lapa-
rotomy (mean 15 weeks vs. 11 weeks in the PTBD group;
P = 03). Therapeutic success was equally effective since
the mean plasma bilirubin levels before laparotomy
were similar in both groups. In 30 patients, EBD was
converted to PTBD due to failure of the endoscopic
approach.
Conclusions: Preoperative percutaneous drainage could
outperform endoscopic stent placement in patients with
resectable HCCA, showing fewer infectious complica-
tions, using less procedures.
P-410
TRANSDUODENAL AMPULLECTOMY;
ITS ELIGIBILITY ON AMPULLA OF
VATER TUMOR
J. R. Kim1, S. H. Choi1, D. W. Choi1, J. S. Heo1,
J. C. Chung2 and C. Y. Ho1
1Department of Surgery, Samsung Medical Center;
2Department of Surgery, Soonchunhyang University
College of Medicine, Soonchunhyang University Bucheon
Hospital
Background: Tumors from ampulla of vater have various
histologic characters from benign to malignant. It is
difﬁcult to get accurate diagnosis with preoperative
biopsy. Recently, endoscopic papillectomy has been tried
for the management of periampullary adenomas. But
surgical resection is treatment of choice for periampul-
lary tumors.
Objective: The aim of this study is to suggest the role of
transduodenal ampullectomy in the management of am-
pulla of Vater tumors by reviewing the results of single
center experience.
Methods: Retrospectively reviewed patients who under-
went transduodenal ampullectomy from January 1999 to
December 2008 at Samsung medical center. Patient
demographics, symptoms, preoperative endoscopic
biopsy, ﬁnal pathology was reviewed. Post op outcomes
were evaluated by length of hospital stay, post op com-
plications and recurrence during follow up period.
Result: Twenty six patients underwent ampullectomy
during this time. Five patients converted to pancreati-
coduodenotomy (PPPD) due to involvement of resection
margin or conﬁrmed malignancy in frozen sections. Five
patients initially presented with jaundice or abdominal
pain and the others were incidentally found on screening
examination. Five patients had post op complications
and there was no mortality. Three patients had previous
endoscopic papillectomy before surgery. For those with
any suspicious test results for malignancy in preoperative
study, transduodenal ampullectomy was performed.
Mean follow up time was 23.4 months. Recurrence was
found in one patient. Preoperative biopsy had matched
with ﬁnal pathology in 11 cases.
Conclusion: Transduodenal ampullectomy can be a
treatment option for recurrent periampullary tumors
after endoscopic papillectomy, benign periampullary tu-
mors not resectable with endoscopic ampullectomy,
failure of complete resection with endoscopic papillec-
tomy, symptomatic periampullary carcinoma who has
poor general condition to go through PPPD.
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P-411
LONG-TERM SURVIVAL AFTER
HEPATECTOMY WITH MULTIMODAL
TREATMENT FOR ADVANCED
INTRAHEPATIC CHOLANGIO-
CARCINOMA
Y. Tanahashi, A. Sugioka, C. Takeura, T. Kagawa,
Y. Okabe, T. Tokoro and Z. Morise
Department of Surgery, Fujita Health University School of
Medicine
Intrahepatic cholangiocarcinoma (ICC) is known for
poor prognosis even after hepatectomy. However, we
experienced some long-term survivors of far-advanced
ICC treated by multimodal approach with surgery and
chemotherapy. Herein, we report two cases. Case 1 is a
57-year old female with a giant ICC occupying the entire
left lobe associated with multiple intrahepatic metastases
and regional lymphnode metastases. This patient under-
went extended left hepatectomy (Segment 1, 2, 3, 4, 5, 6)
with bile duct resection. She is doing well for 6.5 years
with hepatic arterial infusion chemotherapy using CPT-
11, three additional hepatectomies for hepatic recurrence
and one pulmonary resection for lung metastases. Case 2
is a 58-year old female with a large ICC occupying right
lobe with intrahepatic metastases. In addition, multiple
lung metastases and extended lymphnode metastases
including Virchow’s node and paraaoric region were
detected. We started systemic chemotherapy with S-1
plus cisplatin, which brought PR response as necrosis of
intrahepatic metastases, reduction of Virchow’s node and
lung metastases. The patient underwent extended right
hepatectomy after the portal embolization. She is doing
well for 3.3 years with additional hepatectomy for
hepatic recurrence and pulmonary resection for lung
metastases and systemic chemotherapy using S-1. These
two cases suggest that multimodal approach with
aggressive surgery and chemotherapy offers the best
chance of long-term survival for the patients with
advanced ICC.
P-412
KLATSKIN MIMICKING TUMOR
V. Visokai, L. Lipska and M. Levy
Thomayer Teaching Hospital, 1st Medical Faculty Charles
University, Prague
Background: The preoperative and even intraoperative
differentiation between benign and malignant strictures
at the hepatic hilum remains difﬁcult. Most liver hilum
obstructions are caused by malignant diseases. Biliary so
called Klatskin mimicking benign tumors are rare enti-
ties, represents 6% of all extrahepatic biliary tumors.
Aim: To report a case of a patient with Bismuth IV bile
duct stenosis, who deamed inoperable and indicated for
brachytherapy.
Material and methods: The 48-year old male patient with
obstructive jaundice was in district hospital during
operation considered inoperable for Bismuth IV bile duct
stenosis. Perioperative frozen biopsy didn’t conﬁrm
malignancy, despite it brachytherapy through PTD was
performed. There was left liver lobe atrophy due to the
left portal branch obstruction. We performed left hepa-
tectomy with right hepatic duct resection and SI segment
resection. Hepaticojejunostomy of segmental bile ducts
S5, 6, 7, 8 was performed. Histopathologic report didn´t
conﬁrm neither malignancy nor slerosing cholangitis.
The patient is during follow-up without relapse.
Conclusion: Clinical presentation and imaging assess-
ment were similar for Klatskin tumors and benign ﬁ-
brosing disease. Management of obstruction of the liver
hilum is dictated by the suspicion of malignancy; an
aggressive resectional approach is justiﬁed if the malignit
inﬁltration cannot be ruled out.
P-413
A CASE OF INTRADUCTAL PAPILLARY
NEOPLASM OF THE BILE DUCT
D. Etou, I. Hiroto, F. Manami, K. Ryuichi, M. Yuichiro,
H. Toru, S. Takenori, Y. Masahumi, H. Hiroyuki,
K. Hisafumi and S. Kazuo
Kurume University School of Medicine
Intraductal papillary neoplasm of the bile duct (IPNB)
represents a biliary papillary tumor mainly growing in
the bile duct lumen resembling intraductal papillary
mucin producing neoplasm (IPMN) of the pancreas.
However, its clinical spectrum and characteristics have
not been fully evaluated. A 66-year old man was
admitted due to chest pain and slight dilatation of the
left intrahepatic bile duct on imaging studies. Blood
analysis revealed the normal level of serum total bilirubin
and tumor markers (CEA, CA19-9). A contrast enhanced
CT scan showed a well-deﬁned tumor of 22 · 15 mm
diameter at the common bile duct, and the left intrahe-
patic bile duct was slightly dilated. DIC-CT scan showed
a deﬁcit image between the left intrahepatic bile duct and
the common bile duct. The pathological diagnosis on
ERCP was the papillary adenocarcinoma. The patient
underwent left hemihepatectomy and the extrahepatic
bile duct was also resected. Histopathological ﬁndings
revealed Intraductal papillary adenocarcinoma of the bile
duct; with no lymph node metastasis and it extended
continuously to the epithelium of the common bile duct.
It also showed anisokaryosis, hyperchromasia, nucleoli,
and it contained signiﬁcant viscous liquid in the cell. The
predominant immuno-phenotype of this case was pan-
creatobiliary type (MUC1+/MUC2-/MUC5AC+/
MUC6-).No tumor recurrence or biliary dilatation was
observed after surgery. Complete resection of IPNB
results in a good prognosis and no recurrence.
P-414
A RESECTED CASE OF UPPER BILE
DUCT CANCER AND PREDUODENAL
PORTAL VEIN WITH PATHOLOGICAL
COMPLETE RESPONSE TO
NEOADJUVANT CHEMOTHERAPY
K. Taniguchi, R. Matsuyama, H. Takakura, K. Takeda,
T. Kumamoto, Y. Homma, Y. Ota, A. Kobayashi,
K. Nojiri, Y. Minami, M. Ueda, A. Yamada, Y. Nagano,
K. Tanaka, H. Akiyama and I. Endo
Department of Gastroenterological Surgery, Yokohama
City University Graduate School of Medicine
Introduction: We report a patient with upper bile duct
cancer and preduodenal portal vein resected after neo-
adjuvant chemotherapy.
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Case presentation: A 62-year old Japanese woman was
referred to our department because of obstructive jaun-
dice. Abdominal CT disclosed a 4 cm tumor involving
the upper and middle portion of the bile duct and
preduodenal portal vein. An angiographic 3-dimensional
CT image showed that the common hepatic artery arose
from the superior mesenteric artery, and that the tumor
was encircled by the common hepatic artery. Cholangi-
ography demonstrated a 4-cm ﬁlling defect as well as
pancreatobiliary junction abnormalities. Positron emis-
sion tomography showed uptake at an enlarged lymph
node near the common bile duct. Accordingly, we diag-
nosed the patient with bile duct cancer and lymph node
metastasis. We used 100 mg of S-1 and 1600 mg of
gemcitabine in each cycle as neoadjuvant chemotherapy.
After six cycles of treatment, the defect had almost
completely disappeared. PET detected no uptake either
at the primary lesion or at the lymph node near the
common bile duct that had shown signiﬁcant uptake
before chemotherapy. Surgery underwent because of the
likely presence of remaining cancer cells. Extended hilar
bile duct resection with resection of the common hepatic
artery was performed. Macroscopic inspection of the
resected specimen disclosed no apparent mass within the
bile duct mucosa. Microscopically, moderate dysplasia
but no malignant cells were seen. No metastasis was
noted in the resected lymph nodes. The patient had no
postoperative complications, and was discharged 16 days
after the operation. She received adjuvant chemotherapy
and no signs of recurrence were present 12 months after
the operation.
Conclusion: This case suggests usefulness of neoadjuvant
chemotherapy with a combination of these two agents,
permitting curative but less invasive resection that is
capable of improving prognosis in this typically fatal
disease.
P-415
PARAMETERS INFLUENCING
SURVIVAL AFTER RESECTION OF
INTRAHEPATIC CHOLANGIO-
CARCINOMA (IHCC)
O. Farges1, D. Fuks2, D. Azoulay3, P. Y. Le Treut4,
J. Belghiti1, A. Laurent5, P. Bachelier6, E. Boleslawski7,
K. Boudjema8, G. Nuzzo9, A. Herrero10 and
J. M. Regimbeau2
1Clichy; 2Amiens; 3Villejuif; 4Marseille; 5Creteil;
6Strasbourg; 7Lille; 8Rennes; 9Rome; 10Montpellier
Background: Resection is the only curative treatment of
IHCC but parameters inﬂuencing outcome are ill deﬁned.
Staging systems (UICC 5th & 6th edition, LCSGJ) are
poorly discriminative and prognosis analysis (performed
by 32 groups worldwide) has yielded discordant results,
in part due to the limited number of patients analysed
(median 52 per study, range 20–292).
Methods: Analysis was performed on a multicentric na-
tional series of 663 patients operated for a biopsy proven
IHCC (excluding Klatskin tumors, hepatocholangiocar-
cinoma and cystadenocarcinoma). The inﬂuence on sur-
vival of epidemiological (age, gender, symptoms),
tumoral (diameter, number, location, vascular perineural
or lymph node extension, mitotic index) and technical
features (extent of resection, transfusion, margins) was
assessed by uni and multivariate analysis. The 1, 3 and
5 years survival of resected patients were 76, 51 and 33%
respectively. Incidence of tumors with satellite nodules
(SN+), positive lymph nodes (LN+) and of R1 resec-
tions were 43, 32 and 23%.
Results: By univariate analysis male gender, presence of
jaundice, size and number of tumors, vascular or lymph
node extension and R1 resection had a signiﬁcant detri-
mental impact. By multivariate analysis only the presence
of SN+ (RR 2.05) and of LN+ (RR 1.97) was inde-
pendent variables. In LN+ patients the inﬂuence of an
R0 resection was not signiﬁcant (median survival 18 vs.
11 months). In contrast, an R0 resection increased the 5-
year survival of LN- patients (51% vs. 15% P = 0.001),
in particular when they were SN- (67% vs. 20%,
P = 0.004).
Conclusion: Satellite nodules and LN extension are
independent predictors of survival. An R1 resection has
the same detrimental impact in LN- / SN- patients.
Resection of non-papillary IHCC does not appear justi-
ﬁed when two or more of the following criteria are
present: LN+, SN+, anticipated R1 resection. The 5-
year survival is <10% and evaluation of chemotherapy
in this setting is warranted.
P-416
EVOLUTION OF RESULTS FOR
RESECTION OF HILAR CHOLANGIO-
CARCINOMA IN A WESTERN CENTRE
A. Young, T. Igami, R. Adair, S. Farid, R. Prasad,
G. Toogood and P. Lodge
St James’s University Hospital, Leeds
Introduction: Hilar Cholangiocarcinoma (HCCA) re-
mains a surgical challenge. We sought to investigate our
results for surgical resection and assess how our practice
has evolved over the last 15 years with improved expe-
rience.
Methods: A prospectively maintained database was
interrogated to identify all resections. Clinico-patholog-
ical data was analyzed and assessed for impact on sur-
vival. Subsequently data for resections 1994–1998, 1999–
2003 and 2004–2008 were compared.
Results: There were 83 patients who underwent resec-
tion. Almost three-quarters required hepatic trisection-
ectomy. Overall survival was 70% at 1 year, 36% at
3 years and 20% at 5 years. Size of tumour, R0 status,
lymph node status, distant metastasis, tumour grade,
portal vein resection, microscopic vascular invasion,
T-stage and blood transfusion requirement were predic-
tive of overall survival on univariate analysis. Distant
metastasis, lymph node status and blood transfusion
requirement remained signiﬁcant on multivariate analy-
sis. Survival outcomes improved signiﬁcantly in the most
recent time period (P = 0.030) and in addition blood
transfusion requirement was signiﬁcantly reduced in the
most recent time period (P = 0.001).
Conclusion: This is the ﬁrst series to report blood trans-
fusion requirement as an independent poor prognostic
indicator in patients with HCCA. Long term survival can
be achieved following aggressive surgical resection of
HCCA. However a learning curve is apparent in the
surgical management of HCCA which supports the
management of these patients in high volume centres to
achieve improved outcomes.
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P-417
SURGICAL OUTCOME AND
PROGNOSTIC FACTORS OF
PERIPHERAL CHOLANGIO-
CARCINOMA OF THE LIVER
J. R. Lim, K. J. Kang and Y. H. Kim
Department of Hepatobiliary-Pancreatic Surgery,
Keimyung University, Dongsan Medical Center
Background: Peripheral cholangiocarcinoma (PCC) is
relatively rare, accounting for 5–10% of all primary liver
cancers. The prognosis of patients with PCC is poor
because of no well known etiologic factors, delayed
diagnosis due to no characteristic symptoms, and low
rate of curative resection.
Objectives: Until now, outcomes and prognostic factors
after liver resection for these tumors have not been well-
documented. To analyze the surgical outcome and the
prognostic factors inﬂuencing the overall survival and
disease-free survival of PCC patients underwent surgical
treatment.
Methods: Between August 2002 and February 2009 a
total of 45 patients (33 men and 12 women) with PCCwho
underwent hepatectomy were retrospectively reviewed for
operative details, perioperative morbidity and mortality,
pathologic ﬁndings, outcomes measured by tumor recur-
rence and survival, and prognostic factors for outcomes.
Results: Overall survival rates at 1, 3, and 5 years were
71.1, 33.2 and 21.5% respectively. Univariate analysis
revealed that tumor size, lymph node status, portal vein
invasion, microvascular invasion, gross type, histologic
grade, and preoperative CEA level were prognostic fac-
tors. Multivariate analysis revealed that histologic grade
was the only independent prognostic factor (P = 0.019).
Disease-free survival rates at 1, 3, and 5 years were 56.0,
38.9 and 19.2% respectively. Multivariate analysis re-
vealed that tumor size was the only independent prog-
nostic factor (P < 0.001).
Conclusion: It was no difference between overall and
disease-free survival after curative resection and tumor
factors (histologic grade & tumor size) are the most
important prognostic factors after curative resection for
the patients with PCC. So, adjuvant therapy, chemother-
apy or radiotherapy etc, are mandatory for the patients
with tumor size over 5cm and poor histologic grade.
P-418
ENDOLUMINAL THERAPIES FOR THE
TREATMENT OF UNRESECTABLE
INTRAHEPATIC CHOLANGIO-
CARCINOMA
J. R. Ellis1, C. W. Hammill2, J. T. Thiesing3 and
P. D. Hansen2
1Department of General Surgery, Oregon Health Sciences
University; 2Hepatobiliary and Pancreatic Surgery Pro-
gram, Providence PortlandMedical Center; 3Interventional
Radiology, Providence St. Vincent Medical Center
Background: Multiple new technologies including trans-
catheter arterial chemo-embolization (TACE), Yttrium-
90 (Y-90) radioembolization, and drug-eluting beads
(DEB) have emerged as treatment options for unresec-
table primary liver malignancies.
Objective: To review a single institution’s experience and
outcomes with endoluminal therapies in the treatment of
intrahepatic cholangiocarcinoma (ICC).
Methods: Retrospective review of all ICC patients trea-
ted at a single institution with endoluminal therapy from
2007 to present.
Results: Nine patients with ICC were identiﬁed; ﬁve
treated with DEB, two with Y-90, and two treated with
multiple modalities (MM), including a combination of Y-
90, TACE, DEB and transarterial embolization. All
procedures were well tolerated with the exception of one
patient who developed post-therapy congestive heart
failure in the MM group. Of the seven patients with
available imaging, 100% had at least stabilization of
disease, six of which had at least a partial response using
modiﬁed Response Evaluation Criteria in Solid Tumors
(RECIST) criteria on initial post-therapy evaluation. At
a median follow up period of eight months, median
overall survival (OS) was eighteen months.
Endoluminal Therapy: Patient Characteristics, Tumor
Factors and Outcomes
Patient Sex
Age @
present-
ation MELD
Tumor
Size
*(cm)
Tumor
Location Therapy
Initial
RECIST
Survival
(months) Status
1 M 66 18 5 Right,
unifocal
DEB CR 13 NED
2 F 65 12 4.4 Bilobar DEB unavailable 3 DOD
3 F 69 6 10.9 Left,
unifocal
DEB PR 3 AWD
4 F 57 7 14 Bilobar DEB PR 7 AWD
5 M 81 7 3.1 Bilobar DEB unavailable 3 DOD
6 F 80 6 4.7 Left,
unifocal
Y-90 HGPR 20 AWD
7 M 65 15 4 Left,
unifocal
Y-90 PR 8 DOD
8 F 67 7 11 Right,
unifocal
DEB,
Y-90,
TAE
HGPR 13 AWD
9 F 61 7 3.5 Bilobar DEB,
TACE
SD 18 DOD
*Size of largest tumor if multiple lesions present
MELD: model for end-stage liver disease, RECIST: response evaluation criteria in
solid tumors, DEB: drug-eluting beads, Y-90: Yttrium-90 radioembolization, TAE:
trans-arterial embolization, TACE: trans-arterial chemoembolization, CR: complete
response, PR: partial response, HGPR: high grade partial response (>80%), SD:
stable disease, NED: no evidence of disease, DOD: dead of disease, AWD: alive with
disease
Conclusions: Endoluminal therapies provide a low mor-
bidity alternative in the treatment of unresectable ICC
may stabilize disease and prolong survival. Median OS
was eighteen months, which is an improvement on his-
torical data of ﬁve to sixteen months in patients treated
with systemic chemotherapy.
P-419
LIVER SPLITTING FOR DIRECT TUMOR
ABLATION IN UNRESECTABLE
CHOLANGIOCARCINOMA: A CASE
REPORT OF AN EFFECTIVE
ALTERNATIVE TREATMENT
K. Papapolychroniadis, D. Kaimakis, C. Kosmidis,
D. Mpaltzis, I. Kokkinakis, I. Palios and E. Fahantidis
1st Propedeutic Surgical Department, Aristotle University
of Thessaloniki, A.H.E.P.A. Hospital Thessaloniki,
Greece
Background: Local therapies have been developed to
treat patients unsuitable for liver resection who suffer
from primary liver carcinomas. Radiofrequency ablation
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(RFA) has been performed with encouraging results. The
aim of this study is to evaluate the outcome of direct
tumor ablation by liver splitting and wide tumor expose.
This maybe offer best results of ablation causes major
cellular dehydration producing in high degree coagula-
tive necrosis.
Case report: We present a 70-years old housewife who
admitted in 1st Propedeutic Surgical Department with
diagnosis of an 11 cm primary cholangiocarcinoma in the
bare surface of right liver. The tumor was occupying
segments 4, 5 and 8 closely to inferior vena cava (9 mm),
right hepatic vein (12 mm) and right porta-hepatis
(14 mm). From the past history there were three surgical
procedures in extrahepatic biliary tree, for gallstone dis-
ease, 20, 19 and 17 years ago in other Institutes. After
oncological team decision an exploratory laparotomy was
carried out. Following adhesion problems resolving a
difﬁcult to porta hepatis access was achieved. After liver
splitting a tumor exposure was performed; a direct tumor
ablation was applied in three different areas by triple en-
ergy electrodes. Its one site ablated for 11–12 min.
Results: Postoperative period was under respiratory
support in ICU and after a course of 2 weeks the patient
was transferred to a common ward. She was discharged
on 35th postoperative day and was under home care in a
good condition as by follow up data was recorded as well
as tumor size was under control. The patient succumbed
from a sudden cardiopulmonary arrest 12 months after
ﬁrst diagnosis.
Conclusion: Direct liver tumor ablation by liver splitting
and wide tumor exposure maybe have place in thera-
peutical modalities of unresectable primary liver tumors.
Possibly this is an optional effective treatment. Ran-
domized trials of more series case studies are needed for
more correct outcomes.
P-420
THE CHEMOFXTM ASSAY:
RESPONSIVENESS OF 31 PATIENTS
WITH HEPATOPANCREATOBILIARY
MALIGNANCIES
J. R. Lau, I. H. Mckillop, N. Agee, D. Sindram,
J. B. Martinie and D. A. Iannitti
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, North Carolina
Background: Phenotypic chemo response assays have
been used to assess in vitro chemo-sensitivity and chemo-
resistance of breast and ovarian cancer cells. No such
data are currently available for hepatopancreatobiliary
(HPB) malignancies.
Objectives: Determine the outcomes of an ex vivo
chemosensitivity and resistance assay (ChemoFx) for
human HPB maglignancies for 31 patients.
Methods: After resection, up to one gram of the tumor
specimen was isolated and sent to ChemoFx (Pittsburgh,
PA) to isolate, clone and test them against different
chemotherapeutic agents. The sensitivity/resistance of the
cell lines to common chemotherapeutic agents were then
recorded and correlated to patient demographics and
disease states.
Results: A total of 31 patients, (20M/11F), were evalu-
ated. Conventional chemotherapeutic agents for pancre-
atic cancer demonstrated 5 ﬂuorouracil (5-FU) had three
responses (n = 15), while gemcitabine and oxaliplatin
had no responses in cells in vitro (n = 15). The most
sensitive chemotherapeutic agent tested was carboplatin,
which demonstrated 10/15 responses. For hepatocellular
carcinoma, 5-FU and doxorubicin had 2 (n = 6) and 1
(n = 7) responses respectively with gemcitabine demon-
strating the greatest responsiveness amongst the agents
tested (7/7). For cholangiocarcinoma, 5-FU and cisplatin
both had four responses (n = 6), with the highest sen-
sitivity being associated with carboplatin and doxorubi-
cin, each of which had 5 responses (n = 5). Of note, not
all assays were completed due to the inability to culture
cells following resection/isolation.
Conclusion: This study suggests that chemoresponsive
assays may provide clinically relevant information
regarding in vitro tumor responsiveness to chemotherapy,
but the clinical value of such an approach requires vali-
dation.
P-421
BENIGN BILIARY STRICTURE: EARLY
AND LATE OUTCOMES
E. Abdo, M. Perini, A. Montagnini, C. Rohde,
P. Paganelli, S. Penteado, A. Matheus, L. Haddad,
E. Abe, J. Jukemura and I. Cecconello
Hospital das Clinicas, Sa˜o Paulo Medical School
Introduction: Benign bile duct strictures represent a sig-
niﬁcant clinical problem. Surgery is considered the
treatment of choice and good long-term results can be
achieved in 70 to 90%. When vascular damage with liver
atrophy has occurred hepatectomy with resection of the
involved hemi-liver may facilitate bilioenteric recon-
struction.
Aim: Analyse early and late outcomes in patients early
and late referred to a tertiary center to treat the stricture
and in patients with vascular damage requiring major
hepatectomy.
Methods: Eighty two patients underwent surgery at
Hospital das Clinicas-FMUSP between 1990 and 2005.
Variables analysed: age, gender, type and number of
previous surgery, surgery performed, early and late out-
comes, and length of hospital stay. Good surgical results
were rendered as absence of late clinical liver insufﬁ-
ciency and when no more surgical intervention was nec-
essary.
Result: Mean age was 45.5 years with female (81.7%)
preponderance. Mean prior surgical interventions was
1.6 (range 1–7). There were 21 (25%) type I Bismuth
lesions, 26 (31%) type II, 15 (18%) type III and 20
(24%) type IV. Grade of stricture was directly associ-
ated with the number of surgical interventions before
referral (P < 0.05). Roux-en-Y hepaticojejunostomy
was performed in 78 patients (95.1%). Four patients
underwent right hepatectomy with Roux-en-Y hepati-
cojejunostomy (liver atrophy due to previous vascular
lesion). Mortality was null. Three patients were reop-
erated. Mean length of hospital stay was 15 days. Mean
follow up was 5.2 years. Good surgical results were
achieved in 72 patients (87.8%) and 10 (12.2%) devel-
oped late complications.
Conclusion: Biliary injuries are complex problems re-
quires a well–thought-out strategy (even with liver
resection when previous vascular damage with liver
atrophy has occurred), so referral to tertiary centers with
expertise in the management of this problem should be
emphasized.
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P-422
REPAIR OF POST CHOLECYSTECTOMY
BILE DUCT INJURIES IN THE
PRESENCE OF AN EXTERNAL BILIARY
FISTULA
A. Yadav, V. Gupta, S. Singh, H. H. Nag and
A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Introduction: Single centre experiences with the repair of
post Cholecystectomy bile duct injuries in the presence of
external biliary ﬁstula.
Aims and objectives: To evaluate the causes of a persis-
tent external biliary ﬁstula and to study the results of
repair in the presence of biliary ﬁstula.
Methods: Between January 2000 and December 2008,
268 patients were operated for the deﬁnitive repair of
post Cholecystectomy bile duct injuries. 127 (47%) of
these patients had a post operative external biliary ﬁstula
following cholecystectomy. The external ﬁstula closed
prior to the deﬁnitive repair in 102 patients (group I), 25
patients (group II) had a persistent external biliary ﬁstula
and deﬁnitive repair was undertaken in the presence of
the ﬁstula. The peri operative outcomes and long term
results of these two groups were compared.
Results: There was no difference in the type of chole-
cystectomy (laparoscopic vs. open) performed in the two
groups. Fourteen patients in group II vs. 35 patients in
group I underwent an additional procedure prior to
referral (P < 0.01). The distribution of the types of
strictures was similar in both groups. The median dura-
tion between the index cholecystectomy and deﬁnitive
repair was 137 days in group I and 130 days in group II.
The mean duration of surgery was 2.97 hours in group I
vs. 4.25 hours in group II (P < 0.001). 40% patients in
group II needed a stented anastamosis as compared to
19% patients in group I (P < 0.05). Post operative
complications occurred more often in group II patients
P < 0.05 with wound infection being the most common
complication. On long term follow up, four patients in
group I and one patient in group II developed an anas-
tamotic complication.
Conclusions: The presence of a persistent external biliary
ﬁstula at the time of repair was a marker of a more dif-
ﬁcult repair and worse peri operative out comes.
P-423
SHORT TERM QUALITY OF LIFE IN
BILE DUCT INJURY: A PROSPECTIVE
EVALUATIVE STUDY COMPARING
PREOPERATIVE VERSUS
POSTOPERATIVE SCORES
I. Domı´nguez, M. A. Mercado, B. Franssen,
J. M. Urencio and F. Ramirez del Val
Instituto Nacional de Ciencias Me´dicas y Nutricio´n
‘‘Salvador Zubira´n’’
Introduction: Bile duct injury (BDI) after cholecystec-
tomy requires not only restoration of anatomical and
functional impairment but reestablishment of the patient
well-being. Quality of life (QOL) has become an impor-
tant instrument to assess the impact of therapeutical
interventions. It goes beyond physician-centered out-
comes and focuses on the patient’s self perception of
wellness.
Aim: The aim of this work is to evaluate the impact of
bile duct repair in short-term QOL comparing preoper-
ative and postoperative scores within the same group of
BDI patients.
Methods: QOL was evaluated in 28 patients with Stras-
berg E complex BDI who underwent a Roux in Y he-
patojejunoanastomosis with IV segment partial resection.
A general (Short Form SF-36) and speciﬁc (Functional
Assessment of Cancer Therapy Hepatobiliary FACT-
Hep) QOL questionnaires were administered in the pre-
operative and 1 month after surgery. A paired analysis
within the same group of BDI patients was done.
Results: QOL showed signiﬁcant improvements
(P < 0.05) after surgery in all FACT and SF-36 domains
with exception of emotional role (P = 0.07) when com-
paring preoperative vs. 1 month postoperative scores.
In the preoperative setting all SF-36 domains were
signiﬁcantly (P < 0.05) below the Mexican normal
values. One month after surgery all the SF-36 domains
improved towards the Mexican normal values even
surpassing them in the health perception domain.
Preoperative vs. 1 month postoperative QOL scores after
bile duct repair
SF-36 Item
Preoperative
M (SD)
1 month
postoperative
M (SD) Difference P
Physical function 42 (32.5) 61 (23.8) 19 0.01
Physical role 13 (32.2) 31 (43.3) 18 0.01
Body pain 34 (22.5) 66 (19.8) 32 0.0001
Health perception 44 (17) 59 (17.6) 15 0.0001
Vitality 45 (21.8) 62 (21.3) 17 0.0001
Social function 42 (30.7) 62 (24.4) 20 0.002
Emotional role 18 (32.5) 34 (44.4) 16 0.07
Mental health 54 (20) 72 (21.6) 18 0.0001
FACT G 61 (17.2) 73 (17.5) 12 0.005
FTOI 68 (20.5) 90 (19.4) 22 0.0001
FACT-Hep 101 (25.6) 126 (25.8) 25 0.0001
Patients 28 28
Discussion: Roux in Y hepatojejunoanastomosis with IV
segment partial resection has a favorable impact in QOL
of patients with complex bile duct injuries. The FACT-
Hep questionnaire could be a useful instrument to assess
subtle QOL changes in this group of patients.
P-424
HEPATIC RESECTION AS DEFINITIVE
TREATMENT FOR
CHOLECYSTECTOMY ASSOCIATED
BILE DUCT INJURIES
S. Mackenzie, K. Kosari and T. Sielaff
Virginia Piper Cancer Institute
Background: Complex hilar bile duct injuries after lapa-
roscopic cholecystectomy, are a major cause of long term
morbidity despite appropriate surgical repair. Difﬁcult to
reconstruct right hepatic bile ducts and/or low inserting
6/7 sectoral ducts are susceptible to strictures and
obstruction.
Objective: To review patients undergoing partial hepa-
tectomy as deﬁnitive treatment for complex bile duct
injuries.
Methods: More than 30 cholecystectomy associated bile
duct injuries were referred to our institution during a 2-
year period. All bile duct injuries were followed in a
prospectively maintained database.
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Results: Eight patients (8 female: 0 male) from the
database were identiﬁed as undergoing hepatectomy as
deﬁnitive treatment for a complex cholecystectomy
associated bile duct injuries. The majority of the original
cholecystectomies were performed laparaoscopically (six
laparoscopic, one converted to open, and ONE open).
Four of the 8 patients had intra-hepatic right bile duct
injuries, with preservation of the left bile duct. These
patients underwent deﬁnitive right hepatectomy. One
patient demonstrated a hilar injury and associated left
hepatic artery injury, treated with a hepatectomy and
hepaticojejunostomy reconstruction to the right duct.
Three patients demonstrated a low insertion of a 6/7
sectoral duct, which was injured at the time of chole-
cystectomy. In these cases deﬁnitive treatment included
resection of segments 6 and 7. The median blood loss for
bile duct injuries patients undergoing hepatectomy was
400 cc. Two of 8 patients required intensive care unit
monitoring and the median length of hospitalization was
8.2 days. Follow up revealed no long-term complica-
tions, and no evidence of post-repair bile strictures.
Discussion: Hepatectomy may provide deﬁnitive treat-
ment for high unilateral bile duct injuries, preventing the
risk of anastomotic stricture and the associated biliary
interventions.
P-425
INCIDENCE OF BILE DUCT INJURIES
DURING LAPAROSCOPIC
CHOLECYSTECTOMY (L.C.)
I. Kafetzis1, N. Gatsoulis2, N. Roukounakis1,
V. Mouziouras1, I. Christakis1, G. Kavalieratos2 and
N. Andromanakos1
1Department of Surgery, General Hospital ‘‘Athens
Polyclinic’’, Greece; 2Department of Surgery, District
General Hospital of Corfu, Greece
Background: Laparoscopic cholecystectomy is the gold
standard operation for the symptomatic gall stones and
other diseases of the gall bladder. The most important
complication is the bile duct injury that occurs in 0.4–
1.4% of L.C. (750,000/ year L.C, 3,000 to 10,500 injuries).
Aim: The aim of this study is to present our complica-
tions during L.C. Also, regarding the worldwide experi-
ence, we discuss the investigation of injury and the
appropriate therapy.
Methods: During 2004–2008, 1390 laparoscopic chole-
cystectomies were performed in both Hospitals. The 20
among them (1.48%) were converted. 62 patients (4.52%)
left the Hospital the same day (outpatients) and 1096, the
day after surgery (one day surgery). The majority were
women (67.2%- 921 patients) and the rest men (32.8%-
449 patients) with mean age 56.4 years. In 14 (1.0%)
patients a bile duct injury was occurred during L.C. All
injuries were identiﬁed 1–2 days after the main operation.
According to the Stransberg classiﬁcation the nine were
stage A, the two stage E and the other 3, stage D.
Results: Four patients declare a decreased cholorroia
and were treated conservatively. In nine patients, an
ERCP was performed and a stent was put in the bile
duct, with good results. In three patients, a Roux-en-Y
was performed after 1 month (for one patient) and
1 year, respectively, because of stenosis.
Conclusions: The bile duct injuries seem to be aug-
mented. The number decreased after the learning curve.
After the injury a number of specialists must be coop-
erated in order to solve the problem.
P-426
A NEW TYPE OF FULLY COVERED SELF
EXPANDABLE METAL STENT WITH
PROXIMAL LASSO FOR THE
TREATMENT OF BENIGN BILIARY
STRICTURES
J-W. Poley1, R. Voermans2 and M. J. Bruno1
1Erasmus MC, University Medical Center, Rotterdam, the
Netherlands; 2Academic Medical Center, Amsterdam, the
Netherlands
Background: Although the use of fully-covered self
expandable metal stents (fcSEMS) has shown promise in
the treatment of benign biliary strictures, however, re-
moval of these stents can be complicated in some cases
since traditional techniques require the entire surface
area of the stent to detach from the wall of the common
bile duct at the same time.
Aim: We investigated the safety, feasibility and efﬁcacy
of a new type type of fcSEMS with a proximal lasso that
enables removal of the stent inside-out, thereby avoiding
complications during stent removal.
Methods: Non-randomized, prospective follow-up study
with three sequential group of eight patients each with
benign biliary strictures. Patients eligible for inclusion
had iatrogenic bile duct strictures (post-cholecystectomy
or liver transplantation) or strictures due to chronic
pancreatitis. Strictures should be at least 2 cm below the
liver hilum. The ﬁrst cohort of patients underwent stent
placement for 2 months, followed if necessary by
3 months. The second cohort started with 3 months,
followed by 4 months and the last cohort underwent
stent placement for 4 months twice if the stricture did not
resolve after the ﬁrst period. Treatment success was de-
ﬁned by the cholangiogram and the ability to pass an
inﬂated extraction balloon through the former stricture.
Results: Twenty four patients (11 female; age (20–67
years) have been included in this ongoing study. Strictures
were caused by chronic pancreatitis (13), liver transplan-
tation (6), cholecystectomy (3) and papillary stenosis after
previous sphincterotomy (2). At present 39 fcSEMS have
been placed and 25 removed. Removals were all extremely
easy and without complications. In 24 cases removal was
done by grabbing the proximal lasso, in one case the snare
techniquewasused.Tenpatients haveﬁnished theprotocol
at present; treatment was successful in 80%.
Conclusions: This new type fcSEMS is very easy to re-
move. Further data are awaited to evaluate its efﬁcacy.
P-427
MANAGEMENT STRATEGY AND
OUTCOMES OF 44 PATIENTS WITH
BILE DUCT INJURIES AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
S. Paskauskas1, Z. Dambrauskas1,2, O. Deduchovas1,
J. Pundzius1 and G. Barauskas1
1Department of Surgery, Kaunas University of Medicine,
Eiveniu Str. 2, 50009 Kaunas, Lithuania; 2Laboratory for
Research of Digestive System, Institute for Biomedical
Research, Kaunas, University of Medicine, Lithuania
Background: The incidence of bile duct injuries (BDI)
after laparoscopic cholecystectomy (LC) remains high;
the management of these lesions is still controversial.
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Aim: To analyze outcomes of surgical management of
BDI’s after LC.
Methods: A prospective database of BDI patients was
maintained in the period of 2000–2007. The median fol-
low-up after reconstructive surgery was 60 months.
Results: Twenty one patients (48%) presented with
minor BDI’s (MiBDI) (Strasberg A-D type), 23 patients
(52%) with major BDI’s (MaBDI) (Strasberg E type). In
11 cases BDI’s occurred in our department (incidence
0.23%), of which ﬁve were MaBDI. The remaining 33
patients were referred from other hospitals. In MiBDI
group 12 patients (57%) were managed by endoscopist
with good long term outcome in 11 (92%). Hepaticojej-
unostomy was performed in one after unsuccessful
endoscopy. The MaBDI’s with intraoperative diagnosis
(three patients) or with the total proximal duct obstruc-
tion (seven patients) were managed with primary repair
over a T-tube (one patient in a regional hospital) or with
hepaticojejunostomy during the ﬁrst postoperative week.
The patient with primary repair and two patients with
hepaticojejunostomy developed strictures and had to be
reoperated. Delayed hepaticojejunostomy was performed
in 13 due to bile leakage and sepsis. Four (31%) of these
patients developed anastomotic strictures and were re-
operated after median of 18 months.
Conclusion: Endoscopic stenting is an effective treatment
of MiBDI. For MaBDI hepaticojejunostomy is a treat-
ment of choice, but risk of strictures increases, if surgical
procedure has to be delayed due to intraperitoneal bile
leakage.
P-428
COMMON BILE DUCT INJURY –
RESULTS OF ON-TABLE AND EARLY
REPAIR BY ROUX-EN-Y
HEPATICOJEJUNOSTOMY
S. Ghosh1, S. Lahiri1, G. Banerjee2, D. P. Ghosal1 and
S. Paira1
1RG Kar Medical College, Kolkata; 2Calcutta National
Medical College, Kolkata
Background: Traditionally, bile duct injury has been
repaired at 4–6 weeks. Inexperience, undeﬁned injury,
small duct size generally preclude early repair. However
in the absence of sepsis and serious comorbidity, repair
within 7 days may be optimal.
Objectives: This study compares the results of on-table
and early repair with conventional delayed (6 weeks)
repair.
Method: This prospective study was carried out between
November 2005 and December 2008. The patients were
followed up for six months to 2 years. The results eval-
uated and compared according to Macdonald’s grade.
Results: Of the total 32 cases of bile duct injury repaired
during this period, 12 cases (37.5%) had repair within
7 days. Of these, six had on-table repair and six had early
repair (within 2nd to 7th postoperative day). Hanover
class of injury for the on-table group was, three cases
(9.37%) each in Class B and D. For the early group it
was Class B, 4 cases (12.5%) and Class D, 2 cases
(6.25%). The delayed repair group (20 cases) had Bis-
muth Type-III injury 15 (46.8%) and type II-5 (15.6%)
cases respectively. Roux-en-Y Hepaticojejunostomy was
performed in all cases. MacDonald grade of successful
repair were for on-table group, grade A 5 cases (83.3%),
B–1 (16.6%), early repair group grade A 4 cases (66.6%),
B–2 (33.3%) and delayed repair group grade A 18 cases
(90%), B–2 (10%).
Conclusion: The results of early repair of bile duct inju-
ries compare favorably with delayed repair in a selected
group of patients.
P-429
SURGICAL TREATMENT OF BENIGN
BILIARY STRICTURES IN A TERTIARY
CENTER: ANALYSES OF FACTORS
THAT INFLUENCE IN OUTCOMES
F. Barros1,2, R. Fernandes2, M. Enne2, L. Pacheco2,
A. B. Fonseca3 and J. M. Martinho1,2
1Department of Surgery, Antonio Pedro University
Hospital – Fluminense Federal University, Nitero´i, Rio de
Janeiro; 2Liver Transplantation Unit – Clinical and
Surgical Hepatology Program, Bonsucesso General
Hospital, Ministry of Health, Rio de Janeiro; 3Department
of Statistics, Fluminense Federal University, Nitero´i, Rio
de Janeiro
Background: With the increasing number of laparoscopic
cholecystectomy (LC) in the 90s, the bile duct injury
(BDI) had a signiﬁcant increase and continues to be a
problem after almost 20 years since this approach was
considered the gold standard.
Objective: Analyze retrospectively the patients that suf-
fer a BDI and were referred to our Liver Transplantation
Unit to surgical repair.
Method: In the current study, we review a cohort of 53
patients, and churched some variables such as: gender,
age, symptoms, cholecystectomy situation, numbers of
surgical repairs attempts (SRA) before, reference time,
stricture recurrence, surgeries performed in our unit, liver
transplantations and outcomes. The benign biliary stric-
tures (BBS) were classiﬁed according to Bismuth’s clas-
siﬁcation.
Results: From September 1999 to October 2009 we re-
viewed 53 patients with BBS. We studied 17 men and 36
women, median age of 42.66 years. The most common
signal and symptom was jaundice and abdominal pain
respectively, 37 cases (69.8%) in each group. Twenty four
patients had a BBS type II (45.3%); 13 type III (24.5%),
10 type I (18.9%), ﬁve patient (9.4%) type IV and only 1
(1.9%) type V. Of all 53 patients, 39 (73.6%) were sub-
mitted a surgical repair, and 26 cases (66.7%) had an
excellent/good results without stricture recurrence. The
patients with bad outcome (n = 13) had an average
reference time of 61.6 months and 9 (75%) had surgical
correction attempt before referral. However, patients
with excellent results (n = 16) had an average reference
time of 11.6 months and only 7 (43.8%) had a previous
surgical correction. We found statistical signiﬁcance be-
tween these groups analyzing the reference time
(P = 0,004) and the previous surgical correction
(P = 0.05). Until now, six patients were listed to liver
transplantation, but only one was performed. We had
seven deaths, six by liver complications.
Conclusion: Patients with bad outcome had a longer
reference time and higher number of previous repair.
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P-430
EVIDENCE BASED GUIDANCE FOR
MANAGEMENT OF IATROGENIC BILE
DUCT INJURY AT LAPAROSCOPIC
CHOLECYSTECTOMY
D. Malde, S. Jamdar, P. Petras, A. Sheen and
A. Siriwardena
Academic Hepatobliary Unit, University of Manchester,
Manchester Royal Inﬁrmary, UK
Background: Iatrogenic biliary injury (BDI) during
Laparoscopic Cholecystectomy (LC) is an infrequent but
potentially lethal complication. There is less appreciation
that BDI presents with different clinical scenarios.
Aims: The aim of this study is to synthesise current evi-
dence on management in these different settings as a step
towards development of a management criteria.
Methods: Medline databases for the period January 2000
to June 2009 were searched to identify 36 manuscripts
reporting management of 2073 patients with BDI. Data
are presented on management of injury recognised at
operation, transectional injury, biliary peritonitis and
late presentation.
Results: The male to female ratio was 1:2.There was
documentation of concomitant arterial injury in 96
(0.05%) patients whilst 534 (25.8%) injuries were iden-
tiﬁed intra-operatively. Strasberg type E (transectional)
injury was present in 932 patients. Primary repair was
carried out in 174 (8.4%) patients and a bilio-enteric
anastomosis in 1384 (66.8%) patients. The mean time to
delayed stricture formation was 21.5 months.153 stric-
tures were identiﬁed is this group with a mean follow up
of 50.8 months (range 0–89.7); treated with percutaneous
dilatation in 125 and refashioning of the anastomosis in
28. The mortality in different series ranged from 0–
12.2%.Signiﬁcant negative predictors of outcome were
repair in non-specialist setting, late presentation and
concomitant arterial injury (P < 0.05).
Conclusions: Primary Roux loop reconstruction is the
favoured intervention for intra-operative complete tran-
section. Primary repair is feasible for partial transection
and permits subsequent strictures to be managed endo-
scopically. Late presentation with biliary peritonitis re-
quires a two-step approach with laparotomy, drainage
and diversion followed by later reconstruction. It is of
consequence to image for concomitant arterial injury as
this increase the risk for stenosis in the subsequent repair.
P-431
SURGICAL TREATMENT OF
IATROGENIC BILIARY INJURY:
LESSONS LEARNED OVER A TWELVE
YEAR PERIOD
C. Quireze Junior, L. Kenny Moraes, W. de Biase da
Silva Neto, F. Correa Amorim, R. Inacio Guimaraes and
H. Ponciano Trevenzol
Hospital das Clinicas / Federal University of Goia´s School
of Medicine
Backgrounds: Iatrogenic bile duct injuries during chole-
cystectomy are a surgical challenge that may result in
severe patient disability and mortality. This study aimed
the evaluation of the clinical features, diagnostic and
deﬁnitive surgical treatment of iatrogenic bile duct injury.
Methods: Single-center database review of patients re-
ferred for deﬁnitive treatment for bile duct injuries
during both laparoscopic and conventional cholecys-
tectomies at Hospital das Clinicas / Federal University
of Goia´s School of Medicine, from 1998 to 2009.
Variables studied included the classiﬁcation of the bile
duct injury (Bismuth), clinical presentation, diagnostic
studies, deﬁnitive surgical repair and results of the entire
hospital care.
Results: Twenty six patients were eligible for this study.
The majority of the cohort consisted of women (92%),
and the mean age was 46 years old. The injury occurred
mainly during conventional operations (81%), and in-
traoperative cholangiogram was not routinely performed
(85%). Clinical features at admission included obstruc-
tive jaundice (85%), external biliary ﬁstula (12%),
internal biliary ﬁstula (23%) and septic shock (35%).
Elevated values of serum enzymes AST, ALT, FA, gGT
and bilirrubins at admission are reported. Imaging prior
to deﬁnitive repair included CT scans (46%), ERCP
(27%), USG (27%), MR (3.8%). Accordingly to Bis-
muth, the lesions were classiﬁed as B1 (7.7%), B2
(53.8%), B3 (23%), B4 (11.5%) and B5 (3.8%). Associ-
ated lesions included right hepatic artery ligation in two
patients (7.6%). Deﬁnitive repair consisted of choledo-
cal-doudenal anastomosis (7.7%) and Roux en Y
hepatico-jejunoanastomosis (92.3%). Immediate com-
plications included pneumonia (1), anastomotic leaks (3),
and hepatic abscess (1). Operative mortality was 3.8%.
Conclusions: Operative cholangiograms may not prevent
the accident, but helps in identifying it during the oper-
ation; surgical repair is the treatment of choice and
consists of Roux en Y duct-jejunal anastomosis.
P-432
PERSONAL 15 YEARS EXPERIENCE IN
THE REPAIR OF COMPLEX
IATROGENIC BILE DUCT INJURIES
M. Uribe1,2, F. Catan1, S. Uribe-Echeverria1,
J. Ormazaval1 and R. Rebolledo1
1Servicio y Departamento de Cirugı´a. Hospital del
Salvador, Universidad de Chile, Santiago-Chile;
2Departamento de Cirugı´a Clı´nica Las Condes,
Santiago-Chile
Background: Iatrogenic bile duct injuries represent an
important problem in biliary surgery. Outcomes depend
on the kind of injury, timing of repair and the surgical
team experience.
Aim: To present the personal 15 years experience of one
of the authors (MU) in repairing complex iatrogenic
biliary tract injuries.
Method: Patients with iatrogenic biliary tract lesions re-
paired by the author between 1994 and 2009 were in-
cluded. Etiology, reparation techniques and outcome
were analyzed.
Results: Thirty four patients, 25 females and nine males
suffered complete section, burn, ligation or resection of
the bile duct. Twenty ﬁve lesions presented following
laparoscopic cholecystectomy, six following open chole-
cystectomy, and three during hepatic resections. In three
cases there were associated vascular lesions; one of the
common hepatic artery (repaired at the same procedure)
one of the right hepatic artery (no repaired) and one case
of resection of the portal vein (replaced with the internal
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jugular vein). Nine cases were diagnosed intraoperatively
with immediate termino-terminal anastomosis or bilio-
enteric anastomosis. Long term complications were three
cases of biliary ﬁstula resolved with medical treatment
and three cases of anastomotic stricture associated with
vascular injuries. Two were successfully treated percuta-
neously. The other needed a new bilioenteric anastomo-
sis. Median follow-up was 8 years (1–180 months). We
report no mortality in this series.
Conclusions: Complex bile duct injuries are a surgical
challenge that needs to be solved by experienced teams.
In our experience all anastomotic strictures were associ-
ated with vascular injuries, worsening the prognosis. We
present a long term follow-up series with excellent results.
P-433
PERI OPERATIVE MANAGEMENT OF
POST CHOLECYSTECTOMY BILIARY
STRICTURES: A SINGLE CENTRE
EXPERIENCE OF 282 PATIENTS
A. Yadav, V. Gupta, S. Singh, P. K. Mishra, S. Agarwal
and A. K. Agarwal
GB Pant Hospital & MAM College, Delhi University
Aims and objectives: Evaluation of peri operative results
of post cholecystectomy biliary stricture repair at a ter-
tiary referral centre.
Methods: Database of 282 patients with post cholecys-
tectomy bile duct stricture repair between January 2000
and June 2009 were analyzed.
Results: 223 (79%) of these injuries were following open
cholecystectomy. Complete Per operative details were
available for 41 (14.7%) patients. Biliary injury was de-
tected intra operatively in 20 (7%) patients. 64 patients
(23%) underwent another surgical intervention prior to
referral, with laparotomy and lavage for biliary perito-
nitis being the most common procedure (22 patients).
Surgical repair was attempted in 30 patients prior to
referral (hepaicojejunostomy n = 21, end to end repair
n = 5, choledochoduodenostomy n = 4). Jaundice with
or without cholangitis was the most common presenting
complaint. Type II and type III strictures were the most
common (95 and 91 patients respectively). The median
interval between injury and deﬁnitive repair was
254 days. Roux-en-Y hepticojejunostomy was the stan-
dard procedure in all patients. Two patients underwent a
concurrent right hepatectomy Trans anastamotic stents
at the time of repair were placed in 30 (10.6%) patients.
The mean operating time was 3.6 ± 0.6 hours and was
signiﬁcantly higher in patients with a history of post
cholecystectomy bile leak and in the presence of external
biliary ﬁstula at the time of repair P < 0.05. Higher
strictures were more common in patients operated upon
late and in those with a persisting external biliary ﬁstula
P < 0.01. Average stoma size was 25 ± 4.6 mm. Inter-
nal ﬁstulas were observed in 18% patients, the duodenum
was the most common site. Post operative complications
occurred in 28% patients with wound infection being the
most common complication.
Conclusions: Satisfactory peri operative results can be
attained for repair of biliary strictures at high volume
centres.
P-434
SURGICAL MANAGEMENT AND
OUTCOME OF BILE DUCT INJURIES
FOLLOWING CHOLECYSTECTOMY
M. Wojcicki1, J. Lubikowski1, M. Post1, M. Wrzesinski1,
J. Butkiewicz1, A. Bialek2, K. Jarosz1 and P. Milkiewicz3
1Department of Hepatobiliary Surgery and Liver
Transplantation, Marie Curie Hospital, Szczecin, Poland;
2Department of Gastroenterology, Pomeranian Medical
School, University Hospital No 1, Szczecin, Poland;
3Department of Hepatology and Liver Transplantation,
Marie Curie Hospital, Szczecin, Poland
Background: Bile duct injury is a life threatening com-
plication of both open and laparoscopic cholecystec-
tomy. Hepaticojejunostomy (HJ) remains the ‘gold
standard’ treatment; however liver transplantation may
sometimes be indicated.
Aims: Weaimed to evaluate themanagementandoutcome
of major bile duct injuries following cholecystectomy.
Methods: Between October 2001 and March 2009, 37
patients (33 women), median age 54 (range 28–79) years
were referred to our unit with bile duct injury following
cholecystectomy (19 laparoscopic). Management before
referral included endoscopic stenting (22 patients) and/or
percutaneous biliary drainage (6), and surgical recon-
struction (18). Four patients were transferred with diffuse
biliary peritonitis in the immediate postoperative period.
Bismuth type IV injuries were found in seven patients
including four with end-stage liver cirrhosis.
Results: Management after referral included elective HJ
according to the Hepp-Couinaud technique in 30 pa-
tients, which in three cases with biliary peritonitis was
preceded by abdominal lavage and prolonged bile
replacement during external biliary drainage. Liver
transplantation was performed in six patients including
four cirrhotics and two with Bismuth type IV injuries.
After median follow-up of 51 (range 6–97) months, 36
patients (97%) are alive and 34 (92%) remain in excellent
general condition with normal liver function. One patient
who had combined biliary and colonic injury died of
sepsis before the repair. Two patients continue to have
episodes of cholangitis at 2 and 5 years following HJ.
Conclusion: The Hepp-Couinaud HJ offers durable re-
sults, even after previous interventions have failed. In
case of diffuse biliary peritonitis, delayed biliary recon-
struction following external biliary drainage may be the
best option. Liver transplantation remains the only
treatment in patients with end-stage liver disease and
may be indicated when the injury extends beyond the
hepatic duct bifurcation.
P-435
BILIARY RECONSTRUCTION FOR TYPE
IV BILIARY INJURY ASSOCIATED WITH
BILIODUODENAL FISTULA AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
K. Sakabe, A. Sugioka, T. Tokoro, K. Amano,
Y. Sakurai, C. Takeura, T. Kagawa, Y. Tanahashi,
Y. Okabe and Z. Morise
Department of Surgery, Fujita Health University, Aichi,
Japan
Background: Type IV biliary injury according to the
Bismuth’s classiﬁcation, involves the hepatic duct con-
ﬂuence, and often requires hepatic resection.
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Aim: The aim of this study is to clarify the signiﬁcance of
the approach to the hilar plate and glissonian pedicles for
the difﬁcult bile duct injury.
Case: We report a case with Type IV biliary injury
associated with a bilioduodenal ﬁstula successfully re-
paired without hepatic resection. A sixty-year old female
was referred to our institute due to recurrent hepatic
abscess. She had a prior history of laparoscopic chole-
cystectomy 17 years earlier when intraoperative biliary
injury was repaired under laparotomy. Although the
blood chemistry on admission was unremarkable, CT
during drip infusion cholangiography revealed severe
biliary stricture involving the hepatic duct conﬂuence.
Endoscopic retrograde approach was failed due to com-
plete obstruction at the common hepatic duct. A bili-
oduodenal ﬁstula was suspected by the biliary
scintigraphy.
Procedure: In the operation, the extra hepatic bile duct
with the duodenum was resected. Then the remnant
cystic plate was identiﬁed and the hilar plate was widely
exposed. The left, right anterior and right posterior
glissonian pedicles were encircled. Afterwards the each
hepatic arteries and portal branches could be identiﬁed
and secured easily. The intact hepatic ducts along with
hilar plate were cut and the six oriﬁces of the intrahepatic
bile ducts were obtained. The oriﬁces were made up into
two and anastomosed to the jejunal loop. The postop-
erative course was uneventful and she has been doing
well for 4 months.
Conclusion: For the difﬁcult cases of bile duct injury such
as Bismuth’s Type III or IV, the approach to the hilar
plate and glissonian pedicles are useful.
P-436
EXPERIENCE, EARLY AND REMOTE
RESULTS OF THE SURGICAL REPAIR
OF POST-SURGERY INJURIES IN THE
MAIN BILIARY DUCT
H. Losada1,2,3, C. Mun˜oz1,2, L. Burgos San Juan1,2,3 and
J. Silva1,2,3
1HPB surgery team. Surgery Department. Hospital Dr.
Herna´n Henrı´quez Aravena. Temuco; 2Surgery
Department.Universidad de La Frontera. Temuco;
3Surgery Department. Clı´nica Alemana de Temuco
Introduction: Main biliary duct postsurgical injuries
(BDI) are serious and hard to control complications of
the hepatobiliary surgery. There are multiple therapeutic
approaches, depending on BDI type. Our goal is to
present the experience with the early and late results of
the repair techniques of BDI.
Materials and method:
Study design: Cohort Study.
Study period: January 2000–June 2009.
Maneuver: A review of the clinical records of patients
with BDI repair. Periodic controls are performed in order
to evaluate the clinic, laboratory and imaging aspects.
Statistical analysis: Descriptive statistics along with
central tendency and scatter were used. Analytic statistics
were applied to dichotomic and continuous variables.
Excel program was used to collect data and STATA
9.0 program was used to data analysis.
Results: During the study period, 25 patients with BDI
were treated. Average age is 44 ± 13.7 years old and the
76% are female. The injury was most frequently pro-
duced in laparoscopic cholecystectomy. Most of them
correspond to Bismuth type I, II, and III injuries. In 20
patients, the repair was made with Roux-Y hepaticojej-
unostomy (RHJ) using the Hepp-Couinaud technique
modiﬁed in 70% of them. Eight patients presented some
kind of morbidity related to repair, and one patient died
during postoperative period. The hospitalization average
is 21 ± 12.2 days. During the follow-up period, two
patients presented RHJ stenosis with this technique, and
these have been controlled using percutaneous balloon
dilatation.
Conclusion: BDI is a hard to control complication of the
biliary surgery. Our center experience is comparable to
national numbers, in terms of reconstruction and re-ste-
nosis morbimortality.
P-437
A CASE IN WHICH PLACEMENT OF A
LOST STENTWAS EFFECTIVE FOR BILE
DUCT INJURY SUSTAINED DURING
LAPAROSCOPIC CHOLECYSTECTOMY
AFTER EST
R. Higuchi, T. Ota, T. Araida, M. Hamano,
N. Takeshita, H. Kajiyama, T. Yazawa, Y. Yagawa and
M. Yamamoto
Department of Surgery, Institute of Gastroenterology,
Tokyo Women’s Medical University
A 42-year-old man with cholecystocholedocholithiasis.
Endoscopic sphincterotomy (EST), lithotomy and endo-
scopic nasobiliary drainage (ENBD) were performed.
After these treatments, laparoscopic cholecystectomy
was performed. The area around the neck of the
gallbladder was sclerotic due to inﬂammation. We
clipped a cord which we considered to be the cystic duct;
we judged this cord to be indeed the cystic duct.
However, after we cut this cord, we found the ENBD
tube inside. Bile duct injury was conﬁrmed, the bile duct
was cut over about 3/4 of the circumference at the level of
bifurcation with the cystic duct. We sutured the injured
portion of the bile duct with absorbable sutures. We
placed a 6 mm silicone drain as a lost stent because the
patient had undergone EST. We placed the end of the
silicone tube into the duodenum through the papilla of
Vater. Although we switched over to laparotomy due to
bile duct injury, this patient was discharged on postop-
erative day 7. Eight months later we had drawn this tube
by endoscopy, no stricture of the bile duct has been seen.
We conclude that placement of a silicon drain as a lost
stent may be effective in cases of bile duct injury
sustained during LC after EST.
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P-438
PORTAL-VENOUS HEMODYNAMICS
AFTER EXTENDED HEPATECTOMIES
IN PATIENTS WITHOUT PREEXISTING
PORTAL HYPERTENSION
M. Guba1,2, C. Sandroussi1, S. Selvarahjah1, K. Khalili3,
T. Kyoung Kim3, P. Burns4, S. Gallinger1 and
C.-A. Moulton1
1Department of Surgery, Toronto General Hospital.
University of Toronto. Canada; 2Department of Surgery,
University of Munich, Campus Grosshadern, Germany;
3Department of Medical Imaging, University of Toronto.
Canada; 4Departments of Medical Biophysics and Medical
Imaging, University of Toronto, and Imaging Research,
Sunnybrook Health Sciences Centre, Toronto, Ontario,
Canada
Introduction: Liver dysfunction and infection contribute
to morbidity and mortality after liver surgery. Function
and regeneration may be impaired with extended resec-
tion. Perioperative changes in blood ﬂow may aggravate
liver dysfunction. The aim of this study was to measure
the effect of the extent of liver resection on portal venous
pressure (PVP), liver function and integrity of intestinal
barrier function.
Methods: PVP was measured invasively before and after
liver resection on a consecutive cohort of eligible pa-
tients. Portal venous ﬂow (PVF) and total hepatic per-
fusion of the remnant liver was also determined by
ultrasound. On POD#2 and 5 Doppler measurements
were repeated and interstinal permeability (IP) was
measured by a lactulose/mannitol test. Clinical state and
biochemistry was monitored until discharge.
Results: Twenty patients with 14 major and six minor
resections for cholangiocarcinoma (2) colorectal (15),
breast, carcinoid, GIST were prospectively enrolled. 13
had preoperative chemotherapy. The median increase in
PVP and sinusoidal pressure (SNP) was 1 mmHg (-5 to 8,
P = 0.18) and 3 mmHg (-2 to 8, P = 0.001) respec-
tively. PVF did not change. No differences in portal he-
modynamics existed between major and minor
resections. Peak bilirubin (BR) was higher in those with
major resections (P = 0.03), with no difference in other
tests of liver function. Correlation between SNP change
and BR approached but did not reach signiﬁcance
(P = 0.084). IP after surgery was increased but did not
correlate with extent of resection. Morbidity occurred in
35%. There was no association between complications
and change in PVP (P = 0.584), SNP (P = 0.638) and
PVF (P = 0.465).
Conclusion: Even after extended liver resection the rem-
nant liver has signiﬁcant capacity to regulate PVF
keeping PVP in normal ranges. Whether pushing the
limit for much smaller liver remnants (<30%) would
eventually result in frank portal hypertension cannot be
answered in this cohort of ‘‘clinically uneventful’’ pa-
tients.
P-439
NUTRITIONAL PRECONDITIONING:
FASTING INDUCES UP REGULATION
OF HO-1 AND ANTIOXIDANT DEFENSE
AND PROTECTS AGAINST HEPATIC
ISCHEMIA/REPERFUSION INJURY
J. R. van Ginhoven1, M. Verweij1, J. R. Mitchell2,
S. van den Engel1, F. Bonthuis1, E. Torabi1,
J. N. M. Ijzermans1, J. H. J. Hoeijmakers1 and
R. W. F. de Bruin1
1Erasmus MC, Rotterdam; 2Harvard School of Public
Health
Background: Ischemia reperfusion (I/R) injury is an
important factor determining patient outcome after liver
transplantation. Release of reactive oxygen species con-
tributes to reperfusion injury of the liver after ischemia.
We show that 72 hours of fasting protects against hepatic
I/R injury.
Aim: To elucidate the protective mechanisms, we inves-
tigated the effect of fasting on mRNA expression levels
of hepatic HO-1 and antioxidant defense genes.
Methods: Male C57BL/6 mice were fed ad libitum or
fasted for 72 hours prior to surgery. The portal vein to
the left and middle liver lobes (70%) was clamped for
75 min. Liver damage, neutrophil inﬂux and mRNA
levels of mitochondrial superoxide dismutase 2, gluta-
thione peroxidase 1, and glutathione reductase were
determined at 0, 6 and 24 hours after reperfusion.
Results: At 24 hours post-reperfusion, signiﬁcantly low-
er ALAT levels (P < 0.01), signiﬁcantly less hemor-
rhagic necrosis (P < 0.001) and a signiﬁcantly reduced
number of inﬁltrating neutrophils (P < 0.05) was ob-
served in livers of fasted animals. Hepatic HO-1 mRNA
expression levels were up regulated at baseline, with
values signiﬁcantly higher than the ad libitum fed group.
Peak expression level was found 6 hours post-reperfusion
in the fasted group while the control group peaked
24 hours after reperfusion. Hepatic mRNA expression
levels of mitochondrial superoxide dismutase 2, gluta-
thione peroxidase 1 and glutathione reductase were sig-
niﬁcantly up regulated at baseline in livers of 72 hours
fasted animals.
Conclusion: Short-term preoperative fasting protects
against I/R injury. Fasting induces baseline up regulation
of HO-1 and antioxidant mRNA expression levels. HO-1
levels were signiﬁcantly higher and achieved earlier after
I/R injury in the fasted group. This leads to improved
antioxidant defense and reduced organ damage. In
analogy to ischemic preconditioning we coin the term
nutritional preconditioning for the beneﬁcial effects
induced by fasting.
P-440
THE CONTRIBUTION OF THE PORTAL
VEIN ON BLOOD FLOW THROUGH
THE PERIBILIAIRY PLEXUS
J. Slieker, J. de Jonge, W. Farid, C. van Eijck and
G. Kazemier
Erasmus Medical Center Rotterdam/Department of
Surgery
Background: Biliairy complications are the second most
common cause of graft loss after liver transplantation.
The occurrence of these biliairy complications is partly
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attributed to hepatic artery thrombosis. However, the
contribution of the portal venous blood ﬂow to the per-
ibiliairy plexus is unknown, as well as whether distur-
bances in the portal venous blood ﬂow contribute to the
formation of biliairy complications.
Aim: The aim of this study was to analyze the contri-
bution of the portal vein to the blood ﬂow in the per-
ibiliairy plexus.
Methods: Blood ﬂow in the peribiliairy plexus was
determined in 11 patients undergoing pancreaticoduo-
denectomies. In this procedure the common bile duct
(CBD) is transected as it is in liver transplantation. The
microvascular blood ﬂow through the CBD was mea-
sured using a device combining laser Doppler ﬂowmetry
and reﬂectance spectrophotometry. Blood ﬂow was
measured during baseline situation, after clamping the
portal vein, after clamping the hepatic artery, and after
clamping both. After transection of the CBD these
measurements were repeated.
Results: Compared to baseline measurements the blood
ﬂow through the CBD decreased by an average of 30%
(6.7) after clamping the portal vein, 45% (6.3) after
clamping the hepatic artery, and 66% (9.5) after
clamping both. Once the CBD was transected, the blood
ﬂow decreased by an average of 37% (10.7) after
clamping the portal vein, 67% (8.4) after clamping the
hepatic artery, and 75% (5.5) after clamping both. All
the procentual changes in blood ﬂow were statistically
signiﬁcant.
Discussion: Historically, the hepatic artery was consid-
ered the sole contribution to the biliairy blood ﬂow. This
study shows that the portal vein has a considerable role
in the peribiliairy plexus, contributing to an important
part of the blood ﬂow through the CBD even when the
hepatic artery is open. This emphasizes the importance of
the portal vein in the blood ﬂow through the peribiliairy
plexus.
P-441
UTILIZATION OF HEPATITIS C VIRAL
GENOTYPE IN PREDICTING
OUTCOMES FOR HEPATOCELLULAR
CARCINOMA (HCC) FOLLOWING LIVER
TRANSPLANT
J. R. Perkins1,2, C. Sandroussi1,2, M. Selzner1,2,
A. Ghanekar1,2, I. McGilvray1,2, M. Cattral1,2,
L. Lilly1,2, P. Greig1,2 and D. Grant1,2
1University of Toronto; 2Toronto General Hospital
Background/Aims: The relationship between HCV
genotype and HCC outcomes before and after transplant
is unknown. Genotype 1 is associated with a higher rate
of HCV recurrence. We hypothesized that HCV genotype
may inﬂuence outcomes in HCC before and after trans-
plant.
Methods: Patients transplanted for HCV/HCC were
analyzed by genotype, MELD, Milan criteria, stage,
progressive/stable disease, explant pathology, recurrence
and survival.
Results: Hundred and eighty seven patients were trans-
planted between January 1996 and August 2009. Geno-
types (1–6) were available in 94 patients (47.2%): 67
patients (71.2%); six patients (6.4%); 17 patients
(18.1%); six patients (6.4%); two patients (2.1%); one
patient (1.1%). There was no difference in Milan stage
across genotypes (1–38.7%; 2–16.7%; 3–52.9%; 4–50%;
5-50%; 6–100%; P = 0.509). Genotype 1 did not have
progressive disease (3.7%) compared to others (2–40%;
3–22%; 4–6, none, P = 0.196). There was no difference
between genotypes in tumor size, diameter, number,
pathologic staging (P = 0.509), micro/macrovascular
invasion (P = 0.521, 0.111), necrosis (P = 0.320) or
differentiation (P = 0.663). Subtype 1b trended toward
worse overall (77% vs. 95%) and 5-year disease-free
survival (63% vs. 77%) than 1a but this was not signiﬁ-
cant (P = 0.168, 0.282). There was no difference in
recurrence between subtypes 1a and 1b (18.5% vs.
13.3%, P = 0.540) or cause of death (tumor, HCV
recurrence, P = 0.656). There was no overall survival
difference in comparison to other disease types (HCV
71%; HBV 84%; alcohol 73%, other 76%).
Conclusion: Across HCV genotypes, there is no differ-
ence in tumor biology or outcomes for HCV/HCC be-
fore and after transplant. Despite known high
recurrence rates in genotype 1 post transplant, this did
not signiﬁcantly impact HCC recurrence. Genotype is
not predictive of overall or disease-free survival in HCC
or compared to other disease groups using Cox-pro-
portional analysis. Further studies are required to
determine whether this trend may be due to HCV
recurrence.
P-442
THE IMPACT OF OLDER DONOR AGE
(‡50) ON ADULT TO ADULT LIVING
DONOR LIVER TRANSPLANTATION
J. R. Park, S. G. Lee and S. Hwang
Asan Medical Center
Background: The growing discrepancy between the
number of patients listed for liver transplantation and the
inadequate organ supply is a common problem in the
medical community. The use of older donors has long
been recognized as one of the most important prognostic
factors for patient and graft survival.
Aim: To evaluate the impact of older donor age (‡50) on
adult to adult living donor liver transplantation.
Methods: Subjects included patients who underwent
right lobe graft-LDLT at Asan Medical Center from
August 1998 to January 2008. Twenty donors were
50 years of age or older. Clinical parameters of both
recipients and donors were analyzed retrospectively.
Results: In donors, male to female ratio was 8:12. The
mean hospital stay was 14.1 days and postoperative
complication rate was 15%. The mean remnant liver
volume was 39.3%. In recipients, male to female ratio
was 10:10 and the mean age was 47.3 years. The most
common etiology was HBV related liver cirrhosis (45%).
The mean MELD score was 20.3 and the mean Graft to
Recipient Weight Ratio was 1.02%. Mean follow up
period was 20.9 months. The mean graft regeneration
rate at postoperative 1 month was 80.3%. In hospital
mortality rate was 5/20 (25%) and the causes of death
were sepsis (2), pneumonia, intracranial hemorrhage, and
acute cellular rejection. The 1, 3-year survival rates of
recipients were 88% and 79%.
Conclusion: Old organs may work effectively, provided
that old age donors are evaluated with routine biopsy
and have the adequate graft size for recipient.
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P-443
SMALL VOLUME DECEASED DONOR
LIVER TRANSPLANTATION
ALONGSIDE LIVING DONOR LIVER
TRANSPLANTATION
S. C. Chan, C. M. Lo, A. C.-Y. Chan, K. K.-C. Ng and
S. T. Fan
Queen Mary Hospital, University of Hong Kong
Living donor liver transplantation (LDLT) is to date the
only realistic life-saving treatment alternative to deceased
donor liver transplantation. With advances in surgical
techniques and therapeutics in the last decade, despite the
use of a partial graft, which is often small-for-size, LDLT
is at least as good as deceased donor liver transplantation
(DDLT). We looked into the outcomes of DDLT, in
small volume, by international standards, alongside a
matured LDLT service. Comparison was made between
our LDLT and overseas DDLT. From 1991 to the end of
2007, we performed 185 DDLT (Era I, n = 59, Era II,
n = 126). Era I coincided with the ﬁrst 50 LDLT in our
center and was considered the formative period. All
donors were brain-dead and heart-beating with a median
age of 47.5 (range, 9–76 years). Up to 65.9% of recipients
were hepatitis B carriers. Up to 29.7% were transplanted
on high urgency basis and 14.6% for hepatocellular
carcinoma. The Model for End-stage Liver Disease score
was 21 (range, 6–56). Before transplantation, 15.7% were
in the intensive care unit and 19.7% in hospital. Hospital
mortality rate dropped from 13.6% (8/59) of Era I to
4.8% (6/126) of Era II (P = 0.035). Recipient survival
rates of Era I were 84.8, 79.7, and 76.3% and increased to
92.9, 89.6, and 88.0% at 1, 3, and 5 years (P = 0.0147).
Only six recipients underwent retransplantation (3.2%)
and one failed. From Era II, recipient survivals surpassed
the average 1- and 5-year survivals of DDLT by
international standards. DDLT alongside LDLT has
excellent results despite a small number.
P-444
COMPARISON OF OPEN AND
LAPAROSCOPIC LIVE DONOR LEFT
LATERAL SECTIONECTOMY
J. R. Kim, D. H. Jung, H. J. Kim, Y. J. Lee, K. M. Park,
D. Y. Kim, C. S. Ahn, Y. D. Yu, G. C. Park, P. J. Park,
Y. I. Choi and S. G. Lee
Asan Medical Center, Ulsan University, Seoul, Korea
Background: Laparoscopic surgery has become in the
ﬁeld of digestive surgery as a minimally invasive treat-
ment than open surgery that offers improved postoper-
ative quality of life for patients. In this circumstances
minimally invasive donor hepatectomy using laparo-
scopic technique has been occasionally reported and
appeared beneﬁcial for the donor as compared with
standard open surgery. Here we report the comparison of
open and laparoscopic live donor left lateral sectionec-
tomy in pediatric live donor liver transplantation.
Materials and methods: Twenty two patients who
underwent 11 open live donor left lateral sectionectomies
(OLS) and 11 laparoscopic live donor left lateral sec-
tionectomies (LLS) from April 2008 to October 2009 at
Asan Medical Center were enrolled in this study. Their
medical records were retrospectively reviewed.
Results: There were nine pure laparoscopic surgeries and
two laparoscopic assisted surgeries in the LLS group.
The duration of hospital stay and start of diet in the LLS
group were signiﬁcantly shorter as compared with the
OLS group (6.9 ± 0.3 vs. 9.8 ± 0.9 days, P = 0.00,
2.1 ± 0.3 vs. 2.7 ± 0.4 days, P = 0.01). There were no
statistically differences in the operative time and blood
loss between both groups. No morbidity was observed in
the LLS group.
Conclusions: The results of LLS showed shorter hospital
stay, earlier postoperative diet, compatible operative time
and blood loss as compared with those of OLS. It seems
to be beneﬁcial for the live donor and a feasible, repro-
ducible procedure in the ﬁeld of laparoscopic donor
surgery of live donor liver transplantation.
P-445
REDUCTION IN CORTICOSTEROID USE
AND DOSING IN LIVER TRANSPLANT
RECIPIENTS IS ASSOICATED WITH
BETTER PHYSICAL AND MENTAL
HEALTH-RELATED QUALITY OF LIFE
V. Zaydfudim, M. Landman, I. Feurer, D. Moore,
K. Wright and W. Pinson
Vanderbilt University Medical Center
Background: Studies suggest that corticosteroid use
during post-transplant immunosuppression contributes
to signiﬁcant long-term complications in liver transplant
recipients. However, the effect of steroids on post-
transplant physical and mental health-related quality of
life (HRQOL) has not been established.
Objective: To test the effects of steroid-based immuno-
suppression on post-transplant HRQOL in liver trans-
plant recipients.
Methods: Prospective, longitudinal HRQOL was mea-
sured using the SF-36 physical (PCS) and mental (MCS)
component scores, Beck Anxiety Index (BAI), and CES-
D depression scale. Post-transplant steroid use, deter-
mined at every HRQOL data point, was modeled as
continuous (mg/day), binary (yes/no), and multicategory
(none, low <10 mg, high ‡10 mg prednisone/day) data.
Linear mixed-effects models tested the effects of con-
temporaneous steroid use and dosing on post-transplant
HRQOL.
Results: The sample included 186 adult liver transplant
recipients (age = 54 ± 8 years, 70% male) with pre-
and at least one post-transplant HRQOL data point.
Individual follow-up averaged 21 ± 18 months (range:
1–75). After controlling for pre-transplant HRQOL, time
post-transplant, and pre-transplant diagnosis group,
post-transplant steroid use had a negative effect on PCS,
MCS and BAI scores (all P < 0.001). When compared
to patients on higher dose steroids, scores were signiﬁ-
cantly better in patients not receiving steroids (all
P < 0.012), and in those receiving <10 mg prednisone/
day (all P < 0.002).
Conclusions: Steroid use for post-transplant immuno-
suppression in liver transplant recipients is associated
with signiﬁcantly reduced physical and mental HRQOL,
and increased symptoms of anxiety. Patients not receiv-
ing steroids, and those receiving less than 10 mg/day,
have better health-related quality of life over a wide
follow-up period.
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P-446
NATURAL HISTORY AND CLINICAL
OUTCOME AFTER EXTENDED LONG-
TERM FOLLOW-UP FOR CYSTIC
LESIONS IN THE PANCREAS
D.-W. Ahn1, S. H. Lee2, J.-H. Hwang2, C. M. Shin1,
W. J. Yoon1, J. K. Ryu1, Y.-T. Kim1, Y. B. Yoon1,
Y. J. Jung3 and S. C. Park4
1Department of Internal Medicine and Liver Research
Institute, Seoul National University College of Medicine;
2Department of Internal Medicine, Seoul National
University Bundang Hospital; 3Department of Internal
Medicine, Seoul National University Boramae Hospital;
4Department of Internal Medicine, Korea Institute of
Radiological and Medical Sciences, Korea Cancer Center
Hospital
Background: An increasing number of cystic neoplasms
in the pancreas are being incidentally discovered. How-
ever, there is no appropriate guideline for their man-
agement because information on the natural history of
pancreatic cystic neoplasm is not available yet.
Aims/objectives: The aim of this study was to investigate
the natural history and clinical outcome after long-term
follow-up of pancreatic cysts.
Methods: Pancreatic cysts detected from 1998 to 2004
were recruited in patients followed up for more than
3 months. And then, the data were followed up pro-
spectively till July 2009.
Results: A total of 182 patients with incidental pancreatic
cysts (mean age, 59.8 ± 11.6 years, initial mean size,
1.8 ± 1.1 cm) underwent follow-up for an average of
52.8 months. In case of 156 patients followed up without
surgery, the mean duration of follow-up was 54.6 months.
An age ‡60 years was found to be associated with an in-
crease in cyst size, with an odds ratio of 1.80 (P = 0.04).
Twenty six patients underwent surgical resection during
follow-up due to increase of cystic size, changes in cystic
features, pain aggravation, presenting complication or
simultaneous operation on another intrapancreatic or
intra abdominal tumor (mean duration of follow-up till
surgery, 42.4 months). Among them, four cysts were
malignant tumor. Old age was also associated with the
presence of a premalignant or malignant cyst (P < 0.01).
Conclusions: Although the majority of incidental pan-
creatic cysts show an indolent behavior, a few of them
have malignant potential during follow-up. Therefore,
long-term, regular follow-up studies should be consid-
ered for all pancreatic cysts, especially in the elderly.
P-447
SPONTANEOUS DEVELOPMENT OF
GEMCITABINE RESISTANCE IN
PANCREATIC CANCER CELL LINES
C. S. Jennings1, J. D. Coursen1, Q. Dai1, J. R. Firpo1,2
and S. J. Mulvihill1,2
1University of Utah Department of Surgery; 2Huntsman
Cancer Institute
Background: Gemcitabine (GEM) is the standard che-
motherapy for pancreatic adenocarcinoma (PA), but
resistance is a persistent clinical problem. It is unclear if
GEM resistance arises through selection of a pre-existing
tumor cell sub-population or by acquisition of new
mutations. To probe these possibilities, we took advan-
tage of observations in which late passage PA cell lines
led to a modest increase in cell growth rate, which was
associated with increased GEM resistance, despite the
lack of GEM selection.
Objectives: We examined GEM resistance in this system
reasoning that if resistance were solely the result of out-
growth of a faster growing subpopulation we expected
GEM resistance to rise at a similar rate and time across
repeated experiments. If due to new mutation, we
expected resistance to occur at random passages.
Methods: MiaPaCa-2 cells were cultured and passaged
35 times in three replicate sets. Samples were collected
every ﬁve passages. Growth rate and GEM sensitivity
were evaluated for each sample via resazurin assays in
graded doses of GEM. FACS analysis and caspase assays
were used to analyze the effects of GEM on cell cycle and
apoptosis.
Results: In all three replicate sets, a linear increase in
GEM resistance was observed, tracking with increased
growth rate. In two of the three replicate sets, a sudden
increase in GEM resistance was observed at intermediate,
but different, passages. This post-spike resistance corre-
lated with decreased S-phase arrest indicating reduced
GEM incorporation into DNA. Caspase activity levels
also decreased in post-spike resistant passages suggesting
decreased apoptosis.
IC50 and Proliferation vs. Passage Number for each
Replicate Passage Set
Set 1
Passage Number 5 11 16 22 27 32 35
IC50 (nm GEM) 13.5 16.9 33.9 1157 638 850 1656
Proliferation
(ﬂuorescence
change/day)
80.3 140 148 163 244 244 297
Set 2
Passage Number 5 10 15 20 25 30 35
IC50 (nm GEM) 3.4 3.1 39.2 32.5 23.1 49.5 59.6
Proliferation
(ﬂuorescence
change/day)
75.7 78.4 185 119 158 139 275
Set 3
Passage Number 5 10 15 20 25 30 35
IC50 (nm GEM) 3.4 14.1 34.8 57.3 81.7 544 558
Proliferation
(ﬂuorescence
change/day)
75.7 64.8 169 123 167 244 300
Conclusions: These data suggest that GEM resistance
can arise from a pre-existing sub-population as well as
spontaneously. Since both mechanisms of GEM resis-
tance were demonstrated in the absence of GEM treat-
ment, these results may provide an explanation consistent
with a spontaneous mechanism for the development of
inherent resistance in PA cases.
P-448
COMPARISON OF FUNCTIONAL AND
NONFUNCTIONAL NEUROENDOCRINE
TUMORS IN THE PANCREAS AND
PERIPANCREATIC REGION
S.-E. Wang and Y.-M. Shyr
Taipei Veterans General Hospital
Background: NETs are claimed to be relatively indolent.
However, different conclusions were reported regarding
the prognosis in term of functional status.
Objective: To present our experience of 93 neuroendo-
crine tumors (NETs) in the pancreas and peripancreatic
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region, with emphasis on how resectability affects long-
term survival and the impact of functional status on the
survival outcome.
Methods: Ninety-three patients with NETs in the pan-
creas and peripancreatic region were included to compare
the clinical features between functional and nonfunc-
tional NETs. Prognostic factors were determined by
univariate and multivariate analyses.
Results: There were 39 (41.9%) functional and 54
(58.1%) nonfunctional NETs. When further classiﬁed
according to WHO tumor categories, there were 57
(61.3%) well-differentiated tumors, 26 (28%) well-dif-
ferentiated carcinomas and 10 (10.8%) poorly-differen-
tiated carcinomas. Nonfunctional NETs had a higher
percentage of carcinomas (51.8%) than functional NETs
(20.5%). Univariate analysis showed that functional
status of the tumor, tumor stage, lymph node status and
pathological classiﬁcation were prognostic factors for
both disease-free survival (DFS) and disease-speciﬁc
survival (DSS). Resectability did not inﬂuence the sur-
vival outcome, with the resectable and unresectable
groups demonstrating a 5-year DSS of 86.4% and
65.6%, respectively, P = 0.210. Only the WHO patho-
logical classiﬁcation was an independent prognostic fac-
tor after multivariate analysis.
Conclusions: Resectability does not seem to play a sig-
niﬁcant role in the survival outcome, and irresectability
does not necessarily exclude a long-term survival for both
functional and nonfunctional NETs. It is the WHO
pathological classiﬁcation, instead of hormonal func-
tional status, that is an independent prognostic factor
and has impact on the survival outcome of NETs.
P-449
GASTRIC OUTLET OBSTRUCTION DUE
TO DUODENAL INTRAMURAL
PSEUDOCYSTS-CAN EUS HELP?
S. Sachithanandan, K. Raman, R. Ponnudurai and
H. Singh
Selayang Hospital, Kuala Lumpur
Background: Intramural pyloro-duodenal pseudocysts
complicating pancreatitis are a recognized albeit
uncommon cause of gastric outlet obstruction.
Aim: To report the experience from a single tertiary
referral centre of a series of eleven such cases.
Methods: The records of eleven consecutive patients with
symptomatic gastric outlet obstruction due to intramural
pseudocysts managed between January 2006 and June
2009 were reviewed. Patients with extramural collections
were excluded.
Results: All eleven patients were male aged between 21
and 59 years. Nine were Indian in origin, one Chinese
and one Malay. All patients had a preceding history of
acute pancreatitis and symptomatic gastric outlet
obstruction. Aetiology was alcohol (9/11), pancreatic
trauma (1/11) and drug induced pancreatitis (1/11). All
patients had a CT abdomen which revealed a ﬂuid col-
lection but only endoscopic ultrasound (EUS) was able
to demonstrate the exact intramural location. Fluid
aspirated was extremely high in amylase (>10,000 IU/
L). EUS guided aspiration was sufﬁcient to temporarily
relieve symptoms in all patients. Three remained well.
Eight of eleven patients eventually required surgical
intervention for recurrent symptoms. Whipples (3),
Gastro-jejunostomy (3), Pancreatico-jejunostomy (1) and
Billroth Gastrectomy (1). All remain well six months post
operatively with good weight gain and no recurrent
symptoms.
Conclusions: Endoscopic ultrasound guided ﬁne needle
aspiration (EUSFNA) provides an accurate assessment
and characterization of post-pancreatitis pyloro-duode-
nal intramural cystic collections. Majority of patients in
this series required surgical intervention for sustained
relief of gastric outlet obstruction. This entity appears to
be common in Indian male alcoholics with chronic pan-
creatitis.
P-450
USEFULNESS OF PANCREATIC HEAD
RESECTION WITH SEGMENTAL
DUODENECTOMY (PHRSD) FOR
BENIGN AND LOW-GRADEMALIGNANT
NEOPLASMS OF THE PANCREATIC
HEAD
T. Fujii, M. Kanda, Y. Kodera, S. Nagai, T. T. Sahin,
A. Kanzaki, G. Nakayama, T. Kinoshita, T. Watanabe,
H. Sugimoto, S. Nomoto, S. Takeda and A. Nakao
Nagoya University Graduate School of Medicine
Background/Aim: Pancreatic head resection with seg-
mental duodenectomy (PHRSD) has been performed as
an easy and safe function-preserving operation for a
benign or a low-grade malignant tumor such as intra-
ductal papillary mucinous neoplasms (IPMNs) of the
pancreatic head. However, there has been no compre-
hensive study concerning the beneﬁts of this technique.
Method: This is a retrospective analysis of 160 consecu-
tive patients. Seventy-two patients who underwent
PHRSD were compared with 88 patients who underwent
pylorus-preserving pancreaticoduodenctomy or pan-
creaticoduodenectomy (PD group). Long-term prognosis
of non-invasive IPMNs was also analyzed to evaluate the
validity of operative indication.
Results: There was no mortality in both groups. Mean
operative time in the PHRSD group was signiﬁcantly
shorter than that in the PD group (352 vs. 395 min,
P = 0.048), and mean surgical blood loss (469 mL) was
also signiﬁcantly less than those in the PD group
(707 mL, P = 0.001). The incidence of pancreatic ﬁstula
was lower after PHRSD (26%) than after PD (40%), and
the incidence of delayed gastric emptying was higher in
the PHRSD group (17%) than in the PD group (12%),
not statistically signiﬁcant. In terms of long-term nutri-
tional status, decrease in the body weight of the PHRSD
group was signiﬁcantly less than the PD group
(P = 0.033), and serum levels of total protein and
albumin were signiﬁcantly increased in the PHRSD
(P = 0.043, P = 0.046). In the PHRSD group, meta-
chronous IPMN of the remnant pancreas was diagnosed
in one (2.4%) of 41 non-invasive IPMN.
Conclusions: PHRSD was found to be more useful due
to decreased rate of intra- or post-operative complica-
tions and improvement in nutritional status compared to
PpPD or PD. Furthermore, the prognosis was satisfac-
tory among patients with non-invasive IPMNs. PHRSD
can preserve digestive and pancreatic function and is
an adequate choice for benign or low-grade malignant
tumors, resulting in improved nutritional status.
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P-451
CA19-9 AS A PREDICTOR OF TUMOUR
RESPONSE AND SURVIVAL IN
PATIENTS WITH ADVANCED
PANCREATIC CANCER TREATED WITH
GEMCITABINE BASED
CHEMOTHERAPY
B. El-Rayes1, N. Hamad2, L. Heilbrun3, A. Shields3,
M. Zalupski4 and P. Philip3
1Emory University; 2Kingston Hospital; 3Karmanos
Cancer Institute; 4University of Michigan
A major challenge to therapy in pancreatic cancer is
evaluation of tumour response. The aim of this study
was to determine the predictive role of pre-treatment
CA19-9 measurement and its change after one cycle of
Gemcitabine-based therapy for response, time to pro-
gression (TTP), and overall survival (OS). Analyses
were derived from three consecutive Gemcitabine con-
taining phase II clinical trials between 1997 and 2004. A
total of 111 patients (median age 56 years, 60% males)
with locally advanced or metastatic pancreas cancer
were studied. Baseline CA19-9 concentrations were
dichotomized near the median as: < 1,000, and
‡ 1,000 ng/mL. Lower baseline CA19-9 levels were
positively associated with OS (median 9.1 vs.
6.1 months, p = 0.0057) and TTP (median 6.4 vs.4.2
months, p = 0.0044).The covariate adjusted hazard
ratio (HR) for progression among patients with baseline
CA19-9 ‡ 1,000 ng/mL was HR = 1.94 (95% CI: 1.24
– 3.02), with p = 0.0035. The covariate adjusted risk of
death among patients with baseline CA19-9 ‡ 1,000 ng/
mL was similarly elevated: HR = 1.90 (95% CI: 1.23 –
2.94), with p = 0.0039. There was no association
between baseline CA19-9 level and radiologic response
(p = 0.82). Change in CA19-9 levels from baseline to
the end of treatment cycle one did not predict objective
response (p = 0.75). There was somewhat longer OS
(median 8.7 vs. 7.1 months) and TTP (median 7.1 vs.
5.4 months) in patients with > 50% reduction in serum
CA19-9 concentrations, but not statistically signiﬁcantly
so (p = 0.74 and 0.81, respectively). In conclusion,
baseline CA19-9 levels may predict survival in patients
with advanced pancreas cancer. Future clinical trials
should include CA19-9 measurement as a risk stratiﬁ-
cation factor. The change in CA19-9 levels determined
within one month of initiation of therapy did not
predict treatment outcome.
P-452
IMPACT OF OPERATIVE BLOOD LOSS
ON SURVIVAL IN INVASIVE DUCTAL
ADENOCARCINOMA OF THE
PANCREAS
G. Nakayama, T. Fujii, S. Nagai, M. Kanda,
T. Kinoshita, T. Watanabe, H. Sugimoto, S. Nomoto,
S. Takeda, Y. Kodera and A. Nakao
Nagoya University Graduate School of Medicine
Background: There are several factors potentially asso-
ciated with overall survival. Operative blood loss is
considered to be a prognostic factor in pancreatic cancer,
but the extent of the negative inﬂuence has not been fully
discussed.
Objective: To determine the prognostic factors and as-
sess the impact of excessive operative blood loss on sur-
vival, following a pancreatectomy for invasive ductal
adenocarcinoma.
Methods: From the retrospective analysis of a single,
large center experience, 271 patients were eligible for
evaluation. Overall survival was assessed to clarify the
prognostic determinants, including patient characteris-
tics, perioperative factors, and tumour characteristics.
Results: Overall survival was signiﬁcantly affected by the
amount of operative blood loss. Median survival time of
the following three groups (A, < 1000 mL; B, 1000–
2000 mL; C, > 2000 mL) was 26.0, 15.3, and
8.7 months, respectively. (A vs. B, P = 0.0188, B vs. C,
P < 0.0001). On multivariate analysis, estimated blood
loss (EBL) of more than 2000mL remained an indepen-
dent factor (P = 0.003, Hazard Ratio = 2.38). EBL of
2010 mL can be regarded as an appropriate cut off level
for prediction of early mortality, within 6 months, after
resection (sensitivity and speciﬁcity were 0.660 and
0.739). Male gender, year of resection, and plexus inva-
sion were independently associated with excessive blood
loss (more than 2000 mL).
Conclusions: In pancreatic cancer, operative blood loss
was considered to be an independent prognostic deter-
minant and the predictive blood loss level for poor
prognosis is 2000 mL. Successful curative resection with
limited blood loss can contribute to improved survival.
P-453
INFLUENCE OF PROPHYLACTIC
PROBIOTICS AND SELECTIVE
DECONTAMINATION ON BACTERIAL
TRANSLOCATION IN PANCREATIC
SURGERY: A RANDOMIZED
CONTROLLED TRIAL
J. R. P. Diepenhorst1, O. van Ruler1,
M. G. H. Besselink2, H. C. Santvoort2, P. R. Wijnandts1,
W. Renooij2, D. J. Gouma1, H. G. Gooszen2 and
M. A. Boermeester1
1Academic Medical Center Amsterdam; 2University
Medical Center Utrecht
Background: Bacterial translocation (BT) is suggested to
play a major role in the development of infections in
surgical patients. However, the clinical association be-
tween intestinal barrier dysfunction, BT, and septic
morbidity has remained unconﬁrmed.
Objective: To study BT in patients undergoing major
abdominal surgery and the effects of probiotics, selective
decontamination of the digestive tract (SDD) and stan-
dard treatment on intestinal barrier function.
Methods: In a randomized controlled setting, 30 con-
secutive patients planned for elective pylorus preserving
pancreaticoduodenectomy were allocated to receive
perioperative probiotics, SDD, or standard treatment.
To assess intestinal barrier function, Intestinal Fatty
Acid Binding Protein (I-FABP) (mucosal damage) and
polyethylene glycol (PEG) recovery (intestinal perme-
ability) in urine were measured perioperatively. BT was
assessed by real-time polymerase chain reaction (q-PCR)
and Multiplex ligation-dependent probe ampliﬁcation
(MLPA) in MLNs harvested early (baseline control) and
late (after 3 h in PPPD patients) intra-operatively.
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Results: PCR detected bacterial DNA in 18/27 of late
MLNs and in 13/23 of control MLNs (P = 0.378).
Probiotics and SDD had no signiﬁcant effect on the
number of positive MLNs or the change in bacterial
DNA during operation. MLPA analysis showed signiﬁ-
cantly increased expression of only 4 of 30 inﬂammatory
mediator-related genes in late compared to early sampled
MLN (P < 0.05). PEG-recovery was unaffected by
operation, probiotics and SDD as compared to standard
treatment. I-FABP levels were increased shortly postop-
eratively only in patients treated with SDD (P = 0.02).
Conclusions: Probiotics and SDD did not inﬂuence BT,
intestinal permeability, or inﬂammatory mediator
expression. BT after abdominal surgery may be part of
normal antigen-sampling processes of the gut-associated
lymphoid tissue.
P-454
THE ETIOLOGY, SEVERITY, AND
CLINICAL OUTCOME OF ACUTE
PANCREATITIS IN THE ELDERLY
J. R. Ahn1, S. H. Lee2, J. E. Kim2, B. H. Cha2,
J.-H. Hwang2, J. K. Ryu1, Y.-T. Kim1 and Y. B. Yoon1
1Seoul National University College of Medicine; 2Seoul
National University Bundang Hospital
Introduction: The clinical characteristics of acute pan-
creatitis in the elderly have been rarely investigated. The
aim of this study is to investigate the etiology, clinical
feature, the evaluation for estimating the severity
(APACHE II, CT severity index) and clinical outcome of
acute pancreatitis in the elderly (‡ 65 years of age).
Materials and methods: We reviewed retrospectively
evaluated the demographic, clinical feature, laboratory
data and radiology data of 238 patients who admitted
with acute pancreatitis from April, 2003 to March, 2009
in Seoul National University Bundang Hospital accord-
ing to age group (< 65 years vs. ‡ 65 years).
Results: Among 238 patients with acute pancreatitis, 95
elderly patients (‡ 65 years old) and 143 non-elderly
(< 65 years old) were enrolled. The mean age of the el-
derly was 71.9 years (± SD 5.36) and the young was
44.7 years (± SD 11.7) (P = 0.000). The etiology in the
elderly patients was different from the non-elderly. In the
elderly, biliary pancreatitis was the most common cause
(50.5% vs. 29%, P = 0.000) but in the non-elderly pa-
tient was alcoholic pancreatitis (45.4% vs.15.8%,
p = 0.000). The scores of APACHE II score were sig-
niﬁcantly higher in the elderly patients but CT severity
index was signiﬁcantly higher in the non-elderly.
(APACHE II score 9.32 ± 2.39 vs. 4.87 ± 2.89,
P = 0.000, CT severity index 1.58 ± 1.48, 2.19 ± 1.27,
P = 0.000). However, Mean hospital stay was not sig-
niﬁcantly different in both the elderly group and non-
elderly group [10.4 (2–71) day vs.10.9 (3–86) day,
P = 0.641]. Also, Mortality rate was not signiﬁcantly
different in both groups. (3.2% vs.0.7%, P = 148).
Conclusion: In our study, advanced age had no signiﬁ-
cant inﬂuence on mortality and mean hospital stay. As
we didn’t consider elderly patient’s physiologic age, it
seems that APACHE II score system overestimated the
severity of acute pancreatitis about elderly patients
compared to clinical outcome.
P-455
ARTERIAL INFUSION
CHEMORADIATION USING ALTERED
PERIPANCREATIC HEMODYNAMICS
FOLLOWING INTRAOPERATIVE
RADIATION FOR UNRESECTABLE
PANCREATIC CANCER
M. Kurata1, A. Okamoto1, G. Honda1, K. Tsuruta1,
K. Karasawa2 and N. Kamata3
1Tokyo Metropolitan Cancer and Infectious disease center
Komagome Hospital/Department of Surgery; 2Tokyo
Metropolitan Cancer and Infectious disease center
Komagome Hospital/Department of Radiation Therapy;
3Tokyo Metropolitan Cancer and Infectious disease center
Komagome Hospital/Department of Radiology
Background: The survival beneﬁts obtained by radiation
for locally unresectable pancreatic carcinoma have been
limited.
Objective: We studied the use of a newly developed ap-
proach to arterial infusion chemotherapy (AIC) given
during external radiation therapy (EBRT).
Methods: Forty-four patients with locally unresectable
pancreatic carcinoma were treated by intraoperative
radiation therapy (IORT) in combination with EBRT.
The patients were divided into two groups: group A,
consisting of 28 patients who received AIC in conjunc-
tion with EBRT after alterations were made to peripan-
creatic hemodynamics; group B, 16 patients who refused
AIC and received Gemcitabine or Doxiﬂuridine chemo-
therapy alone during or following EBRT. The chemo-
therapeutic agents used in this study were Cisplatin
(CDDP), 5-ﬂuorouracil (5-FU), and gemcitabine. The
drug regimen for AIC consisted of low-dose CDDP
(3 mg/m2/30 min, day 8–12, 22–26) in combination with
5-FU (125 mg/m2/24 h, day 8, 9, 11, 12, 22–26), and
Gemcitabine (100 mg/m2/30 min, day 3, 10, 17).
Results: The one-year survival rate was 53.6% for group
A vs. 37.5% for group B; two-year survival rate was
29.2% for group A vs. 0% for group B. The median
survival for group A was 12.1 months, and for group B it
was 9.1 months. The difference in survival rates between
two groups was statistically signiﬁcant (p = 0.019, log-
lank test).
Conclusions: AIC using altered peripancreatic hemody-
namic during EBRT is a novel therapeutic devise for
locally unresectable pancreatic carcinoma and provides
the patients with dramatic improvement of survival.
P-456
IMPACT OF PREOPERATIVE
NUTRITIONAL FACTORS ON THE
PROGNOSIS AND POSTOPERATIVE
COMPLICATIONS OF INVASIVE
ADENOCARCINOMA OF THE
PANCREAS
T. Watanabe1, T. Fujii1, M. Kanda1, S. Nagai1,
A. Kanzaki1, G. Nakayama1, T. Kinoshita2,
H. Sugimoto1, S. Nomoto1, S. Takeda1, Y. Kodera1 and
A. Nakao1
1Nagoya University Graduate School of Medicine;
2Yokkaichi Municipal Hospital
Background: Nutritional status plays an important role
in the incidence of postoperative complications and the
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prognosis of various tumours. However, there has never
been a large study of preoperative nutritional factors in
pancreatic cancer.
Objectives: A retrospective study was performed to
determine the implications of nutritional status on the
prognosis and incidence of postoperative complications
of pancreatic cancer.
Methods: This study included 319 resected cases of
invasive adenocarcinoma of the pancreas. We surveyed
the correlations between prognosis, postoperative com-
plications, especially pancreatic ﬁstula, and clinico-
pathological parameters with the primary objective of
investigating the contribution of nutritional factors
including three constitutional indexes, 10 blood tests and
the Prognostic Nutrition Index (PNI; 10 · serum albu-
min (ALB g/dL) + 0.005 · total lymphocyte count
(TLC/mm3), normal level ‡ 50).
Results: Preoperative % ideal body weight (% IBW)
£ 90%, low TLC and low ALB were signiﬁcantly asso-
ciated with adverse prognosis (P = 0.0485, P = 0.0302
and P = 0.0226, respectively). Patients with low PNI
had remarkably poor prognosis, even classifying by
pathological staging. Additionally, low preoperative
ALB signiﬁcantly correlated with the incidence of post-
operative complications (P = 0.0055), especially pan-
creatic ﬁstula (P = 0.0016). Multivariate analysis with a
stepwise regression model identiﬁed low PNI as an
independent prognostic factor for survival (Hazard ratio
1.561, P = 0.0231).
Conclusions: In this study, it was indicated that preop-
erative hypoalbuminemia is a predictive factor of prog-
nosis and postoperative complications, especially
pancreatic ﬁstula, in pancreatic cancer. Additionally,
PNI had an even stronger association with prognosis.
Our results offered valuable insight for a method for
evaluation of nutritional status and the importance of
nutritional management in pancreatic cancer.
P-457
IS EARLY ORAL FEEDING SAFE AFTER
PANCREATICODUODENECTOMY?
J. R. Cho, S. E. Hwang, G. W. Ha and H. C. Yu
Department of Surgery, Chonbuk National University
Medical School
Background: We set out to evaluate the incidence of
complications, hospital stay and nutritional intake be-
tween early enteral feeding (EEF) and late enteral feeding
(LEF) in patients undergoing pancreaticoduodenectomy
(PD).
Methods: We retrospectively investigated 100 patients
(68 men and 32 women; mean age 59.4 years; range, 33–
78 years) who had undergone PD between October 2003
and May 2009 at the Chonbuk National University
Hospital. The patients were divided into two groups:
those who started to have an EEF group (n = 50) within
48 h of post operation and LEF group (n = 20) over
48 h of post operation.
Results: There were no signiﬁcant differences in the pa-
tients’ characteristics and other postoperative complica-
tions between the two groups, such as wound infections,
intra-abdominal abscesses, pneumonia and postoperative
bleeding. But anastomosis site leakage and reoperation
rate was signiﬁcantly higher in LEF compared with EEF
(respectively 16.0% vs. 0%; P = 0.01, 20.0% vs. 2.0%;
P = 0.01). Mean postoperative length of stay nutritional
discharge index (LOSNDI) was signiﬁcant longer in LEF
compared with EEF (respectively 28.5 ± 15.0 days vs.
24.1 ± 8.7 days, respectively; P = 0.07).
Conclusions: Postoperative early oral feeding for PD
patients improved the clinical outcome, with a shorter
length of stay, lower anastomotic leak and higher energy
intake on early postoperative phase, compared with the
late feeding. If the patients do not have any contraindi-
cations, the early oral feeding can be safe and feasible.
The type of nutrition support after PD seems to be rel-
evant to the outcome of patients.
P-458
PREVENTION OF PANCREATIC
FISTULA AFTER CENTRAL
PANCREATECTOMY
S. Takahata, M. Nakamura, J. Ueda and M. Tanaka
Department of Surgery and Oncology Kyushu University
Background: Central pancreatectomy (CP) is a one of the
surgical options for benign or borderline diseases. CP has
an advantage in preservation of pancreatic functions.
However, CP also carries a potentially high risk of pan-
creatic ﬁstula because of two pancreatic stumps; those are
pancreatoenterostomy in the distal side and a stump to
be closed in the proximal side. Recently we have em-
ployed modiﬁed mattress pancreatojejunostomy for
pancreatic head resection, and a linear stapler technique
with very slow compression (slow peri-ﬁring compression
method; SPC) for distal pancreatectomy, which resulted
in a reduced rate of pancreatic ﬁstula.
Aim: We investigated usefulness of a combination of
these two operative techniques for central pancreatec-
tomy.
Methods: Thirteen patients who underwent central pan-
createctomy from 2002 through 2009 were enrolled in
this study. The patients were divided into two groups:
early group (n = 6) and late group (n = 7), and clinical
outcomes were compared. Conventional pancreatojej-
unostomy by two-layer anastomosis and closure of
pancreatic stump (main duct ligation and ﬁsh-mouth
sutures) were performed in early group, and mattress
pancreatojejunostomy and linear stapling in late group.
Results: The incidence of pancreatic ﬁstula greater than
grade B (ISGPF classiﬁcation) was 66.7% (4 of 6 pa-
tients) in early group, and 14.3% (1 of 7) in late group
(P < 0.05). Furthermore, no pancreatic ﬁstula occurred
in the latest six patients operated by linear stapling with
SPC. All other clinical parameters including duration
until oral intake (22.8 vs. 14.2 days), drainage tube re-
moval (25.8 vs. 10.8 days), operation time (361 vs.
294 min), and intraoperative bleeding (268 vs. 187 g)
tended to decrease in late group.
Conclusions: The combined technique of mattress pan-
creatojejunostomy and linear stapling with slow peri-ﬁr-
ing compression might be effective to prevent pancreatic
ﬁstula after central pancreatectomy.
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P-459
PORTAL AND SUPERIOR MESENTERIC
VEIN STENTING INCREASES
RESECTABILITY OF LOCALLY
ADVANCED PANCREATIC CANCER
D. Alden1,2, P. Amatulle3, R. J. Friedland3, R. J. Rosen4,
P. L. Reyes5, R. R. Kancherla5, M. J. Maresca5 and
G. F. Agoliati5
1Department of Surgery, Lenox Hill Hospital, New York,
NY; 2Department of Surgery, Vassar Brothers Medical
Center, Poughkeepsie, NY; 3Interventional Radiology,
DRA Imaging, Poughkeepsie, NY; 4Interventional Cardiac
& Vascular Services, Lenox Hill Hospital, New, NY;
5Hematology/Oncology Associates, Poughkeepsie, NY
Background: Extensive invasion of the superior mesen-
teric and portal veins by pancreatic carcinoma is usually
a contraindication to surgical resection. Pancreatectomy
combined with portal vein and superior mesenteric vein
(SMV) resection is controversial due to high complexity
and morbidity. Preoperative neoadjuvant chemotherapy
increases resectability.
Objective: To safely increase resectability of locally ad-
vanced pancreatic cancer in neoadjuvant therapy
responders with portal and SMV occlusion.
Methods: Pancreatic carcinoma patients with portal vein
and SMV occlusion were identiﬁed. Patients able to un-
dergo short segment portal vein resection during a
Whipple procedure were excluded. Eligible patients
underwent preoperative radiological portal vein and
SMV stenting by direct transhepatic portal vein access,
followed by neoadjuvant chemotherapy. Surgery was
offered to chemotherapy responders.
Results: Between July 2003 and October 2009, 40 pa-
tients were identiﬁed. In two, stenting was unsuccessful
due to failure to cross the obstruction; 38 underwent
portal vein and SMV angioplasty and stenting with
endovascular stents either covered or uncovered. In one,
the portal vein stent was unintentionally placed in the
splenic vein. All 38 underwent three cycles of neoadju-
vant GTX chemotherapy and were restaged. Surgery
was not offered to 16 patients with disease progression.
Twenty-two patients were prepped for the Whipple
procedure. In seven, extensive disease was found and
the Whipple was abandoned. The Whipple without
vascular resection was completed in 15 patients. None
died perioperatively. Median survival in the stented,
resected group was 17 months (range 5–70) vs.
9 months (range 3–19) in the stented, nonresected group
(P = 0.0422).
Conclusion: Portal vein and SMV stenting in combina-
tion with neoadjuvant chemotherapy offers increased
resectability and improved survival in selected patients
with locally advanced pancreatic cancer.
P-460
DEREGULATED EXPRESSION OF
PIGMENT EPITHELIUM-DERIVED
FACTOR INCREASES NEUROPATHY
AND FIBROSIS IN PANCREATIC
CANCER
T. Samkharadze1, M. Erkan1, C. Reiser-Erkan1,
E. Demir1, B. Kong1, A. Giese N.2, I. Esposito3,4,
H. Friess1 and J. Kleeff1
1Chirurgische Klinik und Poliklinik Klinikum rechts der
Isar Technische Universita¨t Mu¨nchen, Mu¨nchen,
Germany; 2Department of General Surgery, University of
Heidelberg, Heidelberg, Germany; 3Institute of Pathology,
Technische Universita¨t Mu¨nchen, Mu¨nchen, Germany;
4Institute of Pathology, Helmholtz Zentrum Mu¨nchen,
Oberschleissheim, Germany
Background: Pigment Epithelium-Derived Factor
(PEDF) is a 50-kDa glycoprotein and nonihibitory
member of serine protease inhibitor gene family with
neuroprotective/neuroproliferative and anti-angiogenic
functions.
Materials and methods: The expression of PEDF and its
correlation with neural- and microvessel-density in the
normal pancreas (n = 20) and pancreatic cancer
(n = 55) was quantiﬁed by quantitative-PCR, and
quantitative image analysis of IHC sections. The effect of
hypoxia on PEDF production in eight cancer cell lines
and immortalized pancreatic ductal epithelial cells was
assessed by quantitative-PCR and ELISA. The effect of
recombinant PEDF on pancreatic stellate cells was as-
sessed by immunoblot analysis.
Results: PEDF was homogenously expressed in the acini
of the normal pancreas. High focal expression was found
in tubular complexes, PanIN-lesions and inﬂammatory
cells in pancreatic cancer. Cancer cells expressed various
amounts of PEDF. In cancer cell lines and in human
immortalized pancreatic ductal epithelial cells, hypoxia
increased PEDF-mRNA upto 132- fold. High expression
of PEDF was signiﬁcantly correlated with better patient
survival (21.5 months vs. 17.5 months, P: 0.043), in-
creased neuropathy (P = 0.0251), increased stellate cell
activity and extracellular matrix protein secretion.
Conclusion: Increased focal expression of PEDF in
pancreatic cancer correlated with neuropathy and better
patient survival. PEDF increased pancreatic stellate cell
activity and extracellular matrix production.
P-461
E-CADHERIN PLAYS ROLE NOT ONLY
IN MALIGNANT CELL DETACHMENT
FROM THE PRIMARY CARCINOMA,
BUT ALSO IN TUMOUR CELL
ATTACHMENT TO DISTANT TISSUE
D. Bogoevski, P. Bockenhof, M. Bockhorn, A. Koenig,
P. Busch and J. Izbicki
University Hospital Eppendorf, Hamburg
Background: The role of E-cadherin in carcinogenesis is
of great interest, but few studies have examined its rele-
vance to pancreatic adenocarcinoma.
Patients and methods: We have evaluated E-cadherin
expression by immunohistochemistry in patients with
pancreatic adenocarcinoma from the primary tumour,
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the healthy liver tissue as well as from the synchronic
liver metastasis from 18 patients. As a control group
healthy liver from 26 patients with pancreatic adenocar-
cinoma but without synchronic or metachronic liver
metastasis was examined.
Immunohistochemistry: Unstained 4 lm sections were
deparafﬁnised by routine techniques and placed in
200 mL Target Retrieval Solution. After cooling for
20 min, the slides were quenched with 3% H2O2 for
5 min and then incubated at room temperature with an
appropriate dilution of a primary antibody. Labelling of
antibodies was detected with the Dako Envision system
following the manufacturer’s protocol. A negative con-
trol in each run substituted an equal volume of PBS in
place of primary antibody.
Results: Only three (16.7%) of the 18 patients had a
weak E-cadherin expression into the primary tumour,
whereas no expression was recorded in the rest of the
patients. In none of the liver metastasis an E-cadherin
expression was recorded. On the other hand, into the
healthy liver tissue a weak expression was recorded in ﬁve
patients (27.8%) and in one patient (5.6%) a strong
expression was found. Contrary to this, into the control
group, 17 of the patients had weak and 9 had strong E-
cadherin expression.
Conclusions: It seems that the E-cadherin plays a signif-
icant role not only in the process of malignant cell
detachment from the primary carcinoma, but also in
tumour cell attachment to distant tissue (liver).
P-462
EARLY POSTOPERATIVE
HYPERGLYCAEMIA IS AN
INDEPENDENT RISK FACTOR FOR
COMPLICATIONS AFTER
PANCREATODUODENECTOMY
J. R. Eshuis, J. Hermanides, J. W. Van Dalen,
O. R. C. Busch, T. M. Van Gulik, J. H. DeVries,
J. B. L. Hoekstra and D. J. Gouma
Academic Medical Center
Background: Perioperative hyperglycaemia is an inde-
pendent risk factor for complications after many types of
surgery. This relation was never investigated for pan-
creatoduodenectomy.
Aim(s)/Objective(s): To establish the relation between
perioperative hyperglycaemia and postoperative compli-
cations after pancreatoduodenectomy.
Methods: In a consecutive series of 330 patients from our
prospective pancreatoduodenectomy database, glucose
values were retrospectively collected, divided in three
periods: pre-, intra- and early postoperative. Per period
the average glucose value was calculated for each patient;
then the database was split in duals according to the
median group value. Odds Ratios for complications were
calculated for the upper vs. lower dual, adjusted for age,
sex, ASA-class, BMI, diabetes mellitus, length of surgery,
intraoperative transfusion and octreotide use. The same
procedures were carried out for intraoperative and early
postoperative glucose variability, by using standard
deviation (SD).
Results: Average pre- and intraoperative glucose was
7.4 mmol/L (133 mg/dL); average early postoperative
glucose was 7.9 mmol/L (142 mg/dl). Pre- and intra-
operative glucose values were not associated with
postoperative complications. Early postoperative hyper-
glycaemia (> 7.8 mmol/L or 140 mg/dL) was a signiﬁ-
cant risk factor for complications (OR 2.4, 95% CI 1.5–
3.9). High glucose variability was not signiﬁcantly asso-
ciated with postoperative complications, but patients
with early postoperative high variability combined with
high glucose, had an OR for complications of 3.4 (95%
CI 1.9–6.3) compared to the lower glucose dual.
Conclusion: Early postoperative hyperglycaemia is an
independent risk factor for postoperative complications
after pancreatoduodenectomy. High variability of these
glucose values seems to enhance this risk. Future research
must show whether strict glucose regulation in the early
postoperative period prevents complications in this pa-
tient group.
P-463
LAPAROSCOPY-ASSISTED MAJOR
LIVER RESECTIONS EMPLOYING A
HANGING TECHNIQUE: THE ORIGINAL
PROCEDURE
H. Nitta, A. Sasaki, T. Fujita, H. Itabashi,
K. Hoshikawa, N. Ito, T Takahara, M Takahashi and
G. Wakabayashi
Iwate Medical University School of Medicine
Objective: To assess the feasibility, safety, and short-
term outcomes of laparoscopy-assisted major liver
resections.
Summary background data: The number of reports of
laparoscopic major hepatectomies has gradually been
increasing and living donor hepatectomies for liver
transplant have also recently been performed. However,
because of the high degree of proﬁciency required, major
hepatectomies have not been widespread. We have
developed an original procedure in which the liver is
mobilized laparoscopically and resected by a hanging
technique through a small incision.
Methods: Between November 2002 and December 2008,
43 patients underwent laparoscopy-assisted major liver
resections (LAMLRs) in our institution for hepatocellu-
lar carcinoma (HCC), metastatic liver cancer, and benign
diseases.
Results: LAMLRs were completed for 42 patients
(97.7%). The median age of was 62 years (range: 24–
83 years). Preoperative diagnoses were HCC (n = 15),
metastatic liver cancer (n = 19), and benign disease
(n = 8). The types of liver resection consisted of the
following: right trisectionectomy (n = 2), right hepatec-
tomy (n = 14), left hepatectomy (n = 16), trisegmen-
tectomy 4, 5, 8 (n = 2), right anterior sectionectomy
(n = 4), and extended right posterior sectionectomy
(n = 4). The median operating time was 317 min (range:
192–542 min), and median blood loss was 631 mL
(range: 68–2785 mL). There were neither perioperative
deaths nor reoperations. Five patients (11.9%) experi-
enced postoperative complications, two patients (4.8%)
showed bile leakage, and three patients (7.1%) developed
wound infections. The median postoperative hospital
stay was 13.5 days (range: 6–154 days).
Conclusions: LAMLR with the hanging technique can be
completed safely. The procedure can be performed by
open liver surgeons; and thus may be widely performed
in the future.
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P-464
CURRENT PRACTICE PATTERNS IN
THE MANAGEMENT OF HEPATIC
METASTASES FROM COLORECTAL
CANCER: A SURVEY OF GENERAL
SURGEONS AND MEDICAL
ONCOLOGISTS
L. Sandhu1, J. Zhai1, E. D. Kennedy1, N. N. Baxter2,
A. R. Gagliardi1, R. D. Urbach1 and C. A. Wei1
1Department of Surgery, University Health Network,
University of Toronto; 2Department of Surgery,
St. Michael’s Hospital, University of Toronto
Background: Though the indications for hepatic resec-
tion for colorectal cancer (CRC) metastases have
broadened considerably over the past decade, we
hypothesize that hepatectomy remains underutilized.
Aim: The aim of this study was to assess practice pat-
terns among general surgeons (GS) and medical oncol-
ogists (MO) who refer patients with hepatic CRC
metastases to HPB surgeons.
Methods: A postal survey was sent to all general sur-
geons (n = 628) and medical oncologists (n = 147) in
Ontario, Canada. The questionnaire examined ap-
proaches to referral and perceived contraindications to
hepatectomy for CRC metastases. Physicians were asked
to provide responses on a 5-point scale (1–never, 2–
rarely, 3–sometimes, 4–very often and 5–always).
Results: The overall response rate was 52% (GS n = 307,
51%; MO n = 83, 56%). Physicians whose scope of
practice did not include patients with CRC were excluded
(n = 85, 21%). Seventy four percent of physicians ‘very
often’ or ‘always’ refer patients with hepatic CRC
metastases to HPB surgeons but 24% ‘rarely’ or ‘some-
times’ do so (GS 23%,MO 25%). Ninety seven percent of
physicians reported referring patients with single liver
lesions ‘very often’ or ‘always’. Only 28% would refer
patients with bilateral, multiple CRC metastases (GS
29%,MO 25%).Whereas only 2% ofMO (n = 1) ‘never’
refer patients with bilateral, multiple lesions for surgical
consideration, 17% of GS (n = 36) never do so
(p = 0.01). Perceived contraindications to surgery were
similar across both groups: 25% of physicians ‘very often’
or ‘always’ consider a previous liver resection a contra-
indication to hepatectomy, as compared to 41% for lung
metastases, and 63% for extra-hepatic metastases.
How often do you refer patients with CRC hepatic
metastases for a surgical opinion from a HPB surgeon?
Specialty
1-
never
2-
rarely
3-
sometimes
4-very
often
5-
always
Single
Liver
Lesion (%)
GS 0 1.4 2.3 8.3 88.0
MO 0 0 1.9 11.5 86.5
Unilateral,
multiple
lesions (%)
GS 0.5 2.8 5.1 26.5 65.1
MO 0 1.9 3.8 44.2 50.0
Bilateral,
multiple
lesions (%)
GS 16.7* 24.1 29.7 12.6 16.7
MO 1.9* 30.8 42.3 13.5 11.5
GS = general surgeons
MO = medical oncologists
*p = 0.01
Conclusions: While patients with single CRC liver
metastases are receiving appropriate HPB surgical con-
sultations, the rate of referral declines as the burden of
disease increases. Further research is necessary to identify
the barriers to appropriate referral for patients with more
extensive but potentially curable disease.
P-465
EVALUATION OF AGE-RELATED,
DIFFERENT CLINICOPATHOLOGICAL
FEATURES OF PATIENTS WITH
RESECTABLE HEPATOCELLULAR
CARCINOMA
G.-Y. Chau1, S-H. Tsay2 and C.-W. Su3
1Departments of Surgery, Taipei Veterans General
Hospital, and College of Medicine, National Yang-Ming
University, Taipei 217, Taiwan; 2Departments of
Pathology, Taipei Veterans General Hospital, and College
of Medicine, National Yang-Ming University, Taipei 217,
Taiwan; 3Departments of Internal Medicine, Taipei
Veterans General Hospital, and College of Medicine,
National Yang-Ming University, Taipei 217, Taiwan
Background: Whether age plays an important role in the
outcomes for hepatocellular carcinoma (HCC) patients
after hepatic resection remains controversial.
Aims: In HCC patients with different age groups, we
evaluate the clinicopathological characteristics and pos-
tresectional outcomes after hepatic resection.
Methods: Seven hundred and nineteen HCC patients
who underwent hepatectomy were classiﬁed into younger
group (age < 40 years) (n = 56), middle aged group
(age 40–69 years) (n = 482) and elderly group (age
> 70 years) (n = 181). Clinicopathologic factors and
postresectional outcomes were compared based on the
AJCC TNM staging system. Duration of follow-up was
528 ± 32 months.
Results: The mean age of younger patients was 33.8, 58.2
of middle-aged, and 74.9 of elderly. Younger patients had
higher frequency of family history of HCC, higher fre-
quency of hepatitis B surface antigen positive, lower fre-
quency of hepatitis C infection, higher preoperative a-
fetoprotein level, better liver function. Younger patients
had signiﬁcantly larger-sized tumours, lower frequency of
hepatic steatohepatitis, a lower Ishak inﬂammatory scores
(5.2 ± 2.9 vs. 6.6 ± 3.2, P = 0.008) and more patients in
TNM stage III. The overall incidence of tumour recur-
rence was 56.0%, comparable in three age groups.
Younger patients had higher extra hepatic recurrence rate
than elderly, 38.7% vs. 17.4%. The 10-year survival rates
in the younger group were 35.5%, 20.6% in the middle-
aged group, and 23.3% in the elderly-aged group. Youn-
ger patients with stage I, II disease had signiﬁcantly better
survival than middle-aged and elderly patients.
Conclusion: In early stage (TNM stage I, II) disease,
younger patients had signiﬁcantly better survivals than
elderly. The differences in the background factors in
relation to tumour progression and detection and surgical
factors may be the main reason for the better prognosis.
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P-466
ADDING BEVACIZUMAB TO
OXALIPLATIN-BASED PREOPERATIVE
CHEMOTHERAPY: EFFECT ON LIVER
INJURY AND SURGICAL OUTCOMES
IN COLORECTAL LIVER METASTASES
A. van der Pool1, H. Marsman2, J. Verheij1, F. ten Kate2,
T. van Gulik2, J. Ijzermans1 and C. Verhoef1
1Erasmus University MC - Daniel den Hoed Cancer
Center; 2Amsterdam University MC
Background: Chemotherapy (CTx) before resection of
colorectal liver metastases (CRLM) may cause hepatic
injury and postoperative complications.
Objective: To ascertain whether adding Bevacizumab, a
monoclonal antibody against VEGF, to Oxaliplatin-
based CTx has an inﬂuence on liver injury and postop-
erative complications.
Methods: Patients were divided into two groups: patients
given oxaliplatin-based CTx (n = 53) and patients who
received oxaliplatin-based CTx and bevacizumab
(n = 51). All patients underwent resection for CRLM
from 2003–2008. We compared the two groups in terms
of demographics, clinicopathological data, treatment,
histology, and postoperative outcome.
Results: Of the 74 patients (73%) who underwent wedge
resections and/or segmentectomies, most were in the
Bevacizumab group (55% vs. 45%, p = 0.07). The
overall complication rate (29%) was not signiﬁcantly
different between the Bevacizumab and non-Bev-
acizumab groups. There was sinusoidal dilatation in 57%
(59/104) of all patients but it was not associated with
postoperative complications (31% vs. 27%, p = 0.83).
The bevacizumab group exhibited less moderate sinu-
soidal dilatation (8% vs. 29%, p = 0.01). No difference
in complication rate was found between patients given
fewer than six cycles of CTx and those given six or more
cycles, or between patients with a short (< 5 weeks)
interval between the last dose of Oxaliplatin and resec-
tion and those in which the interval was longer.
Conclusions: Bevacizumab added to Oxaliplatin-based
CTx protects against sinusoidal dilatation without sig-
niﬁcantly inﬂuencing morbidity. Neither duration of CT
nor the time interval between cessation of chemotherapy
and surgery were associated with postoperative compli-
cations.
P-467
LASER LIGHT AND HEPATIC
REGENERATION: A NEW APPROACH
TO THE PROCESS
O. Castro E Silva, V. Bagnato, C. Kurachi, T. Castro E
Silva, J. Ferreira and S. Zucoloto
Faculdade de Medicina de Ribeira˜o Preto da Universidade
de Sa˜o Paulo
Objective: To evaluate hepatic regeneration by laser
spectroscopy in rats submitted to 70% hepatectomy.
Method: Wistar rats were submitted to partial hepatec-
tomy (PH) through a median xipho-umbilical incision.
Plane synthesis of the abdominal wall was performed
with continuous 3–0 cotton sutures. The animals were
sacriﬁced in the Laboratory of Surgical Technique and
Experimental Surgery under general ethyl ether anes-
thesia 12, 24, 36, 48, and 72 h after PH and then 1, 2, 3, 7,
10 and 15 days after PH. Seven animals submitted only
to 70% PH were used as controls. Laser light at 660 nm
wavelength was applied to seven other animals at seven
different points in the regenerating liver after PH
(PH+L) at a dose of 22.5 J/cm2. Additionally, hepatic
regeneration was evaluated by laser ﬂuorescence spec-
troscopy after stimulation with YAG laser at 532 nm
with a Y probe (Ocean Optics-USA) with 600 lm optic
ﬁbers, one of them releasing (excitation light) and six
others capturing light from the liver, and analyzed with a
spectrophotometer - IFSC-USP. Data were analyzed
statistically by nonparametric methods, with the level of
signiﬁcance set at 5% Result:
Laser light induced 30% more hepatic regeneration than
in animals whose livers were not irradiated (P < 0.05).
Laser autoﬂuorescence was signiﬁcantly reduced after 24,
36 and 72 h (P < 0.05), increasing thereafter and reach-
ing control values by 10 and 15 days after PH, demon-
strating an increase and further stabilization of hepatic
regeneration.
Conclusion: Laser light proved to be effective both as an
inducer and an indicator of hepatic regeneration.
P-468
IMPAIRED LIVER REGENERATION OF
STEATOTIC RATS AFTER PORTAL VEIN
LIGATION: PARTICULAR EMPHASIS
ON 99MTC-DISIDA SCINTIGRAPHY
AND ADIPONECTIN SIGNALING
T.-S. Yeh1, I.-T. Hsiao2, K.-J. Lin3, T.-C. Yen3 and
T.-C. Chen4
1Department of Surgery, Chang Gung Memorial Hospital,
Chang Gung University, Taiwan; 2Department of Nuclear
Medicine and Molecular Imaging Center, Chang Gung
Memorial Hospital, Chang Gung University, Taiwan;
3Department of Nuclear Medicine and Molecular Imaging
Center, Chang Gung Memorial Hospital, Chang Gung
University, Taiwan; 4Department of Pathology, Chang
Gung Memorial Hospital, Chang Gung University, Taiwan
Background: Portal vein ligation (PVL) is increasingly
employed prior to major hepatectomy to enhance volume
of future liver remnant (FLR) to avoid post-hepatectomy
liver failure. The efﬁcacy of PVL on subjects with non-
alcohol fatty liver disease (NAFLD) is largely unknown.
Methods: Sprague-Dawley rats fed with normal diet
(control) and methionine-choline deﬁciency diet (MCD)
were used. The animals underwent PVL and were sacri-
ﬁced at indicated time points.
Results: MCD rats exhibited decreased BrdU and Ki-67
labeling index, and increased apoptotic index after PVL
than normal rats; in net, MCD rats exhibited decreased
restituted liver mass and redistributed volume ratio than
normal rats. Normal rats displayed similar ICG15-R
before and after PVL; whereas MCD rats displayed
deteriorated ICG15-R after PVL. Using 99mTc-DISIDA
scintigraphy examination, MCD rats exhibited decreased
HEF and prolonged TE1/2 of FLR after PVL, indicating
deteriorating hepatocyte function despite of volume
shifting. The basal level of plasma TNFa, IL-1a, IL-1b,
and IL-10 of MCD rats were signiﬁcantly increased be-
fore PVL than normal rats; while these cytokines failed
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to further boost in response to PVL as normal rats.
Hepatic adiponectin mRNA was surged in MCD rats
after PVL; whereas its receptors, AdipoR1 and AdipoR2,
were paradoxically down-regulated. PPARa, a down-
stream molecule of AdipoR2 axis, was also decreased in
MCD rats.
Conclusions: Reduced regenerated liver mass and dete-
riorated hepatocyte function of FLR of steatotic rats
after PVL might be associated with deranged Kuppfer
cell-mediated cytokines expression and disrupted adipo-
nectin signaling.
P-469
PREOPERATIVE DIETARY
RESTRICTION REDUCES HEPATIC
TUMOUR MASS AFTER INTRA-SPLENIC
INJECTION WITH COLONCARCINOMA
CELLS
J. R. van Ginhoven, J. W. van den Berg, W. A. Dik,
J. N. M. Ijzermans and R. W. F. de Bruin
Erasmus MC, Rotterdam
Background: The release of reactive oxygen species and
the systemic inﬂammatory response after surgery con-
tribute to tumour development by, but not limited to,
increasing the expression of cellular adhesion molecules.
Dietary restriction (DR) is known to increase lifespan
and decrease cancer incidence. We have shown that
short-term DR, confers protection against reactive oxy-
gen species, namely ischemia and reperfusion injury. We
hypothesized that DR protects against inﬂammatory re-
sponses induced by surgery. This would lead to lower
expression of adhesion molecules and less tumour load in
our mouse model.
Methods: Male BALB/cmice were subjected to twoweeks
DR (30% reduction in calorie intake) prior to the surgical
procedure. Intrasplenic injection of tumour cells (c26) was
followed by splenectomy after 10 min. Animals were al-
lowed to eat ad libitum postoperatively. Tumour load was
scored as a percentage (tumour surface/total liver surface)
on haematoxylin and eosin stained sections after ten days,
by two independent observers. We assessed in vitro tu-
mour growth and adhesion of the tumour cells to endo-
thelial cells. Liver mRNA expression of adhesion
molecules was determined after two weeks of DR.
Results: Preoperative DR led to a signiﬁcant reduction
(p = 0.03) in tumour growth ten days after tumour
inoculation. In vitro experiments showed no inﬂuence of
DR serum on the growth of c26 tumour cells. However
DR signiﬁcantly (p = 0.0025) reduced adhesion of c26
cells to endothelial cells in vitro. mRNA expression levels
of E-selectin in the liver were signiﬁcantly (p = 0.0087)
lower after two weeks of DR when compared to the ad
libitum fed group.
Conclusion: Preoperative dietary restriction reduced he-
patic tumour load ten days after exposure to circulating
tumourcells. Signiﬁcantly reduced in vitro adhesion and
reduced mRNA expression of E-selectin suggest that DR
reduced tumour load by reducing the adhesion of circu-
lating tumour cells to the hepatic vascular endothelium.
P-470
DOES TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION BEFORE
CURATIVE RESECTION FOR
HEPATOCELLULAR CARCINOMA
IMPROVE OUTCOMES?
B.-W. Kim, H.-J. Wang and M.-W. Kim
Ajou University School of Medicine
Objective: To evaluate the impact of preoperative tran-
sarterial chemoembolization (TACE) in the treatment of
patients undergoing curative liver resection for hepato-
cellular carcinoma (HCC).
Methods: Preoperative TACE was performed in 164 of
339 HCC patients who underwent curative resection and
followed up. Retrospective clinico-pathologic analysis
was performed with regard to the safety and response to
treatment, early and late incidence and pattern of
recurrence, and survival.
Results: One hundred and ﬁfty nine patients in the
TACE group (96.9%) were performed of preoperative
TACE only once. The mean waiting time from TACE to
resection was 19.5 days. There was no difference in
operative time, postoperative mortality and duration of
hospital stay after resection between the TACE group
and the non-TACE group. Microvascular invasion was
signiﬁcantly decreased in the TACE group (P < 0.01)
and complete necrosis of the tumour was induced in 21
patients (12.8%) in the TACE group. Overall survival
and disease-free survival rate was not different between
the two groups. But three-year disease-free survival rate
was signiﬁcantly improved in the TACE group
(p = 0.04) and three-year survival rate was also im-
proved (p = 0.06), especially in patients in the AJCC
stage I or II. Multivariate analysis showed microvascular
invasion, large tumour size, presence of daughter nod-
ules, gross portal invasion, Child-Pugh classiﬁcation and
histologic stage of cirrhosis to be risk factors for HCC
recurrence and poor survival rate. Early and late recur-
rence patterns were not different between the two groups.
Conclusion: Preoperative TACE is a safe procedure and
it could improve early postoperative recurrence and
survival rate, especially for patients in stage I or II HCC.
P-471
LAPAROSCOPIC VS. OPEN
HEPATECTOMY – A META-ANALYSIS
M. Soloviy
Lviv Regional Veterans Hospital; Lviv National University
of Medicine
Background: There is an increasing interest in laparo-
scopic liver resection because of its potential beneﬁts to
the patient.
Aim: Aim of the study was to compare laparoscopic and
open liver resection for patients with malignant hepatic
tumours.
Methods: Studies comparing laparoscopic and open liver
resection published between 2002 and 2009 were included
using the Medline search. Endpoints were: operative
blood loss, operative time, hospital stay, postoperative
complications.
Results: Six nonrandomized pair-matched studies were
identiﬁed. They comprised totally 677 patients of which
409 (60,4%) had laparoscopic procedure and 268
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(39,6%) had open surgery. Operative blood loss was
estimated in ﬁve studies where in all but one study it was
signiﬁcantly reduced in laparoscopic group (mean blood
loss = 135 mL vs. 348 mL in open group; P < 0,05).
Operative time was assessed in ﬁve studies where in three
of them it was signiﬁcantly longer in laparoscopic group
(mean time = 173 min vs. 135 min in open group;
P < 0,05). Other two studies failed to show any statis-
tical difference. Hospital stay was assessed in four stud-
ies, where in all of them it was signiﬁcantly shorter in
laparoscopic group (mean stay = 6,45 days vs. 9 days in
open group; P < 0,05). Postoperative complications
were assessed in only two studies where they were sig-
niﬁcantly more often seen in open group (mean rate =
37,4% vs. 9,3% in laparoscopic group; P < 0,05).
Conclusions: According to analyzed studies laparoscopic
hepatectomy is at least as safe as open surgery. In most
studies laparoscopic liver resection has beneﬁts of sig-
niﬁcantly decreased blood loss, shorter hospital stay and
fewer postoperative complications.
P-472
EXPRESSIONS OF VEGF, VEGF
ISOFORM AND ITS RECEPTOR-FLT-1
AND FLK-1 DURING REGENERATION
AFTER 70% HEPATECTOMY RATS
J. R. Li, R. Ma, X. L. Liu, L. Y. Zhang, G. J. Tian,
B. H. Lou, H. Q. Fang and S. Y. Peng
Second Afﬁliated Hospital, Zhejiang University
Background: Angiogenesis play the important role in the
liver regeneration post hepatectomy. It is controversial
that the expression of VEGF-A family and both recep-
tors Flt-1 (VEGFR-1), Flk-1 (VEGFR-2) after 70%
partial hepatectomy (PH) in rats. The aim of the study
was to determine the expression pattern of VEGF splice
variants and both receptors in the PH rat model.
Methods: All Rats were underwent 70% PH. The groups
were classiﬁed by time. 0h group was considered as
control group. After 12 to168 h, liver body weight ratio
(LBR) were assessed, the mRNA of VEGF120,
VEGF144, VEGF164, and VEGF188, Flt-1 and Flk-1
were measured by real-time RT-PCR. Western bolt is
also used to detect the patterns of VEGF164, Flt-1, and
Flk-1.
Results: The LBR was up to the peak at 120 h post
operation (P < 0.05), and at 24 h, 48 h, 72 h, 96 h,
120 h and 168 h, LBR were 1.7, 2.3, 2.9, 3.3, 3.8 and 2.8,
respectively. The mRNA expression of VEGF-A is sig-
niﬁcantly lower at 24 h (2% vs. control, P < 0.05), the
peak was presented at 168 h (64% vs. control, P < 0.05).
The expression of VEGF164 has no statistic signiﬁcant
(P > 0.05). VEGF144 has not been reported in the PH
rat model previously. It was strikingly lower at 24 h (7%
vs. control, P < 0.05) and higher at 120 h (355% vs.
control, P < 0.05). The time of peak of Flk-1 was earlier
than Flt-1 (72 h vs.120 h), and Flt-1 was ascending
strikingly between 120 h (39% vs. control) to 168 h
(197% vs. control) after Flk-1 reached to a certain con-
centration. The protein expression of VEGF164 is sig-
niﬁcantly lower at 24 h (3% vs. control, P < 0.05), and
up to the peak at 72 h (147.6% vs. control, P < 0.05).
The protein expressions of Flt-1 and Flk-1 have a similar
trend.
Conclusions: We observed a strong correlation between
levels of VEGF and both its receptors. VEGF plays an
important role in liver regeneration. This may be due to
its effects on its two of receptors, Flt-1 and Flk-1. This
pathway represents a strategy to optimize liver regener-
ation for PH rats’ model.
P-473
COVERED AND NON-COVERED
STENTS: COMPARATIVE STUDY
J. Bandi1, R. Rostagno2,3, R. Garcia Monaco2,3,
O. Peralta2,3 and F. Petra2,3
1Hepathology Service, Italian Hospital of Buenos Aires;
2Angiography and Endovascular Therapy Department;
3Italian Hospital of Buenos Aires, University of Buenos
Aires
Background: Transjugular intrahepatic portosystemic
shunt (TIPS) is useful to treat portal hypertension com-
plications with high technical and initial clinical success
but due to its tendency to dysfunction (stenosis - occlu-
sion) has not become the ﬁrst choice in all patients when
portal decompression is needed. Ad occ covered stents
are designed to solve this problem.
Objective: The goal of this presentation is to compare the
dysfunction rate of TIPS created using e-PTFE covered
stents with TIPS created using uncovered stents.
Methods: TIPS were performed in 46 patients, 23 using
covered stents (group I) and 23 using uncovered stents
(group II). Both groups were clinically and demograph-
ically similar. Follow up included Doppler ultrasound at
day 1, 7 and 30 and one every three months. Angiogra-
phy with pressure measurements was performed when
shunt dysfunction were seen at US Doppler or with
symptom recurrence. Angiographic dysfunction was de-
ﬁned as in stent stenosis of more than 50% or porto-
systemic gradient higher than 12 mmHg.
Results: After follow-up of a median of 414 days, three
patients (13%) in group I and 10 (43%) in group II
showed TIPS dysfunction (P < 0.05). Symptoms recur-
rence occurred in two patients in group I and seven in
group II (P < 0.05). The actuarial probability to present
encephalopathy was 20% in group I and 35% in group II
(NS). There was no statistical signiﬁcant difference of
survival in either group.
Conclusions: TIPS performed with covered stents im-
prove shunt patency and decreases the number of clinical
relapses without increasing the risk of encephalopathy.
P-474
FRANK INTRABILIARY RUPTURE IN
HILAR CONFLUENCE DUE TO LIVER
HYDATIDOSIS: A SURGICAL
CHALLENGE
J. R Ramia, F. Ruiz, R. de la Plaza, P. Veguillas,
J. E. Quin˜ones, R. Puga, V. Arteaga, F. Adel and
J. Garcia-Parren˜o
Hospital Universitario de Guadalajara
Frank intrabiliary rupture (FIR) is a severe complication
that may occur in about 20% of the patients with liver
hydatidosis (LH). When a FIR is present, the cyst
content could pass to common bile duct and cause
several complications as obstructive jaundice, cholangitis
and pancreatitis. When FIR is located in hilar conﬂu-
ence, the surgical repair is a challenge and data about
optimum treatment does not exist.
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Patients and methods: From May 2007–October 2009 we
have treated 44 liver hydatidosis. FIR was present in six
cases, three located in hilar conﬂuence with severe dam-
age of left bile duct and the roof of hilar conﬂuence. The
three patients were female. The mean age was 54.6 years.
Two of them were new cases and presented in Emergency
Department with jaundice and elevation of liver function
tests. In both cases we performed ERCP preoperatively
to make a sphincterotomy and bile duct clearance. The
third patient had three LH non radical surgical proce-
dures before and presented a new recurrence, but in this
case jaundice was not present off. The cyst was located in
segment IV in all the cases.
Results: Left hepatectomy with hilar conﬂuence recon-
struction was performed in all our patients. Two of them
presented a mild bile ﬁstula that resolved medically. The
third one had an uneventful postoperative course. In
follow-up, neither relapse nor bile duct stenosis has been
observed.
Conclusions: FIR is a severe complication of LH. When
FIR is located in hilar conﬂuence, liver resection is the
best surgical option to solve deﬁnitively the problem.
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MANAGEMENT OF HEPATOCELLULAR
ADENOMA DURING PREGNANCY
J. R. van Aalten, J. E. Noels, D. J. van der Windt,
N. F. M. Kok, R. A. de Man, T. Terkivatan and
J. N. M. Ijzermans
Erasmus Medical Center Rotterdam
Background: Hepatocellular adenoma (HCA) in preg-
nant women implies special considerations regarding
management and treatment because of the risks of
growth and rupture of the adenoma during pregnancy.
To prevent complications related to growth or bleeding
of the adenoma an aggressive approach favouring sur-
gical resection has been recommended often, but small
asymptomatic HCA may be observed.
Objective: To establish the management of hepatocellu-
lar adenoma during pregnancy based on our own expe-
rience and literature.
Methods: Thirteen women with documented HCA were
closely monitored during a total of 17 pregnancies from
2000–2009. There ﬁles were reviewed.
Results: In four cases the HCA were growing during
pregnancy, requiring a Caesarean section in one patient
(two pregnancies) at 36 and 34 weeks because of an as-
sumed high risk of rupture of the HCA. In one case ra-
diofrequency ablation (RFA) therapy has been used in
the ﬁrst trimester of pregnancy because of hormone
sensitive HCA to exclude any further risk. No interven-
tion was performed in the other cases. None of the wo-
men had complications of HCA, and maternal and foetal
outcome were excellent in all pregnancies.
Conclusion: It is safe to closely monitor women with
HCA during their pregnancy, especially in small tumours
(< 5 cm). In women who have large tumours or expe-
rienced complications of HCA in previous pregnancies,
surgical resection has been recommended. It may no
longer be necessary to strictly advise women to avoid
pregnancy.
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SURGICAL TREATMENT OF RENAL
CELL CANCER LIVER METASTASES; A
POPULATION BASED STUDY
J. R. Ruys1, P. J. Tanis1, I. D. Nagtegaal2,
P. van Duijvendijk3, C. Verhoef4, R. J. Porte5 and
T. M. van Gulik1
1Department of Surgery, Academic Medical Centre,
Amsterdam; 2Department of Pathology, Radboud
University Nijmegen Medical Center, The Netherlands;
3Department of Surgery, Radboud University Nijmegen
Medical Center, The Netherlands; 4Department of
Surgery, Erasmus MC-Daniel den Hoed Cancer Centre,
Rotterdam, The Netherlands; 5On behalf of the
Netherlands Task Force for Liver Surgery
Introduction: Renal cell cancer (RCC) has an incidence
of 1200 new patients in the Netherlands each year (12.5/
100 000 inhabitants). According to literature, half of
these patients ultimately develop metastases with a one-
year survival of 10%. The liver is considered to be in-
volved in 20% of patients with metastatic RCC, whereas
resection is feasible in only a minority of patients. Hence,
little is known about outcomes of resectable liver
metastases of RCC.
Aim: To evaluate the outcomes of surgical treatment and
to identify prognostic factors for survival.
Methods: Patients were retrieved from local databases of
the Netherlands Task-Force for Liver Surgery (14 cen-
tres) and from the Dutch collective pathology database.
Patient and tumour characteristics, survival and prog-
nostic factors in this speciﬁc patient population were
analysed by Kaplan-Meier curves and logrank tests.
Results: From the national registries, 33 patients were
identiﬁed who underwent resection or local ablation of
RCC liver metastases (RCCLM) in the Netherlands,
between 1990 and 2008. These patients comprise 1,5% of
the total population of patients diagnosed with RCCLM
in that period. The overall 1-, 3- and 5-year survival rates
were 78.6%, 45.1%, and 40.6%, respectively. Median
survival was 26.6 months. At a median follow-up interval
of 19,2 (3.45–188.9) months, 28 patients showed evidence
of recurrence. Metachronous metastases (n = 23,
p = 0.04) and radical resection (n = 24, P < 0.01) were
signiﬁcant prognosticators of long-term survival. Size
< 50 mm (n = 18, p = 0,84), solitary metastases
(n = 19, p = 0.92) and surprisingly, presence of extra-
hepatic metastases (n = 11, p = 0.21) showed no sig-
niﬁcant inﬂuence on survival.
Conclusions: The survival rates and low operative mor-
bidity found in this nation-wide study indicate that sur-
gical treatment of patients with hepatic metastases of
RCC can beneﬁt from radical resection with 5-year sur-
vival rate of 40.6%.
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IRINOTECAN TREATMENT IMPAIRS
EXPRESSION OF CYTOKINES
REQUIRED FOR EFFECTIVE LIVER
REGENERATION AS A RESULT OF THE
NF-B DNA DAMAGE RESPONSE
J. R. Robinson1,2, J. Mann1, D. M. Manas2,
D. A. Mann1 and S. A. White1,2
1The Liver Research Group, Newcastle University Medical
School, Framlington Place, Newcastle Upon Tyne,
England, UK; 2The Department of HPB and Transplant
Surgery, Freeman Hospital, Newcastle upon Tyne,
England, UK
Background: Surgical resection of colorectal liver
metastasis presents the only opportunity for long-term
cure. Increasingly, chemotherapeutic agents such as Iri-
notecan and Oxaliplatin are used to downstage disease
prior to surgery however these agents have been linked to
increased peri-operative morbidity and mortality as a
result of impaired liver regeneration. Liver regeneration
is a complex process that relies upon many autocrine and
paracrine factors including the cytokines TNFa and IL-6.
Normally the transcription factor NF-B acts as a positive
transcriptional regulator of these factors however in re-
sponse to DNA damage it may function as a transcrip-
tional repressor. The aim of this study was to evaluate the
role of the NF-B damage response in hepatocytes after in
vitro exposure to Irinotecan.
Methods: Isolated human hepatocytes were cultured in
the presence of Irinotecan for 24 h before RNA isolation
and qRT-PCR for TNFa, IL-6 and IL-1b (n = 3). Male
wistar rats were treated with a variety of doses of
Irinotecan for 48 h before being killed and liver tissue
retrieved for analysis. Whole liver tissue was used
for RNA extraction and preparation of cross-linked
chromatin. qRT-PCR was then performed for the above
cytokines. Chromatin Immunoprecipitation was per-
formed using a polyclonal antibody directed at p65 with
subsequent qRT-PCR for genomic IL-6.
Results: TNFa and IL-6 were undetectable in hepato-
cytes treated with Irinotecan for 24 h despite their pres-
ence in control cells. Similarly impaired IL-6 expression
was demonstrated in whole rat liver tissue despite in-
creased binding of p65 to its promoter on the IL-6 gene.
Conclusion: Following treatment with Irinotecan NF-B
functions as a transcriptional repressor impairing
expression of cytokines required for effective liver
regeneration.
P-478
INCREASED ADIPONECTIN IS
ASSOCIATED WITH
HEPATOCELLULAR CARCINOMA
S.-N. Wang1 and K.-T. Lee2
1Department of Surgery, Kaohsiung Municipal Hsiao-
Kang Hospital, Kaohsiung; 2Department of Surgery,
Faculty of Medicine, College of Medicine, Kaohsiung
Medical University, Kaohsiung
Background: Since obesity is considered to be associated
with hepatocelllular carcinoma (HCC), adipokines are
the candidates to explain this association.
Aims: This study investigated if aberrant adiponectin
expressions existed in HCC and further correlated with
its development.
Methods: Radioimmunoassay was used to determine
serum adiponectin levels of the HCC patients and con-
trols. Adiponectin proteins were examined in the cancer
and non-cancer parts of the resected HCC tissues by the
immunoblotting method. XTT, BrdU-labeling test, and
ﬂowcytometry were used to analyze the bioeffects of
increasing doses of adiponectin in Hep-G2 and Hep-3B
cells.
Results: Serum adiponectin levels were signiﬁcantly
higher in the HCC patients than the controls. The sig-
niﬁcant correlations of serum adiponectin levels with
serum triglyceride levels and insulin resistance were
found in the controls, but not in the HCC patients. In
contrast, serum adiponectin levels signiﬁcantly correlated
with serum albumin and alkaline phosphatase levels in
the HCC patients, but this trend was not observed in the
controls. The expression pattern of adiponectin protein
between the paired cancer and non-cancer tissues signif-
icantly correlated with tumour size. The in-vitro assay
demonstrated that adiponectin increased the cell prolif-
eration rate in a dose-dependent manner.
Conclusion: Increased adiponectin expressions were
associated with HCC and this increase might contribute
to tumour growth. Further studies are needed to unveil
the exact mechanisms of adiponectin in HCC.
P-479
LAPAROSCOPIC LIVER RESECTION
FOR HEPATOCELLULAR ADENOMA
P. Herman, F. Coelho, M. Perini, L. D’Albuquerque and
I. Cecconello
Hospital das Clinicas, Sa˜o Paulo Medical School
Background: Laparoscopic liver resection (LLR) is per-
formed nowadays mainly for benign neoplasms. Few
reports focusing on laparoscopic treatment of benign
liver tumours has been published but there is no report
dealing only with hepatocellular adenoma up to now.
Objective: The aim of this study is to assess the feasi-
bility, safety and outcomes of laparoscopic liver resection
for hepatocellular adenomas.
Material and methods: Sixteen patients with histopatho-
logic diagnosis of adenoma submitted to laparoscopic
liver resection were reviewed from a prospective database
from September 2007 to November 2009. Right hepa-
tectomy or right-sided resections were performed using
ﬁve to six trocars and left-sided resections, four trocars.
Liver parenchymal transection was performed with har-
monic scalpel and the surgical specimen was externalized
through a Pfannenstiel incision.
Results: All 16 patients included were women. Mean age
was 35.4 years (range 28–46). Thirteen patients (87.5%)
had a single lesion, one patient (6.3%) had four lesions
and two patients (12.5%) had adenomatosis (‡ 10 le-
sions). Average lesion size was 4.4 ± 2.8 cm (range 1.5
to 12.0 cm). There were three right hepatectomies
(18.8%), six left lateral segmentectomies (37.5%), three
wedge resections (18.8%) and four segmentectomies
(25%). There were no intra-operative complications or
blood transfusion. Conversion and mortality rates were
null. One patient (6.3%) developed right pleural effusion
complicated with empyema. Mean postoperative hospital
stay was four days (range 1–8).
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Conclusions: Laparoscopic resection is technically feasi-
ble and safe, even for the major liver resections with low
morbidity and mortality. Laparoscopic liver resection
should be considered the gold standard treatment for
hepatocellular adenoma in selected cases operated on by
surgeons with laparoscopic and hepatobiliary experience.
P-480
LIVER RESECTION, BILE DUCT
RESECTION, AND
LYMPHADENECTOMY IN
GALLBLADDER CANCER; R0 WITH D2
IS THE UNIVERSAL RATIONALE FOR
CURATIVE RESECTION
H. Yokomizo, T. Hirata, K. Hayashi, Y. Kimura and
T. Yamane
Department of Surgery, Japanese Red Cross Kumamoto
Hospital
Background: The indication for liver resection (LR), bile
duct resection (BDR), and lymphadenectomy (LA) to
treat gallbladder cancer (GBC) are under debate.
Aim: To reevaluate the therapeutic value of these pro-
cedures, and establish a concise surgical rationale for
treating GBC.
Methods: We analyzed 204 consecutive patients after
GBC resection. Of these, 111 with pT2 GBC were further
analyzed.
Results: Five-year survival rates were 91% (n = 68),
78% (n = 111), 15% (n = 15) and 0% (n = 10) for
patients with pT1, pT2, pT3 and pT4 GBC, respectively.
In pT2 patients, 5-year survival were 85% for 81 with
pN0 and 55% for 26 with pN1, 76% for 53 with LR and
80% for 58 without LR, 59% for 13 with BDR and 81%
for 98 without BDR. In 26 with pT2pN1, 5-year survival
were 50% for 15 with LR and 60% for 11 without LR,
30% for 5 with BDR and 60% for 21 without BDR. The
extent of LA in pT2 patients was D2 (pericholedochal,
hilar, periportal, posterosuperior pancreaticoduodenal,
and common hepatic nodes) in 86, D1 (pericholedochal
nodes) in 16, and D0 (e.g. sampling of sentinel node) in
nine. There was no surgical mortality.
Discussion: Both LR and BDR have no apparent ther-
apeutic effect besides securing surgical margins in pT2
GBC. Therefore LR and BDR should be regarded as
options to achieve R0. As to preoperative diagnosis, it is
impossible to discriminate pT2 GBC from pT1 GBC even
with leading-edge modalities, warranting employing LR
and/or BDR with D2 LA for pT1 GBC. In almost all
pT3/pT4 GBC, LR and/or BDR are mandatory to
achieve R0. Extension of LA beyond D2 would be
irrelevant because of the bleak outcome of GBC with
nodal involvement in that area.
Conclusion: Both LR and BDR should be applied only
as optional strategies to achieve R0 during surgery for
GBC, which should be individualized based on ‘R0 with
D2’ and considering the location of cancer and general
status of each patient.
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MARGIN LENGTH OF THE RIGHT
POSTERIOR SECTORIAL DUCT IN
LEFT-SIDED HEPATECTOMY FOR
PERIHILAR CHOLANGIOCARCINOMA
S. Natusme, T. Ebata, G. Sugawara, H. Nishio,
T. Kokuryo, Y. Yokoyama, N. Tsunoda, M. Fukaya,
K. Uehara and M. Nagino
Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine
Background: Although left hemihepatectomy is common
surgical procedure for hilar cholangiocarcinoma, left
trisectionectomy may be a challenging procedure, due to
technical demand or requirement of adequate liver
functional reserve. Beneﬁt on expansion from hemihep-
atectomy to trisectionectomy still remains unclear.
Objective: To verify the beneﬁt of left trisectionectomy,
focusing on a margin length of the right posterior sec-
torial duct (RPSD).
Patients and methods: A total of 181 patients who
underwent left sided hepatectomy (trisectionectomy, L3,
in 69 and hemihepatectomy, L2, in 112 patients) for
perihilar cholangiocarcinoma formed a basis of this ret-
rospective study. Color photocopies of the specimen were
re-reviewed to measure the margin length of the RPSD,
which was deﬁned as the distance from the cut stump to
the epicenter of the conﬂuence of the left hepatic duct.
The conﬂuence pattern of the RPSD was divided into
supraportal (normal) or infraportal type.
Results: The margin length averaged 19.4 mm (ranging
from 7 to 33 mm) and 13.7 mm (3 to 27 mm) in the L3
and the L2 specimen, respectively, in the supraportal
conﬂuence type (p = 0.00004). The length was 18.3 mm
(5 to 34 mm) and 13.0 mm (7 to 22 mm), respectively, in
the infraportal type (p = 0.036).
Conclusion: Comparing left trisectionectomy to hemi-
hepatectomy, the former gains 5 mm-length in the
RPSD. Left trisectionectomy should be recommended
for selected patients with left-predominant perihilar
cholangiocarcinoma, in order to obtain a satisfactory
margin in the RPSD.
P-483
IS CHOLECYSTECTOMY NECESSARY
AFTER ERCP FOR BILE DUCT STONES
IN PATIENTS OLDER THAN 80 YEARS
OF AGE?
T. Yasui, S. Takahata, Y. Mori, K. Tsutsumi,
Y. Sadakari, T. Ohtsuka, M. Nakamura and M. Tanaka
Department of Surgery and Oncology, Graduate School of
Medical Sciences, Kyushu University
Background: Patients with cholecystocholedocholithiasis
are generally referred to cholecystectomy after endo-
scopic sphincterotomy (ES) and common bile duct
clearance. Untreated gallbladder stones are generally
thought to be a risk of biliary complications after ES like
acute cholecystitis or migration into the common bile
duct. However, we often have a conﬂict whether chole-
cystectomy is necessary in very elderly patients with
comorbid diseases.
Aim: We assessed whether cholecystectomy after ES in
elderly patient is justiﬁed.
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Methods: Patients with cholecystocholedocholithias who
underwent ES and stone extraction and were followed-up
for more than 10 years were retrospectively reviewed. We
divided these patients into two groups; elderly group
(equal to more than 80 years old; 77 patients) and young
group (less than 80 years old; 250 patients), and com-
pared late complications focusing on biliary events.
Result: Median overall follow-up duration was
76.3 months in elderly group and 144.1 months in young
group. The ﬁve years cumulative incidence of overall
biliary complications was signiﬁcantly lower in chole-
cystectomized patients than in patient with gallbladder in
situ in young group (6.1% vs. 15.6%, p = 0.0037), but
not different in elderly group (8.3% vs. 7.4%, p = 0.92).
When each complication was evaluated separately, the
rate of recurrent common bile duct stones (CBDS) was
not different, but that of acute cholecystitis was signiﬁ-
cantly lower in elderly group than in young group (4.1%
vs. 16.0%, p = 0.011).
Conclusion: In very elderly patients the incidence of
acute cholecystitis is low even when the gallbladder is
preserved after endoscopic treatment of CBDS and
preserving the gallbladder does not increase the risk of
recurrence of CBDS. Furthermore, cholecystectomy
does not decrease biliary events. Cholecystecomy after
ES for CBDS may not be necessary in very elderly
patients.
P-484
EFFECTIVENESS OF ANTIBIOTIC
PROPHYLAXIS IN
CHOLECYSTECTOMY
B. Darkahi1, G. Sandblom2, P. Videhult3,
M. Ljungdahl4, H. Liljeholm1 and I. Rasmussen4
1Enko¨ping Hospital; 2Department of surgery, Karolinska
University Hospital, Stockholm; 3Department of Surgery,
Va¨stera˚s Hospital; 4Department of Surgery, University
Hospital, Uppsala
Background: Despite the risk of adverse reactions and
concern about the risk of promoting development of
resistant bacteria antibiotic prophylaxis is widely used
when performing gallstone surgery.
Aims: To assess the beneﬁt from antibiotic prophylaxis
(AP) during cholecystectomy in a population-based co-
hort study.
Methods: All cholecystectomies performed in Uppsala
county, Sweden, 2003–2005 were registered prospectively
according to a standardised protocol. Complicated pro-
cedures (CP) were deﬁned as operations for acute cho-
lecystitis and procedures including exploration of the
common bile duct. Postoperative surcical site infections
requiring surgical or percutaneous drainage and non-
surgical infections that prolonged the hospital stay were
deﬁned as major infectious complications (IC).
Results: Altogether 1171 patients underwent cholecys-
tectomy during the period. AP was given to 130/867
(15%) of the patients undergoing uncomplicated proce-
dures (UP) and 205/304 (67%) of those undergoing CP.
Major IC were seen in 6/205 (3%) of the patients
undergoing CP with AP and 1/99 (1%) of the patients
undergoing CP without AP. No major IC was seen after
UP. Minor IC were seen after 5/205 (2%) CP with AP, 1/
99 (1%) CP without AP, 0/130 (0%) UP with AP, and 2/
737 (0.3%) UP without AP. In univariate logistic anal-
ysis, the overall risk of IC was found to be higher with
AP (P < 0.05), but the increase did not remain signiﬁ-
cant if adjusting for age, gender, ASA, CP/UP and sur-
gical approach or limiting the analysis to major IC.
Conclusion: No reduction in the risk of major or minor
postoperative infections was seen in patients receiving
antibiotic prophylaxis. Although a reduced risk perhaps
may have been seen if randomisation had been done, the
incidence of infections was so low that the potential
beneﬁt in terms of reduced risk of predominantly minor
infections has to be weighed against the adverse effects of
antibiotic prophylaxis.
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RADIOTHERAPY FOLLOWED BY
GEMCITABINE AND S-1 THERAPY IN
LOCALLY ADVANCED BILIARY TRACT
CARCINOMA
M. Ishikawa, T. Furukawa, Y. Matsuoka, A. Kihara,
M. Tanaka, Y. Hamada, T. Minato, Y. Yasuhiro,
T. Ichimori, S. Kimura and A. Sakata
Tokushima Red Cross Hospital
Background/Aim: The prognosis of advanced biliary
carcinoma is poor and chemotherapy has not been very
effective. The aim of the present study was to assess the
feasibility of radiotherapy and concomitant Gemcitabine
and S-1 therapy for the treatment of locally advanced
biliary tract carcinoma in comparison with that of oral
Uracil-Tegafur (UFT) therapy.
Patients and methods: We enrolled 33 patients with lo-
cally advanced biliary tract carcinoma. Eighteen patients
(12 were unresectable and 6 had local recurrence) re-
ceived conformal three-dimensional radiation therapy
(50 Gy). Gemcitabine was administrated intravenously at
a dose of 1000 mg/m2 on day 1 and 15, and the dosage
was repeated every 4 weeks. S-1 was administered orally
at a dose of 60 mg/m2 on days 1–14. Fifteen patients (10
were unresectable and 5 had local recurrence) were
administered an oral dose of 360 mg/m2/day of UFT.
Results: According to the RECIST criteria, three pa-
tients (17%) showed partial response and eight patients
(44%) showed no change in the chemoradiation group.
No partial response was observed in the UFT group. The
1-year and 2-year survival rates of the chemotherapy
group were 57% and 34%, and those of the UFT group
were 8% and 0%, respectively. In the chemoradiation
group, two patients (11%) suffered from grade 3 neu-
tropenia (17%) and ﬁve patients (28%) suffered from
grade 3 gastrointestinal disorder. No patients in the UFT
group demonstrated grade 3 or grade 4 adverse effects.
Conclusions: Radiochemotherapy followed by Gemcita-
bine and S-1 therapy is an effective treatment regimen
with manageable toxicity for locally advanced biliary
carcinoma. UFT therapy was well tolerated but ineffec-
tive.
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CLINICOPATHOLOGIAL STUDY ON
BILIARY CANCER ASSOCIATED WITH
PANCREATICOBILIARY MALJUNCTION
(PBM)
H. Kinoshita1, G. Akasu1, K. Mikagi1, R. Kawahara1,
H. Ishikawa1, M. Yasunaga1, H. Horiuchi1 and
Y. Okabe2
1Department of Surgery, Kurume University School of
Medicine; 2Department of Medicine, Kurume University
School of Medicine
Introduction: It has been indicated that PBM causes
continuous reﬂux of pancreatic juice into the biliary tract,
leading to devastation and malignant transformation of
the bile duct epithelium. In this study, we investigated
biliary tract cancer associated with PBM.
Materials and methods: We encountered 70 patients with
PBM in the Kurume University Hospital. Of these pa-
tients, 17 were complicated by biliary tract cancer: 12 by
gallbladder cancer, and 5 by bile duct cancer. These
cancer patients were analyzed for types of bile duct
dilatation, diagnostic methods, stages, surgical tech-
niques and prognosis.
Results: The types of bile duct dilatation based Todani’s
classiﬁcation, ﬁve with Type Ia, four with Type Ic, and
two with Type IV-A, and six with no dilatation. Two
patients were complicated by cholelithiasis. According to
the General Rules for surgical and pathological studies
on cancer of Biliary Tract in Japan, Stage I was found in
one, Stage II in ﬁve, Stage III in one, and Stage IV in the
remaining seven. Of the 14 patients (excluding the three
patients undergoing palliative surgery), two patients
underwent cholecystectomy (C), one patient underwent C
and bile duct resection (BDR), one patient underwent C
and BDR and sphinicteroplasty, one patient underwent
C and left hepatectomy, ﬁve patients underwent C and
BDR and hepatectomy, and one patient underwent
pancreaticoduodenectomy. No patients with Stage III or
higher-stage cancer survived long. One patient with Stage
I gallbladder cancer is alive, three years after surgery.
Three patients with Stage II gallbladder cancer are alive:
25 years, 10 years and 3 years, after surgery. However,
two patients with Stage II bile duct cancer died of
recurrent cancer eight months or four years and eight
months after surgery.
Conclusion: In the diagnosis of PBM, biliary tract cancer
complication should always be kept in mind.
P-487
COMBINED HEPATIC ARTERY
RESECTION FOR PERIHILAR
CHOLANGIOCARCINOMA:
HISTOLOGICANALYSIS IN 59 PATIENTS
Y. Fukami1, T. Ebata1, H. Nishio1, Y. Yokoyama1,
T. Kokuryo1, N. Tsunoda1, T. Igami1, G. Sugawara1,
M. Fukaya1, K. Uehara1, Y. Shimoyama2 and
M. Nagino1
1Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine;
2Department of Pathology and Clinical laboratories,
Nagoya University Graduate School of Medicine
Background: Hepatectomy combined with hepatic artery
resection for locally advanced hilar cholangiocarcinoma
is a challenging procedure, and its pathologic ﬁndings are
still unclear.
Objective: To clarify the mode of tumour spread to the
resected hepatic artery.
Methods: Between 1994 and 2009, 59 patients with hilar
cholangiocarcinoma underwent hepatectomy plus con-
tralateral hepatic artery resection, because of tumour
invasion of the artery by gross intraoperative inspection.
Mode of invasion of the resected hepatic artery was
histologically observed.
Results: Cancer inﬁltration limited to the tunica adven-
titia was found in 26 (44%) patients; involvement of the
tunica media was found in 2 (3%); and no histologic
invasion of the artery was found in 31 (53%) patients. In
the 31 patients, dense ﬁbrosis adjacent to the hepatic
artery was common, and the distance between the
advancing cancer margin and the outer layer of the
adventitia averaged 448 ± 487 lm (0–500lm, n = 20,
501–1000 lm, n = 5, 1001–1500 lm, n = 1, and 1501–
2000 lm, n = 2). As for the pattern of inﬁltration to the
resected artery, direct invasion, perineural invasion and
both were observed in 49 (83%), 7 (12%), and 3 (5%),
respectively.
Conclusions: Half of the patients had no microscopic
invasion of the resected artery, irrespective of gross evi-
dence of invasion. In these patients, however, safety
margin between the leading edge of the cancer cells and
the adventitia was minimal: less than 1 mm in most cases.
Therefore, to obtain tumour-free surgical margin, com-
bined hepatic artery resection is required for the patients
in whom gross invasion of the contra lateral hepatic ar-
tery was encountered.
P-488
IS RADICAL PANCREATO-
DUODENECTOMY BEYOND HOPE?
D. Czarnevicz, L. Cidade, G. Andreoli, S. Cubas,
A. Campos and R. Valin˜as
Department of Surgery IMPASA, Montevideo, Uruguay
Background: Given the poor long-term outcomes of
pancreatoduodenectomy for pancreas adenocarcinomas,
many surgeons have sought to improve survival via a
radical pancreatectomy.
Aims: Evaluate clinical outcome, survival and prognostic
factors following radical pancreatoduodenectomy.
Method: Retrospective review of our prospective data-
base identiﬁed two hundred and twenty two patients with
pancreatic head cancer treated from 1989 to 2009. Pa-
tients were divided into two groups: standard pancre-
atoduodenectomy, SP (n = 77) and radical
pancreatoduodenectomy (RP) combined with retroperi-
toneal nerve, lymph and soft-tissue dissection (n = 145).
Median follow-up interval was 39 months. Preoperative
risk factors, postoperative recovery and pathologic data
were reviewed. Statistical analysis was made by means of
t test, v2 test, Kaplan–Meier method, log-rank test and a
stepwise Cox proportional hazard regression model to
assess independent factors.
Results: There were no signiﬁcant differences between
the two groups in relation to preoperative risk factors.
Lymph node metastases were present in 138 patients and
100 had neural invasion. Forty seven vascular resections
were performed, 40 portal vein and 7 hepatic artery.
Postoperative complications and mortality showed no
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signiﬁcant differences between groups, but recurrence
was signiﬁcant higher in standard pancreatoduodenec-
tomy (37.3% vs. 10.3% P < 0,05). Median and 5-year
overall survival was 35,2 months and 32% with no sig-
niﬁcant difference, but median and 5-year disease-free
survival showed differences, SP 20,5 months and 0%, RP
32,5 months and 29% (P < 0,05). Poor survival associ-
ated with size of the tumour, presence of positive lymph
nodes metastases, neural invasion and a posterior dis-
ease-free margin of less than 1 cm.
Conclusion: Radical pancreatoduodenectomy is safe and
feasible and although it did not show a beneﬁt in overall
survival, the recurrence rate and the disease-free survival
are better than with standard operation.
P-489
PANCREATICODUODENECTOMY WITH
SYNCHRONOUS VASCULAR
RESECTION
G. Marangoni1, A. Amir2, W. Faraj3, P. Srinivasan2,
A. Prachalias2, S. Atkinson2, N. Heaton2 and M. Rela2
1St. Thomas’ Hospital, London; 2King’s College Hospital
London; 3American University of Beirut-Medical Centre
Introduction: Long term prognosis of pancreatic cancer
surgery remains poor and the aim of surgery should be
the achievement of negative resection margins, as R1
resections are associated with early tumour recurrence
and poor survival. We review our Institution experience
of pancreaticoduodenectomy (PD) with en-bloc vascular
resection.
Methods: From January 2001 to December 2008 we
performed 50 PD with vascular resections. In three cases
a synchronous arterial (common hepatic artery) and ve-
nous resection was carried out. Mean age was 61 years
(range 31 – 82). Venous reconstruction was performed
with a primary end-to-end anastomosis in 18 (36%),
primary closure of sleeve resection in 13 (26%), cadaveric
iliac vein graft in 10 (20%), left internal jugular vein graft
in 8 (16%) and a PTFE graft was used in one case (2%)
respectively. Forty PD were performed for pancreatic
adenocarcinoma, eight for other neoplastic pathology
and two for chronic pancreatitis.
Results: Perioperative mortality was 6% (3/50). Mean
hospital stay was 17.6 days (range 7 – 63). There were
four pancreatic leak (8%) with an overall 30% morbidity
(cardiovascular events, leaks, delayed gastric emptying).
Venous thrombosis occurred only in cadaveric grafts (2/
10). Pancreatic resection margins were involved in 2
(4.2%) and the tumour was found at the retroperitoneal
margins in 16 cases respectively (33.3%). PD for pan-
creatic cancer achieved 1-year and 3-year survival in 70%
and 23.5% respectively.
Discussion: Mortality and morbidity rates of PD with
vascular resections are similar to standard PD. R0
resection can cure a minority of patients with pancreatic
cancer and prolong survival. Since detection of venous
involvement is not always predicted by pre-operative
investigations it is important that the surgeon is familiar
with VR and reconstruction techniques as it will increase
the chance of curative resection.
P-490
OPERATIVE OUTCOMES OF
PANCREATICODUODENECTOMY
USING BLUMGART PANCREATICO-
JEJUNOSTOMY: A SINGLE CENTRE
EXPERIENCE
K.-F. Lee, Y.-S. Cheung, S. Liu, P. Ip, M. Chan,
J. Wong and P. Lai
Princes of Wales Hospital
Background: Pancreatic leak remains a major problem
after pancreaticoduodenectomy (PD). Blumgart pancre-
aticojejunostomy (BPJ) is one variant of the duct-to-
mucosa PJ anastomosis where U-sutures are used to
approximate the jejunum to the pancreatic stump. This
allows precise placement of duct-to-mucosa sutures
which may decrease the incidence and degree of pancre-
atic leak.
Objective: To evaluate the operative outcomes of PD in
which BPJ is applied solely for the treatment of the
pancreatic stumps.
Method: This was a retrospective analysis of 61 consec-
utive patients who underwent PD using BPJ in our centre
between January 2004 and September 2009.
Results: There were 33 males and 28 females, with a
median age of 62 years (24–79). Whipple type PD was
performed in 20 patients while 41 patients received
pylorus-preserving PD. PD was performed for malig-
nancy in 95.1% of cases. There was no operative mor-
tality. One or more complications occurred in 27 patients
(44.3%) and these included: pancreatic leak (14.8%),
delayed gastric emptying (9.8%), bile leak (3.3%), intra-
abdominal collection (4.9%), wound infection (11.4%),
chest infection (4.9%), pleural effusion (1.6%), urinary
tract infection (4.9%), worsening diabetes (6.6%) and
others (8.2%). No patient received re-operation. Five
patients required percutaneous drainage for complica-
tions while one patient required embolization for hae-
mobilia due to right hepatic artery pseudoaneurysm
related to bile leak. Otherwise there was no post-opera-
tive intra-abdominal bleeding complication. The median
operative time was 486 min (345–690) while the median
blood loss was 500 mL (100–6800). Blood transfusion
was required in 28% of patients. The median post-
operative hospital stay was 16 days (8–51).
Conclusion: PD using BPJ was associated with accept-
able low pancreatic leak rate. More importantly, there
was no major pancreatic leak leading to intra-abdominal
bleeding, re-operation or death.
P-491
PARENCHYMAL PANCREATECTOMY
FOR INTRADUCTAL PAPILLARY
MUCINOUS
T. Maki, E. Tanaka, S. Hirano and S. Kondo
Department of Surgical Oncology, Hokkaido University
Background: Intraductal papillary mucinous neoplasms
of the pancreas (IPMN) have a variety of pathological
ﬁgures such as adenoma, borderline lesion, non-invasive
carcinoma, and invasive carcinoma. We have performed
parenchymal pancreatectomy (PP) which means pancre-
atic parenchymal resection with preservation of sur-
rounding structures for IPMN unless invasive carcinoma
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is suspected. The category of PP includes duodenum
preserving pancreatic head resection (DPPHR), middle
pancreatectomy (MP), total parenchymal pancreatec-
tomy (TPP), and wedge resection.
Aim: We retrospectively reviewed surgical outcome for
IPMN in our department to verify whether PP is a valid
procedure for IPMN.
Methods: We performed PP in 37 cases and standard
procedures such as pancreatoduodenectomy (PD) or
distal pancreatectomy (DP) in 44 cases for IPMN during
1983–2009. We compared them in terms of postoperative
survival rate, recurrence rate, operative time, operative
blood loss, postoperative hospitalization period, and
morbidity such as pancreatic ﬁstula, ischemia of bile
duct, and gastric stasis.
Results: Except for cases of invasive carcinoma, no sig-
niﬁcant difference of postoperative survival rate was
found between 37 cases of PP and 33 cases of standard
procedures (5 year survival rate; 95% vs. 97%,
p = 0.4633). No recurrence due to positive margin was
found in 37 cases of PP. We modiﬁed the details of
DPPHR in 2000 to resect all parenchyma of pancreatic
head with preservation of the epicholedochal plexus.
Twenty one cases of DPPHR before 2000 were signiﬁ-
cantly inferior to 27 cases of PD in terms of pancreatic
ﬁstula, ischemia of bile duct, and postoperative hospi-
talization period. But 7 cases of DPPHR after 2000 were
statistically equivalent to 27 cases of PD in terms of
operative time, operative blood loss, postoperative hos-
pitalization period, and any morbidity.
Conclusion: PP is a valid procedure for IPMN except for
invasive carcinoma in terms of radical cure, organ pres-
ervation, and safety.
P-492
END TO SIDE DUCT-TO-MUCOSA
PANCREATICOJEJUNOSTOMY WITH
INTERNAL STENT PLUS SUMP DRAIN
IS A RELIABLE METHOD TO PREVENT
PANCREATIC FISTULA
J. R. Fung, S. K. Law, W. N. Fong, W. Chu and
S. H. Lam
Department of Surgery, United Christian Hospital
Background and objectives: Post operative pancreatic
ﬁstula after pancreaticojejunostomy is common in a low
volume center.
Objective: To evaluate the operative outcomes of PD
using end to side duct-to-mucosa with internal stent plus
additional sump drain in a small volume center.
Method: We performed a retrospective review from 2008
to 2009. Starting from 2008, end to side duct to mucosa
anastomosis for PJ with an internal stent bridging across
the anastomosis had been adopted as the main stream
method of anastomosis. In addition, sump drains were
placed around the PJ to reduce the possible collection.
The amylase levels at day 3, day 5 and day 7 were re-
corded and analyzed. The pancreatic ﬁstula was deﬁned
by the ISGPF and the results were reviewed.
Results: From 2008 to Mid-2009, there were 29 cases of
Whipple’s operation done within this period. Eighteen
pancreaticojejunostomy were performed by the surgeons
with the same technique. One 1/18 got Grade A leakage.
The leakage rate was 5.5%. There was no 30 day mor-
tality. The one grade A leakage case subsided by con-
tinuation of the sump drain treatment and the drain was
eventually removed.
Conclusion: End to side duct-to-mucosa pancreaticojej-
unostomy with internal stent bridging across the anas-
tomosis plus sump drain to reduce the possible amylase
rich ﬂuid accumulation is a safe, reliable and easily
reproducible technique to reduce PJ leakage in a low
volume center.
P-493
USEFULNESS OF INTERNAL
PANCREATIC DUCT STENT FOR
PANCREATICOJEJUNOSTOMY IN
PANCREATICODUODEENECTOMY
WITH SHORT TERM AND LONG TERM
OUTCOMES
Y. Minami1, Y. Nagano1, M. Ueda1, K. Taniguchi2,
R. Matsuyama2, K. Tanaka2, S. Fujii1, I. Endo2 and
C. Kunisaki1
1Department of Surgery, Gastroenterological Center,
Yokohama City University, Yokohama, Japan;
2Department of Gastroenterological Surgery, Graduate
School of Medicine, Yokohama City University,
Yokohama, Japan
Background: Pancreaticoduodenectomy (PD) represents
the standard surgical procedure for the pancreatic head
tumours. Long term outcomes of pancreaticojejunosto-
my are uncertain, because they are not reported so much.
Aim: To evaluate the feasibility of internal pancreatic
duct stent for pancreaticojejunostomy in PD with short
term and long term outcomes.
Method: Between 2000 and 2007, 115 patients underwent
PD. Internal lost stent (Internal group, 66 cases) or
external stent (External group, 49 cases) were inserted
into the pancreatic duct of pancreaticojejunostomy. As a
short term outcome, pancreatic ﬁstula rate and hospital
stay after operation were compared between the two
groups. Moreover, thickness of pancreas and remnant
pancreatic duct size at three months and one year after
PD measured on computed tomography were compared
between the two groups as a long term outcome. In
addition, whether diabetes mellitus had deteriorated was
examined at one year after PD.
Result: Pancreatic ﬁstula rate in internal group was
37.8% and in external group was 30.6%, it was not sig-
niﬁcant. On the other hand, there was a signiﬁcant dif-
ference in hospital stay after operation between the two
groups (28.6 ± 12.7 vs. 42.7 ± 10.8 days, P < 0.05).
The three months and one year after PD thickness of
pancreas was 91.3 ± 8.5% and 86.6 ± 12.2% compared
before PD in internal group, and 85.1 ± 9.6% and
81.2 ± 11.4% in external group. A signiﬁcant atrophy of
pancreatic parenchyma was noted in external group
(P < 0.05). However, there were no signiﬁcant differ-
ences in remnant pancreatic duct size compared before
PD at three months (91.6 ± 32.8% vs. 86.0 ± 29.9%,
P > 0.05) and one year (93.7 ± 41.0% vs.
96.7 ± 41.5%, P > 0.05) after PD between the two
groups. Deteriorated diabetes mellitus was admitted ﬁve
cases (7.5%) in internal group and four (8.1%) in
external group (P > 0.05).
Conclusions: Internal lost stent method for pancreat-
icojejunostomy in PD is useful with a short term and a
long term outcome compared with external stent method.
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P-494
COMPARISON OF BLOOD
TRANSFUSION FREE PANCREATICO-
DUODENECTOMY TO
TRANSFUSION-ELIGIBLE
PANCREATICODUODENECTOMY
D. Choi, Y. Choi, J. H. Kim, K.-J. Lee, K. Y. Hur and
S. Y. Ok
Soonchunhyang University Hospital
Background: Pancreaticoduodenectomy (PD) is the
standard operative procedures for periampullary lesions.
Even though surgical techniques and perioperative cares
have been improved, blood transfusions are still often
required to patients undergoing PD. But complications
from blood transfusions, poor prognosis of blood
transfused patients, cost, and availability of blood
products demand transfusion free (TF) surgery in the PD
patients.
Objectives: The purpose of this study is to compare
clinical outcome of TF pancreaticoduodenectomy to
transfusion-eligible (TE) PD.
Methods: We had investigated the possibility of blood
TF treatments for the patients underwent PD from
December 2005 to August 2007. There were 41 cases of
PD performed at Soonchunhyang University Hospital by
one experienced surgeon with the same method: 14 pa-
tients of TF and 27 patients of transfusion eligible (TE)
group.
Results: Most of the TF group patients received peri-
operative blood augmentation and intraoperative acute
normovolemic hemodilution. The results of statistical
analysis between TF and TE group showed that there
were no differences in intraoperative data and postop-
erative outcomes, except preoperative hemoglobin levels,
type of operations, and transfusion amount.
Conclusions: To our knowledge, this is the ﬁrst suc-
cessful PD program in selected patients as a series of
operations without blood transfusion. TF PD can be
done successfully in selected patients without severe
complications.
P-495
PANCREATIC SURGERY IN
OCTOGENARIANS – ANALYSIS OF A
SINGLE CENTRE EXPERIENCE
M. Oliveira-Cunha, A. Aldouri, J. Pine, K. Menon and
A. M. Smith
HPB and Transplant Unit, St James’s University Hospital
Background: The demographics of the UK population
are changing with the fastest in those aged 85 and over.
By 2033 the number of people aged 85 and over is pro-
jected to be more than double, accounting for 5% of the
total population. Therefore, it is important to understand
the surgical outcome in this population to assist surgical
decision making.
Aim: Study mortality, length of stay, complications and
survival in the elderly group that underwent pancreatic
resection in our institution.
Methods: We reviewed 439 consecutive pancreatico-
duodenectomies (PPDs) and distal pancreatectomies
(DP) at our institution over a 7-year period. Data col-
lected included mortality, complications, length of stay
and survival. Patients were divided into two groups (75
to 79 and older than 80 years old) and outcomes were
analysed.
Results: Sixty three patients aged 75 to 79 years old
(18.52%) and ﬁfteen patients (3.4%) older than 80 years
of age underwent PPD or PD. The median length of stay
for patients from 75 to 80 years and older than 80 years
old was 15.5 days (range from 6 to 92 days) and 16 days
(range from 5 to 32 days) respectively. The group of
patients older than 80 years old had a mortality rate of
6.6% (1 of 15) and a complication rate of 18.75% (9 of
48), similarly patients aged 75 to 79 years old had a
mortality of 6.25% and a complication rate of 20% (3 of
15). The median survival for patients aged 75 to 79 years
was 15.5 months also and patients older than 80 had
median survival of 14 months (P = 0.999).
Conclusions: Our results suggest that octogenarians can
safely undergo PPD and DP and that age alone should
not preclude pancreatic resection. Improved surgical
outcomes and an aging population will lead to an
increase in the number of PPDs and PD in the near
future.
P-496
DRAIN AMYLASE AFTER A
PANCREATICODUODENECTOMY (PPD)
DOES IT PREDICT A PANCREATIC
LEAK?
S. Robinson, A. Rahman, R. Lochan, G. Sen, M. Jacob,
J. J. French, B. C. Jaques, D. M. Manas, R. M. Charnley
and S. A. White
Department of HPB/Transplant Surgery, Freeman
Hospital, Newcastle Upon Tyne, UK
Background: Pancreatic ﬁstula is a common complica-
tion after PDD with a reported incidence of 2 to 50%.
Deﬁnitions of pancreatic ﬁstula usually include a mea-
sure of the drain amylase content. The aim of this study
was to determine the utility of routine measurements of
drain amylase in predicting the development of a pan-
creatic leak.
Methods: All patients undergoing PDD over a six year
period and their complications were identiﬁed from a
prospective database. Drain amylase was retrieved
from a prospective database on the 3rd, 5th and 7th
post-operative days. We compared three proposed
deﬁnitions (drain amylase greater than serum upper
level normal, 135I U/mL; more than 3 x serum and
more than 5 x serum) of a pancreatic leak in relation
to drain amylase content to predict the development of
pancreatic ﬁstula.
Results: A total of 385 patients [54% male, mean age
62 years (range 12–82)] were included within this series
with 34% having ductal adenocarcinoma. The incidence
of ﬁstula (as recorded by the patients clinician) was
14.3% (n = 55). The overall reoperation rate for was
6.7% (n = 26). Thirty day mortality was 1.8%. Mean
time to diagnosis of pancreatic ﬁstula was 6.6 days.
Using the same three proposed deﬁnitions neither of
them appear to be predictive of a pancreatic leak.
Conclusion: Drain amylase alone is not a good predictor
for the development of a pancreatic leak following PPD.
Ability of Drain Amylase to Predict Development of a
Pancreatic Fistula.
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P-497
INCREASING RESECTION OF
ASYMPTOMATIC PANCREATIC CYSTIC
LESIONS AT A TERTIARY CENTER
N. Gusani1,2, S. Patel1,2, I. Deshaies1,2, S. Kavuturu1,2,
J. Kaiﬁ1,2, E. Kimchi1,2 and K. Staveley-O’Carroll1,2
1Section of Surgical Oncology, Department of Surgery;
2Penn State College of Medicine
Objective: Cystic lesions of the pancreas are increasingly
being detected due to the rising use of cross-sectional
imaging. We reviewed the presentation, management,
and surgical outcomes for all resected pancreatic cystic
lesions at our institution.
Methods: A retrospective analysis of all patients under-
going resection for cystic lesions of the from June 2002 to
September 2009 was performed.
Results: Fifty six (17M:39F) patients underwent surgical
resection for pancreatic cystic lesions during this time
period. Thirty one patients (55%) were asymptomatic,
with the cyst discovered as an incidental ﬁnding on
imaging for another indication. In patients with symp-
tomatic cysts, the most common ﬁndings were pain
(n = 15) and weight loss (n = 7). Eighteen patients had
cysts in the head/uncinate process, while 38 patients had
lesions in the body/tail of the pancreas. The percentage of
resections performed for incidental cysts rose from 33%
in 2002–2003 to 71% in 2008–2009. The median cyst size
was 3.2 cm. Resections performed included left (distal)
pancreatectomy (n = 37), pancreaticoduodenectomy
(n = 17), and central pancreatectomy (n = 2). The dis-
tribution of pathologic diagnoses varied signiﬁcantly
depending on the presentation. In symptomatic patients,
there were 8 malignant lesions, 20 mucinous cysts, 15,
serous cysts, 8 IPMNs, 2 solid pseudopapillary lesions,
and 3 pancreatitis/pseudocyst. In asymptomatic patients,
there were 3 malignancies, 13 mucinous cysts, 9 serous
cysts, 4 IPMNs, 1 solid pseudopapillary lesion, and 1
pancreatitis/pseudocyst. Outcomes of resection were
similar in terms of operative variables, hospital stay, and
morbidity.
Conclusion: Pancreatic resection for incidental cystic
lesions of the pancreas is becoming more common and
represents an increasing proportion of pancreatic
resection procedures. The underlying pathology of
pancreatic cysts varies between symptomatic and
asymptomatic cysts. Outcomes of resection are similar
in both groups.
P-498
WHIPPLE PROCEDURE: OF WHAT
SHORT AND LONG TERM RISKS
SHOULD WE INFORM OUR PATIENTS?
M. Tavernier1, B. Alkofer1, E. Salame´1, J. Lequet1,
J.-J. Parienti2 and L. Chiche1
1Department of Hepatobiliary Surgery, CHU Caen,
France; 2Department of statistics, CHU Caen, France
Background: Whipple Procedure (WP) is a settled sur-
gical procedure, mainly used in the treatment of pe-
riampullar neoplasms. Although mortality has decreased
in recent years, morbidity remains high, and functional
consequences are not infrequent.
Objective: To analyse the mortality, morbidity, and
long-term outcomes of WP, in order to inform patients of
the real risk of the WP.
Method: Retrospective cohort study of 291 consecutive
patients operated in a single center (> 25WP/year) be-
tween January 1992 and December 2008.
Results: Sixty one percent were men with a mean age of
60 years. Pathology was pancreatic neoplasm (41.2%)
carcinoma of the ampulla (18.5%) chronic pancreatitis
(9.3%), distal common bile duct cancer (8.9%) and
duodenal cancer (5.5%). For malignancy, the average
number of lymph node resected was 16.4. Margins were
negative in 85.7% patients, but 68% had lymph node
involvement.
Pancreatico-gastric anastomosis was performed in 89.5%
of cases, pylorus preserving pancreatectomy in only 6.6%
of cases. Portal or superior mesenteric venous resection
was needed in 14.8% of cases. The median length of stay
was 15 days. Hospital mortality was of 1%. The overall
postoperative morbidity rate was 62.6%. Twenty nine
patients (10%) required reoperation in the postoperative
period. Most common postoperative complications were
wound infection (23%), delayed gastric emptying
(18.6%), pancreatic ﬁstula (11%) and pneumonia
(9.5%), with 70.9% of Clavien grade 1 – 2. The rate of
bleeding was 7.8% and bile duct leakage 4.3%. The long-
term outcomes showed a de novo onset of diabetes in
15.3% in 146 followed patients. Steatorrhea appeared in
70.9% of patients.
Conclusion: WP is a safe procedure, associated with a
low overall mortality and mostly benign postoperative
complications if performed in high volume centers. Pa-
tients undergoing WP should be aware of a high risk of
pancreatic exocrine insufﬁciency and of the outbreak of
de novo diabetes in 15% of cases.
P-499
IS TOTAL PANCREATECTOMY (TP)
SURE AND REASONABLE?
W. Jamal, A. Sauvanet, S. Dokmak, O. Corcos,
A. Couvelard, B. Aussilhou, P. Le´vy, P. Ruszniewski and
J. Belghiti
Hospital Beaujon
Objective: TP is rarely performed since it is presumed
associated with unfavourable results. It can be indicated
preoperatively according to imaging, or intraoperatively
according to results of frozen section, or postoperatively
(completion pancreatectomy). The aim of this study was
to report early and distant results of TP.
Methods: From 1995 to April 2009, 46 patients (median
age = 49 years; range 27–76) underwent elective TP for
intraductal papillary and mucinous neoplasm (IPMN)
presumed invasive (n = 18) or not (n = 18), endocrine
tumour (ET) (n = 6), or adenocarcinoma (n = 4). In 13
patients, TP was performed by means of an elective
completion pancreatectomy. Technically, spleen and
splenic vessels were preserved (except when invasive
carcinoma was suspected in the distal pancreas) and
pylorus preservation was achieved as often as possible.
Results: Intraoperatively, gastric ischemia and/or gastric
revascularization were noted in four patients (9%).
Operative mortality was nil and morbidity rate was 50%
(n = 23). According to deﬁnitive pathologic examina-
tion, there was ﬁve (10%) excessive TP (5 IPMN either
localized or non conﬁrmed). An anastomotic ulcer oc-
curred in seven patients: 7/24 and 0/22 before and after
routine and deﬁnitive prevention by proton pump
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inhibitor (PPI), respectively. After a median follow-up of
21 (3–156) months, there was 16 deaths related to ade-
nocarcinoma (n = 13, including 11 metastatic recur-
rences), acute complication of diabetes (n = 2) and ulcer
(n = 1).
Conclusions: 1) Due to possible misdiagnoses, TP should
be indicated only when diagnosis is conﬁrmed patho-
logically; 2) its operative mortality is very low but dia-
betes-related mortality still occurs; 3) TP can result in
gastric ischemia; 4) PPI are indicated to prevent anasto-
motic ulcer; 5) distant survival is good except after TP for
invasive carcinoma (complicating IPMN or not); in this
indication, TP remains debatable as long as metastatic
disease can not be prevented efﬁciently.
P-500
SURGICAL OUTCOME FOR PANCREAS
BODY AND TAIL CANCER
T. Sano, Y. Shimizu, Y. Senda, K. Yamao and
Y. Nimura
Aichi Cancer Center Hospital
Aim: To evaluate the surgical outcome of distal pancre-
atosplenectomy (DP) for patients with pancreas body
and tail adenocarcinoma (PCa).
Methods: Between 1999 and 2008, 39 patients with PCa
who had undergone DP, were analyzed. There were 18
women and 21 men, with a median age of 65 years (38–
78). Nineteen patients (49%) were symptomatic on pre-
sentation.
Results: Mortality rate was zero, and morbidity rate was
31%. The overall 5-year survival rate and median sur-
vival time were 34.2% and 35.2 months, respectively.
Combined resection of other organs (n = 7) and celiac
axis (n = 2) was performed in nine (23%) patients.
Fourteen patients (36%) underwent intraoperative radi-
ation therapy (IORT). Postoperative adjuvant chemo-
therapy was performed in six (15%) patients.
Pathological curative (R0) resection was achieved in 31
(79%) patients. Median tumour size was 2.5 cm (0.9–
12.0 cm) in diameter. Eighteen (46%) patients had lymph
node metastasis. Pathological invasion of the retroperi-
toneal connective tissue, pancreatic serosa, splenic vein,
splenic artery, and extrapancreatic nerve plexus were
documented in 27 (69%), 27 (69%), 17 (39%), 10 (26%),
and 3 (8%) patients, respectively. There were 4 (10%)
patients with stage IA, 17 (44%) with IIA, 16 (41%) with
IIB, 1 (3%) with III, and 1 (3%) with IV, respectively.
There were signiﬁcant differences in survival between
stage IA and IV (p = 0.045), IIA and IV (p = 0.011).
Tumour recurrence was documented in 27 (69%) of the
patients.
Univariate analysis identiﬁed ﬁve signiﬁcant variables;
asymptomatic (p = 0.014), tumour size <= 2.0 cm
(P = 0.02), without splenic arterial invasion (p =
0.025), CEA<= 2.9 ng/mL (P = 0.031), and CA19-
9<= 125 U/mL (p = 0.009).
Conclusions: Early detection of small size tumour with-
out clinical symptoms seems to result in favorable sur-
vival after DP.
P-501
IMPACT OF RESECTION MARGINS ON
SURVIVAL FOLLOWING
PANCREATICODUODENECTOMY FOR
CANCER
J. R. Liu1, S. Davies2, R. Brais2, A. Jah1, E. L. Huguet1,
N. V. Jamieson1 and R. K. Praseedom1
1Department of Surgery, Addenbrooke’s Hospital,
Cambridge; 2Department of Pathology, Addenbrooke’s
Hospital, Cambridge
Background and objective: Positive resection margin (R1)
has been found to be an independent prognostic factor in
adenocarcinoma involving head of pancreas. The aim of
this study is to evaluate the prognostic value of individual
resection margins following pancreaticoduodenectomy
for cancer.
Methods: Data on all patients who underwent a pan-
creaticoduodenectomy between 01/07/2002 and 30/06/
2009 at Addenbrooke’s Hospital, Cambridge were re-
trieved from a prospectively held database. Resection
margins were inked and prepared according to the Royal
College of Pathologists guidelines. Positive resection
margin (R1) was deﬁned as the presence of tumour cells
within 1mm of any resection margins. Cox regression
analysis was used to identify signiﬁcant variables asso-
ciated with poor prognosis. Survival was analysed using
the Kaplan–Meier method and signiﬁcance was calcu-
lated using the log rank test.
Results: Some 211 patients underwent a pancreatico-
duodenectomy during this period, of which 140 had
adenocarcinoma of the head of pancreas (78), ampulla
(31), bile duct (23) and duodenum (8). Resection margins
were positive (R1) in 85 patients (60.7%), but this did not
signiﬁcantly affect the survival in either the overall cohort
of 140 patients or the individual tumour sites. However,
positive posterior resection margins and positive pan-
creatic transection margins were found to be signiﬁcant
factors affecting survival in pancreatic and ampullary
adenocarcinomas respectively (p = 0.022 and
p = 0.000).
Conclusion: We conclude that among all the resection
margins, positive posterior resection margins and pan-
creatic transection margins are associated with signiﬁ-
cantly lower survival in adenocarcinoma of the head of
pancreas and ampullary region respectively, following
pancreaticoduodenectomy.
P-502
INSULINOMA: ENUCLEATION OR
PANCREATIC RESECTION AS
SURGICAL TREATMENT?
E. Nieveen van Dijkum, O. Busch, T. Van Gulik and
D. Gouma
Academic Medical Center
Background: Insulinoma is most often (90%) a benign
neuroendocrine tumor of the pancreas. Therefore mini-
mally invasive procedures like enucleation is warranted.
Aim of the study: To assess the post-operative morbidity
and follow-up of enucleation compared to pancreas
resection of insulinoma.
Methods: Retrospectively all patients operated for an
insulinoma were reviewed.
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Results: Nineteen patients were operated for insulinoma
between 1995 and 2009, 12 women/7 men, mean age 49
(15–83) years. Three patients have a MEN1-syndrome.
Eleven patients underwent enucleation and eight patients
had a resection. Enucleation was performed in the pan-
creatic head in six (two combined with a pancreaticojej-
unostomy), corpus in two and tail in three patients.
Resections were performed of the pancreatic tail in six,
corpus in one and corpus/tail in one patient.
Complications occurred postoperatively in 5/11 (45%)
enucleation and 2/8 (25%) resection patients. Postoper-
ative complications after enucleation were leakage of the
pancreas in four patients and delayed gastric emptying in
one patient. Patients with leakage after enucleation had
combined complications: bleeding, delayed gastric emp-
tying and one patient with two re-operations for drainage
followed by wound infection and incisional hernia.
Postoperative complications after resection occurred in
2/8 patients and were pancreatic leakage in one patient
after corpus resection and one patient with a pancreatic
tail resection who underwent two re-laparotomies for
bleeding with spleen resection.
Long-term complications were 4/11 (36%) in the enucle-
ation patients, two with diabetes, one with thrombosis of
the portal vein and incisional hernia. Long-term compli-
cations in the resection patients were 2/8 (25%), reﬂux
and diabetes.
Conclusion: Although enucleation is less-invasive, it does
have considerable post-operative morbidity (45%),
probably due to difﬁcult visualisation of the pancreatic
duct. Pancreatic resections are a safe alternative for
enucleation.
P-503
USE OF VESSEL SEALING
TECHNOLOGY IN PANCREATICO-
DUODENECTOMY
T. Chaly and D. Slakey
Tulane University
Background: Pancreaticoduodenectomy is a well-estab-
lished procedure for both benign and malignant neo-
plasms, but remains technically challenging with the
potential for signiﬁcant morbidity. Utilization of new
operative devices and technologies may provide the sur-
geon greater efﬁciency and safety.
Aims: Evaluation of vessel sealing technology for major
dissection during pancreaticoduodenectomy including
division of pancreas.
Methods: Prospective data collection and evaluation of
technique in 20 consecutive pancreaticoduodenectomies.
Results: Twenty consecutive patients underwent pan-
creaticoduodenectomy using the LigaSure vessel-sealing
device. Average age was 61.6 years (range 39 to 81);
there were 10 men and 10 women. Mean blood loss was
418 mL (range 150 to 1200). Eight patients (40%) re-
ceived a blood transfusion, but none more than two
units. Mean operative time was 3 hours 41 min (range
3 hour 4 min to 4 hour 34 min). Pathology was: ade-
nocarcinoma 13, neuroendocrine tumor 1, mucinous
cystic neoplasm 3, and benign 3. Median hospital length
of stay was eight days. Complication rate was 20%.
There were no pancreatic leaks and no patient required
reoperation.
Conclusion: Vessel sealing technology appears to be safe
and effective for dissection, including division of the
pancreas, during pancreaticoduodenectomy, providing
the surgeon efﬁciency and acceptable safety. The tech-
niques of using the device are easy for the experienced
pancreas surgeon to use and apply.
P-504
ROUX-EN-Y DOUBLE TRACT
RECONSTRUCTION AFTER THE
PARTIAL RESECTION OF THE
DUODENUM TO PREVENT
UNNECESSARY PANCREATICO-
DUODENECTOMY
Y. Deguchi, J.-I. Tanaka, H. Kasugai and S.-E. Kudo
Showa University Northern Yokohama Hospital Digestive
Disease Center
Background: Pancreaticoduodenectomy is not dispens-
able for resection of the duodenal GIST or resection of
the colorectal cancer with direct invasion to the duode-
num involving the second and/or third portion. If the
tumor was displaced from ampullar of Vater, partial
duodenectomy can be performed. Avoidance of pan-
creaticoduodenectomy allows the reduction of the risk of
intra- or post-operative complications.
Objective: We report our experience of two patients
successfully treated by a partial resection of the duode-
num with Roux-en-Y duodenojejunostomy. The ﬁrst
patient had colon cancer with direct invasion to the
second portion of the duodenum and the second patient
suffered from a duodenal GIST.
Method: Wide mobilization of the duodenum and en-
bloc resection of the tumor with clear margins were
performed with partial duodenectomy. As direct closure
of large defect of the duodenum may result in passage
obstruction, a retro-colic Roux-en-Y loop of the jejunum
was created and it was anastomosed to the defect of the
duodenum. Side-to-side anastomosis with hand-sewn was
performed.
Result: Postoperative course was uneventful without
paralytic peristalsis or anastomotic leakage. Meal intake
after surgery was satisfactory.
Conclusion: Roux-en-Y double tract reconstruction after
the partial resection of the duodenum was feasible and
safe procedure.
P-505
PANCREATICOGASTROSTOMY AS
SAFE RECONSTRUCTION PROCEDURE
FOLLOWING PANCREATICO-
DUODENECTOMY (PD)
T. Hoshino, T. Ishida, A. Odaka and H. Daijo
Saiatama Medical University, Saitama Medical Center
Usefulness of pancreaticogastrostomy, as a safe recon-
struction procedure following PD, was evaluated.
Materials and methods: Sixty two patients underwent PD
followed by pancreaticogastrostomy reconstruction for
the past ﬁve years. After specimen has been retrieved, a
small silicon tube was placed inside the main pancreatic
duct of the remnant distal pancreas for complete extra-
corporeal drainage of the pancreatic juice. Then, a small
incision was made on the posterior wall of the stomach,
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through which the cut end of the remnant stomach was
inserted into the lumen of the stomach. One-layer pan-
creaticogastrostomy was, then, performed with 4-0 Vicryl
(interrupted suturing). Finally an omental patch was
placed immediately posterior to pancreaticogastrostomy,
to isolate this anastomosis from the area where impor-
tant vessels, such as common / proper hepatic arteries
and portal vein.
Results: This anastomotic procedure took 28 min in
average, and was associated with only few postoperative
complications including minor leakage of pancreatic juice
(13%) without intra-abdominal abscess or hemorrhage.
Deterioration of diabetes mellitus was observed in 14%
and 19% of the patients at two years and ﬁve years fol-
lowing surgery, respectively.
Conclusions: Pancreaticogastrostomy appears to be
technically feasible and could well provide a safe proce-
dure of reconstruction following PD, associated with
acceptable short term and long term results.
P-506
A NEW RECONSTRUCTIVE
PROCEDURE OF GASTRO-
JEJUNOSTOMY FOR PREVENTION
DELAYED GASTRIC EMPTYING
A. Bedzhanyan, N. Ratnikova, G. Shatveryan and
O. Skipenko
Russian Research Center of Surgery
Background: Gastroparesis or Delayed gastric emptying
(DGE) is one of the most often complications after
pancreatoduodenectomy (PD).
Aim: To reduce the frequency of delayed gastric empty-
ing by using original reconstruction methods after PD.
Methods: Sixty seven patients with periampullary cancer
and chronic pancreatitis underwent PD from 2005 to
September 2009. In I group (37 patients) the recon-
structive stage is executed with gastrojejunostomy by the
original technique – antecolic antiperistaltic with the
large curvature of a stomach (side to side). II group (40
patients) with consecutive PD with a standard technique
(the stomach end to jejunum side).For revealing of
advantages of a new technique of gastrojejunostomy in
early postoperative period, the following factors were
analysed: frequency of DGE, duration of the nasogastric
drain, frequency of an anastomosis leakage, complica-
tions rate, postoperative days, use in the preventive
purposes octreotide (0.1 mg every 8 hours, 4 days).
Results: Duration of nasogastric drain in the postoper-
ative period in the group I was 3.5 ± 2.9 days (1–14), in
the control group – 9.4 ± 5.1 days (4–30), P < 0,001.
DGE more than seven days observed at two (5.4%) and
16 (40%) patients accordingly in I and II groups
(p = 0,014). According to deﬁnition of DGE by ISGPS,
35 patients (94.6%) had DGE grade ‘A’, 2 patients
(5.4%) - grade ‘B’ and no patients at grade ‘C’ in I group
vs. 18 patients (45%) at grade ‘A’, 16 patients (40%) at
grade ‘B’ and 6 patients (15%) - grade ‘C’ in II group.
Frequency of anastomosis leakage also was higher in the
control group: 10 vs. 0 (P < 0,002). The total number of
patients with various complications in the control group
was 17 (42.5%), in the investigated group – 5 (13.5%),
(p = 0.014). Postoperative days in the II group was
27.5 ± 18 (7–103), in I group – 18.7 ± 15 (8–77),
(p = 0.002).
Conclusion: Our method of gastrojejunostomy signiﬁ-
cantly reduced the frequency of DGE in the early post-
operative period after PD and also reduced the frequency
of anastomosis leakage.
P-507
DISTAL PANCREATECTOMY THROUGH
SCALPEL AND HAND-SEWN
TECHNIQUE VERSUS USING STAPLER:
AN EXPERIMENTAL COMPARISON
M. Golriz, H. Fonouni, T. Gehrig, M. Esmaeilzadeh,
P. Jarahian, S. Abbasi, A. Majlesara, H. Kenngott,
W. Omri, B. Mu¨ller, C. Gutt, J. Schmidt, M. Bu¨chler and
A. Mehrabi
Department of General, Visceral and Transplantation
Surgery - University of Heidelberg
Background: In recent years, different surgical transec-
tion and closure methods have been used for distal
pancreatectomy, but none of them have achieved perfect
results in preventing the leakage from the resection plane
of the pancreas so far.
Aim: The current experimental animal study compared
the use of stapler with the standard scalpel and hand-
sewn closure technique.
Methods: Sixteen pigs underwent a spleen preserving
distal pancreatectomy. Eight animals were operated with
scalpel method following by hand suturing. Eight pigs
were operated using Endo GIA stapler. Animals were
sacriﬁced on 7th postoperative day and the transection
surface of remnant pancreas was observed for liquid
collection and abscess. A biopsy was taken from area of
transection for histopathological examination.
Results: All animals survived until 7th postoperative
day. There were no signiﬁcant differences regarding ﬂuid
collection, macroscopic and microscopic abscesses be-
tween the two methods. Operating time was found to be
signiﬁcantly shorter in stapler group.
Conclusion: In our present chronic experimental animal
study, stapler seems to be comparable with the standard
transection and closure techniques in distal pancreatec-
tomy in respect of ﬂuid collection, macroscopic and
microscopic abscess.
P-508
GROOVE PANCREATITIS: LONG TERM
FOLLOW-UP AFTER PYLORUS-
PRESERVING PANCREATO-
DUODENECTOMY (PPPD): A TWO CASE
REPORT
R. Isaacs1, E. Lobo1, A. Goldenberg1, T. Trivin˜o1,
F. Apodaca1, J. C. Ardengh1 and G. S. Menasche2
1Department of hepatobiliary and pancreas surgery,
Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil;
2Department of diagnostic imaging, Federal University of
Sa˜o Paulo, Sa˜o Paulo, Brazil
Background: Groove pancreatitis (GP), is a rare form of
segmental chronic pancreatitis that involves the anatomic
space between the pancreas head, duodenum and the
common bile duct (CBD). This term was ﬁrst used in
1973 by Becker.
Abstracts324
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Objective: The aim of our study is to demonstrate the
actual value of performing a PPPD as treatment in se-
lected cases of GP, based on long-term follow-up of two
patients.
Methods: A retrospective review of clinicopathologic
variables of two patients who underwent PPPD between
2003 and 2009 was performed.
Results: The two patients included in our study were
heavy drinkers and presented with abdominal pain,
vomiting, and weight loss caused by duodenal stenosis;
one of them also showed distal CBD stenosis signs. CT
imaging revealed duodenal wall thickening and enlarge-
ment of the head of the pancreas, with no retroperitoneal
collections. Endoscopic studies showed polypoid bulging
over 2nd portion of the duodenum and progressive nar-
rowing of it’s lumen. USE ﬁndings were heterogeneous
parenchyma in the whole pancreas in both cases, with a
mass containing small cysts in the pancreas groove in one
case and a hypodense mass surrounding the distal CBD
in the other. Biopsies collected on these areas showed
scarring of pancreas groove and active chronic inﬂam-
mation with no malignancy. GP was conﬁrmed after
surgery with Brunner’s gland hyperplasia, ectopic pan-
creatic tissue in the duodenal wall and chronic inﬂam-
mation of the pancreas groove area. Both patients refer
no abdominal pain and deny recurrence of gastric outlet
obstruction symptoms. They both gained weight, are
currently on their 6th and 2nd years of follow-up
respectively doing well.
Discussion: PPPD affords symptomatic relief, leads to
adequate weight gain and is the best way to deﬁnitely rule
out malignancy.
P-509
PREDICTORS OF SURVIVAL IN
PERIAMPULLARY CANCERS
FOLLOWING PANCREATICO-
DUODENECTOMY
A. Slepavicius and E. Desiukevicius
Klaipeda University Hospital
Background: Cancers of ampulla of Vater, duodenum,
distal common bile duct and pancreas are known to have
dismal prognoses. We sought to evaluate predictors of
survival for periampullary cancers following pancreati-
coduodenectomy to determine if these cancers have
similar biologic behavior.
Methods: We reviewed the records of all patients that
underwent pancreaticoduodenectomy for periampullary
carcinomas between 1996 and 2009. Demographics,
treatment, recurrence and outcome/survival data were
analyzed. Kaplan–Meier survival curves were created
and compared by log-rank analysis. Multivariate analysis
was undertaken using Cox proportional hazards.
Results: One hundred and sixty six consecutive periam-
pullary malignancies (105 pancreatic cancers, 29 ampul-
lary carcinomas, 28 extrahepatic cholangiocarcinomas
and 4 duodenal carcinomas) treated by pancreaticoduo-
denectomy were identiﬁed. Pancreatic cancer histology
correlated with shortest median survival (17.1 months)
followed by cholangiocarcinoma (17.9 months) and
ampullary carcinoma 44.3 months (P < 0.001). Predic-
tors of decreased survival by univariate analysis included
site of origin, stage of disease, positive resection margin,
nodal metastasis, tumor poor differentiation.
Conclusions: Although ampullary cancers have the best
prognosis overall, when controlled for tumor stage, only
the presence of positive margin and poor differentiation
predict poor survival following pancreaticoduodenecto-
my. Biologic behavior remains the most important
prognostic indicator in periampullary cancer amenable to
resection regardless of site of origin.
P-510
PANCREATIC AND LIVER RESECTION
FOR METASTATIC RENAL CELL
CARCINOMA: A SINGLE-CENTRE
SERIES
A. Rosich-Medina, S.-S. Liau, A. Jah, E. Huguet,
N. Jamieson, R. Praseedom, S. Mohamed and
R. Sivaprakasam
Addenbrooke’s Hospital, Cambridge, United Kingdom
Background: Renal cell carcinoma (RCC) commonly
metastasizes to pancreas and liver. Surgical resection is a
rational management strategy if the RCC metastases are
limited to pancreas or liver. However, the outcome fol-
lowing this is poorly understood.
Aim: To assess the surgical outcome following pancre-
atic or liver resection for metastatic RCC.
Methods: A ﬁve-year retrospective review of patients
who underwent pancreatic (n = 3) or liver (n = 6)
resection for RCC metastasis was performed at Adden-
brooke’s Hospital, Cambridge, United Kingdom.
Results: Pancreatic resection: the mean patient age was
63.7 (range: 61–66) years, (M:F:2:1). All patients had
unilateral nephrectomy (left, n = 2, right, n = 1) for
RCC. The interval between nephrectomy and diagnosis
of pancreatic metastasis was 8, 10 and 21 years
(mean = 13 years). There was no postoperative pancre-
atic leak. Two patients are well on follow-up (up to
30 months) with no tumour recurrence. One patient died
four months postoperatively with a cerebellar mass le-
sion. Liver resection: the mean patient age was 56.3
(range: 35–77) years (M=F). All patients had unilateral
nephrectomy (left, n = 1, right, n = 5) for RCC. Four
patients had combined nephrectomy and hemihepatec-
tomy, the other two had an interval of 3 and 5 years
between the procedures respectively. One patient devel-
oped lung metastasis and died 19 months after the
hemihepatectomy and one developed bone metastasis
and died 8 months postoperatively. Four patients are
well on follow-up. All cases were proven metastatic RCC
on histopathology.
Conclusion: Pancreatic or liver resection is a safe man-
agement strategy for RCC metastases. Prospectively
controlled studies will be needed to justify this mode of
management.
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P-511
EVALUATION OF COMPLICATIONS
AFTER PANCREATICO-
DUODENECTOMY IN OUR
INSTITUTION ~ 43-YEAR EXPERIENCE
IN 531 PATIENTS ~
H. Ishikawa, H. Kinoshita, G. Akasu, D. Eto,
M. Yoshitomi, K. Mikagi, R. Kawahara, T. Hisaka,
M. Yasunaga, H. Horiuchi and K. Shirouzu
Kurume University School of Medicine
Background: The aim of study was to evaluate the results
of pancreaticojejunostomy (PJ) in our institution.
Patients: A total of 531 consecutive patients who
underwent pancreaticoduodenectomy (PD) for various
diagnosis between 1965 and 2008.
Operative Techniques: Pancreas is sharply transected
with a scalpel. The remnant pancreatic stump is coagu-
lated by the VIO soft coagulation system. PJ is under-
taken with an end-to-side anastomosis. PJ is performed
as a single suture between the pancreas and jejunal serosa
using an four-interrupted 4-0 Prolene. A mucosal anas-
tomosis is performed between the pancreatic duct and all
layers of jejunum using eight-interrupted 5-0 PDS II. The
omental ﬂap is set around the hepatic artery to prevent
major vascular complications related to pancreaticojej-
unal anastomotic leakage (AL).
Results: ISGPF grade B/C was identiﬁed in 8.7% (46/
531). Soft pancreatic parenchyma and small pancreatic
duct were risk factors of AL (P < 0.05). Intra-abdomi-
nal hemorrhage (AH) occurred in 2.4% (13/531). The
bleeding source was GDA (45%), stump of pancreas
(23%), SMV (8%), MCA (8%) and PHA (8%). All cases
of AH were treated with TAE were controlled the
bleeding and liver dysfunction was not present. The use
of omental ﬂaps was decreased major vascular compli-
cations (P < 0.05).
Conclusion: The operative mortality rate after PD has
signiﬁcantly declined due to the progression of surgical
techniques and interventional treatments. Pancreatic
duct-to all layers of jejunal anastomosis was acceptable
to prevent the AL. The omental ﬂaps is useful for
decreasing the risk of major vascular complications re-
lated to pancreaticojejunal anastomotic leakage follow-
ing PD.
P-512
AN ALTERNATIVE PANCREATIC
ANASTOMOSIS FOLLOWING
PANCREATICODUODENECTOMY
G. Bitsakou, A. E. Frampton and L. R. Jiao
Division of Surgery, HPB Surgery Unit, Hammersmith
Hospital, Imperial College, London, UK
Background: Pancreatic reconstruction following pan-
creaticoduodenectomy (PD) is performed with either a
pancreatico-jejunostomy (PJ) or a pancreatico-gastros-
tomy (PG). However this is not always feasible.
Aims: An alternative method for pancreatic duct anas-
tomosis following PD is described here for cases where
mobilisation of the pancreatic stump is impossible be-
cause of either an inadequate length of pancreatic rem-
nant or ﬁxation of the stump to the surrounding
vasculature or tissues.
Methods: Three patients underwent PD for cancer at the
head of pancreas with a dilated pancreatic duct (8 to
10 mm). After PD, it was evident that the pancreatic
stump could not be mobilised enough to form either a PJ
or PG, because of complete ﬁxation of the stump to the
splenic vessels (n = 1) and inadequate length of the
pancreatic remnant (n = 2) following resection. After
laying open the pancreatic duct along the resection
margin, a longitudinal pancreaticojejunostomy (LPJ)
with a Roux en Y loop was performed with PDS 3/0
sutures to reconstruct the pancreatic drainage.
Results: The anastomosis was much easier to perform
compared with either PJ or PG, taking on average less
than 10 mins. Postoperatively, all patients had an
uneventful recovery with normal pancreatic endocrine
and exocrine functions.
Conclusion: LPJ is an alternative method for pancreatic
duct reconstruction after PD in patients with a dilated
duct. It is quicker and easier to perform than a PJ or PG
anastomosis.
P-513
USEFULNESS OF INDICATING THE
VALUE OF THE AMYLASE IN THE
DRAIN AFTER OPERATIONS OF THE
PANCREAS
M. Musiewicz1, P. Lampe1, S. Mrowiec1, J. Ciosek1,
A. Badora2, R. Goyszny2 and P. Bdkowska2
1Department of Gastrointestinal Surgery, Medical
University of Silesia; 2Medical University of Silesia
Introduction: Early recognizing of patients with compli-
cations is determining the course and the success of
surgical treatment. Relation between abdominal compli-
cations after operations of the pancreas and a value of
the amylase in the drains is still unclear.
Materials and methods: Sixty patients who had under-
gone a surgery due to pancreatic cancer were included in
the study. The group consisted 31 men and 29 women
with the average age of 60 (23–79) Amylase value in
drains and lipase/amylase value in the serum were tested
tree times in the ﬁrst days (24-hour periods) after the
operation. The analysis was based on the U Mann–
Whitney test. A level of statistical signiﬁcance was as-
sumed: p (a) < 0.05.
Results: Within the study group there have been 39
pancreaticoduodenectomies, 4 distal resections and 2
middle segment resection, 1 extended pancreaticoduo-
denectomies, 3 local excision of tumor, 1 total pancrea-
tectomy, 6 bypass anastomosis. Abdominal
complications [abscess and peripancreatic ﬂuid collec-
tions 18.3%, anastomosis leak 10%, 6.6% acute pan-
creatitis, 1.6% bleeding (haemorrhage)] developed in 22
patients (36.6%). Included in these were four early deaths
(6.6%).Patients without complications had a median
value of amylase in drains of 34 U/L, 60 U/L in the
serum and their medium value of lipase in the serum was
21 U/L. Patients with complications had a medium
797.5 U/L amylase value in the drains (171.5 U/L in the
serum, and their medium value of lipase in the serum was
81.5 U/L. There was a statistical signiﬁcance between
postoperative complications and a high value of amylase
in the drains (p = 0.0008) as well as amylase and lipase
in the blood serums (p = 0.015, p = 0.0158).
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Conclusion: Amylase value in the drains in the early
postoperative period after pancreatic surgery may be a
predicting factor of an increased risk of postoperative
complications.
P-514
OUTCOME FOLLOWING WHIPPLE’S
PANCREATODUODENECTOMY IN
ELDERLY: CAMBRIDGE EXPERIENCE
R. Sivaprakasam, S. Mohamed, S. Liau, E. J. Huguet,
N. V. Jamieson, R. K. Praseedom and A. Jah
Department of Surgery, Box-210, Addenbrooke’s Hospital
Background: Whipple’s procedure is a recognised surgi-
cal treatment for pancreatic malignancies and the out-
come following whipple’s procedure has signiﬁcantly
improved in the last decade. The safety and feasibility of
whipple’s procedure in elderly still remains a debate and
evidence in the literature is limited.
Aim: To assess the safety of whipple’s procedure in el-
derly, we reviewed our experience and analysed the
operative morbidity and medium term outcome.
Methods: The study was performed in the last ﬁve years
and all the patients above the age of 75 years were in-
cluded in this study. The data was collected prospectively
and the data collected were; demographics, co-morbidi-
ties, pancreatic leak, hospital stay and survival at
30 days, 1 and 3 years. The outcomes for Patients aged
over 80 years was compared with those under 80 years.
Results: A total of 58 patients with a median age of
77 years were included in this study. The mean tumour
size was 22.93 mm and 24.1% had R1 resection. The
mean hospital stay was 23.3 days and incidence of pan-
creatic leak of 16.2%. Survival at 30 days, one and three
years were 100%, 80% and 65%. 10/58 patients were
above 80 years of age and when compared with patients
under 80 years, no signiﬁcant difference were observed in
the post-operative morbidity and outcome.
Conclusion: Our experience demonstrates that the whip-
ple’s procedure is feasible and safe in elderly. Therefore
age alone should not be a deterrent in offering whipple’s
procedure as a treatment option in the management of
pancreatic tumours.
P-515
NON-STENTED PANCREATICO-
GASTROSTOMY AFTER
PANCREATICODUODENECTOMY
M. Ishikawa, T. Furukawa, Y. Matsuoka, A. Kihara,
M. Tanaka, Y. Hamada, T. Minato, Y. Yuasa,
T. Ichimori, S. Kimura and A. Sakata
Tokushima Red Cross Hospital
Background: Pancreatic leakage and delayed gastric
emptying are some of the common causes of morbidity
after pancreaticoduodenectomy (PD). The purpose of
this study was to present the early and late results of
pancreaticogastrostomy (PG) after PD.
Methodology: We performed PG following PD in 51
consecutive patients. All pancreatic anastomoses were
performed in one layer between the pancreatic remnant
and the posterior gastric wall without using pancreatic
duct stents. The main modiﬁcation in our technique was
an antecolic reconstruction and setting by the Billroth I
method. We assessed the surgical risks, including pan-
creatic leakage, morbidity, and mortality, and clinical
and radiological parameters associated with this tech-
nique.
Results: Operative time and blood loss were 405 ±
110 min and 740 ± 220 mL, respectively. Postoperative
morbidity was 23% and mortality was zero. Pancreatic
leakage was observed in 5 (10%) patients. No signiﬁcant
postoperative differences were observed with regard to
the diameter of the main pancreatic duct, depth of pan-
creatic parenchyma, and status of diabetes mellitus.
Conclusions: Our technique is simple and appears to be
an effective reconstructive procedure, especially for
patients with a soft, non ﬁbrotic pancreas.
P-516
PANCREATIC TEXTURE IS THE MOST
IMPORTANT PREDICTOR OF
POSTOPERATIVE PANCREATIC
FISTULA RATE AFTER
PANCREATODUODENECTOMY
T. Keck, U. Wellner, F. Makowiec and U. Hopt
Department of General and Visceral Surgery, University of
Freiburg, Germany
Background: Postoperative pancreatic ﬁstula (POPF) is
the most important complication after pancreatoduo-
denectomy. Aim of this study was to prospectively eval-
uate the accuracy of subjective judgement of pancreatic
texture and durability in comparison of objective histo-
logic parameters of ﬁbrosis and the risk of postoperative
pancreatic ﬁstula.
Materials and methods: For 62 patients with pancreatic
head resection between 2006 and 2008, all required
parameters were prospectively evaluated. In particular,
pancreatic texture was subjectively graded by the expe-
rienced pancreatic surgeon to be ‘hard’ or ‘soft’. Inde-
pendent histological evaluation for ﬁbrosis was
performed by pathologist. POPF was deﬁned according
to the ISGPS deﬁnition. For statistical analysis, Spear-
man rank correlation and binary logistic regression of
SPSS Version 15.0 were used.
Results: In univariate analysis, history of acute pancre-
atitis or weight loss, hard pancreatic texture, large pan-
creatic duct diameter on the cut surface and involvement
of the uncinate process as well as histopathologic diag-
nosis of pancreatic carcinoma or chronic pancreatitis
correlated with reduced POPF rate. Multivariate analysis
showed hard pancreatic texture (OR 0.12, p = 0.02) and
history of weight loss (OR 0.84 per kg; p = 0.04) to be
the only independent factors inﬂuencing POPF rate.
Subjective judgement of the surgeon paralleled objective
histologic evaluation of pancreatic texture.
Conclusion: Pancreatic texture, as subjectively evaluated
by the experienced surgeon, is the strongest and most
easily evaluated factor inﬂuencing POPF rate. Clinical
studies on POPF should stratify patients according to
pancreatic texture. Anastomotic techniques may then be
chosen depending on pancreatic texture.
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P-517
EFFICIENCY OF EUS-GUIDED
SIMULTANEOUS INTERNAL AND
EXTERNAL DRAINAGE FOR
PANCREATIC PSEUDOCYST
T. Sanuki, S. Yoshida, M. Sugimoto, H. Kutsumi and
T. Azuma
Department of Gastroenterology, Kobe University School
of Medicine
Background/Aim: Endoscopic ultrasonography (EUS)-
guided pancreatic pseudocyst (PP) drainage has become
standard and safe procedure in many institutes, but the
indication of internal or external drainage is still con-
troversial. The aim of this retrospective study is to clarify
the efﬁciency of these procedures.
Method: We performed EUS-guided PP drainage for 24
patients during three years, seven (three infectious and
four sterile) cases were treated by internal single drainage
(SD) only using a 7Fr bilateral pigtail catheter, 17 (13
infectious and 4 sterile) cases by double drainage (DD)
using both a 7Fr bilateral pigtail catheter and a 7.5Fr
catheter transnasaly.
Result: Successful drainage was accomplished in 24/24
cases (100%). We irrigated PP daily via naso-cystic tube
using saline until abscess disappeared. We removed naso-
cystic drainage between 7 to 21 days after procedure.
Additional drainage for uncontrollable PP were required
in total 11 patients (46%); SD for sterile PP 1/4 (25%), or
infectious PP 3/3 (100%), DD for sterile PP 0/4 (0%), or
infectious PP 7/13 (54%). Extinction or reduction of PP
was observed in 22 patients (92%) during follow-up
(mean 228 days). Surgical drainage was required in only
a patient for uncontrollable abscess. A patient was dead
by renal failure. The procedure related complication was
not occurred.
Conclusion: External drainage was effective in prompt
irrigation for infected PP. We suggested that infectious
PP should be treated in not only internal but also
external drainage simultaneously.
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MANAGEMENT OF PANCREATIC
FISTULA AFTER PANCREATICO-
DUODENECTOMY
J. R. G. Santhanam, V. Velayutham, S. Sivanpillay
Mahadevan, J. Damodaran, J. Sathyanesan,
R. Palaniappan, K. Devigounder and S. Rajagopal
Government Stanley Medical College Hospital, Chennai,
India
Introduction and objective: Pancreatic anastomotic leak
and pancreatic ﬁstula (PF) are the major complications
after pancreaticoduodenectomy (PD). The management
of PF ranges from wide drainage to completion Pancre-
atectomy. We aim to analyze the incidence and outcome
of management of Pancreatic Fistula in our patients who
underwent pancreaticoduodenectomy.
Methods: From January 2005 to December 2008, 198
patients underwent PD. Standard pancreaticoduodenec-
tomy – 185, Pylorus Preserving Pancreatoduodenectomy
– 13. The indications were malignancy of lower CBD in
18, ampulla in 121, Head of the pancreas - 42, duodenum
10 and chronic pancreatitis 6, cystic tumor of the pan-
creas in 1 patient. Reconstruction was by Pancreatoga-
strostomy in 182, and PJ in 16 patients respectively.
Standard lymph node dissection was done in all cases of
malignancy.
Results: Twelve patients developed PF. They were type
A – 9, B – 1, C- 2. Nine patients responded to conser-
vative management. One patient required USG guided
drainage of the collection, and two patients underwent
surgery. The indication for surgery was hemorrhage on
day 5 and day 6 respectively. One patient underwent
ligation of the bleeding vessel and wide drainage. An-
other patient underwent dismantling of the PG anasto-
mosis, external tube pancreastomy, and venting
gastrostomy. Persistent drainage was present in two pa-
tients but responded to conservative management.
Conclusion: Centralization of pancreatic surgery in ter-
tiary care centers has resulted in the lower incidence of
pancreatic ﬁstula and improved outcome of manage-
ment. Improved technical expertise reduces the incidence
of pancreatic ﬁstula. Early recognition of leak and
management of hemorrhagic complications, post opera-
tive enteral feeding and parenteral supplementation and
intensive surgical post operative care has led to the im-
proved outcome.
P-519
RESULTS OF STANDARD AND
EXTENDED PANCREATICO-
DUODENECTOMIES FOR PANCREATIC
DUCTAL ADENOCARCINOMA
V. Egorov, O. Melekhina, V. Vishnevsky and
T. Shevchenko
The Vishnevsky Institute of Surgery, Moscow
Background: Inadequate results of the standard surgical
treatment of pancreatic ductal adenocarcinoma (PDA)
make the further study of extended procedures reason-
able.
Aim: Assessment of short-, and long-term results after
standard (SPD) and extended (EPD) pancreaticoduo-
denectomies.
Methods: A prospective nonrandomized trial of 30
standard (SPD) and 30 extended (EPD) consecutive
pancreaticoduodenectomies for PDA performed from
2004 to 2008.
Results: There were 20 radical and 10 extended radical
operations among EPD, one vessel resection in SPD
(1.6%) and 9 (30%) in the EPD group. The mean num-
ber of excised lymph nodes was signiﬁcantly higher for
EPD (28 vs. 14 for SPD) (P < 0.01). Comparison of
mortality (6.6% for both groups), the mean operating
time (5.05 for SPD vs. 6.4 for EPD), general morbidity
(59% vs. 52%), reoperation rate (8.3% vs. 13.3%), blood
loss (7.1 vs. 8.3 dL) and R0-resection rate (66.6% vs.
83.3%) have shown a signiﬁcant difference in the oper-
ating time and R0-resection rate. the main complications
of SPD were pancreatic ﬁstula (18.3% vs. 3.3% for EPD)
and bile leakage (11.6% vs. 4%). Thirty percent of EPD
were followed by diarrhea and lymphorrhea. The three-
and 5-year overall survival rate (OSR) after SPD was 0,
and 17% and 17% for EPD with median survival (MS)
of 10 and 12 months. For tumors from 2 to 4 cm MS was
10 months after SPD and 19 after EPD (p = 0.01), and
for stage 2b the MS was 9 months after SPD and 16.5 for
EPD. Local recurrence was determined in 59% of cases
after SPD and in 15% after EPD (p = 0.006). Tumor
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stage of 9 (30%) patients after EPD was changed from II
to IV owing to the involvement of para-aortic lymph
nodes.
Conclusion: EPD are technically and time-demanding
procedures, but they are as safe as standard ones. EPD
increases rates of R0-resections and OS and signiﬁcantly
decreases the local recurrence rate. Longer OSR for stage
2b after EPD can be explained both by the effectiveness
of EPD and by inadequate staging after SPD.
P-520
WHICH SHOULD WE SELECT FOR
DUCT-TO-MUCOSA PANCREATICO-
JEJUNOSTOMY WITH A STENT TUBE
OR WITHOUT A STENT TUBE AFTER
PANCREATICODUODENECTOMY?
Y. Toyoki, K. Ishido, D. Kudoh, T. Miura, S. Tutsumi,
S. Narumi, S. Yoshihara and K. Hakamada
Department of Gastroenterologica Surgery, Hirosaki
University Graduate School of Medicine
Introduction: Pancreatic ﬁstula is common complications
and serious problems after pancreaticoduodenectomy,
despite recent advances in operative techniques and
postoperative care. It is controversial that pancreat-
icojejunostomy with a stent reduce pancreatic ﬁstula rate.
We compared the results of pancreaticoduodenectomy
with a stent vs. no stent for duct-to-mucosa pancreat-
icojejunal anastomosis retrospectively.
Patients: Among 139 consecutive patients undergoing a
pancreaticoduodenectomy from January 2005 to May
2009, 65 patients were treared with a duct-to-mucosa
pancreaticojejunal anastomosis. We compared the com-
plications of pancreaticojejunostomy, postoperative
hospital stay and postoperative pancreatic exocrine
function between 10 patients with a stent tube and 55
patients without a stent tube retrospectively.
Results: There were no signiﬁcant differences between
both group about pancreatic ﬁstula, postoperative hos-
pital stay and postoperative pancreatic exocrine function.
Also we compared the complications of pancreaticojej-
unostomy in soft pancreas cases, there were no signiﬁcant
differences between both groups.
Conclusion: We could not ﬁnd the advantage of stenting
tube for duct-to-mucosa pancreaticojejunostomy.
P-521
GASTRO-JEJUNOSTOMIES
PERFORMED WITH A SHAPE MEMORY
ALLOY CLIP DEVICE: A GREAT
PROMISE
K. Papapolychroniadis, D. Paramythiotis,
D. Panagiotou, A. Ioannidis, I. Palios, D. Kouﬁdis,
A. Kourtinos and E. Fahantidis
1st Propedeutic Surgical Department, Aristotle University
of Thessaloniki, A.H.E.P.A. Hospital Thessaloniki,
Greece
Background: The present study describes anastomosis
with a Shape Memory Alloy Clip (SMAC), which has
been selected as a device for upper gastrointestinal tract
anastomosis. Preliminary reports have been published on
both animal and humans patients as well as our previous
successful experience with colonic clip anastomosis on a
group of 12 patients.
Patient and method: Our material was classiﬁed in two
groups of 12 patients in each one, study and control
group. We performed totally 30 anastomosis, 15 by clip
and 15 by stapler technique in a series of 24 patients. The
main disease of this patient series was malignancy (gastric
cancer 12 patients and pancreatic cancer 12 patients). In
gastric cancer group were performed 12 gastro-jejunos-
tomies and three additional jejuno-jejunostomies to
avoid gastric reﬂux. To perform a SMAC anastomosis
between gastric reservoir and jejunal loop these were
positioned parallel by two stitches. Two small incision of
5–6 mm were made closely to each one edge, through
which by applicator device the clips were introduced in an
open position ﬁrstly and then closed strictly by pressing of
the applicator for 20 seconds thereby clamping the two
gastrointestinal segments together. After this step and
incorporated scalpel to applicator device produce a small
incision between gastric and bowel walls. Following that
the clips are delivered in anastomotic edges and the
applicator is removed. The two small incisions of 5–6 mm
are sutured and checked for leakage.
Results: The clips are delivered by faeces the ﬁrst 10 days
postoperatively. There was no one complications like as
leakage, anastomosis obstruction, clip removal or small
bowel obstruction. It is important to refer that it is not
consuming time anastomosis.
Conclusion: Upper gastrointestinal anastomosis with
SMAC device offers a safe, simple and sort operative
time.
P-522
SPLEEN-PRESERVING DISTAL
PANCREATECTOMY WITH
CONSERVATION OF THE SPLENIC
ARTERY AND VEIN
K. Tezuka, W. Kimura, I. Hirai, M. Mizutani,
T. Moriya, A. Takeshita and T. Sato
First Department of Surgery, Yamagata University School
of Medicine, Yamagata, Japan
We have been performed spleen-preserving distal pan-
createctomy (SPDP) as a function preserving surgery.
Sixteen cases of SPDP were enrolled for this study. Our
technique of SPDP preserves both splenic vein and artery
to avoid infarction of the spleen. After opening bursa
omentalis, incise the Toldt’s fascia. Branches of the
splenic vein were ligated and cut toward spleen. Next,
branches of the splenic artery were divided. Parenchyma
of the pancreas is sharply cut, and stump of the pancreas
is sutured like ﬁsh mouth. We had never experienced
postoperative bleeding due to pancreas ﬁstula. Torsion of
the spleen is not occur, even patient walk 1 postoperative
day. We consider indication of SPDP as benign lesion of
the pancreas including intraductal papillary mucinous
adenoma (IPMA).
Results: Operative time was longer than ordinal distal
pancreatectomy (DP) 367 vs. 288 min (P < 0.05). Blood
lost, rate of pancreas ﬁstula, hospital days, preoperative
platelet counts were similar between SPDP and DP
groups. On the contrary, postoperative platelet counts
are signiﬁcantly lower in SPDP group (39.5) than DP
(58.9). And postoperative hemoglobin after one month
are signiﬁcantly higher in SPDP (11.9 ± 1.25) than DP
(11.4 ± 0.7).
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Conclusion: In conclusion, SPDP considered clinically
important for preventing postoperative pulmonary or
cerebral infarction and improving postoperative hemo-
globin after one month. SPDP is useful and safety sur-
gical procedure for benign pancreas neoplasms.
P-523
PANCREATIC DUCT PATENCY AFTER
PANCREATICODUODENECTOMY FOR
DILATED PANCREATIC
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1 and S. Amano2
1Social Insurance Yokohama Central Hospital/Surgery;
2Nihon University School of Medicine/Surgery
Background/Aims: It is important to prevent pancreatic
leakage and maintain pancreatic duct patency after
pancreaticoduodenectomy (PD). We used an implanta-
tion method and a pancreatic stent in pancreaticoga-
strostomy (PG) and achieved good results without
pancreatic leakage; however, PG strictures were observed
in some cases. Using a pancreatic stent, we evaluated the
early postoperative changes in the remnant pancreatic
duct diameter in patients with a mildly dilated pancreatic
duct.
Methodology: We retrospectively analyzed 46 patients
with a mildly dilated pancreatic duct (diameter, 4–7 mm)
who underwent PD with PG. They were divided into two
groups on the basis of the surgical treatment they re-
ceived for pancreatic stump: Group C including patients
who underwent complete ligation of the pancreatic duct
with a pancreatic stent (complete external drainage of the
pancreatic juice), and Group I including patients who
underwent pancreatic duct-to-mucosa anastomosis with
a pancreatic stent (incomplete external drainage of the
pancreatic juice).
Results: The postoperative mean diameter of the rem-
nant pancreatic duct was signiﬁcantly smaller in Group I
(6.22 ± 0.81 mm) than in Group C (6.80 ± 1.10 mm)
(P < 0.0466).
Conclusion: To prevent pancreatic leakage and maintain
pancreatic duct patency, duct-to-mucosa anastomosis
with a pancreatic stent is useful for patients with a dilated
pancreatic duct.
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GROOVE PANCREATITIS: REVIEW OF
23 CONSECUTIVE CASES AT A SINGLE
INSTITUTION
R. Garcı´a-Roca1, J. Samame1, O. Sendino2,
G. Ferna´ndez2, A. Gine´s2, J. Bombi3, J. R. Ayuso4,
J. Ferrer5, J. C. Garcı´a-Valdecasas5 and L. Ferna´ndez-
Cruz6
1Hepatobiliopancreatic Surgery and Transplant, Hospital
Clinic Barcelona; 2Gastroenterology, Hospital Clinic
Barcelona; 3Pathology, Hospital Clinic Barcelona;
4Radiology, Hospital Clinic Barcelona; 5Hepatobiliary
Surgery and Transplant, Hospital Clinic Barcelona;
6Biliopancreatic Surgery and Transplant, Hospital Clinic
Barcelona
Background: Goove Pancretitis (GP) refers to a form of
chronic pancreatitis localized between the duodenum and
head of the pancreas. Differential diagnosis from neo-
plastic disease or other forms of chronic pancreatitis can
be difﬁcult to establish. We retrospectively analyze the
clinical presentation, diagnostic tools and treatment op-
tions.
Method: The Pathology and the Endoscopic Ultrasound
(EUS) databases were analyzed, extracting patients co-
ded with: cystic dystrophy in heterotopic pancreas, ec-
topic pancreas, focal pancreatitis and duodenal wall cyst
or thickening. From the initial patient list, we obtained
23 with conﬁrmed diagnosis of GP. Demographic data,
medical and surgical history, diagnostic studies obtained,
preoperative and ﬁnal pathological diagnosis were col-
lected retrospectively.
Results: From January-01 to June-09, 23 patients were
diagnosed with GP, 17 males and 6 females; the median
age was 48 years (range 22–73). Over 50% had at least
one episode of acute pancreatitis. Similarly, 50% had
history of alcohol abuse and chronic pancreatitis. The
most common presenting symptom was abdominal pain
(74%) followed by weight loss and jaundice. The median
time from initial presentation to treatment was
10 months (range 2–36), shorter times in those with
cancer suspicion. Abdominal CT was obtained in 16, but
only 10 described diagnostic features of GP. MRI was
performed in just six cases, four were diagnostic. All
patients underwent EUS, 16 had GP ﬁndings and in 5
patients was the only diagnostic tool. Surgical resection
was required in 18 patients, with a preoperative diagnosis
of GP on 8 patients and 8 for suspicion of cancer. The
ﬁnal pathology included cystic dystrophy of the duode-
num (11) and ectopic pancreas (8). Adenocarcinoma was
also found in one case.
Conclusions: Diagnosis of GP can become difﬁcult, high
index of suspicion must be raised in younger patients
with repeated episodes of focal pancreatitis, the best
diagnostic tool is EUS and conﬁrmation can only be
made by pathology.
P-525
FUNCTIONAL PROTEIN C LEVELS
EARLY IN THE DISEASE COURSE OF
ACUTE PANCREATITIS
B. Idicula Babu and A. K. Siriwardena
Hepatobiliary Surgery Unit, Manchester Royal Inﬁrmary,
Manchester, UK
Introduction: Protein C modulates the microvascular
thrombosis of sepsis with levels being depleted in severe
cases. Similar changes occur in necrotising acute pan-
creatitis (AP). Treatment of sepsis with recombinant
human activated protein C (Xigris, Eli Lily, USA) ame-
liorates some of the adverse affects and reduces mortal-
ity. Xigris may therefore also be worthy of evaluation in
severe acute pancreatitis. However, as very little is known
of the pathophysiology of endogenous protein C in hu-
man AP this study undertakes an evaluation of protein C
levels in AP.
Methods: In a consecutive series of 57 patients with AP
the chromogenic substrate method was used for deter-
mination of functional Protein C levels in plasma. Pro-
tein C activity was assessed at admission, 24 and
48 hours. The laboratory reference range for functional
Protein C level was 69-154 units/deciliter. Variables re-
quired for calculation of APACHE II scores were col-
lected on admission, at 24 and 48 hours. The severity of
the disease was based on the 1992 Atlanta Classiﬁcation.
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Data were entered prospectively into an electronic data-
base and analysed at completion of recruitment. The
study was approved by regional ethics committee.
Results: The median (range) age was 41 (18–88) with 29
women. 25 (44%) had gallstone related AP. Median
(range) Protein C levels and APACHE II Score on
admission were 97.5 (41–178) and 4 (0–12) respectively.
The median (range) of functional Protein C levels with
mild AP was 104 (70–180) and for severe AP was 93 (41–
169). (Kendall’s correlation coefﬁcient = - 0.12).
Conclusions: In human AP, functional protein C levels
are conserved in mild disease. However, there is evidence
that levels are depleted early in severe disease suggesting
a parallel between the pathobiology of severe sepsis and
severe AP. Further study, with larger patient numbers is
required to evaluate these ﬁndings.
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CLASSIFICATION OF THE SEVERITY OF
ACUTE PANCREATITIS: AN ARGUMENT
FOR A ‘CRITICAL’ CATEGORY
M. Petrov, S. Shanbhag, M. Chakraborty and
J. Windsor
Department of Surgery, The University of Auckland
Background: The Atlanta classiﬁcation of acute pancre-
atitis (1992) deﬁned ‘mild’ and ‘severe’ categories of acute
pancreatitis. However, its limitations have been high-
lighted in a number of publications over the last years
and a call for its revision has been made. A classiﬁcation
of the severity of acute pancreatitis comprising four
categories (‘mild’, ‘moderate’, ‘severe’, and ‘critical’) has
been proposed (1).
Aim: To investigate whether the presence of both organ
failure and infected pancreatic necrosis identiﬁes a sub-
group of patients with ‘critical’ course of acute pancre-
atitis.
Methods: A systematic review of three electronic data-
bases (MEDLINE, EMBASE and Scopus) was done.
The summary estimates of the effect associated with the
infection status of pancreatic necrosis were calculated
using the Mantel-Haenszel model and presented as risk
ratio and 95% conﬁdence interval.
Results: There were a total of 474 patients with organ
failure from 14 studies, comprising 213 (45%) patients
with infected pancreatic necrosis [of whom 92 (43%)
died] and 261 (55%) patients with sterile pancreatic
necrosis [of whom 57 (22%) died]. The presence of in-
fected pancreatic necrosis was associated with a signiﬁ-
cantly increased risk of mortality in patients with organ
failure (risk ratio 1.84, 95% conﬁdence interval 1.40 to
2.41, P < 0.0001). There was no signiﬁcant heterogene-
ity between the studies (I2 = 0%; P = 0.50).
Conclusion: The presence of infected pancreatic necrosis
is associated with more than 80% increase in the risk of
death in those patients with acute pancreatitis who
developed organ failure. This ﬁnding argues for a new
category of patients with acute pancreatitis - those with
‘critical’ acute pancreatitis.
Reference:
1. Petrov MS, Windsor JA. Classiﬁcation of the severity
of acute pancreatitis: How many categories make sense?
Am J Gastroenterol 2009, Oct 20 (E pub ahead of
print).
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LAPAROSCOPIC NECROSECTOMY IN
ACUTE PANCREATITIS
A. Donoso1, R. Funke1, J. C. Patillo2, C. Boza1,
F. Crovari1, G. Perez1, F. Pimentel1, L. Ibanez1,
S. Guzman1, N. Jarufe1 and A. Esalona1
1Departamento de Cirugı´a Digestiva, Facultad de
Medicina, Pontiﬁcia Universidad Cato´lica de Chile;
2Departamento de Cirugı´a, Seccio´n Cirugı´a Pedia´trica,
Facultad de Medicina, Pontiﬁcia Universidad Cato´lica
de Chile
Background: Acute pancreatitis with infected necrosis
has an elevated morbidity and mortality. Most of the
time the treatment involves surgery, nevertheless it is
associated with an elevated morbidity. Minimally inva-
sive surgery has allowed to incorporate laparoscopic
techniques to the treatment of this disease.
Aim(s)/Objective(s): To show laparoscopic necrosectomy
and abscess drainage experience in severe acute pancre-
atitis.
Methods: We reviewed the medical history of all patients
in which a laparoscopic necrosectomy and/or abscess
drainage was performed. We detailed demographic data,
acute pancreatitis etiology, images, surgery details,
complications, reinterventions and late evolution.
Results: The series was composed of eleven patients, all
of them with severe acute pancreatitis. Patients were
operated between April 2006 and June 2009. The average
OR time was 138 min (110–205 min). In all cases a sat-
isfactory laparoscopic necrosectomy and abscess drain-
age was performed. There were no complications derived
from the laparoscopic technique and no open surgery
conversion was needed during the ﬁrst surgery. In four
cases a second procedure was required to complete the
necrosectomy and abscess drainage. Only in one of them
conversion to an open procedure was needed to achieve a
satisfactory drainage. There was no mortality in our
series.
Conclusion: Laparoscopic necrosectomy is an available
and valid alternative in our center, with comparable re-
sults to open surgery, and with satisfactory morbidity
and mortality.
P-528
THE LAPAROSCOPIC APPROACHES TO
DRAINAGE OF PANCREATIC
PSEUDOCYSTS: HORSES FOR COURSS
N. Hamza1,2,3 and B. J. Ammori1,2,3
1Department of Hepato-Pancreato-Biliary Surgery, North
Manchester General Hospital, UK; 2Department of
Hepato-Pancreato-Biliary Surgery, Manchester Royal
Inﬁrmary, UK; 3Department of Surgery, Salford Royal
Hospital, UK
Background: Pancreatic pseudocysts (PP) are tradition-
ally managed by laparotomy. Our experience with the
laparoscopic approach for all comers with PP requiring
surgical drainage is presented.
Aim: This paper describes our tailored and methodo-
logical approach to laparoscopic drainage of PP based on
an anatomical classiﬁcation.
Methods: We adopted the laparoscopic approach in ‘all
comers’ who had PP requiring surgical drainage. The
recipient organ for drainage (e.g. cystogastrostomy,
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cystojejunastomy or cystoduodenostomy) and method of
access (e.g. transgastric, endogastric, exogastric or lesser
sac, and infra-colic) were decided based on preoperative
computed tomography (CT) and intraoperative ﬁndings.
The results shown represent median (range).
Results: Between 2001 and 2009, 34 laparoscopic drain-
age procedures for PP were performed in 32 consecutive
patients. The surgical approach included transgastric
(n = 20) or endogastric (n = 3) cystgastrostomy for
large retrogastric PP (n = 23), exogastric cystogastros-
tomy for small perigastric PP (n = 4), cystoduodenosto-
my (n = 2) under ultrasound guidance, cystojejunastomy
for infracolic PP (n = 4), and one external drainage. The
operative time was 115 (25–300) mins. There was one
conversion to laparotomy (2.9%), low morbidity (2.9%)
and no mortality. The postoperative hospital stay was 2
(1–7) days. At a follow-up of 15 (1–48) months PP
recurred in two patients (6.3%) and were drained by
laparoscopic cystogastrostomy.
Conclusion: CT ﬁndings and laparoscopic exploration
demonstrate the anatomical characteristics of PP and
enable successful planning and execution of their lapa-
roscopic drainage.
P-529
PSEUDOCYST AFTER ACUTE
PANCREATITIS; CONSERVATIVE
TREATMENT IS THE TREATMENT OF
CHOICE: A SINGLE CENTER
EXPERIENCE
M. Massani1, E. Caratozzolo2, D. Lucia2, B. Luca2,
R. Cesare2, C. Paolo2 and B Nicolo’2
1IV Department Surgery, Regional center for HPB
surgery, Regional Hospital Treviso; 2IV Department
Surgery, Regional center for HPB surgery, Regional
Hospital Treviso
Verify the feasibility and analyze the results of a
conservative approach in a selected group of patients
with pancreatic pseudocysts. Data regarding 1221
patients with acute pancreatitis, 866 mild and 355 with
severe was reviewed. In the group of 355 patients with
severe acute pancreatitis clinical data of 46 pancreatic
pseudocysts (in a group of 67) observed in a 13 years
period were analyzed. The correlation between etiology,
type of treatment and clinical outcome was studied.
Surgical intervention was performed only in patients with
lasting symptoms or complications. Twenty eight pa-
tients were successfully managed conservatively. Eigh-
teen required intervention: 3 were treated by
percutaneous radiological drainage; 2 were treated by
endoscopic cystogastrostomy, 3 by distal pancreatectomy
and 10 by open surgical cystic-enteric anastomosis. ll
patients were initially managed conservatively; surgical
intervention was performed only in patients with lasting
symptoms or complications. Twenty eight patients were
successfully managed conservatively. On the contrary, 18
required intervention: 3 were treated by percutaneous
radiological drainage; 2 were treated by endoscopic
cystogastrostomy, 3 by distal pancreatectomy and 10
by open surgical cystic-enteric anastomosis. The indica-
tions for intervention were: persisting abdominal pain
(6), jaundice (2), gastric outlet obstruction (8), dyspepsia
with weight loss (2). One patients treated with endoscopic
gastro-jejunostomy had a major complication. On the
mean follow up of 23 months, one patient died after
5 months from the endoscopic drainage. In the group of
patients treated conservatively none experienced devel-
opment of major symptoms. Conservative treatment for
patients with pancreatic pseudocyst, if clinical or radio-
logical evidence of disease can be managed without
complications. This therapeutic approach has reduced
the complication rate and is successful for selected
patients.
P-530
MEDIUM-TERM CLINICAL OUTCOME
AFTER PERCUTANEOUS
RADIOLOGICALLY-GUIDED
CYSTOGASTROSTOMY
D. O’Reilly1, C. Bent2, P. Thurley2, T. Fotheringham2
and R. Hutchins1
1Department of Hepatopancreaticobiliary Surgery, Royal
London Hospital, London, UK; 2Department of
Radiology, Royal London Hospital, London, UK
Background: Surgical cystoenterostomy is the gold-
standard treatment for pancreatic pseudocyst. Endo-
scopic and ﬂuoroscopic are alternatives, but endoscopic
drainage has a 20% recurrence at ﬁve years. There is little
data about percutaneous radiologically-guided cystoga-
strostomy (PRGCG).
Aim: To examine the outcome of PRGCG.
Methods: Gastropexy sutures were placed percutane-
ously to secure the stomach to the anterior abdominal
wall. Image guided access into the pseudocyst was per-
formed via a transgastric approach. Following position
conﬁrmation, all patients underwent insertion of either
an 8.5F or 10F JJ stent of 3 cm length between the cyst
and the stomach. Seven patients had two JJ stents (six to
expedite drainage and one due to the presence of two
separate pseudocysts). Data were gathered retrospec-
tively using electronic patient records and radiological
imaging archives.
Results: Twenty four patients had PRGCG between
December 2003 and July 2009. Median age 49 years;
M:F:18:6. Aetiology was: Alcohol 6, gallstones 11, idio-
pathic 5, ERCP 1, surgery 1. Median follow-up 4 months
(range 0 to 60).
See table. Stent migration: cases with clinical impact or
where stent fell into the cavity; excludes asymptomatic
luminal passage of stent. Although initial drainage was
achieved in all cases, re-intervention had to be under-
taken in 25% of patients at a median follow-up of
4 months. New episodes of sepsis (only one not treatable
by antibiotics) occurred in 17% of patients immediately
post-procedure. No other procedure-related complica-
tions occurred.
Events subsequent to drainage of pseudocyst by type of
pancreatitis
n
Stent
migration
Further cyst
procedures
Acute
pancreatitis
17 5 2 reposition stent
1 external drain
1 open drainage
Chronic
pancreatitis
8* 1 1 repeat PRGCG
1 open drainage
Total 25 6 6
*8 in 7 patients
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Discussion: PRGCG has previously been shown to be
technically feasible and safe, conﬁrmed by this study.
However, as with endoscopic drainage, the small calibre
and lack of security of the JJ-stent leads to a high inci-
dence of primary failure. Stent redesign could mitigate
this problem. Prospective audit of radiological innova-
tions in HPB surgery should be universal and RCT
should be encouraged.
P-531
SURGICAL MANAGEMENT OF
DISCONNECTED PANCREATIC DUCT
SYNDROME FOLLOWING PANCREATIC
DEBRIDEMENT
J. R. Virk1, A. Savlania2, G. Daga1, S. Sidhu1,
R. Mahajan1 and A. Sood1
1Dayanand Medical College and Hospital, Ludhiana,
Punjab, INDIA; 2PostGraduate Institute of Medical
Sciences, Chandigarh, INDIA
Background: External pancreatic ﬁstula is a common
sequel to pancreatic debridement which heals spontane-
ously in majority. In a group of patients whose viable
pancreas tail is disconnected from its head or body due to
central necrosis, result in persistent end pancreatic ﬁstula
or non-resolving pseudocyst.
Aim: The purpose of this study is to review our clinical
experience managing disconnected pancreas remnant
following surgical debridement.
Methods: A retrospective review of prospectively col-
lected clinical data of patients with pancreatic necrosis or
abscess treated surgically who had complete recovery at
our institution over a period from July 2007 to August
2009.
Results: Five patients developed end external pancreatic
ﬁstula and two developed pseudocyst from disconnected
pancreas tail remnant. Patients were re-operated median
4 months after ﬁrst surgery. MRCP revealed complete
cutoff in all the patients in the mid body region with
dilated distal duct in four patients and in two associated
pseudocysts. Two patients failed endoscopic stent ther-
apy. All patients required operative treatment: three
lateral pancreatico-jejunostomy, two distal pancreatec-
tomy and two cystopancreatico-jejunostomy.
Discussion: Extent and location of pancreatic necrosis is
an important predictor of early and late outcome in acute
necrotizing pancreatitis. Disconnected pancreas syn-
drome occurs when isolated necrosis of pancreatic neck
and/or proximal pancreatic body leave viable distal
pancreatic remnant that is without continuity with gas-
trointestinal tract, resulting in a pancreatic pseudocyst or
persistent pancreatic ﬁstula. MRCP is useful tool in
delineating the anatomy of entire pancreatic duct and
unnecessary endoscopic therapy can be avoided. Surgical
therapy can be resective or drainage procedure depending
upon amount of remnant parenchyma, status of
pancreatic duct, associated pseudocyst and portal
hypertension.
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EVALUATION OF IRON DEPENDENT
AND INDEPENDENT OXIDATIVE
STRESS ASSAYS IN HEALTHY
INDIVIDUALS AND ACUTE
PANCREATITIS PATIENTS
Z. Dambrauskas1,2, P. Beekhof3, J. Cremers4,
A. Gulbinas1,2, G. Barauskas1, J. Pundzius1 and
E. Jansen4
1Department of Surgery, Kaunas University of Medicine;
2Laboratory of Digestive System Research, Institute for
Biomedical Research, Kaunas University of Medicine;
3Laboratory for Health Protection Research, National
Institute for Public Health and the Environment;
4Laboratory for Health Protection Research, National
Institute for Public Health and the Environment
Background: It is suggested that oxidative stress (OS)
may play a central role in the development of pancreatic
insult and extra-pancreatic complications during acute
pancreatitis (AP), but the clinical implication of this
phenomenon is still not clear.
Aim: To evaluate OS in AP patients and healthy indi-
viduals using the iron dependent [ROM (reactive oxygen
metabolites); FRAP (ferric reducing antioxidant po-
tency)] and independent assays [TOC (total oxidative
capacity); TAC (total antioxidant capacity)], since iron
status appears to be signiﬁcantly distorted during AP.
Methods: Blood samples were collected from patients
with mild (n = 22) and severe (n = 17) AP, and a group
of healthy individuals (n = 28). Comparison of two as-
says for oxidative potential (ROM and TOC) and two
assays for the antioxidant capacity (FRAP and TAC)
was performed, and iron status was evaluated in AP and
control groups.
Results: Plasma iron concentration and iron saturation
were signiﬁcantly lower in AP patients comparing to
healthy controls. A good correlation between TOC and
ROM (r = 0.9, P < 0.01) and also between TAC and
FRAP (r = 0.75, P < 0.01) was observed in control
group. However, in AP group the correlation between
TOC and ROM (r = 0.30, P > 0.05) and between TAC
and FRAP (r = 0.53, P < 0.05) was very poor, while
TOC and TAC correlation was good. These ﬁndings
demonstrate that TOC and ROM assays and the TAC
and FRAP assays represent similar ongoing processes are
good indicators of OS in healthy individuals. In AP pa-
tients, however, iron dependent OS assays are not reliable
because of altered status of the antioxidant components
involved in these assays. Especially, ROM appears to be
dependent on a normal iron status.
Conclusion: Preferably, monitoring of OS in AP patients
should be performed using the TOC and TAC assays.
Further studies are needed to evaluate the role of OS in
pathogenesis of AP.
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DISTURBANCE OF MITOCHONDRIAL
ENERGY METABOLISM IN ACINAR
CELLS DURING EXPERIMENTAL
ACUTE PANCREATITIS
S. Trumbeckaite1, O. Deduchovas2, M. Kincius1,3,
Z. Dambrauskas1,2, G. Barauskas2, V. Borutaite1 and
A. Gulbinas1,2
1Institute for Biomedical Research, Kaunas University of
Medicine; 2Department of Surgery, Kaunas University of
Medicine; 3Department of Urology, Kaunas University
of Medicine
Background: Parenchymal cell death of pancreas is a
major complication of acute pancreatitis. Mechanisms of
acinar cell death in pancreatitis are poorly understood.
Mitochondria have emerged as master regulator of cell
death in various physiological and pathological pro-
cesses.
Aim: In this study effects of acute pancreatitis on respi-
ration of isolated rat pancreas mitochondria were inves-
tigated.
Methods: Acute pancreatitis (AP) was induced in 25
male Wistar rats by intraductal application of sodium
taurocholate (5%). Animals were divided into ﬁve groups
(1, 3, 6, 12, 24 hours) reﬂecting the time from induction
of the AP until tissue collecting. Pancreas and liver were
removed for mitochondrial assay. Histological study was
performed to evaluate morphologic changes in pancreatic
acinar cells.
Results: We found slightly changes in mitochondrial
function after 3 hours from onset of AP. However, after
6 hours the mitochondrial State 3 respiration decreased
by 79% with glutamate + malate as substrates followed
by the decrease in respiratory control index by 61%,
whereas succinate dependent State 3 respiration rate was
affected only after 6 hours from onset of AP and de-
creased by 51%. Drastical disturbances of mitochondrial
function for both substrates were detected after 24 hours
(-80% with glutamate + malate and –69% with succi-
nate as substrates). The Complex I activity of mito-
chondrial respiratory chain was also decreased by 67%
after 12 hours and 24 hours. However, no changes in li-
ver mitochondrial function were observed in any exper-
imental group after 6 hours, 12 hours and 24 hours from
the onset of AP.
Conclusion: Our data show that the disturbance of
mitochondrial energy metabolism plays an important
role in the development of acute pancreatitis.
P-534
COMBINATION OF A NEUROKININ-1
AND GALANIN RECEPTOR
ANTAGONISTS AMELIORATES
CAERULEIN-INDUCED ACUTE
PANCREATITIS IN MICE
J. R. Barreto1, C. Carati2, A. Schloithe1, J. Toouli2 and
G. Saccone1
1Flinders University and Flinders Medical Center;
2Flinders University
Both galanin and substance P have been separately
implicated in the pathogenesis of acute pancreatitis. We
compared the efﬁcacy of the combination of the galanin
antagonist galantide and the neurokinin-1 receptor
antagonist L-703,606 with that of either alone in the
treatment of acute pancreatitis. Acute pancreatitis was
induced in mice with 7-hourly caerulein injections.
Galantide was co-administered with each caerulein
injection commencing with the ﬁrst injection (prophylac-
tic) or 2 hours after the ﬁrst injection (therapeutic). L-
703,606 was administered either 30 min before (prophy-
lactic), or 2 hours after the ﬁrst caerulein injection
(therapeutic). Combination of the two agents was also
administered. Control groups received galantide, L-
703 606, or saline, without caerulein. Pancreata were
harvested for histological examination and estimation of
myeloperoxidase activity. Plasma amylase activity was
measured. Prophylactic and therapeutic administration
of galantide reduced the hyperamylasemia by 37% and
30% respectively whereas only prophylactic L-703,606
reduced hyperamylasemia (by 34%). Prophylactic
administration of the combined antagonists reduced the
hyperamylasemia by 44%. In contrast, therapeutic
administration of the combination signiﬁcantly increased
plasma amylase levels by 27%. The plasma amylase
activity in the control groups was similar to pre-
treatment levels. Prophylactic and therapeutic adminis-
tration of either antagonist or the combination signiﬁ-
cantly reduced myeloperoxidase activity. Galantide and
L-703 606 individually, and in combination, signiﬁcantly
reduced the acute pancreatitis -induced necrosis score.
The administration of the combined antagonists does not
offer any further beneﬁt as compared to galantide alone.
An interaction between neurokinin-1 and galanin recep-
tors may occur to modulate amylase secretion.
P-535
MANAGEMENT OF INFECTED
NECROTIZING PANCREATITIS
A. Shabunin1, V. Bedin2, A. Lukin3, D. Shikov4,
M. Tavobilov4, D. Grekov4 and K. Dalgatov4
1Botkin’s Memorial Hospital, Prof., head of surgery
department, Moscow, Russia; 2Botkin’s Memorial
Hospital, head of HPB - surgery unit, Moscow, Russia;
3Botkin’s Memorial Hospital, HPB - surgery unit,
Moscow, Russia; 4Botkin’s Memorial Hospital, HPB -
surgery unit, Moscow, Russia
Background: The results of treatment of infected necro-
tizing pancreatitis (INP) are still unsatisfactory, despite
the use of modern principals of conservative therapy and
surgery.
Aim: The objective of this study was to assess the out-
come in a large unselected population of patients with
INP treated at a single center in relation to different
treatment modalities.
Materials and methods: We performed a retrospective
analysis of 179 patients with INP and evaluated outcome,
morbidity and mortality in relation to different treatment
modalities. All patients were divided into two compara-
ble groups. In all cases the volume of necrosis was 30 –
50, > 50%, grade D, E in accordance to Balthazar.
Group 1 – 85 patients treated during the period from
2002 to 2004. Group 2 – 94 patients, treated during the
period from 2005 to 2008. The choice of way and kind of
surgery based on clinical data and results of dynamic
ultrasound (US), dynamic contrast enhanced CT
(DCECT) and MRI.
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Results: Sixteen (18.8%) patients of Group 1 and 23
(24.5%) of Group 2 underwent only US-guided drain on
the 5–7th day from the onset of disease. Forty eight
(56.5%) patients of the Group 1were treated by lapa-
rotomy. Only 16 (6.2%) patients from the Group 2
needed laparotomy. The combination of both (US-gui-
ded drain on the 3–5th day from the onset of disease and
laparotomy on the 14–17th day) was done in 21 (24.7%)
cases of Group 1. Fifty nine (62.7%) patients of Group 2
underwent both (US-guided percutaneous drain on the
3–5th day from the onset of disease and open surgery
after 21st day) The mortality rate in the 1st group was
30.5% and 11.7% - in second (p = 0.005).
Conclusion: The present study ﬁnds beneﬁts in using
combination of minimally invasive methods and open
surgery in treatment patients with INP. Reduce the
number of laparotomy among the patients with INP
decreased mortality.
P-536
LAPAROSCOPIC TREATMENT OF
ACUTE PANCREATIC PSEUDOCYSTS
O. Mazza, F. Salas C., G. Moriconi, M. Palavecino,
R. Sanchez Claria, J. Pekolj and E. de Santiban˜es
Hospital Italiano de Buenos Aires
Background: Acute pancreatic pseudocysts may be trea-
ted in different therapeutic approaches: endoscopy, per-
cutaneous drainage, open and laparoscopic surgery.
Open surgery remains as Gold Standard treatment, and
such goals should be considered at the moment of
choosing a therapeutic approach.
Objective: To describe the technical aspects and results
of laparoscopic treatment of acute pancreatic pseud-
ocysts.
Setting: Community private hospital.
Design: Case series.
Material and methods: Between November 1996 and
June 2009, 42 patients with 47 acute pancreatic pseud-
ocysts were treated at the hospital. Twenty two patients
with 23 pseudocysts after acute biliary pancreatitis were
operated by laparoscopic approach. Mean age of the
population was 55 years (r 31–77), and 13 of them were
male. Mean evolution time until surgery was 12 weeks (r
8–12), with an average size of the cyst of 11.3 cm (r 5–18):
Laparoscopic ultrasound was routinely performed to
evaluate setting of the anastomosis. In twelfth cysts cys-
tojejunostomy was performed, Cystogastrostomy in three
patient, external drainage in two infected cyst, three
convertion to open surgery, one double cystojejunostomy
and one distal pancreatectomy.
Results: There were tree conversions to open surgery.
Twelve laparoscopic cholecystectomies, one laparoscopic
common bile duct exploration, and one umbilical her-
nioplasty were simultaneously performed. Mean operat-
ing time was 258 min (r 90–360) with an average in
postoperative hospitalization of 3.8 days (r 2–5). All
patients are free of recurrence after 30.3 months of fol-
low-up (r 6–71).
Conclusions: We could perform all maneuvers as we used
in open surgery. A complete and safe necrosectomy un-
der laparoscopic was accomplished in all cases. Extra-
corporeal Roux en Y loop was performed, without
needing staplers. Biliary pathology was treated in same
procedure. We had no mortality and no signiﬁcant
morbidity.
P-537
PLATELETS REGULATE CXC
CHEMOKINE FORMATION AND
NEUTROPHIL INFILTRATION IN
ACUTE PANCREATITIS
B. Jeppsson, A. Abdulla, D. Awla, H. Hartman,
S. Regner and H. Thorlacius
Malmo¨ University Hospital; Lund University
Background: Recent data suggest that platelets not only
control thrombosis and hemostasis but may also regulate
inﬂammatory processes. Acute pancreatitis (AP) is
characterized by changes in both coagulation and pro-
inﬂammatory activities; however, the role of platelets in
AP is not known.
Aim: To determine the role of platelets in AP.
Methods: AP was induced in C57BL/6 mice by repetitive
caerulein administration (50 lg/kg, i.p) and mice re-
ceived a platelet-depleting or a control antibody. Neu-
trophil inﬁltration, myeloperoxidase and macrophage
inﬂammatory protein-2 (MIP-2) levels and acinar cell
necrosis in the pancreas as well as serum amylase activity
and neutrophil expression of membrane-activated com-
plex-1 (Mac-1) and CXCR2 were quantiﬁed 24 hours
after caerulein challenge.
Results: Caerulein administration caused pancreatic
damage characterized by acinar vacuolization and
necrosis, neutrophil inﬁltration, focal hemorrhage, and
increased levels of MIP-2 as well as increased serum
amylase levels. Interestingly, platelet depletion reduced
acinar cell necrosis and serum amylase by more than
65% in AP. Depletion of platelets reduced MIP-2 for-
mation and neutrophil recruitment in the pancreas by
more than 70%. Moreover, platelet depletion had no
effect on Mac-1 and CXCR2 expression on neutrophils.
Conclusion: These novel ﬁndings show that platelets play
a critical role in AP by regulating neutrophil inﬁltration
via upregulation of Mac-1 and MIP-2 formation in the
pancreas.
P-538
PANCREATIC CYSTIC LESIONS AS A
CAUSE FOR’ IDIOPATHIC’ ACUTE
PANCREATITIS
G. Morris-Stiff, G. Lentz, S. Chalikonda, M. Johnson
and R. M. Walsh
Department of Hepato-Pancreato-Biliary Surgery,
Cleveland Clinic Foundation, Cleveland, Ohio
Background: About 5–10% of patients with acute pan-
creatitis (AP) have no aetiology identiﬁed and are la-
belled as idiopathic. The potential causative role of cystic
lesions in relation to idiopathic AP has not been fully
evaluated.
Aims: To report our experience of patients referred for
assessment of idiopathic AP in whom a pancreatic cystic
lesion was subsequently identiﬁed and treated.
Methods: The pancreatic cyst database was accessed to
identify patients referred for evaluation of idiopathic AP
in whom a pancreatic cystic lesion was diagnosed. The
interval between the episode of AP and diagnosis of the
lesion, as well as means of evaluation were documented.
Patients treated for pseudocyst were not included in this
study.
Results: During the study period, 23 patients were
identiﬁed all of whom underwent resection thus provid-
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ing a gold standard. There were 16 females and 7 males
with a mean age of 58.6 ± 13.4 years. Final pathological
diagnoses included: IPMN (n = 11); mucinous cystade-
noma (n = 10); autoimmune pancreatitis (n = 1); and
serous cystadenoma (n = 1). There was a perfect corre-
lation to the ﬁnal histopathology for these patients in
terms of predicting a cystic neoplasm as opposed to
pseudocyst (Spearman’s rho: r = 1, p = 0.01). The
median time from AP to diagnosis of the cystic lesion was
bipartite with 11 having cystic lesions at index presenta-
tion, and 12 developing later at a median time of
12.5 months (range: 3–114) at the time of presentation
with recurrent AP. Three patients had invasive carci-
noma within their lesion, an in two cases there had been a
delay in identiﬁcation of the lesion (3 months,
38 months).
Conclusions: Patients with idiopathic AP should undergo
imaging to examine for a cystic lesion as failure to do so
will result in the risk of recurrent acute pancreatitis. A
cystic lesion identiﬁed in imaging performed at the time
of initial presentation with AP should be regarded as
suspicious for a cystic neoplasm and should be evaluated
further.
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HYPERTRIGLYCERIDEMIC ACUTE
PANCREATITIS: A DIFFERENT
EVOLUTION FROM OTHER ACUTE
PANCREATITIS?
L. Borgno1, G. Secondo1, E. Olano2, G. Sanchez1,
P. Sciuto1, J. Costa1 and J. Rodriguez1
1From the Department of Surgery, Maciel Hospital,
Surgical Clinic ‘2’ from the Uruguayan State University,
Montevideo, Uruguay; 2From The Department of Critical
Care of Maciel Hospital, Montevideo. Uruguay
Background: Although hypertriglyceridemia is an estab-
lished etiology of acute pancreatitis, its clinical course is
not well deﬁned. Levels higher than 1000 mg/dL for
serum triglycerides are necessary for the diagnosis when
other causes were excluded. It has similar clinical pre-
sentation to other causes, but the serum amylase and
lipase are usually normal or slightly increased. The serum
is milky and guiding diagnosis. Initial management is
similar to other causes, also includes insulin, heparin,
ﬁbrates and plasmapheresis. The severity and recurrence
remain controversial issues.
Aim/Objective: To analyze the clinical performance of
hypertriglyceridemia acute pancreatitis and the diagnosis
value of the serum measurement of amylase and trigly-
cerides, their evolution, treatment and complications.
Methods: We studied four patients with this disease
treated between March 2008 and May 2009 in three
hospitals in Montevideo.
Results: The clinical presentation was typical. Two pa-
tients were carriers of morbid obesity and one has history
of alcohol consumption and hypertriglyceridemia. The
serum amylase was normal or less than 1000 U/L in three
patients (75%) and triglycerides exceed 2500 mg/dL in all
cases. Two patients had severe acute pancreatitis, one
died. All were treated similarly to other causes of pan-
creatitis, none required surgery.
Discussion/Conclusion: Hypertriglyceridemia is the third
cause of acute pancreatitis. Serum opalescence and low
levels of amylase are found more frequently than others
etiologies. There seems to be no facts that would explain
a greater degree of severity than the rest. Treatment is
aimed at the normalization of lipids which would prevent
further recurrences. Insulin and heparin are part of the
armamentarium of most patients with pancreatitis, so it
can not be considered exclusive to this etiology. This
entity is not different from the rest and should be kept in
mind in obese, dyslipemics, alcoholics and cholecystec-
tomy patients.
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SERUM BUN PREDICTS ICU STAY AND
RISK OF MORTALITY ACUTE
NECROTIZING PANCREATITIS
T. Keck, U. Wellner, M. Faisst and U. Hopt
Department of General and Visceral Surgery, University of
Freiburg, Germany
Introduction: Clinical and laboratory markers for pre-
diction of outcome and necessity of costly ICU treatment
in severe acute pancreatitis are at need to cut costs of
treatment. The aim of this study was to ﬁnd easy to
determine markers of outcome concerning hospital-stay,
ICU-stay and mortality in acute necrotizing pancreatitis.
Materials and methods: Case records of patients admit-
ted for acute pancreatitis at our institution were checked
for the occurrence of necrotizing pancreatitis. Clinical
and laboratory variables on admission, scores of organ
dysfunction and markers in the course of the disease were
analysed in a prospective database for correlation with
hospital stay, ICU-stay and death.
Results: Of 118 consecutive patients admitted with acute
pancreatitis, 44 patients had a severe acute necrotizing
pancreatitis. Median hospital and ICU stay was 47 and
14 days. Twelve patients died (27%). We focussed on
markers measurable on admission and found blood urea
nitrogen (BUN), pulmonary insufﬁciency, amylase, lipase
to be signiﬁcantly correlated with prolonged ICU stay. In
addition BUN, Quick and metabolic acidosis were sig-
niﬁcantly correlated with mortality. Multivariate analysis
disclosed BUN as independent predictor of prolonged
ICU stay, but not of mortality. Positive and negative
predictive values of BUN level on admission were 89%
and 62% for prolonged ICU stay and 67% and 82% for
mortality when an appropriate cut-off value was chosen.
The predictive values were even better when BUN levels
in the course of the disease were used to predict ICU stay
and mortality.
Conclusion: BUN as a single marker is a useful routine,
easy-to perform and cheap marker to predict ICU-stay
and probable survival in acute necrotizing pancreatitis
and is a valid parameter for the deﬁnition of patients that
can be discharged from ICU to reduce costly treatment
of acute pancreatitis.
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CAN BY-PRODUCTS IN ‘COUNTRY-
MADE’ ALCOHOLS INDUCE ACUTE
PANCREATITIS?
J. R. Barreto1, D. Jardine2, P. Phillips3, M. Bhatia4 and
G. Saccone1
1Flinders University and Flinders Medical Center;
2Flinders University; 3University of New South Wales;
4National University of Singapore
Background: Alcohol predisposes to the development of
acute pancreatitis (AP). While factors like genotype of
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alcohol metabolizing enzymes, individual susceptibility
and the amount of alcohol consumed have been studied,
the actual composition of the various alcoholic products
regularly consumed by patients developing AP has not
been completely analysed. We have reported that the
incidence of AP in the area of Goa, India, is an extremely
high and is associated with the consumption of locally
distilled alcoholic products.
Objective: To analyze the composition of locally pro-
duced alcohol products consumed by a population with a
high incidence of alcohol-related AP.
Material and methods: Three locally distilled alcoholic
products (ethanol content > 20%) regularly consumed
by patients developing AP, as determined by responses in
a patient questionnaire were selected. Three commer-
cially available products with comparable ethanol con-
tent (rum, whisky and brandy) were used for comparison.
Representative samples were analysed using Gas Chro-
matography/Mass spectrometry. Compound assignments
used mass spectral searches of the NIST library (2008).
Results: Commercially available rum, whisky and bran-
dy used for comparison contained the two major con-
stituents, ethanol and water. In addition, the country-
made alcoholic products contained a higher level of
byproducts including toxic long chain alcohols (e.g.
butanol, propanol), aldehydes (e.g. acetaldehyde), acids
(e.g. acetic acid), and even traces of methanol.
Conclusion: Locally distilled alcoholic products contain
many compounds in addition to ethanol. Given the high
incidence of alcohol-related AP in the population where
these products are consumed further evaluation of the
constituents of these products in relation to the induction
of pancreatic damage is warranted.
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THE ROLE OF PERCUTANEOUS
DRAINAGE IN THE TREATMENT OF
INFECTED PANCREATIC NECROSIS
(IPN): STEP-UP
O. Mazza, J. Robin, G. Moriconi, R. Sanchez Claria,
J. Pekolj and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Open necrosectomy remains as gold stan-
dard treatment in IPN, however percutaneous approach
appears as a minimally invasive option for these patients.
Its role as an intermediate or deﬁnitive procedure is still
not deﬁned. The end goal is to diminish morbidity and
mortality.
Objective: To evaluate our experience with percutaneous
drainage in the treatment of patients with IPN.
Methods: Retrospective descriptive study. Seventeen
consecutive patients with IPN treated in our hospital
between January 2000 and June 2009 were included. We
analyzed the presence of organ failure at presentation,
number of drainages, length of percutaneous treatment,
hospital stay length, need for open necrosectomy, mor-
bidity and mortality.
Results: Fifteen patients were male with median age of
56 (r 37–83). Five patients presented with multi organ
failure. Infection was assessed by clinical and bacterio-
logical ﬁndings. Percutaneous drainage was used as ﬁrst
therapeutic approach in 14 patients. Median time from
admission to drainage was 17 days (r 1–30). First cath-
eters (10- to 14-french) were switched for large bore
catheters (24- to 28-french) for removal of necrotic deb-
ris. Percutaneous necrosectomy was applied in three pa-
tients. Six patients underwent further open necrosectomy
with a median time of 35 days from admission (r 2–45).
Surgery was initially performed in two patients with
extensive diffused necrosis. The median hospital stay was
44 days (r 11–136). We had 41% morbidity: three pan-
creatic ﬁstulas, three colonic ﬁstulas, one coloduodenal
ﬁstula. Four patients who presented MOF at admission
died.
Conclusions: Percutaneous approach avoids open nec-
rosectomy in 47% of patients. Patients who presented
MOF at admission have poor prognosis.
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COMPLEX TREATMENT OF
PANCREATONECROSIS WITH THE USE
OF RATIONAL SURGICAL TACTICS,
BACTERIOPHAGES AND ENTERAL
NUTRITIVE SUPPORT
M. Zarivchatskiy, V. Grischuk, G. Bogatireva and
A. Kolevatov
Perm State Academy of Medicine named after Acad. E.
Wagner
Background: The main reason of high lethality from
pancreatonecrosis is suppurative and necrotic complica-
tions, abdominal sepsis and multiple organ failure.
Elaboration of methods and means directed to prophy-
laxis and treatment of the complications is justiﬁed.
Aims: To improve results of complex treatment of pa-
tients with pancreatonecrosis due to introduction of ra-
tional surgical tactics, bacteriophages and enteral
nutritive support.
Methods: Treatment experience of 100 patients with
pancreatonecrosis divided into two groups was summa-
rized. The main group consisted from 49 patients whose
complex treatment included rational surgical tactics
(puncture technologies under USI control – in 10 pa-
tients, laparoscopic interventions –in 3, open operative
interventions from mini-assess – in 36, wide laparotomy –
in 9), polyvalent pyobacteriophage - enteral dosing, local
introduction (into omental bursa, suppurative focus of
retroperitoneal space) and enteral nutritive support with
preparations of the companies Nutricia or Bbraun.
Comparative group (51 patients) was treated by tradi-
tional methods without use of bacteriophages and mini-
invasive interventions. Severity of organic disorders was
estimated by clinical symptoms, laboratory tests, results
of instrumental diagnosis and estimation scale of physi-
ological state severity (PSS).
Results: Normalization of PSS indices in patients of the
main group was 5.0 ± 0.7 days faster than in compara-
tive one. Suppurative and necrotic complications were
developed in 42.8% of patients of the main group and 86,
3% - of comparative one. Lethality was respectively
equal to 16.3% and 39.2%. Progressive multiple organ
failure on the background of abdominal sepsis brought
to death.
Conclusion: Complex treatment of pancreatonecrosis
with the use of sparing surgical tactics, enteral nutritive
support and polyvalent pyobacteriophage promotes
prophylaxis and relief of infection process, reduction of
systemic inﬂammatory response symptoms.
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RECURRENT PANCREATITIS:
THERAPEUTIC APPROACH
V. Neri
University of Foggia; Polyclinic of Foggia
Aim: Acute biliary pancreatitis (ABP) is caused by
alteration of the papillary patency. The normal transpa-
pillar ﬂux and the cleaning of the common biliary duct
(CBD) may prevent potentially avoidable recurrent
pancreatitis.
Patients and methods: In the period September 1997/
december 2008 we have treated 224 ABP (34 severe, 190
mild/moderate): 162 (72.4%) with the ﬁrst attack, 62
(27.6%) with recurrent ABP (second or further attack).
The patients with recurrent pancreatitis had not under-
gone, in the previous hospital stay elsewhere, the evalu-
ation and, if necessary, the treatment of the papillary
obstacle and /or CBD stones, sludge, etc. In ours hospital
all patients had undergone complete treatment of ABP:
intensive therapy, clinical: instrumental control of the
papillary patency, then ERCP/ES (180–80%) within
72 hours from the onset in all SAP, in mild/moderate
with signs of papillary lithiasic obstacle (US/MRCP
conﬁrmation), in all recurrent pancreatitis, and videola-
parocholecystectomy.
Results: In the follow-up of recurrent pancreatitis we
have controlled, clinical and instrumental data, after 90
and 180 days, 35 patients (56%–27 lost): 21 SAP, 14
(mild/moderate). Further recurrence only in one patients
(2.8%); in the other controls recurrence of ABP are not
reported; laboratory (amylases, cholestasis) and instru-
mental tests (abdominal US) has been normal.
Conclusions: Recurrent ABP have been caused, in the
patients discharged from the hospital without additional
treatment, by persistent papillary obstacle (small stones,
sludge, cholesterol crystals, etc.). Therefore we conﬁrm
therapeutic validity of the instrumental control (US/
MRCP) and the possible treatment of papillary or biliary
lithiasic obstacle for the prevention of recurrent ABP.
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PREDICTABILITY OF ACUTE
NECROTIZING PANCREATITIS
M. Levy, V. Visokai, P. Cech, K. Kostlivy and
L. Lipska
Thomayer Teaching Hospital, 1st Medical Faculty Charles
University, Prague
Background: Most attacks of acute pancreatitis (AP) do
not lead to complications, however, some percentage of
patients have a more serious necrotizing AP. Neverthe-
less patients proﬁt from intensive treatment started as
early as possible. Therefore good scoring system is nee-
ded.
Aim: To evaluate contribution of scoring systems (Ran-
som, CRP level) to prediction of AP.
Materials and methods: There were 88 patients treated
for AP from November 2007 to March 2009. Prediction
of course of AP was determined by monitoring of CRP
level and simultaneously by Ranson’s score. Cut-off level
was 200 mg/L for CRP and ﬁve points for Ransom’s
score. In 35 patients (39.8%, 22 men, 13 women) necro-
tising AP was determined using CT or according to
clinical status. In 53 patients (60.2%, 22 men, 31 women)
oedematous AP was determined. All patients underwent
ultrasonography, CT was done in 56 (63.6%), ERCP in 3
(3.4%) and FNA under CT guidance in 3 (3.4%) pa-
tients. Early enteral nutrition had 26 (29.5%) patients,
antimicrobial treatment 28 (31.8%) patients. Operation
was performed in 14 (15.9%) patients. In 10 patients with
oedematous AP cholecystectomy during the same hos-
pitalization was performed. Mortality in all patients was
4.5%, all 4 died patients had necrotizing AP (mortality
11.4%).
Results: Diagnosis of necrotizing AP was diagnosed by
CT in 27 cases (77.1%) and in 8 (22.9%) according
MODS progression. Necrotizing AP was predicted in 24
cases by Ranson’s score, of which only in 17 cases was
necrosis conﬁrmed, in 7 cases the AP was oedematous.
Necrotizing AP was predicted in 40 cases by CRP level,
of which in 29 cases the diagnosis was conﬁrmed and in
11 cases the prediction was false positive.
Conclusion: Our results showed CRP level to be better
predictive factor of necrotizing AP compared to Ranson´s
score.
P-546
SMALL INCISION FOCUSED OPEN
NECROSECTOMY IN NECROTIZING
PANCREATITIS
G. Pupelis, V. Fokin, K. Zeiza, H. Plaudis and
A. Suhova
Riga Eastern Clinical University Hospital ‘Gailezers’
Background: Surgical intervention is the main treatment
modality in necrotizing pancreatitis when conservative
therapy fails to control progression of sepsis. Recently
less aggressive approaches have been developed as an
alternative to conventional open necrosectomy (CON).
Aim: Of this study was review of our institutional expe-
rience with an alternative approach of small incision fo-
cused open necrosectomy (SIFON) in the treatment of
necrotizing pancreatitis.
Methods: The records of 226 patients with necrotizing
pancreatitis who were treated from 1999 to 2009 were
analysed. Infected necrosis, unresolved sepsis, and failure
of the conservative treatment were the main indications
for surgical intervention. CON with semi-open/closed
drainage or SIFON with assistance of preoperative/in-
traoperative ultrasound navigation through the small
retroperitoneal approaches were performed. Two meth-
ods were analysed comparing data from the last 6 years,
when SIFON was started as an alternative procedure.
Results: Totally 105 patients were treated surgically and
majority of them, 78 patients, underwent CON. In the
recent 6-year period 35 patients underwent CON and 27
patients an alternative SIFON procedure, generally in the
late phase of the disease (85%). SIFON was performed in
patients with more evident signs of sepsis and it resulted
in better sepsis resolution rate comparing to CON,
P < 0.005, P < 0.009. Accordingly mean ICU and
hospital stay was shorter in SIFON group (9.3 vs.
26.1 day, P < 0.001 and 42.7 vs. 72.5 days, P < 0.001
respectively. Lower incidence of postoperative bleeding
3.7% vs. 20% and intestinal ﬁstulae 0% vs. 22.9%
characterized postoperative course after SIFON,
P < 0.05, P < 0.01. Finally CON was associated with
22.9% mortality rate comparing to 3.7% in SIFON
group, P < 0.035.
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Conclusion: Small incision focused open necrosectomy
could be reasonable alternative to conventional open
necrosectomy in selected category of patients with in-
fected necrosis.
P-547
OPEN PANCREATIC CYST
GASTROSOMY AND DEBRIDEMENT OF
WALLED OFF PANCREATIC NECROSIS
F. Sutherland, O. Bathe, E. Dixon and G. Munene
Foothills Hospital/University of Calgary
Background: Following an episode of necrotizing pan-
creatitis unoperated patients may develop persistent
walled off pancreatic necrosis (WOPN). These patients
have pain, difﬁculty eating and failure to thrive.
Objectives: We report a series of patients treated with
open debridement of their necrosum through the pos-
terior stomach wall with creation of a pancreatic cyst
gastrostomy.
Methods: All patients had an upper midline laparotomy
and anterior gastrotomy. The WOPN was needled and
then opened through the posterior stomach wall. This
was then enlarged to a size of 5 cm and the necrosum was
completely debrided. The pseudocyst wall was then su-
tured to the stomach. No drains were placed.
Results: Nine patients with necrotizing pancreatitis from
gallstones (5) or alcohol (4) were operated over a 7 year
period. Patient ages ranged from 22 – 79 years (mean 43).
Time from onset of pancreatitis to debridement ranged
from 40 – 280 days (mean 149). In most patients the
necrosis was conﬁned to the body of pancreas behind the
stomach. Three patients had extension of the necrosis
outside this area (head, right paracolic gutter, left upper
quadrant). Postoperatively there were no deaths and
three patients required readmission. Two of the three
patients with necrosis extending beyond the body of the
pancreas required reintervention (percutaneous drain
and ﬂank debridement). Seven of the nine patients had an
excellent long-term outcome at a mean follow-up of
21 months. Two patients with alcohol related pancreati-
tis had poor outcomes (chronic pancreatitis with recur-
rent pseudocyst formation, prolonged pancreatic ﬁstula/
pain).
Conclusion: This procedure is a reasonable option for
patients with symptoms from persistent walled off pan-
creatic necrosis conﬁned to the posterior gastric area.
P-548
FACTORS ASSOCIATED IN SEVERE
ACUTE PANCREATITIS IN MINOR
PATIENTS UNDER 21 YEARS:
RETROSPECTIVE STUDY
L. Moulin, S. Walther, P. Dusso, F. Marti and
A. Guala
General Surgery Department, Jose´ Marı´a Cullen Hospital,
Santa Fe, Argentina
Background: Acute pancreatitis is a frequent complica-
tion of the stone biliary tract disease in adolescents, with
a major frequency of severe episodes in our experience.
Although it presents certain risk factors that are well
known, the real incidence is still unknown.
Aim: To determine the association of certain factors of
risk in the severe acute pancreatitis (SAP), as well as also
to study mortality and morbidity of the pathology.
Method: Study of cases and controls, deﬁning SAP
according to Ranson’s criteria (> 3).
Results: Thirty two cases in whole, 10 SAP and 22 slight.
Inside the SAP, 80% were puerperas, vs. 63% in slight
cases (OR: 2.27, p = 0.35). BMI > 25 was sawn in
100% of the severe cases and in 76% of the slight ones
(OR: 6.60, p = 0.13). The precedent of acute cholecys-
titis and acute pancreatitis was 50% and 13% in SAP
respectively; vs. 27% and 0% (OR: 2.66 and 7.10,
p = 0.19 and 0.31). The mortality of both groups was
0%; with major morbidity of the PAG in what recounts
to days of internment and persistence of clinical and
analytical parameters of severity.
Conclusion: There were a major percentage of puerperas,
overweight and precedents of acute cholecystitis and
acute pancreatitis; but in none of the factors signiﬁcant
differences were situated. The morbidity of the SAP is
major, without mortality in both groups.
P-549
AUTOIMMUNE PANCREATITIS:
UNVEILING A HIDDEN ENTITY
M. Wayne, A. Cooperman, F. Soto and E. Velazquez
St Vincent’s Hospital, Manhattan
Background: After alcohol-induced and hereditary dis-
ease, idiopathic chronic pancreatitis is the most common
cause of calcifying pancreatitis. This designation is used
when no associated cause of chronic pancreatitis is
found. We present six cases of idiopathic pancreatitis in
which the postoperative pathologic examination dem-
onstrated lymphoplasmacytic sclerosing pancreatitis
(LPSP) or autoimmune pancreatitis.
Aim/Objective: Recognize the autoimmune pancreatitis
as a clinical entity.
Methods: Retrospective case series. The charts of six
patients referred and treated for idiopathic autoimmune
pancreatitis were reviewed. The duration of follow-up
varies, the longest being ﬁve years. The pathology and a
literature review are reported.
Results: Six cases of LPSP are presented and suggest that
LPSP should be thought of more often in chronic idio-
pathic pancreatitis.
Conclusion: LPSP is an increasingly recognized cause of
chronic pancreatitis and should be considered in the
evaluation of patients with chronic pancreatitis and no
discernible cause.
P-550
EXTRA PANCREATIC INFECTIVE
COMPLICATIONS IN SEVERE ACUTE
PANCREATITIS
J. R. Sinha, T. D. Yadav, G. S. B. Kishore, R. Kochhar,
P. Ray and J. D. Wig
Post Graduate Institute of Medical Education and
Research, Chandigarh
Background: Infective complications account for signiﬁ-
cant morbidity and mortality in severe acute pancreatitis
(SAP). Does extra pancreatic infections contribute sig-
niﬁcantly to morbidity and mortality is the question.
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Aims and objectives: This study analyzes the incidence,
bacterial ecology and impact of extrapancreatic infective
complications (EPIC) on outcome in patients who
underwent necrosectomy for SAP.
Methods: Twenty patients of SAP who underwent nec-
rosectomy over 1 year were followed up prospectively
until discharge or death. Pneumonia, urinary tract
infection (UTI) and central venous catheter infections
(CVCI) were evaluated and documented according to
standard protocol, deﬁnitions. Patients with and without
EPIC were compared as regards to duration of hospital
stay, ICU stay and mortality.
Results: Seven out of 20 (35%) patients developed EPIC.
Pneumonia occurred in 3, UTI, CVCI in 2 patients each.
Acinetobacter baumanii, Escherichia coli, Staphlyococcus
aureus and Enterococcus faecalis were the isolates. They
were sensitive to third generation Cephalosporins,
Vancomycin. The mean duration of hospital stay was
prolonged in patients with pneumonia (53 vs. 40 days for
no infection), CVCI (72 vs. 44 days) but not for UTI (43
vs.47 days). Overall mortality in this study group was
40% (8 out of 20). Fifty percent of patients (four out of
eight) who died had their course complicated by an ex-
trapancreatic infection. All three patients with pneumo-
nia, one out of two with CVCI died while no patient with
UTI died.
Conclusion: EPIC occur in a signiﬁcant proportion of
patients undergoing surgery for SAP and contribute to
morbidity and mortality. While CVCI prolongs hospital
stay, pneumonia kills. UTI is manageable and makes no
difference to the outcome.
P-551
SEPTIC COMPLICATIONS FOLLOWING
SURGERY FOR ACUTE NECROTIZING
PANCREATITIS
J. R. Yadav, P. K. Sinha, K. Gsb, R. Kochhar, P. Ray
and J. D. Wig
Post Graduate Institute of Medical Education and
Research, Chandigarh
Background: Acute necrotizing pancreatitis is a life
threatening disease. Surgery is considered as the last re-
sort. The question is does post operative septic compli-
cations both loco regional and nosocomial signiﬁcantly
increase morbidity and mortality or it is only the severity
of disease which determines the outcome.
Aims/Objectives: The aim of this study was to know the
incidence, bacterial ecology, antibiotic sensitivity of
bacterial isolates, and impact of septic complications on
outcome in patients operated for acute necrotizing pan-
creatitis.
Methods: It was a consecutive study conducted in a
period of one year in a tertiary care hospital in India. All
patients with severe acute pancreatitis who underwent
surgery were followed from time of admission to dis-
charge or death.
Results: Twenty patients underwent pancreatic necro-
sectomy with post operative closed lesser sac lavage.
Overall mortality was 40% (8). Twelve developed septic
complications. Intraabdominal abscess in seven, wound
infection in four, Enterocutaneous ﬁstula in two, pan-
creatic ﬁstula in two, pneumonia in three, urinary tract
infection in two, and central venous catheter related
blood stream infection in two patients. They were asso-
ciated with higher morbidity but did not increase mor-
tality. Bacterial ecology of loco regional complications
was dominated by gram negative bacteria. Third gener-
ation cephalosporin and aminoglycosides were effective.
Discussion: Infections account for most of the deaths in
acute pancreatitis. Patients are especially susceptible to
infections in the post operative period owing to the
progressive nature of disease, major abdominal surgery
and intensive care unit stay. This study showed that
septic complications increase the morbidity but did not
increase mortality signiﬁcantly. Nosocomial infections
are common and important cause of morbidity. It is
probably the severity of disease which determines the ﬁ-
nal outcome.
P-552
SURGICAL TREATMENT IN ACUTE
PANCREATITIS: EXPERIENCE OF
5 YEARS IN A SINGLE CENTER
R. Almeida1, J. P. Maciel1, T. De Campos1,2,
J. G. Parreira1, S. Solda1, J. Perlingeiro1, J. R. Estelles1
and J. C. Assef1
1Emergency Unit - Santa Casa School of Medical Sciences
- Sa˜o Paulo; 2University of Sa˜o Paulo - LIM 62
Background: Acute pancreatitis (AP) is a common and
potentially severe disease. Surgical treatment remains the
established treatment for patients with infected necrosis
in literature, despite high mortality. The objective of this
paper is to present the experience in a single center in
Latin America regarding surgical treatment of AP during
ﬁve years.
Methods: It is a retrospective study including patients
with AP admitted at Santa Casa of Sa˜o Paulo, a Uni-
versity Hospital, in the period from August 2003 to
August of 2009, with a total of 375 patients. Patients
underwent a procedure to treat AP complications were
considered for this analysis. Patients underwent chole-
cystectomy only were excluded.
Results: Eight patients underwent surgical treatment in
this period (2.1%). The mean age was 46.8 years old and
all patients were men. Most of patients had biliary eti-
ology (62.5%). Mean time between admission and sur-
gical treatment was 13.9 day. Two patients (25%)
underwent operation in the ﬁrst day due to peritonitis
and without diagnosis of AP. One patient (12.5%) was
re-operated. Mortality was 50%.
Conclusion: We conclude that despite improvement in
treatment of AP, mortality of surgical treatment remains
high. Late operation and intensive care treatment could
provide better results to these severe patients.
P-553
SURGICAL CHALLENGES IN
MANAGEMENT OF INFECTED
PANCREATIC NECROSIS: TERTIARY
CARE CENTRE EXPERIENCE
J. R. S. Babra and S. S. Virk
Dayanand Medical College & Hospital Ludhiana Punjab,
India
Background: Strategies for the management of patients
with necrotizing pancreatitis remain controversial. Most
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of time consensus is there regarding operation ie necro-
sectomy for treatment of infected pancreatic necrosis but
opinion differs regarding timing of surgical intervention.
Infected pancreatic necrosis is a late infective complica-
tion of acute pancreatitis characterized by signiﬁcant
mortality and morbidity in 20–50% of patients.
Aim and objective: Main objective of study was to eval-
uate outcome measures for the surgical management of
infected necrotizing pancreatitis.
Methodology: A retrospective review was undertaken for
patients with pancreatic necrosis (CT documented nec-
rotizing pancreatitis and patients with positive needle
aspirate) from March 2004 to June 2009. Total of 47
patients were reviewed. Age, sex, etiology, complications
and mortality was reviewed.
Results: Forty four patients were operated (necrosecto-
my with postoperative closed lavage), three managed
conservatively. Etiology showed Alcohol abuse thirty
seven (79%), gall stone disease eight (17%), unknown
two (4%). There were 41 males and 6 females in our
review with median age 38 range (21–76). Seventy six
percent required ICU stay and median ICU stay was 11
(6–38 days). Overall 88% of patients had complications.
Common complications included ARDS (64%), Wound
infection (60%), Sepsis (38%), Renal Failure (26%),
Pneumonia (20%), Pancreatic Fistula (18%). Overall
mortality rate was 20%.
Conclusion: Aggressive approach and surveillance com-
bined with necrosectomy and closed lavage in patients
with infected pancreatic necrosis lead to signiﬁcant fall in
mortality. Organ failure and high CT score are reliable
predictors for mortality.
P-554
SPLENIC PARENCHYMAL
COMPLICATIONS IN PANCREATITIS
P. Patil1, A. Khalil2, M. Thaha1 and K. Ballantyne2
1Ninewells hospital and medical school, University of
Dundee; 2Queen Margaret hospital, Dunfermline, UK
Background: Splenic parenchymal involvement in
chronic pancreatitis is well documented and is being
increasingly reported in acute pancreatitis. The spectrum
includes perisplenic/ intrasplenic pseudocysts, sub- cap-
sular haematomas, intrasplenic haemorrhage, splenic
infarction and frank splenic rupture. We present a spec-
trum of splenic complications in pancreatitis from sub-
capsular haematoma to splenic rupture. The different
modalities of presentation and progression are depicted
with resultant differences in management. Literature has
then been reviewed to discuss the etiopathology, clinical
features and management of splenic parenchymal com-
plications of pancreatitis.
Cases: The ﬁrst patient had a sub-capsular haematoma
of the spleen. His condition deteriorated 24 hours after
admission caused by bleeding from the haematoma. This
was managed by performing an emergency splenencto-
my. The second patient was diagnosed with a splenic
parenchymal pseudocyst. She presented a week later with
splenic rupture that was treated by splenic artery em-
bolisation followed by surgery. The third patient had a
large sub-capsular splenic haematoma that was managed
conservatively with full resolution in six months.
Conclusions: Splenic parenchymal lesions complicating
pancreatitis are being increasingly recognised and re-
ported with the use of routine CT scans. Their presen-
tation can vary from left upper quadrant pain to that of a
haemodynamically unstable patient. Present evidence
suggests that conservative management should be at-
tempted in a stable patient. Risk factors for failure of
conservative treatment are large splenic parenchymal le-
sions, pseudocysts with ductal communication and pa-
tients with splenic vein thrombosis or segmental portal
hypertension. Prophylactic splenic artery embolisation is
an option in such patients with surgery reserved for the
unstable patient.
P-555
RETROPERITONEOSCOPIC
NECROSECTOMY IN MANAGEMENT
OF ACUTE NECROTIC PANCREATITIS
A. Sileikis, V. Beisa, E. Zdanyte, S. Jurevicius,
A. Tamosiunas and K. Strupas
Vilnius University Medical Faculty, Clinic of
Gastroenterology, Nephrourology and Surgery
Aims: Because of major morbidity and mortality after
open surgery in acute necrotic pancreatitis, regard to
minimally invasive necrosectomy approaches increased.
We report the results of a recently developed minimally
invasive technique that we adopted in 2007.
Methods: Patient was placed on right ﬂank and bent over
his loins by hump. Under guidance of ultrasound three
trocars with 10 mm in diameter were inserted into ret-
roperitoneal ﬂuid collections: ﬁrst on median axillar line
near the ending of XII rib, next two trocars on anterior
axillar and posterior axillar line accordingly. Through
these trocars were suction irrigator and forceps intro-
duced, then necrotic debris and pus were evacuated under
visual guidance. Finally drains were placed through tro-
cars punction sites, and on the next day continuous la-
vage of the cleansed cavity begin.
Results: There were six patients 25–58 (range) years old,
who underwent retroperitoneoscopic pancreatic necro-
sectomy in our hospital between April 2007 and January
2009. All patients had at least 30% pancreatic necrosis
with extensive retroperitoneal phlegmon on the left side,
proved by CT scan. Operations performed on 21st–60th
(range) day of illness, median 32nd day.
The median (range) postoperative hospital stay was 70
(35–100) days. All patients survived. One patient under-
went two additional procedures, two patients – one
additional procedure. Three patients had no requirement
for additional procedures. Two patients underwent
laparotomy because of bleeding and one because of
retroperitoneoscopilcally unremovable pancreas head
necrosis.
Conclusions: We assume, that minimally invasive tech-
niques should be considered as ﬁrst-choice surgical op-
tion in patients with acute necrotic pancreatitis, whenever
it is possible. Retroperitoneoscopic necrosectomy will be
most successful in cases with minor pancreatic necrosis
and considerable ﬂuid collection in left retroperitoneal
space.
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P-556
MINIMALLY INVASIVE PANCREATIC
NECROSECTOMY – HOW TO CHOOSE
THE BEST APPROACH?
A. Nagpal1, H. Soni1, S. Haribhakti1, N. Patel2 and
R. Naik2
1Department of Surgical Gastroenterology and Advanced
Laparoscopic Surgery, Haribhakti Surgical Hospital;
2Department of Surgical Gastroenterology, Sterling
Hospital
Introduction: With increasing technology and experience,
it is now possible to do pancreatic necrosectomy by
minimally invasive techniques. Variations in the extent
and location of the necrosis and the condition of the
patient determines a tailored approach to the treatment
of pancreatic necrosis.
Aim: To describe our experience with the use of lapa-
roscopic and retroperitoneoscopic methods for the
debridement of the necrosis and to determine the correct
approach based on local and systemic factors.
Methods: Eight patients were treated by various mini-
mally invasive techniques for infected pancreatic necrosis.
The mean duration of conservative management before
surgical intervention was 42 days. Evidence of infection
was the presence of gas in retroperitoneum (three cases)
and FNA positivity for infection (two cases).
Results: A total of eight patients underwent minimally
invasive pancreatic necrosectomy. Laparoscopic trans-
peritoneal necrosectomy was chosen in three patients
who had primarily single collection and in patient who
required simultaneous cholecystectomy. Retroperitoneo-
scopic (RP) necrosectomy was attempted in ﬁve patients
who had disease involving mainly the distal pancreas and
the left side of the abdomen. No patient needed conver-
sion to open surgery. However, two patients of the RP
necrosectomy group required repeat RP necrosectomy
and then open necrosectomy later on. Mean operating
time was approximately 100 min with mean post-opera-
tive hospital stay of 35.66 days. Three patients developed
controlled pancreatic ﬁstula after RP necrosectomy,
which healed conservatively. Mortality occurred in two
patients.
Conclusion: Laparoscopic approach is feasible in pa-
tients who have unilocular, retro-gastric ﬂuid collections
with the additional advantage of allowing simultaneous
cholecystectomy. Retroperitoneal approach may be se-
lected in patients with left-sided pancreatic necrosis with
predominantly semi-solid debris.
P-557
PANCREATIC NECROSECTOMY: AN
ALTERNATIVE APPROACH
Y.-J. Chang and V. Mittal
Providence Hospital and Medical Centers
Introduction: Open debridement has been the standard
of care for severe necrotizing pancreatitis, especially in
the presence of infection. However, open necrosectomies
imply high rates of complications and multiple surger-
ies. Various other methods including transgastric
retroperitoneal approach have been utilized with vary-
ing success.
Objective: We present an alternative approach of a
minimally invasive treatment of necrotizing pancreatitis.
Methods/results: A Hispanic female with severe gallstone
pancreatitis, presented with pancreatic necrosis and ret-
roperitoneal ﬂuid collection. CT-guided drainage was
unsuccessful and patient showed progressive sepsis.
Hand-assisted laparoscopic necrosectomy was performed
with near complete debridement of the pancreas. A 32
French chest tube was left in place with two other Jack-
son-Pratt drains creating a closed drainage system. Mul-
tiple irrigations and debridements were performed at the
bedside using endoscope via the retroperitoneal chest
tube. Procedure was successful without any revisit to the
operating room. Irrigations were feasible as an outpatient
without complications and allowing decrease in the length
of stay. Follow-up CT showed complete resolution.
Conclusion: Hand-assist minimally invasive pancreatic
necrosectomy along with endoscopic debridement is a
safe and effective alternative approach for severe pan-
creatic necrosis. A closed drainage system with large
drains is an easy and efﬁcient adjunct that avoids
multiple operations without complications and should be
considered an option for critically ill patients.
P-558
MULTIDISCIPLINARY MANAGEMENT
OF ACUTE PANCREATITIS
COMPLICATIONS: EXPERIENCE IN 104
PATIENTS
H. D’Agostino1, I. Suzuki2, G. Zibari1, H. Shokouh-
Amiri1, K. Crow1, S. Mogghadam1, R. Vea1, Q. Chu,
P. Jordan1, K. Manas1 and E. Jafarimehr1
1LSUHSC-Shreveport; 2Hospital Italiano de Buenos Aires
Purpose: To describe the outcome of patients with acute
pancreatitis complications managed by a hepatobiliary-
pancreatic (HBP) team.
Materials and methods: One hundred and four consecu-
tive acute pancreatitis patients underwent multidisci-
plinary management by surgeons, gastroenterologists
and radiologists. Clinical, laboratory and imaging ﬁnd-
ings were evaluated by the HBP team. The decision for
drainage of pancreatic collections, correction of biliary or
gastrointestinal obstruction, surgery and access for
nutritional support were evaluated daily and reported at
the weekly HBP conference. Parameters measured were
drainage type, operations performed, complications and
patient outcome.
Results: Of the 104 patients, 60 had mild pancreatitis and
44 had severe pancreatitis. Diagnostic workup included a
CT scan of the abdomen and pelvis for all patients and
MRCP for biliary pancreatitis patients (n = 18). All 104
patients had symptomatic pancreatic collections. Inter-
ventions performed included: percutaneous drainage, 104
patients; ERCP, 14 patients (pancreatic stent, 1 patient);
transgastric jejunostomy, 12 patients; surgery, 6 patients
(percutaneous drainage failure, 4 patients [cystogastros-
tomy, 2 patients; surgical drainage, 2 patients]; chole-
cystectomy, 2 patients); thoracentesis, 4 patients; inferior
vena cava ﬁlter, 2 patients. Worsening of the clinical
condition occurred in one patient with severe biliary
pancreatitis after insertion of a stent in the pancreatic
duct. Successful patient outcome with multidisciplinary
management was achieved in 87 (83.6%) patients. There
were 4 (3.8%) patients lost to follow-up and 13 (12.5%)
patients died of multiorgan failure.
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Conclusion: The interaction of HBP team members al-
lowed personalized expert diagnosis and treatment
selection for each patient with acute pancreatitis com-
plications. The multidisciplinary approach resulted in
assertive management and successful patient outcome
except for those with extremely severe pancreatitis.
P-559
INTERVENTION FOR SECONDARY
PANCREATIC INFECTIONS
FOLLOWING ACUTE PANCREATITIS
G. Srikanth, N. Shetty, T. L. V. D. Prasad Babu and
S. Sikora
Department of Surgical Gastroenterology, Manipal
Hospital, Bangalore
Background: Secondary pancreatic infections are poten-
tially fatal. We reviewed our experience with interven-
tions for these during the past seven years.
Materials and methods: Data on patients undergoing
intervention for secondary pancreatic infections was re-
viewed from a prospective data base. Clinical proﬁle,
organ failure, type and timing of interventions, postop-
erative morbidity and mortality were analysed.
Results: Thirty three patients underwent intervention for
secondary pancreatic infections. There were infected ﬂuid
collection (n = 1), pancreatic abscess (PA) (n = 12) and
infected pancreatic necrosis (IPN) (n = 20). The etiology
of acute pancreatitis was alcohol (13), gall stones (8),
trauma (2), hyperparathyroidism (1) and idiopathic (7).
Twelve (60%) and 3 (25%) patients had organ failure at
the time of ﬁrst intervention in IPN and PA groups
respectively. All excepting two patients had an interven-
tion after 21 days post onset of pancreatitis. The inter-
ventions were single in 25 patients (IPN 13, PA 12)
whereas seven patients had a step up approach (2–6
interventions). Interventions were open surgical (23),
minimal invasive (laproscopic/retroperitoneoscopic) (7)
and percutaneous (3).
Three (9%) patients with IPN died. Early morbidity
(external pancreatic ﬁstula, bleed, enterocutaneous ﬁs-
tula) was seen in 19 (58%) patients. Seventeen (IPN 12,
PA 5) patients had an external pancreatic ﬁstula which
closed at interval ranging from 14–140 days. Incisional
hernia (6), intestinal obstruction (2), pseudocyst (1) and
alcoholic hepatitis (1) were encountered on long term
follow-up.
Conclusions: Patients undergoing intervention for sec-
ondary pancreatic infections continue to carry signiﬁcant
early and late morbidity. Delayed timing of intervention
and judicious adaptation of minimally invasive ap-
proaches has resulted in improved results.
P-560
BACKGROUND AND DESIGN OF
RANDOMISED STUDY:
DECOMPRESSIVE LAPAROTOMY VS.
PERCUTANEOUS PUNCTURE IN
ABDOMINAL COMPARTMENT
SYNDROME IN ACUTE PANCREATITIS
D. Bajec, D. Radenkovic, N. Ivancevic, V. Jeremic,
P. Gregoric, A. Karamarkovic, B. Karadzic and
V. Djukic
Clinic for Emergency Surgery, Clinical Center of Serbia
and School of Medicine, University of Belgrade
Background: Development of abdominal compartment
syndrome (ACS) in patients with severe acute pancrea-
titis (SAP) has a strong impact on the course of disease.
Number of patients with this complication increases
during the years due more aggressive ﬂuid resuscitation,
much bigger proportion of patients who is treated con-
servatively or by minimal invasive approach, and efforts
to delay open surgery. There have not been standard
recommendations for a surgical or some other interven-
tional treatment of patients who develop ACS during the
SAP.
Aim: The aim of DECOMPRESS study is to compare
decompressive laparotomy with temporary abdominal
closure and percutaneous puncture with placement of
abdominal catheter in these patients.
Methods: One hundred patients with ACS will be ran-
domly allocated to two groups: I) decompressive lapa-
rotomy with temporary abdominal closure or II)
percutaneous puncture with placement of abdominal
catheter. Patients will be recruited from ﬁve university
hospitals in Belgrade during two years period. The pri-
mary endpoint is the mortality rate within hospitalisa-
tion. Secondary endpoints are time interval between
intervention and resolving of organ failure and multi
organ dysfunction syndrome, incidence of infectious
complications and duration of hospital and ICU stay. A
total sample size of 100 patients was calculated to dem-
onstrate that decompressive laparotomy with temporary
abdominal closure can reduce mortality rate from 60%
to 40% with 80% power at 5% alpha.
Conclusion: DECOMPRESS study is designed to reveal
a reduction in mortality and major morbidity by using
decompressive laparotomy with temporary abdominal
closure in comparison with percutaneous puncture in
patients with ACS during SAP.
P-561
TRANSARTERIAL EMBOLIZATION OF
PSEUDOANEURYZMS OF CELIAC
TRUNK ARTERIES DUE TO
NECROTIZING PANCREATITIS
A. Varabei1,2, D. Karpovich2 and V. Lurye1,2
1Surgical Department of Postgraduate Medical Academy;
2Republican Centre of Surgical Gastroenterology
Background: Arterial bleedings after acute pancreatitis
from pseudoaneuryzms (PA) through Virsung duct and
papilla Vateri in to the duodenum is a very important
and not rare problem of emergency abdominal surgery
now.
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Aims: Diagnosis and mini-invasive treatment of such
difﬁcult kind of duodenal bleeding as virsungorragia due
to celiac trunk branche´s PA.
Methods: Experimental base of safety the lineal artery
embolization at 16 dogs and 31 emergency celiacography
after virsungorragia and exclusion of other reasons of
intestinal bleedings.
Results: Eleven PA was detected (lienalis artery – seven,
including double PA – one; gastroduodenalis artery –
four) after necrotizing pancreatitis (eight), Beger proce-
dure (one), trauma (one), bedsore by choledocholith (1).
Coil transarterial embolisation of PA was performed in
nine cases with success and stopping of bleeding. Acute
(caudal) pancreatitis was registered in one case. After
open surgery one patient dyed.
Conclusion: Interventional radiology with coil emboli-
zation is a successful way in diagnosis and treatment of
the duodenal bleeding due to celiac trunk arteries PA.
P-562
PANCREATIC OR PERIPANCREATIC
NECROSIS CAVITY MANAGEMENT: A
MODIFIED INTERNAL DRAINAGE
OPERATIVE PATTERN – OUR
EXPERIENCE
K. Papapolychroniadis1, D. Paramythiotis1,
E. Karamanlis1, O. Giouleme2, S. Karampatsou2,
T. Didaggelos2, A. Ioannidis1, I. Palios1 and
E. Fahantidis1
11st Propedeutic Surgical Department, Aristotle
University of Thessaloniki, A.H.E.P.A. Hospital
Thessaloniki, Greece; 21st Propedeutic Internal Medicine
Department, Aristotle University of Thessaloniki,
A.H.E.P.A. Hospital Thessaloniki, Greece
Background: Management strategies for pancreatic
necrosis are in process of evolution. Adequate necrotic
material drainage may be achieved by constitution of a
breit design stoma between necrosis cavity and gastric
wall if the decision is over an open surgical procedure.
Aim: The aim of this study is to present our experience of
this effective surgical technique.
Patients and methods: We have reviewed the results of
surgery for pancreatic necrosis patients over 10 years
period (1998–2008) who treated in 1st Propedeutic Surgi-
cal Department. Twenty ﬁve (25) patients underwent open
surgical necrosis material aspiration and removal, fol-
lowing adequate peripancreatic organs mobilization and
wide exposure of lesser sac, retroperitoneum and pseudo-
cyst wall. After wish necrotic cavity lavage, a large design
cavitary-gastrostomy was fashioned more than 9 cm.
Postoperative lavage was applied to necrotic cavity with
normal saline 100–200 mL/h via a nasogastric tube, for the
ﬁrst 7–10 days in relation lavage drainage clearance.
Results: We had no serious morbidity, no infection re-
lapse and no deaths. A bilio-external ﬁstula complication
was treated surgically.
Conclusion: A wise team decision making should be
based on the patients individual needs, sepsis control and
correct timing. If open surgical approach is decided, the
main target is pancreatic necrosis, intra- and postopera-
tive, removing. This is succeeded by a large design stoma
communication between necrotic cavity and gastric lu-
men. A transient nasogastric tube lavage should be ap-
plied the ﬁrst postoperative days.
P-563
PANCREATICOPLEURAL FISTULA AS
A COMPLICATION OF CHRONIC
PANCREATITIS: CLASSIFICATION AND
SURGICAL TREATMENT
M. Straka, M. Sabol and V. Straka
St. Elisabeth Cancer Institute, Department of Surgical
Oncology, Bratislava
Background: Pancreaticopleural ﬁstulas are rare, typical
internal pancreatic ﬁstulas arising most of all during an
acute exacerbation of underlying chronic alcohol - asso-
ciated pancreatitis.
Methods: Between January 1997 and August 2009, 259
patients with chronic pancreatitis underwent surgical
treatment. Clinical data of six patients with chronic
alcohol-associated pancreatitis were analyzed in whom
pancreaticopleural ﬁstula arised always with left-sided
pleural cavity.
Results: In all patients we conﬁrmed pancreaticopleural
ﬁstula with disruption of panreatic duct by means of
ERCP and/or CT and perioperative ﬁstulography. Vi-
sualisation of anatomy and location of pancreatic duct
obstruction is important. In one patient with proximal
pancreatic duct obstruction successful duodenopancre-
atic drainage was performed by endoscopic stent place-
ment. Five patients were operated on after initial
conservative treatment failure. In two patients we created
latero-lateral ﬁstulopancreaticojejunostomy Roux-en-Y.
In one patient we made segmental (central) resection of
the proximal part of pancreas body and termino-terminal
pancreaticojejunostomy Roux-en-Y. Two patients with
communicating pancreatic pseudocyst were solved by
pseudocystogastrostomy. Type of procedures matched
pathomorphologic ﬁnding of pancreatic duct. Postoper-
ative course in all patients was complications free. Post-
operative mortality was 0.0%.
Conclusion: Initial way of treatment is short-term con-
servative practice. In the case of its failure invasive ap-
proach on the basis of imaged pancreatic duct anatomy
should proceed. Fistula is caused by an obstructed pan-
creatic duct followed by its disruption. The aim is to
provide the outﬂow of the pancreatic duct or its part that
possessed impaired drainage. From the surgical strategy
point of view and character of pathomorphologic ﬁnding
of pancreatic duct we classiﬁed pancreaticopleural ﬁstu-
las into three types.
P-564
RESULTS OF BEGER, FREY AND BERN
PROCEDURES FOR TREATMENT OF
CHRONIC PANCREATITIS
V. Egorov1, A. Schastny2, V. Vishnevsky1,
T. Shevchenko1, O. Zhavoronkova1, R. Petrov1 and
A. Siatkovsky2
1The Vishnevsky Institute of Surgery, Moscow; 2Vitebsk
State Medical University, Vitebsk
Background: More than half of the patients with chronic
pancreatitis (CP) need surgery due to intractable chronic
pain. Investigations suggest that inﬂammatory mass in
the head of the pancreas is the trigger of the chronic
inﬂammatory process in the gland and the resection of
this mass must be the critical point of the procedure.
Objective: To assess the results of different duodenum–
preserving pancreatic head resections (DPPHR) for CP.
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Methods: Prospective analysis of surgical treatment of
220 patients, on whom Beger (101), Frey (59) and Bern
(60) procedures had been performed from 2002 to 2008.
Long–term results and quality of life (QL) were assessed
for 174 (79%) patients in 1–6 years with the help of the
SF-36 questionnaire.
Results: Demographic and clinical parameters, including
the pancreatic head size were comparable. The mean
operating time for Beger, Frey and Bern procedures was
equal to 366 ± 64 min, 202 ± 39 min and 288 ±
41 min (P < 0,05), general morbidity – 25%, 11% and
13% (P < 0.05), blood loss – 830 ± 120 mL,
440 ± 150 mL and 650 ± 170 mL (P < 0.05), and the
postoperative hospital stay – 19, 10 and 12 (P < 0.05). A
signiﬁcant difference was found on these subjects be-
tween the Beger procedure and other DPPHR variants.
Lethality was zero. The QL differs insigniﬁcantly, how-
ever full pain control, social and labor rehabilitation were
achieved after the Beger procedure in 94% and 93%,
after Bern in 93% and 93% and after Frey in 80% and
77%. There were no new cases of diabetes mellitus after
one year follow-up.
Conclusion: The Beger procedure and its Bern modiﬁ-
cation more frequently provide full and long–lasting pain
control as compared to the Frey procedure. The Bern
operation is as effective as a classical Beger for pain
management, giving lesser morbidity, blood loss, oper-
ating time and hospital stay.
P-565
BILATERAL THORACOSCOPIC
SPLANCHNICECTOMY FOR
INTRACTABLE PAIN IN CHRONIC
PANCREATITIS
P. Kumar, N. Mohan and A. Ramesh
Meenakshi Mission Hospital and Research Center,
Madurai, India
Background: The management of intractable pain in
chronic pancreatitis (CP) is challenging. The manage-
ment options vary from non-operative to various oper-
ative procedures. The greater, lesser, and least splanchnic
nerves carry sympathetic ‘pain’ innervations to the upper
abdominal viscera, including the pancreas, from the 5th
to 8th, 9th to 10th, and 11th thoracic ganglia, respec-
tively. Thoracoscopic splanchnicectomy (TS) is one of
the management options in intractable pain. Hereby we
describe our experience with TS, outcomes like feasibil-
ity, pain relief.
Materials and methods: Retrospective analysis of pro-
spective database was analysed for the period January
2000 – December 2008.
Results: Total number of chronic pancreatitis was 352.
Majority were tropical (idiopathic) pancreatitis > 90%.
Intractable pain relief was the indication for intervention
– either endoscopic or surgical. More than 95% had prior
surgical intervention for CP and only two patients
underwent primary TS, due to concomitant malignancy
and portal hypertension. Thorascopic splanchnicectomy
was attempted in about 24 cases (6.8%), was completed
successfully in 22 cases (91.6%). Bilateral splanchnicec-
tomy was performed in all cases simultaneously. The
reason for failure to perform TS was dense adhesions.
Mean duration for surgery was 30.5 min (21 – 70 min).
Intra-op desaturation was experienced in two cases,
bleeding from intercostals vessels in one case. ICD
placement was done selectively. The mean VAS score
improved from 7–10 preoperatively to 2–5 post opera-
tively, which lasted for mean of six months. Need for
analgesia requirement decreased post operatively. No
mortality in present series. Mean hospital stay was
3.5 days. Majority had improved QOL with weight gain
and return to employment.
Conclusion: Thorascopic Splanchnicectomy reduces pain
and improves quality of life. Better patient selection im-
proves outcomes and pain relief decreases over a period
of time.
P-566
MODIFIED DUVAL PROCEDURE FOR
SMALL-DUCT CHRONIC
PANCREATITIS WITHOUT HEAD
DOMINANCE
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1, O. Aramaki2 and S. Amano2
1Socila Insurance Yokohama Central Hospital/Surgery;
2Nihon University School of Medicine / Surgery
Background/aims: In the case of small duct chronic
pancreatitis, surgery for pain relief is broadly divided into
resection and drainage procedures. These procedures
should be selected according to the location of dominant
lesion, diameter of the pancreatic duct, and extent of the
disease. The appropriate procedure for the treatment of
small-duct chronic pancreatitis, especially, small-duct
chronic pancreatitis without head dominance, remains
controversial. We developed the modiﬁed Duval proce-
dure for the treatment of small-duct chronic pancreatitis
without head dominance and determined the efﬁcacy of
this procedure.
Method: We retrospectively studied 14 patients who
underwent surgical drainage with or without pancreatic
resection for chronic pancreatitis with small pancreatic
duct (< 7 mm) without head dominance. These patients
were divided into two groups; the modiﬁed Puestow
procedure group and the modiﬁed Duval procedure
group.
Results: No complications occurred in the modiﬁed
Duval group. In the modiﬁed Puestow procedure group,
complete and partial pain relief were observed in 62.5%,
and 37.5% of patients respectively. In contrast, complete
pain relief was observed in all the patients of the modiﬁed
Duval procedure group.
Conclusion: Our modiﬁed Duval procedure is useful and
should be considered the appropriate surgical technique
for the treatment of small-duct chronic pancreatitis
without head dominance.
P-567
CHRONIC PANCREATITIS ASSOCIATED
WITH CHOLEDOCHAL CYST: REPORT
OF TWO CASES
S. Shah, D. Desai, A. Joshi and P. Abraham
PD Hinduja Hospital, Mumbai, India
Background: Choledochal cysts are often associated with
an anomalous pancreatobiliay junction (APBJ). This re-
sults in an increased incidence of acute pancreatitis.
Chronic pancreatitis is extremely rare in association with
choledochal cysts. We report two such cases.
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Patients: Case 1- A 26 year old lady presented with
cholangiitis. Ultrasonography and CT scan revealed a
choledochal cyst Type 1 S with chronic pancreatitis and
calciﬁcation in the uncinate process. As she had no
symptoms of pancreatitis, complete cyst excision alone
was carried out. Over a follow up of 3 years, she has not
been troubled by the pancreatitis.
Case 2: A 30 year old man presented with abdominal
pain radiating to the back. Liver function tests were
normal and lipase was twice normal. Imaging revealed a
Type 1 F choledochal cyst with a uniformly dilated
pancreatic duct with calculi in the head of pancreas. A
cyst excision and a lateral panceticojejunostomy were
carried out with symptom relief.
Discussion: Choledochal cysts are uncommon and
chronic pancreatitis in this setting is even rarer. The
APBJ in this setting may contribute to these changes. It
was interesting to note that in both cases, the pathology
was restricted to the region of the head and uncinate
process of the pancreas.
P-568
SURGICAL MANAGEMENT OF
CHRONIC PANCREATITIS WITH SMALL
PANCREATIC DUCTS
M. Wayne, A. Cooperman, F. Soto and E. Velazquez
St. Vincent’s Hospital, Manhattan
Background: Symptomatic patients with chronic pan-
creatitis and a small pancreatic duct who ‘fail’ stent and
medical therapy represent a unique surgical challenge.
Many of these patients do not have alcohol as the
underlying etiology of their pancreatitis. Pain is the
predominant symptom. At presentation patients may be
younger than alcoholic patients and do not usually have
exocrine or endocrine insufﬁciency. Many propose sur-
gical resection, including total pancreatectomy rather
than duct decompression for this entity. We have utilized
duct decompression as our ﬁrst choice and report our
experience in this population.
Aim/Objective: To demonstrate a safe and efﬁcient ap-
proach to surgically treat symptomatic patients with
chronic pancreatitis and a small pancreatic duct.
Methods: Retrospective case series. Between the 2005
and 2009, of the patients that underwent surgical
decompression of the pancreatic duct during, 12 had
small duct disease. The preferred approach was through
the gastrohepatic omentum and longitudinal duct
decompression. This approach is facilitated by preoper-
ative pancreatic duct stent placement.
Results: All patients in this study had signiﬁcant
improvement after surgery and are pain free. Two pa-
tients had subsequent surgery. One patient underwent a
whipple resection for cancer in the head of the gland;
another had a whipple resection four years after surgery
because of recurrent pain and progressive disease in the
head of the gland.
Conclusions: Patients in this study had signiﬁcant
improvement after surgery and are pain free.
P-569
LATERAL PANCREATICO-
JEJUNOSTOMY FOR CHRONIC
PANCREATITIS WITH PANCREATICO-
PLEURAL FISTULA
S.-H. Chang, H. W. Lee and I. J. Yun
Konkuk University School of Medicine
A 34 year-old female, with a history of recurrent acute
pancreatitis, presented at our hospital with back pain.
She had a multiple admission history for treatment of
acute pancreatitis. She had drunk one or two bottles of
Soju, 25% of 360 mL, which is a popular alcoholic drink
in Korea and had stopped for six months. Abdominal CT
showed a pancreatic pseudocyst with abscess formation
which extends to the paraesophageal area. Chest radiog-
raphy showed a marked amount of left pleural effusion.
Thoracentesis revealed an exudate of amylase-rich ﬂuid.
During admission, she complained left chest pain and a
pancreaticopleural ﬁstula was detected on the abdominal
CT. After three months of conservative management,
there had been no improvement of the ﬁstula; therefore,
the authors decided to operate. The pancreas was hard
and atrophic, with severe adhesion to adjacent tissues.
Several pancreatic duct stones were found intraopera-
tively, with a pseudocyst which was also found at the tail
portion. A suspicious ﬁstula entrance to the pleural
cavity was observed at the posterior aspect of the tail,
which was wrapped with surrounding tissue and could
not be dissected. A lateral pancreaticojejunostomy was
performed. The pancreatic duct was exposured from tail
to head of pancreas. Before making anastomosis, the
ﬁstula entrance was cleared and the content was aspi-
rated. And then it was left opened and included in
anastomosis. Decrease in the amount of pleural effusion
was observed, and the patient was discharged on the 15th
postoperative day, without any complications. There was
no evidence of recurrence at the 12 months follow-up.
P-570
ELECTIVE SURGERY FOR
SYMPTOMATIC CHRONIC
PANCREATITIS
A. Shabunin1, V. Bedin2, A. Lukin3, M. Tavobilov4,
D. Grekov4, D. Shikov4 and K. Dalgatov4
1Botkin’s Memorial Hospital, Prof., Head of Surgery
Department, Moscow, Russia; 2Botkin’s Memorial
Hospital, Head of HPB - Surgery Unit, Moscow, Russia;
3Botkin’s Memorial Hospital, HPB - Surgery Unit,
Moscow, Russia; 4Botkin’s Memorial Hospital, HPB -
Surgery Unit, Moscow, Russia
Background\Aim: Variation in indication for elective
surgery for symptomatic chronic pancreatitis can provide
better outcome.
Material and methods: One hundred and forty ﬁve pa-
tients admitted surgery for chronic symptomatic pan-
creatitis from 2003 to 2009. Indication for surgery was
pancreatic cystic lesion, main pancreatic duct dilatation,
biliary hypertension, duodenal compression. All the pa-
tients were divided into three groups: those went mini-
invasive surgery – 51 (35,2%), resective operations - 67
(46,2%) and main duct drainage surgery – 27 (18,6%).
Results: Thirty seven patients with chronic pancreatic
cyst and without pancreatic duct connection were man-
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aged by external cyst drainage. Due to complex exami-
nation (CT, MRCP, NAB) cystic tumour was excluded.
Six patients with chronic cysts over 5 cm in diameter and
cystic wall closely attached to gastric wall underwent
endoscopic cystogastrostomy procedure. Eight patients
with the jaundice due to bile duct compression underwent
endoscopic bile duct stenting. Surgical treatment with the
procedures being categorized broadly as main pancreatic
duct drainage, duodenum-preserving pancreatic head
resection (DPPHR) or Whipple pancreatoduodenectomy
(PD). Sixty seven patients underwent resective surgery.
Abdominal pain, pancreatic head > 4 cm, biliary
hypertension, tumour suspicion were indication for sur-
gery. Twelve patients underwent PD; DPPHR – three
patients; Bern modiﬁcation of DPPHR – in four cases and
Frey operation in 17 patients. Distal pancreatic resection
was done in 31 cases and two of them laparoscopically.
Twenty seven patients with the main duct dilatation over
5 mm underwent drainage surgery (Puestow procedure).
In-hospital mortality – 1 (1.1%). Elective surgery for
symptomatic chronic pancreatitis provide better outcome.
P-571
UNUSUAL SCENARIO UNUSUAL
SOLUTIONS! GASTRIC TUBE FOR
BILIARY RECONSTRUCTION
S. Sikora, G. Srikanth, T. L. V. D. Prasad Babu,
N. Shetty and T. Ramcharan
Department of Surgical Gastroenterology, Manipal
Institute of Liver and Digestive Diseases
Background: A Roux –Y hepaticojejunostomy is the
standard method of restoration of bilio-enteric continuity
following resection of a Hilar cholangiocarcinoma.
Occasionally, there is difﬁculty in the Roux loop reaching
up to the hilum, due to a thickened or shortened small
bowel mesentery or shortened mesocolon, and estab-
lishing a tension free RY-HJ is technically challenging.
Methods: A ﬁfty-year-old patient presented with history
of progressive, painless jaundice and pruritus associated
with recurrent episodes of cholangitis of six weeks
duration. He had signiﬁcant anorexia and weight loss
since the past two months. He had no previous surgery
and no associated medical disorders. On evaluation with
a CT scan and MRCP he was diagnosed to have a
malignant hilar block with a dilated CBD possibly due to
block at the lower end. He underwent an ERC for eval-
uation of lower end; no abnormality was detected. Post
procedure he developed severe necrotizing pancreatitis
for which he was managed conservatively and required
hospitalization for two weeks. Three weeks post pan-
creatitis, he was taken up for surgery; a left hepatectomy
with hepatoduodenal clearance was performed. Due to
the necrotizing pancreatitis, the small bowel mesentery
was shortened and bringing the Roux loop for a hepa-
ticojejunostomy was technically difﬁcult. A vascularised
gastric tube based on Right gastroepiploic artery was
designed and a bilio-enteric anastomosis was performed.
Postoperative period was uneventful except for wound
infection. He was discharged on day 10 postoperative
and the trans-anastomotic T-tube was extracted endo-
scopically after three weeks.
Conclusions: Vascularised gastric tube (VGT) for biliary
reconstruction could be an additional tool in the arma-
mentarium of an HPB surgeon in difﬁcult scenario. The
anatomical proximity and good vascularity ensures a safe
anastomosis and it also provides a good endoscopic ac-
cess for future intervention.
P-572
CLINICAL FEATURES AND TREATMENT
OF SUMP SYNDROME FOLLOWING
HEPATICOJEJUNOSTOMY
G. Marangoni1, A. Amir2, F. Walid3, N. Heaton2 and
M. Rela2
1St. Thomas’ Hospital London; 2King’s College Hospital
London; 3American University of Beirut-Medical Centre
Background: Cholangitis after Roux-en-Y hepaticojej-
unostomy is usually caused by anastomotic stricture. A
small number of cases present without evidence of
obstruction and are ascribed to reﬂux of gastro-intestinal
content into the biliary tree above the anastomosis (sump
syndrome). Despite prophylactic rotating antibiotic
therapy the cholangitis episode may be severe and life-
threatening.
Methods: From 2001 to 2006 six patients who had
undergone a hepaticojejunostomy presented to our
Institution with recurrent episodes of biliary sepsis.
Anastomotic stricture was excluded with liver MRI/
MRCP and percutaneous transhepatic cholangiogram
(PTC). Barium meal showed reﬂux of contrast into the
biliary tree in all patients. Three patients had a short
jejunal Roux limb (less than 50 cm) on pre-operative
imaging.
Results: Five patients underwent surgery and one patient
had two operations. One patient had a Tsuchida antire-
ﬂux valve and subsequently underwent lengthening of the
Roux loop. Three patients had lengthening of the Roux
loop; one patient underwent re-do hepaticojejunostomy
and one patient had concomitant revision of hepati-
cojejunostomy and lengthening of Roux loop. Two pa-
tients are cholangitis-free two and four years after
surgery respectively; two patients still experience mild
episodes of cholangitis and one is being investigated for
bile reﬂux into stomach/oesophagus.
Conclusions: An adequate length of the Roux loop is
important to prevent reﬂux. However Roux loop
lengthening to 60 cm or more does not always resolve the
problem and cholangitis, although generally less frequent
and severe, may recur despite appropriate reconstructive
or antireﬂux surgery. In these cases life-long rotating
antibiotics is the only available measure.
P-573
THE EFFECTIVENESS OF EXTERNAL
DRAINAGE OF BILE DUCT IN
PANCREATICODUODENECTOMY: A
SINGLE SURGEON’S EXPERIENCE
K. H. Kim1, S. G. Lee1, S. Hwang1, C. S. Ahn1,
D. B. Moon1, T. Y. Ha1, G. W. Song1, D. H. Jung1,
K. W. Kim1, N. K. Choi1, Y. D. Yu1, G. C. Park1,
P. J. Park1, J. R. Choi1 and D. S. Kim2
1Asan Medical Center, Korea; 2Korea University Hospital
Background: The surgery-related complication rate of
pancreaticoduodenectomy (PD) is still very high, reach-
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ing 41%. The main cause of such complication is the
leakage of pancreaticojejunostomy (PJ). Here we report
the effectiveness of external drainage of bile duct in PD
to prevent the leakage of PJ.
Patients and methods: Seventy nine patients who under-
went PD using a single layer continuous suture between
pancreatic parenchyma and jejunum after duct-to-mu-
cosa anastomosis (KH Kim et al. Hepatogastroenterol-
ogy 2007, 54: 1368–72) by a single surgeon from April
2005 to December 2008 were enrolled in this study. The
deﬁnition of PJ leakage that extracts from lots of
manuscripts is as follows; drainage of 3 50 mL amylase-
rich (> 10 000 u/L) and pus-like ﬂuid with symptoms on
or after 7 ~ 10 days. The external drainage of bile duct by
a pigtail drain was performed at the intraoperative ﬁled
via the retrograde transhepatic approach.
Results: There were 35 no external drain (NED) group
and 44 external drain (ED) group.
No statistical differences between both groups were
observed in age, sex, number of total complication,
pancreatic duct size, pancreatic texture and duration of
hospital stay. There was a statistical difference in the
leakage of PJ between both groups (4 in NED vs. 0 in
ED, P = 0.03).
Conclusions: The ED group showed no PJ leakage
according to the overlapping deﬁnition. The external
drainage of bile duct with a pigtail drain to decompress
jejunum and to drain pancreatic and bile juice is thought
to be a useful method to prevent the complications of
pancreatic leakage.
P-574
PROGNOSTIC FACTOR AND FAILURE
PATTERN OF KLATSKIN’S TUMOUR
AFTER SURGICAL RESECTION
S.-H. Chon
Division of Hepato-Biliary and Pancreas Surgery,
Department of Surgery, Asan Medical Center, University
of Ulsan College of Medicine, Seoul, Korea
Background: The 5-year survival rate after Klatskin
tumour resection has reported 20% to 40%, and analysis
of prognostic factors with current surgical technique has
been difﬁcult due to a small number of cases.
Aims/Objectives: To assess the survival rate of Klatskin’s
tumour after surgical resection, to analysis the prognostic
factors, and to evaluate recurrence pattern.
Methods: A retrospective review of 152 consecutive
cases, which underwent operation between January 2003
and December 2008 at a Division of Hepato-Biliary and
Pancreas Surgery, Department of Surgery, Asan Medical
Center was carried out. Clinicopathological data were
analyzed and univariate and multivariate analyses
against outcome was employed to determine the prog-
nostic signiﬁcance of a variety of factors including exci-
sion margin characteristics, AJCC, sixth edition,
perineural invasion, lymphovascular invasion, histologi-
cal grade, and postoperative therapy. And we evaluated
recurrence pattern.
Results: One hundred and twenty four patients under-
went resection (resection rate 81.6%). Median survival
duration of non-resected patients was 7.3 months (95%
CI: 0.82–13.78). Five years survival rate of resected pa-
tients was 24.6%, and median survival duration was
26.4 months (95% CI: 20.9–31.9). Resection margin
status had no inﬂuence on survival rate and lympho-
vascular invasion, postoperative therapy also had no
inﬂuence on survival rate. Factors correlating with
shorter survival were Perineural invasion, poor histo-
logical differentiation, lymph node metastasis in univar-
iate analysis of prognosis. Histological differentiation
had signiﬁcation by multivariate analysis. Eighty four
(67.7%) among 124 patients recurred during ﬂow-up.
Local recurrence was 28 (33.4%), local and systemic 21
(25.0%), and systemic recurrence 35 (41.7%).
Conclusions: Surgical outcome of Klatskin’s tumour
resection may be decided by tumour biology. So
improvements in adjuvant therapy are essential for
improving long-term out come.
P-575
MANAGEMENT OF PATIENTS WITH
MRSA-BACTIBILIA FOR
HEPATOBILIARY RESECTION
D. Takara, T. Ebata, G. Sugawara, H. Nishio,
T. Kokuryo, Y. Yokoyama, N. Tsunoda, T. Igami,
M. Fukaya, K. Uehara and M. Nagino
Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine
Background: Methicillin-resistant Staphylococcus aureus
(MRSA) is resistant to various antibiotics, and it is dif-
ﬁcult to manage MRSA -bactibilia in the schedule of
hepatobiliary resection.
Objective: To deﬁne appropriate management by com-
paring the clinical course, divided by presence or absence
of MRSA-positive bactibilia.
Methods: From January 2001 to September 2009, 350
patients who underwent hepatobiliary resection were
retrospectively reviewed. Bile culture was routinely per-
formed once a week during pre- and post-operative
period. Incidence of surgical site infection (SSI) was
compared.
Results: Among 350 patients, 14 (4.0%) patients had
preoperative MRSA bactibilia (Group A); 246 patients
had bactibilia other than MRSA (Group B); and 90 pa-
tients had no evidence of contamination (Group C). All
14 patients in Group A had hilar cholangiocarcinoma
and underwent percutaneous (n = 13) or endoscopic
(n = 1) billiary drainage, six of whom had cholangitis
and two of whom had MRSA bacteremia preoperatively.
For the treatment of these preoperative MRSA-infec-
tions, ﬁve patients received an administration of Vanco-
mycin (VCM) preoperatively. VCM was administered
during intraoperative or postoperative periods in all pa-
tients, four of whom were administered only on the
operative day. SSI was found in seven (50%) of 14 pa-
tients in Group A: wound infection in ﬁve, intraabdom-
inal abscess in two, and bacteremia in two, with
overlapping. SSI was found in 82 (33%) and 19 (21%)
patients in the Group B and C, respectively, giving no
statistically signiﬁcant difference among three groups
(p = 0.06). Postoperative hospital stay averaged 34, 42,
and 38 days in Group A to C, respectively (p = 0.26).
Conclusion: The incidence of SSI in patients with
MRSA-positive bactibilia is acceptable and similar to
that in patients without. The management comprising of
appropriate biliary drainage and minimal administration
of VCM can enhance the safety for hepatobiliary resec-
tion in patients with MRSA-bactibilia.
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P-576
SURGICAL MANAGEMENT OF HILAR
CHOLANGIOCARCINOMA; A TERTIARY
CENTER EXPERIENCE IN EGYPT
M. Osman, H. E. Soliman and T. Ibrahim
Department of HBP surgery National Liver Institute
Menouﬁa University
Background: Usually primary cancer originating in the
hepatic duct conﬂuence (Klatskin Tumour) is regarded as
unresectable at diagnosis and therefore percutaneously or
endoscopically placed stents have been advocated. Sur-
gery provides the only possibility for a cure.
Purpose: To review the result of surgical management of
hilar cholangiocarcinoma at a tertiary hepatobiliary ser-
vice center in Egypt.
Patients and methods: Between 2000 and 2009, 37 pa-
tients affected by Klatskin tumour were observed. They
were seven women and thirty men underwent surgical
resection at the National liver institute, Menouﬁa uni-
versity and another two private centers in Egypt. The
mean age was 52 years ± 2.5. Twenty ﬁve patients had
curative resection (7 hilar resection, 5, 16 had hilar
resection combined with partial hepatectomy and two
patients had hilar resection with resection of the portal
vein conﬂuence). Ten patients had palliative resection
and surgical drainage by hepaticojejunostomy in eight
patients and two by tube drainage.
Results: Two in-hospital deaths occurred after Rt. Hep-
atectomy. Postoperative morbidity was 15%. Patients
were regularly followed. Twenty ﬁve patients died and 10
were alive at the time of this study. The 1, 2 and 3-year
survival after a curative resection was 74%, 54% and
34%. The median survival was 22.5 ± 10 months. One
year survival in the palliative biliary resection and sur-
gical drainage group was 20%.
Conclusion: Aggressive surgical treatment of Klatskin
tumour can improve the survival of patients. Hepatic
resection including the caudate lobe is often performed in
order to obtain microscopic tumour-free margins and
curative resection. Surgical treatment is characterized by
high technical difﬁculties, and better results can be
achieved by hepatobiliary surgical teams.
P-577
POSTOPERATIVE LIVER FAILURE IS
ASSOCIATED WITH IMPAIRED LIVER
REGENERATION AFTER MAJOR
HEPATECTOMY IN PATIENTS WITH
BILIARY TRACT MALIGNANCIES
A. Okaniwa, A. Kato, F. Kimura, H. Shimizu,
H. Yoshidome, M. Ohtsuka and M. Miyazaki
Department of General Surgery, Graduate School of
Medicine, Chiba University
Background: The aim of the present study was to deter-
mine whether the liver regeneration during early after
major hepatectomy has relation to developing postoper-
ative hepatic failure, in addition to identifying the pre-
dictive factors for postoperative liver regeneration.
Patients and methods: This retrospective study involved
67 patients with biliary tract malignancies who under-
went extensive hepatectomy. Clinical factors and liver
volumetric changes determined by CT volumetry and CT
attenuation values (CT-AV), which may reﬂect the loss of
actual hepatic functional mass, were compared between
patients with and without postoperative hepatic failure.
Results: On multivariate analysis, postoperative lower
CT-AV was the only independent risk factor related to
both postoperative hyperbilirubinemia and fatal outcome
due to postoperative hepatic failure. Presence of preop-
erative obstructive jaundice and higher ICGR15 were the
factors affecting postoperative lower CT-AV.
Conclusion: Morphological liver regeneration and hepa-
tic functional mass after major hepatectomy in patients
with biliary tract malignancies may have an inﬂuence on
postoperative hepatic failure.
P-578
PREOPERATIVE BILIARY DRAINAGE
AND BILIARY CONTAMINATION IN
PANCREATODUODENECTOMY
A. Kausar, L. Tomkow, R. Deshpande, M. Manu,
D. Sherlock and D. O Reilly
North Manchester General Hospital
Background: Preoperative biliary stents have been
implicated in biliary tract contamination and post oper-
ative complications after pancreatoduodenectomy (PD).
However, as most patients have an obstructed biliary
system at presentation, preoperative drainage remains a
common practice.
Aims: To determine the prevalence of biliary tract colo-
nization and its impact on post operative complications.
Methods: Review of our prospectively maintained data-
base of patients who had a PD for all indications from
2007–2009. Further information was obtained on
microbiology results from the hospital computerized re-
cords.
Results: Seventy nine patients were identiﬁed who had
both undergone a PD and had an intraoperative bile
culture swab sent for microbiology at the time of division
of the common bile duct.
65 of 79 (82%) had prior biliary instrumentation (ERCP
and/or PTC) at the time of surgery and 59 (75%) had a
stent in situ.
Sixty nine (87%) of bile cultures had positive results of
whom 57 had a stent in situ. Of the 10 cultures with no
growth, only two had been stented (p = 0.0001). Infec-
tive organism included escheria coli (9), enterobacteria-
ceae (12), candida (5), clostridia (2), streptococci (8),
stenotrophomona (1) as well as mixed coliforms and skin
organisms. All infective complications were in the
patients who had positive biliary cultures. The risk of
an infective complication with a stent was 24% (14/59)
vs. 10% (2/20) without a stent (p = ns). However only in
four wound infections was the same organism found as
had grown on the bile culture. Neither the presence of a
biliary stent nor biliary colonization had any statistically
signiﬁcant impact on length of hospital stay or total
complication rate.
Conclusion: Preoperative biliary stenting increases the
risk of biliary colonization. The risk of post operative
infective complication is increased by biliary colonisa-
tion.
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P-579
INITIAL PRESENTATION, TUMOUR
CHARACTERISTICS, AND PREDICTORS
OF SURVIVAL AFTER SURGICAL
RESECTION OF INTRA-HEPATIC
CHOLANGIOCARCINOMA (IHCC)
A. Bharat, M. Earl, C. Anderson, M. Doyle and
W. Chapman
Washington University/Barnes-Jewish Hospital
Background: The objective of the study was to charac-
terize the natural history of IHCC and identify predictors
of survival in patients undergoing surgical resection for
IHCC.
Methods: Retrospective analysis of patients with IHCC
from January-1 1998 to December-31 2005 at our center.
Results: One hundred and thirty ﬁve IHCC patients were
seen of which 93 (68.9%) had unresectable disease while
42 (31.1%) underwent resection. The mean age was
65.4 ± 11.0 years, F:M ratio was 19:23 and patients
were predominantly Caucasians (83%). The common
initial presenting symptoms were 1) Abdominal pain
(47.8%), 2) Jaundice (19.0%), 3) Pain, jaundice and
weight loss (7.1%). Pre-resection staging revealed that
patients predominantly had a single dominant lesion 31
(73.8%). Only ﬁve (11.9%) patients had satellite lesions.
Ten patients (23.8%) had vascular, seven (16.7%) had
bile duct, and seven (16.7%) had lymphatic invasion on
imaging. Twelve (28.6%) patients required extrahepatic
bile duct resection.
The median survival in the entire study group undergoing
resection was 1.8 years compared to 0.6 years in those
with unresectable disease (P < 0.001). Margin positive
status, multiple tumours, bilateral tumours, large tu-
mours (> 5 cm), lymphovascular invasion, and poor
histological grade were found to be predictors of poor
overall survival (P < 0.05 for each). Importantly, in
multivariate analysis, only margin negative (R0) resec-
tion was predictive of favorable long-term overall
survival [median survival 2.6 years versus 0.8 years, HR
2.4 (2.12 – 2.67), p = 0.04].
Conclusions: The most frequent presenting symptom for
cholangiocarcinoma is abdominal pain. Patients selected
for resection have signiﬁcantly improved survival than
those with unresectable disease. R0 resection favors long-
term survival.
P-580
PREOPERATIVE BILIARY DRAINAGE
(PBD) FOR HILAR
CHOLANGIOCARCINOMA
O. Farges1, J. M. Regimbeau2, D. Fuks2, Y. P. Le Treut3,
D. Castaing4, J. Belghiti1, P. Bachelier5, K. Boudjema6,
G. Nuzzo7, D. Cherqui8, J. F. Gigot9, O. Boillot10 and
C. Ducerf11
1Beaujon Clichy; 2Nord Amiens; 3Conception Marseille;
4Paul Brousse Villejuif; 5Hautepierre Strasbourg;
6Pontchaillou Rennes; 7Sacre Coeur Rome; 8Mondor
Cre´teil; 9Bruxelles; 10Herriot Lyon; 11Croix Rousse Lyon
Background: In all comparative series the risk of hepa-
tectomy is increased when the liver is cholestatic. The
ability of PBD to reduce this risk is controversial. Five
RCT were negative but mainly included patients with
distal obstruction not requiring major hepatectomies.
Three comparative studies focusing on patients with hilar
cancer were also negative but the number of patients was
limited (n < 70).
Methods: Analysis was performed in a representative
multicentric series of 526 patients who underwent hepa-
tectomy associated with resection of the CBD for hilar
cancer in University hospitals. Indication for PBD and
serum bilirubin levels prior to surgery (preoperative SB
stratiﬁed into ﬁve groups < 50, 50–100, 100–200, 200–
300, > 300 lmol/L) were not standardised between
centres. Inﬂuence of these parameters on postoperative
mortality (90 days) and morbidity (Clavien’s classiﬁca-
tion) were stratiﬁed according to the side (right 47%, left
49%, central 4%) and extent of liver resection.
Results: PBD was performed in 66% of patients with
jaundice or cholangitis and the proportion of patients in
each preoperative SB group were 46%, 17%, 17%, 14%
and 7%. Mortality was signiﬁcantly inﬂuenced by the
side of liver resection (right 16%, left 7%) but not by the
number of segments removed. Following right sided
resections mortality was mainly related to liver failure
and correlated with increasing levels of preoperative SB
(9%, 11%, 15%, 21% et 27% respectively). PBD was
independently associated with lower mortality in each
preoperative SB group. Conversely, mortality following
left sided liver resection was mainly related to sepsis, did
not correlate with preoperative SB and was greater in
patients with PBD (overall 13% vs. 3%) in particular if
preoperative SB was still > 100 lmol/L (22% vs. 5%).
Conclusion: Preoperative management of hilar malig-
nancies is heterogeneous. Our results suggest that PBD
reduces the risk of right sided resection but may increase
the risk of left-sided resection especially when incomplete.
P-581
SURGICAL TREATMENT OF
CONGENITAL BILIARY TREE
DILATATIONS IN ADULTS
J. P. Grondona, R. A. Bracco, M. A. Duhalde,
P. J. Angiolini, R. A. Sarquis and J. P. Rastrilla
Associated Units of Hepato-Pancreato-Biliary Surgery
(UNACIR HPB), San Isidro and Mar del Plata, Buenos
Aires, Argentina
Background: Congenital abnormalities of the intra and/
or extrahepatic biliary tree are characterized by cystic
and/or diffuse dilatations and sometimes present pan-
creatobiliary maljunction with a potential risk of malig-
nant transformation.
Aim: To describe the experience in the surgical treatment
of Congenital Biliary Tree Dilatations (CBTD) in adults.
Method: Between January 1991 and July 2009 out of 23
adults patients with CBTD (20 females and 3 males) were
surgically treated. Most frequent lesions observed were
types I, IVA and V of Todani-Watanabe classiﬁcation. In
eight cases (34.8%) a pancreatobiliary maljunction was
detected. In 9 patients (39.1%) the whole extrahepatic
biliary tract, including the convergence of both left and
right hepatic ducts, were removed. In addition, 10 liver
resections were carried out: four left sectionectomies and
six left hepatectomies.
Results: No postoperative mortality was observed and
the morbidity rate was 17.4%. Thorough follow-up was
achieved in 22 patients (95.7%).
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Conclusions: Congenital abnormalities of the intra and/
or extrahepatic biliary tree in adults can be diagnosed by
modern imaging techniques for hepatopancreatobiliary
diseases. It is necessary to remove completely the intra
and extrahepatic cystic areas and to adequate the liver
resections when stenosis, bile stasis and/or intrahepatic
stones are present. The surgical technique must be
accurate in extension and meticulous when performed.
P-582
CHOLECYST-ENTERIC FISTULA
MANAGEMENT: EXPERIENCE IN 65
CONSECUTIVE CASES
A. Valle1,2, M. Vivanco1,2, F. Patin˜o3,4, R. Gonzalez1,2,
A. Rodriguez1,2 and G. Wiedmaier1,2
1General Surgery Service, Hospital Padre Hurtado,
Santiago Chile; 2Facultad de Medicina Clı´nica Alemana-
Universidad del Desarrollo; 3Hospital Dipreca;
4Universidad de Valparaiso
Background: Symptomatic gallstone disease is one of the
most common abdominal emergencies in our country.
The Cholecyst-Enteric ﬁstula is a rare form of presenta-
tion of gallstone disease, with reported incidence of 3%.
The diagnosis generally is intraoperative. The resolution
in the last decade has been generally laparoscopically.
Objective: Show the results of the management of this
disease within our institution.
Methods: Descriptive review of patients that undergo
cholecystectomy in our institutions between January
2000 and July 2009 and intraoperatively a cholecyst-en-
teric ﬁstula was diagnosed. Demographics, etiology,
clinical characteristics, association with gallbladder can-
cer, morbidity and mortality.
Results: Sixty ﬁve patients were selected, median age
58 years, 81.5% female. The most frequent presentation
was abdominal pain in 75%. In 3% of patients the
diagnosis was preoperative with abdominal ultrasound
showing biliary air. The most common ﬁstula was
cholecyst-duodenal in 62% and cholecyst-colonic in
18%. Intraoperative Cholangiography was done in 68%
of patients, encountering 14% of choledocolithiasis.
Surgical approach was laparoscopic in 92% of cases with
a conversion rate of 83%. There was no association with
gallbladder cancer. Morbidity rate was 6.1% and there
was no mortality.
Conclusions: The Cholecyst-Enteric ﬁstula is a rare con-
dition, principally in female with long standing choleli-
thiasis. The diagnosis generally is intraoperative. There
was no association with gallbladder cancer. Currently
there is a high rate of conversion to open surgery; indeed
the laparoscopic approach is safe.
P-583
ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY
(ERCP) DURING PREGNANCY:
USEFULNESS AND SAFETY
A. Ronda´n, O. O. Laudanno, M. Ce´sar, G. Centurio´n,
P. Gollo and A. R. Ferreres
Department of General Surgery ‘Dr. Carlos A.
Bocalandro’ Hospital
Background: ERCP is an important therapeutic tool in
the management of biliopancreatic diseases. Data in
relation to its usefulness and mother-fetal safety in the
resolution of biliar pathology during pregnancy are
scarce.
Aim: Presentation of our experience with the use of
ERCP during pregnancy.
Methods: Between June 1998 and June 2009, 1560 ERCP
were performed at our Department, including 18 preg-
nant patients (1.1%). Indications included: acute cho-
langitis in six, extrahepatic cholestasis in eight and
resolved acute pancreatitis with documented common
bile duct stones in four. ERCP were performed during
the ﬁrst trimester _ unknown pregnancy at the moment
of the proceeding_ in one case, in the second trimester in
six and in the third in 11. Mild-moderate sedoanalgesia
induced with propofol was used in all cases. Patients were
placed in a left lateral position and safety measures in-
cluded non stress fetal test and coverage of the pelvis with
double lead garment.
Results: Sixteen out of 18 procedures were therapeutical:
15 sphincterotomies with bile duct extraction and one
sphincterotomy with temporary eight Fr stent placing
due to a giant stone. Stones were not found in two pa-
tients (suspicion of migration).
There were two complications: one mild pancreatitis
resolved in 48 hours and one acute cholecystitis managed
with antibiotics. Ten patients underwent laparoscopic
cholecystectomy after ERCP but during the pregnancy,
seven in the puerperal period and the remaining was
already cholecystectomized.
All patients were followed up to the end of pregnancy.
Newborns were healthy, APGAR > 8, except in one
with low weight, that required intensive care unit
admission.
Conclusions: The performance of ERCP during preg-
nancy achieves the following goals: a) prevents surgical
treatment of biliary diseases under general anesthesia b)
is safe and reliable, with no side effects to fetus health,
during pregnancy.
P-584
A SELECTIVE ANTIBIOTIC
PROPHYLAXIS POLICY FOR
LAPAROSCOPIC CHOLECYSTECTOMY
IS EFFECTIVE IN MINIMISING
INFECTIVE COMPLICATIONS
P. Mekhail, F. Yanni and G. Morris-Stiff
Department of Surgery, Prince Charles Hospital, Merthyr,
Wales
Background: The identiﬁcation of bactibilia during cho-
lecystectomy is associated with the presence of well-
recognised risk factors. However, current evidence-based
guidance on antibiotic prophylaxis during laparoscopic
cholecystectomy (LC) does not take into account these
factors.
Aims: To assess the effectiveness of a selective antibiotic
prophylaxis policy limited to high risk patients under-
going LC with the development of infections as the pri-
mary endpoint.
Methods: Hundred consecutive patients undergoing LC
were studied prospectively. Data collected included pa-
tient demographics and details of the history of gallstone
disease to determine those with risk factors for bactibilia.
A single dose of antibiotics were administered on
induction to patients with a risk factor present. Infor-
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mation relating to all radiologically or microbiologically-
conﬁrmed infections were documented.
Results: Eighty four of the patients were females and the
mean age was 47.7 ± 16 years. Nineteen percent of the
LC was performed as emergencies with the remainder
elective. A risk factor for bactibilia was present in 35% of
patients. A wound infection was identiﬁed in 4% of
cases, two of which were Staphylococcus aureus (1
methicillin-resistant [MRSA]), one was a coagulase neg-
ative Staphylococcus, and one wound cultured a mixed
anaerobic growth. Three of the infections occurred in
patients receiving prophylaxis (two staphylococcal and
one anaerobic) at intervals of 7, 14 and 19 days respec-
tively. One patient with a BMI of 32 in the no prophy-
laxis group developed a coagulase negative
staphylococcal infection at 10 days. No intra-or extra-
abdominal infections were identiﬁed.
Conclusions: Restricting antibiotic prophylaxis to high
risk patients has no detrimental effects in terms of
increasing the rate of infections in those with no risk
factors. Furthermore, the act of not prescribing to low
risk patients will limits costs and risk of adverse events,
as well as reduce the risk of resistance and clostridial
infections in this cohort.
P-585
LAPAROSCOPIC CHOLECYSTECTOMY
(LC) VS. PERCUTANEOUS
CHOLECYSTOSTOMY (PCT) FOR
GANGRENOUS CHOLECYSTITIS: A
COMPARATIVE STUDY
P. Sanjay, K. Burt, E. Saffouri, I. Zealley and A. Alijani
Ninewells Hospital
Background: The management of gangrenous cholecys-
titis is varied. LC and PCT provide alternate treatment
options for management of GC.
Aims: This study aims to compare LC and PCT as
treatment options for GC.
Methods: All consecutive patients presenting with acute
cholecystitis from 1999–2006 were reviewed retrospec-
tively. GC was identiﬁed from histopathology records.
Patients presenting with GC and undergoing LC and
PCT were compared for preoperative, intraoperative and
postoperative variables and outcomes.
Results: Eight hundred and eighty ﬁve patients under-
went LC of which 115 (13%) patients had GC. Thirty
two patients underwent a cholecystectomy during the
study period. Patients in the PCT group were older (76
vs. 64, P < 0.01) with more number of ASA grade 3 and
4 patients (31 vs. 9, P < 0.01) compared to LC group.
The duration of symptoms prior to admission was longer
in the LC group compared to PCT group (3 vs. 5 days,
p = 0.001). However, the duration of symptoms prior to
intervention was similar between the two groups (6 vs.
4 days, p = 1). No difference was noted in the preop-
erative white cell count and liver function tests between
the two groups. However, mean CRP levels were signif-
icantly higher in the PCT group (185 vs. 119, p = 0.003).
About 6/32 (18%) patients in the PCT group subse-
quently underwent cholecystectomy. The number of
conversions to open cholecystectomy was higher in the
PCT group compared to LC group (5 vs. 18, p = 0.009).
The total hospital stay (19 vs. 8 days) and in-hospital
mortality was higher in the PCT group (28% vs. 0%)
compared to LC group.
Conclusion: Patient selection for surgery in GC is based
on comorbidities and inﬂammatory response. Elderly
patients with more comorbidities and more severe
inﬂammatory process are more likely to undergo PCT
than LC. In comparison to LC, patients undergoing PCT
have increased conversion rate, postoperative stay and
mortality. Only a small fraction of patients with PCT
subsequently undergo LC with relatively high open
conversion rate.
P-586
MANAGEMENT OF BILE LEAK AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
N. Michalopoulos, T. Papavramidis, I. Pliakos,
I. Kesisoglou, E. Kotidis, K. Sapalidis and
S. Papavramidis
3rd Surgical Department, Aristotle University, AHEPA
Hospital, Thessaloniki, Greece
Background: Laparoscopic cholecystectomy (LC) is the
method of choice for symptomatic cholelithiasis man-
agement with many beneﬁts over open cholecystectomy.
The major problem that occurs after laparoscopic era is
the LC-associated higher incidence of bile duct injury
than the open approach.
Aim: The aim of this study is to identify the risk factors
and evaluate the management of bile duct injuries (BDI)
after LC.
Material and methods: Thirty nine patients with bile
leakage after LC (27 women and 8 men with mean age
56,8 years range from 20 to 81 years old) managed in our
department. Initial operation (LC) was performed in 22
patients in our department (Group A) and the others 17
patients referred to our department after bile duct injury
development (group B). A retrospective database was
created with all patients’ characteristics (including past
medical record, previous abdomen operations, inﬂam-
mation of biliary tree), operative values (such as sur-
geon’s experience level, operation time, conversion rate
to open cholecystectomy) and BDI characteristics (type
of bile duct injury, need for re-operation, time of re-
operation, type of procedure, morbidity and mortality).
We compare the two groups as for the above parameters.
Results: There were 19 major BDI (10 in group A, 8 in
group B) and 20 minors (12 in group A, 9 in group B)
according to Strasberg’s classiﬁcation. The mean time of
LC with BDI in group B was 170 min signiﬁcantly higher
from the group A, 110 min (p = 0.01). Five BDI in
group A recognized intraoperatively and managed at the
same time. All major BDI re-operated. The mean time
for intervention was 4.5 days in group A and 10.3 in
group B (p = 0.01). Surgeon’s experience level was not a
risk factor. Two patients died in group B from sepsis and
one in group A. The mean hospitalization in group A was
23 days and in group B 28 days.
Conclusion: Extending duration of LC is a risk factor for
BDI. Early management of symptomatic BDI must be
attempted.
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P-587
EARLY SURGICAL MANAGEMENT OF
ACUTE CHOLECYSTITIS
R. Sanchez Claria, O. Mazza, J. Pekolj and
E. de Santiban˜es
Hospital Italiano de Buenos Aires
Background: Laparoscopic cholecystectomy is now ac-
cepted as being safe for acute cholecystitis; however,
optimal surgical timing and operative technique in the
treatment of acute cholecystitis are of major importance
and are still debatable issues.
Aim: This retrospective study was undertaken to assess
the clinical outcomes, possible advantages and disad-
vantages of early laparoscopic cholecystectomy for acute
cholecystitis.
Material and methods: Records of all patients admitted
for acute cholecystitis with which laparoscopic chole-
cystectomy was attempted between October 2004 and
October 2006 at Hospital Italiano de Buenos Aires were
reviewed. Demographic details, diagnosis, duration of
symptoms, treatment, outcome, post-operative stay and
complications were recorded.
Results: Laparoscopic cholecystectomy was performed
in 176 patients admitted for acute cholecystitis; acute
cholecystitis was conﬁrmed through clinical, laboratory
and radiological tests. Clinical presentation included the
presence of right upper quadrant pain (96%), leukocy-
tosis (97%), fever (13.7%), and jaundice (8.2%). Mean
duration of symptoms prior to presentation was 2.3 days.
All the patients were operated within 72 hours after they
were admitted. Operation time was 78 min (r 28–310)
Conversion to an open procedure became necessary in
ﬁve patients (2, 84%) and there were no deaths. Post-
operative hospital stay was 2 days (r 1–6). Postoperative
morbidity was 14%.
Conclusion: Laparoscopic cholecystectomy for acute
cholecystitis is a safe procedure with a shorter postop-
erative stay, lower morbidity, and less mortality. Early
laparoscopic cholecystectomy in acute cholecystitis is a
viable indication. It has all the advantages that laparos-
copy provides in an elective fashion and similar rates of
morbidity and mortality.
P-588
MANAGEMENT OF CHOLEDO-
CHOLITHIASIS IN LAPAROSCOPIC
ERA – SINGLE CENTER EXPERIENCE
P. Kumar, N. Mohan and A. Ramesh
Meenakshi Mission Hospital and Research Center,
Madurai, India
Background: Choledocholithiasis develops in about
10%–20% of patients with gallbladder stones and the
literature suggests that at least 3%–10% of patients
undergoing cholecystectomy will have common bile duct
(CBD) stones. CBD stones may be discovered preoper-
atively, intraoperatively or postoperatively. The most
common intervention for CBD stones is ERCP and stone
extraction. Other commonly used interventions include
intraoperative bile duct exploration, either laparoscopic
or open. Hereby we report our experience of manage-
ment of CBD stones.
Materials and methods: Analysis was done of the pro-
spectively maintained database of CBD stones from
January 1994 – January 2009.
Results: Total number of pts with CBD Stones was 876.
Male: Female ratios were 1.2:1. Cholangitis was present
in about 16%, ARF was present in about 4%. USG
detected CBD stones in about 77%. ERCP was at-
tempted in about 837 patients (95.5%), primary PTBD
was done in 24 patients (3%), open CBD exploration
done in 15 patients (1.5%).ERC + Cannulation was
successful in 802 (95.8%), ERC failed in 35 patients due
to previous Chronic DU, Perivaterian diverticulum,
duodenal perforation etc. Stone extraction was successful
in 92%, ENBD placement and elective Lap CBD
Exploration done in 6% due to large CBD stones. Mean
number of sessions to clear CBD stones were 1.1 and
missed CBD stone rate was 1.6% and retained CBD
stone rate was 2.1%. Morbidity was noted in 12%.
Mortality rate was 0.9%. Mean duration for cholecys-
tectomy after ERC is 2.1 days. Mean hospital stay was
4.9 days. On multivariate analysis presence of cholangi-
tis, ARF, diabetes mellitus were risk factors for poor
outcome.
Conclusion: Choledocholithiasis can be managed safely
with ERC and Stone extraction. Large CBD stones
(> 1.5 cm) can be managed with elective Lap CBD
exploration. Nasobiliary drain can be used successfully
instead of stent placement & helps in detecting retained
CBD stones.
P-589
THE INCIDENCE OF BACTERIA BILE
COLONIZATION AND POST
OPERATIVE SURGICAL INFECTION IN
ELECTIVE LAPAROSCOPIC
CHOLECYSTECTOMY
N. Ahmed, H. Haron, J. Razman, I. Sagap, H. Othman,
N. Salleh and A. Y. Jasmi
Department of Surgery, University of Kebangsaan
Malaysia Medical Centre, Kuala Lumpur
Aims: A prospective observational study was conducted
to look into the incidence of microorganism in gall
bladder bile culture of elective laparoscopic cholecystec-
tomy specimens. Culture positivity was then analyzed for
Surgical Site Infection (SSI). Other potential secondary
factors were also determined in order to ascertain risk for
culture positivity and SSI.
Method: Bile culture was sampled from a total of 112
patients of elective laparoscopic cholecystectomy in
UKM Medical Center from August 2006 to July 2008.
Samples of gallbladder bile were aspirated during the
operation. The specimen was then immediately sent to
pathology laboratory to be inoculated directly into aer-
obic and anaerobic blood culture bottles. Factors ana-
lyzed include indication for surgery, preoperative
biochemical measures, postoperative parameters and
complications. The outcome measures were positive gall
bladder ﬂuid cultures and detailed organism study was
performed to determine microbial pattern.
Results: A total of 112 patients were recruited in this
study. Twelve patients did not fulﬁll study protocol and
were excluded. The remaining 100 patients comprised of
64 females and 36 males. These involved 56 Malays, 37
Chinese and 7 Indians whose indications for surgery were
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mainly acute cholecystitis and biliary colic. The mean age
was 48.91 ± 12.9 years. Positive bile cultures were found
in 22 patients and factors found to be signiﬁcantly
associated with positive gall bladder ﬂuid culture were
age (P < 0.002), previous history of obstructive jaundice
(P < 0.013) and patients of ASA3 categories (P <
0.013). There was no incidence of SSI in our study.
P-590
OUTCOME OF RESECTION OF BILIARY
CANCER IN PRESENCE OF PRIMARY
SCLEROSING CHOLANGITIS
N. de Liguori Carino, P. J. Goldsmith, S. G. Farid,
M. S. Reddy, G. J. Toogood, J. P. A. Lodge and
K. R. Prasad
HPB and Transplant Surgery, St James’s University
Hospital, Leeds, UK
Aims: To discuss the feasibility, clinical course, man-
agement and outcome of resection of biliary malignan-
cies on a background of primary sclerosing cholangitis
(PSC).
Methods: Between January 2003 and December 2008,
eight patients (seven male, and one female) with biliary
cancer on a background of histologically conﬁrmed PSC
underwent resection. Five were hilar cholangiocarci-
noma, one mid bile duct cholangiocarcinoma, one int-
rahepatic cholangiocarcinoma and one gallbladder
carcinoma. Four patients had preoperative biliary
drainage (3 ERCP, 1 PTC). Protocol follow-up was
based on serial total body CT scan and tumour markers.
Results: Six patients underwent caudate lobe resection
and lymphadenectomy. In addition three patients
underwent right hemihepatectomy, one patient under-
went a right trisectionectomy following preoperative
portal vein embolisation, one underwent left hemihepa-
tectomy and left portal vein reconstruction and one pa-
tient with a gallbladder cancer underwent resection of
segments IVB and V. One had bile duct resection only.
Finally one patient with intrahepatic cholangiocarcino-
ma underwent right anterior sectionectomy. Postopera-
tive complications were seen in two cases. Four patients
had positive resection margin and three had lymph-node
metastases. Follow-up ranged from 6 to 38 months. Five
had recurrence within the liver. The longest overall and
disease free survivals were 38 and 24 months respectively.
Conclusions: This series is the largest reported on resec-
tion of biliary cancer in patients with PSC. Despite being
technically feasible, long term results are poor. More
effort should focus on screening for early stage detection
of cholangiocarcinoma in patients with PSC.
P-591
SURGICAL MANAGEMENT OF
CHOLANGIOCARCINOMA
S. McKay, S. Pericleous, J. Kent-Bramer, L. Jiao,
N. Habib and D. Spalding
Hammersmith Hospital, Imperial College, London
Introduction: Cholangiocarcinoma (CC) is a rare malig-
nancy, accounting for approximately 3% of all gastro-
intestinal cancers. The aim of this study was to assess the
role of surgery and adjuvant therapy on the outcomes of
patients with CC based on the experience of a single
institution.
Methods: From 1992 – 2009, 155 patients were treated
for histologically proven CC. Their surgery, adjuvant
therapy, histology and clinical outcome were reviewed
retrospectively.
Results: There were 84 men and 71 women of median age
62 (range 23–83) years. Tumours were located intra-
hepatically in 53 patients (34%), at the hilum in 68 (44%)
and the external biliary tract in 28 (18%). Ninety three
patients (60%) were deemed potentially curative by sur-
gical resection, of these 19 were found to be unresectable
at operation, and were thus analysed with the unresec-
table group. There were no operative deaths. Histology
revealed adenocarcinoma in 154 patients and adenosqu-
amous carcinoma in 1. Adjuvant therapy of those re-
sected consisted of chemotherapy and/or radiotherapy;
those deemed unresectable were treated with chemo-
therapy alone. At a median follow up of 9 months (range
3–148), 14 patients remained alive. Fifteen patients were
lost to follow-up, with a follow-up range of 7 days to
28 months. Survival analysis showed a statistically sig-
niﬁcant difference in survival between those resected and
those receiving medical management only (P < 0.0001,
HR 2.303, 95% CI 1.540–3.446), with a median survival
of 22 months vs. 8 months.
Conclusions: Cholangiocarcinoma remains a malignancy
with a dismal prognosis and appears more common at
the hilum. Surgical resection is associated with improved
survival compared to medical management alone.
P-592
SUGERY FOR IMPACTED BASKET
N. Fukino1, T. Oida1, K. Mimatsu1, H. Kano1,
A. Kawasaki1, Y. Kuboi1 and S. Amanoh2
1Social Insurance Yokohama Central Hospital / Surgery;
2Nihon University School of Medicine / Surgery
Background/Aims: The treatment for common bile duct
stone are continually being. Impaction of the lithotripsy
basket during endoscopic removal of common bile duct
(CBD) stone was seen in 5–10%. We reported a case of
surgery for impacted biliary basket.
Patient and method: A 66-year-old woman was admitted
to our hospital complaining right upper abdominal pain.
Magnetic resonance cholangiopancreatography revealed
a defect (15 · 20 mm in diameter) of CBD. We diag-
nosed the choledocholith and performed endoscopic
retrograde cholangiopancreatography to remove the
CBD stones. But unfortunately the retrievable basket
around a stone was impacted in Vater ampulla. It was
impossible to treat an endotriptor for the forceps. So
diagnosis was the incarceration of basket and an urgent
surgery performed. At the operation, cholecystectomy
was performed and the bile duct was explored. The
basket and stones were removed through a longitudinal
choledochotomy. The wires leading to the basket were
cut, the basket and stone were extracted via the incision.
Choledochoscopy revealed no residual stone and frag-
ment. A T-tube was inserted, and the choledochotomy
was closed. The postoperative course was uneventful.
Conclusion: We evaluated that if the size of CBD stone is
over 20 mm in diameter, the risk of impacted basket in-
creases. In these cases surgery might be selected as an
initial treatment of CBD stone.
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PROLONGED (> 3 HOURS)
LAPAROSCOPIC CHOLECYSTECTOMY
– REASONS AND RESULTS
G. Subhas, A. Gupta, L. Dubay, L. Ferguson, Y. Goriel,
M. Jacobs, W. Kestenberg, R. Kolachalam, S. Sumet and
V. Mittal
Providence Hospital and Medical Centers, Southﬁeld, MI,
USA
Background: For the experienced surgeon, the average
operative time for a laparoscopic cholecystectomy is
< 1 hour. There has been no study documenting the
causes and results of prolonged (> 3 hours) surgery.
Objective: We wanted to review our experience with
prolonged laparoscopic cholecystectomy.
Methods: A retrospective study was done of patients
who underwent cholecystectomy during January 2003–
December 2007. Three thousand one hundred and twenty
six cholecystectomies were done. After excluding patients
who had a planned open cholecystectomy and patients
who had additional (hepatic, pancreatic, gynecological
and colonic) surgeries, we identiﬁed 70 patients who had
a planned laparoscopic cholecystectomy with operative
time exceeding 3 hours. Charts were reviewed to look at
the indications, investigations and procedure details.
Results: Patients ranged from 21–92 years of age (mean,
57 years) with most of the patients being females
(n = 53). Operative time ranged from 3–6:40 (mean,
3:37) hours. Emergency:elective admission ratio was 5:9.
Acute cholecystitis (n = 40) was the most common indi-
cation, followed by symptomatic gallstones (n = 24) and
gallstone pancreatitis (n = 6). Laparotomy had to be
done in 30 patients. Common characteristics were obesity
(n = 44), dense intra-abdominal adhesions (n = 43),
previous abdominal surgeries (n = 40), obstructive
jaundice (n = 14), large gallstones (> 2.5 cm) (n = 12)
and intraoperative cholangiogram (n = 12). Intra-oper-
ative complications included spillage of stones (n = 6),
bile duct injury (n = 3), and bleeding (n = 3). Histo-
pathological examination revealed 12 gangrenous gall-
bladders. Post operative stay ranged from 1–41 days
(mean, 5 days), and there was one mortality.
Conclusions: The possibility of prolonged laparoscopic
cholecystectomy should be anticipated in patients with
obesity and previous abdominal operations. Prolonged
surgery increases the risk of complications (bile duct
injury, bleeding) and prolongs the postoperative hospital
stay.
P-594
NOTES: TRANS-VAGINAL
CHOLECYSTECTOMY VIDEO
ASSISTED, WITH COMMON
LAPAROSCOPIC INSTRUMENTS,
PRELIMINARY RESULTS
H. Almau1,2, J. Mejias1, J. Arellano2, R. De La Fuente3,
N. Garcı´a4, J. Herna´ndez2, G. Estrada2, C. Noval2 and
W. Uribe2
1Department of Surgery II, Hospital Vargas, Caracas,
Venezuela; 2Department of Surgery, Hospital Pe´rez de
Leon, Caracas, Venezuela; 3Department of Surgery,
Hospital de Clı´nicas Caracas, Caracas, Venezuela;
4Department of Surgery II, Hospital Universitario de
Caracas, Caracas, Venezuela
Background: One of the biggest problems with NOTES it
is that not exists ideals instruments, it could be possible
to create safes access through trans-vaginal way with
regular laparoscopic instruments in well selected patients.
Aim: Describe operative technique, time and post-oper-
ative outcomes, performing Trans-vaginal cholecystec-
tomy video assisted, with common laparoscopic
instruments in a small cases series.
Method: Prospective study of series of cases from June to
September 2009. Previous approvement of the patient
and under exclusion and inclusion criteria, were selected
all the patients. They were summated to trans-vaginal
cholecystectomy Video assisted, with common laparo-
scopic.
Results: Patients: 15, Median Age: 37.4, BMI: 24.7,
Operative time: 51.6 min, Post-operative pain: 1.4/10.
Complications: 01 patients presented diarrhea, 01 patient
presented urinary tract infection, 01 patients presents at
fourth post-operative day a sub-hepatic collection, it was
need to be drain under laparoscopy, it cloud be related to
the rupture of the gallbladder. No one patients presented
dyspareunia. And the median follow-up was two months.
Conclusion and recommendation: The trans-vaginal ac-
cess is a feasibly way to perform cholecystectomy with
common laparoscopic instruments. It is necessary a large
series to establish the learning curve.
P-595
PERCUTANEOUS TRANSHEPATIC
BILIARY DRAINAGE (PTBD) FOR
GASTROINTESTINAL
ADENOCARCINOMA WITH LIVER
METASTASIS
M. Duxbury1,2, S. Wigmore and R. Ravindran1,2
1University of Edinburgh; 2Royal Inﬁrmary of Edinburgh
Background: Palliative PTBD for adenocarcinoma with
liver metastases remains controversial. Identifying pa-
tients most likely to beneﬁt from PTBD would be
advantageous.
Objective: To identify indicators of in-hospital mortality
in jaundiced patients undergoing palliative PTBD for
gastrointestinal (GI) adenocarcinoma with liver metas-
tases.
Methods: Consecutive patients with jaundice and histo-
pathologically-conﬁrmed GI adenocarcinoma liver
metastases undergoing palliative PTBD at our institution
were identiﬁed from a prospectively maintained data-
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base. Patients were grouped by histopathological diag-
nosis: 1. Upper GI/HPB (UGI/HPB), and 2. Colorectal
(CR) adenocarcinoma. All patients received intravenous
ﬂuids pre-PTBD. Demographics, in-hospital mortality,
re-intervention rates, serum biochemistry and procedure-
related complications were assessed.
Results: Forty eight patients (median age 71 years,
26M:22F, 31 UGI/HPB:17 CR) were included. PTBD
reduced serum bilirubin (P < 0.01-clinical success) in 43
(90%). Procedure-related complications occurred in nine
(19%). Unplanned radiological re-intervention was re-
quired in eight (17%). Univariate analysis demonstrated
age, UGI/HPB histopathology, WCC>15, creatinine
> 180 lmol/L following intravenous ﬂuid replacement
and albumin (< 25 g/L) to be associated with in-hospital
mortality. On multivariate (Cox) analysis, age
(> 70 years) and serum creatinine > 180 lmol/L fol-
lowing intravenous ﬂuid replacement were independent
signiﬁcant indicators of in-hospital mortality. Creatinine
> 180 lmol/L at time of PTBD was associated with in-
hospital mortality in both UGI/HPB and CR groups.
Conclusion: PTBD can be performed in patients with
metastatic gastrointestinal adenocarcinoma with high
clinical success rates. PTBD in the presence of bio-
chemical evidence of renal dysfunction despite ﬂuid
replacement is associated with in-hospital mortality.
Palliative PTBD for patients with metastatic adenocar-
cinoma warrants further critical prospective assessment.
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THE APPLICATION OF HEM-O-LOK
CLIPS FOR LIGATION OF DIFFICULT
CYSTIC DUCT DURING LAPAROSCOPIC
CHOLECYSTECTOMY IN ACUTE
CHOLECYSTITIS
J. R. Kim, J. H. Lee, C. W. Chu and J. C. Chung
Soon Chun Hyang University. Hospital
Background: During laparoscopic cholecystectomy, the
application of metal clips is the most popular method of
securing the cystic duct. However, the metal clip ligation
is not safe method sometimes when the cystic duct is
severe inﬂamed, edematous, and ﬁbrous.
Objective: This study compared the efﬁcacy and appli-
cability of Hem-o-lok clips from metal clips for ligation
of difﬁcult cystic duct during laparoscopic cholecystec-
tomy in acute cholecystitis.
Methods: From April 2001 to May 2009, 1669 patients
underwent cholecystectomy, and 247 (14.8%) of them
were diagnosed as acute cholecystitis with difﬁcult cystic
duct. We divided them into two groups. In the group A,
cystic duct was ligated by metal clips (177 patients,
71.7%). And in the group B, cystic duct ligation was
done by Hem-o-lok clips (70 patients, 28.3%). We com-
pared the postoperative complication, conversion rate,
operation time, blood loss and hospital stay between two
groups.
Results: There were no signiﬁcant differences between
the two groups in postoperative complication, blood loss
and postoperative hospital stay. The operation time for
the group B was longer than the group A (95.6 vs.
84.9 min)(P = 0.026). Bile leakage rate in group B (0%)
was less than that in group A (3.4%), but it was not
signiﬁcantly different (P = 0.188). On the other hand,
there was a signiﬁcant difference in conversion rate be-
tween two groups (group A vs. group B, 11.3% vs. 1.4%,
P = 0.012).
Conclusion: Although there were no statistical differ-
ences between the two groups in postoperative compli-
cation, we consider that the application of Hem-o-lok
clip was feasible and safe for ligation of difﬁcult cystic
duct in acute cholecystitis. Its use signiﬁcantly could be
able to decrease the conversion rate.
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HEPATIC RESECTION IN THE
MANAGEMENT OF PREGNANCY
INDUCED RECURRENT PYOGENIC
CHOLANGITIS
K. Kosari, S. Mackenzie and T. Sielaff
Abbott Northwestern Hospital Virginia Piper Institute
Background: Management of pregnancy induced recur-
rent pyogenic cholangitis (RPC) can be challenging and
remains somewhat controversial.
Objectives: The purpose of this poster is to highlight the
role of hepatic resection in the management of preg-
nancy-associated RPC with two case presentations and
review of literature.
Methods: Medical records were reviewed. Demographics
information, hospital course, operative and post opera-
tive ﬁndings, and long-term outcome data were collected.
Illustrative images from pre-operative work up as well as
gross photos of the specimen post operative are pre-
sented. Literature review is presented.
Results: First case is that of a 26 year old healthy woman
with symptoms of RPC who presented 7 years ago while
pregnant. She was treated non-operatively through her
pregnancy with antibiotics. After the birth or her child,
she underwent a right-sided percutaneous transhepatic
cholangiography tube placement through which intra-
hepatic stones were removed. This was followed by a left
hepatic lobectomy with ﬁnding of impacted intrahepatic
bile duct stones. She is currently alive with no residual
RPC symptoms or biliary issues.
Second case is that of a 28 year old woman 35 weeks
pregnant with her second child, who presented with
intermittent right upper quadrant abdominal pain and
choledocholithiasis with dilation of the segment 6/7
sectoral biliary system. After consideration in a multi-
disciplinary fashion, she was managed non-operatively
through her pregnancy. After the birth of her child, she
underwent a right hepatic lobectomy. Gross photographs
of her resected specimen show choledocholithiasis char-
acterized by numerous, almost impacted, yellow stones
ﬁlling the biliary system, with large bile duct ﬁbrosis and
surface epithelial attenuation, and focal bile ductopenia.
She has done well post operatively with no recurrent
symptoms.
Conclusions: Surgical resection has a deﬁnitive role in the
management of RPC associated with pregnancy.
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WITHOUT SURGERY SCAR:
TRANS-UMBILICAL LAPAROSCOPY
CHOLECYSTECTOMY TECHNIQUE FOR
SINGLE INCISION
A. Pellegrino Falcone1 and I. Taronna La Torre2
1Centro Me`dico Loira/Centro Me`dico Docente La
Trinidad; 2Centro Me`dico Loira
Background: Laparoscopy cholecystectomy has evolved
into a single scar in the umbilicus, using the technique of
tri-port or single port. The latter is expensive, requires
angled instruments and is not accessible in all hospitals.
Another technique, less expensive alternative is the use of
wires Kishner of 1–1.8 mm, angled at the tip for the
traction and two trocars of 5 mm trans-umbilical.
Objective: To evaluate a scarless laparoscopy cholecis-
tectomy with alternative technique different to single port
(tri-port).
Method: We included six female patients diagnosed with
gallstones without cholecystitis. We introduced two
5 mm trocars through the umbilicus: one for the cam-
corder 30 degrees and another to use straight instru-
mental and clips. Two guides Kischner of 1–1.8 mm was
introduced into the abdomen through the abdominal wall
and then folds the top into a hook inside the abdominal
cavity, were used to mobilize and pull the fundus and
infundibulum of the gallbladder. The cystic duct and
artery were dissected, tied and sectioned. The gallbladder
was removed through the umbilicus connecting the two
incisions of the fascia.
Results: Median age was 32 years (18–50). The mean
operative time was 80 min (60–100). No procedure was
converted to conventional laparoscopy cholecystectomy.
There were excellent cosmetic results and painless.
Conclusions: This surgical technique for laparoscopy
cholecystectomy is feasible, cheaper and scar-less with
only the umbilical scar. Reduces postoperative pain and
makes an excellent cosmetic result. It can be done with
straight instrumental through the umbilicum.
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EFFECTIVENESS OF SUBCUTANEOUS
LOOP IN BILIOENTERIC
ANASTOMOSIS
V. Carrillo-Maciel, J. E. Carrillo-Maciel, O. Solorzano-
Pineda, A. L. Acosta-Saludado, J. A. Leal-Martinez,
D. E. Fernandes-Madinaveitia and S. Ramos-Linaje
Social Security 71
Background: Karl Langenbuch performed the ﬁrst elec-
tive cholecystectomy on July 15, 1882. There was a pos-
sibility of biliary duct injury. Today the ratio is 0.2–0.6%
and the damage is 95% post- cholecystectomy, the
operation of choice to repair the bile duct through there
exist in 13–30% risk of stricture. Subsequent re-opera-
tion present increased morbidity and mortality. For
12 years we have used a subcutaneous loop by mean of
endoscopic access if developed stricture and resolve it
with local anesthesia.
Objective: To demonstrate the effectiveness of the sub-
cutaneous loop in patients with stricture bilioenteric
anastomosis.
Methods: We reviewed 69 cases with bile duct injuries in
the past twelve years. They were divided into two groups:
Group I: traditional reconstruction with bilioenteric
anastomosis Roux-en-Y and group II: subcutaneous
loop. Data analysis: ‘Statistical analysis system’ Win-
dows version 6.12. For categorical pre and postsurgical
variables, ‘Prog frequency’, for pre and postsurgical
continuous variables ‘Prog Genial Linear Models’.
Descriptive statistics for measures of central tendency,
mean, median, and mode and measures of dispersion,
standard deviation, epidemiologic proﬁle.
Results: There were 54 patients in group I and 15 in
group II. In group I there were no stenoses and in group
II there are three. Those were resolved with hydrostatic
dilatation.
Conclusion: Use of subcutaneous loop is effective and we
recommend it for young patients with Bismuth type II,
III, or IV.
P-600
SINGLE INCISION LAPAROSCOPIC
CHOLECYSTECTOMY: IS IT POSSIBLE
USING CONVENTIONAL
LAPAROSCOPIC INSTRUMENTS?
H. V. Shivaram
Columbia Asia Referral Hospital, Bangalore
Background: Single incision laparoscopic surgery (SILS)
is being performed using various kinds of ports and
reticulating instruments and sometimes ﬂexible scopes.
This involves procuring new ports and hand instruments
and the surgeon has to undergo an orientation course or
a learning process. It also adds to the cost; additional
instruments need to be obtained to start doing SILS.
Aims/Objective: To study the feasibility of doing single
incision laparoscopic cholecystectomy using conven-
tional laparoscopic instruments and ports.
Methods: Twenty cases (14 female and 6 male) of
symptomatic gallstone disease patients underwent cho-
lecystectomy using single incision. During initial three
cases SILS (covidien) port was used. All other cases were
operated using conventional laparoscopic ports and
instruments (Karl-Storz) already available in the opera-
tion theatre. With a single vertical incision of about
1.5 cm over the umbilicus the subcutaneous area was
dissected; one 10 mm port inserted in the center (open
method) and two 5 mm ports were inserted above and
below this. The gallbladder fundus was retracted using a
silk stitch. The gallbladder was dissected using the con-
ventional laparoscopic curved forceps, scissors, hook
cautery and clip applicator. All the regular steps of lap-
aroscopic cholecystectomy were followed.
Results: All cases were completed using above method.
There were no complications and conversions. Using
existing conventional laparoscopic ports and hand
instruments laparoscopic cholecystectomy could be
performed even though the initial cases required more
time and patience. Patients had the added advantage of
less pain and almost no scar as it merged with the
umbilicus.
Discussion/Conclusion: Single incision laparoscopic cho-
lecystectomy is possible using conventional laparoscopic
instruments and ports without the necessity of special
reticulating hand instruments, ﬂexible scope or port.
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EXPERIENCE OF SINGLE PORT
LAPAROSCOPIC SURGERY FOR GALL
BLADDER STONES
T. Kinoshita1, M. Shibata1, T. Fujii2, T. Shikano1,
T. Hachisuka1, T. Mori1, M. Shinohara1, M. Miyauchi1
and A. Nakao2
1Yokkaichi Municipal Hospital; 2Nagoya University
Background: To further reduce the operative trauma of
laparoscopic cholecystectomy, we developed, in patients
with no history of cholecystitis and a normal BMI, a
scarless operation through the umbilicus. The operative
techniques are fully described.
Methods: A female patient underwent transumbilical
single incision laparoscopic cholecystectomy. We made a
zigzag incision to create a nearly scarless wound.
Through the small transumbilical zigzag incision
(25 mm), three trocars of 5 mm were introduced. It was
used to insert two 5 mm rigid laparoscopic instruments
and a 5 mm 30 degree telescope. A babcock forceps was
directly inserted without a trocar and was used to pull up
the gall bladder. Hemostasis was obtained with an
ultrasonic cutting device. The gallbladder was pulled up
and the triangle of Callot was dissected, clipped, cut, and
the gallbladder was subsequently resected. Finally the
gallbladder was taken out through the umbilicus and the
umbilicus was reconstructed.
Results: This case was completed successfully. There
were no perioperative port-related or surgical complica-
tions. No extra skin incision was needed. Operative time
was 118 min. Postoperative hospital stay was only
2 days.
Conclusion: To reduce operative trauma and improve the
cosmetic result following laparoscopic cholecystectomy,
a transumbilical operative technique has been developed.
Results of the operative procedure in a selected patient
with a normal BMI and no signs of inﬂammation are
encouraging. A transumbilical zigzag incision heals very
neatly and is nearly scarless. The umbilicus can be
developed as a natural port for performing various
operative procedures.
P-602
TREATMENT EVALUATION OF
RESIDUAL CHOLEDOCHOLITHIASIS
C. Quireze Junior, L. Kenny Moraes, W. de Biase da
Silva Neto, B. Ferreira Dias, R. Inacio Guimaraes and
H. Ponciano Trevenzol
Hospital das Clinicas/Federal University of Goia´s School
of Medicine
Backgrounds: Choledocholithiasis represents a great
challenge in diagnostic evaluation and therapeutics.
Methods:
Because of it we’ve proposed a retrospective study to
analyse the clinical and laboratorial criteria and image
studies to the diagnosis of such condition. It was possible
to evaluate the treatment (endoscopic or surgical) and
complications with these information.
Results: Thus, with this aim, 32 (thirty-two) patients
were evaluated. They were suffering from residual cho-
ledocholithiasis and were admitted on the Surgical Unit
of the General Hospital of the Medical School of
University of Goia´s, from January 1995 to July 2001. It
was included patients that were performed on a previ-
ous cholecystectomy. The diagnosis of choledocholithi-
asis was get either during the surgery, although the
deﬁnitive treatment had been postponed, or on the
follow-up. We concluded that most part of the patients
with residual choledocholithiasis was icteric and that the
ultrasound study is not an effective method to detect
residual choledocholithiasis (positive around 50%). Be-
sides, both therapeutic procedures (endoscopic and
surgical) were successful in the cleaning of biliary ducts
(above 90%), had low morbidity and no mortality. The
discharge of the patient was faster in case of endoscopic
procedure.
P-603
SURGICAL OUTCOME OF EXTENDED
HEPATECTOMY IN PATIENTS WITH
BILIARY MALIGNANCIES WITH
SPECIAL REFERENCE TO EVALUATION
OF PREOPERATIVE PVE
T. Ota, N. Takeshita, R. Higuchi, H. Kajiyama,
T. Yazawa, K. Onuki, Y. Yagawa and M. Yamamoto
Tokyo Women’s Medical University Institute of
Gastroenterology Department of Surgery
Introduction: Preoperative portal vein embolization
(PVE) is often performed as a routine before an extended
hepatectomy. However, this procedure sometimes is
performed even in an occasion where it is unnecessary.
Aim: The aim of this study is to establish a standard to
apply PVE.
Patients and methods: The subjects were 82 consecutive
patients with biliary malignancies (38 gallbladder carci-
noma and 44 cholangiocarcinoma) who underwent ex-
tended hepatectomy (right hepatectomy or right
trisegmentectomy) from 1997 to 2007. PVE was per-
formed in 14 patients, who basically had a future rem-
nant liver (FRL) volume less than 30%. PVE was
considered unnecessary for the 68 remaining patients.
Patients were classiﬁed into two categories, by whether or
not PVE was performed. Clinical parameters, FRL vol-
ume and postoperative morbidity and mortality were
reviewed.
Results: There was no difference in preoperative liver
function by an ICG R15 test (9.4% vs. 10%) and the
amount of intra-operative blood loss (1660 mL vs.
1774 mL). Preoperative bilirubin was higher in patient
without PVE than with PVE (0.91 mg vs. 1.87 mg,
p = 0.033). FLR volume was signiﬁcantly smaller in
patients with PVE than without PVE (26% vs. 35%,
p = 0.000). There was no signiﬁcant difference in post-
operative morbidity (64% vs. 47%) and mortality rate
(0% vs.1.5%).
Conclusion: The surgical outcome of extended hepatec-
tomy for biliary malignancies was satisfactory. PVE may
be useful for a patient who has a FRL volume less than
30%.
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ELIMINATION OF TRACTION PORTS IN
LAPAROSCOPY CHOLECYSTECTOMY
I. Taronna La Torre1 and A. Pellegrino Falcone2
1Centro Me`dico Loira; 2Centro Me`dico Loira/Centro
Medico Docente La Trinidad
Background: The development of techniques in laparos-
copy cholecystectomy has eliminated traction portals for
the fundus, body and infundibulum, avoiding two or
three scars of 5 mm. The traction has been supplanted by
needle technique with silk.
Objectives: Our objective was to evaluate the feasibility
of this technique.
Method: Twenty patients were enrolled for scarless lap-
aroscopy cholecystectomy between January 2009 and
August 2009. All patients were placed 2 trocars (one of
5 mm and other of 10 mm) in the umbilicus, separated by
a bridge of fascia. Place a job portal of 5 mm in epigas-
trium. The traction of the fundus, body and infundibu-
lum was made with silk sutures, crossing the gallbladder
with straight needles.
Results: There were twelve women and eight men, med-
ian age was 47 (22–82) years. Twelve patients had acute
cholecystitis with gallstones and eight patients with
gallstones without inﬂammation. The mean operative
time was 60 min (45–90) min. No procedure was con-
verted to open surgery. No blood transfusion was re-
quired. There was no morbility, nor mortality. Mean
hospital stay was one day (1–2) days. Oral feeding
starting at four hours in the postoperated. Excellent
cosmetic results.
Conclusions: The elimination of two surgical wounded
by replacing the needle technique is accepted by the
patients about their cosmetic effects and painless. It is a
feasible technique, easy to perform by the surgeons. The
placement of two trocars at the umbilicus is a feasible
technique to work and reduces the costs of a tri-port (R).
P-605
SINGLE PORT LAPAROSCOPIC
CHOLECYSTECTOMY VIA A PREVIOUS
WOUND
J. R. Park, B. S. Sohn, S. J. Kim, S. K. Lee, K. H. Kim,
Y. K. You, K. Y. Sung, S. Lee, D. G. Kim and
E. K. Kim
Department of Surgery, Division of Hepato-Pancreato-
Biliary Surgery, The Catholic University of Korea
Laparoscopic cholecystectomy has been regarded as the
gold standard for gallbladder surgery. With the develop-
ment of new instruments and the accumulation of clinical
experience, many surgeons have shown an interest in
reducing scars and postoperative pain. Recently, single-
port access surgery has generated interest in all surgical
ﬁelds because of the improved cosmesis associated with
this technique. A 46-year-old man had a gallbladder
polyp that increased in size over time. He had undergone
appendectomy via a Mcburney incision 8 years ago. He
underwent single-port access laparoscopic cholecystec-
tomy via the previous incision. The operative time was
140 min. There were no complications due to cholecys-
tectomy, and the patient was discharged on the 3rd
postoperative day. In selected patients, single-port sur-
gery via a previous incision can be considered instead of
making an additional scar.
P-606
AN UNUSUAL COMPLICATION
ENCOUNTERED INCIDENTALLY AT
LAPAROSCOPIC CHOLECYSTECTOMY:
A CASE SERIES
J. R. Uzzaman, M. Nair and F. Myint
North Middlesex University Hospital
Introduction: This is a case series of erosion of the
common bile duct (CBD) by an in situ biliary stent found
incidentally at Laparoscopic Cholecystectomy (LC). To
the best of our knowledge this is one of the ﬁrst reported
such series.
Methods: Case reports (photos included).
Results: Thirty nine patients with an in situ CBD stent
underwent LC for symptomatic gall stones in our insti-
tution over a 4-year period (2005 to 2009). Four patients
were found to have the stent eroding through the wall of
the CBD. In these four patients, ERCP had previously
been performed – extracting stone(s) – followed by
sphincterotomy and insertion of a 7Fr pigtail stent
(measuring 4 cm). The operation was converted to open
in two patients, as the anatomy of Calot’s triangle was
completely distorted. The procedure was abandoned in
one of these cases but completed successfully in the other.
The duration between initial pigtail stent insertion and
LC was 120 and 400 days, respectively. In the other two
patients, the anatomy of Calot’s triangle was delineated
well, and the operator was able to complete LC. The
duration between initial pigtail stent insertion and LC
was 32 and 34 days. On reviewing the previous imaging,
it was clear that these stents had been correctly posi-
tioned initially. None of our patients required a deﬁnitive
repair of the CBD or T-tube placement and the stent was
removed endoscopically at a later date in three, and
passed spontaneously in one. All four patients made a
good post operative recovery.
Discussion/Conclusion: CBD erosion is a complication of
biliary stent insertion. The risk is greater with a pigtail
stent as opposed to straight stent. CBD stent erosion will
make surgery more hazardous especially if it remains in
situ for a signiﬁcant period of time. CBD erosion can be
managed conservatively without the need for surgical
repair Awareness of this complication should prompt
earlier surgery or earlier removal of plastic pigtail stents.
P-607
QUALITY OF LIFE OUTCOMES WITH
LAPAROSCOPIC OR OPEN
CHOLECYSTECTOMY
F. A. Campos, A. Oyakawa, T. De Campos, A. Moricz,
R. A. Silva and A. M. Pacheco Jr
Biliary Tract and Pancreas Group, Department of
Surgery, Santa Casa of Sa˜o Paulo Medical Sciences
School, Sa˜o Paulo, Brazil
Background: Gallstones have a high prevalence, with
10% to up 30% in western population. It is estimated
that up to 3% of these patients evolve with complications
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and need the conventional treatment. The concept of
Quality of Life (QOL) in the Health area has a multidi-
mensional approach and is related to the economic, so-
cial and cultural aspects, psychological and physical. The
measurement of health-related QOL issues makes it
possible to obtain standardized information about a pa-
tient’s perception of the speciﬁc disease and its impact on
his or her life. Then, the best practical daily practice in
the health service can be guided, leading in consideration
QOL as a pointer in the clinical judgment of speciﬁc ill-
nesses.
Objectives: The goal of this study was to evaluate the
health-related Quality of Life improvement of patients
underwent laparoscopic or open cholecystectomy.
Methods: Sixty four consecutive patients from Depart-
ment of Surgery of Santa Casa of Sa˜o Paulo who
underwent on cholecystectomy for nonmalignant disease
were asked to ﬁll a health survey’s QOL questionnaire –
the SF-36 – before and after the procedure. Nonpara-
metric tests (Wilcoxon Sign Rank Test) were use when
some variables did not conﬁrm to a normal distribution.
They were signiﬁcant at P < 0.05 with statistical analy-
ses performed by SigmaStat for Windows, version 3.5.
Results: The all eight outcome scales within the SF-36
health proﬁle from Functional status (Physical func-
tioning, Social functioning, Role limitations attributed to
physical problems, Role limitations attributed to emo-
tional problems), Wellbeing (Mental health, Energy and
fatigue, Pain) until Overall evaluation of health (General
health perception) were found signiﬁcant improvement
(P < 0.001).
Conclusion: The clinical improvement observed on pa-
tients was evaluated and conﬁrmed by statistics, so that
cholecystectomy inﬂuences patient’s life for the better,
independently the access way, bringing beneﬁts to those
ones with impact on their QOL.
P-608
INTRAOPERATIVE ENDOSCOPIC
SPHINCTEROTOMY USING
RENDEZVOUS TECHNIQUE FOR THE
CASE WITH DIFFICULTY IN
CANNULATING INTO COMMON BILE
DUCT
A. Umemura, A. Sasaki, J. Nakajima, T. Obuchi,
H. Nitta, K. Koeda, K. Otsuka and G. Wakabayashi
Department of Surgery, Iwate Medical University
Endoscopic sphincterotomy (EST) is widely accepted as
the sequential treatment of cholecystocholedocholithiasis
before or after laparoscopic cholecystectomy (LC). EST
is very important management for common bile duct
(CBD) stones, but unfortunately there are some cases
could not be undergoing EST because of failure of
selective CBD cannulation. We report the single-step
procedure, without choledocholithotomy, what is called
rendezvous technique for these cases. This procedure is
deﬁned as EST after intraoperative cholangiography
during LC using guidewire insertion through the trans-
cystic route. We report a 62-year-old woman with CBD
stone, and she is often suffering from CBD stone attack,
but twice attempt of selective CBD cannulation under
endoscopic retrograde cholangiopancreatography
(ERCP) was failed. She was underwent intraoperative
EST using rendezvous technique, and ERBD tube was
positioned in the CBD. Rendezvous technique is the
reliable strategy for the patients with cholecystocholedo-
cholithiasis failed selective CBD cannulation under
ERCP. Intraoperative endoscopic approach for papilla
Vater is very difﬁcult because the patient is spine
position; therefore excellent endoscopists are absolutely
needed to perform this procedure.
P-609
POST CHOLECYSTECTOMY MIRIZZI
SYNDROME: AN IMPORTANT RARE
CASE REPORT-COMPLICATION
K. Papapolychroniadis, D. Paramythiotis,
L. Papaefthimiou, S. Panidis, I. Tzeveleki, A. Tsoha and
E. Fahantidis
1st Propedeutic Surgical Department, Aristotle University
of Thessaloniki, A.H.E.P.A. Hospital Thessaloniki,
Greece
Background: Mirizzi syndrome was ﬁrst described in
1948 for uncommon cases of extrahepatic biliary stric-
tures, with cholelithiasis which occurs in less than 0.5%
of cholecystectomies. Extrahepatic, hepatic or common
bile duct, obstruction may occur either of impacted stone
in the cystic duct that cause direct pressure or edema
(Mirizzi type I), or occasionally the stone may erode and
delivered through the wall of cystic duct and into the
common hepatic duct (Mirizzi type II).
Case report: We present a case of a 45-year-old woman
who was admitted in our Department on July 2009, with
symptoms of obstructive jaundice and cholangitis. From
her past history, the patient referred a laparoscopic
cholecystectomy three months ago. Following the re-
search study an ERCP sphincterotomy was performed
and the revealed biliary stenosis was stented by a seven
French plastic tube. Because of the unsuccessful result of
bile duct stent drainage an explorative laparotomy was
planed. There were rare and interesting operative ﬁnd-
ings, such as a common hepatic duct (CHD) stenosis due
to a choloma, just closely to the cystic duct stump which
resulted in a severe degree of extra-ductal pressure and
hepatic duct stenosis; the central tip of ERCP plastic tube
was found intraperitoneally probably by CHD perfora-
tion, during previous ERCP sphincterotomy, in the
location of this stenosis of common hepatic duct (CHD).
An anatomic recognition and preparation of proximal
biliary tract, was performed in porta hepatis, which was
followed by a high hepaticoduodenostomy procedure.
The postoperative period and the up- to- date follow-up
is uneventful and no complications were observed so far.
P-610
SURGICAL TREATMENT OF
INTRAHEPATIC CHOLELITHIASIS:
REPORT OF SIX CASES
N. Antoniadis, V. Papanikolaou, D. Giakoustidis,
G. Imvrios, N. Ouzounidis, G. Tsoulfas, I. Fouzas,
A. Papagiannis, A. Giakoustidis, P. Agorastou,
D. Vrochides, D. Takoudas and A. Antoniadis
Hippokratio General Hospital, Thessaloniki
Introduction: Intrahepatic cholelithiasis is a rare entity,
providing challenges in its diagnosis and treatment.
Therapeutic goals include the elimination of cholangitis
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episodes and the interruption of the progression of the
disease that can lead to biliary cirrhosis and the devel-
opment of cholangiocarcinoma.
Goal: To present the surgical treatment of six cases of
intrahepatic cholelithiasis.
Methods: Four of the patients had previous cholecys-
tectomy, one with a common bile duct exploration and
placement of a Kehr, one with a choledochoduodenal
anastomosis, and one with a choledochojejunal anasto-
mosis. For the purposes of diagnosis a combination of
US together with CT, MRCP and ERCP were used. In
ﬁve patients the intrahepatic stones were localized cen-
trally in relation to the left hepatic duct and in one of
them there were also stones in the common bile duct. In
the patient with the previous choledochoduodenostomy,
there were biliary stones in the common and both hepatic
bile ducts. In ﬁve of the cases there was atrophy of the
left lobe with hypertrophy of the right one. In these cases
the patients underwent a left hepatectomy, whereas in the
case of the bilobar disease clearance of both hepatic ducts
and a Roux-en-Y hepaticojejunostomy took place.
Results: Long-term follow-up of these patients revealed
the effectiveness of hepatectomy as a therapy for unilo-
bar intrahepatic cholelithiasis, as this deals with the cause
of the stones as well.
P-611
SINGLE INCISION MULTIPORT
LAPAROSCOPIC CHOLECYSTECTOMY
H.-J. Han, S.-B. Choi, C.-Y. Kim, W.-B. Kim,
T.-J. Song, S.-O. Suh, Y.-C. Kim and S.-Y. Choi
Korea University Medical College
Introduction: Although single incision multiport laparo-
scopic surgery has recently been the focus of minimally
invasive surgery, the surgical techniques and indications
for this procedure have not been established in many
clinical practices. Herein, we report on our initial expe-
rience with 54 patients, who underwent single incision
multiport laparoscopic cholecystectomy, together with
their clinical outcomes and we determined the learning
curve based on our experience.
Method: The data from 54 patients who underwent sin-
gle-incision multiport laparoscopic cholecystectomy for
gallstones and gallbladder polyps between January and
June 2009 were documented prospectively and then
analyzed. Four surgeons performed this procedure. We
excluded the patients with acute cholecystitis, concomi-
tant choledocholithiasis, a history of previous upper
abdominal surgery, or a suspicion of gallbladder cancer.
We calculated the learning curve with using OLS learning
curve model.
Results: The mean age of the patients was 45.1 years.
The mean body mass index (BMI) was 23.5 kg/m2
(range: 15.68–30.09). Forty patients were symptomatic.
The mean hospital stay was 4.5 days. The mean operative
time was 91.2 (± 32.0) min. In the analysis of operative
time in OLS learning curve model, we could reach the
operation time 68.5 min after performing 7.74 cases. Bile
duct injuries occurred in two patients.
Conclusion: Single incision multiport laparoscopic cho-
lecystectomy is an emerging operative method for
obtaining a scarless abdomen. Experienced laparoscopic
surgeons can safely perform this operation with the
conventional and curved laparoscopic instruments and
overcome the learning curve effect. Keeping an open
mind for conversion to conventional laparoscopic cho-
lecystectomy and assigning a priority to the safety of
patients over cosmesis will help avoid serious complica-
tions when surgeons encounter difﬁculties during this
type of operation.
P-612
MINI-LAP CHOLECYSTECTOMY: AN
ALTERNATIVE MINIMALLY INVASIVE
SURGICAL PROCEDURE
K. Papapolychroniadis, E. Karamanlis,
D. Paramythiotis, A. Mekras, M. Georgiou, I. Palios
and E. Fahantidis
1st Propedeutic Surgical Department, Aristotle University
of Thessaloniki, A.H.E.P.A. Hospital Thessaloniki,
Greece
Background: Minimally invasive surgical procedures re-
duce the cost and the length of postoperative hospital
stay. Procedures such as mini-lap cholecystectomy pro-
vide cost advantages, safe performance of procedure,
rapid and early mobilization and decreased postoperative
morbidity, especially in elderly, either laparoscopic or
mini lap open access.
Patients and methods: We present a study of 128 con-
secutive mini laparotomies for cholecystectomy for
symptomatic gallstones disease through a subcostal 5–
7 cm incision during the last 15 years (1994–2008) in 1st
Propedeutic Surgical Department of A.U. Th.,
A.H.E.P.A. Hospital. The mean operative time was
50 min (40–75 min). Mean postoperative analgesia
requirements were four doses of non-narcotic analgesics.
Mean duration of hospitalization was 36 hours (24–
76 hours).
Results: Non severe complications were recorded and the
‘overall’ patient satisfaction was excellent in relation to
postoperative pain, early recovery, cosmetic result, hos-
pital stay and cost effectiveness.
Conclusion: We can conclude that surgeons experience,
patient’s history data, correct diagnosis and preoperative
research study are the most important parameters for the
ﬁnal decision about the surgical technique of cholecys-
tectomy.
P-613
LONG-TERM SURVIVAL AND FIBROSIS
PROGRESSION ANALYSIS IN
RETRANSPLANTED PATIENTS FOR
HCV RECURRENCE
R. Sobesky1,2,3, V. Delvart1, P. Carrier1,
T. M. Antonini1,2,3, B. Roche1,2,3, F. Saliba1,2,3,
P. Ichai1,2,3, E. Vibert1,2,3, R. Adam1,
A.-M. Roque-Afonso4, M. Sebagh2,3,5, C. Guettier2,3,5,
D. Castaing1,2,3, D. Azoulay1, S. Didier1,2,3 and
J.-C. Duclos-Vallee1,2,3
1AP-HP Hospital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France; 2INSERM, U785, Villejuif, France;
3Univ Paris-Sud, UMR-S785, Villejuif, France; 4AP-HP
Hospital Paul Brousse, Service de Microbiologie
Virologie; 5AP-HP Hospital Paul Brousse, Laboratoire
d’Anatomie Pathologique, Villejuif, France
Body: Patients with positive HCV-RNA prior to liver
transplantation (LT) have post-LT recurrence and the
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natural history of HCV liver graft infection could be
severe. The question of the retransplantation (reLT) is
discussed.
Aims: To study 1) survival of HCV infected patients re-
transplanted for severe recurrence of HCV infection and
2) ﬁbrosis kinetic on the second liver graft.
Methods: ReLT was proposed for 30 patients (45
8 years) in a monocentric population of 504 HCV in-
fected patients transplanted for end stage liver cirrhosis
or hepatocellular carcinoma. ReLT was proposed for
surgical complications (n = 11), for severe complications
of HCV related liver graft infection (n = 13) and because
of chronic rejection or alloimmune hepatitis (n = 6).
Survival of retransplanted patients was compared to an
HCV LT group (n = 125) matched on donor age.
Fibrosis progression on the ﬁrst and the second graft was
studied.
Results: Among the 13 patients retransplanted for severe
HCV reinfection, the interval between the two LT was 95
(68) months. The mean MELD score before reLT was
22.5 (6.2). Four patients had combined kidney and liver
transplantation. Five patients deceased after reLT, three
within 10 months because of infectious complications
and two later because of severe HCV recurrence. Survival
rate after reLT was 67% at one year and 57% at ﬁve
years, respectively. Since the ﬁrst LT, global survival in
the retransplanted group was 65% and 72% in the
matched group (p = ns). In retransplanted patients, the
mean ﬁbrosis progression before and after reLT was 1.27
(1.0) and 1.2 (1.4) METAVIR unit per year, respectively
(p = ns).
Conclusions: Survival after retransplantation of patients
for severe HCV recurrence on the liver graft was 67% at
one year and 57% at ﬁve years, respectively. Retrans-
plantation does not affect ﬁbrosis progression on the
second graft.
P-614
ACUTE LIVER FAILURE DUE TO
ANTITUBERCULOUS THERAPY:
STRATEGY BEFORE AND AFTER LIVER
TRANSPLANTATION (LT)
P. Ichai1,2,3, P. Saliba1,2,3, F. Antoun1, M. Sebagh2,3,4,
T. M. Antonini1,2,3, L. Escaut5, E. Vibert1,2,3,
D. Azoulay1, D. Castaing1,2,3 and D. Samuel1,2,3
1AP-HP Hospital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France; 2INSERM, U785, Villejuif, France;
3UMR-S785, Villejuif, France; 4AP-HP Hospital Paul
Brousse, Laboratoire d’Anatomie Pathologique, Villejuif,
France; 5AP-HP Hospital Paul Brousse, Service Maladies
Infectieuses, Villejuif, France
Antituberculous therapy could induce acute hepatitis and
lead to acute liver failure. In such cases, decisions on
whether to stop or reintroduce a second-line of non
hepatotoxic antituberculous therapy (ATT) in those
patients who have received an incomplete course of
treatment, and when, are dependent on numerous
factors. In addition, ATT following LT is not a widely–
established practice.
Patients: From 1986 to 2008, 14 patients (10F, 4M)
presented with ALF related to INH (four patients) or
PZA (ten patients).
Results: Seven patients were treated at admission and
received second-line ATT (six patients) or an alternative
therapy (one patient). Values for total bilirubin and
prothrombin time were less problematic than in un-
treated patients (180 + 97 lmol/L vs. 368 + 202 lmol/
L and 38 + 14% vs. 14 + 8%, respectively). No treated
patients suffered from encephalopathy, compared to ﬁve
untreated patients. Five of the seven patients improved
spontaneously and ATT was pursued for a mean period
of 9.3 + 4.2 months; one underwent LT and one died.
Reintroduced ATT was well-tolerated. Five of the seven
patients not treated at admission rapidly underwent LT,
and ATT was deﬁnitively discontinued in two. After
transplantation, four patients receiving rifampicin pre-
sented with acute rejection.
Conclusion: In the absence of progressive tuberculosis in
ALF patients, we consider that antituberculous drugs
should be discontinued until liver function parameters
start to improve. In patients with risk factors for a
worsening of their tuberculosis, ATT should be initiated
rapidly. Following LT, we also recommend the use of
second-line ATT (without rifampicin) because of the
risks of acute rejection and a recurrence of hepatotoxicity
during treatment.
P-615
EVOLUTION AND MANAGEMENT OF
DE NOVO NEOPLASMS AFTER LIVER
TRANSPLANTATION: 20 YEAR
EXPERIENCE FROM A SINGLE
EUROPEAN SERIES
G Sapisochin1, I. Bilbao1, C. Dopazo1, L. Castells2,
L. Blanco1, M. Caralt1, R. Rodriguez1, J. L. Lazaro1,
J. Balsells1 and R. Charco1
1HBP Surgery and Transplantation Department, Hospital
Universitario Vall d´Hebron, Barcelona; 2Hepatology
Department, Internal Medicine Deparment, Hospital
Universitario Vall d´Hebron, Barcelona
Introduction: Survival after liver transplantation (LT)
has improved: however, patients are considered at risk of
malignancy due to prolonged immunosuppression.
Aims: Ascertain the long-term outcome of patients who
developed de novo neoplasms (DN) after LT at our
center.
Material and methods: From October 1988–December
2007, 800 LT were performed in 742 patients. Patients
were divided into two study periods according to time of
LT; ﬁrst: October 1988–December 1997, second: January
1998–December 2007. Patients were also divided
according to type of DN (skin and non-skin tumors).
Mean follow-up was 5 ± 4.6 years.
Results: Seventy-one DN were detected in 742 patients
(9.5%). Skin tumors represented the most common DN
(35%), followed by lung cancer 13%. The cumulative
risk for development of DN increased with the time from
LT although no signiﬁcant differences at 3, 5 and
10 years were found when ﬁrst and second period were
compared (3%, 7% and 16% vs. 2%, 4%, 11%, respec-
tively). The incidence of DN and mortality rate was
higher in the ﬁrst period compared with the second:
(11.8% vs. 7.3%; P < 0.04) and (60% vs. 41%;
p = 0.09), respectively. Patient actuarial survival after
DN at 1, 5 and 10-years was 75%, 55%, and 26%
respectively. When both periods were compared survival
after DN at 1, 3 and 5-years was better in the second
period (82%, 71% 65% vs 67%, 48%, 45%, P < 0.04).
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Conclusions: After a 20 year experience, the incidence of
DN was lower in the second period probably due to a
better control of immunosuppression, but on the other
hand, as patient survival increases, so increases the inci-
dence of DN.
P-616
ROLE OF ANTITHROMBIN III IN THE
ANTICOAGULANT THERAPY OF
PEDIATRIC LIVER TRANSPLANTATION
J. Quintero, J. Ortega, C. Venturi, J. Bueno, I. Bilbao
and R. Charco
Hospital Universitario Vall d’Hebron Barcelona Spain/
Pediatric Liver Transplant Unit
Background: Early postoperative vascular thrombosis
remains a signiﬁcant cause of graft loss following pedi-
atric liver transplantation (LT). The highest incidence
occurs in recipients < 3 years. Antithrombin III (ATIII)
can be used in the anticoagulant protocols to prevent
thrombosis.
Aim: To analyze our experience with the use of ATIII in
the postoperative period of pediatric LT.
Patients and methods: The coagulation proﬁles were
monitored by daily determinations of INR, TTPA-r and
ATIII levels. The anticoagulant therapy consisted in the
use of 1 mg/Kg/day of low-molecular-weight heparin
when INR< 2, platelet count > 50 · 109/L and no ac-
tive bleeding were detected. ATIII concentrates were
administered when ATIII were < 60%. Doppler ultra-
sound was daily done during the ﬁrst ﬁve days after LT.
Results: From October 2007 to September 2009, 23
transplants were performed in our centre. The median
age was 51 months (r: 6–196) with a median weight of
18 kg (r: 8–49). Eight (34%) were partial grafts (ﬁve
living donors, one split liver and two reduced grafts) and
the remaining 15 (66%) were whole grafts. The median of
fresh frozen plasma intraoperatively transfused was
49.9 mL/kg (r: 0–250) observing a signiﬁcant difference
depending on the patients’ age. Less than 3 years: median
of 67 mL/Kg (r: 10 to 250) vs. > 3 years median of
7 mL/Kg (r: 0 to 19), P < 0.001. During the ﬁrst 3 days
post-LT ATIII activity was maintained in normal range
(> 60%) in 10 of 23 patients. In the remaining 13, ATIII
was administered to achieve normal levels. No vascular
thromboses were observed during the ﬁrst ﬁve days of
postoperative period.
Conclusion: The early use of ATIII in pediatric liver
transplantation could play an important role in the
postoperative anticoagulation therapy resulting in a nil
vascular thromboses.
P-617
EARLY EXPERIENCE OF LIVER
TRANSPLANTATION IN SOON CHUN
HYANG UNIVERSITY HOSPITAL
C.-W. Chu, H.-C. Kim, K.-K. Lee and J.-C. Chung
Soon Chun Hyang University Hospital
Background: Setting of liver transplantation (LT) is very
hard and complex work. And result of early experience of
LT was not commonly satisfactory in the most centers.
Our center was recently well setting program of LT and
experienced favorable results. The authors report our
experience to be help for the centers beginning LT pro-
gram.
Methods: LT program of our center was set in 2007.
Twenty two cases underwent LT until present. Nine cases
were deceased donor LT (DDLT) and 13 cases were
living donor LT (LDLT). A modiﬁed right lobe with
reconstruction of middle hepatic vein territories was used
for all LDLT cases.
Results: Most donor of LDLT was son. Fatty change
was below than 30% in LDLT. However, even 70%
macro-vesicular fatty changed liver was transplanted in
one case of DDLT and this case remained good liver
function 10 months after LT. All live donors recovered
well. Most common causes of LT were liver cirrhosis by
hepatitis B. Mean MELD score of DDLT was 28.7. All
six hepatocellular carcinoma cases underwent LDLT and
half of them were above Milan criteria. Two patients
developed metastases and all lesions were resected. Four
LDLT cases had portosystemic shunt. Three cases com-
bined with splenorenal shunt underwent ligation of left
renal vein in two cases and ligation of splenic vein shunt
site in one case. One case with mesocaval and mesorenal
shunt underwent renoportal anastomosis with interposi-
tional graft of cadaveric iliac vein. Vascular problem
developed in 11 cases and two cases was surgically cor-
rected and ﬁve cases needed stent insertion. One in hos-
pital mortality and one biliary complication were
developed.
Conclusion: Our early result of LT was relatively favor-
able than other center’s early experience. However, we
should make an effort to overcome common vascular
complications.
P-618
STEATOTIC LIVER GRAFT USE DOES
NOT AFFECT OUTCOMES AFTER LIVER
TRANSPLANTATION, BUT MAY BE
ASSOCIATED WITH INCREASED COSTS
M. Doyle1, N. Vachharajani1, T. M. Earl1, S. Logan1,
J. Wellen1, C. Anderson1, J. Lowell1, S. Shenoy1,
G. Ridolﬁ2 and W. Chapman1
1Washington University School of Medicine; 2Barnes
Jewish Hospital
Introduction: Continuing organ shortages and increasing
wait list numbers, results in use of marginal grafts by
many centers. Hepatic steatosis is encountered in > 30%
of donors, and the incidence is rising. Use of extended
criteria donors has been suggested to incur higher hos-
pital cost due to longer stay and other complications.
Aim: To determine if there was a cost difference in liver
transplantation using donor grafts with signiﬁcant stea-
tosis.
Design: A prospectively maintained database was uti-
lized for the analysis. Recipient demographics, MELD,
survival, transfusion rates, bilirubin and transaminase
levels were assessed.
Results: From January 2006 to December 2008, we per-
formed 316 transplants (271 adults). Donor biopsies were
available in 248 (91.5%). Recipients were grouped based
on the percentage graft steatosis, Group 1 (G1) < 20%
(n = 205), and Group 2 (G2) > 20% (n = 43). One, 2-
and 3-year patient (92.6, 88.6, 88.6% vs 83.3, 83.3, 83.3%
G1 vs. G2, p = .26), and graft (90.7, 85.9, 85.9% vs.
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83.3, 83.3, 83.3%, G1 vs. G2, p = 0.54) survival was
similar in both groups. Follow-up was 30 months.
Median recipient age (55), BMI (28 k/m2), MELD (21),
and cold ischemic time (5.8 hours) were similar
(P = NS). Packed red cell, (3 G1, vs. 5 G2, P = .01) and
fresh frozen plasma (2 G1, vs. 4 G2, P = 0.0004)
transfusion rate was signiﬁcantly increased in G2 recipi-
ents. Mean Intensive care (4.6 G1, vs. 8.9 days G2,
P = .009) and total hospital stay (10.8 G1 vs. 16.6 days
G2, P = .007), was also increased in G2. While no cases
of primary non-function were seen in G2, transaminase
peaks were higher, and grafts remained cholestatic for
longer (p = .02). Median total hospital cost [$100 008
(71 910–355 531] G1 vs. 121 756 (73 335–648 076) G2,
P = .003) was increased in recipients of donor grafts
‡ 20%.
Conclusion: Use of steatotic grafts was not associated
with signiﬁcantly different patient or graft survival but
use of such grafts is associated with increased resources
and cost.
P-619
THE GLUTATHIONE REDOX SYSTEM
AND THE METABOLOME FROM
HEALTHY SUBJECTS AND FROM
PATIENTS AFTER LIVER TRANSPLANT
J. Sanabria1,2, R. Abbas1, K. Subramanian2, K. Goyal1,
R. Ibarra2 and H. Brunengraber1,2
1University Hospitals Case Medical Center; 2Case
Western Reserve University
Background and aim: Liver disease is in the rise in USA.
Glutathione species (GSH/GSSG) expresses the redox
status of the mitochondria and since most plasma GSH/
GSSG are released from liver cells, the turnover of these
species in plasma should reﬂect the overall redox status of
the liver. The present studies were designed to determine
the redox status of the liver and the metabolic ﬁngerprints
of human liver from normal subjects and from patients
after liver transplant with normal liver graft function.
Subjects and methods: The Glutathione-ophthalmate-re-
dox system and the metabolome of healthy subjects
(n = 10), and patients after liver transplant with normal
liver graft function (n = 4) were evaluated in plasma and
urine by mass spectrometry methods (MS). About 0.5%
of the total body water was enriched with 2H2O. The
concentrations of 2H-enriched GSH/GSSG and OA were
measured by LC-MS/MS. The Multi Reactions Moni-
toring (MRM) mode of LC-MS-MS cancels background
signals and allows the measurement of very low species
concentration. In addition, 82 metabolites were measured
in plasma and urine by GS-MS and LC-MS/MS.
Results: GSH/GSSSG ratio was similar in healthy sub-
jects when compared to patients after liver transplanta-
tion. The rate of new synthesized GSH and ophthalmate
as well as their total concentration were similar in both
groups. The concentration of essential and non-essential
aminoacids, glucose derived metabolites and fatty acids
were similar in both groups. Pseudouridine, a metabolite
from the degradation of nuclear acids was signiﬁcantly
increased in patients after liver transplantation when
compared to normal subjects (P < 0.001).
Conclusions: The Glutathione-ophthalmate redox system
of healthy subjects and patients after liver transplant with
normal graft function was similar. Metabolic differences
were found in the metabolites from nuclear cell acids.
Additional metabolites and their correlation with clinical
variables are under investigation.
P-620
DETERMINANT FACTORS IN AN
EXPRESSIVE INCREASING OF LIVER
TRANSPLANT IN A SINGLE CENTER
W. Andraus, V. Pugliese, M. Barros, R. S. N. Pinherio,
E. Figueira, A. Oliveira, R. Pecora, R. Martino,
V. Santos, F. Bitencourt, F. Galvao, R. Meirelles and
L. A. D’Albuquerque
Sa˜o Paulo University Medical School
Introduction: The Clinical Hospital of Sa˜o Paulo Uni-
versity is the biggest hospital of Brazil. The adult waiting
list for liver transplant has about 700 patients nowadays,
and it have had more than a thousand some years ago.
Even though, our number of liver transplants was not so
high (about 50 a year) and we had, as expected, high
waiting list mortality. This year we increased signiﬁcantly
our liver transplant number, increasing in three times our
past few years’ average.
Aim: We would like to highlight the determinant factors
in this expressive increasing number of liver transplants
in a single center in Brazil.
Methods: We analyzed the number of liver transplants in
the same period of the year (from January to September)
in 2008 and 2009 at the Clinical Hospital of Sa˜o Paulo
University Medical School. It was evaluated the reasons
of the increasing rate of transplants in 2009 at this center.
Results: From January to September 2008 and 2009 the
liver transplant number was respectively 35 and 105 cases.
Mass media, public health system policy, transplant team
organization, hospitalization of critical patients, preop-
erative prepare, acceptance of expanded criteria donors,
living donor program, and split livers were determinant in
this raising of liver transplants at this institution. The
short term outcome improved with the increasing number
of liver transplants (64.7% · 85.3%).
Conclusion: It is still possible to increase the number of
liver transplants in developing countries. The mechanism
of such change is multifactorial and it needs government,
institutional and multidisciplinary efforts. Besides the use
of marginal and split livers, the increasing rate of trans-
plants is related to better outcome.
P-621
INDOCYANINE GREEN PLASMA
DISAPPEARANCE RATE: MARKER OF
EARLY GRAFT MALFUNCTION IN
HEPATIC TRANSPLANTATION
J. Quintero, C. Venturi, J. Bueno, S. Flores, R. Charco
and J. Ortega
Hospital Universitario Vall d’Hebron, Barcelona, Spain /
Pediatric Liver Transplant Unit
Background: Early in the hepatic transplantation, liver
allograft could be damaged by several threatening events
such as ischemia reperfusion injury, acute rejection and
hepatic blood ﬂow disorders. Conventional liver function
tests (ALT, INR, and Bile) are not always conclusive.
Indocyanine Green plasma disappearance rate (ICG-
PDR) has been reported to be a good tool to determine
graft dysfunction after liver transplantation (LT).
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Aim: To assess the reliability of ICG-PDR measured by
a noninvasive technique (LiMON, Pulsion Medical Sys-
tem, Munich, Germany) as a predictor of early graft
dysfunction.
Patients and methods: From February 2005 to September
2009, we studied 35 patients who underwent 41 LT. The
ICG-PDR was measured one within the ﬁrst six hours
after reperfusion (PDR6), and three more once daily
(from day 0 to 3 after LT). All de determinations were
perfomed under hemodynamic stability (SatvHb > 70%,
MAP > 60 mmHg, Dif a-v CO2 < 8). We also collect
the INR, AST, ALT, and bile the ﬁrst three days after
LT. The liver function degree was classiﬁed using the
Toronto’s Group classiﬁcation.
Results: We performed 97 ICG-PDR in 41 consecutives
LT. In patients who did not develop any major compli-
cations (29 patients; 80.5%) ICG-PDR remains stable
and high (average 22–75%/min; Range 45–101%/min).
Six patients were classiﬁed as having grade IV dysfunc-
tion after LT. Five complete portal vein thrombosis; one
hepatic artery thrombosis and one suprahepatic vein
thrombosis were diagnosed. In these patients PDR24
values were signiﬁcantly lower (average 6.4%/min;
Range 11.9–0.5%/min). We established as a cut-off for
graft dysfunction an ICG-PDR < 12.8%/min. Our re-
sults were as shown in the following table:
Results:
Table 1.
ICG-PDR6 ICG-PDR24
Sensibility 83.3% 83.3%
Speciﬁcity 97.0% 100%
VPP 83.3% 100%
VPN 97.0% 97.1%
Conclusions: In the postoperative LT, noninvasively
measurement of ICG-PDR could be a signiﬁcant tool to
assess graft dysfunction.
P-622
PRE-TRANSPLANT EMPLOYMENT AND
BETTER PRE-TRANSPLANT PHYSICAL
QUALITY OF LIFE ARE ASSOCIATED
WITH EMPLOYMENT AFTER LIVER
TRANSPLANTATION
V. Zaydfudim, J. Ball, I. Feurer, M. Landman and
W. Pinson
Vanderbilt University Medical Center
Background: Retrospective studies suggest that employ-
ment after liver transplantation correlates with pre-
transplant employment and post-transplant physical
health-related quality of life (HRQOL). However, pro-
spective studies are lacking. The societal value of this
employment over the lifetime of a patient after trans-
plantation is on the order of $1 million per patient.
Objective: To test the effects of pre-transplant employ-
ment, HRQOL, and demographic measures on employ-
ment after liver transplantation.
Methods: Prospective self-reported data on patient
employment status and HRQOL before and after trans-
plantation at our tertiary-care transplant center were
collected. Multivariate logistic regression tested the
effects of age (‡ 60 years), gender, pre-transplant
employment, and pre-transplant SF-36 physical (PCS)
and mental (MCS) component scores on the likelihood of
employment at two post-transplant follow-up durations.
Full-time, part-time, or self-employed patients were
considered employed.
Results: Fifty adults were included: 32 males, 18 females;
age = 55 ± 7. Thirty-eight patients (76%) were em-
ployed pre-transplant. At initial follow-up (9 ± 3
months) 19 patients (38%) were employed. Variables that
were not associated with post-transplant employment
were age, gender, and pre-transplant MCS (all
P ‡ 0.577). However, pre-transplant employment
(p = 0.036) and pre-transplant PCS (p = 0.009) were
associated with post-transplant employment. At longer
follow-up (22 ± 14 months; 40% employed), pre-trans-
plant PCS was the single predictor of employment
(p = 0.016).
Conclusions: Employment in the initial months follow-
ing liver transplantation is related to pre-transplant
employment. Pre-transplant physical HRQOL is
strongly associated with employment in the early and
later post-transplant periods. These ﬁndings suggest that
transplantation prior to decline in PCS or loss of
employment is warranted to maximize patient HRQOL
and to minimize the societal expense of liver trans-
plantation.
P-623
IMMEDIATE POSTOPERATIVE
EXTUBATION IN PATIENTS
UNDERGOING ORTHOTOPIC LIVER
TRANSPLANTATION (OLT) IN A
TRANSPLANT CENTER IN CHILE
G. Rodrı´guez1, M. Quiroga1, I. Correa2, F. Vergara2,
C. Montalva´n1, M. Vin˜uela1, J. Hepp1, H. Rı´os1,
R. Humeres1, J. Palacios1, M. Rius1, R. Zapata1,
E. Sanhueza1, R. Rossi1 and J. Contreras1
1Clı´nica Alemana Santiago; 2UDD Medical School,
Santiago
Extubation in the operating room is an increasingly used
technique in patients undergoing OLT in the large
transplant centers.
Objective: Prospective assessment of immediate postop-
erative extubation in patients undergoing OLT in a cen-
ter which does 10–20 transplants/year. Assess its impact
over ICU stay, hospital stay, costs, relationships with
Child and MELD.
Material and method: All the adult patients (n = 86),
transplanted between October 2002 through October
2009 went into an immediate postoperative extubation
protocol. All the patients (G1) with primary transplan-
tation, no ALF, no encephalopathy nor obesity at the
moment of surgery, with bleeding of < 1.5 blood vol-
ume, hemodynamic stability, normothermic, Vt
> 6 mL/kg and RR < 25 · min at the end of the case,
were extubated in the operating room. The patients who
did not fulﬁll these criteria (G2) were sent intubated to
ICU. Frequency of reintubation, times of mechanical
ventilation (MV), ICU and hospital stay, and costs, were
measured. Relationships with Child and MELD were
measured. To compare between groups, Mann–Whitney
test was used for continuous variables and Chi squared
for categoric variables. Statistic signiﬁcance: P < 0.05.
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Results: About 31/86 patients (36%) were extubated at
the end of the case (G1), two patients had to be reintu-
bated (6.5%). MV time, ICU stay, hospital stay, costs
and MELD achieved statistical difference (see table).
Comparison: extubated vs. non extubated patients
N Patients = 86
Extubated
31 (36%)
Non extubated
55 (64%)
MV (hours) * 0 42.85
ICU days * 3.61 7.27
Hospital days * 13.43 21.16
MELD * 13.85 18.39
Costs US$ * 31,139 74,772
* P < 0.05
Conclusion: It is possible to extubate OLT patients in the
immediate postoperative period, when they fulﬁll the
mentioned criteria, even in a center with a low number of
transplantations. Less time of ICU and hospital stays,
less costs and a low incidence of reintubation, were ob-
served. In this group, MELD, but not CHILD, seems to
inﬂuence the immediate postoperative extubation.
P-624
EVALUATION OF THE ROLE OF
TRANSHEPATIC ARTERIAL
CHEMOEMBOLIZATION AS
PREOPERATIVE TREATMENT FOR
HEPATOCELLULAR CARCINOMA
Y. Kishi, A. Saiura, R. Koga, M. Seki, H. Naoki,
K. Yamada, R. Morimura, R. Yoshioka and
T. Yamaguchi
Cancer Institute Hospital
Background: Previous studies revealed preoperative
transarterial chemoembolization (TACE) for hepatocel-
lular carcinoma (HCC) did not improve prognosis, while
another study showed satisfactory survival by resection
following TACE in cases with macroscopic portal vein
tumor thrombus.
Objective: To evaluate the role of TACE as preoperative
treatment.
Methods: A total of 240 patients who underwent curative
hepatectomy for HCC from 1994 to 2008 were analyzed.
Median follow-up period was 35 months. Clinicopatho-
logic factors were compared between the patients with
and without preoperative TACE, and if TACE inﬂu-
enced patients’ prognosis was analyzed. Continuous
values are expressed as median.
Results: Preoperative TACE was performed in 69 pa-
tients. To compare these patients with those who did not
undergo TACE (n = 158), age was younger (66 vs. 68,
P = 0.01), more patients received major hepatectomy
(35% vs. 16%; P = 0.002) and incidence of positive
surgical margin was higher (52% vs. 28%, P < 0.001).
Incidence of vascular invasion (42% vs. 25%, P = 0.01)
and poorly differentiated HCC (18% vs. 7%, P = 0.02)
was higher. Overall survival (OS) of the patients with
preoperative TACE was worse both in patients with [5-
year survival rate; TACE (+) vs. (-); 5% vs. 64%;
P < 0.001] and without vascular invasion (44% vs. 70%;
P < 0.001). TACE resulted in complete tumor necrosis
in eight patients (11%) with 5-year survival rate of 60%,
but this was not signiﬁcantly better than those without
complete necrosis (25%, P = 0.09). Further, no clinical
predictor of complete necrosis was identiﬁed. Multivari-
ate analysis revealed preoperative TACE [hazard ratio
(HR) = 4.3, 95% conﬁdential interval (CI), 2.8 – 6.6],
vascular invasion (HR = 2.3, 95% CI, 1.4 – 3.6), non-
anatomical resection (HR = 1.6, 95% CI, 1.1 – 2.4), and
blood loss > 1L (HR = 1.8, 95% CI, 1.1 – 2.8) were
independent predictors of poor OS.
Conclusion: TACE should not be applied for preopera-
tive treatment of HCC routinely.
P-625
TRANSJUGULAR INTRAHEPATIC
PORTOSYSTEMIC SHUNT FOLLOWING
LIVER TRANSPLANTATION:
EXPERIENCE WITH 13 PATIENTS
M. Elatrache1, S. Sharma2, A. Yoshida1, D. Kim1,
J. Hundley1, M. Kazimi1, K. Brown3, D. Moonka3 and
M. Abouljoud1
1Henry Ford Health System/Transplant Institute; 2Wayne
State School of Medicine; 3Henry Ford Health System/
Gastroenterology and Hepatology
Background: Transjugular intrahepatic portosystemic
shunt (TIPS) has been fairly effective in the management
of portal hypertension in the setting of cirrhosis.
Aim: The aim is to study the efﬁcacy and safety of TIPS
in patients following liver transplantation (LT).
Methods: Single-center, retrospective study of LT recip-
ients from 1995 to 2008. Indications and outcomes of
TIPS following LT were summarized.
Results: Thirteen patients underwent TIPS at
21.1 ± 24.8 months post LT. Indications for TIPS were
refractory ascites (11), bleeding esophageal varices (1)
and hepatic hydrothorax (1). Six patients (46%) had
complete (C) resolution of ascites while seven (54%) had
partial or no (PN) resolution. Age, sex, race and MELD
scores were similar in the two groups. Portal and portal-
right atrial pressure gradients post TIPS were compara-
ble between the two groups. Liver function tests, creati-
nine and albumin values were higher in both groups post-
TIPS but with no signiﬁcant difference between the two
groups. Occlusion occurred in three patients (2 in C, 1 in
PN). Four patients required retransplantation (2 in C, 2
in PN), three for recurrent hepatitis C and one for graft
failure 8 days post TIPS. Encephalopathy occurred in
two patients (PN group). There were ﬁve deaths (2 in C, 3
in PN) 1, 3, 4, 7 and 24 months after TIPS. The C group
had a 5-year survival probability of 60.0% (CI: 12.6%,
88.2%). The PN group had a 5-year survival probability
of 66.7% (CI: 19.5%, 90.4%). Currently six patients are
alive without clinical evidence of ascites 6, 21, 53, 68, 76
and 86 months after TIPS.
Conclusion: TIPS can be used safely and effectively to
control refractory ascites after LT. Resolution of ascites
with TIPS did not seem to correlate with portal pressure
changes. Retransplantation in the context of organ dys-
function should be a priority when considering TIPS for
refractory ascites.
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PEDIATRIC LIVER TRANSPLANTATION
IN AN ADULT CENTER: 7 YEARS
EXPERIENCE
M. Enne1, L. Pacheco-Moreira1, E. Balbi1,
M. Valladares2, G. Santallucia2, J. Alves1,
R. Fernandes1, K. Stenibruck1 and J. M. Martinho1,3
1Hospital Geral de Bonsucesso - Ministe´rio da Sau´de -
Hepatobiliary and Liver Transplantation Unit; 2Hospital
Geral de Bonsucesso - Ministe´rio da Sau´de - Pediatric
Unit; 3Department of Surgery, Antonio Pedro University
Hospital - Fluminense Federal University
Background: Liver transplantation is a routine therapy
for some childhood liver diseases. Large centers have
reported patient survival to be 80 to 95% at two years.
We report our experience with the implementation of a
new pediatric liver transplantation program. At our State
there were no pediatric liver transplantation program
until 2002, the prompt need has led an adult liver
transplantation program to start a combined pediatric
liver transplantation program.
Objective: The purpose of this report is to describe out-
come after seven years from a starting pediatric liver
transplantation program in a combined established adult
transplant program.
Methods: The outcomes for all children (less than
15 years) who received a liver transplant from March
2002 to September 2009 were reviewed. Outcomes in-
cluded patient survival and complications. We performed
a total of 365 liver transplantations. Among these, 96
cases were pediatric, 62 from LDLT and the remaining
34 from cadaveric donors. Median weight was 15 kg
ranging from 4.600 g to 55 kg, 28 patients were small
children weighing less than 10 kg.
Results: The reasons leading to liver transplantation
were biliary atresia in 45 (46.87%), others cholestatic
diseases in 7 (7.29%), fulminant hepatic failure in 17
(17.70%), autoimmune hepatitis in 5 (5.20%) and he-
patoblastoma in 5 (5.20%). Vascular complications oc-
curred in 7 cases (7.29%), 4 PVT and 4 HAT (one patient
with both complications). Biliary complications occurred
in 8 (8.33%), and intestinal perforation in 7 (7.29%).
Four patients were retransplanted, 2 due to HAT, and 2
chronic rejection. Sixty days operative mortality was
15% (14 cases). 69 patients (75%) were alive at a median
follow-up of 40 months.
Conclusions: As in other programs, most deaths at our
center occurred in the early postoperative weeks. Surgical
complications are comparable to the rates in others
centers.
P-627
INTACT THROMBIN GENERATION AND
FIBRINOLYTIC POTENTIAL IN
PATIENTS UNDERGOING LIVER
TRANSPLANTATION DESPITE
ABNORMAL CONVENTIONAL
COAGULATION TESTS
T. Lisman1, K. Bakhtiari2, I. T. A. Pereboom1,
H. G. D. Hendriks1, J. C. M. Meijers2 and R. J. Porte1
1UMCG, Groningen; 2AMC Amsterdam
Background: Patients with liver disease often show sub-
stantial changes in their hemostatic system, which may
aggravate further during liver transplantation. Recently,
thrombin generation in patients with stable disease was
shown to be indistinguishable from controls provided
thrombomodulin, the natural activator of the anti-
coagulant protein C system, was added to the plasma.
Thrombomodulin is also required for regulation of
ﬁbrinolysis, but thrombomodulin-mediated regulation of
ﬁbrinolysis has not yet been studied in patients with liver
disease.
Aims: To study thrombin generation and ﬁbrinolysis
proﬁles in serial plasma samples taken from ten consec-
utive patients undergoing liver transplantation.
Results: At all time points, the endogenous thrombin
potential (ETP) was slightly lower compared to healthy
volunteers, despite substantially prolonged PT and
APTT values. However, when thrombin generation was
tested in the presence of thrombomodulin, the ETP was
equal to or even higher than that in healthy subjects. In
fact, thrombin generation was hardly affected by
thrombomodulin, while thrombin generation in healthy
subjects decreased profoundly upon the addition of
thrombomodulin. Surprisingly, thrombomodulin-medi-
ated regulation of ﬁbrinolysis was normal or even su-
pranormal compared to healthy volunteers.
Conclusions: Thrombin generation in patients undergo-
ing liver transplantation is equal or even superior to
thrombin generation in healthy volunteers when tested in
the presence of exogenous thrombomodulin. Further-
more, whereas a lack of thrombomodulin-mediated reg-
ulation of coagulation is observed, thrombomodulin-
mediated regulation of ﬁbrinolysis was shown to be in-
tact. Both coagulatory and ﬁbrinolytic potential are thus
preserved during liver transplantation. These results
support the recently advocated restrictive use of plasma
during liver transplantation and warrants further study
of the prophylactic use of anticoagulants after liver
transplantation.
P-628
SUCCESSFUL TRANSPLANTATION OF
A TRAUMA INJURED DONOR LIVER –
A CASE REPORT
M. Goetz, E. Ba¨rthel, R. Voigt, A. Bauschke,
F. Rauchfuss, M. Heise and U. Settmacher
University hospital Jena
Background: Because of a severe donor organ shortage
organs which have been considered as being not suitable
are nowadays being used for transplantation. We report
about the successful liver transplantation using a left split
liver graft of a donor liver injured by trauma.
Patients and methods: As a result of poly-trauma the li-
ver of a 48-year old organ donor with hemorrhagic shock
who had undergone emergency surgery showed a tear in
the parenchyma and a large hematoma in segment VIII.
An ex-situ splitting was performed and the left part (I-VI)
– reduced size transplantation – was used with complete
venous drainage (left and middle hepatic vein). The or-
gan recipient had been listed with a labMELD 9 from
toxic liver cirrhosis. The GW/BW ratio was 0.88. The
transplantation was orthotopic with preservation of the
recipient retrohepatic vena cava via anastomosis of a
caval patch of the donor left and middle hepatic vein as
well as an additional dorsal branch from segment I.
Immunosuppression is administered center speciﬁc as
tacrolimus based quadruple therapy.
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Results: The donor liver showed post-operatively a sta-
ble transplant function without any requirement for
substitution of coagulation substances. There were no
post-operative complications. At 12 months follow-up
the transplant function is stable. The immunosuppressive
treatment is currently managed as mono-therapy with
sirolimus.
Conclusion: The transplantation of a trauma injured
donor liver is feasible if the recipient selection is ade-
quate. Given the continuing shortage of donor organs the
allocation of trauma injured livers is justiﬁed for indi-
vidual cases.
P-629
LIVER TRANSPLANTATION AT THE
UNIVERSITY HOSPITAL, FACULTY OF
MEDICINE OF RIBEIRA˜O PRETO,
UNIVERSITY OF SA˜O PAULO: RESULTS
FOR THE FIRST 113 PATIENTS
O. Castro E Silva, A. K. Sankarankutty, E. D. Mente,
D. Cagnolati, R. B. Correa, F. F. Souza, A. C. Teixeira,
G. Oliveira, G. Mota, R. Kemp, T. Freitas, L. Ziviani,
A. Miranda, W. Campos Filho and E. G. Pacheco
Faculdade de Medicina de Ribeira˜o Preto da Universidade
de Sa˜o Paulo
Objective: To present the initial experience of the Group
of Liver Transplantation of the Faculty of Medicine of
Ribeira˜o Preto-USP.
Patients and methods: One hundred and thirteen patients
submitted to liver transplantation from May 2001 to
May 2009 were evaluated. Twenty-four percent of them
had cirrhosis of alcoholic etiology, 21% had cirrhosis due
to hepatitis C virus, 21% had hepatocellular carcinoma,
10% had familial amyloidotic polyneuropathy (FAP),
10% had cryptogenic cirrhosis, 4% had cirrhosis due to
autoimmune hepatitis, 4% had cirrhosis due to hepatitis
B virus, and 6% cirrhosis of other etiologies. The patients
were divided into two groups over two periods: A–
N = 42, with organ allocation according to the chro-
nologic criterion, and B–N = 71, receiving a transplant
according to the model for end stage liver disease
(MELD).
Results: Mean patient age was 49 ± 11 years (14–
69 years) and 69% were males. Period A: 12% were
Child A, 59.2% Child B, 24% Child C and 4.8% had
FAP. Period B: 35%, 31%, and 23% of the patients were
Child A, B and C, respectively, and 11% had FAP. The
MELD score was 15.3 ± 4.7 for period A and
22.2 ± 4.8 for period B. Intraoperative mortality was 2/
42 patients during period A and 1/71 during period B.
Actuarial survival was 53.85% and 64.71% during peri-
ods A and B, respectively.
Conclusion: Mean MELD score was higher among
patients of period B. The present results show that
postoperative mortality was similar for the two periods
and that the strategy of allocating organs according to
MELD score did not have a negative impact on post-
operative mortality.
P-630
LIVER TRANSPLANT PATIENTS
PROFILE OF A BRAZILIAN
TRANSPLANT UNIT
F. M. Q. Silva, I. Schmidtbauer, W. Andraus,
W. L. Junior Costa, C. E. Pompilio, V. Pugliese and
L. A. D’Albuquerque
Sa˜o Paulo University Medical School
Introduction: Cirrhotic and transplanted patients have
different features related to regions or countries.
Aim: To describe the clinical features of patients under-
going orthotopic liver transplantation (OLT) at Clinical
Hospital of Sa˜o Paulo University Medical School.
Methods: Medical records of all transplanted patients
admitted to the Transplant Unit (TU) between 01/01/
2009 to 11/01/2009 were analyzed.
Results: We performed 120 OLT in 113 patients (seven
retransplantation, seven liver-kidney transplantation and
seven living donor transplantation). The median age was
52 years (42–58), 64.2% males, median MELD 29 (24–
31). The main etiologies: HCV (30%), alcohol (15.8%),
cryptogenic (9.2%), HBV (5.8%), biliary disorders
(7.5%), autoimmune hepatitis (3.3%) and acute liver
failure (6.6%). Hepatocellular carcinoma and hepato-
pulmonary syndrome were present in 34.2% and 2.5%.
Piggyback with cava vein clamp was used in 55.9%,
piggyback without clamping in 31.4%, and conventional
technique in 12.7%. Choledocho-choledocho anastomo-
sis was performed in 89.2% of all cases. The median time
of surgery was 395 min (335–485), the cold ischemia time
was of 405 min (320–513). About 64.5% required trans-
fusion. Cell saver was used in 81.3% of patients with a
volume of 402 mL (170–680). The rate of primary non-
function (PNF) was 8.3%. Non-ideal-grafts were used in
57.7% of patients. Re-OLT causes were: PNF (42.9%),
hepatic artery thrombosis (42.9%) and biliary compli-
cations (14.2%). The median intensive care length of stay
(LOS) was 4.5 days (3–9) and hospital LOS was 19 days
(10–39). 25% of patients required hemodialysis 30 days
before OLT. The causes of death were septic shock
(60%), PNF (24%) and the one month post-operative
mortality was 16.6%.
Conclusion: The liver transplanted patient’s proﬁle
shows critical patients in accordance with our big waiting
list. However, despite the severity of the cases, the short
term results are comparable with international experi-
enced centers.
P-631
LIVING LIVER DONORS’
INCLINATIONS
M.Molinari1, S. Decoutere1, D. P. Renfrew1, I. Alwayn1,
J. M. Walsh1, M. Lareya1 and S. Helton2
1Victoria General Hospital and Science Medical Centre;
2Hospital Saint Raphael, New Haven, Connecticut
Introduction: Living donor liver transplantation (LDLT)
is still controversial. No studies have assessed the incli-
nations of potential donors towards the risks and the
beneﬁts of LDLT.
Methods: We interviewed 71 consecutive potential do-
nors and elicited their inclinations after undergoing a
standardized educational session on LDLT. Inclusion
criteria were: age > 18, emotional or familiar relation-
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ship to a liver transplant recipient on the wait list at our
institution, ﬁtness to undergo partial hepatectomy.
Exclusion criteria were: age > 60, presence of sensory or
cognitive impairment, any condition preventing dona-
tion.
Results: Participants’ mean age was 46.6 years (SD
12.6), 22 were males (31%). LDLT was favored by 68
participants (95.8%). A visual scale (0–10, 0 = non
important and 10 = very important) was used to assess
the value of several variables that could inﬂuence donors’
decisions (Table 1). Among participants who were
interested in LDLT, 92.6% would donate to their par-
ents, 98.5% to their siblings, 52.9% to aunts/uncles,
63.2% to cousins, 98.5% to partners/spouses, 97.0% to
children, 55.8% to grandparents, 94.0% to grandchil-
dren, 77.9% to friends and 1.4% to unknown recipients.
Donation would have been declined in 19.2% if the
recipients had high probability of recurrence, in 14.8% if
the disease was self inﬂicted, in 76.5% if the recipient was
still abusing substances causing liver failure. About
57.3% would donate to recipients older than 65, 22.3%
even if there was a high probability of a cadaveric
donation in the next three months and 58% if the waiting
time for a cadaveric donor was longer than three months.
Table 1. Visual scale values of several variables inﬂuen-
cing participants’ decision making
Variable Mean SD
Perioperative donor’s complications 4.5 3.0
Perioperative donor’s mortality 5.1 3.4
Length of donor’s hospital stay 2.5 2.7
Length of time needed to be off-work 2.3 3.0
Recipient’s survival gain 9.5 1.3
Donor’s potential loss of income 2.9 3.5
Donor’s potential long term disability 4.9 3.1
Causes of recipient’s liver failure 2.6 3.6
Conclusions: Our ﬁndings suggest that the majority of
potential LDLT donors would donate to family members
and friends and that their decision was primarily inﬂu-
enced by the survival beneﬁts for the recipients. Self in-
ﬂicted liver failure and the risk of recurrent disease
signiﬁcantly reduced donation rates.
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LIVING DONOR LIVER
TRANSPLANTATION FOR ACUTE LIVER
FAILURE: A SINGLE CENTER
EXPERIENCE
L. Pacheco-Moreira1, M. Enne1, L. P. Carius1, E. Balbi1,
J. Alves1 and J. M. Martinho1,2
1Hospital Geral de Bonsucesso - Ministe´rio da Sau´de;
2Universidade Federal Fluminense
Orthotopic liver transplantation (OLT) is the principal
therapy for acute liver failure (ALF). The mortality on
the waiting list for deceased donor liver transplantation
(DDLT) is high, principally in countries where donation
rates are low. Living donor liver transplantation (LDLT)
seems an option for the treatment of ALF, although
some ethical issues need to be considered.
Herein we have evaluated LDLT results among patients
with ALF and discussed the ethical aspects of procedures
performed in emergency situations.
Patients and methods: From March 2002 to October
2009, we performed 367 liver transplantations, including
127 from living donors. ALF was responsible for 11.7%
of all transplantations; LDLT was only considered for
pediatric recipients among whom 10 children displayed
ALF.
Results: Three transplanted patients died during the
follow-up. One patient died on postoperative day 33 due
to hepatic artery thrombosis. One patient died at two
months after transplantation due to biliary sepsis, and
the last one died due to sepse during postoperative per-
iod, resulting in an overall survival rate of 70%. The
average time for donor discharge was ﬁve days. No
mortality or major complications were observed in do-
nors.
Conclusions: The survival of children with ALF under-
going LDLT was comparable to published data. Fur-
thermore, despite the fact that the available time to
prepare the donors was limited, no serious complications
were observed in the postoperative period. Thus, using
living donors for children with ALF is an effective, safe
alternative that can be extremely useful in countries with
low donation rates.
P-633
THE INFLOW AND OUTFLOW
RECONSTRUCTION AT LIVING
RELATED LIVER TRANSPLANTATION
O. Kotenko, D. Fedorov, A. Grinenko, A. Popov,
A. Korshak and A. Gusev
Institute of Surgery and Transplantology, Kiev, Ukraine
Introduction: Feature of living related liver transplanta-
tion (LRLT) is deﬁciency of functional weight of a graft
in adult and autovenous a plastic material for perfor-
mance of vascular reconstruction.
Aim: Aim was studying efﬁciency of inﬂow and outﬂow
reconstruction at LRLT.
Materials and methods: Seventy patients with end stage
liver diseases received LRLT from August 2003 till
October 2009, there were 35 adults (49.3%) and 36
(50.7%) patients in the pediatric age group. From 32
patients with biliary atresia in one case took place
agenesis of the portal vein, in one – congenital ﬁbrosis of
the portal vein.
Results: From 71 LRLT venous reconstruction was
made at 67 patients. From seven patients with a portal
vein thrombosis at right lobe LRLT in ﬁve cases has
executed thrombectomy with the subsequent imposing
porto-portal anastomosis. In two cases due to degenerate
changes of a wall portal vein it was resected and recon-
structed. At one case dual LRLT portal vein resection
and the subsequent Y-shaped autovenous plasty portal
vein has made due to portal vein thrombosis. At left
lateral section LRLT in two cases with congenital portal
vein ﬁbrosis portal vein reconstruction in recipient has
made with donor’s left ovarian vein. In other two cases
total cava-portal transposition was made. For this pur-
pose suprarenal part of inferior vena cava was anasto-
mosed with left portal vein of a graft. Total cava-portal
transposition used in one case of right lobe LRLT at the
patient with viral liver cirrhosis and total portal veins
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system thrombosis. In 16 cases adults LRLT right lobe
harvested with middle hepatic vein.
Conclusion: Venous reconstructions of a grafts allows to
expand indications to donation parts of a liver from the
alive donor, to made LRLT of patients with a portal vein
thrombosis which were considered unpromising earlier
and to provide adequate graft function.
P-634
INFLUENCE OF HLA TYPING ON
OUTCOME OF LIVING DONOR LIVER
TRANSPLANTATION
S. Pareek, S. Goja, P. Dargan, N. Goyal, V. Vij and
S. Gupta
Indraprastha Apollo Hospital, New Delhi
Back Ground: Liver transplantation is the accepted
treatment for most acute and chronic liver diseases
resulting in liver failure; however, the scarcity of cadav-
eric donors has become an insurmountable problem.
Living donor liver transplantation offers a unique sce-
nario in which liver from relatives can be transplanted.
So we analysed the outcome of recipients of Living donor
liver transplantation with regards to percentage of HLA
matching between the donor and recipient.
Methods: This study is a retrospective analysis of pro-
spectively maintained data of patients who underwent
Living donor liver transplantation in Indraprastha
Apollo Hospital, New Delhi from September 2006 to
October 2009.
Total of 218 patient underwent Living donor liver
transplantation. HLA records were available in 77
patients. They were divided into three groups. Group A
with less than 50% HLA match, Group B with 50%
match, and Group C with more than 50% HLA match.
All the groups were similar with regards to age and sex of
the patients. Maximum follow-up of the patient was
three years.
Results: There were 11 patients in Group A out of which
3 patients had mortality till date. Group B had 42 pa-
tients out of which 8 patients had mortality. Group C
had 24 patients out of which 5 patients had mortality.
There was no statistical difference in the outcome.
Conclusion: HLA matching between the donor and re-
cipient does not affect outcome in Living donor liver
transplantation.
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DECEASED VS. LIVING DONOR LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA: AN
INTENTION-TO-TREAT ANALYSIS
J. R. Maurette1, M. Konstadoulakis2, B. Blondeau3,
G. Gondolesi4 and M. Scwartz5
1British Hospital of Buenos Aires. Buenos Aires.
Argentina; 2Hepatopancreatobiliary Unit, 1st Department
of Propaedeutic Surgery. Athens. Greece; 3University of
Missouri. Kansas City. Missouri; 4Fundacion Favaloro.
Buenos Aires. Argentina; 5Recanati/Miller Institute.
Mount Sinai Hospital. New York
A number of studies have focused on the outcome of
Cadaveric Liver Transplantation (CLT) for hepatocellu-
lar carcinoma (HCC) based on an intention-to-treat
principle, factoring in the natural history of tumor
progression and drop-out from the waiting list for
OLT. Living Donor Liver Transplantation (LDLT)
offers the potential for the earlier transplantation of
patients with HCC, resulting in lower drop-out rates. The
aim of this study was to compare the overall survival,
drop-out, and recurrence rate after transplantation on an
intention-to-treat analysis in both groups: CLT vs.
LDLT.
Between January-1997/December-2001, 227 patients
listed while waiting for a cadaver organ and 36 patients
who had a candidate for living donation were enrolled in
the current study. Number of tumors, size, location,
vascular invasion, as well as histologic grade were also
evaluated. The median follow-up was 1313 ± 844 days.
All 36 patients with a donor candidate in the LDLT
group were transplanted compared with 44% patients in
the CLT. The waiting time for LDLT patients was
signiﬁcantly shorter than that of CLT patients. There was
no drop-out in the LDLT group compare with 21% in
the CLT group. In LDLT group no death occurred prior
to transplantation, while 88 patients died before trans-
plant in CLT group. The overall survival at 5, 3 and
1 year was 34%, 57% and 88%. Survival on an intention
to treat basis of transplanted patients at 5, 3 and 1 year
was 45%, 71% and 93%. The risk of recurrence after
transplantation at 1, 3 and 5 years was 8%, 20% and
31%. These differences were not statistically signiﬁcant.
Multiple lesions, maximum diameter > 5 cm, portal vein
thrombosis and exclusion from the Milan criteria were all
found at an increased proportion in drop out patients.
These parameters could be viewed as the potential
selection variables for LDLT patients since they are the
most likely to be dropped from the list without under-
going a potential therapeutic operation. Survival with an
intention to treat (survival from diagnosis) and post
transplantation survival in our cohort.
P-636
DONORS’ ACCEPTANCE OF
PERIOPERATIVE MORBIDITY AND
MORTALITY OF LDLT
M. Molinari1, S. Decoutere1, J. M. Walsh1,
D. P. Renfrew1, K. Peltekian1 and W. Helton2
1Victoria General Hospital Health Science Center;
2Hospital Saint Raphael, New Haven, CT
Introduction: Living donor liver transplantation (LDLT)
is still controversial and no studies have assessed poten-
tial donors’ inclinations towards the risks and the beneﬁts
of LDLT.
Methods: We interviewed 71 consecutive potential donors
and elicited their inclinations after undergoing a stan-
dardized educational session on LDLT. Inclusion criteria
were: age > 18, emotional or familiar relationship to a
liver transplant recipient on the wait list at our institution,
ﬁtness to undergo partial hepatectomy. Exclusion criteria
were: age > 60, presence of sensory or cognitive impair-
ment, any condition preventing donation.
Results: Participants’ mean age was 46.6 years (SD
12.6), 22 were males (31%), 38% were spouses, 19%
children, 24% cousins, 13% siblings and 6% had other
relationship with the recipients. LDLT was favored by
95.8% of the participants, 1.4% refused and 2.8% were
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unsure. After eliciting their inclinations, 68 individuals
chose to be donors only if their risks of morbidity was
< 66.3% (SD 36.8), mortality < 41.1% (SD 34.3), if the
need of blood transfusions was < 3.2 units (SD 2.7), if
the risk of being off work was < 30 weeks (SD 24).
Participants declined surgery if the donor’s survival at
one months was < 40.9% (SD 29.5) or at one year
< 32.9% (28.9%), if the recipient was older than
74.1 years (SD 10.6), if the survival beneﬁt of LDLT was
< 10.7 months (SD 22.3) and if the total expenses for
the donor’s family was > $ 22 000 (SD 39 000). Multi-
variable analysis showed that there were no statistical
signiﬁcant differences between donors’ inclinations to-
wards LDLT and the etiology of liver disease affecting
the recipient.
Conclusions: Our ﬁndings suggest that there is disso-
nance in the decisions making between caregivers and
potential donors. LDLT donors would accept higher
perioperative risks even when fully informed that the
potential survival beneﬁts for the recipients are signiﬁ-
cantly lower than what reported in the current literature.
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THE FIRST ATTEMPT TO CREATE A
BRAZILIAN LIVING DONOR LIVER
TRANSPLANTATION REGISTRY
L. Pacheco-Moreira1,2, M. Enne2, R. Fernandes2,
V. Garcia1, B-H. Ferraz1, L. A. C. Albuquerque3,4,
U. Tannuri5, R. C. Afonso6, A. M. Gonzales7,
E. Carone8, J. C. Wiederkehr9 and M. P. Miranda4
1Brazilian Association for Organ Transplantation –
ABTO; 2Hospital Geral de Bonsucesso; 3Hospital de
Clinicas da USP; 4Hospital Beneﬁceˆncia Portuguesa;
5Instituto da Crianc¸a da USP; 6Hospital Israelita Albert
Einstein; 7UNIFESP - Hospital Sa˜o Paulo; 8Hospital do
Caˆncer - A C Camargo; 9Hospital Pequeno Prı´ncipe
The rising demand for liver transplantation in Brazil has
continued to outpace the availability of deceased donor
organs. Efforts to increase deceased liver donation have
seen only modest successes. The ﬁrst living donor liver
transplantation (LDLT) in the world was performed in
Brazil. Although potentially lifesaving for the recipient,
LDLT is a unique surgical procedure that subjects a
healthy donor to a major surgery without direct thera-
peutic beneﬁts. Results concerning donor outcome still
need to be extensively evaluated. Reports of complica-
tions among living donors have been limited to single
centers.
Our aim is analyze the rate and severity of complications
in living liver donors in Brazilian centers.
This is a retrospective study. Participants included all
living donors between 1989 and 2009. This registry was
created in January 2009. All Brazilian centers were
invited to send their data about living donors to the
Brazilian Organ Transplantation Association (ABTO)
webpage.
During the last 20 years, 1451 LDLT were performed in
Brazil by 51 centers. Only six centers performed more
than 100 LDLT. Three donor deaths (0.20%) were
published by Brazilian liver transplantation team. Only
269 (18.5%) living donors were reported in this national
registry. The mean of donor age was 32 years-old (79.8%
was between 18–40 years). The right liver was donated in
72% of cases. 9.1% of donors were re-hospitalized and
2.2% were re-operated. Biliary complications were
observed in 10.8% of cases. None death was reported
in this registry.
In this attempt to elaborate this registry the notiﬁcation
was very low, but according these data LDLT was
associated with signiﬁcant donor complications.
Although most complications were of low-grade severity,
a signiﬁcant proportion were severe or life threatening.
Quantiﬁcation of complication risk may improve the
informed consent process and donor care.
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MINIMIZATION OF DONOR RISK IN
LDLT BY SYSTEMATIC SELECTION OF
GRAFT TYPES AND USE OF CRY-
PRESERVED VEIN GRAFT FOR
OUTFLOW RECONSTRUCTION IN
RECIPIENTS
S. Tamura1, Y. Sugawara1, T. Aoki1, J. Kaneko1,
K. Hasegawa1, M. Makuuchi2 and N. Kokudo1
1University of Tokyo; 2Japanese Red Cross Medical
Center, Tokyo
Introduction: In our adult to adult living donor liver
transplantation (LDLT) program, we have continued to
apply an algorithm for selection of graft types, intending
to minimize the surgical risk in the donor. The algorithm
maximizes the opportunity to preserve the middle hepatic
vein (MHV) in the donor. Simultaneously, we have de-
vised and aggressively applied the technique of venous
outﬂow re-construction with the use of cryo-preserved
vein grafts. In case of right liver (RL) graft without the
MHV, the method is applied to re-construct major ve-
nous tributaries of the para-median sector thereby pre-
venting congestion and allowing the graft to exert its full
potential immediately post re-perfusion. Our approach
is, theoretically the most efﬁcient strategy to circumvent
the issue of ‘MHV controversy’. In the current study, we
assess the morbidity in living donors and evaluate the
beneﬁt of our systematic approach.
Method: Operative complications in 52 consecutive liv-
ing liver donors were prospectively assessed with Clavien
system.
Results: Among the 52 donors, RL graft was procured in
34 cases (65%), and left liver graft in 15 cases (29%). In
three cases, right lateral sector graft was selected and
excluded from the study. In the RL group, 11 cases
(32%) were with the MHV, and 23 (68%) were without
the MHV. Overall, complications were observed in 73%,
43%, and 47% of the donors who were retrieved RL
graft with the MHV, RL graft without the MHV and left
liver graft, respectively. The severity in each group were,
Grade I-II; 63%, 34%, 40%, Grade IIIa;9%, 9%, 0%,
and Grade IIIb;0%, 0%, 7%, respectively. No grade IV
or mortality was observed. Rates and severity of the
complications did not signiﬁcantly differ between groups.
Conclusion: Algorithm based systematic selection of
graft types with the use of cry-preserved vein graft for
venous outﬂow reconstruction in the recipient may be an
effective approach to minimize the surgical risk in living
donor.
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IS LIVING DONOR LIVER
TRANSPLANTATION ADJUSTIFIED FOR
CYSTIC FIBROSIS?
G. Xiao1, D. Schidlow2, S. Shang3, W. Meyers1 and
B. Ringe1
1Department of Surgery, Hahnemann University Hospital,
Drexel University College of Medicine, Philadelphia;
2Department of Medicine, St Christopher’s Hospital for
Children, Drexel University College of Medicine,
Philadelphia; 3Department of Radiology, Hahnemann
University Hospital, Drexel University College of
Medicine, Philadelphia
Background: Chronic liver disease is the second most
common cause of death after lung disease in patients with
cystic ﬁbrosis (CF). With the improvement of medical
management, some pediatric patients live through their
teenager age to young adult. They could develop biliary
cirrhosis and portal hypertension (PTN) which require
liver transplantation (LT).
Objective: CF patients’ Pediatric End-Stage Liver Dis-
ease (PELD) and Model for End-Stage Liver Disease
(MELD) scores are usually not high enough for them to
get a deceased LT even though United Network of Organ
Sharing (UNOS) recently proposed an exceptional
MELD/PELD score for CF patients when FEV1 falls
below 40%. Living donor liver transplantation (LDLT)
may be a reasonable option. There is no serial report
about LDLT for CF patients from our literature search.
Methods: Four patients received LDLT from February
2004 to July 2007. There are two male and two female
patients. Age ranges 11–22 (average 16.5) years old. One
of our patients has been on waiting list for 74 months.
Follow-up time ranges 28–70 (average 49) months. All
patients had liver cirrhosis, PTN and mild to moderate
lung disease. PELD/MELD ranges 5–13. Three patients
received right lobe and one patient received left lateral
lobe LT.
Result: All patients are currently alive with good func-
tioning grafts. Two patients’ FEV1 improved from 65, 70
preoperative to 83, 96 postoperative, respectively. The
other two patients’ FEV1 remained the same after LT.
All patients’ liver function has improved postoperatively.
Conclusion: When CF patients develop PTN, this could
further impair their pulmonary function. LT is the pre-
emptive treatment for CF patients complicated with bil-
iary cirrhosis before they develop the end stage lung
disease. So these patients should be evaluated early for
LT alone to avoid combined liver/lung or liver/heart/lung
transplantation which has unsatisfactory outcome.
LDLT is a good option for CF patients with low PELD/
MELD scores.
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POSTOPERATIVE COMPLICATIONS
AND OUTCOMES IN LIVE LIVER
DONORS AFTER PARTIAL
HEPATECTOMY FOR LIVER
TRANSPLANTATION: IS THERE A
LEARNING CURVE?
R. Saidi, N. Elias, D. Ko, T. Kawai, J. Markmann,
A. B. Cosimi and M. Hertl
Massachusetts General Hospital
Introduction: Donor safety is the ﬁrst priority in living
donor liver transplantation (LDLT). We evaluated the
postoperative morbidity after partial hepatectomy for
LDLT in our unit.
Method: Thirty patients underwent LDLT between 1997
and 2007 at our institution. This represented approxi-
mately 8% of the total liver transplant experience during
that period. The type of graft was the right lobe (seg-
ments 5–8) in 14, left lobe (segments 2–4) in 4, and left
lateral sector (segments 2 and 3) in 12 patients. There
were 18 adults and 12 pediatric recipients. Mean donor
age was 36 years (26–57). The mean follow-up was
48 months (range 18–120 months). Complications were
classiﬁed according to Clavien’s system.
Results: No deaths occurred. Overall eight (26.6%) pa-
tients experienced a total of 14 postoperative complica-
tions. Mean length of hospitalization was 7.5 days (5–
12 days). Donor complications based on graft type were
as follows: left lateral sector (16.7%), left lobe (25%),
and right lobe (35.7%). The experience was divided into
two periods 1997–2001 (15 patients) and 2002–2007 (15
patients). Overall complications during two periods were
40% and 13.3%, respectively (P < 0.001). The incidence
of grade III complication also signiﬁcantly decreased;
66.7% vs. 33.3% (P < 0.01).
Conclusion: Partial hepatectomy in living donors has a
learning curve which appears to be approximately 15
cases. This learning curve is not restricted to the surgeons
performing the procedure but involves all areas of peri-
and postoperative patient care. Our experience empha-
sizes that LDLT can be safely provided by active liver
transplant programs performing only a modest number
of LDLT.
P-641
OUTFLOW RECONSTRUCTION USING
NATIVE LIVER VEINS IN RIGHT LOBE
GRAFTS WITHOUT MHV HARVESTING:
3 YEARS EXPERIENCE
J. R. Soliman, T. Ibrahim, M. Osman, I. Marwan,
O. Hegazy and H. Shoreim
National Liver Institute, Menouﬁa University
Background: Living Donor liver transplantation is a
good alternative in areas without cadaveric transplants.
Variation of the hepatic veins and portal vein are
important factor in determining suitability of grafts for
living donation especially as regard donor safety and
difﬁculty in outﬂow reconstruction due to the lack of
suitable vein grafts.
Aims: We present our experience in vascular recon-
struction of living donor transplants using vein grafts
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from the native liver of the recipient in Right lobe grafts
without MHV harvesting.
Patients and methods: We had performed 66 living donor
liver transplantation in the department of Surgery, Na-
tional Liver institute, Menouﬁa University starting from
28th of April 2003 to the end of December August 2009.
They were 20 pediatric patients and 46 adult patients. We
reviewed the preoperative patient’s data, graft charac-
teristics, operative data, postoperative details including
hospital stay, the in-hospital complications and early
follow. Accordingly, we excluded 10 patients with tumors
and sex patients with portal vein thrombosis.
Results: In right lobe grafts we used vein grafts in 14 out
of 34 patients. We tried to minimize the number of he-
patic veins to a maximum of two anastomosis by this
technique. Long grafts were obtained from the portal
system and the hepatic veins in reconstruction of V5 in
ﬁve patients, V8 in ﬁve cases, middle hepatic vein in ﬁve
cases, inferior hepatic vein in two cases and anterior
patch for the right hepatic vein in eight cases. In two
cases we used a recanalized umbilical vein to reconstruct
two inferior veins in one patient and V5 in the other. In
two cases these grafts were thrombosed postoperatively
but the rest were completely functioning postoperatively
upto two years after transplantation.
Conclusions: The native liver of the recipient is a good
source for vein grafts in living donor liver transplants in
absence of portal vein thrombosis and malignancy.
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GASTRODUODENAL ARTERY STEAL
SYNDROME AFTER LIVING DONOR
LIVER TRANSPLANTATION:
INCIDENCE AND MANAGEMENT
H. E. Soliman1, Y. Hatata2 and T. Ibrahim1
1National Liver Institute, Menouﬁa University;
2Department of Surgery, Fayioum University
Abstract: Arterial steal syndrome (ASS) after liver
transplantation has been reported. ASS causes arterial
hypo-perfusion of the graft liver and devastating conse-
quences. However, the diagnosis tends to be delayed. We
present recognized two cases of a gastroduodenal artery
(GDA) steal syndrome that was diagnosed with intra-
operative Doppler ultrasound and treated with GDA
ligation and coil occlusion after liver transplantation.
One of the patients had a variation of hepatic artery
anatomy left hepatic artery arising from the left gastric
artery that was reconstructed intraoperatively and the
other had a normal arterial anatomy. Doppler ultra-
sound of the liver was performed as usual and detected
weakening of the ﬂow one and absent ﬂow in the other
patient. After ligating the big GDA operatively in the
ﬁrst patient and occlusion by coils in the second, hepatic
arterial waveform inside the liver drastically improved.
The current case should show the efﬁcacy of intraoper-
ative Doppler ultrasound of the liver on ASS and alert
clinician to ligate GDA to prevent ASS if hepatic arterial
ﬂows are suboptimal. We conclude that steal is a rare but
signiﬁcant problem after liver transplantation. Urgent
treatment by embolization, stenting or operative ligation
is mandatory to achieve early clinical improvement.
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MORBIDITY AND MORTALITY
ANALYSIS IN LIVING RELATED
DONOR’S HEPATECTOMY
F. Bersano, V. Ardiles, C. Salas, J. Pekolj, F. J. Mattera,
M. A. Ciardullo and E. de Santiban˜es
Hospital Italiano de Buenos Aires
Background: At present, LDLT is accepted as a thera-
peutic option for patients with end-stage liver disease to
make up for the shortage of donor organs from dead
patients. Although there have been signiﬁcant improve-
ments in surgical techniques, the LDLT procedure is still
associated with donor morbidity and even mortality.
Objective: To analyze the results of the donor surgery in
LDLT in a single center.
Methods: Descriptive, retrospective study LDLT per-
formed in our center between June 1992 and august 2009.
The Clavien 5-tier grading system was applied to register
postoperative morbidity.
Results: In the analyzed period we perform 763 liver
transplants of which 108 were LDLT (adult to adult in 36
cases and pediatric in 72). Sixty-six were female (61%,
CI95 51–70) with a mean age of 32.6 y/o (DS 8.8). Of
these, 62.4% (CI95 52.2–71.8) were donations of the left-
lateral lobe, 5% (CI 1.6–7) were of the left lobe, and
32.7% (CI95 23.7–42.7) were of the right lobe. Median
operative time was 240 min (r: 120–420). Six patients
received 1.2 red blood units. Twenty six patients required
ICU for one day and one patient for 2 days. Mean
hospital stay was 5.8 days (DS1.9) Morbidity was 26%
(Grade I: 21.3% (IC95 14–30); grade II: 1.9% (CI 0.2–
6.5), grade III a: 1.9% (IC 0.2–6.5); grade III b: 1.9% (IC
0.2–6.5), grade IV y V: 0%) and mortality 0%.
Conclusions: In our experience liver resections on living
related donors for transplantation was a safe procedure.
We have no donor mortality. The complications were
mild and easy to resolve.
P-644
MANAGEMENT OF VENTRAL HERNIAS
WITH LIVING DONOR LIVER
TRANSPLANTATION
J. R. Soliman, T. Ibrahim, I. Marwan, M. Osman and
K. Abu Elella
National liver Institute, Menouﬁa University
Background: Optimal management of patients with
umbilical hernias and liver cirrhosis with ascites is still
under debate. Timing of intervention is critical in those
patients waiting for living donor liver transplantation.
Methods: In the period between April 2003 and
December 2007, 72 patients with advanced liver diseases
underwent LDLT in two transplant centers in Egypt. The
records of the patients were reviewed to determine the
type of hernias and whether they were repaired or not
with LDLT. They were 17 children and 55 adults. Ten
females and 62 males with mean age. The operative
repair was identiﬁed and the technique was reported.
Results: Hernia repair was successful without complica-
tions at the end of transplantation in 19 umbilical and 4
inguinal hernias. No recurrences were observed for a
mean of 6 months follow-up period. Operative time was
prolonged with a mean of 25 min for umbilical hernias
and 35 for inguinal hernias.
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Conclusions: Concomitant abdominal hernia with living
donor liver transplantation is feasible and doesn’t add
any additional risks to the recipient procedure.
P-645
LIVING DONOR LIVER
TRANSPLANTATION FOR THE PATIENT
WITH SITUS INVERSUS TOTALIS USING
RIGHT POSTERIOR SEGMENT GRAFT
B.-W. Kim, H.-J Wang and M.-W. Kim
Ajou University School of Medicine
Orthotopic liver transplantation in adults with situs
inversus totalis (SIT) has been considered as very difﬁcult
procedure because of the anatomical abnormality. The
living donor liver transplantation (LDLT) for the patient
with SIT is thought more eligible because meticulous
preoperative evaluation is possible for anatomical feasi-
bility of the partial liver graft to the recipient. Recently,
we experienced successful LDLT in a SIT patient using
right posterior segment graft.
A 60-year-old female patient with SIT, suffering from
end-stage liver disease presenting recurrent esophageal
varix bleeding secondary to B-viral liver cirrhosis,
underwent liver transplantation at our institute in May
2009.
Preoperative donor evaluation showed the volume of
right posterior segment was 0.85% of graft-recipient
weight ratio (GRWR). The preoperative simulation of
right posterior segment graft showed space-ﬁtting in the
recipient hepatic fossa when the graft was rotated
180 degree.
The operation was performed as preoperative simulation
and the patient recovered uneventfully. The graft liver
function and vascular integrity were also excellent for a
while after LDLT. But serum bilirubin and the liver
enzyme were started to elevate slowly after 3 weeks of
LDLT. Doppler ultra-sonogram showed disturbance of
ﬂow in the mid-portion of right hepatic vein due to its
reverse position and it is conﬁrmed by direct hepatic
venogram. A long vascular stent was inserted in the right
hepatic vein. After then the graft function was normal-
ized and the patient was discharged with good liver
function.
The present study showed LDLT using right posterior
segment graft for the patients with SIT is feasible.
P-646
LIVING DONOR LIVER
TRANSPLANTATION FOR CAROLI’S
DISEASE IN CHILDREN – TWO CASES
REPORT AND LITERATURE REVIEW
K. Steinbru¨ck, M. Enne, J. M. Martinho, R. Fernandes,
J. Alves and L. Pacheco-Moreira
Liver Transplantation Unit, Bonsucesso General Hospital/
MS, Rio de Janeiro, Brazil
Background: Caroli’s disease (CD) is a rare disorder
characterized by intrahepatic cystic dilatation of the bile
ducts. When progressive, leads to recurrent cholangitis,
portal hypertension and liver failure. Patients with bilo-
bar or progressive disease may require orthotopic liver
transplantation (OLT). In the MELD era, living donor
liver transplantation (LDLT) raised as the ultimate
treatment option for these patients.
Aim: Describe two cases of patients that underwent
LDLT as a treatment for CD and perform a literature
review.
Methods: From December 2002 to August 2009, 126
LDLT were performed in our unit. Data from two pa-
tients with diffuse CD who had undergone LDLT were
analyzed retrospectively. A literature review was con-
ducted as a search of the MEDLINE databases.
Results: Patient one, a 2-year-old girl, was submitted to a
LDLT and received a 240 g left lobe graft, corresponding
to 1.96% graft to recipient weight ratio (GRWR). Post-
operative recovering was uneventfully and she was dis-
charged on the 16th post operative day (POD). She is in
good health after 80 months post-transplantation. Pa-
tient two, a 19-year-old girl, underwent a LDLT and
received a 706 g right liver graft, corresponding to 1.21%
GRWR. At the 11th POD, a bile collection was diag-
nosed and she was submitted to percutaneous drainage
and antibiotic treatment. She was discharged on the 23rd
POD and is well after one year of follow-up.
On a MEDLINE search, we identiﬁed 25 reports of liver
transplantation for CD, with a total number of 174
transplants, only 7 with living donor.
Conclusion: We successfully performed LDLT for two
patients with diffuse Caroli’s disease. The good postop-
erative courses of the two cases, indicate that LDLT is a
feasible option in the treatment of this disorder, even
when complicated by recurrent cholangitis or carried out
in an early age patient. In the MELD era, LDLT is the
ultimate treatment option for patients with chronic
cholestatic disease and low MELD score.
P-647
ABO INCOMPATIBLE ADULT LIVING-
DONOR LIVER TRANSPLANTATION –
FIRST RESULTS AT A SINGLE
INSTITUTION
E. Ba¨rthel1, S. Rummler2, A. Bauschke1, M. Heise1,
R. Voigt1, D. Barz2 and U. Settmacher1
1Department of General, Visceral and Vascular Surgery;
University Hospital Jena; Germany; 2Institute for
Transfusion Medicine; University Hospital Jena; Germany
Background: Adult ABO incompatible living donor liver
transplantation (ABO-I-LDLT) is being discussed con-
troversially because of a high risk of severe humoral
rejection with consecutive graft loss. We report about
successful ABO-I-LDLT in two patients.
Patients and methods: One patient had a diagnosis of
hepatocellular carcinoma with liver ﬁbrosis. The other
patient had a diagnosis of advanced toxic liver cirrhosis
Child C. There was an ABO incompatibility for both
patients (case 1: donor A2, recipient B; isoagglutinin titer
1:32, case 2: donor A1, recipient O, isoagglutinin titer
1:256). Both recipients have been treated pre-operatively
with plasmapheresis (PEX) or/and immunoadsorption
(IA), respectively. Both patients received a tacrolimus
based quadruple induction immunosuppression which
was initiated pre-operatively. There was no splenectomy
in either case.
Results: In both patients the pre-operative elimination of
the isoagglutinin titers with PEX and IA was successful.
LDLT was performed with a titer of 1:4 in each case. In
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case 1 there was a portal vein thrombosis on day nine
after transplantation with concurrent increase of the
isoagglutinin titer (1:128) reﬂecting a humoral rejection.
The titer has been effectively lowered by a further 13 IAS.
At any point in time, both patients did have stable
transplant function. At current follow up of 18 and
12 months, respectively, the isoagglutinin titers are
titrated at a stable low level (1:8). Both patients are
currently managed with an immunosuppression mono-
therapy (sirolimus or tacrolimus) with a moderate target
level of 5–8 lg/L.
Conclusions: ABO-I-LDLT is feasible through a combi-
nation of preoperative immunoadsorption and intensiﬁed
immunosuppression and shows graft and patient survival
comparable with that of compatible liver transplantation.
A minimization of immunosuppression is possible for
long-term management.
P-648
EARLY STEROID WITHDRAWAL
REGIMEN CAN REDUCE
DEVELOPMENT OF NEW ONSET
DIABETES MELLITUS FOLLOWING
ADULT LIVING DONOR LIVER
TRANSPLANTATION
Y.-K Kim, S. H. Kim, S.-S. Han, S. Y. Cho, T. You,
S.-J. Sang-Jae and K.-W. Lee
Center for Liver Cancer, National Cancer Center
Background: The incidence rate of new onset diabetes
mellitus (NODM) is 10–30%. Steroid early withdrawal
or free regimen is attempted in patients received adult
liver transplantation to decrease metabolic complication
such as diabetes mellitus (DM), hypertension, and dysl-
ipidemia. There were a few of reports that steroid early
withdrawal regimen (ESWR) can reduce development of
NODM.
Aim: The purpose of this study is to evaluate that steroid
ESWR can reduce developments of NODM (America
Diabetes Association/World health Organization crite-
ria) and to analysis the risk factors of NODM after
LDLT.
Methods: One hundred and sixty seven patients were
received adult LDLT from February 2005 to August
2009 in National Cancer Center, Korea. 67 patients were
excluded because of no more than 3 months, deceased
donor liver transplantation, DM before LDLT and
exchanging immunosuppressive agents within 6 months.
ESWR is inducted with interleukin-2 receptor antibody
and maintained with tacrolimus and mycophenolate
mofetil. Hundred patients were divided into two groups;
patients who were applied to ESWR group and patients
applied convention immunosuppression regimen (CISR)
group. We compared ESWR group with CISR group in
developing NODM after LDLT.
Results: Overall incidence of NODM was 13%: 5.7% in
ESWR group (n = 35) and 16.9% in CISR group
(p = 0.112). Multivariate analysis identiﬁed pre-trans-
plant hypertension [hazard ratio: 4.26 (95% CI, 1.10–
16.56), p = 0.036] and age more than or equal to 55 year
[hazard ratio: 5.03 (95% CI, 1.29–19.56), p = 0.020]
before LDLT as the independent risk factors for devel-
oping NODM. In subgroup analysis in age more than or
equal to 55 year, there was signiﬁcant difference between
two groups [hazard ratio: 13.34 (95% CI, 1.13–171.30),
p = 0.040].
Conclusion: The more age increased, the more incidence
of NODM increased. ERWR reduced development of
NODM in the old age patients (age more than or equal to
55 years).
P-649
A CASE-SERIES STUDY OF INDUCTION
IN LIVER TRANSPLANTATION:
OUTCOMES AND ECONOMIC
ANALYSIS
M. Montenovo, A. Cantaﬁo, E. Parks, K. Macleod,
M. Dang, A. Dick, J. Halldorson, R. Bakthavatsalam,
J. Reyes, J. Perkins and P. Salvalaggio
Division of Transplantation, University of Washington,
Seattle, WA, USA
Background: We investigated outcomes and economic
implications of using different induction agents in liver
transplantation.
Methods: From January 2000 to December 2008, 711
liver transplants were performed at our institution. Pa-
tients were divided into antithymocyte globulin (ATG)
group (n = 167) vs. basiliximab group (n = 544).
Maintenance immunosuppression was tacrolimus. End-
points were total charges and resource utilization mea-
sured by length of stay (LOS), complications and re-
admissions.
Results: Transplant LOS was similar in both groups
(14.5 days in ATG vs. 15.9 days in basiliximab). Cost of
the initial admission was higher in the ATG group
(US$209K vs.USS180K; P < .01). Total cost was higher
in the ATG group (US$260K vs. US$217K; P < .05).
There was a trend for higher re-admission rate in the
ATG group (72% vs. 64%; p = 0.06). Overall rate of
complications was similar in both groups (62% ATG vs.
68% basiliximab). Graft survival was superior in the
ATG group (93%, 90% and 89% at 1, 3, and 5 years in
the ATG group vs 90%, 84% and 81% in the basiliximab
group respectively, P < .05). Patient survival was supe-
rior in the ATG group (96%, 92% and 92% at 1, 3 and 5-
years vs 90%, 85% and 82% respectively; P < .05).
Conclusions: Type of induction in liver transplantation
impacts the ﬁnances and outcomes of transplant centers,
but does not inﬂuence re-admission and complication
rates.
P-650
EVEROLIMUS USE AS
IMMUNOSUPPRESSION IN LIVER
TRANSPLANT RECIPIENTS WITH
RENAL INSUFFICIENCY
N. Antoniadis, D. Giakoustidis, V. Papanikolaou,
G. Tsoulfas, G. Imvrios, N. Ouzounidis, I. Fouzas,
A. Giakoustidis, P. Agorastou, D. Vrochides,
D. Takoudas and E. Akriviadis
Hippokratio General Hospital
Introduction: Renal insufﬁciency is a frequent problem
after liver transplantation (LT), especially with the high
use of calcineurin inhibitors (CNI).
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Goal: To evaluate the effect of an immunosuppression
protocol, consisting of a decrease or elimination of CNIs
in connection with adding the mTOR inhibitor Everoli-
mus, on renal insufﬁciency after LT.
Methods: Retrospective study of two groups of patients.
Group A with 7 patients in whom the CNI was replaced
by Everolimus together with Mycophenolate mofetil
(MMF), and Group B with 7 patients in whom the CNI
dose was decreased, MMF was discontinued and Ever-
olimus was added. All patients started with GFR (51Cr-
EDTA) < 60 mL/min/1.732 with follow-up of over a
year since Everolimus was added.
Results: In the ﬁrst year, 6 out of 7 patients in Group A
had an improvement in their GFR (mean increase 11.75)
with the GFR stable in the remaining patient. In Group
B, there was an improvement in the GFR in 5 out of 7
patients (mean increase 16.4). The two remaining patients
had a slight deterioration (D GFR -9 and -8). One patient
in Group B had an acute rejection that responded to an
increase in the immunosuppression regimen.
Effect of Everolimus on Cr and GFR in liver transplant
recipients with renal insufﬁciency
Cr
before
(mean)
GFR
before
(mean)
Cr 1 yr
after
(mean)
GFR 1 yr
after
(mean)
A 1.51 42.2 1.39 52
B 1.36 47.28 1.17 56.6
Conclusion: In cases of renal insufﬁciency after LT owing
to CNI, the use of the mTOR inhibitor Everolimus in an
effort to decrease or, preferably, eliminate CNIs can
stabilize and even improve renal insufﬁciency, while at
the same time maintaining adequate immunosuppression
coverage.
P-651
RECURRENCE AFTER LIVER
TRANSPLANT FOR HEPATOCELLULAR
CARCINOMA
C. Sandroussi1, M. Guba1,2, L. Sandhu1, D. Dubay1,
A. Ghanekar1, M. Cattral1, I. McGilvray1, M. Selzner1,
P. Greig1 and D. Grant1
1Multiorgan Transplant Program, Toronto General
Hospital, University of Toronto, Canada; 2Department of
Surgery, University of Munich, Campus Grosshadern,
Germany
Introduction: The aim of this study is to determine
recurrence rates following transplantation for advanced
HCC, identify predictors of recurrence so that high and
low risk groups can be deﬁned, patterns of recurrence
and outcomes following aggressive treatment.
Methods: About 348 consecutive patients transplanted
for HCC between 1996 and 2008 were analyzed. Clinical
and pathological predictors of recurrence were identiﬁed.
Recurrences were aggressively treated with multimodal
therapy. Outcomes and predictive factors following
treatment of recurrence were identiﬁed.
Results: The median follow up time was 34.5 months.
143/348 (41.1%) patients were outside the Milan
Criteria. Recurrence occurred in 49 (14.1%) patients
(Milan 7.6% vs. outside 22.5%; p = 0.001), 73.5% were
within 2 years. On univariate logistic regression analysis
a-FP > 400 (p = 0.008), progression with treatment
(p = 0.004), number (p = 0.001) size and total tumour
diameter (P < 0.001), macro and micro vascular inva-
sion (P<0.001), beyond milan (P < 0.001) and a >50%
increase in a-FP (P < 0.001) were predictive of recur-
rence. On multivariate analysis Milan post transplant
(OR = 0.294, p = 0.042) and > 50% increase in a-FP
(OR = 59.545, P < 0.001) remained predictive. 69.4%
had a single site of recurrence. The commonest sites were
loco regional (49%) and chest (49%). Median survival
after recurrence was 8.7 months (0–81) and 1, 3 and
5 year survival was 47%, 14% and 14% respectively,
increasing to 38% if recurrence was amenable to surgery.
On uni and multivariate Cox regression only time to
recurrence (HR 0.978, p = 0.018) and surgical treatment
(HR = 0.243, p = 0.006) were associated with im-
proved survival. 5 year overall and disease free survival
was 75% and 71% respectively with no signiﬁcant dif-
ference for within or outside Milan tumours. Conclusion:
Excellent survival and acceptable recurrence rates can be
achieved for LT for advanced HCC, aggressive multi-
modal therapy which includes surgery can achieve long
term survival following recurrence.
P-652
SUCCESSFUL MEDICAL TREATMENT
OF CEREBRAL ASPERGILLOSIS WITH
VORICONAZOLE FOLLOWING LIVER
TRANSPLANTATION
P. T. Cherian, S. Yokoyama, R. P. Sutcliffe,
M. Heneghan, J. Wendon, J. O’Grady, N. D. Heaton,
M. Rela and A. Verma
King’s College Hospital, London
Aims: Extension of invasive aspergillosis (IA) to the
central nervous system (CNS) is associated with high
mortality in part due to poor CNS penetration of anti-
fungal. Voriconzole is a broad spectrum triazole proven
to be a superior alternative to Amphotericin B in IA
which readily penetrates the blood-brain barrier yielding
fungicidal drug concentrations within the CNS. However
hepatotoxicity and interactions with immunosuppressive
drugs, has limited its wide usage in liver transplant (LT)
recipients.
Methods: The medical records of three difﬁcult LT
recipients with radiologically/ culture conﬁrmed diagno-
ses of cerebral Aspergillosis were reviewed for antifungal
treatment and outcome. Results:
Patients one and two were transplanted for drug induced
acute liver failure (Female 50 years; Male 33 years) and
patient three for primary biliary cirrhosis (Female
51 years). Patient one and two developed IA during the
3rd post LT week, but was detected only on week 11 in
patient three. On imaging all three patients had brain and
two had lung lesions. Aspergillus fumigatus was isolated
in two patients. In patient one and two, IA disseminated
whilst on therapeutic doses of amphotericin (3 mg/kg).
Following diagnosis Voriconazole was added on in all
three, whilst amphotericin was continued until clinical
resolution. Voriconazole was continued as single agent
for 6–9 months in all three. Close monitoring of tacrol-
imus levels, liver and renal biochemistry was performed
during initiation of therapy, stabilization and during
subsequent out-patient follow-up. No signiﬁcant side
effects due to Voriconazole were observed. Patient three
was in renal failure prior to onset and continues to have
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chronic renal impairment. Patient one died at 216 days
(chronic rejection and hemophagocytosis), whilst the
other two are currently alive at 221 and 610 days
respectively post LT.
Conclusion: Voriconazole appears to be a safe and
effective agent in the management of cerebral Aspergil-
losis after liver transplantation.
P-653
EVOLUTION OF BILIARY
COMPLICATIONS AFTER LIVER
TRANSPLANTATION: 20 YEARS
EXPERIENCE FROM A SINGLE
EUROPEAN SERIES
M. Caralt, A. Gantxegi, R. Rodriguez, L. Alvarez,
I. Bilbao, J. L. Lazaro, C. Dopazo, L. Blanco,
G. Sapisochin, L. Castells and R. Charco
HBP Surgery and Transplants Department. Hospital
Universitari Vall d’Hebron, Barcelona, Spain
Aims: To analyze changes in the biliary complications
after adult liver transplant (LT) and their treatment over
time.
Patients and methods: Between 1988 and 2007, 1000 LT
were performed in our centre (789 adults and 211 chil-
dren). In order to ascertain the evolution of biliary
complications in adult LT we compared the ﬁrst 100 LT
and the last 200.
Results: Duct-to-duct was the most common biliary
anastomosis performed in both periods (1st: 88.9% and
2nd: 92.4%, P < 0.001). However, the T-tube was more
used in the ﬁrst period (1st: 46.5% vs. 2nd: 5.9%,
P < 0.001). In the remaining cases, a hepaticojejunos-
tomy was performed (1st: 11.1% and 2nd: 7.6%). Biliary
complications were more frequent in the ﬁrst period (1st:
21% vs. 2nd: 9%, P < 0.01). In the ﬁrst period, the use
of the T-tube caused 35% of complications (all of them
choleperitoneum) but none in the last. Arterial throm-
bosis or stenosis was related to biliary complications in
9.5% and 33.3% in the ﬁrst and last period respectively
(ﬁve bile duct necrosis, one bile leak, one stenosis)
(p = ns). The severity of complications according to the
Clavien Classiﬁcation was similar in both periods (IIIa:
19% vs. 43.8%, IIIb: 57.1% vs. 43.8%, IV: 9.5% vs.
6.3%, respectively) (p = ns).
Biliary Complications
1st period Last period
Bile leak 10 4
Anastomotic stenosis 4 6
Bile duct necrosis 2 6
Others 5 2
Conclusions: Biliary complications after LT has
decreased over time, mainly due to the abandon of the
routinely use of T-tube. However, its severity was similar
in the two periods.
P-654
CLINICAL FEATURES OF PULMONARY
METASTASIS OF HEPATOCELLULAR
CARCINOMA AFTER LIVER
TRANSPLANTATION
Y.-M. Jeon1, K.-S. Suh1, T. Kim1, W. Y. Shin1, N.-J. Yi1,
Y. T. Kim2 and K. U. Lee1
1Department of Surgery, Seoul National University
College of Medicine; 2Throracic Surgery
Purpose: Recurrent hepatocellular carcinoma (HCC)
after liver transplantation (LT) has a very poor prognosis.
But the role of surgical treatment for metastatic tumours
has been reported. In this study, we retrospectively ana-
lyzed the transplant population in the treatment of pul-
monary recurrence of HCC after liver transplantation.
Methods: Between January 2001 and October 2008, 51
patients with pulmonary metastasis after LT were retro-
spectively analyzed. Recurrent HCC was treated by sur-
gery, if eligible, or adjuvant therapies. Seventeen of 51
(33.3%) patients underwent a pulmonary metastasecto-
my.
Results: Of the 17, ﬁfteen patients were diagnosed with a
HCC on pathology examination and two patients were
diagnosed with a benign lesion (tuberculosis, cryptococ-
cosis). Patients with benign pulmonary lesions were ex-
cluded from the analysis of this study. Median recurrence
time after LT was 13.4 (1.1–50.1) months. Median sur-
vival time after metastasis was 26.8 (4.9–45.5) months.
Of the patient underwent metastasectomy, ﬁve patients
(33.3%) were dead and 29 patients (85.3%) who had not
undergone a pulmonary metastasectomy was dead. When
the prognosis of metastasectomy group was compared
with unresected patients group, the survival rate was
signiﬁcantly higher in patients who had pulmonary
metatarsectomy than in patients who had not metasta-
sectomy (P = 0.001).
Conclusion: Survival outcome seemed to be good in liver
transplant patients with pulmonary metastasectomy for
HCC recurrence, if it was detected earlier and resectable.
However, for validating survival beneﬁt of pulmonary
metastasectomy, further study is required.
P-655
TECHNICAL ASSOCIATED FACTORS
FOR ARTERIAL THROMBOSIS IN
CADAVERIC LIVER
TRANSPLANTATION
L. Gil, J. Lendoire, G. Rafﬁn, F. Duek, C. Quarin,
V. Garay, A. Oks and O. Imventarza
Hospital Dr Cosme Argerich, Liver Transplant Unit,
Buenos Aires, Argentina
Background: Arterial complications continue to be a
major source of morbidity and mortality after orthotopic
liver transplantation (OLT). The incidence of hepatic
artery thrombosis (HAT) ranges from 1.6% to 8%, with
mortalities reported from 11% to 35%.
Objective: To analyze the incidence of hepatic artery
variations, the arterial reconstructive techniques and the
associated factors for HAT in OLT.
Methods: From July 1995 to march 2009, 389 OLT were
performed. Intraoperative death and split grafts OLT
were excluded. The initial reconstructive technique was
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the end to end arterial anastomosis (aortic Carrel patch)
(EECP); since 1998 the branch patch technique (gastro-
duodenal bifurcation) was used. Selective anticoagula-
tion protocol was indicated. The follow-up consisted in
Doppler ultrasonography and selective angiography.
Variables analyzed associated with HAT were: hepatic
artery variations, back table vascular reconstruction,
procurement arterial injury and recipient artery recon-
struction technique. A comparative patient and graft
survival analysis was performed.
Results: About 361 patients were analyzed, 54% female,
mean age 41.7 years (r = 15–68). Hepatic artery varia-
tions were present in 31% of the donors, back table
reconstruction was required in 19% and an iliac aorta-
hepatic graft was required in 7%. Incidence of HAT was
6.9%. Hepatic artery variations, back table vascular
reconstruction, iliac aorta-hepatic graft utilization and
the presence of procurement arterial injury were not
associated with HAT in the statistical analyzes. Only the
type of reconstruction technique (aortic Carrel patch vs.
branch patch) in the recipient was associated with in-
creased incidence of HAT (p = 0.03). One year graft
survival was 59% (HAT) vs. 81% (non HAT)
(P < 0.001).
Conclusions: Graft survival is reduced in patients with
HAT. EECP technique was associated with an increased
incidence of HAT. Short length of arterial reconstruction
is a crucial factor that prevents this complication.
P-656
SURGICAL REANASTOMOSIS COULD
SPARE RETRANSPLANTATION IN
HEPATIC ARTERY THROMBOSIS
W. Y. Shin, K.-S. Suh, T. H. Kim, Y.-M. Jeon, N.-J. Yi
and K. U. Lee
Seoul National University College of Medicine,
Department of Surgery, Seoul, Korea
Introduction: Hepatic artery thrombosis (HAT) is one of
the most important causes of graft loss after liver trans-
plantation (LT). Recently, the incidence of HAT, regraft
and the mortality related to HAT have decreased because
of successful management of HAT. Hence, in this study,
we analyzed the outcome of HAT according to the type
of management.
Methods: From March 1988 to June 2008, 610 patients
underwent LT. Among these, 17 cases (2.8%) developed
HAT and were retrospectively reviewed. The ﬂow of
hepatic artery was monitored by Doppler daily till the 1st
week and 2–3 times per week thereafter. If ﬂow was
invisible, we checked CT or conventional angiography
for conﬁrmation. The median follow-up period was
14.8 months (2.6–108.8).
Results: Median age was 44-years-old (1–57). There were
14 adults and 5 children, and the incidence was 2.9% in
adults and 3.8% in children. Six cases (31.6%) were
secondary HAT related to predisposing factors. Median
time to HAT was 11 days, and ﬁve cases developed HAT
intraoperatively. Fifteen cases (78.9%) developed HAT
within 4 weeks. There were two mortalities. One patient
died from fungal pneumonia after reLT, and the other
died from aspiration pneumonia during PTBD manage-
ment. Initially 17 cases (89.4%) underwent reanastomo-
sis. Eleven cases (64.7%) preserved arterial ﬂow, but six
cases were re-obstructed. Among these, a patient under-
went reLT. The 1st HAT case underwent reLT for initial
treatment. Hence, the rate of regraft was 10.5% (2/19).
One patient who developed HAT at 12 weeks had ﬁne
collateral arteries, and was treated with anticoagulation.
In 12 (63.2%) cases, biliary complication developed
during follow-up. Ten cases needed interventional pro-
cedures, and the complications were resolved in those
who were treated over a year.
Conclusion: Early detection and early reanastomosis of
HAT could spare reLT. If biliary complications devel-
oped, it could be controlled by aggressive radiologic or
endoscopic interventional procedures.
P-657
ACUTE, SIMULTANEOUS, DUAL
VESSEL THROMBOSIS POST LIVER
TRANSPLANTATION
P. T. Cherian, S. Yokoyama, A. Dhawan, N. D. Heaton
and M. Rela
King’s College Hospital, London
Background: Simultaneous thrombosis of both arterial
and venous inﬂow vessels after liver transplantation is
rare and usually leads to graft loss. The possible causes
may include patient and graft factors and technical
complications.
Methods: We retrospectively reviewed our adult and
paediatric records from 1989 to 2008 to identify and
analyze all such cases to ﬁnd potential patient and graft
risk factors.
Results: Over these 20 years there were 3296 liver
transplants performed in our unit, of which 769 were in
children. We identiﬁed four cases with thrombosis of
both hepatic artery and portal vein either simultaneously
or following sequentially. All occurred in children (8, 7,
7 months and 8-years-old), three with non syndromic
biliary atresia (post previous Kasai procedures), and one
with sclerosing cholangitis all of whom received left lat-
eral segment split grafts. The diagnosis of thrombosis
was made on trans-abdominal ultrasound and PV ﬂow
disturbances were the initial abnormality in all cases. All
four recipients underwent a re-transplant (day one, three,
seven,). No signiﬁcant donor features were found and
cold ischemia time was 6, 8.5, 12 and 12 hours. None of
the children were positive for identiﬁable pro-coagulant
state other than due to the liver disease and all are alive
at last follow-up in 2009.
Table 1. Operative details of Patients with simultaneous
HAT and PVT
No.
OP
TIME
BL
LOSS CIT RE-PERF GRAFT HB AA
PV
Size
1 7 1790 12.3 Portal Red-LL 9.1 CHA
GD-CT
Small 6/0
2 4 1600 8.7 Portal Split-LLS 8.6 CHA
GD-CT
Small 7/0
3 5.3 50 6.2 Portal Split-LLS 12.5 CHA-LHA
replace
Normal
4 4.2 800 12.7 Portal Split-LLS 7.9 N/A N/A
Conclusion: Dual thrombosis is a rare but life threaten-
ing complication that in our hands always required a
re-transplant. Adults appear to be spared this particular
complication presumably due to a combination of large
volume livers; lower resistance blood ﬂow; wide vessels
with a lower risk of technical errors. Protocol ultra-
sounds are valuable and should be part of the routine
post-operative management of transplant recipients.
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P-658
ECTOPIC PLACEMENT OF
SENGSTAKEN-BLAKEMORE DEVICE TO
CORRECT OUTFLOW OBSTRUCTION IN
LIVER TRANSPLANTATION
K. Steinbru¨ck, R. Fernandes, M. Enne, J. M. Martinho,
J. Alves and L. Pacheco-Moreira
Liver Transplantation Unit, Bonsucesso General Hospital/
MS, Rio de Janeiro, Brazil
Background: The liver transplantation is a complex
procedure that has become the unique treatment for
some end-stage liver disease. Some technical features are
very important for the success of the transplantation,
including the patency of vascular anastomoses.
Aim: Describe two cases in which the Sengstaken-
Blakemore (SB) balloon was safely used, in an ectopic
position, to ﬁx drainage complications in orthotopic liver
transplantation (OLT).
Methods: Between December 2001 and September 2009,
366 liver transplantations were performed in our unit. In
two cases the SB device was used to correct outﬂow
obstruction. Retrospective revision of the patient’s charts
was conducted.
Results: Patient 1 was submitted to OLT due to alfa1-
antitripsin deﬁciency cirrhosis. He received a 1600 g full-
size graft, corresponding to 2.3% graft to recipient
weight ratio (GRWR). Patient two was submitted to
OLT because of virus B cirrhosis and hepatocarcinoma.
He got a 1900 g full-size graft, corresponding to 3.0%
GRWR. In both patients, after reperfusion, congestion
aspect was observed in right hemi liver attributed to
graft’s torsion to the right. A SB device was placed in the
hepatic fossa, between the liver implant and the retro-
peritoneum and gastric balloon was inﬂated with 240 ml
of saline solution in patient one and 400 ml in patient
two. Doppler parameters conﬁrm right hepatic vein pa-
tency. The operations were ﬁnished as routine. Both
balloons were totally deﬂated and removed respectively
at 6th and 10th post-operatory day (POD). Patients were
discharged at 28th and 16th POD.
Conclusion: In our experience, the placement of SB bal-
loon in the hepatic fossa to ﬁx graft, avoiding twist,
during whole liver transplantation from cadaveric donor,
was successfully used in two patients. To the best of our
knowledge, herein we report the ﬁrst use of SB balloon to
correct drainage obstruction during whole liver ortho-
topic transplant.
P-659
GRAFT VERSUS HOST DISEASE
FOLLOWING LIVER
TRANSPLANTATION – A DIAGNOSTIC
DILEMMA
A. Kotru, M. Gupta, M. Maloo, D. R. Oreskovich and
C. Varma
Geisinger Medical Centre
Acute GVHD is an uncommon but serious complication
following liver transplantation. The incidence is approx-
imately 1–2% of all liver transplants. The mortality rate
is reportedly high, around 85%. High clinical suspicion is
vital in establishing the diagnosis. The disease occurs
when donor lymphocytes mount a cell mediated immune
response against host’s antigens. The symptoms of
GVHD usually present between 2 to 6 weeks after the
transplantation. Diagnosis can be made by skin biopsy
and colonic biopsy with typical histological features
However diagnosis can be conﬁrmed by demonstrating
chimerism marrow using ﬂow cytometry, ﬂuorescent in
situ hybridization or PCR showing short tandem repeats.
We report a case of Acute GVHD following liver
transplantation. A 66-year-old Caucasian man known
to have cryptogenic cirrhosis and 3.5 cm HCC underwent
an Orthotopic liver transplant from a 64-year-old brain
dead donor. On POD 45 he presented with dry cough and
upper respiratory infection. He underwent extensive
investigation on admission. He was found to be pancy-
topenic Graft versus host disease was suspected. Bone
marrow biopsy was performed, which showed mild
hypercellularity and lymphopenia. Peripheral blood
specimen was sent for chimerism analysis. He also had
a colonoscopy with biopsy. The biopsy showed crypt
epithelial apoptosis. Chimerism analysis showed that the
CD3-positive fraction contains approximately 100%
donor DNA and 0% recipient DNA. Patient died on
45th day after transplant. GVHD is a rare complication
of OLTx. Establishing diagnosis is always a dilemma. We
recommend that centers should establish protocols to
investigate and treat these patients. Early diagnosis might
be the key to achieve successful therapy in these patients.
Macrochimerism and showing short tandem repeats
(STR) can conﬁrm the diagnosis. Treatment with newer
agents such as Alefacept, Etanercept, and mesenchymal
stem cell transplant, may be the future.
P-660
GRAFT VS. HOST DISEASE AFTER
LIVER TRANSPLANTATION: CASE
REPORT AND LITERATURE REVIEW
J. R. Silva1, F. M. Kawamoto1, W. Andraus1,
F. R. Lima2, Evandro S. Mello2, E. Chaib1 and
L. A. C. D’Albuquerque1
1Transplantation Surgery Unit. University of Sa˜o Paulo,
School of Medicine; 2Pathology Department. University of
Sa˜o Paulo, School of Medicine
Background: Graft versus Host Disease (GVHD) is a
very rare, severe and could be a lethal complication after
liver transplantation. Its incidence is about 1% and the
mortality rate can be higher than 80% in adults. Usually
occurs between second and sixth weeks after liver trans-
plantation and early symptoms are not speciﬁc and the
diagnosis may be difﬁcult and not be accurate, leading to
death.
Aim: Case report of GVHD after orthotopic liver
transplantation.
Case report: A 64-year-old patient, male, Child A6,
underwent orthotopic liver transplantation due to Hep-
atitis C Virus and liver cirrhosis with unresectable
hepatocellular carcinoma. Thirty two days after trans-
plantation the patient was readmitted to the intensive
care unit (ICU) presenting leukopenia, erythropenia, low
haemoglobin, fever and low blood pressure levels. Ery-
thematous-papular lesions were also detected and a
biopsy was collected. Final diagnosis was GVHD. A
progressive worsening and a not effective treatment lead
patient to death ﬁve days after the diagnosis, in conse-
quence of sepsis and multiple organ failure.
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Discussion: GVHD after liver transplantation is a
potentially lethal complication of liver transplantation.
Its diagnose can be very difﬁcult mainly because of
infection, drug allergies, or rejection associated with it.
Profound leukopenia, fever, skin rash in a patient
underwent early liver transplantation should alert doc-
tors to GVHD. It’s very important to establish GVHD
diagnosis as soon as possible to initiate treatment,
although possibilities of treatment are not consensual in
literature yet. Patients that develop GVHD usually pri-
marily die of infection-related multiple organ failure.
P-661
POSTOPERATIVE DIALYSIS AND
MORTALITY IN LIVER TRANSPLANTED
PATIENTS
I. Schmidtbauer, W. Andraus, F. M. Q. Silva,
C. E. Pompilio, M. Barros and L. A. D’Albuquerque
Sa˜o Paulo University Medical School
Introduction: Preoperative renal insufﬁciency is related
to morbidity and mortality in liver transplanted patients.
Aim: Evaluated the features and survival of patients that
developed renal insufﬁciency only postoperatively.
Methods: We analyzed 120 patients underwent liver
transplant at Sa˜o Paulo Medical School in 2009. Thirty
patients were excluded because of preoperative dialysis or
renal transplant associated.
Results: Two groups were compared: with postoperative
dialysis (n = 38, 42%) and without postoperative dial-
ysis (n = 52, 58%). The MELD score was the same. The
ﬁrst group received more blood, had more prolonged
intensive care and hospital stay. The rate of re-transplant
was higher in the dialysis group and mortality occurred
only in this group.
Conclusion: Intraoperative transfusion rate is related to
postoperative renal insufﬁciency. Morbidity and mor-
tality are highly associated with postoperative dialysis.
Liver transplant patients feature comparing groups with
and without postoperative dialysis.
P-662
ASYMPTOMATIC HEPATIC ARTERY
THROMBOSIS (HAT) AFTER
ORTHOTOPIC LIVER
TRANSPLANTATION (LOT)
T. Sheng
The Second Afﬁliated Hospital /HarbinMedical University
Objective: To report a case of asymptomatic process of
hepatic artery thrombosis after orthotopic liver trans-
plantation (OLT) and to deduce the possible factors
leading to the survival of the patients. Methods:
Hepatic functional tests colored Doppler ultrasonic
observation; hepatic arteriographic examinations were
done during the course of the development of the hepatic
atherothrombosis. All possible factors leading to the
asymptomatic process were comprehensively analyzed.
Results: From the 4th postoperative day on, thrombosis
started to form along the anastomosis line. By the 2lst
postoperative day, the artery became completely throm-
boses. During this course, serial liver biopsy revealed
intrahepatic cholestasis, hydropic degeneration of he-
patocytes, atrophy of the biliary epithelium and ﬁbrosis
in the portal area. Serial monitoring of liver function
gradually revealed normal with the exception of elevation
of r-GT and ALT. By the 2lst day after OLT, arteriog-
raphy showed that hepatic artery remained completely
occluded, while the collateral circulation and compensa-
tory expansion of the portal vein were established. The
patient didn’t have any symptoms of arterial thrombosis.
Conclusion: In this case, it was the collateral circulation
and the compensation of the portal vein that made the
allograft survive and helped to prevent the patient from
retransplantation after hepatic artery thrombosis. For
those patients who had thrombosis in the hepatic artery,
but lack of clinical ﬁndings and can maintain a normal
Laboratorial Examination of GVHD (Table for P-660)
Preoperative
Immediate
Postoperative (PO) 5 PO 10 PO 25 PO
31 PO
(ICU)
33 PO
(GVHD) 35 PO Units
Kidney Urea 18 41 45 29 42 76 69 109 mg/dL
Creatinine 0.81 0.77 0.55 0.71 1.02 1.25 1.27 2.56 mg/dL
Coagulation INR 1.4 3.2 1.6 1.6 1.1 1.2 1.5 1.8 -
Platelets 95 (VPM =
10.7 fL)
110 (VPM =
11.6 fL)
- 96
(11.6 fL)
114
(9.9 fL)
53
(10fL)
57
(10.4 fL)
284
(11.7 fL)
mil/mm3
Blood Hematocrit 33.90 32.90 34.10 29.40 28.40 28.00 20.10 %
Haemoglobin 11.17 10.7 10.9 9.6 9.5 9.2 6.6 7.4 g/dL
Leukocytes 3.62 10.65
(Neutrophil -
88.50%)
12.55
(Neutrophil
76.8%,
Eosinophil
9.2%)
9.56
(Neutrophil 93%,
Segmented 83%)
3.18 0.45 0.1 43.36
(Neutrophil
93%,
Monocytes
3.0%,
Lymphocytes
3.7%)
mil/mm3
Biochemistry Na 144 140 138 142 135 134 136 135 mEq/L
K 3.7 4.6 3 3.6 4.9 4.9 4 4.4 mEq/L
Glucose 89 - 96 93 - - - - mg/dL
Lactate - - - - - 54 62 59 mg/dL
PCR - - - - - - 329 - mg/dL
Liver Total
Bilirubin
0.95 3.89 6.71 9.08 2.57 1.83 1.42 2.93 mg/dL
Direct
Bilirubin
0.46 2.25 4.74 7.48 1.62 1.32 0.57 2.42 mg/dL
AST 56 2308 136 213 50 60 57 208 U/L
ALT 35 1842 933 319 60 64 31 49 U/L
Albumin - - 2.8 - - 2.4 - 2.1 g/dL
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liver function, the liver protecting treatment and chola-
gogic therapy should be used and the retransplantation
might be avoided.
P-663
RESSECTION OF HEPATOCELLULAR
CARCINOMARECURRED THREE YEARS
AFTER LIVER TRANSPLANTATION
J. R. N. Pinherio, W. Andraus, V. Pugliese,
F. Bitencourt, M. Barros, R. Martino, M. Vanegas,
V. Santos, Estela Figueira, R. Pecora, A. Oliveira,
R. Meirelles and L. A. D’Albuquerque
Sa˜o Paulo University Medical School
Background: Liver transplantation (LT) is the best
treatment option for patients with hepatocellular carci-
noma (HCC) within Milan criteria and end-stage liver
disease. However, in approximately 20% of patients,
recurrent HCC is the rate-limiting factor for long-term
survival. Unfortunately, most present with disseminated
disease and are not candidates for local therapy. How-
ever, aggressive surgical intervention has recently been
advocated for patients with localized recurrence.
Objective: Describe a case of hepatocellular carcinoma
recurrence after liver transplantation treated by surgical
resection.
Methods: The patient was a 48-year-old man with VHB
in a Child A and MELD 10 status, who underwent LT
because of HCC. The specimen showed three nodules of
HCC larger than 1 cm, with moderate differentiation and
the biggest one with 1.9 cm, with vascular invasion.
Three years after the procedure a localized HCC was
diagnosed by CT scan in segment VII, with 6.5 cm
diameter. Further investigation showed no tumour dis-
semination. The AFP was normal. At this time surgical
intervention was indicated.
Results: He was treated by right posterior segmental
hepatectomy with Glissonian pedicle approach of seg-
ments VI and VII. The surgery was initially difﬁcult
because of adherences, but after that it was uneventful.
The patient was released after 10 days and recovered
well. Histological study reported a HCC nodule, with
moderate differentiation and dimensions of 7·6.3·5 cm,
with free margin. In 7 months of follow up there is no
sign of recurrence.
Conclusion: Despite the patient selection and exhaustive
preoperative staging, HCC recurrence remains a chal-
lenge. Usually recurrence is a disseminated disease and
local treatment is not possible. However, when HCC
recurrence is restrict to liver, radical resection is a good
option and it can offer a survival improvement.
P-664
RESPONSE TO PRETRANSPLANT
THERAPY PREDICTS SURVIVAL AFTER
LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
M. Guba1,2, C. Sandroussi1, L. Sandhu1, A. Ghanekar1,
I. McGilvray1, M. Cattral1, M. Selzner1, P. Greig1 and
D. Grant1
1Multiorgan Transplant Program, Toronto General
Hospital, University of Toronto, Canada; 2Department
of Surgery, University of Munich, Campus Grosshadern,
Germany
Background: Loco regional bridging therapies are fre-
quently used to control or downstage hepatocellular
carcinomas (HCC) in patients awaiting a liver transplant
(Ltx). It has been hypothesized but not conﬁrmed that
tumour response to pretransplant therapy might predict
tumour recurrence and survival after Ltx for Milan stage
tumours,
Methods: We studied 130 consecutive patients receiving
bridging/down staging (RFA 63%, TACE 21%, PEI
13%, other 3%) therapy prior to Ltx for HCC between
January 1996-August 2008. Response to treatment
(complete response [CR], partial response [PR], stable
disease [SD], progressive disease [PD]) was determined by
radiographic measurement of tumour lesions prior to
therapy and immediately before LTx using the RECIST
criteria.
Results: The median time of follow up was 31 months.
Overall survival (OS) at 1, 2 and 5 years across all groups
was 93%; 82%, and 69%, Disease-free survival (DFS,
p = 0.003) and overall survival (p = 0.044) 5 years after
LTx was 94%/84% for CR, 82%/64% for PR, 76%/72%
for SD and 55%/52% for PD). For Milan tumours,
progression despite loco regional therapy indicated par-
ticularly unfavorable tumour biology with a 5-year dis-
ease free survival of 47% as compared to 91% in
tumours that were controlled by therapy (CR + PR +
SD) (P < 0.001). Tumour progression was the only
preoperative factor shown to be associated with worse
DFS (HR 3.1, p = 0.001) on both a univariate and
multivariate Cox-proportional hazards model. Similarly
microvascular (HR 2.4, P < 0.001) and macro vascular
invasion (HR = 2.3, p = 0.001) were the only postop-
erative factors which were predictive of worse DFS, with
only macrovascular invasion (p = 0.014) remaining
predictive on multivariate analysis.
Conclusion: Response to treatment for HCC within and
beyond the Milan stage, irrespective of the treatment
modality, increased DFS and OS after LTx. Radiological
response to therapy may identify patients with favorable
tumour biology and may therefore be useful as pre-
transplant selection criteria.
P-665
LIVER HYPER REDUCTION IN
PEDIATRIC LIVER TRANSPLANT
V. Ardiles, M. A. Ciardullo, J. Robin, F. J. Mattera,
J. Pekolj and E. de Santiban˜es
Hospital Italiano de Buenos Aires
Background: A shortage of liver donors for low-weight
transplant recipients has prompted the development of
procedures for liver-reduction, split-liver, and living re-
lated donor transplantations. For pediatric recipients
weighing less than 10 kg, the left lateral segment is often
still too large.
Objective: To describe our experience in hyper reduction
in pediatric liver transplant.
Methods: Descriptive, retrospective study of 15 pediatric
patients in whom hyper-reduction technique was used
between January 1997 and June 2009. Evaluation of
patient’s characteristics, surgery, hospitalization and
their follow up.
Results: During the studied period 765 liver transplants
(242 pediatrics) were made. Of these, 33 weighted less
than 10 kg and hyper reduction was applied in 15
patients (seven girls and eight boys). The mean age was
11.8 months (SD = 4.4) and the mean weight was 7.2 kg
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(SD = 0.84). The etiology includes biliary atresia in 14
cases and Allagille syndrome in one case. 13 were LDLT
and two cadaveric donors. 336 min (SD = 76) was the
mean surgery time and isquemic mean time was 149 min
(SD = 122). The mean postoperative ICU stay mas
16 days (SD = 7.2) with 5.3 days (SD = 5.3) of AMR.
Eleven patients received blood transfusion during the
postoperative period. The morbility was 86%, mortality
6% and global survival was 86.7%.
Conclusions: Successful monosegmental transplantation
is technically feasible and is a valid alternative to be
considered for cases of size discrepancy between the re-
cipient’s volume and the donor’s left lateral segment.
P-666
AUXILIARY TRANSPLANTATION- AN
OPTION WORTH CONSIDERING IN
ACUTE LIVER FAILURE
M. Rela, J. R. Cherian, A. Quaglia, S. Nagata,
M. Heneghan, A. Dhawan, J. Wendon, J. O’Grady and
N. D. Heaton
Kings College Hospital, London
Aim: Auxiliary liver transplantation (ALT) is gaining
popularity as an option for treating patients with acute
liver failure (ALF). Over the last 18 years we performed
67 ALTs, of which 59 were for ALF.
Methods: All were orthotopic, performed between 1993–
2009 either with cadaveric (58) or living donor grafts
(one). Post-operative protocols included serial liver
biopsies, CT volumetry, HIDA Scans with immunosup-
pression withdrawal (ISW) beginning 6 months after
evidence of native liver regeneration (NLR). Methods,
mortality, complications, NLR, ISW and histology are
presented.
Results: Of 59 recipients [28 sero-negative hepatitis
(SNH), 17 paracetamol toxicity (POD), eight acute hep-
atitis B (AHB) and ﬁve others]; of the 59, 20 were chil-
dren. Thirteen recipients died 11 early (median 11days)
and two late [Suicide at 2819 days and Sepsis/MOF at
1505 days]. All mortality in children (15%) were early;
adults suffered eight early and two late deaths (26%
mortality). Complications included ﬁve re-laparotomies
for bleeding and four for auxiliary graft excision, one
cortical blindness, and 1 PV stricture. Four were re-
transplanted (two Chronic rejection; one conduit
thrombosis; one PNF), all survive albeit on IS. Excluding
early deaths 72% of adults underwent NLR (IS com-
pletely off in 58%), whereas 82% of children had NLR
(65% completely off IS). All in the POD cohort and 83%
in the AHB group showed complete NLR in contrast to
65% NLR in SN cohort excluding those being weaned
currently. There were three predominant histological
patterns of hepatocyte loss: ‘diffuse’ (70% good out-
come); ‘maplike’ and ‘complete’ (poor outcome). We
experienced a ‘learning curve’ with 43% mortality in the
ﬁrst 5 years compared to 11% in the last 10 years.
Conclusions: Careful patient selection with consideration
to age, aetiology, hemodynamic stability and neurologi-
cal state should allow ALT with outcomes similar to
whole liver replacement. Regeneration occurred more
readily in children and after ALF secondary to paracet-
amol toxicity.
P-667
MONDAY BLUES OF DECEASED
DONOR LIVER TRANSPLANTATION
S. C. Chan, W. C. Dai, C. M. Lo, K. K.-C. Ng, B. Lam,
Y. M. Kwan, W. Y. Ho and S. T. Fan
Queen Mary Hospital, University of Hong Kong
There is a constant and global shortage of deceased
donor organs for liver transplantation. Donation from
living donors partially alleviates the problem of graft
shortage. Nevertheless, candidates listed for liver trans-
plant but without living donors continue to die. There
has been a modest increase in deceased donor organs
recently. Ways to identify areas for securing potential
deceased donor organs may further improve the supply.
We looked simply into the disparity of the number of
deceased donor liver transplantation (DDLT) performed
on different days of the weeks from January 2000 to the
end of June 2009 (n = 224). It was readily evident that
there were fewer DDLT on Mondays. As shown by the
number of DDLT performed on different days of the
week in ascending order: Monday (n = 17, 7.6%),
Sunday (n = 28, 12.5%), Thursday (n = 31, 13.8%),
Friday (n = 34, 15.2%), Tuesday and Wednesday
(n = 37, 16.5%), Saturday (n = 40, 17.9%)
(p = 0.045). It was twice as unlikely a DDLT was
performed on Mondays as compared to other days. Such
a trend did not change even with an increase in the
number of deceased donor liver grafts in the last
6 months. As consent to donation was obtained from
the donor family the day before DDLT, less consent were
thus obtained on Sundays. These suggested that deceased
donor organ donation activities were less active on
Sundays and could be improved. A rebound in the
number of DDLT on Tuesdays and Wednesdays was not
observed. This further raises the concern of possible
wastage of potential cases for organ donation.
P-668
SIMULTANEOUS COMBINED HEART-
LIVER TRANSPLANTATION WITHOUT
ADDITIONAL USE OF VENO-VENOUS
BYPASS
F. Rauchfuss1, M. Breuer2, M. Heise1, K. Hekmat2 and
U. Settmacher1
1Department of General, Visceral and Vascular Surgery,
University Hospital Jena; 2Department of Cardiac and
Thoracic Surgery, University Hospital Jena
Background: Cardiomyopathies may result in cardiac
related end stage liver disease. Combined heart-liver
transplantation (HLTx) is considered to be the treatment
of choice. In the literature the sequential transplantation
technique is described most frequently where the liver is
being transplanted with use of a veno-venous bypass
after completion of the heart transplantation and wean-
ing from the heart-lung bypass machine.
Objectives: Here, we describe our technique of simulta-
neous heart-liver transplantation without additional use
of a veno-venous bypass.
Methods: Since 2004 three combined HLTx have been
performed at our center. In all cases the liver has been
implanted prior to weaning from the heart-lung bypass
machine. The caval anastomosis was performed with use
of cross clamping (two cases) or piggyback technique.
The mean operating time was 534 ± 247 min.
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Results: The six months survival for our patients is 66%
(one patient died from multiple organ failure on post-
operative day 23).
Conclusion: Apart from individual case reports our series
of simultaneous HLTx without additional use of veno-
venous bypass is the ﬁrst one to describe this surgical
technique. From our point of view the surgical technique
is feasible and has a shorter operating time with com-
parable results as those for the traditional technique. In
addition, there is no further trauma from veno-venous
bypass and its possible complications (e.g. air embolism,
hemorrhagic complications).
P-669
PORTOCAVAL SHUNT IN ORTHOTOPIC
LIVER TRANSPLANTATION: IS IT STILL
WORTHWHILE
J. Lubrano, P. Morati, O. Idelcadi, B. Paquette, B. Heyd
and G. Mantion
Besanc¸on University Hospital
Background: Since the development of modiﬁed piggy-
back in orthotopic liver transplantation (OLT), the need
for portocaval shunt is still debated. Some authors are
still advocating its usefulness in order to preserve portal
ﬂow and maintain splanchnic venous drainage. However,
improvement in liver transplantation’s anaesthesiology
and surgical procedure has led some liver transplantation
centre to avoid its use.
Objectives: The aim of our study was to identify the
factors that may lead to perform a portocaval shunt in
orthotopic liver transplantation.
Methods: During last decade 226 orthotopic liver trans-
plantations have been performed in our centre using the
modiﬁed piggyback technique systematically without
portocaval shunt. The data of our patient were reviewed
in order to ﬁnd out the preoperative factors that have
lead us to perform portocaval shunt during OLT.
Results: Liver transplantation was performed for cir-
rhosis in 51% and for tumours in 34% of cases. Median
age was 51-years-old. A portocaval shunt was performed
in 2.5% of the patients. In multivariate analysis, a he-
patic duration up to 1 hour was statistically associated
with the need of portocaval shunt during OLT
(P < 0.001) whereas cirrhosis was not statistically asso-
ciated. 1, 3 and 5 year survival after OLT were not sta-
tistically different.
Conclusions: Orthotopic liver transplantation can rou-
tinely be performed regardless underlying cirrhosis
without the need of portocaval shunt except in case of a
hepatic phase up to 1 hour.
P-670
LIVER RESECTION IN
HEPATOCELLULAR CARCINOMA
PATIENTS WAITING FOR LIVER
TRANSPLANTATION: BRIDGE OR
DESTINATION THERAPY
M. Altieri1, O. Goria2, G. Lebreton1, L. Chiche1,
M. Scotte2, G. Riachi2 and E. Salame1
1CHU Cote de Nacre, Caen, France; 2CHU Charles
Nicolle, Rouen, France
Introduction: Liver transplantation (LT) is the treatment
of choice for hepatocellular carcinoma (HCC) in cir-
rhotic patients. Organ allocation system based on MELD
score disadvantaged small HCC with low MELD. Those
patients had a high risk of drop-out because of tumour
progression (TP). Liver resection (LR) was evaluated as a
therapeutic option for the control of TP during the
waiting period.
Materials and methods: About 13 listed patients were
selected for LR with a solitary tumour, Child A cirrhosis
and moderate portal hypertension. Mean age was
55 years (38–70), sex ratio 12/1. The mean diameter of
the nodules was 4 cm (2, 2, 2, 2.2, 3, 3, 3.5, 3.5, 3.8, 5, 6.5,
7, and 8). Etiology of cirrhosis was alcoholic (n = 7),
hemochromatosis (n = 2), hepatitis C virus (n = 3),
hepatitis B virus (n = 1). Laparotomy was performed in
9 patients and laparoscopy in 3. Resection was uniseg-
mentectomy (n = 8: I, III, IV, V, VI, VI, VI, VII), left
lateral sectionectomy (n = 2), left hepatectomy (n = 1)
and right hepatectomy (n = 2).
Results: Pathology was correlated with pre-operative
screening in eight patients, additional nodules were
founded in ﬁve, one had cholangiocellular carcinoma
(CCK) and microscopic vascular invasion (MVI) was
identiﬁed in three patients including the one with CCK.
Those three patients were excluded from listing. One of
them developed bone and distant lymph node metastasis
3 months after surgery; the two others are alive with no
evidence of recurrence. From the ten other patients, three
were transplanted with a good long term results and the
seven others are still waiting.
Discussion: About 30% of HCC patients initially listed
for LT will become ineligible after 11 months of waiting
period because of TP. Liver resection offered the double
advantage: better control of TP validating bridging and
histological analysis identifying risk factors for postLT
recurrence (histological grade and MVI). Indication for
LT in those patients must be reconsidered and LR be-
comes destination therapy.
P-671
HEPATIC ARTERY RECONSTRUCTION
IN LIVING DONOR LIVER
TRANSPLANTATION, WITHOUT
MICROSCOPE, UNDER 6· HIGH POWER
MAGNIFICATION LOUPES
M Enne1, L. Pacheco-Moreira1, K. Stenibruck1,
J. Alves1, R. Fernandes1, E. Balbi1, J. M. Martinho1,2
1Hospital Geral de Bonsucesso - Ministe´rio da Sau´de -
Hepatobiliary and Liver Transplantation Unit;
2Department of Surgery, Antonio Pedro University
Hospital - Fluminense Federal University
Background: Hepatic arterial anastomosis is one of the
most demanding procedures in LDLT and, if HAT
occurs life threatening complications and need for
retransplantation are often observed, with a mortality
rate reported as up to 50%. The introduction of micro-
surgical technique almost twelve years ago by the Kyoto
team has triumphed over the high risk of HAT. Since this
ﬁrst report, a need for microsurgical hepatic artery
reconstruction, under operating microscope magniﬁca-
tion, has become an essential technique in LDLT and
remains a technical challenge.
Objective: Our objective is to describe our microsurgical
reconstruction technique with 6· loupes and the clinical
course of the ﬁrst 128 recipients in an initial living donor
liver transplantation program.
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Methods: From March 2002 to September 2009 we per-
formed 367 liver transplantations at our unit, 118 cases
were from living donors under elective condition. There
were 66 adults and 52 children, among then 27 with less
than 10 kg. Reconstructions were with end-to-end inter-
rupted suture with 8–0 or 9–0 monoﬁlament using a 6·
magniﬁcation loupe. All patients were prospectively fol-
lowed by color Doppler ultrasound protocol.
Results: We observed hepatic artery thrombosis in 2.5%
(3/118) of all patients, one adult (1.5%) and two Childs
(3.8%) presented HAT. According to the Fisher’s exact
test P value was > 0.5 comparing adults and children.
There were no HAT in patients under 10 kg.
Conclusion: Hepatic artery in LDLT can be safely
reconstructed with microsurgical techniques without
microscope using, with 6 · loupe magniﬁcations, and can
achieve the same result, between adults and children in
LDLT.
P-672
AORTA-HEPATIC CONDUITS IN ADULT
CADAVERIC ORTHOTOPIC LIVER
TRANSPLANTATION
S. Iype, S. Chakravartty, A. Butler, R. Praseedom,
C. Watson, G. Pettigrew and N. Jamieson
Transplant Unit, Cambridge University Hospitals NHS
Trust, Cambridge, UK
Background: Early graft loss secondary to arterial inﬂow
problems remains a major challenge in liver transplan-
tation. Revascularization of the liver using donor iliac
artery conduits is a well-recognised procedure.
Aim: This study analyzes the indications and outcome of
aorta-hepatic conduits in adult cadaveric orthotopic liver
transplantation (OLT).
Methods: This is a retrospective review of 452 OLTs
from January 2003 to August 2009. The data on indica-
tion, type of graft, complications and survival were ob-
tained from the transplant database and patient case
notes.
Results: Aorta-hepatic conduits were required in 46
(10.1%) patients. The median age of the recipients was 52
(Range: 27 – 68). The male to female ratio was 1.4:1.
Three out of the 46 (6.5%) recipients received the liver
from a non-heart beating donor. In 24 (5.3%) patients
the conduit was created primarily at the time of the ﬁrst
liver transplant. The indications were multiple hepatic
arteries needing reconstruction (11), atherosclerotic/
unsuitable recipient artery (nine) and unsuitable donor
vessel (four). In 21 (4.6%) patients the conduit was cre-
ated for re-transplantation for acute hepatic artery
thrombosis (HAT). In one case, the previous infra-aortic
conduit was thrombosed. The 30 day mortality of the
aorta-hepatic conduits was 6 (13%). Five out of six
deaths were following HAT and re-transplantation. The
conduit patency at three years for the primary and
re-transplantation were 89% and 67% respectively. On
median follow up of 38 months, the three-year graft
survival was 72% and 48% respectively.
Conclusion: The primary aorta-hepatic conduits have a
better patency and graft survival as compared to the
conduits created for HAT and re-transplantation.
P-673
HARM AND BENEFITS OF PRIMARY
LIVER RESECTION AND SALVAGE
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA BY A
MARKOV MODEL
A. Cucchetti, M. Cescon, G. L. Grazi, G. Ercolani,
M. Del Gaudio, M. Ravaioli, M. Zanello, G. Vetrone,
F. Tuci, G. Stacchini and A. D. Pinna
Department of General Surgery and Transplantation,
University of Bologna
Background: Primary transplantation offers longer life-
expectancy in comparison to hepatic resection for hepa-
tocellular carcinoma (HCC) followed by salvage trans-
plantation; however, livers not used for primary
transplantation can be re-allocated to the remaining
waiting list patients.
Methods: A Markov model was developed to investigate
whether the harm caused to resected patients could be
balanced, or outweighed, by the beneﬁt obtained from re-
allocation of livers originating from HCC patients ﬁrst
being resected. Data from the literature or estimated
from the United Network for Organ Sharing (UNOS)
database were used.
Results: The Markov model showed that primary
transplantation offers longer life-expectancy in compar-
ison to hepatic resection and salvage transplantation if
5 year post-transplant survival remains higher than 60%.
The balance between the harm for resected patients and
the beneﬁt for the remaining waiting list depends on: a)
the proportion of HCC candidates, b) the percentage
shifted to hepatic resection, c) the median expected time-
to-transplant. Faced with a low proportion of HCC
candidates, the harm caused to resected patients was
higher than the beneﬁt that could be obtained for the
waiting-list population from re-allocation of extra-livers.
An increased proportion of HCC candidates and/or an
increased median time-to-transplant could lead to a
beneﬁt for waiting-list patients that outweigh this harm.
Conclusions: A policy of primary liver resection and
salvage transplantation can be effectively supported by a
Markov model.
P-674
THERAPEUTIC STRATEGIES
PROPOSED BY THE BCLC
CLASSIFICATION: ARE THEY TOO
RESTRICTIVE IN CURATIVE
TREATMENT FOR HCC ?
A. Herrero, Y. Duni, K. Gazzane, E. Assenat, J. Ramos,
M. Hamoui, B. Gallix, G.-P. Pageaux and F. Navarro
Saint Eloi Hospital
Introduction: The Barcelona Clinic Liver Cancer staging
classiﬁcation (BCLC) proposes curative treatment only
to patients classiﬁed A and B. The aim of this study was
to evaluate the overall survival (OS) and the disease free
survival (DFS) in patients treated curatively for HCC
while they were classiﬁed C or D according to BCLC.
Patients and methods: Retrospective study of patients
treated curatively for HCC on cirrhosis between 1998
and 2008. The patients were classiﬁed according to
BCLC. The curative treatments being analysed were liver
transplantation (LT), partial liver resection (LR) and
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percutaneous radiofrequency (RF). Two groups were
compared in terms of OS and DFS: patients classiﬁed A
or B and patients classiﬁed C or D who should have
received palliative treatment according to BCLC.
Results: A curative treatment was realised in 291 pa-
tients: 86 LT, 123 LR and 85 RF, 216 patients were
classiﬁed A and B (45 LT, 105 LR, and 66 RF) and 75
patients were classiﬁed C and D (41 LT, 18 LR, and 16
RF). The cause of cirrhosis was HCV in 42% of cases,
alcohol in 38%, HBV in 9% and metabolic syndrome in
4%. There were no signiﬁcant differences in these groups
on epidemiologic data’s. Patients transplanted classiﬁed
D were Child C. Those who had resection classiﬁed C
had a multinodular HCC, those classiﬁed D had an OMS
score > 2 or older than 70. The 5 year’s OS and DFS in
the global population were 60% and 54%. There were no
signiﬁcant differences between the groups AB and CD in
terms of OS and DFS (OS: 68% vs. 56%, p = 0.46 and
DFS: 56% vs. 54%, p = 0.73).
Conclusion: Among 291 patients treated curatively, 25%
were classiﬁed C or D according to BCLC, with results
similar in terms of OS and DFS to the patients AB. This
means that indications of curative treatment of HCC on
cirrhosis can be enlarged because of progress in liver sur-
gery, percutaneous treatment and new graft attribution.
P-675
HEPATECTOMIES AND LIVER
TRANSPLANTATION AS DEFINITIVE
TREATMENTS FOR ADULT
POLYCYSTIC LIVER DISEASE: A
MULTICENTER STUDY IN ARGENTINA
L. McCormack1, V. Ardiles2, F. Duek3, G. Pfaffen4,
J. Kerman Cabo1, J. Pekolj2, J. Lendoire3, J. Gondolesi4,
P. Capitanich1, O. Imventarza3 and E. de Santiban˜es2
1Hospital Aleman of Buenos Aires; 2Hospital Italiano of
Buenos Aires; 3Hospital Argerich; 4Favaloro Fundation
Background: The management of polycystic liver disease
(PCLD) is controversial. Many treatments are available,
from cyst rooﬁng to liver transplantation (LT).
Objectives: Describe a multicentre study of hepatecto-
mies and LT as treatment for PCLD.
Methods: Two prospective collected databases (partial
liver resections since 1983 and LT since 1988) from four
institutions were analyzed. We identiﬁed each patient
with diagnosis of PCLD to revise age, symptoms, type of
surgery, complications and outcome. RESULTS: We
classiﬁed patients with PCLD in two groups: PH (partial
hepatectomy): six cases; and LT: 16 cases. Group PH
involved 6/1758 (0.3%) cases with a mean age of 51 years
(44–65) and ﬁve female. All patients had associated kid-
ney cysts and symptoms related to gastric compression.
The liver resections were 1 central hepatectomy, one right
trisectionectomy and four left lateral sectionectomies. All
patients were discharged without major complications.
One patient received a combined kidney- LT 36 months
later due to symptoms recurrence and renal failure. All
others are symptoms-free with a median follow-up time
of 5.5 years. The incidence of PCLD in the group LT was
16/1550 (1%). This group had a mean age of 52 years.
(37–67) and 14 were female. The mean waiting list time
was 7 months (1–27). Thirteen (81%) underwent a
combined kidney- LT. Two patients with massive hem-
orrhage died within 72 hours and two others early due to
sepsis (in-hospital mortality: 25%). The mean hospital
stay was 22.4 days and the mean follow-up time was
5.9 years. One died secondary to a lymphoma 1 year
after LT and all others are symptoms-free.
-LT is a valid treatment for selective patients with diffuse
disease and renal failure, partial liver resection is an
adequate approach with low morbidity and mortality.
P-676
LIVER RETRANSPLANTATION:
VALIDATION OF A PREDICTIVE
MATHEMATICALMODELOF SURVIVAL
J. R. Mattos1, M. M. Linhares1, D. Azoulay2, D. Matos1,
R. Adam2, D. Samuel2, H. Bismuth2 and D. Castaing2
1Universidade Federal de Sa˜o Paulo – UNIFESP;
2Hopital Paul Brousse - Universite Paris-Sud
Aim: To determine preoperative survival in liver trans-
plant patients, we made a multivariate mathematical
model. To test the effectiveness of this model, it must be
validated using a population different than the one used
to build the model.
Methods: The model variables age, recipient creatinine,
urgency of transplantation, interval between primary and
retransplantation, and survival at six months of 92 sec-
ondary liver transplant patients were used in the pro-
posed mathematical model. We compared the areas
under the ROC curves corresponding to the two inde-
pendent samples (derivation and validation samples). By
the log-rank technique, the survival curves were also
compared and classiﬁed into tertiles according to the risk
scores of the original model: high risk (> 32), medium
risk (24–32), and low risk (< 24).
Results: Both age and creatinine and in regards to time
between primary and retransplantation and the urgency
with which patients were enrolled had comparable sur-
vival curves among the derivation and validation sam-
ples. When comparing the areas under ROC curves of the
derivation (0.733) and validation (0.741) samples, there
was no statistically signiﬁcant difference (p = 0.915),
showing that the sensitivity and speciﬁcity ratios between
the two curves are similar. There is also a similarity in the
Kaplan–Meier survival curves of the two samples strati-
ﬁed by tertile (< 24, 24–32, and > 32).
Conclusion: This study made it possible to internally
validate the original mathematical model for predicting
survival at six months using a different sample of liver
retransplant patients in a different time period than the
patients used for making the initial model.
P-677
OUTCOMES OF INCIDENTAL
CHOLANGIOCARCINOMA AFTER
LIVER TRANSPLANTATION:
CAMBRIDGE EXPERIENCE
L. Bonomo, W. Grifﬁth, N. V. Jamieson, E. L. Huguet,
R. Brais, R. K. Praseedom and A. Jah
Addenbrookes University Hospital, Cambridge
Background: Cholangiocarcinoma can be difﬁcult to
detect prior to a liver transplant and may exist in the
background of primary sclerosing cholangitis and other
liver pathologies. Liver transplant generally carries poor
outcome and therefore is not indicated in cholangiocar-
cinoma. However, the outcomes of incidentally detected
cholangiocarcinoma after liver transplant is unknown.
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Objective: To study the outcome of the cohort of pa-
tients who had incidental cholangiocarcinoma detected
after liver transplant.
Methods: We reviewed the explants histology of all the
patients who had undergone liver transplantation at
Cambridge University Hospital between 1996 and 2009.
Records of all the patients with incidentally detected
cholangiocarcinoma were studied for type of liver dis-
ease, tumour characteristics and disease-free survival.
Results: Twelve patients were found to have incidental
cholangiocarcinoma of which nine were male. The
average age at transplant was 54.4 years. PSC was the
commonest reason for transplant (6/12). The median
period of follow-up was 44 months. Four patients were
found to have stage T1 and ﬁve patients stage T2. The
1 year disease-free survival was 100% while the three
year survival was 75% (8/12). Recurrence was found in
58.3% (5/12) and the mean time to recurrence was
23.5 months.
Conclusion: Tumour recurrence is common and there-
fore the patients should be rigorously assessed for cho-
langiocarcinomas prior to the transplant. However,
incidentally detected cholangiocarcinoma tend to be
early stage tumours and usually have satisfactory med-
ium-term outcome.
P-678
ANALYSIS OF RATES SURVIVAL OF
PATIENTS WITH FULMINANT LIVER
FAILURE SUBMIT TO ORTHOTOPIC
LIVER TRANSPLANTATION
J. Roma, J. Alves, G. Gouvea, A. Oliveira,
A. C. Gonzalez, F. Pousa, L. Carius, C. Leal, L. Agoglia,
E. Balbi, M. Enne and L. Pacheco
Hospital Geral Bonsucesso
Background: Fulminant hepatic failure (FHF) carried a
very high mortality. However, after the advent of liver
transplantation (LT), the survival rates were consider-
ably improved. LT for FHF offers a survival between
55% and 75% in the major centers.
Aims: Evaluate the survival rates in the ﬁrst month and
in the ﬁrst year after LT in the adult and pediatric (under
18 years) population with FHF (age, gender, etiology of
the acute failure, the kind of transplant, hemodialysis,
vasopressor amines or mechanic ventilation use, list in
time and MELD score).
Methods: From June 2001 to June 2009: 328 patients was
underwent LT, 42 (12.5%) patients presented the King’s
College criteria of FHF: 26 (61.9%) adults and 16
(38.1%) children. Although all adult patients received the
allograft from a deceased donor, the pediatric group re-
ceived the allograft from both deceased (DD) and living
donors (LD) depending on the severity of the illness.
They were allocated in three groups: group one adult
DD: 26 patients, group two children DD: seven patients
and group three children LD: nine patients. The survival
analysis was demonstrated by Kaplan–Meier’s curves
and Cox model in 30 days and ﬁrst year after LT in the
three groups.
Results: Survival rates 1 month were 76.19% and 1 year
66.7%. Group 1: 1 month was 64% ± 0.10 and 1 year
60% ± 0.10. Group 2: 1 month, 100% and 1 year,
86% ± 0.13. Group 3: 1 month, 100% and 1 year,
78% ± 0.14. ROC’s curve, the best cut to predict survival
in the 1 year was the Meld score bellow 46.1. p = 0.005.
Discussion: The survival rates in our service were higher
than related in world literature. However, when we di-
vided in groups, we can observe that the adult survival
was similar, and the pediatric population was signiﬁ-
cantly higher in the ﬁrst month and in the ﬁrst year. To
conclude, a lower survival in the ﬁrst year could be re-
lated to highs MELD scores in adult patients and the
higher pediatric population survival could be explained
by the living donor transplant.
P-679
ORTHOTOPIC LIVER TRANSPLANT IN
A PATIENT WITH HEMOPHILIA: A
CO-INFECTED WITH HIV, HEPATITIS B
AND D
L. Hammel, Z. Hevesi and M. Hannaman
University of Wisconsin Hospitals and Clinics
Introduction: Many hemophiliacs contracted HIV and
hepatitis from factor replacement therapy obtained from
pools of plasma donors. Cirrhosis develops in 20% of
hemophiliacs infected with viral hepatitis. HIV and
hepatitis co-infected patients progress to cirrhosis rap-
idly. Many centers do not perform liver transplant in
HIV patients. Hemophiliacs present increased risk of
bleeding at the time of transplant.
Case Report: This is a 33 year old male with hemophilia
A, HIV and ESLD due to hepatitis B and D. He has been
on long term HAART. He was treated preoperatively
with recombinant factor VIII and his post-treatment
activity level was 77%. Anesthesia induction and place-
ment of central and arterial lines was without incident.
TEG-based factor replacement resulted in the transfusion
of four units RD platelets before incision and one unit of
FFP after reperfusion of the liver allograft. The patient
was extubated in the OR and taken to ICU for postop-
erative observation. He was transferred to a general care
bed on postoperative day one. His postoperative course
was uncomplicated and he was discharged to home on
postoperative day ﬁve.
Discussion: Liver transplant in patients co-infected with
HIV is controversial but the institution of HAART has
resulted in a 60–80% in the decline of AIDS-related
mortality and opportunistic infections. Recent informa-
tion regarding patients with HIV indicates that early
referral in conjunction with post-transplant anti-viral
therapies results in survival rates not appreciably different
than those in non-HIV infected recipients. Complex
patients with hemophilia and HIV undergoing liver
transplant present a unique challenge for the anesthesia
team. This is the ﬁrst liver transplant performed at our
institution for a patient with this combination of comor-
bidities. Based on our experience we believe future con-
siderations of similar patients for transplant to be justiﬁed.
P-680
LIVER TRANSPLANT FOR SEVERE
LIVER INJURIES
J. R. Polanco, C. Lewis, R. Lopez, T. E. Starzl and
A. B. Peitzman
University of Pittsburgh Medical Center
Introduction: Although severe injury to the liver has been
described as a potential indication for orthotopic liver
transplantation (OLT), it is still infrequent and only
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anecdotal cases have been reported in the literature. We
present the largest series of cases of OLT for severe liver
injuries for a single institution in a Level 1 Trauma
Center and world recognized Transplant Center.
Methods: Retrospective and descriptive review of all the
OLT for liver traumas identiﬁed on the transplant
database of our institution (1981–2008).
Results: Five cases of OLT after liver trauma were
identiﬁed. Four of them had blunt trauma to the liver.
Some patients underwent initial management at outside
hospitals (OSH) and failed initial surgical management.
Three patients survived OLT to leave the hospital and
two of them are still alive. See table for summarized data.
Conclusions: To our knowledge, this is the largest single
institution series of OLT reported for liver trauma. OLT
is an option for severe liver injuries in experienced trau-
ma and transplant centers but still a rare indication de-
spite the increase in incidence of injury to the liver.
Eighty percent of our cases were delayed OLT due to
liver failure after unsuccessful initial management and
operation. Sixty percent of patients survived OLT to
leave the hospital.
P-681
LIVER TRANSPLANTATION WITH
MELD SCORE MORE THAN 35 IN A
BRAZILIAN UNIVERSITY HOSPITAL
W. Andraus, I. Schmidtbauer, F. M. Q. Silva,
W. L. Junior Costa, V. Pugliese, R. Surjan,
R. S. N. Pinherio, M. Barros, V. Santos, E. Figueira,
C. E. Pompilio and L. A. D’Albuquerque
Sa˜o Paulo University Medical School
Introduction: MELD score has been used for organ
allocation in USA since 2002. In Brazil, it is started in
2006, however, due to a huge waiting list; the score
necessary to perform transplantation is very high.
MELD score is related to mortality in waiting list, and
also to higher morbi mortality after orthotopic liver
transplantation (OLT). On the other hand, MELD does
not contraindicate OLT and, although there are patients
called ‘too sick to treat’, they seems to draw the higher
beneﬁts of the procedure.
Aim: The aim of this study is to analyze liver trans-
planted patients with MELD score more than 35.
Methods: Data were collected retrospectively from
medical records of hundred patients underwent OLT at
Clinical Hospital of Sa˜o Paulo University Medical
School from January to September 2009. Fifteen of them
had a MELD score greater than 35 and their morbidity
and mortality were analyzed.
Results: Fifteen patients had MELD score greater than
35 in 93, excluding those with acute liver failure (16%).
The etiology was VHC (53.3%), alcohol (13.3%) and
others (33.3%). Gender was mainly masculine (67%) and
the mean age was 48 (± 13.7). The mean MELD score
was 40.5 (± 4.7), 86.7% were transfused, 46.7% under-
went dialysis preoperatively and 86.7% after the proce-
dure. 53.3% of grafts were marginals. The mean length of
stay in intensive care was 10.8 days (± 4.1). There were
one re-transplant and four deaths (26.7%). Survival rate
in 30 days of patients with MELD > 35 was of 73.3%
and with MELD < 35 was of 84.7%.
Conclusion: Patients with MELD score greater than 35
have high rate of transfusion, renal insufﬁciency and
intensive care stay. However, they have an acceptable
survival rate even with expanded criteria donors.
P-682
INTERMITTENT TREATMENTS
PROVIDE EXCELLENT HCC CONTROL
DURING THE WAIT FOR LIVER
TRANSPLANT
J. R. Carr and C. Doria
Thomas Jefferson University, Philadelphia, PA, USA
Background: The variable months of waiting for organ
donation for liver transplantation for patients with
hepatocellular carcinoma (HCC) has led to patient drop-
out from the transplant waiting list in several reported
series.
Orthotopic liver transplant for severe liver injuries. Summary of data (Table for P-680)
Case N 1 2 3 4 5
Age (years)/ gender 21/M 45/M 18/M 26/F 55/F
Year Trauma: 1984 1987 1989 1990 1992
Mechanism Trauma: MVA Crushed
by a horse
MVA MVA Percutaneous liver
biopsy (OSH)
Prior liver
operation/resection
before OLT
Right
Lobectomy
Right
lobectomy
and atriocaval
shunt (OSH)
No Right Lobectomy+
cholecystectomy
(OSH)
Ex lap. Ligation +
R hep artery (OSH),
Right lobe debridement
Indication for OLT Liver failure Liver Failure Hemorrhage Liver Failure Liver failure
Delayed/Subacute
OLT OLT s/p
trauma day
Yes 66 Yes 34 No 0 Yes 34 Yes 10
Complications
during
trauma admission
Biliary
Stricture,
liver failure
Coagulopathy,
intraventricular
hemorrhage, death
Acute Renal
Failure,
respiratory
insufﬁciency,
death
Liver failure Liver failure
Status at discharge alive dead dead alive alive
Current status alive dead dead dead (4y after
OLT-rejection)
alive
Cause of Death: Still alive MODS
Discontinued
Life Support
MODS Liver disease,
chronic
rejection, ARF
Still Alive
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Methods: Patients with HCC on the transplant wait list
had 3-monthly CT scan follow-up. They received an
initial treatment with TACE, RFA or PEI provided bil-
irubin was < 2.0 mg/dL with absence of major ascites.
Follow-up therapies were given for residual tumor vas-
cularity (viability), tumor growth or appearance of new
nodules.
Results: Eighty three patients (pts) with known HCC
were transplanted at our institution in the period 3/2003
to 9/2009. Median age was 56 years (range 26–75), gen-
der M:F = 4:1. Etiologies were: HCV 61% (M:F =
4:1), HBV 12% (M:F = 9:1), Alcoholism 8% (M =
100%). Patients with bilirubin > 2.0 mg/dL = 42%
(bilirubin range 0.4–52), patients with AFP> 20 ng/
mL = 40% (AFP range 1–294). Baseline tumor size was:
median 2.8 cm (range 1–11) and 51% of patients had
multiple tumors. TACE treatments (trans-arterial
chemoembolization): median # of treatments was two
(range 1–5) and two patients had progressive or new
tumors, both within Milan criteria. The wait list was a
median of 9.6 months (range: 2–25 months). Patient
drop-outs = 6. One was for no residual tumor, one was
for death and four for clinical deterioration.
Conclusions: Intermittent treatment of vascular or
growing HCC resulted in an absence of liver transplant
waiting list drop-out for progressive cancer.
P-683
LIVER TRANSPLANTATION AND
HEPATOCELLULAR CARCINOMA:
CHILEAN EXPERIENCE
M. Gabrielli1, M. Vivanco2, J. Hepp2, J. Martı´nez1,
R. Pe´rez1, J. Guerra1, M. Arrese1, E. Figueroa1,
A. Soza1, R. Yan˜ez1, R. Humeres2, H. Rı´os2, J. Palacios2,
R. Zapata2, E. Sanhueza2, J. Contreras2, G. Rencoret2,
R. Rossi2 and N. Jarufe1
1Pontiﬁcia Universidad Cato´lica de Chile; 2Clı´nica
Alemana/Universidad del Desarrollo
Introduction: Hepatocellular carcinoma (HCC) is the
most common primary malignant tumor of the liver.
Liver transplantation is a good treatment for HCC; im-
proves survival, cures cirrhosis and abolishes local
recurrence. In our study we described the outcomes of
patients with HCC who underwent liver transplantation
in two liver transplantation centers in Chile.
Methods: This study is clinical series elaborated from the
liver transplantation database of Pontiﬁcia Universidad
Cato´lica and Clı´nica Alemana, between 1993 and 2009.
The survival of patients was calculated using the Kaplan
Meier survival analysis. SPSS program 15.0 for windows
was used for statistical analyses. The signiﬁcant alpha
level was deﬁned as less than 0.05.
Results: From 250 liver transplant performed in these
period, 29 were for HCC. At the end of the study 25
(86%) patients were alive. The mean of recurrence free
survival was 30 months (range 5 months–8 years). In our
series ﬁve year survival for patients transplanted for
HCC was over 80% and ﬁve year overall survival of
patients that exceeded Milan criteria on the explants was
66%. There was no difference in overall survival between
patients transplanted for HCC and for other diagnosis
(p = 0.548).
Conclusion: In Chile our series conﬁrm that liver trans-
plantation is a good treatment for patients with HCC
within Milan criteria.
P-684
SELECTIVE INTRA-ARTERIAL
RADIATION THERAPY OF THE LIVER:
REDUCTION IN MORBIDITY AND
IMPROVEMENT OF OUTCOME OVER
SIX YEARS
R. Adib, N. O’Rourke, I. Martin, L. K. Nathanson,
J. Clouston and D. Walker
Wesley Hospital, Brisbane, Australia
Introduction: Selective internal radiation therapy (SIRT)
is a relatively new technique for treatment of malignant
hepatic lesions using (90) Y embedded in resin micro-
spheres, which are introduced directly into the hepatic
arterial circulation. This is a prospective study of 150
consecutive SIRT treatments for management of non-
resectable liver tumours from primary hepatocellular and
secondary colorectal and neuroendocrine sources in a
single institution over 6 years.
Methods: Patients received a single dose (mean 2.0 GBQ
(0.5 – 4.0)) of Y90 spheres via groin puncture technique.
The ﬁrst 50 treatments were associated with signiﬁcantly
high morbidity, including two cases of acute liver failure
and subsequent 30-day mortality. There were also four
cases of cholecystitis and three peptic complications.
With improvement in dose adjustment, usage of selective
coiling and utilization of advanced laparoscopic tech-
nique, including laparoscopic clipping of gastroduodenal
arteries and coiling of cystic artery, the last 50 treatments
were associated with minimal side effects. These included
abdominal pain, back pain, bradycardia and two reac-
tions to contrast. There were no cases of liver failure or
30-day mortality.
Conclusion: In a setting of a multidisciplinary team,
SIRT is a feasible and safe method of treatment for non-
resectable liver disease, with limited side effects in expe-
rienced hands.
P-685
ADJUVANT HEPATIC ARTERIAL
INFUSIONAL CHEMOTHERAPY AFTER
CURATIVE RESECTION OF
HEPATOCELLULAR CARCINOMA: A
PROSPECTIVE RANDOMIZED STUDY
S. U. Kim1, D. Y. Kim1, K. H. Lee2, S. H. Ahn1,
K. H. Han1 and J. R. Kim3
1Department of Internal Medicine, Liver Cancer Special
clinics, Severance Hospital, Yonsei University college of
Medicine; 2Department of Radiology, Liver Cancer
Special clinics, Severance Hospital, Yonsei University
college of Medicine; 3Department of Surgery, Liver
Cancer Special clinics, Severance Hospital, Yonsei
University college of Medicine
Background and aim: Several adjuvant therapies had
been tried in attempt to primarily reduce uni-centric,
intra- or extrahepatic recurrence after curative surgical
resection for hepatocellular carcinoma (HCC). How-
ever, the efﬁcacy of adjuvant therapy after curative
resection is still unknown. In this prospective study, we
intended to determine whether adjuvant hepatic artrerial
infusional chemotherapy with 5-FU and cisplatin could
reduce the incidence of recurrence of HCC after cura-
tive resection.
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Methods: This prospective randomized trial recruited
HCC patients for four cycles of adjuvant intra-arterial
chemotherapy with 5-FU and cisplatin via chemoport
between January 2006 and December 2008. The patients
were randomized to adjuvant therapy or observation
after curative resection. If the patient refused to receive
adjuvant therapy, he was allocated to observation group.
Results: Between adjuvant group (n = 31) and obser-
vation group (n = 104), there was no difference in tumor
characteristics, such as distribution of TNM stage,
pathologic differentiation, portal vein invasion, and
microscopic invasion. During the follow-up, recurrence
developed in 11 (35.5%) and 40 (38.5%) patients in each
group (P = 0.84). There was no difference in the distri-
bution of intra- or extrahepatic recurrence between the
two groups (P = 0.163). Tumor progression after
recurrence was the cause of death in two (28.6%) and
eight (34.8%) patients in each group (P = 0.94). The 3-
year cumulative survival rate was 80% in adjuvant group
and 78% in observation group (P = 0.98). The median
recurrence-free survival rate was 10.5 months in adjuvant
group and 11.9 months (P = 0.80).
Conclusion: Our data show that adjuvant hepatic arterial
infusional chemotherapy with 5-FU and cisplatin did not
offer any beneﬁcial effect on the prevention of recurrence
after curative resection of HCC.
P-686
BEVACIZUMAB DOES NOT DECREASE
LIVER HYPERTROPHY AFTER PORTAL
VEIN EMBOLIZATION
M. Hassanain1,2, P. Chaudhury1,2, C. Dey1,3,
R. Gadahadh1,3, A. Salman1,2, E. Simoneau1,2,
N. Meti1,2, M. Aljiffry1,2, T. Cabrera1,3, N. Bouganim1,4,
P. Kavan1,4, T. Alcindor1,4, D. Valenti1,3 and
P. Metrakos1,2
1McGill University Health Center; 2Department of
Surgery; 3Department of Radiology; 4Department of
Oncology
Introduction: The size of the future liver remnant (FLR)
is a main determinant of liver function after hepatec-
tomy. Portal vein embolization (PVE) redistributes blood
ﬂow to the FLR to stimulate preoperative liver growth.
Preoperative chemotherapy is widely used as part of the
treatment of colorectal cancer liver metastasis
(CRCLM). The addition of the anti-VEGF monoclonal
antibody, bevacizumab (BEV, Avastin), to standard
chemotherapy is increasing. The effect of BEV on liver
regeneration after PVE is unknown.
Aims: This study aims to determine whether prior
treatment with BEV compromises liver regeneration after
PVE.
Method: We conducted a retrospective review of patients
with CRCLM patients treated at our institution from
2002–2009. We identiﬁed 83 patients who underwent
PVE following preoperative chemotherapy. PVE was
done for patients undergoing a trisegmentectomy or as
part of a staged liver resection. PVE was performed via
an ipsilateral approach using 90–180 m PVA and coils to
occlude segmental branches. CT scans prior to, and
4 weeks after the PVE were evaluated. Total liver volume
(TLV) and FLR were measured using dedicated volume
measurement software on a 3-D workstation by two
radiologists who were blinded to the type of chemo-
therapy given.
Results: There were no differences in baseline character-
istics between the BEV and chemo-only groups (table 1).
Both groups received a median of six chemotherapy cycles
before PVE. Mean pre-embolization and post-emboliza-
tion FLR was 20.2% (BEV) vs. 23.4% (chemo-only) and
28.7% (BEV) vs. 32.1% (chemo-only) respectively
(p = NS). The degree of hypertrophy was 8.5% in the
BEV group vs. 8.7% in the chemo-only group (p = NS).
Base Line Characteristics:
Patients Characteristics BEV Chemo-only
Percentage of patients 45.8% 43.2%
Sex (M:F) 1.1:1 1.6:1
Mean age 56 56
Synchronous Liver Metastasis 89.7% 88.6%
Primary tumour (colon: rectum) 4:1 4:1
Repeated PVE 23% 34%
Liver resection 71.8% 75%
Staged liver surgery 43.6% 29.6%
Conclusion: The use of pre-operative BEV containing
chemotherapy in patients undergoing PVE prior to liver
resection for CRLM does not affect liver hypertrophy.
P-687
STEROTACTIC BODY RADIATION
THERAPY FOR NON-RESECTABLE
TUMORS OF THE LIVER: PRELIMINARY
RESULTS
K. Goyal1, D. Einstein1, M. Yeo1, C. Kunos1,
F. Barton1, D. Singh1, C. Siegel1, J. Stulberg1 and
J. Sanabria1,2
1University Hospitals Case Medical Center; 2Case
Western reserve University, Cleveland OH
Background and aims: Stereotactic body radiation ther-
apy (SBRT) has emerged as a treatment option for local
tumor control of primary (HCC & IHC) and secondary
(LM) malignant tumors of the liver. We report on our
updated experience with SBRT in patients with malig-
nant tumors of the liver whom were found not to be
candidates for surgical resection.
Methods: Our ﬁrst seventeen consecutive patients (mean
age 58.1 years) receiving SBRT for non-resectable liver
tumors (HCC, n = 6, IHC, n = 3, and LM, n = 8) are
presented. Mean radiation dose was 34 Gy (range 24–
45 Gy) delivered over 1–3 fractions.
Results: Treated patients had a mean decrease in maxi-
mum pre-treatment tumor diameter from 6.9 ± 4.6 cm
to 5.0 ± 2.1 cm after SBRT at three months after
treatment (P < 0.05, student t-test). The mean total tu-
mor volume reduction was 44% six months after SBRT
(P < 0.05, one sided t-test). Eighty two percent of all
patients (14/17) achieved local control after SBRT with a
median follow-up of 8 months (range 3–20 months). The
best response rate was observed in patients with HCC:
100% of patients with HCC (n = 6) achieved local
control. Patients with surgically (n = 12) placed ﬁducial
markers had no complications related to marker place-
ment. We noted one ﬁducial migration and one bleeding
complication in patients when markers were placed per-
cutaneously (n = 2/5). Three GI ulcers were recorded
(one gastric in a patient with HCC, two duodenal in
patients with secondary liver tumors). All ulcers healed
after medical management.
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Conclusion: Our preliminary results showed SBRT is a
safe and effective local treatment modality in selected
patients with primary and secondary liver malignancies
with minimal adverse events. Further studies are guar-
anteed to deﬁne its role in the management of patients
with HCC.
P-688
SEPARATING THE THERMAL AND
ELECTRICAL EFFECTS OF VESSELS ON
RF AN MW ABLATION: AN EX VIVO
STUDY OF A HOMOGENEOUS LIVER
MODEL
C. Ladtkow and J. Brannan
Covidien
Various authors have reported both qualitative and
quantitative differences in ablative effect near large
vessels with radiofrequency (RF) and microwave (MW)
ablation. Prior literature has noted that MW energy is
deposited deeper into the tissue than RF. However, there
is another possible explanation for the differences
between these modalities near vasculature. This paper
proposes that vessels act as both a thermal energy sink
and an electrical energy sink, and that RF and MW are
affected differently by electrical, not the thermal energy
sink. Two bench liver models are presented that separate
the thermal and electrical effects of large blood vessels
within RF and MW ablation boundaries. The ﬁrst is a
standard bench top bovine liver model with a stainless
steel conductor. The conductor represents the electrical
effect of a blood vessel, and a glass tube with ﬂuid
ﬂowing through it represents the thermal effect of a
blood vessel. The second model includes a homogeneous,
cylindrical tissue environment with similar glass and steel
vessel effect representations. An array of ﬁber-optic
thermal probes and a kinetic damage model were used to
monitor radial ablation effect. A total of 130 ablations in
three groups were performed in the standard bench
model and 25 samples in six groups were performed in
the ground liver model. RF ablations were found to shift
toward the electrical conductor and away from the glass
tube. MW ablations were found to be relatively unaf-
fected by the electrical effect model and to shift away
from the thermal effect model. These results support the
hypothesis that MW ablation is not affected by the
electrical energy sink, while RF ablation is, and that both
modalities are equally affected by the thermal energy sink
effect. This perspective can help guide treatment, probe
targeting and probe design. Ultimately, this distinction
may help clinicians achieve better local tumor control
through improved treatment strategies and specialized
devices.
P-689
LARGE VOLUME ABLATION: CAN IT BE
ACHIEVED WITH MICROWAVE
TECHNOLOGY?
N. K. Lau, D. Sindram, J. D. Whitﬁeld, N. Agee,
I. H. Mckillop, J. B. Martinie and D. A. Iannitti
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, NC, USA
Background: Microwave Ablation (MWA) is a treatment
modality for hepatic lesions. Concerns have arisen in
terms of ablative size and efﬁciency for this new tech-
nology. Currently, small volume hepatic tumors
(< 3 cm) are the most common indication for ablation.
Aim: The aim of this study was to evaluate the rate of
effective ablation, local recurrence, and regional recur-
rence for patients who underwent MWA for hepatic tu-
mor masses > 3 cm.
Objective: Evaluate the rate of successful ablation,
recurrence rate, and survival for patients with hepatic
lesions > 3 cm using 915 MHz and 2.45 GHz micro-
wave systems.
Method: Patients with hepatic lesions > 3.0 cm were
treated byMWA fromFebruary, 2007 to September, 2009
were analyzed. Patient demographics, tumor size, pres-
ence of residual tumor, local recurrence, regional recur-
rence, and distant metastatic recurrence were determined.
Results: A total of 25 patients were analyzed (17 males, 8
females) with a median age of 62 years old (range 43–
83 years). There were 12 hepatocellular carcinomas, 2
neuroendocrine tumors, 5 colorectal liver metastases, 1
cholangiocarcinoma, and 5 other lesions. MWA was used
to treat 25 lesions, 8 with 915 MHz and 17 with
2.45 GHz systems. Mean tumor size was 5.1 cm (range
3.5 to 8 cm). A linear relationship between power and
tumor size existed. There was no 30-day mortality. The
mean follow-up was 5 months and all patients had post
ablation CT scan. There was 1 incomplete ablation, three
local occurrences and four regional occurrences. Three
patients expired during the follow-up period, with overall
mean survival of 9 months.
Conclusion: Large volume hepatic tumor ablation can be
effectively achieved with microwave energy.
P-690
CYTOKINE PRODUCTION BY
COLORECTAL TUMOURS IN RESPONSE
TO IRINOTECAN MAY BE LINKED TO
THE DEVELOPMENT OF CASH
S. M. Robinson1,2, J. Mann1, D. M. Manas2, D. Mann1
and S. A. White1,2
1The Liver Research Group, Newcastle University Medical
School, Framlington Place, Newcastle upon Tyne, England,
UK; 2The Department of HPB and Transplant Surgery,
Freeman Hospital, Newcastle upon Tyne, England, UK
Introduction: Irinotecan based chemotherapy can be
used to downstage unresectable colorectal liver metasta-
sis. However Irinotecan has been linked to the develop-
ment of steatohepatitis (CASH) which impairs the ability
of the liver to regenerate following major surgical resec-
tion. The development of steatohepatitis has been linked
to increased hepatic cytokine levels, in particular the
cytokines TNFa, IL-6, IL-1b and TGFb.
Aim: The aim of this study was to develop an in vitro
model to evaluate the effect of Irinotecan on a colorectal
carcinoma cell line (CRCL) to assess the potential con-
tribution of tumour cells to the development of CASH.
Methods: CRCL SW480 and SW620 were cultured in
DMEM supplemented with 10% FCS. Cells were seeded
in six well plates and after 24 hours media was replaced
with fresh media supplemented with clinically relevant
doses of irinotecan. After 48 hours RNA was extracted
using the Qiagen RNeasy system. First strand cDNA was
then prepared using a standard protocol. Quantitative
real time PCR was carried out to determine expression of
pro-inﬂammatory cytokines in response to a variety of
doses of irinotecan.
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Results: Treatment of SW480/620 cells with Irinotecan is
associated with increased production of pro-inﬂamma-
tory cytokines, particularly TNFa and IL-6, both of
which are strongly linked to the development of steato-
hepatitis.
Conclusion: The results of this in vitro study suggest that
patients with a high tumour burden may be more
susceptible to the toxic effects of Irinotecan with the
potential of expediting the development of CASH.
P-691
COMPLICATIONS OF RADIO-
FREQUENCY ABLATION OF LIVER
V. Vishnevsky, A. Fedorov, D. Ionkin,
O. Zhavoronkova, A. Shurakova and N. Kurushkina
A.V. Vishnevsky Institute of Surgery
Aim: Study possible complications and their reasons at
application radiofrequency ablation (RFA) in group of
patients with liver focus lesions.
Methods: Since 2002 RFA was applied to 124 patients
with liver focus lesions [39 (31.5%) male, 85 (68.5%)
female, middle age – 53.2 year]. Totally 228 RFA sessions
[middle – 2.2 + 1.7 (1 to 8)]. Percutaneous RFA (PrRFA)
was the most often carried method – 179 (78.5%) sessions.
In 29 cases we did ‘open’ RFA. Liver resection with RFA
handling of liver slice has been made in 20 cases.
Results: Complications were divided in groups:
1. Demanded laparotomy: internal hemorrhage 2 (0.8%),
acute cholecystitis 2 (0.8%), coagulation stomach trauma
1 (0.4%);
2. Demanded mini invasion interventions: liver abscess 5
(2.2%), exudative pleurisy 21 (9.2%), hemobilia, (endo-
vasculary occlusion of hepatic artery branches) 2 (0.8%),
gall bladder trauma-1 (0.4%); heart rhythm disturbance,
adrenal crisis and liver insufﬁciency 1 (0.4%). We had
two cases of death after expanded hemihepatectomy (1)
in nearest postoperative period which were caused by
development of cardiopulmonal (1) and acute liver
insufﬁciency.
Liver abscesses after RFA (ﬁve cases), treated paracen-
tetic under ultrasound control. Exudative pleurisy with
volume above 250 mL (25 patients) has been treated by
paracentetic interventions.
Conclusion: Repeated RFA more often lead to different
complications (11.1%) in comparison with primary 5.1%
( < 0.01). Complications, including connected with bil-
iary ducts, were when focuses localizated in the central
segments and in the left lob of liver more often ( < 0.01).
The most complicated course after RFA was in case of
plural hepatic lesion when the diameter of focuses was
above 5 cm and they localizated under liver ﬁbrous
capsula and diaphragmatic liver surface, or near stom-
ach, gall bladder, major ducts and vessels.
P-692
USE OF AORTIC ALLOGRAFTS FOR THE
RECONSTRUCTION OF THE INFERIOR
VENA CAVA (IVC)
K. Saeb-Parsy, A. Jah, N. Jamieson and R. Praseedom
University of Cambridge
Reconstruction or replacement of the IVC may be
necessary to treat obstruction of the IVC after liver
transplantation or to enable excision of tumours invad-
ing the IVC. Here we describe the successful use of aortic
allografts to replace or reconstruct the retro-hepatic IVC
in ﬁve patients.
In two patients with early stenosis of the suprahepatic
IVC following liver transplantation using side-to-side
cavocavostomy, an ascending aortic allograft was anas-
tomosed as a conduit between the re-opened blind end of
the suprahepatic donor IVC and the right atrium,
bypassing the recipient IVC stenosis. In a third patient
with a leiomyosarcoma arising from the retro-hepatic
IVC, a segment of the IVC between the hepatic veins and
the renal veins was replaced with an aortic allograft. A
fourth patient with a central cholangiocellular carcinoma
of the liver and invading the anterior wall of IVC
underwent an extended right hemihepatectomy with en
bloc excision of the anterior wall of the retro-hepatic IVC
and reconstruction using an aortic allograft patch. A ﬁfth
patient with an adrenocortical tumour invading the right
lobe of the liver and the IVC underwent a right
adrenelectomy and right hemihepatectomy including
the IVC, with reconstruction of the IVC using an
ascending aortic allograft.
Blood group-compatible fresh (one patient) or cryopre-
served (four patients) aortic allografts were used in all
patients. Extracorporeal venovenous bypass was used to
facilitate surgical reconstruction and maintain venous
return to the heart. The reconstruction of the IVC was
successful in all patients; one patient died 6 weeks post-
operatively from an unrelated cause and patient ﬁve died
10 weeks post-operatively from carcinomatosis.
Aortic allografts are well suited for the replacement or
reconstruction of the IVC. They allow a good size-match,
are less prone to infection and thrombosis than synthetic
grafts and are less likely to lead to stenosis or aneurysm
formation compared to vein grafts.
P-693
SURGICAL MANAGEMENT OF
HYPERSPLENISM IN NON CIRRHOTIC
PORTAL HYPERTENSION
R. Rajesh, D. Sharma, S. Singh and A. K. Agarwal
GB Pant Hospital and MAM College, Delhi University
Background: Hypersplenism is common in Portal
hypertension due to extrahepatic Portal venous obstruc-
tion (EHPVO) and Non cirrhotic portal ﬁbrosis (NCPF).
The advocated treatment is controversial.
Aims/Objectives: To analyze our surgical experience of
hypersplenism in patients with non cirrhotic portal
hypertension for incidence and efﬁcacy of surgical man-
agement.
Methods: Two hundred and ﬁfty two patients of non
cirrhotic portal hypertension were operated from Janu-
ary 1996–June 2009, in a tertiary referral teaching centre.
Of these 64 patients with hypersplenism form the study
group.
Results: Of the 64 patients, 45 had EHPVO and 19 had
NCPF with an average age 21.81 (4–50) years, sex ratio
(1.1M:1F) Seventy percent had symptomatic hypersple-
nism. The incidence of spontaneous bleed, recurrent
anemia and recurrent infection was 26.6%, 34.3% and
29.9% respectively.
Out of 64 patients, 55 underwent Splenectomy with
Proximal Spleno Renal shunt, 9 underwent devascular-
isation procedure. Patients who had symptomatic
hypersplenism had high incidence of triple cell line defect
(35% vs. 11%), were younger (17 vs. 26 years) and had a
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higher post operative morbidity (30% vs. 17%) than
asymptomatic patients. Twenty two out of 64 patients
had severe hypersplenism (< 2000 WBC/cu.mm and /or
< 75000 platelet/cu.mm) and had increased incidence of
Spontaneous Bleed (40% vs. 23%), Oesophageal varices
(91% vs. 81%), Recurrent infection (45 vs. 28%) average
duration of symptom (8.5 vs. 5.8 years), median age at
surgery (15 vs. 27 years) and post operative morbidity
(41% vs. 19%). The incidence of variceal bleeding, portal
gastropathy, and grade of esophageal varices, symptom-
atic hypersplenism and post op morbidity was signiﬁ-
cantly high in pts with Triple cell line defect.
In all patients hematological parameters normalized at
the time of discharge in both groups i.e. splenectomy with
Shunt or devascularisation.
Conclusion: Splenectomy combined with shunt or dev-
asularization is equally effective treatment for Hyper-
splenism.
P-694
SELECTIVE PORTAL EMBOLIZATION,
PREPARATION FOR HEPATECTOMY,
USING AN ADAPTED BALLON
CATHETER SYSTEM – HOW WE DO IT
J. Alves1, M. Enne1, R. Fernandes1, K. Steinbruck1,
J. M. Martinho1,2 and L. Pacheco-Moreira1
1Bonsucesso General Hospital - MS - Hepatobiliary a
Liver Transplantation Unit; 2Universidade Federal
Fluminense - HUAP
Background: Advances in hepatic surgery have reduced
the mortality rate after major liver resection but com-
plications resulting from inadequate post-resection he-
patic function and size remain. Portal vein embolization
(PVE) is increasing being accepted as a useful procedure
in the preoperative treatment of patients selected for
major hepatic resection. PVE was proposed to induce
hypertrophy of the healthy liver remnant in order to re-
duce such complications.
Objective: Our aim is demonstrate that PVE performed
via trans-ileocolic route, using an adapted balloon cath-
eter system, is a safe, a low costed and effective method
for inducing selective hepatic hypertrophy of the healthy
liver and increase the surgical possibilities of tumors
resections.
Methods: In 17 patients we catheterized a jejunal vein by
laparotomy and passed a wire guide guided by ﬂuoros-
copy until the entrance of the portal vein. By the wire
guide, we introduced hysterosalpingography catheter and
guided through the right portal branch. The insufﬂation
the balloon occludes the vessel. Then another contrast
infused through the catheter conﬁrms the position. To
embolizate the vessel, a gel foam powder plus absolute
alcohol solution in a total of 1 mL/kg is introduced.
Results: We performed the hepatectomy on a second
time in 70% (12) of patients initially non-resectable due a
low reserve of healthy liver parenchyma. The complica-
tion rate was 5.9% (1) (acute renal failure).
Conclusion: This method can be used when interven-
tional radiological facilities are not available for the
percutaneous approach. Others advantages of the open
approach includes an assessment of the peritoneal cavity
at the time of PVE to observe the lesion and the presence
of local affections, associated with the low cost of the
procedure.
P-695
EX VIVO EVALUATION OF A NEW
1.8 MM PERCUTANEOUS MICROWAVE
ANTENNA USING A 2.45 GHZ SYSTEM
J. R. Lau, N. Agee, J. J. Heath, I. H. Mckillop,
D. Sindram, J. B. Martinie and D. A. Iannitti
Section of HPB Surgery, Department of Surgery,
Carolinas Medical Center, Charlotte, NC, USA
Background: Microwave Ablation (MWA) is a modality
for tissue destruction. Currently, only a 5 mm antenna is
approved for laparotomy. A novel, internally cooled
1.8 mm antenna has been developed and its advocacy for
percutaneous use requires assessment.
Method: MWA were performed on ex vivo bovine liver
using a 2.45 GHz system (Microsulis, UK) with the new
1.8 mm and existing 5 mm antennas. Three different
power (60, 120 and 180 Watts) and time settings (2, 4 and
6 min) were used. Tissue was then sectioned along the
plane of the needle and the diameter (perpendicular to
needle) and length (parallel to needle) of the observed
thermo-coagulation zone measured. Ablative volume was
then calculated.
Result: Thirty six ablations were performed on ex vivo
liver tissue. All ablation settings achieved > 3 cm3 burn
volumes except with the 5 mm antenna at 2 min sec-
ondary to system failure. The ablation size ranged from
3.11 to 17.39 cm3. With a time setting of 2 min, no sig-
niﬁcant difference was measured using the two antennas
at 60 Watts (p = 0.62). The time and size of ablation
increased linearly for settings of 60 Watts and 120 Watts.
The largest ablation size was achieved at 6 min with
power settings at 60 Watts and 120 Watts. (p = 0.002
and p = 0.0004). There is no difference in ablation size
between 4 and 6 min ablation times using 180 Watts
power determined by a Tukey’s test.
Conclusion: The new 1.8 mm antenna is an efﬁcient for
achieving tissue ablation on ex vivo bovine liver using the
2.45 GHz system. Its performance is comparable to the
existing 5 mm, while providing advantage of percutane-
ous usage and a smaller needle track.
P-696
ADMINISTRATION OF
BISPHOSPHONATES FOR MALIGNANT
HEPATIC
T. Oida1, H. Kano1, K. Mimatsu1, A. Kawasaki1,
N. Fukino1, H. Miyake2 and S. Amano3
1Social Insurance Yokohama Central Hospital/Surgery;
2Kasukabe Municipal Hospital/Surgery; 3Nihon
University School of Medicine/Surgery
Background/Aim: Hypercalcemia is a paraneoplastic
syndrome that is a serious condition requiring urgent
treatment. We administered alendronate to hypercalce-
mia patients with advanced cancer with metastasized li-
ver tumors or hepatocellular carcinoma (HCC), and then
evaluated the mechanism and anticancer function of this
compound.
Method: We retrospectively studied 17 patients with
hypercalcemia associated with metastatic liver tumor or
HCC. Alendronate (10 mg) was administered via the
intravenous route for patients with metastatic liver tumor
(n = 12), and via the hepatic artery for patients with
HCC (n = 5).
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Results: Intravenous administration of alendronate, re-
sulted in a decrease in serum calcium levels in all patients.
The serum levels of tumor markers also decreased in
66.7% (8/12) of these patients. After intra-arterial
alendronate administration, the serum calcium and
parathyroid hormone-related protein levels decreased in
all the patients. The serum levels of tumor markers such
as AFP and PIVKA- ? were decreased in 80% (4/5) of
these patients. Electron microscopic examination of the
resected hepatic tumor revealed an increase in the vas-
cularization and formation of apoptotic vesicles in the
vascular endothelial cells.
Conclusion: Alendronate is effective not only for con-
trolling hypercalcemia but also for directly enhancing the
apoptosis of HCC cells.
P-697
LEIOMYOSARCOMA OF THE
RETROHEPATIC INFERIOR VENA CAVA
TREATED WITH MULTIVISCERAL
RESECTION AND RECONSTRUCTION
C. Sandroussi, C. Swallow, L. Hawryluk, S. McCluskey,
S. Gallinger and I. McGilvray
Toronto General Hospital
Introduction: Leiomyosarcomas of the IVC are rare, and
resection technically challenging. Herein we report our
experience with multimodal treatment including neoad-
juvant radiotherapy, circumferential resection and
reconstruction of the IVC, and tumor resection en bloc
with surrounding viscera. Methods:
From 2006–2009 data of all patients with resected IVC
leiomyosarcoma at the UHN (Toronto) was recorded.
Recorded variables included patient demographics, com-
plications (Clavien Score), and outcomes following
resection.
Results: Seven patients with retrohepatic IVC tumors
ranging in diameter from 30–108 mm were treated.
Median age was 59 (range 42–71). Preoperative core
biopsy conﬁrmed the diagnosis, neoadjuvant RT was
given to 4/7 (45Gy/25F), 3/7 did not receive RT due to
tumor location (intracardiac) or toxicity (liver). All
underwent resection of the retrohepatic IVC, 4/7 had in
situ hypothermic liver perfusion with HTK, and one was
combined with cardiac bypass. The median ﬂush time
was 40 min (36–90). About 2/7 had en bloc extended liver
resection; the other 5/7 had en bloc right nephrectomy
and adrenalectomy. IVC reconstruction was undertaken
with 20 mm PTFE graft in all cases. Hepatic and left
renal veins were re-implanted into the graft as appro-
priate. Treatment was well tolerated. 4/7 required ICU
admission, median of 1 day (1–9). The median length of
stay was 9 days (5–20 days). Grade III complications
occurred in 1/7 (reoperation for bleeding). Grade I
complications occurred in 2/7 (raised creatinine), 0/7 re-
quired dialysis. All patients are alive with a median fol-
low up of 17 months (1–42 months). About 6/7 are
disease free, one patient has a suspicious lung nodule
(biopsy pending). Surgical margins were negative in all
patients.
Conclusion: Resection and reconstruction of the IVC in
conjunction with involved viscera for leiomyosarcoma is
technically feasible, safe and can result in long term
survival. This challenging clinical entity is best-managed
by a multi-disciplinary approach.
P-698
SYSTEMIC ADMINISTRATION OF
LIDOCAINE DOES NOT ATTENUATE
HEPATIC ISCHEMIA REPERFUSION
INJURY
W. de Graaf1, G. Diepenhorst1, D. Erdogan1,
M. W. Hollmann2 and T. M. van Gulik1
1Department of Surgery, Academic Medical Center,
Amsterdam; 2Department of Anaesthesiology, Academic
Medical Center, Amsterdam
Background: A rat model of hepatic ischemia combined
with 30% partial hepatectomy (PHX) is a clinically rel-
evant model to examine new therapeutic strategies to
reduce ischemia reperfusion (I/R) injury and improve
postoperative liver function. Lidocaine is a local anaes-
thetic and anti-arrhythmic agent, which can modulate
inﬂammatory responses and reduce apoptosis. Systemic
Lidocaine infusion has been reported to attenuate I/R
injury in heart, lung and brain.
Aim: To investigate the effect of systemic Lidocaine on
postoperative liver function after hepatic I/R combined
with PHX.
Methods: A standardized 70% I/R injury model with
60 min of ischemia was used in rats, to study the effect of
lidocaine on I/R injury alone. In a second set of experi-
ments, rats were subjected to 45 min of ischemia com-
bined with 30% partial hepatectomy (PHX) and treated
with lidocaine or saline. Rats undergoing no resection or
ischemia served as a control group (n = 4). Lidocaine
was continuously administered i.v. from 30 min prior to
ischemia up to 20 min reperfusion. At 24 hour reperfu-
sion, hepatic damage (ALT/AST), inﬂammation (tissue
myeloperoxidase (MPO)) and liver function (prothrom-
bin time, indocyanine green (ICG) clearance and biliru-
bin) were measured.
Results: I/R injury resulted in a signiﬁcant increase in
hepatocellular damage, with comparable values in the
saline and lidocaine groups. Postoperative liver function
measured by prothrombin time, plasma bilirubin, anti-
thrombin and the indocyanine green clearance test was
signiﬁcantly impaired in the ischemic groups with no sig-
niﬁcant differences between the lidocaine and saline
groups. Neutrophil inﬂux measured by tissue myeloper-
oxidase was signiﬁcantly increased in the ischemic groups
with again no signiﬁcant difference in the lidocaine group.
Conclusion: Systemic Lidocaine in therapeutic concen-
trations did not attenuate hepatocellular damage and did
not improve postoperative liver function after hepatic I/
R injury.
P-699
PRECLINICAL EVALUATION OF
VESSEL THROMBUS AND
COLLATERAL DAMAGE TO ADJACENT
CRITICAL STRUCTURES DURING
HEPATIC MICROWAVE ABLATION
P. Manley, J. Coe, C. Ladtkow and A. Ross
Covidien, Energy Based Devices
Background: As microwave ablation (MWA) therapies
become prevalent in the treatment of liver lesions, there is
growing interest in understanding collateral damage to
adjacent critical structures while ablating liver.
Abstracts 393
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Objective: This study investigates hepatic vessel and
biliary damage and thermal spread toward organs
adjacent to the liver surface during preclinical hepatic
MWA.
Methods: Study groups included (1) in vivo acute por-
cine (2 hours post-MWA survival) and (2) in vivo chronic
porcine (7 days post-MWA survival). All hepatic MWAs
were created by water-cooled MW antennas (Covidien,
Boulder, CO). Thermal probes (LumaSense Technolo-
gies, Santa Clara, CA) measured temperatures at 0.5 cm
radial intervals from the MW antenna in group 1.
Adjacent vessels were examined for thrombosis, vessel
wall and biliary damage in both groups.
Results: Thermal proﬁles reached steady state after a
heating phase that lasted approximately 200 seconds
post-MWA initiation. Mean maximum steady-state
temperatures reached 81C, 48C and 40C at 0.5, 1.0
and 1.5cm from the antenna shaft and correlated strongly
with our estimates of active heating by MW energy. 2/12
vessels in the 2-7 mm size range in acute animals were
occluded either partially or totally. Both were £3 mm and
their walls touched the ablation boundary. Hematoxylin
and Eosin (H&E) showed effective parenchymal and
vessel wall destruction in both cases. 15/17 vessels (1£x£6
mm) showing comparable vessel wall destruction were
not occluded. No occlusions were witnessed in chronic
tests. 3/4 ablations in these tests revealed mild to mod-
erate bile backup and biliary stricture (shown by H&E
staining) around small ducts, with no associated symp-
toms that were signiﬁcant.
Conclusion: No signiﬁcant symptoms were witnessed re-
lated to vessel occlusion, bile duct injury or adjacent
organ injury after 7 days post-MWA survival. On aver-
age, instantly lethal temperatures were recorded at a
0.5 cm radius.
P-700
NEOADJUVANT CHEMOTHERAPY
(CHT) PREDISPOSES TO INCREASED
REVERSIBLE COMPLICATIONS POST
HEPATECTOMY
S. Pathak, J. M. F. Tang, G. Sarno, A. Al-Sarira,
H. Z. Malik, S. W. Fenwick and G. J. Poston
University Hospital Aintree, Liverpool
Introduction: Neoadjuvant ChT is used increasingly
prior to HPX for colorectal liver metastases. Concern has
previously been raised regarding increased post operative
complications following neoadjuvant chemotherapy.
Aims: To analyse the effect of neoadjuvant chemother-
apy on background liver histopathology and to correlate
these with peri-operative outcomes.
Method: Forty seven patients who had received neoad-
juvant chemotherapy were identiﬁed from a prospectively
maintained database. Fifty ﬁve patients, with similar
demographics, who had not undergone any form of
chemotherapy, were identiﬁed from the same database.
All specimens underwent light microscopy (LM) and a
small subset also underwent electron microscopy (EM).
Complications, length of stay (LOS), degree of steatosis,
blood transfusion requirements and routine day 5 blood
tests were also compared.
Results: There were no LM changes between chemo and
chemo naı¨ve livers. However, there were notable oxali-
platin related changes to intra-cellular architecture
(presence of lipid ﬁlled cytoplasmic blebs, paucity of
mitochondria, and loss of uniformly granulated cyto-
plasm).
No signiﬁcant difference in LOS between chemotherapy
group (n = 55) and control group (n = 47, Log-Rank
P = 0.453). Furthermore, there is no statistical differ-
ence between groups on comparing blood transfusion
requirements or on comparison of pre-and-post operative
bilirubin levels.
Chemotherapy appears to be associated with a signiﬁcant
increase in the likelihood of hepatic speciﬁc complica-
tions e.g. sub phrenic abscess, persistent biliary ﬁstula,
liver failure (Fisher’s Exact, p = 0.0134).
Conclusion: The EM changes to chemotherapy exposed
livers may predispose to short term complications
post hepatectomy. Chemotherapy can be used prior to
HPX providing there is vigilance for post operative
complications.
P-701
EFFECTS OF MICROWAVE (MW)
ABLATION ON BLOOD VESSELS
A. Ross1, P. Manley2, J. Coe2 and C. Ladtkow2
1Covidien, Energy-based Devices, Boulder, Colorado;
2Covidien, Boulder Colorado
Background: Previous work describes the impact of
hepatic vasculature on microwave ablation (MWA)
geometry and efﬁcacy, but information on MWA-medi-
ated damage to vessels is limited.
Objective: This is a multimodal study describing the
impact of MWA therapy on neighboring vasculature.
Methods: Computer simulations (COMSOL) of MWA
temperatures were substantiated with data from three
experimental groups: (1) A ground bovine liver bench
model with ﬂuid pumped through modeled blood vessels,
(2) In vivo porcine with two hours post-MWA survival,
and (3) In vivo porcine with seven days post-MWA sur-
vival. All microwave ablations were created by water-
cooled MW antennas (Covidien, Boulder, Colo.). Ther-
mal probes measured temperatures at the walls, interior
and outlets of vessels in group one. Microwave ablations
in groups two and three were created next to hepatic
vessels of various sizes.
Results: Temperature increases in ﬂuid ﬂowing through
modeled vessels (ex vivo) depended primarily on vessel
size and ﬂow rate. Ground-liver temperature immediately
adjacent to the vessel wall depended primarily on dis-
tance of the vessel to the MW antenna. Temperature rises
inside vessels >3 mm were less than 5C in both
COMSOL simulations and ex vivo tests. In vivo acute
results demonstrated partial and occlusive thrombosis in
two of eight vessels <3 mm and 0/8 in vessels >3 mm.
chronic results showed thrombosis in zero of nine vessels.
Ablation histology showed thermal damage to liver
parenchyma up to and including the walls of nearby
vessels. This damage up to the vessel walls was in
agreement with the high temperatures measured at the
vessel wall during ex vivo testing and COMSOL simula-
tion, and also with previous ﬁndings suggesting limited
heat sink effect with MWA.
Conclusion: Simulation and ex vivo tests showed high
temperatures up to the boundary of vessels, but limited
temperature rises within the ﬂowing ﬂuid during MWA.
In vivo results conﬁrmed these ﬁndings.
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P-702
EMBOLIZATION FOR TREATMENT OF
IATROGENIC LIVER HEMORRHAGE
R. Garcia Monaco, O. Peralta and F. Petra
Angiography and Endovascular Therapy, Department,
Italian Hospital of Buenos Aires, University of Buenos
Aires
Background: Management of liver iatrogenic vascular
lesions is a high mortality procedure if faced surgically.
Endovascular treatment has brought minimally invasive
techniques to control this situation with low morbidity
and mortality rates.
Objective: To report the efﬁcacy of selective emboliza-
tion in the treatment of iatrogenic liver hemorrhagic
complications.
Methods: About 21 patients underwent angiography
between 1993 and 2009 for severe hemorrhage as a
complication of hepatic interventions (10 biopsies, 6
post-surgical, 5 percutaneous drainage placements). The
mean age was 57.5 (range 11–75), 12 men and 9 women.
The symptomatology was: hemoperitoneum (n = 15)
and hemobilia (n = 6) (one associated to intraparen-
quimatous hematoma and another one to a sub capsular
hematoma). The embolic agents used were: Cianocrylate
(n = 11), PVA particles (n = 4), GDC coils (n = 2),
embospheres (n = 1) and combined agents for three
patients (Cianocrylate and gel foam 1, Cianocrylate and
embospheres 1 and PVA particles and gel foam 1).
Results: Angiogram detected 24 abnormalities among
the 21 patients who were treated by embolization (16
pseudo aneurysms, 3 active bleeding, 3 A-V ﬁstula, 1
intraparenquimatous hematoma and 2 hemangiomas).
All patients were successfully embolized and bleeding
was stopped in all cases (100%). Three patients (14.2%)
died as a consequence of multi organic failure despite
successful treatment.
Conclusions: Selective embolization was highly effective
and safe to control hepatic hemorrhage due to iatrogenic
vascular lesions. Treatment must be prompt to avoid
deleterious consequences of continuous bleeding.
P-703
USE OF GORE-TEX ARTIFICIAL GRAFT
FOR RECONSTRUCTION OF HEPATIC
VENOUS TRIBUTARIES IN CENTRAL
HEPATECTOMY
C.-Y. Liu, C.-C. Wang, C.-L. Chen, T.-L. Lin,
W.-F. Lee, C.-C. Lin, Y.-W. Liu, C.-C. Yong,
C.-H. Yang and S.-H. Wang
Departments of Surgery, Chang Gung Memorial Hospital-
Kaohsiung Medical Center
Background: Conventional lobectomy or extended
lobectomy is recommended for hepatoma located within
central liver, but the risk of post operation liver failure
due to insufﬁcient remnant liver volume is high. Central
hepatectomy (CH), resection of central liver and preser-
vation of more functioning liver, is a technically
demanding and complex procedure that decreases the
risk of liver failure. However, this procedure could not be
performed when the tumour is close to the right hepatic
vein (RHV). We report a case of centrally located liver
tumour near RHV to receive CH with reconstruction of
hepatic venous tributaries.
Methods: A 56-year-old male with a history of hepatitis
B virus related liver disease, was referred for evaluation
of resection of a tumour in segment eight of liver. Pre-
operative CTA assessment revealed the size of the left
liver was 285 cm3 (21.26% of standard liver volume). He
was advised to receive CH, but the tumour was found to
be closer to the RHV than expected at operation. We
performed CH, including segment four, ﬁve, seven and
eight. Diaphragm with tumour invasion was resected and
repaired. Segment six outﬂows were reconstructed by
Gore–Tex graft.
Results: The duration of parenchyma transection was
150 min with Pringle’s maneuver. Blood loss was 600 ml
without blood transfusion. The velocity of reconstructed
S6 outﬂow was measured as 15 cm/sec after operation.
The patient had an uneventful postoperative recovery
and was discharged home on postoperative day 14.
Pathology revealed a hepatocellular carcinoma (HCC),
stage II, with clear resection margin. The reconstructed
hepatic venous ﬂow was patent one week after discharge.
Conclusion: The success of hepatic outﬂow reconstruc-
tion after CH depends on detailed image study, complete
intraoperative sonography mapping, and reconstruction
by an experienced surgeon. CH with reconstruction of
hepatic venous tributaries by Gore–Tex vascular graft
may serve as an alternative treatment for HCC closer to
RHV.
P-704
HEPATIC ARTERY INFUSION FOR
RECURRENT OR CHEMO RESISTANT
HEPATIC MALIGNANCY
H. Wanebo1, S. Srinivasa2, C. Taneja3, G. Begossi4,
F. Cummings3 and J. Belliveau1
1Landmark Medical Center; 2Hurley Medical Center;
3Roger Williams Medical Center; 4Roswell Park Cancer
Institute
Introduction: Previously treated Hepatic Colorectal
Metastases (CRC) and advanced hepato cellular ca
(HCC) are commonly chemotherapy (CT) resistant. We
reviewed survival outcome after hepatic artery infusion
(HAI) in 21 chemo resistant CRC patients, 10 HCC
patients, and 6 misc.-CA.
Methods: Of 21 CRC patients (16 male, 5 female aver-
age. age 63) 16 had metachronous (DFI-17 months), and
5 Synchronous CA; liver extent: 76% multiple (> 5) or
bilateral mets, CEA (ng/ml): >100, (eight patients),
> 50 (three patients), < 5 (three patients) and NA–
seven patients. Previous CT: FU/LV (11 patients), Oxa-
liplatin (OX) or Irinotecan (IR) (10 patients). Liver
surgery: Partial Resection/RFA,–9 patients. HCC (9
Patients), Cholangio CA (1), male/female 5/5, average.
age 63. Prev. RX Hepatic lobectomy four patients, RFA/
TACE–three patients. Misc. CA (therapy): Hepatic
lobectomy + HAI were done in metastatic lung (1),
Breast (1), advanced gall bladder cancer (GBCA) (T 3–4)
(2 patients); HAI alone was done in Br. CA (1) Carcinoid
(1) Treatment Protocols: CRC: HAI-FUDR 12–15 mg/
kg/d, Dexamethasone 2 mg.kg/d, Leukovorin 20 mg/m2
/d (14 days) plus (BI) (d1), Oxaliplatin (OX) 130 mg/m2
(or Cisplatin (CIS) 100 mg/m2 dL); Systemic RX: d20–
30. OX I.V. 130 mg/m2, Capecitabine 750–1000 mg/m2/d
·10 days (also used in Misc. CA) HCC: HAI-14 days as
in CRC Protocol. Bolus infusion d1-doxorubicin 75 mg/
m2 or OX or CIS as in CRC schema.
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Results: CRC OS- post HAI = 18 months. Med, 2 year/
5year = 27%/6%, HCC OS = 9 months. Med (3–
12 months) in 9 evaluable patients. 1 HCC pt, recurred
2 year. post central resection and survived 3.5 years.
With HAI + RFA/TACE - (OS-67 months). Misc. CA
OS = 15 months. Med.: lung (11 months), Br CA (23,
9 months) adv. Carcinoid (3 months), GBCA (2 pa-
tients > 60 months), Major Complications; Pump mal-
function (four patients), (two patients), infected pocket
(two patient), duodenal ﬁstula (one patient).
Hepatic Artery Infusion for Progressive Malignancy
Progression
Patients
Primary
Surgery
± CT
± RT
Rx. Of
Liver
Resect/
RFA
Survival *** Med. 24 months.
% 60 months.
CRC 21 *16 Met
5 Sync.
21 9 17 months. 27% 1 (6%)
**DFI-17-0
HCC 10 4-Hep-
Resect
RFA/
TACE 3
9 months. 11% 1 (11%)
Misc. Primary
Surg.
DFI** Hep-
Resect.
Surv.
months.
Total
Br. 2 2 Par.
Mas.
3 year,
6 year.
1 24, 10 25% 0 0
Lung 1 1-Lobect. 2 year 1 9
Car++ 1 0 0 0 4
GBCA 2 C/RT
Resect
0 2 >60 months. 2 (100%)
* Met. - Metachronous
Sync - Synchronous
Hep-R. Hepatic. Resect.
**DFI - Disease free internal
**Survival - Evaluable patients
+ - Par. Mas. - Partial Mastectomy
++ CAR - Carcinoid (Advanced)
Conclusion: HA1 alt. with systemic CT has apparent
survival beneﬁt in selected patients with persistent or
progressive chemo resistant malignancy from metastatic
CRC, HCC, or selected misc. cancers (breast, lung, liver,
gall bladder ca) and warrants further study.
P-705
PALLIATIVE TREATMENT FOR
OBSTRUCTIVE JAUNDICE OF
UNRESECTABLE HEPATOCELLULAR
CARCINOMA: ENDOSCOPIC BILIARY
DRAINAGE VS. PERCUTANEOUS
BILIARY DRAINAGE
J. Choi1, S. Lee2, J. Hwang2, J. Kim2, S. Jung2, J. Park1,
J. Ryu1, Y. Kim1 and Y. Yoon1
1Department of Internal medicine, Seoul National
University Hospital; 2Department of Internal medicine,
Seoul National University Bundang Hospital
Introduction: Percutaneous biliary drainage (PBD) tends
to be preferred to endoscopic retrograde biliary drainage
(ERBD) in the palliative treatment of the patients who
suffer biliary obstruction with inoperable hepatocellular
carcinoma (HCC). However, clinical data comparing
PBD to ERBD in HCC are limited. The aim of our study
is to compare ERBD with PBD in treatment of
obstructive jaundice due to unresectable HCC.
Methods: From January 2000 to December 2005, Pa-
tients who revealed obstructive jaundice with inoperable
HCC on computed tomography and treated palliative
biliary drainage were evaluated retrospectively at two
tertiary referral centers. Patients follow up evaluated
outcomes include overall survival duration, therapeutic
success rates and intervention number in ﬁrst 4 weeks.
Results: The mean age of 66 patients is 59 ± 10 years.
There are classiﬁed according to the level of biliary
obstruction: bile duct tumour located in the second
branch of the biliary tree (n = 5), bile duct tumour
located in the ﬁrst branch of the biliary tree (n = 10),
bile duct tumour located in the common hepatic duct
(n = 46), ﬂoating tumour debris or blood clot from the
ruptured tumour in the common bile duct (n = 1),
compression of extra hepatic mass (n = 3). Patients
receives either ERBD (n = 32) or PBD (n = 34). And
baseline characteristics of both groups have no signiﬁcant
difference. The successful drainage in ﬁrst 4 weeks was
higher in the ERBD group than PBD group (68.8% vs.
41.2%; P = .02). The number of intervention up to
successful drainage was similar in both groups (1.32 ±
0.47 vs. 1.50 ± 0.85, P = .41). The overall median sur-
vival after intervention was no signiﬁcant difference.
(5.53 ± 2.56 vs. 2.36 ± 0.7 months; P = .11). The
procedure related complication in ﬁrst 4 weeks was no
difference in both group.
Conclusions: ERBD can be the preferred ﬁrst approach
in patients with obstructive jaundice due to inoperable
HCC in view of its less invasive nature and patient con-
venience.
P-706
DOWNSTAGING OF HEPATOCELLULAR
CARCINOMA BEFORE LIVER
TRANSPLANTATION USING TRANS-
ARTERIAL CHEMOEMBOLISATION
R. Wilutzky1, H.-J., Dietz2, M. Go¨tz1, M. Heise1 and
U. Settmacher1
1University Hospital Jena; 2Ilmenau
Background: As a result of a shortage of donor organs
and the prolonged waiting time for transplantation, the
importance of bridging procedures is increasing.
Aim: The purpose of this study was to evaluate outcomes
of down staging tumours in patients with hepatocellular
carcinoma (HCC) with Tran arterial chemoembolization
(TACE) before liver transplantation (LT).
Methods: Between January 1995 and December 2008 554
patients with HCC were treated at our department, 76 of
them underwent LT. 39 patients underwent neoadjuvant
TACE before LT.
Results: Initially 16 patients were within and 23 outside
the Milan criteria. After TACE 10 (43%) patients who
were initially outside the Milan criteria had a successful
down staging of their tumours rendering them within the
Milan criteria. By Response evaluation criteria in solid
tumours (RECIST), 51% patients had a stable disease,
31% had a partial remission, 10% had a complete
remission and no one had a progressive disease. After LT
we found a complete necrosis of the HCC in 16, a partial
necrosis in 16 more and vital tumour without necrosis in
7 explanted livers in the explants reviews.
Conclusion: Because of a mean waiting time of 9 months
on the waiting list for LT, the importance of TACE is not
only in bridging to transplantation, but also in downsiz-
ing HCC and improving outcome after transplantation.
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P-707
THE EFFECT OF PORTAL VEIN
EMBOLIZATION BEFORE EXTENDED
HEPATECTOMY ON LIVER
REGENERATION AFTER MAJOR LIVER
RESECTION
J. R. Kim1, S. B. Choi2, Y. K. Hong1, K. H. Lee3,
S. W. Park4, J. S. Choi1, W. J. Lee1 and K. S. Kim1
1Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 2Department of Surgery,
Kuro Hospital, Korea University College of Medicine;
3Department of Radiology, Severance Hospital, Yonsei
University College of Medicine; 4Department of Internal
Medicine, Severance Hospital, Yonsei University College
of Medicine
Background: Although one strategy to improve postop-
erative complication and morbidity is preoperative portal
vein embolization (PVE), few studies were carried out on
liver regeneration after liver resection followed by portal
vein embolization. We designed this study to evaluate the
effect of portal vein embolization on liver regeneration
after major liver resection.
Methods: We reviewed the medical records of 24 patients
who underwent extended hepatectomy due to hilar cho-
langiocarcinomas and CT volumetry between 2001 and
2008. The patients were divided in two groups according
to preoperative portal vein embolization.
Results: The group with PVE consists of seven males and
four females, the other groups without PVE have six
males and seven females. CT volumetry was performed at
the time of 9.9 days after liver resection in PVE group
and 8.8 days in Non-PVE group. The total increased
volume was 241.0 ml in PVE group and 235.8 ml in Non-
PVE group and that the daily increased volume was
30.8 ml/day and 37.6 ml/day in each group. There was
no signiﬁcant difference in increased volume. In PVE
group, the increased volume of Lt. Lateral segment after
PVE was 241.0 ml and 77.2 ml after Rt. extended hepa-
tectomy and daily increased volume was 4.4 ml/day after
PVE and 30.8 ml/day after extended Rt. hepatectomy,
which means that liver regeneration, was promoted better
after liver resection than after PVE.
Conclusions: Liver regeneration after PVE was insigniﬁ-
cant in comparison with extent induced after extended
hepatectomy and PVE ﬁnally could not promote post-
operative liver regeneration.
P-708
OMENTAL FLAP TO CORRECT A
HAMPERED VENOUS OUTFLOW AFTER
EXTENDED LEFT HEPATECTOMY FOR
LESIONS INVOLVING THE HEPATO-
CAVAL CONFLUENCE
R. Dalla Valle, H. Abongwa and N. De’Angelis
University Hospital of Parma, Department of Surgery
Background: Tumour extension and tumour location in
crucial area of the liver can make particularly complex
some extended liver resections. Indeed an outﬂow prob-
lem may sudden arise when only an accessory sovrahe-
patic vein is preserved.
Objectives: Our aim is to suggest a technical solution to
consider when the hepatic venous outﬂow is compro-
mised.
Methods: This study includes three patients submitted to
extend liver resection for lesions involving the hepato-
caval junction. Two patients (one cholangiocarcinoma,
one multiple metastases from rectal adenocarcinoma)
underwent a left hepatectomy extended to segments V-
VIII, with resection of the three sovrahepatic veins and
conservation of an accessory right inferior sovrahepatic
vein (RISV). In the third case (one Caroli disease) we
performed a left hepatectomy with resection of S VIII
and extensive dissection of the right sovrahepatic vein
(RSV), compressed by a cystic lesion. Immediately after
resection, the residual liver, without anatomical ligament,
become congested due to the kinking of the RISV or the
RSV. The hampered venous outﬂow, documented by a
per operatory Doppler ultrasound, caused an immediate
serious bleeding from the liver cut surface. The use of an
omental ﬂap, ﬁxed to the diaphragm as a hammock, al-
lowed a correct spatial repositioning of the residual
parenchyma with limited chance of kinking of the
residual sovrahepatic vein.
Results: In all the procedures, we had no post-operative
complications/mortality and the Doppler conﬁrmed a
normal venous outﬂow.
Conclusions: An accurate preoperative imaging study of
the hepatic vascular ﬂow and anatomy should be rec-
ommended in the surgical management of major hepa-
tectomy for tumours of the liver dome involving the
hepato-caval conﬂuence. An omental ﬂap ﬁxed to the
diaphragm can be considered a good technical solution to
stabilize the residual parenchyma, preserving a correct
venous outﬂow, otherwise hampered by kinking of the
residual sovrahepatic vein.
P-709
REAPPRAISAL OF PARENCHYMA
SPARING RESECTION IN THE ERA OF
PORTAL VEIN EMBOLIZATION:
OUTCOMES AFTER BISEGMENT-
ECTOMY VI-VII OR RIGHT
HEPATECTOMY
S. Zalinski, J. Agostini, S. Kirzin, O. Soubrane and
O. Scatton
Hoˆpital Cochin; Assistance Public - Hoˆpitaux de Paris
Background: Inadequate liver remnant and increased
blood loss are associated with poor outcomes following
liver resection. In patients with cirrhosis, a right posterior
sectionectomy (RPS) may be preferred to a right hepa-
tectomy (RH) to treat tumours in the posterior sector.
Yet RPS is a challenging procedure in cirrhosis and
several theoretical aspects suggest that it may be associ-
ated with increased blood loss and impaired outcomes as
compared to RH. We sought to compare outcomes fol-
lowing RPS and RH, in the setting of cirrhosis. Methods:
From 1999 to 2007, 21 patients underwent RPS at our
institution, including 12 (57%) with cirrhosis. During the
same time frame, 58 patients underwent RH, after right
portal vein embolization (20 RH-PVE) or not (38 RH-
NoPVE). Medical records were retrospectively reviewed
for outcomes. Blood loss, transfusion and postoperative
morbidity were speciﬁcally studied between RPS and
RH-PVE in cirrhotic patients.
Results: Regardless of the liver disease, RPS was asso-
ciated with an increased rate of severe complications (52
vs. 21%, p = 0,006), including a higher rate of septic
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complications (43vs14%, p = 0.01). Six patients were
reoperate in RPS group vs. four in RH group (p = 0.02).
Results: Results were similar when we compared RPS to
RH-PVE with more blood loss (p = 0.02) and more se-
vere complications (p = 0.01). In the subset of cirrhotic
patients (12 RPS and 9 RH-PVE), blood loss was in-
creased in RPS group (p = 0.1). Overall morbidity was
100% in RPS group and 67% in RH-PVE group
(p = 0.08). Liver dysfunction was similar in the two
groups (33%). Ninety days mortality was 25% in the
RPS group and 11% in the RH group (NS).
Conclusion: RPS is associated with increased blood loss
and impaired outcomes in cirrhosis. In such patients
with tumours in the posterior sector a RH may be
preferred than a RPS providing that a PVE is per-
formed preoperatively to ensure a satisfactory liver
remnant (40%) with a sufﬁcient degree of hypertrophy
(5–10%).
P-710
THE USE OF HEPATIC AND
CARDIOVASCULAR SURGERY
TECHNIQUES IN MANAGEMENT OF
LARGE RENAL AND ADRENAL CANCER
INVOLVING THE INFERIOR VENA CAVA
I. Kitazono1, T. Komokata1, M. Kaieda1, M. Fukueda1,
Y. Shimamoto1, T. Ueno1, Y. Iguro1, Y. Yamada2,
M. Nakagawa2 and R. Sakata3
1Department of Cardiovascular, Thoracic, and Hepato-
Billiary-Pancreatic Surgery, Kagoshima University
Graduate School of Medical and Dental Science;
2Department of Urology, Kagoshima University Graduate
School of Medical and Dental Science; 3Department of
Cardiovascular Surgery, Kyoto University
Background: Operation for large renal or adrenal tumours
invading the inferior vena cava (IVC) is a challenging tis-
sue and requires well-designed cooperative strategies by
urologic, hepatic, and cardiovascular surgeons.
Objective: We presented our original team-approaches
for such high-risk and troublesome cases to avoid cata-
strophic complications during the operation, providing
less eventful postoperative course.
Patients: Between September 2000 and May 2009, six
patients with large renal or adrenal tumours invading the
IVC, underwent surgical extirpation. The tumour
thrombi in the IVC was detected in ﬁve patients and
further extended into the oriﬁce of the right atrium (RA)
in two of them. Direct invasion to the IVC wall was
highly suspected in one patient.
Results: Patient characteristics, diagnosis, surgical inter-
ventions and complications were described in Table 1. All
patients were discharged with a mean postoperative
duration of 45 (12–89) days.
Conclusion: Our well-designed surgical strategies coop-
erated by urologic, hepatic, and cardiovascular surgeons
may play an essential role in achieving successful oper-
ation with less mortality and morbidity for such large
urological tumours invading the IVC.
No
Age/
Sex Diagnosis
Intervention
Tumour
thrombus
Blood
loss
(mL) ComplicationsHepatic Cardiovascular
1 64F Rt. adrenal
cancer
Liver
mobilization
Posterior
segmentectomy
Total hepatic
vascular
exclusion
IVC 11735 Pleural
effusion
2 64M Lt. renal
cancer
Liver
mobilization
IVC mobilization IVC 4990 (-)
3 76M Rt. renal
cancer
Liver
mobilization
IVC mobilization RA
oriﬁce
14000 (-)
4 55F Rt. adrenal
cancer
Liver
mobilization
Right hepatic
lobectomy
IVC mobilization (-) 3040 Pleural
effusion
5 67F Rt. adrenal
cancer
Liver
mobilization
Femoro-femoral
bypass
RA
oriﬁce
2410 Pleural
effusion
6 79F Rt. renal
cancer
Liver
mobilization
Total hepatic
vascular
exclusion
IVC 1420 Pleural
effusion
P-711
ONCOGENIC KRAS UNCOVERS A
PRO-METASTATIC ROLE FOR DEATH
RECEPTORS
J. R. H. Hoogwater1, M. W. Nijkamp1, N. Smakman1,
M. R. Sprick2, W J. van Houdt1, M. T. de Bruijn1,
E. J. A. Steller1, B. L. Emmink1, D. A. E. Raats1,
B. F. Westendorp1, J.-P. Medema2, I. H. M. Borel
Rinkes1 and O. Kranenburg1
1Department of Surgery, University Medical Center
Utrecht, Utrecht, the Netherlands; 2Laboratory of
Experimental Oncology and Radiobiology, Center for
Experimental Molecular Medicine, Academic Medical
Center, Amsterdam, the Netherlands
Background: Death receptor agonists are being tested for
their safety and efﬁcacy as anti-cancer agents in clinical
trials, based on their ability to induce apoptosis in
tumour cells. However, death receptors (DR) can also
stimulate proliferation and invasion, which raises the
possibility that such treatment modalities may adversely
affect disease progression. The molecular mechanisms
controlling death receptor signaling output are currently
unknown and biomarkers that predict response to
treatment are unavailable.
Aim: Here we investigated the role of oncogenic K-Ras
in determining death receptor function and metastatic
potential.
Methods: Three sets of isogonics human and mouse
colorectal cancer cell lines differing only in the presence
or absence of the K-Ras oncogene were tested in apop-
tosis and invasion assays using CD95 Ligand and tumour
necrosis factor-related apoptosis-inducing Ligand
(TRAIL) as stimuli. Metastatic potential was assessed by
intrasplenic injections of green ﬂuorescent protein (GFP)
- or luciferase-expressing tumour cells, followed by
intravital microscopy or bioluminescence imaging, con-
focal microscopy and immunohistochemistry.
Results: CD95 Ligand and TRAIL stimulated cell
motility and invasion of colorectal tumour cells in a K-
Ras-dependent fashion. Systemic TRAIL-treatment in-
duced dissemination of micro metastatic tumour cells
through the liver parenchyma. Loss or suppression of
mutant K-Ras switched CD95 and TRAIL receptors
back into apoptosis mode and abrogated metastatic po-
tential.
Conclusions: We present evidence that the K-Ras onco-
gene is at the heart of determining DR signaling output
(apoptosis vs. invasion). We show that this is relevant
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during the formation of liver metastases but also for the
response of metastases to DR agonist’s treatment. An
important implication of these ﬁndings is that treatment
of patients with apoptosis-resistant tumours with DR
Ligand like TRAIL may promote invasion of micro
metastases rather than clearing them.
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WHAT IS AN OPTIMAL TOOL FOR
NUTRITION ASSESSMENT BEFORE
AND AFTER HEPATECTOMY?
J. R. Kwon1, S. B. Choi2, S. J. Bae1, J. S. Choi3 and
K. S. Kim3
1Department of Surgery, National Health Insurance
corporation Ilsan Hospital; 2Department of Surgery, Kuro
Hospital, Korea University College of Medicine;
3Department of Surgery, Severance Hospital, Yonsei
University College of Medicine
Introduction: Most of patient with hepatocellular carci-
noma (HCC) have underlying liver cirrhosis. Liver cir-
rhosis is frequently associated with malnutrition.
Although an adequate nutritional support is essential,
there are no precise tools for nutritional assessment in
cirrhotic patients. The aim of this study is to investigate
the ideal nutritional index.
Methods: We performed a prospective study in 39 pa-
tients with HCC and measured the anthropometric
indices and biochemical parameters before and 3 months
after hepatectomy.
Results: There were 26 male and 13 female. The mean age
was 55.4-years-old in male, 52-years-old in female. The
changes in anthropometric indices for BMI (24.9 ± 3.0
vs. 24.2 ± 2.6), fat mass (23.8 ± 7.6 vs. 24.8 ± 6.8), fat-
free mass (52.1 ± 8.7 vs. 50.1 ± 8.5), mid-arm muscle
circumference (28.1 ± 2.4 vs. 27.4 ± 2.3) and triceps skin
fold (14.6 ± 6.7 vs. 13.8 ± 6.7) and fasting blood sugar
(107.4 ± 37.3 vs. 89.9 ± 33.9) after operation were not
signiﬁcant after operation. However the biochemical
parameters of cholesterol (94.8 ± 25.6 vs. 148.3 ± 29.4),
triglycerides (56.6 ± 18.0 vs. 80.6 ± 33.9), low density
lipoprotein (54.5 ± 19.1 vs. 89.2 ± 21.2), high density
lipoprotein (32.3 ± 10.9 vs. 51.7 ± 13.6), albumin
(3.3 ± 0.3 vs. 3.9 ± 0.4), and transferin (149.3 ± 42.8 vs.
265.7 ± 55.1) were all increased and were signiﬁcant.
Conclusion: The biochemical parameters are more
informative than the anthropometric indices in patients
underwent hepatectomy for nutritional assessments.
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THE MANY FACES OF HEPATIC
ARTERY PSEUDOANEURYSM
J. R. Elnaim, R. Jarmin, H. Othman, M. Sobri and
Z. Rozman
National University of Malaysia Medical Centre
Background: Hepatic artery pseudoaneurysm (HAP) is
rare yet it can be devastating. This is usually due to the
iatrogenic injury to the hepatic artery.
Objective: To highlight the features and management of
HAP cases from our centre.
Method: We had reviewed the cases presented with HAP
that was managed at our centre. In particular, we ana-
lyzed their demographics, clinical presentation, disease
characteristics and outcomes of management.
Results: During the one year period, seven cases of HAP
were recorded. There were six male patients and one fe-
male involved with the age ranging from 15 to 76 years.
Four patients presented hypotension and features of
upper gastrointestinal bleeding and three patients were
found incidentally during the CT abdomen for other
reasons. Three HAPs were related with trauma, two cases
were associated with history of liver surgery, one was
associated with helminthes infestation and another case
was unknown origin. Anatomically, two pseudoaneu-
rysms originated from common hepatic artery, another
three from right hepatic artery and two from the left
hepatic artery. Angiography was the investigation of
choice. The bleeding pseudoaneurysms were arrested in
combination of surgical and radiological intervention.
The overall survival-rate was 86 percent. Median hospi-
talization duration was 33 days (7 – 112 days).
Conclusion: Although HAP can be fatal, a multi-
disciplinary team approach could provide better out-
come. The availability of interventional radiology
has reduced the need for operative measures with
promising results.
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SEVERE HAEMORRHAGIC
COMPLICATIONS DUE TO ARTERIAL
PSEUDOANEURISMS AFTER RADICAL
HEPATOPANCREATOBILIARY
TUMOUR RESECTIONS
E. Esteban, P. Galindo, R. Conradi, M. Marcello,
H. Dura´n, C. Loinaz, N. Sa´nchez-Ferna´ndez, M. Idrovo,
A. Echenagusı´a, E. Santos, Y. Quijano and E. Vicente
Madrid-Norte-Sanchinarro Hospital /Clara Campal
Oncologic Center (CIOCC) / Faculty of Medicine, San
Pablo CEU University, Madrid, Spain
Introduction: Arterial involvement by HPB tumours of-
ten leads to vascular resection and anastomoses or to
aggressive dissections which can weaken the arterial wall.
The risk for severe vascular complications then appears.
We report three cases of arterial pseudoaneurisms after
radical HPB surgery with diverse clinical presentations.
Patients: A 70-year-old woman, a 66-year-old-man and a
75-year-old-man underwent radical surgery for a Bis-
muth type I cholangiocarcinoma (patient 1) and pan-
creatic head adenocarcinoma with suspected hepatic
artery involvement (patients 2 and 3).Patient 1 under-
went a radical celiac trunk, hepatic artery and hepatic
hilus lymphadenectomy, a portal vein resection, and an
extra hepatic bile duct resection. On postoperative day
eight she presented with refractory hemodynamic shock
and death. Necropsy revealed massive haemoperitoneum
due to a right hepatic artery dissection with parietal
necrosis. Patient 2 underwent a total duodeno-espleno-
pancreatectomy, during which a difﬁcult dissection but
no resection of the hepatic artery was necessary. On
postoperative day 32 he was readmitted due to severe GI
bleeding, and angiography showed an aneurismatic
dilation of the common hepatic artery with contrast ﬁll-
ing of the bile duct. An embolization was performed, and
the patient was discharged in 7 days. Patient 3 underwent
a total duodeno-espleno-pancreatectomy with arterial
resection and primary anastomosis. Recurrent gastroin-
testinal bleeding and a late billiary ﬁstula appeared on
postoperative month three. A ruptured anastomotic
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pseudoaneurism was ﬁnally found during an iterative
angiography and embolized. The patient died after a
3 weeks stay in the ICU.
Conclusions: After resection of HPB tumours with
aggressive vascular dissections, the risk for pseudoa-
neurismatic arterial complications must be considered
and, in case of postoperative bleeding, an early angiog-
raphy can be not only the gold-standard diagnostic tool
but also the only useful therapeutic approach.
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LEFT HEPATIC ARTERY FROM THE
SUPERIOR MESENTERIC ARTERY: A
RARE ANATOMIC VARIATION
E. Chaib1, Y. Souza1,2, M. Maruyama1, L. Marinucci1,
M. Aranha1, T. Gananc¸a1,2, M. Carvalho1 and
L. D’Albuquerque1
1Transplantation Surgery unit, Department of
Gastroenterology, University of Sa˜o Paulo, School of
Medicine; 2Universidade Nove de Julho
Background: Knowledge of hepatic arterial vasculariza-
tion and its variations have a signiﬁcant relevance for the
daily practice of hepato-biliary surgeon as well as radi-
ologists.
Aim: Our goal is to highlight the importance of knowing
the hepatic artery anatomy and its variations since we
have found an exceptional replaced left hepatic artery
(LHA) arising from the superior mesenteric artery
(SMA).
Material and method: Human cadaver livers (n = 60)
were obtained from routine autopsies. Resections were
carried out en bloc with liver, celiac trunk (CT), left
gastric artery (LGA), lesser omentum, superior mesen-
teric artery (SMA) and head of the pancreas. Hepatic
artery (HA) was dissected out and recorded carefully
when liver was split into right and left lobe.
Literature review of the liver and abdominal arteries
arising from the superior mesenteric artery
Author Year Findings Comments
Huu et al 1976 GDA 400 cadaver
dissection
Almenar-Garcia
et al
1993 AcRHA Case report
Nagino et al 1993 RAHA Case report
Hiatt et al 1994 RHA 1000 LTD
Pendarvis et al 1997 RA Case report
Ray et al 1998 LGA Case report
Sakamoto et al 1999 RGEA Case report
Gruttadauria et al 2001 RHA 701 LTD
Jones and Hardy 2001 RHA 180 LTD
Covey et al 2002 PHA 600 angiography
Koops et al 2004 RHA 604 LTD
Osawa et al 2004 CHA
and IMA
Case report
Abdullah et al 2006 RHA 932 LTD
Arjhansiri et al 2006 RHA 200 angiography
Iimura et al 2007 CHA Case report
Lo´pez-Andu´jar
et al
2007 RHA 1081 LTD
Nayak et al 2008 IPDA Case report
Yi et al 2008 IMA Case report
Results: The most common anatomic variation for
irrigation of the liver were: the right hepatic artery
coming from the SMA in 15 (25%) cases; in 9 (15%)
cases there was a median HA coming off proper hepatic
artery (PHA); LHA arising from the LGA - 9 (15%),
Common hepatic artery (CHA) originating directly
from the aorta - 11 (18.3%). Furthermore, we have
found one case with an exceptional anatomic variation,
replaced LHA coming off the SMA directly to the he-
patic left lobe.
Conclusion: We would like to draw attention for this
particularly anatomic variation of the origin of the LHA
ensuring that no damage will be made during gastroin-
testinal surgery.
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PREOPERATIVE PORTAL VEIN
OCCLUSION – NEOADJUVANT
CHEMOTHERAPY AND LARGE
TUMOUR SIZE DECREASES LIVER
REGENERATION
C. Sturesson, I. Keussen and K.-G. Tranberg
Lund University Hospital, Lund, Sweden
Aim: The aim of the present retrospective study was to
investigate the inﬂuence of neoadjuvant chemotherapy
and tumour size on liver regeneration after portal vein
occlusion before major hepatectomy.
Method: Between 2003 and 2007, 26 patients underwent
portal vein occlusion, of which 22 had portal vein
embolisation and four portal vein ligation. 15 of 23
patients with colorectal liver metastases had neoadjuvant
chemotherapy.
Results: After portal vein occlusion, the ratio of the fu-
ture liver remnant volume to total parenchymal liver
volume (FLR %) was reduced in patients receiving
neoadjuvant chemotherapy (27 ± 1% vs. 32 ± 1%,
p = 0.03). Tumour size was found to vary positively and
degree of hypertrophy negatively with FLR% before
portal vein occlusion (r2 = 0.22, p = 0.01 and
r2 = 0.18, p = 0.04, respectively). Patients with tumour
size greater than 60 mm showed a decreased degree of
hypertrophy (7 ± 1)% as compared to patients with
smaller tumours (13 ± 1%, p = 0.01). There was one
death shortly after portal vein embolisation. 19/26 pa-
tients were resected with zero operative mortality.
Conclusion: Neoadjuvant chemotherapy has a small
negative effect on liver regeneration induced by portal
vein occlusion. Liver regeneration induced by portal vein
occlusion is relatively large when tumour burden is small.
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POSTOPERATIVE MRSA WOUND
INFECTIONS IN LAPAROSCOPIC
VERSUS OPEN LIVER RESECTIONS
M. Jacob, R. Saif, S. Robinson, G. Sen, D. Manas and
S. White
Freeman Hospital, Newcastle upon Tyne
Introduction and aims: Postoperative MRSA infections
are a signiﬁcant cause of morbidity and mortality in
surgical patients. The aim of this study was to compare
the rates of MRSA infection in laparoscopic and open
liver resections.
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Methods: All patients undergoing liver resection at a
single unit between July 2007 and September 2009 were
included in this study. Patients were swabbed for MRSA
colonisation of nose, throat and perineum on admission
and on discharge. Postoperative surgical site infection
rates were compared between the laparoscopic and open
groups. Patients who were MRSA positive on admission
were excluded. Potential confounding factors such as age,
sex, ASA grade and length of stay were analysed in
multiple univariate analyses. Fisher’s exact test was used
for categorical data, and Mann–Whitney U test for
continuous data.
Results: Rates of MRSA infections in laparoscopic and
open liver resection were 0/43 (0%) and 9/90 (10.0%)
respectively (P < 0.05). Patients undergoing laparo-
scopic liver resection had a signiﬁcantly shorter length of
stay than open resections (median 6 vs. 10 days,
P < 0.05). MRSA surgical site infection was associated
with a longer hospital stay (median 15 vs. 7 days,
P < 0.05). Postoperative MRSA infection was not re-
lated to age, sex or ASA grade (P > 0.05).
Conclusion: Patients undergoing laparoscopic liver
resection had signiﬁcantly lower MRSA surgical site
infection than those undergoing open liver resection. The
reasons for this observation could be related to minimal
access techniques or reduced hospital stay for laparo-
scopic patients. It is proposed that laparoscopic surgery
may contribute to reducing the incidence of an important
hospital acquired infection.
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SUBCLINICAL METHYCILLIN
RESISTANT STAPHYLOCOCCUS
AUREUS (MRSA) INDUCED
CHOLESTASIS FOLLOWING LIVER
RESECTION
R. Jones, B. Al-Sarireh and H. Malik
University Hospital Aintree
Introduction: Methicillin Resistant Staphylococcus Aur-
eus (MRSA) is a major cause of morbidity and mortality
in surgical patients. We describe three cases where sub-
clinical infection with MRSA caused cholestasis in post-
resection patients.
Case 1 A 75-year-old male, right hepatectomy for HCC
Worsening cholestatic LFTs post-operative. Inﬂamma-
tory markers and CT NAD. 8 days post-procedure,
abdominal drain ﬂuid C and S shows MRSA5/7 IV
Vancomycin for MRSA infection. LFTs improve. Anti-
biotics stopped. LFTs deteriorate. Repeat C and S
negative. Repeat CT normal. 5/7 oral Linezolid empir-
ically for presumed undetected MRSA infection. LFTs
return to normal. Normal LFTs 2 weeks post-discharge.
Case 2 68-year-old male, right hepatectomy for CRLM.
Worsening cholestatic LFTs post-op. inﬂammatory
markers and CT NAD.4 days post procedure, wound
slightly cellulitic. Settled with Flucloxacillin. C and S
NAD.Liverfunction tests remained deranged, but patient
well. Discharged home 18 days post procedure.Re-
presents 24 days post-procedure with discharging wound.
Repeat wound C and S showMRSA. LFTs still de-
ranged. 5/7 IV Vancomycin for MRSA infection. LFTs
improve. Normal LFTs 2 weeks post-discharge. Case 3 A
61-year-old male, right hepatectomy for CRLM. Wors-
ening cholestatic LFTs post-op. CT and inﬂammatory
markers NAD.Small area of cellulitis around wound.
Wound C&S NAD. Settled on Flucloxacillin.Repeat
wound swab on day 14 shows MRSA. 5/7 IV Vancomy-
cin for MRSA infection. LFTs improve. Normal LFTs
2 weeks post-discharge.
Discussion: We describe three cases of patients who
demonstrated cholestatic liver dysfunction post-resec-
tion, without any evidence of liver failure. Despite nor-
mal biochemical markers and imaging, sub-clinical
infection with MRSA was proven in each case. Appro-
priate MRSA antibiotic treatment resulted in resolution
of hepatic dysfunction.
Conclusion: Sub-clinical infection with MRSA can cause
cholestasis following liver resection.
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THE MELD-NA SCORE CAN BE
PREDICTS THE PROGNOSIS IN
PATIENTS WITH UNDERLYING LIVER
DISEASE AFTER EMERGENCY
OPERATION UNDER GENERAL
ANESTHESIA
J. R. Bae1, Y. D. Han2, K. H. Choi2, J. S. Choi2,
W. J. Lee2, K. H. Kwon1 and K. S. Kim2
1Department. of Surgery, National Health Insurance
Corporation Ilsan Hospital; 2Department. of Surgery,
Severance Hospital, Yonsei University
Introduction: It is very difﬁcult to undergo any kinds of
surgery especially when the patient is in patient in
emergency status with underlying liver disease because it
may result in high mortality rate and liver failure.
MELD-Na score is a newly applied tool to explain liver
function. We used this MELD-Na score as an index of
prognosis of liver cirrhosis patient who undergone
emergency operation.
Methods: This study is a retrospective study, based on
medical record of 53 cases of liver disease patients who
underwent emergency operation under general anesthesia
in Severance hospital, Yonsei University College of
Medicine from 2001 to 2008. To compare with other liver
function index, preoperative Child-Pugh score, MELD
score, MELD-Na score were calculated, and a postop-
erative mortality rate was compared with difﬁculty of
surgery and operation time.
Results: There were 42 male and 11 female. The mean
age was 53.9-years-old and patients within 40 to 60-
years-old were 41 out of 53 (77.3%). Underlying liver
disease were 8 cases of Chronic hepatitis, 13 cases of
Alcoholic liver disease, 14 cases of Hepatoma. Mean
Preoperative liver function index showed 6.9 in Child-
Pugh score (5-12), 11.3 in MELD score (6–27), 17.6 in
MELD-Na score (1–46.7).About 19 patients expired in
tracing period (post-operation day 3 ~ 1606), and events
happened within 6 months in 74% of total expired pa-
tients. 5 patients among those expired patients, died
within 2 weeks after operation, and their Child-Pugh
score was 9, MELD score was 16, MELD-Na score was
26.2. Compared to these patients, surviving patients
showed 6.4 in Child-Pugh score, 10.5 in MELD score,
15.2 in MELD-Na score.
Conclusion: The difﬁculty of operation may also affect
the postoperative mortality. However, MELD-Na score
can be used to predict prognosis of liver disease patient
who undergo emergency operation, as it reﬂects under-
lying liver function well.
Abstracts 401
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
P-720
MONITORING BY NON-INVASIVE ICG-
CLEARANCE THE HEPATIC FUNCTION
AFTER INTERMITTENT PRINGLE
MANOUEVER
F. Castro-Sousa1, J. Tralhao1, B. Oliveiros2,
M. Martins1, B. Costa1, C. Carvalho1 and F. Botelho3
1Faculty of Medicine, Surgical III Department, Coimbra
University Hospital, Coimbra, Portugal; 2Biophysics /
Biomathematics Institute, IBILI, Faculty of Medicine,
Coimbra, Portugal; 3Biophysics / Biomathematics
Institute, IBILI, Faculty of Medicine, Coimbra, Portugal
Intermittent Pringle manoeuvre or selective portal clamp-
ing are often used to control inﬂow during parenchymal
liver transaction.
Aim: To study was to determinate whether intermittent
Pringle manoeuvre or selective portal clamping is asso-
ciated with adverse hepatic function.
Methods: Liver resection was performed without portal
clamping in 17 patients (Group-1). Selective continuous
portal clamping was performed in 11 patients (Group-2)
and the remaining 33 patients (Group-3) had intermit-
tent non-selective portal clamping (occlusion of the
main portal trunk). The centers’ protocol for total
portal occlusion is 15 min occlusion alternated with
5 min reperfusion in patients with normal liver paren-
chyma or 10 min alternated with 5 min in patients with
abnormal parenchyma. ICG elimination tests were
conducted concurrently using a non invasive monitor
which tracks the plasma disappearance rate (PDR-ICG-
%/min) and its 15 min retention rate after administra-
tion (ICG-R15-%).
Results: There was no statistically difference between the
three studied groups in terms of sequential changes of
ICG-PDR (P < 0.625) or ICG-R15 (P < 0.398).
Conclusion: Our study indicates that 15 min of inter-
mittent Pringle manoeuvre or selective hemi hepatic
continuous portal clamping are safe methods of vascular
control during liver resection, with no adverse effects
regarding hepatic function.
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THE AETIOLOGY AND MANAGEMENT
OF SPONTANEOUS LIVER
HAEMORRHAGE
S. Mikhail, M. Pai, C. Skouras and Duncan Spalding
HPB Surgery, Hammersmith Hospital, Imperial College,
London, UK
Introduction: Spontaneous haemorrhage secondary to
non-traumatic rupture of the liver has life-threatening
consequences. Hepatocellular carcinomas (HCC) are the
commonest cause with an incidence of rupture < 3%
and 12–14% in Western and Asian countries respectively,
the reported mortality being approximately 50% in the
latter. Rarer causes include adenomas, haemangiomas,
liver cysts, metastases, viral hepatitis and amyloidosis.
The aim of this study was to assess the aetiology and
management of patients with spontaneous liver haem-
orrhages based on the experience of a single institution.
Methods: Between 2008–2009, nine patients with spon-
taneous haemorrhage secondary to non-traumatic rupture
of the liver were identiﬁed. Their aetiology, management,
and outcomes were reviewed retrospectively.
Results: There were four men and ﬁve women. Their
underlying pathologies were HCC 3, adenoma one, and
simple liver cyst one, and choriocarcinoma metastases 1.
In three patients no obvious underlying liver pathology
was identiﬁed despite follow-up imaging (thrombocyto-
penia following stem cell transplantation for acute leu-
kaemia 1, chemotherapy for cutaneous melanoma 1, pre-
eclampsia during child birth 1). Seven patients were
managed conservatively. One patient required transarte-
rial embolisation (TAE), whilst a haemodynamically
unstable patient required laparotomy and peri hepatic
packing prior to TAE. One patient with an HCC initially
treated conservatively subsequently had an elective liver
resection. There were no mortalities.
Conclusions: Patient outcome following spontaneous
haemorrhage secondary to non-traumatic rupture of the
liver can be improved by multi-modality treatment in a
specialist centre. If no underlying liver pathology is ini-
tially identiﬁed, then careful follow-up imaging is re-
quired to detect a potentially treatable cause.
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PRIMARY INTRAHEPATIC BILIARY
CYSTADENOCARCINOMA: CASE
REPORT AND REVIEW OF THE
LITERATURE
A. Kamyab, W. Curtiss, V. Mittal and M. Jacobs
Providence Hospital - St. John Health c/o Department
of Surgery, Southﬁeld, Michigan, USA
Introduction: Cystadenocarcinoma is a rare cystic
tumour of the liver accounting for less than 1% of all
intrahepatic tumours. Surgical resection is the standard
of care. We report a case of an intrahepatic biliary
cystadenocarcinoma and a review of the literature.
Case report: The patient is a 66-year-old female with a
past medical history signiﬁcant for COPD and hyper-
tension. Her symptoms included right upper quadrant
pain and an unintentional weight loss of twenty-ﬁve
pounds. Physical exam revealed a well-nourished patient
with a palpable right upper quadrant mass. Serum CEA
level was elevated at 5.5 ng/mL and baseline liver
function tests were normal. Diagnostic imaging includ-
ing CT and MRI revealed mild bilateral intrahepatic
ductal dilatation and multiple septated cysts most
notably within segments four and ﬁve. An intracystic
mass was noted within the segment four cyst compart-
ments. This mass encroached upon the left bile duct as
it passed to the right of the falciform ligament. The
caudate lobe was spared. The patient underwent
exploratory laparotomy and intraoperative ultrasound
that revealed mild bilateral intrahepatic ductal dilata-
tion. The tumour encompassed segments four, ﬁve and
six extending into segment eight. The tumour abutted
the left main bile duct near the bifurcation, necessitating
a right triscectiontectomy/cholecystectomy with resec-
tion of the bile duct conﬂuence and roux-en-Y recon-
struction to establish intestinal continuity. Pathology
revealed a 14 · 12 cm node negative biliary cystic ade-
nocarcinoma with negative margins. Post-operative
recuperation was unremarkable with prompt return of
liver enzymes to normal levels. The patient was dis-
charged on post-operative day eight.
Conclusion: Surgical resection can be curative for
patients with cystadenocarcinoma of the liver.
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LIQUID FIBRIN GLUE OR FIBRIN-
COATED COLLAGEN FLEECE
PATCHES: A CLINICAL COMPARISON
OF POSTOPERATIVE OUTCOME AND
COST EFFECTIVENESS
J. Dietrich1, J. Wang1, D. Ga¨rtner1, J. Jenkner1,
S. Mu¨nch1, A. Scho¨ttler1, M. Schmidt2, M. Kapps1 and
M. R. Scho¨n1
1Department of Visceral Surgery, Sta¨dtisches Klinikum
Karlsruhe, Germany; 2Department of Pharmacy,
Sta¨dtisches Klinikum Karlsruhe, Germany.
Introduction: Achieving haemostasis during liver resec-
tion remains a particular challenge in surgery. The major
purpose of sealing the resection surface with ﬁbrin glue is
to assist in reducing blood loss and the occurrence of
biliary ﬁstulas. Fibrin sealants are available as Dual-
component liquid mixtures or as Fibrin–coated collagen
ﬂeece patches.
Aims: This study compares both ﬁbrin application
methods in 205 liver resections for their differences in
applicability (operation time), efﬁcacy (blood loss during
surgery), biliary leakage and cost per patient. In the ﬁrst
group (n = 166) only ﬁbrin liquid glue for spray appli-
cation was used and in the second group (n = 39) ﬁbrin-
coated collagen ﬂeece patches were applied.
Results: Both groups are similar in age, gender, diagnosis
and extent of liver resection (p = 0.05). No signiﬁcant
differences in operation time (p = 0.078), postoperative
blood loss (Hb) and blood transfusions (p = 0.283) and
biliary leakage (p = 0.167) were measured. The median
cost per person was signiﬁcantly higher in collagen-ﬂeece
patch-group (349 Euro) than in the liquid-glue-group
(136 Euro) (P < 0.001).
Conclusion: This study conﬁrms that both ﬁbrin sealant
applications were easy to apply in liver resection. There
were no differences in the postoperative occurrences of
increased blood loss and biliary ﬁstula. However, appli-
cations of liquid ﬁbrin glues were associated with sig-
niﬁcant lower costs.
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STATE 0F PORTAL–AND-HEPATIC
HEMODYNAMICS AND PULMONARY
FUNC-TIONS AFTER SURGICAL
TREATMENT OF PATIENTS WITH
COMPLICATED
M. Zarivchatskiy, I. Mugatarov, G. Bogatireva,
E. Kamenskikh, D. Smetanin and S. Smolentsev
Perm State Academy of Medicine named after
Acad.E.Wagner
Background: Reasons of hemodynamic disorders in liver
cirrhosis (LC) are not established.
Aims: To estimate results of surgical treatment, indices
of portal hemodynamics, ventilating function of lungs
and thoracic volume of ﬂuid (TVF) in patients with
complicated LC. Methods:
Intrahepatic Porto systemic shunting with tunneling
according to Ishenin was carried out to 15 patients with
LC aged 17–67 (50.73 ± 11.82). Hemorrhage from
esophageal varicose veins dilatation (EVVD) was ﬁxed
in anamnesis of all the patients. In ﬁve cases tunneling
was combined with EVVD endoscopic ligation, in ﬁve –
with splenectomy. Doppler graphy of hepatic, splenic
vessels and pulmonary artery, ﬁbroesophagogastroscopy,
spirography, TVF measurement were fulﬁlled. Stage of
LC was clinically and morphologically estimated.
Results: Before operation II stage of EVVD was revealed
in 3 patients, III – in 12. After operation I stage was
diagnosed in 9 patients, II – in 5, III – in 1 patient.
Diameter of portal vein (PV) before operation was equal
to 1.57 ± 0.11 sm, after operation – 1.25 ± 0.09 sm
(P < 0,05), volumetric blood velocity in PV increased
from 442.07 ± 171.6 to 901.8 ± 70.3 mL/min
(P < 0.001). High-speed ﬂows remaining portal spec-
trum were revealed in tunnels in postoperative period.
Increase of pressure in pulmonary artery was observed in
all the patients. Vital capacity (VC) after operation de-
creased, its increase was registered later. Index of TVF
after tunneling of liver increased from 1.25 ± 0.13 to
1.53 ± 0.03 L/m2 (P < 0.05). Relapse of hemorrhage
from EVVD in postoperative period was observed in four
patients (26.66%). Early postoperative lethality was
equal to 20% (3 patients); hepatic encephalopathy was
formed in two patients (13.33%).
Conclusion: Tunneling of liver is effective in prophylaxis
of hemorrhage from EVVD because it decreases pressure
in PV, provides rehabilitation of hepatopetal character in
portal blood ﬂow.
P-725
INTERNATIONAL MULTI-CENTRE
PROSPECTIVE STUDY ONMICROWAVE
ABLATION OF LIVER TUMOURS: THE
LEICESTER EXPERIENCE
N. Bhardwaj, F. Ahmad, A. D. Strickland, M. Elabassy,
G. Robertson and D. M. Lloyd
Leicester Royal Inﬁrmary, UK
Background: Microwave ablation is now a well estab-
lished treatment option for unresectable liver tumours.
We present the Leicester experience with a new micro-
wave generator and probe, which is currently undergoing
an international prospective multi-centre trial.
Aims: To assess the safety and efﬁcacy of a new
2.45 GHz microwave system for the treatment of liver
tumours. The preliminary results of a prospective trial
including 33 liver tumours in 17 patients.
Methods: Patients were chosen for ablation based on
accepted criteria and entered into this study. Patients were
treated with a new 2.45 GHz microwave system (Acculis,
UK). Patients were treated either laparoscopically or at
laparotomy; the majority was treated with 100 Watts for
2 min. Most patients underwent ablation alone; 10% had
a concomitant liver resection. All patients were followed
up with standard cross-sectional imaging.
Results: About 17 patients were treated. Tumour aeti-
ology included colorectal metastases (eight), hepatocel-
lular carcinoma (six) and neuroendocrine (three).
Average tumour diameter was 25 mm (range 10–70 mm).
Mean follow up was 8 months (1–21 months). No major
complications (bleeding, abscess formation, bile leaks)
occurred and the 30 day mortality was 0%. The recur-
rence rate was 10% with none of the recurrences occur-
ring in the ablated site.
Conclusion: Preliminary results from this trial suggest
that the new 2.45 GHz microwave generator is fast and
safe. It is associated with low local recurrence and mor-
tality rates. However, greater numbers and longer follow
up is required to determine long-term outcomes.
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P-726
TRANSARTERIAL
CHEMOEMBOLIZATION (TACE) IN
HEPATOCELULLAR CARCINOMA
(HCC): COMPARISON OF TWO
SCHEMES FOR PROPHYLACTIC
ANTIBIOTIC THERAPY
S. Marciano1, J. Bandi1, R. Garcia Monaco2,
R. Rostagno2, O. Peralta2 and F. Petra2
1Hepathology Department. Italian Hospital of Buenos
Aires. University of Buenos Aires; 2Angiography and
Endovascular Therapy Department. Italian Hospital of
Buenos Aires. University of Buenos Aires
Background: Infectious complications after TACE for
HCC are unfrequent. Even though some centers apply
long prophylactic antibiotic therapy. The superiority of
this scheme over preprocedure single doses has not been
shown.
Objective: Compare the incidence of infectious compli-
cations between long term prophylactic antibiotic ther-
apy and preprocedure single dose therapy.
Material and methods: Between April 2007 and June
2009 52 sessions of TACE in 34 patients with the diag-
noses of HCC were performed. Two randomized groups
were established: Group 1 (n = 26): Ceftriaxone 1 group
IV + Ornidazol 1 group IV before TACE and Clavula-
nate-Amoxicillin 1group Orally for 5 days after TACE.
Group 2 (n = 26): Ceftriaxone 1 group IV + Ornidazol
1 group IV alone before TACE. Laboratory tests,
including haemoculture, were performed before TACE, 1
day and 7 days after. CT scan was performed at day 30
after TACE. 60 days follow-up was performed.
Results: About 34 patients (28 male, 6 female, 64 years
mean age) were included. Forty ﬁve sessions of TACE
were performed in 28 patients with cirrhosis related HCC
(Child Pugh and Meld mean scores of 8 ± 1.3 and
11 ± 3.1 respectively) and seven sessions in six patients
with non-cirrhotic HCC. No infectious complications
were seen in both groups.
Conclusion: Single doses preprocedure prophylactic
antibiotic is as effective as long term prophylactic anti-
biotic therapy in TACE in patients with HCC. Is neces-
sary to perform this study in a bigger group of patients in
order to corroborate this conclusion.
P-727
TISSUE PRESERVING HEPATECTOMY
IN THE ERA OF ‘BLOODLESS’ LIVER
SURGERY
K. Tepetes1, G. Christodoulidis1, M. Spyridakis1,
S. Barbanis2 and C. Chatzitheoﬁlou1
1General Surgery Department, University hospital of
Larissa; 2Pathology Department, University hospital of
Larissa
Background: Several advances in surgical techniques and
instrumentation have resulted in low postoperative
morbidity and mortality rates in hepatic surgery.
Aim: To describe and evaluate two low blood loss tech-
niques for tissue preserving liver resection, the Atlas lig-
asure vessel sealing system and the Radio frequency (RF)
assisted hepatectomy technique.
Materials and methods: Patients who were scheduled to
undergo hepatic resection due to hepatocellular carci-
noma or hepatic metastases were assigned to either use
the Atlas ligasure vessel sealing system or the Radiofre-
quency assisted hepatectomy technique. Data evaluated
were the hepatic transection time, the amount of blood
loss, length of hospital stay, postoperative liver function,
and the incidence of adverse events.
Results: A total of 40 patients underwent tissue pre-
serving hepatectomy by the Atlas device and 45patients
by the Radiofrequency device. Those suffered from
hepatocellular carcinoma and cirrhosis were 15 in AT-
LAS group and 12 in RF group. Regarding hepatic
metastases 25 patients treated by ATLAS and 33 treated
by RF method. The number of metastatic lesions re-
moved was 38 and 47 respectively. The median operative
time was 150 min in ATLAS group and 168 min in RF
group. The amount of blood loss was similar in both
groups (260 ml in ATLAS vs. 285 in RF). The percentage
of postoperative complications was almost equal to both
treatment groups.
Conclusion: Both the ATLAS ligasure vessel sealing de-
vice and the Radiofrequency device seem to be safe and
efﬁcacious in performing minor liver resections under the
principles of tissue preserving hepatectomy.
P-728
INFRAPORTAL ACCESSORY RIGHT
HEPATIC ARTERY ARISING FROM THE
LEFT HEPATIC ARTERY –
ANATOMICAL DEMONSTRATION AND
SURGICAL IMPLICATIONS
A. C. A. Martins, J. R. Lyra, L. Andrade, M. Petrus,
F. Moura, F. Martins, D. Euclides, C. Souza Lea˜o and
F. Kreimer
Department of Surgery and Transplantation Unit,
Instituto de Medicina Integral Prof. Fernando Figueira –
IMIP Recife – PE, Brazil
Background: Anatomic variations of the arterial anat-
omy of the liver must be recognized properly during liver
transplantation, ‘split liver’ procedures and hepatic
resections. Proper arterial irrigation of the transplanted
organ or liver remnant after resection is very important
to decrease morbidity and mortality associated with these
procedures.
Aim: To demonstrate the anatomy of an infraportal
accessory right hepatic artery arising from the left hepatic
artery arising from the left hepatic artery in an anatom-
ical specimen. Surgical implications in liver transplant
procedures and hepatectomies are also discussed.
Methods: After dissecting 40 cadaveric liver specimens,
this variation was observed in one liver (male, 52 years)
at the Anatomy Dissection Laboratory at the Medical
School of Pernambuco – IMIP. The hepatic pedicle was
carefully exposed and photographic documentation was
accomplished with a Nikon D50 (6.1megapixels, Nikon
corp. Japan) attached to sigma macro 105 mm lens
(Sigma Corp. Japan).
Results: Just after the hepatic artery bifurcation, the left
hepatic artery gives a branch that crosses to the right side
in an infraportal course far from the portal bifurcation.
This accessory artery irrigates segments six and seven.
The right hepatic artery runs in a straight course to
irrigate segments ﬁve and eight.
Conclusion: The liver surgeon must be aware of the
possibility of the presence of an accessory right hepatic
artery with infraportal course and the implications and
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solutions related to ‘split liver, living donor transplan-
tation and hepatic resection procedures.
P-729
CHEMO-EMBOLIZATION OF
INOPERABLE LIVER TUMOURS – A
PILOT STUDY
T. Skalicky1,2, V. Treska1, P. Duras1,3 and V. Liska1,2
1Charles University Prague, Medical Faculty and
University Hospital Pilsen; 2Department of Surgery;
3Radiological Clinic
Background: A small percentage of patients suitable for
radical surgery require that we introduce alternative
palliative methods that lead to the prolongation of a
good quality of life in patients with malignant liver tu-
mours. One of the alternative methods for a palliative
inﬂuence on tumours, apart from thermo-ablation or
cryo-ablation, is the chemo-embolization of tumours.
Methods: A group of 19 patients, who underwent che-
mo-embolization at the Surgical Clinic and Radio diag-
nostic Clinic, Medical Faculty, Charles University in
Pilsen between 2007–2008, were assessed from the point
of view of complications, overall survival and the pa-
tients’ life quality. The DC bead thrombo-spheres were
applied, the sizes being 100–300, 300–500 and 500–
700 microns.
Results: The most common complication was a temper-
ature and pain in the right infracostal area, in connection
with the performed procedure. The patients’ quality of
life after chemo-embolization was very good and the time
of hospitalization was on average only 3.5 days. We had
to perform the procedure repeatedly in 30% of cases. The
chemo-embolization was done on inoperable liver
metastases of colorectal carcinoma and on inoperable
hepatocellular carcinoma.
Conclusions: The Chemo-embolization of secondary and
primary liver tumours is one of alternative methods for
palliative inﬂuence on tumours.
Support: VZ MSM 0021620819 and IGA grant MZ
9727-4 and 9723-4.
P-730
CIRCULATING TUMOUR CELLS AS
MORE THAN PROGNOSTIC MARKERS
L. R. Jiao and J. Stebbing
Hammersmith Hospital, Imperial College, London
Although a rare peripheral cell population, CTCs repre-
sent a potential alternative to invasive biopsies as a
source of tissue in non-hematologic malignancies. We
have, for example, used CTCs to help identify whether
pancreatic lesions are malignant or benign, although the
predictive value of such tests will rely on prospective
studies (data in press). The decrease in CTCs observed
immediately after surgery suggests that these cells are
derived from the primary tumour mass. In the setting of
liver metastasis resection in colorectal cancer, we have
observed this decrease after surgery. On the other hand,
radiofrequency ablation of liver secondaries leads to an
immediate increase in CTCs (in press) and there is
speculation that the coagulative necrosis caused by the
energy waves may cause cancer cell seedling.
P-731
LAPAROSCOPIC LIVER BIOPSY: A SAFE
PROCEDURE
J. R. Bracco, J. P. Grondona, P. J. Angiolini,
M. A. Duhalde, R. A. Sarquis and J. P. Rastrilla
Associated Units of Hepato-Pancreato-Biliary Surgery
(UNACIR HPB) San Isidro and Mar del Plata, Buenos
Aires, Argentina
Background: Liver biopsy remains as the conclusive pro-
cedure to elucidate the etiology, staging and outcome of
diffuse hepatic disease. Blind or ultrasonography guided
biopsies are efﬁcient but not absolutely safe and they may
lead to morbidity and mortality. A laparoscopic approach
allows taking several samples of both lobes and a safe
control of hemostasis by the visualization of the liver.
Aim: To assess the technique and results of the Lapa-
roscopic Liver Biopsy (LLB) during a 15-year period.
Method: Between July 1994 and July 2009 out of 400
LLB were performed with the assumption and/or the
diagnosis of diffuse liver disease, excluding decompensate
cirrhotic patients and liver mass. Under general anesthe-
sia a two-trocar approach was employed placing one
(11 mm in diameter) on the navel and another one (5 mm
in diameter) on the epigastrium. According to the case the
biopsy was incisional and /or by a Trucut-Type needle
punction. In all cases, a pathologist conﬁrmed that the
samples obtained were enough for the histological study.
Results: All patients were discharged within 4 hours
after ﬁnishing the procedure. One dose of Ketorolac, in
average, was required and neither major complications
nor mortality were observed in this period.
Conclusions: The LLB allows an initial macroscopic
evaluation by the visualization of the liver surface at the
beginning of the procedure and, at the end a reliable
control of hemostasis and bilistasis. The laparoscopic
approach is effective and safe, both for the absence of
major complications and mortality and also to obtain
enough material for the histological study in all cases.
P-732
SYSTEMATIC STUDY OF 38 LABORA-
TORY PARAMETERS IN CRITICALLY
ILL PATIENTS SHOWS UNIQUE
ASSOCIATION OF GAMMA-GLUTAMYL
TRANSFERASE WITH OUTCOME
J. R. Alkozai1,2, T. Lisman1,2, M. Hoekstra3,
A. van den Berg4, M. Volgelzang5, I. van der Horst5,
R. J. Porte2, F. Zijlstra5 and W. N. M Nijsten6
1Surgical Research Laboratory, Department of Surgery,
University Medical Center Groningen, University of
Groningen; 2Section of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, University
Medical Center Groningen, University of Groningen;
3Department of Anesthesiology, University Medical Center
Groningen, University of Groningen; 4Department of
Internal Medicine, University Medical Center Groningen,
University of Groningen; 5Department of cardiology,
University Medical Center Groningen, University of
Groningen; 6Department of Critical Care, University
Medical Center Groningen, University of Groningen
Background: Derangements of physiological parameters
are usually more pronounced in sicker patients, which
explain the association of abnormal values with poor
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outcome. However, derangements of certain physio-
logical parameters might represent appropriate com-
pensatory response. Thus patients with better outcomes
might show more extreme derangements for such
parameters.
Objectives: To systematically search, without any priori
mechanistic assumptions, all routinely measured labora-
tory parameters for larger derangements in patients with
a good outcome than in patients with adverse outcome.
Materials and methods: All adults admitted to our re-
gional intensive care for at least 2 days between January
2000 and September 2008 were evaluated. The 38 most
measured laboratory variables were used. The time
course of all these parameters over the ﬁrst 14 days was
compared between survivors and non-survivors. Hospital
survival was the main outcome measure.
Results: In 99% of the patients included in the study,
laboratory parameters were available. Nearly 2 million
laboratory measurements were analyzed. We found sig-
niﬁcant differences for all 38 parameters between survi-
vors and no-survivors. Except gamma-glutamyl-
transferase (GT; P < 0.0001) and to a lesser extent
alkaline phosphatase (AP; p = 0.03) during the second
week, all derangements were higher in non-survivors.
Discussion: Our study presents clinical evidence that
higher AP and particularly GT are associated with a
higher survival in critically ill patients. A potential pro-
tective aspect of both elevated GT and AP in survivors
may be related with the known physiologic functions of
these enzymes. The effects GT have not been studied,
although the effects of AP-administration are currently
studied clinically.
Conclusion: The unique association of elevated GT with
survival deserves further investigation.
P-733
COMPLICATIONS NEARLY DOUBLE
THE COST OF CARE FOR
PANCREATICODUODENECOTMY: A
COST-CENTER ANALYSIS
J. R. Enestvedt1, B. Diggs1, M. Cassera2, C. Hammill2,
P. Hansen2 and R. Wolf3
1Oregon Health & Science University; 2Providence
Portland Medical Center; 3Providence St Vincent Medical
Center
Background: Despite considerable data focused on the
morbidity of pancreaticoduodenectomy (PD), the ﬁnan-
cial impact of complications has been infrequently ana-
lyzed.
Aims: This study evaluates the impact of the most
common complications associated with PD on the cost of
care. Additionally, we identiﬁed cost-centers which were
signiﬁcantly affected by complications.
Methods: A retrospective analysis of a prospective
database in a network of community based teaching
hospitals was performed. All patients (n = 145) who
underwent PD were included for years 2005–2009. Of
these, 144 had complete in-hospital cost data. Compli-
cations were assessed and classiﬁed into major and minor
categories according to Clavien-Dindo. Forty-nine cost
centers were analyzed for their association with the cost
of complications. Univariate and multivariate linear
regression analyses were performed. Signiﬁcance was
reported for P < 0.05.
Results: The median cost for PD was $30,937. Patients
with major complications had signiﬁcantly higher median
cost compared to those without ($56 224 vs. $29 038,
P < 0.001). Independent predictors of increased cost are
shown in the accompanying TABLE along with the
number of associated complications. Cost-center analysis
demonstrated signiﬁcant added charges for patients with
major complications for blood bank ($1018), clinical
laboratory ($3731), CT scan ($4742), diagnostic imaging
($697), ICU ($4986), pharmacy ($33 850) and respiratory
therapy ($1090) (P < 0.05, all).
Complication
Mean Number
Associated
Complications
Relative
Cost
Increase ($) P value
Reoperation 4.94 25,706 0.002
Delayed gastric
emptying
2.64 12,543 0.007
Pancreatic ﬁstula 4.25 15,701 0.024
Bile leak 5.29 23,438 0.032
Pulmonary 5.00 41,875 <0.001
Renal 6.60 43,092 <0.001
Thrombosis 6.00 41,607 0.007
Sepsis 5.62 60,301 <0.001
Discussion: This study identiﬁed the major complications
of PD which are signiﬁcantly associated with higher cost.
Substantial cost center increases were associated with
major complications, particularly in pharmacy ($33 850).
Measures aimed at limiting complications through
centralization of care or care pathways may reduce the
overall cost of care for patients after pancreatic resection.
Independent predictors of increased cost on multivariate
analysis.
P-734
THE SAFETY AND EFFICACY OF
LAPAROSCOPIC LIVER RESECTION
M. Yasunaga, K. Okuda, H. Sakai, T. Ogata,
H. Kinoshita and S. Aoyagi
Department of Surgery, Kurume University School of
Medicine
Background and aim: Laparoscopic liver resection (LLR)
is now a recognized alternative to open surgery. However
the safety and the efﬁcacy of the techniques are still un-
known. This study evaluated suitable surgical treatments
for patients undergoing LLR.
Patients and methods: Between April 2002 and August
2009, patients suitable for liver resection were carefully
assessed. Data were collected prospectively to assess the
outcome including, size of tumour, intraoperative blood
loss, operation time, duration of hospitalization, blood
transfusion requirement. Laparoscopic liver resection in
our technique is as follows. The left lobe was mobilized
by laparoscopically, followed by applying a small inci-
sion, and the left Glisson was handled integrally by the
Endo-linear stapler. Subsequently, under direct vision, a
liver resection was carried out with the SonoSurge or
CUSA using a hanging maneuver. In the lateral seg-
mentectomy, the lateral segment was mobilized using
Hand Assisted Laparoscopic Surgery (HALS), followed
by separating the hepatic parenchyma, and the major
Glissonian pedicles and the left hepatic veins were simi-
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larly treated integrally by the End-linear stapler, followed
by resection of the liver. In the partial liver resection,
Radiofrequency ablation (RFA) was used on Parenchy-
mal transection line for pre-coagulation, followed by
resection of the liver.
Results: Twenty-one patients underwent LLR. Mean size
of tumour was 26.4 ± 6.30 mm, The mean operation
time and blood loss was 306.4 ± 122.1 min and
286.2 ± 412.4 g, The mean duration of hospitalization
was 12.8 ± 3.24 days. No patients had blood transfu-
sion and major complication.
Conclusion: Laparoscopic liver resection can be done
safely and effectively with applying a small incision and
HALS for appropriately selected patients. Division of the
Glissonian pedicles and parenchymal transection with
End-linear stapler will reduce volume of blood loss and
shorten operation time decreasing the operator’s stress.
P-735
ORGANIZATION, DEVELOPMENT AND
PERFORMANCE OF AN HPB SURGICAL
UNIT AND LIVER TX PROGRAM IN A
REGIONAL HOSPITAL OF THE
NORTHEAST OF ARGENTINA
C. Candia, O. Imventarza, J. Lendoire, F. Duek,
N. Cejas, S. Paredes, G. Cueto, M. Prochazco, A. Oks,
R. Civilotti, I. Gonzalez and J. L. Decima
HPB and Liver Transplantation Unit - Hospital de Alta
Complejidad Juan D. Pero´n, Formosa, Argentina
Background: In Argentina 54% of the transplantation
programs are localized in Buenos Aires city and suburbs.
No public center for complex HPB surgery was devel-
oped in the northeast region, an area with an inﬂuence of
about 6 000 000 people.
Objective: Analyze the organization and results of a
Hepatopancreatobiliary Surgical Unit and Liver Trans-
plantation Program in a regional hospital in the province
of Formosa.
Methods: The activities initiated in November 2005 with
tutorial capacitation controlled by trained transplant
physicians and nurse coordinator with a continue medi-
cal education system. The aim of the Programme pursues
integration between local and national professionals. All
the activities were supervised by the Educational and
Investigation Department.
Results: Derivation to Buenos Aires centers decreased
from 90% before 2007 to 20% to the present. Al patients
without health coverage are treated in this center. Eighty-
ﬁve percent of the liver resections, 70% of pancreatic
resections and 75% of complex bile duct injuries are
treated in our Unit. All potential candidates evaluated
for liver transplantation remained for treatment in the
center were 55% of the patients transplanted were from
other provinces of the northeast. HPB complex surgery
performed in a two year period were 110 complex sur-
gery, 95 TX evaluations and 20 liver transplants.
Conclusion: A political decision, an equal administration
and an appropriate professional capacitation made pos-
sible development of an HPB and Transplant Unit in a
regional hospital. Universal beneﬁts were the health ac-
cess for the Formosa and Northeast region inhabitants
with less cost, professional capacitation of local physi-
cians and development of different areas from the local
Institution. Social and cultural problems are being
avoided by this strategy in a big country like Argentina.
P-736
EPIDURAL ANALGESIA FOLLOWING
OPEN LIVER RESECTION – SHOULDWE
BE LOOKING FOR AN ALTERNATIVE?
J. R. Revie1, L. Massie1, S. J. McNally1,
D. W. McKeown2, O. J. Garden1 and S. J. Wigmore1
1Division of Clinical and Surgical Sciences (Surgery),
University of Edinburgh, Edinburgh, United Kingdom;
2Department of Anaesthesia, Critical Care and Pain
Medicine, Royal Inﬁrmary of Edinburgh, Edinburgh,
United Kingdom
Background: Epidural analgesia is currently the gold
standard for the provision of pain relief after major up-
per abdominal surgery. Inadequate analgesia and prob-
lems with hypotension leading to excessive prescription
of intravenous ﬂuid may increase the risk of developing
post-operative pulmonary complications, and prolong
recovery.
Aims: To investigate the effectiveness of epidural anal-
gesia following liver resection and compare the effects of
epidural versus no epidural on post-operative course.
Methods: Data were collected retrospectively on 166
patients who underwent liver resection between June
2007 and June 2009. In the analysis of post-operative
course, patients were grouped based on whether or not
they had a functioning epidural at the start of the surgical
procedure. Data are expressed as median (range). Sta-
tistical analysis was performed using SPSS15.0 software.
Results: Epidural insertion was attempted in 145 (87%)
patients and failed in 7 (5%). Of 138 patients who had an
epidural inserted successfully, 24 (17%) required intra-
venous opiate analgesia on the day of surgery (DOS) or the
ﬁrst post-operative day (POD1). Patients receiving epi-
dural analgesia received signiﬁcantly more intravenous
colloid on DOS [820 (0 – 3500) vs. 1500 (0 – 12000) ml;
p = 0.003], and total ﬂuids on DOS and POD1 combined
[5692 (3500 – 11168) vs. 6338 (2150 – 21880) ml;
p = 0.007]. Respiratory complications were more com-
mon in those who received epidural analgesia, compared
with those who did not [11 (8%) vs. 0 patients; p = 0.06].
Discussion: Epidural analgesia provides inadequate post-
operative pain relief in approximately 20% of patients
undergoing liver resection. Its use is associated with sig-
niﬁcantly greater intravenous ﬂuid administration, and
increased risk of developing respiratory complications.
Alternative opiate-sparing analgesic techniques following
major upper abdominal surgery should be explored.
P-737
SPECIALIZED PRE-SURGICAL
ASSESSMENTS IN PATIENTS WITH
HEPATO-PANCREATO-BILIARY
CANCERS: PRELIMINARY RESULTS
H. Molla1, M. Hassanain1,2, P. Metrakos2,
A. A. L. Vigano1, R. D. Kilgour1,3, B. Trutschnigg1,
E. Lucar1, C. Scheede-Bergdahl1,3 and P. Chaudhury1,2
1McGill Nutrition and Performance Laboratory
(MNUPAL), McGill University Health Centre
(MUHC); 2Department of Surgery, MUHC;
3Department of Exercise Science, Concordia University,
Background and aims: Malnutrition in hepatopancre-
atobiliary cancer (HPBC) patients has been associated
with an increased post-operative morbidity and mortal-
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ity. Our aim was to estimate rates of consent and com-
pliance to specialized pre-surgical assessments (SPA) in
patients with HPBC and to identify potential variations
in nutritional and performance characteristics related to
the time of assessment.
Methods: From March to August 2009 consecutive
consenting subjects with resectable HPBC underwent
laboratory evaluation (CBC, CRP, and albumin), dual
energy X-ray absorptiometry (DXA), 3 day food recall,
upper limb muscle strength, and 6 min walk distance at
two separate visits: visit one, 4 weeks pre-operatively and
visit two, 1 week pre-operatively.
Results: Of the 160 newly diagnosed patients with
HPBC, 55 (34%) patients were eligible and 31 (56%)
consented. Of the consented patients, 23 (74.2%) patients
completed visit 1 and 16 (51.6%) completed visit two.
Difﬁculties with transportation, hospitalization, or par-
ticipation in other studies were the main reasons for not
completing visit 2. Patients who completed only visit 1
were similar to those who completed also visit 2. The
latter patients presented with lower WBC counts (5.7 vs.
7.3 ·109/dL, p = 0.045), and covered longer distances
(499 m vs. 478 m, p = 0.045), on visit two as compared
with visit one. Nutritional and strength parameters did
not change signiﬁcantly between the two visits.
Conclusions: This study reveals that the recruitment of
HPBC patients into SPA is feasible and well received.
The results of this SPA do not appear to be negatively
impacted by the pre-operative waiting period. These data
will inform the design of clinical trials to evaluate the
effectiveness of pre-habilitation interventions, in
decreasing post-operative complication.
P-738
THE IMPACT OF SURGICAL
COMPLICATIONS AND READMISSIONS
ON THE SURVIVAL OF PATIENTS WITH
HPB MALIGNANCIES
R. Saidi1 and M. Jacobs2
1University of Massachusetts; 2Providence Hospital
Introduction: There are numerous prognostic factors that
affect surgical outcomes for patients with HPB malig-
nancies. The impact of surgical complications and read-
missions, however, has not been adequately studied.
Methods: Over a ten-year period (1993–2003), 86 patients
underwent surgical resection for cancers of liver, bile duct
and pancreas. The association between surgical compli-
cations and patients survival; was examined through
proportional hazard regression, adjusting for patient and
tumour characteristic. Kaplan–Meier survival; analyses
were performed. Surgery-related readmissions was deﬁnes
as ‘admission within 30 days after initial discharge’.
Results: Out of 86 patients included in the study, 22
(25.5%) had complications and 30 (34.8%) had surgery-
related readmissions. Patient’s data were adjusted for:
age, gender, tumour location, tumour size, stage, grade,
type of operation and comorbidities. Calculation of the
proportional hazard regression demonstrated that surgi-
cal complication and readmission had an independent
negative association with overall survival; hazard ratio
(HR) 1.6 (CI-1.2–2.0) and HR 1.8 (CI-1.2–2.6), respec-
tively. The mean survival for patients with surgical
compilations was 29.4 months (19.5–39.4 months, 95%
CI) compared to 42.8 months (36.7–49.0 months, 95%
CI) for patients without complications (log rank test,
p = 0.0014).
Conclusions: Apart from the immediate clinical conse-
quences, surgery-related compilations and readmissions
have independent negative associations with the survival
of patients with HPB malignancies.
P-739
TRAINING MINIMAL INVASIVE
APPROACHES IN HEPATO-
PANCREATO-BILIARY (HPB)
FELLOWSHIP: CURRENT STATE AND
FUTURE REQUIREMENTS
G. Subhas and V. Mittal
Providence Hospital and Medical Centers, Southﬁeld, MI,
USA
Background: The increasing role of advanced minimally
invasive procedures in HPB surgery necessitates an HPB
fellowship that provides expertise in both minimally
invasive and open surgery. Although the IHPBA requires
a minimum of 25 cases of each HPB procedure to grad-
uate from an HPB fellowship, no minimum exists for
laparoscopic cases.
Objective: To evaluate fellowship training in minimally
invasive techniques.
Methods: A 14 question electronic survey was sent to 82
worldwide HPB fellowship program directors.
Results: 49% (N = 40) of the program directors res-
ponded. The programs were predominantly university
based (83%, 33/40). 55% of these programs had a trans-
plant service. Programs had either one fellow (55%) or
two fellows (40%) each year. Fellowships lasted one
(45%) or two years (40%). 4–6 faculty members with
formal HPB training were found in 45% of programs.
Programs (35–48%) had average annual volumes of 51–
100 hepatic, 51–100 pancreatic and 25–50 biliary cases.
For many programs,< 10%of hepatic (48%), pancreatic
(40%) and biliary (70%) cases were done laparoscopi-
cally. The average annual fellow case volumes for hepatic,
pancreatic and biliary surgeries were 25–50 (62%), 25–50
(47%), and < 25 (50%). The average annual number of
hepatic, pancreatic and biliary cases done laparoscopi-
cally by a fellow was 9.2, 9.6, and 3.8, which constitutes
37%, 38%, and 15%, respectively, of the IHPBA
requirement. Only some programs were performing ro-
botic (40%) and natural oriﬁce (23%) surgeries.
Conclusions: The low average number of surgeries per-
formed by minimally invasive techniques by fellows is not
sufﬁcient in today’s practice. Should there be an increase
in the minimal number of hepatic, pancreatic and com-
plex biliary cases to 50, 50, and 25, with at least 50% of
these performed laparoscopically? Attempatients should
be made at increasing exposure to robotic and natural
oriﬁce surgeries.
P-740
HPB SURGERY AND TRANSPLAN-
TATION, A DEFINED SUB-SPECIALTY,
INTEGRATED WITHIN THE SURGICAL
DIVISION: PROFESSIONAL, OPERATIVE
AND EDUCATIONAL ASPECTS
M. Ben-Haim, R. Nakache and J. Klausner
Tel Aviv Sourasky Medical Center
Introduction: Establishment of Hepato-Pancreato-Bili-
ary (HPB) surgery and abdominal organ transplantation
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as deﬁned sub specialties of general surgery has been
boosted over the last decade. However, the afﬁliation
(independent service vs. integration within the division of
surgery), the training course (transplantation vs. surgical
oncology) and the referral patterns are still controversial.
Methods: Dedicated HPB and transplantation units were
deﬁned within the surgical division of Tel Aviv Medical
Center. The principals of operation included multidisci-
plinary expert’s teams, uniﬁed and standard treatment
protocols, exposure and involvement of all residents and
attending surgeons of the division to patients, decision
making and peri-operative care, peer review and periodic
publication of clinical results.
Results: Between 2003–2007, 870 major HPB cases were
performed: 70 liver transplants (9 from live donors), 100
organ procurements, 165 kidney and kidney-pancreas
transplants (30% from live donors), 250 hepatic resec-
tions of various types and indications, 35 complex biliary
reconstructions and 250 pancreatectomies. The short-
(morbidity and mortality) and long-term (survival and
disease free survival) rates are compatible with the re-
ported results from centers of excellence around the
world.
Conclusions: Operating HPB and transplantation sur-
gery by trained experts and deﬁned professional units,
but within an academic surgical division, promotes the
achievement of high volume and excellent results
together with optimal exposure, education and training
of the surgical residents.
P-741
HEPATOBILIARY AND PANCREATIC
SURGERY QUALITY ASSESSMENT
ACCORDING TO ACS-NQSIP
STANDARDS, AT A REGIONAL CENTER
IN CHILE
H. Losada1,2,3, C. Mun˜oz1,2, J. Contreras1,2,
L. Burgos San Juan1,2, J. Silva1,2,3 and M. Cuminao2
1Pancreatic and hepatobiliary surgery team. Surgery
Departement. Hospital Dr. Herna´n Henrı´quez
Aravena.Temuco; 2Surgery Department.Universidad de La
Frontera.Temuco; 3Surgery Department. Clı´nica Alemana
de Temuco
Introduction: The American College of Surgeons Na-
tional Surgical Quality Improvement Program (ACS-
NQSIP) was found in 2004 as an initiative to bring to-
gether the quality standards in surgery. Our goal is to
evaluate the results of three surgical procedures in pan-
creatic and hepatobiliary surgery, based on operative
morbidity and mortality, according to the ACS-NQAIP
standards.
Materials and method: Study Design: Cross sectional
study. Study Period: January 2000–2008.Inclusion crite-
ria: Patients surgically treated by the hepatic and biliary
surgery team. The procedures selected for the assessment
are: Segmentary hepatectomy (SH), Roux-Y hepati-
cojejunostomy (RHJ) and pancreaticoduodenectomy
without pylorus preservation (DP). Maneuver: The pa-
tients’ clinical records were evaluated. The general vari-
ables and the presence of morbidity and/or mortality
related to surgery were recorded. The results are com-
pared to the ones reported by ACS-NQSIP. Statistical
analysis: For the data analysis a descriptive statistics was
used, along with central tendency and scatter measures.
The analytic statistics was applied to categorical and
continuous variables in the STATA 9.0 program.
Results: During the study period, 104 surgeries were
performed and these were considered within the evalu-
able data. The surgeries are distributed in: 49 HS, 28
RHJ, and 27 DP. The general hospital morbidity was
22.4%, 26.9%, and 17.8%, respectively. The ACS-
NQSIP reported and expected morbidity rate is 26.4%,
44.2%, and 38.3%. The hospital mortality was 0%, 4%,
and 6% in the three assessed interventions, the reported
ACS-NQSIP mortality was 2.2%, 3.5%, and 4.7%.
Conclusion: The hospital morbidity is reported with
numbers comparable to the ones reported by the ACS-
NQSIP. Concerning the hospital mortality, this rate is
comparable in HS and RHJ, and is greater in DP. The
beginning of this program can be useful in the quality
control of pancreatic and hepatobiliary surgery centers in
Chile.
P-742
A LAPAROSCOPIC CADAVER TRAINING
FACILITY FOR CLINICAL LAPARO-
SCOPIC LIVER RESECTION PROGRAMS
S. White1, J. French1, I. Tait2, G. Sen1, R. Saif1,
B. Jaques1 and D. Manas1
1Freeman Hospital, Newcastle upon Tyne; 2Ninewells
Hospital and Medical School, Dundee
Introduction: At the recent International Consensus
Conference on Laparoscopic Liver Surgery held in
Louisville in November 2008 discussions focused on
regulating and certiﬁcation of training in laparoscopic
liver surgery. The authors would like to present their
experience of using a dedicated cadaver laparoscopic
training facility for clinical laparoscopic liver resection.
Methods: The laparoscopic training facility is part of the
national drive providing courses facilitated by a faculty
of experienced, advanced laparoscopic surgeons provide
an intensive 2 day course of lectures, debate, exchange
and practical hands on with a live link to clinical lapa-
roscopic liver resection operations. Participant evalua-
tion and feedback for each course was analysed as well as
the evolution of the clinical laparoscopic liver program.
Results: After four courses (2007–2009) and training of
32 participants, scores were graded from one (poor) to six
(excellent no improvement). The course was graded for
content, structure, delivery, resources, facility and value
for money. All courses met the expectations of all par-
ticipants. The overall rating for cadaver teaching sessions
scored as follows score six (43%), score ﬁve (32%) and
score four (25%). During this time period our laparo-
scopic liver resection series has evolved to include 43
patients (18 male: 24 female) mean age 63 years (range
32–81 years) with four conversions to open, three pro-
cedures were laparoscopic assisted early in the series.
Types of procedure have included both totally laparo-
scopic and hand assisted resections. Types of resection
included wedge resections (n = 18), left lateral resections
(n = 16), left hepatectomy (n = 6) and right hepatec-
tomy (n = 3).
Conclusion: A dedicated cadaver laparoscopic liver
resection facility provides a unique training opportunity
for laparoscopic liver surgeons. A wide variety of resec-
tions and relevant techniques can be taught prior to
introducing a clinical program.
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P-743
APPLICATION OF GLOBAL OPERATIVE
ASSESSMENT OF LAPAROSCOPIC
SKILLS IN A TRAINER BOX SETTING
W. Mohammad1, D. Trottier1, J. Nadolny2,
M. Labrosse2, K. Tardioli2, E. Poulin1, J. Mamazza1,
R. Fairfull-Smith1, R. Mimeault1, H. Moloo1 and
F. Balaa1
1The Ottawa Hospital - University of Ottawa; 2University
of Ottawa
Background: Although the Global Operative Assessment
of Laparoscopic Skills (GOALS) instrument has been
validated as an intra-operative evaluation tool, it has not
been validated in a simulated environment.
Objective: Determine the face validity, inter-rater reli-
ability, and construct validity of the GOALS instrument
in a simulated ex-vivo laparoscopic cholecystectomy
model.
Methodology: A platform was designed for performing
laparoscopic cholecystectomy on an ex-vivo porcine en-
bloc liver/gallbladder model through a collaborative ef-
fort between the Departments of Surgery and Biomedical
Engineering. Subjects were divided into a junior (PGY 1/
2) and senior group (PGY 4/5). Each trainee performed a
video recorded dissection of the gallbladder. Two blinded
evaluators were asked to view and assess performances
using GOAL. Construct validity was assessed by com-
paring the mean scores for the two groups using an un-
paired t-test and a Mann–Whitney test was used for
sensitivity analysis. Internal consistency for each of the
domain scores was assessed using Cronbach’s alpha.
Trainees completed a post-procedure survey.
Results: Twenty subjects were divided into a junior
(n = 10) and senior group (n = 10). Comparison of
GOAL scores demonstrated a signiﬁcant difference
(mean difference 5.0, 95% CI (1.7, 8.2); p = 0.005). The
t-tests results were signiﬁcant for each of the domains
except for ‘Tissue Handling’. Seventy-ﬁve percent of
trainees strongly agreed ‘that practice on this model
would be relevant to their training as a general surgeon’,
and 80% strongly agreed that ‘repeated practice on this
model would be a productive use of time for a junior
general surgery resident’. Inter-rater reliability between
the evaluators was good (0.73).
Conclusion: The GOALS instrument can be applied to
this model with reasonable construct validity and inter-
rater reliability. The ex-vivo laparoscopic cholecystec-
tomy model as a teaching tool was very well received by
the surgical trainees.
P-744
SIGNIFICANCE OF THE HYPERTROPHY
CONCEPT IN A HEPATOBILIARY
CENTRE
J. R. Stavrou and K. J. Oldhafer
Department of General, Visceral and Thoracic Surgery,
Celle General Hospital
Background: R0 resection is still the most effective
therapy for liver tumours. Technical feasibility, size and
function of the remnant liver are determining resect-
ability. One strategy to augment the remnants he
hypertrophy concept. The portal vein of the tumour
bearing side is either ligated or embolized to induce
hypertrophy in the future remnant. Three hundred and
forty three liver resections were retrospectively analyzed
to detect the method’s signiﬁcance in enhancing resec-
tions in a HPB center.
Materials and Methods: Analysis was based on our
prospective database. All patients undergoing either
portal ligation or embolization were included. For com-
parison patients receiving hemi hepatectomies and ex-
tended hepatectomies were also analyzed.
Result: Between 03/2002 and 08/2009. We performed 343
liver resections in our department, mostly because of
CRLM (157/343, 46%). 106 (30%) patients received
hemihepatectomy (R 74: L32), in 54 (16%) cases ex-
tended resections were necessary (eR 33: eL17: MesoH
4). In case of expected small remnant virtual operation
planning with MeVis Software was used. After that, a
hypertrophy concept was only necessary in 11 patients
(17% of the small remnant group, 3% total). 6 patients
had their portal vein ligated, 5 patients embolized. In 7/
11 (63%) patients the concept lead to resection (3/6 PVL,
4/5 PVE). No patient developed liver insufﬁciency.
Conclusion: The hypertrophy concept can effectively
enhance resection rates. In many cases the added
information of virtual operation planning allows resec-
tions without having to use the concept with its own
morbidity. The hypertrophy concept should be available
in a HPB center, though it was only useful in 3% of our
cases.
P-745
CO-LOCALISATION OF A HIGH-
VOLUME LIVER SURGERY SERVICE
WITH PANCREATIC SURGERY IS
BENEFICIAL FOR OUTCOME:
TOWARDS OPTIMAL DESIGNATION
OF HPB CENTRES
P. Petras, A. J. Sheen and J. R. Siriwardena
Hepatobiliary surgery Unit, Manchester Royal Inﬁrmary,
Manchester UK
Background: It is accepted that high-volume improves
outcome in HPB surgery, however the optimal co-local-
ization of liver and pancreatic surgery services (with or
without organ transplantation) remains uncertain. This
report outlines the inﬂuence of the development of high-
volume liver surgery (and its related infrastructure) on
outcome of pancreatic cancer surgery.
Methods: Patients referred to a regional HPB service for
treatment of either hepatic colorectal metastases
(HCRM) or pancreatic cancer is divided into two equal
time periods: Group A comprises patients from 2003–
2005 and Group B comprises patients from 2006–2009.
The second period included the implementation of a
sophisticated protocol-driven management algorithm for
liver surgery characterized by pre-operative 18FDG-PET,
high-resolution primovist MR, intra-operative ultraso-
nography and latterly CPET (cardiopulmonary exercise
testing). CPET, MR and IOUS are also used in pancre-
atic cancer surgical cases. The principal endpoint is sur-
gical outcome as measured by in-hospital, all-cause death
after operation.
Results: During period 60 patients under went hepatic
resection for HCRM with an operative mortality of
four (6.6%) and 46 patients underwent pancreatico-
duodenectomy with three deaths (6.5%). In period B
there were 251 liver resections with four deaths (oper-
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ative mortality 1.6%; P < 0.01 vs. group A, Mann–
Whitney U–test] and 120 pancreaticoduodenectomies
with three deaths (2.5%) [P < 0.01 vs. group A;
Mann–Whitney U–test].
Conclusion: It is accepted that improvement in outcome
is likely to be multi-factorial. However, the development
of high-throughput liver surgery with an emphasis on
high quality staging and contemporary peri-operative
risk assessment appears to be associated with an
improvement in outcome of pancreatic cancer surgery.
These data support co-localization of liver and pancreas
cancer surgery as beneﬁcial to both disease types.
P-746
THE HPB CLINIC – DO PATIENTS WANT
A COPY OF THEIR CLINIC LETTER?
R. Saif, I. Ansari, G. Sen, M. Jacob, S. Robinson,
D. Manas and S. White
Department of Hepatobiliary and Pancreatic Surgery,
Freeman Hospital, Newcastle upon Tyne, United Kingdom
Background and aims: The Department of Health
guidelines recommend that all patients should be offered
a copy of their clinic letter to increase patient involve-
ment in their care. The concern is that a blanket rec-
ommendation to copy letters to all patients might not
take into account patients with advanced malignant dis-
ease who are still adjusting to the reality of their illness.
The aim of this study was to compare patients’ attitudes
towards their Hepatopancreato-biliary (HPB) clinic letter
with respect to both benign and malignant conditions.
Methods: A 15-item questionnaire designed to evaluate
patient views was handed out to all patients at their ﬁrst
follow-up appointment in the HPB clinic. This ques-
tionnaire had been validated in other surgical specialities.
The ﬁrst 100 completed questionnaires were evaluated.
Results: The majority of patients in both groups (77%
malignant, 86% benign) accepted a copy of their letter at
their ﬁrst clinic visit. There was no difference in under-
standing the content of the letter between the two groups
(48% vs. 50% - all content, 36% vs. 38% - most of the
content, 16% vs. 12% - some of the content). 78% in the
malignant group and 82% in the benign group (p = ns,
Chi-square) did not feel that the contents of the letter
made them worry more about their condition. Only 16%
(n = 8) in the malignant group did not wish to receive
any further correspondence compared to 12% (n = 6)
(p = ns, Chi-square) in the benign group.
Conclusion: This survey conﬁrms that most patients
want to receive copy of their clinic letter and ﬁnd it very
useful. There is no signiﬁcant difference between atti-
tudes of patients based on the underlying diagnosis. The
beneﬁts of copying letters should be recognised and the
process welcomed voluntarily rather than responding to
an imposed directive.
P-747
WHEN WERE HEPATO-PANCREATO-
BILIARY SURGERY ARTICLES
INCREASED? A BIBLIOMETRIC
ANALYSIS OF AN EMERGING
SPECIALTY
O. Guevara1,2, J. Eslava-Schmalbach1, G. Buitrago1,
D. Ovalle1 and J. Belghiti3
1Department of Surgery-Clinical Research Institute,
National University of Colombia, Bogota, Colombia;
2National Institute of Cancer, Bogota, Colombia;
3Department of HepatopancreatoBiliary Surgery and
Liver Transplantation, Beaujon Hospital, University Paris
7, Paris, France
Background: Hepato-Pancreato-Biliary surgery (HPB) is
a relatively young specialty, with a growing ﬁeld. HPB
publications could be an indicator of his expansion, but
has not been well studied when they began to increase.
Aim: To know when HPB surgery was signiﬁcantly in-
creased on the surgical literature.
Methods: A bibliometric study was performed, searching
in PubMed database, from 1966 to 2008. Annual HPB
surgical articles were found using MeSH terms related
to HPB surgical procedures. Total surgical articles were
found using MeSH term ‘Surgical procedures, opera-
tive’. Then, the proportion of HPB articles from total
surgical articles was calculated. A time series analysis was
performed with this proportion, and the effect of 1982-
1987 articles was evaluated by an interrupted time series
analysis (SAS for Windows v. 9.0). To increase the
speciﬁcity, a manual search was performed in Annals of
Surgery, and the proportion of HPB articles from total
original articles was calculated from 1970 to 2008.
Results: In PubMed, a 107% relative increase in HPB
articles was found in the period 1987-1993. Interrupted
time series analysis showed a statistically signiﬁcative
intervention at 1982, with a positive effect since 1987 to
1993 (estimated effect 0.497, p = 0.0006) (ﬁgure1). In
Annals of Surgery, the HPB articles proportion grew
from 10.7% in the period 1970–1979, to 21.4% in 1980–
1989, 29.5% in 1990-1999 and 26.7% in 2000-2008.
Discussion: A signiﬁcative increase in HPB surgical lit-
erature started in 80’s, continued in 90’s and reached a
plateau in 21stcentury.
P-748
DOES SURGERY CONFIRM
CT-ANGIOGRAPHY DATA FOR
CELIACO–MESENTERIC ARTERIAL
ARCHITECTURE?
V. Egorov, N. Yashina, A. Fedorov, V. Vishnevsky,
G. Karmazanovsky and T. Shevchenko
1The Vishnevsky Institute of Surgery, Moscow
Background: It is important to recognize arterial variants
in preoperative planning for extended pancreatic or
multi-visceral resections. A limitation of the majority of
CT-angiographic (CTA) studies of celiac–mesenteric
arterial anatomy (CMAA) is the absence of surgical
conﬁrmation of the accuracy of CTA ﬁndings.
Aim: Assessment of CTA data accuracy in detecting
CMAA variants.
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Methods: Abdominal CTA of 310 patients during rou-
tine CT examinations before major pancreatic or hepa-
tobiliary surgery were performed on a 64- and 256-
MDCT scanner. Variants of CMMA were documented
as 3D reconstructions and were compared in 57 cases of
extended pancreaticododenectomy (EPD), distal pan-
createctomy (EDP) and multi-visceral resections radio-
logical data and operative photographs.
Results: Fifty-seven percent of patients had classic arte-
rial anatomy identiﬁed at CTA. The most common
variants were replaced right hepatic artery originating
from the superior mesenteric artery (13.4%) and replaced
(5%) or accessory (12%) left hepatic artery originating
from the left gastric artery. According to a comparison of
operative photographs and 3D CTA reconstructions,
CTA demonstrated 100% accuracy in identifying
CMMA variants.
Conclusion: 1. The CMMA variant is fairly common and
is of great surgical signiﬁcance in EPD, EDP or multi-
visceral resection planning. 2. Radiological ﬁndings were
fully corroborated by operative data, which means that
CTA is a powerful and reliable tool for the identiﬁcation
of unusual CMMA variants.
P-749
ROLE OF 18 F-FLUORODEOXY-
GLUCOSE POSITRON EMISSION
TOMOGRAPHY IN DETECTING
PANCREATIC LESION
E. Jafarimehr1, D. L. Lilien2, G. B. Zibari1 and
H. Shokouh-Amiri1
1Department of Surgery, Louisiana State University
Health Sciences Center, Shreveport, Louisiana;
2Department of Radiology, Louisiana State University
Health Sciences Center, PET Imaging Center, Biomedical
Research Foundation of Northwest Louisiana, Shreveport,
Louisiana
Background: Long-term survival in patients (patients)
with pancreatic cancer is rare, but radical surgery plus
adjuvant therapy may give good results in carefully se-
lected patients. Several imaging modalities (CT, MRI,
MRCP, EUS) are used to assess operability, but more
recently Fluorodeoxyglucose PET and PET/CT (FDG
PET) have been used for staging to optimally select pa-
tients who can beneﬁt from these major treatments. To
date, no large studies of the efﬁcacy of FDG PET has
been published.
Aim: To evaluate the diagnostic accuracy of FDG PET
in patients with known or suspected pancreatic pathol-
ogy.
Method: This is an IRB approved retrospective review of
charts of 76 patients (40 female, 54 Caucasian) with
pancreatic lesion who had PET (n = 18) or PET/CT
(n = 58) as part of initial evaluation between 2001–
2009.PET ﬁndings were compared with intraoperative
ﬁndings and ﬁnal pathologic diagnosis.
Result: Fifty-four patients had malignancy. FDG PET
was positive in 47 patients, negative in 29 patients. Sen-
sitivity was 85%, speciﬁcity 91%, accuracy 87%, positive
predictive value 96%, and negative predictive value 72%.
There were 8 false negative (FN) and two false positive
(FP) studies. Of eight FN four had tumour size less than
2 cm, one had mucinous adenocarcinoma and one had
activity along stent felt due to inﬂammation. In two cases
no explanation was identiﬁed. Among two FP, one had
pseudopapillary tumour and the other had inﬂammatory
change along stent. Among 29 PET negatives, which ﬁ-
nally underwent major surgery, the ﬁnal pathology
proved to be benign in 21 patients.
Discussion: Due to lack of reliable diagnostic tool,
whipped resection has been done though in smaller
number for changes in pancreatic head which later on
proved to be unnecessary. We have demonstrated that
FDG PET accurately diagnosed 21 out of 29 of patients
with benign pathology. These patients could have
undergone less invasive surgeries.
Conclusion: FDG PET is a very valuable and accurate
diagnostic tool in work up of patients with pancreatic
lesion.
P-750
USEFULNESS OF PET/CT IN
DISCRIMINATING BETWEEN BENIGN
AND MALIGNANT IPMNS
K. Ohta, M. Tanada, T. Inoue, N. Teramoto, H. Iguchi
and A. Kurita
Shikoku Cancer Center
Now international consensus guidelines for management
of intraductal papillary mucinous neoplasms (IPMNs)
and mucinous cystic neoplasms of pancreas are revealed
criteria of surgical decision making but it is still difﬁcult
to judge necessity of resection. We use positron emission
tomography/ computed tomography (PET/CT) to dis-
tinguish benign from malignant IPMNs. We evaluated
the usefulness of PET/CT in discriminating between
benign and malignant IPMNs. From January 2006 to
December 2008, 21 patients with suspected IPMNs were
investigated 18-ﬂuorodeoxyglucose (FDG) PET/CT. 10
patients who were considered benign were put on follow-
up. All of them were branch duct IPMNs and asymp-
tomatic. Mean diameter was 32 mm (range 14–75 mm)
and main pancreatic duct dilatation was recognized one
patient and mural nodule, one. None of them were
showed uptakes of FDG. They were followed from 16 to
28 months. None showed malignancy and substantial
changes in the radiological appearance of their lesions. 11
patients underwent resection. 9 were symptomatic (six
epigastralgia and three diabetic deterioration) Mean
diameter was 29 mm (range 12-70 mm). There were main
duct IPMNs (n = 1), brunch duct (n = 8), and mixed
IPMNs (n = 2). PET/CT showed invasive carcinoma
with IPMNs (n = 3), carcinoma in situ (n = 4), and
benign IPMNs (n = 4). Uptakes of FDG were detected
in seven patients (invasive carcinoma and carcinoma in
situ). Pathological ﬁndings showed seven malignant
neoplasm: 5 invasive carcinomas and three carcinomas
in situ. three patients were proven benign IPMNs. All
patients with uptakes of FDG had malignant neoplasms
and 4 FDG-negative patients were one carcinoma in situ
and three benign IPMNs. Only one case was false
negative. Thus, PET/CT is useful in discriminating
between benign and malignant IPMNs and seems to be
conventional imaging techniques in selecting IPMNs
patients for surgical treatment or follow-up.
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P-751
ROLE OF FDG-PET/CT AS
PREOPERATIVE PROGNOSTIC TOOL IN
PANCREAS ADENOCARCINOMA
M. Marcello , H. Dura´n, P. Galindo, R. Conradi,
E. Esteban, C. Loinaz, M. Idrovo, N. Sa´nchez-
Ferna´ndez, L. Garcı´a Can˜amaque, P. Alonso del Caso,
Y. Quijano and E. Vicente
Madrid-Norte-Sanchinarro Hospital /Clara Campal
Oncologic Center (CIOCC) / Faculty of Medicine, San
Pablo CEU University. Madrid, Spain
Background: FDG-PET/CT is increasingly being used
for tumour characterization and staging.
Aim: To assess FDG-PET/CT value as a prognostic tool
in pancreatic carcinoma.
Material and methods: A retrospective study was per-
formed on 28 patients with diagnosis of pancreatic ade-
nocarcinoma who underwent R0 resection. Preoperative
SUV was compared to known bad-prognosis pathologi-
cal ﬁndings: histological grade, vascular and perineural
involvement, lymph node metastases and tumour size. A
bivariate statistical analysis (t- student and Mann–
Whitney tests for numerical variables and Chi square for
qualitative ones) was performed.
Results: Twenty-ﬁve patients with positive preoperative
PET/CT had ductal adenocarcinomas and underwent
radical resections. Vascular resections were performed in
15 patients: 11 SMV resections, two celiac axis resections,
one hepatic artery resection and two SMV and hepatic
artery combined resection. Mean SUV was 5.57 (range 0–
12.87). SUV in well-differentiated adenocarcinomas (8)
was 3.63, in moderately-differentiated adenocarcinomas
(15) was 6.14, and in poorly-differentiated (2) was 9.03
(P < 0.005 in well and moderately-differentiated le-
sions). No statistically signiﬁcative differences in SUV
value were found when vascular involvement (5.41 vs.
5.85), perineural spread (5.49 vs. 6.43), size > 4 cm
(6.235 vs. 4.87), pathologic conﬁrmation of venous
involvement (5.28 vs. 5.66), pathologic conﬁrmation of
arterial involvement (5.19 vs. 5.58) or TNM stage were
studied.
Conclusions: A statistically signiﬁcative relationship be-
tween SUV and bad-prognosis pathologic factors could
not be found except for histological grade, but our series
showed a lineal progression between SUV and TNM
stage, and a SUV over the mean correlated with size
larger than 4 cm, lymph node metastases and higher
stages (IIb-III). In our series, a higher SUV could cor-
relate to worse prognosis. A higher number of patients
could lead to statistical signiﬁcance.
P-752
DIFFUSION-WEIGHTED MAGNETIC
RESONANCE IMAGING AS A TOOL IN
THE DIFFERENTIATION OF CYSTIC
LESIONS OF THE PANCREAS – A
PROSPECTIVE STUDY
V. Schraibman, S. Goldman, A. Goldenberg, E. Lobo,
N. Abdala, T. Abud, G. Demarchi, A. Gonzalez,
M. Linhares, A. Jakowsky and J. Szejnfeld
Federal University of Sa˜o Paulo, Brazil
Introduction: In the last years with the increasing number
of cross sectional imaging examination a higher number
of pancreatic cysts have been incidentally identiﬁed. Few
studies evaluated the use of diffusion magnetic imaging in
pancreatic cystic lesions and none has established the
value of it.
Objective: To establish if diffusion magnetic resonance
imaging (DWMRI) can be used as a tool to differentiate
mucinous from non mucinous pancreatic lesions.
Methods: Fifty six patients with pancreatic cystic lesions
were prospectively evaluated with DWMRI in order to
differentiate mucinous from non mucinous lesions. All
patients had pathological proof conﬁrmation by surgery
or cyst aspiration, or follow up for a minimum of
24 months in cases that do not required intervention.
Results: Analysis from DWMRI when comparing
mucinous and non mucinous lesions showed sensibility of
80% and speciﬁcity of 98%, P < 0.01 (analysis power:
1.0). When comparing non mucinous lesions DWMRI
presented sensibility of 100% and speciﬁcity of 80%.
Conclusion: DWMRI can be included as part of the
organogram to differentiate mucinous from non mucin-
ous lesions and can help management of cystic pancreatic
lesions.
P-753
SINGLE INSTITUTION EXPERIENCE OF
215 PATIENTS COMPARING ACCURACY
OF ENDOSCOPIC ULTRASOUND WITH
SUBSEQUENT PANCREATIC SURGERY
C. Boutros1, E. Genova1, M. Haniff2, N. Toubia3,
P. Somasundar1 and N. J. Espast1
1Division of Surgical Oncology, Roger Williasm Medical
Center; 2Department of Internal Medicine, Roger
Williams Medical Center; 3Division of Gastroenterology,
Roger Williams Medical Center
Background: No consensus has been reached between the
accuracy of pancreatic endoscopic ultrasound (EUS) and
subsequent surgery.
Aim: To investigate the accuracy of EUS and analyze
factors associated with subsequent pancreatic surgery.
Methods: Using IRB approved prospectively maintained
data base all patients undergoing pancreatic EUS over
20 months in a single institution were reviewed. Demo-
graphics, pathological features, EUS diagnosis and FNA
cytology results were assessed. In patients undergoing
pancreatic surgery, ﬁnal pathology was compared to
EUS diagnosis.
Results: About 215 pancreatic EUS patients were in-
cluded. EUS was aborted in 9. In 206 completed EUS, no
pancreatic lesion was identiﬁed in 65. These patients were
younger (59.2 ± 16 vs. 66.4 ± 14.1, P < 0.05) com-
pared to other patients. In 93, EUS revealed a cystic le-
sion (CL); FNA rate 45%. 12 with EUS identiﬁed
CL had surgery; CL size was larger in the surgical group
(3.4 cm ± 1 vs. 2.1 ± 1.7,P < 0.05) compared to the
non surgical CL group, however there was no difference
in the age, sex, BMI or FNA rate between the two
groups. In 48 EUS revealed pancreatic mass (PM); FNA
rate 62%. 16 EUS identiﬁed PM received surgery. These
patients had higher FNA rate (75% vs.31%, P < 0.05)
but had no difference in age, sex, BMI and mass size
compared to the non surgical PM lesion group. 28
underwent surgery. Compared to the non surgical group,
surgical group was older (69.8 ± 12.4 vs. 63.3 ± 15.3,
P < 0.05) but had no difference in sex, BMI, mass size
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and FNA rate. Compared to the ﬁnal pathology diag-
nosis, the accuracy of the EUS diagnosis was 74% with
or without FNA. For surgical patients with ﬁnal
pathology revealing pancreatic cancer the sensitivity and
speciﬁcity of EUS was 88.8% and 100%, respectively.
Conclusion: Routine EUS can preclude surgery in 31%
of presumed pancreatic lesions. Sex, BMI and mass size
were not associated with a higher surgical rate. FNA did
not affect the accuracy of EUS diagnosis.
P-754
CONTRAST ENHANCED ULTRASOUND
IN THE DIAGNOSIS OF PANCREATIC
TUMOURS
F. Loria1, G. Loria1, S. Basile1, G. Crea1, L. Frosina2
and S. Cantoni3
1Department of Radiology Palmi Hospital ASP 5 Reggio
Calabria; 2Facolta` di Medicina Universita` di Messina;
3Department of Radiology Ospedale S.Martino Genova
Contrast-enhanced ultrasound (CEUS) is a new imaging
method for detection and characterisation of pancreatic
tumours. WE prospectively evaluated CEUS for charac-
terisation of undetermined solid pancreatic tumours. A
total of 112 solitary undetermined pancreatic mass, 70
ductal adenocarcinoma and 42 nodules of other origins
(mass-forming pancreatitis, neuroendocrine and cystic
tumours, non-neoplastic nodules), were prospectively
examined in patients without metastatic disease using
CEUS. Tumour-enhancing features were analyzed in
comparison to the surrounding parenchyma. The sign of
iso-hypervascular of non ductal-adenocarcinoma showed
a sensitivity of 100%, speciﬁcity of 90% and accuracy of
93.8%. The sign of hypovascularity as a sign of ductal
adenocarcinoma showed a sensitivity of 90%, speciﬁcity
of 100% and an accuracy of 93.8%The differentiation of
pancreatic tumours is important for therapeutic planning
and for the evaluation of the prognosis but this is difﬁcult
with current imaging techniques, even when a combina-
tion of various diagnostic procedures is employed.
Although histology is the standard reference. Neoplasms
of the pancreas tend to have a characteristic vasculari-
zation based on angiographic pattern: adenocarcinomas
are often hypovascularized as compared to surrounding
tissue, neuroendocrine tumours are hypervascularized,
mass forming pancreatitis have a different pattern
depend on the degree of inﬂammation. The successful
treatment of pancreatic tumours requires highly sensitive
and speciﬁc diagnostic procedures. CEUS, based on
angiographic pattern, may satisfy this requirement and
can be used with high diagnostic accuracy for differen-
tiation of pancreatic tumours.
P-755
DIAGNOSTIC UTILITY OF EUS-GUIDED
FNA FOR DIAGNOSIS OF
S. Hijioka1, K. Yamao1, A. Sawaki1, K. Hara1,
N. Mizuno1, H. Imamura1, Y. Senda2, T. Sano2,
Y. Shimuzu2 and Y. Nimura3
1Department of Gastroenterology, Aichi Cancer Center
Hospital; 2Department of Gatroenterological Surgery,
Aichi Cancer Center Hospital; 3Aichi Cancer Center
Hospital
Background: The value of endoscopic-guided ultrasound
ﬁne needle aspiration (EUS-FNA) is recognized, but its
precise ability to safely diagnose gallbladder (GB) mass
lesions is unknown.
Objective: To assess the utility and safety of EUS-FNA
in the evaluation of gallbladder mass lesions.
Methods: We retrospectively evaluated records from 12
patients (mean age, 65 ± 8.8 years) who underwent
EUS-FNA for GB mass lesions determined by US or CT
between March, 1997 and August, 2009. In seven cases,
unresectable gallbladder carcinoma was suspected and
the aim of puncture was to obtain histologic evidence
before management. In four of them, intra-abdominal
lymph nodes were detected and initially punctured but
were negative for carcinoma. In another ﬁve cases xan-
thogranulomatous cholecystitis (XGC) was suspected but
could not be distinguished from gallbladder malignancy.
Results: In the 7 unresectable carcinomas, EUS-FNA
revealed adenocarcinoma in six of them and cellular
atypia in one cases only. All these seven cases received
chemotherapy with a median survival of 294.3 days. In
the ﬁve suspected XGC cases, EUS-FNA was insufﬁcient
in one case (XGC was proved by extended hepatectomy)
and no malignancy was found in four cases (in three of
them, foam cells were found and followed-up for a
median observation period of 1008 days and in one case
simple cholecystectomy was done). EUS-FNA samples
were sufﬁcient in 83.3% with accuracy, sensitivity, spec-
iﬁcity ﬁgures of 91.6%,85.7%, 100%, respectively. No
serious complications were reported.
Conclusion: EUS-FNA of GB masses was safe and
effective for differentially diagnosing malignancy and
XGC. Therefore, evaluative EUS-FNA should be con-
sidered when malignancy is clinically suspected.
P-756
DUODENAL DYSTROPHY: RADIOLOGY
DIAGNOSIS AT THE STAGES OF
SURGICAL TREATMENT
Y. Stepanova
A.V. Vishnevsky Institute of Surgery
Unusual localization of pancreatic tissue, which has its
own blood supply and ductal system without any
vascular, nervous or anatomical contact with usually
located (orthotopic) pancreas, is ectopy or heterotopy of
the pancreas. Duodenal dystrophy (DD) - a chronic
inﬂammation of pancreas, ectopied in the duodenum
wall. Cystic and solid variants of DD depend on the
prevalence of ﬁbrosis or cystic changes.
Goal: To determine the possibility of radiology in diag-
nosis of DD.
Materials and methods: The data of 19 patients (16 men,
3 female) with DD (aged 25-65 years) was retrospectively
evaluated. Disease duration ranged 1–14 years. Preop-
eratively diagnosed was the next: the cystic form of DD -
in 16 (84.2%) cases, gastrointestinal stromal tumour - in
1, chronic pancreatitis with a primary lesion of pancreatic
head - in 2.
Results: DD was typical in 18 (94.7%) cases, in 1 -
atypical (signiﬁcant ﬁbrocystic lesion in the duodenum
wall and defeat only the lower part of the pancreatic
head).
The radiology diagnostic criteria of DD cystic forms:
thickening of the duodenum wall with cystic formation/
formations; duodenal stenosis; absence of the blood ﬂow
in the formation’s septa and capsule. Location of the
artery gastroduodenitis to the right of formation is the
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main differential diagnostic criterion for the DD local-
ization in duodenum wall.
All patients were operated on. In two (10.5%) cases
intraoperation US used during the operations, which
data identiﬁed the course of surgical intervention.
Conclusion: Radiology allows diagnosing DD. Intraop-
eration US made it possible to select adequately surgical
interventions.
P-757
THE ROLE OF US AND MRI IN
DIAGNOSING PANCREATIC
PATHOLOGIES
F. Kurti1, F. Bilaj2, J. Basho1 and I. Akshia3
1UHC ‘Mother Theresa’ Service of Gastro-Hepatology;
2UHC ‘Mother Theresa’ Service of Radiology; 3UHC
‘Mother Theresa’ Department of Statistics
Introduction: Ultrasonography (US) is very important in
the diagnosis of the pancreatic pathologies. The Role of
Magnetic Resonance Imaging (MRI) is well recognized,
but it is a more expensive examination and asking for a
MRI requires a justiﬁcation.
Aim and methods: The aim of this study was to examine
the comparable roles of US and MRI in a group of pa-
tients with suspected pancreatic disease during a period
of twelve months. Eighty-six patients were recruited in
the study. All of them underwent abdominal US and
MRI. The indication for US included abdominal pain in
83 patients (96.5%) Jaundice 22 patients (25.5%) and/or
elevated pancreatic enzymes in 60 patients (69.7%).
Indications for MRI included clinical suspicion for pan-
creatic pathologies for 42 patients (48.8%) and ultraso-
nographically for 20 patients (23.2%), suspicion of
biliary pathology in 8 patients (9.3%) or inconclusive
ultrasound in 18 patients (18.6%).
Results: Ultrasound identiﬁed pancreatic pathologies
(inﬂammation, cyst, and carcinoma) in 20 pts (23.2%). A
normal pancreas was identiﬁed in 40 patients (46.5%).
Choledocholithiasis with duct dilatation was identiﬁed in
8 pts (9.3%). Inconclusive Ultrasound accounted for 18
patients (20.9%).MRI identiﬁed pancreatic pathologies
in 30 pts (34.8% of cases and conﬁrmed a normal pan-
creas in 40 patients (46.5% of cases. Choledocholithiasis
with duct dilatation was identiﬁed in 16 patients 18.6%.
Conclusion: In conclusion MRI conﬁrmed all positive
US ﬁndings. The principle beneﬁt of MRI was in estab-
lishing ﬁndings in the 19% of inconclusive US studies.
P-758
CLINICAL IMPORTANCE OF FDG-PET
IN THE PREOPERATIVE EVALUATION
OF BILIARY TRACT CANCER
Y. Isamu, A. Tetsuo, U. Kimihiko, H. Kenro, O. Izuru,
S. Makoto, T. Hirochika, M. Ippei, F. Takumi and
K. Yonson
Department of Hepato-Biliary-Pancreatic Surgery, Kobe
University Graduate School of Medicine
Background: Recently ﬂuorodeoxyglucose positron
emission tomography (FDG-PET) has been shown to be
useful for diagnosis of variable cancers. However, the
role of FDG-PET on the biliary tract cancer remains still
unclear.
Aim: To evaluate the clinical signiﬁcance of FDG-PET
in the preoperative diagnosis of biliary tract cancer, and
clarify the characteristics of false-negative and false-po-
sitive cases among them.
Method: This study involved 59 patients (gallbladder
cancer 10 cases, extrahepatic bile duct cancer 14 cases,
hilar cholangiocarcinoma 13 cases, intrahepatic cholan-
giocarcinoma 17 cases, ampullary cancer 5 cases) which
we underwent FDG-PET for preoperative evaluation of
biliary tract cancer between 2007 and 2008. Positive le-
sion was identiﬁed by two nuclear medicine physicians
when the FDG-uptake was higher than that in the
background organs. The sensitivity and accuracy of
FDG-PET on diagnosis of biliary tract cancer were
examined.
Result: The sensitivity of the FDG-PET was 85% on all
biliary cancers (gallbladder cancer 78%, extrahepatic bile
duct cancer 85%, hilar cholangiocarcinoma 77%, intra-
hepatic cholangiocarcinoma. 100%, and ampullary can-
cer 80%). There were ﬁve false-positive cases, including
one chronic cholecystitis, one hepatic granuloma, two
intrahepatic benign cholangitis, and one benign cholan-
gitis with stone. In ﬁve cases performed exploratory
laparotomy, we could diagnose neither hepatic metasta-
sis, peritoneal dissemination nor periaortic metastasis in
the preoperative FDG-PET examination.
Conclusion: FDG-PET is considered to be useful as a
diagnostic tool for biliary tract cancer. However, it re-
mains a problem that FDG-PET examination misdiag-
noses inﬂammatory lesions of gall bladder or bile duct as
malignant lesion as well as cannot diagnose small distant
metastasis (false-positive).
P-759
THE USE OF MRCP IN
CHOLEDOCHOLITHIASIS TO REDUCE
THE INCIDENCE OF NEGATIVE ERCP
B. Al-Jiffry and A. El-Fateh
Al-Hada Military Hospital
Objective: Proposed pathway in managing choledocho-
lithiasis (CBDs).
Background: There is no consensus up to date on the
protocol to diagnose and treat CBDs. Though ERCP is
the most effective, it has complications up to 10% and
mortality less than 1% with the main problem of being
negative in most reports up to 75% when based on
abnormal LFT only. MRCP can detect CBDs, however
the running coast limits its wide spread availability. We
proposed a pathway in India 2008 and would like to
show the ﬁnal results here.
Methods: All patients from November 2006 till August
2009 with gallstones and presented to the emergency
room with an abnormal LFT (obstructive jaundice) were
included in the study. Ultrasound (US) was done for all
patients and was reported as abnormal if the CBD was
dilated (7 mm) or stones were detected. If the US was
abnormal the patient went for ERCP, were a normal US
was followed by MRCP then intra-operative cholangio-
gram (IOC) to conﬁrm.
Results: Total No was 176.85 (48.3%) showed abnormal
US, 23 (27%) with stone only, 28 (33%) with dilatation
only and 34 (40%) with both dilatation and stones. The
91 (51.7%) with normal US had MRCP, 60 (66%) tests
were normal and IOC conﬁrmed the absence of stones in
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59. ERCP done for 31 (34%) with positive MRCP and
stones were found in 25 (81%) and negative in six (19%).
ERCP done for the 85 with abnormal US, 20 out of 23
(87%) in the stone group, 22 out of 28 (76%) in the
dilatation group and 32 out of 34 (94%) in the group
with both demonstrated stones on ERCP. Total 116
ERCP done with 100 patients with stones and 16 (14%)
negative ERCP. The incidence of stones was 87% when
the US was abnormal and 29% when the US was normal.
Conclusion: Patients with abnormal US have a high
incidence of CBDs and ERCP in indicated and the coast
of MRCP is not warranted. However, if the US is normal
MRCP is indicated to decrease the incidence of negative
ERCP.
P-760
PREOPERATIVE IDENTIFICATION OF
ABDOMINAL SEPSIS – THE ROLE OF
PCT AND CRP
N. Ivancevic, D. Radenkovic, P. Gregoric,
A. Karamarkovic, B. Karadzic and D. Bajec
Clinic for Emergency Surgery, Clinical Center of Serbia
and School of Medicine, University of Belgrade, Serbia
Background: The diagnostic criteria of abdominal sepsis
should allow identiﬁcation of patients at an early stage of
the syndrome. Waiting for bacteriological results may
lead to a delay in initiation of the appropriate therapy.
The sepsis response involves the release of a variety of
mediators. However, most of them are useless in routine
clinical practice, due to their own characteristics (plasma
stability, half-life, sensitivity, speciﬁcity). This may cause
a potential lack of correlation between the clinical (sep-
sis) condition and the biomarker level. Aim The present
study attempted to identify the diagnostic signiﬁcance of
C reactive protein (CRP) and procalcitonin (PCT) in
acute abdominal conditions as well as the range of con-
centrations correlating with the preoperative diagnosis of
abdominal sepsis.
Material and method: This was prospective clinical study
on 98 consecutive patients with acute abdominal con-
ditions who have met the established criteria for SIRS,
58 of which had positive bacteriological ﬁndings and
were included in the sepsis group, while 40 were in-
cluded in non-infectious SIRS group. Results The pre-
operative concentrations of CRP showed no signiﬁcant
differences between the sepsis (153 5± 123.4) and SIRS
(143.5 ± 121.2) groups. Preoperative PCT concentra-
tions were signiﬁcantly higher within the sepsis group
than they were within the SIRS group (median (inter-
quartile range) 2.32 (7.41) ng/ml vs. 0.45 (2.62) ng/ml).
A cut-off value of 1.1 ng/ml yielded 72.4% sensitivity
and 62.5% speciﬁcity. (AUC = 0.740, PPV = 73.7%;
NPV = 61.0%).
Conclusion: Our results indicate that CRP should not be
relied upon as a valid parameter for early, preoperative
diagnosis of abdominal sepsis. However, PCT level
> 1.1 ng/ml together with the presence of SIRS in pa-
tients with acute abdominal conditions, could allow
preoperative identiﬁcation of abdominal sepsis.
P-761
PREDICTING THE SURGICAL
APPROACH FOR CHOLECYSTECTOMY
BY PRE-OPERATIVE CLINICAL
IMAGING
M. Hill, S. Virmani, S. Sumet, L. Ferguson, Y. Goriel,
M. Jacobs and V. Mittal
Providence Hospital and Medical Centers, Southﬁeld, MI.
USA
Introduction: Laparoscopic cholecystectomy is the gold
standard for the treatment of cholelithiasis; however the
conversion rate varies from 1–20%.
Objective: To evaluate the various preoperative risk
factors, especially as detected by imaging, which could
successfully predict the conversion from laparoscopic to
open cholecystectomy.
Methods: A retrospective chart analysis was performed
for all patients who had undergone cholecystectomy over
a 12 month period from July 2007 to June 2008 at our
hospital. Clinical, hematological, and biochemical data,
imaging parameters and operative ﬁndings were re-
corded. Patients with additional procedures planned or
who had a provisional diagnosis of gallbladder cancer
were excluded from the study.
Results: Four hundred and seventy one patients suc-
cessfully underwent cholecystectomy. 2% (9/471) pa-
tients were directly planned for open cholecystectomy.
Overall conversion rate in our study was 4.7% (22/471).
The most frequent reason for conversion was severe
inﬂammation and unclear anatomy at Calot’s triangle
(n = 12) followed by adhesions (n = 6) and gangrenous
cholecystitis (n = 3). One patient had to be converted to
an open approach because of severe obesity and failure to
create a pneumoperitoneum. Multivariate analysis iden-
tiﬁed elderly patients (> 60 years), elevated white cell
count (> 11 000/ml), evidence of gallbladder wall
thickness (> 3 mm), porcelain gallbladder, emphyse-
matous gallbladder and/or peri cholecystic ﬂuid (via
ultrasound or CT scan) and a positive HIDA scan as
independent predictors of conversion.
Conclusion: Pre-operative clinical and imaging ﬁndings
can successfully predict the conversion from laparoscopic
to open approach (or at least alert the surgeon for a
possible difﬁcult surgery). Apart from choosing the ap-
proach, it may also improve patient counseling, help in
better perioperative planning and decrease post operative
morbidity and hospital costs.
P-762
ACCURACY OF PREOPERATIVE
CT-SCAN TO PREDICT CONVERSION
TO LAPAROTOMY RELATED TO ACUTE
CHOLECYSTITIS – A PROSPECTIVE
STUDY
H. Hajji1,2, D. Fuks1,2, B. Robert1,3, C. Iederan1,2,
O. Brehant1,2, A. Dhahri1,2, C. Sabbagh1,2,
S. Blanpain1,3, T. Yzet1,3 and J.-M. Regimbeau1,2
1Amiens North Hospital; 2Department of Digestive
Surgery; 3Department of Radiology
Introduction: Laparoscopic cholecystectomy is the gold
standard of treatment for acute cholecystitis (AC). It is
mainly performed in emergency by young surgeons. In
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case of intraoperative difﬁculties, early conversion to
laparotomy is mandatory. The purpose of this study was
to assess the accuracy of preoperative CT-scan to predict
conversion to laparotomy related to AC.
Patients and methods: Between 2008 and 2009, an en-
hanced CT-scan was performed in all patients with sus-
pected AC. Patients who underwent laparoscopic
cholecystectomy for AC was included. The CT-scan was
analyzed preoperatively by two independent radiologists.
The different causes of conversion related to AC were
noted. Other risk factors of conversion (sex, age, BMI)
were deliberately not analysed in this work.
Results: About 122 patients had a cholecystectomy for
AC. Among these patients, 60 were included. Eighteen
patients (30%) required conversion because of adhesions
(n = 5), hemorrhage (n = 2), inﬂammation of hepa-
toduodenal ligament (n = 3), opening gallbladder
(n = 4) and biliary peritonitis (n = 2). Two patients
were converted for intolerance to laparoscopy but were
excluded of the analysis. Imaging ﬁndings were signiﬁ-
cantly correlated to intraoperative ﬁndings. The presence
on the preoperative CT-scan of: inﬂammation of the
hepatoduodenal ligament (p = 0.30), perivesicular effu-
sion (p = 0.12), apposition to adjacent organs
(p = 0.55), absence of enhancement of the gallbladder
wall (p = 0.09), perivesicular abscess (p = 0.72), im-
pacted stone in the infundibulum (p = 0.28), parietal
pneumatosis (p = 0.27), irregularity of the gallbladder
wall (p = 0.19), portal vein thrombosis (p = 0.32) and
bile duct distention (p = 0.27) were not signiﬁcantly
correlated to the conversion due to AC.
Conclusion: This is the 1st study to assess prospectively
the role of the preoperative CT-scan in the choice of
approach for cholecystectomy in case of AC. The CT-
scan does not seem to predict conversion speciﬁcally re-
lated to AC.
P-763
FIRST EXPERIENCE WITH
INTRAVASCULAR ULTRASOUND IN
PATIENTS WITH TUMOURS OF THE
ABDOMINAL CAVITY
I. Shutikhina, Y. Stepanova, L. Kokov, V. Tsygankov
and E. Dubova
A.V. Vishnevsky Institute of Surgery
Intravascular ultrasound (IVUS) - a new informative
method of investigating the state of the vessels. It is very
important in determining of the tumour’s germination of
the vessel.
Goal: To determine the possibility of IVUS in diagnosis
of tumour’s of the abdominal cavity invasion in magistral
vessels.
Materials and methods: There were six patients (four
men, two female) 47–62 years. The study was carried out
IVUS catheter-sensor diameter 3.2 F (frequency
40 MHz) after angiography. Evaluation criteria are of
tumour’s invasion: the presence/absence of fat layer be-
tween the tumour and vessel, the changes of echogenicity
of the wall and violation of ultrasound structure.
Results: Results of IVUS with suspected germination
vessel showed that: germination of superior mesenteric
artery by pancreatic cancer; pancreatic cancer didn’t
germinate in superior mesenteric and portal vein; IPMN
didn’t germinate in splenic vein; adrenal carcinoma and
liver’s leiomyosarcoma metastases didn’t germinate in
the inferior vena vein.
All patients were operated on. Intraoperative data
conﬁrmed the IVUS data. It should be noted that in
two cases with suspected germination of IVC, by IVUS
data the wall of the vein on the tumour’s border was
thickened, sealed and had a sinuous path. However, there
wasn’t visible germination at IVUS and intraoperatively.
This may be due to ﬁbrosis of the wall, caused by
prolonged compression. This issue requires further gath-
ering of material and its analysis.
Conclusion: IVUS is a reliable method of veriﬁcation of
tumour invasion. The indication for IVUS is question-
able resectability tumour after a full range of diagnostic
activities.
P-764
PROMPT HEPATIC RESECTION FOR
COLORECTAL LIVER METASTASES
IMPROVES PREDICTABILITY OF CT
IMAGING
S. Yang1, S. Hongjinda1, S. Hanna1, S. Gallinger2 and
C. Law1
1Sunnybrook Health Sciences Centre, Toronto, Canada;
2University Health Network, Toronto, Canada
Background: Computed tomography (CT) remains the
primary imaging modality for the diagnoses of colorectal
liver metastases (CLM). Accurate interpretation of pre-
operative CT imaging greatly impacts on the decision to
proceed to potentially curative hepatic resection surgery.
Delays in surgery following imaging diagnosis of CLM
are frequent.
Objective: This study aims to evaluate the impact of time
interval from pre-operative CT imaging to hepatic
resection on the accuracy of CT imaging.
Methods: A retrospective chart review of patients at two
institutions who underwent hepatic resection for CLM
from January 1999 to September 2004 was conducted.
Time interval was deﬁned as days between pre-operative
CT imaging and hepatic resection. Accuracy of CT
imaging was determined by its sensitivity for detecting
CLM and ability to predict resectability.
Results: A total of 219 patients who received hepatic
resection surgery at the University Health Network or
Sunnybrook Health Sciences Centre in Toronto, Canada
were included in this study. These patients had 225
operations and 279 CT studies. Mean sensitivity for
detecting CLM was 83.3%. There was signiﬁcant corre-
lation between time interval to operation and sensitivity
of CT (Pearson’s correlation = -0.42, P < 0.001). Lin-
ear regression analysis showed that sensitivity for
detecting CLM decreases to 92.6, 84.1 and 75.6% at time
intervals 30, 60 and 90 days, respectively. Among CT
studies with resectable disease, 79.7% were resectable at
surgery and 20.3% needed further operations or had
unresectable disease. Correlation between time interval
to operation and prediction of resectability was signiﬁ-
cant (Point-biserial correlation co efﬁciency = -0.33,
p = 0.005).
Conclusion: Time interval between pre-operative CT and
surgery is negatively correlated with sensitivity for
detecting CLM and prediction of resectability. Patients
should undergo hepatic resection promptly following CT
diagnosis.
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P-765
CT MAY DETECT COLON CANCER
METASTASES EARLIER AND IMPROVE
LIVER RESECTION RATES
B. Hjelmeland1, K. Søndenaa1,2, K. E. Storli1,
B. Furnes1, T. Bru3, I. Nesvik3, I. Bukholm4,5 and
G. E. Eide6
1Haraldsplass Deaconal Hospital; 2University of Bergen;
3Stavanger University Hospital; 4Akershus University
Hospital; 5University of Oslo; 6Haukeland University
Hospital;
Background: Historically, around 3% of patients with
colorectal cancer (CRC) are operated for liver metastases
although it has been indicated that it should be more.
Aim: We have compared patients with resection for colon
cancer in three community based hospitals to examine if
extra diagnostic awareness, using CT, will detect more
patients with liver metastases or increase resection rates.
Method: Three community teaching hospitals compared
treatment of colon cancer in 2000 with 2007. The number
of patients studied was 613: Hospital A: 224, Hospital B:
214, and Hospital C: 175 patients. Patients were exam-
ined preoperatively with ultrasonography and chest x-ray
in 2000. CT of chest and abdomen was introduced in
2007 as a routine screening. Follow-up has been sys-
tematic until 5 years postoperative.
Results: In the 2000 group of 269 patients resected for
colon cancer, 11.7% developed liver metastases during
follow-up, 5.7% synchronous and 6.1% metachronous.
In the 2007 group of 344 resected colon cancer patients,
8.5% have developed liver metastases so far, synchro-
nous metastases diagnosed in 7.3% of patients and
metachronous in 1.2%. Introduction of CT in the work-
up showed an incidence of 7%, 9.9%, and 2.7% syn-
chronous metastases in the three hospitals compared to
2.9%, 6.2% and 7.2%, respectively, in 2000. In the 2000
group, 10.3% (1.3% of all) of the patients with liver
metastases underwent liver resection. So far in the 2007
group, this ﬁgure is 25% (1.8% of all). Historically, 23%
of patients with rectal cancer treated before 1992 had
liver metastases and 16% of them (3% of all) underwent
liver resection.
Discussion: The diagnosis of synchronous colorectal liver
metastases increased from 2000 to 2007 and the liver
resection rate increased. CT may diagnose liver metas-
tases earlier in the disease and thus assure an optimal
time for intervention. A follow-up study is under way to
see if this leads to increased survival for these patients.
P-766
COMPARATIVE PRE- AND INTRA-
OPERATIVE IMAGING EVALUATION IN
PATIENTS WITH COLORECTAL LIVER
METASTASES: A PROSPECTIVE STUDY
ON 128 RESECTED METASTASES
G. Ercolani1, M. Zanello1, L. Rojas2, M. Ravaioli1,
M. Cescon1, M. Del Gaudio1, C. Pinto2, R. Golﬁeri3,
G. L. Grazi1 and A. Pinna1
1Hospital Sant’Orsola-Malpighi, Department of Surgery
and Transplantation, University of Bologna; 2Hospital
Sant’Orsola-Malpighi, Department of Oncology and
Pathology, University of Bologna; 3Hospital Sant’Orsola-
Malpighi, Department of Radiology, University of Bologna
Background: Precise detection of colorectal liver metas-
tases (CLM) has a therapeutic and prognostic implica-
tion for successful surgical strategy. There is no
consensus about the most accurate imaging methods.
Aim: To evaluate the best diagnostic accuracy of the
available imaging techniques in patients with CLM and
to deﬁne which preoperative work up should be used.
Methods: Patients with potentially resectable metastases
underwent in 3 weeks before surgery the following
radiologic examinations: preoperatively, contrast-en-
hanced ultrasonography (CEUS-1), CT scan, FDG-PET
scan, Magnetic Resonance-diffusion (MR-DW), and in-
traoperatively, common ultrasound and again CEUS-2.
A multidisciplinary analysis was performed to compare
each pathologic lesion with radiologic imagings.
Results: From November 2008 to May 2009 44 patients,
out of 55 which were prospectively enrolled in the study,
underwent partial hepatectomy (135 nodules were re-
moved). Only one patient underwent unnecessary lapa-
rotomy (2.2%). Neoadjuvant chemotherapy was
administered in 20 (45.4%) patients. The total number of
resected metastases was 128, the median number/patient
was 2.8 (range from 1 to 10). At the ﬁnal pathologic
examination, three resected lesions were benign, and four
were necrotic nodules due to the complete response to
neoadjuvant chemotherapy. The sensitivity, speciﬁcity,
positive and negative predictive values for each technique
is reported in the table 1.
Table 1.
CEUS-1 CT
FDG-
PET
MR-
DW IntraopUS CEUS-2
Sensitivity 90% 91% 63% 93% 97% 98%
Speciﬁcity 66% 60% 50% 60% 43% 43%
Pos pred
value
97% 96% 95% 97% 97% 97%
Neg pred
value
46% 46% 8% 43% 60% 60%
Conclusions: A precise work up reduces unnecessary
laparotomies. MR-DW seems to have the best preoper-
ative sensitivity. FDG-PET scan is useful only to evalu-
ate the presence of extrahepatic disease for staging.
Intraoperative CEUS does not seem to add any advan-
tage to the routine intraoperative ultrasound.
P-767
HEPATIC RESECTION WITH
PREOPERATIVE EVALUATION OF
VENOUS CONGESTION USING 3D
IMAGE PROCESSING SOFTWARE
Y. Mise1, K. Hasegawa1, S. Satou1, T. Aoki1, Y. Beck1,
Y. Sugawara1, M. Makuuchi2 and N. Kokudo1
1Hepato-Billiary-Pancreatic Surgery Division,
Department of Surgery, Graduate School of Medicine,
University of Tokyo; 2Japanese Red Cross Medical Center
Objective: To assess the efﬁcacy of preoperative evalua-
tion of venous congestion using three-dimensional (3D)
image processing software prior to hepatic resection for
malignancies. Background:
Despite growing concern over the negative impact of
venous congestion following dissection of hepatic veins,
preoperative estimations of congestive area have been
difﬁcult, and few reports regarding indication criteria for
venous reconstruction are available.
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Methods: In 28 cases of liver tumour invading major
hepatic veins, preoperative simulation of congestive area
following sacriﬁce of involved veins was performed using
image processing software. Non-congestive liver remnant
(NCLR) was calculated by subtracting congestive area
from the liver remnant. Venous reconstruction was
scheduled in 9 patients according to the following crite-
ria: 1) normal liver function (indocyanine green retention
rate at 15 minutes [ICGR15] < 10%) with an NCLR
smaller than 40% of the total liver volume (TLV), or 2)
slight liver dysfunction (ICGR15 of 10 to 20%) with an
NCLR smaller than 50% of the TLV. In the remaining
19 patents (Sufﬁcient NCLR), simple sacriﬁce of the in-
volved veins was estimated to be possible. Surgical out-
come and volume regeneration were investigated.
Results: Out of 19 patients estimated to have a Sufﬁcient
NCLR, venous involvement was denied intraoperatively
in six patients. As a result, the major hepatic veins were
sacriﬁced in 13 patients (Sacriﬁce group) and were pre-
served in 15 patients (Preserve/Reconstruct group). No
postoperative mortalities occurred, and median hospital
stay was 16 days. Surgical outcome and postoperative
liver function were favorable in both groups, and the
volume restoration ratios in three months were similar in
the Preserve (90%) and Sacriﬁce groups (88%).
Conclusion: Preoperative evaluation of venous conges-
tion using 3D image processing software is useful for
operative planning in patients with liver tumours
involving major hepatic veins.
P-768
COMPARISON OF MSCT AND MRI IN
THE PREOPERATIVE ASSESSMENT OF
COLORECTAL LIVER METASTASES
TREATED WITH NEOADJUVANT
CHEMOTHERAPY
C. van Kessel1, M. van Leeuwen1, M. van den Bosch1,
I. Borel Rinkes1, W. Mali1, P. Westers2 and
R. van Hillegersberg1
1University Medical Centre Utrecht; 2Julius Center
Utrecht
Background: Optimal delineation of colorectal liver
metastases (CRLM) after neoadjuvant chemotherapy
(NAC) is crucial for accurate surgical decision-making.
However, NAC induces parenchymal changes resulting
in diminished lesion delineation and decreased sensitivity
of CT.
Objective: To determine the best imaging modality for
pre-operative detection, characterization and measure-
ment of colorectal liver metastases after neoadjuvant
chemotherapy.
Materials and methods: A total of 79 lesions in 15 pa-
tients with colorectal liver metastases were included in
this study. Following neoadjuvant chemotherapy, all
patients received a multiline liver CT (MSCT) and MRI
that were retrospectively scored by two experienced
radiologists for lesion number, type, diameter (mm) and
segmental location. A consensus reading was performed
to review any differences between the two radiologists.
Intra-operative ﬁndings, histopathology and follow-up
imaging were used as reference standard for surgically
treated patients; non-surgical candidates underwent fol-
low-up imaging.
Results: MSCT and MRI were similar for individual le-
sion detection with a detection rate of 60/79 (76%) and
62/79 (78%) respectively (p = 0.021). Lesion character-
ization was signiﬁcantly superior (p = 0.021) at MRI
with a sensitivity of 89% (kappa 0.747, p = 0.001)
compared to MSCT with a sensitivity of 77% (kappa
0.235, p = 0,005). Inter-observer variability for diameter
measurement was not signiﬁcant at MRI (p = 0.909
[95%CI -1.245 to 1.395]), but signiﬁcant at MSCT
(p = 0.028 [95%CI -3.349 to-2.007]). Differences in
diameter measurement were independent of the observer
(p = 0.131), and no statistical effect from imaging
modality on diameter measurement was observed
(p = 0.095).
Conclusion: For pre-operative assessment of colorectal
liver metastases after neoadjuvant chemotherapy, MRI is
superior to MSCT for lesion characterization and mea-
surement. Lesion detection rates for both modalities are
comparable.
P-769
HOW COMMON IS INCIDENTAL
PANCREATIC PATHOLOGY: RESULTS
OF A STUDY OF ABDOMINAL
COMPUTED TOMOGRAPHY FINDINGS
IN A GENERAL HOSPITAL SETTING
A. Karran and G. Morris-Stiff
Department of Surgery, Prince Charles Hospital, Merthyr,
Wales
Background: Several studies have documented the prev-
alence of incidental pancreatic pathology based on the
ﬁndings of imaging studies. However, all originate from
tertiary referral units, often including patients self-refer-
ring for imaging studies, and thus do not represent the
general population.
Aims: To assess the prevalence of pancreatic pathology
based on computed tomography (CT) in a deﬁned pop-
ulation within a general hospital setting.
Methods: Patients undergoing abdominal CTs were
identiﬁed from the radiology database. Reports were
reviewed to determine the presence of pancreatic
pathology and both request forms and patient notes were
reviewed to determine cases in which the pancreatic
ﬁndings were incidental. Indications for CT, demo-
graphic features and ﬁnal diagnoses were also noted.
Results: During a 12 month period 3000 abdominal CT’s
were performed. Pancreatic pathology was identiﬁed in
35 cases, and in 9 individuals the lesion was an incidental
ﬁnding. The subgroup of incidental tumours consisted of
six females and three males with a mean age of
70.9 ± 13.4. Radiological ﬁndings included: cystic le-
sions (n = 4); solid lesions (n = 4); and chronic pan-
creatitis (n = 1). Indications for CT included: staging of
colorectal cancer (n = 2); investigation of colorectal
symptoms (n = 2); investigation of incidentally noted
deranged liver function (n = 2); investigation of lung
lesion (n = 1); investigation of pheochromocytoma
(n = 1); and investigation of pelvic mass (n = 1). The
ﬁnal diagnoses were: mucinous cystadenoma (n = 2);
pancreatic adenocarcinoma (n = 2); neuroendocrine tu-
mour (n = 2); IPMN (n = 1); microcytic serous ade-
noma (n = 1); and chronic pancreatitis (n = 1).
Conclusions: Incidental pancreatic pathology may not be
as common as previously suggested when ﬁndings of CT
scans in an unselected population are analysed. In ﬁve of
the cases, no further imaging studies were required and
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so the burden of such lesions in terms of requirement of
further study is not signiﬁcant.
P-770
LIVER DIFFUSION: A NEW MRI
TECHNIQUE TO IMPROVE DETECTION
AND CHARACTERIZATION OF FOCAL
HEPATIC LESIONS
J. C. Spina, M. Sidelnik, L. Savluk, J. Zone Puig, M. Ulla
and R. Garcı´a Mo´naco
Hospital Italiano
Background: Over the last few years, diffusion weighted
images (DWI) has become increasingly used in extra-
cranial organs to detect and characterize tumours, for
functional evaluation of different organs and for treat-
ment response evaluation in oncology.
Aim: To demonstrate the utility of DWI to detect and
characterize focal hepatic lesions (FHL).
Material and methods: Between January 2008 and March
2009 we retrospectively analyzed FHL, excluding simple
cysts and indeterminate lesions. Signal intensities were
analyzed in DWI (b50 400 and 800 seconds/mm2) and
ADC based on visual scale. The ﬁnal diagnosis was
determined by typical MRI behavior, follow-up imaging
or histology.
Results: One hundred and seven FHL were detected in
59 patients, 68 benign (3 hydatidic cysts, 50 hemangio-
mas, seven focal nodular hyperplasia, ﬁve adenomas
and three abscesses and 39 malign (25 metastases
(MTS), 11 hepatocarcinoma (HCC) and 3 cholangio-
carcinoma (CC)).DWI b50 identiﬁed 95.6% benign le-
sions, two adenomas and one focal nodular hyperplasia
were not. The combination hiper b800 / hiperADC had
98% Sensitivity (S), 86% Speciﬁcity (Sp), 86% PPV
(Positive Predictive Value) and 98% NPV (Negative
Predictive Value) for hemangioma diagnosis. Abscesses
were hiper b800 and hipo ADC.The remaining benign
lesions were isoADC.Benignity could be predicted with
84%accuracy for hiper ADC FHL.DWI detected 100%
malignant lesions, 82% were hipo or iso ADC (18MTS,
11 HCC and 3CC), 18% hiper ADC (7MTS). 44%
MTS, 36% HCC, and 66% CC were hipo ADC.The
combination hiper DWI/hipo ADC had 43.6%S, 95%
Sp, 85%PPV and 72.8%NPV for malignancy. Whereas
hiper DWI/isoADChad 82%S, 90%Sp, 84%PPV and
88%NPV.
Conclusion: DWI should be added to the study of FHL
because of its high S to detect lesions and good Sp to
differentiate benign from malignant ones.
It could be a useful tool to avoid unnecessary biopsy in
patients with indeterminate lesions without precedents of
malignancy, and to avoid gadolinium in patients with
renal failure.
P-771
VIRTUAL HEPATECTOMY WITH
HEPATIC VOLUME/ FUNCTION
ANALYSIS FOR THE PREDICTION OF
RESIDUAL LIVER FUNCTION
CAPACITY
M. Stockmann, J. F. Lock, R. Ro¨hl, M. Malinowski,
S. C. Schmidt and P. Neuhaus
Department of General, Visceral and Transplantation
Surgery, Charite´ - Universita¨tsmedizin Berlin
Background: Liver tumours could be resected with
curative intention in only in 20% of patients. The resid-
ual liver function capacity is a major limitation for hep-
atectomy. Therefore its valid prediction before
hepatectomy would be extremely beneﬁcial for the
treatment of liver tumours.
Aim: Clinical evaluation of a method for individual
calculation of residual function capacity before hepatec-
tomy.
Methods: Prospective study assessing the diagnostic va-
lue of hepatic volume- function analysis prior surgery.
The preoperative liver function capacity was determined
by the LiMAx test, which evaluates the metabolic func-
tion of the liver, based on cytochrome P450 1A2 capacity
(lg/kg/hour). Virtual hepatectomy was performed with
volumetric analysis, using a 3-D calculation of a 4-phase
contrast-enhanced computer tomography. Residual liver
function capacity was calculated from preoperative
function and predicted residual volume. Values in med-
ian (IQR).
Results: Twenty-four patients have been enrolled yet and
received hepatic volume-/ function analysis. Twelve of
them underwent surgery and were analyzed. Indications
for surgery were hepatocellular (n = 6) or cholangio-
cellular cancer (n = 2), and colorectal (n = 4). Predicted
residual volume was correlated with r = 0.972
(P < 0.0001) vs. actual residual volume. Predicted liver
function capacity was correlated with r = 0.622
(P = 0.031) vs. actual residual liver function capacity.
The difference between predicted and actual values was -
55 (-93, -21) lg/kg/hour. Pringle manoeuvre was identi-
ﬁed as an important factor inﬂuencing this difference.
Conclusion: Hepatic volume-/ function analysis using
LiMAx test has the potential to predict residual liver
function capacity before hepatectomy.
P-772
MAGNETIC RESONANCE IMAGING IN
THE MANAGEMENT OF HYDATID CYST
DISEASE
P. Lattanzio, M. Pontillo, L. Belderrein, D. Segura and
E. Olivera
Maciel, Clinica quirurgica 3, facultad de medicina
Introduction and objectives: Imaging patterns and effec-
tiveness of ultrasonography and computed tomography
(CT) in the diagnosis of cystic hydatid disease are well
deﬁned. Certain aspects in differential diagnosis of other
cystic lesions remain controversial. The contribution of
magnetic resonance imaging (MRI) in differentiating
cystic hydatid disease from other non-parasitic cystic le-
sions is essential. Different imaging patterns enable sur-
geons to distinguish the etiology of cystic lesions, assess
the presence of complications, evolutive forms and
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parasitic viability. The objective of the present study is to
establish the effectiveness of MRI in differentiating cystic
lesions of uncertain etiology.
Material and methods: Observational, descriptive, retro-
spective study of cases where MRI was used in diag-
nosing cystic lesions. Period: 2002–2009, Maciel
Hospital. Montevideo. Universe: 112 patients affected
from cystic hydatid disease in different locations.
Analysis of 3 cases: two men and one female, between
56–63 years. MRI determined etiologic diagnosis of
cystic lesions with controversial imaging pattern in this
patient.
Results: MRI established the etiology on cystic lesions of
uncertain diagnosis in different anatomic sites. In two
cases, the hidatic etiology was ﬁnally differentiated from
the initial diagnosis of soft tissue sarcoma. On hepatic
cystic lesions, MRI deﬁned the hydatic origin as well as
the presence of infectious complications.
Conclusions: Systematic use of MRI increases diagnosis
effectiveness, planiﬁcation and therapeutic management
of cystic lesions in centers where cystic hydatid disease
is prevalent. The sensibility and speciﬁcity of MRI
(91% and 81%) in hepatic cystic hydatid disease in-
creases in the presence of complications and is superior
to the association ultrasonography-CT (46% and
77%).
P-773
NONE INVASIVE ASSESSMENT OF
HEPATIC VASCULAR ANATOMY AND
ITS VARIANTS WITH 64 –MULTISLICE
CT ANGIOGRAPHY
J. C. Spina, E. Levy Yeyati, M. Ulla, N. Napoli,
A. Varela and R. Mo´naco Garcı´a
Hospital Italiano
Objectives: To review and illustrate hepatic vascular
anatomy and its variations in patients studied with 64-
Multislice CT angiography (64-MSCTA) enhancing its
importance in the surgical planning and avoidance of
invasive radiological procedures.
Methods: Between June 2008 and June 2009, 356 hepatic
MSCTA were retrospectively analyzed. Patients with
prior surgical vascular changes were excluded. Three
dimensional reconstructions (3D), maximum intensity
projection technique (MIP) and 2D were selected. The
different ﬁndings were correlated according to Michel’s
classiﬁcation.
Results: 70% of the patients studied showed normal
vascular anatomy (Michel’s type I). In 10.8% the left
hepatic artery (LHA) originated from the left gastric
artery (LGA) (Type II). 9.3% with right hepatic artery
(RHA) from the superior mesenteric artery (SMA) (Type
III). 0.5% showed accessory left hepatic artery arising
from the left gastric artery (SGA) (Type V). 1% with
RHA from the SMA (Type VI). Other 1% had proper
hepatic artery from the SMA. 3.7% showed other types
of variations, including: 1.7% LHA from celiac trunk
(CT), 1.5% RHA from CT and 0.5% LHA originated
straight from the aorta.
Conclusion: Knowledge of hepatic vascular anatomy
and its variations is essential to a better understanding
liver irrigation as well as proper surgical planning. 64-
MSCTA is an effective, fast and non invasive method
that it’s assessment, avoiding invasive radiological
procedures.
P-774
THE ROLE OF PREOPERATIVE [18F]
FLUORODEOXYGLUCOSE POSITRON
EMISSION TOMOGRAPHY PREDICTING
FOR EARLY RECURRENCE AFTER
CURATIVE RESECTION FOR HCC
S. G. Ahn1, H. J. Cho2, M. Yun2, J. S. Choi1, J. D. Lee2
and K. S. Kim1
1Dept. of surgery, Severance Hospital, Yonsei University
College of Medicine; 2Division of Nuclear Medicine,
Department. of Radiology, Severance Hospital, Yonsei
University College of Medicine
Purpose: 18F-ﬂuorodeoxyglucose (FDG) uptake on
positron emission tomography (PET) scan has been
found to reﬂect tumour differentiation and to predict
clinical outcome of hepatocellular carcinoma patients.
We investigated the correlativity of PET scan with tu-
mour differentiation of hepatoma and the clinical sig-
niﬁcance of PET scan for predicting early tumour
recurrence (time-to-recurrence < 1 year) clariﬁed as ad-
verse prognostic factor.
Method: Ninety three hepatocellular carcinoma patients
who underwent curative resection between August 2004
to December 2008 were retrospectively collected in the
study according to inclusion criteria. PET scan was per-
formed preoperatively, and the maximum standardized
uptake value (SUVmax) of tumour and the tumour to
non-tumour SUV ratio (TNR) were calculated from
FDG uptake. Tumour differentiation was measured
using H & E stain.
Results: Early tumour recurrence patients were twelve
among twenty six recurrence patients. SUVmax and
TNR showed a high correlativity with tumour differen-
tiation measured by Edmonson-Steiner classiﬁca-
tion.(p = 0.000) Early recurrence-free and the overall
survival rates in low TNR group (TNR < 2.0) were
higher than in high TNR group (TNR > 2.0) using
Kaplan-Meier method.(p = 0.015, p = 0.007) Accord-
ing to univariate analysis, predictors for early tumour
recurrence were large tumour size (5 cm), high TNR
(TNR 2), high SUVmax (SUVmax 4), high Edmonson–
Steiner grade. However, any predictor for early tumour
recurrence was not statistically proved in multivariate
analysis.
Conclusion: These results suggest that preoperative PET
scan reﬂect tumour differentiation of hepatocellular
carcinoma. Further investigation would be followed to
estimate clinical validity of preoperative PET scan for
predicting early tumour recurrence.
P-775
UTILITY OF DYNAMIC CT IN THE
CONTROL OF THE HEPATOCELLULAR
CARCINOMA AFTER TREATMENT
WITH RADIOFREQUENCY AND
TRANSARTERIAL
CHEMOEMBOLIZATION
S. Kozima, N. Larran˜aga, E. Ridruejo, F. Perazzo,
R. Desmery, R. Oddi, G. Eisele and O. Mando´
CEMIC
Objective: To show the dynamic computed tomographic
(CT) pattern after treatment with radiofrequency abla-
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tion (RFA) and transarterial chemoembolization
(TACE) of hepatocellular carcinoma (HCC).
Material and methods: Between March 2006 to October
2009 a total of 127 patients with diagnosis of HCC were
controlled with triphasic CT. For the treatment, the pa-
tients were divided in two groups according to Barcelona
classiﬁcation. The ﬁrst group randomized the patients
with very early and early stage disease and included 32
patients with 46 nodules and was treated with RFA. In
the second group were included intermediate and ad-
vanced stage disease with 95 patients with 133 nodules
and treated with TACE. A subgroup of patients was
treated with both methods.
Results: After triphasic CT control at the 1st and 3rd
month we continued every 3 months during 3 years, on
the 127patients with 179 nodules, we observed ﬁve dif-
ferent tomographic patterns: 1) absence of enhancement,
2) peripheric enhancement, 3) homogeneous accumula-
tion of iodized oil, 4) partial defect without enhancement
and 5) partial defect with enhancement on treated lesions.
The patients with total o partial enhancement in the
treated nodules with contrast in arterial phase on dy-
namic CT were retreated.
Conclusion: The dynamic CT contrast less as well as the
arterial phase, allowed us monitoring the effectiveness,
residual disease and/or relapse of hepatocellular carci-
noma after RFA and TACE.
P-776
UTILITY OF ROUTINE CT
ARTERIOGRAPHY (CTA) IN THE
DIAGNOSIS OF EARLY ARTERIAL
COMPLICATIONS FOLLOWING ADULT
LIVER TRANSPLANTATION
I. Martineau1, E. Vibert2, L. Gorden2, S. Awad1, S. De la
Serna2, R. Adam2, D. Castaing2, M.-F. Bellin1 and
D. Azoulay2
1AP-HP Hopital Paul Brousse, Service de Radiologie,
Villejuif, France; 2AP-HP Hopital Paul Brousse, Centre
Hepato-Biliaire, Villejuif, France
Background: Arterial complications following adult liver
transplantation (LT) are rare but can lead to biliary
complications and subsequent graft failure.
Aim: Evaluate routine CTA for detection of early arte-
rial complications of adult LT and compare its utility
with Doppler-ultrasonography (US).
Methods: Results from 183 consecutive LT in 181 adults,
including 140 orthotopic, 9 adult living-donors, 8 split
and 26 domino were evaluated. All patients received both
Doppler US with IR (index of resistance) and CTA (40
detector-row, MIP reconstructions) to assess vascular
anatomy post LT. All exams were read by experienced
radiologists blinded to patient clinical history.
Results: Among 183 consecutive LT recipients, 140 had
CT arteriography post LT, 115 of which were done on a
routine protocol, 18 for a low IR, and 7 for investigation
of abnormal liver function tests (LFTs). Overall, there
were 13 arterial complications (7.1%) that included 7
stenoses (3.8%), 3 thromboses (1.6%), 2 pseudoaneu-
rysm (1%), and 1 ﬂow limitation due to placation
(0.54%). These complications were conﬁrmed by surgical
intervention (n = 5) arteriography (n = 2) and as part
of standard follow-up (n = 6). Overall, routine CTA had
a sensitivity of 100% and a speciﬁcity of 99% to detect
signiﬁcant arterial lesions post LT with a positive pre-
dictive value of 80% negative predictive value of 100%.
Routine Doppler US post LT demonstrated a sensitivity
of 69% and a speciﬁcity of 81%, with a positive predic-
tive value of 27% and a negative predictive value of 96%
for arterial lesions post LT.
Discussion: CTA and duplex US are complementary
techniques for evaluation of early arterial complications
post LT however CT retains the greatest accuracy for
detection of early arterial complications possibly requir-
ing surgical or radiologic intervention.
P-777
DIFFICULTY PREDICTION BY 3D-CT
FOR THE LAPAROSCOPIC-ASSISTED
HEPATECTOMY OF LIVING DONOR
LIVER TRANSPLANTATION
H. Katagiri, H. Nitta, T. Takahara, H. Itabashi,
T. Fujita, N. Ito, Y. Kimura, K. Otsuka, K. Koeda,
A. Sasaki, M. Mizuno and GO Wakabayashi
Iwate Medical University
Background: The utility of an anatomic simulation with
3D-CT makes donor hepatectomy safer. We have suc-
cessfully performed 14 consecutive cases of laparoscopic-
assisted donor hepatectomy (LADH) since 2007. It is
beneﬁcial to standardize the procedure of LADH in
reference with 3D-CT to make this surgery safer.
Purpose: To examine the correlation between technical
difﬁculty of LADH and an anatomic simulation with 3D-
CT.
Objective and method: Fourteen donors underwent
LADH between July 2007 and June 2009. Correlations
and differences were examined among the following
factors: body mass index (BMI); graft weight; operation
time; blood loss; depth of the liver; and thickness of body
trunk.
Result: Among six male and eight female donors, 11 and
2 grafts were from right and left lobe, respectively, and
one from lateral sector. Median value of each factor was:
34.7 (age), 22.5 (BMI), 618.6 g (graft weight), 231.4 ml
(blood loss), and 370.1 min (operation time), 108.2 mm
(depth of the liver), and 110.2 mm (thickness of body
trunk). A moderately high correlation was seen between
operation time and thickness of body trunk (r = 0.60);
as well as blood loss and depth of the liver (r = 0.51).
Signiﬁcant difference between two groups was seen in
blood loss (depth of the liver > 140 mm or less,
P = 0.037); and in operation time (thickness of body
trunk > 120 mm or less, P = 0.031).
Conclusion: With the use of 3D-CT, we were able to
estimate factors associated with body shape preopera-
tively. To perform LADH safely, preoperative prediction
of difﬁculty is crucial. Depth of the liver and thickness of
body trunk may be pivotal factors to predict the technical
difﬁculty of LADH. Therefore they could be criteria for
the introduction of laparoscopic-assisted donor hepa-
tectomy at inexperienced institutions.
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P-778
USEFULNESS OF 18F-FDG PET/CT TO
DETECT RECURRENCE OF
HEPATOCELLULAR CARCINOMA IN
POST-TRANSPLANT PATIENTS
Y.-K. Kim, S. H. Kim, S.-S. Han, S. Y. Cho, T. You,
S.-K. Kim, S.-J. Park and K.-W. Lee
Center for Live Cancer, National Cancer Center
Background: Pre-transplant 18F-FDG PET/CT has re-
cently been shown to predict recurrence of Hepatocellu-
lar Carcinoma (HCC) in patients received LT for HCC.
18F-FDG PET/CT has been routinely applied to for the
detection of extrahepatic metastases in HCC before LT
at many centers. However there are a few reports in pa-
tients who had received LT for HCC to detect HCC
recurrence.
Aim: This study is to assess that efﬁcacy of 18F-FDG
PET/CT for the detection of HCC recurrence after LT.
Methods: From February 2005 to December 2008, 93
patients received adult LT (91 living donor LT and two
decease donor liver transplantation) for HCC in National
Cancer Center, Korea. 12 patients developed HCC dur-
ing follow up period. Two patients were excluded owing
to refusal of exam 18F-FDG PET/CT at HCC recurrence.
Ten Patients received exam of 18F-FDG PET/CT and
conventional imaging modalities such as chest contrast
CT, brain contrast CT, liver dynamic CT, bone scan and/
or magnetic resonance when the patients were suspected
to recurrence of HCC. We identiﬁed detection rate of
18F-FDG PET/CT. The precise of 18F-FDG PET/CT is
assessed by imaging study and histological conformation.
Results: The recurrence patterns of HCC after LT are
extrahepatic (n = 6, 50%), intrahepatic (n = 3, 30%),
both n = 1, 10%). The detection rate of 18F-FDG PET/
CT for intrahepatic lesions more than or equal to 1 cm is
20%. The intrahepatic lesions smaller than 1 cm are not
detected by 18F-FDG PET/CT. The detection rate of 18F-
FDG PET/CT for extrahepatic lesions more than or
equal to 1 cm is 92.9%.
Conclusion: 18F-FDG PET/CT could provide additional
information to conventional modalities and contribute to
the clinical management of HCC recurrence patients
suspected of having extrahepatic recurrence. A further
study with a large number of patients is required to
conﬁrm the signiﬁcant of 18F-FDG PET/CT in detecting
extrahepatic recurrence in patients who received LT.
P-779
SPLENIC VEIN AS AN ALTERNATIVE
FOR PORTO MESENTERIC AXIS
RECONSTRUCTION AFTER
PANCREATODUODENECTOMY:
REVIEW AND REPORT OF A CASE
E. Amico, S. A. Joa˜o and E´lio Barreto
Hospital Universita´rio Onofre Lopes
Background: The resection of the Porto mesenteric axis
(PMA) has been increasingly performed in cases of
adenocarcinoma of the pancreas. Despite this there is
no known study as to the best alternative to it. Various
kinds of venous grafts are described and the choice
depends on the preference of the unit in which it is
undertaken.
Objective: This report discusses critically the use of the
splenic vein in the reconstruction of the PMA in a patient
with Frantz’s tumour.Patient MCSS, a 48-year-old wo-
man, with Frantz’s tumour in the pancreatic head. Firm
adherence between the tumour and the PMA as well as
signiﬁcant compression of the upper mesenteric vein was
encountered during Whipple’s procedure. The patient
underwent resection of the PMA. The splenic vein was
then chosen for the reconstruction of the PMA. The
patient progressed uneventfully and left hospital on the
ninth post-operative day.
Discussion: The description of the use of the splenic vein
in the reconstruction of the PMA is old. The advantages
of its use are: practicality, rapidity and, further, the better
exposure of the upper mesenteric artery. The practicality
derives from the fact that no other team is necessary for
the removal of the graft. The rapidity is due to the use of
one and the same surgical ﬁeld associated with the fact
that the splenic vein, near the outlet of the portal vein, is
already practically dissected by the mobilization of the
pancreas. Further, there exists the possibility of exposing
the right edge of the upper mesenteric artery, a region
considered critical for reaching the negative border in
cephalic pancreatectomy more adequately. Curiously and
probably by virtue of the description of cases of seg-
mentary hypertension of the splenic vein after its ligation,
with the consequent appearance of gastric varices, the use
of the graft of the splenic vein practically disappears from
the literature. A review of the literature is presented on
the applicability of the method.
P-780
MAJOR PANCREATIC SURGERY, A
SAFE PROCEDURE
E. Jafarimehr1, H. Dabbous, G. B. Zibari1, Q. Chu1,
S. Laroux1, H. D’agostino2, S. Reddy3, P. Jordan4,
R. Shi5 and H. Shokouh-Amiri1
1Department of Surgery, Louisiana State University
Health Sciences Center, Shreveport, Louisiana;
2Department of Radiology, Louisiana State University
Health Sciences Center, Shreveport, Louisiana;
3Department of Oncology, Louisiana State University
Health Sciences Center, Shreveport, Louisiana;
4Department of Medicine GI Section, Louisiana State
University Health Sciences Center, Shreveport, Louisiana;
5Department of Statistics, Louisiana State University
Health Sciences Center, Shreveport, Louisiana
Background: Pancreatic cancer (PC) is one of the leading
causes of cancer death. Five year survival of 18 – 25%
has been reported in patients with resectable disease.
Aim: To look for factors inﬂuencing outcome of pan-
creatic surgery (PS).
Methods: Retrospective, IRB approved, chart review
and prospectively collected data on 197 patients who
underwent PS between 2000 - 2009 by our team was re-
viewed. Malignant causes were present in 122 patients.
Demographic, operative and follow up data were re-
viewed. Student t test, Chi-square test, Kaplan–Meier
method and log-rank test were used. Cox-regression was
used in multivariate survival data analysis.
Result: Fifty-eight patients were male, 68% Caucasian,
and 97% of lesions were solid. Mean age was 62 (26 –
89), 79% of malignant cases were adenocarcinoma and
10% were neuroendocrine. Among resectable ones
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(n = 93), 72% had R/O resection and 39 had positive
lymph node. There were six preoperative deaths. 72 of
malignant cases had whipple procedure and 13 had distal
pancreatectomy. Only 31% received blood. Length of
stay was 15.8 days. Chemotherapy was given to 53 pa-
tients. Complication rate was 37%. Mortality in patients
with R/O and R1 resection was signiﬁcantly different
(15% vs. 37%, P < 0.04). Only 15% of patients who
received chemotherapy died versus 24% (P < 0.03).
Patients with tumours > 3 cm had signiﬁcantly higher
mortality (P < 0.01). Median survival for malignant
cases was 67 months with a follow up of 1 – 79 months.
Discussion: Better patient selection, intra and Perioper-
ative care, center volume and surgeon’s experience all
have been helpful in recent improvements in the result of
major PS. In our experience the most important factors
in long term survival was size of tumour, resection
margin and use of chemotherapy, but L.N. status played
no role in predicting survival in our patients.
Conclusions: Encouraging long term result is achievable
in patients with PC due to earlier and better patient
selection.
P-781
SHOULD PANCREATICO-
DUODENECTOMY BE PERFORMED IN
ELDERLY?
D. Brachet, E. Lermite, K. Bressolette, S. Mucci,
A. Hamy and J. P. Arnaud
University Hospital Center Angers
Introduction: Pancreaticoduodenectomy (PD) is indi-
cated in benign or malignant pancreatic head diseases. It
is a difﬁcult operation with high morbidity especially in
elderly patients.
Purpose: The aim of our study was to study the mor-
bidity and mortality rate, and to analyse age inﬂuence.
Patients and methods: During 17 years, 173 patients were
operated by Whipple intervention, whatever the disease.
From a prospective database, patients were divided in two
groups (group a 70-years-old, group B < 70-years-old).
Results: Postoperative mortality was not signiﬁcantly
higher in elderly (12% vs. 4.1%; p = 0.06). However, re-
intervention and morbidity were more important in
univariate analysis (p = 0.03 and p = 0.002 respec-
tively). In multivariate analysis, age 70-years-old was not
an independent prognostic factor of mortality (p = 0.27)
and re-intervention (p = 0.07). Whereas, age (p =
0.035) and preoperative morbidity (p = 0.024) were
independent prognostic factors of morbidity.
Conclusion: PD requires a careful patient’s selection.
However, age should not be a limiting factor.
P-782
IS PANCREATICODUODENECTOMY
JUSTIFIED IN ELDERLY PATIENTS?
J. R. C. Kow1, N. A Sadayan2, A. Earnest1, B. Wang1,
C. Y. Chan1, C. K. Ho1 and K. H. Liau1
1Tan Tock Seng Hospital Singapore; 2Yong Loo Lin
School of Medicine, National University of Singapore
Background: Although mortality and morbidity for
pancreaticoduodenectomy (PD) have improved signiﬁ-
cantly over the last 2 decades, the concern for elderly
undergoing PD remains. This study examines the out-
come of the elderly patients who had pancreaticoduo-
denectomy in our institution.
Method: A database comprising of 69 patients who
underwent pancreaticoduodenectomy between 2001 to
May 2008 was analysed. Using WHO deﬁnition, elderly
patient is deﬁned as age 65 and above in this study. Two
groups of patients were compared [Group 1: Age65 and
Group 2: Age > 65].
Results: The mean age of our patients was
62 ± 11 years. There were 37 (54%) patients in Group 1
and 32 (46%) patients in Group 2. There were more
patients in the Group 2 with > 2 co morbidities
(p = 0.03). This was correlated with greater ASA score
in Group 2 (p = 0.01). The following parameters were
comparable including clinical presentation, histology,
tumour size, grade and stage of disease. Morbidity rate in
Group 2 was higher (56% vs 44%, p = 0.04). However,
this was not correlated with the grade of complications
(p = 0.37). There was higher proportion of post-opera-
tive pancreatic ﬁstula (POPF) in the elderly group
(37.5% vs. 16.7%, p = 0.05). Majority of them are
Grade a POPF according to the ISG deﬁnition. There
was no difference in delayed gastric emptying (DGE) and
post-pancreatectomy haemorrhage (PPH), surgical site
infections and respiratory morbidities between the two
groups. The median post-operative length-of-stay (LOS)
in hospital was 9 days longer in Group 2 (p = 0.01).
Mortality rate between the two groups of patients was
comparable (0% vs. 3%, p = 0.28).
Conclusion: Elderly patients are at increased risk of
morbidity in pancreatocoduodenectomy, in particular
POPF. However, morbidity and mortality rate are
acceptable. Therefore, careful pre-operative patient
selection and counseling is important to justify offering
PD to elderly patients who do not have signiﬁcant car-
diopulmonary comorbidities.
P-783
OPEN PANCREATIC STENTING WITH
DUCT-TO-MUCOSA ANASTOMOSIS
FOR PANCREATIC DUCT
OBSTRUCTION AFTER PANCREATICO-
DUODENECTOMY WITH
PANCREATICOGASTROSTOMY
H. Kano, T. Oida, K. Mimatsu, A. Kawasaki, Y. Kenji
and N. Fukino
Social Insurance Yokohama Central Hospital / Surgery
Background/Aim: Pancreatic-duct dilatation is fre-
quently observed in the patients who have undergone
pancreaticoduodenectomy (PD). Endoscopic dilatation is
one of the treatment options for stenosis of pancreatic-
ogastrostomy (PG). However, the failure of endoscopic
dilatation necessitates surgical approaches. We have de-
scribed our technique of open pancreatic stenting with a
duct-to-mucosa anastomosis for a case which the stenosis
of PG could not be resolved by endoscopic dilatation.
Method: A 69-year-old woman had undergone subtotal
stomach-preserving PD with PG for cancer of the head of
the pancreas 1 year previously. Nine months after the
surgery, the patient developed diabetes mellitus (DM)
without recurrence of the original disease. CT images
revealed an irregular dilation of the main pancreatic duct,
which had a diameter of 12 mm. Endoscopy, was per-
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formed aiming for pancreatic stenting. However, we
could not detect the PG opening at the PG site on the
posterior region of the stomach. Then, we decided to
perform intraoperative pancreatic drainage by open
surgery. The opening of the gastrostomy, revealed a lin-
ear scar in the posterior gastric wall. Under ultrasonog-
raphy guidance, a catheter with an 18-G needle was
passed through the posterior gastric wall into the dilated
pancreatic duct. The needle was removed, and a guide-
wire was inserted into the pancreatic duct through the
catheter. A pancreatic stent was inserted into the pan-
creatic duct along the guide-wire. After the placement of
the pancreatic stent, a duct-to-mucosa anastomosis was
added using nonabsorbable sutures. Results:
Three months after the surgery, restenosis was not
observed in the patient’s pancreatic duct, which had
diminished to a diameter of 6 mm, and her DM had
improved.
Conclusion: This technique does not require re-resected
PG or side-to-side pancreaticojejunostomy: the risk of
anastomotic leakage is quite low: and the procedure is
minimally invasive.
P-784
MANAGEMENT OF PANCREATIC
STUMP BLEED: SURGICAL STRATEGY
N. Shetty, T. L. V. D. Prasad Babu, T. Ramcharan,
G. Srikanth and S. Sikora
Department of Surgical Gastroenterology, Manipal
Institute of Liver and Digestive Diseases
Background: Hemorrhage following pancreaticoduo-
denectomy is a serious complication seen in 5–20% of
patients with a mortality of 20–50%. Bleeding from the
pancreatic stump is an important cause of early, intra-
luminal bleed requiring surgical intervention.
Methods: Between October 2006–2009, 25 patients
underwent a Whipple’s PD. Overall morbidity was 20%
and mortality was 4%. Two patients (8%) had early in-
traluminal severe bleed requiring re-exploration. These
two patients had a diagnosis of neuroendocrine tumour
of the pancreas for which they underwent a Standard
Whipple PD. The pancreas was soft and the pancreatic
duct diameter was 2 and 3 mm respectively. Pancreatico
enteric anastomosis was performed by a modiﬁed dunk-
ing pancreatico-jejunal (PJ) anastomosis. In the imme-
diate postoperative period, patients presented with
intraluminal GI bleed through the nasogastric tube. At
surgery, bleed from the pancreatic stump was controlled
through a jejunotomy along the transverse axis of the
bowel opposite the PJ anastomosis. The jejunotomy was
closed with a t-tube decompression. Both patients made
an uneventful recovery.
Conclusions: Pancreatic stump bleed has serious conse-
quences due to the delay in diagnosis and control may
require the disruption of the PJ anastomosis. We describe
a planned surgical strategy to achieve hemostasis while
preserving the PJ anastomosis to control bleed from the
pancreatic stump.
P-785
POSTERIOR APPROACH FOR THE
SURGICAL TREATMENT OF
PANCREATIC PSEUDOCYST
K.-H. Kim1, T.-H. Hong2, S.-K. Lee2, Y.-K. You2,
I.-Y. Park3, S. Lee4, D.-G. Kim2 and E.-G. Kim5
1Uijeongbu St. Mary’s Hospital/ the Catholic University of
Korea; 2Seoul St. Mary’s Hospital/ the Catholic
University of Korea; 3Bucheon St. Mary’s Hospital/ the
Catholic University of Korea; 4St. Paul Hospital/ the
Catholic University of Korea; 5St. Mary’s Hospital/ the
Catholic University of Korea
Pancreatic pseudocysts are common sequelae of pancre-
atitis and pancreatic trauma. The management is based
upon the pseudocyst size and presence of symptoms. For
the large cyst and symptomatic cyst, the treatment of
choice has been internal drainage using several available
options. With the advent of advanced laparoscopic
technique, laparoscopic cystogastrostomy is a less mor-
bid method, alternative to open drainage procedures.
Two approaches are available; transgastric (anterior) and
lesser sac (posterior) approach. We describe one patient
who had pancreatic pseudocyst amenable to laparoscopic
cystogastrostomy. The patient was a 62-year-old man
who developed gallstone pancreatitis and chronic alco-
holics. Follow up abdominal CT scan showed a huge
pseudocyst which was located at the head, body and tail
of the pancreas except uncinate process. The posterior
approach was performed by directly visualizing posterior
gastric wall and pseudocyst. The electrocautery hook
created a cystotomy where the 45 mm linear stapler was
inserted. After laparoscopic necrosectomy, a gastrotomy
about 4 cm long was created on the posterior gastric
wall. Sutured the pseudocyst to the posterior wall of the
stomach yield a cystogastrostomy. The patient was
discharged without complication on the postoperative
5th day. The Posterior approach of laparoscopic cysto-
gastrostomy is a feasible and secure method for large
retrogastric pancreatic pseudocyst and facilitates
debridement of the necrotic pancreas.
P-786
PANCREATICODUODENECTOMY AT A
UNIVERSITY-AFFILIATED HOSPITAL:
IMPACT OF TECHNIQUE ON OUTCOME
AND QUALITY MEASURES
H. Kim, E. Hagopian, Y.-H. Kuo, N. Ahmed, A. Shifrin,
J. Vernick and J. Davis
Jersey Shore University Medical Center
Introduction: The safety and efﬁcacy of performing
pancreaticoduodenectomy (PD) surgery has been ques-
tioned for all but centers that perform this procedure in
large-volume (> 10 operations/year). Recently a number
of studies suggest that centers with expertise in the
technical aspects of this procedure can perform this
operation in lower numbers as safely as high-volume
medical centers. The purpose of this paper is to analyze
our results with respect to the Nationwide Inpatient
Sample (NIS) to evaluate the relative safety of this
operation in a center doing less than 10 PDs per year.
Methods: Standard PDs were performed with mucosa-
to-mucosa ductal anastomoses. Our complications, mor-
tality, and postoperative length of stay were compared to
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intermediate-volume (4–9 operations/year, 207 cases) and
high-volume centers (10 operations/year, 486 cases) in the
2006 NIS data.
Results: From 2003 to May 2009 we performed 34 PDs.
The patients’ mean age (mean ± standard deviation)
was 64.9 ± 14.2 which is similar to the NIS medium-
volume centers (64.0 ± 11.6 years, P = 0.34). The male
to female ratio was 40:60 for our data and 52:48 for the
NIS data (P = 0.27). Our mortality rate of 2.9% was not
different from NIS medium-volume (6.3%, P = 0.70
and high-volume centers (2.5%, P = 0.60). Our POLOS
(9.6 + 3.1 days) was signiﬁcantly shorter compared to
medium-volume (17.8 ± 12 days, P < 0.0001, log-rank
test) and high-volume institutions (14.8 ± 13.4 days,
P = 0.0006).
Conclusion: POLOS was signiﬁcantly longer for both
intermediate and large volume centers as compared to
our POLOS which we believe is due to differences in the
technique (or method) of mucosa-to-mucosa duct
reconstruction.
P-787
FATTY LIVER AFTER PANCREATO-
DUODENECTOMY AND TOTAL
PANCREATECTOMY
K. Tezuka, W. Kimura, I. Hirai, M. Mizutani,
M. Toshiyuki, A. Takeshita, T. Watanabe, S. Sugawara
and S. Okazaki
First Department of Surgery, Yamagata University School
of Medicine, Yamagata, Japan
Metabolic syndrome or nonalcoholic fatty liver (NASH)
are clinically highlighted. Fatty liver sometimes occur
after pancreatoduodenectomy (PD). However, reasons of
fatty liver after PD are not still obscure. Recently we
performed PD (150 cases) and total pancreatectomy (ﬁve
cases) for peri ampullary neoplasms. Among them, ﬁve
cases of postoperative fatty liver after PD or total
pancreatectomy were studied and discussed literally.
Postoperative fatty liver was diagnosed with CT as diffuse
low density area in the liver. Diagnoses of ﬁve cases were
two bile duct cancer and three intraductal papillary
mucinous neoplasms (IPMN). All ﬁve cases were female.
Postoperative serum albumin, cholinesterase, and total
cholesterol were decreased compared to preoperative
levels. On the contrary, endocrine (glucose tolerance)
function was well maintained. Typical CT imaging of fatty
liver after PD or total pancreatectomy will be presented.
Fatty liver changes are also found in short bowel
syndrome or jejunal-ileal bypass. Imbalance between
synthesis and secretion of hepatic triglycerides was con-
sidered for the reason. We speculate triglycerides are not
secreting to blood because of impairment of apoprotein.
P-788
SURGICAL OUTCOME FOR MUCINOUS
CYSTIC NEOPLASM OF THE PANCREAS
(MCN)
T. Ryu, H. Yokomizo, Y. Kimura, K. Hayashi, T. Hirata
and T. Yamane
Department of Surgery, Japanese Red Cross Kumamoto
Hospital
Background: The international consensus guidelines for
management of mucinous cystic neoplasm of the
pancreas (MCN) recommend surgical resection. The aim
of this study was to evaluate the usefulness of these
guidelines for resection of MCN.
Methods: Sixteen patients (15 women, 1 man; mean age,
46 years; range, 27–72 years) with MCN who had
undergone surgical resection at our hospital between
January 1995 and June 2009 were retrospectively ana-
lyzed regarding the effects of treatment. This study used
ovarian-type stroma as a requisite criterion for diagnosis
of MCN.
Results: Mean tumour size was 59.4 mm (range, 25–
140 mm). All tumours were located in the pancreatic
body-tail. Eight patients (50.0%) experienced clinical
symptoms, such as abdominal pain (n = 6) and
abdominal mass (n = 2). One patient (6.3%) showed
metachronous malignant neoplasm in the stomach.
Fourteen patients (87.5%) underwent distal pancreatec-
tomy with splenectomy and two patients (12.5%)
underwent distal spleen-preserving pancreatectomy.
Histopathological examination of surgical specimens re-
vealed adenoma in 12 patients (75.0%), borderline tu-
mour in two patients (12.5%), non-invasive carcinoma in
one patient (6.3%) and minimal invasive carcinoma in
one patient (6.3%). As of a median follow-up of
38 months, no patients had experienced recurrence. All
patients were still alive except for one patient who had
died from advanced gastric cancer.
Conclusion: Patients with MCN showed favorable out-
comes after surgical resection. Unless surgery is contra-
indicated, all patients with MCN should undergo
resection because of the malignant potential and the risk
of acute abdominal symptoms.
P-789
RECENT SURGICAL STRATEGIES FOR
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASM
W. Kimura
Yamagata University
There are various unanswered problems about the
conditions of Intraductal papillary mucinous neoplasm
(IPMN). These are as follows: How can the degree of
tumour spread be determined clinically? Is this tumour
slow-growing after inﬁltration? Can we cure patients with
this disease after the tumour apparently inﬁltrates?
Which surgical procedures are indicated for tumours
with various degrees of spread? What kinds of limited or
organ-preserving operations are possible? These prob-
lems may almost correspond to problems, which degree
of malignant potential invasive carcinoma derived from
IPMN has as compared to ordinary ductal carcinoma of
the pancreas. In our series, invasive carcinoma derived
from IPMN is found in14 out of 60 cases with IPMN, the
ﬁve-year survival after operation is about 40% with the
Kaplan–Meier analysis. These results may suggest that
IPMN is slow-growing after inﬁltration. However, the
results are not satisfactory when comparing the ﬁve year
survival of 100% of cases with non-invasive IPMN.
Therefore, we should take care for the patients with
IPMN as those with more malignant potential than we
thought. There are various limited operations. However,
we take the theory of operation for neoplasm into
consideration that we should not make the patients die of
the recurrent diseases by limited operation. It is also
important that we objectively show what beneﬁts we get
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by the limited surgery. Indication for the organ preserv-
ing limited operation should be very strict.
P-790
SURGICAL TREATMENT OF CYSTIC
TUMOURS OF THE PANCREAS – OUR
EXPERIENCE
O. Deban, M. Sˇkegro, B., Romi and I. Petrovi
University Hospital Rebro, Zagreb, Department for
Hepatobiliary Surgery and Transplantation
In half of the patients with newly detected cystic lesions
of the pancreas, there is no evidence of prior pancreatitis.
Cystic tumours of the pancreas show a wide range of
natural development of disease, from benign to malig-
nant; operations of the pancreas, despite the reduction in
mortality to less than 3% in the best centers, still have a
post-operative morbidity of 50%. Surgical treatment
involves resection or enucleation. Most commonly,
excision of the whole tumour is at the same time the
cure for the patient. Surgical treatment is recommended
in patients that are symptomatic, in those where the
tumour is growing and in cases when the tumour shows
radiological signs of potential malignancy. In the period
2000–2008, 19 patients with cystic tumours of the
pancreas were operated at our Clinic. 9 serous cystade-
noma; three mucinous cystadenoma; one patient had
mucinous cystadenocarcinoma of the pancreas with a
metastasis to the liver; two IPMN, two solid pseudopap-
illary tumour. Two symptomatic patients had a rare
inﬂammatory myoﬁbroblastic tumour (inﬂammatory
pseudotumour). 11 tumours were benign (9 serous
cystadenomas and two solid pseudopapillary neoplasms),
while 7 tumours were of malignant potential (three
mucinous cystadenomas, two intraductal mucinous
tumours and two inﬂammatory myoﬁbroblastic tu-
mours). All patients were symptomatic. 13 tumours were
located in the body or tail of the pancreas, and six in the
head. 10 patients underwent distal splenopancreatecto-
my, six patients’ cephalic duodenopancreatectomy, and
three tumour enucleation. Post-operative mortality was
0%. Complications:
Three pancreatic ﬁstulas, two reoperations (infected
subphrenic hematoma and intraabdominal abscess), one
subphrenic abscess that was evacuated and drained
percutaneously. All patients are still in follow-up.
P-791
TOWARD ZERO PANCREATIC
LEAKAGE AFTER PANCREATICO-
DUODENECTOMY FOR SOFT
PANCREAS IN LOW-VOLUME
PANCREATIC SURGERY CENTERS
T. Oida1, H. Kano1, K. Mimatsu1, A. Kawasaki1,
Y. Kuboi1, N. Fukino1, H. Miyake2 and S. Amano3
1Social Insurance Yokohama Central Hospital / Surgery;
2Kasukabe Municipal Hospital / Surgery; 3Nihon
University School of Medicine / Surgery
Background/Aim: Pancreatic leakage continues to occur
after pancreaticoduodenectomy (PD) and it is a serious
problem. It has been proposed that a normal-sized, soft,
friable, and functionally normal pancreas with a thin-
walled main pancreatic duct is at a greater risk of anas-
tomotic leakage. However, despite the evaluation of
various improvised procedures, pancreatic leakage per-
sists as a complication. Here, we describe our PD tech-
nique that facilitates the prevention of pancreatic leakage.
Method: Our operative procedures includes three stages:
pancreaticogastrostomy (PG), external and continuous
suction drainage of pancreatic juice, and wrapping of the
pancreatic anastomosis by using round ligament and
applying ﬁbrin glue sealant to the surface of the pan-
creatic anastomosis.
Results: Twenty six patients with peri ampullary malig-
nancy with soft pancreas underwent PG without any
pancreatic leakage or ﬁstula.
Conclusions: The combined procedures, including PG,
total external drainage with continuous suction of the
pancreatic juice, and wrapping of the pancreatic anasto-
motic site by using round ligament is a useful method to
prevent pancreatic leakage for cases of soft pancreas in
pancreatic centers that do not encounter many such cases.
P-792
TRANSDUODENAL PANCREATIC
DRAINAGE AFTER DISTAL
PANCREATECTOMY
H. Kano, T. Oida, K. Mimatsu, A. Kawasaki, Y. Kuboi
and N. Fukino
Social Insurance Yokohama Central Hospital / Surgery
Background/Aims: Pancreatic ﬁstula is the most com-
mon and troublesome complication after distal pancre-
atectomy (DP). We developed new surgical technique
transduodenal pancreatic juice drainage (TDPD) for
preventing pancreatic ﬁstula formation after DP, and
evaluated the efﬁcacy of this procedure.
Method: We retrospectively studied 40 patients who
underwent DP. These patients were divided into three
groups: the group that underwent conventional DP
without pancreatic stent insertion (CDP group) (n = 25)
and the group that underwent DP with TDPD (TDPD
group) (n = 15). A pancreatic stent was inserted into the
main pancreatic duct from the papilla of Vater to it’s the
distal side via the duodenostomy, and continuous suction
drainage was performed.
Results: This procedure was performed on 15 patients,
grade a postoperative pancreatic ﬁstula (POPF) was re-
vealed in one patient (6.7%), however, none of whom
developed clinical POPF.
Conclusion: We consider our TDPD technique to be
effective for preventing POPF in patients who have
undergone DP.
P-793
MUCOUS-DUCT AND PANCREATICO-
GASTRIC RECONSTRUCTION
EXPERIENCE IN PANCREATICO-
DUODENECTOMY, AT A LOW VOLUME
CENTER
H. Losada1,2,3, J. Contreras1,2, L. Burgos San Juan1,2,3,
J. Silva1,2,3, J. Bernales1,2, J. P. Droguett2 and
M. Urrutia2
1HPB Surgery Team. Surgery Department. Hospital
Hernan Henriquez Aravena. Temuco; 2Surgery
Department Universidad de La Frontera, Temuco;
3Surgery Department. Clı´nica Alemana de Temuco,
Temuco
Introduction: Pancreaticoduodenectomy (DP) is the only
surgical technique that provides curation chance in peri
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ampullary tumours (PT). There are multiple techniques
for pancreatic reconstruction. Our goal is to describe the
results of a series of patients with duct-to-mucosa pan-
creatogastrostomy (DMPG) for the PD reconstruction.
Objective: Describe the clinic features, surgical indica-
tions, morbimortality and anastomosis PD (DMPG)
outpatient follow-up between years 1996–2008.
Patients and methods: Series of cases of HHHA inpa-
tients between years 1996–2008 with PT diagnosis, who
have gone through DP with DMPG. DMPG was per-
formed in two levels; 2.5·magniﬁcations were used in the
last ﬁve cases. Bio-demographic aspects, etiology, thera-
peutic aspects, complications and mortality were regis-
tered. Descriptive statistics along with central tendency
and scatter were used.
Results: This series included 33 patients, with an average
age of 50 ± 12 years, with prevalence of male subjects
(61%).The preoperative average of bilirubin was of
10.56 ± 10.86 mg/dl and, an albumin average of
4.01 ± 0.56 mg/dl.Morbidity was 37%. The more fre-
quent complications were pancreatic ﬁstula in three pa-
tients, two hematoperitoneums, one digestive
hemorrhage, one colonic perforation, one bile ﬁstula and
two pneumonias. Perioperative mortality was 6%. Kap-
lan–Meier curve was used to calculate the total survival.
Probability of survival of the series (to 5 years) is 30%.
Conclusions: Our PD series with DMPG morbidity was
37% and mortality was 6%. The results of our center
with DMPG are similar to the ones informed in the
chilean series.
P-794
AMPULLARY TUMOURS (AT): OUR
EXPERIENCE IN RESECTION SURGERY
M. Secchi1, L. Quadrelli1, L. Rossi2 and M. Cantaberta1
1Hospital Italiano de Rosario; 2Hospital Italiano de
Rosario and Sanatorio Modelo de Ruﬁno
Background: Ampullary tumours (AT) account for 10%
of all peri ampullary cancers. It is the malignant tumour
that offers the best chances for curative (R0) resection in
the upper gastrointestinal tract. Intraoperative differen-
tiation of an ampullary carcinoma from a pancreatic
carcinoma is sometimes difﬁcult and it should be con-
sidered that the risk for carcinoma in a dysplastic ade-
noma is higher than 50%.
Aim: To evaluate our results in resection surgery of AT
at Surgical Division ‘B’, Hospital Italiano de Rosario-
Argentina.
Method: The indications for ampullectomy include T1
< 0.6 cm, well-differentiated restricted to Oddi and no
lymphatic metastasis. Indications for Whipple pancreti-
coduodenectomy (PD):difﬁculty in differentiating benign
from malignant lesions preoperatively; high grade dys-
plasia and good overall condition, provided morbility
and mortality are low; any T or N (criteria similar to
periampullary cancers without M (stages I, II, III). 12
patients with resectable disease: four benign (three
ampullectomies, one PD) and eight malignant (one
ampullectomy, seven PD- were treated from at the this
series is part of our experience and includes 55 Whipple
PD for periampullary tumours with obstructive jaundice.
Results: Four AT were locally resected: three benign-
adenomas- by ampullectomy and 1 T2 malignant - car-
cinoma (assessed as dysplasia) - by ampullectomy
(recurrence at one year: PD was refused for the patient
and survival at 18 months). There was 25% morbility. 3
patients were veriﬁed to be alive at 5 years. Eight AT was
resected by PD: seven malignant and one benign AT
(unclear biopsy): one PD. Operative morbility was
37%, without procedure-related mortality. Five patients
were veriﬁed to be alive at 3 years and 3 more than
5 years.
Conclusion: All AT tumours must be resected because
the adenoma-carcinoma sequence is very high. Each pa-
tient must be evaluating for the more appropriate pro-
cedure: ampullectomy or Whipple PD.
P-795
MORTALITY AFTER PANCREATICO-
DUODENECTOMY: LESSONS LEARNT
G. Shetty, S. Ingle, P. Shukla and S. Shrikhande
Tata Memorial Hospital, Dr E Borges Road, Mumbai
Background and aim: Pancreaticoduodenectomy (PD)
remains a challenge in HPB surgery. Recent mortality
has decreased to < 5%. We analyzed our experience
with mortalities after PD.
Materials and methods: Retrospective analysis of a pro-
spective database from a single specialized HPB unit.
Results: Two hundred and eighteen PDs were performed
(2003–2009). There were 149 males and 69 females. There
were 10 mortalities (4.5%). They were due to preopera-
tively coexistent causes (30%), operative measures
(50%), and postoperative measures (20%). Four were
ASA I and six were ASA II. The median age was
56 years. Median blood loss was 800 ml. Mean operative
time was 455 min. Five patients underwent preoperative
biliary drainage. The median preoperative bilirubin levels
were 1.26 mg/dl.
Conclusions: On retrospective analysis, 3/10 patients died
due to medical causes / pre-existing medical co morbid-
ities while ﬁve died due to essential speciﬁc intraoperative
steps that could be improved upon. 2/10 patients died
due to postoperative interventions / measures taken. Our
experience reveals a learning curve longer than otherwise
described and is contrary to other published data. This
paper discusses in detail the potential areas that could be
improved upon during perioperative period of PD.
P-796
PANCREATODUODENECTOMY WITH
SUBTOTAL STOMACH PRESERVING
AND ‘UNCUT ROUX’
RECONSTRUCTION
M. Post, M. Wrzesinski, R. Klek, J. Lubikowski and
M. Wojcicki
Department of Hepatobiliary Surgery and Liver
Transplantation, Marie Curie Hospital, Szczecin, Poland
Background: Pylorus preserving pancreatoduodenecto-
my has become the therapy of choice for resectable tu-
mours located in the head of the pancreas and
periampullary region. The addition of a distal gastrec-
tomy may still be required for tumours located in the
dorsal part of the pancreatic head or when there is an
evidence of proximal duodenal invasion. This may bring
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the long-term postoperative complications including
gastric dumping, marginal ulceration, and bile reﬂux
gastritis.
Aims: We report the postoperative course following
subtotal stomach preserving pancreatoduodenectomy
with the ‘uncut’ Roux reconstruction diverting biliary
and pancreatic secretions from the gastric remnant.
Methods: A technique combining subtotal stomach pre-
serving pancreatoduodenectomy with the ‘uncut’ Roux
reconstruction was used in 10 patients (seven males) with
adenocarcinoma of the pancreatic head (seven), periam-
pullary adenocarcinoma (one), and chronic pancreatitis
(two).
Results: The median follow-up was 11.5 (6–19) months.
The postoperative course was uneventful in four patients
and complicated in six. Delayed gastric emptying oc-
curred in 3 patients but was never prolonged beyond the
18th postoperative day. The mean postoperative time to
complete resumption of oral intake was 12 days (range
9–18) while the mean hospital stay since the day of sur-
gery was 18 days (range 14–30). No deaths occurred in
the postoperative period. Nine patients had good clinical
result with stable weight and no signs of nausea,
abdominal pain or postprandial fullness at three and six
months of follow-up. There were no clinical signs of
biliary gastritis in any patient. Three patients died of
tumour recurrence at 6, 8 and 12 months following
surgery.
Conclusion: The ‘uncut’ Roux may represent a good
alternative of gastrointestinal reconstruction following
pancreatoduodenectomy.
P-797
THE CHANGE OF NAFLD RATIO AFTER
PANCREOTODUODENECTOMY
ACCORDING TO A METHOD OF
RECONSTRUCTION
M. Shimoda, T. Shiraki, S. Mori, M. Kato, T. Sawada
and K. Kubota
Dokkyo Medical University, Second Department of
Surgery
Aim: Pancreotoduodenectomy (PD) is the operation
with big damage for patient. After operation, we often
encountered patients who showed poor intake or weight
loss and some patients had sever fatty liver. In this study,
we examined the postoperative NAFLD according to
different reconstruction routes.
Materials and methods: Twenty-six patients who had
undergone PD between January 2008 and April 2009
were included in this study. Weight, Labo data, blood cell
count, trace element were evaluated in pre-operation,
1 week, 3 week, and 3 months POD. NAFLD was de-
ﬁned as that neither HU value was less than 40 HU nor
spleen/liver HU ratio was more than 1.5 using abdominal
CT three months after operation. Compared methods of
reconstruction were R-Y and modiﬁed Traverso’s meth-
od. After operation, all patients received TPN, and trace
element drug 2 ml.
Result: There was no postoperative death. There were 14
male and 12 female patients, with an average age of
63.7 years. Reconstruction with method of R-Y was
performed in 13 patients. Reconstruction with method of
modiﬁed Traverso was performed in 13 patients. In all of
26 patients, Weight, TP, Alb, Zn, Cu, pre-alb were got
down in 1, 3 weeks and 3 months compared before
operation (P < 0.001). There was no difference in start
of oral intake in both groups. Ten of the 26 patients had
NAFLD three months after operation, R-Y group was
ﬁve and Traverso group was ﬁve. However, HU level in
Traverso method was signiﬁcantly lower level than R-Y
group. In addition, Liver function test, AST, ALT,
-GTP, ALP, in Traverso group were signiﬁcantly
higher than in R-Y group one week after PD
(P < 0.05). However, in R-Y group, low level of TP
and Alb were put off after three months. The other
hand, all of the in Traverso group patients were
recovering in same period.
Conclusion: NAFLD ratio was not different in R-Y and
Traverso methods. Traverso method was effective for
recovering nutrient condition.
P-798
SURGICAL OUTCOMES FOLLOWING
PANCREATICODUODENECTOMY FOR
MALIGNANCY AT A LOW VOLUME
HOSPITAL
I.-S. Choi, W. J. Choi, S. E. Lee, D. S. Yoon, T. Y. Koo
and H. S. Min
Konyang University Hospital
Background: Pancreaticoduodenectomy (PD) is a com-
mon surgery for periampullary cancer, however, the
pancreatic ﬁstula remains a serious problem. Several re-
cent reports have shown that morbidity, mortality, and
survival can be improved at high volume centers. Here,
we describe surgical outcomes following pancreatico-
duodenectomy for malignancy during past 10- year and
our PD technique that facilitates the prevention of pan-
creatic leakage at low volume hospital.
Methods: From March 2000 to July 2009 at Konyang
University Hospital, 62 patients underwent pancreatico-
duodenectomy. Patient’s medical records were reviewed
for diagnosis, presenting symptom, surgery, and hospital
stay, postoperative duration for sips of water, compli-
cation and survival.
Results: Sixty two patients (36 (58%) male and 26 (42%)
female; median age, 63 year (range 20–81 year)) have
undergone PD for malignancy. 22 were diagnosed with
distal CBD cancer; 19, ampulla of Vater cancer; 13
pancreatic head cancer; 4, mid CBD cancer; 2, duodenal
cancer; 1, malignant islet tumour; and 1, duodenal GIST.
Fifty six have undergone PPPD and 6, classic Whipple’s
operation. All of 62 patients were performed with pan-
creaticojejunostomy. Of these 62 patients, 61 were per-
formed by mucosa to mucosa and only one, by dunking
method. Mean operation time was 483.5 ± 12.8 min;
mean duration of postoperative sips of water,
6 ± 0.4 days; and, mean hospital stay, 18.4 ± 1.4 days.
Overall complication rate was 13/62 (20.9%) patients. Of
these 13 patients, three patients (4.8%) was PJ ﬁstula;
three (4.8%), delayed gastric emptying; two, postopera-
tive bleeding; one, intraabdominal abscess; one wound
infection; and three pulmonary complication. There was
postoperative mortality in one patient because of PJ ﬁs-
tula induced sepsis.
Conclusion: Major pancreatic surgery can be performed
safely at low volume hospital without serious complica-
tion and mortality.
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P-799
SIMPLIFICATION OF PANCREATIC
ANASTOMOSES: EXAMINATION OF A
TECHNIQUE OF OPEN AND
MINIMALLY INVASIVE
PANCREATICOGASTROSTOMY
J. Stein, K. Han and A. Koffron
William Beaumont Hospital
Background: The pancreatic reconstruction following
right pancreatectomy remains the Achilles heel of pan-
creatic surgery. Various techniques have been utilized
and studied in efforts to characterize, and reduce, pan-
creatic anastomotic complications and morbidity. Pan-
creaticogastrostomy (PG) is now performed with
favorable results and we have adopted this reconstruc-
tion for pancreata of low turgor. Our technique of
reconstruction has been adapted in efforts to avoid un-
due pancreatic surgical trauma, avoid morbidity, and
enhance technical simpliﬁcation of the procedure to-
wards usage during laparoscopic right pancreatectomy.
Aim: We describe our simpliﬁed technique of pancreat-
icogastrostomy and examine outcomes in both open and
minimally invasive applications.
Methods: We performed PG in nine patients after right
pancreatectomy using an invaginated pancreatic neck
and 4–6 anchor sutures. Surgical outcomes were ana-
lyzed.
Results: Seven open and two laparoscopic resections and
reconstructions were performed. A transient pancreatic
anastomotic leak was observed in one patient (11%),
which was managed conservatively by percutaneous
drainage.
Conclusions: This method of PG is technically simpler,
results in less pancreatic trauma, and thus far has
encouraging anastomotic complication rates. This tech-
nique contributes to the advancement of laparoscopic
techniques in pancreatic surgery by reducing complexity
without compromising outcomes. Further study and
long-term follow-up is required to corroborate these
results.
P-800
AGE AS A IMPORTANT FACTOR IN THE
INCIDENCE OF COMPLICATIONS
FOLLOWING
PANCREATODUODENECTOMY
M. Musiewicz1, P. Lampe1, J. Ciosek1, S. Mrowiec1 and
D. Juraszek2
1Department of Gastrointestinal Surgery, Medical
University od Silesia; 2Medical University od Silesia
Introduction: The age of a patient can be connected with
a high risk of post-operative complications and extend
hospital stay.
Materials and methods: Fifty-two patients, who under-
went pancreatoduodenectomy due to pancreas tumour,
were analysed. The patients were divided into two groups
depending on age: group 1 –twelve patients, not older
than 40, group 2- Forty patients aged from 40 to 70. The
studied groups were analysed according to earlier death
rate and the appearance of post-operative complications.
Results: The average age of the patients in group 1 was
32 (from 23–37) and in group 2 the average age was 73
(from 70 to 80). There were ﬁve women and seven men in
group 1, 24 women and 16 men in group 2. Postoperative
complications were more common for group 2
(25%vs.40%). The statistical importance between these
groups was not signiﬁcant (p = 0.34). In studied patient
groups, the following positive correlations of statistical
signiﬁcance were deﬁned: age and early death (p = 0.01),
circulatory-respiratory failure (p = 0,045), stomach
emptying insufﬁciency (p = 0,003), pleural exudates
(p = 0.04), general complications (p = 0,039).
Conclusions: The patients, who are older than 70 can be
subjected to an increased risk of early death and often
postoperative complications.
P-801
HEMORRHAGE MANAGEMENT AFTER
PANCREATICODUODENECTOMY: OUR
EXPERIENCE
E. Colangelo, M. Nardi, A. Ricci, E. Monteferrante,
E. Liberatore, N. Pitrelli, M. Basti and G. Colecchia
Department of Surgery III unit Spirito Santo Hospital
Pescara
Background: Hemorrhage after pancreaticoduodenecto-
my (PD) is the most dangerous complication following
pancreatic surgery, although less frequent, and actually
there are not standardized rules for its management.
Many differences include the onset (early 1–5 postoper-
ative day and delayed after sixth) the severity of bleeding
(mild moderate and severe), intraluminal or extra luminal
bleeding, type of disease and operation.
Methods: From 1999 and 2008 108 patients underwent
pancreatic surgery with 76 PD (Wipple-Machado oper-
ation).
Results: signiﬁcant postoperative bleeding occurred in
four patients (5 6%): only early hemorrhage and intra-
luminal we observed: in two of these the bleeding risen
from pancreatic anastomosis treated by prompt relapar-
otomy for hemodynamic deterioration with enterotomy
and complete hemostatis without disturbing pancreatic
anastomosis Endoscopy was successful in the others two
patients who had intraluminal bleeding risen (second and
third postoperative stay) from gastroenteric anastomosis.
All patients had uneventful postoperative course.
Conclusion: Actually there is no evidence deﬁning the
standard hemorrhage management after PD.It depends
by clinical status of the patients, the onset and severity of
bleeding and institution preference. A prospective study
isn’t feasible. Meta-analysis and more data from referral
centres are necessary to provide more information’s on
this problem.
P-802
PALLIATIVE ENTERIC BYPASS FOR
MALIGNANT GASTRIC OUTFLOW
OBSTRUCTION AFTER
PANCREATICODUODENECTOMY IN
EARLY RECURRENT PANCREATIC
CANCER
N. Fukino, T. Oida, K. Mimatsu, H. Kano, A. Kawasaki
and Y. Kuboi
Social Insurance Yokohama Central Hospital / Surgery
Background/Aims: Recurrent pancreatic cancer has a
poor prognosis and there are there are no established
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therapeutic strategies. We retrospectively studied patients
who underwent palliative surgery for recurrent disease
with gastric outlet obstruction (GOO) after an initial
pancreaticoduodenectomy (PD) for pancreatic cancer.
Methodology: We retrospectively studied four patients
who had undergone a bypass operation, including a
modiﬁed Devine gastrojejunostomy with vertical stom-
ach reconstruction (MDVSR) for GOO to ensure a direct
dietary route to the jejunum, thereby, enabling the gastric
contents to easily reach the jejunum.
Results: MDVSR was performed in four patients, and in
addition to the bypass, one patient underwent a je-
junojejunostomy, and one patient an ileocolostomy. The
median operative time and blood loss were 123 min
(range, 95–150 min) and 164 ml (range 115–235 ml).
After the second surgery, two of four patients received
chemotherapy (one patient: gemcitabine + S1, one pa-
tient: gemcitabine alone). The remaining two patients did
not receive chemotherapy. The mean survival after the
second operation was 145 days (range, 34–386 days).
Conclusion: Palliative surgery including MDVSR is use-
ful to improve a patent’s nutritional state and it is more
effective than chemotherapy for treating recurrent dis-
ease with GOO after a PD for pancreatic cancer.
P-803
HAVE TUMOUR SIZE AN INFLUENCE
ON POSTOPERATIVE COMPLICATIONS
AFTER PANCREATODUODENECTOMY?
M. Musiewicz1, P. Lampe1, S. Mrowiec1 and A. Bratek2
1Department of Gastrointestinal Surgery, Medical
University of Silesia; 2Medical University of Silesia
Introduction: Size of the tumour can probably have
inﬂuence on frequency of surgical complications after
pancreatic resection.
Material and methods: The research group included 53
patients who had undergone pancreatoduodenectomy
due to pancreatic neoplasms. Patients are divided into
groups dependent on the size of the tumour: I:
< 3 cm;15 patients, II: 3,5–4 cm; 16 patients, III:
> 4.5 cm; 22 patients. These groups were compared by
the rate of complications and early deaths.
Results: In study group 53 pancreatoduodenectomies
were performed, including 28 Traverso’s method, 13
Whipple’s method, six Flaunter’s method, ﬁve Claget’s
method, and one Imanaga’s method. The average size of
the tumour was 4.4 cm (1–9 cm).Overall complications
occured in 17 patients (32%), alimentary tract hemor-
rhage (8.8%), delay of gastric emptying (11.7%), sup-
puration of wound (11.7%), haemorrhage to the
peritoneal cavity (8.8%), pancreas abscess (5.9%), ﬂuid
collections (2.9%), subhepatic hematoma (2.9%), acute
pancreatitis (5.9%), anastomotic leakage (14.7%) early
postoperative deaths (26.5%). About 12 of them had
multiple complications (22%). Among the patients with
no complications the average size of tumour was 4.48 cm,
while among patients with complications the average size
of tumour was 4.20 cm. In group I overall complications
revealed in 33%, group II - 43%, group III 22.7%. There
were no statistical differences detected in complications
between groups (I–II p = 0.9 I–III p = 0.8 II–III
p = 0.9). There is no correlation between the size of a
tumour and individual postoperative complications. In
group I correlation between size and anastomotic leak
was close to statistical signiﬁcance (p = 0.06). In group
III correlation between size and pancreas abscess and size
and wound infections was also close to statistical signif-
icance (p = 0.07).
Conclusion: The size of a tumour does not have an
inﬂuence on the frequency of complications.
P-804
RECONSTRUCTION OF THE REPLACED
RIGHT HEPATIC ARTERY DURING
PANCREATODUODENECTOMY
A. Khan, W. Chapman, F. Murad, J. Lowell and
M. Doyle
Barnes Jewish Hospital/Washington University in
St Louis, MO
Background: The arterial supply to the liver can be
highly variable. The classic hepatic arterial anatomy is
only seen in 55–80% of the population. A completely
replaced right hepatic artery arising from the superior
mesenteric artery (SMA) is one of the most common
variants and is seen in about 11% of population. This
artery courses either within or posterior to the pancreatic
head and often gets encased with pancreatic malignancy.
Resection of the involved replaced right hepatic artery at
the time of pancreatoduodenectomy has been shown to
be associated with ﬁstulas and stenosis of biliary enteric
anastomoses.
Aims/objectives: To review our experience with recon-
struction of an involved replaced right hepatic artery in a
patient with cancer of the head of pancreas.
Methods: We describe the case of a patient undergoing
pancreatoduodenectomy for pancreatic cancer with in-
volved replaced right hepatic artery necessitating arterial
reconstruction for preservation of hepatic blood ﬂow.
Results: In our patient the replaced right hepatic artery
was found to be involved at the time of the operation and
had to be resected en bloc with the tumour. Recon-
struction of the replaced right hepatic artery was carried
out using the gastroduodenal artery (GDA) as an
autologous conduit.
Conclusions: Reconstruction of an involved replaced
right hepatic artery at the time of pancreatoduodenec-
tomy for pancreatic cancer can be carried out safely using
inﬂow from the gastroduodenal artery.
P-805
PANCREATIC FISTULA
POSTPANCREATECTOMY. INCIDENCE,
MANAGEMENT AND OUTCOMES
G. Secondo, J. Rodriguez, G. Sanchez, P. Santiago,
C. Barberousse and L. Borgno
From the Departament of Surgery, Maciel Hospital.
Surgical Clinic ‘2’ from the Uruguayan State University,
Montevideo, Uruguay
Background: Pancreatic ﬁstula (PF) remains a sub-
stantial and common complication of pancreatectomy.
The morbidity and mortality in this surgery is frequently
associated with PF.The goal of this study was to describe
our incidence, the current management and outcomes of
clinically signiﬁcant postpancreatectomy PF.
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Objectives: We review a prospectively database identiﬁed
97 patients who underwent pancreatectomy between
February 1999 and September 2009 performed by the
same group of surgeons, to determine the incidence,
treatment and outcomes of PF and performed multivar-
iate analysis to identify factors of PF.
Methods: Complication data were entered into a vali-
dated postoperative complication database, if they were
identiﬁed as having a clinically signiﬁcant PF.
Results: PF occurred in 15 of 97 resected patients
(15.4%) included 61 cephalic pancreatoduodenectomy
(CPD), one total duodenopancreatectomy (TPD), one
medial pancreatectomy (MP) 17 distal pancreatectomy
(DP) 15 for tumours and two posttraumatic, and 17
atypical pancreatectomies in acute pancreatitis (AP).
From the 15 PF 8 were after CPD, ﬁve of them required
reoperation and three of them died. The other three PF
were after DP, two after pancreatic tumours and one
after gastric cancer which invaded the pancreas and was
treated for percutaneous drainage without deaths. The
last four PF were after pancreatic necrosectomy in the
course of AP which remains after the closure of abdom-
inal wall.
Conclusion: The incidence of PF was 15.4%. 13% con-
secutive to CPD and 19, 4% after the other resections,
with 3% of total mortality and 20% of PF mortality
(three out of 15), all of them consecutive to CPD.Mean
drainage time was 32 days (Range 7 to 184 days). The PF
consecutive to DP have a more prolonged drainage time.
The multidisciplinary management of the PF has im-
proved remarkably the outcomes of this complication.
The PF frequency in DP was greater than CPD but its
mortality rate is notoriously inferior.
P-806
MULTIVISCERAL RESECTIONS WITH
PANCREATICODUODENECTOMY:
ONLY AFTER CAREFUL PATIENT
SELECTION
A. Khithani, J. Barton and D. R. Jeyarajah
Methodist Dallas Medical Center, Dallas, Texas
Background: Pancreaticoduodenectomy (PD) is the
treatment of choice for periampullary neoplasms. It may
also be indicated for as part of en block resection for non
pancreatobiliary neoplasms. PD may have to be extended
to resection of additional organs to achieve a complete
resection. The reported experience is mixed. We report
our experience with multivisceral resections (MVR) and
PD.
Methods: Records of patients, with simultaneous MVR
and PD by a single surgeon at a non-university tertiary
training center (NUTTC), were analyzed. We deﬁned a
multivisceral resection as one in which additional viscera
or part of viscera was resected, not a part of the routine
resection in a PD.
Results: Six PDs were performed with MVR. Additional
resections included Total gastrectomy in one, Colonic
resections in four, liver resections in four and ne-
phrectomy in one patient. The primary tumor sites in-
cluded duodenum (one), biliary (two), gastric (one) and
colon (two). The median operating time was 270 min as
against 237 in our overall PD experience. The median
blood loss was 650 ml (350 ml in the OE). The median
length of stay was 15 days (11 days in the OE). 45%
patients required no ICU admission in the OE, all pa-
tients with MVR required ICU stay. There was one pa-
tient with 30 day mortality. All patients developed
postoperative morbidity.
Conclusions: MVR with PD can be done safely, but with
increased morbidity compared with PD alone. These
cases must be taken on with caution.
P-807
EVALUATION OF EARLY
POSTOPERATIVE OUTCOME OF 50
CONSECUTIVE PATIENTS AFTER
WHIPPLE OPERATION USING POSSUM
SCORE
M. Sˇkegro, A. Krivi, O. Deban and I. Petrovi
KBC Zagreb - Rebro, Croatia, Department for
Hepatobiliary Surgery and Transplantation
In the period 2005–2008, a total of 74 resections of the
pancreas were performed, of which 37 were adenocarci-
nomas, 19 cystic tumours, 9 neuroendocrine tumours,
and 9 benign lesions. According to the type of resection
procedure, 54 classical Whipple resections were per-
formed, 17 distal pancreatectomies with or without
splenectomies, and 3 subtotal resections. We analyzed
early outcomes of our last 50 Whipple resections using
Possum score. 32 patients (64%) in a 30 day post-
operative period developed at least one complication. Of
these, 6 patients (12%) had 1st degree complications, 12
patients (24%) had 2nd degree complications, 8 (16%)
3rd degree complications, three patients (6%) 4th degree
complications, and three patients (6%) had the 5th
degree complication – death. 7 patients (14%) developed
a pancreatic ﬁstula. Resection due to the carcinoma was
performed in 43 (86%) patients.
Conclusion: The analysis shows that the preoperative
risk of the patients operated at our institution, as well as
their age, is signiﬁcantly higher than that in centers for
pancreatic surgery, whereas the complications are within
the same range as those performed in such centers. It is
necessary to direct surgical treatment of pancreatic tu-
mours to regional or specialized centers that enable:
better preoperative preparation of high-risk patients;
systemic monitoring of the complications allowing cor-
rection of risk factors with poor outcome; reduced hos-
pital stay and mortality, as well as comparison and
exchange of experiences between different centers or of
the same center in different intervals.
P-808
CORRELATION BETWEEN THE
VOLUME OF REMNANT PANCREAS
AND CHANGE OF GLUCOSE
METABOLISM AFTER
PANCREATICODUODNECTOMY
D. You, S. Choi, J. Heo, D. Choi and M. Kim
Samsung Medical Center, Sungkyunkwan University
School of Medicine
Background: The hormonal abnormalities that follow
pancreatic resection are dependent on the extent and
location of resection.
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Objective: To evaluate correlation between the percent-
age of volume of remnant pancreas and pancreatogenic
diabetes after pancreaticoduodenectomy (PD) through
the perioperative CT volumetry.
Methods: Of patients underwent PD from 2003 to 2004,
55 patients were enrolled, who were able to do pre- and
postoperative CT volumetry and to know whether post-
operative diabetes develops, aggravate, or not. New onset
of diabetes was deﬁned as medication of oral hypogly-
cemic agent for glucose control and aggravation of pre-
operative diabetes as switch from oral agent to insulin
injection.
Results: The median age was 60 years; the median follow
up duration was 67.3 months (57.3–80.8). There were 12
patients with preoperative diabetes and 19 patients with
alcoholic history. Malignant disease was observed in 39
patients and benign in 16 patients. Seventeen patients
had new onset or aggravation of diabetes (DM group), 7
out of 43 (16%) and 10 out of 12 (83%), respectively
(P < 0.001). No difference was observed between DM
group and other patients as for preoperative body mass
index, texture of pancreas, pathology, postoperative
pancreatic ﬁstula and its severity, whether underwent
postoperative adjuvant therapy in malignant disease. The
median percentage of the remnant pancreas in DM group
was 25.8% (8.0–76.6) and 32.3% (10.2–113.0) in control
group (p = 0.456).
Conclusion: New development of diabetes after pan-
creaticoduodenectomy may be not associated with
perioperative clinicopathologic factors and the percent-
age of volume of remnant pancreas, however, aggrava-
tion of preoperative diabetes seems to be closely
associated with volume percentage. More important
mechanism than the extent of removed pancreatic
parenchyma may be related with change of glucose
metabolism after this operation.
P-809
GENE EXPRESSION IN PANCREATIC
DUCTAL JUICE AND MATCHED TISSUE
IN PATIENTS UNDERGOING
PANCREATICODUODENECTOMY
M. Oliveira-Cunha1, A. Sheen1, R. J. Byers2 and
A. K. Siriwardena1
1Academic Hepatobiliary Unit, University of Manchester,
Manchester Royal Inﬁrmary; 2Department of
Histopathology, Manchester Royal Inﬁrmary
Background: Currently there is much emphasis on earlier
diagnosis of pancreatic cancer. Pancreatic juice collected
during ERCP may be a potentially useful biological ﬂuid
for this.
Aim: To explore the feasibility of cancer genome study
by the isolation of RNA from ductal juice and its cor-
relation with pancreatic tissue.
Methods: With informed consent, intra-operative sam-
pling of pancreatic juice and collection of matching tissue
samples was undertaken in 42 patients undergoing pan-
creaticoduodenectomy for suspected tumour. The RNA
isolated was then quantiﬁed by Nanodrop analysis and
RNA integrity by Bioanalyzer. We performed Poly-(A)
PCR on RNA isolated using standard published proto-
cols. Finally real-time PCR was performed. Samples were
normalized for two reference genes (GAPDH and
PSMB6) and tested for 30 Indicator Genes that have
been previously documented to be overexpressed in
pancreatic cancer. Spearman’s rank correlation test was
used to examine the relationship between pancreatic juice
and tissue.
Results: The median volume of pancreatic juice obtained
by intra-operative aspiration was 600 ll (range from 50
to 5000 ll). The median RNA yield in pancreatic juice
samples was 977 pg/ll (range from 4 g/ll to 110 ng/ll).
The median RNA yield in pancreatic tissue samples was
132 ng/ll (range from 3.8 ng/ll to 2594 ng/ll). Poly-(A)
cDNA was generated from mRNA extracted from all
samples. Analysis of 30 Indicator genes demonstrated
that there is no statistically signiﬁcant correlation of the
expression levels between pancreatic juice and tissue
samples.
Conclusions: These results demonstrate that RNA anal-
ysis of pancreatic juice is feasible using the Poly-(A)
cDNA technique, though failed to demonstrate that there
is a statistically correlation between genes expressed in
pancreatic cancer juice and tissue samples.
P-810
CENTRAL PANCREATIC RESECTION –
A TECHNIQUE THAT ACHIEVES A
BALANCE BETWEEN RESECTION AND
PRESERVATION OF PANCREATIC
TISSUE
R. A. Rossi1,2 and R. L Rossi1
1Clı´nica Alemana; 2Hospital Padre Hurtado
Introduction: The central pancreatic resection (CPR) is a
technique used to treat benign pancreatic tumours or
those with low malignant potential, localized in the
central part of the gland, in order to preserve pancreatic
tissue. Few publications in the international literature
report this technique.
Objective: To describe the surgical technique and ana-
lyze the indications, pathology, degree of pancreatic tis-
sue preserved and the morbidity and mortality associated
with CPR.
Material and method: Patients who underwent CPR be-
tween 1995–2009.
Results: Of 28 patients who underwent CPR, 19 had
cystic neoplasms and 9 had solid tumours on imag-
ing.CPR consisted of a segmental resection of the head,
neck and body of the pancreas, leaving a proximal stump
which was closed and a distal stump which was anasto-
mosed in an end to side fashion to the stomach in 23
patients and to the jejunum in ﬁve patients. Pathology
demonstrated: 19 benign cystic neoplasms, one pseudo-
cyst, ﬁve neuroendocrine tumours, one renal cell metas-
tasis and two ductal adenocarcinomas.One patient
underwent a reoperation due to an upper gastrointestinal
bleed originating at the pancreatogastric anastomosis,
which was resolved with a completion distal pancrea-
tectomy and closure of the stomach. Two (7%) patients
presented external pancreatic ﬁstulas through the surgical
drains which resolved at 15 and 20 days.There were no
deaths in this series.The median hospital stay was
8 days.A pancreaticoduodenectomy was avoided in 12
patients and an extended distal pancreatectomy was
avoided in 15.The two patients with ductal carcinomas
are alive at 28 and 78 months.No patients have presented
endocrine or exocrine insufﬁciency.
Conclusions: CPR is a technique that can be performed
successfully with low morbidity by highly experienced
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pancreatic surgeons, resolving the disease process,
avoiding the use of a pancreaticoduodenectomy or ex-
tended distal resection in selected patients, and mini-
mizing the risk of exocrine and endocrine insufﬁciency.
P-811
SURGICAL TREATMENT FOR
INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASM OF THE PANCREAS
H. Akinori, S. Yoshiaki, A. Hideaki, Y. Naohiro,
S. Yuri, O. Manabu, F. Koji, T. Tetsu and T. Yuichi
Nakadori General Hospital / Gastrointestinal Surgery
Background: Pathologic and clinical diversities make
difﬁculty in decision with treatment of IPMN of the
pancreas in some circumstances. Surgical treatment is
generally indicated for main duct IPMN and branch duct
IPMN with suspected malignancy (tumour size> or =
30 mm, mural nodules, dilated main pancreatic duct, or
positive cytology) or prominent symptoms. IPMN has a
favorable prognosis after the resection. However, inva-
sive IPMN (adenocarcinoma) shows poor prognosis We
think our indication of operation from our cases.
Methods: In our hospital, eight patients were performed
surgical treatment for IPMN from August 2006 to Sep-
tember 2009. Patients proﬁles were Male/Female: 3/5,
average age 65-years-old (range51–82).
Results: All cases were mixed type IPMN. Six patients
among eight patients were bigger than preoperative tu-
mour diameter. Average tumour size is 3.4 cm (range1.8
–5.0). Location of tumour is head/body/tail;3/4/1.Two
cases of eight were early pancreatic carcinoma, one case
was gradually increased in size from 3 to 13 cm and one
was detected dilatation of main pancreatic duct with
mucinous secretion. Other cases were not observed the
changing of the size and duct dilatation even if size was
over 3.5 cm or pancreatic ductal dilatation.
Conclusions: Early pancreatic cancer was not rare among
the IPMN, and changing of the size or ductal dilatation
were good indication factor for diagnosing the malig-
nancy.
P-812
REMNANT PANCREATIC RESECTION
FOR PANCREATIC CANCER
Y. Hirabayashi, A. Urakami, H. Murakami, Y. Oka,
H. Okumura, H. Matsumoto, K. Yamashita, T. Hirai
and T. Tsunoda
Department of Gastroenterological Surgery, Kawasaki
Medical School, Kurashiki, Japan
Background: Long-term survival is rarely achieved in
patients with pancreatic cancer. Recurrence and/or
metastasis frequently develop in multiple organs,
including the liver, lymph nodes, peritoneum, lung and
bone, even after curative resection. Only a few reports of
recurrence or second primary lesions in the remnant
pancreas after a pancreatectomy have been reported in
the literature. The value of surgical treatment is unclear
in such situations.
Aim: To evaluate the outcome of surgical treatment in
patients with pancreatic cancer recurrence in the remnant
pancreas.
Methods: All patients who underwent surgical resection
for pancreatic cancer from 1990 to 2009 (n = 105) were
evaluated from the database. Surgical outcomes were
examined in patients who underwent remnant pancreatic
resection for pancreatic cancer recurrence.
Results: Four patients, three males and one female, with
a mean age of 67 (63 – 74) years old at the initial oper-
ation were studied (Table.1). The mean interval between
the initial and second operations was 73.5 (12 –
217) months. The operative procedures were pancreati-
coduodenectomy (PD) followed by distal pancreatec-
tomy (DP) in two patients and DP followed by PD for
other two patients. Histologically, tubular adenocarci-
noma was diagnosed in both lesions in three patients. In
the remaining patient, the initial lesion was intraductal
papillary mucinous carcinoma (IPMC) and the second
was moderately differentiated tubular adenocarcinoma
(tub2). One patient died with peritoneal dissemination.
Two patients are alive with recurrent disease, and one
patient is alive without recurrence.
Table 1. Summary of 4 cases
Case AgeSex Interval Operation Histology Prognosis
1 66M 12 PDDP tub2tub2 48months
died
2 74M 45 DPPD tub2tub2 59months
alive
3 63M 217 DPPD IPMCtub2 224months
alive
4 65F 20 PDDP tub1tub1 26months
alive
Conclusion: Resection for recurrence or second primary
lesions in the remnant pancreas might result prolonged
survival. When a suspected lesion develops in the rem-
nant pancreas, surgical resection should be considered
as an option for the treatment of recurrent pancreatic
cancer.
P-813
CLASSIC PANCREATICO-
DUODENECTOMY IN THE ELDERLY
D. Georgiadou, A. Koliopanos, I. Tsipras, G. Vasiliadis,
A. Katopodi, S. Avlonitis and E. Margaris
George Gennimatas General hospital, Athens, Greece
Introduction: Surgical excision is the only potential cure
for pancreatic malignancies and a useful treatment for
other benign diseases, such as pancreatitis. Both mor-
bidity and mortality rates following pancreatic resection
increase with advanced age, according to population-
based data.
Aims: To present the experiences of treating such
pathologies in 15 years of clinical practice.
Materials and methods: The medical records of 70 pa-
tients who underwent classic pancreaticoduodenectomy
for pancreatic or periampullary tumours between Janu-
ary 1994 and June 2009 were retrospectively reviewed
and patients were divided into two age groups: the ﬁrst
included the patients over 75-year-old and the second
those who were under 75-year-old. The two groups were
compared as regards postoperative mortality, length of
hospital stay, median overall survival time and 1 year
and 5 year survival rates.
Abstracts434
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Results: Fourteen patients were aged 76 years or older
(mean age: 78.14 years) and ﬁfty-six patients were
younger (mean age: 62.96 years). There was no signiﬁ-
cant difference between the two groups concerning the
duration of hospital stay. The postoperative mortality
was 14.28% (2/14 patients) in the ﬁrst group and
10.90% (6/55 patients) in the second group, whereas the
overall median survival was 17.84 months in the ﬁrst
group and 23.12 months in the second. 1 year and
5 year survival rates were 78.57% and 14.28% respec-
tively in elderly patients and 83.63% and 21.81% in
younger patients.
Discussion: Elderly population with pancreatic cancer,
benign disease or premalignant lesions of the pancreas
need to be aware of the increased morbidity, mortality,
and prolonged convalescence they may experience. They
also need to know that surgical resection offers the only
hope for cure and that the beneﬁt of surgical resection
does not diminish with age.
P-814
PANCREATICODUODENECTOMY
AFTER LIVER TRANSPLANTATION
A. Jah1, C. Callaghan1, W. Liu1, S. Davies2,
N. Jamieson1 and R. Praseedom1
1Department of Surgery, Addenbrooke’s Hospital,
Cambridge; 2Department of Pathology, Addenbrooke’s
Hospital, Cambridge
Background: Pancreaticoduodenectomy (PD) after liver
transplantation (LT) is a challenging procedure that risks
damage to the graft arterial supply; only three cases have
been reported previously. We present two PDs performed
16 and 31 months post-LT.
Methods: Our LT database was searched for those who
had undergone post-LT PD. Case notes were reviewed.
Results: 1: A 54 year-old man with alcoholic cirrhosis
had LT in 1993. CT pre-op had shown a pancreatic head
cystic lesion. Cytology showed cellular debris but no
epithelial cells. In 1995 he became jaundiced and CT
showed a 12 cm pancreatic head mass. PD was per-
formed; operative time was 11h with blood loss of 18 L.
Recovery was uncomplicated and the patient was home
16 days later. Histology showed a superﬁcially invasive
adenocarcinoma in the pancreatic head on a background
of IPMN. One year later he required a second LT for
sclerosing cholangitis. Blood loss was 5.7 L and his
recovery was again uneventful. He underwent a third LT
for hepatic artery thrombosis 21 days later. The patient
survived for a further 12 years, dying of sepsis in 2008. A
CT scan in 2006 showed no evidence of tumour recur-
rence.2: A 58 year-old man with alcoholic cirrhosis had
LT in 2005. Unexpectedly, his explanted liver showed
multiple neuroendocrine tumour deposits. Post-operative
CT scans; blood and urine hormone assays, and an
octreotide scan were all negative. CT 3 months later
showed a pancreatic head mass. PD was performed in
2006, operative time was 8 hours, with a blood loss of 1L.
Blood transfusion was not needed and he was home
11 days later. Histology showed a duodenal somato-
statinoma with per pancreatic lymph node metastases.
He is well 24 months post-PD.
Discussion: These cases demonstrate the difﬁculties in
performing PD post-LT and the feasibility of redo-LT
post-PD. This procedure presents unique challenges in
terms of patient selection, operative techniques, choice
of immunosuppressants, and management of compli-
cations.
P-815
PANCREAS TRANSPLANT WITH
ENTERIC DRAINAGE: EXPERIENCE OF
LEFT-SIDED IVC IN TAIPEI VETERAN’S
GENERAL HOSPITAL
Y.-M. Shyr and S.-E. Wang
Taipei Veterans General Hospital
Background: Pancreas transplant is currently the treat-
ment of choice for cure of Insulin-dependent diabetes
mellitus (IDDM) or Type 1 diabetes which eventually
leads to nephropathy, neuropathy, retinopathy and an-
giopathy. According to the International Pancreas
Transplant Registry (IPTR) and United Network for
Organ Sharing (UNOS), over 25 000 cases of pancreas
transplant have been performed worldwide, with an in-
crease of more than 1600 – 1800 cases per year, mainly in
the USA. The 1 year pancreas graft survival rate is
86.0% and 5 year is 69.8%, very close to those of kidney
transplant. Among the whole pancreas transplants, 80%
are simultaneous pancreas-kidney transplant (SPK), 15%
pancreas after kidney transplant (PAK), and 5% pan-
creas transplant alone (PTA).
Methods: In Taipei VGH, 43 cases of pancreas trans-
plant were performed (40 for IDDM and three for
NIDDM) between September. 19, 2003 and October.
2009. The success rates for both pancreas and kidney
transplants are 100%. The blood sugar usually returned
to normal level within 5 hours (median) after revascu-
larization of the pancreas grafts. Among the 37 pancreas
transplants, we have two cases with left-sided Inferior
Vena Cava (IVC). Due to difﬁcult access to the IVC,
portal venous drainage (graft portal vein to recipient
SMV) with head-up placement of pancreas graft in one,
and systemic venous drainage (graft portal vein to re-
cipient right CIV) with head-down placement of pancreas
graft in the other. Both patients recovered smoothly and
have been insulin-independent.
Conclusions: Pancreas transplant provided an ideal
insulin-free solution for DM, especially IDDM. In pa-
tients with left-sided IVC, either portal drainage with
head-up placement of pancreas graft in or systemic
drainage with head-down placement of pancreas graft
could be an ideal alternative for venous drainage.
P-816
DUODENODUODENOSTOMY VS.
DUODENOJEJUNOSTOMY FOR
ENTERIC DRAINAGE IN PANCREAS
TRANSPLANTATION
G. Gunasekaran, A. Wee, J. Rabets, V. Krishnamurthi
and C. Winans
Cleveland Clinic Foundation
Background and objective: Enteric drainage has now
become the preferred modality for pancreatic transplan-
tation andmost institutions performduodenojejunostomy
(DJ). Duodenoduodenostomy (DD) is a novel technique
that may offer additional beneﬁts by allowing access to the
graft. Herein we compare these two techniques.
Methods: We reviewed all pancreas transplantations
done at our institution from January 2008 to May 2009.
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The operative technique involved placement of the pan-
creas graft in a head-up conﬁguration with arterial
anastomosis to the recipient right common iliac artery
and venous drainage via the recipient inferior vena cava.
Stapled enteric drainage was performed in all cases using
a circular stapler. The allograft duodenum was anatom-
ized to the recipient jejunum or duodenum. Total oper-
ative time, graft survival, and major post-operative
complications were compared.
Results: Table 1: About 41 pancreas transplantations
were performed (14 DD, 27 DJ). Two of 14 grafts (14%)
in the DD group thrombosed compared to none in DJ
(P < 0.05). There was no enteric leak or bowel
obstruction in either group. Gastrointestinal bleeding
was higher in DD compared to DJ (4 vs. 0, P < 0.01).
Endoscopy and/or angioembolization were required in
two patients and remaining two patients were managed
with blood transfusions alone. There was no rejection in
either group and all technically successful grafts remain
functional. Mean follow up was 10 (range, 1–18) months.
Table 1.
DD
(n = 14)
DJ
(n = 27) p
Operative
Time (min)
SPK 358 340 NS
PTA 173 170 NS
Complications Thrombosis 2 0 < 0.05
Enteric leak 0 0 –
Bleeding 4 0 < 0.01
DD duodenoduodenostomy, DJ duodenojejunostomy,
SPK simultaneous pancreas and kidney transplantation,
PTA pancreas transplantation alone
Conclusion: Stapled DD using a circular stapler is tech-
nically feasible with no increase in operative time or en-
teric leak. Bleeding rates appear to be greater following
DD, which may be due to the use of metal stapler over
highly vascular duodenum. This should be balanced
against the beneﬁts of endoscopic monitoring and access
to the pancreatic duct conferred by DD drainage. Fur-
ther studies investigating DD using a two layer hand
sewn anastomosis to circumvent anastamotic site bleed-
ing is currently underway.
P-817
PANCREAS-KIDNEY
TRANSPLANTATION: WAITING LIST
DYNAMICS IN THE STATE OF SAO
PAULO, BRAZIL
E. Chaib1, F. Silva1, Y. Souza1,2, R. Meirelles1,
M. Aranha1, I. Siqueira1, M. Maruyama1, E. Massad3
and L. D’Albuquerque1
1Transplantation Surgery unit, Department of Gastro-
enterology, University of Sa˜o Paulo, School of Medicine;
2Universidade Nove de Julho; 3Medical Informatic Unit,
LIM 01, University of Sa˜o Paulo, School of Medicine
Background: In this study it was simulated an hypotheti-
cal increase of 50% in the number of Pancreas-Kidney
(PK) transplantation in the State of Sa˜o Paulo, Brazil,
using a mathematical model we developed previously.
Aim: Assess the performance of our state PK trans-
plantation program also analysing when the number of
transplantation will meet our waiting list demand.
Material and methods: We collected ofﬁcial data from
State Center of Transplantation – State Secretariat of
Sa˜o Paulo about our pancreas-kidney transplantation
program between January 1999 to December 2007. We
projected the size of the waiting list by taking into ac-
count the incidence of new patients per year, the number
of PK transplantation carried out in the year and the
number of patients that died in the waiting list or were
removed from the list for many reasons. These variables
were treated by a model developed elsewhere.
Results: We have found that the waiting list demand will
meet the number of PK transplantation by the year 2022.
Number of PK transplantation (TR), the incidence of
new patients on the list (It) and the number of patients’
who died in the waiting list (DT) in the state of Sa˜o Paulo
since 2000
Year It Dt Tr
2000 163 38 33
2001 126 51 52
2002 128 46 63
2003 138 48 74
2004 143 52 82
2005 169 58 64
2006 213 69 72
2007 167 71 85
Conclusion: We believe that is perfectly possible in the
years ahead minimize the waiting time for pancreas
transplantation since we expand the donor pool using
less-than-ideal donors.
P-818
SURGERY FOR GASTROINTESTINAL
STROMAL TUMOURS OF THE
DUODENUM
C.-Y. Yang1,2, C.-Y. Lee1,2, C.-C. Huang1,3, R.-H. Hu1,2,
P.-H. Lee1,2 and Y.-W. Tien1,2
1College of Medicine, National Taiwan University;
2Department of Surgery, National Taiwan University
Hospital; 3Department of Pathology, National Taiwan
University Hospital
Background: Duodenal gastrointestinal stromal tumours
(GISTs) represent a unique dilemma with varied surgical
treatment options. However, the impact of operative
methods on disease recurrence has never been addressed.
Objectives: The study wanted to compare the feasibility,
complications, and outcomes of pancreaticoduodenec-
tomy, and limited operation as surgical treatment for
duodenal
GISTs.
Methods: We retrospectively reviewed the medical re-
cords of all patients with duodenal GISTs treated at our
hospital from January 2001 to December 2008.
Results: Of the 25 patients included for analysis, 9 had
pancreaticoduodenectomy (PD) and 16 had limited
operation. Comparison of clinicopathological data be-
tween tumours treated by PD and by limited operation
showed no signiﬁcant differences in patient age, sex, and
symptoms, location of tumour, tumour grade, immuno-
histochemical staining pattern, or complications after
surgery. However, patients with tumours large than 5 cm
(P = 0.005) or not diagnosed as GISTs before surgery
(P = 0.004) were signiﬁcantly more frequently treated
by PD. In multivariable analysis, the only signiﬁcant
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predictor for disease recurrence was high-risk duodenal
GISTs.
Conclusion: Based on the fact that type of operation was
not correlated to operative risk and disease recurrence,
limited operation rather than PD should be attempted for
duodenal GIST without involvement of papilla of Vater
to preserve more pancreas parenchyma, duodenum, and
common bile duct.
P-819
PARTIAL AND TOTAL SPLENECTOMY
FOR NON-PARASITIC SPLENIC CYSTS
J. R. Szczepanik1, A. J. Meissner1, A. M. Szczepanik2
and A. Misiak1
1Department of General and Hematological Surgery,
Institute of Hematology, Warsaw, Poland; 2Department of
Internal Medicine, Miedzyleski Hospital, Warsaw, Poland
Background: Non-parasitic splenic cysts (NPSC) are
relatively rare.
Aim: The study was to present our surgical strategy in
the management of NPSC.
Methods: From 2003 to June 2009, 19 patients were
surgically treated for NPSC. Patients with splenic cysts
constituted 4.7% of all 405 patients subjected to sple-
nectomy during the study period. The study group in-
cluded 14 women and 5 men, aged 17–54, 29.9 years in
average. In all patients, splenic cysts were diagnosed by
means of ultrasonography and conﬁrmed by computed
tomography scan. The size and location of the cyst, its
relationship to hilar vessels and dimension of normal
splenic parenchyma were determined. The indication for
operation was a splenic cysts of diameter larger than
5 cm, and rapidly growing cysts. Type of surgery de-
pended on cyst location as well as intraoperative ana-
tomical and technical conditions.
Results: In 12 patients cysts were located in the upper
splenic pole, in two in the lower pole and in ﬁve cen-
trally in the splenic hilus. In 17 patients cysts were
single, in two multiple. The mean diameter of the
treated cysts was 9.5 cm (range 5–17 cm). In 12 patients
open partial splenectomy, in four open total splenec-
tomy and in three laparoscopic total splenectomy was
performed. All patients survived the operation. The
mean operation time was 96 min (range 70–160) for
partial splenectomy, 86 min (70–100) for open total
splenectomy and 71 min (45–114) for total laparoscopic
splenectomy. There were no postoperative deaths and
complications in patients after partial and total sple-
nectomy. Pathological examination showed epithelial
(true) cysts in 15 patients and pseudocysts in four. The
mean hospital stay was 9.7 days (range 8–12 days) after
partial splenectomy, and 7.6 days (range 6–10 days)
after total splenectomy.
Conclusion: We consider partial splenectomy as the
method of choice in the management of NPSC. Total
splenectomy should be performed only in centrally
located and multiple cysts.
P-820
NATURAL LANGUAGE PROCESSING
FOR THE DEVELOPMENT OF A
CLINICAL REGISTRY: A VALIDATION
STUDY IN IPMN
M. Al-Haddad1, J. Friedlin1,2, J. Kesterson2,
J. A. Waters1, J. R. Aguilar-Saavedra1 and C. Schmidt1
1Indiana University School of Medicine; 2Regenstrief
Institute
Introduction: Most medical records exist as free-text
documents. Medical natural language processing (NLP)
systems have been developed to identify, extract, and
encode information within clinical narrative text. To
date, the role of NLP in clinical research and patient care
remains limited. Intraductal papillary mucinous neo-
plasms (IPMNs) of the pancreas are premalignant lesions
requiring periodic surveillance.
Aim: To validate the accuracy of a novel NLP system to
identify patients with IPMNs by comparison to existing
prospectively maintained surgical databases.
Methods: To identify all patients with a surgical path-
ological diagnosis of IPMN, within a multi-hospital
clinical network, a multistep process was used to reﬁne
the search criteria. The system was assessed periodically
by sampling and reviewing medical records. Results
were compared to a manually compiled IPMN surgical
database. Patients not detected by both systems under-
went detailed examination by comprehensive chart re-
view.
Results: NLP detected 5694 patients with mucinous
cysts. Among those, there were 215 patients with surgical
pathology conﬁrming IPMN. NLP identiﬁed all but se-
ven patients present in the surgical database, and iden-
tiﬁed additional 37 IPMN patients not included in the
surgical database. Using the manually collected database
as the gold standard, the sensitivity of NLP was 97.7%
(95% CI: 95–99%), with a positive predictive value of
95.7% (95% CI: 92.6–97.6%).
Conclusion: NLP is a reliable and accurate method for
identifying selected patient cohorts, and represents a
valid alternative to costly and burdensome manual chart
review. This system would facilitate consistent follow-up
and clinical investigation for patients with premalignant
conditions like IPMN.
P-821
SUCCESSFUL OCTREOTIDE
TREATMENT OF CHYLE FISTULA
FOLLOWING PANCREATIC DISORDERS
J. R. Oms Bernad, R. Mato Ruiz, A. Balsach Sole´,
M. Garrido Romero, F. Campillo Alonso and
J. Sala Pedro´s
Consorci Sanitari de Terrassa
Background: Chyle ﬁstula is an unfrequent condition
related to pancreatic diseases or surgery. The ﬁrst line
treatment is medical management which often delays the
recovery of the patient. Octreotide may reduce hospital
stay by early decreasing the output of the ﬁstula, enabling
its closure.
Abstracts 437
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
Aim and methods: We describe four cases of chyle leak
following pancreatic surgery or pancreatitis, successfully
treated with octreotide 100 micrograms/8 hours.
Results: Case 1. An 80-year-old woman underwent
pancreatoduodenectomy due to pancreatic carcinoma.
After an unremarkable early postoperative period, a
daily output of 2000 ml milky ﬂuid appeared from the
drain once diet had resumed. Chyle ﬁstula resolved
within ﬁve days. Case 2. After a severe acute pancrea-
titis requiring drainage of a pancreatic abscess, a 55-
year-old woman was referred for drainage of an
abdominal milky ﬂuid collection. A daily output of
750 ml ceased after seven days of treatment. Case 3. A
75-year -old women with a suspected ampullary tumour
presented a duodenal perforation during a pneumatic
dilatation of an otherwise asymptomatic post pyloric
estenosis. She underwent a Roux-en-Y duodenojejun-
ostomy. A postoperative chyle ﬁstula of 150 ml closed
at the fourth day of treatment. Case 4. Two pancreatic
pseudocysts following a severe acute gallstone pancrea-
titis were drained through a double Roux-en-Y cys-
tojejunostomy in a 73-year -old woman. A chyle ﬁstula
of 750 ml was collected by the drains and was resolved
after six days of octreotide.
Discussion: Chyle leak is a rare complication following
pancreatic disease or resection. In general, it is success-
fully managed with parenteral nutrition. As in our series,
octreotide therapy has shown a rapid response and
minimal side effect in neck, chest or retroperitoneal chyle
ﬁstulas. Thus, it may reduce expenses and patient mor-
bidity in the setting of pancreatic diseases.
P-822
LINK OF HEPATOPANCREATIC
BILIARY AREA DISEASES WITH AN
HELICOBACTER INFECTION PRESENT
IN THIS AREA
V. Lisienko and E. Mikaelyan
Russian Federation, Ekaterinburg, Hospital 7
Background: The research into Helicobacter (HB) infec-
tion prevalence extends. Ulcer eradication therapy, close
anatomophysiologic link of hepatopancreatic biliary area
organs, growing number of patients with complicated
bile ducts (BD) and pancreas (P) diseases made us study
this problem.
Objective: To ﬁnd out possible HB in pathologic BD, to
conﬁrm HB occurrence in pancreatitis and purulent
pancreatitis.
Methods: Cytologic examination of tissue sampling pap
smears – brush cytology from BD mucous tunic. His-
tology and immunology methods: Substantiation of HB
presence in P ducts. HB inﬂuence on process course.
Results: We found HB infection in 10 out of 24 patients
operated for BD diseases. Low degree of infection was in
16%, mean degree – in 34%, high degree – in 50%.
Histology and immunology conﬁrmed HB presence. The
patients received antiHB therapy and showed reliable
clinical and laboratory improvement as compared to the
controls. HBmigration into BD is possibly caused by HB
presence in duodenum during duodeno-stasis, hemato-
genic and lymphogenic means. HB in P is possible in BD
hypertension, BD obstruction. BD pressure is higher
than in P. There is a reﬂux of infected bile into P: 7 out of
37 patients with pancreonecrosis received antiHB therapy
and showed no purulent complications. Three patients
out of 30 without antiHB therapy developed purulent
pancreatitis.
Conclusion: We determined HB in pathologic BD, im-
proved outcome of the disease after eradication therapy.
HB infection presence in pancreatitis was conﬁrmed.
P-823
BLASTOMYCOSIS: A DIFFERENTIAL
DIAGNOSIS OF PERIAMPULLARY
TUMOURS
C. Paganini1, C. Minnani1, F. Pontes2, R. Silva1,
A. Jr, Pacheco1, A. Moricz1 and T. De Campos1,3
1Department of Surgery - Santa Casa School of Medical
Sciences - Sa˜o Paulo; 2Department of Pathology - Santa
Casa School of Medical Sciences - Sa˜o Paulo; 3University
of Sa˜o Paulo - LIM 62
Background: Paracoccidioidomycosis, or South Ameri-
can Blastomycosis, is a systemic mycosis caused by the
dimorphic fungus Paracoccidioides resiliencies. The
objective of this paper is describe two rare patients in
which intra-abdominal paracoccidioidomycosis behaved
like periampullary neoplasia once the bile duct had been
compromised.
Methods: Describe two patients with Blastomycosis that
presented jaundice and that underwent to laparotomy
with diagnosis of Periampullary tumour.
Results: Both patients underwent a palliative procedure,
due to great extension of the disease. The diagnosis of
Blastomycosis was conﬁrmed only after deﬁnitive
pathology diagnosis. After speciﬁc treatment with
Amphotericin B, both patients improved and were dis-
charged.
Conclusion: One hundred years after Adolfo Lutz ﬁrst
described it, paracoccidioidomycosis continues to thrive
in Latin America. Although its incidence has diminished,
thanks to ease of diagnosis and timely therapy, it must be
considered as a differential diagnosis for intra-abdominal
tumours, especially in individuals who come from en-
demic areas.
P-824
PANCREATIC CONSISTENCY IN ASIAN
SUBJECTS
Y. Kitagawa, S.Fukata, K. Kawabata and K. Fujishiro
Department of Surgery, National Center for Geriatrics and
Gerontology
Background: Consistency of the pancreas is one of the
most important prognostic factors for pancreatic anasto-
mosis. However, pancreatic stiffness had been evaluated,
subjectively. We introduce a tactile sensor system (Venous
HandyBiosensor systemTM,AXIOM, Fukushima, Japan)
for measurement the consistency of the pancreas. A
material has its own resonance frequency. If material
touches an oscillated object, a shift of the resonance fre-
quency will be observed. The difference between the fre-
quencies under pre and post oscillate conditions depends
on the stiffness. So, the consistency of material can be
measured by monitoring the shift in the frequency. The
tactile sensor system is composed of a sensor probe, an
ampliﬁer and a ﬁlter; the probe is connected to a piezo-
electric transducer with a resonance frequency of 57 kHz.
Measurements were made 200 times per second, and the
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magnitude of frequency change was processed by con-
nected computer with original software.
Aim: Measuring the consistency of the pancreas in Asian
subjects to clarifying the normal value. Methods:
About 75 patients with mean age 69.8 were registered
with this study. These patients did not have any clinical
sign of pancreatitis. The serum amylase level was
133.4 ± 87.8 IU/dL. Pancreas head and body (neck)
were measured 2 –4 times on the same point. If the
patients had pancreatic tumour, the measurement was
performed far from the tumour.
Results: The consistency of the pancreas head was
699.5 ± 184.3 Hz. The consistency of the pancreas body
was 720.8 ± 143.1 Hz.
Conclusion: This method is easily maintained the con-
sistency of pancreas non-invasively. Further investigation
must be need for elucidate the relationship between
consistency and pancreatic leakage.
P-825
EFFECT OF RIKKUNSHITO, A KAMPO
MEDICINE, FOR GASTRO-INTESTINAL
SYMPTOMS AFTER PYLORUS-
PRESERVING PANCRETO-
DUODENECTOMY (PPPD)
S. Yamada, M. Shimada, T. Utsunomiya, Y. Morine,
S. Imura, T. Ikemoto, J. Hanaoka, H. Mori, S. Iwahashi,
Y. Saito, Y. Kawata and H. Miyake
Department of Surgery, the University of Tokushima,
Japan
Background: Pylorus preserving pancreatoduodenecto-
my (PPPD) has now become the standard procedure for
various types of periampullary diseases; however, gastric
stasis occurs in 30%–50% of all patients, and the optimal
treatment strategy for gastric stasis remains to be eluci-
dated. Rikkunshito (Tsumura, Tokyo, Japan), a Kampo
medicine, has been traditionally used for dyspeptic
symptoms, which has reported to improve cisplatin-in-
duced appetite loss (decreased oral intake) through ele-
vation of plasma levels of acylated-ghrelin
(Gastroenterology 2008). The aims of this study were to
investigate the effects of Rikkunshito for patients with
postoperative gastro-intestinal symptoms after PPPD
and possible mechanism.
Patients and method: Nine patients (ﬁve male, four fe-
male) with gastro-intestinal complaints 2 weeks after
PPPD were enrolled in this study. The patients received
Rikunshito (TJ-43, Tsumura and Co., Tokyo, Japan) at a
daily dose of 7.5 g (2.5 g orally, three times per day). The
plasma concentration of ghrelin (total, acetylated and
desacetylated) and leptin, which had active ghrelin
antagonism, were measured, and the Gastrointestinal
Symptom Rating Scale (GSRS) (Dig Dis Sci 1988) were
also compared between the pre- and post-treatment
periods.
Results: The GSRS scores after administration of Ri-
kkunshito were signiﬁcantly improved compared with
these levels before administration. There was no signiﬁ-
cant difference of total ghrelin levels between pre and
post treatment period. However, in four of nine patients,
acetylated ghrelin levels signiﬁcantly increased after
treatment. Desacetylated ghrelin levels and leptin levels
were not signiﬁcantly increased.
Conclusion: These ﬁndings suggested that Kampo medi-
cine ‘Rikkunshito’ improved gastro-intestinal symptoms
through elevating plasma concentration of acetylated
ghrelin, therefore, become a promising option for pa-
tients with gastro-intestinal symptoms after PPPD.
P-826
THE ROLE OF SIMPLE CLINICAL TESTS
TO DETERMINE THE DISEASE
SEVERITY IN AP
F. Kurti1, J. Basho1, A. Duni2, L. Cakerri3 and
I. Akshia4
1UHC ‘Mother Theresa’ Service of Gastro-Hepatology;
2Central Policlinics of Tirana; 3Department of Biophysics
and Experimental Medicine; 4UHC ‘Mother Theresa’,
Department of Statistics
Introduction: Acute Pancreatitis (AP) is one of the most
common gastroenterological disorders with an incidence
ranging from 5–80 cases /year/100 000inhabitants. Most
patients suffer mild or edematous pancreatitis (75–85%
of cases), with a mortality rate less than 1%, where as
severe acute pancreatitis occurs in 15–25% of cases and
has a mortality risk of 10–24%. A prediction of the
course and outcome of the disease would be desirable
when patients are ﬁrst presented at the hospital.
Aim and methods: Our aim was to prospectively deter-
mine the value of simple clinical tests such as WBC
count, HTK and CRP in predicting the disease severity in
AP.This was a prospective, nonrandomized study. The
study population consisted of 55 consecutive patients, 41
males and 14 females. Mean age of patients was
45.74 years old STD ± 13.05, (range 19–72). All the
patients were diagnosed with AP with clinical, labora-
torial and imaging studies. Six patients (10.9%) had
severe acute pancreatitis according to Ranson score, and
49 patients (89.09%) suffered mild to moderate pancre-
atitis. CRP, Htk and WBC values were measured on
admission, 3rd and 7th day. We retrospectively analyzed
the CRP, Htk and WBC values in the groups with mild
AP and severe AP.
Results: CRP, Htk value and WBC count signiﬁcantly
differ in groups of patients with mild acute pancreatitis
and severe acute pancreatitis. Patients with severe acute
pancreatitis had CRP values more than 150 mg/L, Htk
more than 44% and WBC more than 18·103 /L.
Conclusion: Simple routine clinical test (i.e. HTC, WBC
count and CRP value) are helpful in predicting the
development of severe acute pancreatitis. They are
effective in predicting severity in acute pancreatitis and
can be quickly assessed on admission.
P-827
TWO CASES OF INSULINOMA
MISDIAGNOSED AS
NEUROPSYCHIATRIC DISEASE.
IMPORTANCE OF EARLY DIAGNOSIS
M. Zisa, E. Pulvirenti, A. Toro, T. Guastella and
I. Di Carlo
Universita` degli studi di Catania
Background: Insulinoma is deﬁned by Whipple’s triad.
However, up to 60% of insulinomas show an unusual
presentation. We report two cases misdiagnosed as neu-
ropsychiatric disease.
Case reports: Case 1: A 53-year-old.man was admitted to
Hospital in 2003 because of headache, dizziness, sweating
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and weakness. He was treated for 3 years with psycho-
therapy due to aggressiveness. He appeared tachycardic;
blood pressure was 140/90. Laboratory tests showed
hypoglycemia (38 mg/dL).CT-scan, MRI and dosages of
insulin and C-peptide conﬁrmed a diagnosis of insuli-
noma in pancreatic body. After surgical intervention the
psychiatric disorders disappeared. Case 2: A 48 year.-
old.man was admitted to Hospital in 2008 because of a
car accident due to loss of consciousness. A diagnosis of
complex partial seizure was made two years before. At
the admission, he appeared pale, tachycardic; blood
pression was 130/85.Laboratory tests showed a severe
hypoglycemia (30 mg/dL).Hypertonic glucose solution
was administered with resolution of symptoms. A sub-
sequent CT-scan detected a nodular mass in the pancre-
atic tail, diagnosed as insulin after MRI and dosages of
insulin and C-peptide. The patient was treated with sur-
gical excision and seizure disappeared after operation.
Conclusion: Neurologic or psychiatric presentation in
patients affected by insulinoma could be cause of mis-
diagnosis. Diagnosis of insulin should always be con-
sidered whenever these symptoms occur, especially if
unresponsive to speciﬁc therapy. Early diagnosis of ins-
ulinoma often results in cure, and avoids adverse conse-
quences including neurologic damage.
P-828
ONODERA’S PROGNOSTIC NUTRITION
INDEX IS USEFUL FOR PATIENTS
UNDERGOING PANCREATICO-
DUODENECTOMY
H. Baba1, S. Takahiro1, G. Narihide1 and A. Shigeki2
1Shuwa General Hospital; 2Tokyo Medical and Dental
University
Background: Nutrition status of patients undergoing
surgery is a critical factor for predicting postoperative
course. Infectious complications often occur with mal-
nutrition. Onodera and his colleagues have proposed a
clinically useful nutrition index for predicting outcomes
thirty years ago.
Aim: We aimed to clarify whether Onodera’s prognostic
nutrition index (PNI) is useful for patients undergoing
pancreaticoduodenectomy (PD).
Methods: Twenty ﬁve patients who underwent PD
(conventional or pylorus preserving) were evaluated.
Enteral feeding was started on the ﬁrst postoperative day
and oral diet began soon after. PNI, postoperative hos-
pital stay, surgical site infection, pancreatic ﬁstula, and
anastomosis break down were investigated. PNI is cal-
culated as 10 · alb (g/dl) + 0.005·peripheral lympho-
cyte count (/mm3). Value below 40 is suggested to
postpone the operation. 45 or above is considered safe.
Results: There were ten conventional PD and ﬁfteen
pylorus preserving. Fourteen patients were pancreatic
cancer. There were ﬁve patients whose PNI was under 40.
On the other hand, ten patients were above 45. Average
PNI of pancreatic cancer patients were 41.2 whereas 45.1
in other diseases. Surgical site infection occurred in eight
patients, and pancreatic ﬁstula in six patients. Modality
rate of patients with PNI less than40, between 40 and 45,
and above 45 were 80%, 60%, and 30%, respectively.
Postoperative hospital stay did not associate with the
PNI status.
Discussion: When discussing operative outcomes with
nutrition factors, procedures and postoperative man-
agements must be in uniform and stable. We must also be
aware that PNI was ﬁrst introduced in the era of total
parental nutrition and utilized for advanced colorectal
cancer patients. Applying PNI to different disease and
procedure needs careful consideration.
Conclusion: As far as surgical procedure and postoper-
ative management are well maintained, Onodera’s PNI
may be applied to patients undergoing PD.
P-829
EVALUATION OF SURGICAL OUTCOME
SCORES ACCORDING TO ISGPS
DEFINITIONS IN PATIENTS
UNDERGOING PANCREATIC
RESECTIONS
B. Knight, A. Kausar, M. Manu, D. Sherlock and
D. O Reilly
North Manchester General Hospital
Aims: To analyse the Physiological and Operative
Severity Score for the enumeration of Mortality and
Morbidity (POSSUM), the Portsmouth variant (p-POS-
SUM) and the Glasgow Prognostic Score (GPS) in pa-
tients undergoing major pancreatic resection.
Methods: All consecutive patients undergoing major
pancreatic resection over a 32 month period were in-
cluded. POSSUM, p-POSSUM and GPS score were
calculated for each patient and correlated against the
observed mortality and morbidity using the International
Study Group of Pancreatic Surgery (ISGPS) deﬁnitions.
Results: The O/E ratio for POSSUM mortality, POS-
SUM morbidity and p-POSSUM mortality was 0.24
(P < 0.001), 0.94 (p = 0.13) and 0.79 (p = 0.09).
POSSUM had a ‘poor ﬁt’ with respect to predicting
morbidity (x2 = 21.51, 8 degrees of freedom,
p = 0.0059, underestimating morbidity in the low risk
groups and over predicted morbidity in the high risk
groups. A GPS score of zero was associated with fewer
post-operative complications (p = 0.0026) whereas a
GPS score of greater or equal to one was associated with
a greater number of post operative complications
(p = 0.003).
Conclusion: POSSUM has a limited role as an outcome
score in pancreatic resection. The Glasgow Prognostic
Score may be a novel alternative to POSSUM as a pre-
operative predictor of outcome.
P-830
GASTRIC DUPLICATION CYST OF THE
PANCREAS
K. Kamei1, T. Yasuda1, S. Satoi1, H. Sakamoto2,
M. Kitano2, T. Chikugo3, Y. Takeyama1 and
H. Shiozaki1
1Department of Surgery, Kinki University School of
Medicine; 2Department of Gastroenterology, Kinki
Unicersity School of Medicine; 3Department of Pathology,
Kinki University School of Medicine
Gastric duplication cyst (GDC) is a congenital anomaly
that is rarely seen in adults, and rarely diagnosed
preoperatively, because symptoms tend to be non-
speciﬁc; even it arises in relation to the gastrointestinal
tract. Herein, we report a rare case of a GDC of pancreas
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in an adult. A 45-year-old woman was admitted to our
department for the investigation of anemia. Abdominal
ultrasonography revealed a large cystic lesion, measuring
about 4 by 7 cm with calciﬁcation in the tail of the
pancreas. Contrast enhanced computed tomography of
the abdomen revealed a non-enhanced cystic lesion with
non-enhanced wall. Endoscopic retrograde pancreatog-
raphy revealed a mild extended main pancreatic duct and
an aberrant pancreatic duct, but there is no communi-
cation with the cyst. Because the malignant tumour could
not be ruled out, we performed distal pancreatectomy
with splenectomy. The pathological examination re-
vealed that the inner wall of the cyst consisted of
columnar epithelium and smooth muscle layer. Immu-
nohistochemical analysis revealed that columnar epithe-
lium was immuno-positive for cytokeratin7 (CK7) and
immuno-negative for cytokeratin20 (CK20) and that the
glands were immuno-negative for CK7 and immuno-
positive for CK20. Therefore a diagnosis of the GDC of
the pancreas was made. We conclude that, although
GDC of the pancreas is rare, it should be considered in
the differential diagnosis of cystic tumours of the
pancreas.
P-831
CHOLEDOCHOLITHIASIS AND CDB
EXPLORATION. PRIMARY CLOSURE
OR T-TUBE PLACEMENT?
K. Papapolychroniadis, D. Paramythiotis,
E. Karamanlis, D. Panagiotou, P. Georgiadou and
E. Fahantidis
1st Propedeutic Surgical Department, Aristotle University
of Thessaloniki A.H.E.P.A. Hospital Thessaloniki, Greece
Background/aim: Traditionally, the CBD choledochoto-
my for exploration and stones extraction usually fol-
lowed by T-tube placement for bile drainage. After
meticulous patients’ selection and information we per-
formed CBD primary closure by 5–0 prolene sutures
following exploration and stones removal. We present
our results of this challenge patients study.
Patient-Method: We present a series of 20 patients of
mean age 53 (range 27 ± 86) years, 14 women- 6 men,
with choledocholithiasis in a comparative study which
was performed in 1st Propedeutic Surgical Department
of A.U.Th. In half of 20 patient’s series (10 patients,
main study group) after CBD opening, exploration and
stones clearing, a primary closure of CBD was performed
with 5-0 prolene suture, additionally to cholecystectomy.
An intraoperative cholangiogram via cystic duct was
performed as CBD for clearance and leakage checking.
In the rest 10 patients (control study group), following
CBD exploration and stones removal, a T-tube place-
ment was performed for intraoperative cholangiogram,
postoperative bile drainage and cholangiogram in the
early postoperative period.
Results: There was no severe morbidity in primary CBD
closure patients except temporarily bile leakage in one
patient and the mean postoperative hospital stay was
3 days. In the control group the mean postoperative
hospital stay was 10 days and there was much more
morbidity. We refer and analyze all the parameters of
this study as operative time, postoperative complications,
mean discharge time, and ﬁnancial factors.
Conclusion: Primary CBD closure is a safe procedure
with many advantages in relation to T-tube placement.
P-832
XANTHOGRANULOMATOUS
CHOLECYSTITIS (XGC) –
A DIAGNOSTIC DILEMMA
J. R. Memon, M. Pai, J. Long, H. Nagy and S. Duncan
HPB Unit, Hammersmith Hospital, Imperial College,
London
Introduction: Xanthogranulomatous cholecystitis (XGC)
is an unusual form of chronic cholecystitis characterised
by marked thickening of the gallbladder wall and accu-
mulation of lipid laden macrophages. It is frequently
misdiagnosed preoperatively with gallbladder carcinoma.
The aim of this study was to assess the preoperative
clinical and radiological characteristics, operative ﬁnd-
ings and histological features of patients with XGC based
on the experience of a single institution. In addition a
literature search was performed to identify previously
reported cases.
Methods: The records were reviewed of patients who had
undergone elective cholecystectomy between 2005–2009
in our institution. In addition a literature search for pa-
tients with XGC was performed using PubMed and
MEDLINE.
Results: Eight cases of XGC were identiﬁed in 1589
cholecystectomies (0.5%) performed in our institution;
whilst 1295 cases in 36 582 cholecystectomies (3.5%)
were identiﬁed in the published literature. The most
common presentation was pain (7 and 889) whilst gall-
stones were noted in 8 (100%) and 1071 (83%) patients.
Thickening of the gall bladder wall was noted radiolog-
ically in 7 (88%) and 1010 (78%) patients, with carci-
noma of the gallbladder being suspected preoperatively
in 2 (25%) and 178 (14%). Laparoscopic cholecystec-
tomy was attempted in 4 (50%) and 208 (16%) patients,
but converted to open surgery in 3 (75%) and 83 (40%).
Conclusion: Preoperative differentiation between XGC
and carcinoma of the gallbladder remains challenging
due to similarities in clinical presentation, radiological
and operative ﬁndings. In view of this there should be a
low threshold for conversion from a laparoscopic to an
open procedure.
P-833
PERCUTANEOUS TREATMENT OF
CHOLEDOCOLITHIASIS. THE
ELECTIVE PROCEDURE IN RETAINED
BILIARY DUCT STONES WITH BILIARY
DRAINAGE
G. Secondo, G. Sa´nchez, J. Bado, J. Costa, P. Sciutto
and J. Rodrı´guez
Departament of Surgery, Maciel Hospital, Surgical Clinic
‘2’ from the Uruguayan State University, Montevideo,
Uruguay
Background: The Percutaneous procedure (Mazzariello’s
technique), was the ﬁrst choice for the retained biliary
duct stones treatment, in the presence of external biliary
drainage, because it has a low morbidity and mortality
rate and low cost.
The goal of our studies was to describe our experience
with 82 personal cases; with no mortality and high
efﬁciency when we compare it with endoscopic papillot-
omy and surgery.
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Objectives: We reviewed a prospectively database iden-
tifying 82 patients, between February 1999 and Septem-
ber 2009, analyzing treatment, procedures and outcomes.
Methods: Complication data was entered into a vali-
dated postoperative complication database, for evalua-
tion of the results.
Results: An 80% of successful procedures were achieved,
and in the last ﬁve years, it was superior to 90%. There
was no mortality and the morbidity was rare; with seven
patients with ﬁstula disruption, having no consequences.
Two cases needed reoperation.
Conclusion: The percutaneous procedure of the retained
biliary duct stones was the ﬁrst choice to treat these pa-
tients. The mortality and morbidity of the endoscopic
papillotomy was 0.6– 1% and 8% respectively, higher
than the percutaneous procedure.
P-834
PREVALENCE OF HELICOBACTER SP
IN CHRONIC CHOLECYSTITIS AND
CORRELATION WITH CHANGES ON
THE HISTOLOGICAL PATTERN OF THE
GALLBLADDER
A. De Moricz1, M. Melo2, A. M. Castro3,
T. De Campos1, R. Altenfelder Silva1 and
A. M. JR, Pacheco1
1Department of Surgery, Faculty of Medical Sciences of
Santa Casa School of Medicine, Sa˜o Paulo, Brazil;
2Department of Physiological Sciences, Laboratory of
Molecular Medicine, Faculty of Medical Sciences of Santa
Casa School of Medicine, Sa˜o Paulo, Brazil; 3Department
of Pathological Sciences and Pathological Anatomy
Service, Faculty of Medical Sciences of Santa Casa School
of Sciences of Santa Casa School of Medicine, Sa˜o Paulo,
Brazil
Background: The prevalence of infection in the diges-
tive tract by Helicobacter sp varies in the population
studied, suggesting epidemiological differences in the
distribution of the bacillus in various countries. Histo-
logical changes, considered pre-neoplastic, were dem-
onstrated in the mucosa of gallbladder infected with
Helicobacter sp such as, intestinal metaplasia, hyper-
plasia, dysplasia in addition to eosinophilic inﬂamma-
tion and hyalinosis.
Objective: Establish the prevalence of Helicobacter sp in
chronic cholecystitis and its correlation with the gall-
bladder’s histological ﬁndings.
Methods: 100 patients were operated for chronic chole-
cystitis with cholecystolithiasis. In pathological exami-
nation of the gallbladder, were evaluated the presence of
metaplasia, dysplasia, lymphoid follicles, anaplasia and
tumours that might be related to the presence of Heli-
cobacter plus the presence of the bacilli GiemsaA˚ by
optical microscopy. From the DNA extracted from the
gallbladder’s bile, PCR was performed by using speciﬁc
primers for the identiﬁcation of Helicobacter sp with
ampliﬁcation of the 400 bp segment of rRNA gene16S,
with positive control DNA from Helicobacter pylori. All
the cases negative for isolation of genetic material were
excluded. The cases of PCR and GiemsaQ were used as
negative control group. The histological ﬁndings were
compared to the presence of bacilli and PCR data using a
chi-square and Fisher’s Exact test (CI = 95.0%,
P < 0.05).
Results: Of 68 patients, 42 (61.8%) were PCR for Heli-
cobacter sp and 19 (27.9%) had Giemsa. There was no
correlation between the two ﬁndings. The PCR for
Helicobacter sp was not correlated to the histological
ﬁndings. The presence of lymphoid follicles and meta-
plasia was related to the Giemsa (p = 0.025 and
p = 0.039).
TABELA 5. Comparison between modiﬁed Wright –
Giemsa and PCR.
Histology
G+PCR
Q n (%)
G QPCR
n (%) p X2
Without changes
Metaplasia
4 (50,0) 15 (48,3) 0.756
1 (12,5) 10 (32,3) 0.504
Follicles 0 (0,0) 3 (9,7) 0.862
Follcles + metapasia 3 (37,5) 3 (9,7) 0.164
Total 8 (100,0) 31 (100,0)
Conclusion: There is high prevalence of Helicobacter sp
in patients with chronic cholecystitis and cholecystolith-
iasis without be correlated with the histological patterns
studied.
P-835
PREDICTING COMMON BILE DUCT
STONES PRIOR TO LAPAROSOPIC
CHOLECYSTECTOMY: A 10 YEAR
EXPERIENCE
A. Cockbain and G. Toogood
St James’ University Hospital, Leeds, UK
Background: There is no consensus regarding use of in-
traoperative cholangiography (IOC). Advantages of
identifying duct stones and the opportunity for intraop-
erative retrieval rather than postoperative ERCP in a
minority of patients must be balanced against the extra
time and cost incurred for all patients. Attempatients to
justify selective IOC only for patients at high risk of duct
stones have suffered from a lack of sensitivity of preop-
erative predictors.
Aims: To identify preoperative factors predictive of duct
stones, and evaluate whether selective rather than routine
use of IOC is justiﬁed.
Methods: Preoperative clinical, biochemical and ultra-
sound ﬁndings for all patients undergoing laparoscopic
cholecystectomy and IOC by a single hepatobiliary sur-
geon in a tertiary referral centre between 1999 and 2008
were collected prospectively. Variables were analysed
using Chi square (categorical) and studentst test (con-
tinuous) prior to multivariate regression analysis to
identify preoperative predictors of common bile duct
stones.
Results: Duct stones were identiﬁed in 87 of 1035 patients
(8.4%) who underwent laparoscopic cholecystectomy and
IOC in the 10 year period. Diagnoses of cholangitis
(n = 45) and jaundice (n = 54), CBD > 6 mm on USS
(n = 20), acute surgery (n = 210), alkaline phosphates
> 350 (n = 84), alanine transaminase > 100 (n = 95)
and bilirubin > 30 (n = 46) were all signiﬁcant univari-
ate predictors of duct stones. Only jaundice (p = 0.05,
OR = 1.69), cholangitis (P < 0.001, OR = 1.38) and
alkaline phosphatise (P < 0.001, OR = 3.48) were
independently predictive on multivariate analysis.
Conclusions: A signiﬁcant number of patients had duct
stones on IOC. Although three independently predictive
Abstracts442
 2010 The Authors
Journal Compilation  2010 Hepato-Pancreato-Biliary Association, HPB, 12 (Suppl. 1), 1–468
variables are identiﬁed, their sensitivity is low (45%).
Despite using low thresholds for clinical suspicion of duct
stones preoperatively, 50% of retained stones identiﬁed
at OTC had normal preoperative investigations.
Selective use of OTC cannot be justiﬁed on the basis of
this study.
P-836
MANAGEMENT OF BILE LEAK
FOLLOWING LAPAROSCOPIC
CHOLECYSTECTOMY: DEVELOPMENT
OF AN EVIDENCE BASED
MANAGEMENT ALGORITHM
C. Liyanage1, T. Ackermann2 and S. Gananadha1
1Canberra Hospital, Australian National University;
2Australian National University
Background: Bile leak is a signiﬁcant complication fol-
lowing laparoscopic cholecystectomy (LC). It is essential
that such leaks are investigated and managed effectively
so as to minimise the morbidity and mortality.
Objectives: To analyse the experience of a tertiary centre
in managing bile leaks following LC and to formulate a
management algorithm based on this experience and the
available evidence.
Methods: All patients undergoing LC at The Canberra
Hospital between January 2000 and July 2008 were ret-
rospectively assessed for bile leaks and possible risk
factors for such leaks. A Medline search of recent liter-
ature was performed to compare and formulate a work-
ing algorithm in the management of bile leaks.
Results: About 1047 consecutive patients underwent LC
during the study period. (Elective: emergency, 800:247).
27 (2.57%) patients had a post LC bile leak. (Elective:
emergency 18 (2.25%): 9 (3.6%) p = 0.05). After hour
operations, the principal operator, the duration was not
signiﬁcant predictors of outcome. All patients had an
attempted intraoperative cholangiography. The com-
monest presentations were peritonitis 7/27 (26%) and
bile in drain or from port site 12/27 (44%.) Median time
to presentation was 3.5 days (Range 0–5). Diagnosis was
by CT (5/27), ERCP (10/27), USS (3/27), HIDA (4/27)
and Operative exploration (2/27). The common sites of
leak were cystic duct 11/27 and duct of Luschka in 5/27.
These were managed conservatively or by endoscopic and
surgical intervention. (Refer table).
Mode of management of bile leaks following Laparo-
scopic cholecystectomy
Mode of management Total %
Conservative 8 29
Percutaneous drainage 4 15
ERCP + Sphinctreotomy (ES) 3 11
ERCP + ES + Stenting 7 26
Laparoscopic washout 4 15
Open exploration 1 4
Conclusions: The incidence of bile leaks in this single
centre experience was similar to the reported literature.
The signiﬁcant contributing factors for a leak were
insecure clamping of cystic duct and aberrant anatomy
specially a duct of Luschka. Minimally invasive and
endoscopic management were successful in the manage-
ment of bile leaks as highlighted in the proposed algo-
rithm.
P-837
A COMPARATIVE STUDY OF PATIENT’S
SATISFACTION BETWEEN SINGLE
INCISION LAPAROSCOPIC
CHOLECYSTECTOMY AND STANDARD
LAPAROSCOPIC CHOLECYSTECTOMY
S. K. Y. Chang, J. R. Bicol, C. W. Tay, Y. Y. Lee and
K. Madhavan
National University Hospital
Background: Laparoscopic cholecystectomy is the Gold
standard for the treatment of gallstones and currently
well accepted by patients. Single Incision Laparoscopic
Cholecystectomy (SILC) is a new technique which may
offer better cosmetic effect or even pain control. This
may in turn affect the patient’s choice towards this pro-
cedure and eventual satisfaction.
Objectives: We aim to compare the satisfaction rate of
patients undergoing the SILC and the Standard Lapa-
roscopic Cholecystectomy (LC) and investigate into the
reason for their choice of this relatively new procedure.
Methods: From April to October 2009, 28 patients who
underwent SILC were matched with retrospective data of
28 LC patients based on age, sex and race. Patient’s
demographic and socio-economic status, reason for
choosing SILC, and satisfaction were analyzed.
Results: On each group, the population consists of 17
female and 11 male with the average age of 48-years-old
(26–68). In the SILC group 64.3% has Tertiary education
(39.3% on the SLC group, p = 0.06). Signiﬁcant dif-
ference was found in the monthly income: 53% earning
more than 3 thousand dollars on the SILC group and
17.9% on the LC group (p = .005). The reasons for
choosing the SILC technique includes cosmesis (31%),
prospect of less pain (25%), prospect of earlier return to
normal activity (42.2%) and all the above (42%). Fifty
percent of LC patients would have chosen SILC if given a
choice. Cost was the deterring factor among the rest.
46.4% of the SILC patient rated ‘overall more than
satisﬁed’ with surgery (34% in the LC). Cosmetic satis-
faction was signiﬁcantly different as 50% of SILC patient
rated ‘more than satisﬁed’ as compared to 14.3% in the
LC (p = 0.015).
Discussion and conclusion: Overall satisfactory rate was
not signiﬁcantly different between the 2 groups. How-
ever, cosmetic satisfactory rate was signiﬁcantly higher in
the SILC group. Economic status of the patients may
affect patients’ choice for SILC.
P-838
RESULTS OF SURGICAL TREATMENT
OF CONGENITAL CHOLEDOCHAL
CYSTS IN ADULTS
K. Zieniewicz, W. Patkowski, K. Dudek, P. Nyckowski,
T. Wro´blewski, P. Remiszewski, M. Kotulski,
R. Paluszkiewicz, B. Najnigier, M. Grodzicki and
M. Krawczyk
Department of General, Transplant and Liver Surgery,
Medical University of Warsaw
Introduction: Cystic dilatation of the common bile duct,
known as choledochal cyst (CC), is rare congenital
anomaly in adults. The surgical management, as the
treatment of choice in order to avoid the risk of malig-
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nancy in these patients, has evolved during last two
decades.
Aim: To analyze the clinical presentation, surgical tech-
nique and results of treatment of these patients.
Patients and methods: In the period 2001–2009 21 pa-
tients, 17 women and 4 men, age 18–75, mean 36 years,
were operated on for CC.4 (19%) patients have been
already operated on: one underwent cholecystectomy
with T-tube drainage and 2 – choledocho-duodenal
anastomosis and 1- laparotomy. Diagnostic procedures
were based on US, CT and MRCP examinations. 16
patients have had CC type I according to Alonso-Lej
classiﬁcation. In Todani classiﬁcation: type I: A - 13
patients (62%), C – three patients (14%) and IV – ﬁve
patients (24%). The most common surgical procedure
was the excision of extrahepatic biliary tree with hepati-
co-jejunostomy Roux-en-Y. In two patients left and right
hemihepatectomy accompanied the biliary resection and
in three patients – liver transplantation (LTx) was per-
formed.
Results: All of the patients, except one, who underwent
LTx, are alive in good general condition (95%). Mor-
bidity was limited to the patients that previously under-
went choledocho-duodenal anastomosis. Minor
complications were observed in 8 patients (38%). Tran-
sitional increased serum and urea amylase activity was
observed in 10 patients (48%). No cholangiocarcinoma
has been encountered in this group of patients after a
mean follow up of 38 months (range 3–96).
Conclusions: Patients with CC type I require surgical
management: complete removal of the extrahepatic bili-
ary tree with Roux-en-Y hepatico-jejunostomy as a res-
toration of biliary continuity. The outcome of this
approach is very good. It is effective and safe treatment
in order to reduce the chance of subsequent development
of malignancy. Patients with CC type IV require addi-
tional liver resection or LTx.
P-839
IS THERE A RESIDUAL-BILIARY
PATHOLOGY POST BILIARY-ILEUS
(GALLSTONE ILEUS)? PRELIMINARY
RESULTS OF A COHORT STUDY
C. Mun˜oz1,2, H. Losada1,2,3, C. Manterola1,2,
L. Burgos San Juan1,2,3, J. Silva1,2,3, J. Bernales1,2 and
D. Inostroza1
1Surgery Department. Universidad de La Frontera.
Temuco; 2HPB Surgery Team. Surgery Department.
Hospital Hernan Hneriquez Aravena.Temuco; 3Surgery
Department. Clı´nica Alemana de Temuco
Introduction: Biliary illus (BI) represents 1–4% of bowel
obstructions. Instructions regarding the gallbladder
pathology treatment are a controversial topic. Our goal is
to evaluate the residual-biliary pathology in surgically
involved patients of gallstone ileus, at Hospital Dr.
Herna´n Henrı´quez Aravena de Temuco (HHHA).
Materials and method: Study Design: Cohort Study.
Study Period: January 200 – December 2008.Inclusion
criteria: Patients surgically treated for BI at
HHHA.Maneuver: Patients will receive control and fol-
low-up at the clinic, these will include: hepatic proﬁle,
tumour markers, abdominal echo tomography and
cholangioresonance.Statistical analysis: Descriptive sta-
tistics along with central tendency and scatter were used.
Analytic statistics are applied to dichotomic and ongoing
variables. The database analysis was performed in the
statistical package STATA 9.0.
Results: The cohort is made of 28 patients, with an
average age of 67.4 ± 12.1 years. 83% (23 patients) were
females. 70% were unaware of suffering cholelithiasis.
All were part of a preoperative imaging study, this study
found pneumobilia in the 50% of them. Rigle triad was
positive in the 30% of the patients. An enterolithotomy
was performed in 92% of the patients. In most of them a
big stone (average of 4.15 ± 0.8 cm) was found at the
distal ileum. Contemporary cholecystectomy was not
performed in patients. One of the patients has a spon-
taneous resolution of the condition. The operative mor-
bidity was 25% and the operative mortality was 7%. The
follow-up of 83% (23 patients) of the cohort has been
accomplished, in an average of 34 months. Four patients
(17%) have shown acute events related to biliary stones
during the follow-up period.
Conclusions: The study preliminary results show the
existence of a symptomatic residual-biliary pathology in
patients with gallstone ileus history. The non-symptom-
atic residual-biliary pathology in this cohort could be
larger than expected.
P-840
10 YEAR SINGLE SURGEON
EXPERIENCE OF ROUTINE
INTRAOPERATIVE
CHOLANGIOGRAPHY DURING
LAPAROSCOPIC CHOLECYSTECTOMY
A. Cockbain, J. Ferrier and G. Toogood
St James’ University Hospital, Leeds, UK
Background: Routine use of intraoperative cholangiog-
raphy (IOC) remains contentious. Proponents argue the
importance of delineating biliary anatomy and advanta-
ges of intraoperative retrieval of duct stones over post-
operative ERCP. Opponents argue that the extra time
and cost outweighs the low yield of duct stones.
Aims: To identify the prevalence of duct stones in pa-
tients having laparoscopic cholecystectomy (LC), and the
burden of ‘‘missed’’ stones without routine use of IOC.
Methods: Preoperative clinical, biochemical and ultra-
sound ﬁndings for all patients undergoing LC by a single
consultant hepatobiliary surgeon in a tertiary referral
centre between 1999 and 2008 were collected prospec-
tively. Preoperative suspicion of duct stones was deﬁned
as any one of serum bilirubin > 30, alkaline phosphatase
> 350, common bile duct diameter > 7 mm or diagnosis
of cholangitis. IOCs were interpreted by the surgeon,
with duct exploration for suspected stones.Preoperative
suspicion of duct stones was compared to IOC ﬁndings.
Results: About 1035 patients underwent laparoscopic
cholecystectomy and IOC in the 10 year period. Two
hundred and sixty four patients (25%) had one or more
indicators for duct stones on preoperative assessment.
Eighty seven patients were found to have duct stones on
IOC (8.4%). The prevalence of stones in patient with
abnormal investigations was 16.7% (n = 44) compared
to 5.6% (n = 43) in those normal investigations. Nota-
bly however, half of all stones were found in the latter
group. About 63 patients underwent intraoperative CBD
exploration, with successful stone retrieval in 37 (59%)
40 of the remaining 50 had successful postoperative
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ERCP, and 10 were managed conservatively on the basis
of a normal postoperative MRCP.
Conclusions: About 8.4% of all patients undergoing LC
had duct stones. Half of these had entirely normal pre-
operative investigations, and without routine IOC would
have left hospital with undiagnosed duct stones, at risk of
recurrent symptoms and potentially severe complica-
tions.
P-841
LONG-TERM IMPACT OF GALLSTONE
SURGERY ON GASTROINTESTINAL
QUALITY OF LIFE. A POPULATION-
BASED STUDY
V. Wanjura1, P. Lundstro¨m1, J. O¨sterberg1,
B.-M. Karlsson2, I. B. Rasmussen2 and G. Sandblom3
1Department of Surgery, Mora hospital, Mora;
2Department of Surgery, Uppsala Academic Hospital,
Uppsala; 3Department of Surgery, Karolinska University
Hospital, Stockholm
Background: Despite cholecystectomy being a common
procedure, the impact of gallbladder removal on long-
term gastrointestinal quality of life (QoL) is poorly
known.
Aim: To assess long-term impact of possible predictors
on QoL after gallbladder surgery and compare QoL with
the normal population.
Methods: All cholecystectomies done in Mora hospital
from 2002 to early 2005 were registered in a standardized
form. All patients below 80 years at follow-up were re-
quested to ﬁll in a form including the 36-item Gastroin-
testinal Quality of life Index (GIQLI) form and the
EQ-5D form. The outcome was analyzed internally and
compared to a matched control group of 396 individuals.
Results: Altogether 627 patients (447 women, 180 men)
underwent cholecystectomy, including laparoscopic (n =
524), conversion (n = 43) and open cholecystectomy
(n = 60). Mean age was 53 years. Mean follow-up was
49 months. Response rate was 84%.With multivariate
analysis we found indication for surgery to be the stron-
gest predictor of gastrointestinal QoL. Patients operated
for cholecystitis had a higher gastrointestinal QoL than
patients operated for gallstone pain (p = 0.029). Age had
a negative impact (p = 0.036). There were no differences
with respect to gender, follow-up, smoking or method of
surgery. The correlation between indication and QoL was
stronger for women alone (p = 0.002).Episodes of
abdominal pain after surgery was stated by 43.9% of
subjects. Absence of pain correlated with cholecystitis as
indication (p = 0.008). No other variable had an impact,
including method of surgery. The study group stated
better health than the control group in EQ-5D
(P < 0.001), but also had signiﬁcantly more adverse
gastrointestinal symptoms (P < 0.001).
Conclusion: Indication for surgery has a signiﬁcant im-
pact on long-term QoL after cholecystectomy. Differ-
ences between the study group and matched controls
could be explained both by patient selection and by
possible malabsorption after gallbladder removal.
P-842
MANAGEMENT OF CHOLEDO-
CHOLITHIASIS IN YOUNG PATIENTS
A. J. Rondan1, O. O. Laudano2, M. Cesar1,
G. Centurion1 and A. R. Ferreres1
1Department of General Surgery ‘Dr. Carlos A.
Bocalandro Hospital; 2Department of Gastroenterology
‘Dr. Carlos A. Bocalandro’ Hospital
Background: The current treatment of choledocolithiasis
includes intraoperative laparoscopic management, either
trans-cystic or choledocotomy with primary closure or T-
tube placement or ERCP, performed pre or postopera-
tively. Due to the risks and complications as well as the
controversy of ERCP performance in young patients, the
best approach is the resolution in one step the intraop-
erarative ﬁndings of choledocholitiasis in young patients.
Aim: To assess the advantages of this one step approach.
Methods: Between January 2008 and January 2009 we
performed 480 laparoscopic cholecystectomies. We could
see 66 patients (14%) were less than 25-years-old, of
which 16 patients (24%) were, had cholecholithiasis.
Intraoperative cholecholithiasis was performed in all
patients systematically. We evaluated the intraoperative
approach, complications and follow up.
Results: All the patients had intraoperative instrumen-
tation and we could resolve 13 (11 transcystic and 2
laparoscopic choledocotomy with Kehr). We could not
resolve three patients and we put a transcystic transpa-
pillar guidewire to guide the ERCP canulation of the
papilla. We did not convert to open surgery any patients
and we did not have intra or postoperative complica-
tions.
The median hospitality stay was 3 days (1–6).
Conclusions: The laparoscopic resolution of intraopera-
tive cholecholithiasis in one step seems to be safe and
avoid new procedures. We think that all young patients
with cholecholithiasis should be resolve in one step
without previous ERCP.
P-843
GALLBLADDER PERFORATION: A
REVIEW OF 21 CASES
F. Vyas, P. Joseph, R. Sanghi and S. Venkatramani
Christian Medical College Hospital, Vellore, India
Background: Gallbladder perforation continues to be an
important problem for the surgeons. It may complicate
acute cholecystitis or may occur spontaneously.
Aim: To present our experience with gallbladder perfo-
ration cases.
Methods: Medical records of 21 patients who received
conservative and/or surgical treatment for gallbladder
perforation over a period of 10 years from 2000 to 2009
were reviewed retrospectively. Parameters including age,
gender, symptoms, diagnostic procedures, surgical
treatment, morbidity and mortality were evaluated.
Results: There were 19 male and 2 female patients with
a mean age of 54 (range 21–84) years. Presenting
symptoms were abdominal pain (16), fever with chills
(four) and progressive weakness (one). Six patients had
diabetes mellitus. The diagnosis was based on ultra-
sound or computed tomography of the abdomen. One
patient refused intervention and was managed medi-
cally. Of the remaining 20 patients, 14 patients under-
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went surgical intervention and six patients were man-
aged by percutaneous radiological drainage. Surgical
procedures included cholecystostomy (one patient) and
open/subtotal cholecystectomy (13 patients). Six pa-
tients had type I perforation and 14 patients had type II
perforation according to Niemeier’s classiﬁcation. One
patient died of sepsis and multiorgan failure in surgical
group. One patient in radiological group died of unre-
lated cause.
Conclusion: Early diagnosis of gallbladder perforation is
of crucial importance. Patients with type I perforation
require immediate surgical intervention whereas patients
with localized perforation can be managed by either
percutaneous drainage or surgically. With early diagnosis
and intervention, mortality and morbidity can be
decreased.
P-844
INTRAOPERATIVE EXPLORATION OF
BILIARY TRACT USING
FLUORESCENCE IMAGING OF ICG IN
CHOLECYSTECTOMY
M. Shimoda, N. Tagaya and K. Kubota
Dokkyo Medical University, Second Department of
Surgery
Background: We evaluated laparoscopic intraoperative
exploration of biliary tract using ﬂuorescence imaging of
indocyanine green (ICG) in animal model.
Materials and methods: We evaluated 13 cases, eight
were laparoscopic cholecystectomy and ﬁve were open
cholecysterctomy. ICG was injected intravenously two
hours before operation; we observed biliary tract and
cystic artery under the guidance of ﬂuorescence imaging
produced by special laparoscope (Olympus Corp).
Results: We obtained the clear vision of biliary tract in
all of 13 cases. The local compression of plastic cap
provided with more clear vision in biliary tree including
proximal hilar bile duct. The location and ﬂow of cystic
artery were also conﬁrmed clearly beside the cystic duct.
Conclusions: Although we have to consider the adequate
timing of ICG injection, the results of this method using
a compression of plastic cap were equal to those of or-
dinary intraoperative cholangiography. The advantages
of this method included no cannulation manner into the
cystic duct, no arrangement of X-ray equipment and no
radio-activity.
P-845
CONCOMITANT LAPAROSCOPIC
SPLENECTOMY AND
CHOLECYSTECTOMY
A. Umemura, A. Sasaki, J. Nakajima, T. Obuchi,
Y. Kimura, S. Nishizuka, K. Otsuka, H. Nitta,
M. Kasiwaba, K. Koeda, M. Mizuno and
G. Wakabayashi
Department of Surgery, Iwate Medical University
Background: Hereditary spherocytosis is the most com-
mon red blood cell membrane disorder, and its diagnosis
is often associated with hemolytic crisis and premature
cholelithiasis.The aim of the present study was to assess
the feasibility and outcomes of concomitant laparoscopic
treatment for coexisting spleen and gallbladder diseases.
Methods: Between March 1997 and August 2009, 9
patients underwent concomitant laparoscopic splenec-
tomy and cholecystectomy. Indications for laparoscopic
splenectomy included hereditary spherocytosis (four pa-
tients), splenic artery aneurysm (two), and hypersplenism
(two), and Evans syndrome (one).
Results: The median operating time and the blood loss
were165 min (range: 70 to 300 min) and 36 mL (range:
10 to 274 mL). The median resected splenic weight was
256 g (range: 137 to 820 g). No patient required con-
version to an open procedure. Portal system thrombosis
occurred in two patients. The median length of hospital
stay was 9 days (range: 3 to 15 days).
Outcomes of concomitant laparoscopic splenectomy and
cholecystectomy
Variable
Concomitant laparoscopic
splenectomy and
cholecystectomy (n = 9)
Operating time (min)* 165 (70–300)
Blood loss (mL)* 36 (10–274)
Resected splenic weight (g)* 256 (137–820)
Drain placement (d)* 1 (1–3)
Diet resumption (d)* 1 (1–4)
Hospital stay (d)* 9 (3–15)
Morbidity (n)* 2
*Values are median (range).
Conclusions: With increasing institutional experience,
concomitant laparoscopic splenectomy and cholecystec-
tomy is a safe and feasible procedure and may be con-
sidered for coexisting spleen and gallbladder diseases.
P-846
THE PRESENCE OF AN IN-SITU BILIARY
ENDOPROSTHESIS AT LAPAROSCOPIC
CHOLECYSTECTOMY: FRIEND OR FOE?
J. R. Uzzaman, M. Nair, O. Fafemi and A. Athow
North Middlesex University Hospital
Introduction: In the last 15 years it has become standard
practice to perform ERCP in patients presenting with the
complications of gallstones in which stones in the com-
mon bile duct (CBD) are suspected. Recently, some cli-
nicians routinely insert a CBD stent at the time of ERCP.
Such patients may then present for Laparoscopic Cho-
lecystectomy (LC) with CBD stents in situ. The aim of the
study was to examine the impact of the presence of CBD
stent on the outcome of elective LC.
Method: This is a case controlled study conducted be-
tween January 2005 to June 2008. The patients were di-
vided into three comparable groups; Group 1- those
having LC preceded by ERCP, Group 2 - those having
LC preceded by ERCP and stent insertion, and Group 3 -
those having LC alone.
Results: About 401 LC were performed in the above
period. Five of these were excluded (two with previous
upper abdominal surgery; two with isolated pancreatic
stents; and 1 whose stent was removed the day before
surgery). Of the 396 patients studied, there were 31
patients in Group 1, Thirty ﬁve patients in Group 2 and
330 patients in Group 3. The incidence of conversion,
post-operative bile leak, operating time, and length of
stay were signiﬁcantly higher in Group 2 (P < 0.05). The
duration of in-situ CBD stent varied from 8 to 400 days.
The incidence of conversion increased with the duration
of in situ stent placement (Spearman correlation co-efﬁ-
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cient = 0.34, P < 0.05). No patient, who had an initial
biliary stent less than 40 days before operation, required
conversion to open cholecystectomy. There were also one
case of abandoned cholecystectomy; two cases of CBD
erosion; one case of CBD injury and two cases of in-
hospital mortality – all involving patients in group 2 only.
Conclusion: We conclude that LC in the presence of
CBD stents poses signiﬁcant risk to patients, particularly
if they are left in-situ for long periods of time. Caution
should be exercised in stenting a CBD with intact GB,
particularly in those awaiting cholecystectomy.
P-847
COLEDOCHAL CYST IN CHILDREN
AND ADULTS: A 10 YEARS SINGLE
INSTITUTION EXPERIENCE
M. Germani1, D. Liberto2, C. Salas2, G. Elmo2,
P. Lobos2, E. De Santibanez3 and J. Pekolj3
1Bambino Gesu`, Roma; Hospital taliano de Buenos Aires,
Buenos Aires; 2Hospital taliano de Buenos Aires, Buenos
Aires; 3Hospital Italiano de Buenos Aires, Buenos Aires
Background: Coledochal cysts (CC) are rare congenital
dilatations of the biliary tree. The incidence is 1:150 000.
A correct diagnosis and surgical treatment are important
because of the long term risks of infection and neoplasia.
We report our experience with CC both in children and
in adults.
Patients and methods: We included 28 patients affected
by CC disease who were treated at our institution be-
tween 1999 and 2009. Prenatal, clinical, surgical and
pathological records were analysed.
Results: There were 13 children and 15 adults all affected
by a cystic dilatation type I of Todani’s classiﬁcation. 11
girls and 2 boys in the paediatric group and 12 women
and 3 men in adult’s one. The majority of children pre-
sented jaundice while the presenting symptom in adults
was abdominal pain. The surgical treatment realized for
all patients was a cyst’s excision and a Roux-en-Y-hep-
aticojejunostomy reconstruction, with laparoscopic
(LPS) procedure in four children and seven adults. In
adult’s group, only one case was converted from LPS to
open approach. Results at short and long term follow-up
were good in both series. The complications observed
were: 1 anastomotic billiary ﬁstula, one residual lithiasis
in the pancreatic portion of the duct, and 1 anastomotic
stenosis; the last two cases required reoperation.
Conclusions: Although some authors argue that paedi-
atric and adult CC disease presentation pattern is similar,
we think that it differs a lot. We recommended complete
laparoscopic cyst’s excision and a Roux-en-Y-hepati-
cojejunostomy as the surgical choice, and advocate early
surgery after diagnosis to promote ease of surgery and
prevention of future complications.
P-848
COST UTILITY ANALYSIS AFTER
CHOLECYSTECTOMY IN TAIWAN
K.-T. Lee
Department of Surgery, Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan; Faculty of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan
Introduction: Cholelithiasis is still the most common
abdominal disease in Taiwan. The purpose of this study
was to assess the clinical and economic impact of both
laparoscopic cholecystectomy (LC) and open cholecys-
tectomy (OC) by using decision- tree model.
Methods: This prospective study analyzed 259 cholecys-
tectomy patients (223 LC and 36 OC) at this tertiary
academic hospital. All patients completed theSF-36 and
the gastrointestinal quality of life index (GIQLI) at
baseline and at 3 and 6 months postoperatively. The 95%
conﬁdence interval for differences in responsiveness
estimates were derived by bootstrap estimation. Scores
derived by these instruments were interpreted by gener-
alized estimating equation (GEE) before and after cho-
lecystectomy. To evaluate the cost-utility of LC and OC,
we used a decision-tree model to tabulate costs and
quality-adjusted life years (QALYs) accumulated by each
patients.
Results: The examined population signiﬁcantly
(P < 0.05) improved in both SF-36 subscales and GI-
QLI subscales. The LC patients were more responsive
than the OC patients in terms of average lengths of stay
(ALOS) (-0.23, 95%CI -0.33 to-0.13) and total treatment
cost (-0.43, 95%CI -0.63 to -0.23). The following factors
were associated with considerably increased total treat-
ment cost: advanced age, female gender, presence one or
more co-morbidities, current treatment at a medical
center and long ALOS. The incremental cost-utility ratio
of performing OC procedure as compared with LC pro-
cedure was $3121 per life-year gained.
Conclusions: The government and health care providers
should understand that total treatment cost is dependent
not only on patients attributes but also on hospital
attributes. The results can be generalized to patient
population elsewhere in Taiwan as well as to other
countries with similar patient proﬁle. LC procedure ap-
pears to be cost effective in Taiwan.
P-849
A 5 YEAR ANALYSIS OF
READMISSIONS FOLLOWING
ELECTIVE LAPAROSCOPIC
CHOLECYSTECTOMY (LC) WITHOUT
INTRAOPERATIVE CHOLANGIOGRAM
(IOC)
P. Sanjay1,2, R. Weerakoon1,2, T. Bird1,2, I. Shaikh1,2 and
S. Yalamarthi1,2
1Queen Margaret Hospital; 2Dunfermline
Background: LC is one of the most commonly performed
procedures world wide. However, majority of surgeons
do not routinely follow up patients post surgery resulting
in paucity of data regarding reasons for readmission.
Aims: This study aimed to determine readmission rates,
causes for readmission and outcomes for patients
undergoing elective Laparoscopic Cholecystectomy (LC)
without intraoperative cholangiogram (IOC).
Methods: Timing related to readmissions were grouped
as < 6 weeks, 6 weeks 1 year, 1–2 years and > 2 years.
Outcomes and variables related to readmission were
evaluated.
Results: 101 readmissions (5%) were noted amongst
1523 consecutive LC. There was no difference in the
median age (48 vs. 53 years, P = 0.2) and sex of the
patients between the readmitted and no readmission
groups. The incidence of readmissions (n = 101) within
the ﬁrst 6 weeks, 6 weeks.1 year, 1–2 years and
> 2 years were 43%, 23%, 22% and 12% respectively.
The most common reasons for readmissions were non-
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speciﬁc abdominal pain (NSAP) (36%), obstructive
jaundice (14%), peptic ulcer disease (10%), intraab-
dominal collection (4%) and bile leak (3%), pancreatitis
(3%), and other reasons (30%). Overall, 24 (22%) of
readmissions were related to biliary problems, the
majority of these occurred (15/24, 63%) within 6 weeks
of LC. The incidence of retained stones within the ﬁrst
6 weeks, 6 weeks 1 year, 1–2 years and >2 years were
7%, 5%, 2% and 0% respectively.
Conclusion: Readmission rate following elective LC is
low with the majority occurring within the ﬁrst 6 weeks
and only a quarter of these related are directly to biliary
pathology. In the absence of routine IOC, around 1% of
patients present with retained stones within 2 years of
LC. A small fraction of patients continue to suffer from
NSAP and should be warned prior to the surgery.
P-850
EVALUATION OF A PROTOCOL FOR
PREOPERATIVE DIAGNOSIS OF
COMMON BILE DUCT STONES –
PROSPECTIVE STUDY
P. Kumar, N. Mohan, C. Nivedita and A. Ramesh
Meenakshi Mission Hospital and Research Center,
Madurai
Introduction: 10-15% with symptomatic gall stone dis-
ease will have CBD Stones. Preoperative identiﬁcation
will help in reducing the morbidity and better outcomes.
Studies have been done using clinical, biochemical and
radiological parameters to stratify patients into risk
groups.
Aim: Evaluation of a protocol by prospective controlled
study for preoperative diagnosis of CBD stones in pa-
tients presenting with gallstones based on clinical, bio-
chemical and radiological criteria.
Materials and methods: Consecutive patients were risk
stratiﬁed based on the criteria developed. High risk group
underwent ERC + Stone extraction followed by Lap.
Cholecystectomy, medium risk group Lap. Chole +
IOC, Low risk group underwent only lap.cholecystec-
tomy. Period of study was Jan 2005 – Jan 2007.
Results: Number of patients with gall stones during the
period was 454. 336 (74%) were low risk group, 17
(3.7%) medium risk and 101 (22.3%) high risk group.
Co-morbid illnesses were seen in 39.5%. Low risk group
underwent Lap. Cholecystectomy, no conversion, no
missed stone in follow up (Mean 18 months). Medium
risk category had IOC + Lap chole, no stones detected
in IOC. CBD Stones were detected in about 78% of high
risk group, ERC was normal in about 22% of high risk
category patients. ERC + Stone clearance was done in
84% and Lap CBD exploration done in 16%(> 1.5 cm
stone size). Residual stones were detected in 5.6%.Bile
leak occurred in one patient following CBD exploration.
On statistical analysis using Chi-square test, age> 55,
ALP > 250 i.e., CBD diameter > 10 mm, presence of
IHBRD, detection of CBD stones in USG were signiﬁ-
cant (P < 0.05).
Conclusion: The incidence of CBD stones was about
13.5%. About one ﬁfth of ERC were normal and in
contrast to other published series levels of Sr. Bilirubin
and GGT were not statistically signiﬁcant. The above
risk factors should be included in risk stratiﬁcation and
propose to utilize EUS in medium risk category.
P-851
‘‘GALLBLADDER SIGN’’ ON
INTRAOPERATIVE CHOLANGIOGRAM
AS AN INDICATOR OF ABERRANT
ANATOMY AT THE GALLBLADDER
BED: AN IMPORTANT WARNING SIGN
C. Liyanage, C. Mosse and S. Gananadha
Department of upper GI and HPB surgery, the Canberra
Hospital, Australian National University Medical School,
Canberra, Australia
Introduction: Intraoperative cholangiogram (IOC) is
done to delineate the biliary anatomy and to identify
choledocholithiasis. It may also be helpful to identify
aberrant biliary anatomy especially at the gallbladder bed
in order to avoid bile leaks. We noted the ‘‘Gallbladder
sign’’ (GBS) in a patient with a bile leak from a chole-
cysto-hepatic duct injury. We deﬁned ‘‘Gallbladder sign’’
as a signiﬁcantly lit up gallbladder on the IOC despite the
cystic duct being clamped.
Objectives: To study the usefulness of the ‘‘gallbladder
sign’’ as an indicator cholecysto-hepatic ducts.
Methods: A retrospective review of all patients who had
a bile leak from 2000 to 2008 was undertaken. The IOC
was assessed for the presence of the GBS and this was
correlated with the site of leak identiﬁed on various in-
vestigations. A prospective review of all patients under-
going LC and IOC was undertaken between 2006 and
2009 for the presence of this sign.
Results: Thirty patients with bile leaks over an 8-year
period were retrospectively reviewed and a further 146
patients undergoing LC and IOC were prospectively re-
viewed. Five patients with the gallbladder sign were
identiﬁed. In the retrospective review, two patients were
identiﬁed that had bile leak from cholecysto-hepatic duct
communication at the gallbladder bed and in three pa-
tients potential bile leaks were avoided by observing this
sign.
Conclusions: ‘‘Gallbladder sign’’ is an important sign on
the operative cholangiogram that may help in identifying
aberrant anatomy at the gallbladder bed. It should be a
warning sign to the operating surgeon to a potential
cholecysto-hepatic duct.
P-852
PRENEOPLASTIC LESIONS AND
GALLBLADDER CANCER
P. Sisco, N. Perrone, M. Jaroslavsky, E. Bavio and
I. Alvarez
Pirovano Hospital
Background: The silent development and the late diag-
nosis turned the gallbladder carcinoma in a disease of
high mortality. The metaplasia and dysplasia, commonly
present in the mucosa of chronic calculous cholecystitis,
are considered preneoplastic lesions associated with early
cancer stages.
Objective: To evaluate the prevalence of pre-cancerous
mucosal changes of the gallbladder - metaplasia, dys-
plasia - and the association with gallbladder carcinoma.
Methods: Review of 1260 anatomopathological reports
of gallbladders belonging to 786 (62.3%) female and 474
(37.6%) male patients with chronic calculous cholecys-
titis who underwent to cholecystectomy from January
2003 to September 2009. Analysis of the presence of
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pyloric metaplasia (PMP), intestinal metaplasia (IMP),
dysplasia (DY) and cancer in each case.
Results: Metaplasia was found in 80 cases (6.34%): PMT
58, PMT + IMP 3, PMT + IMP + DY 2. One
PMT + IMP case was found associated to carcinoma in
situ. The other 16 cholesterolosis and adenomyosis were
present simultaneously. Dysplasia was reported in six
(0.47%) cases: associated with cancer four, PMT + IMP
1 and PM + IM + adenomyosis one. Carcinoma was
found in 16 patients (1.26%) of total cholecystectomies.
The age range was 45/92 and the mean 69.06. Of the 16
carcinomas, 12 were in advanced stages and 4 were in-
cidental ﬁndings in histopathological reports. All of the
unsuspected carcinomas were associated with dysplasia
and one of them with adenoma simultaneously.
Conclusions: Although the incidence of gallbladder can-
cer proved to be low, the probability of mucosal changes
associated with chronic inﬂammatory processes was sig-
niﬁcative. Metaplasia and dysplasia were always present
in the early stages and conﬁrmed to be the pathway to
cancer development. They were rarely detected in ad-
vanced stages due to the invasive growth of the tumor.
P-853
MANAGEMENT OF COMPLICATED
CHOLEDOCHAL CYSTS
P. Kumar, N. Mohan and A. Ramesh
Meenakshi Mission Hospital and Research Center,
Madurai, India
Background: Choledochal cysts (CDC) commonly pres-
ent with abdominal pain, jaundice and lump in various
combinations. Cysts can present with various infective
and non infective complications like cholangitis, he-
patolithiasis, portal hypertension, chronic pancreatitis,
spontaneous perforation of CBD, acute pancreatitis etc.
The management and outcomes of these complicated
CDC is varied. Hereby we present our data on compli-
cated CDC.
Patients and methods: One hundred and forty three cases
of Choledochal cyst were managed in a tertiary care
referral hospital in South India, from January 2000 –
June 2009. 28 cases (19.5%) were associated with com-
plicating factors: hepatolithiasis (n = 6), recurrent acute
pancreatitis (n = 6), cholangitis (n = 4), portal hyper-
tension (n = 2), associated malignancy (n = 4), acute
cholecystitis (n = 2), chronic pancreatitis (n = 2),
spontaneous perforation (n = 2). Six patients had more
than one complication. The management outcomes were
compared with uncomplicated group.
Results: Complicated CDC were commonly associated
with Type IV a and Type I fusiform anatomy. Endo-
scopic and percutaneous procedures were performed in
11 cases, prior to deﬁnitive surgical intervention. Deﬁn-
itive surgical procedure was performed in 22/28 (78.5%),
where as more than 95% of uncomplicated CDC patients
underwent deﬁnitive surgery. Early post operative com-
plication was seen in four cases (18.8%), where as 5% of
uncomplicated CDC had early problems. Mortality was
seen in two cases (7.1%), due to massive bleed and pos-
sible sepsis due to leak. Post operative bile leak was seen
in two cases (one mortality). In uncomplicated CDC
morbidity rate was 4%, no mortality. Biliary stricture
was seen in one patient (2.2%).
Conclusion: Complicated CDC’s warrant a carefully
planned treatment strategy. Staged therapeutic interven-
tion may be required.
P-854
XANTHOGRANULOMATOUS
CHOLECYSTITIS: IS IT A
PREMALIGNANT CONDITION?
M. Ghosh, P. Sakhuja, A. K. Agarwal
GB Pant Hospital and MAM College, Delhi University
Introduction: Xanthogranulomatous cholecystitis (XGC)
is an uncommon variant of chronic cholecystitis, char-
acterized by marked thickening of the gallbladder wall.
The premalignant nature of this entity is not known.
Aim: To study the p53, PCNA and beta catenin expres-
sion in XGC in comparison to gallbladder cancer and
chronic inﬂammation.
Materials and methods: Sections from parafﬁn embedded
blocks of surgically resected specimens of gallbladder
cancer (69cases), XGC (65 cases), chronic cholecystitis
(18 cases), and control gallbladder (10 cases) were stained
with the monoclonal antibody p53, PCNA and poly-
clonal antibody beta catenin.Results were scored semi
quantitatively and statistical analysis performed. p53
expression was scored as percentage of the nuclei stained.
PCNA expression was scored as the product of percent-
age of nuclei (0–100) stained. Beta catenin expression was
scored as type of expression- membranous, cytoplasmic
and nuclear staining.
Results: The p53 mutation was positive in 52% of GBC
cases, 3% of XGC cases but was not expressed in both
chronic cholecystitis, and in control gallbladders. p53
expression in XGC was signiﬁcantly lower than in gall-
bladder cancer (P < 0.0001). PCNA expression was
seen in 65% of GBC, 11% of XGC, but not in chronic
cholecystitis, and control gallbladder. PCNA expression
was signiﬁcantly higher in GBC than XGC (p = 0.0001),
Beta catenin expression was positive in all the cases of
GBC, XGC, chronic cholecystitis and control gallbladder
cases. But expression pattern in XGC, chronic chole-
cystitis and control gallbladders was homogenous mem-
branous, where as in case of gallbladder cancer
membranous expression pattern was altered to cyto-
plasmic and nuclear.
Conclusion: The expression of p53, PCNA and beta
catenin in XGC is signiﬁcantly different from GBC and
similar to chronic cholecystitis thus indicating an
inﬂammatory nature of XGC and may not support a
premalignant nature of the lesion.
P-855
CRITICAL VIEW OF SAFETY – AN
ALTERNATIVE TO ROUTINE
INTRAOPERATIVE CHOLANGIO-
GRAPHY (IOC) DURING
LAPAROSCOPIC CHOLECYSTECTOMY,
FOR ACUTE CHOLECYSTITIS
P. Sanjay and D. Exon
Ninewells Hospital and Medical School
Background: There is no data available regarding the
role of CVS during laparoscopic cholecystectomy for
acute biliary pathology and as an alternative to routine
IOC. Achieving a critical view of safety (CVS) as an
alternative to IOC has also been described, but the ab-
sence of common bile duct (CBD) visualisation, limits its
potential for CBD stone exclusion.
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Aims: The study aims to evaluate a policy of CVS for the
prevention of bile duct injuries during laparoscopic
cholecystectomy for acute biliary pathology as an alter-
native to routine Intraoperative Cholangiography with
IOC reserved for suspected choledocholithiasis.
Methods: CVS was attempted in all patients undergoing
same admission LC for acute biliary pathology, over a
three-year period. Selective cholangiography was re-
served for patients with preoperatively deranged liver
function or dilated CBD on ultrasound. Receiver oper-
ator curves (ROC) were used to identify cut-off values in
liver function, predictive of CBD stones.
Results: Four hundred and forty-seven consecutive,
same admissions LC were reviewed. CVS was achieved in
388 (87%) patients. Where CVS was not possible, the
operation was completed open. CBD stones were iden-
tiﬁed in 22/57 patients who underwent selective IOC. Pre-
operative liver function and CBD diameter were signiﬁ-
cantly higher in those with CBD stones (P < 0.001).
ROC curve analysis identiﬁed pre-operative cut-off val-
ues of bilirubin (35 lmol/L), alkaline phosphatase
(250 IU/L), alanine aminotransferase (240 IU/L) and a
CBD diameter of 10 mm, as predictive of CBD stones.
No bile duct injuries occurred in this series.
Conclusion: Achieving a CVS is a safe alternative to
routine IOC during LC, for acute biliary pathology.
Selective cholangiography should be employed when
preoperative liver function and CBD diameter are above
deﬁned thresholds.
P-856
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION IN AN ELDERLY ASIAN
POPULATION
J. R. Chia V. Shelat, C. Y. Chan, C. K. Ho, K. H. Liau
and J. K. Low
Tan Tock Seng Hospital
Background: Laparoscopic common bile duct explora-
tion (LCBDE) is an established treatment for choledo-
cholithiasis. The safety and efﬁcacy of this procedure in
the elderly population is not well studied.
Aim: In this study, we evaluate the safety and outcome
of LCBDE in elderly patients (age > 70 years) in a single
institution.
Methods: A retrospective review was carried out on pa-
tients who had proven CBD stones and underwent lap-
aroscopic common bile duct exploration from 2006 to
2009.
Results: There was total of 62 patients of which 19
(30.6%) were approached laparoscopically and the rest
were open procedures. There were 13 woman (68.4%)
and 6 men (31.6%) with mean age 77 years (72–85 years).
13 (68.4%) patients were ASA class two and the rest were
ASA class three. Pre-operative ERCP was performed in 8
patients (42.1%). The mean operating time was 209 min
(75–465 min). Transcystic choledochotomy was per-
formed in 11 patients (57.9%) while the rest had chole-
dochotomy. Stone clearance was achieved in all patients.
There was no mortality in this series. The average length
of stay was 3.1 days (1–11 days). 5 (26.3%) patients had
either a T tube or an endo biliary stent placed for post
operate decompression of the bile duct. There were no
septic complications except for 1patient (5.3%) with bile
leak.
Conclusion: Laparoscopic common bile duct exploration
can be performed successfully and safely in elderly pa-
tients.
P-857
LAPAROSCOPY FOR COMPLICATED
ACUTE CHOLECYSTITIS – 10-YEAR
EXPERIENCE
P. Kumar, N. Mohan and R. Ardhanari
Meenakshi Mission Hospital and Research Center,
Madurai
Background: The appropriate timing for laparoscopic
cholecystectomy in the treatment of acute Cholecystitis
remains controversial. More recent studies indicate early
laparoscopic surgery may be a safe option in acute cho-
lecystitis, although conversion rates may be higher.
Hereby we present our analysis of prospectively collected
database of complicated acute Cholecystitis over a 10-
year-period.
Materials and methods: Analysis of prospectively main-
tained database on complicated acute Cholecystitis was
analysed between the periods Jan 2000 – Jan 2009. Data
was analysed for risk factors for conversion, post oper-
ative outcomes and complications.
Results: Total cholecystectomy during the study period
was 2167. Complicated acute cholecystitis was about 416
(19.19%). Male: Female ratio was 1.4:1. Majority pre-
sented after 72 hours of pain onset (62%). Co-morbidity
was present in about 27%. On laparoscopy pericholecy-
stic abscess (29%), empyema (43%), gangrene (24%),
internal ﬁstula (4%) was noted. Laparoscopic cholecys-
tectomy was completed successfully in about 94%.
Conversion rate was 6%. Post op overall morbidity was
about 16%. Bile leak in 2%, need for surgical interven-
tion in 2%, IAA in 5%. Overall mortality rate was 1.6%.
Mean post op hospital stay was 4.5 days. On multivariate
analysis male sex, late presentations, presence of CAD
were risk factors for conversion.
Conclusion: Early laparoscopic cholecystectomy can be
done safely in cases of complicated acute cholecystitis.
Need for low threshold for conversion and technical
expertise are required for low morbidity.
P-858
BETTER TREATMENT STRATEGIES
FOR PATIENTS WITH ACUTE
CHOLECYSTITIS AND ASA
CLASSIFICATION THREE OR GREATER
J. R. Yun, H. J. Kim, D. S. Lee, S. W. Park and
D. W. Hwang
Yeungnam University Hospital, Department of Surgery
Background/Aims: Laparoscopic cholecystectomy is the
best choice for treatment of acute cholecystitis. However,
it still carries high conversion and mortality rates. The
purpose of this study was to determine better treatment
strategies for high surgical risk patients with acute cho-
lecystitis.
Materials and methods: Between January 2002 and June
2008, we performed percutaneous cholecystostomy in-
stead of emergency cholecystectomy in 44 patients with
acute cholecystitis and ASA classiﬁcation three or
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greater. We performed this as a bridge procedure before
elective cholecystectomy (bridge group) in 31 patients
and as a palliative procedure in 11 patients (palliation
group).
Results: The mean patient age was 71.6 years (range 52–
86 years). The mean ASA classiﬁcations before and after
percutaneous cholecystostomy were 3.3 ± 0.5 and
2.5 ± 0.6, respectively, in the bridge group; and
3.6 ±0.7 and 3.1 ± 10, respectively, in the palliation
group. Percutaneous cholecystostomy was technically
successful in all patients. There were two deaths after
percutaneous cholecystostomy in the palliation group
due to underlying ischemic heart disease and multiple
organ failure. Resumption of oral intake was possible
2.9 ± 1.8 days after percutaneous cholecystostomy in
the bridge group and 3.9 ± 3.5 days after percutaneous
cholecystostomy in the palliation group. We attempted
17 laparoscopic cholecystectomies and experienced one
failure due to bile duct injury (success rate: 94.1%). The
postoperative course of all cholecystectomy patients was
uneventful.
Conclusions: Percutaneous cholecystostomy is an effec-
tive bridge procedure before cholecystectomy in patients
with acute cholecystitis and ASA classiﬁcation three or
greater.
P-859
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION (LCBDE) AS A SALVAGE
PROCEDURE FOR FAILED
ENDOSCOPIC TREATMENT OF
COMMON BILE DUCT STONES (CBDS)
V. Shelat, C. Chung Yip, L. Kui Hin and H. Choon Kiat
Tan Tock Seng Hospital
Aim: To propose LCBDE as salvage procedure for failed
endoscopic treatment for CBDS.
Methods: Retrospective case note review of patients
managed with LCBDE after attempted endoscopic
treatment for CBDS with particular interest to review the
case notes of ﬁfteen patients who underwent LCBDE
after failed endoscopic stone extraction.
Results: Forty-three patients underwent LCBDE at
TTSH since 2006. Twenty-one out of forty three patients
had an attempt for endoscopic treatment. Six out of 21
patients had successful endoscopic stone extraction. In
the remaining ﬁfteen patients the stone was not success-
fully extracted either due to technical difﬁculty or critical
illness of the patient. The mean age of these ﬁfteen pa-
tients was 64.4 years. Mean interval from endobiliary
intervention to LCBDE was 32.6 days in these ﬁfteen
patients. LCBDE was successful in removing the stones
in all the ﬁfteen patients with one open conversion. Mean
operating time was 253 min. Transcystic approach was
used in seven and in eight patient’s laparoscopic chole-
dochotomy was performed. Three patients had T-tube
placed and two patients had internal C stent placed.
Abdominal drains were used in 12 patients and average
time to removal was 2.9 days with a mean hospital stay
of 2.6 days. There was one bile leak, which resolved
spontaneously. Fourteen patients out of this ﬁfteen were
treated as ambulatory care surgery and one patient as
same day admission.
Conclusion: LCBDE can be safely and effectively pro-
posed as a salvage treatment for failed endoscopic stone
extraction. Training of surgeons in LCBDE has to be
encouraged.
P-860
EARLY LAPAROSCOPIC
CHOLECYSTECTOMY FOLLOWING
ERC STONE EXTRACTION – 10-YEAR
EXPERIENCE
P. Kumar, N. Mohan and A. Ramesh
Meenakshi Mission Hospital and Research Center,
Madurai, India
Background: Timing of cholecystectomy following
ERC + Stone extraction is controversial. It is recom-
mended to wait for 6–8 weeks after stone extraction for
LC. And LC after ERC has higher conversion rate and
complication rate. Hereby we present our data on whe-
ther early cholecystectomy (<72 hours) after ERC is safe
and feasible.
Materials and methods: Retrospective analysis of all pa-
tients who underwent early LC, after ERC were ana-
lyzed. Period of study was Jan 2000 – Dec 2008.
Results: Total number of patients with CBD stones was
473. Male: Female ratios were 1.2:1. Co-morbidity was
associated in 27%. Forty ﬁve patients did not undergo
LC after ERC were excluded. About 363 patients
(84.8%) underwent early LC after stone extraction. 65
patients (15.2%) underwent late LC. More than 85%
were performed by three ports, fundus ﬁrst technique.
Conversion rate was 2.5%, due to dense adhesions,
presence of ﬁstula. No signiﬁcant difference noted in
both groups. Overall morbidity was 12%. Bile leak noted
in two patients, bleeding in one patient, adjacent organ
injury requiring re-exploration in one patient. Presenta-
tion as cholecystitis, mild biliary pancreatitis, intra-
operative adhesions, and presence of CAD was associ-
ated with intra-op difﬁculty.
Conclusion: Early cholecystectomy after ERC and stone
extraction is feasible can be performed with low mor-
bidity and can be recommended.
P-861
ERCP – AN EFFECTIVE TOOL IN
MANAGEMENT OF INTRABILIARY
HYDATID
V. Borgaonkar, V. Borgaonkar and S. Sawai
Seth Nandlal Dhoot Hospital
Background: Intrabiliary rupture is one of the most
serious complications of liver hydatidoses. Incidence is
between 5–25%. Most of these patients are deeply jaun-
diced and often moribund. Accurate early diagnosis and
proper treatment is necessary to reduce morbidity and
mortality.
Objective: To determine the feasibility of ERCP (Endo-
scopic Retrograde Cholangiopancreatography) as a
therapeutic option in management of intrabiliary hydatid
cysts.
Methods: We have successfully managed three cases of
intrabiliary hydatid cyst endoscopically. Obstructive
jaundice was a common presentation. One patient had
associated liver hydatid. Endoscopic sphincterotomy,
saline irrigation and balloon swapping facilitated clear-
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ance of common bile duct (CBD). Nasobiliary catheter
(NBT) was placed in one patient for the purpose of irri-
gation of CBD. After this decontamination procedure, all
three patients made signiﬁcant clinical and biochemical
recovery. Purpose of NBT placement post ERCP in one
patient was to achieve complete clearance of CBD from
daughter cysts in doubtful situations and to attempt
cholangiogram at later date to conﬁrm complete clear-
ance. All patients were placed on oral albendazole regi-
men for 3 months and making regular follow up visits.
Results: All three patients had complete recovery. One
patient with associated liver hydatid underwent laparo-
scopic surgery at a later date. Average hospital stay was
8 days.
Discussion: In the literature, there are innumerable
reports on surgical modalities like either ‘T’ tube drain-
age or choledochoduodenostomy. However, there are
comparatively less reports on endoscopic options.
Major surgical procedure in such clinically moribund
patients deﬁnitely carries high morbidity and mortality.
Hospital stay is also more. With our experience, we
recommend endoscopic procedure as ﬁrst option. Surgi-
cal modality may be reserved for failures with endoscopic
procedures.
P-862
BILIARY MICROFLORA IN PATIENTS
UNDERGOING CHOLECYSTECTOMY
B. Darkahi1, G. Sandblom2, H. Liljeholm1 and
I. Rasmussen3
1Enko¨ping Hospital; 2Department of surgery, Karolinska
University Hospital, Stockholm; 3Department of surgery,
University Hospital, Uppsala
Background: The timing and extent of bacterial coloni-
zation as part of the pathogenesis in cholecystitis is only
partly known.
Aims: To explore the bacterial ﬂora in patients with
uncomplicated gallstone disease and cholecystitis, iden-
tify factors inﬂuencing the risk of bacterial contamina-
tion of the bile and assess the clinical relevance of the bile
ﬂora.
Methods: All cholecystectomies performed at the
department of surgery, Enko¨ping Hospital, Sweden,
from April 2007 to February 2009 were recorded pro-
spectively according to a standardized protocol. Bile was
sampled from the gallbladder in all procedures and sent
for culture. All postoperative infectious complications
were registered in a retrospective review of the patient
records.
Results: Altogether 246 procedures were performed
during the period of study, including 149 (62%) in wo-
men and 93 (38%) in men. Mean age was 49 years,
standard deviation 16 years. Bacterial growth was seen in
34 (14%) of the cultures. Mean age was 64 years for
those with positive culture and 47 years for those with
negative culture (P < 0.001). This difference remained
signiﬁcant even if patient operated for cholecystitis were
excluded (P < 0.003). Postoperative infectious compli-
cations were seen in 14 (6%) of the patients. In multi-
variate logistic analysis, only positive culture was
signiﬁcantly associated with the risk of postoperative
infectious complications (P < 0.05). Age, gender,
ongoing or previous cholecystitis or prophylactic treat-
ment with antibiotics had no signiﬁcant impact on the
risk of postoperative infections.
Discussion: Cholecystitis in elderly seems to have a dif-
ferent natural course than cholecystitis in younger, with
earlier bacterial colonization. Positive culture was the only
factor associated with an increased risk of postoperative
infections, which indicates that the bacterial content is
crucial for developing a postoperative site infection.
P-863
LAPAROSCOPIC CBD EXPLORATION IN
PATIENTS WITH FAILED ENDOSCOPIC
STONE EXTRACTION
I.-S. Song and K.-S. Chun
Department of Surgery, Research Institute for Medical
Sciences, College of Medicine, Chungnam National
University
Purpose: Laparoscopic common bile duct exploration
(LCBDE) has more advantages than conventional com-
mon bile duct surgery, but the route of stone removal and
biliary drainage is still controversial. This study aimed to
investigate the usefulness of LCBDE in patients who had
been failed in the endoscopic stone extraction.
Methods: From November 2005 to August 2008, ﬁfty-
two patients underwent LCBDE due to failure of endo-
scopic stone extraction in Chungnam National Univer-
sity Hospital. Clinical Data were collected and analyzed
retrospectively.
Results: Duodenal diverticulum (23 cases, 44.2%) was
most common cause in failure of endoscopic stone
extraction and large common bile duct stone 12 cases
(23.1%), previous upper gastrointestinal operation 10
cases (19.2%) were followed. Twenty four patients has
not necessary preoperative biliary drainage such as
PTBD, ENBD, PTGBD. Forty-ﬁve patients (86.5%)
among ﬁfty-two patients were performed LCBDE suc-
cessfully but seven cases had to be conversed to open
surgery due to severe intraabdominal adhesion in three
cases, stone impaction in ampulla portion in three cases
and remnant stone in one case respectively. External
biliary drainage were performed in 41 cases with T-tube
(31 cases, 68.9%), PTBD (seven cases, 15.6%), ENBD
(three cases, 6.7%). The stone clearance of LCBDE was
95.6%. Remnant stone were detected in two cases (4.4%)
and removed with choledochoscope via external biliary
drain. Postoperative complications happened in ﬁve cases
(9.5%). Procedure related complications happened in
two cases (3.8%).
Conclusion: LCBDE is useful technique in the patients of
failed endoscopic stone extraction and biliary drainage
maybe necessary for detection and removal of latent
remnant CBD stone.
P-864
LONG-TERM OUTCOME OF
HEPATECTOMY FOR PRIMARY
INTRAHEPATIC CHOLELITHIASIS IN A
EUROPEAN REFERRAL CENTER
P. Bucur, E. Vibert, A. Benkabbou, L. Gorden,
C. Salloum, R. Adam, D. Azoulay and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire,
Villejuif, France
Background: Primary intrahepatic cholelithiasis (PHL) is
a rare disease in western countries. Non-surgical inter-
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ventions including percutaneous cholangioscopic
lithotomy, endoscopic cholangiography, extracorporeal
lithotripsy (NSI), and surgical procedures including
hepatico-jejunostomy and hepatectomy are the principal
treatments for PHL.
Aim: To evaluate immediate and long-term results of
hepatectomy as a treatment for intrahepatic cholelithia-
sis.
Methods: From 1980 to 2007, 23 patients (16 women and
7 men, mean age 45 ± 13 years) underwent hepatic
resection in our service for PHL. Intrahepatic stones were
cholesterol in origin (11 patients) and pigmented stones
in (12 patients). Stones were localized to one side of the
liver in 16 patients and were bilateral in seven. Extrahe-
patic choledocholithiasis was present in 12 patients. Prior
to hepatectomy, 8 patients underwent NSIs and/or he-
patico-jejunostomy. There were 10 major (> 3 segments)
and 13 minor hepatic resections.
Results: Mortality and morbidity were 0% and 30%
respectively in the series. Mean hospital stay was
14 ± 4 days. Median follow-up was 7 years (range 2–
19). At 1, 3, 5 and 10 years 82%, 72%, 65% and 56% of
patients remained asymptomatic. The eight patients that
had recurrence of symptomatic PHL were treated with
NSIs and/or antibiotics. These complementary treat-
ments were successful in relieving symptoms in two pa-
tients. At most recent follow-up, 17 patients were
asymptomatic and six needed on-off antibiotic therapy.
One patient was on the waiting list for liver transplant
due to secondary biliary cirrhosis.
Conclusion: Hepatectomy is a safe and effective deﬁnitive
treatment for PHL in Western countries with an
acceptable long-term recurrence rate and low morbidity.
P-865
HOW TO PREVENT MAJOR BILIARY
COMPLICATIONS DURING
LAPAROSCOPIC CHOLECYSTECTOMY
Y.-G. Yun, H.-J. Kwon, K.-S. Kim, J.-M. Cheun,
S.-G. Kim and Y.-J. Hwang
Kyungpook National University Hospital
Background: Laparoscopic cholecystectomy (LC) is the
standard and safe procedure for gallbladder disease, but
it is still associated with serious complications.
Objectives: In this study, we would introduce a surgical
experience that is useful for the prevention from major
complications associated to LC.
Methods: From 1992 to 2009, 2445 patients that under-
went a LC by a single surgeon were retrospectively ana-
lyzed.
Results and conclusion: Of the 2445 patients, major
complications occurred in 11 cases. Bile duct injury
(two), bile leak of cystic duct (two), small bowel injury by
trochar (two), bleeding(four), incisional hernia (1), and
trochar site cancer (one) happened. Although LC is a safe
procedure, it is still possible to cause various complica-
tions. As such devastating complications are related to
misinterpret the anatomical structures inside Calot Tri-
angle. By doing through dorsal dissection, important
dorsal structure can be precisely seen and conﬁrm the
correct anatomical position. When the gallbladder has
been pulled cephalad, two distinct groups of tubular
structure are displayed on the monitor. One is standing
group which may need to be cut and the other is lying
group which should not be cut. The former has cystic
artery, cystic duct and the latter has right hepatic artery,
right hepatic duct and common bile duct et al. Although
11 major complications were developed at early period,
they have not happened any longer since this technique
was applied. Consequently, Dorsal dissection of Calot
triangle can reduce major complications of LC due to its
precise anatomy of risky points. It can, also, reduce the
need for cholangiography.
P-866
SINGLE INCISION LAPAROSCOPIC
CHOLECYSTECTOMY WITHOUT THE
USE OF A SINGLE PORT DEVICE
G. Srikanth, N. Shetty, T. L. V. D. Prasad Babu and
S. S. Sikora
Department of Surgical Gastroenterology, Manipal
Hospital, Bangalore
Background: Single incision laparoscopic surgery (SILS)
in the last two years has gained wide popularity across
the globe. We present our experience with SILS chole-
cystectomy without the use of single port device and
innovative traction suture for gallbladder fundal retrac-
tion.
Materials and methods: Clinical details, indication for
surgery, operation records, postoperative course and
follow up of patients undergoing SILS cholecystectomy
since July 2009 was studied.
Results: Fifteen patients underwent SILS cholecystec-
tomy during the study period. Indications were symp-
tomatic gall stones in all including two patients with
common bile duct stones. All except two patients
underwent the procedure without the use of commer-
cially available single port device and in twelve patients a
novel fundal traction suture was used. There were no
conversions. Two patients had morbidity namely, sub-
hepatic hematoma in a patient diagnosed postoperatively
with mild hemophilia with no prior history of bleeding
diathesis or prolonged coagulation on preoperative
workup. The other patient had a wound infection. None
of the patients had a bile duct injury. Thirteen patients
were discharged on the ﬁrst and the remaining two on the
2nd postoperative day respectively. One patient (diag-
nosed to have mild hemophilia) required readmission and
minilaparotomy and evacuation of hematoma and factor
VIII level correction. Eleven patients with follow-up of
more than a month remain asymptomatic and had no
discernable umbilical scar at this time.
Conclusions: We have demonstrated the feasibility of
SILS cholecystectomy without the use of single port de-
vice. The primary advantage of procedures done without
the use of a disposable single port device is low cost and
usage of regular instruments.
P-867
ALL RESECTED GALL BLADDERSMUST
BE SENT FOR HISTOPATHOLOGY
J. R. Agarwal, R. P. Singh, S. Singh, S. Mandal and
S. Agarwal
GB Pant Hospital and MAM College, Delhi University
Background: Recently there have been some reports in
the literature against the practice of sending all gall
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bladders (GB) removed at surgery for histopathological
examination (HPE). In our country some surgeons do
not send GB for histology as a routine.
Aims/Objective: To analyse the patients of incidental
Gall Bladder Cancer (IGBC) presenting with a HPE
report vs. IGBC patients presenting late.
Methods: This study was conducted on 148 patients of
IGBC presenting to our centre during 2000–2008. The
patients were divided into two groups; Group 1 - who
present early based on HPE report of gall bladder
available at the time of 1st surgery to those in which the
GB was either not sent or the patient ignored until the
patient presented with symptoms (group 2). The two
groups were compared for timing and mode of presen-
tation, operability, resectability.
Results: Of the 148 patients of IGBC, 17 were excluded.
The remaining 131 patients were divided two groups.
Group 1 (n = 71), Group two (n = 60).Comparing
Group.1 with Group. Two, time to presentation was
mean of 25 days and range of 1–70 days vs. 180 days,
Signs/symptoms suggestive of recurrence at presentation
was none vs. 44 (73.33%) patients. Based on clinical
examination and/or preoperative imaging none vs. 26
(43.33%) were deemed unresectable, patients deemed
resectable based on preoperative imaging was 71 (100%)
vs. 27 (45%). All 71 (100%) were taken up for surgery in
group 1 11 (18.33%), patients undergoing curative
resections were 49 (69.06%) vs. 3 (5%). The overall
resectability rate and the group resectability rate was
69.06% (49/71) in group 1 whereas the same ﬁgures for
group two were 11.11% (3/27) and 5% (3/60).
Conclusion: Group two patients (without the biopsy of
GB) had delayed presentation with higher evidence of
recurrence, signiﬁcantly reduced resectability and thereby
survival. Therefore our analyses suggest that ALL
CHOLECYTECTOMY specimens MUST be sent for
routine histopathology.
P-868
PANCREATICOBILIARY REFLUX IN
PATIENTSWITH CHOLELITHIASIS AND
WITHOUT CHOLELITHIASIS – IS IT A
NORMAL PHENOMENON?
M. Beltran, M., Contreras C. Karina, B. Pujado,
J. Oliva, P. Mendez, L. Jaramillo, N. Lopez-Perez,
N. Lopez-Vergara, M. Avalos, J. Godoy, V. Escobar,
D. Lafferte, R. Galleguillos and R. Jaramillo
Hospital de La Serena
Background: The occurrence of pancreaticobiliary reﬂux
has not been studied in patients without gallstones. We
suggest that pancreaticobiliary reﬂux is a pathologic
phenomenon occurring in patients with gallstones.
Objective: To measure the levels of amylase and lipase in
patients without gallstones submitted to cholecystectomy
as part of another surgical procedure and in controls.
Patients and methods: Prospective observational case-
control study. Outcome measures were the values of
amylase and lipase in gallbladder bile of patients with
gallstones and patients without gallstones, with a normal
pancreaticobiliary junction. A convenience sample of 136
consecutive patients was included. Before the cystic duct
was clipped, 5 cc of gallbladder bile were sampled.
Amylase and lipase levels were measured by colorimetry.
Normal serum amylase levels with this system are 28–
100 U/L and for lipase are 13–60 U/L. There are no
established normal levels for pancreatic enzymes in bile.
However, we considered elevated the bile amylase and
lipase levels whenever they were higher than normal
plasma levels.
Results: One-hundred three patients (76%) had gall-
stones and 33 (24%) had healthy gallbladders. Amylase
and lipase levels were elevated in most patients with
gallstones and were almost inexistent in patients without
gallstones. According to normal plasma levels for amy-
lase and lipase, these enzymes in bile were elevated in
83.5% patients with gallstones, compared to elevated
levels of amylase in 6% patients and lipase in 3% patients
without gallstones.
Highly elevated amylase and lipase levels
Group
Patients
n (%)
Amylase
> 100 U/L
n (%)
Lipase
> 60 U/L
n (%)
Gallstone
disease
103 (100) 86 (83.5)* 86 (83.5)*
Healthy
gallbladders
33 (100) 2 (6) 1 (3)
Total 136 (100) 88 (65) 87 (64)
*p<0.0001
Conclusions: Pancreaticobiliary reﬂux is a common
phenomenon in patients with gallstones and occurs spo-
radically in patients without gallstones. The reﬂux of
pancreatic enzymes into the bile ducts and gallbladder
might be a sporadic normal phenomenon in patients
without gallstones.
P-869
DOUBLE COMMON BILE DUCT WITH
CHOLEDOCHOLITHIASIS AND
CHOLELITHIASIS
J. R. Lee, J. H. Lee, S. Y. Song, H. K. Park and K. S. Lee
College of Medicine, Hanyang University, Seoul, Korea
Background: Double common bile duct (DCBD) is a
very rare biliary anomaly and usually presented as
inﬂammation in and around the biliary system.
Aim: We report the case of 76-year-old Korean male,
whose common bile duct divided into two channels and
describe clinical and radiological features and signiﬁ-
cance for surgeons.
Method: We reviewed the radiological ﬁndings of the
case of DCBD with chole and choledocho-lithiasis and
clinical course of endoscopic retrograde cholangiopan-
creatography (ERCP) procedure and laparoscopic cho-
lecystectomy.
Result: A 76-year-old woman presented to our hospital
on March, 2009, with right upper abdominal pain and
fever. DCBD was diagnosed with computed tomography
and ERCP, and conﬁrmed by operative cholangiogra-
phy. ERCP showed the dilatation of intrahepatic and
common bile duct and multiple stones in gallbladder and
both DCBD. We found a common bile duct that was
divided into two distinct ducts, both the main duct and
involve stones, during its course downwards. The two
bile ducts had a parallel course emerging from both main
hepatic duct, respectively, and rejoin just above the head
of the pancreas and opens into the second portion of the
duodenum at the site of major duodenal papilla. After
stone removal of common bile duct by ERCP, the patient
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underwent laparoscopic cholecystectomy. No complica-
tions occurred during operation and the postoperative
course was uneventful.
Discussion: DCBD is of great importance because the
duplication of the common bile duct can lead to injury to
one of the two ducts during operation, which can be
mistaken for the cystic duct.
P-871
COMPLICATED BILIARY LITHIASIS IN
TEENAGERS. RETROSPECTIVE
ANALYSIS
L. Moulin, J. Schiavetti, M. Candioti, A. Guala and
C. Marchetti
General Surgery Department, Jose Marı´a Cullen Hospital,
Santa Fe, Argentina
Background: Classic the biliary lithiasis (BL) like pro-
gressive pathology increases towards the middle ages of
the life and develops complications in conformity with its
evolution, nevertheless we observe a series of cases in
teenagers that with certain frequency it develops com-
plicated forms.
Aims: To analyze the information on the frequency,
presentation, complicated forms, treatments and results.
Methods: Retrospective analytical study from clinical
histories of 160 patients hospitalized between January,
2003 and December, 2008.
Results: A whole of 160 patients. Asymptomatic cases
two, cholelithiasis 30, acute cholecystitis 66, choledo-
cholithiasis 25, acute cholangitis 5 and acute pancreatitis
32. 130 were surgically solved, 71 laparoscopic and 59
open surgery, needing pre operative ERCP in 42 cases
(100 positive %). Intraoperative cholangiography (IOC)
in 70%. Exploration of biliary tract by laparoscopy in 8
cases and open surgery in 20 cases, being better tolerated
the laparoscopic surgery.
Conclusions: The BL in teenagers shaped, in the studied
period, 7% of the whole the income for the above men-
tioned pathology, appearing high proportion of compli-
cated forms (39%). Eighty one percent were surgically
solved, so much for laparoscopy as open surgery, being
the ﬁrst ones better tolerated. Preoperative ERCP was
needed in 42 cases. The IOC is performed of routine in
the service, but we realize it in 70% successfully, per-
mitting in ﬁve cases to diagnose choledocholithiasis
unsuspected.
P-872
GALLSTONES ILEUS
D. Mladenovik, N. Jakupi, A. Nikolovski and T. Shenol
University City Surgical Clinic St. Naum Ohridski,
Skopje, Macedonia
Background: There is very small number of cases re-
ported in this ﬁeld and the diagnosis and treatment are
questionable.
Aim: To present experience in diagnosis and treatment of
rare type of ileus, caused by cholecysto-duodenal ﬁstula.
Material and methods: During the 25 years time interval
(1983–2008) more than 9000 patients were operated for
biliary tract calculosis; only eight patients, or less than
0.1% were treated for biliary ileus. The male/female ratio
was 7:1, mean age of the patients was 59 (range 48 to
71 years). Seven patients are treated for terminal ileum
obstruction, two for high ileus (one duodenum and one
jejunum).
Results: All patients were treated as acute cases, only one
was diagnosed with ultrasound prior the surgical treat-
ment. Enterotomy and extraction of the gallstones were
used as surgical procedures. Communication gallbladder
– duodenum was not treated, expect in case of duodenal
obturation. Only one patient had prolonged hospital
treatment because of pulmonale complications; there was
no death case.
Conclusion: This very rare form of ileus should be con-
sidered in urgent abdominal surgery. Simple surgical
procedures (enetrotomy) are giving good results. There is
no need for additional interventions on gallbladder and
the ﬁstula, except in case of duodenal bulb stones.
P-873
EARLY LAPAROSCOPIC
CHOLECYSTECTOMY AFTER
ENDOSCOPIC SPHINCTEROTOMY FOR
CHOLEDOCHOLITHIASIS
M. Narasimhan, S. Kalia, K. Palaniappan and
Ramesh Ardhanari
Meenakshi mission hospital and research centre, Madurai
Methods: All consecutive patients who underwent early
(<3 days) LC after successful ES during the same
admission between Jan 2005 and July 2009 were retro-
spectively evaluated. Patients with sepsis, poor general
condition, uncontrolled comorbid conditions and de-
ranged liver function were not selected for surgery after
ES. Unsuccessful ERCP requiring CBD exploration was
excluded. The timing for LC after ES, conversion rate,
operative time, intraoperative and postoperative com-
plications and hospital stay were documented.
Results: We analysed 136 consecutive patients (52 men)
with a median age of 51 years. The mean interval be-
tween ES and LC was 2 days. Nasobiliary drain (NBD)
was placed in 66% of cases after ES and stone extraction.
There was one conversion to open cholecystectomy due
to dense adhesions of previous surgery. Mean operative
time was 70 min (range 35–140 min). Bile and stone
spillage occurred in 35% cases. NBD cholangiogram
showed residual stones in eight cases which required
postoperative ERCP and stone retrieval. Post ES Pan-
creatitis occurred in two cases prolonging postoperative
course. Postoperative complications occurred in six
patients (one bile leak, two prolonged ileus, one respi-
ratory infection, one unstable angina requiring Coronary
angiography and stenting, one reoperation for colonic
injury). Mortality occured in two patients (one postop-
erative decompensated chronic liver disease and one
acute left ventricular failure).Median Hospital stay was
5 days.
Conclusion: Early LC after ES during same admission
for selected patients is effective and should be considered
to reduce morbidity and cost of interval cholecystectomy.
Nasobiliary drain can be utilized for identiﬁcation of
common bile duct (CBD) intraoperatively and residual
stones in CBD. Prospective randomized trials can help
determine the true effectiveness and selection criteria of
this approach to reduce morbidity further.
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P-874
SHORT AND LONG-TERM OUTCOMES
FOLLOWING PERCUTANEOUS
CHOLECYSTOSTOMY FOR ACUTE
CHOLECYSTITIS IN HIGH RISK
PATIENTS
M. Abulfaraj, J. Lipschitz, A. McKay
Department of Surgery, University of Manitoba Winnipeg,
Manitoba, Canada
Background: Acute calculous cholecystitis is a common
emergency in the elderly patient population, and many of
these patients will have serious medical comorbidities
that place them at greatly increased risk following sur-
gery.
Objective: To determine the success rate and complica-
tions of percutaneous cholecystomtomy, as well as the
proportion of patients for whom the procedure may be
the deﬁnitive treatment for their gallbladder disease and
not require further intervention.
Methods: The study consisted of a retrospective chart
review of all patients with acute calculous cholecystitis
treated with percutaneous cholecystostomy tube inser-
tion at two university hospitals since 1995.
Results: There 43 males and 25 females with a median
age of 73.5. They had a median Charlson Comorbidity
score of 2.4 ranging from 0 to 7. 29% of patients were in
shock. The catheters were placed successfully in 98%,
and resulted in clinical success is 85% with an average of
3 days to improvement. 15% of patients died in the
hospital.
Conclusion: Percutaneous cholecystostomy is an accept-
able treatment option for acute calculus cholecystitis in
high risk patients. Successful treatment of the acute
surgical emergency is accomplished in the vast majority
of cases. However, the mortality rate remains high, likely
due to several factors including advanced age, serious
comorbid conditions, and the severity of the acute illness.
P-875
XANTHOGRANULOMATOUS
CHOLECYSTITIS, A CHALLENGE IN
DIAGNOSIS AND SURGERY. WHAT TO
DO?
E. Alqarqaz, A. Seconde´ and M. Johann
Hopital N.D. Bon Secours/ Digestive and Hepatobiliary
surgery Unit, Metz, France
Background: Xanthogranulomatous cholecystitis (XGC)
is a rare, benign inﬂammatory pathology. It could be
locally invasive with formation of ﬁbrosis and adhesions
mimicking gallbladder (GB) cancer and causing technical
difﬁculties during surgery.
Objectives: To demonstrate the diagnostic and technical
challenges imposed by XGC and propose a strategy for
its management.
Methods: Retrospective analysis of the data from the
records of the patients underwent cholecystectomy and
histopathologically proved to have XGC from January
2007 until October 2009.
Results: Twenty one out of 266 patients identiﬁed. Two
thirds were females. Acute presentation was seen in
(71%) of the patients. Appearance in initial investiga-
tions led to suspension of GB cancer in two patients, the
complementary investigations (CTS, MRI, and ERCP)
did not support this. All patients were operated on with
intent of cholecystectomy. In 12 patients laparoscopic
surgery completed, ﬁve converted and four were open
from the start. Initial intraoperative ﬁndings (adhesions,
pseudotumor.) led to suspension of cancer in ﬁve pa-
tients. Considering the preoperative evaluations and
certain morphologic appearances (wet inﬂammatory
thick adhesions rather than dry stony hard ones) led to
decision to do only cholecystectomy for all patients.
Perioperative complications occurred in four patients. In
ﬁnal pathology report, none was associated with cancer
and no long term complications after a median period of
14 months of follow up.
Conclusions: XGC can lead to high rates of conversions
and open surgeries and perioperative complications.
Although it can mimic advanced cases of GB cancer in
initial preoperative investigations and during surgery, we
still believe the treatment should only be cholecystectomy
and more extensive surgery without histopathology proof
is unjustiﬁed and will lead only to higher mortality and
morbidity.
P-876
XANTHOGRANULOMATOUS
CHOLECYSTITIS: NEED FOR
EXTENDED CHOLECYSTECTOMY
A. Kumar, P. Sihag, A. Prakash, R. K. Singh, A. Behari
and V. K. Kapoor and R. Saxena
Sanjay Gandhi Post Graduate Institute of Medical
Sciences, Lucknow
Background: Xanthogranulomatous cholecystitis (XGC)
is a variant of chronic cholecystitis characterized by
intense inﬂammation and local invasiveness. At times it
becomes difﬁcult to differentiate this entity from Gall-
bladder Cancer (GBC), which mandates a radical
resection.
Aim: To review our experience with radical resections
performed for XGC and identify features to differentiate
this from GBC.
Methods: Records of patients who underwent extended
cholecystectomy for XGC and GBC were retrieved from
a prospectively maintained database. Clinical features,
imaging and operative ﬁndings were compared.
Results: Over a period of 18 years, 6150 cholecystecto-
mies were performed. 10%gallbladder specimens
(n = 620) were reported to be XGC on histology. Dur-
ing the same time period, 115 patients underwent
extended cholecystectomy for GBC suspected either on
preoperative imaging or intra-operative ﬁndings. In 15 of
these patients ﬁnal histology revealed XGC (Group I),
while in the remaining 100, it was GBC (Group 2).
Presence of mass on CT scan/operative ﬁnding was the
variable found statistically signiﬁcant in detecting GBC
but with a low speciﬁcity of 52%.
Conclusion: Clinical features, imaging and operative
ﬁndings were not effective in differentiating GBC from
XGC. Though, the presence of mass in the gallbladder,
on CT scan was a pointer towards GBC, but not very
accurate in differentiating from XGC. In such a situa-
tion, extended cholecystectomy is recommended, in a
centre with high volume hepato biliary surgery.
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P-877
ENDOSCOPIC TRANSUMBILICAL AND
TRANSVAGINAL CHOLECYSTECTOMY
USING VARIOUS TYPES OF FLEXIBLE
ENDOSCOPES, INCLUDING R-SCOPE
Y. Starkov, K. Shishin, E. Solodinina, L. Domarev,
I. Nedoluzhko, S. Dzhantukhanova and M. Vyborniy
Institute of Surgery n.a. A.V.Vishnevsky
Background: Despite the considerable interest in trans-
lumenal endoscopic surgery (N.O.T.E.S.) currently there
is no specialized ﬂexible endoscope to perform such
interventions. Operations are carrying out by conven-
tional endoscopes.
Aim: To evaluate the capacity of various types of ﬂexible
endoscopes in order to reveal their beneﬁts and disad-
vantages.
Methods: Since May, 2007 up today 18 patients under-
went cholecystectomies using ﬂexible endoscopes by
transvaginal (4) and transumbilical (14) approaches. To
perform the technique we used single-channel endoscopes
Olympus GIF Q160 (two) and high deﬁnition Olympus
GIF Q180H (two), double-channel therapeutic endo-
scope Olympus GIF 2T160 (six), convex ultrasound-
endoscope with operated elevator Pentax EG-3830UT (1)
and Fujinon EG-530U (ﬁve), along with Olympus
R-scope (prototype).The single-channel diagnostic en-
doscopes were the least convenient and caused the
problems with stabilization of the device in abdominal
cavity due to their signiﬁcant ﬂexibility. The double-
channel therapeutic endoscopes were more stable. Usage
of two tools allowed performing the limited manipula-
tions in gallbladder neck area; however it did not enable
the basic movement-triangulation and thus limited its
application. The ultrasound-endoscopes allowed carrying
out the intraoperative ultrasonography of bile ducts. The
management of device gave greater opportunities for
manipulations by means of operated elevator. Usage of
R-Scope with two channels allowing the management of
tools in two perpendicular planes was accompanied by
best results. The effective technique using two tools
provided for triangulation and an adequate tension of
tissues, thereby achieving ideal visualization and preci-
sion work reducing operative time.
Conclusion: R-Scope appeared to be the most effective
endoscope among all ﬂexible devices, using for trans-
lumenal endoscopic surgery.
P-878
A PROSPECTIVE COMPARISON STUDY
OF TWO-PORT AND THREE PORT
TECHNIQUE IN THE LAPAROSCOPIC
CHOLECYSTECTOMY
C. Kwon Mook, P. Dong Eun and W. Tae Wan
Department of Surgery, Wonkwang University Hospital
Background: Laparoscopic cholecystectomy has been
evolved to various methods: four-port, three-port or two-
port. In recent days, some authors recommend two port
laparoscopic cholecystectomy with useful method.
Aim: We compared the clinical characteristics of the
two-port method and three-port method, and we esti-
mated the usefulness of each port method.
Methods: We performed a prospective analysis of 40
patients that underwent a laparoscopic cholecystectomy
by single surgeon from September 2008 to January 2009.
Two port and three port technique were done alterna-
tively by one surgeon, who had enough experience of
laparoscopic surgery in XXX university hospital, had
done operation during study periods. We compared two
groups with the parameters of operation time, intraop-
erative complication, conversion rate, postoperative
complication, and postoperative hospital stay, trocar site
pain and patient’s satisfaction.
Results: There were signiﬁcant difference between the
two and three port groups in terms of the mean operation
time, conversion rate and intraoperative events. The
mean operation time (two port; 38.95 ± 10 min., 3port;
23.25 ± 5 min: P < 0.01), conversion rate (two port;
ﬁve case, three port; 0 case: P = 0.016) and intraopera-
tive events in three port technique were less than two port
technique (two port; 14 events, three port; two events:
P < 0.01). There were no signiﬁcant difference in trocar
site pain, hospital stay and patient’s satisfaction.
Table 3. Operative outcome
2 ports
group
(n = 20)
3 ports
group
(n = 20) P-value
Operation time (min) 38.95 ± 10 23.25 ± 5 < 0.01
Conversion (case)
To 3 trocar
To open
5
5
0
0
0
0
0.016
Intraoperative events
Bile leakage
(gallbladder perforation)
Bleeding
14
8
6
1
1
0
< 0.01
Postoperative mean
hospital day (days)
3.75 ± 0.55 3.75 ± 0.44 1.00
Postoperative bleeding
and Bile leakage
0 0 0
Conclusion: Considering our results, three port tech-
niques could be regarded as the optimal surgical tech-
nique compared to two port techniques in the
laparoscopic cholecystectomy, as long as the new
instruments for gall bladder traction and new port were
not developed.
P-879
LAPAROSCOPIC CHOLECYSTECTOMY
VIA A TRANSVAGINAL APPROACH –
HYBRID NOTES CHOLECYSTECTOMY
I. L. Park, B. S. Sohn, S. J. Kim, S. K. Lee, K. H. Kim,
K. Y. You Young, S. Lee and E. K. Kim
Department of Surgery, Division of Hepato-Pancreato-
Biliary Surgery, the Catholic University of Korea
Natural oriﬁce transluminal endoscopic surgery
(NOTES) is usually performed using a ﬂexible endo-
scope. However, this instrument shows several limita-
tions in the manipulation of intraabdominal organs. The
use of the laparoscope instead of the ﬂexible endoscope
eliminates the need for new instruments and technical
skills. We used conventional laparoscopic instruments
for improving operative efﬁciency and single-port access
to prevent air leakage from the vaginal port. A 54-year-
old female patient was admitted to our hospital with
uterine prolapse and symptomatic gallstones. She under-
went single-port laparoscopic cholecystectomy via a
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transvaginal approach. Transvaginal hysterectomy was
performed after the cholecystectomy by Gynecologist.
The operative time for cholecystectomy was 86 min. She
was discharged on the 8th postoperative day. This
technique combines the advantages of NOTES and single
port access surgery. We think that this technique can be
easily performed using laparoscopic instruments.
P-880
LAPARO-ENDOSCOPIC RENDEZVOUS:
AN OPTION TO TREAT THE BILE DUCT
STONES DURING THE LAPAROSCOPIC
CHOLECYSTECTOMY
F. Pereira, Y. Venales, J. Bousquet and M. Aboud
Unidad de Cirugı´a de Mı´nimo Acceso. Hospital
Universitario ‘Dr. Luı´s Razetti’
Background: There are diverse minimally access surgical
approach to treat the choledocolithiasis. One of them is
the Laparo-Endoscopic Rendezvous (LER), which al-
lows resolving during the same surgical procedure not
only the gallbladder stones, but also the bile duct stones
(BDS).
Objectives: To describe the technique employed and the
experience obtained with the LER to treat the BDS.
Methods: We analyzed three clinical cases of patients in
whom were employ the LER, during the Laparoscopic
Cholecystectomy (LC), as a minimally access surgical
approach to treat BDS.
Results: In all cases a minimally access surgical strategy
was planned during the same intervention: LC, intra-
operative cholangiography and endoscopic bile duct
clearance, due to high suspicion of BDS. The laparo-
scopic anterograde cannulation of the biliary way was
performed through the cystic duct. The therapeutic
objective was achieved in all patients. There was not
associated morbid-mortality and all patients were satis-
ﬁed with the surgical outcome.
Conclusion: In our experience, the LER results a useful
technical option for the bile duct clearance during the
LC, in patients with high suspicion of BDS. A successive
Endoscopic Retrograde Cholangio-Pancreatography and
instrumentation of the biliary way become unnecessary.
P-881
MIRIZZI SYNDROME: A DIAGNOSTIC
AND OPERATIVE CHALLENGE
R. Sanchez Claria, O. Mazza, M. Bregante, C. Salas,
F. Bersano, J. Pekolj and E. De Santiban˜es
Hospital Italiano de Buenos Aires
Background: Mirizi’s Syndrome is a rare complication of
a long standing cholelithiasis. Many surgical approaches
of varying complexity have been advocated for treat-
ment. Minimally invasive surgery has been used for many
other procedures and it could be feasible to resolve dif-
ferent types of this syndrome.
Aim: To establish the frequency of the Mirizzi Syndrome
in complicated cholelithiasis and analyze the most suit-
able diagnosis and treatment options.
Material and methods: From November 1991 to
December 2004, 6107 patients underwent laparoscopic
cholecystectomy for gallbladder lesions, 12 (0.2%) of
whom were diagnosed with Mirizzi syndrome preopera-
tively and intraoperatively.
Results: The study included eight male and four female
patients with a mean age of 69 years The incidence was
0,2% and type II was more frequently observed Among
the preoperative diagnosis ultrasonography and magnetic
resonance cholangiopancreatography were the radiolog-
ical studies Laparoscopic surgery was done in eight pa-
tients (77.7%) and in the other four we converted to an
open surgery In ﬁve patients we performed a primary
closure of the ﬁstula, in ﬁve patients we made a chole-
dochotomy over a T tube and in two patients we per-
formed an hepaticoyeyunostomy.Operative time was
193 min (r = 130–300), hospital stay was 6.1 days
(r = 2–9), morbidity was observed in four patients (two
patients with mild biliary leak and two with a bile duct
injury in whom we performed: a choledocho-choledocho
anastomosis over a T tube and an hepaticoyeyunosto-
my). Mortality was 0%.
Conclusion: Mirizzi´s syndrome sometimes can be antici-
pated on the basis of preoperative staging, and often is
diagnosed or conﬁrmed during the procedure. The
essential part of the management of patients with Mirizzi
syndrome is to determine the best surgical procedure.
Management choices are in debate; however laparoscopic
surgery appears as a safe procedure with a low threshold
for conversion open.
P-882
ACUTE CARE SURGERY SERVICES:
DOES IT AFFECT THE MANAGEMENT
OF ACUTE CHOLECYSTITIS?
S. Lapierre1, W. Mohammad1, N. Balaa2, M. Akil,
R. Mimeault1, R. Fairfull-Smith1 and F. Balaa1
1The Ottawa Hospital / University of Ottawa; 2University
of Ottawa
Background: Acute care surgery services (ACSS) repre-
sent a new model of care for patients presenting with
surgical emergencies. Recently introduced at our insti-
tution, we evaluated its effect on the management of
patients presenting with acute cholecystitis.
Objectives: To evaluate the impact of an ACSS model on
the management of acute cholecystitis at a tertiary care
academic center.
Methods: A retrospective chart review of patients pre-
senting with acute calicular cholecystitis from the period
of May 2006 to May 2009 was completed. The ACSS
model was introduced at the midway point in January
2008. Patient demographics, investigations, management,
complications and hospital stay were captured.
Results: A total of 123 patients were eligible for analyses.
Fifty-four patients (44%) presented prior to the intro-
duction of ACSS. The mean age was 63.8 years. Sixty-
one patients (49.6%) were females. The mean length of
stay was 14.2 days prior to the introduction of ACSS
period, and 8.6 during the ACSS model.
Conclusion: The introduction of ACSS model at a ter-
tiary care academic center has led to a reduction in the
mean length of stay for patients presenting with acute
calicular cholecystitis.
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P-883
NON-SUSPECTED
CHOLEDOCHOLITHIASIS
F. Sua´rez Anzorena, L. Fernna´ndez Antuejo,
R. Sa´nchez, P. Lynn and P. Ferraina
Instituto Quiru´rgico del Callao
Background: The incidence of non-suspected lithiasis is
5%, despite this there is actual controversy regarding the
use of intra-operative cholangiography. There are many
approaches for this eventuality.
Objective: To Describe the incidence and the manage-
ment of this condition in a cohort of patients treated by
the same working group in an ambulatory surgery center.
Materials and methods: Retrospective, observational and
comparative study. Two hundred and nine patients with
diagnosis of cholelithiasis were cholecystectomized lapa-
roscopically from 08/05/2006 to 04/05/2009. Systematic
intra-operative cholangiography was performed in all
cases. If non-suspected lithiasis was found, a differed
endoscopic approach within 24 hours was done.
Results: Non-suspected lithiasis was found in nine pa-
tients (4.3%), only one had acute cholecystitis. The mean
surgical time was 70 min, non signiﬁcant differences were
found between the non-suspected lithiasis and the non
lithiasis groups. All the cases could be resolved endo-
scopically within 24 hours. Patients with choledocho-
lithiasis were discharged between 48 and 72 hours from
cholecystectomy, except one patient with a post-papill-
otomy bleeding, discharged at 5th day post operatory.
Conclusions: The use of systematic intraoperative chol-
angiography allowed us to identify non-suspected lithia-
sis in almost 5% of our population. The endoscopic
treatment was effective in 100% of our cases.
P-884
CHOLANGIOHYDATIDOSIS: EIGHT
CASES OPERATED
M. Tolino, J. Kidd and J. G. Ojeda
Trelew Hospital
Background: Hydatidosis is endemic in some regions like
Argentinean south. In humans, liver is the more frequent
affectation. Cysts can be complicated with rupture to
peritoneal cavity, to compress near structures or to have
biliary communication, but rarely hydatidic vesicles and
membranes grow into the distal bile duct.
Objective: To describe eight cases of cholangiohidatido-
sis.
Methods: Retrospective study. Between 1990 and 2008,
hepatic hydatidic cysts surgically treated in 302 patients.
Eight cases of cholangiohydatidosis were identiﬁed,
(2.85%).
Results: Eight men, mean age 42. Six patients developed
jaundice, 1 acute cholangitis and 1 acute pancreatitis. All
diagnosis was made by ultrasound but in one patient a
computed tomography and in other cholangioMRI was
required. All patients underwent open drainage of liver
cysts. Intraoperative cholangiography (IOC) and chole-
docotomy were performed in all cases to evacuated ves-
icles and membranes. Mean postoperative stay was
15 days. Cystostomy tube drainages were retired in
21 days (r 6-43). Kehr tubes were retired in 5 weeks.
Morbility: one patient was operated the 2nd postopera-
tive day because Kehr tube was accidentally retired.
Mean follow–up was 14 years. None of patients pre-
sented residual cavity infection, neither hepatic hydati-
dosis, but one of them was operated 4 and 12 years later
by spleen and peritoneal hydatidosis.
Discussion/Conclusion: Cyst-biliary communication in
hepatic hydatid is descript in 7%–64%. Cholangiohi-
datidosis is a rare complication of hepatic hydatid cyst.
IOC or cholangioMRI in preoperative, rarely certify
membranes into the bile duct. Endoscopic treatment was
published. Hydatidic membranes and cysts in bile duct
aren’t frequent, but with certain treatment results may be
excellent.
P-885
OUTCOME OF MIDDLE AND LOWER
BILE DUCT CARCINOMA AFTER
SURGICAL RESECTION –
CLINICOPATHOLOGICAL STUDY
Y. Iso, T. Sawada, J. Kita, M. Kato, M. Shimoda and
K. Kubota
Dokkyo Medical University / Second Department of
Surgery
Middle and lower bile duct carcinoma (MLBDC) is a
difﬁcult disorder for diagnosis and treatment. MLBDCs
are usually in the advanced stage at the time of the
diagnosis and pancreatoduodenectomy (PD) is a golden
standard of the treatment. In this study, we retrospec-
tively reviewed our experiences of MLBDCs, in terms of
clinicopathological features and the outcome. Between
April 2000 and September 2009, there were 50 patients
with MLBDC who underwent PD at our department.
Patient’s clinical backgrounds, operative data, histolog-
ical ﬁndings, and outcomes were reviewed. There were
27 males and 23 females with a mean age of 67.9 years.
PD with extended lymph adenectomy was performed in
all the patients. In ﬁve patients, PD with extended
hepatectomy was performed because carcinoma invaded
hepatic hilus. And two patients underwent PD with
portal vein resection due to portal invasion. Median
operation time was 559 min and median operative
blood loss was 620 ml. Pathological examination
revealed that there were eight cases of stageI: Twenty
cases of stageII: Twelve cases of stageIII, and ten cases
of stageIV. There was lymph node metastasis (LN) in 14
patients, serosal invasion (S) in 25 patients, hepatic
inﬁltration (Hinf) in six patients, pancreatic invasion
(panc) in 32 patients, and portal vein invasion (PV) in
three patients. Overall 1, 3, and 5 year survival rates
were 72%, 52% and 38%, respectively. Median survival
periods of stage I, II, III, and IV were 57.5, 53, 51.4,
and 21.0 months (P > 0.05). Median survival periods
of patients with positive and negative for LN were 13.0
and 57.6 months (P = 0.01) respectively. No signiﬁcant
differences for survival rates were found in S, Hinf,
panc, PV, and arterial invasion. Recurrence was found
in the resected area (40.0%), liver (26.7%), distal
metastasis (20%), and lymph nodes (13.3%). Surgical
resection is highly recommended for MLBDC. Lymph
node metastasis is an only prognostic parameter after
surgical resection.
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P-886
GALLBLADDER SURGERY – ARE WE
INFORMING OUR PATIENT PROPERLY?
J. R. Uzzaman, S. Tayeh, S. Sinha and D. Stoker
North Middlesex University Hospital, London
Introduction: Provision of informed consent prior to
surgery is fundamental in allowing patients to make
balanced choices about their care. It is known that
variations exist in consenting practice in the context of
LC. Furthermore it has been shown that surgeons often
fail to warn patients of serious complications for com-
mon procedures such as inguinal hernia repair.
Aim: To quantify variations in consenting practice for
LC and failure to warn patients of serious complications
resulting from LC.
Methods: Retrospective review of medical notes of all
patients undergoing LC at a busy London district general
hospital between September 2006 – April 2009.
Results: Records were successfully retrieved for 163 pa-
tients. Grade of consenter was SpR (62%): Consultant
(20%): SHO (18%)88/163 (54%) were consented on the
day of surgery 84/163 (51.5%) received a carbon copy of
the consent form 51/163 (31.3%) received a patient
information leaﬂet about the operation The ﬁve most
commonly mentioned complications were bleeding
(99%), infection (95%), conversion to open (93%), bile
duct injury (82%) and visceral injury (65%) There were
27 documented complications in 23 patients9/23 (39%)
patients who suffered a complication were not warned of
thisThe speciﬁc complications omitted from consent were
respiratory complications (three), intra-abdominal ab-
scess (two), bile leak (one), retained CBD stone (one),
urinary retention (one), cardiac complication (one).
Conclusion: The practice of informing patients for LC
remains variable and is resulting in failure to warn pa-
tients of signiﬁcant complications. This has potential
medico-legal implications.
P-887
CHOLEDOCHOSCOPY. INDICATIONS,
USE AND OUTCOMES FOR REMOVING
BILIARY LITHIASIS
S. Bustos1, C. Minotto1, J. Nefa2 and P. Jaureguiberry1
1Surgical Service, Clinica Francesa, Mendoza, Argentina;
2Hospital Italiano de Mendoza
Background: Laparoscopic approach for removing bili-
ary calculi, have demonstrated good outcomes using the
wire-basket under ﬂuoroscopic guidance. However, still
exist residual lithiasis, great radiation exposure and dif-
ﬁcult lithiasis to remove due to its size or position.
Objectives: To assess indications and outcomes of ﬂexi-
ble Choledochoscopy, for retrieving biliary calculi.
Methods: In a 15-years-period, 389 Common-Bile-Duct
Stones explorations for Choledocholithiasis were re-
viewed retrospectively. In 112 patients a ﬂexible Chole-
dochoscopy was carried out. Fourteen patients had
Residual Lithiasis, ﬁve previous Endoscopic Retrograde
Cholangio Pancreatography, two Choledochal Cyst, one
Stricture of biliary-anastomosis, and one pregnant pa-
tient. Choledochoscopy and Duodenoscopy were per-
formed simultaneously in three cases. Choledochotomy
was undertaken when the Cystic-duct was not able for
choledochoscopy.
Results: One hundred and ten lithiasis were successfully
resolved under Choledochoscopy guidance. There were
two residual Lithiasis, one unsuspected and one was left
for postoperative endoscopy. Choledochoscopy was
useful for retrieving intrahepatic lithiasis, great calculi
and fragmentation. Adequate assessment of the papilla
permeability was achieved in 72 cases. Just one patient,
was not attempted by Coledochoscopy and Cholangi-
ography.
Conclusions: Main indications for choledohcoscopy were:
fragmentation of great lithiasis, Lithiasis over the Cystic-
duct insertion, biliary mucosa and papilla assessment.
To achieve a complete biliary clearance, is recommended
the association of Intraoperative Cholangiography with
Cholangioscopy. Choledochoscopy plus Fluoroscopy
offer a real complete map of the biliary tree. Choledo-
choscopy not replace the Cholangiography. Choledo-
choscopy decreases radiation doses. Blind points of
Choledochoscopy must be taken into account.
P-888
CLASSIFICATION OF GALLSTONE
DISEASE BASED ON SYMPTOM
SEVERITY AND PATHOLOGY
M. Schmidt1,2, J. A. Dumot3, S. Rosenblatt4,
T. Hausken5, M. Ramnefjell6, G. Njølstad7, G. E. Eide8
and K. Søndenaa1,2
1Department of Surgery, Haraldsplass Deaconal Hospital,
Bergen, Norway; 2Department of Surgical Sciences,
University of Bergen, Bergen, Norway; 3Digestive Disease
Institute, Cleveland Clinic, Cleveland, Ohio, US;
4Department of General Surgery, Cleveland Clinic,
Cleveland, Ohio, US; 5Department of Internal Medicine,
University of Bergen, Bergen, Norway; 6Department of
Pathology, Haukeland University Hospital, Bergen,
Norway; 7Department of Microbiology, Haukeland
University Hospital, Bergen, Norway; 8Center for Clinical
Research, Haukeland University Hospital, Bergen,
Norway
Background: The indication for cholecystectomy has at
times been arbitrary. Disease severity has been indicated
as a potential selection criterion but lacks a clear deﬁni-
tion.
Aim: The aim was to deﬁne and classify gallstone disease
according to the severity of clinical symptoms as a basis
for future outcome assessment.
Methods: One hundred and ﬁfty-three patients, 53 US
and 100 Norwegian patients, admitted for surgical
treatment of gallstone disease ﬁlled out a structured
questionnaire on abdominal symptoms during the last
three months. The questionnaire was based on a large
experience from previous, prospective studies. Clinical
symptoms were compared with the number and size of
gallstones, bacteriology and histology of the specimens.
A symptom score ranging from 1 to 10 was assigned.
Results: The patients were divided in three groups,
based on frequency of gallstone-associated pain at-
tacks. Thirty-seven patients had one or more pain at-
tacks per week (Severe group 24%), 59 patients had
monthly pain attacks (Moderate group 39%), 34 pa-
tients had pain attacks once every three months or less
(Mild group 22%), and 23 patients had pain without
deﬁnable attacks or chronic pain or discomfort (mainly
nausea/extensive food intolerance) (Chronic group
15%). The mean clinical symptom scores in these
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groups were 6.1, 6.1, 5.9 and 4 (p = 0.001) and a vi-
sual analogue scale for pain intensity showed mean 81,
87, 79 and 75, respectively (n.s.). No signiﬁcant dif-
ferences were found regarding number and size of
gallstones in 67 patients. Histology showed chronic
inﬂammation in 87% of 83 patients while 13% of 79
patients had a positive bacterial bile culture.
Discussion: Frequency of pain attacks was the only
variable that allowed distinct group separation. Appar-
ently patients with a chronic pain pattern must be as-
sessed according to different criteria. Follow-up of these
patients will show if such a classiﬁcation also predicts
outcome.
P-889
CYSTIC DUCT STONES-A BASIS TO
TRANSDUCTAL CHOLANGIOGRAM
AND COMMON BILE DUCT
EXPLORATION
A. Bhattacharjee, T. R. Lazim and A. Rasheed
Royal Gwent Hospital
Background: Cystic duct (CD) stones are a part of the
spectrum of extra-hepatic biliary calculus which can lead
to potential complications like pancreatitis, obstructive
jaundice, post-cholecystectomy syndrome etc.
Objective: To establish the basis of selective per opera-
tive cholangiography (OTC) and common bile duct
(CBD) exploration by correlating incidence of CD and
CBD stones.
Methods: Data was prospectively collected for 240 elec-
tive laparoscopic cholecystectomy patients of 2007- 2008.
CD was skeletonised during each operation to demon-
strate anatomy and its junction with CBD; it was milked
with its contents towards gall bladder and excised to
ensure free ﬂow of bile prior to application of clips. OTC
was performed in all cases revealing stones/sludge from
excised CD. OTC showing ﬁlling defect or dilatation of
CBD had trans-cystic exploration or simple manipula-
tion i.e. saline ﬂush and glucagon injection.
Results: About 39 patients (16%) revealed CD stones
and/or sludge during routine laparoscopic cholecystec-
tomy. CDs in 16 patients were visibly dilated. 13 of them
showed concomittant CBD dilatation/ﬁlling defect on
OTC: 10 of them had laparoscopic radiological trans-
cystic exploration of CBD of which two failed and had to
be opened; eight revealed stones, two did not. These two
had post operative ERCP- 1 revealed multiple stones.
Three had stones ﬂushed with saline and glucagon
injection after OTC with post operative ERCP revealing
no stones.
Discussion: CDs should be routinely skeletonised, milked
and excised during laparoscopic cholecystectomies to
reveal their contents prior to application of clips. If the
contents reveal stones and/or sludge after excision, OTC
is imperative to investigate CBD stone/ sludge. A per-
operative trans-cystic manipulation or exploration is
usually successful in clearing these obstructions. This can
minimise risk of potential complications from extra he-
patic biliary tree obstruction by gall stones in cases of
routine laparoscopic cholecystectomies.
P-890
THE FOLLOW-UP BIOCHEMICAL
PARAMETERS OF CHOLESTASIS AND
OXIDATIVE STRESS INTENSITY IN
PATIENTS WITH OBSTRUCTIVE
ICTERUS INDUCED BY
CHOLEDOCHOLITHIASIS
S. Zajic1,2, M. Jovanovic1,2, R. Zdravkovic1,2,
V. Milojevic1,2, G. Filipovic1,2, M. Miladinovic1,2,
M. Smiljkovic1,2, M. Gajic1,2, A. Kitanovic1,2,
D. Pesic1,2, V. Kulic1,2 and D. Blagojevic1,2
1Health Center Krusevac, Serbia; 2Department of Surgery
Introduction: In cholestasis, induced by cholelithiasis,
there is impossibility of bile ﬂow from liver to duodenum
with consequent regurgitation of bile into hepatocytes
and circulation. Extrahepatic cholestasis is the conse-
quence of mechanical block in bile ﬂow through ductus
hepaticas, choledochus and Vateri papilla, leading to the
appearance of manifested jaundice.
Aim: Monitoring of AST, ALT, g-GT and AP activities,
bilirubin and cholesterol concentrations, as well as oxi-
dative stress intensity in plasma of patients with extra-
hepatic cholestasis induced by choledocholithiasis were
imposed for aims of this work.
Materials and methods: The investigation encompassed
70 patients divided into two groups. The ﬁrst one is
control group (30 healthy), while the second was formed
from 40 patients with intraluminal extrahepatic
obstruction caused by choledocholithiasis.
Results: In plasma of cholestatic patients there is signif-
icant increase of AST, ALT, -GT and AP activities,
compared to control (P < 0.001). Total, direct and
indirect bilirubin levels are increased in plasma of pa-
tients with cholestasis (P < 0.001) compared to control.
Cholesterol concentration in cholestatic patients plasma
is signiﬁcantly increased (P < 0.05). Oxidative stress
intensity, determined through lipid peroxidation level
(MDA) and quantity of oxidatively modiﬁed proteins
(carbonyl groups), is signiﬁcantly higher in patients with
extrahepatic cholestasis compared to control group
(P < 0.001).
Conclusion: In patients with cholestasis induced by cho-
ledocholithiasis the signiﬁcant increase of enzymatic
markers of cholestasis (AST, ALT, -GT i AP) and bili-
rubin has been noticed in plasma. Cholestasis leads to
increase of cholesterol concentrations in patient’s plas-
ma. The oxidative stress intensity is increased in plasma
of patients with extrahepatic cholestasis.
P-891
INCIDENCE OF CHRONIC
CHOLECYSTITIS IN ASYMPTOMATIC
INDIVIDUALS UNDERGOING DONOR
HEPATECTOMY FOR LIVING DONOR
LIVER TRANSPLANTATION
S. Sasturkar, S. Goja, P. Dargan, M. Wadhavan, V. Vij,
S. Gupta
Department of Surgical Gastroenterology and Liver
Transplantation, Indraprastha Apollo Hospital, New Delhi
Background: Chronic inﬂammatory changes in the gall
bladder wall are found even in the absence of gall stones.
Cholecystectomy is performed as a surgical step during
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the donor hepatectomy for living donor liver transplan-
tation.
Aim: To access the incidence of chronic cholecystitis in
these asymptomatic individuals.
Patients and methods: This study is a retrospective
analysis. 200 patients underwent donor hepatectomy
from September 2006 to September 2009. Patients with
gall stones on preoperative imaging are excluded. All
patients were free from any upper abdominal symptoms
and clinical examination was normal. All donors under-
went preoperative evaluation as per the Unit protocol
that includes complete blood count, Liver and Kidney
function tests, viral serology and cardiopulmonary eval-
uation, preoperative CT scan and MRCP. Individuals
with fatty changes in the liver on imaging or biopsy were
not considered for donation. The histopathology of the
gall bladder was categorized as normal, chronic chole-
cystitis, cholesterolosis with and without chronic
inﬂammation.
Results: Two hundred patients, 122 male and 78 females
are included in the study. The median age of male do-
nors: 27 years (18 to 57) and of females was 31 years (18
to 55 years). 179 patients belong to the Indian subcon-
tinent and rest is from other countries. Liver and kidney
function tests, viral serology (HBsAg, anti HCV anti-
body. HIV I and II) were normal in all. The histopa-
thology of the gall bladder was reported as normal in 92
patients, cholesterolosis: four patients, cholesterolosis
with chronic cholecystitis: eight patients and chronic
cholecystitis in 96 patients. The chronic inﬂammatory
changes were reported mild in 14 out of 96 cases.
Discussion: In our study we could analyze the histopa-
thology of gall bladder in essentially healthy individuals
who otherwise do not require cholecystectomy.
Conclusion: Chronic inﬂammatory changes are common
(52% in our study) in the absence of gall stones in
healthy asymptomatic population.
P-892
A CASE OF DOUBLE CYSTIC DUCT
D. Lee, H. Woo and K. Song
Sunlin Hospital
Background: Biliary duct anatomy variation is quite
common, but a double cystic duct is extremely rare.
Many laparoscopic cholecystectomies are performed by
surgeons these days, operative biliary complications are
also increasing.
Objective: So, surgeons must know the many possible
anastomic anomalies to minimize the risk of complica-
tions.
Method: A 17-year-old male was admitted to our hos-
pital with abdominal pain in the right upper quadrant
area for one day. Ultrasound and computed tomography
showed diffuse gallbladder wall thickening with multiple
stones. Liver function laboratory values and bilirubin
were within the normal limits, but leukocytoses were
detected. We decided to do laparoscopic cholecystectomy
for treatment. At exploration, one cystic duct was iden-
tiﬁed and clipped and divided. During further dissection
of the Calrot’s triangle, the other separate, additional
tubular structure was detected. Cholangiography
through this structure showed normal ﬁlling of biliary
ducts. The accessory cystic duct was ligated and tran-
sected, and the remainder of the laparoscopic cholecys-
tectomy was performed routinely. The patient was
discharged on the postoperative 7th day and had no
complications.
Result: Gross pathology examination conﬁrmed two
separate cystic ducts exiting the gallbladder with the two
chambers.
Conclusion: We experienced a rare case of double cystic
duct with cholecystolithiasis.
P-893
CILIATED HEPATIC FOREGUT CYST
REPLACING THE GALLBLADDER AND
MIMICKING BILIARY COLIC
H. Sethi, G. Williams and N. Kumar
University Hospital Wales, Cardiff
Background: Ciliated hepatic foregut cysts (CHFC) are
rare, with less than 100 cases reported worldwide since
1857. Despite its congenital nature it presents in the 4th
decade of life. These cysts are usually benign, though
malignant transformation with a fatal course is recogni-
sed.
Aims/Objectives: CHFC though increasingly diagnosed,
there are no reports from the United Kingdom. CHFC
arising within the gallbladder (GB) have been reported,
however, we present an unusual case of a CHFC
replacing the GB.
Methods and results: A 49-year-old female presented
with biliary colic for 2 years. Bloods tests were normal.
Ultrasound, CT and HIDA scan revealed a 18·17 mm
cystic lesion at the porta communicating with the bile
duct with GB not identiﬁed, which was conﬁrmed on
laparoscopy. A thin-walled bilious cyst communicating
with right hepatic duct was excised through a subcostal
incision. Patient was discharged on day four following a
self-limiting bile leak. Histology showed a benign multi-
locular ciliated foregut cyst, no GB identiﬁed. On 8 week
follow-up, she was asymptomatic with normal LFT.
Discussion: The ﬁrst description by Friedreich was fol-
lowed by Eberth in 1866. Wheeler and Edmondson in
1984 ﬁrst used the term ’CHFC’. Commonly located
within segment IV, GB, and segment VIII/V. Infantile
CHFC may have a biliary communication, in adults they
are viscous or mucinous. Radiological scans cannot
accurately diagnose CHFC. FNAC has a positive pre-
dictive value of 76%, and immunohistochemistry is
supportive. Observation, aspiration, sclerotherapy, enu-
cleation, excision and liver resection have been used to
manage these cysts and recent reports suggest laparo-
scopic excision.
Conclusion: CHFC have been increasingly reported in
the last decade, and unusual presentations need to be
highlighted to increase awareness of this condition. Gi-
ven a 3% risk of cancer with biologically aggressive
behaviour, we recommend surgical excision irrespective
of size.
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P-894
THE MANAGEMENT OF
SYMPTOMATIC CHOLELITHIASIS
DURING PREGNANCY
C. Junior Quireze, L. Kenny Morais, V. Simes,
R. Hartmann, F. Sanches Penhavel,
I. Pires de Abreu Neto, H. Ponciano Trevenzol and
E. Allen Marques de Oliveira
Hospital das Clinicas / Federal University of Goia´s School
of Medicine
Background: The management of symptomatic choleli-
thiasis during pregnancy remains controversial. We
compared outcomes after medical versus surgical man-
agement of biliary tract disease in pregnant patients.
Methods: We reviewed the clinical course of patients
with symptomatic cholelithiasis during pregnancy from
April 1998 to December2008 at university hospital.
RESULTS: twenty-six women pregnancies were
admitted with biliary tract disease. Of the 16 women
who presented with symptomatic cholelithiasis, ten
underwent surgery while pregnant. There were no
deaths, preterm deliveries, or intensive care unit
admissions. Six patients were treated medically. Their
clinical courses were complicated by symptomatic in
ten patients (62.5%), and by premature delivery in one
patient. Each relapse in the medically managed group
accounted for an additional ten days in hospital.
Conclusion:
Surgical management of symptomatic cholelithiasis in
pregnancy is safe, decreases days in hospital, and reduces
the rate of labor induction and preterm deliveries.
P-895
OPEN ECHINOCOCCOSIS CAUSING
CHOLANGITIS IN BILE DUCT
M. Pontillo, C. Chambon, P. Lattanzio, G. Rodriguez
and L. Ruso
Hospital Maciel
Introduction: The opening-up and evacuation of hepatic
hydatic cysts to the bile duct, is the most common
complication, after suppuration (5–8%). Different kinds
of obstruction, infeccion and the highest expression of
septic cholangitis are determined by parasite elements.
The bile-quisted ﬁstulae located at the upper bile inter-
section and its branches are associated with bile stenosis
and secondary bile cirrhosis.
There are numerous proceedings of bile-quistic discon-
nection, based on double quistic and bile duct draining
systems.
Objective: Analyze the cholangitis morbid-mortality due
to hidatic cause, treated by means of bilequistic discon-
nection or liver extraction.
Methods and materials: Retrospective descriptive study
of an 11 cases series, cholangitis carriers, with ﬁstulas
larger than 5 mm. Universe of 107 hepatic hydatic cysts,
Hospital Maciel, Montevideo. Period: 1998–2009.
Results: Seven male, four female, between 17 and 63-
years-old (male: 40-years-old). Simple cholangitis clinic.
64% located in right lobe. Proceedings: quist extraction,
quist and adventitia extraction, liver extraction with bile-
quist disconnection by means of bipolar treatment with
independent drain, and single kehr tube.The morbidity
rate was 36%, whereas the mortality was nil.
Conclusion and discussion: The existence of wide bile-
quistic communication determines the VBP obstruction
and the cholangitis, which its seriousness is changeable.
The preoperatory IRM is efﬁcient for the diagnose of
HHQ complications (91%). The intraoperatory cholan-
giographies determine the ﬁstulae characteristics and its
communication. The bile-quistic disconnection is an
essential procedure to avoid bile stenosis and its conse-
quences. The bile duct drain provides of post operatory
control of the bile duct. Morbidity is associated with bile
complications, ﬁnding the solution by min invasive
techniques.
P-896
A CASE OF HUGE ADENOMA OF THE
GALLBLADDER
H. Kano1, T. Oida1, A. Kawasaki1, K. Mimatsu1,
Y. Kuboi1, N. Fukino1, S. Amano2 and T. Takayama3
1Yokohama central hospital; 2Department of surgery,
School of medicine, Nihon-university; 3Department of
digestive surgery, Nihon-university
We report a case of huge adenoma of the gallbladder.
The patient was 78-years-old man, was detected inciden-
tally the lesion during of follow up urinary bladder post
operation. Abdominal ultrasonography demonstrated a
5.0·4.0 cm hyperechoic mass, with small stone. Abdom-
inal computed tomography described 5 cm homogenous
enhancement tumour. The lesion was diagnosed preop-
eratively gallbladder carcinoma. Open cholecystectomy,
liver bed resection, lymph node sampling was performed.
Histologically, the diagnosis was benign adenoma, no
malignancy. This case suggested, there is the huge benign
gallbladder adenoma that is not possible of the distinc-
tion only with size.
P-897
A CASE REPORT OF THE CARCINOMA
IN ADENOMA OF THE INTRAHEPATIC
BILE DUCT
S. Takamatsu, H. Nagano, S. Ootsukasa, Y. Kawachi
and H. Maruyama
Department of Surgery, Musashino Red Cross Hospital
We experienced a relatively rare case of the carcinoma in
adenoma of the intrahepatic bile duct. The patient was a
52-year-old-male without any abdominal symptoms and
he was occasionally pointed out the high level of the
gamma glutamyl transpeptidase in medical check up. On
ultrasonography, the tumour was detected in the left lobe
of the liver, associated with the dilated intrahepatic bile
ducts; therefore, he was referred to our hospital. On
abdominal enhanced computed tomography, the tumour
which showed the expansive growth without invasion to
neither liver parenchyma nor intrahepatic vessels existed
adjacent to umbilical portion and the intrahepatic bile
ducts of segment three and four of the liver were dilated.
In magnetic resonance cholangiopancreatography
(MRCP), intrahepatic bile ducts in the left lobe was
dilated, but both those of the right lobe and common bile
duct were considered to be intact. We performed the left
hepatectomy with lymphadenectomy of the hepatoduo-
denal ligament in August 2009, under the diagnosis of
intrahepatic bile duct carcinoma so called the intraductal
growth type. Postoperative course was uneventful and
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the patient was discharged at postoperative day 10.
Pathologically, although the most part of the tumour
consisted of adenoma, the component of adenocarci-
noma existed in the very small part of the tumour,
therefore, it was diagnosed as the carcinoma in adenoma
of the intrahepatic bile duct.
P-898
CASTLEMAN DISEASE IN THE HEPATIC
HILUM – A CASE REPORT
J. Ferreira1, G. Martins2, M. Epstein2, R. Fischer de
Andrade1, L. Albuquerque1, G. Mendes1, C. Nahime1,
A. Bonadiman1, Y. Calheiros1, J. Alves Jr, R. Machado
and J. R. Farah
1Surgical General Department of Hospital do Servidor
Pu´blico Estadual; 2Universidade Cidade de Sa˜o Paulo
Background: Castleman Disease (CD) is a rare disease
characterized by a lymphoproliferative disorder of un-
known etiology and histopathological diagnosis.
Aim: To report on a rare case of Castleman Disease in
the hepatic hilum.
Case report: A male patient, age 69, was hospitalized
with a complaint of pain in the right hypochondrium,
associated with jaundice, coluria and unquantiﬁed weight
loss. Admission testing indicated total bilirubin of 4.4
and direct bilirubin of 3.0, with alkaline phosphatase of
579 and gamma-glutamyl transferase of 506. CT of the
abdomen showed dilation of the intra- and extra-hepatic
bile ducts and a poorly deﬁned nodule on topography of
the hepatic hilum. Tumour marker Ca 19–9: 3886. Pa-
tient underwent exploratory laparotomy which found a
single enlarged lymph node in the hepatic hilum, gall-
bladder with signs of inﬂammation and pressing on the
main bile duct, and a diagnosis of Type I Mirizzi Syn-
drome was made. A cholecystectomy and removal of the
altered lymph node was performed. Pathology indicated
an acute attack of chronic cholecystitis and hyaline-vas-
cular CD in a lymph node of the hepatic hilum.
Discussion: CD is a lymphoproliferaltive disorder. The
former is benign and the latter pre-malignant may evolve
into lymphoma or Kaposi’s sarcoma. The treatment of
choice is surgical resection for localized disease. For
multicentric disease, treatment is subject to controversy,
and cytoreduction, radiation therapy, and chemotherapy
using various agents such as chlorambucil and melphalan
are all utilized. Anti-CD20 has been used in the treatment
of multicentric CD and is efﬁcacious against systemic
manifestations.
Conclusion: CD has a good prognosis in patients with
the unicentric form, with average survival time of 26
months. The patient is doing well in his 12th postoper-
ative month with periodical hematological follow-up,
abdominal CT and no evidence, to date, of local or sys-
temic recurrence.
P-899
LONG-TERM RESULTS OF
INTERVENTION ON THE SPLEEN
D. Ionkin and Y. Stepanova
A.V. Vishnevsky Institute of Surgery
Aim: To determine the optimal surgical tactics in
patients with the spleen formations taking into account
long-term results.
Methods: Accumulated experience in performing of the
following operations in spleen’s formations: splenectomy
(90), splenectomy with heterotopic splenic tissue auto-
transplantation (30), spleen’s resection (40), body-saving
laparoscopic intervention (29).
In terms of up to 15 years after the operation were
examined 62 patients: 18 bodies-saving operations (I
group), 18 splenectomy with splenic tissue autotrans-
plantation (II group), 35 splenectomy (III group). Given
the most dangerous manifestations of immune deﬁciency
and disorders of hemostasis, we paid special attention on
relevant indicators.
Results: In the study of hemostatic system there were
changes after any kind of interventions. Given the sig-
niﬁcant difference most studied indicators, a signiﬁcantly
higher risk of thrombosis susceptible individuals after
splenectomy. Patients after body-saving operations
should be included in the risk group of thrombosis
(especially after splenic tissue autotransplantation). We
studied 29 indicators of cellular and humoral immunity.
Manifestations of the humoral immunedeﬁciency were
greatest after splenectomy. In patients after splenectomy
revealed clear signs of immunodeﬁciency, after splenic
tissue autotransplantation is noted only a trend for such
changes.
Clinically hyposplenism syndrome was after splenectomy
(88.6%), splenectomy, and splenic tissue autotransplan-
tation (70%), and body-saving operations (22.2%).
In assessing of the life quality used a modiﬁed classiﬁ-
cation Karnofsky, non-speciﬁc SF-36 scale and a linear
analog scale good results marked in 18% in group III, 53
(II), 79% after body-saving operations.
Conclusion: Long-term results of various interventions
on the spleen with formations show undoubted advan-
tage of body-saving operations.
P-900
PORCINE TO HUMAN LAPAROSCOPIC
SPLENIC BIOPSY USING TISSEEL
FIBRIN SEALANT
S. Robinson1, G. Sen1, M Jacob1, R. Saif1, J. Wallis2,
R. Williams3 and S. A. White1
1Department of HPB/Transplant Surgery, Freeman
Hospital, Newcastle upon Tyne, UK; 2Department of
Haematology, Freeman Hospital, Newcastle upon Tyne,
UK; 3Department of Radiology, Freeman Hospital,
Newcastle upon Tyne, UK
Introduction: Haematological malignancies can often
cause diagnostic difﬁculty. In patients with splenomeg-
aly distinction between lymphoid leukaemia, lympho-
mas and haemolytic anaemia can sometimes be
problematic. However when patients have massive
splenomegly biopsies can be associated with signiﬁcant
haemorrhage in X% cases and is not routinely per-
formed. We describe our technique of laparoscopic
splenic biopsies initially developed in a pre-clinical
porcine model to assess the risk of bleeding prior to
translation to the clinical situation.
Methods and results: German Landrace pigs underwent
general anaesthesia. Pneumoperitoneum was achieved
with a 10 mm blunt port at the umbilicus. As this tech-
nique evolved a solitary 5 mm port was placed in the mid
axillary line. Initially ultrasound guidance was used to
avoid direct puncture of a major vascular tributary. An
18 gauge double lumen needle system (Quick core biopsy
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needle, Cook, Europe) was used for three core biopsies of
splenic tissue. Once the biopsies had been performed the
outer lumen was retained for application of TISSEEL
ﬁbrin sealant (Baxter, UK) to occlude the needle tract.
Upon needle withdrawal haemostasis was achieved in all
cases.
Conclusion: Laparoscopic splenic biopsy using a ﬁbrin
sealant to occlude the biopsy tract is a safe technique
which potentially avoids unnecessary splenectomy due to
severe haemorrhage. Furthermore, this technique could
be applied to a percutaneous technique thus avoiding the
need for general anaesthesia.
P-901
SINGLE PORT LAPAROSCOPIC
PARTIAL SPLENECTOMY
J. R. Park1, T. H. Hong1, B. S. Son2, S. J. Kim3,
K. H. Kim4, S. G. Lee1, Y. K. You1, K. H. Lee5,
I. Y. Park2, S. Lee6, D. G. Kim1 and E. G. Kim7
1Seoul St. Mary hospital, catholic medical college, Seoul,
Korea; 2Bucheon St. Mary hospital, catholic medical
college, Bucheon, Korea; 3Daejun St. Mary hospital,
catholic medical college, Daejun, Korea; 4Uijungbu
St. Mary hospital, catholic medical college, Uijungbu,
Korea; 5Incheon St. Mary hospital, catholic medical
college, Incheon, Korea; 6St. Paul hospital, catholic
medical college, Seoul, Korea; 7St. Mary hospital, catholic
medical college, Seoul, Korea
Background: At present, single-port laparoscopic surgery
(SPLS) is in active progress in that it is scarless and good
for cosmetic purposes. SPLS is generally used for
appendectomy or cholecystectomy.
Method: Authors experienced single-port laparoscopic
partial splenectomy of a 20-year-old man with a gigantic
cystic mass at the superior pole of spleen. The patient
incidentally found out an 11 · 9 cm sized cystic mass
from abdominal CT scan and single-port laparoscopic
partial splenectomy was planned. Under general endo-
tracheal anesthesia, the patient was positioned right
down lateral decubitus. The incision was made on his left
upper quadrant of abdomen and pneumoperitoneum was
made with the help of a wound retractor and a rubber
glove. A 10 mm trocar and two 5 mm trocar were placed
at the rubber glove. Instruments used were laparoscopic
camera, laparoscopic liver retractor, reticulating grasper,
dissector, suction/irrigator, cauterization hook, and
ultrasonic dissector, taking turns. Segmental vessels for
upper pole of spleen was identiﬁed and ligated and the
blood ﬂow to upper pole including the cyst was cut off.
At about 1 cm distal to this boundary of the spleen,
where blood ﬂow was shut, cutting was made with
ultrasonic dissector. The resected tissue of the spleen was
put into laparoscopic endo-bag and removed through the
incision. No drain was inserted.
Result: Total operation time was 145 min and the
amount of bleeding was approximately 100 cc. The
patient started to take meals the day after operation and
was discharged from hospital 4 days after the surgery.
Discussion: As the above instance, laparoscopic partial
splenectomy is considered to be effective surgery for huge
cyst in the spleen in that it prevents recurrence and it also
preserves functions of the spleen.
Conclusion:With a method of single-port, cosmetic effect
can be the greatest and surgical injury the least, which
can lead the patient to feel less pain and to return early to
daily life.
P-902
ASEPTIC SPLENIC ABSCESS WITH
BECHCET’S DISEASE CASE REPORT
K. Tezuka, W. Kimura, I. Hirai, T. Ogata, S. Sugawara,
A. Takeshita, M. Mizutani, T. Nomura, H. Isobe,
O. Hachiya and S. Hasegawa
Department of Gastroenterological and General Surgery,
Graduate School of Medicine, University of Yamagata,
Japan
A 51-year-old Japanese man with Behcet’s Disease (BD)
diagnosed about ten years ago was admitted to our
hospital complaining of left upper quadrant abdominal
pain and fever up to 38 that had persisted for one month.
The diagnosis of incomplete BD was based on oral
aphtha, genital ulceration, and acne-like lesions on the
skin of his foot, intestinal ulceration and joint pain
according to the diagnostic criteria of the Behcet’s
Disease Research Committee of Japan. He had a history
of tuberculosis and small intestinal perforation due to
BD. Computed tomography of the abdomen showed
low-density mass lesions with septation in the spleen. The
repeated cultures of the blood and serologic tests for
various pathogens were all negative. CT-guided percuta-
neous aspiration of spleen abscess was performed. The
bacterial and fungal cultures of the ﬂuid were negative.
The polymerase chain reaction (PCR), cultures, and
Ziehl-Neelsen stain of the purulent ﬂuid for mycobacteria
were all negative. Splenectomy was performed due to
repeated fever and recurrent splenic abscess. Pathologi-
cally, diagnosis of aseptic splenic abscess was made. After
splenectomy, his fever has gone down. Aseptic splenic
abscess complicated by Crohn’s disease and Ulcerative
colitis has been known. This is the ﬁrst reported case of
aseptic splenic abscess with Behcet’s Disease.
P-903
HYDATIDOSIS OF THE SPLEE
J-M. Ramia, R. De la Plaza, P. Veguillas, R. Puga,
J. Quin˜ones, V. Arteaga, F. Adel, F. Ruiz and
J. Garcia-Parren˜o
Hospital Universitario de Guadalajara
Splenic hydatidosis (SH) is very unfrequent. Only 0.5 to
8% of the hydatidosis are located in spleen. It could
present isolated or in combination with other organs. We
present our experience in SH and discuss diagnostic
methods and therapeutical options.
Material and methods: Retrospective review (1993–2008).
We have operated six cases of SH, four male and two
female. Mean age was 44.5 years (range: 30–59). Hy-
datidosis was located only in spleen (four), spleen and
liver (one) and spleen, liver and peritoneal (one).
Abdominal ultrasound and CT was performed in every
patient.
Results: Main symptom was abdominal pain. Hydati-
dosis serology was always positive. Abdominal US and
CT conﬁrm SH diagnosis. Every patient had a unique
splenic cyst. Median cyst size was 13.3 cm (range: 7–
18 cm). We performed total splenectomy (ﬁve) and par-
tial cystectomy (one). We also performed a left lateral
sectionectomy in the patient with liver ans spleen cysts,
and a liver subsegment ectomy of segment III, and
multiple cystectomies in the patient with disseminated
hydatidosis. Four patients presented no morbidity; we
observed wound infection (1) (Clavien I) and a cavity
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abscess solved with percutaneous drainage in the patient
with partial cystectomy (Clavien II). There was no mor-
tality in our series. Median stay was 8 days (range: 5–12).
Mean follow up was 98 months (range: 19–190) without
any relapse of SH.
Conclusions: Splenic hydatidosis is unfrequent (isolated
or with infection of other organs).Total splenectomy is
the best treatment because is safe (low morbidity and
mortality), and without relapse. Total cystectomy is a
good option but it is not always feasible and is more
difﬁcult. Non radical surgery is useful in difﬁcult cases.
P-904
SPLENIC METASTASES
S. Mallappa, D. M. and Spalding Pai
Hammersmith Hospital, Imperial College, London, UK
Introduction: Splenic metastases (SM) from non-lym-
phoid tumours are rare, whilst isolated splenic metastases
in the absence of widespread disease are even rarer. Most
reported cases are asymptomatic and the diagnosis is
usually made during routine post-operative follow-up.
The most common primaries are melanoma and carci-
nomas of breast, ovary, pancreas and lung. Due to their
rarity, there are no well-deﬁned guidelines for the role of
resection in this heterogeneous group. The aim of this
study was to assess the aetiology and role of resection in
patients with SM.
Methods: Between 2002–2009, 11 patients with non-
lymphoid splenic metastases were identiﬁed. Their aeti-
ology and management were reviewed retrospectively.
Results: There were seven women and four men of
median age 69 (range 33–86) years. Histology of the
primary malignant neoplasms was colorectal cancer
(CRC) ﬁve, ovarian two, cholangiocarcinoma two, and
one each of prostatic and laryngeal carcinoma. The
median interval between primary diagnosis and SM was
24 (range 0–312) months. All metastases to the spleen
were solitary and mean size was 3.68 cm (SD ± 0.63).
Five patients had metastases to the spleen alone, whilst
three had synchronous liver metastases and three syn-
chronous liver and lung metastases. Two patients
underwent partial splenectomy (ovarian one, CRC one)
and one total splenectomy (ovarian) for their single site
metastases.
Conclusions: With the improvement of radiological
imaging, the prevalence of SM is increasing, thus neces-
sitating the introduction of guidelines for the role of
resection in this heterogeneous group.
P-905
SURGERY OF EXTRA-HEPATIC PORTAL
VENOUS OBSTRUCTION WITH MORE
THAN 10 YEARS FOLLOW UP
R. Desai1, A. Agarwal2, P. Dhar3, A. Sachdev4 and
A. Chaudary5
1Medwin Hospitals, Hyderabad, India formerly GB Pant
Hospital; 2GB Pant Hosptial, New Delhi, India; 3Amrita
Institute of Medical Sciences, Cochin, India formerly GB
Pant Hospital; 4Fortis Hospital, New Delhi, India
formerly GB Pant Hospital; 5Gangaram Hospital, New
Delhi, India formerly GB Pant Hospital
Objective: Extra-hepatic portal vein obstruction is a
common cause of portal hypertension in Indian Children.
Methods: This study is a retrospective review of the
experience in treating Extra-Hepatic Portal Vein
Obstruction in the department from January 1987 to
June 1997 with a minimum of ten year follow up until
2007.
Results: There were 105 patients with EHPVO- of
whom 73 were males and 32 were females. The etiology
of EHPVO could not be identiﬁed in 94% of cases
including adults with EHPVO.A Proximal Spleno-renal
shunt was done in 74, a Splenoadrenal vein shunt in
four, a Distal Splenorenal shunt in seven, a Mesocaval
shunt in one and a Splenectomy alone in three. Only
splenectomy was done in three for signiﬁcant intra-
operative bleeding. Of these three one died, a devascu-
larisation in one and sclerotherapy to eradicate varices
in one. Primary Devascularisation was done in eighteen;
seven being rescue of patients with a lienorenal shunt;
one for post-operative bleed, two for a dysfunctional
shunt on table and Shunt thrombosis in four individu-
als. One patient developed hypoxic encephalopathy
following post-operative intra-peritoneal bleed. In one
patient with a mistaken diagnosis of Non-cirrhotic
portal ﬁbrosis packing was done to secure hemostasis
from massive bleeding from the porta hepatis.There
were no shunt thrombosis on long term follow-up upto
2007 nor were there recurrent GI bleeds. There was no
evidence of clinical encephalopathy in this patient
population on long term follow-up.
Discussion: In conclusion, PSRS done early in the course
of treatment of EHPVO results in satisfactory control of
recurrent bleed, cures patients with low long term mor-
bidity and mortality. Devascularisation or mesocaval
shunt are viable alternatives when PSRS is either not
possible or fails.
P-906
A CASE OF THE RIGHT TRI-
SEGMENTECTOMY OF THE LIVER
USING ANTERIOR APPROACH
TECHNIQUE FOR HUGE HEPATIC
TUMOR
S. Katagiri, Y. Kotera, Y. Takahashi, T. Kato,
J. Takasaki, K. Kitagawa, S. Ariizumi and
M. Yamamoto
Department of Surgery, Institute of Gastroenterology,
Tokyo Women’s Medical University
The patient is 37-year-old man without hepatitis. CT
scan shows very huge tumor of 25 cm in diameter at the
right lobe. We diagnosed hepatocellular carcinoma with
portal vein tumor involvement at the pre-operation. We
proceed to the J-shaped incision. We could not perform
the glissonean pedicle transection method because of the
huge tumor invaded the hepatic hilus and portal vein.
And, the varices of hepato-duodenal ligament were
severe. The varices were caused to obstruction of portal
vein tumor involvement. We performed the right tri-
segmentectomy of the liver using anterior approach
technique.
In extended right lobectomy, mobilization of the right
lobe is very difﬁcult and sometimes dangerous because of
the possibility of massive bleeding. And there is a great
danger of intraoperative dissemination of tumor cells.
Therefore, the liver dissection must be done without
mobilization, using the non-touch isolation technique.
The procedure referred to as the anterior approach
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technique. The resection begins from the anterior surface
of the liver and extends to the vena cava.
Histopathologically, the tumor was a liver carcinoid of
diameter 25 cm in the right lobe. The specimen weight
was 4 kg. This case presents an extremely rare liver
tumor. And the right tri-segmentectomy, this procedure
is usually done by the anterior approach.
P-907
COMBINED LAPAROSCOPIC
ABDOMINOPERINEAL AND LIVER
RESECTION FOR PRIMARY RECTAL
CANCER WITH SYNCHRONOUS LIVER
METASTASES: CASE REPORT.
C. Efthimiadis1, C. Kosmidis1, G. Anthimidis1,
M. Grigoriou1, K. Vasiliadou1, A. Ioannidis1, S. Baka2
and G. Basdanis1
1Department of Surgery, Interbalkan European Medical
Center, Thessaloniki, Greece; 2Department of Oncology,
Interbalkan European Medical Center, Thessaloniki,
Greece
Background: The optimal surgical strategy for the
treatment of synchronous resectable rectal liver metas-
tasis remains controversial. Laparoscopic combined co-
lon and liver resection emerges as an appealing option.
Aim: The aim of this study is to present a case of a 70-
year-old female with rectal cancer metastatic to the left
lateral segment of the liver.
Methods: The patient underwent laparoscopic abdomi-
noperineal resection and left lateral hepatic segmentect-
omy in a single operation.
Results: The operation was completed laparoscopically
in 250 min. No major intraoperative or postoperative
complication was encountered. The length of hospital
stay was 5 days. The patient received adjuvant che-
motherapy for six months (FOLFOX 4). Twelve months
postoperatively the patient remains free of disease.
Discussion: Laparoscopic combined abdominoperineal
and hepatic resection is a feasible, efﬁcient and safe
procedure for the treatment of primary rectal cancer with
resectable synchronous liver metastases. By avoiding a
second operation and laparotomy overall, the complica-
tion rate may be reduced, with shorter treatment time
and satisfactory cancer outcomes.
P-908
DISTAL PANCREATECTOMY FOR A
BENIGN APPEARING TUMOR AND
LOCAL RECURRENCE: LAPAROSCOPIC
APPROACH
C. Kosmidis1, C. Efthimiadis1, G. Anthimidis1,
M. Grigoriou1, K. Vasiliadou1, E. Toulis2, S. Baka3,
K. Papapolyxroniadis1 and E. Fahantidis1
1Department of Surgery, Interbalkan European Medical
Center, Thessaloniki, Greece; 2Department of Internal
Medicine, Interbalkan European Medical Center,
Thessaloniki, Greece; 3Department of Oncology,
Interbalkan European Medical Center, Thessaloniki,
Greece
Background: Laparoscopic distal pancreatectomy (LDP)
has become an increasingly used technique in the surgical
treatment of several pancreatic diseases.
Aim: We present herein a case of a patient who under-
went total LDP for a benign appearing tumor in the tail
of the pancreas that proved to be malignant. Local
recurrence was conﬁrmed laparoscopically.
Methods: A 72-year-old male patient, which had under-
gone transurethral resection of prostate 14 years ago,
was followed up with computed tomography (CT) which
revealed a lesion in the tail of the pancreas. Preoperative
evaluation led to the possible diagnosis of mucinous
cystic neoplasm. Laparoscopic distal pancreatectomy
was performed. The histology was consistent with pan-
creatic pseudocyst adjacent to moderately differentiated
ductal adenocarcinoma. Resection margins were nega-
tive. No metastasis was found in eight resected peripan-
creatic lymph nodes. The patient received adjuvant
chemotherapy (gemcitabine). One year after the opera-
tion the follow up CT revealed a mass in the resection
bed. The patient was subjected to laparoscopy; the dis-
ease precluded surgical resection and tissue sample was
obtained for biopsy, which conﬁrmed tumor recurrence.
The patient received chemotherapy for six months (XE-
LOX: capecitabine-oxaliplatine).
Results: Postoperative recovery was uneventful and the
patient remained asymptomatic 18 months after the ﬁrst
operation. Local recurrence was conﬁrmed by laparo-
scopic exploration and biopsy.
Discussion: Our case conﬁrmed the feasibility of LDP in
the treatment of pancreatic tumors. However, the fact
that local recurrence occurred 12 months postoperatively
indicates that case selection is crucial. Laparoscopic ex-
ploration conﬁrmed tumor recurrence and spared the
patient a pointless laparotomy.
P-909
THE CLINICAL VALUES OF
METHYLATION STATUS OF P16 APC
GENES IN BILE IN DIAGNOSIS OF
MALIGNANT OBSTRUCTIVE JAUNDICE
X.-Y. Yin, G. Yan, J.-X. Peng and L.-J. Liang
Department of Hepatobiliary Surgery, The First Afﬁliated
Hospital, Sun Yat-Sen University, Guangzhou, China
Background: Preoperative deﬁnitive diagnosis of malig-
nant obstructive jaundice caused by biliary and pan-
creatic carcinomas still remains a major challenge.
Hypermethylation of tumor suppressor genes have been
implied in carcinogenesis of biliary and pancreatic ma-
lignancies. The diagnostic values of methylation status of
tumor suppressor genes in bile in malignant obstructive
jaundice have not been well-documented.
Aims: The present study aimed at evaluating the diag-
nostic values of methylation status of P16 and APC genes
in bile in malignant obstructive jaundice.
Methods: Bile was prospectively collected from 70 pa-
tients with obstructive jaundice treated at our hospital
between November, 2008 and September, 2009. Forty-
eight of them were proved to be malignant obstructive
jaundice (biliary carcinoma in 36, pancreatic carcinoma
in 8 and duodenal carcinoma in 4) by pathological ex-
amination, and 22 were benign obstructive jaundice
caused by cholelithiasis. DNA was extracted from bile
and modiﬁed by sodium bisulﬁte. Methylation-speciﬁc
PCR was run to detect methylation status of P16 and
APC gene promoters. Their diagnostic values in malig-
nant obstructive jaundice were assessed.
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Results: Hypermethylation of P16 promoter was pre-
sented in 72.9% (35/48) malignant obstructive jaundice,
and 9% (2/22) benign obstructive jaundice (P < 0.05).
Hypermethylation of APC promoter was presented in
56.2% (27/48) malignant obstructive jaundice, and 9%
(2/22) benign obstructive jaundice (P < 0.05). With re-
spect to their diagnostic values in malignant obstructive
jaundice, sensitivity, speciﬁcity, positive predictivity and
negative predictivity were 72.9%, 90.9%, 94.6% and
60.6%, respectively, for P16 gene; 56.2%, 90.9%, 93.1%,
48.8%, respectively, for APC gene.
Conclusions: Methylation status of P16 and APC gene
promoters in bile was valuable in diagnosis of malignant
obstructive jaundice, with an excellent speciﬁcity. P16
gene had a higher sensitivity than APC gene.
P-910
USEFULNESS OF GENETICALLY-
MODIFIED LIGHT-EXPRESSING
HEPATOCELLULAR CARCINOMA
CELLS AS TUMOR VACCINES
X.-Y. Yin, Y. Wang, X. Hou, L.-J. Liang and M.-D. Lu
Department of Hepatobiliary Surgery, The First Afﬁliated
Hospital, Sun Yat-Sen University, Guangzhou, China
Background: LIGHT is one member of TNF superfamily
(TNFSF14). Physiologically it is mainly expressed on
immune cells, and induces maturation of dendritic cells,
promotes activation and expansion of T lymphocytes,
enhances secretion of various cytokines and triggers cell
apoptosis. LIGHT has been shown to play an important
role in eliciting anti-tumoral immunity. However, the
usefulness of LIGHT-expressing tumor cells as vaccine
has not been well-documented.
Aims: To investigate the values of genetically-modiﬁed
LIGHT-expressing hepatocellular carcinoma (HCC) as
tumor vaccine against HCC.
Methods: Stable LIGHT-expressing murine HCC cell
line Hepa1-6 (Hepa-LGH) and blank plasmid-trans-
fected Hepa1-6 (Hepa-NEO) was generated by plasmid-
mediated gene transfection and G418 selection. The in-
activated Hepa-LGH, Hepa-NEO and Hepa1-6 were
inoculated subcutaneously on C57Bl/C mice as tumor
vaccines, and their efﬁcacies against the subsequent
subcutaneous re-challenge of Hepa1-6 were evaluated
and compared. The speciﬁc cytotoxicity of splenocytes
from the vaccinated mice against Hepa1-6 was assessed
using LDH release assay in vitro.
Results: The re-challenged Hepa1-6 grew much smaller
on the Hepa-LGH vaccinated mice than that on the
Hepa-NEO and Hepa1-6 vaccinated mice (P < 0.05),
and the tumor size on the latter two groups had no sig-
niﬁcant differences (P > 0.05).The Hepa-LGH vacci-
nated mice survived much longer than Hepa-Neo and
Hepa1-6 vaccinated mice, with a median survival time of
81days, 45days and 41days, respectively (P < 0.01).
Splenocytes from the Hepa-LGH had greater cytotoxi-
city against Hepa1-6 than those from the Hepa-NEO and
Hepa1-6 vaccinated mice (P < 0.05).
Conclusions: The inactivated genetically-modiﬁed
LIGHT-expressing HCC cells could elicit speciﬁc anti-
tumoral immunity in mice, and effectively protect the
mice from HCC.
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